count	word
8933	©
7940	cells
6165	expression
5833	cell
5301	increased
5057	also
4577	mice
4570	results
4262	levels
4235	protein
4180	activity
4131	rats
3874	study
3666	showed
3654	effect
3653	effects
3556	observed
3538	may
3402	induced
3318	role
3287	using
3203	present
3133	reduced
3122	response
3120	control
3092	treatment
2965	different
2890	increase
2871	associated
2838	gene
2775	compared
2762	insulin
2718	human
2718	two
2635	however,
2606	found
2520	elsevier
2442	production
2407	used
2329	presence
2326	data
2322	high
2316	important
2270	higher
2257	significantly
2239	patients
2213	immune
2190	±
2175	2
2141	activation
2132	suggest
2123	involved
2107	inflammatory
2094	receptor
2083	well
2074	cells.
2048	blood
2036	decreased
2030	1
2019	group
2010	rights
1976	analysis
1941	=
1938	significant
1938	reserved.
1911	t.
1866	genes
1864	glucose
1862	animals
1831	dna
1824	changes
1800	responses
1746	studies
1733	investigated
1730	development
1729	proteins
1728	several
1723	evaluated
1711	one
1679	tissue
1665	could
1651	isolated
1642	acid
1640	mechanisms
1639	specific
1618	acute
1615	mrna
1609	new
1605	infection
1582	muscle
1576	strains
1571	show
1571	treated
1568	samples
1564	number
1526	tumor
1522	p.
1520	similar
1520	rats.
1508	h
1475	
1464	first
1453	detected
1437	species
1437	three
1423	disease
1423	neurons
1417	cells,
1417	growth
1406	chronic
1400	factor
1385	days
1373	related
1364	whereas
1355	serum
1354	rat
1352	mice.
1349	study,
1344	inc.
1339	inhibition
1337	caused
1335	molecular
1334	male
1330	indicate
1329	potential
1326	plasma
1307	reduction
1302	revealed
1299	type
1288	resistance
1275	function
1274	<
1269	clinical
1266	obtained
1265	antibodies
1263	findings
1256	vitro
1250	low
1234	ltd.
1230	shown
1226	groups
1224	although
1223	among
1222	infected
1216	system
1204	demonstrated
1194	(p
1181	model
1181	isolates
1174	lower
1156	identified
1155	including
1140	central
1136	presented
1132	macrophages
1130	either
1129	expressed
1124	renal
1121	parasite
1119	et
1118	total
1118	lung
1117	cruzi
1107	due
1101	results:
1099	3
1096	experimental
1096	known
1079	signaling
1078	decrease
1069	release
1063	produced
1060	time
1058	suggesting
1042	rate
1042	addition,
1041	nitric
1037	10
1028	major
1027	performed
1026	vascular
1023	vivo
1023	venom
1020	nucleus
1014	inhibited
1011	secretion
1009	receptors
1006	whether
1006	investigate
1001	use
999	previously
976	positive
975	studied
973	antibody
970	determined
970	synthesis
968	concentrations
964	cellular
963	copyright
959	ii
959	oxide
957	4
957	+
954	without
953	evaluate
951	following
949	within
948	american
939	inflammation
938	characterized
936	able
935	genetic
935	exercise
934	intracellular
933	evidence
933	content
929	mouse
922	pathway
917	b.v.
912	concentration
904	membrane
901	analyzed
900	brain
896	b
895	mechanism
894	tested
890	measured
890	moreover,
889	methods:
889	recombinant
886	exposure
882	injection
881	body
881	normal
877	administration
865	wistar
860	early
860	society
855	differences
854	respectively.
850	functional
849	diabetic
848	main
835	four
834	aim
830	based
830	adult
830	sequence
827	surface
827	malaria
824	inhibitor
823	cancer
822	host
820	induce
819	5
816	bacterial
815	possible
814	region
813	day
810	liver
809	fatty
801	factors
792	al.
787	cardiac
787	binding
785	strain
780	association
779	metabolic
777	enhanced
776	p
772	peptide
765	ability
757	thus,
757	therefore,
754	activity.
751	rats,
751	via
751	since
747	melatonin
746	test
746	therapeutic
744	single
743	described
742	pressure
736	peripheral
730	regulation
729	oxidative
726	adipose
724	l.
723	enzyme
722	mice,
719	stress
719	complex
717	absence
717	play
717	many
716	weight
715	proliferation
712	female
711	bone
711	plasmodium
710	physiological
709	skeletal
708	might
706	24
706	sequences
704	training
701	here,
698	mass
697	respiratory
695	highly
695	induction
692	acids
690	collected
689	affect
687	cytokine
685	heart
681	contribute
679	virus
678	coli
678	increases
678	containing
677	demonstrate
673	protective
672	mediated
672	followed
672	healthy
671	phosphorylation
671	furthermore,
671	brazilian
669	oral
667	lesions
666	active
663	action
663	reported
662	novel
662	6
660	mitochondrial
658	assessed
657	local
655	antigen
652	exhibited
652	confirmed
651	alterations
650	cytokines
648	drug
648	trypanosoma
647	distinct
646	lipid
644	key
644	vaccine
642	previous
641	effective
641	parasites
639	metabolism
637	small
637	examined
636	biological
634	provide
633	systemic
632	mainly
631	distribution
624	part
623	impaired
621	c
620	leptin
618	activities
618	infection.
617	primary
614	responsible
613	formation
613	endothelial
610	indicating
607	target
607	stimulation
607	area
605	conclusion,
604	addition
603	peptides
603	order
602	less
601	amino
601	sensitivity
600	pathways
598	process
598	reaction
598	macrophage
595	kinase
595	influence
592	interaction
591	resulted
590	-
590	animals.
589	method
588	cause
586	pcr
586	induces
585	group.
585	skin
583	per
582	transcription
581	molecules
581	gondii
580	regions
579	indicated
579	apoptosis
578	ph
578	determine
578	pattern
576	level
576	diet
574	severe
573	and/or
572	phase
570	inhibitory
568	work
568	dose
566	lymphocytes
565	received
565	change
565	thyroid
564	neutrophils
562	developed
562	profile
561	report
561	&
560	neutrophil
559	background:
556	affected
555	levels.
555	regulatory
554	suggests
553	conclusions:
550	recent
550	treatment.
550	large
549	extracellular
547	conclusion:
547	considered
547	7
547	loss
547	synthase
546	30
545	conditions
544	allergic
543	essential
543	groups.
543	assay
542	(n
542	death
542	infections
542	survival
541	2012
541	leishmania
540	upon
539	tnf-α
536	parameters
536	oxygen
536	contrast,
536	ifn-γ
532	types
530	vivax
529	tissues
527	common
525	hormone
525	values
524	natural
524	injected
524	mean
523	areas
523	exposed
522	water
521	genome
520	nuclear
519	a.
517	2017
517	damage
516	direct
515	stimulated
515	diabetes
514	food
514	lps
513	2013
513	animal
512	therapy
512	superoxide
511	basal
510	involvement
510	energy
509	methods
508	2010
507	brazil.
506	sodium
506	uptake
506	c.
506	wiley
505	pancreatic
501	disease.
501	peritoneal
500	activated
500	e.
500	cytotoxic
499	submitted
499	de
498	2014
498	chain
497	activity,
497	least
497	dependent
497	frequency
496	despite
496	12
496	detection
494	understanding
493	population
492	rna
491	capacity
490	2011
490	structure
490	hypothalamic
488	still
487	thus
487	immunity
486	modulation
486	migration
483	neuronal
482	igg
480	mg
480	susceptible
479	doses
479	compounds
478	s.
477	2016
477	derived
476	suggested
475	increasing
472	components
472	generation
471	b.
470	plays
470	even
469	expression.
468	15
468	bacteria
467	investigated.
467	lines
466	leading
464	patients.
462	purified
462	adhesion
459	fungal
458	collagen
457	source
457	western
457	science
457	resistant
456	necrosis
456	transmission
455	14
455	innate
454	expression,
454	2008
454	improved
452	cd8+
451	2009
451	differentiation
450	and,
450	enzymes
448	response.
447	culture
446	escherichia
446	antagonist
443	m.
443	taken
442	reactive
442	diseases
442	electron
442	immunized
441	importance
441	properties
440	risk
439	correlated
439	ratio
438	il-10
437	fed
437	pulmonary
437	individuals
436	2007
435	experiments
435	better
434	2018
433	susceptibility
432	greater
432	causes
432	nerve
431	analyses
431	murine
430	anti-inflammatory
429	2006
429	antigens
428	intestinal
428	lateral
427	mm
427	selected
427	light
427	arterial
427	falciparum
426	flow
425	partially
425	observed.
424	respectively,
423	sites
423	produce
423	elevated
422	together,
422	correlation
421	drugs
421	form
420	controls
419	subunit
419	20
418	proximal
418	brazil
417	weeks
416	accompanied
416	aimed
416	injury
416	various
416	generated
416	species.
416	accumulation
415	2015
414	society.
414	prevented
414	multiple
413	8
412	supplementation
410	kidney
410	identify
409	min
409	responses.
408	protection
408	cycle
406	50
406	cd4+
404	likely
403	selective
403	(10
402	l-name
401	ang
401	negative
401	system.
401	cultured
400	modulate
400	t3
399	altered
399	required
398	probably
398	vs.
398	fat
397	assays
397	showing
397	complement
396	abolished
396	period
396	forms
396	mesenteric
395	impact
394	given
394	diversity
394	health
393	markers
391	microscopy
391	combined
390	support
390	μm)
390	levels,
389	six
389	structural
388	encoding
387	calcium
387	immunization
386	production.
386	leukocyte
386	strong
385	blocked
385	models
384	marked
384	result
383	transport
383	little
382	information
382	state
381	led
379	inhibitors
379	review
378	oxidase
378	salivary
376	endogenous
376	phylogenetic
376	extract
375	carried
375	cases
374	patterns
374	balb/c
374	children
373	range
373	five
372	rates
372	brazil,
372	functions
371	displayed
371	putative
370	represent
369	processes
369	site
367	maternal
366	administered
365	ros
365	cardiovascular
364	current
364	glut4
363	critical
363	n
362	populations
361	hypertensive
361	dogs
361	behavioral
360	family
360	islets
358	100
358	that,
358	sympathetic
357	polymerase
357	according
357	resulting
356	epithelial
356	nervous
356	obese
354	difference
354	0.05).
354	spleen
353	c57bl/6
352	markedly
352	maximal
352	comparison
352	viral
351	combination
351	complete
350	stages
350	located
350	sera
350	expressing
350	spp.
349	additional
349	modified
348	leads
348	relative
346	matrix
345	behavior
345	challenge
344	agent
343	published
343	controls.
342	subjects
342	rapid
341	directly
341	particularly
341	interactions
341	products
340	function.
339	completely
339	approach
338	incubation
338	additionally,
338	inhibit
338	rtn
337	hypothesis
337	conclude
337	biochemical
337	dorsal
336	days.
336	along
336	tolerance
336	attenuated
336	strongly
335	g
334	(1
334	identification
333	distributed
333	elicited
332	hand,
332	agents
331	lead
331	long-term
331	toxin
330	promoted
330	infection,
330	inflammation.
330	prevalence
329	finally,
329	especially
329	strains.
329	repair
329	pro-inflammatory
328	60
328	pathogenic
327	plus
327	density
326	nf-κb
326	fibers
326	memory
325	wild
325	reactivity
325	periodontal
324	regarding
324	circulating
324	recently
324	improve
323	conditions.
323	remains
323	independent
323	throughout
323	environmental
322	distal
321	tumour
320	pharmacological
320	mutations
320	seen
320	dcs
320	il-6
319	ethanol
319	describe
319	would
318	×
318	morphological
318	subjected
318	component
317	line
317	whole
317	shows
317	useful
316	free
316	alternative
316	pain
315	divided
315	springer
314	group,
314	dendritic
313	sensitive
313	dysfunction
313	wild-type
313	48
313	together
312	assess
312	provided
312	systems
312	occurred
312	lack
312	pathogenesis
312	targets
312	airmax
311	h.
311	physical
311	injections
311	laser
311	evaluated.
311	neural
310	lymphocyte
309	toxic
308	hours
308	features
308	trained
307	relationship
307	mammalian
307	incubated
306	soluble
306	oxidation
305	reduce
305	numbers
305	size
305	phenotype
305	muscles
305	glutamine
304	develop
304	medium
304	available
303	nadph
303	john
302	tyrosine
301	underlying
301	second
300	daily
300	highest
300	airway
300	nos
299	animals,
299	plant
299	lymph
299	mutant
298	hypertension
298	age
298	objective:
297	blockade
297	occurrence
297	seems
296	quantitative
296	cultures
295	fluid
295	reducing
295	gland
294	μm
293	angiotensin
293	regulate
293	times
293	class
293	medial
292	activation.
292	aspects
292	chemical
291	potent
291	diagnosis
291	intense
290	contributes
290	intake
290	diseases.
290	nucleotide
289	effect.
289	affects
289	hepatic
288	recovery
288	last
288	restored
288	recognized
287	treatment,
287	phagocytosis
286	possibly
286	mediators
285	mononuclear
285	conserved
283	relevant
283	brasiliensis
283	implicated
283	research
282	macrophages.
281	virulence
280	signal
280	considering
280	0.05)
280	south
279	molecule
279	development.
279	são
278	alter
278	events
277	bicarbonate
277	field
277	secondary
276	established
276	genomic
276	months
275	compound
275	saline
275	obesity
275	years
274	occur
273	progression
273	structures
273	authors.
273	fa
273	proposed
272	shr
272	proteins,
272	regulated
272	vs
272	initial
272	characteristics
272	wt
271	approximately
271	differential
271	understand
270	detect
270	characterization
270	roles
270	antioxidant
269	transfer
268	alone
268	μg
268	domain
267	limited
266	contribution
266	index
266	(no)
265	amount
265	real-time
265	reversed
265	consistent
265	mast
265	sedentary
264	ca2+
264	vector
263	open
263	effects.
263	capable
263	2005
263	production,
263	strategies
262	promising
262	remained
262	disease,
262	interestingly,
261	prior
261	seven
261	protein,
261	retinal
260	pathway.
260	yeast
260	profiles
259	luminal
259	act
259	soleus
258	objective
258	proinflammatory
258	invasion
258	acetylcholine
258	bay
257	process.
257	widely
257	efficient
257	unknown.
257	airmin
256	oil
256	infiltration
255	participation
255	knowledge
255	subunits
255	aortic
255	monoclonal
255	efficacy
255	incorporation
254	end
254	poorly
254	syndrome
254	work,
254	>
254	n.
253	humans
253	express
253	genetically
253	gastric
253	genus
253	transcriptional
252	dose-dependent
252	occurs
252	linked
252	adjuvant
252	effector
252	incidence
251	left
251	tissue.
251	autoimmune
251	placental
250	inhibits
250	necessary
250	immunohistochemistry
250	red
250	temperature
250	pineal
249	species,
249	maintenance
249	extracts
249	groups,
249	analysis.
249	frequently
249	e
248	secreted
248	actions
248	impairment
247	involving
247	applied
247	system,
247	nuclei
246	atp
246	control.
246	sequencing
246	visual
245	vitro.
245	b1
245	affecting
245	fraction
245	days,
245	standard
245	deficiency
245	response,
245	licensee
245	11
244	activation,
244	point
244	adaptive
244	t-cell
244	chromatography
244	ventral
243	modulates
243	released
243	laboratory
243	1,
242	long
242	inos
241	cd4
241	corresponding
241	plasmid
240	indicates
240	substrate
240	50%
240	variety
240	inflammation,
240	2004
239	model.
239	apoptotic
238	beneficial
238	cytotoxicity
237	application
237	us
237	2,
237	evaluation
237	inducing
236	offspring
236	phosphate
236	promote
236	cutaneous
235	rabbit
235	composed
235	glutamate
234	another
234	liquid
234	composition
234	layer
234	characterize
234	18
234	treatments
233	appears
233	cholesterol
233	strategy
232	contains
232	status
232	reproductive
231	late
231	antimicrobial
230	reduces
230	restricted
230	vivo.
230	international
230	pregnancy
230	restriction
230	challenged
230	staining
230	motor
230	bothrops
229	general
229	means
229	fish
229	moderate
229	isolate
229	il-1β
228	1.
228	degree
228	patients,
228	included
228	methyl
228	contraction
227	involves
227	fully
227	methods.
227	(c)
227	leukocytes
226	25
226	subcutaneous
226	symptoms
226	public
226	hypertrophy
225	stage
225	terms
225	solution
225	prevent
225	amounts
225	failed
225	mg/kg
225	set
225	discuss
225	histological
225	groups:
225	leishmaniasis
225	white
224	immunohistochemical
224	studied.
224	infectious
224	patient
224	life
224	protocol
223	decreases
223	reference
223	unique
223	interleukin
223	typical
223	proteins.
222	cortical
222	cyclic
222	concluded
222	2.
222	conventional
222	lungs
222	presents
222	neonatal
222	nucleus,
221	secretory
221	analysed
221	)
221	raised
221	basis
221	isolation
221	lesion
221	21
221	platelet
221	mutation
220	tool
219	young
219	genotypes
219	marrow
219	reveal
219	contrast
219	females
218	tubular
218	conditions,
218	transporter
218	maximum
218	subsequent
218	strains,
218	9
218	neurons.
218	toxicity
218	genes,
218	conducted
218	aged
218	periodontitis
218	gh
217	explain
217	spinal
216	(100
216	native
216	extent
216	therefore
216	maintained
216	depletion
216	performance
216	approaches
215	much
215	provides
215	cdna
215	specificity
214	volume
214	yet
214	appear
214	ovalbumin
213	activate
213	assay.
213	mortality
213	delivery
213	tests
213	labeled
212	technique
212	future
212	fluorescent
212	hormones
212	permeability
212	made
211	across
210	versus
210	relation
210	hypothalamus
210	developing
210	inoculated
210	kda
210	mycoplasma
209	agonist
209	infections.
209	residues
209	genotype
209	biosynthesis
208	infusion
208	homeostasis
208	variation
208	partial
208	synthetic
208	th1
208	reactions
208	employed
208	snake
207	overall
207	cortex
207	toward
207	reverse
207	indirect
207	situ
207	pregnant
207	glycogen
207	relaxation
206	responses,
206	projections
205	h,
205	include
205	mucosal
205	science+business
205	immunological
205	inducible
205	stem
205	fever
204	disorders
204	influx
204	analyze
204	receptors.
204	formed
204	percentage
204	pretreatment
203	determined.
203	failure
203	university
203	neither
203	genes.
203	spectrometry
203	improvement
203	feeding
202	nm
202	eight
202	3.
202	plants
202	viability
202	deficient
201	represents
201	tissues.
201	(5
201	blot
201	+/-
201	intraperitoneal
201	selection
201	crucial
201	immunoreactivity
201	bat
200	sham
200	purpose
200	ester
200	pathogen
200	venoms
199	fluorescence
199	almost
199	added
199	diverse
199	phagocytic
199	circadian
199	muscle.
198	40
198	secretion.
198	possibility
198	case
198	transcripts
198	leucine
198	autonomic
197	stationary
197	ion
197	modulating
197	perfused
197	removal
197	individual
197	degradation
197	hyperalgesia
197	vaccines
196	regulates
196	hydrogen
196	intact
196	mm)
196	recovered
196	anterior
196	variable
196	mature
196	recruitment
196	protein.
196	mg/kg)
196	tract
196	tick
196	viruses
195	largely
195	used.
195	th2
195	consumption
195	defined
195	16
195	trypanosomes
195	promoter
195	tumors
194	marker
194	rrna
194	death.
194	author(s).
194	samples.
194	women
194	lipopolysaccharide
194	aorta
194	proportion
193	(1)
193	close
193	european
193	igg1
193	glutathione
192	diminished
192	control,
192	particular
192	recognition
192	gel
192	period.
192	lactate
192	toxoplasma
191	remain
191	potentially
191	stable
191	later
191	week
191	towards
190	reabsorption
190	transient
190	causing
190	specifically
190	receptors,
190	differ
190	polymorphism
190	tlr4
190	biomed
190	fetal
190	around
189	modulated
189	4.
189	media
189	allowed
189	often
189	knockout
189	macrophages,
189	smooth
188	vehicle
188	carcinoma
188	il-4
188	deletion
188	responsiveness
188	prostaglandin
188	amplification
188	overexpression
188	bilateral
187	background
187	springer-verlag
187	balance
187	bovine
187	need
187	exhibit
187	tnf-α,
187	sensitization
187	pathological
187	injury.
187	region.
187	caninum
186	channels
186	internal
186	length
186	network
186	short
186	signals
186	great
186	mitochondria
186	gene.
186	processing
186	humans.
185	clearly
185	ova
185	onset
185	morphology
185	ko
184	spontaneously
184	channel
184	adenosine
184	majority
184	course
184	affinity
184	sp.
184	triggered
184	controlled
184	clear
184	bronchoalveolar
184	paf
184	function,
183	enzymatic
183	glucose,
183	repeated
183	optic
183	fos
182	display
182	environment
182	certain
182	suppression
182	formulations
182	adherence
182	lavage
182	also,
182	glands
182	named
182	toxins
181	tubule
181	urinary
181	nature
181	inhibitor,
181	microbial
181	analysis,
181	organization
181	contained
181	trophoblast
181	targeting
180	regulating
180	determination
180	exogenous
180	resistance.
180	high-fat
179	cytosolic
179	propose
179	ltd
179	sons
178	results.
178	ca
178	microbiology.
178	oedema
177	catalytic
177	(a
177	13
177	already
177	severity
177	elements
177	reports
177	gene,
177	mechanical
177	actin
177	clones
176	understood.
176	value
176	wide
176	maturation
176	fragment
176	pge2
176	fiber
175	pathway,
175	mediate
175	involve
175	myd88
175	cytokines,
175	il-6,
175	scanning
175	paulo
175	formulation
174	article
174	perfusion
174	ranging
174	state,
174	prevalent
174	promotes
174	asthma
174	r.
174	intermediate
174	challenge.
174	titers
174	sensitized
173	nhe3
173	access
173	baseline
173	contain
173	microscopy.
173	content,
173	cd8
173	except
173	help
173	chromosome
173	weight,
173	global
172	mostly
172	fungi
172	evoked
172	sensory
172	akt
171	acidification
171	pd
171	receiving
171	nevertheless,
171	numerous
171	iii
171	coding
171	adipocytes
171	cox-2
170	discussed.
170	techniques
170	condition
170	dehydrogenase
170	pathogens
170	confirm
170	classical
170	usually
170	acquired
170	fractions
170	stimulus
170	paw
170	ganglion
169	depends
169	metabolism,
169	prolonged
169	controlling
169	ige
169	good
169	2003
168	hypothesized
168	activates
168	progressive
168	parallel
168	side
168	(2)
168	currently
168	pathways.
167	grown
167	augmented
167	compare
167	quantification
167	similarity
167	amplified
167	tropical
167	mutants
167	stimuli
167	nine
167	study.
167	visceral
167	spatial
167	chick
166	rapidly
166	untreated
166	closely
166	endemic
166	herein
166	time,
166	frequent
166	iron
166	malaria.
165	like
165	achieved
165	expansion
165	shift
165	differentially
165	publishing
165	classified
165	antibodies.
165	seem
165	homologous
165	edema
164	rise
164	,
164	latter
164	examine
164	lines.
164	endophytic
164	variability
164	candida
164	intensity
164	third
164	lineages
164	candidate
164	chagas'
164	map
164	diets
164	venom.
163	metabolism.
163	rt-pcr
163	2)
163	participate
163	injection.
163	belonging
163	contributing
163	3,
163	peak
163	parasites.
163	alleles
163	synthesized
163	quality
163	melanoma
163	graft
162	original
162	protease
162	-1
162	area,
162	x
162	finding
162	lethal
162	eosinophil
162	development,
162	design
162	locus
161	manner.
161	predicted
161	rather
161	screening
161	extracted
161	presenting
161	domestic
161	polymorphisms
161	domains
161	therapy.
161	cervical
160	reproduction
160	observations
160	inflammasome
160	concomitant
160	ireland
160	quantified
160	activities.
160	sea
160	biofilm
159	potassium
159	alveolar
159	designed
159	product
159	90%
159	signs
159	vaccination
159	arthritis
159	variants
158	serine
158	stimulates
158	segments
158	whose
158	alteration
158	estimated
158	localization
158	assigned
158	mg/kg,
158	immediately
158	activating
158	randomly
158	synthesis,
158	arteries
158	resting
158	bradykinin
158	variant
158	cleavage
157	agonists
157	supplemented
157	average
157	authors
157	aerobic
157	fragments
157	fact
157	lipids
157	elisa
157	recently,
157	interval
157	amazon
157	old
156	upregulated
156	vitro,
156	carbon
156	respectively).
156	interfere
156	decreasing
156	weeks.
156	review,
156	samples,
155	controls,
155	assayed
155	respond
155	inner
155	igm
155	indomethacin
154	corticosterone
154	antitumor
154	extensive
154	tnf
154	cholinergic
154	temporal
153	inhibiting
153	iv
153	load
153	units
153	cancer.
153	curves
153	histamine
153	generate
153	dismutase
153	contractile
153	fusion
153	signalling
153	crotoxin
153	epec
152	spontaneous
152	primarily
152	·
152	smaller
152	intravenous
152	evidenced
152	besides
152	cytoplasmic
152	commonly
152	synthesis.
152	2002
152	hr
152	regions.
152	stability
152	cachexia
152	x.
151	immunofluorescence
151	series
151	paracoccidioides
151	amazonensis
151	il-10,
151	outer
151	evolution
151	e2
151	members
151	myocardial
150	stress,
150	ventricular
150	isoforms
150	sex
150	organs
150	bind
150	dc
150	specimens
150	tissue,
149	suppressed
149	256
149	acts
149	coupled
149	analyzed.
149	deleterious
149	shock
149	endocrine
149	th
149	allele
149	fasting
149	breast
148	tubules
148	growth.
148	diseases,
148	america.
148	proliferative
148	irradiated
148	disruption
148	phenylephrine
148	treat
147	requires
147	nmol
147	acting
147	ad
147	modify
147	larger
147	exert
147	investigation
147	bp
147	17
147	chronically
147	nucleus.
146	medium,
146	(2
146	processes.
146	viable
146	replication
146	il-12
146	polymorphic
146	air
146	protected
146	evolutionary
146	periodicals,
145	electrical
145	1)
145	ml
145	carrying
145	strain.
145	vitamin
145	inside
145	fibrosis
145	substantial
145	leptospira
144	substrates
144	sustained
144	isolates.
144	verify
144	positively
144	72
144	estrogen
144	neurons,
144	proliferation,
144	chagas
144	implications
144	apoptosis.
144	ci
144	fear
144	co
143	hydrolysis
143	identical
143	periods
143	importantly,
143	outcome
143	salmonella
143	wound
143	hypoxia
143	allelic
142	upregulation
142	stimulate
142	walker
142	existence
142	dietary
142	region,
142	primers
142	da
142	β
142	herein,
142	differentiated
142	ouabain
141	gain
141	springer-verlag.
141	summary,
141	paper
141	predominantly
141	immunoglobulin
141	nk
141	killed
141	characteristic
141	labeling
141	redox
141	cord
140	m)
140	pronounced
140	measurements
140	adrenal
140	relatively
140	statistical
140	anesthetized
140	thereby
140	sections
140	origin
140	organ
140	southern
140	diagnostic
140	prevention
140	targeted
140	2019
140	cattle
139	author
139	cl
139	establishment
139	antagonists
139	reached
139	sample
139	factors,
139	protozoan
139	il-1β,
139	stained
139	posterior
139	transcript
139	muscle,
139	hippocampal
139	f.
138	conversely,
138	measurement
138	adaptation
138	0.5
138	factors.
138	abundant
138	epithelium
138	none
138	similarly
138	resistance,
138	16s
138	hybridization
138	organisms
138	treg
138	lesions.
138	material
138	postnatal
138	dopamine
137	normotensive
137	membranes
137	co2
137	artery
137	formation.
137	substances
137	defense
137	survival.
137	cruzi,
137	enhance
137	ultrastructural
137	hippocampus
136	k
136	transduction
136	camp
136	overall,
136	complexes
136	block
136	appeared
136	producing
136	conversion
136	lymphocytes.
136	liver,
136	age,
136	capsaicin
136	epidemiological
136	insect
136	biology
136	developmental
136	endothelium
136	remodeling
135	studies.
135	transition
135	predominant
135	b2
135	independently
135	phenotypic
135	antifungal
135	basic
135	(by
135	toll-like
135	healing
135	blue
135	assays.
135	drinking
135	proteolytic
134	comparable
134	phenomenon
134	clearance
134	providing
134	produces
134	sheep
134	frequencies
134	social
134	best
134	pyruvate
134	vectors
134	cruzi.
134	live
134	apoptosis,
133	.
133	root
133	polyclonal
133	potentiated
133	ovx
133	prepared
133	colonization
133	chabaudi
133	volunteers
132	abundance
132	consequences
132	contact
132	humoral
132	aegypti
132	100%
132	rodent
132	tandem
132	damage.
132	ng
132	paulo,
132	rostral
131	losartan
131	interact
131	continuous
131	2+
131	ratios
131	layers
131	90
131	effects,
131	stimulation.
131	immunity.
131	phases
131	heterologous
131	c3
131	atypical
131	dexamethasone
131	epitopes
131	embryonic
131	synaptic
131	loxosceles
130	conclusions
130	distribution,
130	k+
130	regulator
130	respectively)
130	ten
130	recorded
130	5.
130	preserved
130	arachidonic
130	cytokines.
130	intrauterine
130	a2
130	drugs.
130	amastigotes
129	significance
129	variations
129	clone
129	secretion,
129	confocal
129	antagonist,
129	model,
129	days)
129	consequence
129	press.
129	c-terminal
129	media,
129	assay,
129	sequenced
129	precursor
129	nicotinic
129	elimination
129	diarrhea
129	egg
129	behavior.
128	changed
128	urine
128	localized
128	downstream
128	transgenic
128	search
128	hfd
128	males
128	eosinophils
128	rings
128	connective
127	karger
127	cgmp
127	mechanisms.
127	beta
127	acetate
127	constant
127	r
127	clonal
127	bacterium
127	sources
127	become
127	naturally
127	interferon
127	lps-induced
127	improves
127	α
127	processed
127	cavity
127	terminal
127	fibroblasts
127	poor
127	topical
127	defensive
127	actinomycetemcomitans
126	signaling.
126	hf
126	modifications
126	tumor-bearing
126	underwent
126	minimal
126	step
126	focus
126	areas.
126	epitope
126	parasitemia
126	pparγ
126	cognitive
126	aortas
125	tissues,
125	journal
125	0.1
125	cloned
125	others
125	described.
125	200
125	eukaryotic
125	humans,
125	blackwell
125	test.
125	tail
125	lineage
125	vivo,
125	bound
125	stress.
125	palmitate
125	crotalus
125	ms
124	h+
124	activator
124	probe
124	0
124	medical
124	observed,
124	mediator
124	acid,
124	statistically
124	simple
124	virulent
124	rich
124	peroxidase
124	right
124	pcr.
124	preparations
124	cycle.
124	derivatives
124	tuberculosis
123	nitroprusside
123	demonstrating
123	method.
123	interest
123	linear
123	sufficient
123	ex
123	suitable
123	depending
123	fungus
123	inoculation
123	bal
123	asymptomatic
123	mixture
123	examined.
123	citrus
123	heat
123	erythrocytes
122	comparing
122	45
122	removed
122	capillary
122	establish
122	(50
122	peroxide
122	extravasation
122	n-terminal
122	ribosomal
122	islets.
122	sons,
122	adipocyte
122	dynamic
121	immunoblotting
121	exerts
121	kept
121	must
121	defects
121	antigenic
121	population.
121	release.
121	orally
121	parasite.
121	diabetes.
121	attention
121	tgf-β1
121	coronary
121	nociceptive
121	brain.
121	19
120	performed.
120	double
120	bacteria.
120	mixed
120	growth,
120	respective
120	antigens.
120	materials
120	tools
120	28
120	years,
120	birds
119	influences
119	glomerular
119	hypertension.
119	feature
119	route
119	portion
119	problem
119	(ros)
119	microorganisms
119	living
119	gamma
119	supported
119	22
119	serological
119	community
119	short-term
119	gestational
119	relaxations
119	pituitary
119	exercise.
119	lt
118	apical
118	organic
118	spread
118	counts
118	metabolites
118	pathology
118	comparative
118	molecules.
118	individuals.
118	breathing
118	detectable
118	trypomastigotes
118	infections,
118	nts
117	isoform
117	unable
117	translation
117	expected
117	physiology
117	supporting
117	mild
117	interstitial
117	concerning
117	exclusively
117	aims
117	commercial
117	efficiency
117	dynamics
117	clinically
117	cytometry
117	serotonin
117	lines,
117	crude
117	paraventricular
117	ticks
117	leukemia
117	dengue
116	promoting
116	occurring
116	measuring
116	gut
116	delayed
116	fixed
116	cytochrome
116	paracoccidioidomycosis
116	glycoprotein
116	hybrid
116	h)
116	μg/ml
116	sexual
116	cat
116	verlag
116	this,
116	contamination
116	manner
116	insulin-stimulated
116	retrograde
116	program
116	durissus
116	cold
115	mediating
115	appropriate
115	remaining
115	greatly
115	pressure,
115	growing
115	latin
115	relevance
115	histopathological
115	unclear.
115	4,
115	enos
115	rodents
115	expressions
115	strength
115	lh
115	(v.)
115	zikv
114	elucidate
114	way
114	passive
114	explored
114	defective
114	efficiently
114	glial
114	cytoplasm
114	contractions
114	aging
114	wiley-liss,
114	caudal
114	slc2a4
113	apparent
113	altogether,
113	trigger
113	m2
113	phenotype.
113	5,
113	outflow
113	findings:
113	locomotor
113	interesting
113	genomes
113	antinociceptive
112	unilateral
112	substance
112	f
112	every
112	antibodies,
112	people
112	microvascular
112	pregnancy.
112	simultaneously
112	2001
112	blotting
112	d.
112	cerebral
112	irradiation
112	aggressive
112	tb
112	dental
111	permits
111	part,
111	ventricle
111	arginine
111	phospholipase
111	discussed
111	half
111	detected.
111	protect
111	donors
111	myeloid
111	host.
111	acquisition
111	intrinsic
111	focused
111	lacking
111	superior
111	preventing
111	particles
111	testing
111	disorders.
111	encodes
111	pdi
110	sham-operated
110	enhances
110	v
110	attributed
110	mucosa
110	longer
110	prominent
110	environment.
110	context
110	accordingly,
110	federation
110	monocytes
110	platelets
110	position
110	vertebrate
110	improving
110	cationic
109	hypertension,
109	minutes
109	(3)
109	(from
109	varied
109	ocular
109	content.
109	electrophoresis
109	hosts
109	burden
109	spreading
109	absent
109	leukotriene
109	points
109	treadmill
109	immunodeficiency
109	inputs
109	retina
109	ring
109	pmv
109	cardiomyocyte
108	measure
108	phosphorylated
108	blocking
108	cases,
108	bearing
108	adjuvants
108	models.
108	oa
108	duration
108	bioactive
108	spider
108	venom,
108	creatine
108	encoded
108	cpt
107	er
107	cyclase
107	magnitude
107	extended
107	maintain
107	unchanged
107	ranged
107	aims:
107	95%
107	time.
107	confirming
107	ligand
107	studies,
107	tgf-β
107	neutrophils,
107	splenic
107	proliferation.
107	pvn
107	cats
107	functions.
107	amygdala
106	enterotoxigenic
106	anion
106	allowing
106	unknown
106	avp
106	considerable
106	slightly
106	translocation
106	isolates,
106	influenced
106	neutral
106	strain,
106	band
106	countries
106	steps
106	palmitic
106	initiation
106	nodes
106	aepec
105	stimulatory
105	ag,
105	salt
105	experiments,
105	verified
105	utilization
105	enhancement
105	kg
105	northern
105	monitored
105	successfully
105	phase.
105	aspergillus
105	noradrenaline
105	mediates
105	mch
105	antigen-specific
105	identity
105	clusters
105	loci
105	linkage
105	pathways,
105	cross-sectional
105	aa
105	0.001)
104	reticulum
104	efflux
104	net
104	representing
104	acutely
104	adverse
104	successful
104	modification
104	near
104	bacteria,
104	lymphoid
104	microbiological
104	il-2
104	reaction.
104	molecules,
104	ovariectomized
104	saliva
104	hemorrhagic
104	test,
104	2000
104	parts
104	41-2272
104	moxonidine
103	blocks
103	kinetics
103	canine
103	member
103	pi
103	account
103	processes,
103	injection,
103	press
103	data,
103	simultaneous
103	external
103	estradiol
103	transfected
103	axis
103	80
103	pilocarpine
103	adults
103	dopaminergic
103	opioid
103	brasileira
103	tumors.
103	braziliensis
103	alcohol
103	sc
103	berghei
103	sleep
103	abcb1
102	transporters
102	na+
102	demonstrates
102	sulfate
102	microscopy,
102	determining
102	protocols
102	procedure
102	lectin
102	pathogens.
102	nlrp3
102	group)
102	mosquito
102	up-regulation
102	drive
102	pge
102	management
102	formation,
102	novo
102	merozoite
102	contextual
101	use,
101	gastrointestinal
101	agents.
101	includes
101	(i)
101	wall
101	(3
101	killing
101	transforming
101	igg2a
101	cycle,
101	cluster
101	worldwide
101	full
101	nm)
101	prolactin
101	serotonergic
101	pressor
101	insights
101	brainstem
101	antivenom
101	ep24.15
100	exchange
100	concentrations.
100	0.05),
100	(ii)
100	obtain
100	transferred
100	represented
100	nitrogen
100	diagnosed
100	fundamental
100	2016,
100	node
100	correlate
100	i.p.
100	twice
100	called
100	directed
100	sensitivity,
100	thermal
100	atorvastatin
100	history
100	heme
99	respectively
99	compatible
99	view
99	remarkable
99	integrity
99	impair
99	day,
99	million
99	deposition
99	mab
99	supernatants
99	assessment
99	lymphocytes,
99	constitute
99	(nos)
99	constitutive
99	7,
99	h2o2
99	parasites,
99	abdominal
99	plasmids
99	allograft
98	persistent
98	buffer
98	process,
98	tested.
98	hl-60
98	worldwide.
98	allow
98	profile,
98	iga
98	al;
98	serum.
98	hypothalamus,
98	training.
98	ventrolateral
98	marine
98	jararaca
98	ctx
98	retrotrapezoid
98	mutans
97	final
97	phi
97	receptor,
97	ii)
97	phosphatase
97	solutions
97	hp
97	120
97	require
97	objectives:
97	hemolytic
97	examination
97	myeloperoxidase
97	negatively
97	serious
97	serve
97	consisted
97	obesity.
97	(or
97	a,
97	(p<0.05).
97	families
97	baroreflex
97	gmbh
97	silencing
97	flagellin
97	raphe
96	however
96	μm,
96	found.
96	absorption
96	medium.
96	vessels
96	extraction
96	progression.
96	immunogenic
96	ifn-γ,
96	albicans
96	(20
96	mellitus
96	23
96	constructed
96	irs-1
96	oleic
96	rho
96	doca-salt
96	decidual
96	urban
96	bats
96	adenovirus
96	neurodegenerative
96	rabies
95	wky
95	endoplasmic
95	address
95	(30
95	downregulation
95	evaluating
95	concentration.
95	equivalent
95	administration.
95	excess
95	rdna
95	0.01)
95	immunomodulatory
95	up-regulated
95	median
95	myenteric
95	normalized
95	neutralizing
95	repeat
95	β-cell
95	nnos
95	systems.
95	testosterone
95	interfering
95	brown
95	erythrocyte
95	diclofenac
95	invasive
95	congenital
95	assembly
95	countries.
95	radiation
95	phenotypes
95	candidates
95	astrocytes
95	glioma
95	xanthomonas
94	scientific
94	bladder
94	depend
94	alpha
94	morphometric
94	sought
94	(wt)
94	challenge,
94	pathogenicity
94	regardless
94	relationships
94	amp
94	preparation
94	hela
94	sepsis
94	mi
93	creative
93	commons
93	unrestricted
93	mechanism.
93	agreement
93	cytoskeleton
93	alkaline
93	(0.1
93	sugarcane
93	screened
93	literature
93	stimulating
93	societies.
93	bands
93	curve
93	introduction:
93	identified.
93	airways
93	mechanisms,
93	chromosomal
93	element
93	describes
93	diet.
93	insulin-induced
93	insulin,
93	systolic
93	brain,
93	(p<0.05)
93	asper
92	attribution
92	regulation.
92	peritubular
92	varying
92	implanted
92	long-lasting
92	prevents
92	cpg
92	dissemination
92	limit
92	similarly,
92	pivotal
92	nmda
92	(i.e.,
92	consecutive
92	african
92	l
92	subtilis
92	metformin
92	malignant
92	conditioned
92	endothelium-dependent
92	medicine
92	robust
92	input
92	rural
92	pafr
92	uv
92	fastidiosa
92	csa
92	retina.
91	microperfusion
91	consequently,
91	release,
91	binds
91	flux
91	subtype
91	disorder
91	culture.
91	techniques.
91	minor
91	lumen
91	observation
91	reported.
91	though
91	(r
91	bacillus
91	percent
91	phase,
91	highlight
91	outcomes
91	preferentially
91	lesions,
91	mucus
91	%
91	catalase
91	sod
91	fragmentation
91	llc.
91	allergen
91	aggregation
91	acids,
91	nutritional
91	et-1
91	addressed
91	inactivation
91	resolution
91	aqueous
91	fusarium
90	license,
90	collectively,
90	notably,
90	basel.
90	probes
90	shr.
90	μm),
90	thought
90	respect
90	period,
90	diameter
90	dual
90	abnormal
90	results,
90	intraperitoneally
90	nasal
90	μm).
90	properties.
90	2.5
90	world
90	acids.
90	damage,
90	c-fos
90	dysfunction.
90	therapies
90	placenta
90	rare
90	p53
90	follicular
90	recurrent
90	citri
90	serotypes
90	enteropathogenic
89	level.
89	correlates
89	homeostasis.
89	surface.
89	place
89	column
89	erk1/2
89	areas,
89	30%
89	b,
89	adequate
89	recognize
89	assays,
89	immunoreactive
89	mothers
89	trpv1
89	nk1
89	norepinephrine
89	widespread
89	heterogeneous
89	vasodilation
89	differentiation,
89	oocysts
89	proteasome
89	cysteine
89	periaqueductal
89	hiv-1
88	filtration
88	intestine
88	parameters.
88	starting
88	monitoring
88	concentrations,
88	impairs
88	lowest
88	replacement
88	caspase
88	played
88	2015,
88	birth
88	enzyme-linked
88	asthma.
88	bodies
88	states
88	transmitted
88	10%
88	clock
88	glycemic
88	ic50
88	muscular
88	focusing
88	experimentally
88	hearts
88	etec
87	aim:
87	3)
87	enriched
87	derivative
87	polypeptide
87	300
87	sas.
87	modulatory
87	beginning
87	consisting
87	heart,
87	offspring.
87	6,
87	albumin
87	intervals
87	experiment
87	discovery
87	comprising
87	hyperthyroidism
87	dense
87	connections
87	persistence
87	seropositive
87	forest
87	core
87	eaec
86	effect,
86	goal
86	turn
86	selectively
86	erk
86	participates
86	(a)
86	maintaining
86	evident
86	responsive
86	excision
86	th17
86	america
86	vegf
86	aerosol
86	obesity,
86	ltb4
86	immunosorbent
86	treating
86	confidence
86	year
86	fused
86	separated
86	mammals
86	share
86	diet-induced
86	preference
86	cocaine
86	ot
86	terrificus
86	powerful
86	hypothyroidism
86	toxoplasmosis
86	promastigotes
86	cells)
86	electrospray
86	allodynia
86	p10
85	credited.
85	gmp
85	rate,
85	mapk
85	needed
85	explore
85	blocker
85	implantation
85	increased.
85	mobility
85	lost
85	conscious
85	genera
85	facilitate
85	consists
85	deep
85	causative
85	helper
85	morbidity
85	hypersensitivity
85	weak
85	32
85	trypomastigote
85	i/r
85	cyclooxygenase
85	naive
85	antigen.
85	clade
85	library
85	parasitic
85	linoleic
85	generating
85	reductions
85	striatum
85	subjects.
85	glutamatergic
85	chemoreceptor
85	delivered
85	serotype
85	cac2
84	renin-angiotensin
84	fasted
84	excretion
84	base
84	knockdown
84	increased,
84	i.e.,
84	cisplatin
84	blunted
84	corrected
84	soil
84	forming
84	hyperglycemia
84	il-17
84	acidic
84	chemokine
84	valuable
84	ecm
84	ischemia
84	allergy
84	hemoglobin
84	principal
84	trypanosome
84	rangeli
84	liver.
84	sensitivity.
84	phox
84	elevation
84	exercised
84	appearance
84	envenomation
84	variables
84	find
84	kiss1
84	transplant
83	min,
83	fractional
83	changing
83	opposite
83	identified,
83	socs3
83	extremely
83	reperfusion
83	enteric
83	amph
83	factor-α
83	exposure.
83	peptides,
83	proved
83	broad
83	homology
83	advanced
83	rapamycin
83	0.001).
83	gingival
83	circular
83	shared
83	gram-negative
83	regeneration
83	pag
83	preoptic
83	acth
83	neuropathic
82	injury,
82	ras
82	500
82	na
82	membrane.
82	chloride
82	colon
82	spite
82	never
82	tracer
82	generally
82	allows
82	(4
82	learning
82	contents
82	etiological
82	neutralization
82	factor,
82	immunogenicity
82	later.
82	fast
82	regimen
82	ach
82	nad(p)h
82	regular
82	bed
82	hemodynamic
82	pharmacokinetic
82	sociedade
82	t4
82	β1
82	-/-
82	survey
82	anticancer
82	vaccinated
82	hiv
82	flavus
81	pka
81	homeostasis,
81	at1
81	abnormalities
81	conclusion
81	vasopressin
81	insertion
81	nacl
81	calculated
81	force
81	(b)
81	priming
81	informa
81	i,
81	pretreated
81	electrophoretic
81	behavior,
81	revealing
81	al.;
81	lllt
81	typing
81	compounds.
81	three-dimensional
81	panel
81	antiserum
81	adenine
81	phosphorylation,
81	polyunsaturated
81	ace
81	migratory
81	plasticity
81	larvae
81	death,
81	pla2
81	gomesin
81	u.
81	tablet
80	intake,
80	triggers
80	kidneys
80	extensively
80	supports
80	deprivation
80	transmembrane
80	meat
80	adjacent
80	changes.
80	pm
80	differentiation.
80	(dcs)
80	subsequently
80	f2
80	chemokines
80	il-4,
80	immunodominant
80	green
80	possess
80	interference
80	detailed
80	undertaken
80	associations
80	microscopic
80	location
80	saturated
80	neurological
80	reflex
80	spp.,
80	zone
80	stat5
80	project
80	premammillary
80	corpus
80	oppa
80	oua
80	cystic
79	ii,
79	started
79	progress
79	initially
79	hosts.
79	massive
79	ip
79	tnfα
79	amastigote
79	upper
79	harvested
79	insulin.
79	geographic
79	haplotypes
79	incorporated
79	north
79	run
79	dark
79	a/s.
79	5-ht
79	proteases
79	necrotic
79	accessory
79	aiming
79	stromal
79	pigs
79	chickens
79	cathepsin
79	m1
79	mutagenesis
78	output
78	glucose.
78	concentration,
78	uptake,
78	crf
78	80%
78	manner,
78	intercellular
78	power
78	c,
78	creatinine
78	designated
78	availability
78	sp
78	effectiveness
78	resident
78	dominant
78	weeks,
78	unrelated
78	subcutaneously
78	aedes
78	donor
78	transplantation
78	(lps)
78	uterine
78	thoracic
78	barrier
78	reflect
78	years.
78	mapped
78	entire
78	150
78	cp
78	es
78	leptospiral
78	milk
78	capsule
78	biomass
78	mycobacterium
78	pbmc
78	mirnas
78	ts
77	exchanger
77	indeed,
77	(at
77	basolateral
77	gradient
77	area.
77	organisms.
77	granules
77	excessive
77	suppressive
77	exacerbated
77	neutrophils.
77	apparently
77	mhc
77	b-cell
77	displaying
77	receptor.
77	migration,
77	link
77	elisa.
77	purpose:
77	advances
77	geographical
77	age.
77	stz
77	mammary
77	applications
77	(l.)
77	glut2
77	analgesic
77	fragilis
77	neuropeptide
77	prp
76	activities,
76	obtained.
76	vesicles
76	noted
76	substitution
76	secrete
76	kinetic
76	blood,
76	70%
76	signaling,
76	special
76	parasite,
76	stronger
76	hospital
76	syndrome.
76	thickness
76	integrin
76	1.0
76	chemotherapy
76	metacyclic
76	peptides.
76	captured
76	nox2
76	term
76	citrate
76	terminals
76	muscles.
76	endothelin
76	msg
76	chromatin
76	administration,
76	glutaminase
76	fever,
76	neospora
76	la
76	cancer,
76	publishers
76	emergence
76	falciparum.
76	syncytial
76	metronidazole
76	regenerating
76	pain.
75	aldosterone
75	10,
75	entry
75	(in
75	infants
75	0.2
75	increment
75	70
75	adapted
75	placed
75	adaptations
75	b10.a
75	avoid
75	lungs.
75	laminin
75	no.
75	infect
75	thromboxane
75	triggering
75	purpose,
75	sacrificed
75	l-arginine
75	26
75	subset
75	mammals,
75	polypeptides
75	gastrocnemius
75	months.
75	ne
75	placentas
75	peptide,
75	2017,
75	solitary
75	past
75	avian
75	porcine
75	score
75	regions,
75	purinergic
75	parkinson's
75	prefrontal
75	papillae
75	nigriventer
74	subcellular
74	contributed
74	optimal
74	pathophysiology
74	conclusions.
74	fall
74	slow
74	diet,
74	reach
74	35
74	2018,
74	presentation
74	f1
74	became
74	post
74	studying
74	(iii)
74	ligands
74	infecting
74	mpo
74	satellite
74	dna,
74	shed
74	interacts
74	nearly
74	metabolite
74	adolescent
74	snp
74	kinin
74	arterioles
74	immature
74	mesenchymal
74	morphine
74	atlantic
74	immunosuppressive
74	eggs
74	larval
74	metal
74	hpv
74	ab
74	autophagy
74	thalamic
74	cb1
74	disulfide
74	diversum
74	falciparum,
74	hypercapnia
74	sciatic
73	pressure.
73	cl-
73	research.
73	j
73	acid.
73	action.
73	measured.
73	biochemistry
73	differently
73	fact,
73	employing
73	differentiate
73	cambridge
73	swiss
73	later,
73	regional
73	equally
73	anatomical
73	fo
73	products.
73	(group
73	potency
73	complex,
73	gc
73	pa
73	sao
73	markers,
73	embryo
73	microenvironment
73	berlin
73	sites.
73	hydroxylase
73	agglutination
73	rickettsia
73	regard
73	populations.
73	iodide
73	hep-2
73	ureaplasma
73	at1r
72	p38
72	(the
72	state.
72	unaffected
72	cortex,
72	compartment
72	cultivated
72	communities
72	tests.
72	cultures.
72	suppress
72	a/j
72	naïve
72	predominance
72	circulation
72	icam-1
72	anaphylactic
72	context,
72	pups
72	elucidated.
72	snps
72	epidemiology
72	perform
72	onto
72	ffa
72	correct
72	lean
72	treatments.
72	real
72	cohort
72	hypothyroid
72	nuclei.
72	driven
72	bovis
72	malaria,
72	urea
72	predatory
72	predator
72	ee
71	author(s)
71	dye
71	mm),
71	adrenocortical
71	insight
71	surrounding
71	penetration
71	clustered
71	functions,
71	challenges
71	p2x7
71	exact
71	pb
71	granulomatous
71	a/sn
71	precise
71	far
71	chemotaxis
71	attempt
71	stimuli.
71	inactive
71	time-dependent
71	(control
71	space
71	vasoconstrictor
71	displays
71	largest
71	36
71	contaminated
71	immunoprecipitation
71	rabbits
71	islet
71	hypothalamus.
71	bioavailability
71	enalapril
71	pcr,
71	ap
71	metalloproteinases
71	agar
71	carriers
71	escape
71	cc
71	damaged
71	bdnf
70	shr,
70	na+/h+
70	glycolytic
70	paralleled
70	phosphorylation.
70	5%
70	studied,
70	pkc
70	rates.
70	background.
70	is,
70	g.
70	enzyme.
70	care
70	progesterone
70	elicit
70	recombination
70	effectively
70	focal
70	tlr2
70	destruction
70	publishers.
70	mrnas
70	collection
70	degranulation
70	enzymes.
70	injured
70	gavage
70	infective
70	microsatellite
70	chromosomes
70	myosin
70	heavy
70	carbohydrate
70	line.
70	oxidized
70	randomized
70	endometrial
70	intraplantar
70	nuclei,
70	deficits
70	monkeys
70	endotoxin
70	antiproliferative
70	ionization
69	nutrient
69	functionally
69	solution.
69	findings,
69	lactation
69	changes,
69	consequent
69	oxford
69	event
69	initiated
69	comprehensive
69	abrogated
69	repertoire
69	anti-t.
69	classes
69	downregulated
69	tlr
69	eicosanoids
69	pinealectomized
69	soybean
69	transcribed
69	hypothesize
69	minimum
69	genotyping
69	31
69	cases.
69	threshold
69	cytometry.
69	eliminated
69	vasoconstriction
69	surgery.
69	fibrils
69	safe
69	microinjection
69	knowledge,
69	bentham
69	bcg
69	magnetic
69	typhimurium
69	harbored
69	olfactory
69	storage
69	mosquitoes
69	anterograde
68	components.
68	segment
68	inhibitor)
68	pi3k
68	values.
68	separate
68	attenuate
68	sugar
68	interferon-γ
68	first,
68	subsets
68	spectrum
68	reacted
68	plexus
68	ischemic
68	reductase
68	session
68	anaerobic
68	immediate
68	chagasic
68	copy
68	decline
68	types.
68	p47
68	behaviors
68	progenitor
68	gingivalis
68	complications
68	analogues
68	regression
68	nonetheless,
68	efforts
68	aureus
68	slc11a1
68	cardiomyocytes
68	subgingival
68	eau
67	isoproterenol
67	wk
67	[ca
67	family,
67	(but
67	6.
67	optical
67	gas
67	pseudomonas
67	concomitantly
67	spleen,
67	balanced
67	cell-mediated
67	il-5
67	fecal
67	pre-treatment
67	attachment
67	concentration-dependent
67	27
67	29
67	cd
67	random
67	chow
67	benefits
67	adrenergic
67	mtt
67	delay
67	3-kinase
67	ones
67	consistently
67	protein-1
67	max
67	afferent
67	wat
67	tsh
67	shape
67	denervation
67	dogs,
67	sampled
67	yield
67	staphylococcus
67	st
67	operon
67	p1
67	rac1
67	auc
66	line,
66	pulse
66	min.
66	(ang
66	ic
66	instead
66	slight
66	experiments.
66	consequently
66	(e.g.,
66	parameters,
66	substantially
66	academic
66	embryos
66	actively
66	belonged
66	μmol/l)
66	mortality.
66	america,
66	g1
66	surgery
66	tracheal
66	cns
66	muscarinic
66	(airmax)
66	assessed.
66	compounds,
66	pool
66	preliminary
66	lippincott
66	williams
66	behaviour
66	unlike
66	proteomic
66	similarities
66	brains
66	dogs.
66	42
66	arrest
66	flies
66	α7
66	ucn
65	consensus
65	transepithelial
65	description
65	fine
65	method,
65	cm
65	microbicidal
65	surprisingly,
65	vaccines.
65	circuits
65	manifestations
65	mobilization
65	life.
65	hour
65	96
65	μm.
65	amazonian
65	extreme
65	make
65	1/2
65	mary
65	ann
65	liebert,
65	severely
65	hplc
65	timing
65	biology,
65	enzymes,
65	biologically
65	quantify
65	models,
65	totally
65	heidelberg.
65	suppressor
65	retina,
65	tongue
65	chromatographic
65	ho-1
65	antarctic
65	down-regulated
65	co.
65	degeneration
65	nanoparticles
65	reporter
65	muscimol
65	cardiorespiratory
65	anxiety
65	urchin
65	stec
64	4)
64	persisted
64	[ca2+]i
64	thick
64	min-1
64	enterotoxin
64	next
64	vein
64	known.
64	thin
64	i.v.
64	proper
64	validated
64	leaves
64	conferred
64	tolerance,
64	mrna.
64	ingestion
64	antigens,
64	prophylactic
64	(airmin)
64	colocalization
64	alters
64	tachykinin
64	tamoxifen
64	epimastigote
64	surgical
64	grouped
64	cell.
64	mass,
64	0.3
64	particle
64	polarization
64	serovar
64	spores
64	lipoprotein
64	papillary
64	profile.
64	il-12p40ko
64	glut1
64	hypothermia
64	glucose-6-phosphate
64	contralateral
64	hrsv
64	ameloblastoma
64	axons
64	bioequivalence
63	(15
63	heterogeneity
63	upstream
63	min)
63	(an
63	glycerol
63	pma
63	ed
63	kg-1
63	reaching
63	always
63	limiting
63	lesser
63	infused
63	somatic
63	synthase,
63	regulators
63	colony
63	evidences
63	dead
63	determinants
63	discrete
63	bromide
63	krebs
63	predict
63	dna.
63	belongs
63	loss,
63	180
63	potentiation
63	longitudinal
63	surfaces
63	gabaergic
63	innervation
63	top
63	gray
63	joint
63	mode
63	lamina
63	c6
63	endurance
63	melanin-concentrating
62	nutrients
62	anp
62	stimulation,
62	culture,
62	ld
62	investigations
62	(200
62	(mean
62	chromatography.
62	secreting
62	infiltrate
62	quite
62	ir
62	vagal
62	involved.
62	(tnf-α)
62	sequences.
62	belong
62	concept
62	routes
62	retroperitoneal
62	neuroendocrine
62	dams
62	leptin,
62	fcf
62	relaxing
62	qpcr
62	design:
62	ovarian
62	rest
62	imaging
62	dry
62	medulla
62	newly
62	eye
62	monkey
62	(viannia)
62	survival,
62	μg/ml)
62	x-ray
62	3d
62	aid
62	ultraviolet
62	avoidance
62	b19
62	nis
62	cavernosum
61	guanylate
61	kidney,
61	reduced.
61	hormonal
61	20%
61	antibiotic
61	question
61	structure.
61	histone
61	infiltrating
61	influencing
61	fourth
61	epimastigotes
61	(ir)
61	apocynin
61	failure.
61	seemed
61	ecological
61	selectivity
61	vaccine.
61	rio
61	hydrophobic
61	antisera
61	stimuli,
61	continued
61	receive
61	association.
61	phosphatidylinositol
61	striatal
61	capture
61	imbalance
61	arteriolar
61	geometric
61	farms
61	horses
61	tested,
61	lps.
61	antibiotics
61	encode
61	thymus
61	mabs
61	protects
61	disorders,
61	ipsilateral
61	mitotic
61	tg
61	gaba
61	intimin
61	suis
60	modulator
60	altering
60	intravenously
60	idea
60	retention
60	dramatic
60	define
60	particular,
60	proton
60	weight)
60	cannot
60	reverted
60	dog
60	defect
60	distance
60	sucrose
60	carrier
60	biotechnological
60	site.
60	plants.
60	40%
60	roots
60	biology.
60	supernatant
60	accumulated
60	60%
60	therapy,
60	taylor
60	106
60	former
60	inhalation
60	attenuation
60	undergo
60	enhancing
60	grow
60	microbiota
60	york.
60	ag.
60	emerging
60	sequences,
60	residue
60	subject
60	coli,
60	(pcr)
60	reinforce
60	purification
60	characterized.
60	se
60	16.7
60	cascade
60	ratio,
60	level,
60	fumonisin
60	blockers
60	porphyromonas
60	plaque
60	intravital
60	kinases
60	measures
60	city
60	critically
60	biopsies
60	degradation.
60	surveillance
60	difficult
60	complex.
60	rt
60	qtl
60	intraerythrocytic
60	venoms.
60	structures.
60	coli.
60	epidermal
60	60-2770
59	(shr)
59	it.
59	properties,
59	provoked
59	fluid,
59	mm,
59	inhibition.
59	yielded
59	components,
59	km
59	environments
59	technique.
59	immunity,
59	clarify
59	synergistic
59	overcome
59	s.c.
59	interactions.
59	invasion,
59	understood
59	reliable
59	nature.
59	ligation
59	excitatory
59	1%
59	british
59	analyzing
59	reservoir
59	reading
59	cachexia.
59	gland.
59	dinucleotide
59	pregnancy,
59	lp
59	uncoupling
59	igf-i
59	fencamfamine
59	turn,
59	hypertrophy.
59	triiodothyronine
59	analytical
59	endometrium
59	proliferating
59	snakes
59	running
59	intracerebroventricular
59	identifying
59	chagasi
59	aquatic
59	symptomatic
59	virus.
59	plants,
59	taking
59	streptococcus
59	man
59	ibro.
59	peroxidation
59	zona
59	substantia
59	adenoid
59	aflatoxin
58	expresses
58	moving
58	ag
58	them.
58	monophosphate
58	vary
58	na+,
58	coupling
58	amphotericin
58	introduction
58	done
58	ambient
58	400
58	2014,
58	populations,
58	glucocorticoid
58	utilized
58	expected,
58	academy
58	cd40l
58	burst
58	dectin-1
58	mrna,
58	giant
58	reticular
58	systems,
58	prenatal
58	gestation
58	organism
58	24,
58	b4
58	drugs,
58	guinea
58	specialized
58	divergence
58	division
58	polar
58	subunits,
58	suprachiasmatic
58	translational
58	machinery
58	adiponectin
58	diastolic
58	p65
58	cannabinoid
58	intramuscular
58	non-diabetic
58	children.
58	phoneutria
58	bradycardia
58	exercise,
58	synovial
58	northeastern
58	world.
58	haplotype
58	west
58	influenza
58	synthesize
58	tumour-bearing
58	bjv
58	corn
58	outbreaks
58	hsp65
58	ifn-γ.
58	pv.
58	participants
58	infarction
58	lipogenesis
58	cr
58	caries
58	ew
58	mscs
57	ii.
57	morphology,
57	sequential
57	pump
57	blotting.
57	peptidase
57	immunohistochemistry.
57	disequilibrium
57	washout
57	ec
57	analyses.
57	masson
57	originated
57	pdcs
57	achieve
57	exerted
57	cells;
57	fas
57	b6
57	4th
57	reaction,
57	immunization.
57	fresh
57	densities
57	breeding
57	comprises
57	chains
57	germ
57	messenger
57	(t
57	carnitine
57	exhibits
57	ng/ml
57	emerged
57	hematopoietic
57	condition.
57	tone
57	follow-up
57	poly(a)
57	rejection
57	induction.
57	integration
57	projecting
57	catecholaminergic
57	zoonotic
57	antigen,
57	feed
57	epididymal
57	draft
57	mutated
57	pyrimidine
57	dorsomedial
57	ganglia
57	miltefosine
57	periventricular
57	antimalarial
57	toxigenic
57	bioequivalent
57	rpos
56	ang-(1-7)
56	age-matched
56	0.05
56	reversible
56	phorbol
56	superficial
56	used,
56	placebo
56	homozygous
56	1995
56	analogue
56	absolute
56	combinations
56	mg/kg),
56	combining
56	choline
56	harboring
56	atcc
56	(40
56	antagonist)
56	divergent
56	killer
56	complementary
56	adherent
56	day)
56	mediators.
56	recruited
56	take
56	restore
56	pancreas
56	homogenates
56	kb
56	structure,
56	stages.
56	digestive
56	stored
56	diabetes,
56	triacylglycerol
56	intervention
56	propionate
56	decarboxylation
56	cholesterol,
56	conditioning
56	reveals
56	tumors,
56	bk
56	subtypes
56	agents,
56	mmp-9
56	correlations
56	fewer
56	trial
56	coagulation
56	c5
56	ali/ards
56	dha
56	mutagenic
56	stress-induced
56	adamts-1
56	zika
56	nachr
56	jurkat
56	ventilation
55	lowered
55	adulthood.
55	ta
55	capillaries
55	which,
55	sequence.
55	normally
55	equilibrium
55	partly
55	data.
55	antagonism
55	demonstration
55	surface,
55	comprised
55	hence,
55	earlier
55	unit
55	degrees
55	serum,
55	dysfunction,
55	dramatically
55	role.
55	only.
55	trypanosomatids
55	size,
55	disrupted
55	organized
55	radical
55	virtually
55	venous
55	periodontitis.
55	ss
55	angiotensin-converting
55	wiley‐liss,
55	venom-induced
55	ventromedial
55	ablation
55	projection
55	restraint
55	northeast
55	microplus
55	scores
55	calves
55	intermedia
55	sediment
55	liposomes
55	c1
55	head
55	sporozoites
55	splicing
55	hepatitis
55	6-ohda
55	α8
54	inhibitors,
54	i.
54	rate.
54	hypertonic
54	returned
54	1.5
54	250
54	parenteral
54	switzerland.
54	middle
54	enrichment
54	benefit
54	requirements
54	classic
54	ongoing
54	immunology
54	pathogens,
54	uk
54	further,
54	then,
54	femoral
54	pathogenesis.
54	cultures,
54	supply
54	trachea
54	neuron
54	i.v.)
54	fibroblast
54	southeast
54	null
54	tests,
54	solid
54	glucocorticoids
54	investigating
54	rosiglitazone
54	immunohistochemistry,
54	rhythm
54	aspartate
54	weight.
54	periodontitis,
54	(th)
54	exhibiting
54	limited.
54	2010.
54	metalloproteinase
54	bioassay
54	sand
54	choice
54	sepsis.
54	spots
54	kgaa,
54	prognosis
54	genotoxic
54	erythrocytes,
54	p2
54	lutzomyia
54	crossover
54	odontogenic
54	fever.
54	alzheimer's
54	cfa/i
54	piplartine
53	heat-labile
53	generation.
53	i)
53	cachectic
53	fell
53	center
53	interaction.
53	charged
53	introduced
53	releasing
53	spectrometry.
53	perspectives
53	streptozotocin
53	nm,
53	phagocytes
53	adoptive
53	phenotype,
53	chemotactic
53	inverse
53	them,
53	cycles
53	hours.
53	disturbances
53	platelet-activating
53	prostaglandins
53	repetitive
53	b13
53	advantage
53	communication
53	recommended
53	detecting
53	glycemia
53	general,
53	undernourished
53	compilation
53	transfection
53	caloric
53	discharge
53	doca
53	comprise
53	adipocytes.
53	generalized
53	jararhagin
53	gap
53	rvlm
53	arcuate
53	experience
53	fold
53	(95%
53	anemia
53	acinar
53	outbreak
53	teeth
53	verticillioides
53	msp-1
53	epa
53	sti1
53	(rtn)
52	(control)
52	besides,
52	additive
52	dependence
52	channels.
52	affected.
52	artificial
52	6)
52	segments.
52	33
52	exponential
52	indirectly
52	trait
52	characterised
52	accurate
52	blockage
52	(ova)
52	fungicidal
52	polymorphonuclear
52	aminoguanidine
52	turnover
52	month
52	females.
52	csp
52	exposure,
52	p2x
52	twenty
52	newborn
52	site,
52	bm
52	melatonin,
52	genotypic
52	phytomonas
52	notion
52	assembled
52	outside
52	behalf
52	give
52	insects
52	gave
52	capacity,
52	oligonucleotide
52	(4)
52	accelerated
52	cb
52	peptide.
52	beyond
52	hypotension
52	chemoreceptors
52	differed
52	cysts
52	nested
52	temperatures
52	ml-1
52	immunotherapy
52	wiley-vch
52	enterica
52	pha
52	sem
52	aflatoxins
51	status.
51	movement
51	j.
51	circuit
51	15%
51	database
51	sp.,
51	transcriptome
51	dimorphic
51	alum
51	polarized
51	preferential
51	monocyte
51	interplay
51	antibody.
51	invasion.
51	competition
51	parental
51	24-h
51	migration.
51	(fa)
51	β2
51	significance:
51	indomethacin,
51	objectives
51	ratio.
51	genetics
51	hypothetical
51	37
51	repeats
51	classification
51	hundred
51	uses
51	reservoirs
51	hemolymph
51	exon
51	making
51	population,
51	biosynthetic
51	glucose-induced
51	unchanged.
51	ages
51	training,
51	pnd
51	na,k-atpase
51	d1
51	lv
51	pe
51	gender
51	rolling
51	(300
51	agent.
51	vasodilator
51	improvements
51	working
51	routine
51	stroma
51	leptospirosis
51	nattereri
51	baroreceptor
51	accuracy
51	version
51	2%
51	mirna
51	pancreatitis
51	antibacterial
51	pneumoniae
51	invadopodia
51	livers
51	primer
51	atrophy
51	→
51	prostate
51	saccharomyces
51	cerevisiae
51	overview
51	pediatric
51	weaning
51	potential.
51	caco-2
51	var
51	pain,
51	mmps
51	pnv
51	myotoxic
51	phox2b
50	hyperactivity
50	end,
50	pig
50	edema,
50	solution,
50	d,
50	equal
50	0.01),
50	fluxes
50	meal
50	sites,
50	absorption.
50	questions
50	traits
50	105
50	type.
50	organs.
50	detrimental
50	intratracheal
50	favor
50	glycoproteins
50	primed
50	interface
50	(d)
50	evolved
50	(inos)
50	indicative
50	twelve
50	national
50	accumulate
50	ssu
50	markers.
50	digestion
50	concentrated
50	economic
50	primates
50	lytic
50	array
50	iodine
50	amplitude
50	gland,
50	intake.
50	oxidation,
50	age-related
50	condition,
50	indeed
50	45ca
50	rt-pcr.
50	trials
50	water.
50	lhb
50	afferents
50	chemoreflex
50	captive
50	goats
50	hematological
50	epidemic
50	example,
50	ams
50	bcl-2
50	mb
50	pst
50	copper
50	sessions
50	immobilized
50	malarial
50	eae
50	randomized,
50	measles
50	cgd
50	prpc
50	fb1
49	wasting
49	capacity.
49	features,
49	replaced
49	subjects,
49	depleted
49	rats)
49	group).
49	undergoing
49	methods,
49	rapd
49	pcm
49	highlights
49	striking
49	(ecm)
49	transformed
49	rendered
49	methacholine
49	fibronectin
49	phe
49	neuropeptides
49	follow
49	agent,
49	mapping
49	post-transcriptional
49	representative
49	excellent
49	mammals.
49	whole-body
49	pinx
49	fibroblasts.
49	intermittent
49	pharmaceutical
49	skin,
49	ampk
49	saline,
49	biomarkers
49	interventions
49	inhibition,
49	glands.
49	coordinated
49	skin.
49	stimulus.
49	died
49	dairy
49	episodes
49	parvovirus
49	virus,
49	oxldl
49	iri
49	symptoms,
49	seasonal
49	(including
49	metastatic
49	mycobacterial
49	vivax.
49	hippocampus.
49	malaria-associated
49	marginal
49	attached
49	recipients
49	sos
49	necrosis.
49	crescentus
49	full-length
49	pilocarpine-induced
49	isoprenoid
49	gtpases
49	cdt
49	high-performance
49	(epec)
49	tityus
49	stx2
48	wistar-kyoto
48	hco3-
48	blot.
48	g/kg
48	rat.
48	cloning
48	pco2
48	μg)
48	supplementation.
48	estimate
48	conservation
48	namely
48	suspension
48	easily
48	yeasts
48	microarray
48	spleen.
48	reactions.
48	mcp-1
48	footpad
48	diffuse
48	reserved
48	infiltration,
48	chamber
48	attenuates
48	aspect
48	sets
48	start
48	inferred
48	optimized
48	faster
48	conformational
48	tree
48	zinc
48	behaviors.
48	qualitative
48	safety
48	protection.
48	portal
48	index,
48	deaths
48	transformation
48	locally
48	cart
48	grande
48	dilution
48	older
48	tolerance.
48	percentages
48	cyclin
48	types,
48	egf
48	i.c.v.
48	cpa
48	dodab
48	calcineurin
48	flagellins
47	evaluated,
47	sglt1
47	conductance
47	(pd)
47	loss.
47	paper,
47	mechanism,
47	accounts
47	enzyme,
47	loads
47	explained
47	depolarization
47	considerably
47	no,
47	pairs
47	study:
47	il-12,
47	pmn
47	viruses.
47	pet
47	expanded
47	interferes
47	organisms,
47	fibers.
47	isotype
47	cross-reactivity
47	sizes
47	chemoattractant
47	cox-1
47	events.
47	immunoassay
47	inos,
47	ltb
47	mediators,
47	l-name-treated
47	5.0
47	subclass
47	concanavalin
47	mdpi,
47	basel,
47	lipolysis
47	cortex.
47	(t3)
47	connected
47	antisense
47	wilkins.
47	problems
47	3.5
47	stomach
47	compartments
47	microvessels
47	nω-nitro-l-arginine
47	resonance
47	hind
47	constitutively
47	microglial
47	strategies.
47	μg/kg
47	southeastern
47	raw
47	neoplastic
47	uninfected
47	sterile
47	aromatic
47	codon
47	nac
47	tag
47	xylella
47	odor
47	cyclosporine
47	invade
47	butyrate
47	dentin
47	immobilization
47	plexiform
47	kisspeptin
47	cholera
47	tectum
47	staphylococcal
47	erectile
47	salivation
47	crotalphine
46	8,
46	ions
46	atpase
46	analogs
46	membrane,
46	duct
46	(as
46	paired
46	vessel
46	substrates.
46	lungs,
46	caspase-1
46	pathology.
46	(ifn-γ)
46	covered
46	:
46	preventive
46	bronchial
46	neurotransmitter
46	presumably
46	symptoms.
46	day.
46	cyclo-oxygenase
46	epinephrine
46	subsequently,
46	copies
46	systematic
46	sequence,
46	complexity
46	nmr
46	5.6
46	mass.
46	fragmentation,
46	down-regulation
46	were:
46	modest
46	mitochondria,
46	alanine
46	unusual
46	charge
46	not.
46	venules
46	stage.
46	2-
46	crystal
46	nucleotides
46	gc-1
46	acquire
46	heart.
46	monitor
46	buffalo
46	rhipicephalus
46	neotropical
46	(leishmania)
46	thp-1
46	spectroscopic
46	rarely
46	dimers
46	tgfβ
46	trans-sialidase
46	neutralized
46	cerebellar
46	promoter.
46	arg
46	hemocytes
46	carcinomas
46	msp-2
46	fimbrial
46	nucleatum
46	enamel
46	chicks
46	(etec)
46	bond
46	palmitoleic
46	cybb
46	sgc
46	pylori
46	nx
46	uveitis
45	natriuretic
45	pt
45	tubule.
45	inhibitor.
45	12,
45	conclusion.
45	n-3
45	alkalinization
45	vasoactive
45	originally
45	alone.
45	(0.5
45	experiment,
45	75
45	shorter
45	rats;
45	establishing
45	mineral
45	a)
45	carotid
45	typically
45	viruses,
45	outcome.
45	lysis
45	reduced,
45	cells).
45	immunosuppression
45	rearrangement
45	blackwell.
45	p2x2
45	evans
45	submucosal
45	immunostaining
45	intolerance
45	environment,
45	emphasize
45	multifactorial
45	14,
45	summarize
45	typed
45	fibers,
45	motif
45	traditional
45	platform
45	immunologic
45	adiposity
45	vital
45	transducer
45	events,
45	56
45	propranolol
45	ng/ml)
45	iugr
45	b1r
45	association,
45	performance.
45	linking
45	counteract
45	fetuses
45	(i.e.
45	arrangement
45	accidents
45	hc
45	vaginal
45	colonize
45	exception
45	paulo.
45	leishmaniasis.
45	discovered
45	programs
45	fibrosis.
45	issue
45	needs
45	liii
45	oocytes
45	mollicutes
45	burkholderia
45	noradrenergic
45	commnts
45	naproxen
45	adp
45	serrulatus
44	kidney.
44	atrial
44	chemically
44	irrespective
44	name
44	corroborated
44	respectively),
44	(60
44	approaches.
44	microorganisms.
44	francis
44	1994
44	benign
44	immunoregulatory
44	favoring
44	leukotrienes
44	marrow-derived
44	reactions,
44	c3h/hepas
44	generates
44	underlie
44	leakage
44	counting
44	accumulation.
44	peaked
44	lps,
44	multivariate
44	trypanosomatid
44	separation
44	validation
44	thirty
44	diagnosis.
44	deduced
44	minimize
44	elicits
44	glucose-stimulated
44	anti-apoptotic
44	possibilities
44	functioning
44	pc
44	undernutrition
44	shifts
44	profiles.
44	medicine.
44	cox
44	women.
44	odq
44	spectroscopy
44	fields
44	nl)
44	tracing
44	temperature,
44	varies
44	veterinary
44	chicken
44	inclusion
44	africa,
44	hsp70
44	septic
44	cd36
44	chemotherapeutic
44	caspase-3
44	cancers
44	papillomavirus
44	ethanol.
44	chemotherapy.
44	africa
44	sds-page
44	ae.
44	viability,
44	hemolysis
44	asp-2
44	propolis
44	mmp9
44	[
44	bacteroides
44	pars
44	neurotrophic
44	hippocampus,
44	simvastatin
44	phrenic
44	smase
44	lepr
43	jhco3-
43	unaltered
43	ultimately
43	tendency
43	documented
43	observe
43	mmhg
43	devoid
43	essentially
43	verapamil
43	klebsiella
43	multilocus
43	b)
43	phagocyte
43	suggestive
43	silva,
43	ido
43	il-10.
43	motifs
43	exudate
43	networks
43	parenchyma
43	phenomena
43	gp43
43	count
43	constriction
43	h).
43	drug.
43	neurogenic
43	monolayer
43	(up
43	forms.
43	adhere
43	environments.
43	hosts,
43	distinguished
43	procedures
43	libraries
43	1994.
43	precursors
43	molar
43	facilitating
43	freshly
43	nitrate
43	makes
43	30,
43	preparations.
43	venular
43	h2s
43	ct
43	concentration-response
43	at2
43	hypertrophy,
43	hyperthyroid
43	malnutrition
43	swelling
43	states.
43	junction
43	pcr-rflp
43	(25
43	pigeon
43	ld50
43	foxp3
43	grade
43	micrornas
43	ra
43	iri.
43	yields
43	zymosan
43	nigra
43	hiii
43	pia
43	flagellar
43	chimeric
43	amygdalar
43	dorsolateral
43	proteolysis
43	conformation
43	heparin
43	circumsporozoite
43	aggregatibacter
43	nocturnal
43	amygdaloid
43	geniculate
43	envenomation.
43	hyperalgesia,
43	c-myc
43	nei
43	pic
43	prime-boost
42	recovery.
42	cumulative
42	established.
42	impairing
42	takes
42	hormones,
42	bilayer
42	infusion.
42	reflected
42	progressively
42	structures,
42	exist
42	5′
42	readily
42	gr
42	x-linked
42	cd40
42	engagement
42	pattern.
42	suppressing
42	molecule,
42	brasiliensis.
42	c3h/hej
42	presented.
42	basement
42	undetectable
42	microtubule
42	kluwer
42	kda.
42	clostridium
42	ileum
42	lung.
42	inserted
42	maze
42	ovary
42	withdrawal
42	allergens
42	endothelium.
42	mg/kg).
42	c4
42	leucocyte
42	pointed
42	catabolism
42	elisa,
42	individuals,
42	feces
42	construct
42	chosen
42	subunits.
42	polyacrylamide
42	stat3
42	rhythms
42	45ca2+
42	hexokinase
42	2016.
42	10)
42	retrogradely
42	tibialis
42	ets
42	restores
42	filaments
42	substitutions
42	highlighting
42	induction,
42	bundles
42	hunting
42	canis
42	logistic
42	dose.
42	diversity,
42	adenoviruses
42	e7
42	carry
42	usage
42	hcc
42	marginale
42	non-toxic
42	caulobacter
42	uv-induced
42	yellow
42	receives
42	frontal
42	depots
42	mexicana
42	denv
42	fimbriae
42	fibres
42	expenditure
42	bcr-abl
42	eimeria
42	atopic
42	mycotoxins
41	nox
41	0.01).
41	loop
41	glass
41	generation,
41	mm).
41	route.
41	fungi.
41	compared.
41	(and
41	follows:
41	sixty
41	g)
41	tregs
41	parallel,
41	mycosis
41	disseminated
41	costimulatory
41	2014.
41	periods.
41	infectivity
41	capability
41	pure
41	organs,
41	analyses,
41	believe
41	plasmatic
41	syndrome,
41	(12
41	μg/ml).
41	(l-name)
41	1999
41	k+-atpase
41	correspond
41	indices
41	horizontal
41	searched
41	eliminate
41	correction
41	oxidation.
41	endocrinology.
41	restoring
41	nicotinamide
41	weekly
41	reflecting
41	conjugated
41	endothelin-1
41	males,
41	nmol)
41	phenotypes.
41	vast
41	posttranscriptional
41	enable
41	extend
41	genotypes.
41	swimming
41	microglia
41	mmhg,
41	angiogenesis
41	surveys
41	pará
41	genotyped
41	born
41	health.
41	co-cultured
41	washed
41	refractory
41	patients'
41	protecting
41	tumorigenesis
41	ear
41	intensive
41	vector,
41	(human
41	patient's
41	unconditioned
41	pmd
41	k.
41	pho
41	sensitization.
41	neuroprotective
41	anteroventral
41	aβ
41	suckling
41	transplanted
41	open,
41	cd11c+
41	chemosensitive
40	tubule,
40	limb
40	transport,
40	(map)
40	0.4
40	25%
40	diffusion
40	volume,
40	c)
40	polysaccharide
40	2005.
40	agonist,
40	immunocompromised
40	confer
40	remarkably,
40	dth
40	cd28
40	profound
40	composition,
40	effort
40	plastic
40	next,
40	pair
40	i.p.)
40	compensatory
40	responded
40	gst
40	pleural
40	l-name,
40	pinealectomy
40	individually
40	postulate
40	determinant
40	functionality
40	lineages.
40	genome.
40	taxonomic
40	potential,
40	cdnas
40	eicosapentaenoic
40	measurements.
40	5)
40	phospholipid
40	dissociation
40	l-glutamine
40	men
40	repair.
40	h),
40	sirna
40	aorta.
40	contributions
40	termed
40	asexual
40	hyperalgesia.
40	neurotoxic
40	spectral
40	regenerative
40	histology
40	interrogans
40	dermal
40	pulp
40	hindlimb
40	μl)
40	cerebellum
40	gondii,
40	34
40	diagnosis,
40	worldwide,
40	nodules
40	38
40	foxp3+
40	intranasal
40	targets.
40	necrosis,
40	nos2
40	gram-positive
40	2017.
40	pleiotropic
40	γ
40	subgenus
40	2009.
40	blood-stage
40	molecule.
40	anaemia
40	campestris
40	axonopodis
40	thiamine
40	carcinoma.
40	task
40	septal
40	thiobarbituric
40	athletes
40	mt
40	sickle
40	scfas
40	year.
40	tbars
40	rsv
40	oligopeptidase
40	edrf
40	microemulsions
40	methylobacterium
39	flow.
39	α1
39	surgery,
39	took
39	atp,
39	antagonist.
39	2006.
39	starvation
39	v1
39	apparatus
39	developed.
39	reviews
39	ph,
39	drug,
39	hs
39	analyse
39	accomplished
39	eleven
39	greatest
39	paradigm
39	ahr
39	tlr-4
39	patterns.
39	myd88-/-
39	oxide,
39	pro-
39	exacerbation
39	isotypes
39	integrated
39	tnf-α.
39	(iv)
39	43
39	visualized
39	phenomenon.
39	lung,
39	mk-801
39	consider
39	whereby
39	1,2-nq
39	associate
39	present.
39	exclusive
39	trees
39	tags
39	others.
39	≤
39	adhered
39	overlapping
39	nucleic
39	detection.
39	incubation.
39	possesses
39	images
39	mtor
39	switching
39	nitrite
39	15,
39	75%
39	phosphatidylserine
39	gradually
39	striatum,
39	vessels.
39	2k-1c
39	analysed.
39	infrared
39	slc2a4/glut4
39	investigation.
39	(s)
39	0,
39	hg
39	centers
39	gmbh.
39	transmission.
39	squamous
39	luciferase
39	eyes
39	cs
39	tolerant
39	freshwater
39	c16
39	elusive.
39	cofactor
39	metastasis
39	infant
39	parasite-specific
39	hospitalized
39	latency
39	fgf2
39	pc12
39	α2
39	endopeptidase
39	fh
39	nf-b
39	proline
39	perikarya
39	yoelii
39	trigeminal
39	tegmental
39	peroxisome
39	calbindin
39	hepg2
39	hypoxia-induced
39	carrageenan
39	oc
39	scattering
39	cmv
38	10-6
38	ionic
38	handling
38	accepted
38	ammonium
38	property
38	mol
38	action,
38	loaded
38	7.
38	epithelium.
38	proportional
38	only,
38	preservation
38	disappearance
38	these,
38	whilst
38	referred
38	leukocytes,
38	maturation,
38	invasiveness
38	offspring,
38	programming
38	(24
38	hyperreactivity
38	asthmatic
38	balf
38	accumulation,
38	d2
38	39
38	success
38	filter
38	moiety
38	kda,
38	drastically
38	hypothesis,
38	mechanistic
38	p47phox
38	methodology/principal
38	reflects
38	locomotion
38	regimens
38	depth
38	eta
38	respectively;
38	gonadal
38	doses.
38	unclear
38	longus
38	retained
38	losses
38	(ko)
38	works
38	stage,
38	rescued
38	efferent
38	genesis
38	months,
38	sampling
38	seroprevalence
38	infantum
38	industrial
38	modeling
38	rickettsii
38	diseased
38	phagocytosis.
38	actions.
38	mda-mb-231
38	asc
38	offer
38	silico
38	experienced
38	ig
38	latex
38	attractive
38	tetanic
38	prospective
38	hepatocytes
38	c-reactive
38	innervated
38	lipolytic
38	spiders
38	second,
38	axonal
38	purpose.
38	gbm
38	periplasmic
38	forebrain
38	nerves
38	proliferator-activated
38	msc
38	two-period
38	y.
38	paclitaxel
38	enteroaggregative
38	ventilatory
38	ppgpp
38	pestis
37	pro-apoptotic
37	ugn
37	inhibitor),
37	rodents.
37	decades
37	owing
37	accounted
37	osmotic
37	presently
37	substituted
37	emphasis
37	libitum
37	pd.
37	64
37	found,
37	permeability,
37	continuously
37	spectra
37	origin.
37	consumed
37	).
37	harmful
37	decreased.
37	brief
37	interacting
37	investigated,
37	immunocytochemical
37	residual
37	hamster
37	ones.
37	amongst
37	staining.
37	sera.
37	morphologically
37	sge
37	ischemia/reperfusion
37	low-level
37	remodeling.
37	ovaries
37	2004.
37	submandibular
37	old)
37	annotation
37	midgut
37	vector.
37	ests
37	labelled
37	rodents,
37	construction
37	g,
37	positivity
37	lipids.
37	1991.
37	nicotine
37	islets,
37	granule
37	lipogenic
37	lipase
37	bolus
37	g2
37	65
37	scavenger
37	aging.
37	characterizing
37	reinforcing
37	endothelium-derived
37	monosodium
37	nox1
37	females,
37	proteoglycans
37	pla2s
37	cys
37	probability
37	burning
37	analyzed,
37	statins
37	vectors.
37	serial
37	abc
37	silver
37	blotting,
37	latent
37	capuchin
37	≥
37	sequenced.
37	lts
37	subunit.
37	structurally
37	temperature.
37	alterations,
37	eosinophilic
37	noninfected
37	holtzman
37	researchers
37	limitations
37	°c
37	colocalized
37	infiltrates
37	asia
37	bav
37	mitogenic
37	mmp
37	streptomyces
37	overexpressing
37	behaviors,
37	adsorption
37	oligopeptide
37	ptc
37	tooth
37	bipolar
37	cleaved
37	guanylyl
37	dr
37	cci
37	n(ω)-nitro-l-arginine
37	antiplasmodial
37	neurolysin
37	thimet
37	y1
37	chemoreceptors.
37	p27
36	0.25
36	mimicked
36	balance,
36	2+]
36	channels,
36	mdck
36	permanent
36	mol/l
36	movements
36	44
36	blood.
36	gradients
36	raising
36	spaces
36	situations
36	hair
36	inhibitors.
36	2013.
36	iaa
36	number,
36	1995.
36	converted
36	catalyzes
36	il-18
36	tlr9
36	adhesin
36	peaks
36	neoformans
36	o2-
36	kda)
36	sixteen
36	2019,
36	plasma.
36	specifically,
36	oedema.
36	vesicular
36	plates
36	lipoxygenase
36	(1.0
36	wet
36	clustering
36	amazon.
36	competitive
36	infects
36	160
36	true
36	deviation
36	demonstrated.
36	2-fold
36	ways
36	prl
36	postulated
36	suppresses
36	(e.g.
36	neurochemical
36	brazil)
36	cox-2,
36	sm
36	ameliorated
36	kappa
36	cross
36	metalloprotease
36	tetrahydrobiopterin
36	well.
36	prostacyclin
36	microcirculatory
36	phospholipases
36	antinociception
36	distribution.
36	applications.
36	layer.
36	characteristics.
36	mmp-2
36	0.001),
36	twenty-four
36	implant
36	embedded
36	chondroitin
36	filamentous
36	visible
36	granular
36	vagus
36	feedback
36	proven
36	μg/kg)
36	seropositivity
36	assessing
36	leptospires
36	(lt)
36	children,
36	sometimes
36	cell-free
36	syngeneic
36	allogeneic
36	anti-tumor
36	enrolled
36	targets,
36	leprae
36	genome-wide
36	macmillan
36	precision
36	vivax,
36	africa.
36	adopted
36	pg
36	raise
36	bridges
36	neurodegeneration
36	royal
36	antiviral
36	medicinal
36	muscles,
36	plantaris
36	intradermal
36	adhesion,
36	reck
36	plasmodial
36	venoms,
36	(90%
36	trail
36	puberty
36	metabotropic
36	ly
36	scn
36	neuroinflammation
36	adolescents
36	volunteers.
36	guanosine
36	transplantation.
36	ns1
36	polymer
36	lipophorin
36	odn
36	kcnq
35	s.c.)
35	103
35	transiently
35	image
35	1993
35	electronic
35	mmhg)
35	fluid.
35	water,
35	catalyzed
35	decreased,
35	giving
35	potentials
35	positions
35	4%
35	free-living
35	alterations.
35	opportunistic
35	migrate
35	way,
35	paracoccidioidomycosis.
35	pattern,
35	interactions,
35	phospholipids
35	discriminate
35	mounted
35	architecture
35	ultrastructure
35	examined,
35	trypanosomes.
35	cytokine-induced
35	ovariectomy
35	(i.p.)
35	il-13
35	accordance
35	so,
35	suffering
35	injuries
35	con
35	well-known
35	strips
35	discrimination
35	brener
35	standardized
35	variance
35	origins
35	diversity.
35	serology
35	sialic
35	theophylline
35	interpretation
35	dhea
35	gluconeogenesis
35	potentiates
35	jnk
35	density,
35	fat-rich
35	concurrent
35	anaesthetized
35	lumbar
35	descending
35	contractility
35	degradation,
35	vsmcs
35	nitrergic
35	pertussis
35	pathophysiological
35	denervated
35	corresponded
35	complications.
35	weakly
35	55
35	parasympathetic
35	therapies.
35	ch
35	cut-off
35	amblyomma
35	2011.
35	cows
35	subsp.
35	countries,
35	concern
35	limits
35	scale
35	arthritis.
35	coconut
35	aeruginosa
35	world,
35	admixed
35	p21
35	phylogenetically
35	cytosol
35	flagellin,
35	il-12/il-23-/-
35	stria
35	phaseolus
35	axis.
35	mandibular
35	egfr
35	(ic50
35	hours,
35	transdermal
35	adhesive
35	venomous
35	envelope
35	glur1
35	(ec
35	palmitoyltransferase
35	pharmacokinetics
35	biflorin
35	hct-8
35	gp91-phox
35	cvid
35	klotho
34	uptake.
34	physiologic
34	vacuolar
34	mitogen-activated
34	kinase,
34	consequence,
34	myristate
34	newborns
34	microelectrodes.
34	cachexia,
34	unexpectedly,
34	dependent.
34	enough
34	54
34	differing
34	solely
34	remove
34	parameter
34	situation
34	isoforms.
34	37°c
34	tryptophan
34	immunologists,
34	tgf-β,
34	mannose
34	ubiquitous
34	silva
34	delayed-type
34	neutralize
34	cell,
34	periphery
34	1998
34	titres
34	47
34	9,
34	advantages
34	occlusion
34	reperfusion.
34	(mpo)
34	(bal)
34	mesentery
34	euthanized
34	subpopulations
34	breakdown
34	(enos)
34	controversial.
34	group;
34	incubation,
34	gestation.
34	),
34	weeks)
34	prazosin
34	annotated
34	evasion
34	criteria
34	family.
34	follows
34	report,
34	pulsed
34	difficulties
34	ceramide
34	140
34	wheat
34	phosphodiesterase
34	half-life
34	acyl
34	interleukin-6
34	night
34	retinas
34	detail
34	sole
34	anoxia
34	rearing
34	fifteen
34	presynaptic
34	overexpressed
34	pruritus
34	neonates
34	reasons
34	diameters
34	products,
34	golgi
34	splenocytes
34	irregular
34	steroid
34	tissue-specific
34	bmd
34	gain,
34	histochemical
34	2.0
34	yet.
34	neurotransmission
34	time-course
34	il-1
34	sad
34	striated
34	positive.
34	tick-borne
34	colonies
34	sample.
34	locations
34	dcs.
34	freund's
34	behind
34	eat
34	monocyte-derived
34	ldl
34	(nf-κb)
34	kg-1)
34	fate
34	peculiar
34	understood,
34	projects
34	detected,
34	december
34	deficiency.
34	epigenetic
34	maturation.
34	etiologic
34	spliced
34	corroborating
34	hygiene.
34	species-specific
34	fumonisins
34	aminotransferase
34	cruzi-infected
34	(tb)
34	biomarker
34	glioblastoma
34	xpa
34	players
34	examples
34	portions
34	lactating
34	nephropathy
34	bile
34	dp
34	acta
34	biofilms
34	protocol.
34	haemolytic
34	rubella
34	febrile
34	msp119
34	fima
34	ag73
34	mcs
34	infarcted
34	fos-ir
34	cx36
34	calcium-binding
34	displaced
34	exhaustive
34	-1)
34	enterotoxins
34	c(max)
34	shiga
34	hemopressin
33	reabsorption.
33	microelectrodes
33	attributable
33	hf.
33	domains.
33	balance.
33	ingested
33	activators
33	mmol/l
33	jk
33	modifying
33	indicator
33	object
33	orange
33	hormones.
33	hormone,
33	uninephrectomized
33	bidirectional
33	steroids
33	moderately
33	vessels,
33	rates,
33	reviewed
33	extent,
33	emission
33	literature.
33	methodology
33	probable
33	season
33	104
33	d)
33	iv)
33	truncated
33	cd40l-deficient
33	constitutes
33	formulations.
33	post-infection
33	sense
33	histologic
33	nude
33	igg3
33	reactivity,
33	non-infected
33	mimic
33	both.
33	motility
33	formaldehyde
33	i.e.
33	acetyltransferase
33	factor.
33	88
33	umbilical
33	opening
33	field.
33	millions
33	tc
33	deletions
33	corresponds
33	distinctive
33	use.
33	18s
33	protozoa
33	genome,
33	homogeneous
33	immunoblot
33	met
33	gp91
33	t3.
33	proinsulin
33	institute
33	adipocytes,
33	depression
33	chapter
33	repair,
33	par2
33	mitochondria.
33	surrounded
33	nfκb
33	endothelium-intact
33	hepatocyte
33	relaxant
33	at2r
33	physiology.
33	dyslipidemia
33	matrix.
33	tightly
33	1.8
33	predisposition
33	participating
33	excised
33	n-
33	residues,
33	3t3-l1
33	phases.
33	lesion.
33	training-induced
33	etiology
33	hypoxia.
33	(nts)
33	•
33	exercise-induced
33	swine
33	corroborate
33	leopardus
33	pigeons
33	leukocytes.
33	autologous
33	microsomal
33	galectin-3
33	factor-κb
33	nf-κb,
33	l929
33	thymocytes
33	mic
33	hpv-16
33	responding
33	weinheim.
33	urethane
33	intercross
33	odds
33	date,
33	tsetse
33	east
33	homologues
33	diarrhea.
33	glands,
33	subclasses
33	2d
33	damaging
33	syndromes
33	complementation
33	deficiencies
33	subtropical
33	transduced
33	extension
33	attack
33	lesioned
33	vero
33	abca1
33	microplusin
33	body.
33	morning
33	ectoplacental
33	routes.
33	ds
33	schizophrenia
33	glutamic
33	hmb
33	mtorc1
33	lu.
33	nlrp1
33	ehec
33	aldh2
33	pf
33	ouabain-treated
33	stathmin
32	m,
32	biphasic
32	10-9
32	β-adrenoceptor
32	renin
32	nephron
32	resin
32	technique,
32	3-
32	preincubation
32	served
32	fractionation
32	zero
32	rat,
32	s-1
32	field,
32	inulin
32	(two
32	slower
32	7.5
32	enlargement
32	epithelium,
32	salts
32	a1
32	immunotherapeutic
32	decided
32	pathogen.
32	outcomes.
32	th1/th2
32	setting
32	interface.
32	proteinase
32	51
32	phagocytosis,
32	forms,
32	explants
32	hq
32	toxicity.
32	48/80
32	mellitus.
32	prostanoids
32	hydroxide
32	peritoneum
32	potentiate
32	neglected
32	computational
32	stocks
32	transcription,
32	genomes.
32	oligonucleotides
32	multiplex
32	enabled
32	107
32	residues.
32	dodecyl
32	silica
32	decay
32	wolters
32	β2ko
32	2012.
32	actions,
32	erk3
32	86rb
32	saline.
32	oliveira,
32	probing
32	non-selective
32	carrageenan-induced
32	caliber
32	captopril
32	estimates
32	practice
32	becomes
32	resorption
32	slices
32	hemorrhage
32	insulin-resistant
32	continuing
32	plate
32	utilize
32	tachycardia
32	free-ranging
32	collected.
32	black
32	increasingly
32	inoculation,
32	gapdh
32	nematode
32	glycol
32	tumor.
32	colitis
32	knee
32	impacts
32	previously,
32	grain
32	arrested
32	comet
32	responder
32	theileri
32	calibration
32	switch
32	gelatin
32	agonists.
32	aki
32	erythrocytes.
32	pfc
32	xeroderma
32	cleave
32	regulon
32	cho
32	circuitry
32	motion
32	ob/ob
32	7)
32	length,
32	condylar
32	müller
32	gag
32	wheezing
32	rif
32	fur
32	pbmcs
32	nbor
32	ps
32	auclast,
32	thermoregulatory
32	bla
32	mds
31	causal
31	remarkably
31	segments,
31	hallmark
31	delivery.
31	transcriptase
31	(mrna)
31	ascending
31	agonist)
31	path
31	program.
31	8)
31	approaches,
31	laboratories
31	non
31	-2
31	explanation
31	drop
31	ha
31	large-scale
31	fourteen
31	mutants,
31	(treg)
31	fatal
31	categories
31	intratracheally
31	caspases
31	initially,
31	isolate,
31	host,
31	antigen-presenting
31	1st
31	il-5,
31	confirms
31	examining
31	mother
31	comparisons
31	adjuvant.
31	(6
31	endowed
31	multiplication
31	adults.
31	bites
31	agonist.
31	degranulation.
31	smoke
31	integrins
31	influx,
31	dose-response
31	stimulus,
31	commercially
31	confluent
31	inflamed
31	highlighted
31	distant
31	shuttle
31	l-name.
31	−1
31	proximity
31	out.
31	australian
31	brucei
31	subgroups
31	3%
31	contrary
31	technology
31	coated
31	isolated.
31	c57bl/6j
31	β-cells
31	health,
31	phox,
31	co-localization
31	t3-induced
31	fifth
31	signal-regulated
31	akt,
31	degenerative
31	rhythmic
31	unexpected
31	(which
31	(2.5
31	(sc)
31	interval.
31	develops
31	equine
31	endothelium,
31	mg)
31	hg,
31	vasomotor
31	non-specific
31	post-translational
31	antihypertensive
31	converting
31	peroxynitrite
31	ameliorate
31	relaxed
31	(aa)
31	biomedical
31	binding.
31	weights
31	non-treated
31	myocardium
31	phosphate-dependent
31	lysosomal
31	(with
31	electrolytic
31	vertical
31	gondii.
31	(7
31	ehrlichia
31	rickettsial
31	(ms)
31	1000
31	evaluation.
31	january
31	education
31	promoters
31	nimesulide
31	mg/kg/day
31	exclusion
31	al
31	cultivation
31	sewage
31	ps.
31	herpes
31	antibody,
31	(ci)
31	otherwise
31	c3,
31	worse
31	cartilage
31	juvenile
31	adding
31	leader
31	fb
31	tuberculosis.
31	gives
31	immunization,
31	elucidation
31	stages,
31	rotavirus
31	spectrometry,
31	fungi,
31	catalytically
31	gfp
31	rhynchosciara
31	mevalonate
31	high-risk
31	faecalis
31	myelin
31	gnrh
31	creb
31	vulgaris
31	i.d.
31	ad.
31	ionotropic
31	nociception
31	endooligopeptidase
31	statin
31	thermogenesis
31	μg/100
31	mea
31	longipalpis
31	tadalafil
31	sr140333
31	sphingomyelinase
31	dna-hsp65
31	maspin
31	mycotoxin
31	flic
31	ankhd1
30	(wky)
30	nhe1
30	protein-coupled
30	10-7
30	intercalated
30	adulthood
30	exists
30	amiloride
30	w
30	cytoskeleton.
30	u
30	hormone.
30	8.
30	mm.
30	antimony
30	perhaps
30	plasma,
30	procedure,
30	medullary
30	promotion
30	putatively
30	isolate.
30	students
30	mr
30	(30%)
30	fitness
30	described,
30	cytoplasm.
30	(no),
30	lipids,
30	believed
30	eosinophilia
30	kill
30	dba/2
30	rt-pcr,
30	68
30	ineffective
30	(hfd)
30	healthcare
30	μg/kg,
30	anxiety-like
30	cigarette
30	trafficking
30	7-day
30	(tlr)
30	oscillations
30	detachment
30	repeatedly
30	imply
30	oils
30	(paf)
30	58
30	sylvatic
30	decarboxylase
30	frame
30	matter
30	existing
30	branch
30	(elisa)
30	prototype
30	84
30	actual
30	domain.
30	entirely
30	requirement
30	(2),
30	originating
30	perspective
30	optimum
30	atropine
30	(500
30	normalization
30	pads
30	catalase,
30	inducers
30	2o
30	systematically
30	c-jun
30	static
30	modulators
30	(sod),
30	deprived
30	catabolic
30	tea
30	fuel
30	preclinical
30	striatum.
30	dissected
30	home
30	stereotyped
30	injections.
30	questionnaire
30	weeks).
30	releases
30	precontracted
30	p<0.05).
30	responders
30	microscope
30	cytotoxicity.
30	autophagic
30	undifferentiated
30	rattlesnake
30	digitorum
30	crotalid
30	regulation,
30	thalassophryne
30	reason
30	f-actin
30	(ap)
30	survive
30	grains
30	eventually
30	ranges
30	(hr)
30	tractus
30	firing
30	reproducible
30	issues
30	lasting
30	facilitated
30	overlap
30	municipality
30	tachyzoites
30	anaplasma
30	mato
30	sporadic
30	feeding,
30	spotted
30	sequencing.
30	sources.
30	tube
30	(lps),
30	interleukin-1β
30	sle
30	cavity.
30	biogenic
30	braf
30	(pbmc)
30	neoplasm
30	(airmax
30	tumorigenesis.
30	fly
30	biosynthesis.
30	substrate.
30	instability
30	parasitemias
30	rational
30	pigmentosum
30	cyclobutane
30	doxorubicin
30	antioxidants
30	oncogenic
30	ner
30	adenoviral
30	elements.
30	coenzyme
30	phage
30	prey
30	midbrain
30	extensor
30	ductal
30	sunflower
30	(1,
30	ls
30	high-throughput
30	dichroism
30	oocyte
30	cx43
30	geodiamolide
30	asian
30	pvmsp-1
30	lactobacillus
30	q
30	lamellar
30	fatigue
30	bmp-9
30	amygdala,
30	fipronil
30	(mi)
30	(7%
30	cg
30	aversive
30	p2y1
30	adipokines
30	seb
30	nanoemulsion
30	opp
30	afb1
29	(10-6
29	(er)
29	nh4cl
29	flow,
29	scandinavian
29	(hf)
29	actinomycin
29	h+-atpase
29	playing
29	(rt-pcr)
29	10-5
29	pufa
29	decades,
29	minute
29	ptx
29	that:
29	depressed
29	disclosed
29	1992
29	analogous
29	s,
29	nm.
29	membranes.
29	coefficients
29	values,
29	o.
29	two-dimensional
29	nadh
29	optimization
29	trials.
29	chromatography,
29	niche
29	agricultural
29	characteristics,
29	iii)
29	velocity
29	vegetative
29	life-threatening
29	press,
29	antiinflammatory
29	membrane-bound
29	mice;
29	inability
29	sharing
29	il-2,
29	eosinophilia,
29	internalization
29	adhesins
29	dust
29	microenvironment.
29	78
29	inbred
29	universal
29	non-pathogenic
29	histopathology
29	conferring
29	hybrids
29	trypsin
29	matched
29	igg,
29	transferase
29	(ovx)
29	24h
29	homeostatic
29	airways.
29	purine
29	amphetamine
29	inherited
29	fluctuations
29	1992.
29	benznidazole
29	pathogenesis,
29	exploratory
29	unknown,
29	restoration
29	attempts
29	opens
29	artificially
29	subdivided
29	vectors,
29	spot
29	flanking
29	bp,
29	radioactivity
29	form.
29	fraction,
29	freezing
29	rnas
29	gsis
29	explored.
29	aii
29	irs-2
29	stearic
29	phosphatidylcholine
29	feeding.
29	glycolysis
29	source.
29	irreversible
29	memory.
29	4.5
29	lc
29	centrally
29	t3,
29	hoe
29	elderly
29	plasminogen
29	interaction,
29	an.
29	tetrodotoxin
29	edl
29	arise
29	biglycan
29	biopsy
29	obtained,
29	approach,
29	created
29	direction
29	permissive
29	speed
29	dextran
29	tract,
29	innervate
29	definitive
29	terrestrial
29	ifat
29	predictive
29	threat
29	smears
29	primates.
29	scorpion
29	zoonosis
29	coast
29	transmission,
29	vl
29	segregated
29	rescue
29	inoculum
29	cd86
29	isolation,
29	homolog
29	cecal
29	fibrosis,
29	rheumatoid
29	transcription.
29	triglycerides
29	engineered
29	dispersion
29	streptococci
29	attenuating
29	immunosuppressed
29	high-affinity
29	problem.
29	attempted
29	trophic
29	drastic
29	replication.
29	ozone
29	singlet
29	xp
29	chloroquine
29	keratinocytes
29	homologue
29	replicate
29	emotional
29	perceptual
29	auditory
29	annual
29	enhancer
29	soy
29	parotid
29	life,
29	química.
29	mi,
29	mobile
29	stratum
29	intraocular
29	sarcoma
29	toxin,
29	erythrocytic
29	ctla-4
29	xylose
29	mucosa.
29	periodontopathogens
29	brain-derived
29	diurnal
29	imhv
29	ap-1
29	endings
29	palatine
29	mep
29	efs-induced
29	sildenafil
29	μg/ml.
29	sf-295
29	pisosterol
29	prion
29	sf-1
29	ethanol-induced
29	laeta
29	fty720
29	uveitogenic
29	chemoreception
28	way.
28	lithium
28	opossum
28	cycloheximide
28	0.04
28	ip)
28	extrusion
28	46
28	blocker,
28	but,
28	ion-exchange
28	differences,
28	s)
28	driving
28	membranes,
28	permeability.
28	0.6
28	depended
28	polyamine
28	fixation
28	quantities
28	quantity
28	sa
28	mutants.
28	rhifn-γ
28	hydrocarbon
28	ifnγ
28	paracoccidioidomycosis,
28	tlrs
28	exudates
28	performed,
28	mcp-1,
28	2011,
28	virulence.
28	mimics
28	infiltration.
28	die
28	constituted
28	inoculation.
28	host's
28	conspicuous
28	gels
28	influx.
28	pre-treated
28	sd
28	male,
28	parenchyma.
28	nodes.
28	responsiveness.
28	rely
28	exposition
28	treatments,
28	eb
28	present,
28	united
28	definition
28	lacks
28	relies
28	match
28	genotype.
28	origin,
28	freely
28	neighboring
28	allocated
28	similar,
28	subgroup
28	defining
28	evolution.
28	amplify
28	(e)
28	leishmania,
28	invertebrate
28	features.
28	favors
28	acetylcholine,
28	shifted
28	walker-256
28	evidencing
28	fermentation
28	docosahexaenoic
28	speculate
28	pi3k/akt
28	voluntary
28	organelles
28	homogenate
28	accumbens
28	quantitatively
28	women,
28	low-grade
28	bleeding
28	isometric
28	ach-induced
28	sepsis,
28	stretching
28	cyclooxygenase-2
28	rhoa
28	p<0.05)
28	hypotensive
28	pmol
28	nonspecific
28	micrurus
28	avoiding
28	noticed
28	dermis
28	reciprocal
28	section
28	originate
28	processing.
28	elucidated
28	dysregulation
28	variability,
28	adjustments
28	thermogenic
28	1.2
28	foundation
28	municipalities
28	fail
28	(boophilus)
28	wildlife
28	ci:
28	cryptosporidium
28	younger
28	lupus
28	river
28	risks
28	fifty
28	primate
28	foci
28	archaea
28	t1d
28	survived
28	il-8
28	pge2,
28	membrane-associated
28	μg/ml),
28	yac-1
28	hyperalgesic
28	high-resolution
28	layers.
28	required.
28	degrade
28	h1
28	pristane-induced
28	dmba
28	mucous
28	vaccine,
28	abiotic
28	parasitaemia
28	seeds
28	single-stranded
28	tolerated
28	myc
28	(cs)
28	cosmomycin
28	glycosylation
28	thi1
28	xac
28	virulence-associated
28	selection,
28	baculovirus
28	amv
28	pl
28	endodontic
28	c-terminus
28	reproduction.
28	innovative
28	gained
28	mir-146b-5p
28	nadph-diaphorase
28	fusobacterium
28	cebus
28	apella
28	enterocytes
28	formulation.
28	hgf
28	lingual
28	α-synuclein
28	neurotransmitters
28	tectum.
28	asp49
28	pgd2
28	ezetimibe
28	adiposity,
28	pomc
28	diphosphate
28	vitellogenin
28	celecoxib
28	multidrug-resistant
28	(aepec)
28	serpinb5
28	α2/3-na,k-atpase
28	endometriosis
28	rti
28	kf
27	background/aims:
27	(ras)
27	iso
27	(0.3
27	morphological,
27	tubules,
27	filled
27	fructose
27	nongenomic
27	(shr).
27	discussion
27	disrupt
27	describing
27	electrophysiological
27	fluids
27	1990
27	mg/ml
27	electrochemical
27	solute
27	(h
27	ascribed
27	established,
27	purposes.
27	union
27	cfu
27	plasmacytoid
27	limited,
27	expansion,
27	defined.
27	notably
27	2013,
27	tlr4,
27	illustrate
27	tnf,
27	scarce
27	nodes,
27	mortality,
27	dose,
27	amylase
27	form,
27	considered.
27	point,
27	62
27	hyperresponsiveness
27	mothers.
27	disorder.
27	ova.
27	l-selectin
27	week,
27	dimorphism
27	(cns)
27	granulocytes
27	reversion
27	1h
27	calretinin
27	katp
27	(oa)
27	phenol
27	indicators
27	remodelling
27	methysergide
27	perivascular
27	morphology.
27	web
27	acid)
27	3.0
27	preferred
27	tr
27	mutations.
27	domain,
27	immunofluorescence.
27	inactivated
27	encountered
27	lowering
27	mellitus,
27	intolerance,
27	ameliorates
27	thereafter,
27	subunit,
27	streptozotocin-induced
27	paracrine
27	lactation.
27	jugular
27	case,
27	behavioural
27	notable
27	cee
27	(lv)
27	focuses
27	aortas.
27	becoming
27	t2dm
27	immunoblotting,
27	th-induced
27	failure,
27	decorin
27	maternal-fetal
27	κb
27	glycaemic
27	cardiomyocytes.
27	microcirculation
27	bradykinin,
27	estrous
27	suspensions
27	synthetase
27	product,
27	aortae
27	granules.
27	offers
27	iii,
27	stability.
27	undergoes
27	arranged
27	insulin-like
27	biotinylated
27	vimentin
27	(pvn)
27	(
27	fibrotic
27	bout
27	thirteen
27	americana
27	non-human
27	cats,
27	pneumonia
27	amazonensis.
27	2015.
27	triglyceride
27	premature
27	cpv
27	calf
27	genus.
27	low-density
27	cd4+,
27	physiopathology
27	bridge
27	articular
27	aspirin
27	sediments
27	dispersal
27	authors;
27	separately
27	currently,
27	distinguish
27	mutation.
27	segregation
27	sclerosis
27	closest
27	orthologs
27	distributions
27	lethality
27	rough
27	hyperplasia
27	histocompatibility
27	tem
27	doses,
27	sporozoite
27	apcs
27	correlating
27	ifn-γ-/-
27	cd11b
27	engaged
27	frequency,
27	silenced
27	cpds
27	vision
27	sun
27	e3
27	repression
27	pyrophosphate
27	synthesizing
27	learned
27	n-methyl-d-aspartate
27	processing,
27	(nmda)
27	proportions
27	bite
27	ci,
27	pretectal
27	ends
27	vaccination.
27	aet
27	easy
27	nf-kb
27	overload
27	(bat)
27	glut
27	cysteine-rich
27	mosquitoes.
27	trophozoite
27	protein-2
27	guyanensis
27	toxin.
27	p16ink4a
27	long-lived
27	avidity
27	cent)
27	kanamycin
27	cx
27	gpx
27	hypothermia.
27	a5
27	horn
27	6-hydroxydopamine
27	(ad)
27	cgrp
27	glur2/3
27	neuropil
27	ms100a9p
27	leukemic
27	cmax,
27	jak2
27	wnt
27	agglomerans
26	antagonist),
26	glucagon
26	transport.
26	immunoblotting.
26	shrs
26	likewise,
26	modulation.
26	acid-base
26	sb
26	deprivation.
26	units,
26	alone,
26	0.01
26	12)
26	kcl
26	evaluations
26	change.
26	saturation
26	110
26	solvent
26	carbachol
26	labelling
26	biosynthesis,
26	(21
26	enterobacter
26	proposed.
26	generations
26	20,
26	98
26	pcm.
26	allergy,
26	clearance.
26	motivated
26	recover
26	2010,
26	laminin,
26	cryptococcus
26	size.
26	reserved:
26	permitted.
26	59
26	inversely
26	namely,
26	acetyl
26	complication
26	s100β
26	low-dose
26	moment
26	lymphatic
26	mda
26	(such
26	pro
26	saline:
26	instillation
26	thereafter.
26	alloxan-induced
26	synthases
26	oil,
26	10.
26	paf-induced
26	platelets.
26	tci
26	prompted
26	technologies
26	lineages,
26	recipient
26	physicians
26	tract.
26	specificity,
26	integral
26	evolution,
26	positioned
26	electrophoresis.
26	pol
26	similar.
26	profiles,
26	epitopes.
26	hybridization.
26	77
26	hydrolyzed
26	(approximately
26	blocker.
26	pioglitazone
26	impairments
26	virgin
26	oleic,
26	genital
26	oxidase.
26	ensure
26	49
26	hr.
26	diets,
26	composition.
26	weighing
26	2.1
26	caffeine
26	postsynaptic
26	phenylephrine-induced
26	diabetics
26	thrombin
26	immunofluorescence,
26	arteries.
26	leukocyte-endothelial
26	sixth
26	aberrant
26	mg/kg/day)
26	stores
26	obtaining
26	decidualization
26	other.
26	versican
26	constructs
26	extract,
26	conclusions/significance:
26	trabecular
26	junctions
26	recordings
26	respiration
26	hr,
26	integrity,
26	circulatory
26	icv
26	(et)
26	arising
26	cap
26	uncover
26	memory,
26	manipulation
26	completed
26	mat
26	harbor
26	island
26	sex,
26	caninum.
26	feline
26	phylogeny
26	illness
26	41
26	opportunity
26	prevailing
26	61
26	encephalitis
26	brought
26	(pge2)
26	tc-1
26	protocol,
26	leishmanicidal
26	milieu
26	findings.
26	hard
26	lifestyle
26	interest,
26	2a
26	presumptive
26	mcf-7
26	gingivalis,
26	bactericidal
26	chemotaxis.
26	insects,
26	lewisi
26	anemia,
26	acanthamoeba
26	draining
26	nkt
26	ethyl
26	autoimmunity
26	metastasis.
26	context.
26	intermediates
26	progression,
26	transposon
26	recognizing
26	briefly
26	condensation
26	stretch
26	attentional
26	pag,
26	os
26	nasopharyngeal
26	consumption,
26	myotubes
26	glut-4
26	tropicalis
26	commensal
26	α3
26	α5
26	der
26	stop
26	approved
26	fibronectin,
26	tgfβ1
26	ngf
26	macroscopic
26	sweet
26	egr-1
26	crotapotin
26	corpuscles
26	awake
26	leprosy
26	aggregation,
26	liquid-liquid
26	clarithromycin
26	edematogenic
26	mt-iii
26	k562
26	rejection.
26	c4bp
26	diarrheagenic
26	oxygenase
26	av3v
26	co2/h+
25	1.6
25	redistribution
25	tubules.
25	ringer
25	0.08
25	investigation,
25	inverted
25	cm-2
25	control:
25	blot,
25	4.6
25	1996
25	h-ion
25	injecting
25	transported
25	yielding
25	creating
25	23%
25	steady-state
25	limitation
25	oxytocin
25	pools
25	cost
25	leaf
25	reduction.
25	difficulty
25	microbiology
25	microorganism
25	(c
25	opposed
25	leishmaniasis,
25	(tlrs)
25	adsorbed
25	monocytes,
25	uncontrolled
25	interleukin-12
25	reversal
25	65%
25	overproduction
25	lectins
25	lysates
25	53
25	74
25	column.
25	amastigotes.
25	picture
25	24 h
25	days).
25	males.
25	forced
25	sexually
25	interleukin-10
25	operated
25	(sod)
25	anaphylaxis
25	vitamins
25	foreign
25	glibenclamide
25	endogenously
25	postmenopausal
25	hydroxyl
25	oedema,
25	alloxan
25	aluminum
25	one,
25	helpful
25	atp-binding
25	cassette
25	microorganisms,
25	elongation
25	boost
25	links
25	est
25	frames
25	error
25	serologic
25	coefficient
25	additionally
25	(1),
25	simulated
25	connection
25	costs
25	migrated
25	18%
25	unstable
25	theoretical
25	hyperglycemia,
25	methylation
25	cytoprotective
25	radioimmunoassay
25	(ffa)
25	metabolized
25	closure
25	12-month-old
25	potentiating
25	(ach)
25	facilitates
25	0.8
25	(ne)
25	cerebrospinal
25	rings.
25	inherent
25	–
25	1.3
25	status,
25	counterparts
25	nitrotyrosine-containing
25	unstimulated
25	3-fold
25	vacuoles
25	nifedipine
25	apart
25	hence
25	constituents
25	decidua
25	thyroidectomized
25	reinforces
25	formulation,
25	glandular
25	pre-
25	matrix,
25	specificity.
25	subpopulation
25	clear.
25	enlarged
25	neuroanatomical
25	ageing
25	modern
25	accurately
25	felids
25	oocyst
25	(8
25	parasitological
25	57
25	house
25	sorghum
25	(igg)
25	ae
25	leptospirosis.
25	poly
25	axis,
25	discussion:
25	puncture
25	favorable
25	constituting
25	3-week
25	promastigote
25	lipoproteins
25	(l-name;
25	μmol
25	thioglycollate-elicited
25	far.
25	cent
25	metals
25	penicillium
25	surfaces.
25	°c.
25	approach.
25	patterns,
25	framework
25	result,
25	t-cells
25	esters
25	recurrence
25	bias
25	prognostic
25	(air)
25	recessive
25	78%
25	routes,
25	crithidia
25	branches
25	testes
25	gfap
25	effectors
25	(uv)
25	breaks
25	neuromuscular
25	gliomas
25	triple
25	double-stranded
25	task.
25	lha
25	organizing
25	session.
25	motivational
25	periapical
25	factor-alpha
25	ligature
25	select
25	myoepithelial
25	prove
25	yolk
25	tlr2,
25	micronucleus
25	co-administration
25	smad4
25	cell-cell
25	stool
25	actinobacillus
25	perfringens
25	ccr4
25	epidermis
25	parabrachial
25	pontine
25	sikvav
25	design.
25	2009,
25	ltda.
25	aversion
25	n-6
25	constants
25	l-alanine
25	immobilization.
25	2carko
25	c18
25	thioglycollate
25	urocortin
25	persons
25	cmax
25	fluconazole
25	cetirizine
25	antivenoms
25	colostrum
25	humanized
25	ln
25	e6
25	moda
25	bt
25	bfp
25	achase
25	probiotics
25	bitis
25	rtn.
25	hypercapnia.
24	na+-h+
24	colonic
24	nova
24	collecting
24	obtained:
24	or,
24	keeping
24	transporters,
24	0.12
24	cover
24	micromolar
24	alkalosis
24	range.
24	nephrectomy
24	tip
24	compromised
24	acidosis
24	techniques,
24	curves,
24	programmed
24	eighteen
24	genotypes,
24	repressed
24	producer
24	accumulating
24	calmodulin
24	(c),
24	brasiliensis,
24	(b10.a)
24	oxidase,
24	abilities
24	particulate
24	organism.
24	predominated
24	tended
24	enter
24	masses
24	autosomal
24	were,
24	serotonin,
24	parasitized
24	collected,
24	(lps)-induced
24	route,
24	degranulation,
24	antagonists.
24	not,
24	oliveira
24	calcium,
24	remote
24	pecam-1
24	obstruction
24	oxidant
24	add
24	serves
24	reflux
24	co-stimulatory
24	stimulant
24	non-immunized
24	(day
24	preceded
24	paf.
24	ltb4,
24	phylogenies
24	theory
24	igg1,
24	parasitology
24	incomplete
24	screen
24	indigenous
24	lppg
24	trypomastigotes.
24	specificities
24	epitopes,
24	1987.
24	sensing
24	test)
24	flavonoids
24	glycation
24	eif5a
24	eef1a
24	autocrine
24	importantly
24	adjustment
24	important,
24	review.
24	ac
24	1989.
24	o2
24	february
24	adolescence
24	(da)
24	light,
24	naloxone
24	apomorphine
24	fluoxetine
24	flx
24	hot
24	sexes
24	cancers.
24	prone
24	aorta,
24	preserve
24	ng/ml,
24	immunoperoxidase
24	program,
24	vehicle-treated
24	(western
24	ep
24	altered.
24	methylene
24	physicochemical
24	toxins,
24	swollen
24	media.
24	wat,
24	euthyroid
24	resembling
24	activin
24	glycosaminoglycans
24	primordial
24	morphometry
24	temporally
24	intensities
24	glutamate,
24	μl
24	45%
24	material.
24	si
24	solitarii
24	snasg
24	deficit
24	corticotropin-releasing
24	terminals.
24	lasted
24	validate
24	ether
24	ah
24	serovars
24	immunofluorescent
24	research,
24	cats.
24	medicina
24	americas.
24	twofold
24	2008.
24	climate
24	city,
24	creatinine,
24	positioning
24	ancient
24	bartonella
24	microcephaly
24	apicomplexan
24	carries
24	cattle,
24	arginase
24	georg
24	wave
24	cytotoxicity,
24	hb
24	tracers
24	compound,
24	identifies
24	ml-1)
24	alcohols
24	broth
24	mo-dcs
24	option
24	prevotella
24	2006,
24	folding
24	regeneration.
24	years)
24	polymorphism,
24	drawn
24	mycoplasmas
24	lacked
24	fruit
24	superfamily
24	uva
24	lesion,
24	strand
24	splice
24	gsh
24	pathologies.
24	layer,
24	site-directed
24	3′
24	rlpag
24	orexin
24	epilepsy
24	protein)
24	albuminuria
24	nutrition
24	untrained
24	microplus.
24	acanthoscurria
24	transcripts,
24	alkaloids
24	peanut
24	puff
24	nerolidol
24	il4
24	duffy
24	2018.
24	demographic
24	hiv-infected
24	msp1
24	dissolved
24	β-lactamase
24	dentate
24	admitted
24	marmoset
24	cortisol
24	neurogenesis
24	upr
24	adjuvants.
24	aggregation.
24	nerve.
24	axon
24	tectal
24	dgcs
24	mt-ii
24	caterpillar
24	crotoxin,
24	shc
24	standard.
24	cga
24	sarcoplasmic
24	fungiform
24	mif
24	isoprenic
24	pep
24	penile
24	cavernosal
24	80-125%
24	naja
24	kd
24	omeprazole
24	cd100
24	aire
24	mir-22
24	hc11
24	ghrelin
24	il-10/tnf-α
24	pvama-1
23	fraction.
23	expand
23	publishers,
23	(pka)
23	-6
23	nh
23	different.
23	carbonic
23	finally
23	available.
23	loading
23	utilizing
23	gfr
23	steady
23	analog
23	36%
23	preparation.
23	birkhäuser
23	verlag.
23	practically
23	differences.
23	importance.
23	abnormalities.
23	trend
23	qualitatively
23	indication
23	studied:
23	hypertrophic
23	severity.
23	plasticity.
23	(pcm)
23	article,
23	adaptor
23	ova-induced
23	co-cultures
23	both,
23	contrary,
23	characterized,
23	pb18
23	manifestation
23	cytoskeletal
23	organism,
23	months)
23	destruction.
23	(at)
23	6th
23	narrow
23	layers,
23	i.v.,
23	villous
23	usa,
23	animal's
23	booster
23	clinics.
23	implicate
23	mch.
23	minimally
23	airmin,
23	mac-1
23	(mch)
23	mg,
23	dysfunctions
23	extravasation.
23	inhibitor).
23	mn
23	schedule
23	deposition.
23	splanchnic
23	unaffected.
23	counterparts.
23	eosinophils,
23	bayesian
23	proposition
23	ccc
23	protein-coding
23	orestes
23	cardiomyopathy
23	thousands
23	guide
23	network.
23	usual
23	encompassing
23	triatomine
23	alignment
23	spacer
23	cd25
23	hyperimmune
23	primers.
23	neuraminidase
23	85
23	000
23	label
23	ins
23	(16.7
23	reverses
23	ran
23	synthase.
23	irs2
23	tetrazolium
23	desensitization
23	incubating
23	unsaturated
23	face
23	l-leucine
23	rewarding
23	cns.
23	csf
23	systemically
23	ii-induced
23	par
23	time-
23	ar
23	n-stz
23	~
23	amlodipine
23	adiponectin,
23	epidemiologic
23	partially,
23	hek293
23	(wat)
23	binding,
23	tx
23	al.,
23	trophoblastic
23	svmps
23	inadequate
23	accelerate
23	radiation.
23	irradiation,
23	hypoxia,
23	interleukin-1
23	prognosis.
23	angiotensinogen
23	ext
23	frozen
23	demand
23	evaluates
23	therapeutics
23	perceived
23	acetic
23	130
23	farm
23	ticks.
23	71
23	pooled
23	livestock
23	negative.
23	pantanal
23	(for
23	phlebotomine
23	disposal
23	hundreds
23	dehydrogenase,
23	recognised
23	patent
23	33%
23	mental
23	surviving
23	applicability
23	faecal
23	soft
23	intravascular
23	parasite's
23	opportunities
23	5-lipoxygenase
23	lipopolysaccharides
23	shock.
23	isogenic
23	edema.
23	a2,
23	arises
23	substrate,
23	archaeal
23	adapt
23	soils
23	swabs
23	antileishmanial
23	diffraction
23	c4b
23	scfv
23	rapid,
23	genes)
23	caiman
23	ortholog
23	replicative
23	trypomastigotes,
23	selection.
23	clinical,
23	dot
23	anka
23	perc
23	x10/4
23	proteinuria
23	mø
23	(nk)
23	target,
23	alternatives
23	crosstalk
23	chemistry
23	families.
23	duplication
23	arabidopsis
23	chlorosis
23	variegated
23	basomedial
23	compartment.
23	attacks
23	orexinergic
23	directional
23	export
23	resveratrol
23	nfkb
23	thieme
23	noteworthy
23	(gh)
23	consumption.
23	μg/ml,
23	proteinases
23	pna
23	reared
23	villi
23	lactate,
23	deregulation
23	difficile
23	neck
23	falciparum-infected
23	malariae
23	food,
23	aminoglycoside
23	tannerella
23	enterobacteriaceae
23	nickel
23	haemolysis
23	melatonin.
23	serca2
23	intergeniculate
23	u937
23	vta
23	lateralis
23	laminin-111
23	pbm
23	vanilloid
23	sc.
23	transection
23	7-nitroindazole
23	amacrine
23	tectum,
23	lys49
23	acetylcholinesterase
23	myofiber
23	obliqua
23	bonds
23	atria
23	(zikv)
23	parainfluenza
23	br
23	filiform
23	mammillary
23	steatosis
23	pvh
23	bifunctional
23	strains)
23	p10,
23	atb-346
23	between-run
23	bothropic
23	bap1
23	stx
23	enterohemorrhagic
23	denv2
23	serotypes,
23	ckd
23	kgy
23	chf
23	hemoplasma
23	gla
23	bcaa
23	sympathoexcitatory
23	dgf
23	pahsa
22	t84
22	requiring
22	physiology,
22	emphasizes
22	alternatively,
22	specially
22	mmol
22	avp,
22	ca2+-dependent
22	procedures.
22	0.02
22	microscope.
22	acridine
22	border
22	(ph
22	unx
22	adjusted
22	well-defined
22	unaltered.
22	0.5%
22	behave
22	determines
22	times,
22	endophytes
22	source,
22	inorganic
22	resolved
22	2.8
22	internalized
22	d-glucose
22	burdens
22	burst,
22	tolerogenic
22	replication,
22	aryl
22	type-2
22	neutrophilic
22	cd4+foxp3+
22	negligible
22	insufficient
22	alternatively
22	whole,
22	granulocyte
22	interleukin-4
22	oxide.
22	deliver
22	capsular
22	preparations,
22	regarded
22	horse
22	quickly
22	distress
22	phosphate-buffered
22	pollution
22	partner
22	eosinophils.
22	arthritis,
22	exudation
22	feasible
22	contaminant
22	conflicting
22	fetus
22	differs
22	reported,
22	ancestral
22	extracts.
22	proteome
22	databases
22	applying
22	flagellates
22	utility
22	blast
22	lineage.
22	comprehension
22	scaffold
22	performing
22	possessed
22	conjunction
22	likelihood
22	sequencing,
22	triton
22	assumed
22	glycemia,
22	(about
22	small,
22	line)
22	refeeding
22	gcs
22	mo
22	long-chain
22	γ-linolenic
22	disturbance
22	p70s6k
22	aggravated
22	leaving
22	dose-
22	transduction,
22	irs1
22	neonate
22	co-culture
22	perifused
22	leptin.
22	pharmacologically
22	mg/kg.
22	sexes.
22	epcs
22	elucidating
22	1.1
22	baseline,
22	shares
22	anabolic
22	qrt-pcr
22	birth.
22	emax
22	metabolites.
22	needed.
22	collagen,
22	heavily
22	rbc
22	sbp
22	vasodilatation
22	radicals
22	blockade.
22	76
22	isolated,
22	ctl
22	cues
22	tshb
22	fibroblasts,
22	β2-adrenoceptor
22	168
22	disorganization
22	collectively
22	type,
22	mouse,
22	detection,
22	glutamine.
22	well-established
22	haemodynamic
22	diminish
22	integrative
22	hybridized
22	sciences
22	bradycardic
22	52
22	birds,
22	land
22	emphasizing
22	diluted
22	abortion
22	universidade
22	caught
22	monte
22	community.
22	seronegative
22	parvum
22	asia,
22	(p<0.01)
22	santos
22	2),
22	web2170
22	polymicrobial
22	cd86,
22	cisplatin-induced
22	immunology.
22	eicosanoid
22	nk1.1+
22	amazonensis,
22	(0.2
22	arginini
22	complexes.
22	impacted
22	docking
22	å
22	urgent
22	matrigel
22	hypoxic
22	annexin
22	src
22	orchestrate
22	interpreted
22	pia.
22	beads
22	bmc
22	adenoma
22	uncovered
22	rearrangements
22	4.0
22	plasmodium.
22	(pm)
22	integrate
22	mutagenesis.
22	details
22	solar
22	proteasomal
22	old,
22	actually
22	scar
22	flexibility
22	xylem
22	pigment
22	threats.
22	perception
22	gluconeogenic
22	(edl)
22	calorie
22	v/v)
22	sculptum
22	(18
22	mygalin
22	aspartic
22	alkaloid
22	ethanolic
22	unlikely
22	planktonic
22	brdu
22	signature
22	limonene
22	codes
22	pccl3
22	rhob
22	versions
22	ill
22	sf
22	sacchari
22	k12
22	(mmps)
22	distinction
22	rem
22	non-invasive
22	encephalomyelitis
22	astrocyte
22	gsk-3β
22	psychiatric
22	test).
22	elevations
22	(mscs)
22	(tbars)
22	lps-stimulated
22	(150
22	commissural
22	ubiquitinated
22	lpl
22	clp
22	diets.
22	tmj
22	propylene
22	anxiogenic-like
22	perifornical
22	oligopeptides
22	sandfly
22	diazepam
22	μg/paw)
22	spla
22	dermonecrosis
22	aldehyde
22	cd4+cd25+
22	immunodeficiencies
22	sf1
22	polyphasic
22	1826
22	mir-29c
22	lycopene
22	lactogenic
22	apob
22	probiotic
22	haemofelis
22	cpg/cfp
22	phs
22	ssnd
21	sta
21	g-protein
21	sglt2
21	lumen.
21	vesicles.
21	compartments,
21	brush
21	μm;
21	rose
21	m),
21	staurosporine
21	(pkc)
21	yet,
21	sensitive,
21	addresses
21	solutions.
21	ph.
21	component,
21	significant.
21	resemble
21	buffers
21	7%
21	;
21	times.
21	cannula
21	recording
21	exploited
21	march
21	proliferate
21	souza
21	c-type
21	canonical
21	nlrp3,
21	adjuvants,
21	ifn-α
21	traps
21	classically
21	chain,
21	contrasting
21	igg2b
21	deeper
21	histoplasma
21	2nd
21	encapsulation
21	characterizes
21	ground
21	γδ
21	(v)
21	sulfated
21	spore
21	fast,
21	w.
21	albino
21	kind
21	cytochalasin
21	(i/r)
21	repercussions
21	adrenaline
21	adenosine,
21	ischemia.
21	il-17,
21	secretions
21	total,
21	symptom
21	kc
21	low-intensity
21	spleens
21	toluidine
21	5th
21	(10-100
21	-induced
21	1991
21	amastigotes,
21	derivatives,
21	tcbat
21	closer
21	monophyletic
21	gold
21	evolving
21	hybridization,
21	strain-specific
21	subdivisions
21	hemagglutination
21	evaluation,
21	technical
21	decade,
21	rabbits.
21	contamination.
21	2012,
21	deal
21	(akt)
21	ly294002
21	before,
21	86rb+
21	normoglycemic
21	atp-sensitive
21	hexokinase,
21	instead,
21	glutamine,
21	abuse
21	(14
21	(lllt)
21	j/cm2
21	alternate
21	therapeutics.
21	risk.
21	protection,
21	deposition,
21	il-8,
21	nitroprusside,
21	nonsteroidal
21	shrs.
21	lee
21	author.
21	child
21	properly
21	kallikrein
21	%)
21	atherosclerotic
21	sciences.
21	(ace)
21	vehicle.
21	10),
21	thickening
21	rod
21	(mab)
21	trap
21	inactivate
21	drg
21	dried
21	luteinizing
21	investigates
21	neutrophilia
21	trabeculae
21	deposited
21	body,
21	absent.
21	biochemically
21	vertebrates.
21	(t)
21	chains.
21	preganglionic
21	atenolol
21	dm
21	thir
21	inositol
21	pmol)
21	confined
21	(type
21	/
21	sag3,
21	states,
21	primates,
21	clones.
21	800
21	suffer
21	hematophagous
21	3-phosphate
21	63
21	67
21	anti-
21	country.
21	room
21	haemagglutination
21	masseter
21	(p<0.01).
21	week.
21	2.2
21	co-injection
21	atherosclerosis
21	up-regulate
21	2007,
21	tumor,
21	complemented
21	domains,
21	react
21	integrating
21	applications,
21	industry
21	proteomics
21	strategy,
21	mdcs
21	treponema
21	propria
21	gingivitis
21	carcinogenesis.
21	niches
21	herpetomonas
21	lima
21	bases
21	peptidases
21	blastocysts
21	sulphate
21	images.
21	weinheim
21	sense,
21	hindquarter
21	impairment.
21	mutagenesis,
21	challenging
21	photoproducts
21	options
21	mdm2
21	drosophila
21	transcripts.
21	angiogenic
21	xyli
21	carotenoids
21	occur.
21	reward
21	colliculus
21	painful
21	neuroscience.
21	0.0001).
21	l6
21	abcg1
21	fasting,
21	postpartum
21	colonized
21	ivm
21	assume
21	potently
21	poorer
21	homing
21	reorganization
21	emulsion
21	hamsters
21	presumed
21	meta
21	permease
21	adhesion.
21	maebl
21	flavivirus
21	bioinformatics
21	sigma
21	antibiotics.
21	poultry
21	saliva,
21	(hrsv)
21	chaperone
21	p,
21	taste
21	parvalbumin
21	syndecan-1
21	disposition
21	calcitonin
21	myelinated
21	anxiogenic
21	capsazepine
21	envenomations
21	spla2s
21	intrathecal
21	spla2
21	somata
21	immunoreactivity.
21	pla
21	gln
21	2a/α
21	tablets
21	raji
21	mn-sod
21	cascade.
21	(cgmp)
21	isoprenoids
21	lodenafil
21	clopidogrel
21	bioavailability.
21	eotaxin
21	mocambique
21	eae,
21	associates
21	pteronyssinus
21	lcpa
21	immunised
21	pep5
21	yohimbine
21	(eaec)
21	granzyme
21	n-pomc
21	m-protein
21	pilus
21	na+,k+-atpase
21	multinodular
21	breathing.
21	gp82
20	losartan,
20	glp-1
20	unravel
20	voltage
20	transporters.
20	immortalized
20	(mapk)
20	significant,
20	volume.
20	mv
20	method:
20	10-4
20	tetraethylammonium
20	double-barreled
20	nacl,
20	mg-1
20	removed,
20	0.03
20	(crf)
20	back
20	half-times
20	create
20	attained
20	other,
20	rats).
20	minimized
20	augmentation
20	pk
20	accompanying
20	ecs
20	rhizosphere
20	nosocomial
20	maize
20	facultative
20	-9
20	animal.
20	acted
20	nm).
20	days),
20	pdc
20	proline-rich
20	dcs,
20	a549
20	chain.
20	(tnf-α),
20	c3b
20	reactivity.
20	killing.
20	coculture
20	evade
20	albicans,
20	sustain
20	12.5
20	colony-forming
20	resultant
20	quantitation
20	ileal
20	marrow,
20	height
20	i/r.
20	intranasally
20	birth,
20	space.
20	adulthood,
20	thymus,
20	insult
20	control)
20	(tnf)
20	cellularity
20	rats:
20	precluded
20	(cox)
20	ischemia-reperfusion
20	ova-challenged
20	(elisa).
20	integrity.
20	nk2
20	immune-mediated
20	juice
20	ovalbumin.
20	toxicity,
20	ldh
20	14.
20	intervals,
20	3rd
20	haemorrhagic
20	recognized.
20	clades
20	selecting
20	hla
20	alleles.
20	decade
20	databases.
20	heterozygous
20	nineteen
20	basin
20	insects.
20	helicase
20	americas
20	kit
20	mini-exon
20	environments,
20	programme
20	equimolar
20	44%
20	low,
20	mildly
20	low-protein
20	deficiency,
20	derive
20	compensate
20	82
20	sequestration
20	evoke
20	slowly
20	mg/kg;
20	saline-treated
20	hva
20	plasticity,
20	declined
20	progenitors
20	tap
20	(ach),
20	contracting
20	senescence
20	pharmacology
20	pocket
20	μg/site)
20	contraction.
20	unspecific
20	factor-α,
20	interferon-γ,
20	p-selectin
20	histologically
20	(snp)
20	peptidergic
20	remodeling,
20	altogether
20	gp91phox
20	neurotoxicity
20	hypothyroidism,
20	histochemistry
20	tomography
20	antigen-induced
20	implantation.
20	sertoli
20	situated
20	forty
20	wounds
20	occupied
20	counted
20	peripherally
20	neurones
20	t,
20	dos
20	oxytocinergic
20	55%
20	supraoptic
20	kidneys.
20	cord,
20	morris
20	objective.
20	reproduced
20	permitted
20	germany,
20	sag2,
20	(ifat)
20	alleles,
20	animal,
20	grosso
20	felis
20	island,
20	para
20	sheep,
20	108
20	vertebrates,
20	dilutions
20	ancestry
20	donkeys
20	climatic
20	capybaras
20	milder
20	cns,
20	(cebus
20	3.2
20	heat-shock
20	practical
20	(mirnas)
20	lysine
20	adenocarcinoma
20	obstructive
20	cd80,
20	erythematosus
20	interferon-gamma
20	(la)
20	cells),
20	resembles
20	lct
20	edta
20	immunizing
20	morphologic
20	10-fold
20	metagenomic
20	ecology
20	prokaryotic
20	proteases,
20	problem,
20	implying
20	simplex
20	phagocytes.
20	cytomegalovirus
20	rpf151
20	thymic
20	denticola
20	endostatin
20	donors.
20	extract.
20	genotoxicity
20	crosses
20	germline
20	opsonized
20	prime
20	rangeli,
20	j774
20	sympatric
20	country
20	paralogous
20	template
20	mycobacteria
20	chemokines,
20	suboptimal
20	chronic,
20	discusses
20	sunlight
20	ala
20	emissions
20	aids
20	pathologies
20	application.
20	stability,
20	bax
20	iih
20	anopheles
20	thi4
20	surface-exposed
20	shrimp
20	0.7
20	paths
20	flash-lag
20	finger
20	delays
20	glut4,
20	sp1
20	angiogenesis,
20	(to
20	gomesiana.
20	(one
20	p19
20	(3),
20	disintegrin
20	mariner-like
20	hs578t
20	acl
20	appliance
20	anti-malarial
20	cytoadhesion
20	spread.
20	subclinical
20	breastfeeding
20	ferritin
20	extracts,
20	g+c
20	helicobacter
20	crp
20	immunocompetent
20	sting
20	establishes
20	fat,
20	lipolysis,
20	retrochiasmatic
20	phosphoprotein
20	p24
20	compacta
20	snc
20	incerta
20	ethanol,
20	arc
20	carvacrol
20	(8%
20	cx45
20	gp91phox-/-
20	enucleation
20	fos-positive
20	anti-ige
20	l-lactate
20	cryolesion
20	proapoptotic
20	mφ
20	hantavirus
20	notch
20	vmh
20	(mabs)
20	vkh
20	detrusor
20	ncx-2216
20	inotropic
20	cgd.
20	dialysis
20	nka
20	toxins.
20	cdtv
20	p-i
20	2s
20	endophyte
20	gc-24
20	il8
20	mite
20	bortezomib
20	t(b)
20	cysa
20	hiv-1-infected
20	gallinaceum
20	mtdna
20	mir-133
20	aggregative
20	stx1
20	bfpa
20	pfge
20	mesophilicum
20	cs280-288
20	l-proline
20	moxonidine.
20	urbp
20	sakuranetin
20	myelodysplastic
19	clearance,
19	exchanger,
19	significantly,
19	gradient.
19	isoforms,
19	p<0.05),
19	acidification,
19	york
19	24%
19	munich-wistar
19	doubled
19	marker.
19	0.09
19	infusions
19	42%
19	26%
19	droplets
19	anion,
19	crop
19	biocontrol
19	antagonistic
19	substances,
19	grew
19	scheme
19	season.
19	viability.
19	101
19	opposing
19	(no
19	one.
19	reserve
19	periods,
19	mmol/l)
19	procedure.
19	ontology
19	summarizes
19	particles.
19	paradoxical
19	susceptibility.
19	il-12.
19	abolishes
19	(rapd)
19	indistinguishable
19	shedding
19	deposits
19	type-1
19	resistant,
19	increase.
19	rr
19	(ip)
19	target.
19	reperfusion,
19	(il)-1β,
19	occupational
19	immunolabeling
19	21.
19	ehrlich
19	(5)
19	instance,
19	initiating
19	s-transferase
19	daily)
19	fragmentation.
19	abnormalities,
19	restriction.
19	bronchi
19	matching
19	assay).
19	synchronized
19	after,
19	extravascular
19	axenic
19	(snps)
19	sister
19	trypanosomatids,
19	scenario
19	rhodnius
19	nt
19	translated
19	representation
19	extends
19	pulsed-field
19	assist
19	eukaryotes.
19	24sα
19	digested
19	intraspecific
19	trypanosomatids.
19	diverged
19	epitope.
19	125
19	350
19	hypotheses
19	2.3
19	clones,
19	vesicles,
19	radioactive
19	fractions.
19	strictly
19	dispersed
19	thiol
19	dex
19	48,
19	ages.
19	unbalanced
19	p67
19	sc,
19	dose-dependently
19	[u-
19	raises
19	dams.
19	11,
19	8.3
19	(pa)
19	cytosol,
19	supplied
19	aging,
19	overnight
19	ml)
19	precede
19	determined,
19	originates
19	rings,
19	(sp)
19	non-surgical
19	sulfide
19	tunel
19	endothelium-denuded
19	synergistically
19	obesity-associated
19	relaxes
19	labyrinth
19	hyperglycaemia
19	defenses.
19	ascorbic
19	topically
19	nitro-l-arginine
19	l-
19	removing
19	α-
19	burden.
19	κ-opioid
19	cytoskeleton,
19	folk
19	camp-dependent
19	(90
19	osteocalcin
19	microtubules
19	stabilization
19	ki67
19	femur
19	elastic
19	envenoming
19	column,
19	immunocytochemistry
19	islands
19	thyroxine
19	colonization,
19	interconnected
19	ectopic
19	ammonia
19	scattered
19	implications:
19	hallmarks
19	strains),
19	operational
19	oocysts.
19	penguins
19	positive,
19	sul
19	btub,
19	caninum,
19	69
19	herds
19	28,
19	confirmation
19	(pi)
19	obligate
19	birds.
19	minas
19	toxocara
19	ecosystems
19	ggapdh
19	diagnose
19	(odds
19	phosphatase,
19	anti-n.
19	sporulated
19	summary
19	titer
19	assemblage
19	chagasi,
19	2007.
19	economically
19	date
19	reconstruction
19	phylum
19	records
19	fourfold
19	cd80
19	protamine
19	tumour.
19	δ
19	bowel
19	factor-β
19	severity,
19	txb2
19	pg/ml
19	enables
19	intra-articular
19	mepyramine
19	cyclophosphamide
19	atmospheric
19	culturing
19	cotton
19	enterococcus
19	1a
19	rh
19	designing
19	cd83
19	candidates.
19	enabling
19	initiate
19	postoperative
19	compromise
19	carcinomas.
19	phenotypically
19	airmaxss
19	(r)
19	ifn-
19	quantifying
19	amazonia.
19	293
19	historical
19	hyperosmotic
19	november
19	agarose
19	cone
19	above-mentioned
19	methanol
19	triphosphate
19	log
19	rupture
19	accelerates
19	oligomerization
19	sylvio
19	helping
19	factor-1
19	cd95
19	merozoites
19	sds
19	arrest,
19	partners
19	whole-genome
19	plasmid,
19	information,
19	apoptosis-inducing
19	societies
19	copenhageni
19	canker
19	completion
19	stabilized
19	(pag)
19	(nnos)
19	pmv-lesioned
19	plan
19	latencies
19	pursued
19	stroke
19	canal
19	hsv
19	selected.
19	repressor
19	24-hour
19	cml
19	inguinal
19	thioredoxin
19	(h)
19	-1,
19	smoking
19	0.5,
19	thyroidectomy
19	expressed,
19	carcass
19	cyclization
19	mosquitoes,
19	eccentric
19	cx43,
19	disrupts
19	(80
19	divisions
19	braziliensis,
19	sesquiterpene
19	neurite
19	coelomocytes
19	il-1,
19	sublingual
19	p19arf
19	introduce
19	directions
19	necessarily
19	1:1
19	(denv)
19	actinomycetemcomitans.
19	actinomycetemcomitans,
19	reagents
19	gonadotropin
19	anti-inflammatory,
19	aeme
19	faa
19	leucoagglutinin
19	igl
19	innervates
19	ameloblastoma.
19	crush
19	phox2b-expressing
19	lew
19	propionic
19	laminae
19	1-week
19	saa
19	college
19	hrv
19	(p<0.05),
19	trans
19	(rpat)
19	vldl
19	mosquito-borne
19	vallate
19	anoxic
19	osmium
19	tight
19	xenopus
19	mucocutaneous
19	formulation)
19	ligands,
19	cmax.
19	test/reference
19	analyte
19	rightward
19	relaxations.
19	41-2272.
19	trinitrate
19	malignancies.
19	(5-ht)
19	ventilated
19	mg/dl
19	signatures
19	sol
19	transplantation,
19	phytopathogen
19	mucin
19	toxin-producing
19	mra
19	orfs
19	anti-intimin
19	nut
19	stainless
19	steel
19	hgcl2
18	0.13
18	diarrhoea
18	biased
18	(phi)
18	drives
18	convoluted
18	connecting
18	10-8
18	dppiv
18	calculation
18	ester,
18	deprivation,
18	35%
18	12-myristate
18	anhydrase
18	co2,
18	return
18	19)
18	significantly.
18	crypt
18	32%
18	0.18
18	determinations
18	0.9%
18	σs
18	1988
18	transfer.
18	albumin,
18	temperatures.
18	imposed
18	passage
18	reduction,
18	propagation
18	fertilization
18	sources,
18	suggestion
18	crystalline
18	clusters.
18	-5
18	l-glutamate
18	(pcm),
18	recognition,
18	trading
18	summarized
18	replicates
18	correctly
18	invading
18	reinforced
18	transitory
18	host-parasite
18	reproduce
18	coordinate
18	antagonized
18	compact
18	unrestrained
18	asked
18	cure
18	diminishes
18	pathogenicity.
18	sample,
18	sera,
18	igg.
18	material,
18	scored
18	mice)
18	fluorescein
18	ethidium
18	immunodiffusion
18	clamp
18	aerosolized
18	calretinin,
18	12%
18	ova-specific
18	maximally
18	cytometry,
18	leucocytes
18	pentobarbital
18	(pcr).
18	suspended
18	trachea,
18	chambers
18	worsening
18	dexamethasone,
18	habitat
18	loci,
18	year,
18	chromosomes.
18	serodiagnosis
18	2005,
18	groups;
18	iia
18	84%
18	79
18	spectroscopy.
18	preferences
18	isoenzyme
18	soon
18	judged
18	reagent
18	inserts
18	immunoglobulins
18	hydrolysis,
18	]
18	light/dark
18	sc)
18	(il-6)
18	dihydroethidium
18	ins-1e
18	dpi
18	carbohydrates
18	dismutase,
18	casein
18	literature,
18	β-cells.
18	coa
18	nitrotyrosine
18	wilkins,
18	demonstrated,
18	augment
18	irs-1,
18	perinatal
18	8%
18	lsd
18	2).
18	(10%
18	af
18	helps
18	phosphoinositide
18	spike
18	example
18	quinine
18	concerns
18	administrated
18	substances.
18	cut
18	pvat
18	dystrophic
18	factor-β1
18	sports
18	conjugate
18	nsaids
18	txa2
18	beds
18	sprague-dawley
18	acetylcholine-induced
18	high.
18	detail.
18	(16
18	estrus
18	receptor-mediated
18	reaches
18	bodies,
18	pre-incubation
18	argue
18	backbone
18	circulation.
18	follicle
18	registered
18	v,
18	polyadenylation
18	staining,
18	biochemical,
18	.05)
18	achieved.
18	testicular
18	subepithelial
18	round
18	34%
18	lining
18	(hr),
18	aspects,
18	chat
18	abstract:
18	baroreceptors
18	resetting
18	disrupting
18	diaphragm
18	vasopressinergic
18	school
18	vertebral
18	21%
18	pigs.
18	domestica
18	spp
18	gra6,
18	zoo
18	deer
18	threats
18	eastern
18	ms.
18	diversification
18	sp,
18	chagasi.
18	amplicons
18	anuran
18	glyceraldehyde
18	te
18	pigs,
18	triglycerides,
18	harbors
18	98%
18	sequenced,
18	2008,
18	chorionic
18	households
18	hfd,
18	iu,
18	mir-155
18	antagonists,
18	pi3k,
18	water)
18	endothelins
18	known,
18	colitis.
18	tumoricidal
18	(no).
18	intraepithelial
18	bn
18	h2o2,
18	6%
18	(1.5
18	cluster.
18	coastal
18	°c,
18	symbiotic
18	contaminants
18	compartment,
18	(hpv)
18	multifunctional
18	interrupted
18	capsaicin,
18	boosting
18	anti-proliferative
18	ascaris
18	carcinogenic
18	refolding
18	allele.
18	locus,
18	up-
18	usefulness
18	homozygosity
18	patient,
18	homologs
18	mixtures
18	interest.
18	pilot
18	hemoplasmas
18	(ts)
18	(l)
18	configuration
18	corpora
18	broader
18	monkeys.
18	devastating
18	suspected
18	atrox
18	sensor
18	il-1α
18	latter,
18	il-12p40
18	cord.
18	igg1.
18	(tgf-β1)
18	abrogate
18	sorting
18	gaps
18	ligase
18	productivity
18	intermediary
18	assessed,
18	mansoni
18	(control),
18	mimicking
18	1o2
18	β-lactam
18	mating
18	promoter,
18	(rt)
18	demands
18	terminalis
18	+.
18	angle
18	(glut4)
18	sterol
18	glycaemia
18	erα
18	pad
18	shep
18	solid-phase
18	spectrometric
18	(csa)
18	achieving
18	reversed-phase
18	defence
18	yields.
18	lens
18	permit
18	inflammasomes
18	transposase
18	orf
18	braziliensis.
18	autochthonous
18	antiparasitic
18	ornithine
18	uncomplicated
18	variant-specific
18	variants,
18	eradication
18	episode
18	variants.
18	denv-3
18	cytophilic
18	epicoccum
18	psts
18	selections
18	mutant,
18	plaques
18	nd:yag
18	low.
18	cranial
18	daytime
18	light-dark
18	efficacious
18	biogenesis
18	window
18	itself.
18	cell-specific
18	res
18	densely
18	inferior
18	subdivision
18	gpnmb
18	tumoral
18	reconstituted
18	ck
18	ian
18	gene-related
18	ampa
18	(st)
18	anxiety.
18	mi.
18	retinorecipient
18	panic
18	(pbmcs)
18	(con
18	bilayers
18	t-lymphocyte
18	admsc
18	sh
18	unsaturation
18	anaplastic
18	(cpt
18	myoglobin
18	ng/ml.
18	amine
18	fibrous
18	karnovsky
18	lidocaine
18	clk2
18	terminus
18	sdf2
18	leishmanial
18	monomeric
18	(area
18	phentolamine
18	monoxide
18	platelets,
18	co-treatment
18	chronotropic
18	bthtx-i
18	(cgd)
18	186
18	mda-mb-435
18	goiter
18	ep24.16
18	thermolysin
18	steroidogenic
18	atrogin-1
18	(x.
18	409a
18	hexagonal
18	agmnpv
18	fractalkine
18	coq10
18	5′-nucleotidase
18	mnr
18	ciu
18	mirabilis
18	interdisciplinary
18	nigrum
18	flicd
18	pdt
18	rmtg
18	pacari
18	nip7
18	smases
18	imidazoline
18	kyn
18	ssg
18	salivation.
17	0.10
17	(10-7
17	β-adrenergic
17	forskolin
17	activity)
17	constantly
17	physiologically
17	tonic
17	pharmacologic
17	electrolyte
17	1-h
17	(gr)
17	segment.
17	ducts
17	(avp)
17	thapsigargin
17	(after
17	perfusate
17	centered
17	reversibly
17	threefold
17	dominated
17	shortly
17	stopped-flow
17	absorption,
17	maintained.
17	cisplatin.
17	fluxes,
17	1989
17	m).
17	pd,
17	experiment.
17	64%
17	1985
17	converts
17	principles
17	deoxycorticosterone
17	seventeen
17	occurred.
17	conditions:
17	suffered
17	nm),
17	tyr
17	precipitation
17	indoleamine
17	pcm,
17	infection;
17	viewed
17	wt,
17	hyphal
17	t-helper
17	anergy
17	cd4+cd25+foxp3+
17	myd88,
17	reactivation
17	microbes
17	ifn-gamma
17	inducer
17	mount
17	exacerbate
17	pathologic
17	colony-stimulating
17	(usa).
17	operating
17	intra-
17	parasitism
17	host-cell
17	athymic
17	lies
17	noticeable
17	plated
17	18,
17	sn
17	bloodstream
17	color
17	llc,
17	motility,
17	quantified.
17	catheter
17	(chat),
17	calbindin,
17	(45
17	ova-immunized
17	psychological
17	nonselective
17	ova-sensitized
17	dysfunctional
17	molecule-1
17	sensitization,
17	abrogates
17	fa,
17	plexuses
17	resection
17	tnf-
17	(160
17	reasonable
17	change,
17	weaning,
17	wk,
17	expiratory
17	mg-atpase
17	web-2170
17	instilled
17	goat
17	orthologous
17	tandemly
17	intensely
17	biotechnology
17	cured
17	kinetoplast
17	intergenic
17	insertions
17	night.
17	genomics
17	strain)
17	list
17	transfusion
17	twenty-one
17	specimens.
17	fg
17	sorted
17	network,
17	high,
17	kdna
17	blots
17	2.6
17	1993.
17	glycoconjugates
17	autoradiography
17	1990.
17	1985.
17	nigra,
17	tonus
17	direction.
17	voltage-dependent
17	gavage)
17	myostatin
17	92%
17	(gsh)
17	carboxylase
17	iii.
17	hydroethidine
17	rinm5f
17	(bp)
17	tail-cuff
17	hg)
17	66%
17	augments
17	upregulates
17	included.
17	mg/dl,
17	favored
17	available,
17	least,
17	phenomenon,
17	coincides
17	1.7
17	isomerase
17	tobacco
17	cross-sensitization
17	learning,
17	na,k-atpase,
17	otherwise,
17	21:00
17	0.9
17	possessing
17	regard,
17	removal,
17	par-2
17	ligature-induced
17	(ot)
17	kallikrein-kinin
17	<0.05).
17	vasorelaxation
17	amide
17	(et-1)
17	recorded.
17	afforded
17	bh4
17	o-glcnac
17	veins
17	b1-/-
17	dilation
17	chlorpropamide
17	diclofenac,
17	patients;
17	17,
17	anesthesia
17	unanesthetized
17	atherosclerosis,
17	fsh
17	320
17	suggested.
17	l-type
17	microcirculation.
17	4-week
17	(es)
17	retinoic
17	carrageenin
17	expensive
17	(lh)
17	iv,
17	illnesses
17	enters
17	amphetamine-regulated
17	methodologies
17	bnp1
17	morphogenesis
17	postimplantation
17	barely
17	hypothyroidism.
17	tenascin
17	periodic
17	gracilis
17	large,
17	itself,
17	thymidine
17	promptly
17	continues
17	(on
17	somatosensory
17	indole
17	bioassays
17	signs,
17	purposes
17	cyst
17	humidity
17	c22-8,
17	c29-2,
17	l358,
17	ecosystem
17	molecularly
17	cysts.
17	chinese
17	yr
17	come
17	50,
17	hygiene
17	measures.
17	vaccinia
17	(three
17	record
17	entomological
17	felid
17	aspirates
17	(p<0.001)
17	(60%)
17	ms,
17	condensed
17	gi
17	nematodes
17	exclude
17	chance
17	cycles.
17	immunostained
17	bioactivity
17	moreover
17	p50
17	il6
17	(il-1β)
17	(pg)
17	(tnf)-α
17	ap.
17	b2r
17	allergy.
17	monocytic
17	ng/ml).
17	supernatants.
17	rhinitis
17	plates,
17	ulcer
17	mathematical
17	heat-killed
17	peaking
17	th2-type
17	resistant.
17	1.0,
17	(250
17	deep-sea
17	anthropogenic
17	margin
17	antarctica
17	versatile
17	consortium
17	zones
17	derivatives.
17	pp
17	hadv-41
17	emergent
17	resources
17	g-csf
17	immunotherapy.
17	wasp
17	subtilisin
17	intermedia,
17	μ
17	(hp)
17	elimination.
17	(qtl)
17	pristane
17	anti-hsp65
17	phenotypes,
17	prediction
17	adults,
17	loci.
17	2bh4
17	monocytes.
17	subpatent
17	leishmania.
17	mbp
17	built
17	taxonomy
17	306
17	cerebellum,
17	89
17	sg
17	intron
17	tuberculosis,
17	pereira,
17	b-1
17	as,
17	antibody-mediated
17	tgf-β1,
17	dot-elisa
17	endonuclease
17	opened
17	autophagy,
17	bacterium.
17	tumours
17	mutations,
17	progressed
17	strategy.
17	inspired
17	continue
17	llc
17	mu
17	date.
17	product.
17	seed
17	computer
17	apparatus,
17	polymerization
17	physically
17	gray,
17	elements,
17	canals
17	to,
17	regulations
17	pointing
17	insulin-treated
17	unchanged,
17	insulin-sensitive
17	overactive
17	wat.
17	fasting.
17	saliva.
17	rnase
17	transporter,
17	ns
17	cyanide
17	bme26
17	hatching
17	gm
17	cyclosporin
17	insensitive
17	hydrophilic
17	musca
17	(mainly
17	participated
17	laboratory,
17	plasmodium,
17	aggressiveness
17	biosorption
17	tubulin
17	mentioned
17	pre-rrna
17	exosome
17	3).
17	unit.
17	antimitotic
17	dr.
17	shawi
17	donovani
17	gtpase
17	ce
17	enucleated
17	fibrillary
17	swelling,
17	bilaterally
17	candidate.
17	predictor
17	strongest
17	nonsynonymous
17	malaria-endemic
17	multidrug
17	hypo-
17	g6pd
17	genbank
17	producers
17	ag-specific
17	covering
17	ucp1
17	mel
17	loops
17	protocols.
17	aanat
17	intrahippocampal
17	pd98059
17	cingulate
17	midline
17	thalamus
17	facial
17	rotational
17	frey
17	regeneration,
17	purkinje
17	gabaa
17	hyperglycemic
17	attracted
17	soya
17	mfs
17	reverse-phase
17	atp-dependent
17	cc.
17	ectodomain
17	fenofibrate
17	cafeteria
17	trh
17	mtj
17	receptor-expressing
17	renal,
17	concentric
17	(i.c.v.)
17	ihy
17	expenditure,
17	flaviscutellata
17	161-180
17	tablet)
17	(mrm).
17	u/ml)
17	each)
17	substrates,
17	(-
17	capsaicin-pretreated
17	formulations,
17	sod2
17	pnv-induced
17	t(max)
17	sucralfate
17	p-iii
17	diterpenes
17	yield.
17	irrigation
17	map,
17	allergen-specific
17	vitronectin
17	spirochetes
17	pod-1
17	tlr5
17	mdr
17	ketones
17	δ-opioid
17	polyfunctional
17	lamp/gag
17	capsulatum
17	afb
17	mycoflora
17	irbp
17	interphotoreceptor
17	yersinia
17	spliceosome
17	breakpoints
17	vehicle:
17	f2.4
17	modafinil
16	mas
16	heat-stable
16	(range
16	units.
16	+-atpase
16	43%
16	0.06
16	(10-9
16	chelator
16	9%
16	filtered
16	38%
16	nh3
16	recovery,
16	0.14
16	range,
16	pore
16	normal.
16	wk.
16	returning
16	calculate
16	artery.
16	permitting
16	resistances
16	slope
16	mixing
16	transit
16	soil,
16	stems
16	assignment
16	advance
16	aluminium
16	(25%)
16	document
16	p450
16	gain-of-function
16	mlt
16	cooperation
16	14-3-3
16	(tlr4)
16	cd28-/-
16	adaptative
16	unrecognized
16	on,
16	encapsulated
16	noted.
16	satisfactory
16	aggregates
16	86
16	width
16	yeast.
16	prerequisite
16	phagocytosed
16	ali
16	(sd)
16	i/r,
16	bd
16	abortus
16	modifies
16	minutes,
16	recruitment,
16	(e2)
16	ischemia,
16	artery,
16	down-regulates
16	motility.
16	comparison,
16	pca
16	explaining
16	fa.
16	put
16	exposures
16	metabolites,
16	interruption
16	6.5
16	housed
16	stressful
16	ntr
16	thrombocytopenia
16	trypanosomes,
16	variation,
16	trypanosomiasis
16	explains
16	cognate
16	fashion,
16	genomes,
16	certainly
16	sat
16	epimastigotes.
16	non-coding
16	goals
16	implementation
16	consideration
16	tertiary
16	profiling
16	marsupials
16	circulate
16	37°c.
16	globally
16	(90%)
16	od
16	complement-mediated
16	fractionated
16	igm,
16	voltage-gated
16	currents
16	dexamethasone.
16	accentuated
16	hypoglycemia
16	(pinx)
16	gsis.
16	p53,
16	isp
16	insulinemia
16	francis.
16	amyloid
16	peroxidase,
16	ameliorating
16	substrate-1
16	(ros).
16	measured,
16	monounsaturated
16	olive
16	thermolabile
16	abolish
16	hexose
16	phenomena.
16	energetic
16	acetyl-coa
16	coincided
16	gsh/gssg
16	glycine
16	14co2
16	(pnd)
16	decades.
16	dissociated
16	behaviour.
16	photodynamic
16	crevicular
16	(sm)
16	(i.d.)
16	(p < 0.05).
16	vasculature
16	(sc),
16	lacking.
16	dystrophy
16	overexpression.
16	rmax
16	hyper
16	(pge
16	removal.
16	(pe)
16	tone.
16	2ko
16	litter
16	prostanoid
16	indomethacin.
16	kg-1,
16	(using
16	fascia
16	bradykinin.
16	ii),
16	aldose
16	minalrestat
16	mimetic
16	norepinephrine,
16	aggravates
16	pressures
16	marker,
16	structure-activity
16	exogenously
16	organ.
16	perchlorate
16	thyrotoxicosis
16	principally
16	stroma.
16	deeply
16	snakebite
16	(tnf)-α,
16	d3
16	munksgaard.
16	branching
16	gram
16	successive
16	instrumented
16	rest,
16	shape,
16	granules,
16	nitrogen.
16	morphogenetic
16	28%
16	beef
16	contacts
16	transformation.
16	li
16	(high
16	compartments.
16	ti
16	chapter,
16	(rvlm)
16	japanese
16	butyric
16	anaesthetised
16	beats
16	111
16	restrain
16	mediation
16	relay
16	biome
16	toxoplasmosis.
16	bioassayed
16	variability.
16	73
16	pk1,
16	free-range
16	pará,
16	identification.
16	retrospective
16	pets
16	peccaries
16	clade.
16	cattle.
16	gerbils
16	faculdade
16	biodiversity
16	(p>0.05).
16	amazonia
16	basin.
16	communities.
16	meat,
16	102
16	glycosomal
16	practices
16	urea,
16	humor
16	occasional
16	fr
16	(40%)
16	(cns),
16	19%
16	nearby
16	august
16	(ct)
16	tannins
16	rondônia,
16	centre
16	habitats
16	infer
16	problems.
16	60,
16	offered
16	(lts)
16	irradiation.
16	b16f10
16	hemoglobin,
16	rantes
16	x-higm
16	parenchymal
16	mam
16	(iri)
16	(alloxan,
16	griess
16	pancreas,
16	seeking
16	asthma,
16	kg-1),
16	shock,
16	malnourished
16	(bjv)
16	comparatively
16	min).
16	bw
16	future.
16	spring
16	rrna,
16	cf.
16	elongated
16	bring
16	antibiotics,
16	forest.
16	catalyze
16	ketone
16	exposing
16	antineoplastic
16	lipophilic
16	cytotoxic,
16	active.
16	(ifn)-γ
16	ferreira,
16	point.
16	classes.
16	deciduous
16	extrinsic
16	fight
16	non-steroidal
16	index.
16	neoplasia
16	patient.
16	b.w.)
16	anti-dna
16	single-nucleotide
16	arrays
16	informative
16	retroviral
16	complement-dependent
16	dmh
16	families,
16	97
16	subspecies
16	vaccines,
16	folic
16	implication
16	far,
16	vivax-infected
16	extraction.
16	aminotransferase,
16	thirty-two
16	call
16	serogroups
16	specific,
16	5'
16	stage-specific
16	hypervirulent
16	eradicate
16	peroxidation,
16	seemingly
16	visualize
16	pyroptosis
16	tend
16	+,
16	il-12/il-18
16	cd4-
16	preserving
16	cytolytic
16	translesion
16	tls
16	repaired
16	crescentus.
16	(ner)
16	cq
16	atrophy.
16	albeit
16	huge
16	transcriptomic
16	orofacial
16	damages
16	u87mg
16	sage
16	macroarray
16	eggs.
16	reconstructed
16	fastidiosa,
16	sv40
16	ccr2
16	occasionally
16	bp.
16	(cd)
16	(>
16	parent
16	1990,
16	learning.
16	conspecific
16	placing
16	85%
16	so-called
16	cue
16	aggression
16	odor,
16	hunting.
16	nbor.
16	synonymous
16	adjunct
16	48%
16	serotypes.
16	soleus,
16	cre
16	l,
16	tubulointerstitial
16	(50%)
16	mesangial
16	nefa
16	fertility.
16	probe.
16	erβ
16	diameter,
16	investigators
16	(1-10
16	anionic
16	candidiasis
16	biodistribution
16	covalently
16	(qpcr)
16	sublethal
16	von
16	n-terminus
16	modes
16	interacted
16	radiolabeled
16	hydrolysis.
16	flagella
16	promastigotes.
16	repetition
16	cardiomyocytes,
16	chrysotile
16	sperm
16	burden,
16	(ic
16	amb
16	indexes
16	th1-type
16	ciliary
16	paraffin-embedded
16	c9
16	diaphorase
16	pcl
16	plasmid.
16	abs
16	combat
16	(msp-1)
16	span
16	com
16	em
16	tetracycline
16	histidine
16	tpel
16	imipenem
16	iv.
16	supragingival
16	co2)
16	(tg)
16	fibres.
16	unresponsive
16	pstat5
16	unfolded
16	vas
16	gd
16	mutant.
16	mesencephalic
16	edinger-westphal
16	immunoreactivity,
16	cryolesioned
16	β-catenin
16	oscc
16	occlusal
16	er:yag
16	(bdnf)
16	neuroinflammatory
16	procedures,
16	antiapoptotic
16	ampa-type
16	myc.
16	7-ni
16	hypercapnic
16	thalamus,
16	soma
16	s100a9
16	double-labeling
16	snakebites
16	lastly,
16	agonists,
16	transference
16	dnase
16	pa,
16	c2c12
16	knock-out
16	gs
16	oleate
16	imatinib
16	bouts
16	opioidergic
16	ho
16	i.p.),
16	5-ht1a
16	(pmv)
16	mir-491-3p
16	cocaine-
16	motoneurons
16	evt
16	grafts
16	5/6
16	dapaconazole
16	seb-induced
16	victims
16	chemistry.
16	bark
16	dermonecrotic
16	bundle-forming
16	sphingomyelinases
16	hypothermic
16	expenditure.
16	molybdate
16	diarrheic
16	hydrolyze
16	thallium
16	phb
16	mvs-mscs
16	tac
16	gemmatalis
16	nucleopolyhedrovirus
16	ace2
16	a/e
16	hus
16	loxoscelism.
16	(meat)
16	rpat
16	pai-1
16	nattectin
16	dublin
16	oncoproteins
16	odc
16	baumannii
16	bristles
16	sicarius
16	iwat
16	podocyte
16	hg2+
16	phox2b+th-
16	nmol/1
16	adstringens
16	allo
16	mkd
15	inhibited,
15	(nhe3)
15	excretion.
15	(protein
15	upregulate
15	pkg
15	superfusion
15	2-min
15	implicating
15	finely
15	(pi3k)
15	2+]i
15	hereditary
15	(anp)
15	synergic
15	13-acetate
15	pkc,
15	adenylate
15	furosemide
15	reabsorption,
15	vesicle
15	surfaces,
15	bafilomycin
15	9)
15	pth
15	dependent,
15	(peak
15	(pma)
15	okadaic
15	alkalotic
15	jv
15	9.
15	maintenance.
15	acetazolamide
15	implies
15	4-
15	37%
15	68%
15	columns
15	capillaries,
15	depletion.
15	used:
15	buffered
15	component.
15	reporting
15	changed.
15	genera.
15	bacterium,
15	acinetobacter
15	pantoea
15	hplc.
15	prepare
15	calcium-dependent
15	(10-11
15	resin.
15	acceleration
15	cerrado
15	accumulates
15	v.
15	dysregulated
15	preserves
15	confers
15	alum,
15	immunodeficient
15	il-10)
15	host-pathogen
15	precocious
15	clarified.
15	il-23,
15	cytokine,
15	e.g.,
15	degenerated
15	dominance
15	chemiluminescence
15	stain
15	uric
15	microbiota,
15	female,
15	ifn
15	mk-801,
15	combination,
15	icam-1,
15	carcinoma,
15	indoor
15	malondialdehyde
15	(balf)
15	nos,
15	chat-ir
15	50%,
15	nitration
15	irritation
15	bath
15	oa-induced
15	inhaled
15	(maximum
15	pentoxifylline
15	box
15	cocoa
15	kt
15	acid),
15	effluent
15	concomitantly,
15	ltd.,
15	formerly
15	representatives
15	(t.
15	numerical
15	taxa
15	mutational
15	unidentified
15	adopt
15	1),
15	anti-cd3
15	glycoconjugate
15	immunoprecipitated
15	diameter.
15	lose
15	pilocarpine.
15	clock,
15	arylalkylamine
15	anorexia
15	periepididymal
15	catecholamine
15	landes
15	nursing
15	5).
15	collagenase
15	scavengers
15	erk1/2,
15	b1,
15	mt1
15	cocktail
15	no-mediated
15	83
15	exported
15	examines
15	supraphysiological
15	onset,
15	provoke
15	μmol/l).
15	il
15	fails
15	errors
15	mg/kg/day,
15	task,
15	pretreatment.
15	horseradish
15	photobiomodulation
15	mp
15	scratching
15	stabilizing
15	periodontally
15	manganese
15	baths
15	toll
15	ligands.
15	rantes,
15	epo
15	hyperthyroidism.
15	pre-incubated
15	tendon
15	end-organ
15	passed
15	cycling
15	celecoxib,
15	implantation,
15	apnea
15	japan.
15	spermatic
15	nr
15	predispose
15	(bk)
15	anesthetics
15	analgesia
15	downregulates
15	decrement
15	0.0001)
15	5.5
15	1.4
15	h2
15	estimated.
15	dynamics.
15	n-type
15	vir
15	strict
15	monomers
15	transform
15	unveil
15	pulses
15	minimizing
15	effects;
15	amplification,
15	scaffolds
15	sns
15	littermates.
15	healing,
15	thrombosis
15	problem:
15	testis
15	begins
15	hypo
15	transverse
15	pole
15	intensity,
15	dermatan
15	rockefeller
15	degeneration.
15	store
15	challenges,
15	blood-brain
15	mg/ml,
15	multicellular
15	(t4)
15	prompt
15	eliciting
15	approach:
15	postrema
15	excitability
15	myocyte
15	(shr
15	sna
15	p<0.01)
15	upward
15	pi3-kinase
15	meeting
15	n-acetyltransferase
15	cerebellum.
15	anti-toxoplasma
15	forest,
15	genotype,
15	brazilain
15	sag1,
15	cutoff
15	extra
15	frog
15	(or:
15	brucella
15	captivity
15	sul,
15	outbred
15	villages
15	september
15	bats,
15	herd
15	92
15	vitreous
15	epidemiology,
15	amazon,
15	inferences
15	p.i.,
15	shortage
15	trial.
15	nonpathogenic
15	peg
15	sepsis-induced
15	(pafr)
15	note
15	cd11c
15	cavity,
15	hagedorn
15	smads
15	dying
15	(cox-2)
15	challenges.
15	mitogen
15	ltd4
15	dioxide
15	kupffer
15	chamber.
15	diarrhea,
15	52021
15	promethazine
15	53%
15	relaxation.
15	particles,
15	autumn
15	alphaproteobacteria
15	(ca.
15	dealing
15	crystals
15	aerial
15	ml-1).
15	eukaryotes
15	spectroscopy,
15	platforms
15	plates.
15	100,
15	hydrocarbons
15	wastewater
15	pristine
15	serogroup
15	asymmetric
15	creek
15	(dc)
15	professional
15	externalization,
15	(tem)
15	il-1β.
15	lymphocytic
15	mc
15	edge
15	t-cells.
15	investigative
15	ideal
15	setting.
15	addressing
15	wells
15	qrt-pcr.
15	defines
15	cd69,
15	ligand-binding
15	il-6.
15	counterparts,
15	adenomas
15	autoimmunity,
15	(s.c.)
15	lysozyme
15	began
15	parents
15	(~
15	shotgun
15	igg2a,
15	outbreak.
15	pleomorphic
15	l-like
15	here.
15	parasitemia,
15	amniotic
15	myocarditis
15	t4,
15	coat
15	smallest
15	efficiency.
15	man,
15	retrospectively
15	presentation.
15	roles.
15	weaker
15	jes6-1
15	high-dose
15	mdcs.
15	trophozoites
15	atr
15	loss-of-function
15	coordination
15	length.
15	bypass
15	uvb
15	efficiency,
15	g:c
15	palate
15	self-renewal
15	(cpds)
15	crescentus,
15	rice
15	maintains
15	s1
15	engage
15	anti-predatory
15	cues.
15	trials,
15	lobe
15	flashing
15	lm
15	reads
15	clinic
15	winter
15	contents.
15	ppt
15	arg,
15	central.
15	neuropathy.
15	pparα
15	semi-quantitative
15	meal.
15	7.8
15	detraining
15	8-week
15	diet-fed
15	cdss
15	interfered
15	arthropods
15	colonization.
15	topics
15	boophilus
15	p1,
15	sh-sy5y
15	software
15	peptidases,
15	promastigotes,
15	threonine
15	assumption
15	worsened
15	travel
15	thickness,
15	souza,
15	searching
15	sophisticated
15	adamts
15	flanked
15	library.
15	nucleolar
15	conditional
15	alginate
15	occurs,
15	deletion.
15	vimentin,
15	synthesizes
15	compound.
15	settings
15	steatosis,
15	lna
15	acid-reactive
15	diode
15	β-galactosidase
15	coadministered
15	pairwise
15	cytoadherence
15	childhood
15	codons
15	frequency-dependent
15	k1
15	housing
15	(k
15	envenomation,
15	short-chain
15	implants
15	immersion
15	fimbriae.
15	rankl
15	taqman
15	non-lethal
15	timps
15	seen.
15	pinealocytes
15	lactation,
15	kiss1-expressing
15	sessions,
15	seizures
15	migraine
15	oxidize
15	destroyed
15	h10407
15	e1a
15	manuscript
15	oculomotor
15	protrusions
15	relate
15	tau
15	neuroprotection
15	hi
15	arc,
15	amyloid-β
15	breathing,
15	peptidome
15	gyrus
15	limbic
15	vulnerability
15	(nachrs)
15	darpp-32
15	α-bungarotoxin-sensitive
15	microspheres
15	endo‐oligopeptidase
15	selectivity.
15	hfd-fed
15	characterization,
15	ω-3
15	non-stimulated
15	bristle
15	linoleic,
15	high-intensity
15	adipogenesis
15	farnesyl
15	volunteers,
15	g/kg)
15	ibuprofen
15	hcv
15	conjunctival
15	foliate
15	lpo
15	dmso
15	88%
15	mannitol
15	menaquinone
15	anti
15	eau.
15	(sgc)
15	dsm
15	(cas
15	muta
15	nanomolar
15	nephrotoxicity
15	subplantar
15	iloprost
15	salivation,
15	myonecrosis
15	toxicological
15	pht
15	pidd
15	dermatophagoides
15	uremic
15	ccl2
15	anapyrexia
15	repetitions
15	crotoxin.
15	ucp
15	nf-i
15	polymeric
15	cheese
15	aeromonas
15	eca
15	anticarsia
15	chia
15	aquasalis
15	interline
15	ectonucleotidase
15	cspc
15	katg
15	smad7
15	dermatitis
15	il-17a
15	lll
15	attaching
15	tir
15	sba-15
15	pp-1
15	hop
15	eugenol
15	(eau)
15	1rm
15	pbp
15	elps
15	let-7
15	aqp1
15	kynurenic
15	il1b
15	pdx1
15	pip4k2a
14	dibutyryl
14	localization.
14	localize
14	microperfusion.
14	mediated,
14	ablation.
14	10-
14	spironolactone
14	retention.
14	di
14	microvillar
14	0.05,
14	[ca2+]
14	0.001
14	schering
14	ringer's
14	perfusion,
14	half-time
14	resin/reference
14	receptors)
14	electrode
14	(80%)
14	increments
14	accessible
14	depletion,
14	mol/l)
14	side,
14	sham,
14	building
14	(ta)
14	load.
14	adrenalectomized
14	intramuscularly
14	above.
14	lumen,
14	ionophore
14	estimating
14	compensated
14	(ld)
14	pmol/min
14	movement.
14	109
14	(pd).
14	mmhg).
14	titration
14	83%
14	cation
14	emerge
14	orders
14	1977
14	distances
14	excreted
14	stenotrophomonas
14	assign
14	housekeeping
14	culturable
14	sugarcane,
14	4.2
14	60%,
14	i),
14	cytosol.
14	c:
14	2-3
14	vegetation
14	imported
14	nm;
14	lima,
14	asc,
14	(th2)
14	dordrecht.
14	recognizes
14	edman
14	alpha,
14	granulomas
14	allied
14	deactivation
14	gm-csf
14	dedicated
14	airborne
14	defense,
14	ril-12
14	infected.
14	animals:
14	dissect
14	post-infection.
14	increase,
14	pathogenicity,
14	117
14	bivalent
14	tetanus
14	locus.
14	incubations
14	penetrate
14	groups)
14	publishing.
14	days/week,
14	(nos),
14	nos-,
14	30.
14	extravasation,
14	sick
14	analyzes
14	i.p.,
14	ileum.
14	(ova).
14	i.v.),
14	abolished.
14	(tregs)
14	periphery.
14	(2.0
14	bronchus
14	e-selectin
14	hydroquinone
14	ppm
14	colorimetric
14	pollutants
14	calretinin-ir
14	septum
14	anti-ova
14	2-h
14	treatment:
14	5-hydroxytryptamine
14	(ahr)
14	th2-mediated
14	(experiment
14	examination,
14	boosted
14	amp-dependent
14	(5.0
14	plausible
14	fundacao
14	serpens
14	illustrates
14	broadly
14	addressed.
14	acids)
14	clusters,
14	contigs
14	therapies,
14	two-fold
14	ruled
14	regulated.
14	microarrays
14	2.5%
14	twenty-three
14	probes.
14	topology
14	nuclease
14	hsp
14	aligned
14	amplification.
14	identification,
14	insert
14	human,
14	600
14	immunize
14	rna.
14	0.1%
14	galactose
14	n-linked
14	97%
14	note,
14	glycolysis,
14	rises
14	digital
14	(2.8
14	l-arg
14	synchronization
14	phosphoenolpyruvate
14	documented.
14	depolarizing
14	mated
14	mate
14	palmitate,
14	generated,
14	3-kinase,
14	gradual
14	transcription-polymerase
14	although,
14	fat.
14	amines
14	α2-adrenergic
14	starved
14	inexpensive
14	1986
14	dehydrogenase.
14	relating
14	atp.
14	role,
14	medication
14	intervals.
14	relapse
14	variation.
14	imipramine
14	(cns).
14	(snp),
14	atrophy,
14	estrogens
14	par1
14	controversial
14	reviewed.
14	metformin,
14	gavage,
14	anti-tlr4
14	salicylate
14	rats),
14	incorporation.
14	synergism
14	cross-talk
14	(cp)
14	latter.
14	(il-6),
14	tension
14	id
14	bf
14	post-capillary
14	modifications.
14	control;
14	decidualized
14	proteoglycan
14	immunizations
14	mg/l
14	age)
14	nourished
14	vasodilation.
14	migrating
14	xanthine
14	(vitamin
14	disappeared
14	zymosan,
14	(around
14	1994,
14	inactivating
14	silent
14	preceding
14	machinery,
14	fshb
14	ribosomes
14	antimesometrial
14	uterus
14	(ltb4)
14	polluted
14	qpcr,
14	cytoplasm,
14	placenta,
14	gp
14	osteoclasts
14	catalysis
14	(il)-6,
14	strikingly
14	favour
14	(∼
14	placenta.
14	non-irradiated
14	mechanism(s)
14	spatially
14	ruthenium
14	electron-dense
14	pgs
14	7th
14	move
14	hand
14	vacuole
14	directions.
14	closed
14	performance,
14	(average
14	rhythms.
14	decisive
14	(vegf)
14	anorexigenic
14	termination
14	magnocellular
14	projections,
14	nonpharmacological
14	ras,
14	produced.
14	toxoplasmosis,
14	briii
14	lambs
14	gene)
14	das
14	ixodes
14	oocysts,
14	coll
14	parasitology.
14	socioeconomic
14	cajennense
14	farms,
14	p.i.
14	babesia
14	veterinaria
14	flocks
14	marinkellei
14	collapse
14	waters
14	metropolitan
14	maned
14	people,
14	localities
14	fish,
14	quality.
14	fox
14	ca.
14	rainforest
14	bats.
14	americas,
14	sri
14	colombian
14	colombia
14	structured
14	(vl)
14	(120
14	nested-pcr
14	retain
14	twenty-eight
14	july
14	calves.
14	409
14	days;
14	intestine.
14	necessity
14	subfamily
14	impaired,
14	acetylation
14	h3
14	microenvironment,
14	tlr3
14	5-lo
14	ascitic
14	bmp-7
14	socs-1
14	chemotherapy,
14	hominis
14	(ra)
14	intraductal
14	transcriptase-polymerase
14	disodium
14	pge2.
14	3.1
14	paws
14	histopathologic
14	carbonate
14	asphalt
14	alive
14	seasons
14	george
14	methane
14	lds
14	30°c
14	aeruginosa,
14	damage-associated
14	melanoma.
14	ifn-γ-producing
14	(mtt)
14	melting
14	ige,
14	mdcs,
14	il-12p70
14	noninvasive
14	orange/ethidium
14	c3.
14	fh,
14	fi
14	hemodialysis
14	validity
14	metastases
14	examination.
14	1995,
14	proliferated
14	suum
14	over-represented
14	tumorigenesis,
14	modifier
14	94
14	tnfα,
14	monocytogenes
14	pbs
14	checked
14	fc
14	crocodilian
14	entering
14	predictions
14	immunolocalization
14	instituto
14	pcr-based
14	(central
14	programmes
14	endemicity
14	possible.
14	dosage
14	amazonia,
14	catl-like
14	gels.
14	vertebrates
14	distinguishing
14	hitherto
14	josé
14	cd4<sup>+</sup>
14	domain-containing
14	pathogen-associated
14	cords
14	astrocytic
14	pathophysiology.
14	reside
14	(mhc)
14	c57bl6
14	isoelectric
14	2b
14	employed.
14	(xp)
14	defects,
14	pluripotent
14	regulon.
14	tmz
14	mutation,
14	6-4pps
14	flexible
14	cis
14	attention.
14	culminating
14	kynurenine
14	thaliana
14	carbonyl
14	coexpressed
14	accidental
14	lai
14	functional,
14	colonizing
14	pv
14	mutagenicity
14	signal,
14	dna-binding
14	nucleosides
14	lengths
14	micrococcus
14	shapes
14	region)
14	subjective
14	aggression.
14	care.
14	morphine-treated
14	hunting,
14	vestibular
14	2000.
14	cre-site
14	nuts
14	consuming
14	concluding,
14	exons
14	glomerulosclerosis
14	incipient
14	dn
14	weeks),
14	measurements,
14	quercetin
14	resuscitation
14	49%
14	mrnas.
14	stz-induced
14	neuroblastoma
14	(pi
14	tick,
14	active,
14	cream
14	electrostatic
14	clotting
14	polypeptide,
14	food.
14	away
14	virtual
14	lymphoproliferative
14	unfortunately,
14	oncogenes
14	epithelial-mesenchymal
14	zymography.
14	recurrence.
14	naiffi
14	pentavalent
14	efficacy.
14	rhodamine
14	dolichol
14	outgrowth
14	forward
14	ola
14	mmp-2,
14	propulsive
14	zileuton,
14	strikingly,
14	interventions.
14	entered
14	underscore
14	microvasculature
14	ratios,
14	fy
14	arbovirus
14	hypoendemic
14	toxoplasmic
14	6),
14	(msp119)
14	weanling
14	porto
14	sinensis
14	biodegradable
14	mutability
14	leukotoxin
14	forsythia
14	longevity
14	forsythia,
14	clindamycin
14	mucosa,
14	nile
14	hepatotrophic
14	haemorrhage
14	industry.
14	master
14	exercises
14	malic
14	anxiety,
14	rm
14	leaflet
14	(test
14	integrates
14	terminalis,
14	monoaminergic
14	gray.
14	reticularis
14	neoplasms
14	ame-hpv
14	neoplasms.
14	myoepithelioma
14	acc
14	bone.
14	pseudocystic
14	temporomandibular
14	pep19
14	endotoxic
14	neurokinin-1
14	6-ohda-lesioned
14	ethanol-treated
14	nachrs
14	flip
14	cardiolipin
14	myofibers
14	ω-6
14	evokes
14	(pparγ)
14	ubiquitin-proteasome
14	g6pdh
14	ucp3
14	myopathy
14	planar
14	contributor
14	cp-pgs
14	depolarization,
14	gs-x
14	transition.
14	pr
14	ventricles
14	exhaustion
14	provision
14	semen
14	piglets
14	t<inf>3</inf>
14	(at1r)
14	tshβ
14	(both
14	oval
14	nerves.
14	spurr
14	branched
14	render
14	odors
14	coffee
14	sensorimotor
14	tcr
14	adp,
14	melanin
14	1-deoxy-d-xylulose-5-phosphate
14	caenorhabditis
14	elegans
14	psychodopygus
14	sandflies
14	residuum
14	wellcomei
14	hexane
14	arboviruses
14	p38α
14	pubertal
14	hydrochlorothiazide
14	erection
14	cavernosa
14	haem
14	60-2770.
14	cyproheptadine
14	(lc-ms-ms)
14	d-name
14	peritonitis
14	myotoxin
14	antivenom.
14	sargassum
14	(melanoma),
14	thallium(iii)
14	puberty.
14	trpv6
14	computed
14	dioctadecyldimethylammonium
14	zeta-potential
14	24.15
14	permeabilized
14	tr1
14	nod
14	ligb
14	saprophytic
14	leptospira.
14	monoolein
14	vastus
14	radicicol
14	cyclosporin-a
14	hsp60
14	polystyrene
14	20s
14	homoallylic
14	nanodispersion
14	pbmt
14	chikv
14	mir-1
14	metaphase
14	lira
14	espb
14	(ehec)
14	o26
14	citricarpa
14	glyceroneogenesis
14	quail
14	exocytosis
14	lpr
14	uveoretinitis
14	polymyxin
14	ama-1
14	p139-512
14	nc886
14	brp
14	selenomonas
14	homeobox
14	hsp72
14	neostriatum
14	vasp
14	vagotomized
14	2/h
14	μ1)
14	tim-3
14	pahsas
14	tet2
13	μmol/l
13	buffering
13	natriuresis
13	bimodal
13	ions.
13	outlined
13	hemodynamics
13	electrogenic
13	wortmannin
13	(10-12
13	duct.
13	0.26
13	mouse.
13	8-bromo-cyclic
13	it,
13	responds
13	exchange,
13	ph-sensitive
13	disposed
13	perinuclear
13	v2
13	load,
13	clues
13	(chronic
13	mg2+
13	calcium.
13	lower,
13	circuit.
13	+/‐
13	approached
13	discrepancies
13	56%
13	ml-1.
13	(blood
13	1-3
13	may,
13	1981
13	developments
13	1979
13	of:
13	acetate.
13	ml/min
13	(b
13	polyamines
13	genera,
13	phytopathogenic
13	nitrogen-fixing
13	observing
13	nitrogen,
13	as:
13	marcescens
13	harboured
13	electrons
13	nitrogenase
13	v)
13	99
13	mg/100
13	(cd40l)
13	(via
13	presented,
13	costa,
13	agreement,
13	mycoses
13	settings.
13	cooperate
13	c4,
13	chemotaxis,
13	eicosanoids,
13	susceptible,
13	initiates
13	are,
13	manifested
13	sugars
13	monthly
13	presentations
13	learn
13	destroy
13	seventh
13	restrict
13	fibrillar
13	gross
13	abundantly
13	adcc
13	cells:
13	braga,
13	intracranial
13	vehicle,
13	(il-10)
13	culminates
13	i-i/r
13	accounting
13	cat,
13	diesel
13	exhaust
13	(35
13	occlusion.
13	plethora
13	(bm)
13	cages
13	contraction,
13	15),
13	stressed
13	oil.
13	co-incubation
13	ltb4.
13	curative
13	trypanocidal
13	oswaldo
13	cruz.
13	untranslated
13	figure
13	alcoholic
13	b.v..
13	event.
13	polymorphism.
13	kernel
13	strengthen
13	sciences,
13	guidelines
13	device
13	all,
13	iib
13	opossums
13	perfect
13	electrophoresis,
13	95
13	1989,
13	17%
13	incorporate
13	approximate
13	productive
13	isolation.
13	depolarized
13	pgz
13	place.
13	(nox)
13	c-peptide
13	carboxykinase
13	19th
13	bioscience.
13	(t,
13	delivery,
13	(ths)
13	(42%)
13	evidence,
13	ir,
13	important.
13	13%
13	ingestive
13	efflux.
13	obvious
13	krebs-henseleit
13	deplete
13	ka
13	10.0
13	cage
13	dose-related
13	fashion.
13	acetoacetate
13	malate
13	mpd
13	addiction
13	concepts
13	(fcf)
13	sniffing
13	anova
13	hyperactivity,
13	1986.
13	coeruleus
13	vasoconstriction.
13	j/cm2,
13	wall.
13	hemostatic
13	18th
13	igg-treated
13	mnsod
13	interleukins
13	hematoxylin
13	picrosirius
13	associacao
13	alloxan-diabetic
13	injuries.
13	diclofenac.
13	mmp-9,
13	odq.
13	endocannabinoid
13	sensitizing
13	electrically
13	nitroprusside.
13	(shr),
13	(doca)-salt
13	hydralazine
13	shear
13	placentation
13	ascertain
13	bk,
13	acetylcholine.
13	diabetes-induced
13	α,
13	counts.
13	ejection
13	failing
13	relates
13	defects.
13	(sod,
13	careful
13	territories
13	coral
13	rarefaction
13	dilated
13	neuron-specific
13	paralysis
13	patch-clamp
13	arylalkylamine-n-acetyltransferase
13	enkephalin
13	company
13	3.8
13	3h-estradiol
13	(tx)
13	tri-
13	shell
13	mc3t3-e1
13	pcna
13	iκb
13	intriguing
13	macromolecular
13	electric
13	trβ-selective
13	apposition
13	calculated.
13	ameloblasts
13	p.m.
13	(sem),
13	nmol/min
13	moisture
13	myofibrillar
13	complexes,
13	projections.
13	(map),
13	santos,
13	rest.
13	assay)
13	nts,
13	moderate-intensity
13	barrier.
13	brainstem,
13	inputs,
13	group),
13	lf
13	myocardium.
13	groups).
13	held
13	+/+
13	hypotension,
13	plateau
13	mo,
13	distensibility
13	compliance
13	57%
13	(i.v.)
13	breed
13	surveyed
13	rattus
13	degraded
13	europe.
13	santa
13	ticks,
13	gender,
13	bird
13	serologically
13	examinations
13	occurrences
13	significance.
13	papers
13	topic
13	zootecnia.
13	327
13	federal
13	(23
13	intestines
13	indian
13	asia.
13	giardia
13	sedimentation
13	usa.
13	usa
13	anurans
13	semiarid
13	prevalences
13	ago
13	pasteurella
13	mammal
13	classify
13	station
13	october
13	sporozoites,
13	29%
13	capybara
13	parasitologists
13	accomplish
13	its1
13	(p<0.001).
13	worm
13	adenovirus,
13	pre
13	isotopic
13	weighed
13	8).
13	appropriately
13	percoll
13	household
13	employed,
13	levels;
13	type-i
13	tgf-
13	situations,
13	homogenates.
13	(40%),
13	capacities
13	unraveling
13	ec50
13	hyperreactivity,
13	score,
13	occurs.
13	(inos),
13	step.
13	acid-induced
13	le
13	infiltrate,
13	(a/j
13	depot
13	acoustic
13	cobalt
13	reproduction,
13	consist
13	(4),
13	continental
13	cycles,
13	depths
13	fauna
13	firmicutes
13	extending
13	ml-1),
13	denaturing
13	proteomes
13	variables,
13	fertility
13	(ag)
13	volatile
13	genus,
13	legionella
13	cost,
13	compares
13	subtypes.
13	facing
13	angiogenesis.
13	neuropathy
13	hla-dr
13	bfd-22
13	s-phase
13	b16f10-nex2
13	cd3+
13	practice.
13	derivative,
13	generic
13	devices
13	deserves
13	(lp)
13	epithelia
13	(co)
13	expressed.
13	airmin)
13	chemokines.
13	g1/s
13	(hiii)
13	(liii)
13	(ab)
13	2.5-fold
13	airmaxrr
13	polygenic
13	bead
13	inflammation-related
13	sd)
13	c3h
13	haplotype.
13	catl
13	strategies,
13	parameters:
13	kinetics,
13	scaling
13	rnai
13	evansi
13	catfish
13	dispar
13	denominated
13	biting
13	sub-saharan
13	salvage
13	apolipoprotein
13	points,
13	flagellated
13	(a,
13	infants.
13	ia
13	(13
13	lizards
13	grouping
13	injury/acute
13	proposes
13	tissue-derived
13	reminiscent
13	consequences.
13	ifn-γ-induced
13	(cm)
13	igg2a.
13	parasitism,
13	(il-12)
13	hairless
13	committed
13	μg,
13	basically
13	polymerases
13	replicated
13	tn5
13	repair-deficient
13	absorbed
13	cma
13	density.
13	erythroid
13	front
13	double-strand
13	syndromes,
13	counteracting
13	noncoding
13	co-expressed
13	reprogramming
13	application,
13	colloid
13	maturity
13	signal.
13	transposable
13	wavelength
13	pro-drug
13	transgene
13	therapeutical
13	simian
13	luteus
13	threats,
13	consolidation
13	sides
13	decision
13	controversy
13	neurobiological
13	accelerating
13	glycated
13	age-albumin
13	esr2
13	complications,
13	bulk
13	diminishing
13	(dm)
13	adjunctive
13	2.7
13	folds
13	edl,
13	post-myocardial
13	hydroxy
13	non-esterified
13	lifespan
13	mets
13	ramipril
13	(tnfα)
13	refed
13	stuttgart
13	familial
13	nephropathy.
13	1b
13	colonizes
13	amps
13	engorged
13	ivermectin
13	surfactant
13	glycine-rich
13	candidiasis,
13	fungus.
13	obligatory
13	asp
13	endocytic
13	read
13	esi-ms
13	man.
13	flagellum
13	kinds
13	residence
13	goalkeeper
13	intoxicated
13	afternoon
13	oriented
13	conduction
13	(cr)
13	fetus.
13	lymphokine
13	mitosis
13	aberrations
13	spheroids
13	clearing
13	eukaryotes,
13	recruit
13	producers.
13	reticulum,
13	cones
13	cytogenetic
13	sphingomyelin
13	rna,
13	ipc
13	amazonensis-infected
13	pyridoxal
13	unresponsiveness
13	major,
13	methanolic
13	acceptor
13	tpc-1
13	equivalents
13	lysophosphatidic
13	rhoa,
13	cdc42
13	exerting
13	foot
13	trypan
13	northwestern
13	pvdbp
13	low-cost
13	69%
13	rbcs
13	meiotic
13	children's
13	ovale
13	blend
13	curtobacterium
13	x,
13	oligopeptide-binding
13	nucleatum,
13	secretes
13	osteoclast
13	etbf
13	mann-whitney
13	ccr5
13	sgm.
13	leukotoxic
13	mmps,
13	trace
13	organelle
13	connectivity
13	suture
13	thyrotropin
13	leptin-induced
13	agrp
13	leptin-deficient
13	amitriptyline
13	sessions.
13	food-restricted
13	α1-adrenergic
13	degenerating
13	deafferented
13	deferens
13	imprinting
13	intra-nasal
13	lt1
13	cgmp-dependent
13	dr,
13	varicosities
13	post-cryolesion
13	(cac2)
13	immunolocalized
13	dehydrated
13	papillae.
13	inflation
13	infancy
13	synapsin
13	(ad).
13	(cc)
13	(hc)
13	syp
13	(cci)
13	gj
13	(fos-ir)
13	etm
13	diacetate
13	thoroughly
13	innervation.
13	hmg-coa
13	plantar
13	flop
13	neurotensin
13	icu
13	ppar-γ
13	manumycin
13	force,
13	weaned
13	ischaemic
13	leukemia.
13	trophoblast,
13	(p<
13	l-carnitine
13	microemulsion
13	hl-60,
13	30%.
13	cent),
13	(cpt)
13	hep2
13	115
13	rhesus
13	rv
13	hospitalization
13	glyphosate
13	hrsem
13	mouth
13	exploring
13	incerto-hypothalamic
13	ni
13	vmax
13	oligopeptidases
13	mch-ir
13	motoneuron
13	audiogenic
13	stress-inducible
13	nontoxic
13	(is)
13	medically
13	5-fu
13	(ckd)
13	aucinf,
13	counteracts
13	3-nitrotyrosine
13	(r2
13	ta100
13	sod1
13	bothropstoxin-i
13	rbcc
13	β-adrenoceptors
13	donors,
13	bmv
13	oxysporum
13	piperine
13	trβ
13	cholesterol-lowering
13	fastidiosa.
13	(stec)
13	hybridoma
13	pichia
13	ctx,
13	26s
13	22.19
13	autoantibodies
13	liga
13	uropathogenic
13	cxcl12
13	febrigenic
13	agp
13	hemin
13	s100a8
13	th.
13	mstn
13	deregulated
13	fam3b
13	dcd
13	lipoic
13	tacrolimus
13	allodynia.
13	s2
13	slices,
13	cd56
13	pathotypes.
13	loxoscelism
13	gabbr1
13	herbicide
13	mycelial
13	seedlings
13	cultivars
13	iso-treated
13	(fb1)
13	cyclopiazonic
13	afb1/kg
13	sows
13	aerosols
13	≅
13	aki.
13	recipients.
13	immunodominance
13	rl
13	pvcsp
13	msp119-specific
13	pvmsp1
13	esbl
13	ogn
13	smad
13	c5a
13	aae
13	urethane-anesthetized,
13	cyp3a5
13	tsc1
13	sporothrix
13	itraconazole
13	arhgap21
12	inhibition)
12	isotope
12	cotransporter
12	exchanger.
12	perfusing
12	due,
12	excretion,
12	expansion.
12	end-diastolic
12	s3
12	ru
12	expressive
12	kyoto
12	effective,
12	pi)
12	mg·kg-1·day-1
12	jh
12	(0
12	h+-atpase,
12	withdrawal.
12	41%
12	osmolality
12	permeant
12	ba2+
12	ouabain,
12	46%
12	hypotonic
12	absorptive
12	switched
12	parathyroid
12	abundance.
12	again,
12	2-4
12	was,
12	u-b
12	impaired.
12	supplement
12	0.54
12	adrenalectomy
12	0.15
12	ca2+.
12	clamping
12	electrodes
12	mmhg;
12	questioned
12	previously.
12	degree,
12	situations.
12	methodology.
12	pores
12	normalize
12	fibre
12	hypervariable
12	traits.
12	wider
12	resource
12	skills
12	230
12	camp.
12	replace
12	g-1
12	substitute
12	favourable
12	cytokine.
12	(pmn)
12	(a/j)
12	β-glucan
12	inefficient
12	tgf-β.
12	tlr2-/-
12	skewing
12	presentation,
12	others,
12	iga,
12	exacerbates
12	dendrogram
12	susceptibility,
12	internalization.
12	adherence,
12	collagen.
12	histopathology,
12	counts,
12	112
12	123
12	walls
12	criteria.
12	c5-deficient
12	stock
12	radial
12	laboratory.
12	reproducibility
12	bbg
12	deterioration
12	bifidobacterium
12	methacholine.
12	sudden
12	i.p.).
12	shown.
12	(1%,
12	e2.
12	behavioral,
12	inosine
12	allergen-induced
12	(0.25
12	txb
12	trauma
12	th2-like
12	apocynin,
12	space,
12	plexus,
12	oligomeric
12	titanium
12	ensuing
12	defense.
12	(phe)
12	(il)
12	ligated
12	formalin
12	cell-derived
12	16,
12	(increased
12	(nt)
12	5-day
12	(positive
12	gmp-dependent
12	guinea-pig
12	14-day
12	oa.
12	adrenoceptors
12	dtus
12	urgently
12	three-fold
12	200,
12	3),
12	62%
12	dtus.
12	titers.
12	coming
12	reproduces
12	debate.
12	nd7
12	interval,
12	bioenergetics
12	updated
12	developmentally
12	ber
12	walter
12	employ
12	costs.
12	kits
12	forty-four
12	standardization
12	el
12	didelphis
12	discriminated
12	lit
12	cope
12	superantigen
12	14%
12	rabbits,
12	gluconeogenesis,
12	glycogenolysis
12	pro-oxidant
12	oxygen.
12	dehydroepiandrosterone
12	20th
12	intolerance.
12	(erk1/2)
12	(nos).
12	5);
12	anions
12	vulnerable
12	weighed,
12	equipped
12	hfd.
12	mmol/l).
12	reversing
12	[1-
12	insulin-producing
12	(5.6
12	insulin-signaling
12	(10%)
12	non-activated
12	contact,
12	outflow.
12	voltage-sensitive
12	eventual
12	(5,
12	metabolic,
12	italian
12	injections,
12	9:00
12	apo
12	homovanillic
12	higher,
12	forty-five
12	transduction.
12	cox-1,
12	ang-ii
12	cee-ld
12	gcf
12	intradermally
12	co-injected
12	c48/80-induced
12	peroxide,
12	deficiencies.
12	unclear,
12	player
12	amelioration
12	(csa),
12	divulgacao
12	cientifica.
12	(l-name),
12	track
12	routinely
12	prescribed
12	obstruction,
12	volunteer
12	contractions.
12	sr
12	(except
12	endothelium-independent
12	gavage.
12	eosin
12	o-glcnacylation
12	volumes
12	combined,
12	precursor,
12	stroma,
12	intensively
12	chloral
12	(intravital
12	(rt-pcr).
12	discussed,
12	pgi2
12	histamine,
12	hoe-140
12	ne.
12	baseline.
12	treatment;
12	sod,
12	distilled
12	inhibited.
12	catecholamines
12	microtubule-associated
12	antinociception.
12	channel,
12	inc.,
12	quiescent
12	6.3
12	phosphate.
12	falls
12	feasibility
12	adds
12	decidua.
12	ages,
12	placentas.
12	organization,
12	(so)
12	qpcr.
12	starts
12	sections.
12	α2c-ar
12	fs
12	viper
12	expression;
12	gonad
12	co-localized
12	he-ne
12	settlement
12	femur,
12	gc-1.
12	thyroid-stimulating
12	ossification,
12	egp
12	linearly
12	orientation
12	sequentially
12	(65
12	popularly
12	mobilized
12	packed
12	otergic
12	hypertension-induced
12	hf,
12	incompletely
12	session,
12	sed
12	(hplc)
12	cardiopulmonary
12	campos
12	actin,
12	(icv)
12	5ptase
12	awareness
12	displacement
12	tgr(asraogen)
12	compromising
12	nts.
12	daily,
12	above,
12	(only
12	animals)
12	sheep.
12	park
12	specimen
12	dsb
12	veterinarians.
12	infestation
12	tufted
12	clade,
12	wolves
12	2-month-old
12	hospitals
12	171
12	barcode
12	dionisii
12	(ggapdh)
12	vicinity
12	islands,
12	necrotizing
12	peru
12	187
12	communities,
12	biomes
12	kit.
12	(higher
12	deforestation
12	callosus
12	(m.
12	europe,
12	hyopneumoniae
12	crab-eating
12	sporocyst
12	sustainable
12	(ssu)
12	composite
12	facilities
12	points.
12	coronavirus
12	maintenance,
12	geographically
12	colostral
12	negro
12	locations.
12	arm
12	(stz)
12	radiotherapy
12	stat-1
12	(tgf-β)
12	carrageenan.
12	atherosclerosis.
12	trimeric
12	stimulators
12	lamps
12	cyclo-oxygenase-2
12	r-954
12	pneumoperitoneum
12	s.c.),
12	cd4,
12	case-control
12	pancreatitis.
12	(ets)
12	pufas
12	b220+
12	μg/kg),
12	ewi
12	hypothermia,
12	bcg.
12	2.5,
12	kidneys,
12	biodegradation
12	proteobacteria
12	community,
12	skeleton
12	labile
12	admiralty
12	king
12	retrieved
12	cellulose
12	coast.
12	coverage
12	acetate,
12	competence
12	importance,
12	g2/m
12	g0/g1
12	liposome
12	(gd)
12	oncoproteins.
12	sua
12	fibrosarcoma
12	jq1
12	immunologically
12	evasion.
12	revert
12	(17
12	woman
12	context:
12	malignancy
12	rcc
12	(hcc)
12	il-12p40,
12	kras
12	gonçalves
12	qtls
12	polycyclic
12	phenotyped
12	(lod
12	slc11a1ss
12	backgrounds
12	tnfα.
12	repertoires
12	evolutionarily
12	bp)
12	deanei,
12	rounded
12	amphibian
12	groel
12	pm,
12	yacare
12	congopain
12	behaviour,
12	valid
12	unprecedented
12	biologic
12	died.
12	dpi.
12	split
12	fum1
12	aflp
12	gels,
12	passages
12	signs.
12	disclose
12	(70%)
12	slides
12	borges
12	recapitulate
12	expands
12	spm
12	t-
12	(tem).
12	anticipated
12	naip5/nlrc4
12	victims.
12	rather,
12	cm,
12	non-conventional
12	activated,
12	corroborates
12	cd8-
12	(il)-10
12	synchronous
12	produced,
12	onset.
12	immunosuppression.
12	chronological
12	cancers,
12	clastogenic
12	sunlight.
12	ubiquitination
12	xp-c
12	polymers
12	xpc
12	missense
12	circumvent
12	brands
12	doxorubicin.
12	topoisomerase
12	now,
12	phytopathogens,
12	citri,
12	operator
12	aegypti,
12	explored,
12	exonuclease
12	treatment)
12	offering
12	employs
12	internucleosomal
12	progeny
12	da,
12	defeat
12	simulations
12	predator.
12	sign
12	(pmv).
12	predicting
12	prey.
12	(pmd)
12	epilepsy.
12	diencephalic
12	facilitation
12	organize
12	dots
12	genseed-hmm
12	datasets
12	zp60s
12	afterwards,
12	zeta
12	elution
12	(emsa)
12	quantification.
12	ppar
12	vegfa
12	rt-qpcr
12	glut2,
12	setting:
12	siblings
12	emsa
12	aureus,
12	mrsa
12	mlc/migf-1
12	hdl
12	hdl-cholesterol
12	myocytes
12	6).
12	extension,
12	channel.
12	normal,
12	(0.5,
12	neonatally
12	hsd
12	detoxification
12	cloacae
12	(amps)
12	transmit
12	cerevisiae.
12	restrained
12	pest
12	tryptic
12	proteinases,
12	cps
12	5.8
12	furthermore
12	1d
12	fractions,
12	(28
12	spent
12	pigeons.
12	know
12	(or,
12	1-2
12	cleared
12	mcf7
12	connexin
12	connexins
12	pull-down
12	cleavage,
12	c8
12	tumorigenic
12	dolichols
12	parasitophorous
12	transwell
12	chaperones
12	tributyrin
12	sdf-1α
12	constriction,
12	cleavage.
12	orthopedic
12	acinus
12	retinas,
12	rate-limiting
12	vip
12	b16
12	retrovirus
12	schizont
12	multiple-clone
12	districts
12	fuccs
12	prevalent.
12	cost-effective
12	income
12	recombination.
12	headache
12	teaching
12	39%
12	igg2
12	polyhydroxyalkanoates
12	alternaria
12	constituent
12	(oppa)
12	microbiome
12	resorption.
12	downregulate
12	amoxicillin
12	penicillin
12	co-induction
12	inc..
12	mandible
12	subinhibitory
12	ulcerative
12	volumetric
12	cirrhosis.
12	nerve,
12	rna-dependent
12	(gc)
12	altiparanae
12	lamellae
12	hepatocytes.
12	oocytes.
12	spermatozoa
12	night,
12	acute,
12	phosphorylates
12	neuroscience
12	tricarboxylic
12	(oua)
12	fluoro-jade
12	8:00
12	carcinosarcoma
12	factor(s)
12	photic
12	(ec50
12	courses
12	derivative.
12	knob
12	laminin-1
12	(dr)
12	rostromedial
12	commissure
12	varicose
12	(chat)
12	hif-1α
12	graded
12	phosphoric
12	hydroxyapatite
12	junctional
12	synaptophysin
12	ibro
12	neurotransmission.
12	adolescents.
12	nf
12	snpc
12	cort
12	editora
12	nf68
12	omega-3
12	glur
12	aspects.
12	glur1,
12	axotomy
12	glur4
12	pla2,
12	synaptosomes
12	ige.
12	pain-enhancing
12	unmyelinated
12	rd
12	bradykinin-potentiating
12	griseum
12	telencephalic
12	urethane-anesthetized
12	mt-ii-induced
12	externalization
12	hfd-induced
12	vo2max
12	seconds
12	acid-rich
12	lonomia
12	gestation,
12	adipogenesis.
12	glucocorticoids,
12	(aβ)
12	apoe
12	intermembrane
12	allodynia,
12	oxide-cyclic
12	cytometric
12	(0.01
12	macrophage-like
12	1-
12	uc
12	branched-chain
12	swab
12	crops
12	(median
12	flavus,
12	bw,
12	corrosion
12	μm2
12	spherical
12	dehydration
12	unusually
12	kcn
12	proestrus
12	electroacupuncture
12	tactile
12	ccl25
12	(p=0.0001),
12	warmed
12	operons
12	stimulator
12	sporocysts
12	xii
12	lc-ms/ms
12	laboratórios
12	contractility.
12	i.d.)
12	glyceryl
12	relaxations,
12	nitrite/nitrate
12	sildenafil,
12	vla-4
12	precision,
12	ts3
12	neca
12	albuminuria,
12	pla2.
12	oedematogenic
12	μmol/kg)
12	mmf
12	k(e)
12	day-1)
12	(terminal
12	resistances.
12	(k(i)
12	inhalational
12	polyvalent
12	corneum
12	chemicals
12	helvetica
12	chimica
12	diterpene
12	naphthoquinones
12	amd
12	vegetable
12	phenolic
12	writhing
12	shp-1
12	plasmon
12	ediii
12	sv
12	co-adsorbed
12	cpp
12	ep24.15.
12	faseb.
12	(uniprotkb:)
12	()
12	ccr4ko
12	il-22
12	mog
12	autotransporter
12	lig
12	ba2103
12	ficolin-2
12	epec,
12	lipl32
12	gipr
12	zndpbg
12	asp-2.
12	cryolesion.
12	sarcomeric
12	ctx-injured
12	hmucp
12	operon,
12	aminoglycosides
12	endo-pdi
12	isoproterenol-treated
12	necessary.
12	nlrc4
12	(mdr)
12	aml
12	hypervalent
12	3hv
12	βcd-carvacrol
12	cus
12	nahs
12	trpa1
12	trpv-4
12	(cvid)
12	jha1
12	crotalphine,
12	bnip3
12	cspd
12	β‐1
12	tβri
12	lhrh
12	cholecalciferol
12	effacing
12	ganglioside
12	gmp-pkg
12	non-neoplastic
12	thuringiensis
12	conidia
12	nrf2
12	neuroinflammation.
12	depots.
12	grains.
12	thioester
12	egcg
12	mia
12	disinfectants
12	immunogenicity.
12	cloud
12	anti-irbp
12	retinoid-binding
12	il-9
12	nh36
12	yf
12	penicillin-binding
12	extended-spectrum
12	ctx-m-15-producing
12	ellagic
12	lanceolatus
12	denture
12	w;
12	(δ
12	na:k
12	agonism
12	gp82,
12	canrenone
12	expiration.
12	(rtn).
12	α2-adrenoceptor
12	bicuculline
12	ppy
12	rx
12	821002
12	cvlm
12	endmt
12	adsc
12	plp
12	nt157
11	overstimulation
11	output.
11	(pt)
11	jh+
11	adenylyl
11	cyclase,
11	phlorizin
11	microelectrodes,
11	increases,
11	pp1
11	dephosphorylation
11	(sham)
11	posttranslational
11	pulse,
11	units/min
11	microdomain
11	h+-atpase.
11	[ca2+]i.
11	lys
11	centrifugation
11	ringer,
11	5.3
11	situation,
11	inhibitor]
11	micropuncture
11	0.29
11	investigations.
11	balancing
11	10-3
11	preincubated
11	proposed,
11	monolayers
11	0.
11	exchange.
11	0.07
11	7).
11	sulfate.
11	vasopressin,
11	(expressed
11	intensified
11	sec.
11	(gfr)
11	ca2+,
11	0.22
11	0.24
11	0.43
11	pump,
11	(na)
11	turned
11	missing
11	dependency
11	0.28
11	na<sup>+</sup>
11	t/2
11	conductance.
11	phosphate,
11	ecv
11	buffer.
11	-4
11	exit
11	1982
11	116
11	spaces.
11	isotonic
11	nacl.
11	translocation.
11	segmental
11	embryogenesis
11	diazotrophic
11	22%
11	agriculture
11	solubilization
11	sparse
11	mineralocorticoid
11	aldo
11	stores.
11	econazole
11	sem.
11	higher.
11	hyper-igm
11	promyelocytic
11	extant
11	trp
11	immunoprotection
11	disseminate
11	renders
11	ability,
11	immunopathology
11	inos-/-
11	anchored
11	pathogen,
11	(dth)
11	forty-eight
11	isotypes.
11	manifestations.
11	il-4.
11	bands,
11	αβ
11	collagens
11	ivic
11	8th
11	motile
11	numbers.
11	17β-estradiol
11	mip-2
11	cbd
11	aim.
11	chat-,
11	repercussion
11	24.
11	sma
11	(il-1β),
11	bal,
11	count,
11	(sns)
11	(1%)
11	numbers,
11	tregs,
11	(mch),
11	abrupt
11	production;
11	(gpx),
11	(cat),
11	immunohistochemistry;
11	expressions.
11	marrow.
11	47%
11	pups.
11	systemically,
11	ova,
11	huvec
11	pleurisy
11	integrin.
11	bhr
11	intoxication
11	nevertheless
11	hydrochloride
11	ninety
11	kinase.
11	886
11	immune-complex-induced
11	bn-52021
11	concentration-dependently
11	partitioned
11	verified.
11	patients:
11	databases,
11	orthologues
11	characterisation
11	polymorphisms,
11	conjugates
11	fasciculata
11	adaptation.
11	151
11	cruzi-specific
11	dnas
11	cluster,
11	nd
11	syntenic
11	implemented
11	discriminative
11	abundant.
11	sybr
11	code
11	sum
11	rflp
11	epimastigotes,
11	microsatellites
11	laboratories,
11	fragments,
11	propensity
11	scientists
11	bac
11	precisely
11	maps
11	probed
11	dot-blot
11	dna-based
11	extraction,
11	pdx-1
11	(gsis).
11	(dhea)
11	well-documented
11	(nadph)
11	(not
11	(c,
11	(rp)
11	pentose-phosphate
11	(g
11	amphiphilic
11	undoubtedly
11	(serine
11	glucokinase
11	[2-
11	atp/adp
11	signalling.
11	functioning.
11	(52%)
11	0.05;
11	ob
11	proposal
11	14c-glucose
11	diacylglycerol
11	22-hr
11	rotating
11	contrasts
11	steadily
11	quinine,
11	antimycin
11	rb
11	incompatible
11	europe
11	addiction.
11	short-
11	12-h
11	3.7
11	student
11	discontinuation
11	(hva)
11	relationship.
11	open-field
11	vulvovaginal
11	ovx,
11	ovx.
11	<0.05)
11	(h2s)
11	ros,
11	system),
11	bioavailability,
11	antioxidant,
11	radioimmunoassay.
11	(superoxide
11	glutamate-induced
11	quadriceps
11	proteases.
11	vasodilatory
11	redox-sensitive
11	constrictor
11	wt.
11	-dependent
11	factor)
11	akt.
11	l-selectin,
11	regimens.
11	20.
11	na,
11	ketamine
11	imbalance.
11	zealand
11	hydrolytic
11	vcam-1
11	0.0001),
11	competent
11	α-tocopherol
11	nutritionally
11	et(b)
11	vasodilator,
11	papaverine
11	isoproterenol,
11	4.4
11	(60%
11	submaximal
11	protocols,
11	bear
11	multigene
11	rising
11	popular
11	excluded
11	replacing
11	diagnosing
11	particularly,
11	toxic,
11	ablation,
11	lumican
11	fibrin
11	tibial
11	consistently,
11	disturbs
11	fibrils,
11	helped
11	healing.
11	localization,
11	fibrils.
11	junctions.
11	hold
11	disorganized
11	67%
11	trβ1
11	involution
11	ng/ml),
11	diminished.
11	area)
11	venule
11	wall-to-lumen
11	information.
11	light.
11	incorporation,
11	get
11	sensitivities
11	bradycardia,
11	(bp),
11	almeida
11	discoveries
11	non-pharmacological
11	exaggerated
11	premotor
11	evolve
11	study?
11	importance?
11	sino-aortic
11	pcr)
11	neurons)
11	rsna
11	hope
11	parvocellular
11	science.
11	tachycardic
11	n-acetylserotonin
11	signals.
11	hz,
11	pituitary,
11	(20%),
11	synapses
11	ah.
11	20%,
11	cuts
11	tongue,
11	manifestations,
11	clinicians
11	240
11	horses,
11	ovine
11	(mat
11	transplacental
11	coccidian
11	ib
11	100%.
11	larvae,
11	buffaloes
11	immunohistochemical,
11	(gallus
11	138
11	patch
11	sampled.
11	aa,
11	1988.
11	broad-spectrum
11	210
11	sanitary
11	subgenera
11	v7v8
11	(ssu
11	diffusely
11	gerais
11	1:50
11	pacific
11	flies.
11	habits
11	bat,
11	(strain
11	infantum,
11	schizotrypanum
11	barcoding
11	descriptions
11	temperate
11	sporozoites.
11	management.
11	ethnic
11	seroconversion
11	exotic
11	counties
11	market
11	gt
11	faeces
11	leptospirosis,
11	isolates)
11	10%,
11	(ah)
11	polyethylene
11	management,
11	myriad
11	nondiabetic
11	infiltrated
11	adjuvant,
11	monoterpene
11	facs
11	till
11	parenchyma,
11	foam
11	secondarily
11	(eat)
11	ascites
11	i-κbα
11	t-bet
11	pkcδ
11	arms
11	(l-name,
11	late-phase
11	infiltrate.
11	expose
11	2086
11	effective.
11	myotropic
11	contracted
11	86%
11	localised
11	frontier
11	degrading
11	sulfur
11	rock
11	ml-1,
11	raman
11	fingerprints
11	chloroform
11	antimicrobials
11	intended
11	newcastle
11	brazil).
11	summary:
11	l.)
11	metallic
11	putida
11	two-step
11	hexon
11	probe,
11	calorimetry
11	oncoprotein
11	enormous
11	film
11	exosomes
11	il-1α,
11	(il)-4
11	follicles
11	il-10-producing
11	violet
11	adenocarcinomas
11	6;
11	priming.
11	constraints
11	hepatocellular
11	"
11	carcinogenesis
11	bi-directional
11	relatives
11	members,
11	congolense
11	conorhini
11	cl,
11	deanei
11	(mds)
11	gametocytes
11	venezuela
11	ancestor
11	expanding
11	french
11	nature,
11	phase;
11	cryptic
11	terrificus.
11	lineatus
11	viperidae
11	e,
11	plant,
11	collections
11	convenient
11	(th1)
11	cxcr4
11	precursors,
11	lpm
11	rp
11	anka.
11	extensions
11	polarization,
11	parasitemia.
11	invariant
11	cd44
11	cd3
11	autoantibody
11	mol.
11	wiley‐vch
11	mice).
11	xp-v
11	transitions
11	novel,
11	doxo
11	spine
11	printed
11	aetiological
11	delivering
11	anthracycline
11	cdna,
11	cleaves
11	deacetylase
11	lexa
11	-3
11	myoblasts
11	lewis
11	redundancy
11	exploit
11	observations.
11	risk,
11	regulon,
11	amino-terminal
11	frameshift
11	rearranged
11	predator-related
11	circuit,
11	outline
11	0.001,
11	cues,
11	brightness
11	defeated
11	tuberal
11	long,
11	prey,
11	ones,
11	therein
11	epileptic
11	well,
11	windows
11	conceptual
11	intrinsically
11	simply
11	looking
11	(nbor)
11	simulate
11	51%
11	purifying
11	phylogeographic
11	reconstruct
11	finishing
11	regulations.
11	frontiers
11	s.a.
11	sirt1
11	forces
11	introns
11	fsgs
11	c-
11	janus
11	unequivocal
11	refeeding.
11	(cat)
11	(320
11	13)
11	myotubes.
11	surgically
11	hearts.
11	pregnancy-induced
11	interscapular
11	recognizable
11	surprising
11	high-sodium
11	7%,
11	anthropometric
11	50%.
11	mg/dl),
11	vasopressor
11	arthropod
11	fxa
11	fibrinogen
11	cascades
11	corneal
11	peptidomics
11	yeast,
11	ribosome
11	vannamei
11	α-chain
11	biol.
11	agglutinin
11	phospholipids,
11	homogeneity
11	firstly,
11	proteins;
11	refers
11	gain.
11	penalty
11	la,
11	illustrated
11	compass
11	keep
11	nod1
11	macrophage-mediated
11	acute-phase
11	pbl
11	cells/ml)
11	manifest
11	teixeira,
11	(mmp)
11	multipolar
11	erbb1
11	constructing
11	bioreactor
11	patients)
11	scars
11	gentamicin
11	urethra
11	time-lapse
11	schedules
11	papain
11	isoform,
11	cytokeratin
11	apparatus.
11	lines:
11	trial,
11	gaining
11	vacuolization
11	keratinocyte
11	ulcers
11	polarity
11	amelogenin
11	j/cm
11	isdn.
11	maxilla
11	(five
11	sem,
11	du145
11	high-level
11	ifn-β
11	oncogene
11	show,
11	movement,
11	drug-resistant
11	carefully
11	instances
11	heads
11	19-kda
11	pvmsp-119
11	figures
11	flaviviruses
11	prophylaxis
11	54%
11	intimate
11	bagasse
11	bran
11	complexed
11	meaningful
11	k-12
11	ltx
11	colorectal
11	companion
11	co-express
11	(sem).
11	supposed
11	(tnf-α,
11	molars
11	radiographic
11	diarrhoeal
11	opg
11	cdc
11	safer
11	marmosets
11	enterocyte
11	manufactured
11	dimethyl
11	notothenia
11	spawning
11	acini
11	adrenocorticotropic
11	10 days
11	thermogenesis,
11	night-time
11	hypothalamic-pituitary-gonadal
11	evening
11	tolerability
11	(aanat)
11	organotypic
11	p50/p50
11	oua-induced
11	trained,
11	thereafter
11	cm.
11	prostatic
11	graduate
11	operation
11	non-toxigenic
11	lt2,
11	replication-defective
11	odq,
11	modules
11	dorsal,
11	chemosensory
11	(snc)
11	habenula
11	insular
11	fluorogold
11	double-labeled
11	colliculus,
11	smooth-muscle
11	metalloproteases
11	(sem)
11	teeth.
11	zymography
11	n-cam
11	old.
11	thrombus
11	substance.
11	uruguay
11	infarct
11	21 days
11	genetic,
11	peph
11	neuropsychiatric
11	(cgrp)
11	neuroprotection.
11	(nm)
11	protein-protein
11	ganglia,
11	unpredictable
11	neurogenesis.
11	(trpv1)
11	ieg
11	brdu-positive
11	experiences
11	neurotransmitters,
11	lfa-1
11	pbmcs.
11	serotonergic,
11	nebulized
11	spiriform
11	convert
11	eopa
11	ventricle.
11	interpeduncular
11	wulst
11	p50/p65
11	twenty-five
11	cremaster
11	aspirate
11	(scfas)
11	p47-phox
11	(dna
11	rapamycin,
11	hypercholesterolemia
11	triathletes
11	(mi).
11	asolectin
11	lipoxin
11	involved,
11	158
11	(bcg)
11	phenylephrine.
11	refolded
11	century
11	methimazole
11	l-thyroxine
11	meal-fed
11	npcs
11	course.
11	metapneumovirus
11	hmpv
11	adaptations.
11	rash
11	i-
11	seminal
11	goiter,
11	low-risk
11	advancement
11	papillae,
11	herbal
11	abluminal
11	fimbria
11	dentine
11	supplying
11	acid-isoleucine
11	dpag
11	fos-immunoreactive
11	subiculum
11	subregions
11	hpa
11	acth,
11	zi
11	rpa
11	design,
11	explores
11	pbmc.
11	p-gp
11	extravillous
11	ubiquitously
11	tf
11	sphingolipid
11	carotenoid
11	diphosphate,
11	immunoenzymatic
11	culex
11	tipulae
11	parametric
11	congenic
11	fgf-2
11	1-7
11	p2x3
11	phosphodiesterase-5
11	(pec
11	.05).
11	spectrometer
11	pde5
11	α1-
11	5.0,
11	electrical-field
11	2-period
11	farmacêutica
11	voiding
11	cyp
11	95%ci
11	auclast
11	fda,
11	-1).
11	oxygenated
11	nmol/site)
11	(1000
11	no-releasing
11	pla2-induced
11	capsaicin-sensitive
11	enantiomer
11	duodenal
11	minocycline
11	ineffective.
11	irl
11	et‐1
11	preparation,
11	neutralizes
11	c2
11	(leukemia),
11	methicillin-resistant
11	non-viable
11	hct-8,
11	ethnopharmacological
11	anti-cancer
11	acerola
11	v79
11	kaurenoic
11	etoh
11	patents
11	aldehydes
11	anergic
11	carcinomas,
11	forty-nine
11	mites
11	educational
11	ligand,
11	category
11	ferric
11	purity
11	a4
11	nf-κbp65
11	chimera
11	tnbs
11	tlr4-/-
11	(dodab)
11	apc
11	multiprotein
11	cleaving
11	proopiomelanocortin
11	cell-to-cell
11	y-1
11	cold-seeking
11	anapyrexia.
11	hbo
11	(ho-1)
11	pereira
11	(asp-2)
11	murf1
11	ups
11	ssua
11	solved
11	p-nitrophenyl
11	maltose
11	citri),
11	unit-cell
11	(opp),
11	ppar-α
11	antiangiogenic
11	jak2v617f
11	metal-free
11	hsp27
11	3hhx
11	rutin
11	(ee)
11	(cdt)
11	oxide-releasing
11	ns5
11	fission
11	modular
11	t-cell-mediated
11	lef-2
11	scores,
11	f3
11	ltp
11	th1-like
11	coq
11	coq10p
11	post-mi
11	infarction.
11	imuabc
11	blastocladiella
11	β-casein
11	stat5a
11	anti-hiv
11	basophils
11	anti-dp
11	tepec
11	eae+
11	intimin,
11	igg-enriched
11	gabbr2
11	evs
11	anisopliae
11	roseus
11	alternata
11	ouabain.
11	o2)
11	regain
11	nps
11	brd
11	'candidatus
11	pm2.5
11	aod
11	cd4+cd25highfoxp3+
11	natterins
11	hsptx
11	asta
11	omphalitis
11	agnps
11	ret/ptc
11	ru2gla
11	aβos
11	leptin's
11	dnc
11	l−1
11	rtn,
11	prebötc
11	parafacial
11	schenckii
11	‘candidatus
11	case/control
11	aptamers
11	subfraction
11	spint2
10	reabsorptive
10	microelectrode
10	medullar
10	intrarenal
10	ouabain-sensitive
10	nhe1,
10	nhe4
10	insulinotropic
10	diuresis
10	handling.
10	microvilli
10	([ca
10	bcecf-am
10	-12
10	antidiabetic
10	dipeptidyl
10	together.
10	u/min
10	10-12
10	nppb,
10	0.025
10	triphosphatase
10	benzoate
10	14)
10	physiol
10	10-11
10	staurosporine,
10	1-5
10	atpase,
10	moved
10	11)
10	0.35
10	pellets
10	predominates
10	transfers
10	16)
10	inversion
10	"in
10	7.0
10	steady‐state
10	0.30
10	negative,
10	0.20
10	sham-operated,
10	paracellular
10	work.
10	vigorous
10	straight
10	verapamil,
10	t1/2
10	0%
10	co2.
10	7.6
10	maleate
10	asymmetrical
10	nl
10	7.4
10	transients
10	method)
10	tf/p
10	liberation
10	1980,
10	inflow
10	perfusion.
10	altered,
10	ethylene
10	enterobacterial
10	cane
10	encourage
10	energy,
10	spermidine
10	5.7
10	ionomycin
10	(c:
10	0.58
10	exceeded
10	yeasts.
10	th1/th17
10	dectin-2
10	p3
10	dioxygenase
10	dissemination.
10	araújo,
10	unexpectedly
10	intracellularly
10	il-18,
10	budding
10	il-27
10	activated.
10	kc,
10	arginase-1
10	hyphae
10	cloned,
10	severe,
10	cr3
10	killing,
10	cocultured
10	pb265
10	elastase
10	(100%
10	sulfate,
10	interleukin-2
10	(a/sn)
10	catalase.
10	bands.
10	histoplasmosis,
10	laid
10	(f
10	tropism
10	efficiencies
10	measurable
10	susceptibilities
10	c3h/he
10	lipopolysaccharide,
10	standards
10	(ali)
10	circulation,
10	dose)
10	martins,
10	water).
10	factor-kappa
10	supernatant.
10	occluded
10	calretinin-immunoreactive
10	h/day,
10	280
10	undisturbed
10	(6)
10	challenge)
10	lvp
10	episodes.
10	il10
10	m3
10	benzene
10	(1.
10	(mda)
10	assay;
10	i/r-i
10	translocation,
10	nitrites
10	1,2-naphthoquinone
10	(total
10	done.
10	cytoplasmatic
10	(mn)
10	3-day
10	aminoguanidine,
10	metyrapone
10	6h
10	induced,
10	bronchi,
10	butter
10	pneumonitis
10	acid).
10	albumin.
10	txa
10	immune-complex
10	distinct,
10	agree
10	emphasized
10	y,
10	bz
10	tcii
10	rationale
10	brucei.
10	robustly
10	fashion
10	reservoirs,
10	phylogeographical
10	matches
10	binary
10	identity.
10	unit,
10	zymodeme
10	z3
10	modification.
10	assemblies
10	rank
10	(ests)
10	biogenesis.
10	emergency
10	3.3
10	accessed
10	cistrons
10	mandatory
10	well-characterized
10	(didelphis
10	element.
10	reliability
10	triatomines
10	janeiro,
10	157
10	doubling
10	map.
10	mab.
10	ceramide,
10	ccc,
10	lysate
10	epitope,
10	thin-layer
10	recombinants
10	oligosaccharide
10	metabolically
10	interiorization
10	gangliosides
10	sulfate-polyacrylamide
10	cations
10	succinate
10	complicated
10	myogenic
10	hyperinsulinemia
10	per2,
10	(gsis)
10	diphenylene
10	(75
10	pancreas.
10	specie
10	mg·kg-1·day-1)
10	rapamycin-treated
10	(gcs)
10	evaluate,
10	flavonoid
10	bax,
10	24h,
10	scarce.
10	scfa
10	p47(phox)
10	map2
10	up-regulates
10	irs-2,
10	high-salt
10	nsd
10	intra-arterial
10	19,
10	141
10	α-subunit
10	was:
10	10%.
10	pyruvate,
10	lipid-enriched
10	coinciding
10	20%)
10	schedule,
10	manipulations
10	[1-14c]pyruvate
10	cannulated
10	regime
10	habituation
10	homogenates,
10	wheel
10	outward
10	6-phosphate
10	temperatures,
10	(0.4
10	(3.5
10	sensitizes
10	behaviorally
10	(csf)
10	estrogen.
10	incidence,
10	prevalence,
10	cee-sd
10	lr
10	itching
10	(msg)
10	(obese)
10	contradictory
10	relaxation,
10	non-obese
10	duchenne
10	denuded
10	vsmc
10	(ros),
10	biomechanical
10	adipokines.
10	adipokine
10	week-old
10	phenylephrine,
10	overactivation
10	sirna,
10	aortas,
10	no-dependent
10	control).
10	malnutrition,
10	(e
10	hours)
10	d).
10	corrects
10	g-protein-coupled
10	interface,
10	chiefly
10	vasoconstriction,
10	ketamine/xylazine
10	enalaprilat
10	3.4
10	iliac
10	enos,
10	at1/at2
10	catheters
10	bms
10	pressure-lowering
10	ovaries,
10	prostaglandins,
10	bradykinin-induced
10	nonstimulated
10	immunoassay.
10	121
10	l-nmma
10	(l-name).
10	arterioles,
10	fragmented
10	neurospheres
10	(drg)
10	inward
10	decrease.
10	hypothesis.
10	low-conductance
10	filaments.
10	6.7
10	adjust
10	900
10	wounded
10	analysis;
10	lectin,
10	talk
10	endometrium.
10	myometrium
10	histology,
10	uteri
10	strength.
10	chondrocytes
10	α2-ar
10	adult.
10	d1,
10	α-actin
10	(il)-1β
10	creates
10	heparan
10	munksgaard,
10	odontoblasts
10	μg),
10	nulliparous
10	cytochemical
10	shrs,
10	sizes.
10	envelope.
10	non-pregnant
10	microbiota.
10	pdg
10	alanine,
10	transduce
10	crossed
10	junctions,
10	maxillary
10	pvn.
10	arrest.
10	associating
10	belém,
10	bpm,
10	(hf),
10	points:
10	impairment,
10	grp78
10	frequency.
10	beats/min,
10	muscle;
10	lsna
10	testing.
10	venules.
10	catheterized
10	relationship,
10	(±
10	operates
10	blood-borne
10	microinjections
10	(48
10	27%,
10	equids
10	1:64
10	chi-square
10	non-archetypal
10	bri
10	pan
10	100%,
10	κ
10	zoological
10	100,000
10	immunohistochemically
10	hepatozoon
10	(leopardus
10	caimans
10	99%
10	bioassay,
10	anti-neospora
10	abortion,
10	care,
10	coinfection
10	cities
10	goats,
10	bahia,
10	(19
10	cysts,
10	helminths
10	marsupial
10	leeches
10	frogs
10	matrices
10	equatorial
10	cows.
10	canis,
10	environmentally
10	calomys
10	anti-mouse
10	%).
10	herpesvirus
10	animals'
10	phosphorus
10	hertigi
10	feces.
10	93
10	harbouring
10	collection.
10	isolating
10	duodenalis
10	april
10	(pc)
10	tachyzoite
10	pigeon.
10	scarce,
10	declining
10	113
10	bovines
10	(gi)
10	district
10	persist
10	l1
10	attempting
10	identities
10	seventy
10	two,
10	dmem
10	(são
10	rickettsii,
10	reacting
10	153
10	p<0.001).
10	(t1d)
10	pten
10	keratinocytes.
10	signals,
10	stat1
10	20-fold
10	paf-like
10	shaping
10	phospholipids.
10	phase)
10	sharp
10	pro-fibrotic
10	cd40,
10	ccr7
10	cinc-1
10	fcγr
10	pkc-δ
10	30min
10	homogenized
10	(il)-6
10	65%,
10	cinc-2
10	included:
10	programs.
10	cd8+,
10	mam-induced
10	rectal
10	(pufas)
10	fold,
10	ar.
10	cheek
10	35%,
10	lak
10	lymphokines
10	heat-coagulated
10	cavities
10	barriers
10	radicals,
10	μg/g
10	interspersed
10	benthic
10	ocean
10	brine
10	earth
10	japan
10	discover
10	shaped
10	bacilli
10	cog
10	nutrition.
10	bay,
10	actinobacteria
10	mtb
10	cocci
10	dispersive
10	richness
10	scale.
10	β-tubulin
10	intimately
10	soils.
10	estuary
10	cf
10	specimens,
10	reservoirs.
10	chiral
10	solvents
10	city.
10	june
10	propidium
10	antitumoral
10	modcs
10	priority.
10	(hsv-1)
10	(i:c)
10	scd40l
10	twenty-two
10	(mcs)
10	simplified
10	amphipathic
10	elemental
10	sheds.
10	advantageous
10	technological
10	vaccination,
10	(m)
10	relief
10	fv
10	melanocytes
10	45,
10	(ig)
10	urethane-induced
10	(pia),
10	airmaxss,
10	allele,
10	restricting
10	reacts
10	lin-
10	52%
10	lod
10	(slc11a1)
10	bjv.
10	wound-healing
10	29%,
10	(s.
10	scan
10	parasitaemia.
10	vivax-like
10	hidden
10	acetylated
10	angomonas
10	symbiont
10	162
10	leptomonas
10	stationary-phase
10	niger
10	fish.
10	bodies.
10	depression,
10	thai
10	different,
10	deaminase
10	fleas
10	lizard
10	earliest
10	toads
10	87
10	sub
10	end-stage
10	relatedness
10	phytomonas.
10	402
10	relevance.
10	abstract
10	pneumonia,
10	cd69
10	operate
10	p2x7-/-
10	ali/ards.
10	sensors
10	internalize
10	irbcs
10	nlrc4,
10	redundant
10	flagellin.
10	mns
10	stereological
10	immunoreactivities
10	liver-infiltrating
10	parasitaemia,
10	indispensable
10	cd95l
10	(ifn-γ),
10	littermate
10	mitogens
10	(ck)
10	cross-reacted
10	wavelengths
10	beam
10	(tls)
10	replicating
10	cpd
10	stably
10	mismatch
10	error-prone
10	nascent
10	context-dependent
10	temozolomide
10	micronuclei
10	intronic
10	cleft
10	uv-irradiated
10	txnip
10	tp53
10	kinases,
10	cytostatic
10	dimer
10	xanthomonadales
10	dox
10	fpg
10	accessibility
10	operon.
10	trna
10	publications.
10	duplications
10	recovering
10	resolution.
10	business
10	37°c,
10	dinb
10	repression.
10	organism's
10	primitive
10	xanthan
10	suicide
10	ie
10	excited
10	dimers.
10	supf
10	degenerate
10	cos7
10	polymerization.
10	4.8
10	chloramphenicol
10	rostrodorsal
10	reuniens
10	refined
10	tasks.
10	blocks,
10	experts
10	appetitive
10	pha-l
10	medial,
10	predictability
10	odor.
10	retrieving
10	planning
10	be,
10	cortices
10	manipulated
10	equation
10	translation.
10	resources.
10	regularly
10	hsv-1
10	mw,
10	fbs
10	rotaviruses
10	intestine,
10	overt
10	6.4
10	p.o.
10	155
10	site),
10	bw)
10	lie
10	(sedentary
10	(control,
10	iron-deficient
10	hnf-1α
10	flux.
10	placebo.
10	determinations.
10	denervation.
10	rocky
10	mycelia
10	(b.)
10	hemoglobin.
10	arsenal
10	macromolecules
10	automatic
10	170
10	defensin
10	spiders.
10	secondly,
10	stomach.
10	vitellin
10	alkaloids,
10	amastigote-like
10	hexanic
10	depicted
10	kills
10	(time
10	192
10	mucosae
10	eating
10	hr)
10	multinucleated
10	mollicutes.
10	prognosis,
10	metalloproteases.
10	division.
10	phagocytose
10	answered
10	ramar1
10	smokers
10	hemolysis.
10	xenograft
10	compartmentalization
10	meglumine
10	repeats,
10	isoprene
10	l-1,
10	progenitor/stem
10	double-blind
10	4°c
10	plaques,
10	lg
10	gtpases.
10	methionine
10	proteins:
10	60 days
10	ip,
10	ophthalmology.
10	igf-ii
10	stressor
10	aromatase
10	assembly.
10	(ranging
10	ltr
10	variables.
10	manaus
10	endemicity.
10	networks.
10	stable.
10	p. falciparum
10	−
10	4-fold
10	population-based
10	alarming
10	heterozygote
10	discontinued
10	hampered
10	heterozygosity
10	initiatives
10	interspecies
10	ferreira
10	16%
10	pfmsp-1
10	3d7
10	season,
10	cross-reactive
10	industrialized
10	single,
10	trends
10	non-immune
10	stay
10	12-
10	xylose,
10	optimize
10	(smase
10	forty-six
10	(82%)
10	healthy,
10	gulae
10	microbiologia
10	thirty-eight
10	(l.
10	(mic)
10	biofilms.
10	distasonis
10	macrophages;
10	pd-1
10	stools
10	mutans,
10	63%
10	inclusions
10	coriiceps
10	teleost
10	hexameric
10	fibres,
10	glucagon,
10	hcg
10	shape.
10	gonadotropin-releasing
10	(f)
10	rhythmicity
10	ko)
10	trimester
10	retinohypothalamic
10	agouti-related
10	seizure
10	seizures,
10	rorα
10	experiencing
10	lyase,
10	counteracted
10	nissl
10	(camp)
10	fatigue,
10	(scn)
10	rchb
10	(pha-l)
10	antitumour
10	ventrale
10	operation.
10	15-20
10	lt2
10	hrsv.
10	tag,
10	brainstem.
10	caudally
10	amygdala.
10	pallidus
10	circuits.
10	counterpart,
10	tracers.
10	cancer-related
10	oral.
10	egf,
10	cuticular
10	(eae)
10	neurodegeneration.
10	neurodegeneration,
10	traumatic
10	pbm.
10	(6-ohda)
10	buffer,
10	st.
10	nnos,
10	nigrostriatal
10	(ngf)
10	(von
10	stimulation-induced
10	collaboration
10	30)
10	in-vivo
10	(cd),
10	cb,
10	(pla2).
10	noradrenergic,
10	situation.
10	e7,
10	zone.
10	npy
10	(epa)
10	s-nitrosation
10	β,
10	kg,
10	generator
10	®
10	pa-induced
10	(pa),
10	endocrine,
10	lipid-lowering
10	(commnts)
10	triathlon
10	genetics.
10	metabolizing
10	geranylgeranyl
10	pyrophosphate.
10	pdtc
10	cocaine.
10	intoxication.
10	semiquantitative
10	bid
10	lipoperoxidation
10	glutaminolytic
10	7),
10	nos-2
10	70-kda
10	scc
10	74%
10	cent).
10	m(r)
10	cashew
10	starvation.
10	astrovirus
10	co-expression
10	paraná
10	attending
10	stresses
10	center.
10	cfa/i-specific
10	1997
10	conjunctivitis
10	month-old
10	excluding
10	3,5-t2
10	possibility,
10	ewat.
10	fluorogenic
10	igf-1
10	cimetidine
10	naoh
10	avp-ir
10	vip-ir
10	casts
10	tetroxide
10	atrophic
10	mode.
10	laterodorsal
10	cued
10	cell-surface
10	malignancies
10	cv
10	metalloendopeptidase
10	assessment.
10	century.
10	wars
10	mea,
10	(ob/ob)
10	infertility.
10	appetite
10	(nts),
10	preeclampsia
10	anxa1
10	aza
10	klf6
10	il1b,
10	piper
10	ubiquinone
10	isopentenyl
10	fosmidomycin
10	carnivorous
10	whitmani
10	silvatic
10	18.
10	remission
10	intracavernous
10	contractions,
10	rygb
10	nanorap
10	guanethidine
10	th,
10	125%
10	(0.6
10	vardenafil
10	mycological
10	(bay
10	scd
10	deceased
10	transmitter
10	mg·kg
10	pylori-positive
10	amiodarone
10	diethyl
10	insularis
10	chromatographed
10	(pla2)
10	c-fiber
10	medley
10	flour
10	(pnv)
10	celiac
10	(0.3-3
10	cofactors
10	lymphoma
10	gr73632
10	capsaicin-induced
10	carrageenin-induced
10	site-1)
10	jararacussu
10	prtx-i
10	c(max),
10	pge1
10	terrificus,
10	kd,
10	264.7
10	stingray
10	myotoxins
10	aminopeptidase
10	hf3
10	platform.
10	bioadhesive
10	(ec50)
10	pharmacognosy.
10	chitinase
10	eudistoma
10	(5),
10	potato
10	chromomycin
10	mercury
10	hl60
10	p)
10	alendronate
10	pid
10	scid
10	trecs
10	calmette-guérin
10	bacterial,
10	tlr5,
10	uncommon
10	cvc
10	stx2.
10	hybridomas
10	(ctx),
10	gaucho
10	protease,
10	zebrafish
10	el28
10	purification,
10	(ep24.15)
10	electroporation
10	hemoglobin-derived
10	acth.
10	eae.
10	35-55
10	regulators,
10	biflexa
10	(tepec)
10	aepec.
10	pneumotropica
10	lhcgr
10	prop1
10	mosaicism
10	prpc-null
10	deadly
10	tidal
10	ho-co
10	chikungunya
10	261
10	oligodeoxynucleotide
10	squat
10	psts,
10	lymphoblastic
10	p20
10	prins
10	myvacet
10	mk2i
10	vitk
10	(pha)
10	copolymer
10	whole-cell
10	mφs
10	gallic
10	kaolin
10	tbev
10	df
10	·day
10	oxyr
10	spdr
10	pili
10	rpoe
10	(citrus
10	-receptors
10	(stat5)
10	pathotypes
10	tccp/tccp2
10	eaec.
10	stx2,
10	st,
10	mr/p
10	ypsb
10	acetaldehyde
10	medius
10	cacao
10	s14.
10	16:1n7
10	deoxynivalenol
10	films
10	nuts.
10	aflr
10	fb1/kg
10	c57b1/6
10	weight-stable
10	pair-fed
10	hemotrophic
10	co-infected
10	pulmonis
10	uveitis.
10	irbp.
10	il-33
10	sham:
10	tspo
10	ih
10	cd8α+
10	h-2kb-restricted
10	quil
10	ck18
10	nmvs
10	(pbps)
10	polypropylene
10	mcr-1
10	blimp-1
10	(ptc)
10	v600e
10	dio3
10	jp2
10	phylotypes
10	aqp1a
10	gh-responsive
10	tempol
10	canis-infected
10	nmol/50
10	sirolimus
10	cyp3a4
10	pcsk9
10	scarb1
10	2k
10	antiphosphotyrosine
10	high-fructose
10	11β-hsd1
10	tag-glycerol
10	pyridostigmine
10	neostriatum/hyperstriatum
10	mediorostral
10	mnh
10	ndc
10	gal-3
10	pfrg
10	late-e
10	chemoreception.
10	chemoreceptors,
10	μmol/kg
10	end-expiratory
10	mg/7
10	pbg
10	av3v-lesioned
10	th-1
10	th9
10	preeclampsia.
10	nlrs
10	card8,
10	il18
10	(prpc)
10	pxr
10	adometdc
10	tcan26
9	basel
9	nmol/l
9	camp,
9	ingestion.
9	na+-dependent
9	nhe3-mediated
9	nahco3
9	whereas,
9	activator,
9	madin-darby
9	sheds
9	15-
9	486
9	glucagon-like
9	versatility
9	regulated,
9	adapting
9	mechanistically,
9	pi,
9	activator)
9	([ca2+]i)
9	m;
9	dimethyl-bapta-am
9	(pka),
9	(45%)
9	v1-receptor
9	0.16
9	%,
9	defined,
9	acidification.
9	min),
9	analysing
9	luminally
9	crypts
9	superfused
9	5),
9	atpase.
9	picomolar
9	added.
9	titratable
9	pma.
9	ml/min)
9	(ed)
9	perfusions
9	capillaries.
9	(t/2)
9	pump.
9	saturable
9	affected,
9	physiol.
9	corticosterone,
9	elevating
9	buffers.
9	attenuated,
9	g/100
9	hco-3
9	dids
9	calculations
9	(hs)
9	hs.
9	infusion,
9	rigid
9	exploration
9	uptake;
9	(ha)
9	elevated,
9	somewhat
9	please
9	enterobacteria
9	growth-promoting
9	reflection
9	beijerinckia
9	cellulase
9	lichen
9	serratia
9	derxii
9	amorphous
9	angiotensin-(1-7)
9	(mr
9	value,
9	sa,
9	pulse.
9	(i
9	ii-mediated
9	sustaining
9	post-infection,
9	cd16
9	scarcely
9	colombia,
9	argentina.
9	oligodeoxynucleotides
9	costa
9	cysteinyl
9	(il-10).
9	goal,
9	(acute
9	tregs.
9	tlr4.
9	(pb)
9	anti-cd25
9	cd25+
9	glycolipids
9	glycosylphosphatidylinositol
9	immunoprotective
9	postinfection,
9	yeasts,
9	(pb18)
9	trying
9	anti-cd8
9	self
9	delaying
9	eighth
9	combine
9	coexistence
9	observed:
9	(ifn-γ).
9	ifn-γ)
9	euthymic
9	titers,
9	ahead
9	14th
9	43,
9	virulence,
9	daily.
9	cobra
9	nonadherent
9	bright
9	heating
9	isr
9	(epo)
9	ir.
9	ferreira.
9	longum
9	determination.
9	balloon
9	histology.
9	pollutant
9	burst.
9	tnf-alpha
9	uterus.
9	depressive
9	i.v.).
9	responsiveness,
9	london
9	hyper-responsiveness
9	h/day
9	microvessel
9	hyperresponsiveness,
9	anaphylaxis.
9	dep
9	(myd88)
9	irritant
9	detachment.
9	material:
9	12 h
9	uniform
9	cromoglycate
9	afterwards
9	reestablished
9	immunostimulatory
9	l-663,536
9	identical.
9	96%
9	argentina
9	dtu
9	nifurtimox
9	synthesized.
9	(abc)
9	serpens,
9	poses
9	post-treatment
9	pathologies,
9	agreed
9	unified
9	divergent.
9	kinetoplastid
9	look
9	non-parametric
9	searches
9	translation,
9	pieces
9	karyotype
9	competed
9	attributes
9	constrained
9	isoenzymes
9	confirmatory
9	discordant
9	applicable
9	peridomestic
9	(38
9	5.8s
9	endonucleases
9	tracts
9	rangeli.
9	ago.
9	traditionally
9	confirmed.
9	hr;
9	hinders
9	generally,
9	recall
9	(100%)
9	epi
9	immunoblots
9	eluted
9	lacz
9	lipidic
9	(y
9	antisera.
9	8.0
9	organelles.
9	estimation
9	portion.
9	anorexia,
9	pentose
9	defenses
9	weaning.
9	nutrient-stimulated
9	gpr40
9	mcfa
9	diphenyleneiodonium
9	retinopathy,
9	(hfd).
9	eif5a,
9	excised,
9	nontreated
9	mapks
9	couple
9	species)
9	palmitate.
9	5.6-mmol/l
9	trans-
9	wortmannin,
9	propionate,
9	nitroblue
9	acylation,
9	examined:
9	stimulated,
9	phagocyte-like
9	nbt
9	co-culture.
9	arachidonic,
9	palmitic,
9	tca
9	forms)
9	pre-exposed
9	swift
9	g).
9	lpd
9	undernutrition.
9	dopamine,
9	ef
9	omission
9	tpa
9	meal,
9	modality
9	conductance,
9	lactic
9	epinephrine,
9	discontinuous
9	concentration),
9	article.
9	abuse.
9	addictive
9	nicotine.
9	(10.0
9	pre-clinical
9	powder
9	duration.
9	8.4
9	two-way
9	7.3
9	6.0
9	licking
9	1983.
9	fluorimetric
9	estrogen,
9	flank
9	(iugr)
9	epc
9	bed.
9	protease-activated
9	periodontopathogen
9	sma,
9	h2s-releasing
9	depth,
9	cycloxygenase
9	testosterone,
9	pathways)
9	prb
9	p27,
9	cox2
9	angii
9	srt
9	ng/kg/min
9	(%
9	scavenger,
9	(qpcr).
9	instillation.
9	sections,
9	erythropoietin
9	mdx
9	p-akt
9	j,
9	mw)
9	walking
9	element-binding
9	hypotension.
9	dyslipidemia,
9	include:
9	bred
9	metformin-treated
9	anesthesia.
9	(emax)
9	veins,
9	mlc
9	hg;
9	knowing
9	cd18
9	cases)
9	arterioles.
9	generated.
9	venules,
9	end-product
9	leukocyte-endothelium
9	(o
9	leu
9	absorbance
9	non-genomic
9	p22phox
9	(lower
9	ascorbyl
9	(edrf)
9	isoproterenol.
9	magnesium
9	depolarization.
9	autophagy.
9	lasting,
9	neurofilament
9	(p.
9	clonally
9	delta
9	brasiliana
9	disulphide
9	bonds,
9	lower.
9	directly,
9	downregulating
9	burn
9	multidisciplinary
9	burns
9	blotting)
9	bone,
9	mrnas,
9	machinery.
9	endometrium,
9	retention,
9	intricate
9	mmp2
9	(56
9	eosinophilia.
9	disturbed
9	tail.
9	immunoreaction
9	α2a/α2c-arko
9	turnover,
9	remodeled
9	mpa
9	disruption.
9	replacement.
9	uncertain.
9	epiphyseal
9	decidualization.
9	glycosaminoglycan
9	gonads,
9	myofibroblasts
9	untreated.
9	estrogenic
9	post-implantation
9	crest
9	hyaluronan
9	vacuoles.
9	(named
9	arteriole
9	hyaluronic
9	technology,
9	desirable
9	glutaminase,
9	utilization,
9	banding
9	(if)
9	(11
9	heightened
9	sinoaortic
9	(hf).
9	hmgb1
9	iκb-α
9	pvn,
9	12),
9	ap,
9	command
9	mmhg),
9	governing
9	(real-time
9	downward
9	hyperpolarizing
9	threshold,
9	bradycardia.
9	181
9	vo2
9	bpm
9	tonically
9	block.
9	summer
9	fine-tuning
9	(50%
9	astrocytes,
9	preexisting
9	tachycardia,
9	postmortem
9	average,
9	underestimated
9	hg).
9	distending
9	flat
9	horses.
9	abortions
9	decision-making
9	rehabilitation
9	sarcocystis
9	152
9	serra
9	(mat)
9	apico
9	dilution.
9	farming
9	infestations
9	lowland
9	ifat.
9	neosporosis
9	lived
9	endangered
9	paraíba
9	pose
9	slaughtered
9	epidemics
9	drug-induced
9	neurona
9	(ca)
9	septa
9	three,
9	dominate
9	uncharacterized
9	puma
9	characterization.
9	females)
9	infantile
9	inappropriate
9	118
9	sensu
9	anti-leishmania
9	hemisphere
9	coexist
9	ppv
9	automated
9	ast
9	revised
9	211
9	parasitologists.
9	continent.
9	planned
9	(ifa)
9	foxes
9	insectivorous
9	vampire
9	conception
9	co-infection
9	(75%)
9	annually
9	fowl
9	(n=
9	5000
9	seroconverted
9	25,
9	locations,
9	duplicate
9	66
9	worms
9	reinfected
9	81
9	tigrinus,
9	60-day
9	haemoglobin
9	rondônia
9	desired
9	regression.
9	criteria,
9	discovery.
9	syntheses
9	receptor-dependent
9	eucalyptus
9	(clp).
9	paf,
9	suppression.
9	monocytes/macrophages
9	hek
9	fermentans
9	(sle)
9	nf-κb.
9	melanoma,
9	(750
9	(il-1β,
9	etb
9	30 min
9	(43
9	undernourishment
9	jejunum
9	pparγ.
9	minutes.
9	chambers.
9	24 h.
9	albicans.
9	tryptase
9	lps-activated
9	(18%)
9	asthma-like
9	hemorrhage.
9	b220
9	cs,
9	rain
9	hen
9	aggregated
9	balb/c,
9	monolayers.
9	0.1,
9	72,
9	exudates.
9	pg/ml,
9	mining
9	sessile
9	medicine,
9	extraordinary
9	biogeography
9	heterotrophic
9	illumina
9	single-cell
9	ice
9	input.
9	wall,
9	treatments:
9	antarctica.
9	biotransformation
9	hostile
9	ade
9	dioxygenases
9	(sf)
9	dgge
9	cloacal
9	undescribed
9	distantly
9	bioremediation
9	40%,
9	aliphatic
9	analytes
9	obstacles
9	pea
9	synthesized,
9	hoechst
9	(cmv)
9	cdk4
9	capsaicin.
9	one-step
9	bioinformatic
9	analogues,
9	availability.
9	simultaneously,
9	induced.
9	cp.
9	dentistry
9	fibroblast-like
9	var.
9	c5,
9	fd
9	verlag,
9	neoplasm.
9	4.3
9	single-chain
9	epstein-barr
9	bcg-activated
9	extracellularly
9	bcg,
9	intercrosses.
9	(pia)
9	proliferation;
9	180.
9	assisted
9	segregate
9	multiplicity
9	pas1
9	descent
9	listeria
9	nests
9	continents
9	copyright:
9	fflb
9	clades.
9	algorithm
9	31%
9	congruent
9	gathered
9	atomic
9	alignments
9	(elisa),
9	opening,
9	dehydrogenase)
9	dividing
9	delineate
9	rodrigues
9	invaded
9	g1,
9	fetuses.
9	smear
9	thailand
9	hct
9	mycotoxins.
9	anticoagulant
9	surveys,
9	peculiarities
9	invertebrates
9	(crotalus
9	restriction,
9	individual.
9	urine,
9	archival
9	quick
9	fragments.
9	nlrp3-inflammasome
9	100-fold
9	álvarez
9	tb.
9	gut-associated
9	p2x7r
9	(aki)
9	arginine,
9	singular
9	sharply
9	intrahepatic
9	aminoguanidine.
9	il-12/il-23
9	transferring
9	rifn-γ
9	cd8low
9	tcrlow
9	lymphocytes;
9	perturbation
9	terrificus)
9	toxicon
9	shh
9	auricular
9	unrepaired
9	centers.
9	industry,
9	mutator
9	dna-damaging
9	syndromes.
9	intriguingly,
9	proficient
9	ssdna
9	assemble
9	csb
9	ner-proficient
9	shrna
9	success.
9	avoidance,
9	anrassf1
9	light-induced
9	hereby
9	mutagen
9	concern.
9	ner-deficient
9	violaceum
9	trichothiodystrophy
9	photolyase
9	thiamin
9	(encoding
9	over-expression
9	xpb
9	two-component
9	library,
9	two-thirds
9	transcript.
9	site-specific
9	substitutions,
9	regards
9	import
9	oxygen,
9	metallothionein
9	g0
9	moieties
9	(<
9	stringent
9	combines
9	pag.
9	lateral,
9	relevance,
9	immediate-early
9	biases
9	soccer
9	turning
9	arousal,
9	vulgaris-leucoagglutinin
9	attraction
9	execution
9	predators
9	dams,
9	(relative
9	location.
9	76%
9	intranuclear
9	lysed
9	thousand
9	82%
9	(27%)
9	soleus.
9	beta-adrenergic
9	esr1
9	high-density
9	calpain
9	twitch
9	proteolysis,
9	cd68
9	experience,
9	relevance:
9	hospital.
9	consanguineous
9	gh3
9	b2m
9	ligatures
9	0.002)
9	hypoxia-inducible
9	hsa
9	±.
9	w,
9	administered.
9	shortening
9	methylbutyrate
9	kdr
9	transports
9	obesity-related
9	(dp)
9	pg/ml;
9	killed,
9	monitored.
9	diabetogenic
9	(c).
9	disturbances.
9	.001).
9	physiopathological
9	(irs-1),
9	b.w.
9	euglycemic
9	(control:
9	bat.
9	immune-related
9	mountain
9	bilayers.
9	jnk,
9	microplus,
9	chemistry,
9	helix
9	gomesin,
9	bonds.
9	50)
9	non-polar
9	subsite
9	tarantula
9	respiration,
9	13c
9	embryogenesis.
9	modifications,
9	immunobiological
9	activity;
9	(derived
9	throughput
9	cysteines
9	hydrophobicity
9	chromosome.
9	clone.
9	hydrolyzing
9	timed
9	humidity,
9	occur,
9	workers
9	valley
9	modelling
9	roughly
9	fields.
9	intervillous
9	dengue,
9	tcgf
9	spans
9	13.
9	aneuploid
9	(brdu)
9	pcd
9	thrombospondin
9	vegf,
9	rna-binding
9	mellifera
9	ureaplasmas
9	organizer
9	filament
9	keratinized
9	nop53p
9	c-3
9	residents
9	residing
9	er,
9	sibling
9	antimoniate
9	essential.
9	phytochemical
9	hamsters.
9	uniformly
9	1.9
9	polyisoprenoids
9	(ctx)
9	reductase,
9	glycemia.
9	bcpap
9	cd206
9	rhob,
9	coexpression
9	placode
9	t98g
9	rearrangement,
9	cartilage.
9	tgfβ2
9	igfs
9	light-damaged
9	tunel-positive
9	photoreceptors
9	photoreceptors.
9	(pcna)
9	iec-6
9	decrease,
9	cross-linking
9	protein-1,
9	il-15,
9	purposes,
9	stopping
9	port
9	follow-up.
9	coadministration
9	reticulocytes
9	episodes,
9	boundary
9	10%)
9	patient-derived
9	93%
9	folate
9	efficacy,
9	scope
9	pvs230
9	one-third
9	(csp)
9	haplotype,
9	polymorphisms.
9	(x
9	vietnam
9	196
9	fc27
9	ic1-type
9	follows.
9	karitiana
9	detergent-soluble
9	subclasses.
9	tsc
9	page
9	uma
9	pks
9	walls.
9	u/ml
9	catabolite
9	esterase
9	olindensis
9	trichoderma
9	blends
9	snakes,
9	solve
9	cosd
9	stress-related
9	aminoglycosides.
9	lysogenic
9	presence.
9	enteritis
9	arbitrary
9	aggravation
9	220
9	dysbiosis
9	disk
9	bft
9	(between
9	ccl4
9	114
9	predisposing
9	capsule,
9	ribotypes
9	zinc,
9	ljp
9	pesticides
9	nanoparticles,
9	clot
9	amoebocytes
9	varieties
9	granuloma
9	spermatogonia
9	α-msh
9	vitellogenic
9	germinal
9	ruptured
9	pinealocytes,
9	dio2
9	unconventional
9	photoperiod
9	coordinates
9	ambulatory
9	mt2
9	astrocytes.
9	microdialysis
9	aberrations.
9	photoreceptor
9	(mimicking
9	146
9	a.m.
9	peri-epididymal
9	convergent
9	cyclase.
9	affinity.
9	nucleocapsid
9	ctb
9	quaternary
9	boscardin,
9	hpv.
9	disordered
9	baculoviruses
9	ni-nta
9	maltose-binding
9	reverse-transcription
9	autophosphorylation
9	(hiv)
9	tat
9	(cell
9	affective
9	fluoro-gold
9	sends
9	supramammillary
9	conditioning.
9	septum,
9	lot
9	bulb
9	interneurons
9	accompany
9	hodological
9	immunoexpression
9	calcifying
9	ccot
9	med.
9	superimposed
9	timp-2
9	yigsr
9	dentinal
9	hz
9	enamel.
9	plga
9	pc-12
9	coarse
9	axial
9	lindane
9	lactones
9	resistance-associated
9	fertility,
9	(28%)
9	feed.
9	autism
9	oscillatory
9	triacylglycerol,
9	(stz)-induced
9	neurofilaments
9	tdzd-8
9	(th).
9	telencephalon
9	ventilation.
9	cx36,
9	neurotoxin
9	apomorphine-induced
9	milk,
9	antidepressant
9	t-maze
9	parkinson
9	progress.
9	afferents.
9	axotomized
9	cx45,
9	enolase
9	dendrites
9	5a
9	hindbrain
9	t-lymphocytes
9	glia
9	atorvastatin-treated
9	glur2
9	(cb)
9	(d:
9	c-fibers
9	(ew)
9	neurotoxicity.
9	thiol-activated
9	isoform.
9	optokinetic
9	antiserum.
9	1991,
9	lys-49
9	race
9	mtor,
9	adipose-derived
9	119
9	(oa),
9	preconditioning
9	corticosteroid
9	including:
9	caspases,
9	exercise-trained
9	maltodextrin
9	thermogenesis.
9	jak2,
9	rarefaction,
9	∼
9	lac
9	mn-superoxide
9	bad
9	divalent
9	catalyses
9	leukaemia
9	order:
9	glutaminolysis.
9	ibd
9	untreated-ly
9	nmol/1010
9	tg-ly.
9	3.4-fold
9	inactivates
9	parp
9	scientifiques
9	sonication
9	laboratories.
9	cu/zn-sod
9	87%
9	hemorrhage,
9	(uc)
9	fat)
9	radiochemical
9	3-hydroxybutyrate
9	covalent
9	free-feeding
9	flagella,
9	wintering
9	aiv
9	outbreaks.
9	90%,
9	malformations
9	hrsva
9	ba
9	lentivirus
9	araraquara
9	pz
9	regimen.
9	identified:
9	oryzomys
9	circumstances
9	erythrovirus
9	viremia
9	non-structural
9	shigella
9	mapk/erk
9	nai
9	pituitaries
9	pups,
9	dexa
9	stomatognathic
9	yield,
9	developed,
9	acceptance
9	counterpart
9	p2,
9	sapajus
9	stratified
9	buds
9	observations,
9	postfixed
9	pterygoid
9	cadmium
9	suprahyoid
9	dermatology
9	fractured
9	nadh-diaphorase
9	viscosity
9	apella)
9	sinus
9	food-seeking
9	anti-mch
9	epm
9	mouth.
9	maze.
9	encompass
9	prc
9	pmv.
9	ileum,
9	ucn3
9	db/db
9	ng/0.2.
9	marker)
9	(mnr)
9	neuropeptides,
9	zikv-infected
9	anti-tnf-α
9	scavenging
9	(ec)
9	counter
9	3-kinase/akt
9	isoprenylation
9	fpps/ggpps
9	biosynthesized
9	immunoprecipitation,
9	miconazole
9	vt1
9	vt2
9	glycosylated
9	nodular
9	le.
9	mcl
9	mdh
9	ceará
9	sporulation
9	uveitis,
9	neurons).
9	efs
9	vi
9	ulceration
9	hz)
9	expressions,
9	prostate,
9	acetonitrile
9	inf
9	strips.
9	penis
9	bladder.
9	carbachol,
9	ca<sup>2+</sup>
9	ecp
9	(upr)
9	retrieval
9	(seb)
9	lachesis
9	dimeric
9	0-inf
9	dl-propranolol
9	formulation).
9	rc-3095
9	carvedilol
9	dichloromethane
9	gabapentin
9	mycophenolate
9	p-bromophenacyl
9	pla2s.
9	blockers,
9	diltiazem
9	ischaemia
9	bismuth
9	gtn.
9	(52
9	(pma,
9	cetirizine.
9	potamotrygon
9	etoricoxib
9	prolyl
9	variant,
9	svmp
9	os/
9	hydroxylation
9	hct-116
9	safe,
9	bioassay-guided
9	saponin
9	zürich.
9	antiplatelet
9	(pbmc).
9	(colon),
9	(1.8
9	phoma
9	conjugative
9	pristimerin
9	denatured
9	qsox1
9	goiters
9	pids
9	sirp-α
9	igg4
9	b558
9	toxoid
9	(stx)
9	cd34+
9	rebmab200
9	okt3
9	pastoris
9	pld
9	formyl
9	(ln)
9	epoxomicin
9	3.4.24.15;
9	a23187
9	8-10
9	3-copy
9	quenched
9	hyperleptinemic
9	ef-tu
9	ba589
9	ficolin-3
9	synergy
9	sry
9	hpv16
9	antipyretic
9	(tc)
9	clps
9	heme-lysinate
9	nmol,
9	hce
9	annually.
9	ladder
9	cfos
9	trb3
9	nf-қb
9	smad2/3
9	(st),
9	raptor
9	idiopathic
9	citri.
9	s. mutans
9	rpsts
9	caries.
9	alkanesulphonate
9	canker.
9	adp-ribosylation
9	human-derived
9	abc-type
9	bl21
9	lt-i
9	ua159
9	agathisflavone
9	afmk
9	gp90
9	(ttn)
9	ptd
9	znpcso
9	mcg
9	saphenous
9	pac
9	hydrophila
9	p(3hb)
9	nanocomposites
9	limitation,
9	pit
9	head-withdrawal
9	rve1
9	nk1+/+
9	ncx-701
9	zea
9	kernels
9	tramadol
9	constriction.
9	mhv3
9	trnas
9	diphosphohydrolase
9	(sbp)
9	cspa
9	cellulases
9	tlr7/tlr8
9	tlr7/8
9	blomia
9	pils
9	lpfa
9	epec.
9	casei
9	enterohaemorrhagic
9	proteus
9	o157:h7
9	antigal
9	8-br-cyclic
9	rgs
9	colletotrichum
9	greenhouse
9	beauveria
9	aα-syn
9	nx-ci
9	detrained
9	(tag)
9	barley
9	fum
9	peanuts
9	afm1
9	c1s
9	dx
9	cla
9	homa-ir.
9	melanocortin
9	endometriosis.
9	hyorhinis
9	"candidatus
9	cbc
9	immunogen
9	indeterminate
9	parenterally
9	pfrack
9	ameiva
9	scruin
9	rsg
9	b10.riii
9	ask
9	hyaluronidase
9	hpg
9	dec
9	apec
9	dec205
9	17d
9	ts-specific
9	pv-ies
9	tlr2-/-,
9	psi
9	dri
9	pgd-e7e6e5
9	−/−
9	bte
9	mir-17-92
9	orthotopic
9	h-ras
9	ruibp
9	arietans
9	c5ar
9	candidiasis.
9	agonist).
9	mcpg
9	gyk
9	aldehydic
9	hydroxylase-immunoreactive
9	mb17
9	wnt-5a
9	co2/h+-dependent
9	p2-receptor
9	(gaba-a
9	lpbn
9	phox2b.
9	stryphnodendron
9	gp43,
9	p10-primed
9	melanized
9	prox1
9	shed-cm
9	pedicle
9	sgf
9	rabv
9	rvgp
9	ovis
9	rbp4
9	rs10754558
9	pias1
9	pfpdx1
9	intracortical
9	virions
9	uhmk1
8	h+.
8	s3226
8	jhco3-,
8	radioimmunoassay,
8	at1r,
8	microperfusion,
8	nephrology.
8	postprandial
8	site)
8	transcellular
8	(mr)
8	phirr
8	function;
8	sodium,
8	cytological
8	pendrin
8	0.11
8	irptc
8	mapk,
8	border.
8	(67
8	bcecf.
8	solution;
8	0.37
8	of,
8	probes,
8	33)
8	(mdck)
8	(camp),
8	(tea)
8	[ca2+]i,
8	avoided
8	covers
8	visualization
8	0.02).
8	lumen-negative
8	v(t)
8	combination.
8	mv,
8	anion.
8	adx
8	simulates
8	-7
8	ed.
8	solutions,
8	parameter.
8	proceeds
8	15)
8	acidosis,
8	0.33
8	hypertrophied
8	back-flux
8	0.27
8	star
8	glomeruli
8	operations
8	drag
8	flows
8	entrainment
8	filling
8	9.6%
8	hydration
8	1983
8	methodological
8	pool.
8	1972
8	offset
8	semi-arid
8	sisal
8	roots,
8	leaves.
8	paenibacillus
8	indole-3-acetic
8	lyase
8	promotion.
8	online
8	concatenated
8	fingerprint
8	solubilized
8	diagrams
8	reductive
8	inactive.
8	e)
8	(standard
8	(reduction
8	rate),
8	silencing,
8	bapta
8	fluo
8	(d),
8	kg-1).
8	10).
8	intratubular
8	(81%)
8	detail,
8	ept
8	sodium-glucose
8	depolarize
8	cd40l-cd40
8	feriotti,
8	il-1ß
8	nod-like
8	colloidal
8	carbon,
8	(ahr).
8	alum-based
8	ova/alum/cpg
8	anti-microbial
8	curdlan
8	tlr-4,
8	fumigatus
8	resembled
8	concurrently
8	m2-like
8	complement.
8	pre-existing
8	concert
8	phagocytes,
8	deleted
8	il-4-/-
8	granulocyte-macrophage
8	il-
8	oppose
8	comes
8	event,
8	capsulatum,
8	outcome,
8	22,
8	intensity.
8	parallels
8	fungus,
8	multifocal
8	monovalent
8	10th
8	hc,
8	properdin
8	predisposes
8	ribeiro,
8	menopause.
8	ovariectomy.
8	(ova)-alum
8	cnos
8	following:
8	(7)
8	swim
8	bronchoconstriction
8	lavage.
8	relied
8	reserpine
8	people.
8	mdma
8	outdoor
8	-2,
8	fmlp
8	shown,
8	chat,
8	9.5
8	prenatally
8	12.
8	worsen
8	1%,
8	subchronic
8	airways,
8	dulbecco's
8	(1,2-nq)
8	bronchus.
8	ester)
8	associated,
8	monoamine
8	ester.
8	transaminases
8	suppose
8	inhalation,
8	ifn/nor
8	nor/ifn
8	(ldh)
8	conceivably
8	min;
8	eicosanoids.
8	aliquots
8	sound
8	(eb)
8	l-929
8	topographic
8	(ne),
8	plots
8	α2-adrenoceptors
8	raven
8	silvio
8	failures
8	tomato
8	fruits
8	flagellate
8	recommendations
8	antigen-1
8	fit
8	glycolysis.
8	scenarios
8	hybrids.
8	distributions.
8	sporadically
8	subtelomeric
8	gipls
8	criterion
8	rnas,
8	removes
8	promise
8	time-consuming
8	accommodate
8	specific.
8	c6,
8	1.7-fold
8	mapping.
8	band.
8	classification.
8	(rna
8	bank
8	d7
8	geniculatus
8	hierarchical
8	parsimony
8	build
8	tenth
8	subgroups,
8	false
8	project.
8	meetings
8	committee
8	strategic
8	constructed.
8	abs.
8	oligosaccharides
8	discriminatory
8	cardiopathy
8	ccc.
8	subcloned
8	radioiodinated
8	antigenicity
8	strain).
8	50%)
8	reagent.
8	sonic
8	mn2+
8	3-4
8	rifampicin
8	fire
8	canadian
8	zncl
8	dipeptide
8	lipases
8	leucine,
8	melatonin-treated
8	starch
8	(fo)
8	(p)
8	senescence.
8	c).
8	sirna.
8	(glucose
8	(ages)
8	3t3
8	thinner
8	lp,
8	vo
8	(p47
8	sensibility
8	jak/stat
8	tuned
8	[u-14c]glucose
8	(ria).
8	pkcζ/λ
8	spectrophotometric
8	1.5-fold
8	acylation
8	14c]
8	80%.
8	locked
8	[u-14c]-glucose
8	pre-exposure
8	rule
8	short-lived
8	pronounced,
8	sufficiently
8	d‐glucose
8	mobilize
8	1981.
8	half-maximal
8	1980
8	exceeds
8	sparing
8	intragastric
8	ml/kg)
8	psychostimulant
8	initiation,
8	sch
8	15-min
8	psychomotor
8	pools.
8	seventy-two
8	tuberculum
8	mhpg
8	gpi
8	gpi,
8	cee+t.
8	term.
8	bm.
8	bm-derived
8	cardiometabolic
8	gingipain
8	c48/80
8	foxo3a
8	nadph-oxidase
8	improvement.
8	(at1
8	csa,
8	myostatin,
8	ng-nitro-l-arginine
8	p-enos
8	(ampk)
8	hydrolase
8	(t2dm)
8	fluorescence,
8	pressure)
8	nox4
8	metformin.
8	hyperinsulinemia.
8	(400
8	nmol/l)
8	immunocytochemistry.
8	independent.
8	n=6)
8	salt-sensitive
8	ca2+-independent
8	o-linked
8	question,
8	p-selectin,
8	(bk),
8	et-1,
8	biglycan,
8	premenopausal
8	pediatria.
8	showed,
8	(conversion
8	superoxide.
8	hydrate
8	microscopy),
8	8.9
8	bms182874
8	zymosan-activated
8	post-mortem
8	estrogen-treated
8	enos.
8	vasodilatation,
8	cardiology.
8	182874
8	steroids,
8	microscope,
8	galactosemic
8	pmns
8	myocytes.
8	aggravate
8	(dpi),
8	(subcutaneous
8	ovx-doca
8	noradrenaline,
8	methylated
8	inhibitable
8	deoxycholate
8	0.2%
8	appearing
8	spla2s,
8	voltage-activated
8	matter,
8	homologies
8	value.
8	simulation
8	b-
8	burned
8	engineering
8	instrument
8	osteoblasts,
8	(glut)
8	fibromodulin
8	(ige)
8	(cd4
8	transducers
8	cytotrophoblast
8	stain.
8	4g
8	tartrate-resistant
8	demonstrate,
8	nonlinear
8	cytoarchitecture,
8	underlies
8	topographically
8	leucine-rich
8	ver
8	e2,
8	follistatin
8	embryos.
8	analysed,
8	blastocyst
8	fibrillin-1
8	nowadays,
8	immunogold
8	guidance
8	orientation.
8	histomorphometry
8	72%
8	reverts
8	averages
8	pgc
8	digestion,
8	45%,
8	hlf
8	chondroitinase
8	vo2max)
8	illuminated
8	embryos,
8	aspartate,
8	[u-14c]glutamine
8	2.9
8	sudan
8	differentiating
8	incisor
8	11th
8	(s),
8	(ap),
8	age-dependent
8	augmenting
8	medulla,
8	bbb
8	deficits.
8	weeks;
8	precedes
8	rvlm.
8	(nos
8	arteries,
8	questions.
8	habit
8	content).
8	wky,
8	(hr
8	neuroplasticity
8	adjustments.
8	28%,
8	at1a
8	aogen
8	paramount
8	dbs
8	blunting
8	subnucleus
8	et.
8	son
8	subdiaphragmatic
8	orchestrating
8	nat
8	reflex,
8	at,
8	beats/min
8	(1.25
8	(22
8	ng)
8	μl),
8	thickness.
8	clip
8	listed
8	reinfection
8	magellanic
8	stranded
8	(9
8	endpoint
8	tachyzoites.
8	white-lipped
8	peruvian
8	nymphs
8	ectoparasites
8	continents.
8	asymptomatic,
8	(especially
8	brasilianum
8	wolbachia
8	pará.
8	sergipe,
8	surveys.
8	epidemiology.
8	fernando
8	1:10
8	1:20
8	(ifat
8	places
8	invertebrates.
8	inhabit
8	(ifat),
8	rdna)
8	area;
8	2.4%
8	species:
8	inconvenience
8	chickens.
8	apply
8	distinguishes
8	breeds
8	amazonas,
8	wiedii,
8	herein.
8	(pcr),
8	127
8	feral
8	aborted
8	129
8	cs3
8	154
8	felids,
8	(serum
8	popliteal
8	(polymerase
8	molossus
8	vietnam.
8	farms.
8	goats.
8	caev
8	births
8	prevalence.
8	meat.
8	(27
8	hazard
8	monkeys,
8	mongrel
8	monkey,
8	91%
8	1200
8	gender.
8	world's
8	oysters
8	gii
8	(15%
8	(47%)
8	southwestern
8	254
8	13,
8	threatened
8	neotropic
8	encounter
8	considered,
8	globular
8	128
8	0.14,
8	5.5%
8	illness.
8	(hsp70)
8	l.,
8	genbank.
8	paf-receptor
8	tnf-α)
8	t1dm
8	grows
8	cox1
8	myd88-dependent
8	tegumentary
8	ratio;
8	(ams)
8	hla-dr,
8	skewed
8	mycoplasmal
8	arthritidis
8	martins
8	tumour,
8	taurocholate
8	(38%)
8	fcγr-mediated
8	inos-derived
8	histopathology.
8	subset.
8	daf-2
8	units)
8	background/aim:
8	28.
8	finding,
8	h2o
8	hematology.
8	arthus
8	expression)
8	coagulation,
8	pouch
8	emulsions
8	mw-3
8	sin-1
8	5-fold
8	content),
8	prostaglandins.
8	mycoplasma-infected
8	(bsa)
8	bjv-induced
8	<.05).
8	12.1
8	hypothalamic-pituitary-adrenal
8	duodenum
8	break
8	(primary
8	dependently
8	immunoassays
8	joints
8	b2,
8	acetylsalicylic
8	glycogen,
8	1978
8	remnant
8	basin,
8	extrapolated
8	amplicon
8	2.4
8	clostridia
8	similarity,
8	rodrigues.
8	managed
8	entrance
8	gh1
8	czech
8	forests
8	structure-function
8	reservoir.
8	frequent,
8	estuarine
8	mangrove
8	phyla
8	alk
8	rhodococcus
8	brazil),
8	pneumophila
8	inference
8	80%,
8	monooxygenase
8	rivers
8	(also
8	fernandes
8	liposomes,
8	e7-specific
8	gde7
8	'
8	therapeutically
8	cd83,
8	apoptosis-related
8	rodrigues,
8	analogues.
8	integrin,
8	oncology
8	α-helical
8	another.
8	pipeline
8	exfoliated
8	(mdcs)
8	(il-2,
8	treated,
8	one-year
8	neoplasia.
8	setting,
8	padre
8	dc-based
8	hp.
8	meet
8	microparticles
8	dermatology.
8	conducted.
8	euthanasia
8	c1q,
8	renewed
8	tumor-infiltrating
8	mri
8	29,
8	expansions
8	hiv+
8	135
8	pia,
8	48 h
8	(bmcs)
8	cell-cycle
8	point-mutated
8	arthritic
8	cxcl9,
8	hydrocarbons,
8	ahrb1
8	airmin)f2
8	pedigrees
8	femurs
8	c5.
8	11a
8	airmaxrr,
8	airminrr
8	airminss
8	breedings.
8	coincidently,
8	containment
8	anti-cd4
8	resident,
8	teixeira
8	camargo,
8	clades,
8	triatoma
8	savannah
8	hotspot
8	rift
8	in-house
8	identity,
8	(herpetosoma)
8	pcr-amplified
8	metacyclogenesis
8	glyceraldehyde-3-phosphate
8	typing.
8	history.
8	(brazil)
8	scarcity
8	phytophagous
8	trees,
8	marginale,
8	parasite-host
8	unresolved.
8	(sl)
8	assessments
8	aware
8	ago,
8	mogi
8	related,
8	scale,
8	symbionts
8	rts
8	boundaries
8	sl
8	co-cultivated
8	cruzipain
8	leukocytosis
8	waste
8	resist
8	fum19
8	concordant
8	achieved,
8	ada
8	peptidases.
8	general.
8	wild-caught
8	(100%).
8	serous
8	(20%)
8	locality
8	cycle)
8	kangaroo
8	sheath
8	simple,
8	end.
8	3f6
8	cd73
8	persistence,
8	tfh
8	implicates
8	implications.
8	cd4(+)
8	"why
8	livers,
8	(neuronal
8	domain-like
8	caspase-1-mediated
8	pyroptosis,
8	sequelae
8	cox-2.
8	subsets,
8	nk,
8	nk1.1-
8	(tcr)
8	drug-treated
8	cd11b+
8	ifn-γ+
8	pannk+
8	evolves
8	(sylvio
8	progresses
8	c3h/hepas)
8	convincing
8	defect.
8	(il-4)
8	ruling
8	tc1
8	phenotype;
8	thymectomized
8	transferrin
8	reactivities
8	immunochemical
8	phytohemagglutinin
8	(pfc)
8	pfc,
8	substitution,
8	righting
8	forks
8	carcinogenesis,
8	seaweed
8	predominate
8	c:g
8	recognition.
8	photolyases
8	modulators,
8	cockayne
8	microcephaly,
8	synapse
8	3'
8	mitosis,
8	single-strand
8	genética.
8	erythema
8	p53.
8	unspliced
8	lncrnas
8	recruits
8	dangerous
8	see
8	anthracyclines
8	trisaccharide
8	multiforme
8	gambiae
8	transfer,
8	lentiviral
8	egfp
8	aphidicolin
8	cells'
8	damage-induced
8	orthologs.
8	eggs,
8	homologue,
8	agrobacterium
8	tk
8	storage,
8	retaining
8	photoreactivation
8	hbsag
8	kda).
8	evident.
8	nucleotides,
8	89%
8	progeny.
8	blaa
8	anteromedial
8	predator-associated
8	defeat-associated
8	included,
8	wherein
8	participant
8	aggression,
8	observers
8	offside
8	position.
8	attacking
8	hypothalamic,
8	defensiveness
8	tried
8	decisions
8	output,
8	acceptable
8	cardinal
8	(aged
8	circuitry.
8	blocks.
8	empirical
8	0.005).
8	lentiform
8	rotation
8	(co
8	crucially
8	21-day
8	hav
8	phototherapy
8	780
8	hep-2,
8	relationships.
8	strengthens
8	ultracentrifugation
8	segment,
8	hk2
8	blockers.
8	(cml)
8	(lc-ms/ms)
8	ligases
8	(p < 0.05)
8	(pd),
8	glomerulosclerosis,
8	luteal
8	rela
8	traffic
8	(.
8	statins.
8	edl.
8	(soleus
8	e-box
8	repressing
8	guarantee
8	race.
8	infarction,
8	hormone-sensitive
8	(anova)
8	todos
8	direitos
8	reservados.
8	amp-activated
8	iac
8	msg-treated
8	pp185
8	polyadenylation,
8	kitt
8	resistive
8	anemic
8	0.04).
8	members.
8	2-week
8	(24%)
8	diabetic,
8	(wat),
8	receptor-α
8	such,
8	carbohydrate-free
8	anti-insulin
8	manipulate
8	(amp)
8	(mg)
8	warranted
8	β-sheet
8	mg.
8	traces
8	amp,
8	fluconazole.
8	α2m
8	melanization
8	proteinase,
8	steps.
8	bmap
8	warrant
8	spot,
8	termini
8	biophysical
8	permeabilization
8	a.,
8	matrix-assisted
8	bridges.
8	micelles
8	β-turn
8	carboxyl
8	hypochondrialis
8	anion-exchange
8	storage.
8	lysis.
8	40-kda
8	gap,
8	ataxia
8	derives
8	separately.
8	e1
8	valence
8	anti-parasite
8	ccl5,
8	nk65
8	restimulation
8	cy-tc
8	antibody-dependent
8	il-2.
8	serum-free
8	hydrolysate
8	cinnamic
8	micronucleated
8	phases,
8	mollicutes,
8	ureaplasma.
8	polytene
8	intermediates.
8	sac
8	formula
8	puffs
8	terms,
8	b-2
8	characteristically
8	looked
8	parietal
8	lcl
8	monotherapy
8	miltefosine.
8	imaging.
8	relapses
8	guyanensis.
8	fill
8	pocket.
8	cu(ii)
8	crystallization
8	percutaneous
8	(ic50)
8	s-nitrosoglutathione
8	discriminating
8	subvert
8	αv
8	(mcp-1)
8	urchins
8	(er),
8	cytodifferentiation
8	pak3
8	xviii
8	pg,
8	amylase,
8	spreading,
8	postural
8	cartilage,
8	somatotrophs
8	sagittal
8	decalcified
8	-4,
8	rounding
8	ducts,
8	jun
8	adrgd-pgp53
8	p53-responsive
8	pc3
8	unexplored.
8	pclpg
8	merkel
8	loop.
8	australasian
8	gametocyte
8	vl.
8	outcomes,
8	amazonians
8	artemisinin
8	series.
8	robust,
8	detects
8	rare,
8	reliably
8	heparin,
8	bleeding.
8	contributors
8	methodology:
8	anemia.
8	chimpanzee
8	billion
8	ligand.
8	mesoendemic
8	intra-host
8	heights
8	unambiguously
8	prospectively
8	brasil
8	located.
8	142
8	apart,
8	spanning
8	decade.
8	(ds)
8	applied.
8	interspecific
8	adults)
8	type-specific
8	exist,
8	high-avidity
8	attack.
8	thiocyanate
8	cnidarian
8	nas
8	phou
8	7.2
8	selected,
8	polyketide
8	publications
8	l2
8	colonial
8	bamhi
8	ipt
8	pneumosintes
8	foods
8	epsilon
8	cpe
8	osteoclastogenesis
8	prosthetic
8	teeth,
8	fisher's
8	denticola,
8	nigrescens
8	cdtb
8	cdtc
8	ccl5
8	parabacteroides
8	cefoxitin
8	rankl,
8	orphan
8	glabrata
8	rt,
8	ccl3
8	k,
8	tt
8	hiv-positive
8	24-48
8	pumps
8	diarrheal
8	stasis
8	preoperative
8	ab,
8	file
8	cr,
8	carbofuran
8	noxious
8	echinoderm
8	shallow
8	fairly
8	sulfoxide
8	duration,
8	hexamerin
8	phases:
8	astyanax
8	step,
8	histological,
8	seek
8	ontogeny
8	intermingled
8	ripe
8	21st
8	pg/ml)
8	6-sulfatoxymelatonin
8	arh
8	ucp1,
8	offspring's
8	neurobehavioral
8	rhythm,
8	silveira,
8	epilepticus
8	lights
8	third,
8	oscillation
8	responsible,
8	synthesised
8	polycystic
8	ne-mediated
8	tracer,
8	inductor
8	circadian-like
8	(ifn)
8	(mitogen-activated
8	intermediolateral
8	parvicellular
8	circumstances,
8	proviral
8	enterotoxicity
8	delivery)
8	(lt1
8	nucleoprotein
8	bicistronic
8	hydrocortisone
8	integrins,
8	(ctb)
8	prelimbic
8	apex
8	accumbens,
8	ganglia.
8	outputs
8	a7
8	coeruleus,
8	pedunculopontine
8	ca1
8	lateralis,
8	ht1080
8	caspase-3,
8	ame
8	mmp2,
8	res.
8	ccot.
8	cks
8	trauma,
8	poa
8	twenty-seven
8	its2
8	gonotrophic
8	emulsified
8	eae-induced
8	london.
8	molars,
8	gaas
8	synapsin,
8	neurofilaments,
8	peptidomic
8	threshold.
8	unilaterally
8	disruptions
8	avenue
8	cci.
8	pro-survival
8	(gj)
8	(clp)
8	ucms
8	autism.
8	(cx)
8	scn,
8	pregeniculate
8	expectancy
8	ex7
8	ex3.
8	relays
8	peroxidation.
8	snt.
8	lipoxygenase-derived
8	2-induced
8	c-sensitive
8	arousal
8	emotionality-related
8	spiriformis
8	lentiformis
8	mesencephali,
8	ache
8	isoprenaline
8	indications
8	calretinin-positive
8	angles
8	α8‐li
8	(among
8	retinae
8	a‐like
8	retino-recipient
8	downward-nasal
8	post-operative
8	marathon
8	scf
8	(dha)
8	(lps).
8	enteral
8	(tumor
8	formoterol
8	mg/dl)
8	sle,
8	worth
8	6.1
8	mg/day/4
8	nr1h2
8	nr1h3
8	glycophorins
8	dexamethasone-treated
8	trh.
8	ffa,
8	spectrofluorometric
8	slco2b1
8	cyanobacterial
8	arachidonate
8	-independent
8	cava
8	bromide)
8	aconitase
8	lifelong
8	non-tumor-bearing
8	cp-pg
8	tm5
8	58%
8	nutrients,
8	pma-stimulated
8	immunodeficiency.
8	evaluated:
8	periphery,
8	inf-γ
8	targeting.
8	(0.15
8	isomers
8	(ibd)
8	(il)-2
8	1010
8	cascades,
8	mitochondrially
8	(o2-)
8	crotalic
8	hc.
8	mln
8	canola
8	pu
8	electrophilic
8	tail-flick
8	linoleate
8	spare
8	hydrogenated
8	vagotomy.
8	mosm/l
8	pufa-rich
8	lipolysis.
8	(w/w)
8	precursor.
8	purines
8	bronchiolitis
8	npc
8	antigenically
8	hantaviruses
8	paid
8	admission
8	necessary,
8	vp2
8	npv
8	babies
8	vice
8	precfa
8	2.8%
8	viral,
8	recommend
8	(tsh)
8	ppar-a
8	ths
8	symporter
8	milk.
8	hyperthyroidism,
8	pakt
8	pax8
8	update
8	department
8	course,
8	down-regulate
8	decapitation
8	190
8	snp,
8	poly-a
8	thermoregulation
8	proposing
8	protein;
8	somatostatin
8	diminished,
8	opioids
8	revealed.
8	laminar
8	stent
8	epithelium-connective
8	today,
8	anesthetic
8	melted
8	plexus.
8	fixative
8	paraffin
8	convergence
8	sphenoid
8	prosencephalic
8	(nei)
8	subfornical
8	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
8	immobilisation
8	incerta,
8	preoptic,
8	(vmh)
8	tuberomammillary
8	3′utr
8	enhancers
8	metallopeptidase
8	3.4.24.15
8	codon.
8	stomach,
8	cessation
8	antalarmin
8	incerta.
8	r,
8	ew,
8	historically
8	orexigenic
8	cas
8	advent
8	subtle
8	mgop
8	(acth)
8	sp-ir
8	pvh.
8	medulla.
8	measures:
8	(odns)
8	inborn
8	3/7
8	(tlr4),
8	placentas,
8	ncf1
8	trophoblast.
8	tnfa
8	oxidases
8	alpaca
8	occupies
8	post-ovalbumin
8	phytoene
8	fpps
8	intra-erythrocytic
8	methylerythritol
8	modestly
8	competitively
8	llc-mk2
8	sag
8	conserved,
8	quinquefasciatus
8	entomopathogenic
8	ny.
8	shawi.
8	132
8	dat
8	alat,
8	al,
8	ph8
8	p38a
8	lcm
8	nnos-/-
8	esophagus
8	icp
8	kgaa.
8	pharmaceuticals
8	dustri-verlag
8	feistle.
8	bladders
8	score.
8	isocratically
8	endoscopic
8	v/v).
8	urethral
8	enhanced,
8	ureteral
8	1.8%
8	nano
8	(pde5)
8	thrombin-induced
8	0.3,
8	erection.
8	no-deficient
8	cantor
8	onoo-
8	sea-
8	md
8	nmol/site),
8	1h-[1,2,4]
8	oxadiazolo
8	neurokinin
8	semi-synthetic
8	licensed
8	1400 w
8	metoprolol
8	p<0.01).
8	-1),
8	cascavella
8	microchemotaxis
8	sq
8	rolipram
8	flurbiprofen
8	tsv
8	serotonin.
8	venom)
8	myotoxicity,
8	30-day-old
8	bothropstoxin-ii
8	assaying
8	campinas,
8	paws.
8	d-arginine
8	pirajai
8	μ-opioid
8	(c(max))
8	non-cirrhotic
8	prothrombin
8	auc([0-∞])
8	i/ii
8	inspiratory
8	methysergide,
8	l‐arginine
8	o2,
8	myotoxicity
8	(histamine
8	mt-iii-induced
8	moojeni
8	(bav)
8	cyclooxygenases
8	authors,
8	w/w).
8	unloaded
8	mellonella
8	singly
8	6-fold
8	safety.
8	mda-mb435
8	atzd
8	alginates
8	svhv
8	redox-dependent
8	sf-295,
8	in-vitro
8	functionalized
8	aureus.
8	1,2-dihydronaphthalenes
8	co-factor
8	vulgare
8	svlv
8	formocresol
8	immunoadjuvant
8	partitioning
8	craniofacial
8	(bw)
8	gc-24,
8	fiber-type
8	17/2.8
8	fm
8	scd100
8	p27kip1
8	project,
8	transplants
8	creation
8	apeced
8	4000
8	il-23
8	ibd.
8	activation-induced
8	p-specific
8	c4a
8	advances,
8	fab
8	dermonecrosis,
8	(svmps)
8	(de3)
8	sizing
8	bilayer-covered
8	nonanaphylactic
8	cfa
8	19s
8	nmol),
8	multipotent
8	dynorphin
8	ep24.15)
8	trimer
8	phe,
8	cfp
8	nep
8	demyelination
8	adipose-secreted
8	treg-cell
8	5-ht3
8	leptospira,
8	ficolins
8	pneumotropica,
8	macular
8	neisseria
8	mϕ
8	perforin
8	tumor-associated
8	(sge)
8	h;
8	(co),
8	monoglyceride
8	oblongata
8	warmth-seeking
8	monophasic
8	nl),
8	anapyrexia,
8	cold-induced
8	tb,
8	g6pdd
8	cd4+/cd8+
8	glomerulosa
8	lrh-1
8	chymotrypsin-like
8	calpain-3
8	serca
8	crystallography.
8	crystallography
8	hvr
8	crystallized
8	tungstate
8	thioredoxin-1
8	trx-1
8	ct,
8	dispensable
8	pathogen-specific
8	bcr-abl-positive
8	no2-fas
8	diastereoselective
8	indan
8	sacchari.
8	ttn
8	indans
8	elacridar
8	psoriasis
8	intimal
8	hsp20
8	lactose
8	monomer
8	p3hb
8	anadenanthera
8	lanio
8	apap
8	igg(t)
8	mucin-like
8	rvfv
8	erv-k
8	egt
8	polyhedrin
8	aegypti.
8	apolipophorin
8	hsp65.
8	elispot
8	segregants
8	cardioprotective
8	modulation,
8	14 days
8	nucleoside
8	zur
8	paradigms
8	c/ebpα
8	lamp-1
8	pepsinogen
8	canalicular
8	ad,
8	lp.
8	il-7
8	cd107a
8	preconception
8	hesn
8	(bt)
8	phylogroups
8	stx1,
8	o111
8	espa
8	042
8	effacement
8	haemolysis,
8	bla,
8	self-administered
8	pons,
8	nlx
8	pho-s
8	nnos-1-/-
8	biomolecules
8	guarana
8	plant.
8	p9
8	s14
8	thalidomide
8	s7
8	nitroglycerin
8	pad.
8	glycerokinase
8	breast-feeding
8	zearalenone
8	grains,
8	sorghinum
8	kgy.
8	aflatoxigenic
8	(afb1)
8	mycobiota
8	flavi
8	alternariol
8	proband's
8	peritumoural
8	chow-
8	rttb
8	ldl-c
8	depot-specific
8	chf.
8	mlst
8	(pfge)
8	haemocanis
8	entrapped
8	itraconazole.
8	nigericin
8	submicron
8	hematologic
8	anti-venom
8	mangiferin
8	maculosa
8	cinnamaldehyde
8	fimbriae,
8	ama1
8	1826,
8	dii
8	non-palindromic
8	adaptor-pcr
8	p154/13
8	lt-iib
8	15-mer
8	lt-iia
8	anti-stx2b
8	64855
8	peel
8	cytolethal
8	mir17-92
8	ret
8	pkcε
8	megakaryocytes
8	microdilution
8	premolis
8	caries-active
8	rhbg
8	squid
8	prolactin-induced
8	α1-adrenoceptor
8	lepr-expressing
8	prolactin-responsive
8	tdtomato
8	avpv/pen
8	alboserpin
8	pir
8	dlg1
8	fkn
8	pon1
8	tyrosyl
8	β-ar
8	lacrimal
8	polyp
8	dd
8	idh1
8	scd2
8	deptor
8	α2a/α2carko
8	especl
8	pptg
8	vagotomized,
8	bulbospinal
8	co2/h+-sensitive
8	hcn
8	gaba-a
8	ssp-sap
8	(end-expiratory
8	balls
8	snd
8	sporotrichosis
8	mmp20
8	oraov1
8	thymoglobulin
8	casp1,
8	gn
8	car
8	leptospiruria
8	card8
8	siglec1
8	cias1
8	pfaspat
8	vccs
8	osi-906
8	namalwa
8	spint2/hai-2
8	ruxolitinib
8	fmnl1
7	nmol·cm-2·s-1
7	p22phox,
7	llc-pk1
7	exchangers
7	nhe2,
7	dphi/dt
7	diarrhoea.
7	(at1)
7	nhe3,
7	colocalizes
7	nephron.
7	(shrs)
7	phosphatase-1
7	happens
7	kt5823
7	cgmp,
7	fluo-4-am,
7	aldosterone)
7	diuretic
7	+/h+
7	prehypertensive
7	abolishing
7	effectors.
7	s-
7	0.008
7	concanamycin
7	nrc.
7	recycling
7	0.50
7	14),
7	(14%)
7	-1.
7	group:
7	cotransport
7	exocytotic
7	nh4+
7	alteration.
7	jw
7	permeable
7	minute,
7	side.
7	retarded
7	0.19
7	0.36
7	cpm
7	7.8%
7	2.1%
7	duct)
7	transient,
7	compensation
7	corticosteroids
7	steroids.
7	0.51
7	egta
7	secretion)
7	sec
7	sits
7	alkalosis,
7	(jhco3-)
7	equilibrated
7	17)
7	20)
7	24)
7	gradients,
7	5-7
7	na/h
7	mumol
7	brush-border
7	gradients.
7	kinetics.
7	series,
7	ca++
7	(92%
7	+)
7	air.
7	below.
7	include,
7	controversial,
7	split-droplet
7	(62%)
7	zero.
7	toad
7	equilibration
7	green,
7	embryogenesis,
7	epiphytic
7	soil.
7	leifsonia
7	pectin
7	pectinase
7	fix
7	fifty-three
7	intra
7	activity),
7	(pkc),
7	59%
7	b),
7	stains
7	ph(i)
7	[ca2+](i)
7	mpt
7	words)
7	](i)
7	li+
7	0.31
7	11.5
7	rescues
7	calich
7	brasiliensis-stimulated
7	dectin-1,
7	anti-fungal
7	fitness.
7	ros.
7	postinfection
7	p2x7r-/-
7	shifting
7	cd8+t
7	profoundly
7	tlrs,
7	ltc4
7	2,3-dioxygenase
7	temporary
7	4.9
7	infection).
7	mcp-1.
7	govern
7	cooperative
7	(il)-12
7	coinjection
7	cohabitation
7	architecture,
7	repertoire.
7	diversified
7	c3h/hej,
7	capsulatum.
7	permanently
7	gelatinase
7	kda;
7	correspondent
7	plating
7	1992,
7	12th
7	21.2
7	cristae
7	junk
7	behaved
7	sephadex
7	stocks,
7	mixture.
7	1980.
7	meaning
7	ovariectomy,
7	bites.
7	cellularity,
7	non-manipulated
7	donor.
7	(bal),
7	mechanics
7	obstruction.
7	(rats
7	15.
7	foetal
7	38,
7	a3
7	accordingly
7	hyporesponsiveness
7	administered,
7	anesthesia,
7	data:
7	(amph)
7	(il-4,
7	situ.
7	industries,
7	(gr),
7	(gst),
7	nos-ir,
7	42%,
7	utero
7	30-day
7	mk886
7	leak
7	bacteremia
7	probably,
7	sacrificed,
7	orchestrates
7	fe
7	encompasses
7	μg/kg).
7	fibrogenic
7	no-independent
7	intrapulmonary
7	hindered
7	bal.
7	allergenic
7	glucocorticoids.
7	duodenum,
7	nt.
7	shocks
7	ultrasonic
7	2170
7	benzenepropanoic
7	haemorrhage,
7	unresponsive.
7	leukotrienes,
7	eia,
7	epinephrine.
7	anti-parasitic
7	tcabcg1
7	tciii
7	tcv
7	tools.
7	behaves
7	124
7	funpec-rp.
7	maxicircle
7	haplotypes.
7	bootstrap
7	©funpec-rp.
7	ranking
7	some,
7	immunochromatographic
7	knowledge.
7	gruyter
7	false-positive
7	rdna.
7	views
7	bugs
7	element,
7	chile,
7	positives
7	ordered
7	taxon
7	branch.
7	subsets.
7	moiety,
7	rrna.
7	(balb/c)
7	70%)
7	glycosphingolipids
7	hydrolysed
7	1982.
7	cations.
7	saturating
7	considerations
7	voltage-clamp
7	wasting,
7	bmal1,
7	cry1,
7	homa-ir,
7	(nph,
7	corticosterone.
7	iodonium
7	40%)
7	hyperinsulinemia,
7	rapamycin.
7	overweight
7	(isp)
7	2.3-fold
7	hypoglycaemia
7	medium-chain
7	insulin-mediated
7	advocate
7	metabolism).
7	flavonoids,
7	nfkb1
7	chemiluminescence,
7	retinopathy
7	4-hydroxynonenal
7	alongside
7	(rns)
7	ros/rns
7	-8
7	synthesis;
7	polydipsia,
7	[nad(p)h]
7	time-dependently
7	p22
7	nh2-terminal
7	ly294002,
7	[an
7	angii-induced
7	1.4-fold
7	akt-1
7	mg/dl).
7	22.2
7	islet,
7	(no)-mediated
7	24-hr
7	b-cells
7	forskolin-induced
7	(ac)
7	(for)
7	(so),
7	changed,
7	prelabelled
7	12-month
7	high-protein,
7	hit
7	secretagogues
7	232
7	gating
7	bcnu
7	l-glutamine,
7	with,
7	nucleotides.
7	endocrinology
7	biggest
7	4.7
7	locomotion,
7	circumstances.
7	probenecid
7	5‐hiaa
7	hk,
7	anesthetized,
7	phe-induced
7	(ovx),
7	660
7	comorbidities.
7	mtdna,
7	tlr9,
7	(gcf)
7	beds.
7	ta.
7	ta,
7	(within
7	channel-dependent
7	bouts,
7	initiators
7	(h2o2)
7	anti-diabetic
7	sixteen-week-old
7	days/week
7	qrt-pcr,
7	elastin
7	senescence-associated
7	elafin
7	counterbalanced
7	recording.
7	chemerin
7	et-1.
7	(ap-1)
7	hydroalcoholic
7	rolling,
7	insults
7	1).
7	period;
7	pugnac
7	acid;
7	diabetes-related
7	n-stz.
7	et-3
7	cases).
7	nicotinamide-adenine
7	(snp).
7	normalizing
7	kinins
7	microscopy)
7	cu/zn
7	female.
7	subgroups:
7	mg/kg/d
7	television
7	cuff
7	porphyrin
7	caffeine,
7	issue,
7	irl-1620
7	donor,
7	e-
7	(either
7	microcirculation,
7	adducts
7	choose
7	reduction)
7	situ,
7	evoking
7	ach,
7	introduces
7	crotamine
7	radiometric
7	charybdotoxin
7	ca2+-activated
7	myocytes,
7	filaments,
7	actin.
7	aa-induced
7	explanations
7	materials.
7	thyrotropin-releasing
7	ribosomes,
7	3h-thymidine
7	desmin
7	ecm.
7	lasers
7	pseudopregnant
7	decorin,
7	steps,
7	cytoskeletons
7	(socs3)
7	bioengineered
7	artemia
7	tibia
7	osteoblast-like
7	adrenoceptor
7	skeleton.
7	(ecm),
7	images,
7	obesity-induced
7	triglyceride,
7	collagenous
7	cell-matrix
7	post-natal
7	zones,
7	iodothyronine
7	nonpregnant
7	stabilize
7	dprp
7	15th
7	joined
7	chamber,
7	continually
7	vo2max).
7	(10-20
7	acid-schiff
7	rods
7	nets
7	prevailed
7	killed.
7	o,
7	location,
7	formulated
7	kb)
7	re-established
7	flattened
7	6-day
7	(paf),
7	intravenously.
7	(li)
7	preautonomic
7	isothiocyanate
7	shr-s
7	30),
7	pbs.
7	deficits,
7	sympathoexcitation
7	cruz,
7	(tr)
7	cannulas
7	cardiac,
7	angiotensinogen,
7	pba
7	pcr),
7	clocks
7	loop,
7	exp
7	(sna).
7	slowing
7	(sad)
7	wall/lumen
7	first-order
7	ribeirão
7	intense,
7	coarctation
7	nts/dmv
7	(corresponding
7	sympathovagal
7	eminence,
7	61%
7	dilatation
7	(32%)
7	cisterna
7	duplicated
7	cosmopolitan
7	chilean
7	(based
7	pectoral
7	(mat),
7	peccary
7	(tayassu
7	reserves
7	ifat,
7	conjugate.
7	reptiles
7	descriptive
7	(bubalus
7	ectoparasite
7	borrelia
7	(panthera
7	bovis,
7	reaction-restriction
7	agouti
7	caribbean
7	pi.
7	ruminants,
7	biomarkers.
7	(sa),
7	captivity.
7	wauwau
7	(six
7	table
7	categorized
7	cystoisospora
7	ancylostoma
7	espírito
7	remnants
7	concordance
7	seasonally
7	40,
7	felids.
7	geoffroyi,
7	jaguars
7	animals;
7	ifa
7	cryopreserved
7	540
7	25)
7	found:
7	(87%)
7	barbosa
7	thirty-three
7	t.gondii
7	municipality,
7	perform,
7	u.s.
7	government
7	globally.
7	callithrix
7	taxonomically
7	pernambuco,
7	communal
7	ehrlichiosis
7	characterise
7	recommended.
7	(63%)
7	(p>0.05)
7	sexes,
7	325
7	flocks.
7	177
7	pepsin
7	fowl.
7	20),
7	ai
7	assemblages
7	6-month
7	fetuses,
7	acacia
7	l3
7	igm.
7	161
7	19.4
7	queens
7	holstein
7	problems,
7	brasileiro
7	veg
7	laboratorial
7	monospecific
7	removed.
7	venezuelan
7	brains,
7	bnc
7	sanguineus
7	164
7	(wt).
7	il4,
7	mutually
7	collaborative
7	myd88.
7	scenario,
7	alves
7	carcinoma)
7	monitoring.
7	f4/80
7	signalling,
7	gpcr
7	aggravating
7	institut
7	uuo
7	(oxldl)
7	hek293t
7	raft
7	engages
7	prosurvival
7	pathogens;
7	ams.
7	socs1
7	nph
7	(45%),
7	e-selectin,
7	zileuton
7	tumours.
7	inhalation.
7	il-10),
7	(70%),
7	23%,
7	(~40%)
7	(72%)
7	fcγ
7	reperfused
7	warm
7	(ltb
7	addition.
7	μg).
7	(48%
7	tracer.
7	(txb2)
7	1:3
7	endotoxemic
7	36,
7	70%,
7	isotypic
7	hypersensitivity,
7	stream
7	time-related
7	ndga
7	corporation.
7	schedule.
7	washing
7	(0.1,
7	ducts.
7	dropped
7	non-anaphylactic
7	disturbances,
7	scales
7	deception
7	fishes
7	91
7	peninsula
7	otus
7	seep
7	inhabiting
7	ocean.
7	gb
7	affiliated
7	batch
7	amine,
7	autotrophic
7	cold-adapted
7	variations,
7	germination
7	homogenization
7	presently,
7	methanogenic
7	emerges
7	mdpi.
7	33.3%
7	methanol,
7	densities,
7	puerto
7	alkane
7	excess.
7	culture-independent
7	degradative
7	pcb
7	sewage-polluted
7	pumping
7	electropositive
7	proteobacteria,
7	reducer
7	24%,
7	gains
7	determination,
7	tumor-specific
7	uniquely
7	clonogenic
7	liposomes.
7	immunotherapy,
7	inflammasome.
7	(dcs),
7	γ1
7	c16-induced
7	peptide-induced
7	cortactin
7	analogue,
7	overcomes
7	aside
7	safety,
7	plus-maze
7	bromodeoxyuridine
7	melanomas
7	mot
7	time:
7	fb,
7	high-grade
7	(rcc)
7	durations
7	membrane-anchored
7	2002,
7	published.
7	computerized
7	(scfv)
7	cancer)
7	micrograms
7	carvalho
7	pristane,
7	prevalent,
7	biogel
7	7,12-dimethylbenz(a)anthracene
7	p53-dependent
7	dmba-treated
7	inflammation)
7	genotype-assisted
7	bioarrays
7	affinity,
7	non-inbred
7	orthodontic
7	pge2levels
7	136
7	downmodulation
7	7,12-dimethylbenz[a]anthracene
7	typhimurium,
7	(dmh),
7	105,
7	process:
7	thymocyte
7	ontogenetic
7	follow-up,
7	homozygote
7	grayi
7	tabanids
7	ralphi
7	tabanid
7	dionisii,
7	simiae
7	acre
7	(acl)
7	repertoire,
7	flies,
7	(catl)
7	recapitulates
7	3000
7	relationships,
7	ms/ms
7	leishmanias
7	harbours
7	rrna)
7	(46%)
7	wa
7	pantanal,
7	enzootic
7	well-developed
7	msp5
7	wandering
7	triad
7	histories
7	5s
7	1.25
7	anestrus
7	(schizotrypanum)
7	conservative
7	thirty-one
7	ataxia,
7	(megatrypanum)
7	well-supported
7	merely
7	histologically,
7	venezuela.
7	sizes,
7	biotic
7	resolving
7	history,
7	tciic
7	tciia
7	optimally
7	a).
7	blindness
7	degeneration,
7	related.
7	2003,
7	warning
7	endemic.
7	sloth,
7	genes).
7	fastidious
7	pvu
7	placement
7	acellular
7	cathepsins
7	checkpoint
7	intervention.
7	recapitulated
7	(nac)
7	mycobacteria.
7	avium
7	ectodermal
7	ccl-2
7	specialization
7	precursors.
7	pao
7	respiration)
7	(irbcs)
7	crisis
7	bacilli.
7	vicious
7	primes
7	il-1β/il-18
7	caspase-
7	bav.
7	cruzi-induced
7	destruction,
7	8-fold
7	(p<0.01),
7	il-12p70,
7	quality,
7	persistence.
7	anti-il-2
7	(mø)
7	earlier,
7	nk1.1
7	(105
7	labeled.
7	parasitaemias
7	inasmuch
7	≈
7	(fas),
7	il-4-dependent
7	dissemination,
7	schizonts
7	rupture,
7	pathology,
7	t-cells,
7	antibody-secreting
7	loose
7	perturbations
7	subfractions
7	uvc
7	methyltransferase
7	grooming
7	photoprotective
7	hgt
7	vertically
7	plasmids.
7	imuc
7	chelators
7	citratus
7	sunlight,
7	manage
7	tracts.
7	ubiquitin
7	aspect,
7	glioma.
7	cysteine,
7	3-7
7	(low
7	alternative,
7	owner
7	(6-4)
7	xp-a
7	instability.
7	ipscs
7	oppositely
7	rendering
7	scientists.
7	compiled
7	argentina,
7	xpd
7	uv,
7	(uv).
7	confluence
7	imua
7	illustrating
7	carmustine
7	cuticle
7	schistosoma
7	prevention.
7	exciting
7	myoblast
7	polymerase,
7	continuation
7	contiguous
7	arisen
7	wealth
7	retrotransposon
7	arabidopsis.
7	stunting
7	high-quality
7	fusions
7	endoperoxide
7	canker,
7	decline.
7	ganciclovir
7	septicemia
7	(prl)
7	protein).
7	episomal
7	residue,
7	background,
7	duplex
7	acetone
7	predator-responsive
7	defeat.
7	reinforcement
7	6%,
7	(lha)
7	p<.
7	modeled
7	luminance
7	quantum
7	psychophysical
7	spatiotemporal
7	ball
7	pursue
7	(mea)
7	manual
7	monocular
7	faced
7	seizures.
7	collision
7	boys
7	fle
7	spatio-temporal
7	straightforward
7	amplifying
7	antipredatory
7	capturing
7	implements
7	agency
7	fixed,
7	paradigm.
7	said
7	predictable
7	assembly,
7	proof-of-concept
7	bacteriophages
7	subfamily.
7	contig
7	hadv
7	irradiations
7	hospital,
7	serotyped
7	co-circulation
7	2000,
7	2b.
7	past,
7	(creb)
7	rt-qpcr.
7	(days
7	resistance;
7	content;
7	sum,
7	expect
7	cetp
7	one-way
7	rage
7	sarcopenia,
7	aetiology
7	hba1c
7	0.03).
7	(39
7	ovulation
7	glut4.
7	48-h
7	surprisingly
7	/h
7	pty
7	(hmb)
7	(auc)
7	(hsl)
7	(cl)
7	1α
7	chemiluminescence.
7	propranolol.
7	reestablishing
7	site(s)
7	abe&m
7	a),
7	administering
7	crp,
7	digitalis
7	1.14
7	leg
7	slc5a1
7	go
7	pd98059,
7	(ep)
7	tgf-β1.
7	discrepancy
7	l3.
7	achievement
7	extra-cellular
7	factors:
7	(nf-κb).
7	saline-injected
7	1.5,
7	(n=13)
7	sm,
7	territorial
7	nonesterified
7	afternoon,
7	subjects:
7	bpm)
7	lyme
7	transmits
7	abrogation
7	managing
7	anaplasmosis.
7	aureolatum
7	modification,
7	oviposition.
7	infected,
7	esi
7	β-hairpin
7	cruz
7	saccharalis
7	metals,
7	larva
7	pore-forming
7	proteolysis.
7	larvae.
7	(esi)
7	hemocyte
7	hemolymph.
7	hinge
7	cloning,
7	feeds
7	terminus,
7	fluoride
7	(al)
7	70,
7	kda),
7	activities;
7	35-
7	parasites;
7	isoleucine
7	leucine.
7	high-pressure
7	low-
7	smell
7	comment
7	controls).
7	cie
7	facilitatory
7	maize,
7	exploiting
7	caged
7	shifts,
7	crystallographic
7	er.
7	parasitism.
7	caspase-1-dependent
7	19).
7	vivax-exposed
7	differentiates
7	non-cytotoxic
7	histones
7	linker
7	cytokinesis
7	72h
7	metamorphosis
7	pupal
7	americana.
7	spindles
7	pterocarpan
7	amorim
7	warrants
7	motifs)
7	reason,
7	americana,
7	bud
7	infertility
7	marques
7	instar
7	sponge
7	matrigel.
7	ploidy
7	antibacterial,
7	febs.
7	diploid
7	carriers,
7	nuclear,
7	ultrafiltration
7	number.
7	dph
7	copolymers
7	mf
7	tamoxifen,
7	antimonial
7	stepwise
7	ideally
7	bioluminescence
7	molecular,
7	calls
7	priority
7	undesirable
7	shortened
7	new,
7	9.0
7	dolichol,
7	donovani,
7	immunisation
7	recognise
7	mirnas,
7	ctx.
7	antioxidants.
7	fibronectin.
7	time-points
7	malignancy.
7	compression
7	variegatus
7	(fh)
7	registration:
7	laminin-111.
7	distension
7	(tgfβ)
7	tβrii
7	osteoblastic
7	lpa
7	malocclusion
7	igf
7	retinas.
7	0.87
7	enterocytes.
7	5-year
7	ablated
7	rationale:
7	guarantees
7	tool,
7	cd4+t
7	lying
7	papua
7	non-synonymous
7	(0,
7	first-line
7	dimorphic.
7	surveillance.
7	hev
7	(rbcs)
7	brazilians
7	(ifn)-γ,
7	infections;
7	(or)
7	translate
7	deletion,
7	borders.
7	1990s,
7	protective.
7	predictors
7	(msp-2)
7	identical,
7	immunogenicity,
7	stevor
7	myanmar
7	csp.
7	haplotypes,
7	poc
7	1996.
7	kb,
7	(region
7	(family
7	speciation
7	n,
7	(groups
7	taenia
7	moment,
7	micrograms/100
7	rhodotorula
7	air,
7	character
7	foi
7	entre
7	micromonospora
7	actinomycetes
7	snakes.
7	thirty-four
7	lignocellulosic
7	vntr
7	spores.
7	propagated
7	retamycin
7	dsdna
7	digestibility
7	dialister
7	inform
7	nod2
7	microbiologia.
7	rectus,
7	alba
7	cdta
7	morphometric,
7	ampicillin
7	cd14
7	periodontopathic
7	eliminating
7	biofilm.
7	gingiva
7	endodontalis
7	rectus
7	electron-lucent
7	chlorhexidine
7	breakpoint
7	columnar
7	sheets
7	insecticide
7	72 h
7	uncouplers
7	highlighted.
7	red,
7	affinities
7	adhering
7	vitamins,
7	ink
7	biol
7	tem,
7	macerated
7	sectioned
7	protein/dna
7	gonadosomatic
7	spermatogenesis.
7	chose
7	dmrt1
7	sox9
7	emptying
7	neuromodulatory
7	oocytes,
7	manipulation.
7	stages:
7	androgen
7	resting,
7	came
7	nonshivering
7	organ,
7	mind,
7	hyperphagia
7	mesor
7	sms
7	se,
7	(1.2
7	browning
7	assuming
7	ensuring
7	oua,
7	12h
7	drinking,
7	lactogens
7	enzyme)
7	isoproterenol-stimulated
7	14co
7	receptor-β
7	prolactin,
7	agrees
7	suramin
7	(less
7	0.002).
7	hyperstriatum
7	visually
7	pelvic
7	(lt1),
7	(ltk63)
7	cell-dependent
7	(n)
7	retains
7	(mbp)
7	sds-page.
7	raec
7	laminin-1.
7	predation
7	circuitries
7	top-down
7	retrorubral
7	cea,
7	traced
7	pallidum,
7	agranular
7	innervation,
7	globus
7	pontis
7	pontomedullary
7	keratocystic
7	laminin-derived
7	mcf-10a
7	mt1-mmp,
7	3 days
7	invasiveness,
7	(egf)
7	e6/e7
7	(erk)
7	interested
7	(ecm).
7	67lr
7	spp,
7	(cac2
7	mj,
7	cooling
7	topography
7	commitment
7	mix
7	microns
7	(tmj)
7	nodule
7	mozo
7	adoption
7	loricatus
7	(rattus
7	haemolymph
7	(26
7	nest
7	4-6
7	gaba,
7	(nox2),
7	acrobatic
7	exercises.
7	ad-related
7	ad-like
7	trpm7
7	(pbm)
7	emitting
7	(arc)
7	usually,
7	multifactorial,
7	receptor-γ
7	coactivator
7	pgc-1α
7	depression.
7	4,5-diaminofluorescein
7	synaptogenesis
7	hypercapnia,
7	enucleation.
7	nox2,
7	reticulata
7	minocycline,
7	analgesia.
7	(etm)
7	alzheimer
7	postlesion.
7	pgn
7	syn
7	bad,
7	bcl-2,
7	pcna,
7	post-lesion
7	box.
7	α-adrenergic
7	75%.
7	atorvastatin,
7	ms100a9p.
7	subtypes,
7	habenular
7	aversion.
7	allergen,
7	deafferentation
7	test),
7	spla2-induced
7	cholinoceptive
7	kcl,
7	enkephalin-containing
7	suggestions
7	catecholamines.
7	spl
7	non-radioactive
7	co-occurrence
7	anterior,
7	heterogeneous.
7	enkephalins
7	preformed
7	mt-ii,
7	(farnesyltransferase
7	nmda-src-ras-like
7	glutamine;
7	(crp)
7	charge,
7	chelating
7	(cog
7	ppargc1a
7	dimensional
7	quinone
7	alt
7	liposuction
7	butyrate)
7	lecithin.
7	slo
7	β3-adrenergic
7	terminally
7	myod
7	post-mi.
7	s-nitrosylation
7	0.005)
7	(sh)
7	myopathy.
7	lysosomes
7	6.8
7	pa.
7	cyclopentenone
7	(nf-κb),
7	0.75
7	survivors
7	(gpx)
7	vena
7	lecithin
7	635
7	abl
7	decapitation.
7	dha,
7	foundation,
7	low-threshold
7	devised
7	(dio)
7	unmodified
7	non-enzymatic
7	95%.
7	dlc
7	3b
7	clenbuterol
7	peroxides
7	(2.6-fold)
7	éditions
7	médicales
7	μl,
7	urea.
7	roc
7	unbalance
7	unilamellar
7	meal-feeding
7	food-restriction
7	theoretically
7	glutaminolysis
7	3.9
7	(64
7	threatening
7	leukemia)
7	carcinosarcoma-bearing
7	immunodetection
7	oxaloacetate
7	atp-citrate
7	exhaustion.
7	acids-rich
7	[3-14c]
7	organ-specific
7	(single
7	f,
7	notified
7	weighted
7	-3,
7	paola
7	adopted.
7	convalescent
7	penguin
7	139
7	rbcs.
7	pet28a
7	b19,
7	vp1
7	malassezia
7	belém
7	utilizes
7	5%,
7	aflatoxins,
7	glycoprotein.
7	testing,
7	henselae
7	pardalis,
7	asthmatics
7	vlps
7	admissions
7	transcription-pcr
7	samples)
7	ribosomes.
7	lfd
7	fasting-induced
7	per2
7	somatotropic
7	(0.05%)
7	tsh,
7	(ci).
7	(mb)
7	1.5-
7	bw;
7	t3-treated
7	opn
7	case.
7	hmβ
7	thyroid.
7	30th
7	sprague
7	medicines
7	svz
7	maturing
7	(lpo)
7	colon.
7	cr.
7	ventilation,
7	gaseous
7	alcohol,
7	cg.
7	filiform,
7	0.12,
7	z
7	jeol
7	transection.
7	lamellated
7	schwann
7	micro
7	intra-uterine
7	21,
7	reticulum.
7	flexion
7	fundamentally
7	vein,
7	autonomic,
7	cyclicity,
7	words,
7	(mptp)
7	surge
7	endocytosis
7	htlv-i
7	inter-assay
7	endopeptidases
7	metallo
7	crfr2
7	chow.
7	pepck
7	cirrhosis,
7	cirrhosis
7	protein-deprived
7	secretomotor
7	wars.
7	mch-
7	relevant,
7	common,
7	startle
7	(gaba)
7	animals).
7	distributional
7	crf-r2
7	antisera,
7	circumference
7	hours;
7	histomorphological
7	malformations.
7	tnf-α/il-10
7	bed,
7	interfaces
7	recipients,
7	enzymic
7	ifn-γ-dependent
7	roles,
7	infertile
7	materials,
7	pre-term
7	lyophilized
7	complement,
7	nodules,
7	grafts.
7	poh
7	tunicamycin
7	imidazole
7	twentieth
7	wpip
7	telomere
7	visit
7	itaipu
7	whitmani,
7	lainsoni
7	multicase
7	linkage.
7	individuals)
7	a2.
7	stieda
7	pgm,
7	micropyle,
7	proechimys
7	deaths.
7	neuronally
7	guinea-pigs
7	expert
7	pde-5
7	capecitabine
7	elaborated
7	micturition
7	cystometric
7	indústria
7	piracetam
7	(odq,
7	mirabegron
7	usm
7	i.d.).
7	intra-batch
7	73-6691
7	(efs)
7	thrombotic
7	no-cgmp
7	introduction.
7	editio
7	escitalopram
7	seb.
7	lmtx-i
7	prolong
7	enterotoxins,
7	d-name)
7	medications
7	u46619
7	ncx899
7	mabp
7	auc(0-∞)
7	accession
7	slow-release
7	quinoxalin-1-one
7	allosteric
7	bombesin
7	mg).
7	catuama®
7	liposomal
7	ib-meca
7	48-well
7	ipla2
7	nx.
7	pnv-
7	concentration-time
7	specified
7	neurologic
7	ki
7	biopsies.
7	inert
7	t(1/2)
7	bthtx-ii
7	constituents.
7	auc((0-∞)),
7	t(
7	nitrate/nitrite
7	statistics.
7	ranitidine
7	nx,
7	aggregate
7	envenomed
7	indo
7	(associated
7	overload,
7	4-sulphate
7	(prp
7	poly-l-arginine
7	vasodilatations
7	perilipin
7	(nsaids)
7	lb
7	crotaline
7	summarized.
7	thermally
7	poisonous
7	lfa-1,
7	multidomain
7	disintegrin-like
7	svmp.
7	disintegrin-like/cysteine-rich
7	butantan
7	antivenom,
7	chromitite
7	salinispora
7	metabolomic
7	nanocarrier
7	unreported
7	sterols
7	meoh
7	ascidian
7	tenella
7	erythrina
7	biomimetic
7	substituent
7	mda-mb-435,
7	contamination,
7	stressors
7	sf295
7	withaphysalin
7	hdlp
7	(+)-cordiaquinone
7	mais
7	ovalbumin-specific
7	1.7%
7	osteoblasts
7	arβ2ko
7	ibat
7	dual-energy
7	viz.,
7	(sol)
7	slow-to-fast
7	myocardium,
7	laborious
7	adenomas,
7	fidelity
7	hsct
7	skipping
7	câmara,
7	tyk2
7	seicap.
7	centers,
7	autoinflammatory
7	non-catalytic
7	stings
7	il17
7	ebv-transformed
7	rhuifn-γ
7	bacteriocin
7	hemolysis,
7	dtxd
7	gaucho,
7	laeta,
7	cell)
7	(alum)
7	il-4(-/-)
7	intracellularly.
7	proteasome.
7	kt5720
7	pockets
7	sh2
7	neurol
7	brings
7	cb2
7	nel
7	bond.
7	exocytosis.
7	i-converting
7	stoichiometry
7	factor-1α
7	early-onset
7	th1-biased
7	sweetened
7	allergen.
7	dgc
7	c3b.
7	adhesins.
7	immunoglobulin-like
7	at.
7	pathotypes,
7	g0/g1-arrested
7	entry.
7	recruitment.
7	monocaprylin
7	littermates
7	cold.
7	hyperthermia
7	nmol/0.5
7	normoxia
7	var2csa
7	vk210
7	csa.
7	380
7	almeida,
7	armc5
7	counter-regulatory
7	1-28
7	univariate
7	atrogin-1,
7	type-ii
7	smad-7
7	murf-1
7	retinoid
7	gum
7	substrate-binding
7	amblyomin-x
7	mes
7	(hpv-16)
7	marengo
7	lt1,
7	c-domain
7	vapour-diffusion
7	multi-component
7	synchrotron
7	(xac),
7	wire
7	mra.
7	myeloproliferative
7	dyes.
7	es-treated
7	sge,
7	caspase-8,
7	adoptively
7	vasconcelos
7	protein-tyrosine
7	optimizing
7	indanes
7	ring-contraction
7	iodine(iii)
7	thallium(iii)-mediated
7	polyhydroxybutyrate
7	benzalkonium
7	periampullary
7	skin)
7	ptds
7	yara
7	mol%
7	pts
7	cepacia
7	uncaria
7	tomentosa
7	nafld
7	stomachs
7	incision
7	lyso-7
7	synovitis
7	sensed
7	clo
7	endotoxin-induced
7	ncx-4016
7	hct-3012
7	antiretroviral
7	immunosuppression,
7	ifn-γ-deficient
7	cmi
7	anti-denv
7	ngc
7	crops.
7	spodoptera
7	gbv-c
7	echinococcus
7	pre-erythrocytic
7	ridl
7	cci-induced
7	fractalkine-induced
7	gate
7	methionine,
7	biogenesis,
7	langendorff
7	sga
7	ntpdase
7	rnd
7	starvation,
7	σ54
7	pepf
7	obesogenic
7	serpin
7	stat5b
7	tgfβ1,
7	tgfα
7	planus
7	fcγriib
7	me-49
7	cvid.
7	(ova),
7	ciu.
7	(iga)
7	eaec,
7	(a/e)
7	enterohemolysin
7	nonmotile
7	eaf
7	uti
7	ciprofloxacin
7	plasmid-encoded
7	antibothropic
7	aldh
7	consume
7	(b6
7	fyn
7	pons
7	cbz
7	irs
7	art
7	gα
7	chordae
7	non-nmda
7	involuntary
7	methylotrophic
7	guignardia
7	transformants
7	seedlings.
7	flaccumfaciens
7	aki,
7	α-klotho
7	(pf)
7	24-month-old
7	phe.
7	na+k+-atpase
7	depot.
7	tenuazonic
7	photoelectron
7	(afb
7	antifungals
7	tester
7	afb1.
7	c5+
7	smad3
7	(il-6,
7	(s,
7	mtp
7	vldl-tg
7	trachomatis
7	parvum.
7	vaginalis
7	balanoposthitis
7	acholeplasma
7	haemofelis,
7	hemolysin
7	cl.
7	tl
7	gko
7	splenocyte
7	thioacetamide
7	ip3
7	k+/h+
7	bromo
7	eutopic
7	campaign,
7	hmscs
7	allografts
7	renca
7	autoimmunity.
7	limbal
7	vß
7	ct4s
7	ktp-nh2
7	bmem
7	antithrombin
7	plumieri
7	natterin
7	prepubertal
7	hyperprolactinemia
7	pelf
7	gilz
7	ligation/puncture
7	(flic)
7	peo5
7	hybridised
7	(ih)
7	(etec),
7	colonisation
7	(ama-1)
7	pvmsp119
7	αdec205
7	vaccine-induced
7	trans-sialidase,
7	reexpression
7	combating
7	muñoz,
7	taborda.
7	lt-iiab
7	anti-pcm
7	(cfa/i)
7	fla
7	envelopes
7	pbp3
7	ta98
7	meningitidis
7	blactx-m
7	hospital-associated
7	colistin
7	multi-drug
7	aer.
7	inkt
7	grrk
7	hypercholesterolemic
7	lncap
7	ret/ptc3
7	let-7f
7	meningioma
7	panip7
7	jatropha
7	anaphylatoxins,
7	semirufa
7	adelaida
7	olfersii
7	t-daf
7	lactobacilli
7	p. gingivalis
7	halitosis
7	cariogenic
7	bronchiectasis
7	ionomer
7	gagp
7	micra
7	caries-free
7	aqp1,
7	ncbe
7	mc4r-expressing
7	irx3
7	prolactin.
7	adipocyte-derived
7	hpv-positive
7	ap-5
7	(irs-1)
7	e2348/69
7	tg-derived
7	945
7	mrp-14
7	hpma
7	hpmb
7	spared
7	aldh2∗2
7	ψgapdh
7	pkcβii
7	filial
7	mnps
7	cl-14
7	melk
7	astrocytoma
7	galatrox
7	phox2b-derived
7	(rtn),
7	saporin
7	co2-activated
7	diaemg
7	kölliker-fuse
7	proanthocyanidin
7	sporotrichosis.
7	fiv-infected
7	[ci:
7	incl
7	acei
7	msc-treated
7	fawn
7	senile
7	tccana2
7	573
7	poly(i:c)
7	ccr5δ32
7	geraniol
7	cinca
7	pipkiiα
6	[ang-(1-7)]
6	a779
6	mitigated
6	(na
6	hoe-694
6	question.
6	trv120023
6	okp
6	availability,
6	conductive
6	tips
6	preincubation)
6	0.41
6	1.26
6	e.g.
6	genistein
6	i40
6	9%;
6	nhe
6	inject
6	0.21
6	free-flow
6	sv40-immortalized
6	v2-selective
6	0.88
6	h89,
6	renoprotective
6	k+-cl-
6	ions,
6	amiloride,
6	δph
6	gradient,
6	serosal
6	unidirectional
6	'in
6	na+-free
6	observation.
6	0.62
6	bbm
6	hp,
6	20.3
6	krebs-ringer
6	dependence.
6	0.004
6	anp.
6	(8)
6	acidosis.
6	acidity
6	urine.
6	32%,
6	efve
6	kcl)
6	k+,
6	early,
6	cisplatin,
6	(ph)
6	trans-epithelial
6	acetazolamide,
6	steeper
6	h+-ion
6	approaching
6	perfusates
6	supplements
6	js
6	extent.
6	equations
6	non-linear
6	dnp
6	s).
6	h‐ion
6	ca<sup>++</sup>
6	reabsorplion
6	observed;
6	0.99
6	0.57
6	transport;
6	sodium-dependent
6	jhco-3
6	jhco3
6	microperfusions
6	hg),
6	protons
6	diffusible
6	0.34
6	0.42
6	vasodilating
6	vasodilatation.
6	8-9
6	acetazolamide-infused
6	1976
6	progesterone,
6	furosemid
6	controls;
6	ratios.
6	1.29
6	ant
6	response;
6	(ecs)
6	line).
6	rhizospheric
6	synthesise
6	brevibacillus
6	(icbr
6	acetylene
6	ssp.
6	soils,
6	agitation
6	(e.
6	coli)
6	po
6	(6),
6	na+/h
6	(10-5
6	(d
6	m)-mediated
6	3′,5′-cyclic
6	(am)
6	at1-receptor
6	herbacea
6	(mpt)
6	l-1
6	munich
6	neutropenic
6	(rhifn-γ)
6	cd40l.
6	(eg,
6	syk
6	subpopulations,
6	factor-88
6	crc
6	gomes,
6	garcia
6	dampen
6	il-10-deficient
6	exudate,
6	ribeiro
6	cyslts
6	lx
6	immunomodulation
6	il-10-/-
6	ingesting
6	lap
6	th1,
6	coalescent
6	mbl
6	loads,
6	disease:
6	aseptic
6	mice:
6	il-4-deficient
6	precludes
6	indirectly,
6	defences
6	emphasized.
6	75,
6	c57bl/6,
6	(cfu)
6	argues
6	resides
6	(pb
6	18)
6	(at).
6	variant.
6	empty
6	1987
6	opsonic
6	brilliant
6	45 min
6	atraumatic
6	(isr
6	14-d
6	assayed.
6	collect
6	tnf-a
6	franco,
6	hyperresponsiveness.
6	mosquito's
6	(distillated
6	properties;
6	bd.
6	(salmonella
6	ali.
6	calbindin-,
6	calretinin-,
6	ppm,
6	sensitised
6	trauma.
6	(0)
6	nacl;
6	granulocytes,
6	(9)
6	post-i/r
6	hpa-axis
6	andrade
6	peptidomimetic
6	(660
6	j/cm2)
6	(il-10),
6	inos.
6	neuroimmune
6	cyclooxygenase,
6	fshs
6	fa/ova
6	ans
6	post-menopausal
6	ppm)
6	96-well
6	dep-induced
6	trpv1,
6	mind
6	passages,
6	anomalous
6	atmosphere
6	(nitric
6	ligation.
6	travels
6	oestradiol
6	48/80,
6	nor/nor
6	gut,
6	degranulated
6	extravasation)
6	operation,
6	lavages
6	trachea.
6	dt
6	blue.
6	s-nitroso-n-acetylpenicillamine
6	dye.
6	dazoxiben
6	postcapillary
6	thromboxane,
6	effluents
6	plot
6	circumstantial
6	outbreaks,
6	implicated.
6	analysis)
6	thirty-six
6	nitrofuran
6	rules
6	over-expressed
6	tcvi
6	piece
6	phytomonas,
6	fermentation,
6	existed
6	genotyping,
6	inferring
6	pedigree
6	functionality.
6	nomenclature
6	report.
6	midgut.
6	murf1,
6	wilcoxon
6	697
6	populated
6	175
6	telomeric
6	symbols
6	2004,
6	blind
6	coded
6	183
6	352
6	country,
6	accepts
6	banks
6	(rflp)
6	structuring
6	chromosomes,
6	(pfge).
6	nonchagasic
6	panstrongylus
6	albiventris
6	re-establishment
6	cistron
6	colombia.
6	lambda
6	transferase,
6	armadillos
6	trypanosomatidae
6	aaagdk
6	antigenicity.
6	gerais,
6	amazonas
6	inocula
6	tagged
6	drawback
6	genetics,
6	(ccc)
6	crossreactivity
6	crossreactive
6	lppg-like
6	taq
6	chagas"
6	ca1,
6	sds-page,
6	incorporates
6	fluctuation
6	broken
6	7.7
6	order,
6	glucose-cultured
6	hypoinsulinemia,
6	per1,
6	cry2
6	insulinemia,
6	in vitro
6	stimulus-secretion
6	preserved.
6	superoxide,
6	diabetes-like
6	rosiglitazone.
6	(dex)
6	noninvasively
6	8-and
6	normoenergetic
6	stress)
6	96h
6	bcl2
6	rns
6	polypeptidic
6	process;
6	8-wk
6	rp),
6	dpi,
6	episodic
6	ppp
6	n-acetyl-l-cysteine
6	fluidity
6	oxidase-dependent
6	202
6	(thr202/tyr204)
6	phosphorylations
6	c-jun,
6	14c]-glucose
6	lactate.
6	(49%)
6	il-1beta
6	ceramide-
6	(macrophages)
6	(110
6	mg/dl;
6	secretagogue
6	switches
6	hit-t15
6	14c]-palmitate
6	(pc),
6	supposedly
6	tolerable
6	perifusion
6	glut-2
6	ol
6	tumor-
6	ultrastructure,
6	somehow
6	efflux,
6	d-glucose,
6	occupancy
6	elevation.
6	14c-labelled
6	only)
6	feeding/22-hr
6	averaged
6	(secondary
6	32p
6	l-glutamine.
6	persists
6	133
6	tea,
6	theories
6	(200-250
6	rats'
6	3.5,
6	cpp.
6	(6.0
6	hyperactivity.
6	mesolimbic
6	olfactorium
6	fluorometric
6	(1-30
6	leftward
6	showed:
6	magnitudes
6	dihydroxyphenylacétic
6	ldh,
6	students,
6	hk
6	old),
6	ns-398,
6	ovx-shr
6	menopausal
6	sex-related
6	mtdna/tlr9
6	indices,
6	(ta).
6	pruritus,
6	gyy4137
6	125i-albumin
6	na2s
6	histamine-mediated
6	pruritus.
6	(ct),
6	obese-msg
6	(vsmc)
6	testosterone-induced
6	p47phox.
6	(tc),
6	ii+los
6	hypertrophy;
6	metalloproteinase-2
6	wd
6	se.
6	senescent
6	anandamide
6	α-actin,
6	td
6	vein.
6	(txa2)
6	athletes.
6	butanolic
6	(bf)
6	castration
6	litters
6	(control).
6	sport
6	(cox)-2
6	140,
6	pd123319
6	(0.001-1
6	premise
6	(cnos)
6	tone,
6	n=8)
6	n=6),
6	ser-473
6	lacunae
6	morbidity.
6	ireland.
6	safely
6	gavage).
6	n-stz,
6	ur
6	xylazine
6	pco
6	dilator
6	pgf2α
6	txb2,
6	(bh4)
6	ros/no
6	losartan.
6	cerebrovascular
6	(icam-1)
6	could,
6	captopril,
6	conversion,
6	bk.
6	(ovx
6	oe
6	4.00
6	15).
6	(measured
6	nuclei;
6	uninx,
6	(pmns)
6	undernutrition,
6	diet-restricted
6	hyperpolarization
6	fluorescence.
6	(p<0.0001),
6	blocker)
6	thicker
6	vasodilation,
6	μmol/l),
6	inhibitors),
6	(n=7)
6	paramagnetic
6	anti-hypertensive
6	7.5,
6	yields,
6	(p<.05)
6	reduction),
6	blue,
6	2k1c
6	endothelin,
6	hypertensive,
6	rabbit,
6	lanthanum
6	inspection
6	condensation,
6	centrosome
6	anemone
6	l-,
6	p/q-type
6	ω-conotoxin
6	norepinephrine.
6	superfamily,
6	subfamilies
6	superfamily.
6	(i.pl.)
6	da.
6	cell-attached
6	dilute
6	seawater
6	capabilities
6	fourier
6	synthetized
6	phosphorylation;
6	obesity:
6	hypothalamus-pituitary-thyroid
6	(ctls)
6	non-secretory
6	underweight
6	fetal/placental
6	embryo,
6	d2.
6	59,
6	re-stimulation
6	dimensions
6	endocrine-metabolic
6	α-tubulin
6	delayed,
6	papilla
6	experimentally.
6	micro-computed
6	(μct)
6	vertebra,
6	(cart),
6	β2-ar
6	littermates,
6	clonidine
6	ecm,
6	svmps,
6	neonates.
6	profile;
6	adiponectin;
6	4;
6	(30%,
6	diestrus
6	v3
6	constrictions
6	endochondral
6	deiodinase
6	testis,
6	spermatogenesis
6	interimplantation
6	outstanding
6	perlecan
6	granulated
6	radiation,
6	(λ
6	fibril
6	rat's
6	instrumentation
6	decidua,
6	(t3),
6	eut
6	columns,
6	tenascin-c
6	hi,
6	60%)
6	polyol
6	defect,
6	impressive
6	gametes
6	50-60%
6	acidophilic
6	anti-rat
6	(pgs)
6	apposed
6	polyhedral
6	organogenesis
6	endodermal
6	strands
6	packaging
6	irradiated.
6	neutrophils;
6	12.8
6	6-
6	punctate
6	glycogen.
6	accompanies
6	connective-tissue
6	presympathetic
6	stereotaxic
6	(pvn).
6	expression/activity
6	inactivity.
6	shr-t
6	(hplc),
6	30).
6	hf-induced
6	patients’
6	(sed)
6	pre-autonomic
6	0.05);
6	restored.
6	(electrophoretic
6	(without
6	postrema,
6	melatonin-induced
6	wky-intact
6	pb0.01)
6	(δmap:
6	nontrained
6	tachycardia.
6	mo.
6	sad.
6	overactivity
6	(rsna)
6	converge
6	(sham
6	low-frequency
6	(lf)
6	strains;
6	64%,
6	capillary-to-fiber
6	(p<0.05
6	solitarius
6	reset
6	second-order
6	conduct
6	presentations.
6	personal
6	experience.
6	et,
6	neurosecretory
6	sedentary,
6	gastrocnemius,
6	muscle)
6	indoles
6	coronal
6	cryostat
6	coarcted
6	high-
6	eminence
6	(ch)
6	pulsatile
6	tree.
6	increases.
6	pulsation
6	intravertebral
6	cutaneous,
6	municipalities,
6	twin
6	330
6	birds),
6	monodelphis
6	norte,
6	common.
6	genotypically
6	pernambuco
6	collared
6	(mat).
6	switzerland
6	statistics
6	7.5%
6	santarém,
6	infested
6	pearson
6	adult,
6	euthanised
6	159
6	necropsy,
6	excrete
6	donation
6	(16%)
6	wildlife.
6	lineage,
6	undercooked
6	paraíba,
6	bioassays.
6	ocelot
6	(p=0.000,
6	each.
6	grey
6	abortion.
6	feces,
6	(meriones
6	outpatient
6	(ifat).
6	stillbirth,
6	trough
6	chiroptera
6	tapirapé
6	ihc
6	archipelago
6	(cut-off
6	caused.
6	bioassay.
6	manatees
6	earth.
6	protozoa,
6	santo
6	1.5%
6	grosso,
6	riverine
6	installation
6	chickens,
6	turtles
6	compromises
6	next-generation
6	amounts.
6	coccidia
6	flock
6	182
6	canis.
6	(genus
6	endosymbiont
6	caution
6	189
6	12).
6	hyopneumoniae,
6	multocida
6	uncommon.
6	lifetime
6	kits.
6	sampling.
6	pasture
6	anti-e.
6	(cerdocyon
6	(23%)
6	characterizations
6	coccidiosis
6	desmodus
6	lanka
6	(designated
6	congenitally
6	retardation,
6	chances
6	canids
6	alert
6	10,000
6	ever
6	530
6	3.2,
6	1,000
6	nowadays
6	foodborne
6	giii
6	126
6	cows,
6	pregnancies
6	32,
6	cuniculi
6	hammondia
6	heydorni
6	transmitting
6	patologia
6	sixty-six
6	30.6%
6	sized
6	patoc
6	inhabits
6	gerbil
6	six,
6	pork
6	p<0.01),
6	reconstitution
6	diabetics.
6	rag
6	melanoma)
6	gamma-terpinene
6	interleukin-6,
6	diet)
6	(ltb4),
6	cyclooxygenase-1
6	non-diabetics.
6	(tgf)-β
6	mir-146b
6	ureter
6	oxldl.
6	co-immunoprecipitation
6	plaques.
6	thymocytes,
6	intense.
6	nfκb,
6	il-17.
6	cox-2-derived
6	systemic,
6	10μm)
6	factor-alpha,
6	hydroxide,
6	μg/0.4
6	1/2,
6	wk)
6	stools,
6	mu/ml)
6	(41%),
6	bq-123
6	comfort
6	8h
6	aerosol.
6	coincident
6	pancreatitis,
6	enumeration
6	nzw
6	neutrophil-dependent
6	);
6	(42
6	pufas.
6	nos2-/-
6	(90%),
6	(ifnγ
6	zymosan.
6	ltc4/d4
6	(ar)
6	(4.7
6	37.4
6	alumen
6	intraarticular
6	hypersensitivity.
6	analyzed:
6	ppd
6	lesions).
6	20.0
6	nmol/105
6	immunoassays.
6	underline
6	guinea‐pig
6	(33
6	congestion
6	scales.
6	modelled
6	maritime
6	uv-c
6	archaea.
6	peninsula.
6	dna)
6	assimilation
6	margin,
6	uncultured
6	oligotrophic
6	pigments
6	bacteroidetes
6	magnetotactic
6	proteobacteria.
6	layered
6	archaea,
6	β-glucosidase
6	simulating
6	exiguobacterium
6	b7
6	transcriptomes
6	0°c
6	rna-seq
6	0°c.
6	cellulolytic
6	700
6	solitum
6	cold,
6	harbour
6	have,
6	monensin
6	squares
6	(2%)
6	ecosystems.
6	zones.
6	alkb
6	biphenyl
6	amoebae
6	plain
6	gastroenteritis
6	filtration.
6	hybridize
6	ability.
6	p-a
6	waters.
6	3f
6	limitation.
6	 t
6	transcriptome,
6	dectin
6	cell–specific
6	vdac
6	appreciated
6	platinum
6	tetramer
6	superiority
6	cancer-associated
6	alkyl
6	cyclins
6	allergens,
6	detergent
6	137
6	sheds,
6	hinder
6	unchecked
6	es,
6	preimplanted
6	devices.
6	preloaded
6	entries
6	settings,
6	cd1a+
6	(apcs)
6	effusion
6	milieu,
6	cd86.
6	cupana
6	0.84
6	c9,
6	thirty-five
6	pool,
6	accuracy,
6	fulfill
6	cea
6	clone,
6	anti-tnf
6	isotype.
6	explanted
6	cited.
6	(pia).
6	igg3,
6	pahs,
6	k409a
6	non-functional
6	affymetrix
6	419
6	(l
6	cosegregated
6	rs3719497
6	peak.
6	tgfb1,
6	parents,
6	(irm1:
6	irm2:
6	-3)
6	198
6	themes
6	11.
6	low-affinity
6	modifiers
6	acf
6	susceptible.
6	iii).
6	software.
6	40-fold
6	452-kb
6	livers.
6	phagocytize
6	clandestinus
6	terena
6	guts
6	archived
6	unveiled
6	sar
6	productivity.
6	clots
6	generalist
6	visits
6	occurred,
6	cruzi-like
6	retrotransposons
6	copies,
6	flea
6	settlements
6	metacyclogenesis,
6	autophagy-related
6	methods/principal
6	robustness
6	revision
6	endotrypanum
6	neves,
6	inter-
6	clarified
6	symbiont-harboring
6	outbreak,
6	latex,
6	protistologists.
6	phylogeny,
6	marginale.
6	trypanosoma.
6	crocodilians
6	(small
6	subunit)
6	leech
6	non-endemic
6	propagation,
6	trypanosomosis
6	subgroups.
6	fasciculata,
6	exceptions
6	are:
6	ubiquinone,
6	undergone
6	overrepresented
6	ewes
6	ewe
6	hematological,
6	herpetomonas.
6	brucei,
6	trees.
6	plantations
6	(diptera:
6	ruminant
6	40°c,
6	diminazene
6	ruminants
6	(dpi)
6	meningitis
6	disclosing
6	microscopical
6	fumonisins,
6	(correlation
6	evansi.
6	tanzania.
6	arboreal
6	keratitis
6	osmotically
6	h2b
6	spliced-leader
6	absent,
6	myositis
6	placement,
6	depots,
6	g1/g2
6	(sg)
6	tubes
6	multicopy
6	(19%)
6	abstract.
6	sap
6	tuberculous
6	(mycobacterium
6	beijing
6	h37rv
6	cd39
6	inflammasome-mediated
6	fonseca,
6	nascimento,
6	heart-infiltrating
6	(atp)
6	cassado,
6	500,000
6	(inhibitor
6	iκb-α,
6	(bav),
6	ccl-2,
6	bav,
6	d'império
6	lpms
6	broaden
6	issues,
6	(ali/ards)
6	issues.
6	dtx
6	distended
6	inflammasome-independent
6	multiply
6	icm
6	assay),
6	jes6-1-treated
6	myelo-monocytic
6	cd1d
6	i-a
6	augmented.
6	crown
6	b220low
6	cd11b,
6	progresses,
6	chabaudi.
6	cd28.
6	cd40l,
6	drug-cured
6	coreceptor
6	ig-isotype
6	th2-prone
6	up-regulation,
6	reinvasion.
6	parasitemias,
6	inoculum.
6	cd45rb(low)
6	(vi)
6	fluorescence-activated
6	immunoglobulins,
6	bloodstream,
6	glomerulonephritis
6	prospects
6	autoantigens
6	autoreactive
6	dias
6	193
6	antivenoms.
6	fractionation,
6	returns
6	sunlight-induced
6	fork
6	bapa
6	crossing
6	polymerases,
6	η
6	template.
6	orbicularis
6	bacteriophage
6	duox1
6	nontumor
6	mg/ml)
6	chromophore
6	flavor
6	oils,
6	dimers,
6	polη
6	keratinocytes,
6	forks,
6	stalled
6	fanc
6	heterodimer
6	(3d)
6	economical
6	deficiencies,
6	(cs).
6	destabilization
6	instability,
6	sunscreens
6	cisplatin-treated
6	sulfoximine
6	n-acetyl
6	hypersensitive
6	rassf1a
6	represses
6	lip
6	malformation
6	8.8
6	sds-polyacrylamide
6	degrades
6	catechol
6	sunscreen
6	spf
6	chitosan
6	avenues
6	nanoparticles.
6	symposium
6	contaminants.
6	anti-tumoral
6	ttd
6	dsbs
6	chromobacterium
6	deserve
6	avoids
6	uv-c-induced
6	destructive
6	naked
6	considers
6	lgt
6	reca,
6	cdnas.
6	©2007
6	gambiae.
6	eggshell
6	possible,
6	encouraging
6	limitations,
6	skm+
6	0.4%
6	14.8
6	thiazole
6	protein),
6	xpv
6	functional.
6	hydroperoxide
6	mitomycin
6	dnae2
6	elucidates
6	homologs.
6	frames.
6	pseudogenes,
6	cellulase,
6	undertook
6	43,141
6	(33%
6	bioenergetics,
6	aug
6	insult.
6	muty
6	deals
6	plant-associated
6	adhesins,
6	cultivars,
6	xp12ro
6	ways,
6	century,
6	xylem-limited
6	9a5c,
6	goes
6	motifs,
6	construct.
6	water-soluble
6	rearrangements.
6	extrachromosomal
6	packaged
6	xtha
6	stretches
6	recombinational
6	threat.
6	convey
6	ideas
6	shock-based
6	participants,
6	167
6	posner
6	tasks
6	compose
6	discussing
6	overload.
6	alternatives,
6	medial/perifornical
6	(cea)
6	viewing
6	sensory,
6	behavior)
6	hunt
6	causality
6	roaches.
6	head,
6	escape.
6	morphine-induced
6	incremental
6	378
6	guides
6	order.
6	predictable.
6	(scc)
6	clv-br
6	chhv5
6	biopsies,
6	alves,
6	alpavirinae
6	hmms
6	newbler
6	hmm
6	projects,
6	seeds.
6	phycodnaviruses
6	prolonging
6	7-9
6	serotyping,
6	sensitizer
6	human.
6	disposal.
6	arch
6	perk
6	britain.
6	polarization.
6	antagonizes
6	dm.
6	glutamate.
6	trim63
6	(gm)
6	0.01,
6	milieu.
6	possibly,
6	molars.
6	controls)
6	aeci
6	min/day,
6	immunoblot,
6	dm2
6	p=.
6	regulators.
6	heavier
6	resp.).
6	reverting
6	p38mapk
6	(nefa)
6	slc2a2
6	13.5
6	(trained
6	dh
6	into:
6	times)
6	37%,
6	<0.05),
6	(kitt)
6	extensorum
6	reflexes
6	renal-denervated
6	hyperlipidic
6	(treadmill
6	sglt1,
6	0.03),
6	(sna)
6	(wat).
6	microsome
6	gh,
6	nucleus;
6	og
6	tail,
6	disturb
6	(arg)
6	hif1-a
6	0.2,
6	4-month
6	powdered
6	reversion.
6	densitometry
6	conserved.
6	measurements:
6	[u-14c]-glutamine
6	23.5
6	tm
6	tick-pathogen
6	peroxiredoxin
6	luteus,
6	favoured
6	imd
6	incriminated
6	upregulated,
6	ivm-treated
6	analogs,
6	core.
6	candidacidal
6	amidated
6	bis-acylpolyamine
6	(ivm)
6	packet
6	cryptococcosis.
6	scapularis
6	nothing
6	hemocidins
6	bmcl1
6	silk
6	mutual
6	(residues
6	α4
6	homogeneity.
6	(esi-ms)
6	ovaries.
6	cascade,
6	masuda,
6	h.,
6	rosa
6	desorption/ionization
6	acanthoscurrin,
6	fluconazole,
6	d-
6	hb33-61a
6	(that
6	lactam
6	spiders,
6	shrimps
6	organization.
6	solvent.
6	unchallenged
6	amino-acid
6	luminescence
6	1,10-phenanthroline,
6	edta,
6	aeruginosa.
6	35-kda
6	lysates,
6	supplementary
6	(pna)
6	z-phe-alachn2
6	by:
6	precipitated
6	l-amino
6	variations.
6	musical
6	music
6	expertise
6	practice,
6	football
6	trips
6	travelers
6	inventory
6	connections.
6	ms)
6	inexperienced
6	curve.
6	pitch
6	landscape
6	angular
6	uniaxial
6	p-type
6	cyclotron
6	interpret
6	sdh
6	waves
6	santana
6	mer+myd88flox+/+
6	ministry
6	caspase1
6	il-1r
6	relying
6	(asp-2).
6	asp-2-specific
6	out,
6	reg-tc
6	supernatants,
6	srbc
6	chicken,
6	phytohaemagglutinin
6	tonsil
6	heat-inactivated
6	49782
6	mitosis.
6	5-bromo-2-deoxyuridine
6	newer
6	multilevel
6	langmuir
6	sensitize
6	chemotherapeutics
6	drug-free
6	persisting
6	labeling.
6	e-cadherin,
6	atta
6	e-cadherin
6	spermatozoids.
6	bee
6	synoviae
6	hsc70
6	diptera
6	gjic
6	r2
6	communication.
6	trans-acting
6	junction.
6	ramar2
6	anomalies
6	two-hybrid
6	didemnum
6	populations:
6	phosphatase.
6	(cin
6	nonsmokers
6	sil
6	tunicate
6	needle
6	3c
6	establishment.
6	schemes
6	ed50
6	projects.
6	overcoming
6	raloxifene
6	autophagosomes
6	meta1
6	meta2
6	intrarectal
6	permeation
6	dithiothreitol
6	virulence-related
6	organisation
6	transition,
6	d-glucose)
6	diabetic-derived
6	pericellular
6	lamellipodia
6	lps)
6	actin-based
6	p16ink4a,
6	pax6
6	ophthalmology,
6	lytechinus
6	colorless
6	cisterns
6	i-mediated
6	curcumin
6	erk,
6	wounding.
6	fak
6	invagination
6	arrangements
6	cytodifferentiation,
6	(aki).
6	homocysteine,
6	explain,
6	gtp-binding
6	d30,
6	d60,
6	disassembly
6	igfbp-3,
6	condyles
6	days-old
6	entry,
6	pak4
6	stressors.
6	each),
6	myofibrils
6	disruption,
6	botulinum
6	dominant-negative
6	weight-1,
6	p21,
6	ccl3,
6	(mouse
6	debate
6	infants,
6	halts
6	tailored
6	growth-inhibitory
6	mabs,
6	present-day
6	nonhuman
6	policy
6	helminth
6	inhabitants
6	ozzardi
6	m2-maebl
6	thailand,
6	antenatal
6	7.9%
6	microcephaly.
6	missed
6	5.2
6	rounds
6	vsa
6	pfemp-1
6	expectations,
6	dbl1α
6	breadth
6	pasteur
6	india
6	mci
6	tracking
6	answer
6	1980s
6	timely
6	pf-ies
6	fucose
6	4%)
6	(il)-10,
6	5x
6	sera5
6	inter-population
6	(pv)
6	morbidity,
6	directing
6	senegal
6	candidate,
6	toxocariasis
6	pets.
6	questionnaire.
6	environmental,
6	responses)
6	poverty
6	elsewhere
6	fcr3
6	k1-type
6	lumbricoides
6	(22%)
6	unstained
6	comparisons.
6	(block
6	indians
6	non-cytophilic
6	candeias
6	(thereafter
6	anti-p.
6	practices.
6	interventions:
6	parasitologically
6	mobility.
6	plasmodia
6	equipment
6	iron,
6	kb.
6	foram
6	surface-sterilized
6	phytopathogens.
6	submerged
6	fed-batch
6	bioprocess
6	(svmp)
6	im
6	meningitis,
6	clindamycin,
6	cfia
6	aminoglycoside-resistant
6	(36%)
6	ycw
6	class.
6	beagle
6	gulae,
6	enteritis.
6	myonecrosis,
6	netb
6	enlargement.
6	(a.
6	sialidase
6	eruption
6	palatal
6	sixty-five
6	biotype
6	apah
6	cdtabc
6	ccr1
6	osteoclastogenic
6	correlation.
6	-γ,
6	bft-1
6	enterotoxin.
6	resorption,
6	endodontists.
6	osteomyelitis
6	non-jp2
6	sabouraud
6	dextrose
6	broth,
6	agar,
6	croton
6	ht-29
6	sterilized
6	ag-treated
6	512
6	subtype.
6	difficile,
6	apella.
6	32)
6	(p<0.0001).
6	agglutinate
6	1999.
6	gills
6	zn
6	nanostructured
6	nanotubes
6	denser
6	opsonization
6	sn-aif-1
6	spixii
6	wap65
6	rations
6	biopsy,
6	enveloped
6	forcing
6	defence.
6	coverslips
6	pc,
6	square
6	calmette
6	thread
6	basophilic
6	clear,
6	<0.01)
6	protein-energy
6	biotechnology.
6	gonads
6	anat
6	rec,
6	neurohormone
6	vesicle,
6	day).
6	m2,
6	412
6	(mt
6	rhythms,
6	cp,
6	photoperiodic
6	hippocampal-dependent
6	mmd
6	donato
6	men,
6	pupillary
6	cocaine-induced
6	bonferroni
6	acrophases
6	monitoring,
6	xpf
6	(bdnf),
6	leukemia/lymphoma
6	rev-erbα
6	reproductive,
6	fatigue.
6	sarcoendoplasmic
6	β-cells,
6	(aerobic
6	untrained,
6	trained.
6	pma,
6	photostimulation.
6	intact,
6	(igl)
6	values)
6	cosinor
6	≃
6	prefer
6	imprinting.
6	medina-armenteros,
6	farinha-arcieri,
6	ventura,
6	sbrogio-almeida
6	(following
6	(lt2),
6	lt-treated
6	dose-base
6	p24-specific
6	ltk63,
6	lt2)
6	(hsv)
6	hiv,
6	purify
6	virion
6	gmp,
6	realized
6	matter.
6	ventral,
6	efferents
6	anterodorsal
6	amygdalostriatal
6	mid-rostrocaudal
6	homogeneously
6	tubercle
6	interfascicular
6	rli
6	mediodorsal
6	amygdalopiriform
6	apir
6	(phaseolus
6	leucoagglutinin)
6	substance,
6	anti-dopamine
6	(nucleus
6	cortical,
6	infralimbic
6	oralis
6	c-met
6	suprabasal
6	invasiveness.
6	kot
6	ahnak
6	(phospho-akt)
6	boyden
6	meso-2,3-dimercaptosuccinic
6	emt
6	carious
6	actinomyces
6	sikvav,
6	promising.
6	sikvav-enriched
6	pulps
6	tensile
6	artglass
6	similarities,
6	muscle-specific
6	microtubules,
6	microtubules.
6	arteriography
6	thrombi
6	cross-resistance
6	fipronil-resistant
6	attain
6	lc50
6	conflict
6	bellii
6	psp
6	trapped
6	colonies,
6	subjacent
6	magnus
6	drn
6	infancy,
6	adolescence.
6	(sed,
6	parkinson’s
6	gp91phox−/−
6	intrastriatal
6	hypoxic-ischemic
6	disorder,
6	(syp),
6	1-4
6	sys
6	subcortical
6	eg
6	regrowth
6	mpz
6	sae.
6	hernandes
6	postlesion
6	unraveled.
6	hemopressins,
6	dopamine.
6	interneurons.
6	depressive-like
6	(pag),
6	epidural
6	asymmetry
6	(53%)
6	pain-related
6	unique,
6	novelty
6	experience-dependent
6	participation.
6	kappa-b
6	(sc).
6	(ae)
6	anticipate
6	upregulation,
6	ob.
6	zenk
6	zif268
6	(cb),
6	ca3
6	nr1
6	histogenesis.
6	3-month-old
6	horn.
6	pigmented
6	models:
6	massively
6	glutamatergic,
6	endocannabinoids
6	(0.1-10
6	(eif5a)
6	(glur)
6	(70%
6	crotapotin,
6	contribute,
6	stores,
6	rd/rd
6	20 μm
6	cholesterol.
6	trypsin,
6	sligrl-nh
6	nociceptor
6	unpleasant
6	refinement
6	fangs
6	(catalytically
6	spla2-asp49
6	spla2-asp49.
6	(cr),
6	cb.
6	5-10%
6	hyperplastic
6	(p1)
6	postmitotic
6	b.w.),
6	α7,
6	elapidae
6	patagoniensis
6	ventralis,
6	paraformaldehyde
6	[3h]thymidine
6	α8-positive
6	sliding
6	2/3
6	digoxigenin
6	tecti,
6	from,
6	subunits)
6	medium-sized
6	glv
6	α-bungarotoxin-insensitive
6	mirrored
6	npy-li
6	cholecystokinin
6	glv.
6	double‐labeled
6	cpla2
6	supra-physiological
6	measured:
6	hematopoiesis.
6	bm,
6	cunha
6	catabolism.
6	polish
6	mg/dl.
6	pkr
6	(irs)-1
6	hif1-α
6	1β,
6	anti-catabolic
6	compositions.
6	glycerol,
6	regenerate
6	β2-adrenergic
6	lipoprotein,
6	review:
6	(fas)
6	(40,
6	peroxide.
6	p38,
6	oxidative/nitrosative
6	(tnf-α).
6	benzoquinone
6	(alt),
6	(acetate,
6	48h
6	fibrinogen.
6	bona
6	fide
6	pufa)
6	noting
6	(nuclear
6	control),
6	(il-1β
6	pbmcs,
6	(ly)
6	fragility
6	(ups)
6	f-box
6	akt2
6	receptor-4
6	eye,
6	myod,
6	echocardiography,
6	fas,
6	hour.
6	ldt
6	validation,
6	abcg2
6	atorvastatin.
6	7-mo-old
6	(α
6	physical,
6	(iih)
6	iih.
6	performed:
6	fats
6	unsat
6	esterification
6	stuttgart.
6	(gs)
6	whey
6	ftase
6	troponin
6	stearic,
6	phosphorylase
6	epsilon4
6	(44%)
6	bsa
6	thiobarbituric-acid-reactive-substances
6	n-3)
6	dismutases
6	l-gln
6	gssg
6	mrp1
6	lipovenus
6	raised.
6	(acridine
6	chow-fed
6	c-myc,
6	opsonised
6	ensures
6	glutaminase.
6	(ldl)
6	lde
6	immobility
6	peroxidase.
6	nbd-cholesterol
6	bullfrog
6	alp
6	(wk
6	[14c]glycogen
6	since,
6	late-stage
6	compelling
6	transplants.
6	anti-p1
6	ifn-αb
6	desorption
6	opa
6	license
6	o2̄
6	15.0
6	ls,
6	expense
6	ring.
6	adm
6	rbl-2h3
6	(29%)
6	demonstrable
6	preferably
6	k(m)
6	months).
6	cuzn-
6	mitochondrion.
6	ageing.
6	inhibitions
6	thymus.
6	(cc),
6	2.6-fold
6	nonexercising
6	intermeal
6	ruddy
6	(cdc).
6	malformations,
6	semen),
6	influenza,
6	service
6	chlamydia
6	higgs
6	canada.
6	(rsv)
6	hku1
6	gb3
6	myotis
6	rocha
6	maximize
6	anatomic
6	subtype-specific
6	crops,
6	felv
6	nrrl
6	hepatitis.
6	class,
6	xhoi.
6	microtiter
6	ivig
6	diarrhoeic
6	5%.
6	tαt1
6	(cga)
6	we,
6	tg,
6	ribosome,
6	transcriptionally
6	12-24
6	abundance,
6	teachers
6	schoolteachers
6	operative
6	propylthiouracil
6	polysome
6	chx
6	realtime
6	l6-glut4myc
6	attach
6	muscles;
6	surgeons
6	extrathyroidal
6	gruyter.
6	(2.7
6	dawley
6	thyroid,
6	ml,
6	neuropathy,
6	calr-ir
6	dystrophy.
6	huc/d-ir
6	efficient,
6	nogueira
6	neurochemistry
6	(hrsem)
6	p14,
6	maceration
6	tongue.
6	tetroxide,
6	magnification,
6	axoplasmic
6	caveolae
6	sarcomere
6	fungiform,
6	sirolimus-eluting
6	classification,
6	submucosa
6	cast
6	bottom
6	(tem),
6	torquatus
6	exodontia
6	alteration,
6	movements.
6	endings.
6	demineralization
6	osteocyte
6	colon,
6	colons
6	sealing
6	270
6	pass
6	architectural
6	tables
6	sinus,
6	dissection
6	hormone-immunoreactive
6	dlpag
6	documented,
6	undefined.
6	central,
6	intranigral
6	relational
6	thiopental
6	lhasfa
6	odors.
6	prototypical
6	anaesthesia
6	tu
6	bundle
6	microrna
6	sp3
6	carriers.
6	aquaporin
6	laevis
6	crf2
6	neuropeptide,
6	ucn3-ir
6	vmh,
6	astressin
6	luzindole,
6	lha,
6	(25.
6	r)
6	(cart)
6	neurochemistry.
6	supportive
6	theme
6	physiological,
6	alprazolam
6	nadphd
6	gad-67
6	(cart).
6	pmv,
6	pheromone
6	efhc1
6	humana
6	rp-hplc
6	tcap-1
6	warranted.
6	prepro-ucn
6	true-blue
6	iontophoretic
6	poa,
6	(pvh)
6	3-5
6	study)
6	while,
6	nlrp1,
6	ccr9
6	oligomers
6	upregulating
6	creta
6	mother.
6	immunosuppressant
6	autistic-like
6	(p=0.0001)
6	post-term
6	folding,
6	qsox
6	ifn-gamma;
6	hyperinsulinemic-induced
6	β-galactosyl
6	rat-1
6	grafted
6	naphthoquinone
6	hepatocytes,
6	pyrophosphate,
6	allylic
6	dimethylallyl
6	[ic
6	thorough
6	(mep)
6	derivatization
6	protozoa.
6	mm;
6	sesquiterpenes
6	monosaccharide
6	fungicide
6	ats
6	cx.
6	elegans,
6	database,
6	incompatibility
6	haploid
6	polycistronic
6	laying
6	guyanensis,
6	ears
6	republic
6	protozoans
6	forested
6	(combined
6	zymodemes
6	flaviscutellata,
6	infectivity.
6	houses,
6	g6pd,
6	referring
6	disparate
6	contracts
6	gliding
6	utinga
6	vogt-koyanagi-harada
6	cd4+il-17+
6	cells/mm2
6	nephrectomized
6	colitis,
6	cpt-11
6	(cg)
6	neurons),
6	cypionate
6	(lc-ms/ms).
6	urological
6	bmi,
6	riluzole
6	non-
6	prodrug
6	propafenone
6	cc,
6	eotaxin-induced
6	41-2272,
6	cystometry
6	carbachol-induced
6	rebamipide
6	endoscopy
6	for0811
6	glibenclamide,
6	strips,
6	pec50
6	(1-100
6	inter-batch
6	αiibβ3
6	cav1.2
6	(no)-independent
6	concentration-
6	l-name-induced
6	(odq;
6	fibrinogen,
6	validated.
6	recoveries
6	n-nitro-l-arginine
6	accuracies
6	ltda
6	pantoprazole
6	high)
6	pif/dcd
6	11-kda
6	m/z
6	heparin-protamine
6	bintx-i
6	anococcygeus
6	merck
6	qc
6	-denuded
6	gemfibrozil
6	phenylalanine
6	fmlp-induced
6	4.1
6	lactone
6	days/wk,
6	ferulic
6	nof
6	340
6	capsules
6	abbott
6	(formerly
6	cipe
6	hippocampi
6	nnos-ir
6	methotrexate
6	fad
6	intrapleural
6	aprotinin
6	sr140333,
6	terbinafine
6	peptic
6	mofetil
6	mabs.
6	site-1),
6	piperidin-3-yl]
6	c(max).
6	sr140333.
6	naja,
6	17%,
6	hydroxy-metronidazole/metronidazole
6	l-name-
6	norfluoxetine
6	ofx
6	auc([0-24])
6	infinity),
6	c(max)),
6	ott
6	hcv-infected
6	anti-hcv-positive
6	nsaid
6	cewin
6	constant),
6	dihydrochloride
6	139317
6	μg/kg/min)
6	site).
6	polylysine
6	1620
6	hydroxy‐metronidazole
6	hydroxy‐metronidazole/metronidazole
6	insufficiency
6	cl28a
6	o2‐
6	(kf)
6	alternatus
6	coxs
6	μg/paw),
6	viperine
6	bap1-induced
6	(lps)-stimulated
6	inflicted
6	hf3,
6	algogenic
6	tools,
6	jararhagin,
6	envenomations.
6	phenylbutazone
6	stereoselective
6	amphidinolides
6	saint
6	rpe
6	chitosan.
6	het-cam
6	galleria
6	procera
6	those,
6	pyrogenic
6	thermodynamic
6	©2015
6	fumitremorgin
6	ease
6	crab
6	positional
6	(5.
6	prototypes
6	size-exclusion
6	pfcm
6	triterpene
6	clerodane
6	casearia
6	cerevisiae,
6	salmonella/microsome
6	ascaridole
6	evaluations.
6	piperlonguminine
6	physalin
6	(log
6	trimethylsulfonium
6	(ki
6	viridis
6	halitoxin
6	skeleton,
6	mscs,
6	acid-binding
6	mct8
6	absorptiometry
6	typing,
6	(bmd)
6	(pdi)
6	agammaglobulinemia
6	(pid)
6	gvhd
6	condino-neto.
6	splicing.
6	aire-knockdown
6	dystrophin
6	cell-intrinsic
6	immunodeficiencies,
6	implementing
6	preterm
6	registry
6	biochem.
6	il-5-
6	erythrophagocytosis
6	cgd,
6	jsle
6	papilloma
6	diapocynin
6	counseling
6	(31%)
6	cisapride
6	gerd
6	metalloproteases,
6	cds
6	colicin
6	(hus),
6	vascularized
6	responses;
6	biosimilar
6	(fh),
6	transfectants
6	carrier.
6	isozymes
6	alum-adjuvanted
6	down-modulate
6	pbs-injected
6	huvecs
6	igy
6	moab
6	envenoming.
6	cpg,
6	trif
6	il-12/ifn-γ
6	natterri
6	(asc)
6	anti-ifn-γ
6	proteasomes
6	cytosolic,
6	metallopeptidases
6	immuneproteasome
6	oligodendrocyte
6	agh
6	s-glutathiolation
6	view.
6	a23187-stimulated
6	ser
6	dimerization
6	iv),
6	tfus
6	69.2%
6	(cvc)
6	internally
6	kininogen
6	att20
6	cd25+cd4+
6	expansion/proliferation
6	set,
6	fullerene
6	two-bottle
6	signaling-related
6	neuro-2a
6	(hfd),
6	c4b-binding
6	moonlighting
6	plasmin,
6	c4b.
6	flexneri
6	nonstructural
6	o111ab:h2
6	o71
6	(ehly)
6	serum-
6	gata-4
6	mϕs,
6	mϕs
6	irf-1
6	prnp0/0
6	intrathymic
6	erk-mapk
6	breathe
6	thermoeffector
6	lps-injected
6	lp-mc
6	food-deprived
6	tc.
6	fevers
6	intra-avpo
6	5-ht7
6	dca
6	co,
6	awake,
6	microinjected
6	ma-ali/ards
6	(omps)
6	f4/80+ly6g+
6	interventional
6	h295r
6	spheroid
6	(pomc)
6	pomc-derived
6	notch1
6	igf-ir
6	deprivation-induced
6	myogenesis
6	m-band
6	stretching.
6	ubiquitin-ligases
6	deubiquitinating
6	non-neurotoxic
6	myotoxins.
6	cryolesioning
6	lipogenesis,
6	(abc
6	phosphate-binding
6	caries,
6	citri)
6	bioinformatics,
6	oxidoreductase
6	diffracted
6	sulphonates
6	operon-like
6	lt4
6	oppa,
6	ushers
6	oligogopeptide
6	trxr-1
6	(mra)
6	maladaptive
6	mg•kg•day,
6	phosphatidylserine,
6	inxs
6	transgenes
6	hairpin
6	cd34
6	bovis.
6	ep2
6	disc
6	apoptogenic
6	single-positive
6	[1].
6	bcr-abl.
6	ice/ced-3
6	xenografts
6	nrc
6	omm
6	herniation
6	oxidizing
6	pharmacists
6	franz
6	photosensitizer
6	asm
6	poly-3-hydroxybutyrate
6	hexanoic
6	coir
6	heterologously
6	ut
6	lipase,
6	proteinase-activated
6	sulfide-releasing
6	hyperamylasemia
6	colubrina
6	hot-plate
6	agonist-induced
6	normality
6	anti-nociceptive
6	sp5c
6	cirrhotic
6	cinods
6	nk1-/-
6	1-/-
6	stroke,
6	non-infectious
6	isotypes,
6	grading
6	tryp
6	denv-4
6	cell-based
6	(agmnpv)
6	baculoviruses,
6	hiv-1.
6	ghost
6	arthropod-borne
6	sfmnpv
6	agb
6	nesenpv
6	promoters.
6	nef
6	(irbp)
6	peptide-based
6	relapse.
6	ptp1b
6	hexamerins
6	anti-ngf
6	mor
6	kor
6	14 days.
6	accidents.
6	mirror-image
6	8-week-old
6	airmax,
6	multispecific
6	car-r
6	tnp
6	restrictive
6	prx1
6	shuttling
6	myopathy,
6	nad+
6	ferredoxin
6	cox15p
6	immunocontent
6	recruiting
6	dependence,
6	reca
6	siderophores,
6	bfr
6	tonb-dependent
6	cspb
6	acclimation
6	rpon
6	low-molecular
6	swarmer
6	predivisional
6	taca
6	predicts
6	germination,
6	today
6	mfc
6	-receptor
6	nms
6	immunolabeled
6	wnt/β-catenin
6	tgf-β3
6	smad2
6	2 h
6	3 h.
6	(erα)
6	smoke,
6	(cl097)
6	down-modulation
6	dim
6	mother-to-child
6	anti-gag
6	allergens.
6	dp-fed
6	graft.
6	(stec).
6	ecpa,
6	tccp2
6	pathotype
6	o:h
6	stx2b
6	etec.
6	epec/ehec
6	wb
6	intimin.
6	omps
6	scfv,
6	(bfp)
6	mannose-resistant
6	mrpa
6	neuroadaptations
6	γ-aminobutyric
6	crf1
6	pp-2a
6	c-epsilon
6	protein-1)
6	anorectic
6	plastome
6	spores,
6	aatrs
6	torque
6	391
6	scapular
6	μ-
6	alda-1
6	anxa2
6	gal3
6	fbxw7
6	l-dopa
6	utricularia
6	acidobacteria
6	sr1.6/6
6	mesophilicum,
6	orchid
6	metarhizium
6	cyanobacteria
6	compatibility
6	metolachlor
6	pcr-dgge
6	p9r
6	pod
6	mood
6	dvl-2
6	insults.
6	barnes
6	tlr4-deficient
6	mg2+-atpase
6	tb14
6	16:1n7,
6	pparα-deficient
6	atgl
6	hsl
6	pparα.
6	echocardiography
6	ser-ryanodine
6	conditionally
6	svf
6	brewing
6	files
6	graminearum
6	30f35
6	parasiticus
6	caiapó
6	hepatotoxic
6	afl
6	(corn
6	sclerotia
6	ray
6	afb1,
6	ionizing
6	hulls
6	convertase
6	decay.
6	wsc
6	pre-dm
6	ctrl
6	(hfd)-fed
6	cachexia-related
6	paraneoplastic
6	cis-ex
6	(ec),
6	60min/day,
6	il-10/tnf-
6	rpat.
6	(e0
6	(e2
6	(e6
6	m/min
6	e6,
6	(apob)
6	frequency/low
6	ldl-cholesterol,
6	(sham-operated
6	vitória
6	sts
6	bhk21
6	pneumonic
6	pfge.
6	haemominutum"
6	gy
6	vegetables
6	sb-lp
6	ppads
6	versa.
6	insp
6	yoelii,
6	serine/threonine
6	frcs
6	fires
6	restricts
6	serotyping
6	ångström
6	aerosols,
6	cd4+cd25-
6	cd49b
6	k409
6	coagulation.
6	cardiomyopathy.
6	sp35
6	grafting
6	stingrays
6	elliptica
6	b220neg
6	nattectin,
6	gr.
6	igga
6	vacht
6	(hpg)
6	gh.
6	ip7
6	iri,
6	clp+o3
6	oxygenase-1
6	(ms100a9p)
6	aggr
6	pastoris.
6	rpym2-maebl.
6	rpym2-maebl
6	ca4
6	his6flic-msp119
6	subclass.
6	igg1/igg2c
6	flici
6	acnes
6	igg1/igg2a
6	rating
6	thirty-nine
6	posttraining
6	cd8α-
6	trm
6	flid
6	anticaries
6	cs21
6	endospores
6	αdec-ns1
6	travassos
6	saliva-coated
6	anti-ltb
6	anti-cfa/i
6	pbps
6	ev76
6	plague
6	64,855
6	biocide
6	blactx-m-15
6	phylogroup
6	colistin-resistant
6	esbl-producing
6	doc/amb
6	dod/amb
6	periodontopathogenic
6	tlr-2
6	c3heb/fej
6	ptc.
6	dicer
6	δ337t
6	meningiomas.
6	meningiomas
6	tenella,
6	snrnp
6	ftsj3
6	pua
6	(gla)
6	gls
6	scratch
6	high-gla
6	gabonica
6	aejg
6	ornatus
6	[ts
6	planing
6	atc/ttc
6	rhamnosus
6	dentalcult
6	xylitol
6	mdpb-containing
6	slabs
6	(phs)
6	rhcg
6	aqp5
6	(lepr)
6	brain-specific
6	mhb
6	gabaergic.
6	pomc/lepr+
6	pomc/lepr-
6	postrestriction
6	foxo1
6	pkc-θ
6	histoplasmosis.
6	hr-hpv
6	polyomavirus
6	g-light
6	euhydrated
6	tsna
6	6%)
6	srl
6	mmr
6	mdr1
6	aim2,
6	20-month-old
6	3-kinase.
6	3-kinase)
6	anti-phosphotyrosine
6	substrates-1
6	(u
6	irbc
6	5-aza
6	mtsc1ko
6	defciency
6	11β-hydroxysteroid
6	g3p
6	sbf
6	phospho-thr
6	mlssw
6	dorsocaudale
6	degus
6	mpc2
6	excg1
6	astrocytomas
6	hnrnp
6	pp'dde
6	yerba
6	artinm
6	hemopexin
6	aldosterone-induced
6	db4
6	samba
6	proteinuria,
6	slug
6	rvrg
6	hypercapnia-induced
6	6-ohda-treated
6	tonic–clonic
6	war
6	chemoreflexes.
6	rtn/pfrg
6	current.
6	zd7288
6	stainless-steel
6	ml·kg-1·min-1)
6	(phox2b+th-)
6	non-catecholaminergic
6	pef/lh
6	submandibular/sublingual
6	(ssg)
6	α-chloralose
6	commnts,
6	(ssnd)
6	(cholinergic
6	dnqx
6	isoflurane
6	av3v+commnts
6	instantly
6	peep
6	min-1).
6	non-albicans
6	c7a
6	prm
6	fiv-uninfected
6	μg·50
6	bgp-15
6	retinol-binding
6	sleinactive
6	iocl
6	pneumococcal
6	vth
6	stm
6	microdose
6	fmol/mg),
6	j18,
6	587
6	(nlrp1,
6	dc-it
6	nalp1/nlrp1
6	nomid/cinca
6	mkd,
6	pstat3
6	prnp
6	pfatc
6	icdh
6	d-amb
6	p-amb
6	24-smt
6	trb
6	cytogenetics
6	rhoc
6	snp-a
6	mds.
5	antagonist]
5	ang-(1-7).
5	uroguanylin
5	(ugn)
5	camp/pka
5	mtorc2
5	enterotoxins.
5	(concentration
5	h89
5	forskolin,
5	cgmp.
5	ending
5	(glp-1)
5	na+-glucose
5	sglt
5	nhe3.
5	ion-selective
5	(pkg)
5	605
5	(phirr)
5	(1-h
5	chelator)
5	(ic)
5	y-shr
5	(dppiv).
5	-atpase
5	cftr
5	nppb.
5	30-min
5	ren
5	phosphatidylinositol-3-kinase
5	border,
5	detected:
5	nhe.
5	(j
5	0.38
5	maxi-k
5	hexamethylene
5	iberiotoxin
5	0.024
5	mek1/2,
5	28080
5	(jk)
5	(pma),
5	(p),
5	wp
5	acetate-stimulated
5	vasopressin.
5	mol/l,
5	(n=12)
5	cl-,
5	nh3.
5	messengers
5	0.23
5	(n=11)
5	n=7)
5	n=7).
5	0.17
5	nih
5	0.015
5	slopes
5	hepes
5	0.020
5	(avp),
5	j(k)
5	0.90
5	pellets,
5	thyroparathyroidectomy
5	thyroxin
5	6400
5	27.7
5	ptx.
5	0.95
5	0.010
5	23)
5	0.006
5	utilized.
5	turtle
5	loads.
5	(b),
5	phorbol-12-myristate-13-acetate
5	(10-8
5	0.48
5	dog.
5	pkc.
5	a23187.
5	chloride,
5	mask
5	flux,
5	nephron,
5	gfr,
5	hematocrit
5	raffinose.
5	half‐time
5	0.70
5	0.050
5	a1,
5	ionophore,
5	aldosterone,
5	ph-stat
5	oh-
5	0.02,
5	cm‐2
5	ion-sensitive
5	am.
5	fluxes.
5	tracers,
5	hyperbolic
5	low-sodium
5	perfusate,
5	countertransport
5	half‐times
5	curves.
5	marked,
5	0.78
5	1984
5	-ion
5	1984,
5	nmol·cm
5	·s
5	equilibrium.
5	vivo"
5	37°
5	energies
5	impermeant
5	satisfactorily
5	stellate
5	0.05.
5	na+.
5	74%,
5	31%,
5	epithelium)
5	realistic
5	acidotic
5	conductances
5	tends
5	stopped
5	sodium.
5	secretion;
5	1973
5	split-drop
5	michaelis-menten
5	1972.
5	loading.
5	loops,
5	elite
5	maldi-tof/tof
5	permissions,
5	semi-solid
5	(iaa)
5	n-free
5	fusarium.
5	83.3%
5	plant-bacteria
5	icb
5	maltophilia
5	hybridisation
5	n2
5	gamma-proteobacteria
5	biosyntheses.
5	complex)
5	(2.5,
5	phase),
5	mek
5	sb.
5	chelator,
5	11).
5	translocated
5	nhe-1
5	nhe2
5	orange,
5	d-α-tocopherol
5	ip).
5	d:
5	2.30
5	receptors).
5	suspension.
5	(10-4
5	underground
5	0.49
5	slit
5	0.39
5	1.12
5	(dt)
5	(pdcs),
5	ido1
5	(dcs).
5	multimeric
5	pro-th2
5	anti-allergic
5	th1/th2/th17
5	regressive
5	(wt),
5	anti-mr
5	lymphoproliferation
5	treated.
5	gm-csf,
5	functions:
5	prrs
5	nalp3
5	lxa4
5	(th1),
5	th2,
5	adhesin,
5	mannan
5	effector/memory
5	(gpi)
5	tlr2-deficient
5	untreated,
5	onward,
5	fasl
5	(il-4),
5	il-4-depleted
5	g2a
5	(pcm).
5	-/-)
5	balb,
5	non-virulent
5	(nos2)
5	multidimensional
5	microfilament
5	glycoproteins,
5	paper.
5	2001.
5	epithelioid
5	governed
5	interposed
5	33,
5	kd)
5	nu/nu
5	spots,
5	cba/j,
5	nonactivated
5	macrophage,
5	ifnγ,
5	collaborators,
5	us.
5	unexposed
5	caucasian
5	proteoglycans,
5	cocoon
5	daughter
5	(highly
5	separating
5	gel.
5	evident,
5	reisolation
5	reisolated
5	month.
5	(ivic
5	265
5	18).
5	2052
5	10-20
5	vacuoles,
5	inheritance
5	backcross
5	(srbc)
5	(adcc)
5	stocks.
5	1979,
5	penetration.
5	(vehicle)
5	1 h
5	low-fat
5	cinc-1,
5	ex-vivo
5	vegf.
5	blunts
5	puberty,
5	hemodynamics,
5	16%,
5	pollutant,
5	period)
5	1β
5	supernatant,
5	chp
5	(lps;
5	receptor-immunoreactive
5	nos-immunoreactive
5	a2a
5	mpo.
5	cox-1.
5	thymus-derived
5	airmax.
5	maria
5	castro
5	(icam-1),
5	abused
5	(pbs)
5	epithelium;
5	gpx,
5	sod-1
5	sham-ovx
5	(mch).
5	fa-induced
5	endothelium-leukocyte
5	calretinin.
5	calbindin-positive
5	nos-ir
5	explants.
5	90min
5	bal-cultured
5	cells.conclusions:
5	fertile
5	pollution.
5	(50mg/kg
5	sr48968,
5	daily),
5	(huvecs)
5	(oa,
5	seeded
5	gastroesophageal
5	juice.
5	(mast
5	non-cholinergic
5	aminoguanidine)
5	48/80.
5	ovx-allergic
5	progesterone.
5	doses)
5	remodelling.
5	response)
5	oestrogen
5	tonus,
5	ifn-γ-treated
5	breastfed
5	(ptx)
5	atopy
5	l-arginine.
5	cellularity.
5	ovalbumin-induced
5	-30
5	0)
5	13th
5	(0.4%
5	mesentery.
5	8-bromo-cgmp
5	mk
5	b4,
5	ro-0254094
5	(2-[(5-carboxypentyl])oxy]-6-[6-[3,4-dihydro-4-oxo-8-propyl-2h-1-benzopyran-7-yl)oxy]hexyl]
5	(nw-nitro-l-arginine
5	paf-receptors
5	(5-(2-chlorphenyl)-3-4-dihydro-10-methyl-3-((4-morpholinyl)carbonyl)-2h,7h-cyclopenta
5	(4,5)thieno(3,2-f)(1,2,4)-triazolo-4,3,a)91,4)diazepine),
5	(3-[1-(4
5	chlorobenzyl)-3-t-butyl
5	thio-5-isopropylindol-2-yl]-2-2-dimethylpropanoic
5	histologically.
5	bronchi.
5	31,
5	overcame
5	(indomethacin),
5	econazole,
5	undetermined
5	(dtus),
5	sas
5	(nf),
5	x10
5	genealogy
5	tci.
5	tciii,
5	fruits.
5	cruzi)
5	hemisphere.
5	tsa-1
5	demanding
5	ii-restricted
5	anti-b13
5	singletons.
5	transcribed.
5	non-redundant
5	tcii,
5	conservation.
5	couples
5	15.6
5	(mitochondrial
5	chile
5	monophyly
5	succinate.
5	195
5	discarded
5	156
5	screenings
5	b13,
5	motif.
5	phenetic
5	assumes
5	(rrna)
5	band,
5	rejected
5	(indirect
5	minicircle
5	subspecies,
5	cross-
5	marsupials,
5	s4,
5	68%.
5	helical
5	28°c
5	metacyclics
5	initiative
5	holding
5	support.
5	to:
5	technologies,
5	occasion.
5	(epi)
5	lppg,
5	lipopeptidophosphoglycan
5	faint
5	trypomastigote-specific
5	evolutive
5	bears
5	ria
5	discriminates
5	b12
5	immunoelectron
5	galf
5	form)
5	73%
5	released.
5	radiolabelled
5	nitrocellulose
5	(igg
5	transglycosylase
5	1977.
5	exponentially
5	lag
5	observation,
5	esters,
5	atropine.
5	(met)
5	gsk3-β
5	ins+gdp
5	mitigate
5	unripe
5	fo,
5	postweaning
5	immunoblotting)
5	8-
5	2.1-fold
5	(β2ko)
5	(g1
5	needed,
5	bax/bcl2
5	lucigenin-amplified
5	akt1,
5	day-1,
5	non-phagocytic
5	s6
5	40s
5	insufficiency.
5	polyuria,
5	(ep),
5	fructosamine
5	(ras),
5	jak2/stat1
5	jak2/stat3
5	jak2.
5	physiologically,
5	gprs
5	(reactive
5	©2011
5	4-hydroxy-2-nonenal
5	(5-10
5	oscillations,
5	(stat3).
5	(tyrosine
5	irs1.
5	b1.
5	transporter-2
5	(p47phox
5	(pi3k
5	inhibitors)
5	insulin-secreting
5	(ucp)
5	propionate.
5	aims/hypothesis:
5	conclusions/interpretation:
5	double-staining
5	hyperlipidemia.
5	hsd2
5	hsd1
5	triacylglycerols
5	ca2+-atpase
5	na+/ca2+
5	ncx
5	nifedipine.
5	rt-pcr:
5	hyperlipidemia
5	(ps),
5	phosphatidylethanolamine
5	interesting,
5	fuel,
5	(26%)
5	circulates
5	(long
5	substantiate
5	decarboxylation,
5	justifies
5	keeps
5	(hc,
5	fuels
5	leukotrienes.
5	langerhans
5	fast.
5	sufficient,
5	exceeding
5	for,
5	d-mannose
5	account,
5	mannose,
5	menadione
5	in86rb
5	[u-14c]
5	ratio)
5	couples.
5	lipogenesis.
5	(cpp)
5	decapitated
5	(8.2
5	ip),
5	cocaine,
5	behavior).
5	bmax
5	caudate
5	coc
5	stereotypy.
5	region-specific
5	haloperidol
5	(dopac)
5	phenoxybenzamine
5	behaviours
5	ventricular-cisternal
5	3.5%
5	tranylcypromine
5	9.6
5	mw
5	(epcs)
5	(restricted
5	programming.
5	(cee)
5	thrombosis.
5	restricted.
5	antonio
5	reagent,
5	μmol/site)
5	range).
5	(plasma
5	alternative/complementary
5	ultimately,
5	ne-induced
5	androgens
5	mini-review
5	ii)-induced
5	individually.
5	vasculature.
5	probing,
5	receptor-1
5	(bal).
5	instillation,
5	senescence,
5	(nsaids),
5	(lllt,
5	diclofenac)
5	810
5	mmp-13
5	receptors-mediated
5	moraes
5	(β
5	apocynin.
5	15-week-old
5	(interleukin
5	(gene
5	rat).
5	plethysmography
5	wistar.
5	pregnancy:
5	hyperpolarization,
5	(msg)-induced
5	imbalanced
5	pi3k.
5	drink
5	(maximal
5	[in
5	malnutrition.
5	-nitro-l-arginine
5	(n-stz)
5	count.
5	(assessed
5	plethysmography.
5	amlodipine,
5	diameters,
5	restorative
5	guided
5	exactly
5	99.7%
5	(confirmed
5	(nadph
5	vivo-in
5	losartan-treated
5	difference,
5	nitric-oxide
5	pre-pro-et-1
5	arteriographic
5	marginally
5	sight,
5	tetrahydrobiopterin.
5	nos-dependent
5	measurement,
5	conversion.
5	ang(1-7)
5	cams
5	selectin
5	two.
5	mesenteries
5	hearts:
5	0.65
5	phenomena,
5	9),
5	bk-induced
5	(pgi2)
5	bromide-positive
5	raised,
5	activity/expression
5	cyanotic
5	bosentan
5	(e-)
5	tunica
5	remainder
5	1.0%
5	oyster
5	(n=8)
5	ng-methyl-l-arginine
5	p<0.001)
5	exteriorized
5	unless
5	edrf.
5	aortae.
5	relax
5	synapses,
5	debris
5	apoptotic,
5	spla2s.
5	neuroblasts
5	limbs
5	paralysis.
5	inconsistent
5	apamin
5	aplysia
5	patches.
5	nordihydroguaiaretic
5	bursting
5	salinity
5	sides.
5	anions,
5	dorsum
5	diamond
5	sensitive.
5	auxiliary
5	gene/protein
5	assays;
5	synthesis/secretion
5	progress,
5	mesometrial
5	sensitivity;
5	(50%).
5	mmp9.
5	coherence
5	oct
5	embryo.
5	beside
5	cd11c).
5	co-exposure
5	(pma
5	ionomycin)
5	(cd4+/ifn-γ+)
5	+/il-17+)
5	vehicle-matched
5	disarrangement
5	thyrotrophs,
5	(qpcr),
5	vi,
5	cxcl2/mip-2
5	activations
5	α2a-ar
5	tomographic
5	vertebra
5	versican,
5	excitation
5	histomorphometric
5	narrowing
5	tnf-α;
5	ikk-α
5	non-decidualized
5	splicing,
5	involution.
5	perlecan,
5	preparing
5	3h-proline
5	repairing
5	coelomic
5	mesenchyme
5	incident
5	sides,
5	edges
5	gc-1,
5	(hypo)
5	(t4),
5	(tsh),
5	chondrocyte
5	gc-1-treated
5	deviations
5	syndecan-4
5	separation,
5	pulp.
5	spaces,
5	(s).
5	transcardiac
5	a.m.).
5	wavelength,
5	40-60
5	pgcs
5	#2
5	gaalas
5	#1,
5	pregnancy)
5	salt,
5	fermented
5	healed
5	activity:
5	ammonia,
5	instrumental
5	predecidual
5	phagocytosing
5	phagosome
5	incisors
5	clc
5	sectors
5	[3h]-thymidine
5	onwards,
5	immunohistochemistry)
5	hypothesised
5	8 weeks
5	rostroventrolateral
5	melo,
5	impacting
5	subnuclei
5	(qrt-pcr)
5	ras.
5	(heart
5	counterbalance
5	(1-7)
5	wky-s
5	metaboreflex
5	contemporary
5	pvn-nts
5	input-output
5	α-smooth
5	middle-aged
5	(55%
5	2.2-fold
5	density)
5	reciprocally
5	wky),
5	18%,
5	going
5	(pi3-kinase)
5	polyphosphate
5	(increase
5	(dorsal
5	otko
5	diaphragm,
5	(2).
5	(hr).
5	age-
5	n(g)-monomethyl-l-arginine
5	163
5	vehicle-
5	intensities.
5	h-1)
5	abnormality
5	ventricle,
5	(all)
5	flat,
5	funding
5	section,
5	is:
5	lopes,
5	serology.
5	motivation
5	brazil:
5	lagoa
5	3.3%
5	lasiurus,
5	(21%)
5	anaplasmataceae
5	32.5%
5	made,
5	cs3.
5	mexico
5	scrofa
5	ground.
5	catarina
5	inhabited
5	bubalis)
5	(0.5%
5	fisher
5	(sag1,
5	unsuccessful
5	gallus
5	formalin-fixed
5	abortus,
5	jaguar
5	theileria
5	(dasypus
5	(possibly
5	questionnaires
5	pearson's
5	genotyping.
5	pcr-rflp.
5	warm-blooded
5	researches
5	mainland
5	island.
5	(mat,
5	innocuous
5	1:5
5	totaling
5	access,
5	schizotrypanum,
5	megatrypanum
5	tropical.
5	ca,
5	(felis
5	areas;
5	pteronotus
5	attend
5	5.7%
5	ocean,
5	apologise
5	maranhão,
5	20).
5	mounting
5	anthelmintic
5	synanthropic
5	50.
5	7.1%
5	maranhão
5	cerrado,
5	(canis
5	131
5	an01
5	parque
5	arthropods.
5	flock-level
5	454
5	176
5	dasypus
5	anteaters
5	(state
5	1:40
5	1:80
5	battery
5	filarial
5	immitis
5	musculus
5	samples).
5	microscopically
5	anteater
5	sentinel
5	maternal,
5	bordetella
5	stands
5	25).
5	seriously
5	223
5	174
5	975
5	stray
5	anti-b.
5	prepatent
5	369
5	rotundus.
5	rotundus
5	1:100.
5	fifty-five
5	acquiring
5	portuguese
5	workers,
5	hearing
5	bitches
5	node,
5	negro,
5	rondonia,
5	1:25
5	81%,
5	(titer
5	denoted
5	(n=10)
5	set.
5	black-eared
5	ict
5	hypochlorite
5	(37
5	203
5	184
5	(3%)
5	(hydrochaeris
5	hydrochaeris)
5	reaction)
5	3.1%
5	(1.6
5	(3.1%)
5	canids,
5	(presence
5	partum
5	g2,
5	28th
5	encephalitis,
5	reactant
5	county
5	colégio
5	haemonchus
5	cte
5	paraná,
5	(rio
5	calves,
5	justify
5	258
5	(1.6%)
5	apicomplexa,
5	apicomplexa.
5	(103
5	apicoplast
5	homemade
5	33342
5	rate)
5	commonest
5	parkeri
5	04
5	18.7%
5	gata3
5	pro-tumorigenic
5	chip
5	(aa),
5	(tc-1
5	transactivation
5	macrophages)
5	pafrko
5	ascitis
5	(probably
5	clp.
5	for:
5	pafr.
5	epithelial-to-mesenchymal
5	(emt).
5	nephropathy,
5	cd36.
5	membrane;
5	cd36,
5	x-higm.
5	pkcα
5	tlr3,
5	(cinc)-1
5	p-
5	production/release
5	10μm),
5	(53%),
5	(akt,
5	iκbα
5	(57%)
5	(65%)
5	(67%)
5	reaction;
5	(ova)-challenged
5	nox-
5	orally.
5	mucus.
5	(mam)
5	(iri).
5	amplifies
5	insoluble
5	in:
5	analysed:
5	fluid;
5	∼40%
5	pneumoniae.
5	leakage,
5	h-2
5	guanidine
5	h-2k
5	(79%)
5	scoring
5	fits
5	106)
5	undetectable.
5	1.65
5	cocultures,
5	f35
5	(tnf),
5	(hb)
5	detrimental.
5	8.6%)
5	no2-
5	introducing
5	(more
5	paw,
5	(35%)
5	infiltration;
5	patchy
5	oxygen-free
5	μg.
5	plenum
5	peptidic
5	d4
5	42,
5	ml−1)
5	ng).
5	histamine.
5	c5-sufficient
5	purple
5	thymol
5	geological
5	biodiversity.
5	posed
5	dataset
5	seeps
5	cores
5	extremophiles
5	tremendous
5	thereby,
5	antarctica,
5	phytoplankton
5	0.6,
5	bacilli,
5	actinobacteria,
5	attract
5	underneath
5	database.
5	southwest
5	71%
5	place,
5	occupying
5	sponges
5	geochemical
5	ecosystems,
5	(0.8
5	dynamics,
5	devoted
5	waters,
5	algae
5	(dgge)
5	antarcticum
5	folding.
5	cultivable
5	conidial
5	earth's
5	discovering
5	micro-organisms
5	-,
5	bc
5	1970s
5	vicente
5	interferences
5	averaging
5	methanobrevibacter
5	ndv.
5	embryonated
5	amended
5	catalyse
5	enantiomeric
5	predominating
5	biomes.
5	2c
5	affording
5	bases,
5	man-made
5	petroleum
5	heated
5	ultracentrifugation.
5	waterborne
5	tryptone
5	suitability
5	relevant.
5	modulate,
5	designed,
5	executed
5	4f
5	polydispersity
5	©2017
5	aacr.
5	anal
5	hpv-induced
5	tumor-induced
5	myeloid-derived
5	gd,
5	(scd40l)
5	scd40l.
5	universally
5	ifns
5	oxaliplatin
5	sorafenib
5	stat6
5	tempting
5	extruded
5	immunomodulation.
5	pd-l1
5	(ht1080).
5	pungent
5	cycle-related
5	trpv-1
5	mastoparan
5	nmr,
5	ifn-γ-secreting
5	mo-dcs.
5	prototypic
5	label-free
5	co-cultivation
5	mdc
5	mab,
5	1 week
5	unsolved
5	priming,
5	cd1a
5	g/ml
5	ovalbumin,
5	conspecific.
5	cd68+
5	merit
5	(c3)
5	guarani
5	jaundiced
5	2003.
5	qualities
5	predictions.
5	breast,
5	neutralization.
5	intratumoral
5	feeder
5	(240
5	59)
5	validation.
5	(lin-)
5	d1.
5	(minimal
5	19.
5	cxcl5,
5	segregating
5	ahrd
5	(pas1)
5	rr,
5	1064
5	(snps),
5	eia
5	phenotype-selected
5	(bmc)
5	c5d
5	©2008
5	(known
5	intercrosses
5	urethane-treated
5	.001)
5	(selection
5	subacute
5	focus,
5	strengthened
5	reproducible.
5	intra-assay
5	251
5	fcγr,
5	healthy.
5	crocodiles
5	kaiowa
5	cultured,
5	ethiopia,
5	mbp,
5	mucins,
5	acdps
5	underestimated.
5	mozambique
5	lewisi,
5	quantified,
5	n-terminally
5	lineages:
5	phlebotomines
5	deanei.
5	desouzai
5	interdependent
5	pave
5	mitochondrion
5	packing
5	strigomonas
5	mutualistic
5	faces
5	(all
5	isolates),
5	hemotropic
5	rpob
5	exoantigens
5	(atl)
5	symptomless
5	grooves
5	tree,
5	chaffeensis
5	abeli
5	pcr-positive
5	al.this
5	resolve
5	areas)
5	haematological
5	exchanges
5	non-mammalian
5	subclade
5	nutritional,
5	jointly
5	seeding
5	endosymbionts
5	phylogenomic
5	synteny
5	herpetomonas,
5	sleeping
5	improvement,
5	cruzipain,
5	discussions
5	aceturate
5	irritans
5	melophagium
5	especially,
5	pale
5	questions,
5	deer,
5	verticillioides,
5	northeast,
5	polyphaga
5	now.
5	frequencies,
5	tanzania
5	lymphopenia
5	houses
5	lp1/lp2
5	serovars,
5	herpetosoma
5	segregation.
5	(74%)
5	synapomorphic
5	giemsa-stained
5	genus-specific
5	sap.
5	fifty-four
5	1471
5	amaral,
5	bmdm
5	(ccc),
5	(lt),
5	lo
5	senses
5	(pba)
5	elastase)
5	anti-oxidant
5	nac.
5	dysplasia
5	bortoluci.
5	origins.
5	disappear
5	luana
5	described;
5	debris.
5	fetus,
5	necrosis;
5	malaria-infected
5	elimination,
5	5/nucleotide
5	flagellin-induced
5	inflammasome-induced
5	(pamps)
5	cure.
5	serum-specific
5	development;
5	denoting
5	cd3,
5	anka,
5	elias
5	bitten
5	efforts,
5	ksr
5	sox2
5	blastocysts.
5	immunoglobulin.
5	guaranteed
5	immune-deficient
5	non-sterile
5	(nk),
5	(il)-12p40
5	(il-12/il-23-/-)
5	il-12/il-23,
5	(ril-12)
5	ifn-γ-dependent,
5	il-12/il-23-/-ifn-γ
5	il-12/il-23.
5	(cd28
5	incapacity
5	(absence
5	(as),
5	potentiality
5	th1-prone
5	rifn-γko
5	aj
5	thickened
5	cristina
5	caprylic
5	lyt
5	lectin.
5	effector,
5	1986,
5	n-acetylcysteine
5	(nac),
5	arose
5	autonomous
5	survive.
5	polymerases.
5	paradoxically,
5	absorbing
5	hgt,
5	imposes
5	fires.
5	influential
5	uvrd
5	a:t
5	hardly
5	property.
5	polh
5	founder
5	uv.
5	gap-filling
5	6-4pp
5	ape1
5	xpc-deficient
5	formed.
5	dram-1
5	whole-exome
5	danio
5	last,
5	pyrimidone
5	photoproducts,
5	site;
5	lip/palate
5	ner.
5	xp/cs
5	c-1
5	warming
5	latitudes
5	incidence.
5	cardiotoxicity.
5	repair-proficient
5	ralstonia
5	depicting
5	atm
5	nad
5	up-regulating
5	acnu
5	access.
5	darkness
5	tfiih
5	alphaproteobacterium
5	p53wt
5	schistosomiasis,
5	epidemiologically
5	extracting
5	life-cycle
5	tolerate
5	ligases,
5	templates
5	still,
5	thiols
5	easier
5	identity).
5	duplication,
5	afimbrial
5	sugarcane.
5	307
5	sugars,
5	abscisic
5	sucest
5	in-frame
5	assure
5	(75%),
5	(xac)
5	abscission
5	darkening
5	exopolysaccharide
5	industries.
5	shared,
5	photoreactivation,
5	ascertained
5	insertion.
5	plastid
5	stresses,
5	guanine
5	52.7%
5	gc-rich
5	nutrient-poor
5	cytosine
5	prl,
5	sv40-based
5	decomposition
5	218
5	single‐stranded
5	plasmids,
5	heteroduplex
5	lethality,
5	obstacle
5	consolidation,
5	expectation
5	uncertainty
5	fear.
5	threat,
5	conditioning,
5	juxtadorsomedial
5	avoidance.
5	begin
5	orient
5	pss
5	landmark
5	soa
5	defeat,
5	intentional
5	erroneous
5	assistant
5	performances
5	(rlpag)
5	fear-related
5	inputs.
5	nuclei)
5	purely
5	predictability,
5	sleep-wake
5	sleep.
5	chase
5	planning,
5	flash
5	extrapolation
5	fle.
5	predator,
5	rostro-caudal
5	forepaw
5	lidocaine.
5	handling,
5	employment
5	ignored
5	attributes.
5	instructed
5	percentile
5	33).
5	eccentricity
5	positions.
5	peripheral,
5	semicircular
5	fitting
5	canal.
5	pools,
5	ballooning
5	zanotto,
5	capsid
5	dataset,
5	standalone
5	facilities,
5	(negative
5	concentrates
5	(vero
5	(npa)
5	types;
5	procedures:
5	serotype,
5	disposal,
5	vat
5	62.5%
5	(∼30%)
5	(slc2a4)
5	(aet)
5	a-i
5	vascularization
5	activation;
5	il6,
5	fbxo32
5	30 days.
5	sarcopenia
5	(60%),
5	(pl)
5	cn
5	differently,
5	maybe
5	yearly
5	(p.o.)
5	pathway;
5	dm2-hsa
5	slc2a1
5	(50%,
5	(66%,
5	(w)
5	marcelo
5	6-month-old
5	uk,
5	(glut
5	localisation
5	(sglt1)
5	h:
5	6-months
5	reproducibility,
5	codified
5	ia,
5	angiotensin-i
5	am251,
5	(nf)-κb
5	(crp),
5	gsk3
5	meals
5	minutes)
5	(20,
5	(pp)
5	(1.5,
5	did.
5	0.04;
5	*;
5	diabetic-hypertensive
5	forty-one
5	derangement
5	μeq
5	cotransporters
5	sb203580,
5	hnf-3β
5	(ir),
5	(stat)
5	post-receptor
5	supershift
5	confirmed,
5	mef2d
5	coexpress
5	glimepiride
5	appetite,
5	15-day
5	oxidative,
5	erα-/-
5	arko
5	1-a
5	insulin-
5	irs-2.
5	libitum.
5	(ivgtt)
5	ivgtt
5	2-mo
5	obese,
5	α-glucosidase
5	chow)
5	insulin-responsive
5	diet-adapted
5	same.
5	beta-1
5	antibody;
5	ffe
5	(bat),
5	family)
5	burgdorferi
5	spirochete
5	a. marginale
5	microplusin.
5	labruna,
5	(cdss)
5	unstructured
5	blood-feeding,
5	upshift
5	blood-feeding
5	melanogaster
5	longevity,
5	(lethal
5	gm.
5	buried
5	60°c
5	purity.
5	five-fold
5	(nmr)
5	a-induced
5	post-injection.
5	sub-lethal
5	(lc
5	oviposition
5	bacteriostatic
5	microplusin,
5	combinatorial
5	vectored
5	willebrand
5	diatraea
5	2de
5	castellanii
5	p5
5	p85
5	c.,
5	byc
5	digest
5	partition
5	ferritin,
5	neoformans,
5	cryptococcal
5	[d-thr2,6,11,15,
5	micelles.
5	(16%
5	acylated
5	micellar
5	potent,
5	annotation,
5	(1999)
5	oogenesis
5	residues)
5	intramolecular
5	moth
5	compete
5	lysozymes
5	lepidopteran
5	apparently,
5	introns.
5	collections.
5	pmsf,
5	chymostatin
5	zeitschrift
5	für
5	(escherichia
5	cloacae,
5	subtilis,
5	given,
5	lv79
5	megasomes
5	amastigotes)
5	azocasein
5	proteinases.
5	serially
5	agglutinated
5	inhibitor-free
5	leu-ome.
5	antipain
5	1987,
5	lever
5	informed
5	mere
5	holds
5	salient
5	infl
5	discomfort
5	questionnaire,
5	terminal.
5	stated
5	(95
5	conditions;
5	confusion
5	interior
5	contact.
5	implied
5	sprouting
5	seeds,
5	wheat,
5	resonances
5	insb
5	holes
5	(≈
5	module
5	adaptor,
5	cre-loxp
5	infection),
5	barrier,
5	hemozoin
5	acre,
5	insecticides
5	liberate
5	(pha).
5	pha.
5	ctc
5	rezende,
5	diversum.
5	vincristine
5	scarring
5	(pcd)
5	pterocarpans,
5	t47d
5	spindle
5	ag1478
5	messenger,
5	(active
5	ain-93
5	gfp-tagged
5	apis
5	publisher
5	transposons
5	portland
5	localizes
5	radiography
5	emitted
5	differentiation:
5	in-situ
5	rows
5	extremities
5	intact.
5	antifungal,
5	unquestionable
5	c-8
5	chromatin,
5	helices
5	histochemistry.
5	decreases.
5	calcineurin,
5	(first
5	pre-incubating
5	phospholipid.
5	cytotoxic.
5	aggressiveness.
5	predominates.
5	rna)
5	scheme,
5	appreciable
5	isomer
5	retard
5	pharmacophore
5	(amb)
5	(although
5	ergosterol,
5	lipid.
5	polyprenols
5	nerolidol,
5	mexicana,
5	protrusion
5	serving
5	metastasis,
5	7 days.
5	dictates
5	pro-resolving
5	y27632
5	eyes.
5	(proliferation
5	urchins,
5	echinometra
5	lucunter
5	proportions.
5	cos-7
5	prospective,
5	reality
5	(lna)
5	aminotransferases
5	melo
5	polarity,
5	invagination.
5	morphogenesis;
5	rac1,
5	mt1-mmp.
5	(gbm).
5	fibers;
5	3.15
5	laser,
5	mode,
5	(igf-i
5	igfbp-5
5	ios
5	arrangement,
5	contacts,
5	anti-adhesive
5	actin-rich
5	immobilization,
5	vitreal
5	concerted
5	ngf,
5	kinases.
5	neurites
5	adenohypophyseal
5	swimming-trained
5	adhesions,
5	check
5	p70
5	shaking
5	villus
5	nox1,
5	raldh2
5	nutlin-3
5	temperature-sensitive
5	enlarged,
5	glioblastoma.
5	(gbm)
5	synergize
5	28-day
5	(33%)
5	antimalarials.
5	mhcii
5	binding-inhibitory
5	0.6%
5	637
5	summarise
5	incorrectly
5	6.2
5	between-population
5	efforts.
5	complicating
5	cohort.
5	eradication.
5	relapsing
5	interruption.
5	pfkelch13
5	acts.
5	caribbean,
5	policies
5	unequivocally
5	contacted
5	uncovering
5	occupation
5	(ci),
5	histories,
5	incomplete.
5	fucosylated
5	begun
5	infectiousness
5	peru,
5	town
5	mg/l,
5	77%
5	octamer
5	(amino
5	transmission-blocking
5	nonapeptide
5	myanmar,
5	person-years
5	recrudescence
5	indonesia
5	pcr;
5	in,
5	nonimmune
5	repeats.
5	(brazil).
5	partial,
5	malaria-exposed
5	(pvmsp-1),
5	asian/african
5	whole.
5	(hi)
5	independent,
5	centres
5	honduras1-type
5	vietnam,
5	confounding
5	primers,
5	extinction
5	family-specific
5	stable,
5	'loci'
5	neighbouring
5	4a,
5	4b,
5	4b
5	4a
5	igg-subclass
5	subpopulations.
5	(pcr)-based
5	241
5	predominant.
5	evidence.
5	strain),
5	repletion
5	schizonts,
5	probit
5	anti-plasmodium
5	ferrous
5	sectional
5	regimen,
5	(si)
5	berghei,
5	gravity
5	11%
5	stygium
5	sucrose,
5	synthesising
5	marks
5	renewable
5	atoms
5	spectrometer.
5	array.
5	nitrocefin
5	amoxicillin/clavulanic
5	1.36
5	osmolarity
5	avermectin
5	42°c
5	fragment,
5	biotypes
5	ltxa
5	(0%
5	amines,
5	putrescine,
5	forsythia.
5	ap-pcr
5	poisoning
5	gingivalis.
5	30 days
5	c. perfringens
5	broiler
5	mineralized
5	peptidoglycan
5	microcomputed
5	osteoclasts.
5	nlr
5	editorial
5	dentistry.
5	biofilm,
5	imaging,
5	(bmi)
5	bmi
5	(etbf)
5	non-enterotoxigenic
5	ntbf
5	flowers
5	microorganism.
5	(oc)
5	hoc
5	tukey
5	31.8%
5	gr1+
5	immunoregulation
5	verified,
5	mucositis
5	success,
5	(rankl)
5	cp/htlv-1
5	htlv-1
5	anaerobe
5	interleukin-10,
5	interleukin-1β,
5	interleukin-17
5	inflammation-induced
5	il-1β(3954)
5	additively
5	eva
5	agar.
5	a. actinomycetemcomitans
5	pvc
5	formation)
5	recovered.
5	10;
5	enterotoxin,
5	cxcl10
5	peri-implant
5	chloride.
5	nucleatum.
5	microflora
5	overgrowth
5	screened,
5	periodontopathogens.
5	themselves,
5	finger-like
5	verifying
5	quantity,
5	akadémiai
5	fe,
5	as.
5	nanomaterials
5	gill
5	lamellae,
5	assembling
5	pahs
5	iodide.
5	chromatography-mass
5	substrates:
5	taxonomy,
5	biologists
5	23°c.
5	slowed
5	302
5	(eds)
5	aa.
5	spixii.
5	stasis,
5	guiding
5	germicidal
5	(pi),
5	granulocytic
5	heterogeneous,
5	(difference
5	made.
5	resolved.
5	hypoplasia
5	intertubular
5	altiparanae.
5	indexes,
5	lipophilicity,
5	neurohypophysis
5	pituitary.
5	teleosts.
5	intend
5	(brazil),
5	hormone)
5	fecundity
5	fasciatum
5	beginning,
5	rainfall
5	2400
5	(t),
5	(pbs).
5	workers.
5	choroid
5	pinna
5	neurodevelopment
5	buonfiglio,
5	adiposity.
5	nighttime
5	crack
5	rhythmicity.
5	double-blind,
5	placebo-controlled
5	2-8
5	enrolled.
5	ml/min,
5	mt2,
5	0.8%
5	extracted,
5	periodicity
5	homodimer
5	euthanasia,
5	(cp),
5	oua-na,k-atpase
5	nmda-mediated
5	(bcl2)
5	2/3-na,k-atpase
5	mainly,
5	phal
5	intravitreal
5	irβ,
5	pi3k-dependent
5	6-sulphatoxymelatonin
5	sleep,
5	migraine,
5	caudalis
5	innervations
5	marsh
5	su
5	8.00
5	2-deoxyglucose
5	β-subunit
5	dysregulation,
5	time)
5	tract-tracing
5	barrington's
5	n′‐acetyl‐5‐hydroxytryptamine
5	a.m.)
5	ultradian
5	pd2
5	theta
5	emg
5	subparaventricular
5	isocaloric
5	basis,
5	kg.
5	two-stage
5	pecking
5	reinforcement.
5	solubilize
5	i.m.
5	(hrsv),
5	digoxigenin-labeled
5	p21ras
5	non-symptomatic
5	(hc).
5	overexpress
5	separable
5	nigra.
5	jawed
5	optogenetic
5	gustatory
5	hedonic
5	posterodorsal
5	meav
5	parts.
5	terminalis.
5	prelimbic,
5	precentral
5	caudomedial
5	reward,
5	send
5	laterally
5	entorhinal
5	parasubthalamic
5	eac
5	dorsocaudal
5	ipac
5	raphe.
5	rostrally
5	bsts
5	forebrain.
5	posterolateral
5	nuclei),
5	distribute
5	subthalamic
5	stn
5	cortices.
5	hgf.
5	normal-like
5	cortactin,
5	10 days.
5	neoplasm,
5	(timps)
5	mmp9,
5	(mmps),
5	surg.
5	solid/multicystic
5	β-catenin,
5	egfr,
5	(four
5	timp-1,
5	surface-coated
5	metalloproteinases.
5	(controls)
5	uncoated
5	integrins.
5	(sirna)
5	α3,
5	α3β1
5	375
5	laminin-1,
5	fissure
5	fissures
5	n-cam.
5	masticatory
5	ceramic
5	non-ceramic
5	excretory
5	alfa
5	nucleus).
5	colocalize
5	plate.
5	capping
5	mural
5	thrombosis,
5	tmj.
5	interestingly
5	pas
5	(food
5	(lc),
5	≥2
5	dog,
5	uncertain
5	pedreira
5	peru.
5	bufo
5	causes.
5	asd
5	(600
5	lc,
5	3r4f
5	cigarettes
5	adolescence,
5	(aif)
5	nigral
5	(th),
5	glua1
5	biolife,
5	s.a.s.
5	cgrp,
5	(pd
5	pet,
5	(gfap)
5	map2,
5	egr-1,
5	(se)
5	parvalbumin-positive
5	pyramidal
5	myelination
5	diencephalon,
5	telencephalon,
5	diencephalon
5	occlusion,
5	ach-relaxation
5	torres
5	co<inf>2</inf>)
5	(snpc),
5	neurotrophins
5	injury;
5	proteomics,
5	schizophrenia,
5	schizophrenia.
5	(snpc)
5	nestin
5	neurodevelopment.
5	(mc)
5	doublecortin
5	(dcx)
5	receptors),
5	postlesion,
5	nitrosative
5	fos,
5	transdural
5	d2)
5	cx-mediated
5	caspases.
5	effort.
5	short-term,
5	subgranular
5	preference,
5	gaba-positive
5	gfap,
5	gallus)
5	cerebella
5	channel-specific
5	gcl
5	x)
5	heteromeric
5	fibers/terminals
5	messengers,
5	d-28k
5	rostrocaudal
5	cr-ir
5	pv,
5	map-2
5	(nachr)
5	synapses.
5	down-regulated,
5	atp-induced
5	disposition,
5	dopamine-
5	camp-regulated
5	densest
5	glur3
5	posthatching
5	(cea).
5	cea.
5	anterogradely
5	nebulization
5	relieved
5	short,
5	(spla2),
5	hindpaws
5	support,
5	(7-ni),
5	uninephrectomy
5	(spl)
5	forebrain,
5	mismatches
5	labels
5	axons.
5	inclination
5	leave
5	microtome
5	tracing,
5	c57
5	crna
5	α‐bungarotoxin‐insensitive
5	(α7
5	(dgcs)
5	excited,
5	(considered
5	(equivalent
5	motion.
5	aos
5	coordination,
5	mt-ii.
5	nefas
5	il-1ra
5	cd45
5	leukopenia
5	not)
5	assessment,
5	hypercortisolism
5	euthanized,
5	futsal
5	(68%)
5	cinc-2αβ
5	beta-hydroxy-beta-methylbutyrate
5	mp-1
5	2.4-fold
5	dystrophin-deficient
5	4e-bp1
5	radical.
5	(pufa)
5	gamma-linolenic
5	toxicology
5	alimentary
5	autoantibodies.
5	symmetrical
5	[tumor
5	sle.
5	pparγ-dependent
5	(palmitic
5	90,
5	synthase),
5	lgp
5	(mtorc1)
5	myofibers,
5	repress
5	sympathoexcitation.
5	3;
5	acids;
5	mass;
5	(17%)
5	phosphofructokinase
5	crs
5	peroxisomal
5	mnps-dmsa
5	hypusination
5	tnfr1
5	biotin
5	nellore
5	mfi
5	0.004)
5	open-circuit
5	microcystins
5	l-arginine,
5	gc7
5	(iih
5	l-alanine.
5	4-nerolidylcatechol
5	pc.
5	competition.
5	bcl-xl
5	(cp-pgs)
5	withdrawn
5	interleukin-8
5	(nmda
5	aβ.
5	pgj2
5	(fo,
5	(nmol
5	(25,
5	imatinib.
5	es.
5	fasl,
5	cjun
5	heparinized
5	oa,
5	stat5,
5	iterative
5	g.,
5	l-ala
5	first-line-of-defense
5	pma-induced
5	(mtor)
5	ucps
5	mitogen-induced
5	pterocarpans
5	c.d.
5	problematic
5	conjugation
5	(mφ)
5	anions.
5	(30,
5	hypercholesterolemia,
5	(83
5	dl-carnitine
5	μu/ml)
5	(7.5
5	gel,
5	g.kg-1
5	bcl-xs
5	(ast),
5	27%
5	metabolite,
5	metabolization
5	16-fold
5	(43%)
5	biochemically,
5	dipyrone
5	(parp)
5	chimeras
5	gsh-px
5	extra-hepatic
5	oat
5	pc(a-s)
5	ohc
5	(p2)
5	iptg
5	dialysis.
5	(overseas
5	association)
5	capacitance
5	suv
5	oil-enriched
5	25%,
5	exhaustion,
5	(55
5	larynx
5	hela,
5	(promyelocytic
5	pga1
5	ht29
5	(where
5	communicate
5	18-carbon
5	79%
5	(78%)
5	(g)
5	cecum
5	13%,
5	t24/83
5	krebs'
5	oxoglutarate
5	exercising
5	less.
5	interconversion
5	suffers
5	oropharyngeal
5	uganda
5	leite,
5	mrs
5	(ps)
5	open-access
5	boy
5	twenty-six
5	coinfections
5	psittacine
5	264
5	quickvue®
5	petrel
5	costa-da-silva
5	(zikv
5	subregion
5	shorebirds
5	north-eastern
5	juquitiba
5	immunoprophylaxis
5	neonates,
5	prescription
5	(rv)
5	lots
5	h7
5	co-circulating
5	daycare
5	eptesicus
5	cloning.
5	denv-1
5	3b,
5	occasions
5	guillain-barré
5	backgrounds.
5	illness,
5	vp1/vp2
5	donations
5	310
5	retroviruses
5	virus-like
5	ad8
5	pairs.
5	paediatric
5	co-agglutination
5	one-
5	tgfa
5	anova,
5	guidelines.
5	αvβ3
5	thyrotrophs
5	consumes
5	hyperthyroidism-induced
5	pituitary-thyroid
5	nis,
5	(diabetic
5	(dt3).
5	slc26a4
5	t2
5	sodium-iodide
5	ewat,
5	autoregulatory
5	academia
5	lh.
5	sham-operated.
5	half-life,
5	dosage,
5	(control);
5	gravity,
5	5′-untranslated
5	physicians,
5	np
5	0.92
5	5'-d
5	fast-twitch
5	131i
5	nerve;
5	ctcs
5	shapes.
5	few,
5	rms
5	sarcomeres
5	ample
5	invaginations
5	(dmd)
5	amply
5	angioarchitecture
5	denticles
5	hydrodynamic
5	lpg
5	ependymal
5	tio
5	-np
5	standardize
5	stiffness
5	(scn),
5	(vip)
5	(hrsem).
5	term,
5	-9.
5	overdose
5	sarcolemma
5	disk,
5	stents
5	groupings
5	immersed
5	tongues
5	guianensis
5	macroscopically
5	impregnation
5	perimeter,
5	cd.
5	dentin.
5	dentin,
5	underdeveloped
5	smooth,
5	glutaraldehyde
5	etching
5	ligament
5	foramina
5	core,
5	disposition.
5	loops.
5	paratrigeminal
5	mandibles
5	juxtaposed
5	delicate
5	cytology.
5	board
5	apella,
5	grandry
5	(pag).
5	rostrolateral
5	mch/nei
5	associative
5	implement
5	competing
5	immunostaining,
5	anxiolytic-like
5	10.3
5	reactivated
5	excitotoxic
5	proestrus.
5	foraging
5	anti-predator
5	cck
5	neurotoxins
5	snc-lesioned
5	conveyed
5	hd
5	(phal)
5	36s
5	body-specific
5	precommissural
5	periventricular,
5	absolutely
5	3.4.24.15)
5	ei
5	nei.
5	wake-promoting
5	crf,
5	crfr1
5	mch,
5	choroidal
5	ganglion.
5	(dmh)
5	(125
5	anxiolytic
5	ghrelin.
5	ikkε
5	vasculosum
5	calbindin-ir,
5	(ew),
5	habits,
5	(callithrix
5	(war).
5	kindled
5	adaptation,
5	crf-related
5	motoneurons.
5	prepro-mch
5	(arc).
5	paradigms,
5	nadph-d
5	methodology,
5	ewn
5	double-label
5	crf-r1
5	(median,
5	prominently
5	participants:
5	misfolded
5	caspase-8
5	inflammasome,
5	biomarkers,
5	ng/ml;
5	cpf
5	10.5
5	preeclamptic
5	sdf2-like
5	o2),
5	bewo
5	digestion.
5	first-trimester
5	cr-1
5	pgf
5	ec.
5	stag
5	(inos).
5	ifn-γ-mediated
5	irs-1/pi
5	pcos.
5	pregnancy-associated
5	tgc
5	useful.
5	glycans
5	vitro)
5	rcho-1
5	breached
5	ubiquinones,
5	plant-derived
5	farnesylation
5	tagging
5	discovered.
5	isoprenoids.
5	organelles,
5	octaprenyl
5	s-farnesylthiosalicylic
5	proof
5	non-infective
5	feasible,
5	vitellogenin,
5	oscheius
5	polypeptides.
5	vitellins
5	colonies.
5	104,
5	cockroach
5	elaboration
5	edp
5	aspiration
5	umbratilis
5	leishmaniases
5	sandflies,
5	166
5	148
5	fly,
5	st2
5	anthropophilic
5	ccl
5	nonparametric
5	ii/iii
5	jorge
5	marajó,
5	ellipsoidal,
5	discriminant
5	dissected,
5	para,
5	spherical,
5	28°c.
5	11.4
5	bahia.
5	viscera
5	chagas’s
5	18.4
5	panamanian
5	noninfectious
5	sb203580
5	extension.
5	pv-ir
5	5-fluorouracil
5	(5-fu)
5	ckd,
5	sulfonic
5	estrogens,
5	co-expressing
5	(nnos),
5	baishideng.
5	nadh.
5	d42
5	coeliac
5	neun
5	intramural
5	igles
5	minority
5	neurons;
5	mothers,
5	chelonoidis
5	pre-contracted
5	(sgc
5	7 days
5	bariatric
5	open-label,
5	prilocaine,
5	daily).
5	naproxen.
5	fenticonazole
5	(efs)-induced
5	ketoconazole
5	aucinf
5	agency,
5	eurofarma
5	amniotes
5	tablet,
5	ova-challenge
5	coincubation
5	ether/hexane
5	1-100
5	0.5-50
5	lc-ms-ms
5	kaplan-meier
5	pharmacodynamic
5	two-week
5	formic
5	respectively:
5	clean-up
5	(mrm)
5	dermatological
5	(0.001-100
5	hemipenes
5	c57bl6/j
5	tmax,
5	set);
5	hydrolyzes
5	cavernosum.
5	ciprofibrate
5	inactivation.
5	ttx.
5	41-2272)
5	10-ml
5	cacl2,
5	force-displacement
5	41-2272-induced
5	thrombin-activated
5	0.0001;
5	cefuroxime
5	axetil
5	(sea)
5	vardenafil,
5	seb)
5	0.999).
5	fda
5	icatibant
5	(0.03-0.3
5	(mpo),
5	nk-1
5	benzilate
5	embolism
5	bioequivalent.
5	solution)
5	α-helix
5	0.06)
5	administration)
5	thromboplastin
5	(pla2),
5	aa-861
5	escalation
5	(0.01-10
5	1.9-fold
5	food-producing
5	(ici
5	p7.
5	(54.6
5	potencies
5	2s.
5	mg/rat
5	precisions
5	(eds),
5	(rbcc)
5	4%,
5	moiety.
5	β-amyloid
5	cereal
5	ttx
5	prejunctional
5	fn
5	spider.
5	s.c.,
5	acr
5	calmodulin,
5	cofactors,
5	1-50
5	protonated
5	juice,
5	nmol/paw)
5	urease
5	(25-100
5	aav
5	drop,
5	micromol/l;
5	neca,
5	microvasculature,
5	ethyl]-4-phenyl-1
5	[2.2.2]octane
5	can,
5	amines.
5	asp-49
5	industria
5	purinoceptor
5	(spla2)
5	t(max),
5	(18%
5	capsaicin-treated
5	laboratorios
5	variable.
5	pae
5	auc((0-∞))
5	clamicin(r)
5	subnitrate
5	pharmacokinetics.
5	hydraulic
5	caterpillars
5	lippincott-raven
5	(119
5	phase).
5	ppk
5	(ic25
5	6-oxo-prostaglandin
5	effluent.
5	fr139317
5	histamine-
5	nmol).
5	tbe
5	mg/l)
5	d‐arginine
5	et‐3
5	thrombin,
5	il1-β
5	thioperamide
5	mt-iii.
5	c3g
5	peritonitis,
5	115-129
5	viperid
5	asper,
5	bap1.
5	hypernociception
5	sc-560
5	isotype-matched
5	clodomiro
5	picado
5	jararaca,
5	luanga
5	magnitude.
5	halimane
5	unicellular
5	non-tumor
5	lc3
5	supply.
5	(colon
5	gas-phase
5	brea
5	pre-tumor
5	non-apoptotic
5	46.3
5	(0.4%,
5	4.5-fold
5	nanoencapsulation
5	nanocarrier,
5	synergism.
5	<0.1
5	≤500
5	intraductally
5	ceramide.
5	il1-β,
5	(hl-60,
5	t1
5	biflorin,
5	capraria
5	aberration
5	immunoaffinity
5	caspase-9
5	sedative
5	7-11
5	cu,
5	n-cadherin
5	(colon)
5	quinones
5	platinum(ii)
5	quassinoids
5	thiocholine
5	3h,
5	(mart.)
5	pisolithus
5	lc-ms/ms.
5	biflora
5	sylvestris
5	coriacea
5	(red
5	casearin
5	cem
5	pc-3
5	mdamb-435
5	exocyclic
5	acyclic
5	dft
5	hl60,
5	regelianus
5	(+)-mutisianthol
5	cf-pls
5	atividade
5	hydropic
5	physalins
5	occidentale
5	abdominis
5	α2c-ar-/-
5	ultimate
5	osteoblasts.
5	osteoblast
5	t<inf>3</inf>-induced
5	non-alcoholic
5	hypercaloric
5	monocarboxylate
5	bones
5	each,
5	yoghurt
5	immobilization)
5	osteopenic
5	wt)
5	lysosomes,
5	plexin
5	b2.
5	underlined
5	engaging
5	sulfhydryl
5	grades
5	krecs
5	hypomorphic
5	immunodeficiency,
5	monogenic
5	p1104a
5	abd
5	(range,
5	ptb.
5	disease-causing
5	referral
5	wes
5	mites,
5	illnesses,
5	immunologists
5	non-canonical
5	hypogammaglobulinemia
5	(trail)
5	urogenital
5	situations).
5	(sscp)
5	coli;
5	candidal
5	250,000
5	polyposis
5	9.5%
5	cribs
5	proband
5	oxidants
5	inhalant
5	u/ml),
5	hemostasis
5	degraded,
5	blood-fed
5	9a5c
5	sorting,
5	potency.
5	radiotracer
5	robotic
5	attaining
5	regulator-acquiring
5	vitronectin.
5	enrollment
5	pre-targeting
5	anti-human
5	revs-chi
5	humanization
5	featured
5	amorim,
5	aspergillosis,
5	(cpg)
5	dodab,
5	bond,
5	(cfa)
5	(moab)
5	kda/14
5	crassiceps
5	diameter)
5	oa-specific
5	ctx-treated
5	cfa,
5	(spf)
5	mhv+
5	pep5,
5	cell-penetrating
5	polyglutamine
5	nln
5	psychoactive
5	half-lives
5	chem
5	his600
5	metabolize
5	oligopeptidase.
5	s-glutathionylation
5	abz
5	ala,
5	anchor
5	ep24.15/16
5	enzyme's
5	1-copy
5	carrageenin.
5	exons,
5	catalog
5	delineation
5	kcat/km
5	ace,
5	mm-1
5	phosphopeptide
5	att-20
5	enzymatically
5	amarus
5	th1-cell
5	fraga,
5	kennewicki
5	pattern-recognition
5	gaf
5	(alternative
5	c2,
5	plasmin
5	multifaceted
5	lipoproteins,
5	surrogate
5	(eaec),
5	activators,
5	plasmas
5	o26:h11
5	interrogans.
5	c1q
5	lyse
5	tlyc
5	lsa21
5	cyp21a2
5	genotype-phenotype
5	interconnections
5	perspective.
5	proceed
5	exacerbating
5	oncogenes.
5	nascimento
5	hpv-associated
5	prpc-sti1
5	sti1,
5	prpc,
5	neurosphere
5	alphamed
5	puzzle
5	anti-mitogenic
5	mek1
5	pd98059.
5	2h
5	enlighten
5	penetration-enhancing
5	paclitaxel,
5	2;
5	subneutral
5	dmh,
5	well-controlled
5	controlled,
5	proteins)
5	oncogenesis
5	ephrins
5	eph
5	deuteroporphyrin
5	2,4-bis
5	aminophylline
5	avt
5	registered.
5	vaccinal
5	berghei-var
5	imbalances
5	(nkt)
5	plasmepsin
5	pam
5	asp-2,
5	nilotinib
5	mitotane
5	(n-pomc
5	fifty-seven
5	acth39
5	myotube
5	vps34
5	th-treated
5	(1.35
5	leucine-supplemented
5	ubiquitination.
5	hyperactivity-induced
5	hydroperoxides
5	na+/k+-atpase
5	wasting.
5	murf1/murf2
5	rictor
5	one-repetition
5	288
5	gasp-1
5	7-nitroindazole,
5	h9c2
5	mef-2a
5	thermostable
5	(pr)
5	oncoprotein.
5	[wt]
5	[sle]
5	pep.
5	rlosac
5	∼10-fold
5	hanging-drop
5	å,
5	k12.
5	å.
5	transformants.
5	(xcc).
5	usage,
5	npcf
5	pamps
5	bcr-abl1
5	1.8-fold
5	ia-restricted
5	prame
5	haematopoietic
5	naip5
5	inflammasomes,
5	pyroptosis.
5	tcr/cd3
5	nfat
5	a4m
5	caspases-3
5	myriadenolide
5	flora
5	b-induced
5	perforin,
5	belizário
5	probiotics,
5	(p10)
5	intersubunit
5	glu
5	t-regulatory
5	her2
5	recombinase
5	cyclin-dependent
5	ee.
5	trans-1,3-disubstituted
5	ao
5	xyla
5	montmorillonite
5	scheduled
5	almond
5	antifungals.
5	codrug
5	(w/w).
5	me-mc
5	surfactants
5	lauryl
5	lp-20
5	keloid
5	cofilin
5	azx100
5	droplet
5	dsc
5	ampar
5	strains:
5	hemicellulosic
5	nanodiamonds
5	verification
5	elucidated,
5	g-1,
5	°c)
5	ipt101t
5	streptomycin
5	grip
5	musculoskeletal
5	questionable.
5	ankyrin
5	discs
5	strength,
5	joint.
5	stress-mediated
5	(spla
5	simvastatin,
5	anti-thrombotic
5	mesalamine
5	no-naproxen
5	lornoxicam
5	purchased
5	arv
5	md2
5	cxcr3
5	zikv,
5	reassortment
5	rvf
5	fusing
5	flaviviruses.
5	serotype.
5	hcv,
5	continual
5	codivergence
5	accretion
5	multicapsid
5	vf
5	ns(s)
5	‘genetically
5	sterile’
5	phosphotyrosine
5	[ala
5	fifty-one
5	deployment
5	aati
5	increasing.
5	hex-f
5	kappa-opioid
5	(serotype
5	peri-sciatic
5	chemoattractants
5	bl34
5	gtf1
5	dehydrogenases
5	span.
5	atp25
5	adck3
5	unlinked
5	dyslipidemia.
5	pup
5	ecto-nucleoside
5	angiotensinergic
5	vegf-a
5	sos-induced
5	siderophore
5	dps
5	neto
5	footprinting
5	-80°c
5	services
5	spain
5	cd13
5	ebs
5	c/ebpβ
5	zymogenic
5	pedf
5	ru486
5	cks1
5	sialo
5	suckling,
5	tgfβ3
5	basophily
5	tc22/th22
5	tcd8
5	idec-like
5	tlr7
5	cd4+ifn-γ+
5	i/iii
5	eu
5	(ad,
5	dp-immunized
5	urticaria
5	halt
5	(nka)
5	curitiba,
5	tgf-β2
5	(bfp),
5	yamamoto,
5	low-income
5	iha,
5	x-100,
5	cv.
5	broth.
5	gm1
5	clumps
5	reexposure
5	oprm1
5	oprk1
5	neurotoxicity,
5	scavone
5	u69593
5	baclofen
5	disproportionate
5	self-administration
5	ethanol-fed
5	pons.
5	sleep-deprived
5	conflicts.
5	jumonji-related
5	osteoarthritis
5	isokinetic
5	6g
5	bds
5	paw.
5	(aldh2),
5	alda-1,
5	gk
5	proteolytic,
5	antagonised
5	cullin
5	lg/j
5	peg3
5	nandrolone
5	periwinkle
5	seminalis
5	virens
5	anthracnose
5	siderophores
5	gladioli
5	25°c
5	pr1a
5	libraries.
5	phou,
5	cross-species
5	catharanthus
5	perniciosa
5	pcr-denaturing
5	pumilus
5	cultivars.
5	flaccumfaciens,
5	optima
5	fsl
5	cladosporium
5	vasconcelos,
5	detoxifying
5	5d
5	sevelamer
5	lock
5	(n=14)
5	sarcolemmal
5	rcc.
5	nih/3t3-lendsn
5	pparγ,
5	s7,
5	adipogenic
5	ketonemia
5	visfatin,
5	pparα,
5	2max
5	t)
5	ptld
5	hadvs
5	hadv-3
5	isotherm
5	mold
5	kgy,
5	non-bt
5	2b710
5	fb1.
5	flavus.
5	niv
5	15-adon
5	hx
5	fb2
5	rhizopus
5	(10%),
5	sa/so
5	wind-dispersed
5	brewers
5	10mg
5	dermatophyte
5	capão
5	b10a
5	c5−
5	ald
5	cfh
5	aph
5	alpha2m
5	acceptors
5	46%,
5	retro
5	aids,
5	carcinosarcoma)
5	y)
5	hi-it
5	calories
5	traf6
5	12-week
5	im.
5	depot,
5	congestive
5	periportal
5	imtag
5	genitalium
5	conquista,
5	urealyticum
5	vaginalis,
5	crackle
5	placentitis,
5	alveolitis,
5	taxa,
5	hemoplasmas,
5	guimaraes
5	immunogens
5	iha
5	laidlawii
5	paired-end
5	graph
5	adventitial
5	cervix.
5	mics
5	trichoepithelioma
5	gg
5	cd8,
5	qol
5	cxcl12,
5	sdf-1
5	olp
5	n=20)
5	ictx
5	γ-rays
5	dosed
5	apicomplexa
5	pfnf-yb
5	breast-fed
5	yoelii.
5	cytoadherent
5	monensin,
5	asa
5	laryngopharyngeal
5	eye.
5	retinochoroiditis
5	aerosols.
5	tsp-1
5	anti-cmv
5	succumbed
5	asy
5	allogenic
5	protective,
5	d),
5	atroxlysin-ia
5	(myd88-independent)
5	b220pos
5	henlei
5	kks
5	orpotrin
5	dermonecrosis.
5	ests,
5	collilineatus,
5	β-v59m
5	pel
5	bt.
5	bbci
5	clp+o2
5	ms100a9p,
5	expec
5	(hus)
5	α-hly
5	eric-pcr
5	biofilms,
5	f42
5	iif
5	immunoproteasome
5	subdominant
5	(poly
5	(ama1)
5	csp-specific
5	(pvama-1)
5	adjuvants:
5	(alum),
5	interferon-γ-dependent
5	atrioventricular
5	broadening
5	vivo;
5	tlr4-/-,
5	ifn-γ+cd4+
5	immunogenity
5	9-mer
5	(syvpsaeqi)
5	h2d-restricted
5	(cs280-288)
5	cs280-288-specific
5	(flic),
5	(padre)
5	dna-priming
5	dna-immunized
5	+56
5	aemc
5	warm-up
5	passenger
5	oral,
5	shiga-like
5	aroa
5	fluid-phase
5	(gp43)
5	cfab
5	flagellin-specific
5	(aa
5	pseudotuberculosis
5	nitroreductase-deficient
5	pbp5s
5	(dsc),
5	dodab-bf
5	integrons.
5	carbapenems
5	hm
5	aminoglycosides,
5	β-lactams,
5	plasmid-mediated
5	β-lactamases
5	ctx-m-15
5	extruder.
5	bap
5	meca
5	isotherms
5	nephrotoxic
5	filtrate
5	jambolanum
5	cdt.
5	silicosis.
5	wild-type,
5	atlas
5	atc.
5	mpnst
5	braft1799a
5	smad7,
5	hras
5	5’d-ii
5	rnf113a
5	cwc24p
5	u2
5	nip7p
5	gbm.
5	gliomas.
5	gls2
5	ku80
5	cnps
5	gossypiifolia
5	c5a.
5	rhinoceros
5	1-13
5	anti-bothropic
5	caves
5	c-regulators
5	hyperpolarized
5	macroglands
5	anti-se
5	e(h)
5	lagp
5	pericoronitis
5	hap-1
5	8%)
5	gata3,
5	mdpb-free
5	pmc
5	aqps
5	rhag,
5	ut-b
5	3}
5	/{\text{nh}}-{
5	4}{}^{
5	}
5	pstc,
5	sleep-restricted
5	epithalamic
5	g120r-hgh
5	rmtg,
5	gad67
5	prolactin-treated
5	leptin-treated
5	lufaxin
5	ado
5	sialol
5	histoplasmosis
5	gr-1+
5	cfags
5	hpv-negative
5	hpv-18
5	neutrons
5	(21%
5	(commnts).
5	(ssna)
5	nmol/50.
5	ap1
5	decerebrated
5	(kyn,
5	(mcpg;
5	neuromodulation
5	slco1b1
5	0.42,
5	abcc1
5	g2677t/a
5	ami
5	95%:
5	c161t
5	oip5
5	liraglutide
5	blocker).
5	irss
5	anti-irs-1
5	sodium/potassium
5	p110
5	p<inf>i</inf>
5	rposam
5	infectivity,
5	cdpk1
5	clinmaldb
5	scope:
5	ibat,
5	r132h
5	pce
5	beige
5	adicerko
5	acyltransferase
5	(compound
5	ampd
5	nfo
5	nc
5	upec
5	arb
5	er/gr
5	decoy
5	diamidines
5	tcprodh
5	orc1/cdc6
5	co-localizes
5	t4c
5	rc29
5	baltmpi
5	rbaltmip
5	mooa
5	ibcb
5	macadamia
5	npm
5	npm1
5	2-de
5	fw
5	cramoll
5	msna
5	arrhythmias
5	ct4
5	hgcl2,
5	isovolumic
5	neuritogenesis.
5	cscrt2
5	lnac
5	immunotoxin
5	non-motor
5	hemichannels.
5	breathe.
5	(vrc),
5	agenesis.
5	agonist;
5	atp-mediated
5	xe991
5	amplitude.
5	nacn
5	lutzii.
5	melaleuca
5	anti-gp43
5	nonmelanized
5	htlv
5	wnt5a
5	oscc.
5	lact
5	ckd.
5	mros
5	p =
5	plns.
5	t1d,
5	wj-mscs
5	rejection,
5	αgalcer
5	sleactive
5	stnfr2
5	b1rbk
5	post-transplantation
5	ho-1,
5	ota
5	ul97
5	ascs
5	gsl-1
5	crcl
5	banff
5	posttransplant
5	post-transplant
5	cd20
5	csa-treated
5	caox
5	ebi3
5	gitr
5	ccr5-/-
5	rrvgp
5	laminitis
5	chrebp
5	j18
5	(i.e.:
5	rs11651270
5	cnot1
5	aminobisphosphonate
5	histatin
5	sti1.
5	qsar
5	pdxk
5	pyrophosphokinase
5	satena
5	muellerianus
5	leiocarpus
5	1o
5	pdx2
5	pdx2,
5	lipoylation
5	odc/adometdc
5	geniculocortical
5	prhc
5	e5700
5	er-119884
5	clonogenicity
5	hel
5	siva
4	2.40
4	pro-inflammatory,
4	thought.
4	(snp,
4	(jh+)
4	552
4	beta-arrestin
4	(okp)
4	swelling.
4	supraphysiologic
4	electrophysiology
4	difference.
4	cortex;
4	guanylin
4	methods/results:
4	serine-552
4	(nhe3),
4	ph-dependent
4	phirr,
4	(10-
4	6-min
4	(15-
4	(ca
4	mr)
4	gr)
4	486).
4	potassium,
4	(1%
4	atpases
4	(1.08
4	youth
4	p-nhe3/total
4	microvilli,
4	hco
4	sirna-mediated
4	exendin-4
4	∼50%
4	observations:
4	h-89
4	exendin-4,
4	transporter.
4	1 μm
4	cm-
4	bcecf,
4	na+-independent
4	ii-dependent
4	1-h,
4	spironolactone,
4	(63
4	7%;
4	c11
4	akin
4	reference)
4	0.63
4	0.038
4	(n=12).
4	(intracellular
4	34)
4	0.022
4	antiporter,
4	v1-
4	(am
4	2000).
4	0.71
4	nmol.
4	(bapta).
4	iberiotoxin,
4	16%.
4	total),
4	dimethyl-bapta/am
4	dimethyl-bapta/am,
4	minute)
4	slowly.
4	dids.
4	0.77
4	(pth).
4	pth.
4	compared:
4	8.2%
4	1.3%
4	(when
4	gluconate
4	vivo'
4	microfluorescence
4	(connecting
4	benzamil
4	jhco3−
4	(=
4	cl-/hco3-exchange
4	gluconate.
4	antidiuretic
4	(early
4	(unx)
4	(jv)
4	pco2,
4	cli+
4	added,
4	-depleted
4	kg‐1
4	0.056
4	1.45
4	supplementation,
4	tptx
4	vitro"
4	(apparent
4	10-4m
4	markedly,
4	(gfr).
4	11.0
4	(renal
4	pump-perfused
4	nahco3,
4	pco2.
4	polyene
4	[k+]
4	further.
4	1.60
4	js,
4	jv,
4	60-fold
4	0.32
4	quantitate
4	withdrawal,
4	(gii)
4	(erpf)
4	(gil)
4	s‐1
4	0.73
4	7.25
4	1.32
4	gertz
4	ringer's.
4	(jhco-3)
4	oncotic
4	electrode.
4	0.97
4	6-7
4	hydrostatic
4	1982,
4	"closed"
4	permeance
4	view,
4	finite
4	stereotaxically
4	potentials.
4	intraluminal
4	(13%),
4	stop-flow
4	meq/liter
4	meq/liter),
4	29%.
4	compute
4	minor.
4	diamox
4	alkalosis.
4	31.9
4	omega
4	lined
4	simplify
4	nonelectrolyte
4	p(co2)
4	p(co2).
4	p(co2),
4	discontinuing
4	hypochloremic
4	mineralocorticoids
4	testosterone.
4	duct,
4	1.23
4	effect"
4	embryogenic
4	desirable.
4	line),
4	s-adenosylmethionine
4	putrescine
4	bahia
4	mpn
4	fixation,
4	iaa.
4	family),
4	hydrolases
4	subject.
4	gram-negative,
4	89t
4	lmg
4	dna-dna
4	nearest
4	neighbours.
4	roots.
4	azospirillum
4	ardra
4	(72.6%)
4	medium)
4	combined-n
4	indoleacetic
4	mm);
4	2.5.
4	activity).
4	(36
4	52%,
4	(number
4	stimulated/impaired
4	sa.
4	w13
4	calmidazolium
4	ii).
4	6.43
4	t:
4	v2-receptor
4	avp.
4	(54%)
4	0.210
4	2.16
4	81%)
4	(vell.)
4	mpt).
4	(1.54
4	520
4	mid-proximal
4	day-1
4	6.73
4	mv).
4	facts
4	diphtheria
4	neutropenia,
4	preite,
4	condino-neto,
4	pontillo,
4	loures.
4	signaling)
4	(tregs),
4	(ido)
4	venezuela,
4	loures,
4	calich.
4	apoptosis-associated
4	caspase-1.
4	burdens,
4	undesired
4	non-polarized
4	(ido),
4	loss-
4	th17/tc17
4	laminarin
4	pro-il-1β
4	nalp3,
4	(pdcs)
4	(tregs).
4	cr3,
4	cd25,
4	foxp3,
4	tlr4-defective
4	cd28,
4	(pb265)
4	cxc
4	minireview
4	dictate
4	fasl-sufficient
4	fasl-deficient
4	attracts
4	interferon.
4	(c57bl/6)
4	anti-il-4
4	(igg2a)
4	major.
4	predominated.
4	(il-2),
4	plasmocytes
4	individualized
4	afford
4	emerging.
4	architecture.
4	(il-2
4	associated.
4	lucigenin-enhanced
4	brasiliensis-infected
4	nu/+
4	(igm)
4	anatomy
4	singer-vermes
4	co-investigators
4	wu-hsieh
4	ferrante
4	anti-candida
4	moser
4	co-workers
4	blastomyces.
4	defences.
4	fraction;
4	footpads
4	(nzb
4	c57b1/6,
4	proteoglycans.
4	pb339
4	pb18av
4	correspondence
4	5×106
4	op
4	loses
4	intermediate,
4	martinus
4	nijhoff/dr
4	immunodepression
4	yeast-like
4	40-50%
4	leucocytes.
4	characteristics:
4	nonirradiated
4	ims
4	appreciably
4	u.v.
4	conclusively
4	1979.
4	private
4	personnel
4	(50 mg/kg
4	trafficking.
4	menstruation
4	51a,
4	51a
4	barros
4	il-13.
4	equi,
4	il-6)
4	huc/d-immunoreactive
4	calbindin-immunoreactive
4	estradiol.
4	(12)
4	(13)
4	(14)
4	sickness
4	chat-immunoreactive
4	menstrual
4	sensitisation
4	cyclooxygenase-derived
4	ovalbumine
4	ovalbumine-sensitized
4	ligeiro
4	(intrinsic)
4	(extrinsic)
4	vigorously
4	gallamine
4	juciane
4	annexin-a1
4	mitigating
4	(i-i/r)
4	lung's
4	pecam-1,
4	inlet
4	hypothalamus-pituitary-adrenal
4	generations.
4	gr,
4	12.5,
4	exposures,
4	3h
4	neubauer
4	platelet-endothelial
4	(pecam-1)
4	tracheae
4	regard.
4	neuron,
4	33%,
4	-ir
4	ova-alum
4	(booster).
4	revisited
4	orchestrated
4	cytokine/chemokine
4	explants,
4	cultured-bal
4	nose
4	microplates
4	atmosphere.
4	tlr/myd88
4	90-min
4	(n-nitro-l-arginine
4	detached
4	(evans
4	nstz
4	120 h
4	plate-shaped
4	pieces,
4	ti,
4	non-adrenergic
4	protector
4	(bhr)
4	bhr.
4	preventable
4	©2007the
4	2-day
4	reproducing
4	cd1
4	drainage
4	journals
4	0).
4	smgx
4	nor-dihydroguaiaretic
4	inescapable
4	nonstressed
4	mesentery,
4	nonimmunized
4	nitrates/nitrites
4	5823
4	5720
4	complex-induced
4	ro
4	(upper
4	web-2086
4	5‐hydroxytryptamine
4	aps
4	venoconstriction
4	alveolitis
4	intrabronchial
4	progressing
4	thromboxanes
4	-stimulated
4	postjunctional
4	differ.
4	associations.
4	(bz)
4	intragenic
4	hits
4	screening.
4	discovery,
4	screens
4	toxicities
4	t. cruzi
4	end-products
4	(orestes)
4	339
4	singletons
4	contigs.
4	195-bp
4	orienting
4	haemoculture
4	nd4
4	favours
4	polyphyletic
4	probabilities
4	reads,
4	(cardiac
4	esmeraldo
4	merged
4	bayboots
4	(ber)
4	interpretation.
4	automatically
4	neighbor
4	recognized,
4	gmbh,
4	berlin/boston.
4	eluates
4	(cl
4	1/2).
4	clusters:
4	451
4	57.1%
4	neglectus
4	rdna,
4	era
4	turns
4	reconstruction.
4	lsu
4	p542
4	(kdna)
4	dead-box
4	single-copy
4	myr
4	non-transcribed
4	marsupialis
4	'core'
4	pb13,
4	configuration,
4	peptides'
4	domiciliated
4	(68
4	(lit)
4	performs
4	launched
4	mapping,
4	cl-brener
4	constructed,
4	bacs
4	(rapd).
4	branches.
4	bioactivity,
4	trypanosomal
4	bi3
4	b13.
4	epi,
4	chronic-phase
4	affinity-purified
4	ama
4	8-13
4	heart-specific
4	surface-bound
4	ria.
4	209
4	[3h]
4	culture-derived
4	(y,
4	autoradiograms
4	blots.
4	fragment.
4	tunicamycin-treated
4	t.cruzi
4	1.33
4	[35s]methionine
4	mn2+.
4	vibration
4	polymerase.
4	high-glucose
4	exocytosis,
4	regulator.
4	(ins)
4	ins,
4	intraperitoneal)
4	n-acetyltransferase,
4	pgz + ins
4	big
4	(atgl)
4	48-hour
4	(dhe)
4	ubm
4	(oral
4	(gsis),
4	hypertriglyceridemia,
4	isp,
4	(irs-1,
4	(20mm)
4	nutrient-induced
4	(gpr40)
4	dpi)
4	homoeostasis
4	hyperinsulinaemia,
4	signal-related
4	hyperinsulinaemic
4	(model
4	n-6/n-3
4	(350
4	glycoaldehyde
4	(irs)/pi3k/akt
4	insulin-resistance-induced
4	(p22
4	phox).
4	eif4e
4	(sc,
4	(ep
4	(erk1/2,
4	1mm
4	10mm
4	palmitoyl
4	[u-c]glucose
4	hydroethidine.
4	(erk1/2),
4	15-minute
4	(extracellular
4	sapk/jnk
4	diphenyleneiodonium,
4	diacetate.
4	glucokinase.
4	gp91phox).
4	objectives::
4	methods::
4	results::
4	conclusions::
4	ins-1
4	(igf-r)
4	mek/erks
4	accepted,
4	glucolipotoxicity
4	(11.1
4	brin
4	bd11
4	gf109203x.
4	(prl).
4	map2.
4	companied
4	erk3/map2
4	fa)
4	pancreata
4	akt-1,
4	akt-2;
4	dhea-treated
4	(107
4	-1;
4	8.3,
4	α-ketoisocaproate
4	sugar.
4	non-insulin-dependent
4	hox.
4	(nbt)
4	bysindoylmaleimide
4	(gf109203x)
4	pkc-specific
4	-palmitate
4	(pe),
4	phosphatidic
4	glycerol-phosphate
4	rhythm.
4	3′,5′
4	-cyclic
4	produce,
4	just-weaned
4	7%),
4	the,
4	(8.3
4	(ef)
4	2-month-old,
4	fmol/mg
4	(0.1-100
4	staurosporine.
4	(hp),
4	(hl)
4	oxalacetate
4	amounted
4	microu/ml
4	fasting)
4	carbamylcholine
4	time-and
4	non-insulinotropic
4	flush
4	vastly
4	sigmoidal
4	provokes
4	tumor-promoting
4	membrane).
4	acidified
4	α-ketoglutarate
4	harm
4	mg/kg);
4	prt
4	post-training
4	[3h]-dopamine
4	7:00
4	(38.3
4	t-test
4	fcf.
4	(apo)
4	imi
4	dmi
4	stimulant-induced
4	cross-sensitization.
4	(1.0-10.0
4	fencamfamine-induced
4	stereotypy
4	anoretic
4	fencamfamine.
4	(0.02
4	olfactorium,
4	(lc)
4	abstract—
4	1978.
4	pfk,
4	congress
4	1974.
4	offspring)
4	concentration-effect
4	endo+
4	(cox)-1
4	(sham),
4	cee+t
4	cyp/20-hete
4	anatomy,
4	cells/ml
4	j/cm2;
4	joule
4	(ang-ii
4	(par-2)
4	(sma)
4	‘gasomediator’
4	slow-releasing
4	(gyy4137)
4	(na2s
4	lawesson's
4	lr)
4	(c48/80)-dependent
4	na2s,
4	0.3–100
4	(neutrophil
4	recruitment).
4	gyy4137.
4	tyrode
4	euthanised;
4	isoenzymes.
4	prooxidant
4	started.
4	p-erk1/2
4	anti-tlr4-treated
4	determinants.
4	nadphox
4	60-min
4	(b1r)
4	des-arg
4	mini-pumps
4	hplc,
4	<0.01).
4	(1.0μg/g)
4	(1.5μg/g)
4	intranasally.
4	rhepo
4	breakdown.
4	calphostin
4	pre-pro-endothelin
4	ser473,
4	ser1177,
4	ser633
4	(rmax)
4	(10 μmol/l
4	ozrs.
4	overloading
4	(td
4	id),
4	photobiology.
4	achilles
4	tendons
4	6/group)
4	et-1-induced
4	gender-related
4	t2dm,
4	ana
4	villela
4	pyrilamine
4	2-ar
4	(toll-like
4	(spontaneously
4	elusive,
4	minutes).
4	flutamide,
4	(wistar-kyoto
4	3-(4-chlorophenyl)
4	1-(1,1-dimethylethyl)-1h-pyrazolo[3,4-day]pyrimidin-4-amine
4	castrated
4	shrsp
4	stim1
4	generation;
4	ogt
4	antagonist).
4	(mlc)
4	(daf-2)
4	animal)
4	mn,
4	micronutrient
4	fundus
4	ω
4	pyk2
4	materials:
4	mg·kg-1·d-1,
4	discarded.
4	connect
4	britain
4	eliminated.
4	diphtheria-tetanus-whole
4	suspect
4	ng/kg
4	cdnas)
4	citrulline)
4	cytometry),
4	mntmpyp
4	(sod
4	ach.
4	hydrate.
4	proteins).
4	ridogrel,
4	6-keto-pgf1α,
4	microvessels.
4	l-citrulline),
4	(rt-pcr),
4	(diaminofluorescein),
4	(spectrophotometry)
4	(acute)
4	vasodilators
4	(-log
4	endothelium-
4	correction.
4	(enos
4	inos)
4	a-779
4	ed-1
4	enalapril,
4	nad(p)h-oxidase
4	lh/fsh
4	leu,
4	replacement,
4	(cad)
4	cad
4	lvef
4	non-failing
4	1.43
4	35%.
4	22mm
4	minalrestat,
4	permeability-increasing
4	po)
4	uninx.
4	/et
4	female)
4	radical,
4	irl-1620-induced
4	worsens
4	(e+)
4	e+
4	5-ht,
4	ridogrel
4	liberated
4	(l-nmma)
4	nmol/l,
4	spin
4	correcting
4	concentrations)
4	effect;
4	ascorbate
4	0.3%
4	sulfonate
4	(30%
4	ng-monomethyl-l-arginine
4	papaverine,
4	bathing
4	edrf,
4	maintainance
4	gil,
4	completely,
4	1984.
4	ionomycin,
4	β-hydroxylase
4	cat.
4	model),
4	gamma-aminobutyric
4	10-20%
4	hearts,
4	nigriventer,
4	q.
4	shrinkage
4	patches
4	stabilizes
4	kg)
4	avp-induced
4	cis-unsaturated
4	3-h
4	golden
4	challenging.
4	1800
4	calculations.
4	disruptor
4	genes/proteins
4	perchlorate-treated
4	dio1
4	monitored,
4	(fsh)
4	imbalances.
4	weapons
4	galectin-1
4	gal1
4	autoradiographic
4	paucity
4	vapor
4	non-invasively
4	biopsied
4	shg
4	enlarge
4	conceptus
4	profile)
4	influence.
4	race-pat
4	transcript,
4	onward.
4	(stat3)
4	dop
4	dop.
4	stat3,
4	fibrillogenesis.
4	followed.
4	asymptomatic.
4	di-
4	spongiotrophoblast
4	osteopenia
4	α2a-,
4	α2c-
4	(slrps)
4	(mpa)
4	slrps
4	myometrium.
4	jararhagin-c
4	test);
4	metabolic-hormonal
4	mrna;
4	interactive
4	epithelia.
4	visible,
4	(mmp)-2
4	e18.5,
4	intramembranous
4	p14.
4	result:
4	peri-implantation
4	nondecidualized
4	632.8
4	collagen-containing
4	predominated,
4	implanting
4	formed,
4	l∥
4	occipital-caudal
4	organized.
4	engineers.
4	surround
4	polygonal
4	dissimilar
4	femur.
4	(hcs;
4	igf-i,
4	tibia,
4	mineralization
4	arrive
4	substratum
4	odontoblast
4	ameloblast
4	calcification
4	predentin
4	pulp,
4	intraperitoneally)
4	decidualization,
4	fixative.
4	shrt
4	ac,
4	caps
4	#3
4	autoradiography.
4	pgs.
4	4-day
4	gags
4	charqui
4	nitrite,
4	dehydration,
4	wounds.
4	1997).
4	oxoglutarate,
4	concentration:
4	5-
4	pcc
4	attaches
4	colchicine
4	synoviocytes
4	day-old
4	afterwards.
4	6-h
4	cardiovascular,
4	protocols:
4	(qpcr
4	(griess
4	(power
4	†
4	vagus,
4	neuroplastic
4	(bbb)
4	(pvn),
4	fitc
4	lf/hf
4	uncovers
4	cardiomyocytes'
4	1.19
4	17th
4	ambiguus
4	dbhir
4	(32
4	(ext)
4	(i.v.,
4	(i.p.,
4	(dihydroethidium
4	blotting),
4	(wistar
4	fall.
4	(dm).
4	posterior,
4	arch.
4	(81%,
4	unloading
4	(17%,
4	(wky),
4	capacity)
4	groups),
4	prevention,
4	arterioles)
4	(123
4	(high-performance
4	chromatography)
4	(lsna)
4	wky.
4	neuroprotection,
4	content)
4	(t;
4	wall:lumen
4	36%)
4	capillarity
4	recordings,
4	afferents,
4	(nor)adrenergic
4	boutons
4	preto,
4	students.
4	attributes,
4	weekly.
4	stressing
4	(35%,
4	17.5%
4	5-hydroxytryptophan,
4	tph
4	controllers
4	activity/pressure
4	ng/kg/min)
4	(900
4	modulates,
4	(104
4	(electrolytic
4	gauge
4	morphometry.
4	(21%),
4	stress-strain
4	1.06
4	(pra)
4	147
4	coherent
4	6.8%
4	plateau,
4	38%,
4	magna
4	postrema.
4	2-20
4	75%,
4	rhr
4	pig.
4	(phylum
4	respiratory,
4	visited
4	1:50,
4	farm,
4	donkeys,
4	carthorses
4	ultrasound
4	occured
4	brl
4	santo,
4	caatinga
4	biome,
4	5.3%
4	mat.
4	biome.
4	albiventris,
4	auricularium,
4	loricatus,
4	domestica,
4	abattoir
4	exports
4	biomolecular
4	pecari)
4	domesticus)
4	titrated
4	reference.
4	standard,
4	(ms).
4	amphibians
4	squamata
4	nymph
4	level;
4	rhinella
4	forests.
4	herds.
4	sampled,
4	lice
4	3.4%
4	bengal
4	paca
4	(cuniculus
4	pathological,
4	alt.
4	homes
4	mammals)
4	ruminantium
4	germany.
4	rabbit.
4	paraíba.
4	(12/15)
4	(pcr-rflp)
4	piroplasmida
4	herds,
4	subsistence
4	runs
4	brii
4	rflp.
4	noronha
4	1:25)
4	(0.9%)
4	herpetosoma,
4	hemoculture,
4	measures,
4	karajá
4	tapirs
4	institution
4	catus)
4	splenomegaly
4	(ihc)
4	haemoculture,
4	attentive
4	dam
4	districts,
4	polymorphism)
4	zoos
4	(male,
4	flotation
4	20.5%
4	16.1%
4	(nasua
4	omnivorous
4	coatis
4	tietê
4	1:16)
4	1:200
4	333
4	river.
4	variable,
4	yagouaroundi
4	pardalis
4	(chrysocyon
4	canid
4	beings.
4	(enzyme-linked
4	vl,
4	sentinels
4	neighborhoods
4	(ifa),
4	riverside
4	restrictions
4	reliable,
4	intends
4	climates
4	nc-1
4	1.09
4	nymphs,
4	cajennense,
4	humerale.
4	bellii,
4	fauna,
4	rickettsiae
4	8.6%
4	aurita)
4	pastures
4	mt,
4	oncilla
4	ompb
4	1:160
4	7.6%
4	mus
4	%),
4	seminested
4	abortions,
4	ancestor.
4	felines
4	16.6%
4	marinkellei,
4	tigrinus
4	margay
4	14.6%
4	captivity,
4	9-10
4	ilha
4	37.6%,
4	6.4%,
4	four,
4	1.1%
4	sag2
4	caprine
4	failures.
4	(9.8%)
4	ninety-one
4	0.014)
4	ihat
4	(kappa
4	samples),
4	(25.9%)
4	(11.1%)
4	isolations
4	(33.3%)
4	culling
4	farm.
4	sex.
4	56,
4	territory
4	genders,
4	diagnoses.
4	jaguarundi
4	(puma
4	armadillo
4	1400
4	encephalitozoon
4	popularity
4	mussels
4	(n.
4	(p.i.)
4	days);
4	body-weight
4	pigeons,
4	260
4	(igm),
4	cerdocyon
4	thous
4	parvovirus,
4	cdv
4	foxes,
4	4.3%
4	institutions
4	conservation,
4	spread,
4	saprophyte
4	carnivores
4	(50%),
4	epg
4	32.5
4	litter.
4	faeces,
4	pooled,
4	pepsin,
4	nelore
4	recommendation
4	county,
4	seropositivity.
4	livestock.
4	[95%
4	glta
4	toxoplasma,
4	hammondia-like
4	humour
4	liters
4	1:
4	protozoan,
4	autumnalis
4	(4.7%)
4	ai.
4	distance.
4	unwanted
4	27.3%
4	antigens:
4	219
4	mares
4	5.8%
4	reprogramming.
4	(m1)
4	stat1,
4	5lo
4	5lo−/−
4	m1-like
4	levels).
4	diterpenoid
4	repopulation
4	mirnas.
4	kbp
4	repopulation.
4	stat1/myd88
4	anacardic
4	kbm
4	junior
4	pafr-antagonists
4	adaptor.
4	heretofore
4	interleukin-6.
4	receptor)
4	atms
4	transcription-quantitative
4	ly6c
4	(5-lo)
4	(signal
4	f4/80+
4	validating
4	filgueiras
4	tgf-β-induced
4	micrornas.
4	mir-146b,
4	blt1
4	immunologists.
4	uscap,
4	rafts,
4	(dc).
4	(ac),
4	efferocytosis
4	machado
4	melanomas.
4	293t
4	(x-higm)
4	(cd80
4	etiopathogenesis
4	reactive.
4	0.9%,
4	0.07,
4	10.5,
4	(124
4	8.94
4	(79
4	4.2,
4	mg/0.4
4	thereafter:
4	cys-lt
4	igg-srbc
4	microenvironmental
4	paf-r
4	kc)
4	(hoe
4	laparoscopic
4	(pg)-e
4	(64%),
4	(52%),
4	(43%),
4	pharmacological,
4	(balf).
4	bioavailable
4	limit.
4	tγδ+
4	bq123
4	bq
4	superantigens
4	weather
4	(cox)-2,
4	(eia).
4	sirs
4	tyr-326
4	(48%),
4	nkt,
4	hsps
4	ovalbumin-alumen
4	dapi
4	9.1
4	8.7
4	shedding,
4	myeloperoxidase,
4	ecv-304
4	inhibition).
4	(lps,
4	750
4	2o2
4	(55%),
4	31.5
4	ir-et
4	paf-antagonist
4	(nimesulide
4	(43%
4	enhanced.
4	apart)
4	vβ
4	pretreatment,
4	coisogenic
4	deficient)
4	mg/ml),
4	unfractionated
4	ldl.
4	fat-free
4	cages.
4	compositions
4	(lct)
4	fed,
4	(4%
4	c4/d4
4	coagulated
4	ova/al
4	(1.14
4	arginini-infected
4	infected-cell
4	24.5
4	f35,
4	solidified
4	th2-
4	u-83836e
4	cd-1
4	35,
4	arginini.
4	(34.7
4	no2-).
4	(61.4
4	9.1%;
4	(48.5
4	no2-;
4	subcutaneously,
4	shedding.
4	anti-bovine
4	polycarbonate
4	baec
4	fluids.
4	down-regulation,
4	85%,
4	anaphylaxis,
4	aia
4	intraperitoneally,
4	intra‐arterial
4	spasmogen(s)
4	srs
4	passing
4	functioning,
4	understudied
4	province,
4	cobalt-rich
4	oceanic
4	formulate
4	biogeochemical
4	thermophilic
4	salmon
4	salinity,
4	hydrothermal
4	composition;
4	winter,
4	gammaproteobacteria
4	5.0%
4	(of
4	(otus)
4	affiliation
4	dominant,
4	macro
4	suite
4	biota
4	gulf
4	video
4	in-depth
4	bioproducts
4	cultivating
4	masses,
4	83.8%
4	sediments,
4	morphotypes
4	firmicutes,
4	pico
4	abundances
4	pigmentation,
4	republic,
4	gc-ms
4	heidelberg
4	fifty-two
4	habitats.
4	extremophilic
4	(referred
4	oxidoreductases
4	racemic
4	arthrobacter
4	emissions.
4	positivity.
4	pyrosequencing
4	arguing
4	psychrobacter
4	libraries,
4	ecology.
4	oil-degrading
4	naphthalene
4	alkm
4	optically
4	alcohols.
4	keller
4	mannich
4	operations.
4	vials
4	(rh
4	alkb1,
4	alkb2,
4	lives
4	chaves
4	pirajussara.
4	sixty-two
4	41,
4	analyses)
4	(37°c)
4	bph
4	hygienic
4	sulfite
4	bacteriological
4	presence/absence
4	immunosurveillance
4	tumor-reactive
4	a2058
4	impose
4	effectiveness,
4	cross-presentation
4	rhifn-γ.
4	3–grabbing
4	nonintegrin
4	â
4	'/â
4	dc-tumor
4	fusion.
4	cmv-specific
4	cll
4	stat3.
4	phosphatidylcholine,
4	stat-3
4	mc,
4	nci-h460
4	mirna-mediated
4	(isobm).
4	caspase-dependent
4	dc-derived
4	receptor-2,
4	amphiregulin
4	receptor-2
4	prioritize
4	mda-mb-231)
4	accessible,
4	cd11c,
4	ifn-γ),
4	nanotechnology
4	rodrigo
4	particle-bound
4	m-mddcs
4	cocultures
4	principle
4	block,
4	mhc-ii,
4	propria.
4	(paullinia
4	(c4bp),
4	(common
4	associação
4	harvest
4	grounds,
4	b-lymphocyte
4	lymphocyte,
4	choosing
4	computation
4	leptomeningeal
4	vh
4	lidocaine-treated
4	hcc.
4	ra,
4	jussara
4	manifestation.
4	(biogel).
4	immune/inflammatory
4	post-biogel.
4	biogel,
4	(pah)
4	(mba),
4	(ahrd)
4	(ahrb1)
4	dmba,
4	cytoslide
4	ciclin
4	bmcs,
4	chronic-degenerative
4	(adult
4	lupus-prone
4	cxcl1,
4	franco
4	cm)
4	granulocyte-
4	multiplicity.
4	arrays,
4	age.results:
4	tuberous
4	restoration.
4	airmin).
4	(lod)
4	pg/μl,
4	juveniles
4	(biogel)
4	granulopoiesis,
4	biogel.
4	codelink
4	(36k
4	upregulations
4	biogel-treated
4	740
4	a/j.
4	homozygosis
4	(dmba)
4	endosomes
4	sublines
4	hole
4	0.5ml
4	cytokine-secreting
4	immunospot.
4	13.3%
4	arthritic.
4	th0/th2-type
4	typhimurium).
4	s. typhimurium)
4	airminrr,
4	airminss.
4	slc11a1rr
4	800-times
4	airminss,
4	(ab
4	qtl)
4	d3mit100
4	genomewide
4	(hiii
4	intercross.
4	(air),
4	xenogeneic
4	effecters
4	ingest
4	thioglycollate-stimulated
4	tnfα/cachectin
4	(susceptible),
4	(intermediate)
4	(resistant)
4	factor/cachectin
4	(normal
4	consanguinity
4	clades:
4	dwarf
4	log-phase
4	cultivated,
4	madeirae
4	phyllostomid
4	survey,
4	glossina
4	godfreyi
4	kilifi
4	ungulates
4	surveillance,
4	reinvasion
4	lainsoni,
4	carbohydrates,
4	evasion,
4	protists
4	(brazil
4	incriminating
4	invader
4	introduced.
4	tc-stams2
4	enriettii
4	martiniquensis.
4	hemipterans
4	intra-specific
4	(its
4	prokaryote
4	biogeographical
4	smears.
4	(rnai)
4	silico.
4	atl
4	buffalo.
4	mlgs
4	anaplasmosis
4	defenses,
4	families;
4	rosettes
4	tomography.
4	msp5,
4	i).
4	trypanosome.
4	passes
4	simultaneously.
4	divergence,
4	multivesicular
4	semiarid.
4	(cytochrome
4	panama
4	congolense.
4	nannomonas.
4	(cd).
4	niger,
4	endosymbiotic
4	protozoans,
4	slender
4	trypanosomatidae.
4	hindering
4	1974
4	cyt
4	weakness,
4	(genotype
4	216
4	contents,
4	obscure.
4	betaproteobacteria
4	congruence
4	tef-1α
4	alleles)
4	commodity.
4	bugs.
4	overlaps
4	b;
4	salivarian
4	phylogeography
4	ecotopes
4	niches.
4	30461
4	morphometrical
4	parasitaemias.
4	4),
4	an02
4	bicolor
4	unfavorable
4	2002.
4	sixty-four
4	hypoglycemia,
4	globulin
4	ssurrna
4	deer.
4	rangeli-like
4	taxa.
4	salvador
4	assesses
4	(termed
4	244
4	amazônia
4	crithidia,
4	(probing
4	camargo
4	principle,
4	similarities.
4	easy,
4	slot
4	nonradioactive
4	bgl
4	24s-alpha
4	3f6,
4	ctsb
4	pd1-pdl1
4	boosting.
4	rbcg-ltak63
4	p2x7-deficient
4	cd45.1
4	c57bl/6>cd45.1
4	>cd45.1
4	sercundes
4	manifesting
4	(ali/ards).
4	hemorrhaging,
4	hypoxemia.
4	neutrophil-attracting
4	(nets)
4	amd3100
4	pulmozyme
4	dnase)
4	sivelestat
4	xl-eda-id
4	normally,
4	(tlr2-/-)
4	accumulation;
4	txa2.
4	bone-marrow-derived
4	spms
4	pathogens),
4	ortolan
4	hyperparasitemia
4	x-ray,
4	(enhanced
4	pause
4	clodronate
4	encounter,
4	cell-rich
4	subcapsular
4	crisis.
4	nk65gfp
4	myd88-deficient
4	unanswered:
4	immunity?"
4	pathology?"
4	(p2x7r)
4	bav-injected
4	forelimb
4	36.3%
4	(m1),
4	down-
4	antivenoms,
4	fcs
4	(perc)
4	(lpm),
4	il-12-producing
4	(conventional
4	protagonists
4	cd1d-restricted
4	decipher
4	+nk1.1+tcr-αβ+,
4	overproduced
4	viable,
4	increased:
4	sardinha
4	cd138+
4	sigg2a+
4	activated/memory
4	14.1%
4	il-12p40-ko
4	ifn-γ-ko
4	ifn-γ-protective
4	inos-ko
4	cd28-ko
4	cd28-mediated
4	6-8-fold
4	il-12/il-18-primed
4	ifngr,
4	(irf-1)
4	(myd88)-dependent
4	il-12/il-18-programmed
4	ifn-γ-independent
4	(ifn-γ)-deficient
4	cd8-deficient
4	expanded.
4	pannk,
4	vβ8.
4	(cd3+
4	nk1.1+)
4	pannk
4	(tcrα),
4	tcrγδ.
4	(40-
4	100-fold)
4	tcrγδ+
4	nk-t
4	(fas
4	>3
4	1-yr
4	igg2a-producing
4	non-b,
4	non-t
4	challenged,
4	x10/4).
4	clone)
4	lesions)
4	(il-12p40ko)
4	(rifn-γ)
4	specificities.
4	ig-secreting
4	ring-infected
4	encountering
4	splenocytes,
4	igg2a-
4	reticulotropic
4	il-4/il-5
4	re-infected
4	cd45rbhigh
4	cd45rblow
4	replaced.
4	axillary
4	p90
4	igg2b.
4	chabaudi,
4	v.,
4	venom:
4	rbc.
4	nitrate,
4	profile:
4	mirror
4	splenectomized
4	nox3
4	nsc
4	uva-induced
4	blocked,
4	exposed.
4	oxidatively
4	thr
4	impairments,
4	traveled
4	phyllanthus
4	radiations
4	glycosylase
4	contexts
4	rrna-based
4	fertilization.
4	counterpart.
4	burning.
4	interchange
4	(ner),
4	cosmetic
4	muts,
4	pharmacognosy
4	azide
4	cymbopogon
4	stabilization.
4	oncogene.
4	bypasses
4	perspective,
4	ultraviolet-induced
4	sumo
4	martins-pinheiro
4	dozen
4	ogg1
4	glioma,
4	bso
4	lysosome
4	p53-mutated
4	3'-end
4	transcription-coupled
4	bulky
4	uvb-induced
4	klc2
4	rerio
4	underscoring
4	(tmz),
4	u138mg
4	glutathione.
4	bso,
4	(ggr)
4	mdm2,
4	photoprotection
4	biosensors
4	oxidised
4	repressive
4	e2f1,
4	hub
4	morphogenesis.
4	dna-repair
4	siblings,
4	effectiveness.
4	achromobacter
4	phenol,
4	(2d
4	chitosan,
4	biomolecules.
4	amounts,
4	radiation-induced
4	ataxia-telangiectasia
4	dox-induced
4	xtt
4	basically,
4	sensors,
4	98.0%
4	scientists,
4	rico
4	discovered,
4	(xp-a
4	xp-c)
4	z-vad-fmk
4	cleavages
4	fpg-sensitive
4	eutropha
4	korean
4	pyrimidine-pyrimidone
4	alkylating
4	chloroethylating
4	bak
4	photosensitivity
4	science,
4	xanthomonas,
4	mosaic
4	prokaryotes,
4	methylating
4	occasionally,
4	imub,
4	gliomas,
4	non-mutated
4	non-homologous
4	preemptive
4	cell/gene
4	ad5rsvvegf-165
4	collateral
4	skm
4	(700
4	capillaries/mm2,
4	1.6%,
4	moiety)
4	thiazole,
4	deleted,
4	adxpv-egfp
4	dinb,
4	reca-dependent
4	c-induced
4	cooperates
4	transversions.
4	horizontally
4	search,
4	chloroplasts
4	gus
4	thaliana.
4	atxpb1
4	by-products
4	homolog.
4	photorepair
4	schistosome
4	publication
4	(orfs)
4	pectinase,
4	arrests
4	(est)
4	total)
4	insert.
4	pfam
4	>90%
4	dimorphism,
4	codons.
4	deviates
4	photorepair.
4	non-confluent
4	lifestyle.
4	γ-subdivision
4	(xcc)
4	rot,
4	crucifers
4	brassica
4	wilting
4	gum,
4	viscosifying
4	xcc.
4	belie
4	(cho)
4	thi1,
4	search.
4	fastidious,
4	2,679,305-base-pair
4	'two
4	51,158
4	1,285
4	to47%
4	2,904
4	predicted,
4	bacterium-bacterium
4	bacterium-host
4	bacteriophage-derived
4	phage-mediated
4	subdiploid
4	hygromycin
4	interrupts
4	lacz′
4	recombination,
4	trapping
4	orientations
4	laco
4	single-
4	ri
4	distance,
4	cos
4	inserting
4	fluence
4	ethologically
4	aggressor
4	(re),
4	probability,
4	exploration,
4	freezing.
4	deepened
4	socially-relevant
4	resident-intruder
4	context;
4	post-encounter
4	sham-lesioned
4	first.
4	detectability
4	signal-to-noise
4	tasks,
4	pmddm
4	intruder
4	aggression),
4	(comprising
4	fitted
4	perceive
4	choices
4	repeating
4	outperformed
4	(pha-l),
4	rlpag.
4	pheromonal
4	manipulated.
4	(re)
4	re.
4	scig,
4	obstacles,
4	everyday
4	deficit,
4	comorbidities,
4	quotient
4	differentiable
4	forth
4	unitary
4	caudoputamen
4	broad,
4	illusions
4	indisputably
4	flashed
4	feed-forward
4	elected
4	latencies,
4	correlation,
4	nonetheless
4	facilitation.
4	contingent
4	channels)
4	generators
4	team
4	off,
4	motion,
4	initiator
4	rep
4	sanger
4	secretions.
4	toledo,
4	seed-driven
4	(msa)
4	vp4
4	phylodynamics
4	virus-neutralization
4	titres.
4	hadv-2
4	(3.8
4	cytopathic
4	(8.2%)
4	campaigns
4	result.
4	sa-11
4	(cpv)
4	epizootic
4	reevaluated
4	81%
4	(elisa
4	filters
4	<3
4	carbenoxolone
4	cbx
4	(slc2a4
4	8-br-camp
4	-480/-473
4	creb/crem
4	concentration;
4	mir-29b-3p
4	slc2a4,
4	glycosuria
4	esr1,
4	(emsa),
4	dpn
4	90%)
4	cholesteryl
4	abca-1
4	(28%,
4	30%,
4	diet),
4	ddost
4	statins,
4	ager,
4	ku
4	atherogenesis
4	lxr
4	tissues;
4	gene).
4	extranuclear
4	proto-oncogene
4	freitas,
4	pyr
4	nfkb1,
4	polyphenol
4	insulin;
4	(insulin
4	slc2a2/glut2
4	evidence-based
4	frozen.
4	4-hne
4	(cn)
4	pulpal
4	ighd
4	dna-protein
4	(dn)
4	(fsgs)
4	hek-293
4	dkd
4	offspring;
4	(hfd
4	au,
4	14.2
4	txn
4	(egfr)
4	0.04,
4	(il6)
4	alpha/beta
4	resp.)
4	~2-fold
4	ribonucleic
4	companies
4	enhancer,
4	investigate,
4	insulinaemia
4	test;
4	soleus;
4	facilitative
4	(dh)
4	feature.
4	-134/-113.
4	coadjuvant
4	kh
4	tert-butyl
4	(cb1)
4	cnr1
4	(p<0.001,
4	high-lipid
4	kitt.
4	(5.5
4	(ex)
4	(ss)
4	exposition,
4	ex:
4	ss:
4	es:
4	0.3;
4	**
4	(rd)
4	jump
4	(os)
4	21%,
4	sna.
4	detraining,
4	one-week
4	(sb)
4	∼20%
4	collects
4	normoglycemic,
4	(hif-1a),
4	mef2d,
4	hif-1a,
4	investigated:
4	(og)
4	pioglitazone,
4	cortex)
4	arresting
4	12-mo
4	(main
4	11-13
4	(l3).
4	postpartum.
4	20-day
4	caveolin-1
4	discriminate,
4	contraction-induced
4	1-day
4	abolition
4	rsna.
4	(-21%
4	(17%).
4	hyperglycemia.
4	injection;
4	pinealectomy.
4	∼70%),
4	pinealectomy,
4	streptozotocin-diabetic
4	μg/24
4	4-mo
4	acarbose
4	sglt2,
4	∼100%,
4	filtrated
4	(controls),
4	calorie-restricted
4	(hsd)
4	hyperinsulinemic
4	(tm)
4	sympathetically
4	pixr
4	rna-mediated
4	midgut,
4	downregulated.
4	aminoacid
4	longipin
4	guilliermondii
4	zwitterionic
4	galletti
4	aureolatum.
4	microfluidic
4	sg,
4	dipteran
4	jak/stat,
4	melanogaster,
4	transovarial
4	(ratio
4	°c/28
4	acaricide
4	0.5.
4	ivm-resistant
4	dichroism,
4	micelle
4	aggregates.
4	monomers.
4	equipotent
4	mdm8
4	(rmsf),
4	procoagulant
4	prothrombinase
4	analyzer.
4	spray
4	98-114
4	alpha-helical
4	permeabilization.
4	defending
4	azoles
4	paulensis
4	identity)
4	(40%
4	solani
4	xenobiotic
4	(mic
4	fungistatic
4	neoformans.
4	mark
4	instance
4	hybridizations
4	subtractive
4	flagelliform
4	hds1
4	ni,
4	hatching,
4	blood-sucking
4	gomesiana
4	m.f.,
4	endopeptidases.
4	sheet
4	proline,
4	migrate.
4	sequestered
4	extracellularly.
4	(0.1-1
4	gametocytes,
4	pro9]-d-gm
4	noteworthy,
4	joining
4	cd,
4	lpc
4	detergent,
4	gomesin.
4	phyllomedusa
4	purified,
4	arachnid
4	hemocytes,
4	amplified,
4	ncbi
4	acanthoscurrins
4	(pma).
4	heine
4	1.28
4	sugars.
4	pyroglutamic
4	hemolin
4	lychnophora
4	single-dose
4	triterpenes
4	luteolin
4	paraflagellar
4	blots,
4	lesion-derived
4	(mics)
4	gelatin-containing
4	diazomethane
4	125i-labeled
4	(above
4	ultrastructurally
4	microscopically,
4	hydrolyse
4	musicians
4	circle-drawing
4	participants.
4	tied
4	task-specific
4	kick
4	goalkeeper's
4	debilitating
4	kicker
4	flight
4	items
4	basis.
4	ss-16
4	stroop
4	misconception
4	socio-economic
4	cultural
4	(bac)
4	left.
4	dissociate
4	colors
4	navigation
4	navigational
4	vanishing
4	parkinsonism
4	competitions
4	listeners
4	farmers
4	importance:
4	rice,
4	anomaly
4	zenith
4	symmetry
4	3h2o
4	travelling
4	cd28ko
4	policies.
4	lion
4	child.
4	knotting,
4	feasible.
4	[or],
4	immunodepressed
4	(pbl)
4	srbc,
4	hierarchy
4	licc
4	pha,
4	lectins,
4	barbosa,
4	timenetsky
4	supplements.
4	homologues.
4	multinucleation
4	regression,
4	bridge,
4	internalization,
4	five-year
4	prospect
4	microscopies
4	store,
4	retrieve
4	fixed-bed
4	frequently,
4	patients).
4	scars,
4	2,3,9-trimethoxypterocarpan
4	ht-144
4	m30
4	htc
4	telomerase
4	rananos
4	categories,
4	(class
4	sexdens
4	rubropilosa
4	mariner
4	mauritiana
4	asmar1
4	orf.
4	tridimensional
4	mollicute
4	zymography,
4	(p<.05).
4	fates
4	cytokinesis.
4	fluorochrome-labelled
4	vitro;
4	frame.
4	d,d(34)d
4	spheroids.
4	rahsc70
4	(cx43)
4	transfection.
4	60s
4	28s
4	rar2
4	microfilaments
4	panoramic
4	micronuclei,
4	eggs)
4	depsipeptide
4	geodia
4	hs578t,
4	non-ltr
4	measurement.
4	provided.
4	deletions,
4	harmless
4	depilatory
4	epidermis.
4	(lytechinus
4	dinoflagellates
4	spinning
4	non-ribosomal
4	27s
4	ascidians
4	sciarid
4	cycles)
4	0.005),
4	dscr2
4	dscr1
4	serine-threonine
4	protein's
4	c-terminal,
4	cytology
4	eagle's
4	(dmem)
4	t-47d
4	non-diploid
4	abnormally
4	α-amanitin
4	tolerant,
4	(lcl)
4	mg/day
4	intention
4	58%,
4	side-effects.
4	c57bl/6.
4	arise,
4	miltefosine,
4	hamsters,
4	goiás,
4	16.2
4	adenosine.
4	longipalpis.
4	metallodrugs
4	standardizing
4	ulcers.
4	orange.
4	gsno
4	(mva)
4	nerolidol.
4	pvuii
4	adhesions
4	polarizing
4	months-old)
4	closure,
4	reepithelialization,
4	αv,
4	(cinc-2αβ),
4	(mirs)
4	mir-146b-5p,
4	antagomir
4	non-differentiated
4	fibrogenesis
4	sphere
4	fh-deficient
4	fhr127h
4	(tb;
4	lps-
4	acid-stimulated
4	shc,
4	ultra
4	(ola)
4	(h2o
4	protein-3
4	laminin-binding
4	rocki
4	dspp.
4	mt1-mmp
4	smg
4	trafficking,
4	rhoc,
4	mandible,
4	musculature
4	somatotrophs,
4	hsg
4	appliances
4	igfbp-6
4	igfbp-3
4	igfbps
4	wore
4	c20
4	microprojections
4	demosntrated
4	phosphotyrosine.
4	pak1,
4	serum-starved
4	intralobular
4	percentage,
4	positivity,
4	loading,
4	swimming,
4	cdc42,
4	e18.
4	synaptogenesis.
4	dialyzed
4	dfmo
4	asparagine
4	dissolution.
4	laminin.
4	egf-induced
4	hypoactivity
4	(anterior,
4	gtp,
4	fgd1
4	isoprenylated
4	1.98
4	0.55
4	0.25,
4	2.8-fold
4	0.93
4	leukopenia,
4	oxidants,
4	ifnβ
4	adpgp53
4	pairing
4	th1-related
4	applied,
4	retrovirus-mediated
4	cq-resistant
4	primaquine
4	pq
4	recurrences,
4	dbpii
4	reticulocyte
4	imposing
4	rhoptry
4	pvron2
4	nhp
4	saimiri
4	sinusoids
4	remain,
4	diagnostics.
4	afflicted
4	antimalarials
4	findings/conclusions:
4	antigen-driven
4	candidates,
4	pvrbp2b
4	tfr1
4	8.0%
4	pregnancies.
4	continent
4	publicly
4	admixture
4	hhs
4	adjusting
4	92.6%
4	laboratory-confirmed
4	vsa.
4	endemicity,
4	anti-vsa
4	cd127
4	continents,
4	resistance)
4	lessons
4	maney
4	population;
4	anti-hev
4	indonesia,
4	co-infections
4	185
4	prions
4	cryosections
4	infectious,
4	pvmdr-1
4	4%),
4	mixed-species
4	fulminant
4	on-site
4	carriage
4	120.
4	perspective:
4	relapse,
4	7.5.
4	diversifying
4	238
4	anatomically
4	pfrh2b
4	community-based
4	dbp
4	tetranucleotide
4	tetrapeptide
4	unexplored
4	theory,
4	visiting
4	successively
4	nausea,
4	(msp-2),
4	fc27-type
4	606
4	affected).
4	radius
4	margins
4	pfmsp-119
4	skew
4	pvmsp-1.
4	boosting,
4	47.6%
4	cladistic
4	transportation
4	localizations
4	examine,
4	nonreciprocal
4	467
4	ic1.
4	pfcrt
4	housing,
4	misdiagnosed
4	programmes.
4	(ls)
4	allele-specific
4	meanwhile,
4	household-based
4	trichiura
4	1985,
4	helminthic
4	preliminary,
4	prophylaxis.
4	non-vivax
4	block-17
4	(map
4	range:
4	rondônia.
4	semi-nested
4	world-wide
4	multivalent
4	africans,
4	subjects'
4	malariae,
4	hbv
4	non-random
4	prominence
4	22)
4	pf72/hsp70-1
4	rainy
4	concentrations:
4	ns)
4	iron-supplemented
4	restricted,
4	senegalese
4	written
4	foods,
4	chaotropic
4	slide
4	2:
4	1.7%,
4	9th
4	icb2-5
4	episode.
4	spearman
4	oldest
4	que
4	nbs
4	metalloproteinase,
4	annulohypoxylon
4	assimilation,
4	fermentation.
4	xylanase
4	9.4
4	71%.
4	xylan
4	(its)
4	superfamilies
4	sugarcane-derived
4	australia
4	(cosd)
4	aglycone
4	quadrupole
4	inter-specific
4	cepa
4	fermentations
4	sorbitol,
4	intercalation
4	visualisation
4	298
4	k-12.
4	decarboxylases,
4	φbp1
4	φbp2
4	tails
4	ii;
4	genotyped.
4	gingivalis-induced
4	il-17ra-deficient
4	31)
4	commodities
4	(58%)
4	borne
4	(nlrs)
4	disks
4	hydrophilicity
4	categories.
4	campylobacter
4	collagen-induced
4	th1.
4	immunology,
4	girls
4	trimesters
4	kruskal-wallis
4	flp-.
4	neuraminidase,
4	(68.6%)
4	vmga
4	ultrapure
4	corrodens,
4	staphylococci
4	metronidazole.
4	ccr5ko
4	(determined
4	il-17a,
4	co-induction.
4	lns
4	restrains
4	edentulous
4	candida.
4	pd/pia
4	gata-3
4	encouraged
4	timp-1
4	kc.
4	lymphotropic
4	samples;
4	frequent.
4	(previously
4	endarterectomy
4	coincidental
4	nonsmoking
4	tnfa-308
4	actinomycetemcomitans-induced
4	infection-induced
4	osteoprotegerin
4	periodontopathogens,
4	37.5%
4	exudative
4	fimbria-like
4	subtyping
4	fragilis.
4	μl).
4	(86%)
4	intragastrically
4	timps,
4	ribotyping
4	sulcus
4	copper,
4	nickel,
4	forsythus
4	plaque.
4	antimicrobials.
4	predisposed
4	β-cyclodextrin
4	bacteriocin-like
4	p35
4	jejunal
4	munksgaard
4	rh+;
4	eighty
4	tetracycline.
4	ethers
4	pcbs
4	regret
4	a-
4	+;
4	presented]
4	pseudostratified
4	compartmentalized
4	localizing
4	kiadó,
4	neutron
4	single-step
4	eliminates
4	conductivity
4	2.0,
4	marginatus
4	2.75
4	herbicides
4	0.5 m
4	vibrio
4	prochilodus
4	33°c
4	spend
4	glutathione-s-transferase
4	(55%)
4	lc/ms/ms
4	interlamellar
4	aquaculture
4	parotoids
4	jimi
4	(sa).
4	perivisceral
4	9.8
4	dsrna
4	(vv
4	harvesting
4	borders
4	mdhex-l
4	amebocytes
4	2.27
4	thread.
4	spherule
4	territory.
4	trail,
4	constitution
4	decipiens
4	concerned
4	neglecta
4	lamina,
4	fischer
4	species'
4	spermatogonial
4	self-renew
4	envelope,
4	nucleoli,
4	characiformes
4	asynchronous
4	gonadotropic
4	constant,
4	distalis
4	nutrition,
4	discharges
4	dah.
4	dah,
4	trichrome
4	encephalic
4	bulb,
4	thalamus.
4	innervating
4	impediment
4	atretic
4	middle,
4	nuclei).
4	chorion
4	homogenous
4	(gnrh)
4	pacu
4	24).
4	7.1
4	expected.
4	pinealocytes.
4	fluorimetry
4	(arh)
4	intake;
4	dio2,
4	cold-exposed
4	mother's
4	adequately
4	demands.
4	detachment,
4	cognition
4	(agrp),
4	orexin.
4	breeders
4	photoperiod.
4	reverted.
4	peh
4	morning,
4	4).
4	(mt1
4	mt2)
4	ca2
4	methamphetamine
4	aeme-induced
4	mammopoiesis
4	(one-third
4	pups).
4	basal/myoepithelial
4	erbb4
4	nrg1,
4	178
4	users.
4	post-exercise
4	(random
4	syrian
4	asmt,
4	cumulus
4	aanat,
4	mt1,
4	period),
4	(zeitgeber
4	sine
4	c-fos,
4	self-sustained
4	oscillator
4	vision.
4	nmda,
4	formamidopyrimidine
4	se)
4	streptozotocin.
4	perisuprachiasmatic
4	goal-oriented
4	14-3-3:aanat
4	(34%)
4	80,
4	c-fos-positive
4	night),
4	(melatonin
4	d-[u-
4	estimated,
4	per-1
4	knockdown.
4	fulfilled
4	14c]-glucose,
4	insulin-binding
4	melatonin's
4	insulin)
4	toxin-sensitive
4	immunomodulatory,
4	fourteenth
4	existence,
4	(77%)
4	mobilization.
4	kinase)
4	107,
4	photo-inhibition
4	ibotenic
4	synchronizes
4	hexamethonium
4	hatched
4	destroyed.
4	chicks.
4	firstly
4	cofactor,
4	antibody-based
4	including,
4	hsp90
4	native-like
4	intermolecular
4	refolding.
4	co-immunoprecipitated
4	hrsv,
4	virus-associated
4	gag,
4	psh-g
4	co-circulated
4	botucatu
4	seasonality
4	sh.
4	delivers
4	malfunctioning
4	α6β1
4	ej-ras-transformed
4	β1-integrins
4	hr5
4	maximum,
4	parts,
4	infusions.
4	cortices)
4	vta-nigral
4	vta,
4	rr.
4	hydroxylase-positive
4	moreira
4	pretest
4	well-acknowledged
4	pre-training
4	system)
4	territories,
4	piriform,
4	reuniens,
4	perikaryal
4	dorsoventral
4	amygdala;
4	part.
4	sector
4	innominata,
4	cognitive,
4	intralaminar
4	visuomotor
4	motor,
4	sleep-waking
4	h1,
4	discussion,
4	liss,
4	(kot)
4	microarrays.
4	cell-ecm
4	aggrecan
4	kot.
4	(ccot),
4	om
4	β2-adrenoceptors
4	21 days.
4	(mmp-2)
4	post-cryolesion,
4	(hif-1α)
4	pathol.
4	radiol.
4	endod.,
4	111,
4	474).
4	oncogenes,
4	egf-treated
4	egfr.
4	mmps.
4	barriers.
4	transendothelial
4	b.v./international
4	pseudocysts
4	resin-modified
4	(acc)
4	silver-stained
4	ductlike
4	enamel,
4	cylinders
4	hydrofluoric
4	hrs
4	mechanically
4	uncommon,
4	benign,
4	8,18
4	cisternae
4	ap2
4	thin,
4	bcc
4	nors
4	perimeter
4	angioplasty
4	1993,
4	tooth.
4	gaba-cl
4	portugal
4	ait
4	lpt
4	diagnoses
4	pests
4	with:
4	koch
4	ctenocephalides
4	polygenis
4	opossum,
4	norvegicus)
4	suburban
4	cruzes
4	190-kda
4	lizard,
4	plica
4	csp,
4	spleens,
4	spirochetes,
4	opioids,
4	th-ir
4	(ex),
4	(sed),
4	(ex
4	multisubunit
4	(ian)
4	ian-injured
4	exercise-dependent
4	neurogranin
4	(tg).
4	ian-injury
4	glua2
4	cgrp.
4	(pet)
4	pet.
4	early-life
4	hz).
4	xrn2
4	papd4
4	olig1
4	synaptophysin,
4	psd95
4	o<inf>2</inf>),
4	(24μg/μl)
4	(th<sup>+</sup>)-neurons
4	tachypneic
4	th<sup>+</sup>
4	v4
4	remyelination
4	tackled
4	encephalopathy
4	peritonitis.
4	nox2-derived
4	invested
4	(nox),
4	parvalbumin,
4	(gad)
4	structure-specific
4	(sn)
4	(5-ht).
4	restraint.
4	dcx-positive
4	exercise-related
4	3×/week
4	nnos-positive
4	904
4	cm2,
4	disinhibition
4	cci-injured
4	style.
4	departments
4	colleagues
4	glur2/3,
4	ex3,
4	ex7.
4	ex3
4	9.5,
4	capsazepine,
4	blockade,
4	capsazepine-treated
4	nf160
4	ex15.
4	nr1-positive
4	glur2/3-positive
4	phenomenom
4	(snt).
4	l3-l5
4	snt
4	(randall
4	selitto
4	(sham-animals).
4	(rexed's
4	i-iv
4	snt,
4	(1469%).
4	anxiety-
4	alcohol-related
4	fearful
4	3′-untranslated
4	anxiety-related
4	sublamina
4	circuitry-related
4	cholinergic,
4	cage,
4	acutely,
4	desensitized
4	embryonal
4	p2y2
4	18β-ga,
4	cx50,
4	(pgn),
4	(pv),
4	activity-dependent
4	(cx),
4	(ctb).
4	β2,
4	enucleation,
4	kirsten
4	virus-transformed
4	shafts
4	dova
4	antigen-containing
4	cells/100
4	cells/1,000
4	icam-1/gapdh
4	(4.0
4	ratio).
4	tnf-α-induced
4	controlling,
4	post-hatched
4	cajal's
4	14).
4	seldom
4	paraventricular,
4	fluorocitrate,
4	spla2.
4	allergy-induced
4	α-bungarotoxin
4	olivary
4	co-localize
4	n-domain
4	weighed.
4	e7.
4	medialis,
4	neurotensin,
4	mesencephalon
4	ache,
4	posthatching,
4	time-courses
4	e12.
4	co-localization.
4	milked
4	reserpine-treated
4	jararaca.
4	snakebites.
4	cabps
4	1-7)
4	colliculus.
4	(amacrine
4	α4,
4	α3‐li
4	e.,
4	amacrines,
4	α7‐like
4	αbgtachr
4	evenly
4	α8)
4	enkephalin-like
4	organum
4	fibrosum
4	p-like
4	(sp-li)
4	rhodamine-labeled
4	sp-li.
4	doubly
4	quadrants.
4	sp-li
4	transmitters
4	ms).
4	enkephalin‐containing
4	npy-labeled
4	nucleus)
4	leucoagglutinin.
4	nonretinal
4	transmitters,
4	chat-li.
4	cck-li
4	upward-temporal.
4	interocular
4	sd,
4	receptive
4	mct/lct
4	stay.
4	catalytically-inactive
4	height,
4	tes
4	aicar
4	il-1ra,
4	intensification
4	95%,
4	externalization.
4	(oua),
4	activation:
4	(tnf-β;),
4	(n-methyl-d-aspartate
4	pp-1(src-family
4	pp-1,
4	(gln)
4	non-supplemented
4	gln.
4	tlr-2,
4	players.
4	6.9
4	(2.5-fold)
4	tdi
4	sdi
4	4%).
4	twofold)
4	lipid,
4	ergogenic
4	g/day
4	cog)
4	l-lactate,
4	centralized
4	myogenin
4	activity-induced
4	cdna.
4	peroxidase)
4	pufa.
4	tolerated,
4	hdac
4	mct/ω-6
4	out:
4	butyrate.
4	lowering-cholesterol
4	abcg1,
4	sfa,
4	persistently
4	attributed,
4	mechanisms:
4	st-iih
4	lt-iih
4	inactivity
4	week)
4	freeze-injured
4	comprehend
4	c/ebp
4	chop
4	days/wk
4	doppler
4	5%).
4	3%).
4	sm.
4	4-5
4	(2.9-fold)
4	submitting
4	enzymes;
4	[muscle
4	smad5
4	taci
4	swam
4	6.0%
4	thorax
4	pem
4	strenuous
4	ck,
4	ald,
4	flame
4	crh
4	ffa-induced
4	lipopolysaccharide.
4	system;
4	cardioprotection.
4	(mi),
4	neurotransmitter,
4	limbs.
4	gsk-3
4	interferon-
4	(genbank
4	60th
4	mufa
4	zn2+,
4	lipokine,
4	abcc2,
4	abcb1,
4	2a/
4	23390,
4	necrosis)
4	flip-flop
4	epa.
4	o2•-
4	(50-100
4	40%.
4	ceramides
4	sse
4	speeds
4	springer.
4	β-peptide
4	glia,
4	(6,
4	hr).
4	adaptive,
4	ciglitazone
4	15-d
4	(before
4	pparγ)
4	cyanide,
4	k-atpase,
4	non-carriers.
4	(controls
4	offatty
4	lucigenin
4	(il-2)
4	indirect,
4	ionophores
4	8.3-fold
4	xo
4	l-g
4	chemotactic,
4	guanosine-3′-5′
4	8),
4	production)
4	(gssg)
4	melan-a
4	morphometry,
4	continuously,
4	mrp1/gs-x
4	ucp-3
4	(ppar)
4	granularity,
4	jeopardize
4	bleomycin
4	pgc-1α,
4	hkii
4	172
4	platymiscium
4	nonviable
4	a4,
4	isocitrate
4	on:
4	a)-stimulated
4	a-stimulated
4	γ-lna
4	production).
4	corn,
4	bean
4	conductances.
4	8.37
4	controls:
4	hypertriglyceridemia
4	interview
4	dphpc
4	dphpc/cholesterol
4	gun
4	selectivity,
4	edible
4	weight),
4	maze,
4	41%,
4	pulses,
4	fade
4	fiber-rich
4	636
4	mφ.
4	function:
4	naloxone,
4	superoxide-generating
4	cytokine-mediated
4	>80%
4	llc-wrc256
4	crex
4	(de)
4	de-mf
4	(166
4	scintillation
4	(66%)
4	[1-14c]-
4	pyruvate.
4	bacille
4	(mfs)
4	2-hour
4	npr
4	ht,
4	hyperleptinemia
4	ucp2
4	dissipating
4	(154
4	elongate
4	ß-adrenergic
4	interferon-α
4	breach
4	harwood
4	mg2+,
4	fit-rich
4	nadph-dependent
4	4h
4	tested:
4	(70
4	(44
4	imbalance,
4	likewise
4	comparison.
4	electrophiles
4	k562,
4	virtue
4	o2.-
4	60-70%
4	(thymus,
4	12.8%
4	(hydrogen
4	obd
4	myristate,
4	oleate,
4	(μm)
4	bran,
4	former.
4	c]-palmitate
4	carcass,
4	nodes)
4	(ufc)
4	spleen)
4	2.33
4	3.37
4	(61
4	ageing,
4	(decreased
4	depressed.
4	synthase)
4	(lpl)
4	w/w)
4	92.5%
4	60%.
4	emptying,
4	[14c]glutamine
4	dichloroacetate
4	energy.
4	requirements.
4	6-phosphogluconate
4	emergence,
4	calicivirus
4	positive-sense
4	turnstone
4	nephritis
4	macaque
4	1947
4	kawahara,
4	zikv-br
4	(blood,
4	tachypnea
4	h6
4	official
4	sent
4	flavivirus,
4	569
4	year-round
4	299
4	heads.
4	chapparvoviruses
4	male.
4	wien.
4	alphaviruses
4	ml.
4	notorious
4	mastitis.
4	indiana
4	grounds
4	plumage
4	breakthrough
4	rsv.
4	rsv-positive
4	adélie
4	rabies.
4	colorado
4	pandemic
4	2008).
4	456
4	wnv
4	crucially,
4	ndv
4	rhinovirus
4	424
4	(felv)
4	haematophagous
4	lasiurus
4	virus-specific
4	hospital-acquired
4	santiago
4	individually,
4	lyme-simile
4	measles,
4	pain;
4	trunk
4	dichroism.
4	487
4	ifa,
4	b19.
4	maternally
4	lutz
4	montenegro
4	50%),
4	0.6%,
4	iu/ml
4	315
4	mycotoxins,
4	propagate
4	mothers'
4	peanuts,
4	(antibody
4	self-limiting
4	intracerebral
4	annually,
4	rash,
4	(precfa),
4	1/36
4	radiological
4	immunochemiluminescent
4	nasopharynx
4	(0.5%)
4	coagglutination
4	transcriptase-pcr
4	(ivig)
4	primer.
4	(35%),
4	(30%),
4	clinic.
4	amplitude,
4	(lhb)
4	thyrotroph
4	t3-αvβ3
4	pept1,
4	atrogenes
4	demand.
4	(nis)
4	thyroglobulin
4	(saline)
4	ie-exposed
4	methylation,
4	tod-dependent
4	cardiomyocyte-specific
4	pepck,
4	wolff-chaikoff
4	ciencias.
4	post-transcriptionally
4	applicability,
4	non-receptor
4	hypogonadotropic
4	lh,
4	spermine
4	(~250
4	glut3
4	perchlorate,
4	serca1
4	(dexa)
4	dental,
4	(~75%)
4	scintigraphy.
4	itd
4	aminoacids
4	1.40
4	psoas
4	storing
4	transporting
4	pb131i
4	cholesterol-enriched
4	ng/100
4	ppnl
4	simpler
4	favorably
4	papilla.
4	disabilities.
4	subventricular
4	(-ir)
4	conical
4	sarcoplasmatic
4	myotendinous
4	µm)
4	triangular
4	lllt.
4	ciliated
4	poles
4	niche.
4	(f1)
4	25.
4	fjb-positive
4	excitotoxicity
4	tem.
4	(n=6)
4	relieve
4	(three,
4	coexisted
4	hydrogels
4	7.4)
4	mechanoreceptors
4	endothelialization
4	stents,
4	bundles.
4	fusion,
4	vegfr-2
4	portion,
4	interdigitations
4	thick,
4	formations
4	paraffin.
4	smaller,
4	720
4	clean
4	dosages
4	tortuous
4	openings
4	bradypus
4	geniohyoid
4	micrographs
4	tbs
4	stacks
4	plicae
4	sociedad
4	pulpectomy
4	contacts.
4	post-synaptic
4	spines
4	mechanoreceptive
4	numeric
4	high-power
4	non-erupted
4	oblique
4	melt
4	basilar
4	small.
4	tags.
4	protein-deficient
4	base.
4	membranous
4	calcified
4	elaunin
4	clinoid
4	cholinesterase
4	che
4	drying
4	branches,
4	zygomatic
4	diminution
4	apella).
4	vein;
4	ingestive,
4	hypoxia-sensitive
4	precipitate
4	prevented.
4	shock-paired
4	caring
4	medication.
4	pilo
4	(vmh),
4	internuclear
4	foraging.
4	ofc
4	vlcp
4	pmd,
4	extra-maze
4	version.
4	mptp
4	s-r
4	did,
4	cell-related
4	decrements
4	freezing,
4	responsivity
4	(12.5
4	familiar
4	(phase
4	mptp-lesioned
4	cannulae
4	(epm)
4	schematic
4	(nos)-
4	intrahypothalamic
4	coursing
4	zone,
4	levels:
4	ventromedial,
4	hypothalamus;
4	copulatory
4	suprachiasmatic,
4	ventrally
4	egr1
4	pka-dependent
4	β-chain
4	htlv-i-positive
4	oligoclonal
4	11%,
4	polyuria
4	c),
4	gtp
4	(ipc)
4	neuropeptides.
4	spns
4	co-transmission
4	mpoa
4	sita,
4	bittencourt.
4	crf.
4	etm,
4	2-b
4	converging
4	thr343
4	hypothalami
4	ng/0.2
4	acb
4	[termed
4	ew-mediated
4	re-fed
4	calbindin-
4	answers
4	noticed.
4	terminology
4	6-ht
4	administration;
4	bc1
4	nei-immunoreactive
4	(fs)
4	mch/gaba
4	cd44,
4	jaw
4	14-day-old
4	prohormone
4	crns
4	mcx
4	(hpa)
4	zi.
4	dual-label
4	avpv
4	pheromones
4	pfx.
4	supragranular
4	dual-labeled
4	ucn-immunoreactive
4	vii
4	subdivisions,
4	colocalized.
4	stressed.
4	advances.
4	controversies
4	(rpa)
4	ucn-ir
4	immunopositive
4	zim
4	(poa),
4	rpa,
4	nge
4	(sd:
4	(prospective
4	gynecological
4	(mif)
4	mcp-1)
4	azathioprine
4	<.005).
4	<.05)
4	ccr9+
4	144
4	(nd)
4	(evt)
4	tlr4-dependent
4	expectations
4	(p=0.001).
4	ncf2
4	morphologically,
4	foxo3a,
4	endosomal
4	myelomonocytic
4	ovary,
4	tgc.
4	placentae
4	glycoproteins.
4	(yeast
4	thioglycolate
4	mart.
4	3.6
4	penetrating
4	endoderm
4	cytochemistry
4	similarly.
4	polysaccharides
4	tocopherol
4	usnic
4	glycosphingolipid
4	µm
4	risedronate,
4	bisphosphonate
4	rpffpps
4	geranyl
4	risedronate.
4	tlc
4	algae.
4	risedronate
4	crescent
4	reductoisomerase
4	polyisoprenoid
4	isoprenoids,
4	reductoisomerase.
4	tlc,
4	terpenes
4	parasites'
4	n-glycosylation
4	dolichyl
4	two-
4	(tulahuen
4	180,
4	tc-85
4	heterogeneity.
4	specificities,
4	columns.
4	etc.
4	pbm,
4	tipulae.
4	leaves,
4	tetracycline,
4	x-114
4	metazoan
4	phosphorylated,
4	coiled-coil
4	1975.
4	tourists
4	(fi)
4	nyssomyia
4	neivai
4	neglected.
4	traps,
4	shawi,
4	davisi
4	dominican
4	vectorial
4	register
4	-specific
4	(sts)
4	dll1,
4	scans
4	distributions,
4	gene(s)
4	ulcers,
4	arithmetic
4	leishmanin
4	0.003).
4	north-east
4	nramp1
4	single-gene
4	intramacrophage
4	leprosy,
4	(soluble
4	100%).
4	classifications
4	myeloma
4	residuum,
4	immunopathological
4	asat,
4	mdh,
4	tergal
4	miniature
4	compared,
4	∼0.5
4	guyannensis
4	didactylus,
4	choloepus
4	(asat,
4	protozoal
4	character,
4	schistosomiasis
4	pneumocystis
4	9%,
4	umbra,
4	nnn
4	teiid
4	rainfall,
4	scarring.
4	glutathione,
4	(il)-17,
4	(vkh)
4	(sb203580)
4	msk-1/2-deficient
4	msk1
4	msk1/2
4	mapk-msk1/2
4	retina:
4	μg/g)
4	microdissection
4	preservative
4	amplifiable
4	div5.
4	(3.0
4	huc/d
4	(nx)
4	pdx1,
4	34,
4	astroglial
4	post-parturition
4	detectable.
4	casein,
4	(5%
4	trinitrobenzene
4	projected
4	(52%).
4	ganglionic
4	atria,
4	unipolar
4	pchat
4	intestines,
4	immunoreactive,
4	section.
4	jones
4	(auc
4	covered:
4	(no)-cyclic
4	(ed).
4	a/s
4	phenylephrine-precontracted
4	ma,
4	prilocaine
4	(250 mg
4	(550 mg
4	forty-two
4	diameter),
4	ulcer.
4	s-releasing
4	issues:
4	pantherophis
4	guttatus
4	processes:
4	cavernosum,
4	type-5
4	biolab
4	nebivolol
4	bioequivalence,
4	60-2770-induced
4	elevates
4	(pec50)
4	100mg
4	3.75
4	rho-kinase
4	eczema
4	(hplc-ms/ms).
4	antrum
4	1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
4	baths.
4	(80/20,
4	configured
4	run-time
4	(odq)
4	-26
4	pigmentation
4	urothelium
4	prevail
4	ng.ml
4	6.2%
4	hplc-ms-ms
4	curves:
4	n=12,
4	pde9
4	max)
4	1.25,
4	tmax
4	anti-platelet
4	fibrinogen-coated
4	(dsm)
4	α,β-methylene
4	non-void
4	normalizes
4	doxylamine
4	(0.0001-10
4	hplc/ms/ms
4	renovascular
4	(2k-1c)
4	76.2%
4	41-2272),
4	coitus
4	nω
4	(ttx;
4	thrombin-stimulated
4	(onoo-)
4	anti-aggregatory
4	3-morpholinosydnonimine
4	(sin-1)
4	(250 ng/trachea).
4	(tachykinin
4	sr48968
4	sea-induced
4	bromazepam
4	7.4%
4	10.9%
4	reference,
4	abusers
4	pde
4	u+
4	(pec50
4	u-
4	ca2+-induced
4	cc-chemokines
4	fibronectin-coated
4	μg/kg.
4	il-13,
4	3h]inositol
4	sixfold
4	dihydroergotoxine
4	dosing
4	mesylate
4	(cmax)
4	deprotonated
4	dissolution
4	ph-independent
4	0-72h
4	no2/no3
4	grade,
4	pharmacodynamics
4	μmol/kg,
4	industries
4	pge2)
4	(no,
4	short-lasting
4	isosorbide
4	cotreatment
4	parsalmide
4	pa31
4	ta98,
4	ta100,
4	ta102,
4	biosintética
4	betamethasone
4	imprecision
4	(qc)
4	(0.3-10
4	cinc-3
4	sea-treated
4	toxin)
4	ici
4	μm)-treated
4	10-min
4	n-terminal,
4	malignancies,
4	ependyma
4	cyproterone
4	olacoides
4	adp.
4	hlb
4	cpa,
4	ib-meca.
4	synthase;
4	abuse,
4	carrageenan,
4	sinusoidal
4	2%)
4	0.3%,
4	(nx),
4	nephropathies.
4	snap
4	plasmin.
4	euglobulin
4	μmol)
4	ryanodine
4	screening,
4	objectives.
4	(ttx,
4	cross-over
4	msd,
4	bioequivalence.
4	collilineatus
4	rat-isolated
4	depolarizations
4	veratridine
4	y25130
4	crtp
4	(pp),
4	(nx).
4	subsensitivity.
4	90-day-old
4	n-formyl-methionyl-leucyl-phenylalanine
4	gmp.
4	intra-day
4	5.4
4	inter-day
4	wems
4	eae-iii
4	nadph.
4	sclerosis.
4	(apis
4	pharmacol.
4	1-(2-trifluoromethylphenyl)
4	s/a
4	lymphoma,
4	rsd921
4	dyspeptic
4	peppers,
4	5-ht.
4	nsaids.
4	μmol/paw)
4	anxiolysis
4	ke,
4	australis
4	2.7%
4	mg/5
4	officinalis
4	noncholinergic
4	(nanc)
4	ib-meca,
4	(s)-1-[2-[3-(3,4-dichlorphenyl)-1
4	(3-isopropoxyphenylacetyl)
4	azaniabicyclo
4	ast,
4	na)
4	bthtx-i,
4	prtx-i-induced
4	auc((0-24
4	125i-labelled
4	p-(7-11)
4	n-[2-(4-chlorophenyl)
4	ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2h-2-benzazepine-2-carbothioamide
4	purinoceptors
4	within-
4	(t(max))
4	hepatopathy
4	hydroxy-metronidazole
4	hepatopathy.
4	roxithromycin
4	half-life),
4	butoxamine
4	vera
4	furazolidone
4	suppression,
4	sertraline
4	auc((0-96)
4	(h)),
4	biaxin(tm).
4	lys-bk
4	kallikreins
4	amoxycillin
4	hydroxy-metabolite
4	1.2%
4	bromide,
4	xi
4	sapp
4	celong
4	redoxon
4	(t(max)).
4	pmol/site)
4	indirectly.
4	ke
4	h.p.l.c.
4	(geometric
4	mean)
4	(median)
4	(0.01-10.0
4	45.0
4	paf-
4	(40-50
4	(placebo
4	non-peptide
4	kallikrein,
4	polylysine-induced
4	adp-induced
4	μg/108
4	36.7
4	enalapril-treated
4	carrageenin,
4	1620.
4	tuft
4	fr.
4	chief
4	(0.4-400
4	child‐pugh
4	schistosomic
4	(cl),
4	bradykinin-
4	5-hydroxytryptamine-induced
4	d-arg
4	nitro-d-arginine
4	(ed50
4	pytori
4	4-sulfate
4	suppurative
4	spectrophotometrically
4	component(s)
4	pgi2,
4	na.
4	(lnmma),
4	8644
4	nucleated
4	(3-fold)
4	b.a.
4	mlv
4	mlv-induced
4	lemnitoxin
4	pmv-induced
4	etoricoxib,
4	nsaids,
4	stingrays.
4	pgd2,
4	(af)
4	lds.
4	adrp
4	(mt-iii),
4	bmv-induced
4	polyspecific
4	elicits,
4	mt-iii,
4	(mφs)
4	pop
4	(i.art.)
4	i.art.
4	(sds-page).
4	lethality.
4	chelation
4	lecam-1,
4	μg/ml;
4	endotoxemia
4	mβ
4	rofecoxib
4	magnitude,
4	cd18,
4	meloxicam,
4	188
4	corticosteroids.
4	pleurisy,
4	catalysts
4	vortex
4	within-day
4	amphidinolide
4	grandis
4	hydrodistillation
4	dias,
4	mpas
4	innovation
4	nucleophilic
4	seriniquinone
4	palythoa
4	calotropis
4	unfolding
4	thioesterase
4	phosphorus,
4	heterotrimeric
4	acnistus
4	hct-116,
4	buoh
4	steroidal
4	hl-60.
4	©2016
4	epimeric
4	(sf-295)
4	dimethylsulfoxide
4	(glioblastoma),
4	cereus,
4	farmacognosia.
4	endophyte.
4	(6).
4	/g
4	stigmasterol
4	erythraline
4	leukemia),
4	coffea
4	olefins
4	vannamei,
4	antinociceptive,
4	mg/kg/day),
4	3e
4	neosergeolide
4	pore,
4	esterases
4	cae
4	prodigiosin
4	arabinose,
4	chlorine
4	pisosterol,
4	anacardiaceae,
4	kielmeyera
4	dpph
4	α-santonin
4	longest
4	recombinogenic
4	ipomoea
4	(pbmc),
4	(c16)
4	ka,
4	thalidomide,
4	copaifera
4	langsdorffii
4	seeks
4	(anacardium
4	one-pot
4	configurations
4	hexane,
4	bark,
4	salazinic
4	bioguided
4	b-16
4	por
4	p:
4	psammatodes
4	(pulses
4	polyploidy
4	5-bromo-2′-deoxyuridine
4	tanshinones
4	lectins.
4	fuse
4	naturforschung.
4	cem,
4	15.8
4	slices.
4	©2005
4	ashae-ppt
4	α2a-
4	th-sns
4	subtype,
4	load)
4	s-nitrosylation,
4	pui
4	chemomechanical
4	ca(oh)<inf>2</inf>
4	α-tricalcium
4	β1ko
4	trα1
4	(t3;
4	thyromimetic
4	6-week
4	bmd,
4	t3-responsive
4	ord
4	manipulation,
4	thyrotoxicosis,
4	disarray,
4	3-induced
4	bone-specific
4	1,25
4	tryparedoxin
4	trypsin-like
4	mca
4	mitophagy
4	cvs
4	pdi,
4	chaperone,
4	trios
4	goiter.
4	disease-free
4	inflammatory,
4	transplant.
4	hsct.
4	zurro,
4	(apeced)
4	pids.
4	gene:
4	stat4
4	dko
4	dmd
4	imunodeficiências
4	receiver
4	trecs/μl,
4	gme
4	pyogenic
4	gwsa
4	bt,
4	achievements
4	interferon-γ.
4	pneumoniae,
4	secure
4	practitioners
4	nik
4	nk-cell
4	cytidine
4	tlr7,
4	nb4
4	hoxa-as2
4	pediatricians
4	β-actin
4	rw
4	non-rw
4	sirpα
4	monocyte/macrophage
4	70%.
4	0.036).
4	paranasal
4	i-deficient
4	consanguinity.
4	mattress
4	disease;
4	(il-8)
4	g→a
4	chest
4	efa
4	neu
4	esteves,
4	mixture,
4	lipocalins,
4	immunity-related
4	thrombocytopenia,
4	fabc11:stx2
4	gx1
4	clonepix
4	cho-s
4	adabut
4	rgd-gx1
4	(fgf2),
4	manufacturing
4	purity,
4	(mac)
4	c4bp,
4	ngr
4	envisaged
4	initiated.
4	juliana
4	technetium-99m
4	dup-1
4	morpholino
4	okt3.
4	freund
4	anti‐cd3
4	distortion
4	batista,
4	plds
4	lgrec1
4	cromolyn
4	tnbs-colitis
4	factor-related
4	eumenine
4	wasps
4	moabs
4	recombinant,
4	cationized
4	particulates
4	silica/dodab
4	biocompatible,
4	inexpensive,
4	ovalbumin/aluminum
4	allergen-driven
4	ige-mediated
4	(cdtv)
4	lgg1
4	(pca).
4	piii
4	mhv
4	mhv-
4	asc-specific
4	anti-oa
4	g1/s-specific
4	β5i
4	huntingtin
4	u.s.a.
4	(cb
4	hp-induced
4	β-globin
4	sci
4	281:5668-5676,
4	2006;
4	2003;
4	setton-avruj
4	203:568-578,
4	2007;
4	hb-derived
4	oligopeptides,
4	fret
4	glu,
4	gly
4	(cfp)
4	3.4.24.16;
4	nociception.
4	489
4	citrus,
4	grapevine
4	far-uv
4	kcat
4	s-1,
4	asn
4	22.19.
4	bridging
4	ersching
4	suboptimal,
4	epitope-specific
4	(tr1)
4	encephalomyelitis.
4	th2-cell
4	th17-cell
4	leptin-free
4	b2ar
4	il-4-producing
4	alloimmune
4	lepob/ob
4	surgeons.
4	(admscs)
4	admscs
4	contact-dependent
4	t1d.
4	+cd25
4	+cd4
4	il-17-producing
4	blinded
4	non-host
4	opsonization,
4	ggdef
4	vasconcellos,
4	isaac.
4	pathway),
4	(classical
4	pathways).
4	mac
4	pic,
4	c3/c3b
4	(c4bp)
4	(lig)
4	contrarily
4	(ns1)
4	denv-infected
4	(aepec).
4	lcpa,
4	2a,
4	dh5α
4	c2.
4	mntc
4	opportunist
4	acquires
4	cytolysin
4	lic11947
4	metaperiodate
4	nonclassical
4	lsa24
4	haploinsufficiency
4	yy1
4	col18a1
4	melim
4	ssc
4	wilms'
4	retinoblastoma
4	rb1
4	xx
4	xy
4	©2019
4	sw
4	tams,
4	anogenital
4	hpv,
4	cd45,
4	mitogen,
4	24h.
4	proto-
4	‒1
4	intracerebroventricularly
4	phasic
4	rer
4	neuromodulators
4	nad+/nadh
4	synchrony
4	irritant),
4	il-1α.
4	costs,
4	vanilloid-1
4	rimonabant
4	cryogenic
4	sc-236
4	vivo)
4	amg0347
4	©2006
4	responses:
4	avpo
4	biotelemetry
4	lc-lesioned
4	pge2-induced
4	(pha),
4	normoxia,
4	biotelemetry.
4	located,
4	intra-poa
4	(152
4	v̇e
4	paracnemis.
4	vehicles
4	haeme
4	i.pl.
4	temperature)
4	(t(b))
4	nmol/4
4	haematocrit
4	proteome,
4	past-infected
4	underestimation
4	(mip)
4	alto
4	(cd4+
4	berghei-infected
4	nanoliposome-based
4	parasite-derived
4	office
4	pfemp1
4	intraperitoneally.
4	culled
4	distress.
4	vaccinations.
4	boosting).
4	53.5
4	cross-prime
4	-t-cell-dependent
4	tcf21
4	pmah
4	(sf1)
4	acth-induced
4	pro-opiomelanocortin
4	recently.
4	pod-1/tcf21
4	shp
4	turnover.
4	(pomc)-derived
4	n-pomc1-28
4	bridges,
4	odns
4	anti-atrophic
4	mafbx/atrogin-1
4	4e
4	durable
4	day);
4	myhc-ii
4	t3-dependent
4	mafbx/atrogin
4	men.
4	12-wk
4	(mstn)
4	mstn,
4	time-points.
4	bench
4	110%
4	soreness
4	lifted
4	(1rm)
4	(50%-1rm
4	75%-1rm
4	stretch.
4	pla2s,
4	fk506
4	hsp70-overexpressing
4	muscle/body
4	tre
4	corepressor
4	frozen,
4	slow-
4	postsurgery.
4	ssua-knockout
4	est8
4	resolution,
4	psts.
4	est3
4	est16
4	modeling,
4	hyd-4
4	phoa.
4	losses.
4	sugar-binding
4	trehalose
4	kunitz-type
4	sulphur
4	dipole
4	(md)
4	gds,
4	losac
4	transcutaneous
4	c-domain.
4	123.59,
4	2.24
4	molybdate.
4	elt
4	operons,
4	triornithine
4	molecular-replacement
4	nuca
4	his-tag
4	amylose,
4	tropics.
4	ischaemia/reperfusion
4	pdgf
4	raf
4	nox2ds
4	po),
4	(ct:
4	ctγ
4	stabilization,
4	begell
4	house,
4	4-nitrophenyl
4	best-characterized
4	assembled.
4	zap-70
4	cd8§ssup§+§esup§
4	replication-deficient
4	polyphenolic
4	burkitt
4	laryngeal
4	survive,
4	optimal.
4	overlapped.
4	apoptotic-signaling
4	adenoviral-vaccinated
4	adenovirus-vaccinated
4	elusive
4	card
4	anti-pathogen
4	fibrin,
4	bcr-abl-mediated
4	bid,
4	jak-1
4	myelogenous
4	tyrosine-phosphorylated
4	cpp32
4	prodomain
4	tissue-resident
4	friendly
4	query
4	erbb
4	quorum
4	grmd
4	imm
4	promoters,
4	pi3k/akt/mtor
4	dokeb
4	permeabilization,
4	tnf.
4	(tnf-a),
4	koser's
4	[hydroxy(tosyloxy)iodo]benzene
4	ciclização
4	cetonas
4	iodine-catalyzed
4	indatraline
4	xyl
4	steric
4	laparoscopy
4	laparotomy
4	palliative
4	laparotomy.
4	transepidermal
4	p-glycoprotein
4	1500
4	gelation
4	post-application.
4	spadari,
4	options.
4	alginate-based
4	nanocarriers
4	penetratin
4	me-t
4	multitude
4	penetration,
4	w/w,
4	carrier,
4	me-lo
4	mk2
4	ethanol)
4	cubic
4	g25
4	immunocytochemistry,
4	sacchari,
4	poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
4	flask
4	biocomposite
4	biomass,
4	p(hb-hv)
4	incidents
4	second-generation
4	pentoses
4	(phb)
4	bactericide
4	prpc.
4	g-1.
4	alcaligenes
4	-mediated
4	(ut)
4	(nafld)
4	pbmt,
4	3-j
4	castoldi,
4	regulatory-like
4	oxide)
4	m1-mφs.
4	cx3cr1
4	lhae
4	l-arginine-induced
4	sligrl-nh2
4	hc-030031
4	hydrosulfide
4	infiltration).
4	obtusifolium
4	knee.
4	hindpaw.
4	(nk1)
4	(ag,
4	anti-granulocyte
4	bhe
4	biochemistry,
4	3-nt.
4	(tlr-4)
4	co-administered
4	periodontitis-induced
4	tmj,
4	csa-induced
4	chronic-active
4	(7-ni).
4	bdnf,
4	polistes
4	tachykinin-like
4	h2o2.
4	(sd
4	1+/+
4	sclerosis,
4	ml/kg
4	(eia)
4	synthesis).
4	(hbv)
4	il-10(-/-)
4	partners.
4	(during
4	xbp-1,
4	ire-1α
4	dystrophies.
4	eiu.
4	intraocularly
4	keratinocyte-derived
4	il-12(p40)
4	protracted
4	gpi-mucins
4	eyes,
4	micronesia.
4	cai
4	chikv-infected
4	flaviviridae.
4	causally
4	single-shot
4	env-specific
4	conjunctivitis.
4	disagv
4	homolog,
4	epidemic.
4	impact.
4	agmnpv.
4	(rvf)
4	cxfv
4	tetrameric
4	non-p
4	non-w
4	transfusion.
4	hps
4	frugiperda
4	npvs
4	herv-k
4	mybp
4	tool.
4	tata
4	baculoviruses.
4	spongiform
4	discordances
4	juno
4	deployed
4	tsr
4	(aii)
4	vc5
4	retro-aii
4	gallinaceum.
4	tyrosine,
4	ox513a
4	dss
4	maciel
4	simplicity
4	phosphatases
4	dengue.
4	annotate
4	character.
4	mouse-adapted
4	neurovirulence
4	mini
4	diseases)
4	foundation.
4	262
4	2000)
4	piura
4	proteinaceous
4	america;
4	hexamer
4	(ltp)
4	cci,
4	ox-42,
4	pod1
4	dor
4	(5 mg/kg,
4	spinally
4	inflammation;
4	allodynias
4	(quantitative
4	65-kda
4	(dna-hsp65)
4	breedings
4	car-s
4	asymmetrical:
4	heritability
4	segregant
4	liv
4	assortative
4	mta1,
4	gep5
4	msc6p
4	crassa
4	atp9
4	prkaa1
4	atp8
4	cleavable
4	oct1
4	transamidation
4	glutaminyl-trna
4	coq7p
4	her2p
4	neurological,
4	nde1p
4	coq8
4	rmnd1
4	mtg3
4	macroautophagy
4	cox24
4	ergosterol.
4	mirna-29b
4	(at2r)
4	cardioprotection
4	(bpm),
4	s100a8,
4	(sham:
4	mi:
4	hf60%
4	+dp/dt
4	mct4,
4	sf.
4	spectrophotometrically,
4	p-erk/erk,
4	p-akt/akt,
4	p-mtor/mtor
4	(45%).
4	aif
4	p-erk
4	2r
4	akt/gsk-3μ/mtor
4	birthweight
4	childhood.
4	t4-10
4	0.02%
4	ecto-5′-nucleotidase
4	e-ntpdase
4	5′-nucleotidase,
4	0.19,
4	unannotated
4	operator-constitutive
4	degradosome
4	rhle
4	low-iron
4	cc_0557
4	stresses.
4	cspd,
4	cztr
4	nhaa
4	emersonii
4	insertional
4	mr=
4	tonal
4	cajal
4	neuroactive
4	(neun)
4	neun-positive
4	(10.
4	ght
4	-receptor,
4	computer-assisted
4	jacchus
4	occupy
4	reuptake
4	phosphoforms
4	proving
4	ectoderm
4	b16‐f10
4	suckling-weaning
4	mnc
4	cdh1
4	immunostaining.
4	metaphasic
4	18-
4	(hsp)
4	strongyloidiasis
4	hute
4	patterns)
4	mock
4	hapten
4	sézary
4	serodiscordant
4	esn
4	γ,
4	b10
4	nkg2c
4	nkg2d
4	phenotypical
4	cxcl10,
4	cxcl8,
4	cxcl8
4	esns
4	tlr2/tlr4
4	subclasses,
4	filaggrin
4	cd57
4	gag-specific
4	surgery),
4	(laser
4	breastfeeding.
4	(odn)
4	ciu,
4	hiv.
4	(lll)
4	iga-deficient
4	il-3
4	hemocyanin
4	anti-iga
4	bwf1mice
4	factor-beta
4	hepatomegaly
4	pil
4	bfpa,
4	nunes,
4	ecprabcde
4	tccp
4	spates
4	sepa
4	(4.1%),
4	aepec,
4	harmlessly
4	extraintestinal
4	19.2%
4	hemolytic-uremic
4	stec,
4	ralt
4	(wb)
4	stx-negative
4	espa,
4	adheres
4	casei-int
4	rodentium
4	sada
4	(tepec).
4	omp
4	tepec,
4	more.
4	maldi-tof
4	antiserum,
4	eae-negative
4	bfpa/pera
4	(uti)
4	15min
4	gm1.
4	(vf)
4	neuroadaptive
4	ethanol's
4	enduring
4	abstinence
4	oprd1
4	free-choice
4	becs
4	gabab
4	(l,
4	v/v
4	"addicted"
4	sch-23390
4	(gst)
4	gr/gpx
4	self-administration.
4	(d2)
4	paradigms.
4	investigator-administered
4	cleft.
4	oblongata,
4	sleep-deprived:
4	g(m1)
4	mazindol
4	sp38
4	orthology
4	duplication.
4	quantification,
4	ohr
4	bamboos
4	tet/jbp
4	epigenetically
4	cassettes
4	lineage-specific
4	7tm
4	surfaceome
4	u/l),
4	j/cm(2),
4	j/cm(2)
4	electromyographic
4	pet/ct
4	spect/ct
4	bunodosoma
4	ischial
4	opioids.
4	co-cultivation,
4	polybia-mp-i,
4	heterodimeric
4	fulvonin
4	ctenus
4	keyserling,
4	(brown
4	spider)
4	acknowledged
4	(hgf)
4	timp-3
4	wd-pr
4	sm/j
4	(bpv)
4	bpv
4	nnos-1
4	lsd.
4	dampened
4	histamine-induced
4	wadayamensis
4	oncidium
4	hydrocarpa
4	33.1:pjtt
4	cry
4	(green
4	33.1
4	(16s
4	cultivar
4	rhizoplane
4	soybean,
4	agglomerans,
4	pyraclostrobine
4	sinensis)
4	fungicides
4	carbendazim,
4	aspergillus,
4	pegia
4	dsza
4	(ckd
4	nephrology
4	alternating
4	a30p
4	nf-k{cyrillic}b
4	balb/c-bearing
4	bcl-3
4	tnfr2
4	2-/-
4	ration
4	parthenolide
4	gcs,
4	α2,3
4	glutamate-cyclic
4	c3h/hen
4	cd14,
4	(flavin
4	fmn
4	pmol.mg-1.min-1.
4	irs1,
4	erk1
4	immunometabolic
4	stage)
4	βhb
4	ppar-γ,
4	briefly,
4	(16:1n7,
4	(16:0,
4	(18:1n9,
4	(s
4	(as)
4	pads,
4	antipsychotics
4	adipocyte-specific
4	thr-phospholamban
4	303
4	enlargement,
4	labor
4	overloaded
4	i-form
4	10:00
4	infectologia
4	penton
4	dodecahedra
4	hia
4	malting
4	beer
4	panels
4	(don)
4	zen
4	(xps),
4	(cpa)
4	mycotoxigenic
4	metalloprotease,
4	nonaflatoxigenic
4	trichothecene
4	hypocrea
4	nps.
4	fb<inf>1</inf>
4	kurstaki
4	nomius
4	feedstuffs
4	pods
4	aflatoxins.
4	flasks
4	hat
4	60co
4	dichloran
4	monomethyl
4	(cfu/g)
4	aoh
4	covered;
4	1/kg
4	afb1/kg+
4	200μg
4	haugh
4	(p>
4	rays
4	ng/g)
4	worst
4	2,450
4	microsporum
4	piglets.
4	feed;
4	corn-based
4	spp.).
4	cba/j
4	c1-inhibitor
4	b6c5-
4	27,
4	lysis,
4	dbss
4	cation-exchange
4	rm,
4	ethics
4	mexican-mestizo
4	metainflammation,
4	(at),
4	(atms).
4	ifngr1
4	post-tumour
4	decaffeinated
4	vascular-stromal
4	low-cost,
4	disease-related
4	(walker-256
4	(epf)
4	lipopolysaccharide-treated
4	(p50
4	p65)
4	spf.
4	lasts
4	myd-88,
4	pge2content
4	steatosis.
4	pads.
4	overtrained
4	nf-kbp65
4	n=8).
4	recruited.
4	(∼12
4	vcam/cd106
4	0·05).
4	110%-1
4	ldl-cholesterol
4	cholesterol/hdl-c
4	sedentary)
4	13-20
4	disease-associated
4	vldl-cholesterol
4	(ip),
4	scs
4	scc.
4	mφ{symbol}s
4	posttest
4	(mrsa)
4	endometriosis,
4	tracheobronchial
4	mycoides
4	brd.
4	fermentum
4	plantarum
4	trichomonas
4	gardnerella
4	ciprofloxacin,
4	avai
4	pgfs
4	(pig
4	grpe,
4	gapn,
4	designed.
4	suis.
4	suis,
4	nadh,
4	exam
4	bela
4	(cbc)
4	disinfectant
4	(43.3%)
4	leishmania-infected
4	tgf-beta
4	delisa
4	faculty
4	immunizations.
4	clinicopathological
4	ga
4	communis
4	astro
4	phoenix
4	tcd8+
4	tcd4+
4	serology,
4	ks
4	midzone
4	midzonal
4	aim,
4	balt
4	scvr
4	trochophore
4	comparably
4	leprosy.
4	pfpk7
4	synchronicity
4	schizonts.
4	znppix
4	mrp2
4	serpentine
4	discharged
4	thapsigargin,
4	cysteine-protease
4	noradrenaline-induced
4	0.02)
4	respect,
4	insp3
4	radiative
4	albedo
4	sausage
4	salami
4	joinville
4	sjögren
4	dncs
4	droplets.
4	issue.
4	non-refractory
4	ground-based
4	cm-3
4	bb
4	lsg
4	retinitis
4	ts.
4	owned
4	isograft
4	post-transplantation.
4	graft-infiltrating
4	fty720-treated
4	diagnostics
4	pmbok
4	exponents
4	rygb.
4	climate.
4	ui
4	cd25highfoxp3+
4	chronic-inflammatory
4	(eae).
4	igg2a/igg1
4	glycerol/mem
4	uveitic
4	eau,
4	acuity
4	ags
4	anti-il-12
4	t(h)1
4	anti-il-4.
4	thymectomy
4	reproducibly
4	lethally
4	nonprotective
4	3x
4	peyer's
4	apps
4	haptoglobin,
4	hbp
4	envenomated
4	(myd88-dependent)
4	nattectin.
4	fishermen
4	bj-pro-5a
4	fibrinogenolytic
4	kallidin
4	visualised
4	trpc5
4	depolarizes
4	autophagosome
4	hypolipidemic
4	caco
4	septicaemic
4	non-diarrheic
4	(lt-i,
4	lactose,
4	k88,
4	s32
4	vt
4	k99
4	biken
4	anti-choleragenoid
4	lt+
4	hemagglutinating
4	casamino
4	acids-yeast
4	lt.
4	non-etec
4	vk247,
4	montanide
4	nussenzweig,
4	dec205+
4	αdec-msp1
4	ectodomains
4	i-restricted
4	status:
4	αdec-asp2
4	polyriboinosinic:
4	polyribocytidylic
4	radvax
4	multi-epitope
4	cross-present
4	yf17d
4	tewetgqi
4	msp-3
4	msp-3α
4	histidine-tagged
4	pvmsp-3α
4	pvmsp-3β
4	saponins
4	nkt)
4	immunodominance.
4	breath
4	disappointments
4	prime-adenovirus
4	pil-15
4	his6msp119,
4	c57bl
4	perforin-deficient
4	tcd4+ctla4+foxp3+
4	(i.n.)
4	ectodomain.
4	odn.
4	(cd86
4	ligand)
4	odn-assisted
4	cd8+-t-cell
4	trans-sialidase.
4	his6msp119-dydvvylkplagmyk-padre
4	t-cell-dependent
4	protein-boosting
4	(i.m.)
4	pan-allelic
4	immunogenic,
4	boosters
4	nonprotective,
4	1g7
4	gp-10/20
4	hoehn
4	(rti)
4	fes-i
4	rti.
4	abpv
4	sddn
4	psqi
4	scdec-ediii
4	czs
4	ethical
4	(p139-512)
4	adec205
4	adcir2
4	stxb-e75
4	motab
4	anti-flid
4	enteropathogenic,
4	pgm-csf
4	(id)
4	lt-iic
4	anti-ns1
4	αdcir2-ns1
4	g33d
4	(cfa).
4	dioctadecyl-dimethylammonium
4	radiotherapy.
4	anti-full-length
4	iptg,
4	vehicles.
4	(cfab)
4	(ltb),
4	gsib
4	pgsib
4	plasmid-based
4	igg)
4	non-replicative
4	(odc)
4	o153:h45
4	live,
4	(im)
4	(coding
4	σs.
4	(sds-page)
4	anti-trypanosomal
4	102.
4	minerals,
4	omvs
4	kpc-2-producing
4	(wgs)
4	alg-gs
4	thermogravimetric
4	quinolones
4	metallo-β-lactamase
4	(agnps)
4	twin-screw
4	(xrd),
4	(esbl)-producing
4	kpc-2
4	resort
4	aerogenes
4	methylase
4	nanocomposite
4	0.5%;
4	blacmy-2
4	incx4
4	adamantium
4	promiscuous
4	carbapenem
4	(cna,
4	qpvp-c5
4	ctx-m
4	integrons
4	blatem
4	jandaei
4	(pss)
4	cpg/cfp-immunized
4	hypochlorous
4	bte.
4	lafoensia
4	etanercept
4	rubrum
4	ivα14
4	a-primed
4	mir18a
4	emt.
4	brafv600e
4	thrβ
4	echocardiography.
4	hes1,
4	mir-19
4	tetraploid
4	rnas.
4	lgals3
4	tpc-1,
4	t98p
4	c-myc.
4	frtl-5
4	ttf-1
4	ests.
4	βb
4	amifostine-treated
4	refractoriness
4	repeat-rich
4	maxima
4	eimeria.
4	spliceosome.
4	nestedness
4	complex),
4	gbms
4	a172
4	circumventricular
4	ku70,
4	bcl2,
4	dha/epa
4	mannoheptulose
4	glycophorin
4	annulifera
4	metalloproteinases,
4	erythromelas
4	mcp
4	anaphylatoxins
4	bev
4	injection)
4	nep-like
4	c3a,
4	tenuiflora
4	cd59
4	smased
4	line]
4	(ts
4	nudel-oligopeptidase
4	co-ossification
4	gecs
4	oba-9
4	(pdt)
4	(4th
4	apdt
4	plla
4	acidophilus
4	a.a.
4	tci/cci
4	neovestitol
4	faecalis.
4	aacdt
4	ll-37
4	lased
4	mutacin
4	3-year
4	(wild
4	lithobates
4	aqp9
4	co2/hco3
4	phs)
4	>0
4	amtb
4	ta98nr
4	ghr
4	p110β
4	lowers
4	erα.
4	mea.
4	mrn
4	gh),
4	lepr-reporter
4	prolactin’s
4	kisspeptins
4	[ko])
4	pstat5-immunoreactive
4	rmtg.
4	flox/flox
4	leprb
4	bcaa,
4	trali
4	24th
4	vimang®
4	ultrasonically
4	(0.18
4	trex1
4	adc
4	snail
4	e6ap
4	mct4
4	alui
4	hypoxia)
4	(30 mg kg
4	 day
4	hfd-h
4	min-1;
4	guide-cannulas
4	arterially
4	cnts
4	heart-brainstem
4	neurohumoral
4	chemoreflex.
4	pmol/50
4	sfo.
4	rs2242480
4	rs15524
4	cyp3a4/5
4	cyp3a
4	cyp3a5*3c
4	c3435t
4	semitendinosus
4	akt/mtor
4	ci.
4	ovx+e2
4	pi(3)-kinase
4	resistance:
4	gh-induced
4	irs-1/shp2
4	anti-pi
4	blotted
4	cna
4	fructose-fed
4	grb2.
4	shptp2
4	orthophosphate
4	alarmone
4	phor
4	rpos,
4	mg1655
4	spanc
4	ihf
4	ar,
4	ext-ts
4	surf
4	knocked-down
4	msp9
4	pfcdpk1
4	(pparγlox/lox
4	pyrin
4	proanthocyanidins
4	cooh
4	glyceroneogenic
4	glyceride-glycerol
4	fcn
4	fosfomycin
4	mmcb
4	(led)
4	leds
4	1551-2
4	agga
4	(55.6%),
4	salt-12:
4	imt
4	(msc)
4	aldh2,
4	δpkc
4	anti-remodelling
4	mi-hf
4	βiipkc
4	handling-related
4	(pn)
4	n=12),
4	neostriatal
4	ndc,
4	pep5-cpp
4	tcgs
4	consumed,
4	cruzain
4	tbp5cdh
4	tcp5cdh
4	cgl
4	aspat
4	heme,
4	gp90,
4	h4
4	tcp2β
4	(97
4	pmal-c2
4	c-sle
4	urm
4	7401
4	bj-crp
4	lacps1
4	stmn1
4	fluorotic
4	lbrc
4	nucleophosmin
4	rkip
4	g/mg
4	rartinm
4	sl-cathl
4	lobes
4	0.56
4	bjussump-i
4	jacalin
4	paracoccin
4	w15
4	ns,
4	ps),
4	formalinized
4	fibrillation
4	anti-contractile
4	preglomerular
4	profibrotic
4	trpv4
4	mechanoreflex
4	post-rest
4	lmi
4	sitagliptin
4	ornitho-kinin
4	ouabain-induced
4	t+s.
4	t+s
4	1k1c
4	myosin-va
4	neuritogenesis
4	patterning
4	cep-1347
4	aspartase
4	40 days
4	rvlm-c1
4	photostimulation
4	pre-bötzinger
4	dpcpx
4	arl67156
4	(diaemg)
4	ggemg
4	β-hydroxylase-saporin
4	chemoreception,
4	(α2-ar
4	(α1-ar
4	α2-
4	β-ars
4	hypoventilation
4	sympathoinhibition
4	co2/h+.
4	5-ht7-receptor
4	ih.
4	978
4	interneuron
4	(ssp-sap)
4	motoneurons,
4	ccrtn
4	ssna,
4	furo
4	automaticity
4	sk+channels
4	no-exercise
4	+-sensitive
4	+-evoked
4	ssna
4	(8-10%
4	(av3v)
4	6,7-dinitro-quinoxaline-2,3-dione
4	(dnqx;
4	(contained
4	(pnd).
4	cgp
4	35348
4	=+
4	pre-weighted
4	anti-salivatory
4	ppgal
4	mrna-positive
4	phox2b+/th-
4	biotinamide.
4	galanin
4	apnoeic
4	inflation.
4	peritrigeminal
4	ints
4	20 nmol)
4	(80,
4	320 nmol)
4	(20 nmol)
4	(320 nmol)
4	snd.
4	vrc,
4	mesenteric,
4	(160nmol)
4	atropine-mb
4	tribromoethanol
4	cholinergic-induced
4	fluconazole-resistant
4	f2.4)
4	coccidioides
4	lutzii,
4	mycology.
4	t-cd4+
4	owners
4	dermatobac®
4	lutzii
4	chitooligomers
4	cryptococcosis
4	ajoene
4	m10
4	prozone-like
4	12a1
4	lobo's
4	bout.
4	β<inf>2</inf>ko
4	tβr-i/smad2/3
4	akirin1
4	tennis
4	doms
4	dmem/ham's
4	paecs
4	câmara
4	5/6nx
4	adenine-enriched
4	adriamycin
4	nox-independent
4	capillaritis
4	glomerulitis
4	cd56+
4	associatedwith
4	ilcs
4	bm-mscs
4	.004),
4	pnu-282987
4	rhabdomyolysis-associated
4	post-reperfusion
4	arazyme
4	endocytosis,
4	wasinski
4	smoke-induced
4	vehicle);
4	rbp4,
4	stnfr1
4	clp,
4	correa-costa
4	tin.
4	b2rbk-knockout
4	th-17
4	gcv
4	gd3
4	cera
4	censored
4	nicotinamide,
4	sirius
4	bmmcs
4	galectin-9
4	kt/v
4	postnephrectomy
4	ptx-gn
4	raasb
4	antilymphocyte
4	vα24
4	dna-hsp
4	pvaxhsp65
4	cfp/cpg
4	narcolepsy
4	mazama
4	haemominutum’
4	leptospiremia
4	white-tailed
4	ovis.
4	23s
4	phalanx
4	ppe
4	consolidation.
4	vocal
4	rbp4-induced
4	ttr
4	caveolar
4	gp35/50
4	rs2670660
4	siglec-1
4	hpv+
4	nalp1
4	nalp3-inflammasome
4	ggpp
4	(mkd)
4	r92q
4	gscs
4	co-chaperone
4	gsc
4	230-245
4	(sti1)
4	axonogenesis
4	-ln
4	adam23
4	hop/sti1
4	anti-prpc
4	ctsp-1
4	selex
4	structure-based
4	pparδ
4	oligomerisation
4	pfpdx2
4	pfsod2
4	pfsod1
4	heterotetrameric
4	glutamicum
4	cosmid
4	rpfhinge-odc
4	thalamocortical
4	sporotrichosis,
4	amb-d
4	amb-d/itz
4	mg/l.
4	'barbatimão'
4	anti-cd36
4	tj
4	ron4
4	bmmsc
4	clonogenicity,
4	mad1l1
4	zyxin
4	ser157
4	yap1
4	numb
3	[10-6
3	2.04
3	56),
3	(iso)
3	(sta)
3	(dphi/dt)
3	snp.
3	peptide-1
3	incretin
3	state;
3	barrel
3	pre-hypertensive
3	y-shrs
3	a-shrs.
3	h<sup>+</sup>-atpase
3	(pka
3	mdck-c11
3	h+-sensitive
3	cardiorenal
3	0.003
3	antagonist],
3	glucose-dependent
3	microvillus
3	italiana
3	confinement
3	clc-5
3	pka,
3	0.80
3	0.60
3	na+/h+exchanger
3	[10
3	[z(no2)]-pyrrolidide
3	(i40;
3	noninhibitory
3	lys[z(no2)]-oh
3	i40.
3	isopycnic
3	intermicrovillar
3	(81
3	end-proximal
3	ph/hco3-
3	i40-treated
3	remainder,
3	nppb
3	0.014
3	0.061
3	difference)
3	bapta.
3	(k+
3	0.85
3	4.98
3	1.56
3	hma,
3	(atpase)
3	romk
3	(irptc),
3	7.08
3	7.18
3	0.018
3	deprivation-dependent
3	uo-126,
3	sb-203580
3	h+-k+-atpase).
3	(10-12-10
3	2-receptor
3	ddavp
3	(10-12-10-6
3	8-brcamp,
3	278:f809-f816,
3	cm-2.second-1;
3	[phorbol
3	(pkc)].
3	nmol.cm-2.seconds
3	bis
3	(2-aminophenoxy)
3	ethane-tetraacetic
3	avp-stimulated
3	36.4%,
3	avp-independent
3	(plc)/ca2+/pkc
3	cyclase/camp/pka,
3	maxi-potassium
3	(w),
3	1.07
3	g/day).
3	2.64
3	7.0)
3	8.0.
3	pumps,
3	28080,
3	(10-12,
3	k+.
3	ratiometric
3	preincubating
3	h+-k+
3	(n=7).
3	short-circuit
3	bath.
3	aquaporins
3	transcellular,
3	limits.
3	cl-/hco3-
3	(n=10),
3	yellow.
3	min-1,
3	48)
3	ringer.
3	0.011
3	0.012
3	21)
3	mcmv
3	brattleboro
3	ptx:
3	690
3	54.6
3	0.041
3	7.15
3	21),
3	furosemide,
3	channels),
3	reviewed,
3	0.069
3	0.042
3	0.005
3	shunting
3	(v(t))
3	1.21
3	cooked
3	26.9%
3	bicarbonate.
3	complete,
3	(adx)
3	(a),
3	reaching,
3	47.2%
3	aldosterone-treated
3	(u-b
3	pco2)
3	1.99
3	rat)
3	(10-3
3	disappearance;
3	3.90
3	6.33
3	(inhibition
3	h7,
3	(bicarbonate
3	reabsorption)
3	(ca2+)
3	(into
3	oh-,
3	k-depleted
3	14c
3	electrodes.
3	-h
3	j(hco
3	-atpase,
3	49%,
3	-k
3	mosmol
3	secretion),
3	0.040
3	100-110
3	h<sup>+</sup>
3	ringer’s
3	bicarbonate-
3	0.79
3	cm/s.
3	thyroparathyroidectomized
3	bicarbonate-infused
3	27.9
3	21.3
3	amiloride.
3	4.75
3	(jhco3)
3	2.18
3	pth,
3	constant.
3	cable
3	cm2
3	pah
3	ml‐1
3	mmhg.
3	2.84
3	antimony,
3	zero,
3	barrelled
3	6-8
3	cm/s
3	attenuated.
3	100-200
3	26.6
3	1.74
3	levels)
3	drinking.
3	isosmotic
3	unstirred
3	0.67
3	non-bicarbonate
3	28)
3	bicarbonate,
3	microcalorimetric
3	7.8)
3	micro‐electrodes.
3	(t1/2
3	progressively.
3	equilibration,
3	(phosphate)
3	7.0.
3	jh+,
3	bicarbonaturia.
3	6.78
3	nmol/cm
3	·.
3	−66.6
3	−20.2
3	/hco(formula
3	presented.)
3	indicates,
3	t/2,
3	jhco-3.
3	permeabilities
3	albumin)
3	10(-4)
3	1.77
3	0.53
3	j(v)
3	0.82
3	stayed
3	8.48
3	equation.
3	antiarrhythmic
3	10(-3)
3	micrometer
3	micro‐electrodes
3	1‐10
3	66.0
3	slows
3	alkaline.
3	13.2
3	c1.
3	streaming
3	adh
3	medium;
3	bladder,
3	differences;
3	5.6.
3	7.4,
3	ha,
3	definite
3	1969
3	closes
3	pine
3	angustifolia
3	(free
3	(2-de)
3	burkholderia,
3	surface-disinfected
3	seventy-four
3	endoglucanase
3	enterobacter,
3	klebsiella,
3	pseudomonas,
3	rhizosphere.
3	[pseudomonas]
3	nov.
3	mlsa
3	nifh
3	(66%),
3	(80%).
3	enterobacteriaceae.
3	cyanobacteria-deprived
3	canoparmelia
3	parmotrema
3	chemo-organotrophic
3	courses.
3	organizer.
3	bacteria:
3	derxii,
3	varied,
3	destination
3	nitrogenated
3	arginine.
3	non-diazotrophic
3	shaken
3	rate;
3	enumerated
3	rpm,
3	(plc),
3	fura
3	fura-2
3	am,
3	(gr
3	49%.
3	cam
3	(s2)
3	hco3-,
3	([ca2+]
3	hat1
3	ca2+-free
3	52)
3	47%.
3	camp-independent
3	7.74
3	5.92
3	(ed;
3	tubule)
3	(ld;
3	h+-sensitive,
3	8-bromoadenosine
3	(deamino-cys1,
3	d-arg8)
3	234
3	pm)
3	(33%).
3	2.12
3	0.060
3	0.031
3	(asteraceae)
3	perennial
3	cerrado.
3	discarding
3	ml/min.
3	(ept)
3	2.46
3	2.47
3	2.45
3	d-glucose.
3	1.02
3	mpt,
3	dissipation
3	nonredundant
3	ifns.
3	dectin-3
3	pdc-p.
3	2,3
3	ecuador
3	antigenemia,
3	deactivate
3	(trp)
3	(kyn)
3	tgf-ß
3	ido1-/-
3	i.t.
3	frequencies.
3	russo.
3	anti-infectious
3	araújo
3	129sv
3	ido-mediated
3	knock-in
3	(prrs)
3	felipe
3	(prr)
3	no-synthase
3	il-β
3	lipoxins
3	cyslt
3	infections)
3	(il-12),
3	interferon-,
3	mr,
3	1×106
3	lipid-rich
3	f1,
3	f3a
3	claimed
3	cd28-deficient
3	costimulation
3	lately
3	pb18,
3	(nhs)
3	c4b,
3	pb18.
3	concise
3	gm-csf.
3	cd40.
3	mycosis,
3	sterilizing
3	(igg1),
3	neutrophil-depleted
3	igg2b,
3	well-organized
3	(il-4
3	il-3,
3	similarity.
3	non-virulent,
3	virulent,
3	similarity).
3	(a/sn),
3	-infected
3	(igg1
3	immunopathology.
3	foster
3	fungus-host
3	glucuronoxylomannan
3	aspergillosis
3	foci,
3	fungi;
3	isham.
3	responses).
3	(tnf-α
3	ephemeral
3	(intermediate
3	23,
3	luminol
3	encapsulating
3	b10.d2/osn
3	hyperactive
3	(sheep
3	pb45
3	pb47
3	pb44
3	pb50
3	encapsulation.
3	engulfed
3	(very
3	filtrates
3	electrophoresed
3	dissociated.
3	kd.
3	subcultivation
3	subculturing
3	rs
3	(isolates
3	192,
3	anti-tetanus
3	fab'
3	slow,
3	fu/tube
3	35°c
3	fast-growing
3	10(6)
3	f2,
3	apathogenic
3	pb267)
3	pb267
3	g-75
3	peptone
3	fda-eb
3	speed,
3	cof
3	author's
3	9.7%
3	(bbg),
3	(isr)
3	100 mg/kg,
3	bbg50
3	bbg100
3	neurofilament-200,
3	isr.
3	curi,
3	(ovalbumin)
3	adjuvant-free
3	(sge).
3	penh
3	peribronchoalveolar
3	mixed-type
3	igg1/ige
3	(th2-related)
3	(th1-related)
3	(bd)
3	sex-dependent
3	cannabidiol
3	elastance,
3	histol
3	histopathol.
3	sod-2
3	14days
3	neurochemical,
3	naïve,
3	cage-mates
3	depressive-
3	neuroendocrine,
3	46.7,
3	(0.001-10
3	(i/r).
3	(lvp)
3	l-name;
3	(rrs)
3	elastance
3	ischemia/reperfusion.
3	ac2-26
3	(lllt).
3	i-i/r.
3	irradiating
3	amph.
3	aerosol,
3	drained
3	(hq)
3	vehicle;
3	lab
3	effect:
3	(ova)-sensitized
3	(inos
3	lps-inflamed
3	countings
3	depressed,
3	neuron.
3	endotoxins
3	(macrophages,
3	experimentally-induced
3	booster,
3	ligand-deficient
3	2-deficient
3	immune-modulation
3	(icam-1).
3	concerned.
3	(ova
3	estradiol-treated
3	(il)-4,
3	humid
3	(dep),
3	neurogenic-mediated
3	125i-bovine
3	(nk1
3	nk2)
3	nmol/kg)
3	l-732,138,
3	1,2-nq-induced
3	bronchus,
3	endotoxin,
3	al(oh)3,
3	one-day
3	23.
3	non-ovx
3	exists.
3	hydroxide.
3	early-phase
3	nw-nitro-l-arginine
3	oophorectomy
3	topographical
3	mmc
3	post-ova
3	no-donor
3	b4.
3	(ntr)
3	(pca)
3	mepacrine
3	(eb),
3	anti‐rat
3	44,
3	thrombocytopenic
3	(mepyramine;
3	(methysergide;
3	(paf).
3	l-663,536,
3	immune-complex-mediated
3	(bn-52021)
3	(econazole),
3	(ndga).
3	thromboxane.
3	(4-6
3	α2-adrenoceptors.
3	tcbat.
3	nifurtimox,
3	bzd.
3	anti-trypanosoma
3	bug
3	ic<inf>50</inf>
3	3.17
3	bz-susceptible
3	dtu-specific
3	undescribed.
3	indolic
3	auxin
3	conjugates,
3	pdc/ipdc
3	development:
3	tsa-1,
3	tci-tcvi.
3	435
3	complements
3	division,
3	tci,
3	455
3	bolivia,
3	phylogenies.
3	debated.
3	50-100
3	2-3%
3	30-fold
3	maxicircles
3	minicircles
3	uridine
3	tarentolae
3	edited
3	anchoring
3	model-free
3	graphical
3	analysis:
3	serpens.
3	452
3	ends,
3	inference.
3	propositions
3	stat-pak
3	99.6%
3	9.3%
3	9.0%
3	e12
3	four-
3	fgqaaagdkpsp-lamb
3	16.6
3	den
3	stat
3	393
3	197
3	checking
3	documentation.
3	1/2.
3	characters
3	iic
3	hybrid,
3	carboxy-terminal
3	lsu,
3	277
3	mix-elisa
3	discrepant
3	diagnosed,
3	opossums.
3	(25%).
3	spacers
3	dichotomy
3	subclusters
3	maximum-likelihood
3	riboclades
3	once.
3	(lsu)
3	endotrypanum.
3	semipurified
3	reagents.
3	opossums,
3	tamarins
3	composing
3	triatomines.
3	equally.
3	allopurinol
3	profiles;
3	fingerprinting
3	determined:
3	benznidazole.
3	1;
3	proposals
3	financial
3	365
3	equivalents.
3	invaluable
3	genes:
3	(defined
3	gipl
3	mitogenesis.
3	cutoff.
3	anti-cardiac
3	doublet
3	10-6).
3	anti-lppg
3	galactose,
3	glycan
3	authentic
3	80-90
3	copy.
3	radioiodination
3	disaccharide
3	promoted,
3	sialyl
3	gangliosides.
3	neuraminidase.
3	tunicamycin.
3	reincubation
3	[35s]methionine-labeled
3	(tc-85)
3	rf
3	radioactivity.
3	1.51
3	unlabeled
3	co-purification
3	10-fold)
3	thawing
3	mn2+,
3	mn.
3	siphon
3	dose-effect
3	insignificant
3	it;
3	d-tubocurarine
3	glucose-mediated
3	kv
3	meneses-santos
3	once-daily
3	nadph,
3	gdp
3	(hsl),
3	30%)
3	4.3-fold)
3	glucosestimulated
3	nox-derived
3	(mass
3	ubs
3	β-cell.
3	intolerances,
3	rapamycin-induced
3	insulin's
3	osteoporosis,
3	longterm
3	(immunoprecipitation
3	1.3-and
3	catecholamine-mimetic
3	kcl-
3	leucine-induced
3	(mcfa)
3	mcfa-fed
3	bα
3	(akt1)
3	prole
3	supplemented).
3	g2).
3	lipidemia
3	(ir,
3	akt).
3	n-6:n-3
3	flavonoids.
3	48h,
3	pregestational
3	phox),
3	phox)
3	(isoform
3	oxidase-nox2)
3	ofroson
3	peroxide-metabolizing
3	gsh-based
3	levels.herein,
3	vulnerabilityof
3	forgshsynthesis
3	themaintenance
3	mtor/p70s6k
3	triiodo-l-thyronine
3	(eif2),
3	p-eif2,
3	ef1a,
3	(4e-bp),
3	p-4e-bp,
3	p70s6k,
3	p-p70s6k.
3	eif2,
3	(eef1a).
3	4e-bp,
3	p-eif2
3	eif2
3	decoding,
3	polydipsia
3	epidid-ymal
3	polyphagia
3	assessment-insulin
3	smallerthan
3	ep,
3	acetyl-coenzyme
3	(aii),
3	(3.
3	thatoaacts
3	(ppp).
3	peroxide-specific
3	membrane-permeable
3	rebelato
3	2•-
3	review)
3	(irs1
3	irs2),
3	kinase-1
3	[tyr]),
3	(threonine
3	[thr202]/tyr204),
3	[ser727]).
3	0.1-mmol/l
3	[ser727])
3	30-minute
3	mmol/l),
3	thymoma
3	[nad(p)h]oxidase
3	/3-cells
3	/3-cell
3	for1hor
3	2,7-dichlorodihydrofluorescein
3	porter-2,
3	subunit]
3	/-cells
3	/-cell
3	(scfa)
3	(84%)
3	decarboxylation.
3	iodonium,
3	demise.
3	nonstimulatory
3	(notably
3	lc-acyl-coa)
3	lc-acyl-coa
3	(formed
3	coculture.
3	low-salt
3	0.15%
3	nacl)
3	during,
3	(92
3	pp185.
3	2-bromopalmitate,
3	palmitoyl-coa
3	transferase-1
3	cerulenin,
3	non-stimulatory
3	acyl-coa
3	(lc-coa)
3	tothe
3	138%
3	(pi).
3	carbons
3	(namely
3	(af),
3	(ol).
3	af,
3	ol).
3	test-gtt)
3	normoinsulinemic
3	b-cells,
3	86rb+,
3	[3h]-phosphoinositide
3	14c]glucose
3	perifusing
3	(lpd)
3	(gtt)
3	(lpd
3	g;
3	npd
3	gtt
3	p<
3	avoided.
3	required,
3	(f),
3	(e),
3	b-cells.
3	cationic,
3	(tpa)
3	verapamil.
3	vasopressin-induced
3	anaplerotic
3	postulates
3	acetyl-coa.
3	(one-third).
3	2-hr
3	lib
3	scheme.
3	regular-fasting
3	(2-hr
3	(d-glucose
3	l-leucine)
3	single-fasted
3	regular-fasted
3	secretagogues;
3	cyclometer
3	secretagogues,
3	theophylline,
3	l-leucine,
3	11.1
3	alpha‐ketoisocaproate
3	tolbutamide,
3	9-aminoacridine,
3	prelabeled
3	pyridine
3	mmol/l,
3	12-o-tetradecanoylphorbol-13-acetate
3	(1.4
3	any,
3	(tea;
3	5%)
3	mole
3	nutrients.
3	α-ketoglutarate.
3	transamination
3	smoking.
3	sal
3	mpd-pretreated
3	femproporex
3	p.o.,
3	crossings
3	5720,
3	5823,
3	light/12-h
3	(lights
3	32.1
3	striata
3	(250-300
3	preference.
3	(0.05
3	fcf-induced
3	metoclopramide
3	amphetamine,
3	stimulants
3	distinguishable
3	dihydroxyphenilacetic
3	re-evaluation
3	5-hydroxytryptamine,
3	5-hydroxyindoleacetic
3	lc.
3	velocities
3	commission
3	pk,
3	(flx)
3	endo-
3	l-nil
3	sex-specific
3	dantas
3	desire
3	p-450
3	2.85
3	standpoint
3	expansive
3	(eight
3	carlos,
3	equidistant
3	(aged:
3	19-20
3	amount,
3	thr495.
3	angiotensin-ii
3	(mtdna)/toll-like
3	(tlr9)
3	soares
3	16-week
3	preserved,
3	proteinase-3
3	(pvat)
3	pvat,
3	uncoupling,
3	pvat.
3	renin-angiotensin-aldosterone
3	model.material
3	mg/kg/15
3	(ctm),
3	(otm).
3	analyzed.key
3	insulin-ir-erk1/2
3	tumor.significance
3	(nfκb)
3	trif,
3	flutamide
3	(androgen
3	ceravolo
3	-leu
3	-bradykinin
3	(angii+dal
3	[(mmhg)
3	184±5.9
3	115±2.3],
3	hydroxyethidium/dihydroethidium
3	(eoh/dhe):
3	21.8±2.7
3	6.0±1.8]
3	218.3±29.4
3	100±0.25].
3	ii+dal
3	(eoh/dhe:
3	9.17±3.1)
3	erk1/
3	(137±20.7%)
3	proliferating-cell
3	[h3]leucine
3	ii/b1r
3	tiron
3	redox-regulated
3	dabk
3	periodontology.
3	(par
3	(kc,
3	microscopy;
3	samr1
3	computer.
3	(tgf-β1),
3	(par2)
3	c;
3	evaluated;
3	aortas;
3	losartan)
3	anandamide,
3	anandamide-induced
3	modality.
3	(810
3	mmp-3,
3	chemerin.
3	1r
3	brasiliense
3	pequi
3	(che)
3	2-adrenoceptor
3	diseases).
3	hypertension-associated
3	antibody)
3	intraperitoneal).
3	(thromboxane
3	(shrs).
3	c-src
3	wistar)
3	postinjury
3	photobiology
3	l-nitro
3	ns-398.
3	ns-398
3	(bh4).
3	prostacyclin/tromboxane
3	obesity/insulin
3	uncoupled
3	flank.
3	enzymes:
3	pathway.methods
3	(vsmcs)
3	gef
3	veins.
3	celecoxib.
3	(vsmcs).
3	(pi3k/akt)
3	vsmcs,
3	desoxycorticosterone
3	(16±3
3	(doca-salt)
3	(arbitrary
3	inhibitor;
3	ser-1177
3	(2-day-old)
3	3.5 mg/kg
3	(ang-(1-7))
3	et-2
3	1-31
3	vasoconstrictor,
3	disappears
3	pertussis-haemophilus
3	influenzae
3	protocol),
3	followed-up
3	minipump.
3	apocynin)
3	collaborating
3	na+k+-atpase.
3	(8-9
3	undernourishment.
3	mimetic)
3	experimentation
3	constrictive
3	15-fold
3	(enzyme
3	(basal)
3	(txb2),
3	2α
3	(pgf2α
3	a-779,
3	e-64,
3	(chronic).
3	chosen.
3	resistin,
3	(0.9
3	ec50:
3	1.62
3	sticking
3	enalaprilat.
3	(baseline
3	44.5
3	neointimal
3	neointima
3	1.30
3	differ,
3	(through
3	(et-1),
3	(cam)
3	(vcam-1),
3	doca-salt.
3	enalapril.
3	gonadotropins
3	pghs-2
3	endothelin-1.
3	at1,
3	oxypurinol,
3	corrected.
3	(sbp,
3	tetrakis
3	(1-methyl-4-pyridyl)
3	voltage-operated
3	-free
3	(male
3	(e2),
3	oxyradicals
3	acyanotic
3	nonresponders.
3	ec50s
3	kcl.
3	(%)
3	lipoxygenase,
3	papaverine-induced
3	ineffective,
3	scavenged
3	might,
3	adduct
3	flows.
3	epr
3	hyperemia
3	chaps
3	(52%
3	through:
3	dimension
3	(l-nmma),
3	agent)
3	supramaximal
3	isoproterenol-induced
3	spleens.
3	chromaffin
3	mlx-8
3	embryoid
3	model).
3	lissencephaly
3	iva,
3	4-aminopyridine
3	(inhibitors
3	small-conductance
3	glybenclamide,
3	glybenclamide
3	diazoxide
3	-40
3	peptide's
3	sub-nanomolar
3	shocks.
3	inside-out
3	d-induced
3	hormone-induced
3	antagonize
3	80%)
3	californica,
3	mmol·l-1
3	vm
3	mmol·1
3	falling
3	biopsy.
3	reflectance
3	registering
3	ftir
3	conformation.
3	osteocalcin,
3	uncarboxylated
3	crown-like
3	mrna/protein
3	synthesis/secretion,
3	gonadotrophs,
3	target-driven
3	(gal1),
3	fas-fas
3	so.
3	and;
3	(albage)
3	albage
3	lipogenic,
3	(89%)
3	normal-weight
3	90-110d
3	harmonic
3	(ftir)
3	subject,
3	biglycan.
3	d2,
3	myometrium,
3	fibrillogenesis,
3	cytoskeletons.
3	evinces
3	trophoblasts
3	12-14
3	copenhageni.
3	jaundice
3	salina
3	(ver)
3	nucleosides,
3	(β2-ar)
3	(rank),
3	osteoclasts,
3	conspicuously
3	hormone-dependent
3	third-degree
3	multiphoton
3	imaged
3	760
3	(females
3	(svmps).
3	svmps.
3	lowering,
3	il-1β;
3	(ikk)-α/β
3	23-week-old
3	(42%,
3	ikk-β
3	(73%,
3	(∼15%,
3	ikk-α/β
3	insulin-sensitization
3	fibrillogenesis
3	dcn-/-
3	(10-50
3	medroxyprogesterone
3	uterus,
3	fertilization,
3	centrifugal
3	quantities,
3	fibre.
3	16.5
3	ossification.
3	deiodinases
3	(d2
3	d3)
3	hypothyroidism-induced
3	prolactin-related
3	interstitium,
3	leydig
3	gonad.
3	full-thickness
3	post-wounding
3	homotrimer
3	mesonephric
3	ridge
3	aforementioned
3	center,
3	birefringence,
3	photo-optical
3	replicas
3	impedes
3	thyromimetic,
3	trβ1.
3	(trβ1)
3	twenty-one-day-old
3	ug/100
3	bw/day
3	(1xt3),
3	5xt3,
3	(1xgc-1
3	5xgc-1).
3	(igf)-i
3	dxa.
3	(egp)
3	hypothyroid-,
3	5xgc-1-,
3	5xt3-treated
3	[eut]
3	chondrocytes.
3	diaphysis
3	(48%,
3	(2.3-fold,
3	mineralizing
3	(4.3-fold,
3	(10-fold,
3	trβ-specific
3	users
3	processed,
3	histomorphometry,
3	digoxin
3	pgcs.
3	aggrecan,
3	redifferentiation
3	immunochemically
3	ridges.
3	glycosaminoglycans,
3	meshwork
3	hydrated
3	situations:
3	(3.9-
3	2.9-fold
3	shrt.
3	pseudopregnancy
3	p.m.,
3	disperse
3	perpendicular
3	transformation,
3	endometria
3	ridges
3	pregnancies,
3	p-polarized
3	trans.
3	measuring:
3	nh4cl.
3	oxidized.
3	lamina.
3	meats
3	denaturation
3	desmosome
3	adherens
3	phagosomes
3	lysosomes.
3	(range:
3	digested.
3	odontoblasts.
3	21-,
3	extrauterine
3	aneurysms
3	rare.
3	pertinent
3	nmol/100
3	reaction).
3	neuroendocrinology
3	t-induced
3	variabilities
3	dbh+
3	ot+
3	analysis),
3	wky-t
3	ace-angii-at1
3	shr-t,
3	singapore
3	pte
3	end-point
3	organs:
3	neurohormonal
3	neurones.
3	determinations,
3	acetyltransferase,
3	chatir
3	ext,
3	function)
3	cxcr4,
3	(5%).
3	0.9%),
3	(tlr4
3	4-phenyl
3	(parallel
3	somatomotor
3	(real
3	(-13%)
3	(-32%)
3	(snasg)
3	(wky-intact)
3	(wky-sad).
3	threemajor
3	+77±14
3	mmhg);
3	(δmap:-30±3
3	wky-sad
3	phenylephrine-evoked
3	+56±6
3	pharmacological-induced
3	circumferential
3	(8%)
3	(-10%)
3	inactivity,
3	lifestyle,
3	basal/stimulated
3	(thir)
3	arteries/arterioles
3	(∼3-4-fold
3	wky;
3	(2.4-
3	5.3-fold
3	either:
3	wky):
3	+34%
3	+17%
3	only).
3	gracilis)
3	(temporalis)
3	temporalis
3	baroreceptors,
3	coexists
3	barosensitive
3	vpergic
3	phosphatases.
3	phosphoinositide-specific
3	brazil;
3	finished
3	sponsored
3	brief,
3	(son)
3	decaying
3	densitometry.
3	catheters.
3	sedentary.
3	group-specific
3	output)
3	(nat)
3	(tph)
3	(phenylephrine/sodium
3	otant
3	beats/min).
3	long-descending
3	coarctation,
3	loading/unloading
3	comp
3	(l-arg)
3	373
3	(57
3	stem.
3	(58%
3	age).
3	v1receptors
3	transit-time
3	quantitated
3	state).
3	kg-1·
3	conscious,
3	ng,
3	nitroprusside-induced
3	geometry
3	geometrical
3	growing,
3	9.4%
3	(43%,
3	chloralose
3	intracisternal
3	ncr.
3	51%,
3	pressure;
3	pigs;
3	acosta
3	grant
3	dyspnea,
3	involvement.
3	sport,
3	134
3	visited,
3	(61%)
3	filho,
3	soares.
3	stillbirths
3	reinfections
3	infection:
3	bioassays,
3	(spheniscus
3	145
3	birds).
3	non-preserved
3	galea
3	necromys
3	ehrlichial
3	1:25.
3	consumers
3	alt.sag2,
3	#13
3	mammal,
3	game
3	tajacu)
3	(4.9%)
3	ifats
3	florianópolis
3	ectoparasites,
3	given.
3	ectoparasites.
3	(mazama
3	(sapajus
3	(dasyprocta
3	dilution)
3	179
3	(cutoff
3	2009–2012,
3	sp.),
3	woolly
3	(micoureus
3	sp.).
3	americana)
3	apico,
3	protozoon
3	12.5%
3	babesia,
3	pardalis),
3	novemcinctus),
3	(caiman
3	mesoregions
3	region;
3	coyotes
3	pertain
3	post-inoculation
3	unguiculatus)
3	clinics,
3	outpatients
3	(2.6%).
3	anti-s.
3	1:5).
3	or:
3	sergipe
3	trypanozoon.
3	branco
3	(0.4%)
3	maria.
3	tapir
3	(tapirus
3	terrestris)
3	twice,
3	institutions.
3	dyspnea
3	hepatitis,
3	intralesional
3	archetypal
3	belo
3	5.1%
3	14.2%
3	3.9%
3	(petrolina)
3	park,
3	sula
3	phaeton
3	seabirds
3	(restriction
3	antillean
3	coasts
3	100)
3	25.8%
3	31.1%
3	depth.
3	ranges.
3	breed,
3	(chi-square
3	(over
3	reserve,
3	spp.)
3	cutoff≥
3	25);
3	100).
3	pantanal.
3	donkeys)
3	lábrea,
3	cutoffs
3	authorities
3	unambiguous
3	its-1
3	felis.
3	wolf
3	17.6%
3	urbanization
3	(cvl)
3	mata
3	14.5%
3	131%
3	cvl
3	brucella,
3	(bos
3	(60.0%)
3	(100%),
3	neosporosis.
3	declared
3	reasons,
3	adulteration
3	parks
3	0.008)
3	rdna),
3	tissues)
3	forage
3	buffalos
3	seropositive.
3	coxiella
3	226
3	ovale,
3	humerale
3	oligoryzomys
3	3.7%
3	65.5%
3	environment;
3	304
3	213
3	vogeli,
3	vogeli
3	dogs),
3	(11.9%)
3	novemcinctus,
3	glta,
3	candidatus
3	18.2%
3	serological,
3	(47
3	horses)
3	fve
3	specie,
3	44)
3	pigeon,
3	nc-bahia
3	mossoró
3	ggt
3	norte
3	artibeus
3	biomes,
3	rainforest.
3	rainforest,
3	terrestris
3	n.,
3	subgenus.
3	4.8%
3	(v7v8
3	6.7%
3	yagouaroundi)
3	disposable
3	>25
3	(16.6%)
3	thous),
3	district,
3	(71.4%)
3	conflicts
3	ohioensis-like
3	anti-l.
3	72%,
3	47.3%
3	apico.
3	capybaras,
3	italy
3	two-year
3	923
3	169
3	1:50)
3	pre-established
3	(fr)
3	slaughter
3	thigh
3	physicians.
3	hydrocephalus,
3	polimerase
3	(7.4%)
3	b1).
3	happened
3	pcr-negative
3	5.2%
3	caninum-positive
3	seroconversions
3	icterohaemorrhagiae
3	veterinarians
3	ifat-positive
3	97%,
3	(ppv)
3	96%.
3	avirulent
3	(alouatta
3	ostriches
3	elsewhere.
3	(2-3
3	masseter,
3	attended
3	towns
3	spp.),
3	each;
3	estadual
3	1:100
3	trypanosomiasis.
3	toxoplasmatiid
3	seven).
3	capybaras.
3	successful.
3	slaughterhouse
3	patos,
3	paraiba
3	tannin
3	trichostrongylus
3	colubriformis
3	drenched
3	bw).
3	(columba
3	sample)
3	(58.3%)
3	pressures,
3	hamper
3	non-vaccinated
3	percent,
3	distemper
3	0.002),
3	wolves.
3	mammals'
3	capuchins
3	wild.
3	threaten
3	caballi
3	bri,
3	(infected
3	burdens.
3	nephritis.
3	heydorni.
3	minced
3	unsporulated
3	mouse-virulent
3	(giii)
3	provoking
3	males)
3	1:320
3	1:640
3	heartworm
3	ubatuba,
3	cities.
3	pens.
3	ceará,
3	8.2%,
3	predominant,
3	farms)
3	19%.
3	0.62,
3	contortus,
3	rs,
3	(od
3	carcasses
3	99%,
3	(equine
3	vs,
3	19),
3	37)
3	cryptosporidium,
3	malachite
3	supplies
3	4-month-old
3	nc-5
3	brains.
3	329
3	173
3	(34
3	state)
3	seven,
3	sul.
3	apart.
3	cystoisosopora
3	(8.3%),
3	giemsa
3	macrophagic
3	infesting
3	amblyommii,
3	parkeri,
3	p=0.01).
3	antigens;
3	(4.2%)
3	(22.5%)
3	araçatuba,
3	splenocytes.
3	(itt),
3	arg1,
3	diabetics,
3	nos2,
3	il12
3	m2-macrophages
3	beneficial,
3	sirs.
3	hela)
3	factor-like
3	(low)
3	deacetylases
3	(hdac)
3	(b16f10
3	(pafr
3	fine-tune
3	(gpcr)
3	poly(i:c).
3	interleukin-10.
3	(platelet-activating
3	(adipose
3	(high-fat
3	liver;
3	potentiated,
3	t1dm.
3	hematocrit,
3	(nph)
3	prostaglandin-e2
3	α-sma-positive
3	anti-fibrotic
3	pafr-ligands
3	subverts
3	pasteur.
3	speculation
3	protein/creatinine
3	rios
3	web2170,
3	tg-elicited
3	(il-10
3	microdomains
3	cerqueira
3	caecal
3	gαi-coupled
3	co-transfection
3	cd86)
3	albicans-
3	brasiliensis-pulsed
3	coculturing
3	monocyte/dc
3	synthase-1
3	ingestion,
3	lipid-associated
3	competes
3	monocytes/macrophages.
3	oxldl-induced
3	(2.57
3	15.63
3	18.1×104
3	23.2×104
3	15.72
3	balf,
3	fcγr.
3	5min
3	pkc-δ,
3	coupling.
3	(cox-2),
3	dtic
3	mediators/cytokines.
3	(monocytes
3	(ac-orn-[oic2,
3	α-mephe5,
3	d-βnal7,
3	ile8]desarg9-bradykinin),
3	cytokines/chemokines.
3	(lipid
3	formation),
3	pro-angiogenic
3	[il-6],
3	(cinc-2)
3	(62%),
3	balf.
3	aminoguanidine),
3	cnos-derived
3	envisage
3	24 h,
3	(b1ko)
3	wang
3	123.
3	antibodies)
3	granule-derived
3	fcγrii
3	(ams).
3	immunobloting;
3	(sirs)
3	mediators/cytokines
3	(4.7-fold)
3	(54%),
3	(60%).
3	(c57bl/6
3	balb/c)
3	tγδ
3	(hsps)
3	elisa;
3	hsp70.
3	cross-regulation
3	6 h
3	spontaneously,
3	receptor(s)
3	(ecv-304
3	(et
3	(pg)e2
3	nω-
3	number:
3	(l-name
3	antigen-antibody
3	fibrinolysis.
3	thiorphan
3	methacholine,
3	h-2d
3	pouch.
3	(platelet
3	2170,
3	ox
3	(83%)
3	(84%
3	(le)
3	(n-3
3	lw-3
3	n-3-n-6
3	mediators;
3	incapacitation
3	10-100
3	joints.
3	least-squares
3	(l660-711;
3	anti-leishmanial
3	heat-
3	ng/mg,
3	31.7
3	29.7
3	17.6
3	(ewi)
3	57,
3	et(a)
3	mpo,
3	(4.5%).
3	63.3%
3	cells/5
3	fields).
3	ovalbumin-
3	boosters.
3	hen's
3	alveoli,
3	bsa.
3	1996,
3	cerulein
3	dose).
3	<.001)
3	bell-shaped
3	62,
3	exudates,
3	on.
3	(ppd)
3	lesion)
3	e2(pge2)
3	49.0
3	txb2.
3	51,
3	mediator,
3	100%)
3	gplps
3	additions
3	170,
3	fold.
3	non-steroid
3	4%.
3	services.
3	impedance
3	crusts
3	crushing
3	steep
3	saprolegniasis.
3	banned
3	anti-saprolegniasis
3	546
3	duarte,
3	spring,
3	diatom
3	13c-labeled
3	8 days
3	pgm
3	pipeline,
3	kegg
3	oxidation)
3	brazil's
3	worms,
3	genomics,
3	infrequently
3	metagenomics),
3	(south
3	(1.1
3	(mtb)
3	magnetosomes
3	alphaproteobacterial
3	biostimulated
3	synechococcus
3	nanoeukaryotes
3	dcm
3	recombinantly
3	30°c,
3	biocatalyst
3	tolerances
3	sediment.
3	rna-seq.
3	lake,
3	string
3	bait
3	carboxymethylcellulose
3	ita1-ccma
3	faecalis,
3	texture
3	salinities.
3	halophilic
3	homogenizing
3	methanosarcina
3	methanogens
3	tucuruí
3	hydroelectric
3	lake
3	lakes,
3	climate,
3	biochar
3	uses,
3	agriculture.
3	ruminal
3	additives
3	crenarchaeota
3	planet,
3	madeira
3	enantioselective
3	martel
3	methanobacterium
3	enrich
3	santos-são
3	variance.
3	efficiencies.
3	nocardia
3	phenylethanols
3	acetophenones
3	exploitation
3	legionellaceae
3	legionellae
3	mesophilic
3	discharge,
3	sip
3	detect,
3	1a,
3	(yield
3	e.e.
3	terreus).
3	lipase.
3	sixty-seven
3	results-
3	microcosms
3	uncontaminated
3	tellurium
3	costly
3	80°c
3	alkb1
3	overflow
3	creeks
3	(hadv-40
3	hadv-41),
3	edu
3	four-litre
3	taql,
3	hadv-40
3	rsal
3	(89.8%)
3	(62.9%)
3	(pseudomonas
3	arctic
3	1.9%
3	groundwater
3	tanks
3	wells,
3	polychlorinated
3	streptococci,
3	should,
3	consideration.
3	clostridia.
3	coliform
3	proliferative,
3	dormancy,
3	stochastic
3	patient’s
3	danger
3	barbuto.
3	3f,
3	mcf-7,
3	lipophilicity
3	obstacle.
3	drove
3	cervicitis.
3	neat
3	head/neck
3	virus-1
3	(gde7).
3	gde7,
3	(i:c),
3	(cd44
3	 cd62l
3	 cd8α
3	 and
3	bdca3
3	 dendritic
3	(dc),
3	gde7-based
3	(mo-dcs)
3	apes,
3	speck
3	ifn-β,
3	ifn-α/β
3	efficient.
3	carboplatin.
3	stimulators.
3	benzofuroxan
3	cfse
3	braf,
3	(mo-dcs).
3	defective,
3	moraes,
3	chelerythrine
3	(kafdityvrlkf,
3	chain)
3	(cal27)
3	rhodamineconjugated
3	decorates
3	rpf151,
3	sulfonamide
3	simulation.
3	(huvec)
3	dc-exo
3	mo-dcs,
3	il-12p70.
3	routines
3	ms-based
3	(mm)
3	amides
3	cd4+foxp3+il-10+
3	conclusion/significance:
3	analysis.results:
3	non-viral
3	body's
3	scalable
3	mhc-ii
3	sphingosine
3	minute.
3	bacterial-unstimulated
3	cd123
3	economy,
3	microparticle
3	formats
3	lps).
3	contrastingly,
3	theracyte®
3	2-month
3	devices,
3	plasma)
3	(csp).
3	xiiia+
3	sulcular
3	junctional/pocket
3	tumor-affected
3	non-affected
3	cd1a,
3	(lung
3	non-adherent
3	(factor
3	guaraná
3	(co:
3	gua:
3	c7
3	sarcomatous
3	malignancy,
3	paulista
3	cholestasis,
3	deficient.
3	unvaccinated
3	dialytic
3	co-morbidity.
3	(859
3	u/106
3	paraformaldehyde-fixed
3	tighter
3	adenocarcinomas.
3	researcher
3	binomial
3	priori
3	construct,
3	linker.
3	ovarian,
3	lines;
3	iga.
3	substratum.
3	calmette-guerin
3	carcinogens
3	c57bl/6)f4
3	(cta
3	cga).
3	mbp)
3	(2025
3	1043)
3	mir-132-3p/212-3p,
3	mir-106-5p,
3	mir-27b-3p,
3	mir-25-3p
3	(il10,
3	sp1r1).
3	infirmity.
3	(gly169asp)
3	290)
3	(lodscore>4)
3	(27k
3	cxcl13
3	hemeoxigenase
3	(decycling)
3	(dmba),
3	airmin-treated
3	(biogel
3	p-100,
3	bio-rad,
3	france)
3	693
3	(logarithm
3	urethane,
3	(89%).
3	alpha-methylacyl-coa
3	racemase
3	cd10.
3	879
3	662
3	(rtm1),
3	23.4
3	15.8),
3	rs3696835
3	(tsc2)
3	eker
3	heterozygous-null
3	tsc2(+/-)
3	cystadenomas.conclusions:
3	rtm1
3	jensen
3	794
3	674
3	735
3	1616
3	punch.
3	dap12
3	trem1
3	(irm1)
3	(irm2),
3	p=6.3
3	-7;
3	p=8.2
3	-5)
3	p=1.9
3	-16;
3	p=1.1
3	-6).
3	(p<3.4
3	p-100
3	1-logarithm
3	116.75
3	139.75
3	mb,
3	3.61)
3	9.35).
3	11a1
3	nramp-1.
3	(airmaxrr)
3	unregulated
3	intercrosses,
3	sublines.
3	two-millimeter
3	punches
3	ear-wound
3	1,2-dimethylhydrazine
3	(acf)
3	300-475
3	co-segregated
3	(146)
3	liii)
3	mapmanager
3	qtx
3	candidacy
3	pas1s
3	pas1r
3	kras2
3	lymphoid-restricted
3	(lrmp)
3	pro→
3	nonconservative
3	allelotype.
3	(air).
3	(dmba)/12-o-tetradecanoylphorbol-13-acetate-induced
3	compatible,
3	nramp-1
3	polymorphism;
3	cells/well
3	interassay
3	antimouse
3	t‐cells.
3	antibody-treated
3	caimans,
3	transoceanic
3	neobat
3	rotundus,
3	valley,
3	pallidipes
3	287
3	proboscises
3	ethiopia
3	kinetoplastids.
3	kinetoplastids
3	(fluorescent
3	thecatl-pcr
3	lewisi-like
3	transitioning,
3	proteome-wide
3	rewiring
3	preparatory
3	origins,
3	ssrrna,
3	(ggapdh),
3	tra[tve-tco]
3	drawbacks
3	platforms.
3	(sauroleishmania)
3	sloths
3	ambiguus.
3	chrysomya
3	kdna,
3	h1.
3	culicis,
3	kaps
3	shts
3	(ea)
3	tvv
3	vivax)
3	ea
3	duttonella
3	caimani
3	meronts
3	322
3	cpcr
3	kinetoplastids,
3	seymouri
3	drought
3	(115
3	fruits,
3	solanaceae
3	hemipteran
3	herthameyeri
3	phagocytophilum,
3	phagocytophilum.
3	megistus
3	tcbat,
3	african,
3	crocodylus
3	(glycosomal
3	crocodilus
3	grayi,
3	undetected
3	unreliable
3	morphometrically
3	trypanosome,
3	pcv
3	vivax-specific
3	non-inoculated
3	(23.1
3	anorexia.
3	pcrs
3	congolense,
3	subgroup.
3	subclades
3	homologues,
3	partners,
3	tpes
3	vitamins.
3	basins
3	evidenced.
3	complementing
3	mozambique,
3	betaproteobacteria,
3	relatives.
3	clarification.
3	evansi,
3	thanks
3	oceans
3	sea,
3	colonised
3	herd.
3	keds
3	megatrypanum.
3	star-shaped
3	homogeneous,
3	cytophatic
3	sirc
3	epidemiological,
3	80.0%
3	cough,
3	brazilian.
3	sac.
3	meningoencephalitis
3	buffalo,
3	(cyt
3	allopatric
3	g3,
3	hct,
3	culicis
3	appropriated
3	mat-1
3	n=13)
3	post-infection;
3	fleas,
3	tanzania,
3	ssrrna
3	(37)
3	iib,
3	(catl-like)
3	armadillos,
3	identically
3	dtt
3	(20%
3	∼25%
3	survey.
3	unravelling
3	tesa-blot
3	94.1%
3	microhaematocrit
3	exams
3	testes.
3	bufonidae,
3	leptodactylidae,
3	leiuperidae
3	phlebotomines,
3	rubrovaria
3	(east
3	biological,
3	colubridae
3	bruxism.
3	necropsy
3	twenty-nine
3	homogeneous.
3	sero-positive
3	coincidence
3	't.
3	leptospires,
3	amplified.
3	copenhageni,
3	microagglutination
3	spacer,
3	(brazil,
3	species-specificity
3	phytomonas-specific
3	samuelpessoai
3	cultivation,
3	(atcc)
3	fruit.
3	wombat
3	fingerprints.
3	names
3	hypothesise
3	questionable
3	ri,
3	leptomonas.
3	29.3%
3	rbcg
3	ltak63
3	salles
3	rupture.
3	n-acetyl-cysteine
3	anti-mycobacterial
3	(nemo)
3	nemo
3	nemo-deficient
3	(damps)
3	niche-specific
3	co-existence
3	classified,
3	spms,
3	perc,
3	clearance)
3	(diphtheria
3	toxin)-treated
3	c57bl/6.cd11c-dtr
3	(cllip),
3	cllip
3	malaria:
3	pre-crisis
3	closure.
3	rp.
3	pre-crisis,
3	relevancy
3	cell:endothelium
3	congested
3	anka-infected
3	2014aitken
3	mp287/03).
3	p2x7r-dependent
3	amaral
3	parasite-infected
3	immunosuppression;
3	medeiros
3	(aj
3	effector/effector
3	<inf>em</inf>)
3	ifn-inducible
3	hyperresponsiveness).
3	>70%
3	t/t<inf>em</inf>
3	parasite-driven
3	t<inf>em</inf>
3	straintranscending
3	atrox,
3	poisoning.
3	protozoosis
3	neuropathology,
3	(153%,
3	demyelization
3	nitrosylation,
3	(317.0%,
3	macrophages/microglia
3	bombeiro
3	associated-acute
3	creatininuria
3	oxidizability
3	(cox-1
3	cox-2)
3	(mns)
3	pluripotency
3	(fcs)
3	extensively,
3	zago
3	interact.
3	perc.
3	(spm)
3	β-galactosidase,
3	perc;
3	cassado
3	b-restricted
3	b-/-
3	(non-conventional
3	finishes
3	muxel
3	perforin+
3	s100β,
3	liver-cleared
3	mac1
3	+cd8+,
3	cd69+cd4+
3	+cd122+cd4+
3	cd25-cd122+cd4+
3	(ifn)-γ-producing
3	abs,
3	guaranteeing
3	(ig)g2a
3	cd138
3	(p.i.).
3	61.1%
3	13.0%
3	cd38,
3	b7/cd28
3	(cb28-/-)
3	+/+)
3	ligand);
3	anamnesic
3	cd28+/+
3	aj,
3	primary-infected
3	schizont-infected
3	(ig)g
3	reinvasion,
3	fc-dependent
3	(tcr)αβ,
3	(cd44high
3	cd62llow
3	cd45ra,b,clow).
3	(mac-1),
3	parasite-activated
3	anti-cd3/cd28
3	resting.
3	benznidazol.
3	high-dose-infected
3	b220-
3	cd5-
3	(b220+),
3	cd45rb(high)
3	(ig)-secreting
3	antibody-induced
3	ig-induced
3	immunoprotected
3	cd45rb
3	subset,
3	parents.
3	stand
3	myosin,
3	non-self
3	truly
3	individuals;
3	bothrops.
3	jararacussu,
3	neuwiedi
3	f(ab′)2m
3	8.7%
3	20.7
3	(pfc).
3	themselves.
3	eqlb
3	(xp-v)
3	carbonylated
3	n-acetylcysteine,
3	γh2ax
3	gait
3	stride
3	rev1,
3	noncanonical
3	uvb,
3	dosimeter
3	shrna.
3	pm10
3	seaweeds
3	muty,
3	mutl
3	mutation-preventing
3	t:a.
3	(dnae2)
3	antigenotoxic
3	photolesions
3	deuterated
3	curiously,
3	consequences,
3	antioxidants,
3	(xp),
3	myc,
3	mitigates
3	mutations:
3	polh,
3	unexpected,
3	(as).
3	(pds)
3	rnapii
3	pds.
3	6-4
3	(cpd)
3	rev1
3	fanconi
3	biallelic
3	thrive
3	neuropathology
3	(ipscs)
3	unbiased
3	(tmz)
3	2-related
3	fighting
3	uvc-induced
3	uvc,
3	(mmp),
3	(doxo)
3	resumption
3	spoan
3	11q13
3	buthionine
3	uvb-irradiated
3	latitudes.
3	complementary,
3	cpds,
3	tumor-suppressor
3	rassf1
3	prc2
3	nscl/p
3	underpin
3	e2f1.
3	uv-
3	cuban
3	phenol-degrading
3	catechol,
3	self-assembly
3	mg/ml).
3	transversions
3	8-oxodg
3	unprotected
3	genotoxicity.
3	biosensor
3	dna-dosimeter
3	notwithstanding,
3	glucosamine
3	monomer.
3	stratospheric
3	turbidity
3	articles
3	featuring
3	sustains
3	uv-radiation
3	anthracyclines.
3	subdivision,
3	helix-distorting
3	dox.
3	unscheduled
3	sites;
3	hydroxylated
3	blockage,
3	bacteroidetes,
3	exemplified
3	(uv-c)
3	up-regulation.
3	solar-uv
3	chemicals,
3	alleviate
3	bringing
3	ttd/xpd
3	blockage.
3	inspected
3	represented,
3	lexa-dependent
3	gttcn7gttc
3	sos-regulated
3	lesions:
3	longstanding
3	p53mt
3	(dsb)
3	melanogaster.
3	p450,
3	worms.
3	gamma-proteobacterium
3	gene),
3	caspase-9,
3	lentiviruses
3	(5.3
3	photosynthesis
3	routes:
3	uvsbatr
3	prohibitin
3	photosensitive
3	colonies)
3	petites
3	y-family,
3	umuc
3	umudc
3	c.crescentus
3	dnae2,
3	c.crescentus.
3	tagenesis.
3	imub
3	y-family
3	bypass.
3	imuab
3	transducing
3	grants
3	cockayne's
3	orthologue
3	followed,
3	transposons.
3	237,954
3	xyli,
3	ratoon
3	ctcb07
3	2,044
3	heteropolysaccharides,
3	wilt-inducing
3	lysozyme,
3	desaturase.
3	stunting,
3	inhabits.
3	directs
3	chloroplasts.
3	scanning,
3	metazoa,
3	(1o2)
3	3,3′-(1,4-naphthylidene)
3	hemolysins,
3	(28%),
3	(tk)
3	ie,
3	recovers
3	double-helix
3	distortion,
3	(tcr).
3	muristerone-a
3	pinxa.
3	inxa15
3	(sucest)
3	t-dna
3	chloroplastic
3	α-helix,
3	(fpg
3	1o2-induced
3	t:a
3	approx.
3	methanesulfonate
3	(mtdna)
3	tridactylus)
3	condensation.
3	poly(adp-ribose)
3	metals.
3	1o2.
3	(mms)
3	reactivate
3	λ
3	schizosaccharomyces
3	autographa
3	californica
3	(acmnpv)
3	acmnpv
3	dipropionate
3	hotspots
3	transversion
3	deoxyguanosine
3	terminated
3	transfection,
3	molecules;
3	lagging
3	constructions
3	triplet
3	1983,
3	20 min
3	acquisition,
3	circuit;
3	(pmd),
3	memories.
3	cortico-hippocampal-amygdalar
3	burying
3	outlined.
3	judge
3	cue.
3	0.001.
3	networks,
3	noise
3	invalid
3	society,
3	asynchrony
3	(soa)
3	express,
3	(likely
3	conditions).
3	judgments
3	referees
3	ars
3	sub-optimal
3	animats
3	roach).
3	chasing
3	medial/perifornical,
3	predictability.
3	binocular
3	capture.
3	accomplishing
3	consummatory
3	where,
3	cues)
3	spending
3	epilepsy,
3	capturing,
3	(fle)
3	spotlight
3	scrutinize
3	trajectory
3	constraining
3	moral
3	adhd
3	instinctive
3	conspecifics
3	ratings
3	dissociations
3	mouth,
3	roaches,
3	devise
3	spanish
3	saline-
3	avidly
3	unsuspected
3	ischemia-induced
3	tle
3	happen
3	observer's
3	indicated,
3	manipulating
3	subject's
3	intersubject
3	fellow
3	ball.
3	conceived
3	eccentricity,
3	revealed,
3	plane
3	(lm),
3	canals.
3	reclaimed
3	sandberg,
3	moreno-gallego,
3	moura,
3	durham,
3	mehnert,
3	reyes
3	gruber.
3	genseed-hmm,
3	unassembled
3	markov
3	(hmm).
3	assemblers.
3	hmm-driven
3	assemblies,
3	alpavirinae-specific
3	(vp1;
3	(genome
3	(running
3	assembler)
3	(global)
3	execution,
3	metrics
3	hmm,
3	drug-resistance
3	phytoplankton,
3	oily
3	(hadv)
3	prolongation
3	401
3	hek-293,
3	ncl-h292
3	hadv-3a,
3	hadv-7h,
3	hadv-7h1;
3	hadv-1d10,
3	hadv-2d25,
3	hadv-5d2,
3	hadv-6d3.
3	7h,
3	7h1,
3	7b,
3	7h1
3	3a
3	hadv-7h
3	preto
3	vp7
3	rotavirus.
3	obviating
3	cpv-2a
3	microporous
3	(zeta
3	ultracentrifugation,
3	effecting
3	10-month
3	ffu/liter
3	t1d-like
3	reduced;
3	h3k9me3
3	(chip)
3	cebpa
3	rela,
3	nfkb-binding
3	mir-199a-5p
3	regulations,
3	(rt-qpcr),
3	complexation
3	sp1/esr1
3	pinto,
3	14c-cholesterol
3	gamma,
3	lox-1
3	rct
3	ikk
3	flaxseed
3	customized
3	28.5
3	cycloheximide,
3	carboxymethyllysine
3	vegfa,
3	factors;
3	(ppt),
3	mpp
3	immunoblot.
3	tbars,
3	mrc
3	(t2dm),
3	blotting);
3	contract
3	blotting;
3	mir-1-3p,
3	mir-29a-3p,
3	weight/tibia
3	deserving
3	(macrophage
3	(bax,
3	agt,
3	reagent)
3	affordable
3	(homa-ir).
3	av
3	sirtuin
3	glycosuria.
3	aeruginosa)
3	trx
3	sediment,
3	ml/min/1.73
3	<5
3	days/week).
3	<sup>3</sup>h-cholesterol
3	(hsa)
3	n=12)
3	altered;
3	sat.
3	propranolol,
3	propranolol-induced
3	0.74
3	pgc1α
3	wistar,
3	at-rich
3	tnf-induced
3	post-prandial
3	pharmacopeia
3	(sglt)
3	refeeding;
3	0.5-2
3	echocardiographic
3	(protocol
3	rt-pcr)
3	long-term,
3	(glut1)
3	flt1
3	forkhead
3	hnf-1α,
3	(wky-d),
3	(mets)
3	mets:
3	stuttgart,
3	amlodipine.
3	(tail-cuff
3	a:
3	r:
3	au)
3	0.001;
3	comparedwith
3	ms),
3	validated,
3	pm.
3	esr1-agonist
3	with/without
3	2-dg
3	société
3	française
3	evaluate:
3	(h).
3	gastrocnemius.
3	(heart:
3	(jnk)
3	inducer.
3	ends-poly(a)
3	(race-pat).
3	1.08
3	(t1dm).
3	smoker
3	treadmill,
3	1.16
3	rd-shr,
3	rd-stz-shr,
3	0.9,
3	min/day
3	14%,
3	experiments:
3	cm-1,
3	khz,
3	hypotrophy,
3	physiologica
3	(∼50%,
3	blot)
3	(shr:
3	wky:
3	jnkl
3	six-day
3	wat;
3	longus,
3	genesis,
3	∼30%
3	myotubes,
3	insulin-sensitizer
3	overexpression,
3	tissue;
3	later:
3	1-6
3	4 weeks,
3	erβ,
3	degrees.
3	myocite
3	(mef2
3	a/c/d),
3	(hif1-a)
3	(35-80%)
3	mef2a,
3	glut4-ebox
3	glut4-at-rich
3	mef2s.
3	(ivitt)
3	denervation-induced
3	(tgf-β1).
3	(controls,
3	twenty-four-hour
3	shr-d
3	18.2
3	(ir)-β,
3	(irs)-1,
3	normal-sodium
3	normalisation
3	7-month-old
3	(15%)
3	substitution.
3	hormonal/metabolic
3	glycosuria,
3	nefa,
3	∼70%
3	0.72,
3	(kcn)
3	(99
3	μu/ml).
3	bpm/mmhg,
3	depressor
3	aurothioglucose
3	62.4
3	5.9
3	autg
3	(autg)
3	parasitizing
3	s-transferase,
3	gut.
3	metabolome
3	ways.
3	r. microplus.
3	fujita,
3	fogaça.
3	rickettsii.
3	(rna-seq).
3	delineating
3	ft-ir
3	conformations
3	synthetases
3	arthropods,
3	favouring
3	°c).
3	suppression-subtractive
3	(syn)
3	sds,
3	micelles,
3	tropicalis,
3	disadvantage
3	rickettsiosis.
3	starving
3	10°c
3	-:
3	va
3	thrombin.
3	tix-5
3	electrophoresis)
3	(hb
3	adopts
3	spider,
3	antimalarial,
3	tripeptide
3	vagina
3	albicans-infected
3	pink
3	penaeid
3	extra-
3	flora.
3	aiding
3	variabilis
3	279
3	tick-transmitted
3	nimodipine
3	mapk/erk,
3	(lepidoptera:
3	oviposition,
3	vector-borne
3	(wortmannin
3	blocked.
3	m.,
3	oligopeptides.
3	inclusions,
3	palladium
3	898
3	556
3	(sds),
3	6.25
3	anticandidal
3	amidation.
3	techniques:
3	toac
3	conformation,
3	monocyclic
3	degraded.
3	hemolytic,
3	(ests).
3	clustered,
3	transglutaminase
3	litopenaeus
3	c-terminus.
3	novelty,
3	scant
3	220kda
3	androctonin
3	hydrophilic,
3	plasmatocytes
3	apoproteins
3	(35%
3	crabs
3	scorpions.
3	mosquito,
3	abdomen
3	429
3	5'-
3	calpains
3	patterns:
3	gland;
3	thirdly,
3	tartrate
3	fermenting
3	antiprotozoal
3	acm
3	congo
3	fplc
3	megaterium,
3	maximized
3	apigenin
3	kaempferol
3	(7),
3	trypanocidal,
3	determinate
3	documenting
3	um-54
3	azocaseinolytic
3	apparent.
3	tropicalis.
3	metalloproteinase.
3	34°c
3	74,
3	e-64
3	protein-free
3	chased
3	acrylamide
3	ranks
3	esters.
3	aposymbiotic,
3	cruzi),
3	(31
3	tapping
3	(continuous
3	formal
3	movement-based
3	timing.
3	movements,
3	resilience
3	practiced
3	ignored.
3	save
3	kickers
3	accuracy.
3	traits,
3	fl
3	arrival
3	uence
3	state-trait
3	smd
3	aircraft
3	aetiology.
3	sticks
3	synapse,
3	text
3	"synaptic
3	something
3	upsit
3	upsit-40
3	82.1%
3	left,
3	centre.
3	(expt
3	suited
3	image.
3	1995).
3	law
3	constellation
3	before.
3	temporarily
3	homeward
3	releases.
3	sol,
3	tones
3	mcdonald
3	sun's
3	afternoon.
3	schmidt-koenig,
3	trade
3	electroreflectance
3	ge
3	hamiltonian
3	insb.
3	twofold:
3	landau
3	theory.
3	e//1
3	(sdh)
3	magnetoresistance
3	t-1)
3	1975
3	c33
3	1973.
3	non-hematopoietic
3	effector-memory
3	germinal-center
3	cd38
3	http://creativecommons.org/licenses/by/4.0/.
3	il-1/il-18
3	hl-1
3	myd88-mediated
3	heart-recruited
3	overshadow
3	malaria-associate
3	iaxo-101,
3	tlr4/cd14
3	malaria-induced
3	communicating
3	notification
3	translocating
3	well-established,
3	nlrp3-
3	z-yvad-fmk
3	nlrp3-mediated,
3	il-1r-independent
3	leucocytes,
3	hemozoin.
3	0.021)
3	lectin-induced
3	ox,
3	lends
3	hybridomas,
3	tonsils
3	pha-induced
3	pha-stimulated
3	disassembling
3	campos,
3	marques.
3	il-1b
3	procollagen
3	asbestos,
3	aurora
3	interphase.
3	laser-scanning
3	microscopes.
3	mining,
3	biomass.
3	cscs
3	wound.
3	pictures
3	abdominoplasty
3	mammoplasty
3	us,
3	significance,
3	refer
3	instructions
3	holometabolous
3	functionalities
3	isoflavonoids
3	interphase
3	ngm
3	(egfr),
3	freitas
3	oogenesis.
3	castes
3	mmp1
3	breakdown,
3	proenzyme
3	commercialized
3	asbestos
3	established:
3	nurse
3	(clsm).
3	48.
3	author(s),
3	bovine.
3	reconstructions
3	puff.
3	sdo1p
3	rrnas.
3	x-rays
3	scored.
3	corticostylifera,
3	mcf
3	10a
3	spheroid-like
3	7s
3	retrotransposons,
3	aneuploidy
3	heterochromatin
3	formulas
3	geodiamolides
3	chloride)
3	mexicanum
3	cocoon.
3	iodide,
3	sciaridae
3	dimension.
3	fitc.
3	determine,
3	(sil)
3	periodically
3	inmates
3	cytologic
3	mcdb
3	dmem,
3	phallusia
3	concentrate
3	3.44
3	(66%
3	1.00
3	colchicine,
3	cultures:
3	bsf
3	colchicine.
3	fine-needle
3	hk-1
3	designate
3	heparitin
3	h.u.
3	227
3	appearance.
3	fractionations
3	(composed
3	tocantins,
3	randomised
3	(0.1%
3	tamoxifen.
3	cream,
3	alkaloids.
3	(ed50)
3	monotherapy.
3	draws
3	luciferase-expressing
3	india.
3	lc-luc
3	pires
3	species;
3	phenols,
3	expensive.
3	la-luc
3	fluorinated
3	flagella.
3	hasp
3	epimastigote,
3	mock-treated
3	antitumoral,
3	147.0
3	46.0
3	braziliensis-infected
3	chagasi-infected
3	pentamidine
3	7.9
3	3h]farnesyl
3	acid/auxin
3	nylon
3	(mirnas),
3	mir-221,
3	tetrasodium
3	converged
3	(vitamins
3	b.w.,
3	tbars.
3	post-wounding;
3	postwounding,
3	ly6g+
3	p40
3	mig+/cd206−
3	cd206+/mig−
3	(5 mm
3	(30 mm
3	kymography,
3	transwell,
3	(0.22
3	polarity.
3	mir
3	(independently
3	m2-
3	il13
3	macrophage-depleted
3	fibrosis-related
3	mmp7,
3	extracellular-related
3	dermis.
3	stratification
3	missing.
3	(ce),
3	(general
3	nsc23766
3	(rac1
3	(rho-associated
3	[rock]
3	p27kip,
3	chx10
3	chx10,
3	p27kip
3	p16ink4a.
3	(activation
3	inactivation)
3	reprogramming)
3	intertidal
3	arg127his
3	prodrug)
3	adiponectin.
3	clinicaltrials.gov
3	chemoattractant-2αβ
3	wounding
3	hyperprolinemia
3	oc.
3	germs
3	rocks
3	reck,
3	t98g/reck+
3	inefficiency
3	kes28kda
3	0.021).
3	glycogen/glycoprotein
3	(smg)
3	hyperhomocysteinemic
3	propulsor
3	cell-binding
3	cytoskeleton-associated
3	panorama
3	somatotroph
3	alpha1
3	reorganization,
3	verifies
3	effectors-p21-activated
3	(paks)
3	3-was
3	paks
3	photoreceptors,
3	rac1-positive
3	tunel-positive,
3	pak2,
3	pak5
3	clarke
3	(hk)
3	acini,
3	team,
3	igf-ii)
3	more,
3	model-based
3	evolutions
3	amacrine,
3	hypophysectomized
3	gfap-immunoreactive
3	v14rhoa
3	n19rhoa
3	branching.
3	~50%
3	outgrowth.
3	hypophysis
3	androgens.
3	α-difluoromethylornithine
3	plating.
3	electron-density
3	matrices.
3	plastic,
3	retards
3	adp-ribosyl
3	exoenzyme
3	morphometrically,
3	cdc42hs.
3	assayed,
3	(1.74
3	0.10,
3	0.47
3	autoregulated
3	rgd
3	bystander
3	strategically
3	platform,
3	il1β,
3	epicardium,
3	epicardially
3	cosmc
3	(rat
3	analyses.results:
3	integration,
3	multiforme,
3	rat-derrived
3	p16-expressing
3	rb.
3	bi-polar
3	senescence-like
3	pclp16
3	strauss
3	al:licensee
3	prb,
3	p16
3	cell-
3	account.
3	(cq)
3	juruá
3	cq-pq
3	2.2%
3	peoples
3	africans
3	pvron21828-2080
3	underscored
3	neglect
3	diagnostics,
3	india,
3	plans
3	malaria-causing
3	fil+
3	z-scores
3	[ci]
3	disequilibrium,
3	local,
3	31),
3	mixed-effects
3	(pvdbp)
3	hazards
3	biab
3	amazonians.
3	gene-encoded
3	(vsa)
3	vsas
3	low-endemicity
3	single-species
3	complicate
3	anopheline
3	feedings
3	fixed-dose
3	parasitologic
3	(most
3	headache,
3	south-east
3	madagascar
3	bottleneck
3	recombinants.
3	snps.
3	(limit
3	heterozygosity,
3	remansinho
3	years;
3	settlers
3	(16.3%)
3	alleviating
3	(pf-ies)
3	trophoblast;
3	antiadhesion
3	(gags),
3	pf-ie
3	gag-based
3	(fuccs),
3	cucumber,
3	fuccs.
3	multi-locus
3	oceania,
3	contaminating
3	purchasing
3	slide-confirmed
3	protease.
3	imperative
3	(sr)
3	non-repeat
3	perfectly
3	lay
3	pyrimethamine
3	malarias
3	implications,
3	antigen-coding
3	(icp)
3	pvdbpii
3	disequilibrium.
3	(cd123+),
3	myeloid/plasmacytoid
3	(il-10)/tumor
3	infrastructure
3	holoendemic
3	belem,
3	nonhomologous
3	sixty-eight
3	lanka.
3	11.3
3	73.3%
3	settlements.
3	households,
3	cohorts
3	substitutions.
3	non-repetitive
3	4.2%
3	covariates
3	342
3	3,000
3	array,
3	mixtures,
3	household,
3	403
3	subjects;
3	isolation;
3	18.4%
3	dizziness,
3	diarrhea)
3	semi-immune
3	socioeconomic,
3	unconditional
3	bottle
3	soil-transmitted
3	(24.5%)
3	crowded
3	rivers,
3	(64.0
3	habitual
3	376
3	pvmsp-119.
3	sin
3	var,
3	1998,
3	(72.2%)
3	3.6%
3	than,
3	msp-119
3	6-13
3	cross-reactivity,
3	formidable
3	(g6pd)
3	primaquine,
3	classic-type
3	pair-wise
3	malaria-vaccine
3	solomon
3	k1,
3	families)
3	nucleoticle
3	uniform.
3	(ci
3	chance.
3	(te)
3	205
3	toxoplasma.
3	pvtrap
3	features:
3	(36%
3	microbiologically
3	1990s.
3	holo-endemic
3	giardiasis
3	nurseries
3	honduras-1
3	mosquito.
3	f(st)
3	336
3	239
3	0.007).
3	bloodstage
3	(unique
3	temporal,
3	assortment
3	anti-hbs
3	nonrandom
3	diagnoses,
3	microtitre
3	(3.8%)
3	sub-unit
3	areas:
3	naturally,
3	sex-matched
3	(pfmsp-1)
3	(39%)
3	deviate
3	(msp1)
3	236
3	msp1,
3	village
3	residents,
3	crosssectional
3	24),
3	ds)
3	(35-46%)
3	periodate-sensitive
3	interviewed
3	regressions
3	(nh
3	407
3	(p<0.0001)
3	anaemic
3	organization)
3	10.0%
3	8.8%
3	agro-industrial
3	rondonia
3	(plasmodium
3	borderline
3	(pvmsp-1)
3	3.4%;
3	peak,
3	antigens)
3	508
3	velho,
3	comprehending
3	concentration)
3	bloodspot
3	immunobinding
3	unidentified,
3	sanitation
3	patented
3	aroused
3	ichiwaki
3	cnidarians
3	cnidaria.
3	não
3	metagenômica
3	biossintéticos
3	(pks)
3	biblioteca
3	sequências
3	sobre
3	novos
3	xylanolytic
3	jellyfish
3	antimicrobial,
3	olindias
3	nematocysts
3	sambaquiensis
3	hemicellulases
3	β-glucosidase,
3	ascomycete
3	dr47
3	dr02,
3	bagasse.
3	combined.
3	solubilization.
3	low-nutrient
3	violaceum.
3	garrido
3	er1/6,
3	branch,
3	~3.4-mb
3	3,100
3	liquor
3	repression,
3	rojas
3	daufpe
3	5622,
3	beechwood
3	atroviride
3	talaromyces
3	wasp,
3	race,
3	membership
3	polyketides.
3	bioprospection
3	producers,
3	poly(3-hydroxybutyrate)
3	icb20
3	(loss
3	ionisation
3	daunorubicin
3	(esi-ms).
3	dx.
3	septicemia,
3	signatures,
3	ribonucleoproteins
3	icb20.
3	g/l
3	g/l.
3	moieties.
3	glycosyltransferase
3	method;
3	miniprep
3	penicillin,
3	4-128
3	≤0.25-256
3	16-256
3	penicillin.
3	6.4-
3	3.8-kb
3	c68c
3	2.8-1.8
3	6.4-kb
3	7.0,
3	intercalate
3	luria
3	(l2)
3	rifampincin,
3	(gentamicin,
3	neomycin,
3	amykacin
3	tobramycin).
3	oppa.
3	aminoglycoside-sensitive
3	aminoglycoside-
3	methanesulphonate
3	phages
3	α-amylase
3	revertants
3	revertants.
3	communications
3	gingivitis,
3	biotyping,
3	pockets.
3	periradicular
3	inter-individual
3	prtc
3	anaerobiosis
3	enteritis,
3	(+)
3	(66.6%)
3	invasive.
3	lagos
3	(ap-pcr)
3	broilers
3	governments
3	beta,
3	inflammation-mediated
3	statement
3	zro2
3	bmi.
3	difficile.
3	reservation,
3	endodontalis,
3	brazilians,
3	(b.
3	highest.
3	citral,
3	chewing
3	fstula
3	(11.4%)
3	fimbria,
3	apah,
3	(85.7%),
3	macacae,
3	erythromycin
3	actinomycetes,
3	black-pigmented
3	ccr5,
3	cellular,
3	cephalexin
3	ccr5+
3	rankl+
3	inoculation)
3	pseudomonads
3	krusei,
3	77.8%
3	enterobacteriaceae,
3	nondiarrhea
3	atheromatous
3	980-nm
3	peri-implantitis
3	lasers.
3	decontamination
3	chemokine.
3	osteolysis.
3	surgeries
3	chemokine,
3	actinomycetemcomitans)
3	hemin,
3	colocalization.
3	sets.
3	hyperinflammatory
3	extra-oral
3	-/-),
3	examinations.
3	chloramphenicol,
3	114)
3	75.4%
3	non-localized
3	non-diarrhoeal
3	fimbriae-like
3	api
3	mosby,
3	corrodens
3	(15)
3	proportions,
3	(u)
3	ld50.
3	antagonic
3	p55
3	32.
3	bft-2
3	monoassociated
3	germ-free
3	opg,
3	protein/ml,
3	ccl4,
3	cadmium,
3	mercuric
3	trypticase
3	fn5047
3	pseudomembranous
3	60°c,
3	d-galactose,
3	d-galactose.
3	nickel.
3	forsythus,
3	boiling,
3	26.7%
3	nontoxigenic
3	citotoxicity
3	chlorhexidine,
3	triclosan,
3	heterogenicity
3	aids.
3	48h.
3	triclosan
3	aids/nup
3	megacolon
3	air-water
3	drain
3	rh-;
3	microaerophilic
3	rh+
3	gather
3	organochlorine
3	particularities
3	vegetation,
3	bars
3	[figure
3	bioaccumulation
3	(mt)
3	danae
3	only;
3	rb,
3	praia
3	forensic
3	tilapia
3	pb+carbon
3	sectioned,
3	index;
3	hematoxylin-eosin
3	cost.
3	oceanographic
3	commercially,
3	cerium
3	23°c
3	echinoderms,
3	affinities,
3	provinces
3	faunas
3	richest
3	depths,
3	amphisbaena
3	subterranean
3	carp
3	eds
3	(k)
3	xenobiotics
3	608
3	humans;
3	invertebrates,
3	cathorops
3	chaperones,
3	spelling
3	rakers
3	(vp)
3	requirements,
3	crystalloids
3	ppm).
3	germicide
3	contaminants,
3	rectum.
3	implant.
3	acrophase
3	alt)
3	alveolus
3	expelled
3	hpp
3	coelom
3	peristomial
3	0.52
3	(1.46
3	spidroins
3	cruentata
3	(araneae:
3	compacted
3	dyes,
3	[silva
3	7-15
3	retraction
3	handicap
3	dispersion,
3	mysella
3	diazotrophicus
3	spans.
3	heterophils
3	validus
3	precloacal
3	moves
3	trail.
3	(15-30
3	gustav
3	amphioxus
3	a. altiparanae
3	—
3	spermatozoa.
3	aund*
3	testis.
3	altiparanae,
3	estradiol-17β
3	spermatids
3	round-shaped
3	and/
3	reintroduction
3	bones.
3	salminus
3	(nh)
3	teleosts
3	construction,
3	hilarii
3	ganglion,
3	satisfies
3	pseudoplatystoma
3	hormonally
3	(rg
3	40th
3	day),
3	rates)
3	vitelline
3	variably
3	prominent.
3	vitellogenesis
3	(final
3	tripartite
3	institute,
3	perchlike
3	(gsi)
3	pg/ml).
3	fabry
3	phenotypes:
3	sleepiness
3	(starting
3	< 0.05,
3	24 hours
3	(irap)/at4
3	irap
3	hyperphagic
3	cidea
3	reports,
3	positron
3	homa
3	dark.
3	palmar
3	grasp,
3	free-fall
3	zeitgeber
3	mel,
3	bohlen,
3	ferreira-neto,
3	cipolla-neto,
3	frazao.
3	non-seasonal
3	short-day
3	anti-gonadotropic
3	photoperiodism
3	postexercise
3	evening,
3	p=0.04),
3	flashes
3	reports.
3	silent,
3	anhydroecgonine
3	pyrolysis
3	60.
3	month,
3	masked
3	dawn
3	maturational
3	(immature
3	cry1
3	pacemaker
3	insulin-dependent
3	shiftwork
3	effect)
3	rev-erbα,
3	diel
3	clock.
3	creb,
3	salicylate,
3	acts,
3	triggering,
3	(hg)
3	pnx
3	(pi3k),
3	tnf-α's
3	glutamate's
3	ampa,
3	darine
3	(fpg)-sensitive
3	(2.50
3	0.50/100
3	1.8/100
3	85.8%
3	melatonin-mediated
3	cp-induced
3	ccs
3	7-8
3	bmal1
3	cell-type
3	igf-1r,
3	comorbidities
3	12-hour
3	6);
3	i/ii)
3	neurovascular
3	(bmp-9),
3	nonparenchymal
3	insulin-sensitizing
3	(hiss).
3	bmp-9expression
3	(72
3	refeeding-induced
3	anti-bmp-9
3	hiss-like
3	hiss
3	amt6s
3	19.0
3	hydroxylase,
3	hydroxyindole-o-methyltransferase
3	(serca2),
3	calorimetry.
3	(hexokinase,
3	4:00
3	transitional
3	summer.
3	incubation).
3	(75%
3	dl
3	(95%)
3	luzindole.
3	a.m.,
3	lipids)
3	(cm),
3	20.00
3	(dp).
3	8:00-10:00
3	(ach)-induced
3	(pd2
3	classifying
3	sleep)
3	spectra.
3	(imhv)
3	accessorium
3	chicks'
3	ribonucleoprotein
3	remodel
3	pentamer
3	pentameric
3	tween
3	mhc-i
3	(hpv),
3	(hiv).
3	concept,
3	hiv-derived
3	trivalent
3	hsv,
3	sf9
3	v5
3	c-terminus,
3	adenovirus.
3	bhk-21
3	resin,
3	july.
3	transducer,
3	p21ras,
3	p21ras.
3	no-stimulated
3	n17ras-expressing
3	erk1/2.
3	(52.9%).
3	immunomodulators
3	transactivator
3	(tat)
3	l-pha-reactive
3	oligosaccharides,
3	centrifuged
3	gut-to-brain
3	error,
3	mistakenly
3	transneuronal
3	dopamine-excitable
3	unpalatable
3	(me)
3	posteroventral
3	(fg)
3	me.
3	orbital,
3	(infralimbic
3	cortices).
3	divisions.
3	(vta)
3	(rr)
3	mesencephalon.
3	mesotelencephalic
3	km,
3	dc,
3	tfc.
3	tfc
3	specializations.
3	accumbens.
3	pallidal
3	gabaergic,
3	striatopallidal
3	surroundings
3	gyrus.
3	(cholera
3	entl
3	perirhinal
3	incertus,
3	caudate-putamen,
3	continuum
3	pseudorabies
3	conducting
3	postinoculation
3	alliance
3	infralimbic,
3	subiculum,
3	pallidus,
3	ansa
3	gp.
3	bundle,
3	forel,
3	(stn)
3	stn,
3	afferentation
3	conform
3	investigators,
3	(ob)
3	posteromedial
3	alan
3	velocity.
3	hgf,
3	radicular
3	instruction
3	contextualize
3	expansively
3	(mcf10-a)
3	(mcf7
3	nucleoli
3	invadopodia-related
3	tks4,
3	mmp-3
3	heparin-binding
3	microvesicles
3	nontransformed
3	invasive,
3	s100
3	nonneoplastic
3	vim
3	208,
3	spearman's
3	β-catenin.
3	timp-2,
3	ameloblastomatous
3	pro-mitotic
3	microsc.
3	tech.
3	(oscc)
3	(egf),
3	erk.
3	endovenous
3	α1-derived
3	ag73-enriched
3	gm6001
3	ag73-mediated
3	co-receptors
3	ag73,
3	double-knockdown
3	cooperation.
3	oligos
3	ag73.
3	(treated)
3	(pas)-positive
3	restorations
3	(96%)
3	mandible.
3	pleomorphism
3	α6
3	α6,
3	ruffle
3	correlated,
3	neurotropism
3	inducer,
3	bfa
3	myoepithelioma.
3	osteonectin
3	erupted
3	epithelial-myoepithelial
3	resected
3	disturbing
3	recrystallization
3	acrylic
3	bur
3	(n-cam)
3	(transwell
3	promises
3	histopathological,
3	(plga)
3	cytokeratins
3	msa
3	clefts
3	coiled
3	plate,
3	at+
3	ethylenediaminetetraacetic
3	14.1
3	0.025).
3	cementum
3	direction,
3	condyle
3	injured.
3	diameter;
3	shaft,
3	lindane,
3	cyclodienes
3	lindane-resistant
3	1960s
3	fipronil.
3	lit.
3	cypermethrin
3	(tpp),
3	(rf)
3	uruguayan
3	rr50
3	(porto
3	alegre,
3	generations,
3	fao
3	ait,
3	taxonomy.
3	four-fold
3	alegre
3	c6/36
3	(f2)
3	campinas
3	vial
3	seventy-five
3	17-kda
3	(titers
3	females),
3	geochelone
3	(l.),
3	carbonaria
3	14.3
3	12.0
3	tortoise
3	silky
3	spiracular
3	didelphidis.
3	triturated
3	bmg
3	chicks,
3	stimuli;
3	scotopic
3	ctr
3	exposure-free
3	elderly,
3	4 weeks
3	amyloid-β,
3	gp91phox−/−.
3	cytokines’
3	nox2-dependent
3	6-hydroxy-dopamine
3	2 days
3	(gallium
3	arsenide,
3	laserpulse,
3	ibramed
3	904 nm,
3	9500 hz,
3	60 ns,
3	(gsk-3β)
3	caspase-3.
3	drive.
3	glua1,
3	glua2/3
3	excitability.
3	alzheimer’s
3	neurodevelopmental,
3	“omics”
3	peptidomics.
3	callosum
3	data-dependent
3	(dda).
3	peph,
3	atl.
3	serum-deprived
3	neuro2a
3	started,
3	tg.
3	fenofibrate,
3	repeated,
3	(map2),
3	egr-1.
3	epileptogenesis.
3	flow;
3	diacetate,
3	inadequacy
3	(cg),
3	(mpz).
3	cci-nm
3	sheaths
3	inter-axonal
3	neuroplasticity.
3	cxs
3	neurodevelopmental
3	(gp91phox-/-)
3	apocynin-treated
3	justified
3	methodologies,
3	nox-2
3	inflammatory-mediated
3	(6-ohda)-induced
3	negligible,
3	6-ohda-mediated
3	gp91phox-/--lesioned
3	immunolabel
3	escape,
3	(ucms)
3	unstressed
3	k252a
3	non-exercised
3	parkinsonian
3	nitration,
3	ampa/kainate
3	clamp,
3	cort,
3	imipramine.
3	overlapping,
3	cornus
3	ammonis
3	operant
3	rested
3	dg
3	neurocircuitry
3	microglia)
3	repetitive/restricted
3	autism-like
3	cbx,
3	(68%
3	ensue
3	(nf)
3	non-photic
3	igl.
3	(gfap).
3	(ex3),
3	18-month-old
3	tna
3	mcs.
3	chapters.
3	affective,
3	glurs
3	66%)
3	transection,
3	axotomy.
3	values),
3	trpv2
3	p60,
3	(lew)
3	(3′-utr)
3	3′-utr
3	dark-adapted
3	atp/adenosine
3	(ieg),
3	drug-seeking
3	(2.0 g/kg)
3	15 days.
3	indistinctly,
3	context-independent
3	neuronal-differentiated
3	marmoset,
3	connexin43
3	10/10
3	46.2
3	sad,
3	dnd
3	large-sized
3	cytoarchitectonic
3	igl,
3	m1,
3	ctb-positive
3	α2,
3	shall
3	p2x1
3	canaliculi.
3	abcb1-mediated
3	rhodamine123
3	0.30;
3	0.31;
3	0.010).
3	post-lesion.
3	1-8,
3	5b
3	e10,
3	metal-catalyzed
3	radiolabeling
3	synaptosomal
3	allergy-activated
3	ova-allergic
3	cromolyn,
3	stabilizer,
3	μm2,
3	(10.9
3	units).
3	antinociception,
3	cognition,
3	(stratum
3	chick,
3	cb1,
3	ensues
3	(th2)-skewed
3	anti-venom.
3	inflict
3	phospholipase-a2
3	spla2-lys49
3	inactive)
3	active)
3	(randall-selitto
3	(il1)
3	l-n6-(1-
3	iminoethyl)lysine
3	(l-ni),
3	cyclooxygenase-2,
3	random-dot
3	ova-containing
3	facilitator
3	intra-nigral
3	one-day-old
3	teo.
3	e9.
3	glur4,
3	endo-oligopeptidase
3	oligopeptidase,
3	enkephalins.
3	(nachrs),
3	(ache),
3	nachrs,
3	system-related
3	semilunaris),
3	visual,
3	bilaterally,
3	connections,
3	cisternae,
3	α-adrenoceptor
3	subunit-specific
3	perikarya.
3	immunocytochemically
3	mechanical,
3	combinations,
3	squirrel
3	acetylocholine
3	α‐bungarotoxinsensitive
3	α8,
3	2–4
3	α8‐like
3	suprachiasmaticus.
3	retinoreceipient
3	bipolar,
3	(β2
3	α3)
3	doubly-labeled
3	pretectum,
3	0.1%).
3	intercalatus
3	superficiale
3	cells/mm2,
3	affected)
3	3.4.22.19,
3	(30.3
3	mu/mg,
3	deviation)
3	(7.0
3	mu/mg).
3	5.5′‐dithiobis(2‐nitrobenzoic
3	retinae.
3	double‐labeling
3	immune‐reactivity
3	[leu5)‐enkephalin‐like
3	immuno‐reactivity.
3	(visual
3	upward-temporal
3	(inl)
3	th-immunoreactive
3	inl
3	1982).
3	th-positive
3	head.
3	ventralis
3	(chat).
3	fibers)
3	direction-selective
3	directions,
3	antidromic
3	oil-based
3	pre-operative
3	fole
3	(pla
3	(pgd2)
3	(mpges-1).
3	581/591
3	astaxanthin
3	(compared
3	(nefas)
3	blunt
3	c/ebp-α
3	dha.
3	chemoattractant-2
3	aocs.
3	pcp
3	cholesterolemia
3	drug-related
3	runners
3	55%,
3	dha-rich
3	stz-treated
3	alleviated
3	lead.
3	(fo).
3	(t1)
3	pkr-/-
3	(cd
3	nunes
3	(tnf-
3	integrity)
3	5.1
3	match.
3	(1.5-fold),
3	streptozotocin-diabetes
3	50-70%
3	force)
3	anisotropy
3	sphingomyelin.
3	presented).
3	energy-demanding
3	circumvented
3	epididymal,
3	admsc-treated
3	admsc.
3	admission,
3	treated)
3	pre-treatment.
3	reversely
3	gluconeogenesis.
3	esther
3	-enolase
3	uncoupling.
3	anticardiolipin
3	gpr43
3	phenylacetamide-1
3	glucose-fatty
3	(vo
3	max).
3	coloured
3	(oleic
3	(linoleic
3	(saa)
3	gpcrs
3	latest
3	(lt-iih)
3	u/kg)
3	l-alanine,
3	dag
3	(9%),
3	(86%),
3	(28%).
3	(ezetimibe)
3	(statins)
3	mg/day/8
3	each/day/4
3	meanwhile
3	cytokines;
3	x-box
3	factor-kappab
3	adventure
3	lymphocytes:
3	integrity;
3	(1.5-fold)
3	saturated/unsaturated
3	hemolysis:
3	phospholipases.
3	deformability,
3	fragility.
3	(csa);
3	ligases/deubiquitinating
3	(murf1)
3	(mafbx)/atrogin-1]
3	ups-driven
3	weeks:
3	(np)
3	the:
3	reduced:
3	pfk
3	hkii,
3	translocate
3	adapter
3	(crs)
3	ironman
3	competition,
3	monohydrate
3	transaminase
3	dye,
3	mobilization,
3	ffa.
3	tissue-
3	e-,
3	transmigration
3	hypusine
3	ectoderm,
3	ischaemia.
3	(di).
3	mip-1α
3	sdt
3	nellore,
3	three-way
3	capn4751
3	cast/ddei
3	breed.
3	(nt,
3	90th
3	adipokines,
3	(abcb1,
3	abcc2)
3	supression
3	protein(s)
3	ap-1,
3	2a-
3	2c-adrenergic
3	advanced-stage
3	(iia
3	iix)
3	salicilate
3	(apoptosis
3	n1-guanyl-1,7-diaminoheptane
3	chemoresistance
3	4-nc
3	life;
3	100.0
3	ca+2-dependent
3	tukey's
3	(dag),
3	(tnfα),
3	unbound
3	cytokines:
3	hepatotoxicity
3	mc-induced
3	blind,
3	amidotransferase
3	pouches
3	aβ-induced
3	aβ1-40
3	(src-family
3	[mitogen-activated
3	inhibitor],
3	[phosphatidylinositol
3	(pi3-k)
3	hr);
3	pp1,
3	ly294002.
3	iκb,
3	pi3-k
3	(hrv)
3	nonsurvivor
3	indexes.
3	(jurkat
3	leukaemic
3	laparotomy,
3	glucagon.
3	ω-9
3	ooe
3	(cona)
3	phosphatidylcholine.
3	(those
3	(apoe)
3	mn-sod,
3	neutropenia
3	n-6)
3	jak3,
3	jak1,
3	2max)
3	pediatrics
3	lipocardium
3	tetravalent
3	action:
3	(epa,
3	p67phox
3	plethysmographically
3	lifting
3	ureagenesis
3	l-ala,
3	l-a
3	(are)
3	(2×107
3	(rich
3	supplementations
3	hyperlacticidemia,
3	(nacl)
3	fat-specific
3	dio
3	cytoprotection
3	proliferator
3	wash
3	(gata
3	1a)
3	γ)
3	(ucp-2
3	nonphosphorylation
3	(predominantly
3	ucps,
3	calorigenic
3	modulations
3	8);
3	toxic.
3	tears
3	gsh.
3	[(+)-vesticarpan]
3	floribundum.
3	arachidonate-derived
3	(g6pdh),
3	nadp+-linked
3	[1-14c]
3	pump)
3	extrudes
3	s-conjugates.
3	64.3
3	thio-treated
3	ureogenesis
3	inter-organ
3	p47phox,
3	gp91phox,
3	(49
3	s-1)
3	cellulosae
3	scolex
3	metacestode
3	bcl-xl,
3	(2.12,
3	3.75,
3	nm/ml),
3	(1.43,
3	2.86,
3	nm/ml)
3	neuropathology.
3	have:
3	invited
3	462
3	(scc),
3	total).
3	26.5%
3	subtilisin-like
3	15d
3	catabolism,
3	over-express
3	anti-tumour
3	hoescht
3	nbd-cholesterol.
3	(line
3	oil),
3	(ggt),
3	oil-treated
3	16:0,
3	12.3
3	u/g
3	14%.
3	erythematosus.
3	b-lymphocytes
3	inf-γ,
3	tension.
3	helper-1
3	(ly),
3	co-culture,
3	[1-14c]aa
3	(thioglycolate
3	treated)-ly
3	(tg-ly)
3	tg-ly
3	tg-injected
3	[14c]
3	1071
3	[14c]aa
3	(8.7
3	aa-preloaded
3	mu/ml
3	p44/42
3	cycle).
3	glutamine/glutamate
3	cytochromes
3	hypoglycemia.
3	phosphodiesterases,
3	(v/v)
3	395
3	lauric
3	42%),
3	γ-interferon
3	antioxidative
3	(mnsod
3	pufas,
3	biocompatible
3	cuzn-superoxide
3	cuzn-sod
3	assessed:
3	weight).
3	phosphofructokinase,
3	12.6
3	11.2
3	imposed.
3	(chx),
3	(unstimulated),
3	(thioglycollate-stimulated),
3	guérin
3	h202
3	nitrogen-reactive
3	vanadate-sensitive
3	mln,
3	(53.3%).
3	proportionally
3	0.66
3	(48%)
3	received,
3	μu
3	(soy
3	th1-
3	1999,
3	cochlear
3	ohcs
3	omega-6
3	thromboxanes,
3	glycogenolysis.
3	ifn-α.
3	solvent,
3	curvature,
3	n.v.
3	imprint,
3	gordon
3	wrc256
3	chylomicron-like
3	(ce)
3	cations:
3	(mesenteric
3	thymus)
3	glycogen-elicited
3	dismutase-inhibitable
3	μu/ml
3	thioglycolate-elicited
3	elicitation
3	mmol/g),
3	mostly,
3	(urea
3	(88
3	mercury.
3	worker
3	export.
3	1-10
3	73%,
3	mu,
3	organs;
3	mg2+)
3	food-restriction.
3	radicals)
3	(respectively,
3	cancer-bearing
3	(inflammatory)
3	expression/activity,
3	webster
3	n(g)-nitro-l-arginine
3	β-oxidation
3	(132%
3	inner-membrane
3	immuno-detection
3	ii-specific
3	69,000
3	54,000)
3	normal-sized
3	69,000)
3	macrophage-derived
3	influence,
3	detector
3	leptin)
3	soleus)
3	(69%)
3	(75%).
3	(82%
3	thf
3	wbd
3	(18%),
3	10-30
3	9.2
3	(fcs).
3	fcs.
3	(26%),
3	netherlands
3	c-oleate
3	subfractions.
3	graves'
3	suppressed.
3	mmi
3	months),
3	coa's
3	nadp+-dependent
3	acetoacetyl-coa
3	3-oxoacid-coa
3	(3%
3	oil).
3	mitogen.
3	332
3	422
3	ldlox
3	hmdm
3	exercise-training
3	random,
3	mmol/l.
3	non‐immune
3	(46
3	(41
3	(fourfold)
3	mmol/1
3	[2-14c]-thymidine
3	ala.
3	w-3
3	cond
3	saving
3	free-fed
3	focussing
3	15.1
3	triacylglycerol.
3	non-detectable
3	(arenaria
3	unsuccessful.
3	coronaviruses
3	covs
3	vieira
3	wide-ranging
3	(npc)
3	women),
3	chemokines),
3	(mrs).
3	mrs,
3	conceive
3	(isnv),
3	pediatria
3	virus-1,
3	(ari)
3	ps-induced
3	parvoviruses
3	peixe
3	h6n1
3	thous).
3	rabies,
3	on-1
3	na-2
3	45.8%
3	282
3	h4n7
3	non-breeding
3	neurological/autoimmune
3	zika-mosquito
3	rockefeller,
3	rexville
3	intrathoracically
3	zikv-mosquito
3	assemblies.
3	clinical/epidemiological
3	hrsvb
3	multisystem
3	mastitis
3	pneumonia.
3	copies/ml
3	world’s
3	(hps)
3	h11n9
3	hrsv-b
3	interviews
3	araujo
3	(crs).
3	igm-positive
3	rubella.
3	definitely
3	gentoo
3	53)
3	interpreting
3	reverse-transcriptase
3	transcription-pcr.
3	coronaviruses.
3	double-dose
3	1g,
3	ga2
3	ari
3	epidemics,
3	h5,
3	hemagglutinin
3	throat
3	(1956-2006).
3	circulated
3	washes
3	1.4%
3	decreases,
3	pets,
3	hrsvb.
3	fifty-nine
3	782
3	hbov
3	dominicanus
3	191
3	co-circulate
3	2-year
3	545
3	landmarks
3	(91%)
3	(9%)
3	unnecessary
3	contexto
3	mammalians,
3	ica-bd
3	297
3	explosive
3	(hcv)
3	donations.
3	sorghum.
3	infants'
3	a5,
3	soybeans,
3	total-dna
3	randomic
3	hiv-rna
3	feet
3	henselae.
3	1997.
3	(mv)
3	(cfa/i),
3	hsv-2
3	hyperemia,
3	1,2
3	i;
3	2/18
3	preponderant
3	difficult,
3	exanthema
3	resurgence
3	d6
3	vlps,
3	culture;
3	occurrence,
3	(0.8%),
3	(0.4%).
3	(seven
3	ad7
3	cases),
3	apv
3	earlier.
3	otitis
3	hhv-6
3	new-onset
3	vasculitis.
3	remission.
3	chemiluminescent
3	(22%),
3	astrovirus.
3	enteropathogens
3	time-of-day-dependent
3	pubmed
3	(hazard
3	>5
3	(lfd)
3	ptu
3	ucp3,
3	h3,
3	protein-based
3	(0.05%
3	iodine-treated
3	gapdh,
3	(ewat)
3	(miliplex
3	kit)
3	ewat
3	(dp/dtmax)
3	(dp/dtmin)
3	iodide-induced
3	thyrocytes,
3	half-life.
3	prolongs
3	causes,
3	hypogonadism,
3	pg/ml.
3	30min.
3	c-gmp
3	(ser
3	arg.
3	microrna-350
3	(mir-350),
3	mir-350
3	concentrations;
3	nai,
3	mfr
3	(con)
3	bolus)
3	energy-restricted
3	measure:
3	containing:
3	mentioning
3	chewing,
3	(opg)
3	mineralization,
3	possibilities,
3	clue
3	(hmβ)
3	protein-restricted
3	diet;
3	(-19%
3	pathologists
3	atrium
3	(v),
3	injected.
3	cit
3	(trh)
3	0.03%
3	incubates
3	t4-treated
3	slow-twitch
3	thyroidal
3	radioiodine
3	t/s
3	chd
3	µl
3	wave)
3	f1.
3	lllt&f1
3	non-injured
3	(svz)
3	(rms)
3	interneurons,
3	seen,
3	deposit,
3	evaginations.
3	α-tocopherol/ascorbic
3	chat-
3	cardiolipin.
3	lv,
3	cg,
3	lg,
3	dutp
3	mushroom
3	agaricus
3	withdrew
3	rapidly,
3	cost-benefit
3	gabriela
3	groove.
3	southern-fur-seal
3	structurally,
3	bundles,
3	hah
3	width,
3	glutaraldehyde,
3	0.1m
3	microplicae
3	morphometrics
3	0.1%)
3	p1.
3	endothelium;
3	irradiations,
3	filliform
3	pgp
3	protrusions.
3	desmosome-type
3	strut
3	polymer-coated
3	eluting
3	(mtj)
3	"finger-like
3	extremity
3	interdigitations.
3	digastric
3	infoldings
3	spongy-like
3	meshes
3	rhea
3	endings,
3	impregnation,
3	specialised
3	g/kg,
3	post-fixed
3	radiating
3	professionals
3	liter
3	separated,
3	statistic
3	eosin.
3	power,
3	myofibrils,
3	contacting
3	axoplasm
3	ostrich
3	portions,
3	(adenosine
3	milohyoid
3	1010,
3	mpa)
3	herbst
3	attached.
3	coccus
3	round,
3	chilena
3	perineural
3	corpuscle.
3	diameter).
3	lamellae.
3	energy-dispersive
3	papillae).
3	surface;
3	450
3	elliptical
3	(ar).
3	9-month
3	antero-posterior
3	(ache)
3	nine-banded
3	norvegicus
3	microvilli.
3	cristae.
3	morphofunctional
3	papilla,
3	hcl
3	acini.
3	longitudinally
3	microns.
3	rc
3	caveolae.
3	okajimas
3	folia
3	anatomica
3	japonica.
3	extensions.
3	noted;
3	lapse
3	crania
3	observable
3	increases)
3	clivus-sphenoidal
3	petrosquamous
3	unpaired
3	sinuses
3	stable;
3	unimportant.
3	clivus
3	skull
3	cephalic
3	defensive,
3	arena
3	(fsb)
3	arena,
3	digging.
3	digging
3	mch-mediated
3	pre-ingestive
3	septo-hippocampal
3	commonalities
3	entrapment
3	fk888
3	postures
3	lordosis
3	hormone-containing
3	hypothalamus),
3	immunoperoxidase,
3	basket
3	reviewing
3	perhaps,
3	emotion
3	lidocaine,
3	spatial/relational
3	(s-r)
3	pmd.
3	iso.
3	anxiogeniclike
3	fornix
3	morphine.
3	17.
3	privileged
3	needs.
3	expensive,
3	intra-maze
3	craving.
3	lrs
3	cck2
3	k/x
3	delineated
3	incertus
3	components),
3	postshock
3	short-latency
3	midbrain.
3	acupuncture
3	zusanli
3	h/day)
3	non-point
3	partly,
3	unanesthetized,
3	inactivation,
3	disabilities
3	extrastriatal
3	assuring
3	fos-responsive
3	benserazide/l-dopa
3	attains
3	(dpag)
3	[3h]arginine
3	[3h]citrulline
3	non-exposed
3	no/cgmp
3	divisions,
3	agonistic
3	tentatively
3	tuberal,
3	a13
3	parataenial
3	lobe,
3	drug–drug
3	sp1,
3	sp1/egr-1
3	5'-flanking
3	5'fs
3	t-lymphotropic
3	clonality
3	standard-curves
3	bcr
3	region),
3	reproducible,
3	acy
3	osmolality,
3	nkcc2
3	gem-81
3	ca2+/calmodulin-dependent
3	opiod
3	[hexxh].
3	amiloride-sensitive
3	(88%
3	non-epithelial
3	mounts
3	peduncular
3	hpt
3	neurobiology
3	orexin-immunoreactive
3	stress/anxiety-related
3	wpns
3	bi-directionally
3	neuromodulator
3	battagello,
3	diniz,
3	candido,
3	lotfi,
3	casatti,
3	lovejoy
3	(ucn3)
3	(crf2)
3	ucn3-containing
3	(pfa),
3	paraolivary
3	ucn3-immunoreactive
3	(ucn3-ir)
3	ucn3-coding
3	ucn3,
3	(ls).
3	ucn3-producing
3	corticotrophin-releasing
3	intra-vmh
3	diniz
3	modalities
3	refeeding,
3	μg/0.2
3	n=
3	bdl
3	pupil
3	accommodation,
3	non-ocular
3	stress-like
3	stressors,
3	250.
3	vomeronasal
3	hypophagia
3	colocalization,
3	calretinin-ir,
3	regions:
3	ew.
3	fostered
3	benzodiazepines
3	(a).
3	odors,
3	glur2-flip
3	reanalyzed
3	message
3	eur
3	sci.
3	reflex.
3	(zi).
3	neurochemistry,
3	(rem)
3	(avpv)
3	adjustments,
3	conveying
3	areal
3	esi-ms/ms
3	mo5
3	systematically.
3	teneurin
3	(ob/ob
3	hypogonadism
3	arcuate,
3	(ucn)-like
3	nonprimate
3	labeling)
3	ucn-expressing
3	preprohormone
3	ix.
3	flocculus
3	(zi)
3	enzyme),
3	completing
3	moments
3	r1
3	overlapped
3	stress-
3	thoracic,
3	urotensin
3	pervasive
3	nei-ir
3	ms/dbc
3	lha(t)
3	sources:
3	obscurus
3	poa.
3	rmg,
3	(neuropeptide
3	ppmch
3	hypoglossal
3	rmch
3	cruzeiro
3	(retrospective
3	newborns,
3	neurotropic
3	anti-mif
3	regulator,
3	cd68.
3	syncytiotrophoblast,
3	fluctuated
3	(anxa1)
3	matings
3	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
3	pests.
3	analogy
3	villous,
3	anticipation
3	bip
3	gene-specific
3	polβ
3	embryo-trophoblast
3	perigestational
3	gelatinolytic
3	0.02;
3	sdf2l1
3	(39%
3	(p = 0.0275)
3	(p = 0.026)
3	(p = 0.0176)
3	(p = 0.002).
3	(p = 0.036)
3	(p = 0.0433).
3	nfkb.
3	(nicotinamide
3	cyba
3	oxidase-mediated
3	vegfr-1
3	17.5
3	high-fat-fed
3	substrate/
3	25),
3	immunochemistry
3	erythrophagocytosis.
3	mesoderm
3	(pcos)
3	150,
3	multinucleate
3	mitoses
3	binucleate
3	bncs
3	fusions.
3	conjugates.
3	4.5)
3	(8.5%)
3	alpha-chain
3	ifn-gamma.
3	alpha-chain.
3	post-implantation.
3	bacteria)
3	(mp)
3	maternofetal
3	lactogen
3	maytenus
3	attempts,
3	(tcs)
3	non-inactivated
3	tcs.
3	lodged
3	cricetid
3	plasma;
3	c3b,
3	non-sensitized
3	depletes
3	provided,
3	rodent,
3	sjögren's
3	febs
3	uv-maldi-tof
3	terpenes,
3	10.4
3	(fpps/ggpps)
3	cercosporin
3	necessitates
3	mitigation
3	erwinia
3	cleaning
3	ggoh
3	shikimate
3	(ipp)
3	photosynthetic
3	nonphotosynthetic
3	off-line
3	collision-induced
3	tcspps
3	fractionation.
3	∼100
3	michaelis
3	farnesol,
3	limonene,
3	1.22
3	glucosylceramide
3	udp-glucose
3	farnesyltransferase
3	intermediates,
3	[3h]farnesyl
3	[3h]geranylgeranyl
3	monoterpenes,
3	schizogony
3	uag
3	antigenuria
3	tn
3	150-160
3	(85kda,
3	trypsin.
3	scatchard
3	tul
3	anti-homologous
3	synopsis.
3	oti-vit-6,
3	philcoxia
3	pipiens
3	-).
3	peroxidase-conjugated
3	poor,
3	phosphorylated.
3	polypeptide.
3	phosvitin
3	dolichorhabditis
3	stretches.
3	elegans.
3	ce-vit-6
3	intron.
3	polypeptides,
3	v1,
3	fluorography
3	ddt
3	(cluster
3	iguaçu
3	longipalpis,
3	species’
3	shannon
3	amapá,
3	squamiventris
3	naiffi,
3	unpublished
3	tropica,
3	inoculating
3	hirsutus
3	(1).
3	squamipes
3	uniqueness
3	avl
3	competence,
3	transcriptomics,
3	priority,
3	spines.
3	peridomiciliary
3	rita
3	blastocystis
3	-positive
3	phf10,
3	c6orf70,
3	psmb1,
3	tbp
3	194
3	family-based
3	dll1
3	.01)
3	amaraji
3	(1.3%)
3	whitmani.
3	233
3	(one),
3	leisure
3	multipoint
3	provisional
3	0.011)
3	impossible
3	fascinating
3	developments.
3	interests
3	carrerai
3	erythematous
3	lato
3	algorithms
3	package.
3	phenogram
3	carajás
3	complexus
3	bone-marrow
3	parasite-positive
3	(88%)
3	comds
3	immigrants
3	rain-forest
3	(lutz
3	spotty
3	oligogenic
3	nonhealing
3	marajó
3	cladistical
3	devastation
3	leprae,
3	catches
3	corticulata
3	lainson
3	subspherical,
3	13.4
3	micropyle.
3	complexus.
3	viscera.
3	30.4
3	ellipsoidal
3	pep,
3	mpi
3	mpi,
3	mouthparts
3	ward
3	baits,
3	starch-gel
3	n.sp.
3	colourless
3	steida
3	jari
3	secondary,
3	incurable
3	28.1
3	μm:
3	∼1.5
3	lumenal
3	microgametes
3	delicate,
3	17.9
3	chicago
3	practical,
3	os,
3	sub-groups
3	trans-amazon
3	highway
3	marabá
3	colonists
3	chagas’
3	semester
3	altamira
3	bite.
3	capito
3	fatal,
3	exo-antigen
3	fallisia
3	simplex,
3	plasmodia,
3	philodryas
3	isospora
3	carajás,
3	1968
3	gallate
3	(gfap),
3	antivimentin,
3	lighting
3	on-bipolar
3	αpkc-ir
3	mehg
3	μg/g.
3	div4,
3	mecamylamine
3	chat.
3	7-day-old
3	attribute
3	paralysis,
3	ocs
3	a8
3	pkc-li
3	hybridizing
3	gaba‐positive
3	engineering,
3	nx/hp
3	expressional
3	dithizone
3	ipans
3	cpt-11-induced
3	pre-pubertal
3	hu
3	crohn’s
3	(cg:
3	og:
3	(cg).
3	calr
3	(nnos-/-)
3	wildtype
3	p2x2-expressing
3	nadph-
3	(obtained
3	irregular,
3	immunoreactive.
3	0.1)
3	opinion:
3	med
3	roux-en-y
3	(rygb)
3	nausea
3	cox.
3	gcc
3	antidiarrheal
3	advances:
3	directions:
3	ttx-resistant
3	51.
3	dapaconazole,
3	non-fasting
3	(rt,
3	sanus
3	sulfide.
3	(equimolar
3	(efs;
3	hydrochlorothiazide.
3	48 h,
3	stimulator,
3	58-2667
3	cystitis.
3	nonvoiding
3	compliance.
3	58-2667.
3	reactive-oxygen
3	b.i.d.
3	randomization
3	5;
3	formulations:
3	(1-32
3	bay41-2272
3	(odq),
3	tosylate
3	84.6%
3	co-incubated
3	beta-3
3	β3-ar
3	5μm
3	hplc-ms/ms
3	physician
3	(cyclic
3	endothelia
3	(prp)
3	intromittent
3	hemipenises,
3	retractor
3	bladders.
3	pi3k/akt/enos
3	bladders,
3	(hplc-ms-ms).
3	97.5%
3	4.6%
3	96.0%
3	cobalamin
3	females).
3	weight:
3	tmax.
3	good.
3	(training
3	n=11,
3	concentration-responses
3	carbonate.
3	8-br-cgmp
3	odq-insensitive
3	collagen-
3	hypercontractility
3	mg/rat/day)
3	7-fold
3	acetonitrile/water
3	aucs
3	kidney-one
3	2/m
3	37-344
3	bezafibrate
3	interday
3	corporeal
3	racc
3	snp-induced
3	l-vocc
3	6.0,
3	(mabp),
3	mabp.
3	d-sd
3	trinitrate,
3	14-
3	gpiib/iiia
3	onoo-.
3	gallate,
3	nanospray
3	cgmp-independent
3	2-pyridylacetic
3	formulation:
3	shrimp,
3	poultry,
3	matrices,
3	20%.
3	submaximally
3	each).
3	biociências
3	calculating
3	subplantarly
3	0.004),
3	carbonate,
3	sildenafil.
3	(0.0001
3	degranulation)
3	separator.
3	elevate
3	(spla2s)
3	ω-nitro-l-
3	th2-dominant
3	(elispot)
3	pylori-negative
3	immunoresponse
3	gastritis,
3	il-4)
3	editrice
3	physiopathology.
3	0.03,
3	time-of-flight
3	kg).
3	dihydroergocristine
3	μg/l,
3	dihydropyridine
3	breakfast
3	24.2
3	boehringer
3	ingelheim
3	plough
3	proteolysis-inducing
3	dl-propranolol.
3	atenolol.
3	60 min,
3	atherogenic
3	0.04)
3	photospray
3	(loq)
3	ng-nitro-l-
3	machine
3	recursive
3	publishing,
3	mpap
3	gliclazide
3	ems
3	roche
3	4 h
3	(ltb4
3	47.3
3	53.8%
3	bn/grp
3	5-mononitrate
3	pa10
3	s9
3	typhymurium
3	(12%)
3	epigallocatechin
3	(sao
3	1h-[1,2,4]-oxidiazolo[4,3-a]
3	(losartan
3	97.2%
3	(70:30;
3	micromass
3	chromatographies,
3	dhec
3	0.46
3	(lc-ms)
3	graduation
3	(sea).
3	cinc-2,
3	chromatography-electrospray
3	nitrofurazone
3	ts1
3	μmol/l,
3	acetonitrile-water
3	wash-out
3	citalopram
3	ltda.,
3	farmaceutica
3	(fmlp;
3	m)-induced
3	guanosine-3′,5′-monophosphate
3	spicules
3	equivalent,
3	0.994).
3	p7,
3	liquid/liquid
3	catigua
3	(56.7
3	ticlopidine
3	(80:20,
3	(cpa),
3	bromoenol
3	tumescence
3	ga-al-as
3	metaproterenol,
3	22,536
3	3%)
3	no-cyclic
3	(fmlp,
3	i.d.,
3	streptokinase
3	iu/ml)
3	s.a.,
3	93.8%
3	predose
3	auc(0-∞),
3	regitine
3	vasomax
3	pretreating
3	priapism
3	(tsv)
3	renitec
3	activators.
3	cd49d
3	125i-human
3	μg/site)-induced
3	nociceptive,
3	injections)
3	benzodiazepine
3	diazepam,
3	(kd)
3	(bmax)
3	[3h]-quinuclidinyl
3	da)
3	(rvr),
3	uf
3	(hs;
3	densities.
3	subfields.
3	obey
3	farmacêutica,
3	0.7%
3	μg/cavity)
3	piratoxin-i,
3	47%,
3	piratoxin-i
3	non-natural
3	nω-nitro-d-arginine
3	amt
3	trim
3	terbinafine.
3	sexes)
3	nos1
3	inducible,
3	nos3
3	non-hodgkin's
3	40)
3	time-concentration
3	meloxicam
3	b.i.d.)
3	system).
3	hind-paw
3	erosive
3	paws,
3	finasteride
3	(7-ni,
3	(mmf)
3	hs,
3	hs+n
3	3.3,
3	amoxil
3	auco-∞and
3	z.
3	(same
3	aerated
3	infusing
3	tsv-induced
3	3-30
3	125i-albumin.
3	1,3-dipropyl-8-cyclopentylxanthine
3	alt,
3	(k(e))
3	moderate,
3	(gbm),
3	(bthtx-i)
3	μg/cavity
3	[14c]5-ht
3	(4,
3	armed
3	(phoneutria
3	nigriventer)
3	1%).
3	h))
3	pmol/site),
3	(sr140333;
3	(capsazepine;
3	nmol/site).
3	degranulate
3	decrease)
3	pla2(s)
3	(naja
3	mocambique,
3	phospholipasic
3	cefadroxil
3	auc0-α
3	farmaceutica,
3	auc((0-
3	resinate
3	suspension,
3	abusers,
3	vai
3	hemodynamics.
3	no-treated
3	ventricles.
3	(6.25
3	(6.3
3	t(1/2),
3	parameter,
3	natriuresis.
3	ot-induced
3	ot.
3	portugal,
3	14.7
3	(16.0
3	(2.9
3	(fda)
3	eradicating
3	biosintetica,
3	usa).
3	auc((0-48h))
3	guidelines,
3	met-lys-bk
3	9.9
3	coagulant
3	0-24
3	c(max))
3	arms.
3	swan-ganz
3	(45.0
3	ng/kg,
3	on-line
3	(paf,
3	(zap)-induced
3	spectro-photometrically.
3	zap-induced
3	140333
3	(flogan,
3	(sapp)
3	continuously.
3	min-1)
3	nitrates
3	anaemia.
3	n(ω)-nitro-d-arginine
3	nm)-
3	particles/cell)-induced
3	systemically.
3	prp.
3	iloprost,
3	10.6
3	pmol),
3	f1α
3	tne
3	(gs).
3	gs.
3	gs,
3	fr139317,
3	et<inf>a</inf>receptor
3	philadelphia.
3	psychogenic
3	histamine‐induced
3	(fraction
3	xiii
3	pnv3
3	(pge2),
3	6‐oxo‐pgf1α
3	dose‐related
3	et‐1.
3	eradicated
3	polycation
3	methysergide.
3	8.5
3	completely.
3	guanidino
3	atom(s)
3	thrombin‐induced
3	(o2‐)
3	nitro‐l‐arginine
3	l‐arginine.
3	zymosan‐
3	pma‐induced
3	kininase
3	pnv1
3	rcm
3	rcm-induced
3	i.e.)
3	nociceptors.
3	(bk,
3	(12,
3	charge.
3	constricting
3	itching.
3	(sodium
3	ulcerogenic
3	il1
3	lipidomic
3	15-d-pgj2
3	plin2
3	mediator.
3	(mlv)
3	tachykinins
3	interrupt
3	(bjv).
3	(62%
3	(cox-2
3	mt-iii-stimulated
3	p38mapk,
3	diminishment
3	salts.
3	lbs
3	(bmv)
3	undertaken.
3	bap1,
3	hypernociception.
3	(bjv),
3	fcγ,
3	pyroglutamyl
3	zinc-dependent
3	haemorrhage.
3	(5-20μg/paw)
3	(p-bpb),
3	(il-1).
3	guanethidine,
3	atenolol,
3	yohimbine,
3	sympathomimetic
3	txa2,
3	(il)-1
3	(avib,
3	(avcp,
3	aspar
3	venom).
3	cross-neutralization
3	avcp
3	avib
3	batimastat
3	(pain
3	(5-ht
3	nitrogen-derived
3	(5-15
3	bn52021
3	anti-interleukin
3	(ld50)
3	-bk
3	belt
3	horizons
3	silicates
3	certified
3	2700
3	ma.
3	1993)
3	reef
3	exudate.
3	pellet
3	similis
3	(3,
3	(2,
3	solubility
3	isomeric
3	(vs)
3	(15.8
3	between-days
3	stragulum
3	peter
3	paul
3	lucas
3	fishing
3	lignans
3	tethered
3	caribaeorum
3	(3).
3	ecd
3	cytotoxicity),
3	epidermis,
3	model)
3	13-fold
3	chitinases
3	shrub
3	sepharose
3	lpp1
3	carcinoma),
3	ovcar-8
3	lpp1-p4
3	bra
3	actinomadura
3	toxicants
3	risks.
3	floating
3	acoet
3	b9
3	ericoides
3	voltammetry
3	3-o-α-l-rhamnopyranosyl-(1
3	4)-α-l-rhamnopyranosyl-(1
3	(25r,s)-5α-spirostan-2α,3β-diol
3	parapsilosis,
3	mbs
3	juniae
3	perezone
3	proves
3	xylaria
3	endophytes.
3	habitats,
3	alkaloid,
3	(-)-chlorizidine
3	pseurotin
3	12,13-dihydroxy
3	kaurane
3	carboxylic
3	distinctly
3	cytotoxicities
3	2×10
3	nci
3	dermcidin
3	personalized
3	c-15
3	compounds:
3	11-bromoroquefortine
3	installed
3	down-regulating
3	nmr.
3	platinum(iv)
3	1b-3b
3	nor-β-lapachone
3	prototype,
3	alkaloid/amide
3	piplartine,
3	soldiers
3	diterpenes,
3	smallanthus
3	sonchifolius
3	protopalythoa
3	hsqc,
3	hmbc,
3	cockles
3	cockle
3	oleanolic
3	cordia
3	cordiaquinones
3	antifouling
3	alternatives.
3	withaphysalins
3	suppressors
3	michael
3	qphno
3	12.7
3	enrichments
3	3a,
3	(moderate
3	appealing
3	edulis
3	ribose
3	liver)
3	3e,
3	bromine
3	correlated.
3	tinctorius.
3	blastula
3	lc-ms
3	(46%),
3	annona
3	mdamb-435,
3	3a/3b
3	casearins
3	ripeness
3	cytoxicity
3	ao/eb
3	(asteraceae),
3	(11),
3	α-amino
3	laas
3	1b)
3	1a/1b
3	(r1
3	hl4
3	hl
3	antileukemia
3	(bone
3	(murine
3	(leukaemia),
3	ether,
3	phosphatidyl
3	arylamino
3	dichloromethane,
3	(bacillus
3	duguetine
3	photochemical
3	transformations
3	anhydrous
3	selenium
3	(10)
3	cancer;
3	propolis.
3	2-methylanisole.
3	olefin
3	menor
3	correlação
3	clog
3	pentacyclic
3	(methyl
3	hematology
3	24-well
3	g1/s,
3	43.0%
3	hyptis
3	meoh:h2o
3	(ald)
3	ald.
3	osteolysis
3	4′-dehydroxycabenegrin
3	variegatus)
3	glucose/mannose
3	analgesic,
3	megakaryocytic
3	rad52
3	chloroform,
3	blastulae
3	(esi-ms/ms)
3	medicines.
3	substantiated
3	team.
3	copaiba
3	physalis
3	terminals,
3	r.p.,
3	markus,
3	(wga)
3	0.01;
3	oroxylum
3	3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2h-tetrazolium
3	0.40,
3	nepetin
3	protocatechuic
3	23.8
3	blastula,
3	derricin
3	oncocalyx
3	fraction),
3	convulsion
3	g),
3	amphimedon
3	gel-filtration
3	hydroethanol
3	butanol
3	osteopenia,
3	α2a-ar-/-
3	shoulder
3	rotator
3	mscs.
3	reductase-deficient
3	journal.
3	α<inf>2a/2c</inf>-ar<sup>-/-</sup>
3	intolerant
3	thrb
3	10-10
3	differentiated.
3	isoflavones
3	deranged
3	tissues/organs
3	(trα)
3	(trβ).
3	phs.
3	(mhciia)
3	(serca1),
3	mhciia
3	gc-24.
3	20-fold)
3	two-fold).
3	30-40
3	manipulations:
3	(along
3	immobilization).
3	(wet/dry)
3	(gas).
3	maximizes
3	possibility.
3	absorptiometry.
3	hp)
3	quartile
3	/100
3	thirty-seven
3	years).
3	osteoporosis.
3	kg;
3	mbmd
3	weighting
3	hacat
3	atheromas.
3	vdr
3	bacitracin,
3	coimmunoprecipitation.
3	adenoma.
3	classifiers
3	nonamplified
3	arna
3	(g-csf)
3	redirected
3	immunotherapies
3	pre-mrna
3	synthetase,
3	registration
3	(scid)
3	immunophenotyping
3	albuquerque,
3	junior,
3	impetigo
3	europeans
3	lymphoblastoid
3	sea.
3	(3-30
3	anti-mhc
3	mhc,
3	side-effects
3	behçet's
3	ikbkg
3	nonhematopoietic
3	kindreds
3	engraftment
3	graft-versus-host
3	tratamento
3	circles
3	digeorge
3	(hla)
3	consanguinity,
3	(lasid)
3	abscesses
3	recombination-activating
3	prick
3	lasid
3	sanguinis
3	residency
3	fungal,
3	higm
3	atra-induced
3	hyper-ige
3	(sp).
3	worked
3	cd47
3	expedite
3	picked
3	un-stimulated
3	programme.
3	jiroveci
3	definitions
3	(pbmcs).
3	non-atopic
3	f-apocynin
3	facilities.
3	abscess
3	consistent,
3	male;
3	eda-id
3	affections
3	0.006).
3	rica,
3	panama,
3	capsulated
3	nursery
3	hdm
3	whatever
3	nonfunctional
3	spectrophotometrically.
3	duncan
3	interleukin-5
3	wheezing.
3	scintigraphy
3	efa.
3	penultimate
3	destabilize
3	mon
3	(hplc).
3	igg2a-specific
3	immunomodulator
3	sialotranscriptome
3	unfed
3	pupae
3	(cvc),
3	stimulon
3	antidote
3	plasma-derived
3	consistency
3	frequency:
3	neutralized,
3	60 min
3	revolutionized
3	indications,
3	prevailed.
3	%.
3	b16-f10
3	globally,
3	20-kda
3	(c4bp):
3	(lcpa).
3	(scr20)
3	lcpa.
3	lcpa-vitronectin
3	zn2+-induced
3	arm,
3	eligible
3	pfs
3	display,
3	anti-digoxin
3	exceptionally
3	μg/μl
3	biodegradability,
3	biocompatibility,
3	hemi-humanized
3	scfvs
3	bimab
3	histotype
3	anti‐tn
3	isozymes,
3	jm,
3	immunogen,
3	lps-incubated
3	maeda,
3	jesus
3	cintra,
3	mathias-santos,
3	faquim-mauro,
3	johnston,
3	vitro-generated
3	(ltb)
3	(ediii),
3	non-adjuvanted
3	immunosignature
3	lt-adjuvanted
3	ediii-specific
3	epitope-binding
3	ediii,
3	dc-sign
3	phosphorylcholine
3	mannan,
3	down-modulatory
3	n-glycosylated
3	treated:
3	weakness
3	irrelevant
3	molecular-weight
3	down-modulates
3	il-10-mediated
3	(in)
3	vcam-1,
3	smval4
3	(matrix
3	immunisation,
3	isotype,
3	(bsa),
3	adsorption,
3	ab-mediated
3	pro-type
3	(er-803022)
3	tlr4-,
3	myd88-,
3	trif-,
3	il-12/ifn-γ-deficient
3	hyper-reactivity,
3	th1-affiliated
3	lung-specific
3	il-10-dependent
3	pi-specific
3	ahr.
3	e-asc
3	threshold)
3	subunits:
3	phospolipase
3	bled
3	anti-il-10
3	3.4.24.16
3	receptor-selective
3	fluorescently
3	reintroduced
3	caspase-like
3	dasgupta
3	peptidomes
3	huntington's
3	glutamines
3	(cb1).
3	off-target
3	(pep5-cpp),
3	derivates
3	bortezomib.
3	hemopressins
3	thiol-disulfide
3	atom
3	globins
3	gomes
3	cpefat/fat
3	neuropeptide-metabolizing
3	constitutive,
3	ep24.15,
3	bpp-ap
3	ser,
3	eddnp
3	rhodopsin.
3	insertion,
3	metalloendopeptidases
3	(b2r)
3	(pka).
3	2-copy
3	ep24.16)
3	hemopressin,
3	dpp
3	initiative,
3	(tfu).
3	43.1%
3	59,975
3	432
3	tfus,
3	(ep24.16)
3	m-1
3	almond,
3	coffee.
3	temecula
3	r-r
3	entropy
3	peptidase.
3	hypothesizing
3	brefeldin
3	soluble,
3	metalloenzyme
3	val
3	phenanthroline,
3	φ=
3	peptide-loaded
3	bmdc.
3	β2ar
3	gcn2
3	cc-chemokine
3	(ccr4)
3	function.we
3	allergic,
3	anti-cd25-treated
3	ccr4,
3	amylin,
3	homeobox-1,
3	admsc-based
3	box,
3	il-9,
3	mip-1β,
3	il-21
3	immune-induced
3	latency-associated
3	(lap)
3	abs-75
3	cd3-specific
3	acea
3	2018-ios
3	signaling-3
3	imbalances,
3	(socs3
3	(ms),
3	hallmarks.
3	opcs
3	bcl-2.
3	amyloid-beta
3	culture-attenuated
3	interrogans,
3	improper
3	c3b-like
3	dose-dependent.
3	barbosa.
3	wondered
3	basophils,
3	diguanylate
3	lcd1
3	flaviviridae
3	polyprotein
3	like-1
3	(c4bp).
3	(ba589)
3	pic-producers
3	picba589
3	ba589δpic
3	ba589,
3	(peaf)
3	pilus,
3	ba2103)
3	o26:hnm.
3	fibronectin-associated
3	anti-h11
3	anti-groel
3	leptospire
3	ficolins,
3	ficolin
3	anti-ficolin
3	patoc.
3	fromm.
3	(dh5α
3	hb101).
3	enteroaggregative/shiga
3	(o104:h4)
3	pic.
3	hb101(ppic1)
3	α'
3	flexneri,
3	weil's
3	plasminogen.
3	e-mail:
3	journals.permissions@oup.com.
3	haemolysins.
3	hae-molysins
3	cytolysins
3	fibronec-tin.
3	enterohaemolysins
3	(clya).
3	haemolysins
3	ehlys
3	clya
3	tlyb
3	non-functioning
3	girl
3	tcof1
3	sla
3	gata-6
3	gonadoblastoma
3	46,xy
3	intersexuality
3	sisters.
3	father
3	agenesis
3	mϕs.
3	ectopically
3	agencies
3	by,
3	il-6/stat3
3	c33a
3	siha
3	(sti1),
3	neuritogenesis,
3	neurospheres.
3	sti1-prpc
3	stemness
3	hpv-related
3	tam
3	(fgf2)
3	fgf2,
3	enforced
3	mycer
3	antimitogenic
3	akt/pkb
3	initiation.
3	fgf2.
3	vap-1
3	akt/pkb.
3	µg/kg,
3	consumption;
3	(lipopolysaccharide
3	assists
3	v̇o2
3	brij-based
3	triton-x100
3	cool
3	receptors:
3	intra-abdominal
3	resiniferatoxin
3	aea
3	thermoeffectors
3	nonthermal
3	muscimol.
3	(tnf)-α.
3	thermogradient
3	lps-processing
3	(external
3	(ta),
3	non-tlr4-signaling
3	dlps
3	characteristic,
3	(tb).
3	5-ht2
3	normoxic
3	thermoneutrality
3	agp,
3	pyrogen
3	uncontrolled,
3	(norepinephrine)
3	thermogenesis)
3	hyperventilation.
3	hyperventilation
3	camp-
3	(av3v),
3	intra-po
3	tc,
3	controller
3	biliverdin,
3	(vt)
3	(0.3,
3	endothelial,
3	co-heme
3	4100
3	coagulopathy,
3	microvasculature.
3	hyperbaric
3	observational
3	marinho
3	ip.
3	ies
3	berghei.
3	(ifn-γ
3	vk247
3	(104)
3	(≤
3	growth-inhibiting
3	sinasc
3	elizabeth
3	f4/80+and
3	homologs,
3	(pam)
3	amenable
3	recrudescence,
3	recrudescent
3	everolimus,
3	sunitinib
3	bub1b,
3	embryological
3	(f/r)
3	f/r
3	glomerulosa.
3	adenomas.
3	fosb
3	monophosphate,
3	bfgf,
3	base-pair
3	3′utr.
3	o3
3	trophicity.
3	s100a8.
3	(th)-prompted
3	(nf-қb),
3	s100a8/myd88/nf-қb
3	nf-қb.
3	messages:
3	cardiomyocytes.s100a8
3	t3.s100a8
3	t3.nf-қb
3	post-injury.
3	myomesin
3	embryonic-heart
3	myomesin,
3	reestablish
3	overactivation.
3	(patients
3	disuse
3	mass)
3	(wnt1:
3	0.0001
3	lef1:
3	na+/k
3	bowman's
3	calcineurin/nfat
3	(mtor),
3	post-test
3	mechanogrowth
3	flst
3	soreness,
3	1-rm,
3	cortisol,
3	res),
3	(pre)
3	(24,
3	(i,
3	inducer)
3	nfatc1
3	s6k1
3	ligand-dependent
3	minimizes
3	(race)
3	tube.
3	t4.
3	5'-dii
3	ne,
3	transporter)
3	sbpcysuwa
3	(sbp),
3	periplasmic-binding
3	sbp,
3	sulfoxide.
3	orthologues.
3	(pst),
3	(rpsts)
3	a-secreting
3	s. mutans.
3	ng8
3	transcripted
3	proteorhodopsin
3	periplasm
3	conserves
3	porin
3	xa
3	sulphur-containing
3	organosulfur
3	sulphur.
3	(ssuedacb)
3	desulphurisation
3	alkanesulphonate-binding
3	ssuc
3	ssub,
3	mops,
3	hepes,
3	unravels
3	phytopathogen.
3	tófoli
3	molybdate-binding
3	(moda)
3	coinhibitory
3	relevantly,
3	[nzbxnzw]f
3	352-371,
3	409a+leader
3	pep+wt
3	352-371
3	hsp60.
3	k213e,
3	hyper-variable
3	(hvr)
3	insoluble.
3	cassette-type
3	(oppa),
3	(oppabcdf)
3	agalactiae.
3	anti-oppa-specific
3	oppb
3	aminopterin,
3	(opp)
3	ss320
3	tetra-peptides
3	tetrapeptides.
3	modabc
3	campestris)
3	apoprotein.
3	orthorhombic
3	maltodextrins
3	sequence)
3	ortholog.
3	protein-dependent
3	(oppa,
3	oppb,
3	oppc,
3	oppd/f),
3	33.8-kbp
3	roseofulvus
3	oppd/f
3	nonfunctional,
3	placei,
3	placei
3	120,000
3	oxidase)
3	crosslinked
3	a′
3	hyperinflammation
3	rossoni
3	lopes.
3	fluorescence),
3	(p-erk
3	azurophilic
3	ct.
3	peroxynitrite.
3	o2/·-
3	p47(phox),
3	ossification
3	aln
3	npfb,
3	[water]
3	constants,
3	dampening
3	branco,
3	over-activation
3	inflammasome-dependent
3	nlrc4/caspase-1
3	flagellin:
3	parp1
3	artd1)
3	constricted
3	chromosome,
3	phospholipase,
3	hemolysin,
3	bcl-x
3	facilitating,
3	mosquito-bite
3	(concentrations
3	(cd4§ssup§+§esup§
3	bim.
3	caspase-3-
3	caspase-8-dependent
3	cell-lymphocyte
3	bizzarro
3	sub-acute
3	biflavonoid
3	agasthisflavone.
3	3h]-thymidine
3	2.4μg/ml
3	(4.45μm).
3	agathisflavone.
3	ezh2
3	knocking
3	programme,
3	conclusion-
3	v617f
3	c-flip
3	domain)
3	(tlr)-activated
3	(aicd).
3	apcs,
3	tlr4/myd88.
3	apc-derived
3	aicd
3	ep4,
3	ep4
3	aicd.
3	tlr4/myd88-dependent
3	cd95-mediated
3	bcl-xl.
3	anoikis.
3	afmk.
3	caspases-9
3	caspase-6
3	tyrosine-kinase
3	chromosome-positive
3	bcr-abl,
3	hl-60.bcr-abl
3	dexamethasone-induced
3	[2].
3	(tgf-β),
3	etoposide,
3	bcl-x(l)
3	preapoptotic
3	(aml)
3	hl-60/bcr-abl
3	oncogenesis.
3	caspase-mediated
3	cytoplasts
3	cpp32,
3	gp23/45
3	microbiota-derived
3	caspase-7
3	(q)
3	user
3	complexity.
3	organogenesis,
3	perturbed
3	survival-promoting
3	escaping
3	alarmins.
3	myeloma.
3	conduit
3	transgenesis
3	plasmidial
3	interleukin-1α
3	(tlrs),
3	taf15
3	position-dependent
3	morphometrically.
3	nonapoptotic
3	caspase-1,
3	(adp-ribose)
3	butyrolactone
3	(il-1),
3	pg/ml),
3	reagents,
3	α-alkynylation
3	iodine(iii)-mediated
3	alkenes
3	benzoyl
3	94%
3	(htib
3	vinyl
3	cepacia,
3	alcohols,
3	indanes,
3	silyl
3	rendimento.
3	symmetric
3	endocyclic
3	disproportionation
3	1,2-dihydronaphthalene
3	presented)
3	ch3cn,
3	(xrd)
3	iodobenzene
3	clay
3	resection.
3	preoperatively
3	resection,
3	benefited
3	laparoscopy.
3	iris
3	clinicopathologic
3	(p-gp)
3	nanometric
3	incisional
3	isopropyl
3	mepg
3	irritation.
3	lopes
3	corneum.
3	manuscript,
3	(across
3	me-w
3	phytosphingosine
3	me-wphy
3	w/w/w)
3	(w/w),
3	ranked
3	conductivity,
3	[e
3	d]
3	naltrexone
3	moderate-to-severe
3	irritant)
3	cell-permeant
3	hspb6
3	mg-containing
3	pgt
3	polysorbate
3	me-hi
3	ctgf
3	lbm
3	non-covalently
3	pki-gfp
3	asm,
3	mo-based
3	(olive
3	(cysa)
3	though,
3	non-liposomal
3	p20,
3	fails.
3	polyhydroxyalkanoate
3	medium-chain-length
3	tests:
3	engineers
3	shake
3	dma
3	nd,
3	(p3hb)
3	device,
3	glycerol.
3	assumption,
3	drill
3	ft,
3	p3hb-co-3hhx
3	3hhx.
3	lfm828,
3	hexoses
3	biodegradability
3	namely:
3	ccpa
3	acnm
3	deleted.
3	3hv/prp
3	g·g
3	production:
3	lyase.
3	whitening
3	-based
3	mg/kg/day).
3	ut.
3	(pbmt)
3	animals’
3	(muscle
3	3 j
3	(107.1 j/cm
3	agudelo,
3	amano,
3	cenedeze,
3	camara.
3	cd90,
3	mariana
3	(≥100
3	lps-treated
3	increase)
3	p.o.)
3	(trpa1)
3	h2s,
3	(tac)
3	(gapdh)
3	spectrophotometry.
3	infltration
3	µg
3	c-fibres
3	lipopolysaccharide-
3	mip-1β
3	m-csf
3	myeloperoxidase.
3	hippocampus-dependent
3	et/hcl
3	malonaldehyde
3	(ckd).
3	(uuo)
3	(tmj),
3	rheumatology.
3	inos-knockout
3	cdt,
3	als
3	neuro-immune
3	thrombocytopenia.
3	rve1.
3	(et),
3	nectandra
3	falcifolia
3	laser-irradiated
3	fk-506
3	(eae),
3	jia,
3	post-ischaemic
3	aspirin,
3	ischaemia-reperfusion
3	ncx-701,
3	apap,
3	adherence.
3	scavenge
3	(ifn)-α
3	no-mesalamine
3	lname
3	provocation
3	mast‐cell
3	ipec
3	(eca)
3	usage.
3	grp78,
3	gated
3	compromised.
3	endotoxaemia
3	cpg-odn
3	ifng,
3	'intensive'
3	regimes.
3	veterinarian
3	behaving
3	messages
3	hypogammaglobulinemia.
3	(interferon
3	il-12-
3	(gko)
3	eiu
3	anchors
3	trypomastigote-derived
3	hydrophobic-interaction
3	viremic
3	(denv-4)
3	janeiro
3	guarujá
3	introductions
3	historic
3	re-emerging
3	ecsa
3	tropism,
3	(ns5)
3	(jha1).
3	arthralgia
3	alphabaculovirus
3	286
3	non-adjacent
3	discordance
3	mauritania
3	odv
3	bv
3	virion.
3	(orfs).
3	maximizing
3	grn
3	germany
3	crf29-bf,
3	curitiba
3	localities.
3	integrase
3	arboviral
3	agricultural,
3	sigmodontinae
3	dated
3	superimposition
3	sfmnpv-19
3	exigua
3	agb3
3	emagb
3	env
3	polyhedra
3	fumiferana
3	mnpv
3	drug-naive
3	orfs,
3	flaviviruses,
3	ecdysteroid
3	(orf)
3	cospeciation
3	reconstructing
3	codons,
3	hemophiliac
3	parsimony,
3	particle.
3	dione
3	tick-
3	3'-untranslated
3	334
3	billions
3	improved.
3	facility,
3	underway
3	operationally
3	setup
3	cm3
3	copulation
3	institutional
3	(>80%)
3	ae. aegypti
3	post-release
3	-terminal
3	cayman
3	sit
3	(f3)
3	supplies,
3	vector-host
3	aael001919
3	ptp
3	aquasalis.
3	t-boc
3	aii,
3	brackish
3	darlingi.
3	two-domain
3	eggshell.
3	n-terminus,
3	updates
3	mosqguide
3	(df),
3	(dhf)
3	fitness,
3	kazal-type
3	kazal
3	raati
3	(decs)
3	transcribes
3	iquitos
3	hex-l
3	hexamerin,
3	g/ml.
3	housefly
3	intrathecally
3	hindpaw;
3	pod2.
3	(dor)
3	(mor),
3	(kor)
3	system.results:
3	orally;
3	0.0006
3	naltrindole,
3	norbinaltorphimine,
3	1h-(1,2,4)
3	oxadiazolo[4,3-a]quinoxaline-1-one,
3	crotalphine.
3	(0.2-5 μg/kg)
3	(400-1600 μg/kg)
3	(1 μg/paw)
3	(200 mg/kg,
3	p.o.),
3	surpasses
3	(sin)
3	extraterritorial
3	zymosan-induced
3	prevails
3	il10,
3	cxcl5
3	(mcp-1),
3	hsp60,
3	il-4-secreting
3	'low'
3	566-m
3	microbeads,
3	chronicity
3	γb
3	intercrossing
3	opening.
3	mta2,
3	pet130
3	rpm2
3	fmt1
3	respiratory-deficient
3	pentatricopeptide
3	diversion
3	neurospora
3	aep3
3	incorporating
3	recoded
3	multi
3	msc6
3	v111
3	s114
3	glutamyl-trna
3	pet112p
3	gatfab
3	respiratory-chain
3	dihydrolipoyl
3	respiration.
3	coq8p
3	raffinose
3	lactis
3	atp25p
3	292
3	cox24p
3	q6
3	cox17p
3	cox15p,
3	reductase.
3	yah1
3	cox15
3	yah1p
3	adrenodoxin
3	jnk-dependent
3	mirna-22
3	(mir-22)
3	mechanohormornal
3	1-7,
3	signature.
3	mct1,
3	(t4,
3	bw/day,
3	mir-208a
3	(10,
3	post-mi,
3	maladaptative
3	(reduced
3	ecto-5'-nucleotidase
3	newer,
3	(losartan,
3	(70%,
3	ectonucleotidases,
3	e-npp
3	(hw),
3	hw,
3	rvw/bw
3	lvw/bw
3	30 min.
3	(0.025
3	weight/day
3	nociception,
3	(fd)
3	60-day-old
3	hw/bw
3	oc).
3	hw
3	uncompetitive
3	ferritin-like
3	fusions,
3	indirect.
3	iron-using
3	cobalt,
3	cspb,
3	catalase-peroxidase
3	54-dependent
3	csds.
3	pilin
3	σe
3	ecf
3	transposome
3	ppid
3	acidic,
3	pxf51
3	identifiable
3	license.
3	oscillators
3	osteometric
3	0.015).
3	supraoptic,
3	(cts)
3	undefined
3	education,
3	soy-diet
3	clin
3	vague
3	symptoms;
3	midbrain,
3	clomipramine
3	fluoxetine,
3	food'
3	non-transformed
3	tgf
3	mp-/-
3	re-expression
3	ccaat/enhancer
3	stat5b,
3	dishes
3	pcd.
3	stat5b.
3	dip
3	mist1
3	hyperplasia,
3	eca.
3	reprogram
3	skp2
3	tgf-β-mediated
3	cbg
3	neoplasias.
3	p27.
3	men1
3	18-day-old
3	(cyclin
3	fifteen-day-old
3	17days,
3	40-day-old
3	enteroendocrine
3	smad2p
3	stercoralis
3	leibovitz
3	l15
3	ki-67
3	erα,
3	proliferates
3	smads,
3	corticoids
3	corticosterone;
3	(n).
3	chow,
3	tc22
3	tcd4
3	brasileiros
3	allergies
3	aim2
3	cd56bright
3	tlr8
3	irradiated,
3	polyfunctionality
3	tlr9.
3	tnf-,
3	monofunctional
3	(simultaneous
3	eus
3	etiology.
3	herv
3	interferon-inducible
3	claudin
3	17a
3	hiv-exposed
3	p55gag
3	lamp
3	dp.
3	(un)
3	cesarean
3	suture,
3	(euthanasia
3	procedure),
3	rhinitis,
3	point),
3	t1ad
3	ia-2a
3	lysosome-associated
3	(ciu).
3	basophil
3	asst
3	siga
3	(ctl)
3	immunizations,
3	igad
3	peptide-specific
3	(tt)
3	cd203c
3	excreting
3	keyhole
3	limpet
3	anti-pc
3	downmodulate
3	bt-immunized
3	0.016)
3	polyreactive
3	anti-d
3	preexposure
3	f(ab′)2
3	antigenemia.
3	b/w
3	pbag
3	anti‐mouse
3	subpopulation.
3	immunopathogenesis
3	munhoz,
3	abe,
3	fima,
3	pils,
3	papa,
3	fems
3	strain-to-strain
3	rocha,
3	broad-range
3	acquiring,
3	acquired,
3	definitions,
3	o157
3	reliability,
3	lt-,
3	luz
3	antibodies;
3	anti-pet
3	scfv-intimin
3	(ehec).
3	3e2
3	2e11
3	lecitinase
3	accumulations
3	anti-int
3	275
3	492
3	intimin-conserved
3	1·3
3	eae-positive
3	(lal)
3	lal
3	o48:h7,
3	antibiotic.
3	salmonella,
3	disintegrins
3	manifestations:
3	laeta.
3	depends,
3	inoculated.
3	gal
3	72-68
3	occasion,
3	cocaine's
3	otr
3	underlining
3	mesocorticolimbic
3	camarini.
3	three-bottle
3	(bla).
3	ee24h
3	ee3h
3	glun2b
3	μ,
3	κ,
3	(es
3	quinine-adulteration
3	pcreb
3	alcoholism.
3	ad),
3	(water,
3	mice),
3	drinkers,
3	toxicology.
3	g/kg).
3	alcohol's
3	pp-2
3	α2/3-na,k-atpase,
3	surmount
3	gmp-pkg-pp-1
3	(glu)
3	(b6)
3	self-administration,
3	nr2b
3	nmdar
3	nr2b-containing
3	crf-deficient
3	paired-pulse
3	rsa
3	gyrus,
3	(achase)
3	fenfluramine
3	phytopathogenic,
3	neto,
3	sp38,
3	co-evolution
3	pursued.
3	mfohr
3	merostachys
3	bambuseae
3	basidiomycete
3	polyimmunity
3	organizational
3	cargo
3	hedgehog
3	nad-utilizing
3	adaptations,
3	innovations
3	gαs
3	xanthomonas.
3	iron-dependent
3	impetus
3	citrus.
3	cancer/testis
3	asrt
3	divisome.
3	diviva.
3	amin
3	mitral
3	valve
3	functionality,
3	forty-seven
3	lps-control
3	0,05).
3	supplementation;
3	absenteeism
3	thiourea
3	active-site
3	state-sensitive
3	opioid-like
3	d-phe-cys-tyr-d-trp-orn-thr-pen-thr
3	isquiatic
3	u50-488h
3	honeybee
3	protonectarina-mp-oh
3	melittin,
3	crystallized.
3	cd-146
3	cana2edta
3	seric
3	(evs)
3	cargo,
3	adamts-1,
3	neddylation
3	acp02
3	acp03
3	disease-modifying
3	hpf
3	gelatinases
3	apelin
3	wd-pr.
3	l-dopa-induced
3	culminated
3	aha
3	fluorometry
3	impulsive
3	5-ht1b
3	diphenhydramine
3	allergies,
3	breviscapa
3	micro-
3	oxysporum.
3	productions
3	a23
3	imazapyr
3	sr1.6/6.
3	pink-pigmented
3	2008),
3	cfu/ml)
3	acridum
3	(0.4%),
3	phou).
3	mxaf
3	33.1::pnkgfp
3	endochitinase
3	reads.
3	extorquens,
3	(cvc).
3	ar1.6/2
3	aregla
3	diaporthe
3	phaseolorum,
3	mangiferae,
3	phanerochaete
3	mangiferae
3	spot.
3	conidiogenesis
3	sd1
3	conidia/ml
3	(ardra)
3	non-transgenic
3	fusarium,
3	greenhouses
3	acyl-homoserine
3	erwinia/pantoea
3	(4%),
3	promotion,
3	(gfp).
3	pauca,
3	korea.
3	tangerine
3	aflp,
3	capacity),
3	sublineolum
3	cvc-asymptomatic
3	heterokaryons
3	occurrence.
3	cvc.
3	clevelandii
3	analyzer
3	egla
3	stems,
3	pr2/7
3	boiling
3	dbt
3	dszc
3	sepsis-related
3	kl/+
3	α2,3-nka
3	creb.
3	levels.conclusions:
3	α-klotho,
3	mi-t,
3	(wt
3	degaspari
3	milliplexmap
3	aversive-related
3	(nx-ci)
3	(nx-m
3	n=12
3	n=20
3	nx-groups
3	nx-m
3	nx-induced
3	(85%)
3	(p65),
3	hyperactivation
3	nih/3t3-lxsn
3	0.031),
3	renagel®
3	uraemia
3	adenine-induced
3	4-,
3	wnt-3a
3	co-factors
3	anti-and
3	kinase),
3	sapk/jnk,
3	(124%
3	125%)
3	(231%
3	nuclear-to-cytoplasmatic
3	(51%);
3	rigs
3	damage:
3	(iso,
3	gcs.
3	cage.
3	α1,
3	anti-tnf-α,
3	nac,
3	nos.
3	j774-g8
3	anti-tgf-β
3	autoreceptors
3	g/day)
3	(losartan)
3	3ace
3	stage),
3	cd68+,
3	ketogenic
3	co<inf>2</inf>
3	(2×107)
3	(40.7
3	vaspin,
3	16:0
3	wk;
3	ppar-gamma
3	ap2-b1/b1-/-
3	(t).
3	preadipocytes
3	olanzapine
3	reduced/oxidized
3	shortening,
3	vomiting
3	mediastinal
3	lymphoma.
3	perilipin,
3	liposuction.
3	harvest,
3	<.001).
3	insulin’s
3	tissue)
3	ocular,
3	exacerbations.
3	belisa
3	non-protective
3	7-aad
3	negative”
3	wheat.
3	sorghinum,
3	90%.
3	retail
3	ag/ag2o
3	industrial-scale
3	(s1)
3	maize.
3	fujikuroi
3	f. verticillioides
3	harvest.
3	nigri
3	(fb
3	dmat
3	cpa.
3	andrade,
3	yg
3	salvadori
3	lixii
3	acceptable.
3	pseudo-second-order
3	(aflatoxins
3	afs
3	husk
3	husks
3	weevils
3	kernels)
3	13.8%
3	96-h
3	malt
3	afb2
3	γ-radiation
3	agar)
3	afb1/(kg
3	penicillium,
3	fb1/
3	quail.
3	waste.
3	thapsinum
3	sorghum,
3	reservoir,
3	15.3
3	afb1/kg,
3	1/kg.
3	(fluorescein
3	proliferatum
3	necropsies
3	g-1).
3	bonito
3	100-μg
3	adversely
3	fb1/100g
3	1-year
3	0.86
3	ng/g,
3	lpf
3	hfdg-fed
3	hfde-fed
3	schistosomes
3	immunodiffusion,
3	1277c
3	(p-value
3	dysfunctions.
3	yr)
3	pathway-dependent
3	alpha-2-macroglobulin
3	pre-immunized
3	α2-macroglobulin
3	thioester-bond
3	colostrum.
3	a2m
3	stat-1,
3	ip-10,
3	fadd,
3	ip-10
3	cytokines/chemokines
3	benefits.
3	cancer-cachexia
3	lipc
3	biguanide
3	(ctrl)
3	mtp,
3	satiety,
3	impede
3	waist
3	wc
3	17),
3	ml/kg,
3	cr)
3	retroperitoneal,
3	scat
3	nonalcoholic
3	ii-iii
3	(hfd)-induced
3	concomitance
3	tumor-host
3	(cis-ex)
3	hdl-c
3	weight-loss
3	15-19
3	records.
3	cancer-induced
3	nfκbp65
3	pad,
3	e6.
3	rpat,
3	fatty-acid-binding
3	(l-fabp)
3	(cla)
3	(tr),
3	7;
3	0.049)
3	"repeated
3	effect",
3	advisable,
3	therapeutic,
3	"non-damaging"
3	forces,
3	"low-grade"
3	diminished/avoided,
3	"less
3	demanding"
3	β-trcp,
3	resistance-trained
3	week).
3	β-trcp
3	(skp
3	ligases),
3	(tg),
3	cholesterol)
3	bouts.
3	50%-1
3	75%-1
3	(triglycerides,
3	hdl-cholesterol,
3	0.006)
3	m/min)
3	exhaustion).
3	(41.64
3	61.19%,
3	4ebp-1,
3	eif2bε
3	(regulators
3	initiation)
3	modified.
3	wr1339
3	metabolism)
3	(chf)
3	belief
3	(33%),
3	utilisation
3	(kc),
3	opposition
3	v/w)
3	resistome
3	measure(s):
3	result(s):
3	conclusion(s):
3	sounds
3	21.5%,
3	mucus,
3	(mlst).
3	spa
3	pvl
3	homeless
3	se-aflp
3	hyorhinis,
3	gallisepticum
3	120,
3	(hemoplasmas)
3	547
3	circumscription
3	hypochlorite,
3	sp4
3	bulls
3	vesiculitis,
3	limit,
3	(cpcr).
3	cpcr.
3	salivarium
3	conjunctiva,
3	laidlawii.
3	engine
3	742,431
3	hypoxanthine,
3	yagouaroundi;
3	banks.
3	mycoplasmas,
3	sows.
3	binacional
3	orale
3	inoculum,
3	glass.
3	ribotype
3	chimpanzees
3	cysteine.
3	0.1%;
3	antivenin
3	(od)
3	ma-fel
3	sb-fel
3	il.
3	false-negative
3	tourism
3	employees
3	artesunate
3	trimethoprim
3	mombin
3	(ci):
3	p=0.019)
3	squamosa
3	muricata
3	avidity,
3	rib
3	ft
3	bthx-1
3	preservation.
3	rrop2
3	one-round
3	af146527
3	hhv-8
3	aids-ks
3	haart
3	s100+
3	scores.
3	cd20+
3	dyes
3	sdf-1β
3	degree.
3	cheese.
3	(cf)
3	detoxify
3	≤100
3	precipitation,
3	seronegativity
3	anhydride
3	translating
3	(fret)
3	kn-62
3	ip5i
3	posaconazole
3	yoyo-1
3	n-acetyl-serotonin
3	plc
3	[ca2+]c
3	protoporphyrin
3	vacuole.
3	insp3r2
3	treats
3	dove
3	u73122,
3	rack1
3	topologies
3	u73122
3	purines,
3	fluo-3,
3	ghosts
3	pc2500
3	limulus
3	chapeco
3	tregcell
3	tregcells
3	blindness.
3	pv1
3	eye-infiltrating
3	pv1-treated
3	fibroblastic
3	gfas1
3	gfed3
3	constrain
3	vapours
3	tower
3	canopy
3	factorization
3	long-range
3	no-indomethacin
3	physicians'
3	m-3.
3	plume
3	between-group
3	gpi-anchored
3	boc2
3	t-reg
3	(lpr)
3	alessandra
3	allografts.
3	acceptance.
3	phenotyping
3	(flow
3	emissions,
3	(<1
3	zoster
3	morbidly
3	transformations,
3	cloud-forming
3	(log-rank
3	0.0028).
3	eddy
3	covariance
3	(th17)
3	dealt
3	0.03)
3	lymphomas
3	(balb/c
3	donor-derived
3	(1:1)
3	undiluted
3	factor);
3	4);
3	lpr.
3	hsv/vzv
3	rgal-1
3	(bl)
3	(ft)
3	microchimerism
3	conjunctiva
3	cardiomyopathy,
3	ragweed
3	subretinal
3	cyclosporine,
3	disease-enhancing
3	irbp,
3	institute.
3	th1-dominant
3	low),
3	anti-igd
3	gε
3	(irbp).
3	(presumed
3	histocompatible
3	unprimed
3	zoonoses
3	komegae
3	lagoon
3	down-modulated
3	mmp-9.
3	porichthys
3	conclusive
3	beings
3	b2)
3	egress
3	peritoneum,
3	natterins,
3	accident
3	(kks)
3	kininogenase
3	amphibium
3	nattereri.
3	(niquim)
3	niquim
3	anti-hemorrhagic
3	pusa
3	(pnor
3	pnor
3	cissus
3	sicyoides
3	lethal,
3	defibrinating
3	t. nattereri
3	(1.4%),
3	kininogenases
3	nattereri,
3	pro-coagulant
3	pinheiro
3	(jak2)
3	60 min.
3	bibo3304
3	nmol/kg,
3	nerves,
3	somatomammotropin
3	c57bl6j
3	kir6.2
3	α-cell
3	martins.
3	distinctively
3	ip6k1
3	anxa1.
3	io
3	lactated
3	bauhinia
3	bauhinioides
3	kunitz
3	iapp
3	i-κb
3	rl.
3	coagulopathies
3	demonstrates,
3	pyrimidines
3	(tca)
3	o6
3	(80%),
3	b1)
3	antigen;
3	o55:h7
3	eighty-one
3	adherence-like
3	α-hlycabd
3	chromosomally
3	transposon-like
3	efa,
3	resistances,
3	csga,
3	(apec)
3	rep-pcr
3	microcolony
3	(strains
3	irp2
3	shf.
3	adhesion-related
3	(13%)
3	heterogenous
3	enteroinvasive
3	myocarditis,
3	f18ac
3	k99,
3	cytotoxins,
3	maximum-security
3	piglet
3	40.7
3	(page)
3	agid
3	gm1,
3	less-equipped
3	adsorption.
3	daltons
3	lt,
3	08
3	mrmh
3	gut/carcass
3	enterocolitica
3	pf-like
3	strains).
3	(vk210,
3	bargieri,
3	(csp),
3	tko
3	(analysis
3	cd107a+
3	ifnγ+
3	world-threatening
3	binding-like
3	ama1,
3	m2.
3	maebl-m2
3	rokaryotic
3	igg2c
3	anti-maebl
3	ym
3	strain)-infected
3	(ie),
3	hydroxyurea.
3	monophosphoryl
3	(nh36)
3	pss1
3	anti-csp
3	(heterologous
3	ad-asp2
3	msp-3β
3	bitencourt
3	hla-drb1*04
3	fml
3	cruzi-elicited
3	cd8+pfn+
3	(b,
3	tc1)
3	his6-tagged
3	ni-agarose
3	(vk210)
3	protein-specific
3	(plasmid
3	riddles
3	depicted,
3	carriers/adjuvants.
3	carrier/adjuvant
3	daniel
3	bargieri
3	nhs
3	cytoadherence)
3	(pv-ies)
3	cryosections.
3	cytoadhere
3	pv-ie
3	(vir),
3	pv-ie-endothelial
3	sialylation
3	sialylation,
3	(flic).
3	tlr5-binding
3	quil-a,
3	immunising
3	tlr9-/-
3	tlr4-driven
3	b10).
3	complete/incomplete
3	qs21
3	survival)
3	generating,
3	anti-gitr
3	(dta-1)
3	(tlr5)
3	flic,
3	linked,
3	flic.
3	ags.
3	(flicd,
3	fljb)
3	ovalbumin-derived
3	cell-restricted
3	(ova257-264).
3	peptide-pulsed
3	prophylatic
3	coverage,
3	hexa-histidine
3	(his6msp119).
3	(his6msp119-padre).
3	c57bl/
3	his6msp119-padre
3	tc52
3	radasp2
3	radts
3	interferon-γ-producing
3	benznidazole-treated
3	merits
3	re-stimulated
3	89.9%
3	rpvmsp119-padre
3	trypomastigote,
3	sialylated
3	682
3	44.4%
3	b:4:p1.15
3	pora
3	anti-sporozoite
3	yoelll
3	yahr
3	values:
3	decline,
3	suicidal
3	non-consecutive
3	moca
3	bfr-i
3	(n=30)
3	p<.05).
3	systolic/diastolic
3	p<0·05,
3	on-medication
3	pre-to
3	soares,
3	(it)
3	11),
3	msa.
3	endurance,
3	upper-body
3	v̇o2max),
3	24%)
3	pil-10r
3	pgde7h
3	toxin;
3	electroporation.
3	anti-colonization
3	mutans.
3	her2/neu
3	e75
3	hla-a2
3	technology.
3	e6e7
3	(cfs)
3	interleukin-12p40
3	vaccinations
3	lt-iic,
3	lt-i,
3	c600
3	surface-localized
3	switching.
3	cs21-expressing
3	cd8(+)
3	detoxified
3	gran-ulomatous
3	thermo-dimorphic
3	+and
3	(qtliaihtlairyan),
3	[aluminum
3	(dodab)]
3	reduc-tions
3	infec-tion.
3	dodab.
3	pep-tide
3	mayorga,
3	lincopan,
3	carboxyfluorescein
3	beings,
3	primer-booster
3	cfa/i-expressing
3	flagellin-
3	ev
3	pbp2
3	43,000
3	pbpb
3	(tif)
3	integron
3	carbapenemase-producing
3	nextseq
3	kpc-kp
3	pmrb
3	(mmt)
3	screw
3	miseq
3	incn
3	genes),
3	4.0%
3	(esbl)
3	exchanged
3	nanoclay
3	compatibilizer
3	a027ind
3	beta-lactamase
3	oxa-type
3	blaoxa-23
3	oxa-producing
3	mara
3	wwtps
3	s1-pfge
3	mscramm
3	(cps)
3	providencia
3	bla<inf>ctx-m</inf>
3	(72%),
3	blashv
3	blages-7
3	homodisperse
3	1.75
3	dodab/amb
3	uv-visible
3	pmma
3	stiff
3	(amb),
3	th-2
3	tt-specific
3	(elps)
3	ova-model
3	(bt).
3	(uplps)
3	ifn-γdeficient
3	(pamcsk4)
3	pamcsk4
3	barboza
3	lipid-binding
3	(inkt)
3	cell-deficient
3	ber/lipid
3	unanticipated
3	60-65
3	cpg-oligodeoxynucleotides
3	presensitized
3	cissampelos
3	baf;
3	rbcg-s1pt
3	sucrose.
3	palatability
3	aps,
3	(200 mg/kg)
3	22.
3	(ahr),
3	normo-
3	unseparated
3	ptcs
3	demethylating
3	xenografts.
3	leukemia,
3	ret/ptc1
3	kimura.
3	atc
3	notch-1
3	smad4,
3	autoregulation.
3	adenoma,
3	g12v
3	explained,
3	(smad
3	aro
3	(ac=
3	aa=
3	ftc
3	pax8-ppargamma
3	rtsh
3	types:
3	policy,
3	nodules.
3	βa
3	hematopoiesis
3	megakaryocytes.
3	presurgical
3	goiters,
3	adenomatous
3	prazosin,
3	coccidiosis,
3	eimeria,
3	acervulina,
3	repository
3	egene
3	cascading
3	sub-complex
3	sbds
3	pyrococcus
3	abyssi
3	ruibpcl
3	subpial
3	low-toxicity
3	arsenic
3	message:
3	ibp.
3	facets
3	ki67,
3	ibuprofen,
3	n-6,
3	n-3,
3	monosaccharides
3	carbon-7
3	hyaluronidase,
3	kn-ba
3	ophthalmia
3	non-spitting
3	bothrops,
3	corneas
3	nigricollis
3	angolan
3	aejm
3	(treatment
3	bev,
3	lox-c3
3	[des-arg1]-proctolin.
3	mmp7
3	tetracyclines
3	pedroso
3	pararama,
3	nasicornis,
3	loxosceles.
3	ulceration.
3	substituting
3	lagochilascariosis
3	c4.
3	arachnids
3	corynebacterium
3	(pld)
3	deimatic
3	lmv
3	decay-accelerating
3	glycophorins.
3	c-dependent
3	melanoleuca
3	m-csf,
3	astringent
3	(hap-1)
3	(il8)
3	hap-2
3	(cal),
3	mayer.
3	wearers.
3	wearers
3	agt/ttc
3	pt,
3	parvimonas
3	sha
3	vaginal,
3	trap+
3	cement
3	light-emitting
3	p.gingivalis
3	macrorestriction
3	cdt-
3	hbd-3
3	cal
3	il4+
3	burs
3	microleakage
3	sputigena
3	n=30)
3	lagp.
3	arcb
3	sucrose-rich
3	hardness
3	glucan
3	wig
3	sanguis
3	sub-mic
3	“trans”
3	rhag
3	(δphs)
3	subtracting
3	aqp5,
3	aqp6
3	(∞)
3	aqp1.
3	s(co
3	{\text{nh}}-{
3	incoming
3	na+-driven
3	cl-hco3
3	(psts,
3	cl64,855
3	conserve
3	(ghr)
3	mc4r.
3	area-specific
3	(sf-1)
3	g129r-hprl
3	(mhb)
3	(lhb).
3	(bla)
3	most,
3	hyperphagia,
3	(dr),
3	(suppressors
3	phosphatases)
3	(lepr),
3	ovariectomy)
3	leptin-resistance
3	phox2b-cre
3	kyt
3	hypothalamus-pituitary-gonad
3	infertile.
3	hypogonadism.
3	kiss1-cre
3	β-galactosidase.
3	fasted,
3	wc-aa
3	pf-con
3	wc-con
3	ain-93m
3	failures,
3	sges
3	nigrimanum
3	aptamers,
3	5′amp
3	anst-d7l1
3	sialostatin
3	il-5-dependent
3	cystatin
3	cin3
3	papillomaviruses
3	polyomaviruses
3	mmp-9/reck
3	cd147
3	pro-mmp-2
3	alui,
3	g-banded
3	chemosensitivity,
3	(mmp9)
3	rvlm,
3	rvlm/c1
3	/tyrosine
3	fos-activated
3	cont
3	anaesthetic-free
3	high-sucrose
3	(chf).
3	cx3cr1,
3	ssna.
3	(20.
3	nmol/1.
3	commnts-lesioned
3	nmol:
3	dehydration.
3	pre-collicular
3	contractility,
3	dp/dt.
3	son.
3	(133
3	trans-acpd
3	apnoea
3	eaa
3	trans-1-amino-1,3-cyclopentanediocarboxylic
3	(ap-5;
3	antidromically
3	ml/120
3	μeq/120
3	mir-103-3p
3	drug-metabolizing
3	rs1045642
3	232:
3	co/d
3	psgl-1,
3	p=0.001).
3	cyp3a5*1d
3	rs693
3	hypercholesterolemia.
3	caco-2,
3	c.726
3	pharmacogenetics
3	interindividual
3	fog
3	161t
3	pro12ala
3	ppar-γ2
3	ala12
3	cell-autonomous
3	arg-1,
3	naip/nlrc4
3	mycelium
3	week-1)
3	phe-contraction
3	dhea,
3	cu/zn-sod,
3	mmol)
3	day-
3	k+-atpase.
3	2+atpase
3	ir/ptp1b
3	ship2
3	gh:g120k-peg
3	shp2
3	jak2/shp2
3	85%.
3	shc.
3	phncde
3	ppgpp.
3	tetraphosphate
3	lrt9.
3	lrt9
3	pho-box
3	pho-constitutive
3	phoa,
3	phoa
3	perabc
3	mc4100tf
3	pstb
3	mc4100
3	phob
3	non-destructive
3	hepatocarcinogenic
3	gst.
3	tlr1
3	tlr6
3	frα
3	remodelling,
3	surfin4.1
3	brasilianum,
3	cruzii
3	(x2df=1
3	eba175
3	schizogony.
3	dd24
3	azevedo
3	gp27
3	(ucp1)
3	nucleosome
3	rosiglitazone,
3	mtorc1-dependent
3	metabolomics
3	vf,
3	cambuci
3	hfhs
3	fat-1
3	(11β-hsd1)
3	c]
3	dinb(oc)
3	sham-dtms
3	cb1r
3	mjtx-i
3	photobiostimulation
3	optc
3	optb
3	37a
3	metalloprotease.
3	tepec.
3	lee5
3	lee4
3	hlya
3	participate.
3	pyelonephritis
3	espd,
3	espf
3	tif
3	aafa,
3	mi;
3	ldl-knockout
3	brs,
3	brs
3	pressure:
3	(mi
3	(222
3	proteostasis
3	infarction-induced
3	sham-treated
3	ipsc
3	mitophagy.
3	drp1
3	medicine/blackwell
3	(cr
3	(ncx),
3	286-camkii
3	α2-,
3	workload
3	mlssc
3	caveolin
3	expectation,
3	lhb.
3	analog,
3	ca2+-binding
3	5-ht+
3	archistriatum
3	lobus
3	parolfactorius
3	socio-emotional
3	octodon
3	degus.
3	(mnh)
3	dorsolateralis
3	darpp-
3	procyclic
3	(km
3	mpc
3	asat
3	vacuole,
3	optimised
3	kj/mol.
3	δ1-pyrroline-5-carboxylate
3	memantine
3	tvmf
3	heme.
3	orel
3	prereplication
3	traverse
3	tcbdf2
3	glycine,
3	calflagin
3	pet-32a
3	lectin-like
3	bp1/bp2
3	ghsr
3	hs-crp
3	palmitoleate
3	hla-g
3	post-conc
3	15s
3	integument
3	cuticle.
3	amelcpr
3	laccase
3	decolorization
3	384
3	diaphorina
3	dccathb
3	lbrm
3	lbrpgf2s
3	hnrnpa/b-like
3	scytalidium
3	bpirmp
3	neurospheres,
3	rsl-cathl
3	ts15
3	u5
3	.02)
3	elisas.
3	x-
3	humicola
3	pi31
3	jacalin,
3	novo,
3	glcnac,
3	jacalin.
3	gst,
3	xyna
3	membrane-damaging
3	w129
3	lifetimes
3	rrf
3	(f18ab)
3	glucoamylase
3	km+
3	β-prism
3	2134p
3	hsm
3	tyr-151,
3	cyclohydrolase
3	eugenol-induced
3	(rmax:
3	rosta
3	myograph.
3	(rmax
3	msas
3	ca(2
3	bm-mnc
3	ml/min).
3	flow-pressure
3	sdd:
3	trd
3	(56%)
3	(8.0
3	(pd2)
3	(before:
3	after:
3	eps-induced
3	na+-pump
3	kc1
3	(dauc:
3	rat-tail
3	langendorff-perfused
3	beating
3	pr-interval
3	apkc
3	40love/samba
3	rst-neph
3	cup
3	bms493
3	generator,
3	dnac
3	kindling
3	ribcage
3	postinspiratory
3	(prebötc)
3	(pfrg)
3	pn
3	genioglossus
3	abdemg
3	(c1
3	anti-dβh-sap
3	co2-sensitive
3	(ppads,
3	chemoreceptors;
3	co2).
3	co2-evoked
3	(mrs2179)
3	apnea,
3	co-ordinates
3	(lpbn)
3	lpbn,
3	(vglut2)
3	slice
3	nacn.
3	(121
3	vglut2
3	(-41
3	463
3	blastomyces
3	antiviral,
3	(alone
3	fluconazole-
3	dermatophytosis
3	p10-pulsed
3	ishida,
3	prolificans
3	pbsod1
3	pbsod3
3	1996-2006
3	sulfamethoxazole/trimethoprim
3	gxm
3	promiscuously
3	(gp43),
3	gattii
3	itraconazole,
3	cr4.
3	cu,zn
3	htlv-ii
3	(s:
3	emmprin
3	margins.
3	hoxd10
3	non-tumoral
3	bmp-4,
3	demineralized
3	.0001;
3	huvecs;
3	pi3kγ
3	c-x-c
3	(dgf)
3	free-forskolin
3	renoprotection
3	adr
3	xod
3	uuo.
3	naffah
3	cith3
3	cd16+
3	(age:
3	co-transplantation
3	pcos
3	silva.
3	nlrp3-/-
3	plns
3	baccharis
3	po-mscs
3	bm-mscs,
3	(s727)
3	mvs
3	atn
3	cd68-positive
3	intragraft
3	offspring);
3	emphysema
3	tubule-interstitial
3	jα18ko
3	adenine-fed
3	(diabetics
3	180th
3	intestinalmicrobiota
3	deacetylaseinhibiting
3	akimodel
3	lowlevels
3	infiltration/activation,
3	autophagy.moreover,
3	inducecd4<sup>+</sup>
3	andcd8<sup>+</sup>
3	acetate-producing
3	clp+4f
3	frederick
3	clipped
3	bmp-7,
3	submission
3	iga1
3	asc-treated
3	vimentin.
3	adriamycin-induced
3	clp+epo
3	clp+cera
3	(dgf).
3	.001),
3	ml/min/y
3	plgf
3	.02),
3	a299g/t399i
3	ctg
3	534
3	fluorescent-activated
3	somatostatin,
3	(can).
3	t-bet,
3	lipectomized
3	non-vascular
3	(can)
3	b1ko
3	retinol
3	gb1
3	gb4
3	urothelial
3	urothelium.
3	survivals
3	ganciclovir-resistant
3	no-ar
3	novo.
3	one-yr
3	(rr
3	avr
3	cd4+d25+
3	+vβ11
3	il-27p28
3	(hsp65)
3	cytokine-producing
3	garp/ltgf-β1
3	bcg/dna-hsp
3	furiralis
3	n2a
3	iv-a
3	bison
3	mb.
3	vista
3	sanctuary
3	pan-hemoplasma
3	fawn's
3	coccoides
3	apartments
3	apartment
3	haemominutum'
3	tg-ee
3	tg-ctrl
3	aβ,
3	kob1aβ
3	trials)
3	aβkob2
3	fmol/mg)
3	castration.
3	(pahsas)
3	adchrebp
3	9-pahsa
3	lit1-null
3	cd200-/-
3	dephosphorylated
3	tct.
3	tct
3	eiec
3	gp82-deficient
3	gp82.
3	gp30
3	spz
3	spzs
3	mpl
3	αdec-csp.
3	(dc)-based
3	rs2043211
3	rs5744256
3	(hiv+)
3	ifn-dc
3	al-hiv
3	hiv+tb+
3	mutation-negative
3	auto-inflammatory
3	geranylgeranyl-pyrophosphate
3	(ggpp)
3	lon
3	histatins
3	his2
3	pin1
3	-842
3	defb1
3	tnfrsf1a
3	transmissible
3	self-renewal,
3	cochaperone
3	ln-γ1
3	exosomal
3	prpc-dependent
3	(sti1).
3	mglurs
3	rprpδ51-90
3	asn171ser
3	indole-3-glyoxyl
3	druggability
3	transcarbamoylase
3	de-novo
3	fabi
3	pfpdxk
3	thiaminase
3	5-(2-hydroxyethyl)-4-methylthiazole
3	apicoplast,
3	r5p
3	4pehz
3	pixels
3	geraniin
3	pfmdh
3	vitamers
3	pyridoxine
3	pfodc
3	pfadometdc
3	metaplasticity
3	ras-grf1
3	ergosterol
3	stricto
3	d-amb,
3	itc.
3	antibiofilm
3	tc19,
3	polymer-rich
3	itc,
3	amb,
3	flc
3	squalene
3	28707
3	μg.ml-1for
3	motors
3	vccs.
3	kif3a
3	gametocytes.
3	ptex
3	gliding.
3	pip4k2b
3	pip4k2c,
3	pip4k2c
3	underexpression
3	leukemogenesis.
3	jak1/2
3	mpn.
3	(irs2)
3	igf1r
3	(aml).
3	mds,
3	nvp-bkm120
3	hsc
3	mastocytosis
3	k509i
3	γ-globin
3	fmnl1-depleted
2	angiotensin-1-7
2	120);
2	jhco3-:
2	10-6,
2	a779,
2	~100
2	)atpase
2	cgmp/pkg
2	pkb
2	pkg-dependent
2	(nhes)
2	nhes
2	(phi),
2	activator).
2	glp-1r
2	exendin-9
2	receptor/g
2	proteincoupled
2	beta-arrestin-biased
2	protein-mediated
2	receptor/beta-arrestin
2	trv120023,
2	coupling,
2	coactivation
2	sgltmediated
2	ion,
2	552.
2	(pp1)
2	sodium-sensitive
2	(pt),
2	jhco
2	mek/mapk
2	llc-pk1,
2	fructose,
2	fructose-stimulated
2	(llc-pk1).
2	pkg.
2	intricately
2	+/h
2	radiofrequency
2	pkadependent
2	undertaking
2	+-free
2	0.064
2	17/74)
2	concanamycin.
2	phirr.
2	58).
2	preincubation,
2	[mineralocorticoid
2	[glucocorticoid
2	di-methyl-bapta
2	-12-10
2	glp-1-induced
2	microdissected
2	(pka)-dependent
2	cl-/
2	società
2	(y-shr;
2	5-wk-old),
2	(a-shr;
2	14-wk-old),
2	nmol/cm2xs),
2	(0.59
2	nmol/cm2xs).
2	a-shr
2	(p-nhe3/total).
2	retracted
2	nhe3-dppiv
2	exendin-4-induced
2	inhibition;
2	mek1/2
2	u-0126
2	epac
2	renoguanylin
2	(ren)
2	10 μm
2	10 μm;
2	sv40-transformed
2	-12,
2	10-10,
2	15-or
2	(pi)]
2	(these
2	hoe694
2	s3226).
2	(jh)
2	3.68
2	mm/min.
2	eipa
2	entirely,
2	nhe4;
2	hypertonicity
2	jh.
2	--dependent
2	nhe4,
2	cl-dependent
2	bcecf-am.
2	0.009
2	28080.
2	valinomycin
2	punctured
2	fdc-green-colored
2	kcl/l
2	ugn/l,
2	exponentially,
2	k).
2	-51.0
2	-50.3
2	iberiotoxin/l,
2	abolished:
2	nmol·cm-2·s
2	ugn,
2	nahco
2	3/l.
2	nmol·cm-2·s-1).
2	(hma)/l,
2	+-atpase.
2	jk+
2	[protein
2	(pkc
2	bartter's
2	hypokalemic
2	henle's
2	bartter
2	post-weaning
2	5-10
2	2.94
2	2.99
2	(0.90
2	(∼37%),
2	(∼32%),
2	(∼62%),
2	(∼26%).
2	(-10%
2	operative.
2	cortransport,
2	[(dihydroindenyl)oxy]alkanoic
2	ba2+,
2	fluo-4/am,
2	h+/k+-atpase.
2	δph.
2	(n=5).
2	secretary
2	isc,
2	cotransporter,
2	isc
2	constitution,
2	filters,
2	bcecf
2	epifluorescence
2	0.099±0.008
2	0.086±0.01
2	minute).
2	vitro'
2	0.051
2	lucifer
2	vanadate
2	7.17
2	0.023
2	7.21
2	cl-/hco3/-
2	na+/hco3/-
2	tubules)
2	β-
2	hp:
2	hyperparathyroidism
2	(2.1
2	h-1);
2	implanted;
2	hypoparathyroidism
2	(bbm)
2	22na.
2	840,
2	9225
2	505,
2	12205
2	39.3
2	sizeable
2	units/min.
2	na+,k+,2cl-
2	7.89
2	impulse
2	extremes
2	1920s
2	revived
2	16).
2	0.007
2	electrogenicity
2	ling-gerard
2	5-nitro-2-(3-phenylpropylamino)
2	benzoic
2	(nppb).
2	nmolcm-2.sec-1
2	anion;
2	(gfr
2	98.5
2	ml·min-1·1.73
2	39.9
2	m-2).
2	reabsorbing
2	2.65
2	adx.
2	minus
2	amiloride-treated
2	18-oh-b
2	nephrons
2	controversially.
2	actuation.
2	1,2-dioctanoyl
2	(dog)
2	(jhco3−)
2	‘in
2	vivo’
2	halftime
2	4.22+0.23
2	6.27
2	61%),
2	(tptx
2	beta-intercalated
2	acute)
2	nmol/cm2
2	h-atpase
2	interstitium.
2	(cli(i)),
2	unx.
2	jhco3-.
2	(efve)
2	90-120
2	15%,
2	reabsortion
2	jv.
2	(ed
2	ld,
2	tonicity
2	hypo‐
2	fastest
2	shunt
2	path,
2	1.03
2	ld)
2	-0.02
2	(hco3-)
2	load-dependent
2	k+-h+
2	6-mg/kg
2	4.44
2	10.2
2	shunting.
2	resin/pd
2	calcium-supplemented
2	a23187,
2	18-hydroxycorticosterone
2	(pth)
2	ca2+).
2	3.76
2	1.53
2	protonmotive
2	conditioitions
2	lumen-positive
2	intaluminal
2	electrogenic,
2	micropipettes,
2	sb/reference
2	hc1-filled
2	adjustable
2	conductance).
2	point-like
2	oil-blocked
2	1.05
2	clearances
2	one‐third
2	4.70
2	value;
2	5.43
2	micro-severinghaus
2	(ca).
2	(made
2	henderson-hasselbach
2	equation)
2	indicazting
2	acetazolamide.
2	k+-adapted
2	used;
2	c14-sucrose
2	h3-inulin
2	entrained
2	mmole/l)
2	jv=0,
2	diffusive
2	sieving
2	0.76-0.91,
2	1.0-1.1
2	wide.
2	tentative
2	acidify
2	mg/ml)-containing
2	29)nmol
2	cm-2s-1
2	bicarbonate-containing
2	buffers,
2	depletion),
2	na+-ca++
2	10(‐3)
2	m‐dinitrophenol
2	(dnp)
2	5.8)
2	phosphate‐buffered
2	(6.2
2	dnp,
2	6.6‐6.8
2	7.1‐7.2,
2	3‐5
2	hco3-.
2	oil;
2	eifect
2	rale
2	10<sup>-5</sup>m
2	reabsorptlon,
2	-ca<sup>++</sup>
2	0.088
2	(ecv)
2	h+/hco-3
2	[hco-3]
2	[14c]inulin
2	(0-8-15
2	minimal,
2	phco-3
2	lumen-to-capillary-directed
2	backflux
2	(h+)
2	glycodiazine,
2	[hco3-]
2	p(hco3-)
2	recessed-tip
2	electrodes,
2	reversible.
2	(0.1-0.4
2	co2/hco3-
2	46°
2	10°
2	flowing
2	permeancy
2	henderson
2	hasselbalch
2	"open"
2	nonionized
2	thesis
2	glycodiazine
2	dmo.
2	cystem.
2	thereupon
2	non-ionized
2	disputed
2	one-half
2	one-twentieth
2	re-collection
2	doca,
2	natriuresis,
2	0.03.
2	neurohypophysial
2	voltage-clamped
2	stimulated.
2	fluid-to-plasma
2	unity,
2	(glycodiazine),
2	mg/min
2	ureter,
2	ml/min/kg.
2	rpf
2	8--9
2	filar
2	10-turn
2	potentiometer,
2	recorder,
2	analogue-digital
2	convertor,
2	computing
2	automatically.
2	ifmbe.
2	10-3m,
2	5‐5.
2	(chloride
2	cm/sec,
2	microperfusions.
2	pump‐leak
2	half‐times.
2	anydrase
2	diamox.
2	first‐order
2	manoeuvres,
2	of32p-phosphate
2	phosphateraffinose
2	(5.5),
2	(8.2).
2	77.0
2	86.6
2	perfusions.
2	7.43
2	transtubular
2	cm2.
2	electrolytes,
2	forthcoming
2	plotting
2	depresses
2	delayed.
2	mannitol.
2	accidification
2	change;
2	acidifying
2	depressed;
2	42k
2	partaking
2	42k‐ringer
2	tracer‐free
2	potassium‐depleted
2	potassium‐loaded
2	(ha).
2	inulin,
2	ha;
2	na+/in
2	inspite
2	reabsorbed
2	skins,
2	mineralocorticoids,
2	low-cl
2	hypochloremia
2	1.35,
2	microelectrode,
2	ha.
2	furosemid,
2	brailykinin
2	problematic.
2	well-formed
2	ses
2	capabilities,
2	ethylene.
2	email:
2	rhizosphere,
2	cucumber
2	endospore
2	cohnella
2	solubilisation
2	liberation.
2	rhizobacteria
2	technologies.
2	farming.
2	chemotaxonomic
2	recognisable
2	fixing
2	(mpn)
2	capability,
2	cdeb
2	fertilizers
2	lichens
2	maltophilia,
2	lichens.
2	oxidizable
2	diagrams,
2	textbook.
2	diagrams.
2	(iaa),
2	ethylene,
2	cultures).
2	agitation.
2	endophitic
2	pgr
2	cultures;
2	(decrease
2	43-
2	partner.
2	cellobiose
2	stirred
2	(aldo)
2	unknown;
2	(basolateral
2	([ca2+]i).
2	(irptc)
2	chelator),
2	2013;
2	2.82
2	(50).
2	(15),
2	aldo.
2	hnhe1.
2	1k3r/4e
2	4.71
2	fluorometrically.
2	solution),
2	synthesis),
2	bcecf/am
2	4/am,
2	(nhe)
2	0.114±0.005
2	(n=35).
2	hoe-694,
2	concentration-dependently.
2	2+]i,
2	phi,
2	bcecf-am,
2	4-am
2	0.118
2	106%
2	45)
2	epoxygenase).
2	epoxygenase-dependent
2	t),
2	t).
2	0.22;
2	0.20;
2	μm2).
2	phi.
2	anp,
2	(ph(i))
2	([ca2+](i))
2	[ca2+](i),
2	(anp,
2	na+/h-
2	kci)
2	hco-
2	/3
2	(avp,
2	hco-/3
2	0.931
2	0.171
2	s-1]
2	[from
2	0.542
2	0.086
2	1.67
2	0.111
2	].
2	[(d
2	(ch2)5,
2	(et)2)
2	vasopressin]
2	5-(n,
2	n-hexamethylene)
2	avp-
2	63.7%)
2	34.1%)
2	a(l)
2	avp-mediated
2	31.7%)
2	bicarbon-ate
2	0.930
2	0.850
2	2.03
2	cm-2·
2	perfusion)
2	0.310
2	0.130
2	0.151
2	0.530
2	0.211
2	perfusion).
2	5-(n,n-hexamethylene)amiloride
2	54%)
2	33%).
2	h+-adenosinetriphosphatase
2	vernonia
2	2.54
2	1.64
2	3.25
2	fluorometrically
2	](i).
2	(17.5
2	s),
2	4.07
2	(2.24
2	dt-treated
2	episodic,
2	cyclic,
2	differentiation)
2	syk,
2	galdino,
2	kynurenines
2	(nlrp3)
2	(i.t.)
2	casp1/11-/-,
2	cd4+cd25+foxp3
2	mirotti,
2	alberca
2	custódio,
2	rammauro,
2	araujo,
2	aluminum-containing
2	formulations;
2	caveat
2	tlr-dependent,
2	pro-th1/th17
2	il-10/il-12-deficient
2	il-10/il-12
2	alum/cpg-based
2	paracoccidiodomycosis
2	106p.
2	brasiliensis-yeasts.
2	ifn-β.
2	ifn.
2	cd4+and
2	pdc-depleted
2	il-35.
2	brasilienis
2	2,3-dioxygenase-1
2	ido-deficient
2	ido-inhibited
2	bazan
2	foxp3gfp
2	rag1-/-
2	cd4+foxp3-
2	eradication,
2	tc17
2	motivating
2	tlr-2-/-,
2	tlr-4-/-
2	anti-dectin-1
2	mr.
2	(intraperitoneal
2	(ltb4,
2	β-glucans
2	sugar-rich
2	mannans
2	glucans.
2	laura
2	(cyslts)
2	(lxs)
2	mtl
2	b10.a,
2	5-and
2	15-lipoxygenase
2	mtl-treated
2	fcrγ
2	h3.
2	(nets).
2	dectin-1-sufficient
2	dectin-1<sup>-/-</sup>
2	il-β,
2	il-4-,
2	il-17-positive
2	(cr3)
2	paralleling
2	mice.conclusions/significance:our
2	non-organized
2	bernardino
2	gitr,
2	tlr2-
2	develops.
2	granulomas,
2	overwhelming
2	(treg
2	pb.
2	c5b-c9.
2	(mbl)
2	mannan.
2	(pb),
2	macrophage-colony
2	igg3).
2	high-virulence
2	low-virulence
2	restraining
2	paracoccidioidomycosis;
2	(b10.a),
2	nos2-deficient
2	sulfate-treated
2	nos2-derived
2	facultative,
2	(week
2	igg3)
2	antigen-stimulated
2	conceivable
2	accomplished,
2	carbohydrate-binding
2	fumigatus,
2	interplay.
2	explains,
2	fumigatus.
2	thl
2	granulomata
2	(immune
2	68,
2	64,
2	luminol-enhanced
2	halide
2	oxygen-reactive
2	resided
2	anergic.
2	omentum/pancreas,
2	γ/δ
2	disseminates
2	pulmonary-
2	t-cell,
2	indicate:
2	on)
2	(pb18).
2	b10d2/osn,
2	b10d2/nsn,
2	akr,
2	nzw)f1,
2	(a/sn
2	b10.a)f1,
2	carboxylated
2	active),
2	brasiliensis:
2	virulent),
2	virulence).
2	masses:
2	pb56
2	ld50%
2	(pb56
2	pb57)
2	titres,
2	samples:
2	(rs).
2	subculturing.
2	antiovalbumin
2	anti-ovalbumin
2	(isolate
2	2052)
2	f(ab')2
2	2);
2	267,
2	sn,
2	campo
2	192).
2	grande,
2	9;
2	267
2	192)
2	pbr
2	parent.
2	(growth
2	puromycin
2	15,000
2	"y"
2	"cl"
2	appears,
2	thioglycollate.
2	anti-macrophage
2	56°c
2	edta.
2	polymorphonucleocytes.
2	199
2	immunoelectrophoretic
2	laboratory's
2	18.7
2	i.u./ml.
2	(ards).
2	(intestinal
2	ir)
2	(vegf),
2	sacrificed.
2	mediated.
2	fromthe
2	bag
2	mendes,
2	acetturi,
2	thomas,
2	crisma,
2	murata,
2	camâra,
2	setubal,
2	valduga,
2	dias-neto,
2	tavares-de-lima
2	probiotic,
2	re-exposure
2	lipopolissacaride
2	(0.92mg/m<sup>3</sup>)
2	water),
2	1h/day,
2	5mg/kg,
2	toll-likereceptor-4
2	(cbd)
2	(ali).
2	(tnf
2	(mcp-1
2	panneuronal
2	anti-huc/d,
2	(glial
2	marker).
2	receptor-,
2	calbindinimmunoreactive
2	12%,
2	offspring.pregnant
2	(0.75.
2	days)),
2	water))
2	non-manipulated).
2	evaluated.our
2	explant
2	experimental.
2	booster.
2	5×10
2	("companion
2	partner").
2	cohabitation,
2	noradrenaline.
2	(interleukin-1β
2	pan-neuronal
2	anti-huc/d.
2	22.6
2	39.8,
2	21.7,
2	post-i/r.
2	a2b
2	(17β-estradiol,
2	(nω-nitro-l-arginine
2	hydrochloride)
2	lvp,
2	ovx-i/r
2	mechanics.
2	submitted,
2	ers
2	open-channel
2	(amph)-induced
2	ards
2	rheumatism
2	vmat2-driven
2	cathecolamines
2	cnos)
2	nadph-oxidase,
2	90.
2	smears;
2	β3
2	leukocytes;
2	(i/r-i)
2	-immunoreactive
2	i/r-i,
2	plexuses.
2	i/r-i.
2	55.8%
2	26.4%
2	-ir,
2	49.7%,
2	72.6%,
2	lymphocytes)
2	count;
2	amph,
2	progesterone.methods:
2	(ovx).
2	sensitized-rats
2	(sham-ovx).
2	counted.
2	expontaneous
2	e-selectin.results:
2	treated-ovx
2	nitrites.
2	incubates.
2	ultrafine
2	exacerbations
2	24-72
2	tracheas
2	(tlrs).
2	microscopically.
2	(fa/ova
2	fa-untreated
2	(ova/ova
2	challenge-induced
2	(platelet-endothelial
2	expositions
2	air-borne
2	non-responsive
2	neutrophil-
2	lymph.
2	anti-il-6
2	(nstz)-induced
2	p.)
2	c.)
2	counts)
2	extravasation).
2	nstz-diabetic
2	withdrawals
2	singularly
2	α5β1
2	no),
2	(n-l-nitroarginine
2	glibenclamide.
2	bhr,
2	n-l-nitroarginine
2	(oa)-sensitized
2	oa-challenge
2	oa-anaphylactic
2	(hq),
2	mg/kg/day;
2	45-min
2	(scg),
2	scg
2	fetal/maternal
2	interchanged
2	mothers:
2	(ifn/nor),
2	(nor/ifn)
2	(nor/nor).
2	peribronchial
2	ifn/nor,
2	provocations
2	ligation,
2	significant)
2	(ischemia:
2	reperfusion:
2	(l-929
2	bronchopulmonary
2	ru-486.
2	(mmc)
2	ctmc
2	decayed
2	(20mg/kg,
2	(30mg/kg,
2	lypopolysaccharide
2	reduces,
2	staining)
2	footshocks
2	canceled
2	vocalizations
2	sensitized,
2	adminstration
2	greatly.
2	eb.
2	non-additive
2	(5-(2-chlorphenyl)carbonyl)-3,4-dihydro-10-methyl-3-((4-morpholinyl)-2h,7h-cyclopenta(4,5)thieno(3,2-f)(1,2,4)-triazolo-(4,3-a)(1,4)-diazepine).
2	(3-[1-(4-chlorobenzyl-3-t-butyl-thio-t-isopropyl-indol-2y-1]-2-2-dimethylpropanoic
2	0254094
2	(2-[(5-carboxypentyl)-6-[6-[3,4-dihidro-4-oxo-8-propyl-2h-1-benzopyran-7-yl)hexyl]
2	c4/d4,
2	ntr,
2	ru38486
2	ntp
2	vasopermeability.
2	(eb)-labelled
2	inner)
2	pca-4248
2	(txa
2	fold)
2	dry:
2	haemoglobin,
2	(econazole)
2	(l-655,240).
2	bn-52021,
2	(l-660,711)
2	schild
2	(bzd)
2	methylene]
2	hydrazides
2	(hcs).
2	nitroheterocyclic
2	cl1
2	2149
2	cl10
2	1.17
2	tcabcg1,
2	bz-resistant
2	(dtus)
2	tcv,
2	parentals
2	ipdcs
2	γ-proteobacteria.
2	tryptophan.
2	hypocotyl
2	efficacies
2	antitrypanosomal
2	02
2	carbohydrates.
2	cytochrome-mediated
2	phytobacteria
2	crithidia.
2	pdc,
2	t-independent
2	igg2,
2	taxonomy-related
2	eco-epidemiological
2	vl10
2	fast-evolving
2	>100
2	non-cured
2	sub-population
2	(indeterminate
2	immunogenetic
2	cchd
2	(discrete
2	sub-lineages
2	deletions.
2	meeting.
2	contigs,
2	retroelements,
2	prolixus.
2	attachment.
2	lengths.
2	isolates;
2	different-sized
2	pre-edited
2	characterised,
2	editing.
2	editing
2	cr4
2	user-friendly
2	web-based
2	's
2	intuitive
2	t-test,
2	at:
2	245
2	kog
2	brener,
2	brener.
2	satellites
2	(4.6%)
2	99.9%
2	emergencies
2	665
2	hybridisations
2	genotype)
2	(11.5%)
2	belongs.
2	disclosed.
2	listing
2	explicit
2	to.
2	format
2	(98.5%
2	sensitivity)
2	specificity).
2	countryside
2	dendrograms
2	probes)
2	repeat,
2	clonal,
2	sexuality
2	1800bp
2	1.5mbp
2	1.1mbp
2	1f8
2	ii:
2	iid
2	iie
2	iia/iic
2	eukaryote
2	carboxyl-terminal
2	heptapeptide
2	inconclusive
2	elisa).
2	excreted-secreted
2	99.6
2	triatomids
2	8.3%
2	(68.7%)
2	(6.3%),
2	domiciliation
2	houses.
2	itss
2	d7-24sα
2	dates
2	divergence.
2	mya).
2	mya),
2	coevolution.
2	amplifications
2	facs.
2	688
2	helicases
2	(myr)
2	pliocene
2	ago)
2	caviomorph
2	oligocene
2	ago).
2	salvador,
2	guatemala,
2	honduras,
2	golden-lion
2	d7a
2	mobilities
2	gdkpslfgqaaagdkpslf-nh2
2	hexapeptide
2	gdkpslfgqaaagdkpslf-nh2,
2	fgqaaagdk-nh2,
2	qaaagdkps-nh2,
2	s5,
2	s5
2	91,
2	86,
2	sub-populations
2	fingerprinting,
2	infusion-tryptose
2	lit-20%
2	grace's
2	isoenzymatic
2	schizodeme,
2	schistosoma,
2	train
2	countries;
2	expertise,
2	carlos
2	yacs
2	rapd-derived
2	tree;
2	mitogenesis
2	phosphoinositol
2	55-65%
2	5-9%
2	myosin-crossreactive
2	(ama)
2	patient-seropositive
2	140/116-kda
2	b13-whose
2	140-
2	116-kda
2	band-was
2	ama.
2	1442-1447
2	aaaldk
2	(1442-1447)
2	(lppg)
2	furanoic
2	gtll.
2	'polar'
2	(lppg).
2	lppg.
2	λgt11,
2	pmsgt11,
2	paptg-agarose
2	immunoselect
2	140-kda
2	97%.
2	b12,
2	82%.
2	forms;
2	immunoadsorption
2	macromolecules.
2	deae-sephadex
2	(acetate
2	temperature-and
2	yuyu,
2	ra)
2	western-blotting
2	western-blot
2	(s1),
2	igm)
2	immunoprecipitate
2	β‐d‐galactofuranosyl
2	sialoglycolipids
2	[3h]fetuin
2	catalysed
2	x-100.
2	(3h)-palmitic
2	nab3h4
2	175-180,
2	120-125,
2	90-95
2	agglutinin-sepharose,
2	tunicamycin-sensitive
2	sphinganine
2	periodate
2	borotritide
2	glycolipid
2	nana7
2	folch
2	nana
2	immunoprecipitations
2	phosphodiesterase.
2	glucose-6-phosphatase
2	atp2-
2	inhibitory.
2	hill
2	2.0.
2	transforms
2	parabolic
2	bursts
2	(high-glucose)
2	(kv) current
2	metabolism-dependent
2	oral)
2	diet:
2	(nf);
2	zncl2
2	(nfz);
2	(hf);
2	(hfz).
2	(ipgtt)
2	(ipitt)
2	homa-β
2	ipitt,
2	homa-β,
2	fat-fed
2	sc),
2	tumor-bearing.
2	1–2
2	g10,
2	rogfp1
2	rogfp2-orp1
2	ui/kg,
2	gdp,
2	consistency,
2	vas2870
2	144%)
2	nadph/nadp+
2	3-fold).
2	(dv)
2	glucose),
2	banana
2	rs)
2	28 days.
2	analyzed.results:
2	υ-3
2	glucose-6-phosphatase.
2	ser473
2	rapamycin-mediated
2	(dhea-s)
2	mir-29
2	brin-bd11
2	deposit
2	deterioration,
2	ager
2	72h,
2	β-nadh
2	79%,
2	82%,
2	oleic.
2	hatanaka
2	low-to-moderate
2	(lp,
2	week-1
2	2max).
2	carol
2	góis
2	leandro
2	p38mapk),
2	p38mapk)
2	curiously
2	malonyl-coa/long-chain
2	currents.
2	(glucose-stimulated
2	leak.
2	extra-mitochondrial
2	free-albumin,
2	(dpi-diphenyleneiodonium),
2	(calphostinc)
2	transferase-i
2	(cpt-i)
2	(etomoxir).
2	5.6mm
2	(gpr40).
2	proliferation/death.
2	(described
2	[erk1/2]
2	stress-activated
2	kinase/c-jun
2	[sapk/jnk])
2	10-mmol/l
2	jnk/sapk,
2	v-akt
2	oncongene
2	473)
2	phosphorylations.
2	undoubtably
2	14c]-
2	14c]-pyruvate
2	fluorescence-based
2	1.75-fold,
2	1.8-fold,
2	il-1beta-dependent
2	anti-p47(phox).
2	nsd.
2	(mm
2	5.6,
2	glucose:
2	unsaturated.
2	pmca
2	(94%)
2	phospholipids:
2	four-fold,
2	glycogenesis,
2	pinealectomy)
2	glucose-metabolizing
2	b-cell-
2	phase-advancing
2	active).
2	activity-rest
2	export,
2	≫
2	palmitic.
2	87.6%
2	59.9%
2	53.1%
2	36.9%
2	ester),
2	(63.1%)
2	(70-90g
2	nutrition-ain.
2	authorize
2	(gsp)
2	gsp
2	0.96).
2	α-ketoisocaproic
2	50-60%)
2	first-phase
2	instead.
2	outflow,
2	b-cell,
2	6.0-7.0
2	mci/ml
2	(k-h)
2	effect(s)
2	α-kic
2	right-hand
2	oxoglutarate),
2	12-month-old,
2	(submitted
2	iv-gtt
2	perifusion.
2	high-carbohydrate,
2	high-lipid,
2	balanced,
2	prandial
2	microsomes
2	biphasic;
2	(hc),
2	different;
2	hl).
2	u14c-glucose
2	malonyl-coa,
2	radioisotopic
2	[1-14c]acetyl-coa
2	glutamate-oxalacetate
2	transaminase.
2	d-[3,4-14c]glucose
2	pyruvate/citrate
2	180-200
2	(10(6)
2	(180
2	nordihydroguairetic
2	(regular-fasted)
2	(single-fasted)
2	single-fasted-period
2	hexose.
2	outflow)
2	1,4,5-triphosphate
2	dose-related,
2	participation,
2	maintain,
2	stimulate45ca
2	l-valine,
2	(4.4
2	9-aminoacridine
2	b-cell.
2	measuring,
2	pyruvic
2	45ca,
2	attributable,
2	6-phosphate.
2	dependency.
2	close-to-physiological
2	(tea),
2	k+conductance,
2	k+conductance
2	theophylline.
2	casa
2	oligomycin
2	ca2+-sensitive
2	glucose)
2	depend,
2	for.
2	extrusion.
2	additive.
2	(instead
2	c]-leucine
2	nadh/nad+
2	menadione,
2	oxaloacetate),
2	glutamine-induced
2	unavoidable
2	(mes),
2	dispensing
2	errors.
2	(sal)
2	33.
2	sal-pretreated
2	(postnatal
2	(caf)
2	(adolescent
2	24;
2	rears
2	ampc
2	gmpc,
2	nonadditive
2	23390
2	sulpiride,
2	(pkg).
2	transmitter.
2	fcf,
2	(sniffing,
2	locomotion)
2	(28.6
2	relase
2	detector.
2	(390
2	420
2	stimulants.
2	15:00,
2	03:00
2	pretreatments
2	ide
2	dsp4
2	pcpa
2	microdialysis,
2	mesostriatal
2	fencamfamine,
2	cross-interaction
2	lend
2	(id50)
2	tubercullum
2	fencamfamine-treated
2	3,4-dihydroxyphenylacetic
2	stereotypic
2	fencamfamine-pretreated
2	dihydroxyphenylacetic
2	[3h]spiroperidol.
2	gnawing
2	rearing,
2	changed;
2	dihydroxyphenilacétic
2	amphetamine.
2	lumbar-cisternal
2	19.2
2	perfusate.
2	hrp
2	ventricles,
2	gdh,
2	(75–80
2	(endo+)
2	(endo-)
2	flx-exposed
2	ceravolo,
2	echem,
2	hashimoto,
2	santos-eichler,
2	jiménez-altayó,
2	akamine,
2	carvalho.
2	flashes,
2	hypoactive
2	(hsdd)
2	hsdd
2	p-450-induced
2	20-hete
2	(ovx-shr)
2	created:
2	[(cee)
2	μg/kg/day/po]
2	[(cee+t)
2	mg/kg/weekly/im].
2	het0016
2	cyp4f3
2	cyp4f3/20-hete
2	shutdown
2	tw-256
2	(tumor-bearing
2	animals/group):
2	1j
2	35,7
2	107,14
2	214,28
2	(thera
2	dmc®,
2	(j)
2	j–35,7
2	[conjugated
2	0.625
2	mg]
2	(0.30
2	(21.5
2	(14.7
2	ceesd.
2	o2-.
2	erb
2	pocket,
2	rgpb
2	(p < 0.01).
2	mitochondria-derived
2	(mn-sod)
2	(changes
2	neo-antigens
2	(lipopolysaccharide)
2	pathway.main
2	μg/day)
2	(i.p.).key
2	shr.significance
2	saline),
2	mol/l),
2	molecule)
2	flutamide.
2	female:
2	(ovx+cee)
2	(ovx+cee+t).
2	(nadph-oxidase
2	cee+t,
2	ovx-associated
2	nadphoxidase
2	oxidasederived
2	libitum,
2	(srt),
2	(trt).
2	123,319.
2	iugr-associated
2	trt
2	(mapks)
2	erk1/2-induced,
2	hagihara
2	gcf,
2	gcf.
2	periodontium.
2	vegf).
2	mas,
2	myography;
2	(rhepo)
2	(rhepo=0.60±0.11,
2	control=1.07±0.11).
2	(rhepo=0.95±0.14,
2	control=1.05±0.16)
2	(rhepo=0.73±0.20,
2	control=1.01±0.09).
2	mmp-8,
2	tezosentan,
2	norepinephrine-stimulated
2	(p-)
2	p-endothelial
2	(5 mmol/l)
2	(25 mmol/l)
2	100 μmol/l
2	indomethacin)
2	(0.1 μmol/l
2	tezosentan)
2	(pkc;
2	0.1 μmol/l
2	glucose-treated
2	zucker
2	(enos),
2	relaxation;
2	(at2r),
2	induced-decreased
2	(hyper).
2	apparatus:
2	calponin
2	(p-mlc).
2	(angii),
2	p-mlc
2	at2r/akt/no
2	carrillo-sepulveda
2	ovx-shr.
2	tendons.
2	orthopaedic
2	(bq123)
2	fading
2	(cox-2).
2	2-ar)
2	2ko),
2	nadph-derived
2	cvds
2	(cardiovascular
2	5-week-old
2	(anti-tlr4
2	(noradrenaline)
2	(cyclo-oxygenase)-1
2	(vsmcs),
2	(genomic
2	nongenomic)
2	c-src,
2	0-120
2	[shr]
2	[both
2	strains]).
2	(c-src
2	(antioxidant/nadph
2	oxidase-derived
2	c-src-dependent
2	(intact
2	orai1/stim1
2	-loading
2	orai1
2	(sarcoplasmic
2	18-week-old
2	norepinephrine-induced
2	pgi2/txa2
2	athletes'
2	photochemistry
2	β-n-acetylglucosamine
2	(o-glcnacylation)
2	rhoa/rho-kinase
2	c-potentiated
2	venoconstrictor
2	123319,
2	right,
2	vsmc-derived
2	3-kinase/protein
2	no-specific
2	(no2)
2	nos.conclusion
2	drink.
2	n=5).
2	mn;
2	mn)
2	deoxycorticosterone-
2	moles]:
2	vehicle).
2	folate,
2	(b1-/-).
2	ca2+-dependent,
2	zaprinast
2	snp-stimulated
2	fundus.
2	(o-glcnacase
2	(126
2	uni
2	tyrphostin
2	a-9
2	15 days
2	antimigratory
2	intra-vital
2	(180.0
2	2.3),
2	(163.4
2	5.1)
2	(156.3
2	4.3)
2	(183.1
2	4.4).
2	cd-18
2	insulin-resistance
2	(et-1
2	mitogenic,
2	antinatriuretic
2	arterial,
2	et-1-mediated
2	day.2
2	type.i
2	convulsions
2	(e-nos)
2	(n-stz).
2	e-nos
2	chlorpropamide-
2	homoeostatic
2	(homa-beta),
2	chlorpropamide-treated
2	immunohistochemistry),
2	hypocellularity
2	(ur)
2	(nr;
2	16 weeks
2	(10 mg/kg/15 days)
2	(15 mg/kg/21 days)
2	(ace),
2	(500 mg
2	(167 mg
2	(33 mg
2	ketamine/xylazine.
2	reducing,
2	diabetic-linked
2	bed),
2	immunoassay),
2	pgf2α,
2	527,
2	(endothelium-dependent
2	vasodilators)
2	(endothelium-independent
2	vasodilator)
2	pai-1,
2	adypokines
2	*),
2	123,319
2	*)
2	(emax:
2	0.91
2	endothelial(e),
2	inducible(i),
2	neuronal(n)
2	(et-1).
2	vwbcand
2	(4.8
2	pgi2.
2	ace)
2	uninjured
2	5.5-fold
2	iivascular
2	estrus,
2	hyporeactive
2	artery)
2	(p-selectin),
2	(e-selectin)
2	rolling.
2	doca-salt,
2	participates,
2	cams,
2	at-1
2	(ie,
2	fsh),
2	leu),
2	oe.
2	enhancement,
2	decompensation.
2	(lvef)
2	<35%
2	>60%
2	l-[h3]-arginine
2	l-[h3]-citrulline.
2	trapscription-polymerase
2	1.54
2	2.19
2	gp91phox.
2	(vehicle
2	c-treated
2	(ascorbic
2	e-treated
2	(α-tocopherol,
2	vitamin-treated
2	intrauterine-undernourished
2	(8-10-week-old).
2	splitter
2	(histamine,
2	factor-paf,
2	diestrous
2	ang-(1-7)+bk
2	f2α
2	i2
2	preparations;
2	mg/kg/day/7
2	galactosemia.
2	minalrestat.
2	galactosemia
2	hyperpolarization.
2	210±9
2	(44.9±10.3%
2	(uninx)
2	(118±3
2	18.5±3%,
2	(170±4
2	120±3
2	(21.7±6
2	11.9±7%).
2	(18.8±7%)
2	sbp.
2	uninx
2	182874.
2	(75.8±4.2%
2	95.4±1.9%,
2	93.5±4.5%.
2	pressure-independent
2	undernutrition:
2	nacl/kcl.
2	k8644
2	stores)
2	et-1/et
2	(oe),
2	hydroethidine,
2	oxyradical
2	(nadph)-oxidase
2	mg-1·
2	min-1(p<0.0001)
2	children:
2	suc-[glu,(9)ala(11,15)]-et-1(8-21)
2	(irl-1620),
2	estradiol/progesterone
2	(ep).
2	nacl/kcl)
2	vivo/in
2	et(a/b)
2	gapdh.
2	ovx-control
2	(et(a)/et(b)
2	et-1/et(b)
2	responses/expression
2	mg/day/rat
2	fluid)
2	(responders)
2	ec50)
2	constrictors).
2	53.3%
2	txa2/pgh2
2	(5-ht),
2	u/ml).
2	indo,
2	edcfs
2	pgh
2	factor(s),
2	(lipoxygenase
2	*p<0.05
2	co-infusion
2	radicals.
2	underscores
2	-treated
2	nitrovasodilators
2	number-dependent
2	pmol/mg
2	occlusions
2	collagenase,
2	beds,
2	image-splitter
2	(edrf)/nitric
2	agent).
2	d-nmma
2	disappear,
2	d-arginine.
2	edrf/no
2	(edcf)
2	edcf
2	unrubbed
2	microvessels,
2	21-amino
2	goldblatt
2	closed-circuit
2	endothelin.
2	gil
2	dismissed.
2	macro-
2	aortae,
2	na-precontracted
2	(cardionatrin)
2	antibiotic,
2	mlx-9
2	(δψm)
2	shrinkage,
2	blebbing,
2	nucleosomal
2	lemniscatus
2	elapid
2	innumerous
2	(lis1)
2	element-like
2	excitable
2	hind-limb
2	crotamine.
2	(soleus)
2	(nifedipine,
2	gvia,
2	ω-agatoxin
2	gvia.
2	p/q-
2	70-80
2	socio-economical
2	multiple-infected
2	δ-
2	(blockers
2	channel)
2	large-
2	[d-pen2.5]
2	(dpdpe),
2	(+)-trans-(1r,2r)-u-50488
2	(u50488),
2	pinacidil,
2	openers,
2	plateau.
2	aps.
2	activating,
2	ω-phonetoxin-iia,
2	8362.7
2	high-voltage-activated
2	low-voltage-activated,
2	t-type
2	ω-phonetoxin-iia
2	ω-agatoxin-iii
2	(ccd).
2	depolymerization
2	root-extract
2	(20-80
2	(ccd)
2	high-k+
2	dibutyryl-camp
2	ccd.
2	35-ps
2	(5.1
2	(2.6
2	osphradium
2	osmoregulatory
2	rheogenic
2	vcl
2	(n=23)
2	gluconate,
2	(series
2	technically
2	motivate
2	atr-ftir
2	thermo
2	chemometric
2	bending
2	conformationally
2	routine.
2	(rt-qpcr)
2	inflammassome
2	analysis).
2	challenge;
2	naclo4
2	hormone/cytokines
2	qpcr/western
2	t4/t3
2	morphology/gene
2	perchlorate-induced
2	rmar
2	biflorus
2	unk
2	competence.
2	gsk3,
2	pro-inflamatory
2	pro-oxidative
2	nrf2,
2	chronically,
2	30–50
2	90-110d.
2	(30-50d)
2	(90-110d)
2	malformations/fetal
2	femtosecond
2	burns.
2	deciduoma
2	pseudopregnancy.
2	myometrial
2	lumican,
2	90-100
2	eml
2	iml
2	collagen-associated
2	lumican.
2	disease),
2	alpha-amanitin
2	superinduction
2	(dop)
2	immunodetected
2	scaffold,
2	scaffolds,
2	liposomic
2	epidermal,
2	depmal,
2	telogen/anagen
2	coffagen
2	imunohistochemical
2	(68%).
2	viabilities
2	quasi-equilibrium
2	labyrinth,
2	exchanges.
2	(α2a/α2c-arko),
2	connected,
2	(tracp)
2	osteoclast-related
2	α2b-
2	α2b-,
2	β2-ars
2	18.5-day-old
2	35-day-old
2	α-ar
2	phentolamine.
2	fibromodulin,
2	(p4)
2	salgado
2	two-photon
2	label.
2	tpefm
2	mhz
2	(olympus
2	width.
2	subdermal
2	autofluorescence
2	differents
2	depths.
2	visible.
2	spie.
2	immunodetection.
2	svmp)
2	(disintegrin-like/cysteine-rich
2	proestrus,
2	slrp
2	(decorin,
2	fibromodulin)
2	mononucleated
2	14.5,
2	18.5.
2	e16.5.
2	chondrocytes,
2	e16.5,
2	minimum.
2	e14.5
2	(p14).
2	e18.5
2	2.5-fold)
2	spongiotrophoblast.
2	hyaluronan,
2	cords.
2	integrin-binding
2	reichert's
2	pre-decidual
2	proteoglycan,
2	radioautographical
2	heterotypic
2	collagens.
2	(opd)
2	cryogenerated
2	perpendicularly
2	opd
2	opds
2	periimplantation
2	digitalics
2	estrogens.
2	manipulated,
2	digitoxin
2	weak.
2	(pgcs)
2	spatiotemporally
2	hindgut,
2	epithelia,
2	fourth,
2	pentobarbital-anesthetized
2	exteriorized,
2	(carrageenan,
2	leukocyte-endothelium,
2	weakly.
2	decidualised
2	non-decidualised
2	pre-implantation
2	eletrophoresis
2	chondroitin-0-sulfate,
2	chondroitin-6-sulfate,
2	syndecan-4,
2	hexammine
2	trichloride
2	hyaluronan.
2	rht
2	(hlf)
2	(hexamethonium
2	hydralazine).
2	(gracilis)
2	(-11%)
2	hlf.
2	(shrs),
2	km/h;
2	workloads,
2	(shrt)
2	(wkyt)
2	hlf,
2	infusion),
2	(-17
2	(density,
2	wkyt,
2	wkys
2	arachis
2	p.m.)
2	pas-positive
2	gland).
2	spie
2	cuprolinic
2	hyaluronidase.
2	(50-60%
2	capillary/fiber
2	10-day-old
2	#1
2	estrus.
2	analyse,
2	ancestors
2	extragonadal
2	adhesiveness
2	locomotion.
2	hurdles
2	deteriorating
2	(biochem.
2	soc.
2	25:249,
2	(pdg).
2	caracterization
2	nh4c1.
2	ram.
2	ram,
2	2-oxoglutarate,
2	nh4c1,
2	addtion
2	kidney-type.
2	cells-1.
2	protein-1.
2	low:
2	~27%
2	~84.6%
2	intralumenal
2	crypt.
2	aw
2	jb
2	30-40%
2	z-lines
2	3h-tryptophan
2	9-day-pregnant
2	black)
2	(pcc)
2	sudan-black-stained
2	pcc.
2	streptavidin-biotin
2	membrane‐bound
2	mouse‐decidual
2	electron‐dense
2	lysosomelike
2	(clc)
2	sacrifice,
2	5-,
2	non-pathological
2	2nd,
2	(2nd
2	intracytoplasmic.
2	lysosome-like
2	"thick"
2	40-68
2	abnormality.
2	vessel.
2	old).
2	after3h
2	(pvn
2	catheterization
2	8 weeks.
2	microscopy).
2	michelini.
2	(t2).
2	(osmotic
2	(t2),
2	(dhe
2	staining),
2	wb)
2	ß,
2	vst
2	wky-t),
2	-t
2	oxidative/pro-inflammatory
2	deactivation.
2	zanluqui,
2	raquel,
2	martins-pinge.
2	derangements
2	6 weeks
2	6 weeks.
2	(atropine
2	(rvlm).
2	dp/dt,
2	ihr,
2	tonus.
2	menopause,
2	(otergic)
2	subnuclei.
2	michelini
2	implanted.
2	(tr:
2	cardiovascular-controlling
2	(t2
2	on).
2	catheterization.
2	sdf-1,
2	14-fold
2	angii/ang
2	axes,
2	peptide)
2	(brs),
2	neun,
2	brs.
2	exercise:
2	training)
2	hplc),
2	(172±3
2	(358±7
2	b/min),
2	(4.04±0.31
2	2.31±0.19
2	b/min/mmhg
2	shr-s).
2	(1.9-fold)
2	(-28%)
2	(-7%)
2	neurohormones
2	chronotherapeutic
2	luciana
2	plasticity/activity
2	(perfused
2	denervation,
2	ramped
2	(snp)-induced
2	(0.11 mg/kg)
2	(0.43 × 10-9 mol/l
2	0.65 ml/h
2	30 min)
2	(+20%).
2	(apx
2	(101 ± 3
2	116 ± 3 mmhg,
2	p < 0.05
2	apx
2	reflexes,
2	(shr;
2	metalloproteinase-2/tissue
2	(mmp-2/timp-2)
2	hypertension:
2	arteriole,
2	elastic,
2	pvn;
2	eutrophic
2	hyperemic
2	(nts
2	(35s-oligonucleotide
2	hybridization)
2	shr).
2	changes)
2	exercise)
2	neuroplasticity,
2	shr)
2	peak;
2	(locomotor/
2	nonlocomotor)
2	(+30%;
2	(+29%;
2	(+50%
2	hyperemia.
2	dp/dtmax
2	dp/dtmax)
2	23).
2	(tibialis
2	non-locomotor
2	141%,
2	122%,
2	(174
2	19%,
2	15%).
2	19%),
2	tissue-dependent
2	starts,
2	(brain
2	s-oligodeoxynucleotide
2	5-phosphatase
2	(5ptase
2	substrate-2,
2	pi3-kinase.
2	phosphorthioate-modified
2	inositols
2	academic,
2	cultural,
2	attendance
2	career
2	(et).
2	trains
2	mncs
2	vp
2	beta-actin
2	postsurgical
2	afterward.
2	at1b
2	<0.01),
2	vehicle)
2	β1-adrenergic
2	+5
2	-4.1
2	reserve.
2	(inner
2	nonlocomotor
2	radiometricaly
2	tgr(asraogen).
2	32.4%
2	5-hydroxyindole
2	lowered.
2	5-hydroxyhyptophan
2	33-75%
2	tph.
2	at1-receptors.
2	intravenously)
2	nts/dmv.
2	-61
2	-35
2	(sedentary).
2	po).
2	(anesthetized
2	(at(1))
2	dl,
2	(dmv)
2	pmol/200
2	ot-receptor
2	brain-stem
2	weight-matched
2	nl/min)
2	3h-citrulline
2	(185
2	(significant
2	unchanged)
2	(l-nmma(nts)
2	ng/kg/min),
2	l-arg(nts)
2	l-nmma(nts).
2	accordance,
2	(25%
2	5.05
2	discharge.
2	(goldblatt
2	clip)
2	implanted)
2	(179
2	(95%);
2	6-mo
2	aortas)
2	growth/aging.
2	calibers,
2	thicknesses,
2	near-constant
2	distensibility.
2	extrathoracic
2	20-30
2	tachycardiac
2	response).
2	1-mm
2	slower,
2	(ang)
2	sham-coarcted
2	day-1po)
2	(132
2	nephrectomy.
2	captopril.
2	viscerosensory
2	(4.9
2	times).
2	impairment:
2	minute/mm
2	beats/min/mm
2	saralasin
2	base-line
2	mechanoelastic
2	aorta)
2	pulsation,
2	(dynamic
2	(iv),
2	avp].
2	tangential
2	hg.
2	(20%).
2	brii).
2	loin
2	femoris),
2	topside
2	sirloin
2	tenderloin,
2	cuts,
2	incorrectly.
2	1298
2	mules.
2	49.
2	gondii;
2	andg3
2	lambs.
2	magellanicus)
2	coast,
2	birds)
2	coccidians
2	rdna).
2	confusões
2	petrolina,
2	spixii,
2	seroprevalences
2	(29
2	rattus),
2	ornithodoros
2	auricularium
2	rattus)
2	natal.
2	toxodb-rflp
2	529
2	heron
2	canids.
2	tayassuidae
2	(sus
2	1:50.
2	anti-swine
2	ib.
2	98.9%,
2	tayassu
2	6.9%
2	tick-host
2	18.5%
2	(sensu
2	11.5%
2	51.6%
2	santarém
2	farming,
2	screened.
2	brocket
2	americana),
2	apella),
2	paca).
2	serogroup,
2	(pcr-rflp).
2	cs3)
2	briv
2	leghorn
2	#2,
2	(1:25
2	12-week-old
2	1:25).
2	(49.2%)
2	(22.2%)
2	flavius
2	(genera
2	reptiles,
2	pecari).
2	onca)
2	(cavia
2	demerarae),
2	(oryctolagus
2	cuniculus).
2	291
2	brain)
2	slaughterhouses
2	(caribbean
2	theileria,
2	cytauxzoon
2	paca),
2	42.85%
2	quarantine
2	dunghill
2	monteiro,
2	48.3%
2	microregions.
2	neospora-like
2	oocysts;
2	prescribe
2	-neospora
2	vultures
2	5.4%
2	sertão
2	680
2	1,200
2	64).
2	0.000;
2	disinfection
2	0.003;
2	1.37
2	tapajós-arapiuns
2	extractive
2	(ssurdna
2	region).
2	(emballonuridae,
2	molossidae
2	northern,
2	470
2	reserves.
2	(1.5%)
2	herbivorous
2	≥25).
2	firm,
2	hydroeletric
2	(brazilian
2	glycosomal-3-phosphate
2	10.2%
2	19.7%
2	25.7%
2	dogs;
2	archipelago.
2	dactylatra
2	leucogaster
2	aethereus
2	lepturus
2	640.
2	wish
2	collapsed
2	(cases
2	esophagitis
2	ulcerations
2	(case
2	markers)
2	uberlândia,
2	markers:
2	tgchbrud1
2	toxodb
2	accord
2	(types
2	i-iii)
2	diverse,
2	luis
2	1:16).
2	(trichechus
2	1:500
2	1:3,200
2	southernmost
2	30.3%
2	25.4%
2	young,
2	rop18
2	rop5
2	narrow,
2	sedimentation.
2	fisher’s
2	cati
2	(5.5%)
2	year),
2	breeds,
2	anthelmintics.
2	nasua)
2	70)
2	veado
2	343
2	3.5%,
2	1:400
2	1:800
2	χ2
2	2.3%
2	hughesi
2	(69
2	(sat
2	66)
2	purus
2	sampling,
2	flooded
2	dogs)
2	road
2	sarcocysts
2	brachyurus),
2	52.9%
2	puts
2	(vl),
2	960
2	(baixada
2	amazônia,
2	onca),
2	taurus),
2	brucellosis
2	(apicomplexa)
2	570
2	314
2	231
2	river,
2	coevolutionary
2	(atlantic
2	an05
2	few.
2	microarray,
2	natal,
2	(ccz)
2	0.027)
2	hemocultures
2	habits.
2	localities,
2	flocks,
2	3.2;
2	0.033).
2	avian,
2	oblongoguttatum,
2	longirostre,
2	rhipicephali
2	naponense
2	africae
2	grosso.
2	marsupials.
2	(akodon
2	nigripes
2	41.3%
2	98.8%
2	b. abortus
2	grippotyphosa
2	foetuses
2	brucellosis,
2	social,
2	bordering
2	mules
2	ethnicity,
2	chi-squared
2	ethnicity
2	dogs).
2	(amblyomma
2	stricto,
2	tigrinum,
2	(tamandua
2	tigrinus),
2	hoary
2	pcr-restriction
2	apico).
2	sul)
2	ompa
2	66.7%
2	floor
2	3.0%
2	(1/33)
2	hepatozoon,
2	rickettsia.
2	dirofilaria
2	immitis.
2	nematodes,
2	parasitological,
2	rodents:
2	russatus
2	afer
2	burrowing
2	insemination
2	cow
2	(dpi;
2	hemisphere,
2	variant)
2	#10
2	(chinese
2	#5
2	vehicles,
2	pcv2
2	multocida.
2	ci)
2	tajacu
2	non-volant
2	(≥
2	penicillata
2	redefining
2	equatoriensis
2	endotrypanum;
2	enriettii.
2	throws
2	supercontinent
2	validates
2	chiroptera,
2	trypanozoon
2	hemoculture
2	biome)
2	marinkellei.
2	recife
2	(marmosa
2	geoffroyi
2	geoffroy's
2	wiedii
2	transmissibility
2	16.4%
2	syringes
2	surveying
2	42.6%,
2	(40.3%)
2	gondii:
2	cs3,
2	shelters.
2	37.6
2	beagles
2	10(4)
2	solteira,
2	anti-ehrlichia,
2	75.3%,
2	17.2%
2	3.2%
2	283
2	molossus,
2	domesticated
2	hmd
2	caninum-seropositive
2	samplings
2	caev/t.
2	caev/n.
2	(cft)
2	buck
2	≥1:16
2	38.8%
2	81.6%
2	encouragement
2	spectrum,
2	biologists,
2	elementary
2	(3.7%)
2	1:5120
2	heart)
2	hens,
2	(40.7%)
2	87.5%
2	prioritized
2	3.90%
2	cow-years
2	inunguis
2	butembo
2	217
2	captured.
2	rodent.
2	rattus,
2	norvegicus,
2	exoantigen
2	54.8%
2	dolphins
2	anti-capybara
2	mat,
2	(gdh)
2	seroconvertion
2	(4.5%)
2	0.97,
2	gerbils,
2	titer,
2	handed
2	howler
2	yagouaroundi),
2	dois
2	pk1
2	1:16
2	(12.4%)
2	(23.3%)
2	(76.9%)
2	cuniculi.
2	61.5%
2	7.7%
2	(gt),
2	mussels.
2	gondii)
2	caninum)
2	36.2%
2	(47/130)
2	45.0%)
2	2,048,
2	(4/130)
2	7.7%)
2	6,400.
2	(ncsrs2)
2	p30
2	(tgsag1).
2	6,000
2	(l3)
2	colubriformis.
2	giv
2	(gi
2	(fec)
2	treatments;
2	livia)
2	maria,
2	(12.8%)
2	negro.
2	fox),
2	ancylostomidae
2	irritans.
2	(rhea
2	mossoró,
2	propitious
2	aracaju,
2	pumas
2	concolor),
2	leptospiras
2	(12.5%)
2	zoo,
2	zoos,
2	499
2	(10.5%).
2	(acari:
2	ixodidae)
2	dermacentor
2	nitens
2	neumann,
2	1897,
2	(fabricius,
2	cft
2	celisa.
2	(epg)
2	(bcs)
2	31.1
2	partum.
2	brii,
2	briv.
2	stillbirth
2	kittens
2	lw)
2	trickle
2	punctata
2	29th
2	29.6
2	1920
2	intermediately
2	mouse-virulence
2	blindness,
2	(dat,
2	(ifat,
2	(27.4%)
2	10-15
2	pcr-its1
2	pcr-hsp70
2	≥1:25);
2	canines,
2	(gii).
2	(65.7%)
2	20.7%
2	(53.3
2	26,
2	1:1,280
2	signifcant
2	immitis,
2	tigrinus)
2	oncillas
2	17.1%
2	natural,
2	pens,
2	municipalities.
2	hatch
2	(cte)
2	contortus
2	inês
2	undrenched
2	(p=0.026),
2	(p=0.003)
2	sul).
2	btub.
2	venopuncture
2	fluorescent-antibody
2	win
2	experiment;
2	humour,
2	antigen)
2	r-elisa
2	antigen).
2	measure.
2	colostrums
2	dilutions.
2	1:100,
2	vitrinus
2	(ae).
2	nematodes.
2	(peg)
2	15.6%
2	equid
2	eva,
2	stomatitis
2	eee,
2	42.0%
2	equines
2	all.
2	three-hundred
2	24.5%
2	host-adapted
2	60-kda
2	anthroponotic
2	brain/cerebellum
2	gondii-free
2	anti-leptospira
2	habit.
2	(10.0%)
2	shermani
2	ratio:
2	3.9;
2	interval:
2	p=0.003).
2	(46.4%)
2	five,
2	3500
2	(27.7%)
2	(31.5%)
2	(12.7%),
2	(4.4%),
2	(2.6%),
2	giardia,
2	(p≤0.05).
2	(bnc)
2	hoeschst
2	(given
2	sp),
2	sp).
2	1-3,
2	rhipicephali,
2	parkeri.
2	276
2	(10.2%)
2	(14.5%)
2	(g).
2	p<0.001),
2	13.2%
2	herpesvirus-1
2	15.1%
2	ltb4-stimulated
2	joão
2	guimarães
2	ym1,
2	inspire
2	phomactins
2	achieves
2	brakes
2	tensin
2	(pten)
2	myeloid-specific
2	pten-mediated
2	siha,
2	chemo-and
2	acetyltransferases
2	h3k9ac
2	fluc+)
2	fluc+
2	(kbm)
2	(kbp).
2	kbm.
2	(cd206+).
2	ildefonso
2	(pafr),
2	ko).
2	(gr1+)
2	(cd11c+)
2	(cd206+)
2	pafr-antagonist
2	pafr-deficient
2	tbet
2	ova-loaded
2	pafr-antagonist.
2	(i:c).
2	p105
2	lipopolysaccharide-induced
2	cycloxygenase-2
2	(wild-type)
2	diet).
2	ccr7,
2	il12,
2	il10.
2	(myeloid
2	5×105
2	gr1
2	double-positive
2	neutrophils)
2	ali-secondary
2	(α-sma)
2	myofibroblast
2	a-sma
2	qrt-pcr;
2	immunoblotting;
2	psa
2	α-sma,
2	β1/bmp-7
2	smad-2,
2	smad-3.
2	β1.
2	stumm
2	micrornas,
2	ltb4-mediated
2	blt1,
2	(uuo),
2	present:
2	lysyl
2	oxidase-1
2	(lox-1)
2	(bmp-7)
2	(3.3-fold
2	tgf-β/bmp-7
2	ratio);
2	molecule-related
2	genes;
2	rafts
2	βcd
2	flotillin-1,
2	(web2086,
2	pca4248)
2	(indomethacin,
2	ns-398)
2	mhcii,
2	cpaf.
2	pg-synthesis
2	cv)
2	francisco
2	colocalisation
2	pafr,
2	matheus
2	ali,
2	sub-tumorigenic
2	coinjected
2	tm1
2	pca4248
2	skmel37
2	cytometry;
2	blot;
2	cox-
2	brake
2	c-δ
2	(pkcδ)
2	(lamps)
2	(mam
2	superantigen)
2	mam,
2	pg21
2	pg18
2	<49
2	≥20
2	hominis)
2	<102
2	≥58
2	fermentans)
2	lamps.
2	5-lo-deficient
2	map-kinases
2	taurocholate.
2	7.5%.
2	trypsinogen
2	inflammation.methods:
2	selectins
2	challenge.results:
2	migration.conclusion:
2	(42mg/kg,
2	i.v.);
2	igg-opsonised
2	(igg-srbc)
2	igg-srbc.
2	(zileuton,
2	(cp105.696,
2	(mk571,
2	20min
2	igg-srbc,
2	inhibitor/antagonists
2	web2170.
2	(ascites,
2	[tnf-α]),
2	(amylase,
2	(myeloperoxidase
2	[mpo]
2	diagnosis),
2	(mitochondria
2	insufflation
2	(erk,
2	59%),
2	46%),
2	(pkc)-
2	(inos,
2	32%)
2	(cox-2,
2	46%)
2	(74%,
2	(cinc)-2
2	iu
2	(67%),
2	3′-kinase,
2	l-κbα
2	(~30%),
2	b220+,
2	factor;
2	(r-954,
2	(hoe140,
2	(r-954)
2	gata-3,
2	airway.
2	gassed
2	(mixed
2	a/b
2	antagonist;
2	10 mg/kg,
2	level)
2	cow's
2	duodenum.
2	(monocyte
2	(i-κb)α
2	supresses
2	(tnf).
2	(phosphorylation)
2	(3.6-fold),
2	(4.4-fold),
2	(4.7-fold),
2	(6.9-fold),
2	(2.3-fold).
2	(39%).
2	pkcs
2	mk571
2	injure
2	complaints
2	(hot)
2	alternately
2	j774,
2	hsp70,
2	1.5%.
2	no-sensitive
2	(dapi).
2	(nos2),
2	(17.8
2	47.5
2	homogenates),
2	(54.5
2	133.7
2	nos2.
2	non-parenchymal
2	iap.
2	recovered,
2	(c3h/hepas)
2	genetically.
2	immunologisis,
2	ic-induced
2	(paf)-receptor
2	(web2170
2	cv3988),
2	pro-metalloproteinase-9
2	(prommp-9)
2	(il-1;
2	[phe22]biget-1(19-37)
2	(ece))
2	co-cultures,
2	(50-70%
2	(70-100%
2	prommp-9
2	(40-50%
2	(60-75%
2	prommp-9.
2	degranulate.
2	gelatinases,
2	2o2)
2	(nos2-/-)
2	nitro-l-arginine-methyl-ester
2	(65%).
2	64%;
2	58%).
2	affect.
2	lt-induced
2	lts,
2	(arthus
2	extravasations
2	(ar),
2	(ir-et)
2	(bn52021;
2	ar-induced
2	bq-788
2	(web2170)
2	ns398).
2	mam-stimulation
2	expression).
2	1-eα
2	(c3h/hepas
2	c3h/hej)
2	(balb/c),
2	rifnγ
2	j774a.1
2	(h-2d),
2	pouches.
2	bradykinin)
2	(mct)
2	(mct
2	(lct
2	13).
2	intake/body
2	articular)
2	(ai).
2	1400w,
2	(txb
2	e:t
2	50:1)
2	(10:1,
2	e:t)
2	thioglicolate
2	web2086,
2	more-selective
2	12.13
2	(1.13
2	11.8
2	prostation,
2	hemoglobinuria
2	endotoxin-free
2	intimation
2	developed;
2	(th2)-
2	ovalbumin-sensitized
2	cytokines)
2	(sb
2	209670)
2	-8,
2	9-,
2	normoproteic
2	hypoproteic
2	bodyweight,
2	protein-calorie
2	passively
2	alumen,
2	(10.4%).
2	(529
2	peribronchial,
2	perivascular,
2	bronchoconstriction;
2	trapping,
2	joints,
2	l-655,240,
2	50-70
2	pancreatic-derived
2	embolization.
2	(baec)
2	micropore
2	u44069
2	(10-8,
2	l655240
2	lipoxygenases
2	bn52021,
2	rtis
2	edyn
2	peribronchiolar
2	vasopermeability,
2	paf/mouse,
2	(0.03-3.0
2	cimetidine.
2	dexamethansone
2	279,
2	66,
2	87,
2	subarachnoid
2	manufacture
2	radioimmunoassays.
2	arises,
2	(aia),
2	polyarthritis
2	helper/t
2	(80.8%
2	56.0%
2	63441
2	(80.4%).
2	grew,
2	(<10%).
2	mg/kg/twice
2	(50-60%)
2	peroxidase-phenol
2	macrophages-tumor
2	17.0
2	inflammed
2	guinea-pig,
2	(paf;
2	2.9,
2	cyclo‐oxygenase
2	ml−1),
2	spasmogenic
2	formamide
2	l-655,240
2	oky-046
2	complex-mediated
2	lending
2	suggestion.
2	bronchoconstriction.
2	b10.d2/nsn
2	c5molecule
2	carragenin,
2	acculation
2	aspirin.
2	16,16‐dimethyl
2	strip
2	bromocresol
2	atlantic,
2	south-american
2	crust
2	centuries.
2	modelling,
2	high-quality,
2	rise,
2	plans.
2	dive
2	seepage
2	non-asphalt
2	isotopes
2	ecosystem.
2	volcanoes
2	extremophiles.
2	distances,
2	subzero
2	fumaroles
2	glaciers
2	geothermal
2	desiccation
2	psychrophiles
2	hyperthermophilic
2	astrobiological
2	licence
2	mutagenicity.
2	diorcinol
2	worm,
2	bendia,
2	signori,
2	pellizari.
2	vents,
2	summer,
2	stations
2	bransfield
2	alpha-diversity
2	euryarchaeota,
2	clade)
2	assimilating
2	13c-dna
2	prevalently
2	betaproteobacteria.
2	assimilate
2	torrent
2	genus)
2	ascomycota
2	rhodosporidium
2	seeps.
2	epsilonproteobacteria
2	(97%)
2	cycling.
2	chemosynthetic
2	country's
2	cruise
2	seafloor
2	megabenthic
2	clams,
2	mussels,
2	pelagic
2	uncultured,
2	shetland
2	melting,
2	nutrients)
2	magnetosomes.
2	prismatic
2	magnetite
2	magnetically-enriched
2	gathering
2	propagules
2	nanoplankton
2	pico-
2	prochlorococcus
2	nutrient-rich
2	(dcm)
2	offshore
2	eabgl1a
2	40°c
2	cocktails
2	volcano
2	atacama
2	planetary
2	bloom
2	floor.
2	oxygenation.
2	psychrotrophic
2	rna-seq,
2	564
2	(absolute
2	p-value
2	<0.001)
2	ms/ms.
2	omic
2	cold-shock
2	haloferax
2	60°c.
2	cmaa
2	microbiology,
2	v.v.i.
2	952
2	alpina
2	linolenic
2	geochip
2	4.0,
2	992
2	forest-to-pasture
2	acidity,
2	500,
2	its1-5.8s-its2
2	biocatalysis
2	assis
2	psychotropic
2	+3
2	mangroves
2	synopsis
2	(bc).
2	ring-hydroxylating
2	venn
2	(arhd)
2	grain,
2	mbg-d
2	hints
2	(rs)-1-(phenyl)ethanol
2	psychrophile/psychrotroph
2	(s)-enantiomer
2	flavobacterium
2	inlet,
2	budget
2	comandante
2	methane.
2	eacf
2	wastewater.
2	uncultivated
2	(ndv)
2	(62°08s,
2	58°25w).
2	rhizospheres
2	shetlands
2	(fish)
2	polar,
2	michigan
2	hydrocarbon-contaminated
2	box-pcr
2	obtained;
2	sewage.
2	alkm)
2	rugosa,
2	putida,
2	6.4t
2	amoebic
2	lakes
2	selects
2	pneumophila.
2	sphingomonas
2	acquisition.
2	bp-utilizing
2	bias,
2	propiophenone
2	(s)-1b
2	baeyer-villiger
2	para-methoxy-phenol
2	enantiomerically
2	phenylpropanols
2	1b,2b
2	lipase-catalyzed
2	99%)
2	potentiator
2	microorganism,
2	bioremediation.
2	hydrocarbons.
2	microcosms,
2	biodegradation.
2	headspace
2	syringe
2	dioxygenases,
2	toluene
2	culture-dependent
2	(colony
2	soils;
2	(5°c)
2	flocculation
2	profuse
2	notice
2	disinfecting
2	chlorinated
2	decomposers
2	cemeteries
2	coliforms,
2	lipolitic
2	(75.7
2	indicators,
2	stm-pa
2	clostridia,
2	extended,
2	92%.
2	intra-tumor
2	angiogenic,
2	attractor
2	bifurcation
2	his/her
2	pinho,
2	bergami-santos
2	phosphoethanolamine
2	104.6
2	fatality
2	rafts.
2	overproduction.
2	pd-l1/cd274
2	locally,
2	modcs,
2	1,2-dioleoyl-3-trimethylammonium
2	propane
2	1,2-dioleoylphosphatidylethanolamine
2	290
2	0.17.
2	0.40
2	(dsc).
2	cell-tumor
2	(damp),
2	crystalized,
2	(sua)
2	crystals.
2	(ocr)
2	sua,
2	interferons
2	harnessing
2	carboxamide
2	antichagasic
2	nci-h1299
2	labmol-12
2	controversy.
2	elispot.
2	v-fitc/pi
2	suppressed,
2	decoupled
2	socs5.
2	stat3-dependent
2	socs5
2	mitogen-stimulated
2	mc-idc
2	a549,
2	nci-h1299,
2	nsclc
2	structure–activity
2	chili
2	pepper,
2	synthetized,
2	rpf151.
2	3-[4,5-dimethylthiazol-2-yl]-2,5diphenyltetrazolium
2	phosphatidyl-serine
2	ac-yvad-amc,
2	d3,
2	trail-r1/dr4
2	trail-2/dr5
2	trpv-1-independent,
2	pungency-based
2	pungency
2	(δψm),
2	<sup>13</sup>c
2	conformer
2	attracting
2	tumor-derived
2	exo
2	function-associated
2	jq1,
2	bet
2	readers,
2	jq1-treated
2	gm-csfr,
2	mo-dc
2	adaptive-immune
2	proteaseactivated
2	il-33r
2	st2,
2	proallergic
2	il-33,
2	lymphopoietin,
2	il-5-producing
2	agpromoting
2	well-designed
2	discovery-based
2	secretomes
2	algorithms,
2	microarrays,
2	topological
2	applications;
2	(sheds)
2	derived-dcs
2	(modcs),
2	(modcs)
2	bdca-1
2	sheds-exposed
2	idcs
2	(fluorescence
2	anti-cd83
2	cd14+
2	3 months
2	nephrectomy,
2	harvested,
2	chrcc
2	s-phase,
2	redirection
2	padre,
2	0.21μm-0.37μm/minute
2	0.36μm-0.52μm/
2	biotek™
2	m-mddc
2	0.04),
2	0.009).
2	semipermeable
2	permeated
2	cognizant
2	comm.
2	corp.
2	"companion
2	partner"
2	chp,
2	iab
2	(pgs),
2	monocytes'
2	paniculata
2	(brdu).
2	(gm-csf)
2	dc-sign,
2	p9,
2	gingivitis.
2	langerhans'
2	propria,
2	chemopreventive
2	0.26,
2	0.24,
2	cyclins.
2	c8.
2	(cr)1
2	cr4)
2	cr2
2	extrahepatic
2	(f)i,
2	report:
2	colorimetrically
2	scc,
2	adenocarcinoma).
2	likely,
2	extinction.
2	self-replicating
2	addressed:
2	recurrence,
2	submaxillary
2	sialectomy
2	til
2	(lda)
2	lda
2	expectations.
2	(mri)
2	effusions
2	10-14
2	invariably
2	suspensions,
2	pbbl
2	hiv-specific
2	substratum,
2	diesters.
2	10(5)
2	dismutation.
2	(bcg).
2	lilian
2	rego
2	diethylnitrosamine
2	(den).
2	(airmax×airmin)
2	cristiano
2	rossato
2	pia-resistant
2	immunophenotyped
2	(ccl2/ccl3/ccl5/ccl12/ccl22)
2	0.5 ml
2	180 days.
2	(hsp),
2	phylogeneticaly
2	(k409a)
2	120-
2	270-days
2	adult"
2	aged"
2	compared.results:
2	hiii)
2	alterations.conclusions:
2	gender-effect
2	baldon
2	francisca
2	vorraro
2	(females)
2	[f1(h
2	(34.8
2	(qtls).
2	802
2	(lod)=3.56,
2	3.52,
2	15.74,
2	3.34,
2	multiplicity,
2	(lod=12.18
2	4.69,
2	incisors.
2	112.60
2	pg/μl
2	tumori
2	illβ,
2	06,
2	cyplbl
2	carcinogen.
2	a375v
2	dmba;
2	375a
2	(ahrb1),
2	375v,
2	(ahrd),
2	dmba.
2	cell-adhesion
2	(cam).
2	ia(k),
2	anti-ia(k)
2	anti-cd4/cd8
2	had,
2	(200-fold)
2	(caa)
2	subconfluent
2	(plated
2	non-bound
2	non-specifically
2	blank
2	0.200
2	cro
2	fcμr,
2	cr3.
2	bcg-,
2	fcμr
2	immunocompetence
2	zy
2	(c3h,
2	bio.a)
2	(colombian
2	cl)
2	balb
2	bio.a
2	(c3h)
2	t‐lymphocytes
2	(helper/inducer),
2	anti‐cd4+
2	t-helper-cell-dependent
2	heterozygotes
2	ch50
2	heterozygotes.
2	normality.
2	inheritance.
2	caimans.
2	novy,
2	lineage)
2	flies);
2	tabanids,
2	crocodile.
2	colonises
2	host-switching
2	wetlands
2	madeirae.
2	infestans.
2	constraint
2	9.4%,
2	tsavo
2	(16.7%),
2	(3.5%)
2	nsnp,
2	reliance
2	motus.
2	(hrm)
2	protist
2	lifestyles.
2	extracellular,
2	conorhini.
2	species-
2	gorongosa
2	niassa
2	(mz),
2	morsitans
2	(gnp/nnr):
2	vivax/t.
2	identify,
2	dwellings
2	venezuela),
2	mozambique.
2	subgenera,
2	lizard-snake
2	bugs,
2	protein-70
2	bat-restricted
2	vespertilionis
2	cimicids
2	schizotrypanum.
2	signatures.
2	dixenous
2	lizards:
2	colombiensis,
2	equatorensis,
2	herreri,
2	hertigi,
2	sloths,
2	porcupines
2	polii
2	ggapdh)
2	porcisia
2	porcupine
2	(mundinia)
2	zelonia
2	leishmania-endotrypanum-porcisia
2	siamensis
2	australiensis
2	nomem
2	nudums.
2	blowflies
2	host-symbiont
2	chrysomya.
2	lucilia
2	disjunct
2	(nigeria)
2	y486
2	igg3.
2	tryptose
2	balb/c.
2	topology.
2	symbiont-free
2	(duttonella)
2	(wa)
2	263
2	ea,
2	tvl
2	(sa)
2	duttonella.
2	forwarded
2	hosting
2	hemoplasmas.
2	dicer1
2	fasciculata.
2	tvicatl-pcr.
2	30.4%
2	(55.6%)
2	phloem
2	leptodacylus
2	centrale,
2	2.00
2	centrale
2	(tci)
2	triplicate
2	(some
2	ancestor,
2	26.5
2	shelters
2	melanosuchus
2	sp.)
2	mouths
2	armoured
2	catfishes
2	luetkeni
2	cultures)
2	rod-like
2	donkeys.
2	(8.9
2	pcr-positive,
2	pcv,
2	(identified
2	sequences)
2	pinto
2	associations,
2	ecuador,
2	(18s
2	cytb
2	andes.
2	dtu.
2	peculiarity
2	loci)
2	burkina
2	ghana,
2	guiana
2	nagana,
2	(savannah,
2	kilifi)
2	congopain,
2	(cp2)
2	il3000,
2	il3000
2	intra-isolates:
2	archetypical
2	sav1-sav3
2	(variants)
2	sav4
2	kilifi.
2	canl
2	alcaligenaceae
2	proteobacterial
2	thiamine,
2	pantothenic
2	b6.
2	klein
2	inferences.
2	subclades.
2	alligatorid
2	symbionts,
2	(ornithine
2	symbiont.
2	livingstonei
2	trypomastigotes)
2	insect-infecting
2	kinetoplastibacterium
2	reconstruction,
2	betaproteobacterial
2	(pcv),
2	necropsy.
2	pregnancy;
2	140th
2	pericarditis,
2	epididymitis
2	hyperthermia,
2	527
2	flagellates,
2	redefined
2	trypanosomoses
2	gambiense
2	fatal.
2	biologically,
2	pathogenicity:
2	(dtus
2	tci-tcvi)
2	tcvi,
2	genealogies,
2	dtu-
2	worlds.
2	blown
2	recent.
2	haematobia
2	stomoxys
2	keds.
2	non-opportunistic
2	(t1-t17)
2	(t7,
2	t8,
2	t9,
2	t17)
2	(~1200
2	comandoni
2	t9),
2	t17,
2	divergence)
2	thermotolerance,
2	osmotolerance,
2	63.3%,
2	parasites/ml),
2	aceturate.
2	(81.82),
2	lethargy,
2	coat,
2	watery
2	pericardial
2	malacia
2	tabanus
2	antelope
2	divergences,
2	g2.
2	(hct)
2	theileri.
2	tthi
2	retrotransposons.
2	cannot,
2	endosymbionts.
2	strigomonas.
2	oncopelti
2	blastocrithidia
2	gibberella
2	moniliformis
2	agriculturally
2	(aflp,
2	mat-2.
2	r=0.95
2	r=0.79
2	p<0.0001);
2	r=0.93
2	r=0.78
2	p<0.0001).
2	abdomen,
2	beta-1,
2	consuming.
2	mammals:
2	a;
2	bovids
2	~1.7
2	600-720
2	cervids
2	z-phe-arg-amc
2	(herpetosoma).
2	lewisi.
2	flea-borne
2	livestock,
2	proboscides,
2	midguts
2	12.9%,
2	(49.3%)
2	centre,
2	northeast.
2	bodonids
2	(rangelipain)
2	(cruzipain).
2	(a-d)
2	rhodnius.
2	z3,
2	(acc01)
2	keratitis-causing
2	(∼99%
2	acc01
2	multiplying
2	hyperosmolar
2	neutral/alkaline
2	acc01.
2	grazing
2	redescribed
2	bovines.
2	buffy
2	opacity
2	anthropic
2	biogeographic
2	tciia),
2	intra-lineage
2	tra643
2	tra1719
2	tesa
2	(trypomastigote
2	positivities
2	10.7%
2	imprints
2	(an01-04)
2	an04
2	anurans.
2	hylidae
2	bufonidae;
2	an03
2	infestans,
2	nyala
2	nigeria
2	(west
2	kenya
2	(39.6%)
2	(12.9%)
2	459
2	tuberculata
2	durissus.
2	259
2	families),
2	distinguished,
2	affected;
2	parturition.
2	leucopenia
2	hypoalbuminemia.
2	sixty-one
2	elisa)
2	(p=0.007).
2	endomyocardial
2	propose:
2	type-species
2	subgenus;
2	rangeli-clade'
2	taxon.
2	host-species
2	opossum)
2	randomly-amplified
2	(tra625)
2	innocuousness
2	another,
2	china
2	dyskinetoplastic
2	non-phytomonas
2	thought,
2	hemiptera
2	characters,
2	228
2	pentatomidae
2	tubes.
2	flower
2	assigning
2	cultured.
2	juices
2	slides.
2	free-
2	certainty
2	(sl3')
2	platypus
2	tropism.
2	[trypanosoma
2	(c.
2	undesignated
2	thermophila
2	arginase,
2	360
2	muscarum,
2	diverges
2	endotrypanum,
2	flagellates.
2	800-bp
2	doubts
2	ssu,
2	eco
2	24s-beta
2	genus-related
2	genus-restricted
2	cassava
2	tulahuen
2	metacyclics.
2	mp287/03)
2	ectonucleotidases
2	(ifn)î
2	3-producing
2	ifnî
2	lage,
2	andrade.
2	h37rv-infected
2	salgado,
2	d'império-lima
2	alvarez.
2	30-35%
2	(pd1)
2	pdl1
2	anti-pd1
2	anti-pdl1-blocking
2	detriment
2	(tfh)
2	apoptotic-like
2	th1/tfh
2	cd4-deficient
2	bomfim,
2	salles,
2	lasunskaia,
2	hirata,
2	d'império-lima.
2	p2x7-dependent
2	(bm)-derived
2	(mp287/03
2	bovis),
2	immature-like
2	ly6gint
2	p2x7-/->cd45.1
2	(ly6ghi)
2	(ptb)
2	ptb
2	anti-oxidants
2	(xl-eda-id)
2	calmette–guérin
2	c.1238a>c/p.h413p.
2	exudate:
2	ltb4;
2	cox-2;
2	(tlr2-/-bav)
2	(wtbav),
2	(pmns),
2	tlr2-/-bav
2	wtbav
2	venom-associated
2	(vamps)
2	reparatory
2	best-studied
2	(perc),
2	(lpms)
2	(spms).
2	lpms,
2	(mhc).
2	f4/80lowmhc-iihigh
2	monocyte.
2	tissue-independent
2	acid-dependent
2	henrique
2	lima.
2	complimentary
2	metallophilic
2	(mmmφs)
2	(mzmφs)
2	b-cell-rich
2	mmmφs
2	mzmφs
2	(rpmφs)
2	rpmφs
2	(acute,
2	as-irbcs
2	(pcirbcs)
2	liver-tregs
2	spleen-tregs.
2	7-infected
2	(damps).
2	(myd88-/-)
2	boosts
2	parasitemias.
2	marrow-
2	mp287/03
2	m1/m2
2	pgd
2	(ivp)
2	(icm)
2	(groups:
2	pluripotency-related
2	fcs,
2	skin-resident
2	skin-migrated
2	+nk1.1-tcr-αβ+
2	cd1d-α-galcer
2	tetramer,
2	cd4+nk1.1+
2	experienced/activated
2	(cd44hicd69hicd122hi)
2	+nk1.1+
2	cd4+nk1.1-
2	cd8+nk1.1+
2	cd8+nk1.1-
2	immune-compromised
2	glia-derived
2	neurofilament,
2	nitrotyrosine,
2	s100β.
2	microdensitometric/morphometric
2	disarrangements,
2	(46.4%,
2	(239%,
2	(544%,
2	(16%,
2	(38%,
2	(21%,
2	ifn-γ-labeled
2	(plasma)
2	(s)igm,
2	(i)igm
2	cd69.
2	iigg2a
2	iigm.
2	29.2%
2	sigg2a,
2	40-day-infected
2	parasite-unrelated
2	2/immunoglobulin
2	(th2/igg1)
2	predefined
2	recalled
2	iggl-secreting
2	non-living
2	infection)
2	chloroquine-cured
2	(large)
2	nitroso
2	(enu;
2	backcrossed
2	es10
2	wrinkled.
2	membranoproliferative
2	rhino
2	over-production
2	"inflammatory"
2	reactivities,
2	p90,
2	intermedius
2	immunoglobulin-secreting
2	primed,
2	p90-treated
2	system:
2	tambourgi,
2	marques,
2	kipnis.
2	783-786,
2	1991.-in
2	c57bi/6
2	dba/j
2	30,000
2	immunogenic.
2	f(ab′)2b
2	prepared.
2	alkylation
2	(igg),
2	milligram
2	20.2
2	preparative
2	focusing.
2	daltons.
2	f5'ep-asfv
2	plaque‐forming
2	immune‐protected
2	accentuates
2	tritiated
2	autoradiography,
2	and.
2	alagoas
2	depositional
2	ccnd1
2	uva,
2	stalling
2	(ddr)
2	ddr
2	atr/chk1
2	kmt2d
2	balb/cj
2	hypotonia
2	hypotonia,
2	θ
2	photoprotectors.
2	(fpg)
2	supercoiled
2	p. orbicularis
2	prokaryotes.
2	w3110
2	inherited,
2	processed.
2	knocked
2	doxorubicin,
2	duox1-silenced
2	fossil
2	pm10,
2	(ddr),
2	pharmacy
2	breaks.
2	postulated.
2	phytocompounds
2	electrophoretically
2	transmittance
2	capacities.
2	wavelengths.
2	endonucleases,
2	photosensitization
2	absorb
2	stapf
2	fractioning
2	fractions)
2	essentials
2	oils.
2	bases.
2	hereafter
2	cip2a
2	dephosphorylation.
2	dermatologists
2	xp,
2	locate
2	+1
2	hyperphosphorylation
2	eta.
2	(ssdna)
2	forks.
2	monoubiquitination
2	fancd2-fanci
2	collective
2	ubiquitin-like
2	chemotherapy-mediated
2	(ercc6).
2	hormone/insulin-like
2	polyesters
2	(mostly
2	3-hpa
2	tmz.
2	sk
2	exposition.
2	mg/
2	quinolone
2	alerting
2	equitoxic
2	(2d)
2	ignoring
2	(3d
2	doxo.
2	3d-cultured
2	2d-cultured
2	uv-irradiation
2	ubiquitylation.
2	(pol
2	216-bp
2	uncovered,
2	g2-phase
2	knock
2	breaks,
2	templates.
2	(spf).
2	tmz,
2	platination.
2	(bso)
2	synchronized,
2	cs-b
2	clearly,
2	(ner).
2	polycomb
2	(lncrna)
2	prc2.
2	non-tumor,
2	rassf1c
2	h3k27me3
2	rna/dna
2	location-specific
2	appointed
2	rad51
2	xpg
2	(euphorbiaceae)
2	mrc5-sv
2	1.1%,
2	16.1
2	c-1,
2	(cubatão,
2	aerobically
2	semialdehyde
2	biotreatment
2	phenol-containing
2	(cis)
2	latitude.
2	(dox)
2	(involved
2	cmc.
2	cmc
2	broadly,
2	biomolecules,
2	investments
2	long-standing
2	collection,
2	daunorubicin,
2	choice.
2	olindensis,
2	tetrahydrotetracene.
2	(sub-g1)
2	(alkaline
2	gamma-proteobacteria.
2	resolved,
2	indels
2	deepest
2	(icl)
2	adducts,
2	xp-d,
2	mrc5
2	sub-g1
2	supercoiled-dna
2	(74
2	bioengineering
2	wavelengths,
2	lipoperoxide
2	perpetuate
2	pathway)
2	temozolomide,
2	abundant,
2	prous
2	(ttd)
2	(tfiih)
2	cooh-terminal
2	(ner)-deficient
2	atm/atr
2	xpa-deficient
2	cyclin/cdk
2	p21waf1/cip1,
2	p21waf1/cip1.
2	(confluent)
2	(lgt)
2	drivers
2	prokaryotes
2	selfish
2	pyrimidine-(6-4)-pyrimidone
2	(6-4pps),
2	cpd-photolyase
2	6-4pp-photolyase
2	cpd-photolyase,
2	photolyase.
2	uv-killing,
2	photosensitivity,
2	lomustine
2	[p53
2	cnu-induced
2	cross-links
2	(affecting
2	era,
2	fly.
2	utr
2	pigmentosum,
2	follicles.
2	uniformity
2	alpha-proteobacterium
2	orthologs,
2	tmz-induced
2	mgmt
2	o6meg-triggered
2	post-mitotic
2	rescuing
2	nonischemic
2	(skm),
2	(skm+)
2	289
2	318
2	(skm)
2	(11.8
2	(1005
2	524
2	528
2	(5.3-14.8%)
2	2-methyl-4-amino-5-hydroxymethylpyrimidine
2	(pyrimidine
2	4-methyl-5-(β-hydroxyethyl)
2	(thiazole
2	moiety).
2	2-carboxylate-4-methyl-5-β-(ethyl
2	5′-diphosphate)
2	nidulans
2	1,700
2	paraquat.
2	η;
2	(adxpv-egfp)
2	η-egfp
2	apoptosis-induction
2	excision-repair
2	xpb-mutated
2	thi4-disrupted
2	(petite
2	(w303).
2	w303.
2	β-glucuronidase
2	plant's
2	rad25
2	atxpb2
2	atxpb1,
2	traced,
2	duplicated.
2	lexa,
2	(lgt),
2	organisms'
2	duplications,
2	potentiality.
2	cpd-photolyase-egfp
2	dark,
2	has,
2	transcriptomes.
2	expressed-sequence
2	mansoni,
2	up,
2	schistosomula
2	three-
2	40,000
2	(oryza
2	monocots
2	monocot-specific
2	260,000
2	35.6%
2	14,409
2	communication/signal
2	40,821
2	1415
2	reassembling
2	assembling.
2	33,620
2	tagged.
2	31,000
2	thiamin,
2	tz-201
2	thiamin.
2	tz
2	thiamin;
2	(gfp)
2	codon,
2	leaky
2	(6-4
2	pps).
2	proneness
2	photolyase-proficient
2	(ttd)/xpd
2	uv-mediated
2	diproprionate
2	tumefaciens,
2	campestris,
2	compatibility,
2	quantifiable
2	(gcv).
2	usefulness,
2	(ad-tk)
2	(pcmv
2	en1)
2	ad-tk
2	gcv.
2	pcmv
2	en1
2	critical,
2	photolyase,
2	(national
2	(ncbi)
2	(mips)
2	database).
2	kingdom.
2	joining,
2	delay,
2	mms,
2	organellar
2	chloroplast
2	electronically
2	(singlet
2	1o2)
2	1o2,
2	endoperoxide,
2	soxrs
2	1o2-damaged
2	uvrabc
2	excinuclease
2	violacein,
2	violacein
2	ferrioxamine
2	repair-related
2	tags)
2	absorbs
2	aplacental
2	light-illumination,
2	kangaroo,
2	potorous
2	tridactylus,
2	photorepairing
2	photoreactivation-proficient
2	linked.
2	hairy
2	transconjugant
2	ptk2
2	die.
2	thaliana,
2	biosynthesis;
2	(uv,
2	(mms).
2	(potorous
2	uv-irradiation.
2	uv-irradiation,
2	endpoints
2	ebv
2	episome
2	3'-termini
2	phage.
2	(hbsag).
2	uv‐induced
2	polyhedrosis
2	(ndpo2).
2	t7
2	alkali-labile
2	mnng
2	strand-derived
2	ndpo2
2	phosphodiester
2	double‐stranded
2	(sv40)-based
2	water‐soluble
2	target)
2	ris
2	unirradiated
2	convenience
2	single‐strand
2	discontinuities
2	fluences
2	(3t3
2	strands.
2	dimer,
2	exposure)
2	(blaa),
2	blaa,
2	(amv)
2	pmd-amv
2	defeat)
2	context).
2	hub,
2	matching,
2	people's
2	recency
2	(amv),
2	cat-related
2	gray)
2	thalamic-hippocampal
2	threat-associated
2	confining
2	crouch-sniff
2	postures)
2	septo/hippocampal–hypothalamic–brainstem
2	rangel,baldo,canteras
2	hahn.
2	particular,a
2	pathway-tracing
2	macroconnections
2	regions,have
2	distinct,and
2	connections,the
2	(lhajd)
2	lhajd.
2	testing:
2	pre-encounter
2	intruders
2	however,changes
2	habituation,or
2	encounters,did
2	lhajd
2	connections,and
2	judgment
2	toj
2	hemifield
2	feher
2	baldo.
2	cue;
2	circuits,
2	slowest
2	psychonomic
2	bias.
2	outlining
2	paths,
2	(pmddm).
2	pmddm,
2	intruders,
2	intruder,
2	intruder-the
2	(presently
2	aggression).
2	formalism
2	language
2	language,
2	empirically
2	testable
2	compressed
2	illusion,
2	amateur
2	return.
2	perseverating
2	by-product
2	predator;
2	non-olfactory
2	crouch
2	sniff
2	postures),
2	nursing)
2	non-defensive
2	(amv).
2	threat)
2	pmd's
2	amv)
2	spikes
2	wakefulness
2	(scig).
2	forage,
2	hunt,
2	scig
2	alignment.
2	inquiry
2	ordinary
2	determinants,
2	considerations.
2	efs,
2	opponents
2	(dominant
2	conspecifics).
2	innately
2	subordinate
2	conspecific,
2	predators,
2	claim
2	launching
2	bindings
2	mislocalisation
2	mnemonic
2	(2008).
2	roach
2	chasing,
2	assistance,
2	moving,
2	morphine-sensitized
2	cockroaches
2	morphine-
2	switch.
2	(vo2)
2	0.07).
2	svi
2	dot.
2	covertly
2	perception.
2	emanating
2	optical,
2	(srt)
2	pressing
2	hand.
2	verbal,
2	eeg
2	tasks;
2	pictorial,
2	games,
2	opponents'
2	second-to-last
2	defender.
2	offence
2	attacker
2	mistakes
2	judging
2	offence,
2	(oudejans,
2	verheijen,
2	bakker,
2	gerrits,
2	steinbrückner,
2	beek,
2	404
2	oudejans
2	al's
2	mistakes.
2	referees'
2	misjudgments
2	setups
2	real-life
2	dots,
2	(flash-lag
2	effect).
2	eccentricities
2	concur
2	displacements
2	rotations
2	objects
2	axes
2	hs1
2	hs2
2	metagenomics.
2	p6
2	rep-encoding
2	fibropapillomatosis
2	(fp),
2	often,
2	(chelonia
2	mydas),
2	chelonid
2	(chhv5)
2	anthropogenically
2	chhv5.
2	40.9%
2	succession,
2	dimethylsulphoniopropionate
2	earth-the
2	basin-that
2	(pol)
2	phycodnaviridae.
2	coarse-grained
2	(kybp),
2	limeira,
2	taqi
2	endonuclease.
2	limeira
2	hadv-2.
2	fastidious.
2	penton-base
2	non-lytic
2	non-irradiated;
2	sec);
2	low-energy
2	design/materials
2	(780
2	cesspit
2	legislation
2	too.
2	fluorpentane
2	(zp60s),
2	vertrel
2	xf,
2	rt-seminested
2	natura
2	g4).
2	(25.8%)
2	(74.2%).
2	(cpv-2)
2	cpv-like
2	cpv-2
2	cpv-2a,
2	cpv-2b
2	(zp60s)
2	strategy'
2	sa-11,
2	seeded,
2	8,000-fold
2	rotavirus-positive
2	electropherotyped
2	segments)
2	mabs).
2	(9%).
2	electropherotypes
2	z,
2	electropherotyping,
2	2a4
2	(vat)
2	(sat)
2	conjugating
2	ubc9
2	srebp1
2	11βhsd1
2	t2d-like
2	mef2a/d
2	biochem
2	amp-responsive
2	(cre)
2	3t3l1
2	transientely
2	cre-sites.
2	cre-site,
2	(chip
2	ccaat/enhancer-binding
2	differentiation/glucose
2	adipose-tissue
2	(age-albumin)
2	nf-kappa-b
2	(∼50%)
2	hypothetically
2	hk2/hk2
2	mir-29c-3p
2	mir-93-5p,
2	mir-532-3p
2	fructosamine,
2	mir-29b-3p,
2	mir-29c-3p,
2	repressed.
2	ivyspring
2	publisher.
2	esr2-mediated
2	e2;
2	iborra,
2	okuda,
2	machado,
2	passarelli.
2	cetp-tg
2	three-month-old
2	m/min;
2	rt-qpcr,
2	sr-bi
2	hdl2
2	39%,
2	pellets),
2	tissues).
2	(sirt1)
2	[group
2	35;
2	old;
2	34.5
2	proteasome,
2	pyrraline
2	(pyr)
2	cycloheximide.
2	(hif1a)
2	(solute
2	esr1-selective
2	(mpp)
2	ddost,
2	t2dm.
2	slc2a2,
2	pck1
2	(key
2	revealed:
2	mir-133a-3p,
2	depict
2	victor
2	prediabetes
2	(nac).
2	(cml,
2	ren,
2	protein-to-creatinine
2	notoriously
2	column-based
2	pl.
2	thwart
2	bioscientifica
2	ighd.
2	brother
2	c.-223c>t
2	collected;
2	(pck1)
2	pck1,
2	g6pc
2	dir
2	(dkd),
2	(61%
2	21.0
2	mimic,
2	proteinuric
2	0.0007).
2	0.57;
2	gsm
2	asl
2	icaco
2	(sc
2	extract's
2	0.032)
2	luteum
2	steroidogenesis,
2	dioestrus,
2	il6.
2	antiatherogenic
2	oleoyl
2	18h
2	dm2-hsa-treated
2	desaturase
2	atherogenesis,
2	2.4.
2	rs3820589
2	agac
2	(50-400
2	slc2a4-binding
2	diabetic-shr.
2	beta-blockade,
2	augusto
2	christoffolete
2	migf-1
2	(mlc/migf-1).
2	(37.4
2	31.8
2	(3.25
2	2.39
2	0.03%/min,
2	glycolysis-related
2	pfk-1
2	~3-fold
2	pparβ/δ,
2	shr.conclusions:
2	(tnf,
2	(nfkb1)
2	(hypoxia
2	90%),
2	nfkb-site
2	pi3k/akt-dependent
2	a1c
2	sglt2.
2	bcecf/am.
2	nhe-3
2	hoe-694-sensitive
2	rsk
2	(i),
2	iat
2	30%).
2	presented:
2	overload;
2	characterised.
2	glut1/slc2a1
2	hif1a,
2	ovulation.
2	p<0.03)
2	2a2
2	(slc2a2)
2	codifies
2	(hnf-1α
2	hnf-4α
2	foxa2
2	srebf1
2	srebp-1c
2	hyposalivation
2	structural,
2	(fluorometric
2	102.8
2	mg/24
2	syndrome),
2	proposals.
2	pharmacogenomics
2	slc2a4;
2	motif-based
2	-83/-62
2	eletrophoretic
2	p50-
2	p65-binding
2	promote,
2	(ss),
2	smoker.
2	(pm),
2	esr1-antagonist
2	factor-
2	ac.
2	kh.
2	ia)
2	pharmacologie
2	thérapeutique.
2	methylatropine
2	glucose/insulin
2	(39.3%),
2	times),
2	srebp-1
2	model.methods:
2	54%,
2	50%;
2	69%,
2	quercetin.
2	(glut4),
2	tnfα-induced
2	inflammatory-related
2	(cn).
2	high-carbohydrate
2	(1-6
2	carbohydrate-
2	carbohydrate-enriched
2	glucose-insulin
2	(itts)
2	(gtts)
2	carbohydrate-or
2	nongenomically
2	evaluating,
2	(tx
2	100μg/100g
2	[sol]
2	[edl])
2	centrifugations
2	anti-glut4
2	rate-pressure
2	(~80%)
2	(6.9
2	post-ischemic
2	inadvertently
2	6u-
2	9u-treated
2	7.2,
2	<0.05
2	ss).
2	37,
2	stz-shr
2	running,
2	a-dependent
2	proximal,
2	cm-1),
2	sympathetic-
2	(pka)-mediated
2	(shr-d)
2	pka/sglt1
2	(∼30%,
2	diabetic-
2	hypertensive-induced
2	malabsorption
2	antagonizing
2	detraining.
2	(19%),
2	(24%),
2	(+36%)
2	fat:
2	0.60,
2	vegetable-oil
2	(100μl)
2	sb-
2	sf-induced
2	sband
2	sf-treated
2	∼60%
2	(∼150%)
2	(30%).
2	(arg),
2	mg/d),
2	fortotal
2	1/3/5,
2	p85a/55a
2	phosphotyrosine-ir,
2	phosphotyrosine-ir
2	phosphoserine-akt
2	phosphotyrosine-stat5
2	phosphotyrosine-janus
2	extenso-
2	rum
2	phosphotyrosine-stat3
2	p85a
2	p55a
2	(mef2d),
2	(trα).
2	hormonal,
2	tra
2	nucleosome,
2	hif-1a-binding
2	trα
2	hyperestrogenism,
2	gestational-induced
2	(∼200
2	l6,
2	hyperestrogenism
2	glimepiride,
2	(o)
2	4weeks
2	lowbody
2	polyphagia.
2	pioglitazone-treated
2	pioglitazone-
2	insulin-,
2	hnf-1
2	streptozotocin,
2	(12-mo)
2	(2-mo)
2	∼80
2	adenines
2	unchanging
2	(∼100%,
2	35 mg/day)
2	dilating
2	(arko)
2	erβ-/-
2	saline-injected),
2	induced:
2	modulation;
2	low-rsna
2	renal-denervated,
2	renal-denervated.
2	high-rsna
2	wky-diabetic,
2	shr-diabetic.
2	normal-rsna
2	wky-diabetics
2	(83%).
2	-15%,
2	c-d
2	c-d,
2	alone:
2	2.34
2	28.8
2	microsome,
2	(ns-0.5%),
2	(ls-0.06%),
2	(hs-3.12%)
2	(wat,
2	(∼40%),
2	(∼240%)
2	(∼80%)
2	(electroimmunoassay)
2	intra-renal
2	(6905±287,
2	3506±193,
2	4144±246
2	5204±516
2	au
2	(127.3±12
2	111.8±24
2	(45.9±3
2	13.4±4
2	glutamate-
2	(2-mo),
2	(4-mo)
2	(7-mo)
2	measured;
2	45%)
2	220%
2	7-mo
2	msg-mice
2	40%),
2	28%),
2	92%).
2	retarding
2	glut2.
2	acarbose-free
2	phosphofructo-1-kinase,
2	(pk).
2	(sglts)
2	(gluts).
2	15-month
2	glycosuria;
2	(ns),
2	(ls),
2	na+-diet
2	∼36%,
2	∼20%,
2	∼150%,
2	(msg),
2	msg/kg
2	1-14c-glycerol
2	glyceride
2	u14c
2	3h-2-deoxy
2	reutilization
2	morphostructural
2	streptozotocin-injected
2	anti-glut1
2	electroimmunoassay,
2	(r=0.65,
2	(lsd),
2	(nsd),
2	(msg).
2	diabetic:
2	(4u/100g
2	(autg)-
2	(msg)-treated
2	microgram
2	msg,
2	10.9
2	(0.75
2	autg-
2	glut-4,
2	thioredoxin,
2	upregulated.
2	burgdorferi,
2	scapularis,
2	pixr,
2	microbiome,
2	relish
2	amblyomma,
2	aureolatum,
2	(mic:
2	popg:popc
2	upshift,
2	independently,
2	blood-feeding.
2	rmsf.
2	toll,
2	imd,
2	signalling-associated
2	microplus)
2	intrastadially
2	interstadially
2	jaboticabal
2	preoviposition
2	acaricides
2	acaricides.
2	ivm,
2	bme26-ivm
2	(ssh)
2	(circular
2	(cmc)
2	freedom
2	activity-relationship,
2	shepherin
2	(shep
2	g<sup>1</sup>ygghgghgghgghgghgghghgggghg<sup>28</sup>.
2	heating.
2	products'
2	truncation
2	pronounced.
2	carboxyamidation
2	carboxyamidated
2	(3-28)a
2	(6-28)a
2	amps,
2	zncl<inf>2</inf>
2	hemolytic.
2	90028
2	fluo-shep
2	5(6)-carboxyfluorescein,
2	upshift.
2	(t4ss)
2	vector's
2	(fxa)
2	fxa-mediated
2	thrombin-mediated
2	injector
2	hemocidin
2	bond)
2	[thr2,6,11,15,d-pro9]-gm
2	pglu1
2	arg16-glu-arg18-nh2
2	enhancements
2	spermidine.
2	mygalin-induced
2	mygalin-activated
2	haemocytes
2	drugs:
2	polyenes,
2	echinocandins;
2	biodistribution.
2	technetium-99
2	gomesin's
2	permeabilisation
2	(α2m)
2	farfantepenaeus
2	detoxification.
2	copper-chelating
2	copper-dependent
2	laccase.
2	capsule.
2	nymphal
2	p8,
2	p19,
2	p23
2	microbes,
2	bioscience
2	(hemocidins).
2	hemocidins.
2	bmap,
2	bmcl1.
2	p1'.
2	biofilm-like
2	(amps).
2	gomesin-treated
2	streptomycin.
2	foliar
2	anaplasmosis,
2	(rickettsiales:
2	insure
2	tick-anaplasma
2	pheochromocytoma
2	in-gel
2	hyalophora
2	trichoplusia
2	helicoverpa
2	armigera
2	pest.
2	histidine-rich
2	termini.
2	80).
2	sequester
2	c-termini,
2	assignments
2	1h,
2	anti-m.
2	again.
2	anti-microplusin
2	hemocele,
2	trophozoites,
2	insect,
2	haemocytes.
2	incubations,
2	3-oh
2	hierarchically
2	reversed.
2	i.s.,
2	sorgine,
2	abreu,
2	gonzales,
2	j.c.,
2	p.l.,
2	1998.
2	jr.,
2	immunol.
2	vn
2	fluids,
2	folds.
2	histidine,
2	lysine.
2	electrostatically
2	gomesiana,
2	acanthoscurrin.
2	progomesin
2	propeptide.
2	(bme26)
2	meso-porphyrin
2	(pd-mp)
2	rhodamine-hemoglobin,
2	(microplusin
2	defensin).
2	(dsred2)
2	dsred2
2	suggested,
2	cryptococcosis,
2	[thr2,6,11,15,
2	(hb33-61)
2	hb33-61a,
2	amidation
2	417
2	mygalin,
2	(ms/ms)
2	n1,n8-bis(2,5-dihydroxybenzoyl)spermidine,
2	2,5-dihydroxybenzoic
2	(h2o2).
2	[ser2,6,11,15,
2	membrane-mimetic
2	dermaseptins
2	'de
2	novo'
2	bioactivities,
2	linearized
2	bicyclic
2	hemocoel
2	ixodidin
2	ixodidae),
2	chymotrypsin.
2	prepared:
2	(primary)
2	(normalized).
2	7584
2	3723
2	classes:
2	hemocyanin,
2	chem.
2	joins
2	α-chain.
2	10,204da
2	originality,
2	4285da
2	cysteines,
2	prepeptide
2	prepromolecule.
2	profit
2	residues).
2	acanthoscurrin
2	post-translationally
2	agglutinating
2	schmitti
2	(bovine
2	linkages.
2	antiparallel
2	granulocytes.
2	luminol-amplified
2	12-miristate
2	(help).
2	354,000
2	lipids),
2	lipoproteins.
2	heine.
2	(braz,
2	coelho,
2	curr.
2	703-706).
2	55fe-labeled
2	heme-help
2	2270.4
2	α-amide,
2	tachyplesin
2	polyphemusin
2	horseshoe
2	protegrins,
2	3,205.7
2	entities
2	executing
2	iodinated
2	cecropia
2	calpa
2	calmodulin-like
2	lysp
2	lyss
2	larvae;
2	lysp,
2	b-like
2	25,000
2	lysd
2	alternamide
2	tricyclic
2	phagotrophic
2	cm-sepharose
2	co-eluted
2	tiliroside
2	stages)
2	encystment
2	aureus)
2	chresta
2	leishmanicidal,
2	aurone
2	aurantiamide
2	gomphrena
2	epidermidis
2	steryl
2	glycosides
2	blutaparon
2	overlay
2	phenanthroline
2	ovoid
2	culinaris
2	lca
2	n-benzyloxycarbonyl-tyrosyl-alanyl
2	(z-tyr[125i]-alachn2)
2	z-tyr[125i]-alachn2
2	28-
2	31-kda
2	saturation,
2	pulse-chase
2	low-molecular-weight
2	(25-35
2	axenically
2	125i
2	l-leucine-methyl
2	(leu-ome).
2	leu-ome
2	pace
2	(leu-ome)
2	z-phe-alachn
2	25-
2	chymostatin.
2	[3h]leucine
2	mtt.
2	enzyme(s)
2	oncopelti,
2	valine
2	saccadic
2	200-ms
2	braun
2	janzen,
2	ranvaud.
2	musicians,
2	circle
2	pacing
2	finger-tapping
2	timing,
2	resources,
2	high-pressure.
2	respond.
2	shortest
2	goalkeeper-independent
2	adopting
2	landing
2	destination.
2	heights,
2	travel.
2	(pearson
2	signifi
2	cant
2	16-item
2	sniffin'
2	(ss-16)
2	inclined
2	confict
2	alcohol.
2	color-word
2	explicitly
2	culprit
2	words
2	start.
2	saturate
2	brazilian-portuguese
2	pennsylvania
2	income.
2	familiarity
2	norms
2	89.0%
2	(106
2	83.5%
2	(rts)
2	divide
2	arachnophobia
2	k-means
2	arachnophobic
2	nonarachnophobic
2	color-based
2	chromatic
2	subsystem
2	isoluminant
2	magenta
2	yellow,
2	chromaticity
2	diagram.
2	0.038).
2	found;
2	tending
2	turquoise
2	anosmia
2	bearings
2	better,
2	albinism
2	(closed
2	meant
2	key-press
2	acoustical
2	doves
2	soybeans.
2	brachiaria
2	foods.
2	kramer
2	restlessness.
2	azimuth
2	altitude
2	circle,
2	trans-equatorial
2	schmidt-koenig
2	map-and-compass
2	equinox,
2	updating
2	ephemerides
2	equator
2	flew
2	anomalously
2	march,
2	al.).
2	brasil)
2	blowing
2	hensel
2	suzuki
2	lattice
2	terms.
2	derived.
2	bracket
2	exciton
2	alloys
2	mn**
2	0+δ
2	1+δ
2	edges.
2	magneto-optical
2	faraday
2	k)
2	dependences
2	garcia.
2	(100)
2	{norm
2	matrix}
2	aitken
2	chrysomelas
2	268
2	sinan
2	plasmodium-exposed
2	intervillositis.
2	41),
2	mononucleates,
2	polymorphonucleates,
2	plasmodium-induced
2	knotting
2	4.21,
2	0.045),
2	25.59,
2	4.02,
2	0.046)
2	vivax-score
2	plasmodium)
2	power.
2	(reg-tc)
2	(cy-tc).
2	106t.
2	(spontaneous
2	clearance),
2	(ac-ims)
2	ac-ims
2	ac-ims,
2	cells/ml),
2	stimulation;
2	rosetting
2	il‐2.
2	cell‐mediated
2	1981,
2	licc,
2	rosette
2	2%.
2	(ctc)
2	monomolecular
2	rf-13r
2	organotelluranes
2	santos-junior,
2	brito,
2	queiroz,
2	martens,
2	siqueira,
2	assumpção,
2	machado-santelli,
2	bastos,
2	guimarães,
2	ci-gota
2	tlr2/4,
2	lipoprotein-exposed
2	photoaged
2	5,131
2	drosophila,
2	chrysotile,
2	aneuploidy,
2	7-epiclusianone
2	(egfr).
2	synchronize
2	visualization.
2	widefield
2	microscopes,
2	super-resolution
2	clarity
2	picomol
2	instrumentations
2	genomic,
2	academic-private
2	collaborations.
2	merge
2	rational-design
2	copper.
2	sorption
2	alive.
2	niero
2	aesthetic
2	rated
2	iv:
2	orders.
2	larva-specific
2	rhynchosciara,
2	histolysis
2	ecdysone.
2	fabaceae,
2	2,3,9-
2	trimethoxypterocarpan
2	(mcf7,
2	hs578t).
2	3,4-dihydroxy-9-methoxipterocarpan,
2	prometaphase.
2	monastral
2	anti-γ-tubulin
2	double-dot
2	72hs
2	v/dead
2	fluorochromes
2	(pamps).
2	nevus
2	binucleation
2	machado-santelli;
2	high-malignancy
2	(triple-negative
2	her-2).
2	tubulogenesis.
2	(vegfr2)
2	function-blocking
2	(htc)
2	(erk
2	gsk-3β)
2	[e-cadherin,
2	(cx26),
2	(cx32)].
2	cx26,
2	cx32
2	ser9-gsk-3β
2	(inactive
2	tyr216-gsk-3β
2	rananos.
2	nanos
2	specifying
2	transposition,
2	transposase,
2	transposition
2	queen
2	templates,
2	transposable-element
2	homology.
2	asmar1.
2	ant,
2	messor
2	bouvieri.
2	hymenoptera.
2	avascular
2	breast-derived
2	(mcf-7)-derived
2	bulls,
2	prepuce
2	gentamycin
2	spermatozoids
2	intracellularity
2	reorganisation
2	spindle-shaped
2	four-week-old
2	non-protein-modified
2	(casein).
2	aging-related
2	fiber-free
2	cortez
2	cystocytes
2	72.
2	libertas
2	academica
2	genome;
2	transpose
2	"cut-and-paste"
2	rhynchosciara.
2	(ramar1
2	ramar2)
2	hollaenderi,
2	millerii,
2	baschanti,
2	rmar1
2	rmar2
2	mollicute,
2	aswell
2	(rahsc70)
2	hepatocarcinoma
2	pre-60s
2	co-immunoprecipitates
2	(18s,
2	5s,
2	28s)
2	non-long
2	rar2,
2	3p
2	5′-truncated
2	ovarioles.
2	ants
2	strong,
2	dentists
2	arcade
2	gentle
2	feulgen-rossenbeck
2	counterstained
2	karyorrhexis
2	intriguingly
2	pre-rrnas,
2	nop17p
2	(lines),
2	retrotransposable
2	scrape
2	ramar2,
2	pericentromeric
2	boundaries,
2	cosmetics
2	siloxanetriol
2	pharmaceutical,
2	corticostylifera
2	bivalve
2	etc.)
2	microalgae
2	dinoflagellates.
2	apolar
2	2.96
2	(sciaridae)
2	polyteny
2	meaning,
2	categorization
2	'electronic
2	northern'
2	glucose-containing
2	nonpermissive
2	25s
2	feulgen's
2	cystodytes
2	2.5-kb
2	cocoon,
2	polytenization
2	puffs,
2	hardening
2	bradysia
2	hygida
2	c-4
2	requested
2	karyolysis
2	cone,
2	polyploid
2	non-giant
2	endoreduplication
2	polyploidization.
2	c-terminal.
2	lamin
2	atypia,
2	1-3)
2	premalignant
2	tatuape
2	lsil
2	t-47d,
2	hs-578t
2	kidney)
2	dmem.
2	elongated,
2	tunicates
2	rotary
2	vacuum
2	evaporator.
2	<500
2	h]-thymidine
2	24-hincubation
2	fora
2	choline-containing
2	2.86
2	foul
2	histogenetically
2	(hsf),
2	(bsf),
2	(bbf)
2	(hk),
2	hsf
2	(4,7%
2	4,9%,
2	bbf
2	(2,6%)
2	end-points
2	66.2%
2	22.4
2	18.8
2	buccal
2	puffs.
2	serum-supplemented
2	carcinoembryonic
2	(dph)
2	collagenase.
2	chondroitin-4,6-sulfate
2	coat.
2	subcultures.
2	dedifferentiation
2	high-molecular
2	ros3
2	[3h]-sphingosine
2	myo-[3h]-inositol,
2	hptlc
2	inositolphosphorylceramides
2	(ipcs)
2	phosphatidylinositols
2	(pis)
2	ipcs
2	d16:1/18:0-ipc,
2	t16:0/c18:0-ipc,
2	d18:1/18:0-ipc
2	t16:0/20:0-ipc)
2	pis
2	(sn-1-o-(c18:0)alkyl
2	-2-o-(c18:1)acylglycerol-3-hpo4-inositol
2	sn-1-o-(c18:0)acyl-2-o-(c18:1)acylglycerol-3-hpo4-inositol)
2	myo-inositol
2	7.68–9.37),
2	thiol-specific
2	(tsa)
2	tolerated.
2	lindenbergi
2	(ethanol
2	antimonial.
2	sandflies.
2	trypanothione
2	ethylenediamine
2	ethanolamine
2	diethylenetriamine
2	copper(ii)
2	lipophilic.
2	dihydrorhodamine
2	-(β
2	22.9
2	combinations.
2	[l.
2	amazonensis]
2	courses,
2	nude,
2	coelho
2	luciferase.
2	post-inoculation,
2	tamoxifen's
2	reimão
2	models)
2	background:the
2	continuous.
2	culminate
2	btp
2	alternative.
2	axoneme
2	flagellum,
2	redox-active
2	hasps
2	leishmania-specific
2	hasp-like
2	tamoxifen-treated
2	subcontinent
2	(calculated
2	metallodrug
2	252.0
2	intrarectally
2	15-23
2	dolichol.
2	familiaris).
2	s8.
2	mtt,
2	intravacuolar
2	16.4
2	(gsno)
2	snac
2	l-1.
2	food-flavoring
2	85,
2	[2-14c]mevalonic
2	[1-14c]acetic
2	nerolidol-treated
2	[1(n)-
2	ointments
2	(la-pat1)
2	+/amino
2	symporters.
2	la-pat1
2	calpain-like
2	(mcp)-3
2	11.5-kda
2	spacer.
2	trans-splicing
2	oligonucleotides.
2	tropica
2	cspg
2	rhoa.
2	mir-206,
2	mir-222,
2	[3-(4,5dimethylthiazol-2-yl)-2,5-diphenyl
2	bromide]
2	22·86
2	amazonensis-mediated
2	elder
2	streptozotocin-
2	(mip-1).
2	vascular-endothelial
2	angiopoietin-2
2	(angpt-2).
2	mirs
2	(ptc),
2	(pccl3)
2	(tpc-1
2	bcpap,
2	backgrounds),
2	mimics-mir.
2	matrigel®).
2	2-3x
2	(10x)
2	gelatin.
2	(exogenous)
2	146b-5p.
2	ret/ptc),
2	tissue-localized
2	(p40il12
2	(arg1
2	(hereafter,
2	m0)
2	lps),
2	(il4
2	il13)
2	m0,
2	amore
2	ofm(ifnγ
2	–/–
2	inflammation-
2	(thbs1,
2	mmp8,
2	mmp13).
2	hemostasis.
2	spinosum,
2	anti-age
2	bioindicators.
2	subtidal
2	urchins.
2	l.variegatus.
2	e.lucunter,
2	(fhr127h)
2	fhr127h,
2	r127h
2	4-phenylbutiric
2	fh.we
2	sterechinus
2	counting,
2	crystalloid
2	coelomocytes.
2	(mip-3)
2	mip-3α
2	microarchitecture
2	nih-3t3
2	oc),
2	protrusion.
2	blebbistatin
2	invaginate
2	rho-rock
2	pan-rho
2	exotoxin
2	myosin.
2	rock.
2	sialophosphoprotein
2	(dspp)
2	odontoblasts,
2	ameloblasts;
2	mesenchyme.
2	rockii,
2	pak3,
2	dspp
2	elucidated;
2	exocytosis/endocytosis.
2	gliobastoma
2	ruffles
2	hypermethioninemia
2	808
2	mw/cm
2	hyperhomocysteinemia
2	smg.
2	metalloprotease-disintegrin
2	[costa,
2	e.p.,
2	44(8),
2	861-870.]
2	cartilage-derived
2	arginine-glycine-asparagine
2	(rgd),
2	rgd-binding
2	mechanotransduction.
2	(d30
2	d60).
2	(tβrii),
2	(psmads
2	2-3)
2	(ltbp1).
2	ltbp1
2	d30
2	d60
2	psmads
2	f-
2	g-actin
2	pituitaries,
2	(hsg)
2	(ecm;
2	matrigel)
2	(lpa).
2	rock,
2	pi3-kinase-independent
2	[d.
2	hajjar,
2	m.f.
2	e.t.
2	kimura,
2	(2003),
2	635-642].
2	bioefficacy
2	(igfbp).
2	igfbp-4,
2	igfbps,
2	igfbp-4.
2	appliance,
2	igfbp-4
2	paraffin-embedded.
2	(c20).
2	(t9).
2	α2-positive
2	t30
2	mpa,
2	(lpa)
2	vimentin-containing
2	depolymerization,
2	adhesions.
2	(n=100)
2	officially
2	chippaux
2	angle.
2	angle,
2	foot,
2	neutrality
2	deae-cellulose
2	club
2	taken.
2	1,10
2	expressively
2	stronger.
2	contexts.
2	mathematic-computational
2	mappings,
2	convolution
2	wavefront
2	non-stationary
2	well-known,
2	(e5)
2	e7-8
2	e9-10
2	e10
2	infundibular
2	hypophysectomy,
2	hypophysectomy.
2	decarboxylase,
2	mg.kg1
2	mg.kg-1
2	z-line
2	intakers
2	extents.
2	lh-adenohypophyseal
2	dbl-like
2	guanine-nucleotide
2	dbl
2	cdc42hs
2	vip-immunoreactive
2	sialadenectomy
2	intestine:
2	villus,
2	sialadenectomy,
2	(3.53
2	(5.01
2	(4.16
2	0.61
2	(2.58
2	1.9-
2	(4.14
2	8.36
2	(2.41
2	modalities.
2	(ifnβ)
2	adrgd-pg
2	mimetics
2	ifnβ,
2	adcmvp53
2	adpgp53,
2	interferon-β
2	il1α,
2	cosmcs
2	coordinately
2	repressors
2	pclpgp19
2	curve,
2	challenging,
2	γc
2	curing
2	leukemogenesis
2	cooperating
2	promoter/transgene
2	u3
2	converted,
2	p16(ink4a),
2	p21(cip1),
2	p21.
2	exclusion.
2	204
2	(arm
2	recrudescences
2	(this
2	receptor-ligand
2	duffy-binding
2	(darc)
2	dbpii-darc
2	dbpii-specific
2	igg+
2	transcending
2	vivax-endemic
2	platyrrhine
2	(nhp)
2	(aotus
2	makers
2	advancements
2	restructuring
2	mansonella
2	mitogens.
2	fil-
2	agenda.
2	(maebl)
2	immunoinformatics
2	mhci,
2	hinting
2	pan-reactive.
2	outwitting
2	rbps
2	rbp1:f8
2	malaria-free
2	anemic.
2	first-
2	disability.
2	greatly,
2	cytomegalovirus,
2	diagnosed.
2	sequences),
2	outcrossing.
2	entrenched
2	rcd
2	(hh)
2	parasitemic
2	76.8%
2	antigen/receptor
2	(pfemp-1)
2	5878
2	outnumbered
2	madagascar,
2	darc-negative
2	cambodia.
2	cambodian
2	globe,
2	>200
2	asmq
2	carriage.
2	artemisinin,
2	propeller
2	(acts),
2	malaria-related
2	anti-relapse
2	entity
2	arthralgia,
2	agenda
2	debate;
2	pacific,
2	pacific.
2	apes
2	coding).
2	42-snp
2	captures
2	mayaro
2	mayv
2	grossly
2	chills,
2	sweating,
2	bolivian
2	imported,
2	community-wide
2	gametocytemias
2	23.8%
2	2010)
2	(56.6%)
2	slaughterhouses.
2	brazil.methods:
2	82.9%
2	&#60;
2	crowding
2	0.028)
2	endemic,
2	127)
2	m-ratio
2	mci,
2	barcodes
2	348
2	east,
2	cambodia,
2	[he],
2	0.66,
2	(16.2
2	p=0.07).
2	descent.
2	duffy-negative
2	duffy-independent
2	pvs25
2	failed,
2	(61.9%)
2	undiagnosed
2	(greater
2	northwest
2	deficiency;
2	13.6%,
2	10.3%,
2	95%ci,
2	cardoso
2	papain-like
2	sera5.
2	445
2	or-
2	sr-haplotypes
2	(<5%)
2	wright's
2	unstable.
2	inconvenient
2	ricardo
2	unresolved
2	sulfadoxine,
2	dhps
2	sulfadoxine-resistant
2	infrequent
2	cell's
2	blood-group
2	single-point
2	a+b-
2	minisatellite
2	parts:
2	pvs230.
2	erythrocyte-binding
2	122
2	pvdbpii,
2	3-d
2	elude
2	sousa
2	nets,
2	spraying
2	monkey-adapted
2	~40%
2	substructure
2	commentary:
2	makeup
2	within-population
2	0.95)
2	invades
2	senegal,
2	dimorphisms
2	msp-2,
2	(18.6%)
2	(36.0%)
2	elisa-positive
2	425
2	lanka,
2	geography
2	ancestry.
2	public.
2	accidentally
2	migrate,
2	migrans
2	liverpool
2	56.8%,
2	enrolled,
2	22.3%
2	occupation,
2	one-quarter
2	reappearance
2	msp4
2	pvmsp4
2	thailand.
2	evolutively
2	msp-6
2	msp-9
2	reichenowi
2	13.9%
2	2-9
2	5-90
2	high-prevalence
2	42m
2	inaccurate
2	individual,
2	microsatellites,
2	breaking
2	classes,
2	worthy
2	exploration.
2	26.8%
2	[ci],
2	hookworm
2	extra-amazonian
2	0.5-3
2	non-sterilizing
2	vomiting,
2	(57.1%),
2	myalgia
2	52.6%
2	19.1%
2	3d7-type
2	paradoxically
2	6-59
2	demographic,
2	<4
2	replacements
2	speciation,
2	(average,
2	(msp)-1
2	(pvmsp-1
2	(pfmsp-119)
2	unini
2	jaú
2	69.6%)
2	(51.6
2	52.0%),
2	19.3%
2	(142
2	malariometric
2	amazonia;
2	54.3%
2	variant(s)
2	pvmsp-1-based
2	200)
2	3.7%,
2	towns.
2	children;
2	2000-2004
2	redundant.
2	intrastrain
2	overlap.
2	pexel
2	essential,
2	surfin
2	ofmsp-2
2	slippage
2	th2r
2	th3r
2	bao
2	high-transmission
2	32).
2	falciparum).
2	98.9%
2	(3.3%)
2	msp-119.
2	strata
2	mixed-genotype
2	(currently
2	vaccination),
2	cross-recognized
2	backgrounds,
2	ciet
2	capita
2	day-care
2	helminths.
2	(poor
2	formazan
2	855
2	1286
2	myanmar.
2	variant-type
2	pov
2	nigerian
2	i/cdc
2	(sera)
2	fcr3,
2	allotypes
2	(creating
2	pvmsp-1,
2	nonrepeat
2	0.009)
2	(4.4%)
2	trichuris
2	(1.0%).
2	z-score
2	prediction,
2	(mph)
2	345
2	south-eastern
2	cells/μl
2	manner;
2	qualitative,
2	iv).
2	pftrap
2	constraints.
2	dimorphic,
2	variant-specific,
2	s20
2	indians,
2	hyperendemic
2	fy,
2	(msp-119)
2	(novel
2	replacements),
2	brazil-1
2	(e-tsr-f)
2	brazil-2
2	(q-tsr-f).
2	msp-i
2	3.83-4.99
2	kb).
2	'epidemic'
2	msp-1.
2	67).
2	secular
2	results/conclusions
2	13.1%
2	care)
2	sixty-nine
2	islands.
2	derivation
2	consideration,
2	stephen
2	rich,
2	disequilibria
2	drift
2	polymorphic,
2	clonality.
2	harder
2	heterozygosities
2	(f(st)
2	non-african
2	hypoendemicity
2	blocks)
2	spatial,
2	isolate-specific
2	kawamoto,
2	liu,
2	(3.4%)
2	anti-hcv
2	(1.7%).
2	isolate)
2	same,
2	africans.
2	life-long
2	indians.
2	44).
2	standardization.
2	karitiana,
2	cytophilic.
2	age-groups
2	4.75;
2	1.31-17.42),
2	low-igg1
2	mad20,
2	ro33.
2	mad20-type
2	(4a)
2	(4b),
2	immunoepidemiologic
2	pfr44,
2	pf72/hsp70-1,
2	jamari,
2	pfr44
2	(pfag-t).
2	parasitologic,
2	g/l).
2	erithrocytic
2	spf66
2	semi-immune,
2	reinfection.
2	low-avidity
2	short-lived,
2	lower;
2	breastfeeding,
2	scn)
2	immunoassay,
2	histogram
2	'tolerance
2	distribution',
2	convalescence.
2	(23.8%)
2	2-12
2	6-12
2	primaquine.
2	91)
2	6.6%
2	cross-sectional,
2	2.1,
2	unstable,
2	indoors
2	sero-epidemiological
2	six-month
2	urupá,
2	non-cytophilic)
2	exoantigens,
2	(p=0.052).
2	(feso4
2	7h2o)
2	normal-iron
2	(tsc).
2	(si
2	49.2
2	0.7%)
2	iron-sufficient
2	186.5
2	27.3
2	3:
2	137.3
2	2.3%).
2	2.3%)
2	groups.(abstract
2	velho
2	eligible.
2	village,
2	(38.4%),
2	(5.7%)
2	inhabitants,
2	seroepidemiological
2	(spearman
2	0.540,
2	cycling,
2	pollution,
2	pyrosequencing.
2	442
2	ascomycota,
2	glomeromycota,
2	mycosphaerella
2	demand,
2	seasonality.
2	vegetation.
2	phytopathogens
2	epicolactone,
2	sentence
2	(grant
2	capes
2	fapesp
2	anthozoa
2	universidad
2	solo
2	é
2	microrganismos
2	potencial
2	compostos
2	avaliar
2	objetivo
2	deste
2	positivos
2	além
2	possível
2	11-29,
2	cellulolytic,
2	rigorous
2	celluclast
2	hydrothermally
2	low-pi
2	solid-state
2	dr02
2	pentose-rich
2	fed-batch,
2	secretome
2	43.7
2	saccharification
2	plantation
2	64%.
2	esculin
2	glycohydrolases
2	dr17
2	dr19,
2	dr45,
2	stigyum
2	wortmannii
2	decompose
2	phyla,
2	intriguing,
2	innovations.
2	minireview,
2	agar-based
2	bd-inhibitory
2	spectrophotometer
2	ascomycetes,
2	β-ketoacyl
2	c-methyltransferase
2	neighbour-joining
2	chemistry-based
2	non-reducing,
2	pkss.
2	reveals,
2	melioidosis
2	pseudomallei
2	baker
2	(phas)
2	polymers.
2	(dx)
2	footprint
2	1/2b,
2	1/2a
2	chemostat
2	mg/g.h,
2	cosmomycins
2	c-7
2	deoxysugar
2	ph-controlled
2	6.0-8.0,
2	retamycin,
2	(absorbance)
2	232%
2	16-mer
2	β-rhodomycinone
2	improved,
2	bioprospecting,
2	palindromes
2	8.2
2	ipt-85,
2	phages,
2	φbp2,
2	wl6.φbp1
2	icosahedral
2	65.7%
2	37.8%
2	530-bp
2	ycw,
2	perfringens,
2	(p <.05)
2	ycw.
2	butyrate,
2	beneficial.
2	fermentability
2	netb-toxins
2	(27.3%)
2	(−)
2	perfringens.
2	(44.7%)
2	(aia)
2	(scfas),
2	close,
2	(54.8%),
2	(100%,
2	0.0002),
2	smithii
2	food-borne
2	nigeria.
2	toxinotyping
2	multiplex-pcr
2	(22.7%)
2	(4%)
2	nucleotide-binding
2	gram-negative/gram-positive
2	nod1-deficient
2	bone-sparing
2	nod2-ko
2	times/wk
2	multi-ligand
2	nod2-
2	rip2-deficient
2	rankl-induced
2	periimplant
2	abutment
2	(ti)
2	monospecies
2	roughness
2	be.
2	pylori,
2	years-old)
2	cochran
2	mantel-haenszel
2	natives
2	alba)
2	(f.
2	etiology,
2	inoculations
2	erosion,
2	cii-specific
2	disease-induced
2	cell-driven
2	(49.1%)
2	(pg);
2	immune-inflammatory
2	variance,
2	(receptor
2	periodontol
2	ltx,
2	(57.1%)
2	canifelinum
2	eikenella
2	56%,
2	met-rantes
2	cd19+
2	chromogenic
2	(99%),
2	(23%),
2	cepa,
2	79.8%
2	chemoattraction
2	cxcr3,
2	f4/80+,
2	(induced
2	[induced
2	challenges],
2	[cytokine
2	(lns)]
2	pd/al
2	pd+al
2	κ-light-chain-enhancer
2	(mmp)-13
2	interferences,
2	parapsilosis.
2	enterococcus,
2	22.2%
2	actinomycetemcomitans-
2	(mmp)-13,
2	pia/pd
2	rorγ
2	hyper-inflammatory
2	(ctla-4)
2	gallium
2	arsenide
2	1064-nm
2	sand-blasted
2	acid-etched
2	(49.4%)
2	peri-implantitis.
2	ccr1+
2	(mmp-1,
2	ccl3.
2	osteolytic
2	(htlv-1)
2	htlv-1-seronegative
2	(cp
2	virus)
2	pds
2	fusobacterium,
2	jaws
2	nucleatum-periodonticum-simiae
2	64.1%
2	(called
2	red-complex
2	(actinobacillus)
2	(mmp)-2,
2	8.33%
2	pair.
2	pneumosintes,
2	enterococci
2	non-oral
2	ppe2,
2	ppf18,
2	macrodilution
2	ppe1,
2	ppf18
2	1/16
2	ppf19
2	0.1-1.3%.
2	nctc9343
2	(bsc)
2	non-conjugated
2	(bsm).
2	(biofilm
2	bsc
2	bsm
2	appendages
2	rnd-type
2	ompa.
2	salt-treated
2	co-aggregation,
2	specimens;
2	anaerobically
2	32-a
2	imipenem,
2	concern,
2	perpetuation
2	(43.3%),
2	amplicons.
2	(64%)
2	(12%).
2	crossbred
2	ecologic
2	owners.
2	amino-guanidine
2	(bacteroides
2	fragilis)
2	six-week-old,
2	c57b1/6j
2	nephelometric
2	cefoxitin,
2	(breakpoint
2	5.5-kb
2	(70.2%)
2	galactose.
2	(84.37%)
2	non-diarrhea
2	ulceration,
2	gnotobiotic
2	(tissue
2	mmp/timp
2	rankl/opg
2	ecori
2	ribotyped
2	43718
2	ccl1
2	times:
2	titanium,
2	silver,
2	sulcus,
2	ash
2	ramosum,
2	septicum,
2	butyricum,
2	barattii,
2	bifermentans,
2	monomicrobial
2	(37.5%)
2	d-mannose,
2	d-xylose
2	anaerobes
2	imipenem.
2	(2.97,
2	1.88
2	4.70).
2	(90)
2	(91)
2	tcda+/tcdb+
2	tcda-/tcdb
2	(tcda-/tdcb-).
2	multiplex-polymerase
2	dentistry,
2	metronidazole,
2	hydrophobicity,
2	resonance.
2	eubacterium
2	aids-associated
2	megacolon.
2	microflora.
2	arbitrarily
2	susceptibility;
2	aids-related
2	matches.
2	m8171
2	pd-aids
2	pair,
2	(6%)
2	bacteriocins
2	haemolysin
2	haemagglutinin
2	aa1416
2	periodontitis)
2	spittoons
2	absorbent
2	lincomycin,
2	β-lactamases.
2	marmosets.
2	(usually
2	seabird
2	non-essential
2	pops
2	58)
2	biphenyls
2	(pcbs)
2	diphenyl
2	animal-derived
2	acclimatization
2	gills,
2	epithelialis
2	dynamic,
2	villi.
2	budapest,
2	hungary.
2	facile
2	porous
2	well-suited
2	proof-of-concept,
2	(oreochromis
2	niloticus)
2	nanotubes.
2	tilapias.
2	acid-treated
2	hno
2	dislocation
2	grouper
2	epinephelus
2	biliary
2	semi-static
2	puncture.
2	paraplast,
2	roosevelti
2	(sterechinus
2	neumayeri)
2	echinoderms
2	(curimbatá),
2	procholodontidae
2	ecologically.
2	prata
2	flow-cytometry
2	(charged
2	precipitate),
2	format.
2	33°c.
2	23°c,
2	biogeographical,
2	appendix
2	book.
2	traditionally,
2	canary
2	1,539
2	crinoidea,
2	392
2	asteroidea,
2	521
2	ophiuroidea,
2	242
2	echinoidea
2	holothuroidea.
2	panamic,
2	galápagos
2	biogeographically
2	indian,
2	lusitania
2	faunal
2	bathymetrical
2	caribbean-atlantic
2	domination
2	vermicularis
2	microcephala
2	delimited
2	pneumocytes
2	(cyprinus
2	(dmso)
2	μg/l).
2	urchin.
2	oxidoreductase,
2	tropomyosin
2	metabolim
2	chemists.
2	poecilia
2	vivipara
2	salinity.
2	rearing.
2	neumayeri
2	fisheries
2	perl's
2	telemetric
2	neoplasic
2	tilt
2	parotoid
2	honeycomb-like
2	alveoli.
2	myoepithelium
2	obstructs
2	jet
2	clarias
2	gariepinus
2	hpp.
2	sd).
2	ms/mmhg
2	ms/mmhg,
2	papaya
2	meleira
2	ampullate,
2	tubuliform
2	(hf
2	(62.5%)
2	nutrient.
2	coriiceps,
2	10.5%)
2	circumscribed
2	(1998)
2	wound,
2	60-90
2	black.
2	(mdhex-l)
2	brooding
2	dispersal.
2	fish)
2	coverslip
2	isles.
2	crop,
2	herbaspirillum
2	ferritin-labeled
2	snake,
2	boa
2	threads
2	heterophilic
2	heterophils,
2	thrombocytes,
2	harcourt
2	starfish
2	odontaster
2	mid-gastrula
2	cautiously
2	peripatus
2	acacioi
2	kidney-shaped
2	spherules
2	granular,
2	figures.
2	onychophora
2	antoniazzi
2	plugs
2	brittle
2	plugs.
2	tiny
2	diffused
2	amputation
2	whit
2	hepatectomy,
2	regenerated
2	hepatectomy.
2	(portal)
2	triiodothyronine.
2	suture.
2	proportion,
2	emaciation
2	commercial,
2	karnovsky's
2	flexibility.
2	gamete
2	niche,
2	cytoplasm;
2	aund
2	spawning.
2	atresia
2	descriptions.
2	stereological,
2	spermatogonia,
2	spermatocytes
2	spermatogenic
2	maculatus
2	(seasonal
2	gth
2	maculatus,
2	(dah),
2	16h,
2	leporinus
2	elongatus
2	details,
2	yolk,
2	rationalized
2	stalk
2	delimiting
2	lobes.
2	sinusoids.
2	hilarii,
2	adenohypophysis
2	previtellogenic
2	somatolactin
2	mesopotamicus
2	224
2	released,
2	unimodal
2	fishes,
2	(ppd),
2	fusiform
2	perinucleolar,
2	oocytes)
2	postovulatory
2	fasciatum,
2	histology)
2	150th
2	visualized.
2	eclosion
2	sertoli-germ
2	germ-germ
2	937.5
2	matrinxã,
2	microscopy:
2	alveoli
2	structure:
2	vale
2	piaractus
2	da);
2	2300
2	gsi
2	ovulate
2	8.1
2	evidences,
2	nonclassic
2	epworth
2	region-specific;
2	pgc1α,
2	lacking,
2	hibernating
2	activator.
2	geophysical
2	dysfunctions,
2	extrapineal
2	topic,
2	extra-uterine
2	(mmd)
2	somatic,
2	sexes;
2	walking.
2	(zt3
2	zt24).
2	light-cycle
2	dark-cycle.
2	dark-cycle
2	parthimos,
2	dantas,
2	andrade-silva,
2	ramos-lobo,
2	matos,
2	sinésio,
2	motta-teixeira,
2	donato,
2	reiter
2	cipolla-neto.
2	(mel),
2	conveys
2	unclear;
2	mel-treated
2	signal-transducer
2	league
2	"a
2	attention,
2	neuroprotective,
2	order):
2	signed
2	sleep/wake
2	iprgc
2	470-nm
2	melanopsin
2	(direct
2	activation).
2	organismal
2	interventions,
2	renin–angiotensin
2	alleviates
2	(tle).
2	receptor-related
2	(rorα)
2	bmj
2	unfavourable
2	placebo,
2	amitriptyline.
2	pre-exercise
2	photoperiods.
2	photoperiods
2	photoperiods,
2	photoperiod,
2	cumulus-oocyte
2	rorα,
2	ramos-lobo
2	reestablishes
2	or/and
2	studied;
2	anti-androgen
2	(24-hr
2	(chronobiotic
2	events:
2	(atp-citrate
2	(zt)
2	vectensis
2	per1-luciferase
2	cycled
2	free-running
2	β1-adrenoceptors
2	pyrrolidine-dithiocarbamate
2	ne-synchronized
2	disturbance,
2	chronodisruption
2	clock-controlled
2	progeny,
2	pernicious
2	ultrahigh-performance
2	high-mean-glycemia
2	(pnx).
2	camkii
2	p-creb
2	(sm),
2	norepinephrine-
2	(ne-)mediated
2	(ob-rb).
2	ob-rb
2	arylalkylamine-n-acetyl
2	(icer)
2	icer
2	exception.
2	peliciari-garcia
2	intolerant.
2	secretions,
2	(mel)
2	cognition.
2	receptors'
2	scavenger.
2	serine/threonine-protein
2	(upr),
2	regulatory-associated
2	mel.
2	upr,
2	lightdark
2	demostrated
2	cardiopathologies.
2	(mt1,
2	created,
2	1nm
2	luzindole
2	nonparticipation
2	ctb.
2	extended.
2	defensive)
2	adaptively
2	norepinephrine(ne)-synchronized
2	radiometry.
2	"night".
2	timed-insulin
2	(tss),
2	pi3k(p85),
2	pp85
2	294002
2	insomnia,
2	container
2	headaches
2	migraine.
2	7);
2	(ins)]
2	ins.
2	fulfilled.
2	present)
2	absent),
2	[glucose-6-phosphate
2	(fas)]
2	(hormone
2	lipase)
2	(bmal-1b,
2	cry-1)
2	fas;
2	rhythmically
2	0.001].
2	nifedipine,
2	(ne)-mediated
2	8m)
2	norepinephrine-mediated
2	(tpoh)
2	(12h
2	ne-stimulation,
2	ne),
2	hydroxyindole-o-methyltranferase
2	(hiomt),
2	tpoh,
2	hiomt,
2	prl.
2	power),
2	adipose,
2	wool
2	(rm)
2	19:00
2	(21:00
2	(60-hr
2	intermittently
2	12-hr
2	105%.
2	alone)
2	readjustment
2	(d-[u-
2	l-[u-14c]-lactate,
2	[2-14c]-
2	[1-14c]-palmitate)
2	(esterification),
2	(lipogenesis)
2	wk),
2	l-[u-
2	14c]-lactate,
2	14c]-acetate
2	adipocyte,
2	120%.
2	(105%),
2	(250%)
2	synergism,
2	subtype)
2	coactivated
2	ng/mg
2	(sham-operated).
2	11.00
2	p.m.).
2	hypercorticosteronemia
2	exposes
2	(insulin,
2	corticosterone).
2	determinations)
2	leptinemia
2	tuberalis
2	irs-1/pi(3)-kinase
2	irs-1/shp-2
2	comorbid
2	12:12
2	47)
2	60).
2	zt
2	(hplc-ed).
2	(sbnec)
2	sections:
2	chronobiology
2	(rchb),
2	photo-stimulation.
2	sugar,
2	photostimulated
2	neuroendocrine-immune
2	pineal/lamina
2	intercalaris
2	illumination
2	ganglionectomy,
2	deferens,
2	hypogastric
2	α,β‐methylene‐atp
2	(mf,
2	h/22
2	feeding/fasting,
2	[3h]-2-deoxyglucose
2	microci)
2	0.175
2	0.678
2	0.398
2	n.u.),
2	i.u.)
2	6:00
2	3:00
2	deferens.
2	"ill-adapted"
2	cosine
2	(slow
2	post-graduate
2	eating,
2	population-mean
2	0.007),
2	(training)
2	work)
2	destroying
2	(ha;
2	incubator,
2	imhv,
2	hemispheres
2	peck
2	m2-1
2	transcribe
2	(egfp)-tagged
2	chaperones.
2	small-molecule
2	efficiently.
2	(hhp)
2	non-denaturing
2	(ctb),
2	hhp
2	bar
2	hrsv-infected
2	(pires
2	oligomerize
2	car,
2	knob,
2	car.
2	rabies-virus
2	g-gene
2	bhk-21/psh-g+
2	anti-l
2	agreement.
2	(15/84)
2	1957
2	spike-like
2	homooligomer
2	hydrofobic
2	padeno-x
2	padeno-f
2	padeno-g
2	raf-1
2	mock-transfected
2	raec.
2	autophosphorylation.
2	70.8%
2	say
2	(hiv-1)
2	ej-ras
2	(l-pha).
2	non-transfected
2	moreover.
2	psh
2	fork,
2	cscl
2	intermediate-density
2	175,
2	4m
2	4n
2	print
2	version,
2	apologize
2	triumph
2	chemogenetic
2	predatory-like
2	musculatures,
2	pursuit
2	pursuit.
2	instruct
2	sweetness
2	anterodorsal,
2	profusely
2	l-serine
2	serine.
2	rev
2	vta.
2	paranigral
2	terminate
2	medial-to-lateral
2	procedural
2	(2003)
2	tfc,
2	cfc
2	supraoculomotor
2	habenula.
2	reportedly
2	olfactory-guided
2	entl.
2	cortices,
2	coeruleus.
2	eac,
2	piriform
2	commissure.
2	acsh
2	a10dc
2	fg/th
2	bstl.
2	sublenticular
2	mediolateral
2	ipac,
2	interconnected.
2	postinoculation.
2	prv
2	bilaterally;
2	supracapsular
2	components).
2	(medial
2	insular,
2	commissure,
2	caudoventral
2	portions.
2	(gp)
2	subparafascicular
2	cuneiform
2	perirhinal,
2	rostroventral
2	areas),
2	mesencephalic,
2	luys
2	extrapyramidal
2	territory),
2	parafascicular
2	magnus,
2	considered;
2	tubercle,
2	adamts-1.
2	(ht1080-mpa)
2	velocity,
2	adamts-1-enriched
2	fibrosarcospheres,
2	microtumors
2	microtumors,
2	(rounded
2	morphology).
2	hgf-related
2	ameloblastoma,
2	(rc)
2	(n = 10)
2	df.
2	kot,
2	formations.
2	laminins
2	gpnmb.
2	(glycoprotein
2	non-metastatic
2	c16-mediated
2	tks5
2	21 days,
2	3 days;
2	notch1,
2	exosomes,
2	nonbiased
2	neuroblast
2	cytokeratins,
2	3.342
2	(vim,
2	timp2,
2	timp1,
2	acta2
2	plag1).
2	(hsg).
2	mmp2.
2	falcão
2	(pathol.
2	pract.,
2	225;
2	(oral.
2	ameloblastomas
2	(phospho-akt),
2	(phospho-nf-b),
2	cyclin-d1,
2	cyclin-d1
2	β-catenin;
2	cyclin-d1;
2	(phospho-nf-b);
2	(phospho-nf-b)
2	ecm-bound
2	egf/egfr
2	(ame-1)
2	(hpv16)
2	(sirna),
2	ameloblastoma-derived
2	(ccot).
2	c16,
2	ag73-
2	invadopodia.
2	c16-
2	ag73-related
2	(mt1-mmp)
2	fluorescent-substrate
2	matrigel-gelatin-fitc
2	cortactin.
2	73:99-108,
2	ag73-induced
2	invasiveness1.
2	(tgf)-α
2	mmp-1,
2	tgf-α
2	timp-2.
2	(activated)
2	antigen-1,
2	[formerly
2	laminin-1;
2	aumailley
2	(2005).
2	326]
2	secretory-like
2	diastase-resistant
2	laminin-induced
2	narrower
2	(98%)
2	a6
2	upside
2	fluctuations,
2	chemotherapeutical
2	protease-inducing/activating
2	sikvav.
2	bsp
2	streptomycin,
2	humidified
2	(ser-ile-lys-val-ala-val)
2	noncontact
2	fiberoptics
2	noncarious
2	handpiece
2	gold.
2	silane
2	(m1
2	matrigel,
2	chamber).
2	(105)
2	dispensed
2	filter.
2	(%).
2	5.28±0.04%.
2	6.53±0.2%
2	anti-invasive
2	vx
2	cd-68
2	foamy
2	histogenesis
2	myxoma.
2	hydroxyapatites
2	counted,
2	(cks)
2	myoepithelial-like
2	plasmalemmal
2	agnor
2	ors
2	interphase,
2	elevations,
2	globules
2	intracoronary
2	percent.
2	at-
2	(sensitivity,
2	fibrin-rich
2	angioplasty,
2	22.7
2	youngest
2	glenoid
2	fossa,
2	(n=20)
2	(n=8),
2	deferoxamine
2	(n=6),
2	sod-treated
2	piedra
2	finds
2	dieldrin)
2	gaba-gated
2	rdl
2	t290
2	l)
2	(canestrini),
2	(lindane
2	dieldrin).
2	fao's
2	arriving
2	conorii
2	rrs
2	pyrethroid
2	cypermethrin,
2	synergized
2	(kdr)
2	tpp
2	rfs
2	uruguay,
2	pyrethroids
2	(differences
2	1.35
2	resistance).
2	acaricides,
2	(rr50)
2	14.9
2	lpt,
2	ticks;
2	hardy-weinberg
2	heterozygous.
2	population).
2	41)
2	5.36
2	(its2)
2	zoonoses.
2	1,207
2	felis,
2	rhopalopsyllus
2	(r.
2	alegre)
2	ivermectin.
2	(glta,
2	ompb,
2	17-kda)a
2	cruzes,
2	(d.
2	transstadial
2	bellii.
2	cooperi
2	(31.3%)
2	2001,
2	swine,
2	sus
2	(mean,
2	oblongoguttatum
2	scalpturatum
2	neumann
2	tortoise,
2	denticulata
2	215
2	(201
2	margins,
2	molted
2	umbra
2	anteater,
2	cyclopes
2	didactylus
2	didelphidis
2	fonseca
2	trj
2	colonies).
2	colony,
2	4.9%,
2	neighbor-joining
2	simile
2	borrelia-like
2	s.s.
2	norvergicus
2	callus
2	molt
2	n1
2	reasons:
2	changes;
2	19.5
2	vpa
2	mglur5
2	nrm,
2	(enk)
2	dhsc
2	infancy.
2	katherine
2	ravelli
2	demyelination,
2	mog35-55
2	encephalopathy.
2	synapsin-i
2	(ae,
2	conformational-sensitive
2	ditaddeplt
2	diiaddeplt
2	(pep19),
2	adipocytes;
2	perk1/2
2	tetrad,
2	cylinder
2	trpm7,
2	immunoblots,
2	lesion).
2	70 mwpk,
2	∼0.1 cm2,
2	6 j/cm2.
2	(nfs),
2	(mpz)
2	mpz,
2	nfs
2	3β
2	gsk-3β,
2	astrogliosis.
2	hyperexcitability
2	corticostriatal
2	gluas
2	(aβ),
2	14 days,
2	1(trpv1),
2	tvpv1,
2	(ex).
2	[11c]pbr28
2	[18f]fdopa
2	iba-1
2	toxin-induced
2	scenarios,
2	(pgc-1α)
2	thirty-day-old
2	depressive-like,
2	(non-social)
2	max-myc
2	(sys),
2	nf,
2	epileptogenesis
2	hilus,
2	ca1.
2	papd4,
2	xrn2,
2	functional-opposed
2	myelination.
2	infant.
2	ets,
2	myelin-specific
2	adjusts
2	enos/nnos/pi3-kinase/akt
2	diseases;
2	fromlate
2	(p3-p73).
2	(0.73
2	nicotine/cigarette)
2	workingmemory
2	(p20-p29),
2	(p37-p42)
2	(p67-p72).
2	p15,
2	referencememory
2	ets-exposed
2	quadrant
2	platformlocation
2	memory;
2	40.1
2	regimens,
2	duration)
2	undetermined.
2	over-expressing
2	hi.
2	anticipates
2	epileptiform
2	'-omics'
2	schizophrenic
2	connectivity,
2	sepsis-
2	(sae)
2	survivors.methods:
2	post-sepsis.
2	mice.results:
2	impairment.conclusions:
2	sae
2	closing
2	remain.
2	g-coupled
2	(egp),
2	(igp)
2	(snpr)
2	igp
2	snpr
2	egp,
2	gad
2	chaves-kirsten
2	probabilistic
2	deterministic
2	circumstance
2	intersected
2	genders.
2	disinhibiting
2	somatotopy
2	mcs-induced
2	(forelimb,
2	tail),
2	fos.
2	descendent
2	ceruleus.
2	histological/neurochemical
2	(6-ohda),
2	(clt),
2	pd),
2	(exb
2	exa),
2	(exa).
2	(caudate-putamen,
2	cpu).
2	cpu.
2	6-ohda,
2	trpv1-expressing
2	nerve-related
2	(ian).
2	crile
2	(emitting
2	wpk,
2	∼0.1
2	9500
2	preliminarily
2	(bdnf).
2	(cort)
2	release)
2	imipramine,
2	(dg)
2	mpfc
2	subfield
2	(zif268/fos)
2	centromedian-parafascicular
2	zif268,
2	δ-aminobutyric
2	(gaba),
2	9.5),
2	[th]
2	d1a
2	(astrocytes
2	(ultrasonic
2	vocalizations)
2	(t-maze
2	alternation)
2	(play
2	hypoactivation
2	summarize,
2	(gfap).results:
2	session)
2	111%,
2	(l3-l6)
2	(108%).conclusions:
2	(map2)
2	te,
2	geniculohypothalamic
2	(pgn)
2	primate,
2	(syn),
2	(brdu),
2	(ex7)
2	(ex15).
2	ex15,
2	sensorial
2	100μg/kg
2	tone-shock
2	(experimental
2	zenk-positive
2	eg,
2	newborn,
2	approaches;
2	immunolabel,
2	phenomenological
2	consciousness
2	(neurofilaments,
2	nfs)
2	(ex3,
2	ex15).
2	ex15
2	ex7,
2	time-point
2	syn,
2	(dlg),
2	dlg
2	deafferentation,
2	dlg.
2	dlg,
2	nox-induced
2	giemsa,
2	(giemsa,
2	p<0.01;
2	nr1,
2	p<0.03).
2	10%),
2	9%).
2	55%)
2	nr1.
2	hemichannels
2	interkinetic
2	overriding,
2	(carbenoxolone,
2	cbx)
2	cx36/cx50
2	(quinine)
2	proliferation/apoptosis
2	cbx-injected
2	histogenesis,
2	distinct.
2	endows
2	rodless
2	cx50.
2	onto-
2	phylogenesis
2	particularities.
2	dopaminergic,
2	gaba-ergic,
2	"new"
2	nitrinergic
2	neurotransmitters.
2	p2y
2	p2x4
2	p2y2,
2	adp-,
2	varicosities,
2	(sad),
2	(sad
2	operation),
2	18β-glycyrrhetinic
2	(18β-ga,
2	(kcl,
2	4.7-120
2	2/10
2	(82.7
2	relaxation),
2	5.3%)
2	kcl-induced
2	(9.85
2	(cx).
2	cx56
2	cx56,
2	cx50
2	establishment,
2	cerebellum).
2	glur1.
2	glur2/3+
2	pole.
2	cavy.
2	cb-ir
2	cb-
2	(2-30
2	nachr-
2	machr-mediated
2	cgmp-phosphodiesterase
2	β4
2	machr
2	nachr-induced
2	p2y4
2	synthase-positive
2	diaminofluorescein
2	anti-nociception
2	(ms100a9p),
2	(sligrl-nh
2	trypsin)
2	(hek),
2	(knrk-par
2	(knrk)
2	ms100a9
2	sligrl
2	knrk-par
2	chemoarchitecture,
2	9-15.
2	5a,
2	darpp-32+
2	porphyria
2	poisoning,
2	(ala)
2	accumulates.
2	succinylacetone
2	weri
2	ala-
2	aip
2	(icam)-1-mediated
2	iu/day
2	1.01
2	1.18
2	lenght),
2	μm2)
2	(1.15
2	(e4)
2	sublayers
2	laminae,
2	album
2	centrale;
2	5-6.
2	nuclei:
2	rhomboid,
2	awareness,
2	chick.
2	brain-gut
2	ovo
2	neuritic
2	pretectum
2	pv-positive
2	cr-positive
2	cb-positive
2	pt.
2	5-6
2	deposits.
2	circuitry,
2	arrives
2	(unx).
2	protein-to-dna
2	(protein/dna
2	s3226,
2	s3226.
2	glur2,
2	15%)
2	e14
2	pretectalis,
2	glur4-positive
2	neunte
2	immunoblottings,
2	α7-containing
2	(eopa,
2	3.4.22.19),
2	non-radiotopic
2	meynert.
2	anticipated,
2	recognizably
2	β2.
2	gaba-like
2	α8-
2	α5-positive
2	(embryonic
2	3.5-4),
2	cerebellum),
2	lateralis),
2	throclear
2	themes:
2	topics:
2	p15-21,
2	p15-21
2	optic,
2	rhodopsin
2	parvalbumin.
2	ß
2	diencephalon.
2	ß2.
2	(β-
2	duvernoy's
2	gallus,
2	sex)
2	neuropil.
2	(cajal's
2	(layers
2	8-13).
2	geniculate,
2	overcast
2	backup
2	(143
2	bearings),
2	α3-positive
2	e11.
2	1-15
2	isthmo-optic
2	differential,
2	α-amino-3-hydroxy-5-methyl-isoxasole-4-propionate
2	(ampa)/kainate
2	ka-1
2	glur7
2	avidin-biotin
2	35s-labeled
2	naqhr
2	α‐bungarotoxin‐sensitive
2	α3‐like
2	(α3‐li)
2	(e4.5).
2	plexiform,
2	α3‐li;
2	α8‐li,
2	acetyltransferase‐positive
2	αbgtachrs
2	disparities
2	cholecystokinin8-like
2	leucine-enkephalin-like
2	(11-18
2	12–26
2	contralateral,
2	enkephalinergic
2	α‐bungarotoxin‐binding
2	nachrs.
2	isthmic
2	interstitio‐pretecto‐subpretectalis,
2	dorsomedialis
2	root,
2	interpeduncularis,
2	β2‐li
2	cholecystokinin-like
2	(14-23
2	(accessory
2	5200
2	root.
2	superior-nasal
2	inferior-temporal
2	(25-32
2	modulators.
2	temporal-to-nasal
2	nasal-to-temporal
2	excited).
2	affected),
2	first-spike
2	(13.0
2	nystagmus.
2	expt.
2	detelencephalated
2	postsurgery
2	(npy).
2	visually-related
2	npy.
2	y-like
2	(npy-li)
2	npy-containing
2	(aos)
2	wulst)
2	preferences.
2	upward-nasal
2	impinge,
2	aos,
2	(gcl).
2	inl.
2	(ipl).
2	1988).
2	gcl.
2	7000
2	(nbor),
2	neurotransmitters/modulators,
2	gad-like
2	(gad-li)
2	anti-gaba-a
2	anti-nicotinic
2	(npy-li),
2	(cck-li).
2	(nt),
2	leucine-enkephalin
2	(l-enk),
2	(vip).
2	th-li
2	chemically-specific
2	arborize
2	(th-li,
2	sp-li,
2	chat-li,
2	gad-li,
2	5-ht-li,
2	npy-li,
2	nt-li,
2	l-enk-li,
2	vip-li
2	gad-li
2	(glv)
2	histochemically-distinct
2	hydroxylase-like
2	former,
2	downward-temporal
2	non-retinal
2	tyrosine‐hydroxylase
2	rhodamine‐labeled
2	10–15%
2	medium‐
2	large‐size
2	axis)
2	dgcs.
2	(21–28
2	th‐positive
2	commissures
2	lesioned,
2	recordings.
2	reflexes.
2	(icu)
2	cd32
2	(cpla2),
2	(ipla2)
2	(ptk),
2	mt-ii-activated
2	(tes)
2	technique:
2	-bodipy
2	radical-sensitive
2	tes-treated
2	men)
2	5′amp-activated
2	recruited,
2	marathon.
2	decompression
2	two-month-old
2	cd117
2	inos-induced
2	consultation
2	t2dp
2	workup
2	(dex
2	il-4),
2	20%),
2	marathon,
2	concanavalin-a-stimulated
2	4e-bp1)
2	(murf-1
2	mafbx)
2	4.2);
2	lambertucci
2	sandro
2	hirabara
2	3-(triazolyl)-coumarins
2	π⋯π
2	triazolyl-substituted
2	coumarins,
2	t0),
2	mcts/lcts
2	(7%)
2	β.
2	n-6),
2	n-6).
2	laureane
2	masi
2	(3.3-fold)
2	[tnf-α],
2	59.7
2	(1.6-fold).
2	(1.3-fold),
2	sedentary-diabetic
2	(sdi),
2	trained-diabetic
2	(tdi)
2	consumption-vo2max).
2	invasively;
2	flows,
2	(twitch
2	fivefold)
2	fourfold)
2	(1.2-fold)
2	polybia
2	fluidity,
2	athletic
2	frap
2	56.
2	glycaemia.
2	(daf-2-da)
2	daf-2-da
2	oxidase),
2	sod-peg.
2	(admsc)
2	(24-week-old).
2	amplex
2	(cd11
2	f4-80)
2	(cd3)
2	admscs-treated
2	μg/kg/d)
2	formoterol-treated
2	postinjury.
2	prognoses.
2	(target
2	lowdensity
2	120)
2	fa-activated
2	accordantly,
2	acids-induced
2	randle
2	fatiguing
2	(ldh),
2	trizol
2	5.91
2	muscle-derived-reactive
2	amplex-ultrared
2	33.7%,
2	(jurkat)
2	pa-treated
2	non-oxidative
2	l-nitro-arginine
2	(nl)
2	(dha),
2	pufa,
2	non-germ
2	facility.
2	conventionalized
2	ikkβ-iκb-nfκb
2	caricilli
2	2hr)
2	(cams)
2	pre-i/r
2	(ast)
2	prd
2	silicone
2	consecutively
2	aberrations,
2	elevation,
2	indices.
2	(cinc-2αβ)]
2	butyrate).
2	peritonium
2	tributyrin.
2	[14c]-glycogen
2	[u-14c]-d-glucose
2	gpr43-dependent
2	rac2,
2	(hdl)
2	abca1and
2	(0.01-1
2	(0.5-5.0
2	(0.01,
2	statin-treated
2	ezetimibe,
2	peroxisome-proliferator
2	(fa;
2	mufa,
2	haemodynamics,
2	(bfs),
2	max),
2	resultsmale
2	sedentary-infarcted
2	(si),
2	trained-infarcted
2	(ti).
2	5070
2	invasively.
2	bfs
2	microspheres.
2	(54)
2	conclusionearly
2	et-induced
2	(j774
2	acids),
2	(p<0·001)
2	(p<0·001).
2	sulphonylureas
2	lg.
2	(2mm),
2	(5mm)
2	(p<0·05).
2	aa-dependent
2	lox
2	15-h
2	(st-iih)
2	(normoglycemic
2	(mg/dl)
2	26.2
2	(st
2	(lt-iih
2	35.3
2	highlight,
2	vo2max,
2	fragmentation).
2	cross-section
2	cryolesion+rapamycin
2	cryolesion-only
2	0.44
2	lna.
2	(membrane
2	β2-integrin
2	lxr-target
2	nonfamilial)
2	statin-or
2	ezetimibe-treated
2	(lxr-)
2	(lxr-α)
2	(1.0-5.0
2	atf4
2	10nm
2	ventilated.
2	(54
2	-16
2	enterocytes,
2	14c]-labeled
2	(la),
2	radioactively
2	day;
2	predominance.
2	bmp9
2	smad5,
2	and-independent
2	anaplerosis
2	atp:adp
2	cataplerosis
2	npl
2	disarranged.
2	polysome;
2	shark
2	(2-dg)
2	(pfk),
2	pfk.
2	traf-6
2	(ck),
2	(ald),
2	got
2	gpt
2	3.5.
2	tnfαis
2	tnfαcan
2	consumption/co2
2	receptor-γcoactivator-1α,
2	generelated
2	proopiomelanocortin,
2	tnfα-treated
2	infliximab
2	wastage
2	(oleic,
2	integrin-dependent
2	stomodeum,
2	8):
2	ventricle:
2	hif1-α,
2	il8r),
2	(glut-1
2	glut-4)
2	(hif1-α,
2	il8r)
2	foxo1.
2	thermogenesis-related
2	irβ/irs-1
2	clamp.
2	(cytokine-induced
2	compilation.
2	h-fasted
2	phosphorylation)
2	long-duration
2	competitions.
2	anticachetic
2	cd4/cd8
2	generations)
2	accession)]
2	55.7%
2	tenderness
2	0.006),
2	stichting
2	calorimeter.
2	nt+lp
2	elaidic
2	(sa;
2	o2̇-
2	leptine
2	ω-7.
2	pre-adipocytes
2	(adipogenesis)
2	aim:statin
2	efflux/
2	(slco1b1,
2	slc22a1)
2	investigated.methods:quantitative
2	statins.results:differences
2	abcc2abcg2abcb1slco1b1slc22a1slc
2	o2b1
2	slco2b1abcc2abcb1abcg2slc22a1
2	slc22a1,
2	treatment.conclusion:these
2	simm
2	abcb1.
2	5′-end-labeled
2	(-198
2	+43)
2	nf-y,
2	sp1.
2	nf-y
2	(half-lives
2	mc-lr
2	scant.
2	(gh+)
2	trans-unsaturated
2	protein-independent
2	ffa:
2	diffusional
2	autoimmune,
2	rinm5f,
2	(satellite
2	(gc7),
2	p22phox)
2	fmlp.
2	amp.
2	pothomorphe
2	pubmed,
2	keywords
2	programming,
2	16.3
2	(13.5
2	introduction/purpose:
2	l);
2	tnf-α),
2	400,
2	600,
2	cpt-1
2	imtg
2	acyl-coenzyme
2	(lca-coa).
2	substrate-1/2
2	(irs),
2	phosphatidylinositol-3-kinase,
2	(nfkb),
2	uncoupler
2	sem)
2	meticulous
2	technology)
2	unraveled
2	myristic,
2	polyunsaturated/saturated
2	pkcδ.
2	designs:
2	h-exposure,
2	h-exposure
2	h-exposure.
2	stearate,
2	short-period
2	persistent,
2	(il-8),
2	mgln
2	(0-20
2	ketogenesis
2	interleukin-1beta
2	©2008the
2	pgj2-induced
2	silencing),
2	(express
2	ciglitazone-induced
2	pparγ-independent
2	investigated).
2	α-tocopherol.
2	(co,
2	wco
2	(280
2	pre-treatment,
2	(swimming)
2	5-minutes
2	intensities,
2	subcutaneous,
2	response-associated
2	(0·1-0·4
2	daf-2-fm
2	fura-2-am.
2	dihydroethidine
2	146,
2	ofbsa
2	(0-20/o)
2	(bax
2	bcl-xs)
2	(bcl-xl)
2	pbs,
2	c22:6
2	n-3),
2	c20:5
2	c16:0),
2	(oa;
2	cd25-α
2	epa,
2	la.
2	pkc-ζ
2	uncomfortable
2	vo2max.
2	f2-isoprostanes,
2	boys,
2	girls;
2	y).
2	f2-isoprostane
2	race-
2	gender-adjusted
2	multivariable
2	liposome-based
2	stream,
2	macrophage-foam
2	receptor-deficient
2	astonishing
2	precursor),
2	proliferation),
2	assumed.
2	c18:0),
2	doped
2	bilayer.
2	simplification
2	(ba2+)
2	charges,
2	calculates
2	mclaughlin
2	[mclaughlin,
2	s.g.a.,
2	szabo,
2	eisenman,
2	gen.
2	physiol.,
2	(1971)
2	667-687.]
2	cu,zn-
2	(xo)
2	cu,zn-sod.
2	cu,zn-sod
2	fo.
2	oil)
2	hypovolemic
2	210-226
2	long)
2	uncovered.
2	monocytes/macrophages,
2	hfgln
2	hexosamine
2	cardiotoxic
2	doxorubicin-induced
2	(mrp)
2	atpase)
2	(2.4-fold)
2	g-6p
2	rg
2	(bax)
2	(bcl-2)
2	(dha)-rich
2	20:5,
2	(22:6,
2	n-3/n-6
2	145%
2	128%.
2	epa-rich
2	(588
2	1-alpha
2	(92.2%
2	changed).
2	(22%
2	neutrophil,
2	(j774)
2	(peroxisome-proliferator-activated
2	molecules:
2	non-trained
2	γ-linolenic,
2	side-effect
2	glomerulonephritis,
2	bleomycin-induced
2	(50-200
2	(+)-2,3,9-trimethoxy-pterocarpan
2	(+)-3,9-dimethoxy-pterocarpan
2	[(+)-homopterocarpin]
2	(+)-3-hydroxy-9-methoxy-pterocarpan
2	[(+)-medicarpin]
2	(+)-3,4-dihydroxy-9-methoxy-pterocarpan
2	6:1,
2	30:1,
2	60:1
2	(zymography).
2	(56%),
2	(500%)
2	(oa).
2	nad+-linked
2	[u-14c]palmitic
2	(pma)-stimulated
2	72-kda
2	protein:
2	ucp-2
2	hypertriacylglycerolemia,
2	fo-fed
2	6:1
2	pre-loaded
2	lymphocyte)
2	(found
2	oils)
2	proton-mediated
2	electrometer
2	(scc).
2	membrane-forming
2	3.6-fold
2	120%
2	cysticerci
2	revised.
2	sk-mel
2	microregions
2	(30.0%)
2	(∼17
2	wt.%)
2	(charged)
2	diphytanoylphosphatidylcholine
2	(dphpc,
2	neutral)
2	(blms).
2	electrometer.
2	(0.4-2.0
2	units),
2	(symmetrically,
2	40-65
2	proton-related
2	(gun
2	gh)
2	proton.
2	reflecting,
2	kamp
2	[biochemistry
2	(1995)
2	11928].
2	asolectin,
2	cholesterol/pa
2	order-inducing
2	acyl-chains.
2	generalize
2	gp96
2	gp96),
2	(dlc)
2	glucose/glutamine
2	ciglitizone
2	[14c]-thymidine
2	pgj
2	inf-γ.
2	o2-,
2	activities:
2	culture)
2	(0.999)
2	cholesterol-rich
2	lde-carmustine
2	carmustine.
2	u/kg
2	(1mm)
2	(ma)
2	20.8%
2	gamma-glutamyltransferase
2	25%)
2	6.13
2	co-cultured.
2	mø)
2	[14c]-aa
2	[3h]-chol
2	n)
2	ncb)
2	fragmentation;
2	(inf)-γ,
2	d-carnitine
2	3.1%,
2	2.4%,
2	hemicholinium-3
2	bowel.
2	crohn's
2	ibd,
2	fiber.
2	(g6pdh)
2	mitochondrial,
2	dodecanoic
2	ethoxylated
2	d-[u-14c]glucose
2	2-deoxy-d-[2,6-3h]glucose
2	[2-14c]pyruvate.
2	substrate-1/2,
2	bromopalmitate,
2	non-metabolizable
2	[u-14c]palmitate
2	(r=0.99).
2	(randle
2	5-carbon
2	glutamine-utilizing
2	many,
2	acid-
2	post-treatment.
2	aa-stimulated
2	dismutase.
2	tocopherol.
2	44%)
2	crucial,
2	cytokine-sensitive
2	cytokine-stimulated
2	pufas)
2	60%),
2	capric
2	bmf
2	pre-coated
2	(7.5-fold)
2	lucigenin,
2	(6-diazo-5-oxo-l-norleucine),
2	time-dependent.
2	tocopherol,
2	[6-14c]-glucose,
2	[u-14c]-palmitic
2	[2-14c]-pyruvate
2	intra-peritoneal
2	(9.1
2	lps;
2	(cog)
2	day-5g
2	(mf13th
2	(beyond
2	mrp/gs-x
2	disproportionately
2	2•-)
2	(5.8-fold)
2	fo-rich
2	mealtime
2	(8.00-10.00
2	8.00-10.00
2	mfs,
2	council,
2	placentae.
2	parturition
2	(placental
2	d-1),
2	supplemented.
2	ht
2	mufas
2	cis.
2	(gsh-px)
2	iu/kg
2	fermentable/nonfermentable
2	glutaminolysis,
2	calmette-guérin-stimulus
2	leptin-cultivated
2	eventually,
2	(ucp2)
2	(ucp3)
2	ucp2.
2	esu
2	arachidonic:
2	chains,
2	naomi
2	nonessential
2	electromotility,
2	voltage-driven
2	motor.
2	subtracted
2	electromotility
2	prestin
2	glut-5
2	α-receptors.
2	ß-receptor
2	messenger)
2	(ifn-α)
2	93-260
2	261-410
2	(ifnar
2	1-ec)
2	prset
2	bl21(de3)plyss
2	anti-p2
2	daudi
2	(>6.25
2	hep
2	2/c
2	encephalomyocarditis
2	[14c]palmitate
2	all-glass
2	adsorbance
2	(diphytanoyl
2	phosphatidylcholine)
2	(azolectin)
2	(8.8
2	1.9)
2	(10.3
2	2.2)
2	glutamine)
2	tissue),
2	14c]-thymidine
2	0.013
2	(234
2	lipopolysaccharides.
2	cachexia;
2	(suv)
2	rev.
2	natl.
2	acad.
2	1952,
2	adrenaline.
2	nadph-producing
2	beneficially
2	(mln),
2	day-aged
2	glututhione
2	cutalase
2	lucigenin-dependent
2	oxygen-derived
2	2-deoxy-d-[3h]-glucose
2	μmol/h-1/g-1
2	(24.7
2	mmol/g.
2	glucagon-stimulated
2	self-protection
2	cells/rat)
2	support:
2	(swimming
2	load).
2	uptake)
2	(cc);
2	butter;
2	diets;
2	mercurial
2	neurovegetative
2	anamnesis
2	deviated
2	[1-14c]acetate
2	14c-incorporations
2	[4-14c]cholesterol
2	incorporations
2	pu,
2	liver:
2	68%,
2	na2+
2	(fr),
2	(fr-tb).
2	fr-tb.
2	(zn2+,
2	o.-2
2	mg2+-dependent
2	s-conjugate
2	(gs-x
2	(mrp1)
2	dnp-sg
2	α,β-unsaturated
2	(1-2
2	l-nna
2	nucleus),
2	45-50%
2	14c]-palmitic
2	able,
2	supplements,
2	β-oxidative
2	lymphocytes/107
2	(3.06
2	(cells
2	t24/83,
2	-0.956
2	-0.995)
2	concurrently,
2	(u-14c)d-glucose
2	(110%)
2	(1.40
2	162%
2	not-leptin-cultivated
2	(92%).
2	leptin:
2	lipids;
2	cu/zn-
2	(adm)
2	adrenodemedullation
2	(mln
2	(76%),
2	2.45).
2	c]-radioactivity
2	aa).
2	bubalus
2	knterocytes
2	(1×10
2	counter.
2	adenocarcinoma),
2	b1/6j
2	melanoma),
2	ever,
2	days:
2	155,
2	oils;
2	myristic
2	(2.3-fold)
2	(31%),
2	3h]-labeled
2	arachidonate.
2	arachidonate,
2	25-38%
2	17-73%.
2	0.02),
2	6.6
2	8.6
2	two-month
2	15-20%
2	17-fold
2	178-fold
2	controls©
2	triiodothyronin
2	(61%),
2	(500%),
2	hypercalcemia
2	amsterdam
2	70,000,
2	non-tumour-bearing
2	(gastrocnemius-sm)
2	(23%
2	200%,
2	c-triolein
2	mmi,
2	aspartate.
2	insulin:
2	bcg;
2	thyroxine,
2	nmoles/min/mg
2	deter-mined
2	(sfc)
2	ufc
2	inteimediary
2	peroxidative
2	oxygen),
2	'malic'
2	(aspartate
2	endurance.
2	macrophage.
2	thiolase
2	transferase.
2	[3-14c]-pyruvate
2	(coconut
2	[u-14c]-glucose,
2	[1-14c]-pyruvate
2	(3.7-fold)
2	lacticemia.
2	arterial-venous
2	14-20
2	hyper,
2	hypervg,
2	vagotomy;
2	salinevg,
2	(2400
2	mosm/l),
2	proposition,
2	(white
2	portion)
2	w-6
2	polyunsaturated-rich
2	(pentose-phosphate
2	(krebs
2	(thiobarbituric
2	(cuzn-
2	acylcoa
2	18.43
2	143.29
2	10.35
2	321.76
2	1.73
2	0.95,
2	thioglycollate‐injected
2	tumour‐implanted
2	[2‐14c]‐thymidine
2	[5‐3h]‐uridine
2	[5-3h]-uridine
2	fortified
2	c]glucose
2	fuels.
2	hormone-treated
2	5-aminolevulinic
2	(ala),
2	ala-treated
2	g-6-pdh
2	acitivity
2	carcinosarcoma.
2	satisfy
2	semistarvation.
2	semistarvation
2	mg++
2	carbohydrate,
2	tg-fa
2	(ibat),
2	substrates),
2	exercise;
2	hyperglycemia;
2	more;
2	citrate,
2	nadp+-isocitrate
2	carboxylase.
2	inter
2	lymphocyte.
2	(3-month
2	44.5%
2	21.4
2	"endogenous"
2	trebled
2	catabolites
2	(glucose,
2	cyanide.
2	(ad
2	unlabelled
2	(0-10
2	14co2,
2	[3-14c]pyruvate
2	3-oxoacid
2	utilise
2	carboxylate
2	carboxykinase,
2	lymph-node
2	stevia
2	rebaudiana
2	grams
2	eliminated,
2	turnstones
2	interpres)
2	~7
2	documents
2	ecohealth
2	alliance.
2	symptomatology.
2	(zika
2	fever).
2	ceara
2	(9/132)
2	prnt.
2	zikv-positive
2	zikv-associated
2	reiterate
2	etiopathogenic
2	rosa-fernandes,
2	cugola,
2	russo,
2	freire,
2	bassi
2	stern,
2	angeli,
2	durigon,
2	larsen,
2	beltrão-braga
2	palmisano.
2	(ms)-based
2	neuroprogenitor
2	zikv-af,
2	ps,
2	[p
2	cxcl1
2	assurance
2	parvoviridae)
2	medical,
2	(hts)
2	(aiv)
2	1212
2	(8),
2	un
2	attacked
2	fox,
2	anelloviridae
2	anelloviruses
2	provisionally
2	sy-napomorphic
2	(hpiv-3)
2	hpiv-3
2	brasiliensis)
2	nestlings
2	psittaci
2	wooden
2	cpcv
2	transcription-
2	apmvs
2	99.3%,
2	93.2%
2	pediatrics.
2	virologic
2	charadriiformes
2	retrieved.
2	aon1
2	hemisphere;
2	alphavirus
2	arthritogenic
2	encephalitic
2	(cae)
2	induration,
2	vsv
2	carajas,
2	tecnologia
2	semipalmated
2	sandpiper
2	(calidris
2	moulting.
2	october,
2	november,
2	april,
2	nearing
2	fatalities.
2	(aiv).
2	flyways
2	hcps
2	virol.
2	hospitalizations
2	difficult.
2	hrsv-a
2	hampering
2	rsv-specific
2	pz.
2	receipt
2	hemispheres.
2	warmer
2	(pygoscelis
2	penguins.
2	viruses:
2	adv,
2	rsv,
2	npa
2	adv
2	(mit),
2	(h1n1)
2	open-label
2	oseltamivir
2	standard-
2	1b,
2	2b)
2	wards
2	ba.
2	(wnv)
2	neutralisation
2	(ai)
2	h9
2	h9;
2	(12.90%)
2	h7;
2	wildlife,
2	sybr-green-based
2	spreads
2	1983)
2	hrsva.
2	60-nucleotide
2	(gb3
2	insert),
2	ga5
2	culprits
2	re-infecting
2	katzov-eckert
2	rubella,
2	contagious
2	2007-2008
2	ls)
2	(hmpv),
2	(hpiv1,
2	hpiv3
2	hpiv1
2	hpiv2
2	humidity.
2	economy
2	1997,
2	(fcov),
2	felv,
2	non-haematophagous
2	nonhaematophagous
2	municipal
2	cough.
2	coinfections.
2	(prematurity,
2	breastfeeding).
2	associations).
2	akodon
2	riparius
2	panel,
2	furinalis
2	clarification
2	(desmodus
2	rotundus)
2	rabies-specific
2	roost
2	hospitalised
2	community-acquired
2	albopictus
2	br543
2	(once
2	(hmpv)
2	genescan
2	purging
2	scarlet
2	irritability
2	predominately
2	suspicion
2	rash.
2	winter.
2	hrsvb,
2	"flipflop"
2	reversals
2	widespread.
2	epizooty
2	succeeded
2	(a1,
2	3b.
2	(37.2%)
2	newborns.
2	31-40
2	meatus
2	85.0%
2	92.9%
2	(amazon),
2	85%)
2	(prevalences
2	re-infections
2	"pressure
2	pan".
2	nci-h292
2	(39)
2	(29)
2	hela-i
2	scanned
2	6.8%,
2	(dn/ds
2	"in-house"
2	donation,
2	issued
2	rate).
2	nat-only
2	largest;
2	vp1,
2	vp3
2	msb-1
2	cav
2	luminex
2	b).
2	1955,
2	default.
2	(uh)
2	(usp)
2	(multiplex)
2	discrimination.
2	paralytic
2	china,
2	hemispheres,
2	vireo
2	olivaceus
2	versa,
2	elaenia
2	mesoleuca
2	cough
2	d5
2	antibody-inducing
2	bacterial/viral
2	subclass,
2	precfa-elicited
2	lentivirus,
2	retroviridae,
2	(blastocerus
2	bromide.
2	urti;
2	urti
2	non-asthmatics
2	123)
2	attacks,
2	≥3
2	months;
2	(hpv
2	76.5%
2	hhv
2	inhabitants)
2	responsible.
2	vaccine-associated
2	6550
2	5940,
2	(vlps)
2	(em)
2	three-segmented
2	dsrna.
2	5940
2	non-a-e
2	(2.3%)
2	transfusions
2	submassive
2	survived.
2	g4,
2	[6]
2	scrapings,
2	endonucleases:
2	bamhi,
2	bgii,
2	bgiii,
2	hindiii,
2	kpni,
2	saci,
2	saii,
2	smai,
2	xbai,
2	ad8,
2	ad7.
2	variants-
2	ad8/d11
2	ad8/d12
2	ad7b
2	ad7h,
2	07
2	exanthem
2	pneumovirus
2	(apv)
2	turkeys
2	turkey
2	non-specificity
2	come,
2	directly.
2	(4.8%)
2	hhv-7
2	anti-adenovirus
2	necrotising
2	vasculitis
2	microwell
2	self-limited
2	aplastic
2	enteropathogen
2	(10%).
2	(38%),
2	admission.
2	rotavirus,
2	415
2	hypothyroid,
2	thyrotrophic
2	(per2)
2	particular.
2	lats
2	1.04
2	recommends
2	(antithyroid
2	drug)
2	glut5,
2	fat-cd36,
2	fatp4,
2	npc1l1
2	fat-cd6
2	npc1l1,
2	glut5
2	fatp4
2	condition).
2	fatty-acid
2	elucidation.
2	sodium/iodide
2	tshr,
2	thyroperoxidase
2	(alloxan-induced)
2	c);
2	d);
2	(t3);
2	(gsk3)
2	methyltransferases
2	dams'
2	ribosome.
2	non-genomic/posttranscriptional
2	coexisting
2	ie-treated
2	3,3′-t2
2	utilization.
2	later).
2	thrb1
2	symporter,
2	draw
2	nai.
2	thyrocytes.
2	(mb),
2	"winter
2	physiology"
2	lectures
2	schools
2	teachers.
2	prepared,
2	audience
2	concepts,
2	supervising
2	professor.
2	curriculum
2	vitae
2	letter
2	intent.
2	lectures.
2	≥4.0,
2	(high).
2	followup,
2	instructors
2	outreach.
2	skills.
2	thyrotrophs.
2	trh-induced
2	intrapituitary
2	gonadotrophs
2	chronically-treated
2	t<inf>3</inf>.
2	novelinsights
2	trhr
2	(o2)
2	irreplaceable
2	(pi3k)/protein
2	thyrocytes
2	(2-fold),
2	(14%).
2	(gh).
2	synthesis/release,
2	[15.
2	μmols]
2	gonadotropins.
2	hypergonadotropic
2	(gonadotropin-releasing
2	decapitated,
2	epididymis,
2	polysomes.
2	543
2	germinative
2	androgen-responsive
2	(ventral
2	prostrate:
2	[bw];
2	undrained:
2	drained:
2	insulinoma
2	pi3k/akt/gsk-3β
2	(pdx-1).
2	th-depleted
2	(actd),
2	pgsk-3β
2	actd,
2	barth
2	nonoate
2	no/c-gmp
2	p-ampk-α
2	(ser473),
2	acc,
2	(gh),
2	pituitaries.
2	g)were
2	halves,
2	hemi-pituitaries)
2	(71
2	(8-br-cgmp,
2	arg-induced
2	hemi-pituitaries
2	somatostatinergic
2	nos/no
2	genomically
2	(slc2a)
2	glut1,
2	myc-tagged
2	(l6-glut4myc)
2	(l6-glut1myc)
2	(tx),
2	l6-glut1myc
2	glut3,
2	discount
2	glut.
2	estradiol,
2	lh;
2	seminiferous
2	reserves;
2	nai+naclo
2	nai+methimazole,
2	race-pat;
2	actinomycin-d-treated
2	0-6h.
2	methimazole,
2	epm-1
2	(res)
2	immunosupressant
2	dexa-treated
2	(tx).
2	evaluating:
2	osteopontine
2	(opn)
2	masseter.
2	24/group)
2	tx,
2	(~50%)
2	(itd)
2	na+/i-
2	(nis)-mediated
2	radioiodide
2	itd.
2	-54
2	(-54c>t)
2	whentransfected
2	cells.themutation
2	mrnalevelsremainedsimilar
2	tothosein
2	transfectedwithwild-type
2	polyribosomes-associated
2	nis-mediated
2	pedagogical
2	detective
2	institution's
2	gh/igf-i
2	(igf-i)
2	time-pcr,
2	(2,000
2	90-
2	trend.
2	ultrasonography
2	grater
2	confusing
2	tell
2	troublesome
2	endocrinologists,
2	preservation,
2	[a
2	orn)
2	hemipituitaries
2	gh-releasing
2	(d2).
2	t3;
2	met-treated
2	(thyroid
2	weight/day)
2	atp-supported
2	ofthe
2	muscles'
2	bw48-80
2	polymer)
2	cromoglycate,
2	ovary.
2	cromoglycate.
2	g%)
2	(31.0
2	27.6
2	g%
2	14.6
2	pb131i/131i
2	71.83
2	ml).
2	7.57
2	(0.34
2	ml),
2	hypothesis:
2	hevea
2	lowest.
2	noted,
2	swedish
2	(ctcs)
2	apex.
2	(dpn)
2	unsatisfactory
2	frequency)
2	dpn-induced
2	diabetic-neuropathy
2	pbm-induced
2	neuropathic-pain
2	parkin
2	dpn-mice.
2	pbm-therapy
2	dpn.
2	(mob),
2	svz,
2	dcx-ir
2	sox2-ir
2	tangentially
2	late-development
2	mob
2	mob,
2	early-developed
2	calb-ir
2	post-partum
2	301:1570–1584,
2	(o),
2	mtj,
2	dmso,
2	mm/1.0
2	defences,
2	δψm
2	duchenne-like
2	(canine
2	dystrophinopathy)
2	huc/d-
2	dogiel
2	dmd.
2	301:673–685,
2	cardiolipin,
2	mg kg(-1)
2	microvascularization
2	bone-tendon
2	elasmobranchs
2	lalandii
2	cusp
2	oropharynx
2	(p1).
2	pg.
2	haemmerle,
2	watanabe.
2	(lv)—the
2	brain—have
2	cilia
2	lllt;
2	asphyxia.
2	deoxynucleotidyl
2	transferase-mediated
2	nick
2	(tunel)
2	fluoro-jade®
2	(fjb)
2	(p2,
2	p60).
2	p60.
2	(dg),
2	ca2-3,
2	somato-dendritic
2	ca2-3
2	dg,
2	p60
2	quadrant.
2	authors'
2	dermis,
2	femoral,
2	suborder
2	australis)
2	anastomosis
2	exhibit.
2	neurofunctional
2	(vip-ir)
2	(avp-ir)
2	wavelength)
2	(n=10):
2	crushed
2	ig.
2	angioarchitecture.
2	vegfr-2.
2	pinocytic
2	ca+2
2	(cgrp)-
2	(pgp
2	b9.5)-containing
2	axoplasms
2	interlamelar
2	4.83
2	79.24
2	27.24
2	24.23
2	mucosae.
2	xylazine,
2	(vv)
2	shapes,
2	rounded,
2	vallate,
2	papillar
2	amyelinated
2	lubrication
2	stents.
2	sternomastoid
2	groupings.
2	processes"
2	franciscana
2	llli
2	(vegf
2	dosages.
2	markings
2	belly
2	intracardiac
2	subsarcolemmal
2	endomysium
2	lm,
2	hrsem,
2	freeze
2	bulbs
2	intermingling
2	ultra-thin
2	sotalia
2	rostral,
2	bill
2	non-keratinized
2	alcian
2	pas,
2	non-encapsulated
2	age;
2	uranyl
2	(n=5),
2	(p<0.05);
2	works.
2	volume/area
2	contour
2	cdcl2
2	anesthetic.
2	"alfac"
2	nucleus/cytoplasm
2	34.86
2	18.56
2	cd-treated
2	irregularities
2	633
2	punctiform
2	sarcolemma.
2	endoneurium
2	junction,
2	basal,
2	unguiculatus).
2	digastric,
2	degrees,
2	hypofunctional
2	queratinized
2	(tbs)
2	(λ=2.94
2	10);
2	biometric
2	0.043),
2	0.044).
2	extractions
2	ligament.
2	(450
2	prints
2	bouin
2	dispositions
2	furrows
2	sweat
2	osmium-dmso-osmium
2	sheets.
2	lamella
2	osmiun
2	critical-point
2	glycocalyx.
2	hrsem.
2	hitachi
2	septum.
2	fracture
2	mercox®
2	casts.
2	epon
2	interplicae
2	anteriorly
2	bacteriae
2	bacteriae.
2	anatomía.
2	ramified
2	(som)
2	som
2	ian-transected
2	spines,
2	histochemistry,
2	palate.
2	intermediate-type
2	laser-hard
2	phosphorous
2	subsurface
2	crank-nicolson's
2	4-7
2	incisal,
2	canaliculi,
2	ring-like
2	extremities.
2	"bridges"
2	obliquely
2	br.
2	superpulsed
2	alike
2	44%.
2	streptococci.
2	corrosive
2	polishing
2	ndyag
2	carbonized
2	áreas
2	watts,
2	depressions
2	vitrified
2	premolars
2	fissure.
2	alterations:
2	papillae)
2	crest-like
2	aspect.
2	acinar,
2	cytoplasms
2	desmosomes
2	freeze-cracked
2	grooves.
2	lobule
2	body:
2	straight,
2	granulation,
2	interlobular
2	sponge-like
2	jena
2	armadillo,
2	microns,
2	calibre.
2	histopathologically
2	weber's
2	microfilaments,
2	(npy)
2	ache-positive
2	npy-immunoreactive
2	specializations
2	ebner's
2	foraminae
2	460
2	oesophagus
2	bundle.
2	oxytalan
2	intraganglionic
2	esophageal
2	skulls
2	(2.22%);
2	co2laser
2	neurotubules
2	caveolae,
2	sandwiched
2	desmosome-like
2	microvillous
2	terminates
2	interlaminar
2	ultrathin
2	grids
2	figures,
2	radiography,
2	split-line
2	zygomaticomaxillary
2	osseous
2	und
2	posture
2	masseterectomy
2	split‐line
2	12‐month
2	veins;
2	sinuses;
2	postglenoid
2	posture,
2	absent;
2	kcn-evoked
2	alarm
2	blanchard
2	(focused
2	stimuli)
2	corticolimbic
2	5-ht2c
2	sp-nk1
2	(epm).
2	epm,
2	proceptive
2	proestrus-to-estrus
2	gnrh)
2	reproduce,
2	chew
2	(us)
2	amyl
2	ofc.
2	cortical-hippocampal-amygdalar
2	pavlovian
2	hunt.
2	stimulus-response
2	17-21
2	agonist),
2	β-1
2	convulsive
2	subconvulsant
2	5.5;
2	fimbria-fornix
2	arms,
2	3.7;
2	0.049).
2	1.5.
2	mm1.5
2	1.0.
2	β-blockers
2	odor;
2	odor-related
2	tradeoffs
2	anticipating
2	footshock.
2	notes
2	rotate
2	turns.
2	turns,
2	medium-size
2	chemoarchitectural
2	deficit.
2	relations
2	sr48692
2	(hrs)
2	amphetamine-induced
2	opiates
2	morphine's
2	μg/side)
2	hydroxylase-immunostained
2	amnestic
2	(constant
2	(hd)
2	population's
2	(25×25×25
2	hydroxylase-
2	prey-related
2	neglect,
2	innate,
2	unpredicted
2	opiate
2	pre-optic
2	manipulations,
2	(ea36s).
2	faradic
2	(repeated
2	opposite,
2	thirds
2	pitfall
2	h/
2	ea36s
2	(ni)
2	postnatally.
2	vitread
2	mptp-treated
2	footshock
2	(prc)
2	jumps
2	(predator)
2	telencephalon.
2	pathways:
2	zone;
2	traveling
2	beneath
2	part)
2	bst,
2	vulgaris‐leucoagglutinin
2	reuniens.
2	vmh.
2	cingulate,
2	ahn
2	input,
2	corticohypothalamic
2	basolateral,
2	dorsally
2	raphe,
2	outputs:
2	(perhaps
2	serotoninergic
2	(particularly
2	stn.
2	hepg-2
2	48 h-treatment
2	48 h-statin
2	3′utr,
2	two-fold,
2	superexpression
2	(pg-p)
2	pth-induced
2	pth-treated
2	5'fs.
2	-889
2	+55
2	immunophenotype
2	clonality,
2	tcr-beta
2	grα
2	urinary-concentrating
2	acy.
2	na-k-2cl
2	hyperphosphatemia
2	acy-induced
2	magnesium,
2	concentrating
2	na-pi-iia
2	aqp2
2	aqp2.
2	(phospholipase
2	kinase).
2	hbdde
2	melanocytes.
2	(skin
2	(chicken)
2	na+/h+exchange
2	material/methods:
2	nhe2.
2	preconditioning.
2	summarizing,
2	intervening
2	e2-treated
2	ar-expressing
2	perturbing
2	motivation,
2	unveiling
2	stops
2	nursing.
2	orexin-synthesizing
2	amygdalas,
2	raphe)
2	(spns)
2	sleep–wake
2	[mch]
2	mch-containing
2	mch-immunoreactive
2	(crfr1)
2	well-described
2	integration.
2	objective:to
2	cdc2-like
2	(clk2)
2	balance.subjects:swiss
2	hypothalamus.results:hypothalamic
2	(phosphoinositide
2	3-kinase)-dependent
2	tg003
2	(phosphoenolpyruvate
2	carboxykinase)
2	mediobasal
2	phenotype.conclusions:thus,
2	panic-related
2	litter,
2	15-21,
2	acb?
2	accumbal
2	acbsh.
2	extra-pineal
2	[ew],
2	ew-ewpg],
2	ew-ewcp],
2	ewcp
2	[lha]
2	[cem].
2	ew-lha
2	ew-cem
2	ucn1
2	fos-immunoreactivity
2	(250.
2	relieving
2	(lh),
2	hypot
2	p-pm
2	(plh).
2	(p2x
2	undernourished,
2	(protein-deprivation)
2	(p)42,
2	p42,
2	p42.
2	double-immunohistochemistry
2	(profile
2	reversible,
2	(re-feeding)
2	nos-positive
2	re-feeding.
2	studies;
2	(b1-/-)
2	wylie
2	neuroscience,
2	manipulative
2	jacchus).
2	sympathetic,
2	parawixia
2	thβc
2	non-protein
2	(audiogenic
2	kindling)
2	l-thyroxine,
2	triiodothyronine,
2	(cas),
2	urocortins
2	(r),
2	replies
2	alprazolam.
2	(nadphd,
2	(gad-67,
2	gaba-synthesizing
2	gad-67,
2	contextualized
2	nadphd/cart
2	α-melanocyte
2	(αmsh)
2	(vmhvl)
2	vmhvl
2	ictal
2	(ampa)
2	bruxism
2	dentition
2	(nei),
2	sounds.
2	appositions
2	hunger
2	thirst.
2	neurochemically
2	(mcx)
2	collaterals
2	ppt.
2	(ihy)
2	mch/cart-expressing
2	aminobutyric
2	eminence.
2	(ucn
2	(pfx),
2	(mea).
2	urocortinergic
2	3-immunoreactive
2	nadph-d-positive
2	stained.
2	nmr),
2	neurotoxic,
2	retrograde-labeled
2	(rp-hplc),
2	ac-[ser117]lep116-140-nh2
2	proprotein
2	teneurins
2	triple-label
2	(a13
2	(th,
2	(ucn)
2	ewn.
2	foramen
2	tzu
2	pitfalls
2	(74±15%
2	85±15%).
2	(histaminergic
2	discussion.
2	ucn.
2	crf-r
2	ei,
2	mgop-containing
2	expression:
2	mantle,
2	(ucn),
2	rpa.
2	fluorescent,
2	retrogradely-labeled
2	peri-
2	(dorsal,
2	ventro-lateral),
2	(laminae
2	v-x
2	sacral
2	spcd
2	lha(p).
2	coextensive
2	(rmg)
2	(rob).
2	elsewhere,
2	fluorogold,
2	fast-blue,
2	iontophoretically
2	pericaria
2	somatic-visceral
2	pha-l,
2	subnuclei,
2	rob,
2	(pva),
2	(spvz)
2	cocruleus
2	pva,
2	retino-
2	suprachiasmatic-recipients.
2	retino-suprachiasmatic-recipient
2	downstream,
2	pituitary-adrenal
2	urotensin-like
2	(45%
2	activation)
2	ss‐28
2	iβ
2	806
2	(acre,
2	deliveries
2	circumference.
2	maternal-child
2	pathologists.
2	teratogenic
2	chorion,
2	(h/r)
2	(fccp)
2	h/r,
2	rmif
2	villous.
2	glucocorticoid-regulated
2	implantation;
2	labyrinthine
2	fibrinoid
2	<.005)
2	blastocysts,
2	cones,
2	3.5-7.5
2	ccr9+α4β7+
2	(f4/80+11b+ly6c-tgf-β+
2	pre-implantation)
2	(f4/80+11b+ly6c+tnf-α+
2	post-implantation).
2	ccl25/ccr9-axis
2	baby
2	organophosphate
2	(op)
2	dehydratase
2	(alad)
2	obscure
2	conceptuses
2	dysraphia
2	dpc
2	utero.
2	inadequately
2	cytotrophoblasts
2	htr8/svneo
2	reoxygenation
2	double-minute
2	mif,
2	gdm
2	(ape1,
2	fen1)
2	(hogg1,
2	ninety-two
2	0.0095).
2	cf-d4.
2	pyknotic
2	tf-d5
2	72-hour
2	immunoregulation.
2	saa,
2	formalin-fixed,
2	accreta,
2	increta,
2	percreta,
2	β-trefoil
2	ensues.
2	maternal/fetal
2	second/third
2	(decidua
2	villi)
2	elective
2	caesarean.
2	(cba)
2	(0.0112)
2	wider:
2	(p=0.0089)
2	(p=0.0002).
2	immunosuppressors
2	feto-maternal
2	microscopy.results:
2	haemochorial
2	xenarthrans.
2	csiro
2	ros-producing
2	peroxide-generating
2	[reduced
2	form])
2	maternalfetal
2	7.5-gestational
2	dihydroxyethidium
2	(gp91phox),
2	(p22phox),
2	ncf4
2	(p40phox),
2	(p47phox),
2	(p67phox),
2	macrosomia
2	gd7.5
2	gd10.5
2	blastocyst,
2	bax/bcl-2
2	births.
2	endosomal/lysosomal
2	quiescin
2	anti-recombinant
2	extracellularly,
2	resorptions
2	spn
2	(ifn-gamma;)
2	inductive
2	(jak)-signal
2	(stat),
2	jaks
2	stat2
2	transcriptions.
2	no-inos
2	manifests
2	anovulation,
2	hyperandrogenism,
2	(hcg)-treated
2	phosphatidyl-inositol
2	hcg,
2	androstenedione
2	irs/pi
2	(near
2	agglutinin,
2	homologous,
2	heterologous,
2	(elisas)
2	igg-peroxidase
2	a-peroxidase
2	(ifn-gamma)
2	microbe
2	(74.6%)
2	locals,
2	pesticide
2	0.0,
2	mp.
2	mp,
2	severe.
2	epitheliochorial
2	lama
2	horn,
2	extraembryonic
2	openings,
2	acp
2	diffuse,
2	gondii-infected
2	dop,
2	ilicifolia
2	embryotoxic
2	alpacas.
2	hybrid.
2	bi/tri-antennary
2	bisected
2	glycans.
2	cryopreservation
2	reasons.
2	cryoprotectant
2	cryoprotectants
2	morulae-early
2	vitrification.
2	fetal-maternal
2	emphasise
2	preimplanting
2	situ)
2	immunodetected,
2	anti-inos,
2	γ-interferon.
2	differentiation-dependent
2	tcs
2	suggest,
2	day-1),
2	peaked,
2	(69.5%;
2	rb6-8c5
2	mab-treated
2	(retinal)
2	noon,
2	8-day-old
2	nonhemorrhagic
2	embryoblastic
2	hn
2	labial
2	4-hydroxyphenylpyruvate
2	chloroquine-sensitive
2	(3d7)
2	µm,
2	(p < 0.0001).
2	phylloquinone
2	farnesyldiphosphate
2	synthase/geranylgeranyldiphosphate
2	handful
2	fosmidomycin,
2	dosing.
2	0.99.
2	3d7.
2	algae,
2	(psy)
2	psy
2	squalestatin
2	psy-overexpressing
2	phytofluene
2	squalestatin-resistant
2	erythritol
2	(fpps),
2	pf3d7-18400
2	pgex2t
2	pf3d7-1128400
2	[4-14c]
2	diphosphate.
2	rpffpps,
2	michaelis-menten;
2	(rpffpps)
2	fpps/geranylgeranyl
2	(ggpps)
2	2.06
2	haemagglutinin-tagged
2	fpps.
2	foh
2	jordão
2	maldi
2	bisphosphonates
2	88.9%
2	imperative.
2	organelle,
2	chloroplast.
2	"plant-like"
2	intermediated
2	menaquinone.
2	48-8071
2	off-targets
2	c40
2	scavenging,
2	plastids,
2	carotenoids.
2	radioisotopes,
2	norflurazon,
2	sample-consuming
2	cationization
2	adducts.
2	proof-of-principle
2	[14c]palmitic
2	[14c]glucose
2	spf2
2	d,l-threo-phenyl-2-palmitoylamino-3-morpholino-1-propanol
2	pathway-associated
2	fosmidomycin-treatment
2	tcspps.
2	(molecular
2	equivalents,
2	[3h]fpp
2	ubiquinones.
2	10-unit
2	polyprenyl
2	terpene
2	decaprenyl
2	1-deosy-d-xylulose-5-phosphate,
2	2-c-methyl-d-erythritol-4-phosphate,
2	4-(cytidine-5-diphospho)-2-c-methyl-d-erythritol,
2	4-(cytidine-5-diphospho)-2-c-
2	methyl-d-erythritol-2-phosphate,
2	2-c-methyl-d-erythritol-2,4-
2	cyclodiphosphate.
2	(dolichols
2	ubiquinones).
2	ubiquinones
2	acceptors,
2	(coenzyme
2	intermediate.
2	uncharacterized,
2	ras-
2	rap-specific
2	rap
2	immunoprecipitated.
2	plantlet
2	gc/ms
2	80-kda
2	leishmaniases.
2	rnp
2	slip
2	(nunc).
2	(mop)
2	anti-rabbit
2	(r2=93.99,
2	nac-d-glucosamine.
2	12/15
2	(pip
2	cag
2	kilodaltons,
2	polyribosomal
2	post-polyribosomal
2	iodinatable
2	two‐dimensional
2	(epimastigote)
2	forms:
2	3,4
2	saccharide
2	1966.
2	(de
2	nrs
2	moura
2	relative,
2	heterorhabditis.
2	(vt1,
2	vt3
2	vitellogenins
2	phylum.
2	(wpip
2	viable.
2	females;
2	ligand-blotting
2	p100
2	rhabditid
2	metazoans.
2	tipulae,
2	indexed
2	korea
2	lpp1,
2	heterorhabditis
2	indica,
2	baujardi.
2	indica
2	100.8
2	briggsae
2	hermaphrodite
2	photographs
2	(113,
2	27.2
2	yolk.
2	phosvitin.
2	sl2.
2	operons.
2	appreciated.
2	1.1-kb
2	deadenylation
2	cew1-vit-6
2	vit
2	page.
2	chymotryptic
2	phosphoproteins.
2	lipovitellin
2	92.6
2	27.8
2	electrophoretical
2	v2,
2	240,000
2	47,000.
2	pupation,
2	(third
2	14c-ddt
2	inocula.
2	book
2	foz
2	phlebotominae
2	stakeholders
2	inevitable
2	calibrated
2	tendencies
2	a.a.a.
2	paraensis
2	umbratilis,
2	zampieri
2	nacional
2	(cdc)
2	(2);
2	multi-host
2	self-resolving
2	10/18
2	bryce
2	walton,
2	isoenzymes,
2	(mlsa).
2	waltoni
2	hispaniola
2	threatens
2	hutias
2	solenodon.
2	chemotype
2	vigilance
2	eco-epidemiology,
2	mediterranean
2	(9.3%)
2	guyanensis/l.
2	serodemes
2	naming
2	complexa,
2	st3
2	sudanese
2	multispecies
2	resequencing
2	6q27
2	(1.27
2	complexa
2	migonei
2	reproductively
2	seventy-seven
2	serodeme
2	mlee
2	multiclonal
2	copies.
2	this.
2	chaos
2	405
2	linkage,
2	caxambu,
2	convened
2	protozoology
2	http://www.sbpz.org.br.
2	society's
2	website.
2	expertise.
2	fuller
2	tables,
2	seminars
2	posters
2	consulted
2	http://www.sbpz.org.br/livroderesumos2005.php.
2	shaw
2	(178
2	grass
2	2/12
2	(viannia).
2	ioc/z74
2	seeing
2	xenodiagnosis
2	insensitivity
2	comds,
2	nplall
2	(tdt)
2	tdt
2	manaus,
2	(2.8%)
2	upgma
2	paragominas,
2	paragominas
2	exist.
2	multi-case
2	0.000002,
2	hla-dqa1
2	-308
2	pointer
2	two-locus
2	(mabs),
2	persons.
2	neiva),
2	substructuring.
2	maringá
2	44.7%
2	(7.3%),
2	63.6%
2	viannia.
2	gp46.
2	(dat)
2	comds.
2	codominant
2	0.039;
2	0.025)
2	1980s,
2	2'
2	il5,
2	from:
2	dat.
2	complexus,
2	domiciliary
2	des,
2	attractiveness
2	marajo
2	n3
2	tamandua
2	tetradactyla
2	coccidial
2	tamanduae
2	lainson,
2	shaw,
2	marajoensis
2	(length/width)
2	striations
2	irregularly
2	curved
2	refractile
2	ligating
2	recombinants,
2	dam.
2	inapparent
2	blood-agar
2	naso-pharyngeal
2	claims
2	10.7
2	inoculated,
2	(mab),
2	venezuelensis
2	luxuriantly
2	separates
2	panamensis
2	221
2	586
2	psychodidae)
2	"wellcomei"
2	commas,
2	wellcomei,
2	hamster.
2	p.s.maripaensis
2	antunes
2	damasceno
2	(causing
2	"pian
2	bois"
2	salvaterra,
2	inner,
2	thicker,
2	yellowish
2	15.7
2	microgamonts
2	macrogamonts
2	∼13.0
2	isoniazid
2	(proechimys
2	novem-
2	keys
2	z1
2	beans,
2	coendou
2	prehensilis
2	reduviidae)
2	electrocardiographic
2	firm
2	highway.
2	1973;
2	6.5%
2	18.0%
2	simulium
2	(15.7%),
2	proechimys,
2	1971
2	1974,
2	snails
2	carinii
2	nasua
2	histoplasma,
2	leishmanin,
2	235
2	sp.nov.
2	effusa
2	gen.nov.,
2	garnia,
2	tropidurus
2	really
2	garniidae,
2	carini,
2	filiformis,
2	ellipsoid
2	residuum.
2	man-biting
2	encountered,
2	wetter
2	drier
2	forests,
2	zoites
2	slender,
2	sporogonic
2	ear.
2	kala-azar
2	2,774
2	2,731
2	lives.
2	724
2	dark-adaptation
2	m̈uller
2	arpe-19
2	occludin
2	fovea
2	cebus,
2	macaca
2	multipotential
2	("ciliary
2	zone").
2	inummohistochemically
2	acetyltransferase.
2	anti-protein
2	starburst
2	(cx26,
2	cx31.1,
2	cx37,
2	cx40,
2	cx57)
2	(cx57),
2	(cx45),
2	(cx36
2	cx43)
2	adaptation;
2	(cx50)
2	(cx31.1
2	cx37);
2	(cx26
2	cx40)
2	cx43.
2	methylmercury
2	(mehg)
2	mehg-exposed
2	wholemount
2	mehg-treated
2	cells/mm2;
2	(lcm)
2	cryostat.
2	trizol®
2	[125i]-α-bungarotoxin
2	stimuli:
2	within,
2	unimpaired.
2	diffuser
2	patterned
2	curare
2	perfused,
2	a-bgt
2	subunit).
2	a8-li
2	#x00b1;
2	(5.4
2	cloned.
2	reside,
2	gaba‐like
2	receptor‐like
2	s100b
2	gliosis
2	pentamidine,
2	5-fu-induced
2	hemochorial
2	decellularization
2	0.25%
2	ionized
2	nx/lp
2	uremia
2	tumorigenic.
2	2,4,6-trinitrobenzene
2	(marker
2	plexus),
2	34%,
2	33%.
2	25%.
2	4days
2	p450c17
2	hu-immunoreactive
2	s100β-immunoreactive
2	immunoreactivity/cm2
2	hu-positive
2	calretinin-
2	s100β-ir
2	bodies/cm
2	calbindin-ir
2	p2x2r
2	(μm2)
2	29.6%
2	p2x2r-ir
2	impairments.
2	transected
2	(dr).
2	receptor-ir
2	esophagus.
2	r42
2	preand
2	protein-restriction
2	2-d
2	sulphonate
2	neuropathies
2	distorted
2	(26%
2	1107
2	(nadh)
2	diaphorase,
2	(asn).
2	subepicardium.
2	cranially
2	(66.7%).
2	shape:
2	(multipolar
2	(78.9%),
2	(5,3%).
2	whole-mount
2	cchat,
2	cchat
2	pchat-ir
2	cchat-ir
2	(npy)-immunoreactive
2	npy-
2	5′-triphosphate
2	diaphorase.
2	distinguished.
2	(pde-5)
2	stimulator),
2	0.2),
2	0.7;
2	130.3
2	ethinyl
2	levonorgestrel
2	0.4 mg
2	ecg.
2	(1st
2	luts
2	bph.
2	5-alpha
2	diuretics
2	icp.
2	/ca
2	claudino
2	(94
2	2 months
2	ablative
2	single-center,
2	forehead
2	s)-releasing
2	2-week,
2	endoscopically.
2	(≥3-mm
2	(>94%)
2	atb-346-treated
2	(≥5-mm
2	dyspepsia,
2	gastro-oesophageal
2	reflux,
2	analgesic/anti-inflammatory
2	atb-346,
2	anticonvulsant
2	(lc-ms-ms).
2	(lloq)
2	∗
2	s-100
2	either.
2	s-based
2	antioxid.
2	cavernosa.
2	non-venomous
2	prostacyclin)
2	smoking,
2	(biochemical
2	urinalysis).
2	(hplc/ms/ms)
2	(t/r)
2	arrhythmias,
2	debrisoquine
2	gases
2	a-803467
2	3-iodo-l-tyrosine
2	salsolinol
2	single-pill
2	nebilet
2	hct™
2	(nebivolol
2	menarini)
2	nebilet™
2	(1 mg/kg/day,
2	(α1
2	(1–5 μm)
2	chemotaxis;
2	(10 μm)
2	amino}methyl)benzoic
2	α1-subunit
2	pe-induced
2	(300 nm)
2	intercontraction
2	urothelium,
2	gastroprotective
2	naproxen-induced
2	550mg
2	cryer
2	0;
2	3α-hydroxytibolone
2	livolon
2	libiam™
2	libbs
2	nmol/l.
2	hydrogel
2	cryotherapy
2	well-tolerated
2	0.99).
2	(piracar®
2	270/330
2	(nootropil®
2	81 mg
2	50 mg
2	vardenafil.
2	for0811.
2	tosylate,
2	versicolor
2	log-rank
2	rules.
2	bju
2	(g)-nitro-l-
2	sgc,
2	(dsm),
2	(phe;
2	nanotechnological
2	proprieties
2	methanol/acetonitrile/water
2	6.62
2	selective,
2	mirabegron,
2	(crc)
2	mirabegron-induced
2	60-2270
2	(cgmp),
2	cavernous
2	(ethyl
2	(hplc-ms/ms)
2	phenomenex
2	gemini
2	declustering
2	loq
2	4μm
2	cacl2
2	tenfold
2	vohmteers
2	i-iii
2	electrocardiograms
2	(0.23
2	sgc-cgmp
2	5.82
2	analyze.
2	hemipenis
2	basalis
2	trib3,
2	hydroxocobalamin
2	99.0%
2	10.9%,
2	101.6%
2	ng/
2	age:
2	height:
2	max,
2	ng.hr.ml
2	carlo
2	splits
2	n=20,
2	73-6691-treated
2	exams,
2	0.75,
2	4.5,
2	ecg
2	©2012
2	oxide-independent
2	cell-permeable
2	(1-300
2	(0.01-100
2	phorbol-12,13-dibutyrate
2	post-void
2	μm)-induced
2	dextromethorphan,
2	dextrorphan
2	(lle)
2	v/v/v)
2	dextromethorphan
2	(%cv)
2	bay60-2770
2	-)
2	8%,
2	pec
2	emp
2	pmp
2	(rho=-0.57,
2	p=0.005).
2	diethyl-ether/dichloromethane
2	alltech
2	[cyproheptadine+cobamamide]
2	farmacêuticos
2	cobavital®
2	ether/dichloromethane
2	tm)
2	41-2272-treated
2	international.
2	urothelium-intact
2	neuronal,
2	non-nervous
2	900.
2	glomeruli.
2	41-2271
2	(0.56
2	(c-sd),
2	(cgmp)-phosphodiesterase
2	rattlesnakes
2	non-spiny
2	5-cyclopropyl-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine
2	100μm),
2	1h-[1,
2	4]
2	oxadiazolo[4,3-a]quinoxalin-1-one
2	1μm).
2	cavernosa,
2	immunostaining).
2	5.84±0.17
2	5.10±0.08
2	(n=3-4),
2	no-cgmp-pde5
2	coitus.
2	(efs,
2	(1μm)
2	platelets/ml)
2	adhere.
2	clopidogrel,
2	atorvastatin/clopidogrel
2	(v1
2	(d1
2	(liquid
2	glyco
2	91phox
2	(gp91phox)
2	acetylcholine-
2	mg/5ml
2	suspension)
2	auclast.
2	sin-1.
2	sin-1-induced
2	α-actinin
2	apsen
2	©2010
2	lc-esi-ms/ms
2	powerlab
2	(83%
2	(3 ng/trachea)
2	pretreatments,
2	(histamine/5-hydroxytriptamine
2	7222
2	(5-ht3
2	sea-exposed
2	novartis
2	auc0-inf.
2	(lmtx-i)
2	lmtx-i-induced
2	mepyramine,
2	liability.
2	midazolam
2	non-psychiatric
2	(f[5,57]
2	f[5,57]
2	beagles.
2	(lc-ms/ms),
2	(10-fold)
2	(0.0001-30
2	units/ml)
2	conflicting.
2	(adhesion
2	(vla-4
2	(eotaxin
2	rantes)
2	byimmunomagnetic
2	133%
2	cc-chemokine-induced
2	(avidity
2	affinity)
2	lintomen
2	transducers,
2	denudation
2	(5-
2	19-fold
2	tadalafil,
2	cgmp-specific
2	microwave-assisted
2	102625-70-7)
2	elispot,
2	gastritis
2	7-30
2	3h]quinuclidinyl
2	([
2	3h]qnb)
2	3-adrenoceptor
2	3h]qnb
2	3h]
2	supersensitivity
2	3-adrenoceptor-mediated
2	embolism.
2	hypoxemia
2	hydroxy-dihydroergocornine,
2	hydroxy-dihydroergocryptine
2	hydroxy-dihydroergocristine
2	hydroxy-metabolites
2	μg/l.
2	nifedipine)
2	marketed
2	28.0
2	[range,
2	investigational
2	(sorocaba,
2	quim.
2	brazil);
2	three-period
2	factor/dermcidin
2	(pif/dcd)
2	12q13.1,
2	110-amino
2	native-state
2	∼16-kda
2	nonreduced
2	non-well-defined
2	tfe/water
2	non-micellar
2	pondr®,
2	disembl™,
2	disprot,
2	glob-plot™
2	predictors,
2	19-50
2	pif/dcd.
2	100.2
2	(96.0-104.7)
2	72-h
2	salicylic
2	(ir).
2	occluding
2	(70:30,
2	μg·h/l
2	enalaprilat,
2	machines
2	(c-sd:
2	c-tr:
2	ln-tr:
2	(mpap),
2	ipvr,
2	spo2
2	iu/kg)
2	pcwp
2	servier
2	diamicron
2	(ireland)
2	249.16%
2	298.54%)
2	clonazepam
2	bintx-ii
2	staphylocococcus
2	(seb).
2	(pbs,
2	0.4 ml).
2	(7.5-250 ng/trachea)
2	post-seb
2	post-seb.
2	(mature
2	(0.5 mg/kg),
2	(3 mg/kg),
2	(5 mg/kg)
2	(200 μg/kg).
2	serum-coated
2	richly
2	non-myelinated
2	hemopoiesis
2	(8-10
2	(13.1
2	preprotachykinin
2	(ppt)-i
2	(nk)-1
2	nk-2
2	ppt-i
2	escalated
2	angina
2	pectoris.
2	88.8%
2	l-name+bay
2	pa7
2	ames
2	exceed
2	triatec®
2	ramiprilat
2	potassic
2	cozaar®
2	losartan/cozaar®
2	99.1%
2	98.5%
2	98.1%
2	methanol-water
2	103.1%,
2	loq.
2	17.3%
2	bromocriptine
2	8′-oh-dhec
2	dhecm
2	μg/l.h
2	chemists
2	market.
2	(25-fold
2	(2.1-
2	counts).
2	c-18
2	lmtx-ii
2	nitrofurans
2	furazolidone,
2	receptor-independent
2	β1-
2	118,551)
2	saxitoxin
2	site-2
2	site-4
2	site-5
2	cipramil
2	auc0-inf
2	n-formyl-methionyl-leucyl-
2	μm)-
2	(pma;
2	(il)-g,
2	(cinc)-s
2	particles/cell)
2	5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]
2	-pyrimidin-4-ylamine
2	formyl-methionyl-leucyl-phenylalanine
2	3-isobutyl-l-methyl-xanthine
2	(ibmx;
2	gastrin-releasing
2	post-natum),
2	post-natum).
2	horns
2	postaxotomy
2	trichilia
2	ptychopetalum
2	zingiber
2	stimulant,
2	energetic,
2	phentolamine-induced
2	(59.7
2	2.3%;
2	ether-hexane
2	apotex
2	ticlid
2	aminoamides
2	α-tocopherol,
2	lisinopril
2	cartridges
2	neca.
2	(spla2
2	(30-300nm)
2	spla2,
2	(katp)
2	86.2
2	(15.4
2	14.4
2	ova-challenge,
2	enos)
2	lansoprazole
2	inter-run
2	semicarbazide,
2	metabolite.
2	hydroplethysmometer.
2	fenoterol,
2	(3-100
2	noncompetitive
2	[3-[4-(2-fluoro-α-methyl-[1,1′
2	-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic
2	4-nitrooxy
2	butyl
2	ester]
2	(antioxidant)
2	flurbiprofen;
2	centrally.
2	(≤12
2	(los),
2	nitroflurbiprofen
2	(vehicle),
2	(nof),
2	los/nof
2	los
2	(0.001-1.0
2	(chemotaxis
2	lexotan
2	produtos
2	47-kda
2	plasmin-specific
2	s-2251™.
2	streptase™
2	unitinase™
2	solustrep™
2	semicarbazide
2	flour,
2	semicarbazide.
2	(m/z
2	1-300
2	precision)
2	(na,
2	75-90%
2	pnv.
2	sigmasporin
2	microoral
2	sandimmune
2	neoral
2	whole-blood
2	(ria)
2	infusion)
2	indomethacin-treated
2	tsv.
2	20mg
2	iprc,
2	amman,
2	jordan.
2	netherlands)
2	julphar,
2	uae)
2	volunteers;
2	cartesius
2	usp,
2	auc0-t,
2	auc0-∝,
2	brands,
2	fda.
2	julphar's
2	netherlands.
2	aconitine,
2	ω-nitro-l-arginine
2	oxidiazolo[4,3-α]
2	(vla-4)
2	vla-4-specific
2	mac-1-specific
2	nocodazole,
2	(0.05-0.5
2	μg/site).
2	capsaicin-sensitive,
2	c-fibres.
2	5-hydroxytriptamine
2	(rr,
2	tropisetron
2	rs39604
2	tropisetron,
2	rs39604.
2	life)
2	diazepam.
2	(cipe)
2	diazepam-induced
2	(pbr)
2	cipe.
2	(threefold)
2	1h-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one
2	9%.
2	n(omega)-nitro-l-arginine
2	rbcc,
2	(uf),
2	rvr,
2	fractions:
2	nx;
2	puncta
2	ca2,
2	fd,
2	noergic
2	degranulating
2	methotrexate,
2	240hr
2	(86
2	3.1-fold
2	(2.4-fold
2	increase).
2	72hr
2	60-
2	nevirapine
2	viramune
2	70.
2	methyldopa
2	dopa-phenyl-d3
2	20-5000
2	7.3,
2	-8.0,
2	-1.3
2	-2.0%
2	7.7,
2	-1.1
2	-2.3%,
2	methyldopa.
2	(wem)
2	(0-iii)
2	flavin
2	(fad),
2	bh4.
2	wem
2	pac-f-s-r-eddnp
2	venom),
2	bothropstoxin-ii,
2	(10-1000
2	(30-1000
2	(0.3-30
2	(30-300
2	(10-300
2	heparitinase
2	piratoxin-i-induced
2	(d-name)
2	intraday
2	6.5%,
2	92.2%
2	ny-ir
2	(mm).
2	nhl.
2	nhl,
2	(20.0
2	(nsaid)
2	b.i.d.),
2	cyclooxygenase-2.
2	(pnv;
2	(10-200
2	pmol/paw).
2	μmol/kg;
2	pmol/paw)
2	gastric/duodenal
2	(nsaid),
2	11b
2	(200-600
2	seb-treated
2	(12.5-50
2	seb-injected
2	acetaminophen
2	(5000
2	neurotin
2	auc(0-36h)
2	auc0-48
2	(300μm),
2	norvasc®
2	pfizer
2	agency.
2	(1/x)
2	10.0-2000
2	6.3,
2	2.3,
2	(nisulid,
2	astra
2	médica,
2	nisulid
2	93.1-109.6%
2	87.7-99.8%
2	88.1-99.7%
2	auc0-∞.
2	formulations)
2	amoxicilina/amoxil
2	amoxicilina
2	cupana,
2	(11%
2	catuama®-induced
2	(1mg/ml)
2	(0.01-1.0
2	24.0
2	4.7%,
2	micromol/l)
2	tsv,
2	nonadrenergic,
2	(n6-cyclopentyladenosine,
2	(5′n-ethylcarboxamidoadenosine,
2	(n6-[3-iodobenzyl]-n-methyl-5′-carboxiamidoadenosine,
2	0.01-3
2	intravenously-injected
2	(ib-meca
2	adenosine).
2	(5-50
2	ib-meca-induced
2	(dpcpx,
2	0.3-3
2	cpa-induced
2	3,7-dymethyl-1-proprargylxanthine
2	(dmpx,
2	neca-induced
2	(sr140333),
2	(s)-n-methyl-n[4-acetylamino-4-phenyl
2	piperidino)-2-(3,4-dichlorophenyl)-butyl]-benzamide
2	(sr48968),
2	site-1).
2	a3,
2	phenobarbital
2	bilirubin
2	indocyanine
2	ccl4-treated
2	(0-oo),
2	differences).
2	albuminuria.
2	~35%,
2	ss.
2	φ
2	(prtx-i)
2	cells/cavity,
2	μg/cavity,
2	[14c]5-hydroxytryptamine
2	synovium
2	(44%),
2	before)
2	before).
2	(1-3
2	homologue.
2	polyanions
2	platelet-induced
2	evaporation
2	calcort
2	d-ala-[l-pro9,me-leu8]substance
2	(gr73632;
2	abolished)
2	cgrp-(8-37),
2	[d-ala2,me-phe4,gly-ol5]enkephalin
2	(damgo),
2	anaesthetic,
2	lignocaine,
2	(verapamil,
2	mviia
2	mviic,
2	carbamazepine,
2	5'-triphosphate
2	(atp;
2	5'-diphosphate
2	(adp;
2	(28%
2	adamanteus
2	mellifera)
2	ltd,
2	(clamicin
2	biaxin
2	ke.
2	μgxml-1
2	inaccuracy
2	89.4%
2	85.4%
2	80.1%
2	fourteen-day
2	pm-off
2	(oh-met/met)
2	alcohol-induced,
2	child-pugh
2	oh-met/met
2	ethanol-abusing
2	alcohol-induced
2	vai.
2	oxygenation,
2	(norepinephrine
2	isoproterenol),
2	pilocarpine),
2	(34%
2	ischaemia,
2	(186
2	evening)
2	436
2	homoscedastic.
2	94.9%
2	102.6%
2	fluconal
2	zoltec
2	18-fold
2	kaliuresis
2	pae.
2	pae,
2	oxygenation
2	·ml-1
2	metabolizers
2	metabolizers)
2	86.1%
2	pharmacology.
2	auc(0-72
2	benzotriazinone
2	benzoyltriazole
2	anaesthetic
2	ofloxacin
2	(ofx)
2	(ott,
2	laboratorio
2	atral
2	tarivid,
2	germany)
2	(12m,
2	12f)
2	achieved),
2	(14.8
2	tarivid),
2	(5.9
2	(0.12
2	[1993],
2	short-lasting,
2	arrhythmia,
2	β1-adrenoceptor
2	cgp-20712a
2	(≤100
2	μg)-induced
2	8-methyl
2	n-vanillyl-6-nonenamide
2	(capsaicin;
2	s.c.).
2	30-60
2	evaluations,
2	hydroxyclarithromycin
2	pre-dose
2	clarithromycin.
2	hidroxyclarithromycin
2	c22-3
2	c200.
2	similar,in
2	kinin-induced
2	des-arg9-bradykinin
2	bk-,
2	q.d.s.),
2	b.d.)
2	reassessed
2	nof,
2	daily;
2	0.7,
2	hirudin
2	oedema)
2	(0.125-5
2	polyanion
2	iu/site)
2	iu/ml).
2	(ach;
2	(gtn;
2	0.5-10
2	[4,3,
2	alquinoxalin-1-one]
2	irreversible.
2	n(g)-iminoethyl-l-ornithine
2	(l-nio;
2	ach-
2	(trim,
2	[3h]-l-arginine
2	[3h]-l-citrulline.
2	(trasylol;
2	(d-arg-[hyp3,thi5,d-tic7,
2	oic8]-bk;
2	non-tachyphylactic
2	xii)
2	capsaicin-insensitive
2	nanc
2	o2/5%
2	portal,
2	intraportal
2	(test:
2	whitehall;
2	standard:
2	winthrop
2	effervescent
2	roche)
2	t~~
2	redoxon,
2	11.6%
2	phoneeutria
2	(8-methyl
2	n-vanillyl-6-nonenamide)-pretreated
2	((δava[l-pro9,
2	n-meleu10]
2	capsaicin-pretreatment
2	(angipress
2	atenol
2	wellcome
2	auc((0-24))
2	c(max)/auc.
2	angipress/atenol
2	auc((0-24)),
2	auc,
2	102.8%
2	97.8%
2	c(max)/auc,
2	80-125%,
2	two-kidney
2	one-clip
2	non-l-name-treated
2	aims.
2	(2000
2	post-dose
2	auc(0,8
2	[2265
2	1815-2827)
2	1821
2	(1295-2562)]
2	[1135
2	898-1436)
2	701
2	(501-981)]
2	[t(max)
2	0.5-2.0)
2	(0.5-4.0)].
2	(mabp/carotid)
2	μg/heart)
2	μg/heart).
2	d-name-
2	(17.2
2	12.2
2	(11.5
2	eater
2	d-[arg-hyp3,thi5,d-tic7,oic8]bradykinin
2	bolus).
2	nmol/ml
2	no-nitro-l-arginine
2	d-name,
2	(37%
2	fio2
2	(spherisorb
2	sax,
2	post-column
2	copper-plated
2	cadmium-filled
2	diazotization-coupling
2	naphtylethylendiamine
2	sulphanilamide
2	(urine
2	cartridges,
2	deproteinized
2	3000).
2	0.05-0.1
2	linearity
2	nitroimidazolic
2	sucralfate.
2	μmol/rat/day
2	(eupressin
2	biosintetica
2	dhome,
2	(enalaprilat
2	maleate)
2	(auc[0-24]),
2	activity-time
2	fasciculations,
2	defecation
2	(d-arg-[hyp3,thi5,dtic7,oic8]-bradykinin)
2	(3-(4-(2-chlorophenyl)-9-methyl-6h-thieno-(3,2f)
2	(1,2,4)-triazolo-(4,3-a)
2	(1,4)-diazepine-2-yl)-(4-morpholinyl)-1-propanone)
2	((s)1-{2-[3-(3,4-dichlorophenyl)-1-(3-iso-propoxyphenyl
2	acetyl)
2	ethyl}-4-phenyl-1-azoniabicyclo[2.2.2]
2	octane,
2	48968
2	((s)-n-methyl-n-[4-(4-acetylamino-4-phenylpiperidino)-2-(3,4-dichlorophenyl
2	-butyl]benzamide)
2	((r)2-[(r)-2-[[1-(hexahydro-1h-azepinyl]carbonyl]amino-4-
2	methyl-pentanoyl]amino-3-[3-(1-methyl-1h-indoyl)]propionyl]
2	amino-3-(2-pyridyl)
2	μg/kg/min),
2	(40-120
2	(3-
2	(kdic)
2	merck,
2	pla),
2	(subacute
2	omeprazole,
2	ome
2	(t(1/2))
2	auc([0-∞])/t(1/2)
2	kdic
2	auc([0-∞])/t(1/2),
2	desired.
2	iso,
2	hyperfiltration
2	water;
2	dm,
2	n(w)-nitro-l-arginine
2	(l-
2	name)
2	(cgrp,
2	(0.03-1
2	co-injected,
2	formation;
2	0.001);
2	pnv,
2	(mepyramine
2	alone;
2	sr140333).
2	esp5),
2	esp6
2	50.4
2	ppk-induced
2	37°c).
2	18.1
2	sulphate-polyacrylamide
2	pnv4
2	(117.2
2	5.8,
2	161.8
2	122.0
2	(1.36
2	0.13,
2	1.48
2	mg/g,
2	kidney-1
2	model;
2	(140
2	μmol/rat/day)
2	prostacyclin,
2	(20-1000
2	(zetir
2	zyrtek
2	ucb)
2	auc0-24
2	infinity)
2	auc0-24,
2	treatment),
2	(5/6
2	(l),
2	name,
2	moment-to-moment
2	(0.06%
2	beats/min.
2	participate,
2	et<inf>b</inf>receptors
2	0.025%
2	osier
2	nifedipine-treated
2	tailcuff
2	171±7
2	143±3
2	10.1±2.2%
2	glomeruli,
2	hut
2	[125i]human
2	shaved
2	gtn
2	(0.4-40
2	pge1.
2	pge1,
2	impotence.
2	tumescence.
2	attested
2	reversed‐phase
2	(auc0,24h),
2	half‐life
2	(t1/2),
2	auc0,24h,
2	auc0,24h
2	(et-1;
2	s6b
2	et-1-
2	s6b-induced
2	sequence:
2	(60-70%)
2	(l-arg),
2	l-arg,
2	μmol/paw,
2	(<10%)
2	48/80-induced
2	(>40%).
2	endothelin‐1
2	(et‐1,
2	u46619.
2	sucralfate,
2	mu/ml).
2	12.4%)
2	217-225,
2	1994.-crotoxin,
2	(crotapotin)
2	payton
2	aggregometer
2	radio-immunoassay
2	(15-50
2	(50-500
2	(8-80
2	(207
2	<0.001,
2	crotoxin-induced
2	pro-aggregatory
2	nmol/rat)
2	intrapleurally
2	kd).
2	poly-l-arginine-induced
2	lavage,
2	syrup
2	polycation.
2	adrenaline,
2	xiii-induced
2	e1.
2	non-ionic
2	intracarotid
2	(cap).
2	bk-elicited
2	(rr),
2	outlasted
2	bw755c,
2	incubate
2	colitic
2	sc45662
2	sc41930
2	nitro-l-arginine-treated
2	et‐1,
2	equieffective
2	elevated.
2	ferricytochrome
2	aggregating
2	endothelium‐derived
2	(40–100
2	(10–20
2	r59022
2	8.6–9.5)
2	day‐1
2	ml‐1)
2	siliconized
2	allowed,
2	repeated.
2	twenty‐seven
2	(5‐20
2	ml‐1).
2	hydroplethysmometer
2	evans'
2	bw755c
2	polycation-induced
2	nicardipine
2	intra-arterially
2	vasoconstrictions
2	des-arg9-bk,
2	des-arg9-bk
2	conclude,
2	(1.7
2	gelatin-coated
2	sod.
2	dihydropyridine-sensitive
2	et-3.
2	overwhelmed
2	3':5'-cyclic
2	gmp)
2	microcarrier
2	beads,
2	rp-hplc.
2	o2.
2	lyso-paf
2	effluents.
2	18:1
2	giia
2	cb-induced
2	thioperamide,
2	hoe-140,
2	lemniscatus,
2	near-infrared
2	motoro
2	(cromolyn)
2	pgd<inf>2</inf>
2	pge<inf>2</inf>.
2	(cox-1/cox-2
2	pmv-injected
2	antihistaminic
2	coordinating
2	saturated,
2	tlr2/myd88
2	sb202190,
2	presumable
2	gametogenic
2	salts,
2	(lds),
2	noncytotoxic
2	plin2.
2	ipla
2	cpla2,
2	bioconversion
2	herbimycin
2	(cox
2	pla2)
2	preeminent
2	h3/h4
2	serine-proteases
2	(coxs)
2	mgkg
2	(dppiv)
2	algesic
2	mφs,
2	synthases,
2	μg/paw
2	bjv,
2	rt2
2	valine.
2	pecam-1.
2	catalytically-active
2	(mt-ii),
2	stimulator.
2	(130%
2	increment)
2	(0.5-2.5
2	206%
2	increment).
2	aminopeptidases
2	follows,
2	myonecrosis.
2	methylxanthine
2	reparative
2	adams
2	svmp-induced
2	disintegrin-like/
2	plethysmometry.
2	antigranulocyte
2	67%,
2	blistering,
2	edema-forming
2	1-hr
2	hypersensitivity)
2	(5μg/paw)
2	(h1
2	(sympathetic
2	anti-interleukin-1
2	cana2edta.
2	140.
2	des-arg9,
2	[leu8]-bradykinin,
2	μg/animal)
2	(3-48
2	1991).
2	top.
2	chromite
2	chromite.
2	(table
2	carius
2	'wpr-1'
2	8,302
2	(luck
2	allegre,
2	1983).
2	γos
2	emplacement
2	2σ
2	chromitites
2	chromitites;
2	bushveld
2	merensky
2	crustal
2	haemoconcentration
2	factor(s).
2	cury,
2	leucopenic
2	beryllium
2	pentobarbital-induced
2	zoxazolamine.
2	salt.
2	summation
2	c-2
2	seriniquinone,
2	uv-hplc
2	sonication,
2	acetonitrile–water
2	(adjusted
2	<15%.
2	bicolor.
2	stragulin
2	plectranthus
2	macedo,
2	furnish
2	networking
2	saliniketals
2	(2018)
2	aichi
2	divert
2	(−)-trachelogenin
2	agalactiae
2	(mic 3.1 μg/ml),
2	non-tumour
2	1,2-naphthoquinones
2	(breast
2	adenocarcinoma)
2	lawsone
2	cycloaddition
2	substituents
2	isoobtusadiene
2	co-encapsulated
2	(0.35%)
2	(0.50%)
2	nanoemulsions
2	post-application
2	microemulsion,
2	nanocarrier-mediated
2	(paclitaxel)
2	(ceramide),
2	nanoemulsion-mediated
2	co-encapsulation
2	2.5–4.5-fold,
2	nanoemulsion,
2	(ovarian
2	(glioblastoma)
2	speciation.
2	psu,
2	real-world
2	lapachol
2	ornatin
2	(hresims)
2	rationally
2	ritterazine–cephalostatin
2	(moa)
2	confines
2	grp78.
2	zoanthids
2	variabilis.
2	(nmr),
2	actinomycete
2	prospection
2	prodiginine
2	lines-of-evidence
2	phases;
2	descriptors.
2	mucuripe
2	pecém
2	impacts,
2	scaffolding
2	eif4a
2	beach
2	withanolides,
2	(1d
2	hresims
2	withanolide
2	zürich
2	remotely
2	piericidins
2	(5).
2	pacoti
2	(ceará,
2	(vtg)
2	negligible.
2	dredged
2	van
2	waals
2	saponins,
2	4)-[(1
2	2)-α-l-rhamnopyranosyl]-β-d-glucopyranoside
2	cestrum
2	laevigatum.
2	26-o-β-d-glucopyranosyl-(25r,s)-5α-furost-20-ene,2α,3β-diol
2	(hct-116),
2	subtilis.
2	(zn)
2	l-1).
2	fragmentations
2	rearrangements,
2	cis-trans
2	cycle:
2	g2m
2	chloramphenicol.
2	sitosterol
2	expedition
2	agardh
2	tenella.
2	alga
2	nigrospora
2	oryzae
2	cytocha-lasin
2	heteronuclear
2	kapakahine
2	uptaken
2	moieties,
2	(9),
2	six-membered
2	acetylgliotoxin
2	phosphatidylserine.
2	ferrocene
2	pipelines
2	journey
2	panel.
2	(hsa).
2	c-12
2	assisting
2	1940s,
2	pyrrolinonodithioles
2	pyrroloformamide,
2	1960s,
2	(4).
2	verna,
2	jacobsen
2	phenylalanine.
2	roquefortine
2	arabica,
2	halogenated
2	halo
2	ent-trachyloban-18,19-diol
2	(7).
2	legally
2	n-cadherin,
2	historically,
2	dredging
2	β-dihydrofuran
2	app
2	-e
2	electrochemistry
2	bioactivity-guided
2	0109
2	ic50values
2	hl1;
2	n-heptyl,
2	n-decyl,
2	1a-3a.
2	pt4+/pt2+
2	©2013
2	thiazolidine
2	pepper
2	genotoxic,
2	antitumor,
2	anxiolytic,
2	genotoxicity,
2	rippertane
2	vulgare,
2	ceramides,
2	palyosulfonoceramide
2	13c,
2	1h-13c
2	hexadecanamide
2	triterpenoids
2	cucurbitacin
2	cayaponia
2	racemosa
2	hydrazone
2	(3e)
2	7-chloro-4-quinolinylhydrazones
2	portugal.
2	(melanoma)
2	potato-dextrose
2	mellein,
2	penicillic
2	>95%).
2	lecythis
2	ursolic
2	simaroubaceae
2	f.,
2	(hl-60).
2	pbmc,
2	pptn
2	edule
2	thioacetate
2	esterases.
2	phenyl
2	1-methoxy-9-propyltetracene-6,11-dione
2	vannamei.
2	(cosy,
2	zn,
2	ecotoxicological
2	3i,
2	(3h)
2	hb4a-c3.6
2	overexpression),
2	hb4a-c5.2
2	hb4a
2	(4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone
2	(pht)
2	phenstatin
2	pterocarpanquinones
2	olefins,
2	antineoplasic
2	(hct-8),
2	3n,
2	3r
2	3u
2	fluorine
2	nitro
2	tetrasubstituted
2	myracrodruon
2	urundeuva
2	μg/ml]
2	eemus
2	himatanthus
2	drasticus
2	immunostimulating
2	mirabilin
2	8bβ-hydroxyptilocaulin
2	ptilocaulin
2	pisosterol.
2	locus-specific
2	u343
2	ahol1
2	β-pyran
2	β-lapachone
2	mcpba
2	mcpba,
2	μg.ml-1)
2	mda/mb-435
2	glioblastoma)
2	(breast),
2	(2-(benzo[d]thiazol-2-yl)-8-
2	α,β-amyrin
2	8.08
2	(mtt
2	1,2,3-triazoles
2	o)
2	(10),
2	14.7,
2	α-methylene-γ-lactone
2	(1a
2	zoanthid
2	(hct-8,
2	1a-5a
2	(prostate).
2	hl5
2	ta102
2	h2o2-induced
2	2,5-bis(alkylamino)-1,4-benzoquinones
2	sativus
2	(monocotyledonous).
2	weed
2	295
2	(brain)
2	laticifer
2	(ka),
2	aberration,
2	xylopic
2	ka.
2	mono-
2	agents:
2	fucata,
2	5-methoxy-1,4-naphthoquinone
2	39.5%
2	hsrs
2	larvicidal
2	2,4-dimethoxy
2	hplc-ecd
2	influences.
2	(hexane,
2	methanol),
2	isobenfuranones
2	title
2	nut-shell
2	caseargrewiin
2	dialdehyde
2	4-ome,
2	4-i,
2	3-i,
2	4-cn,
2	3-cn,
2	3-no2)
2	b3lyp
2	6-311+g(2d,p)
2	(rotamers
2	kcal
2	twigs
2	(3-5)
2	(ic50,
2	(1:1
2	acetonitrile,
2	borohydride
2	ascaridole,
2	33.9%
2	2h-azirines
2	2h-azirine-2-azetidinones
2	leukemia;
2	melanoma;
2	tinctorius,
2	8q24
2	aberration.
2	myeloblastic
2	polychromatic
2	lichexanthone,
2	(15,37?).
2	hydrogénation
2	nonfunctionalized
2	iridium
2	iodine(iii).
2	mda-mb-435.
2	μg/l)
2	leucopeny
2	discreet
2	blazei
2	(ast
2	citotóxica
2	contra
2	seis
2	valores
2	parâmetros
2	eletroquímicos
2	p).
2	apesar
2	ausência
2	anel
2	(quinone
2	heterocyclic
2	anodic
2	data;
2	colon),
2	batyl
2	microscale
2	frameshift,
2	(fe)
2	feso4
2	g1.
2	piperine,
2	5-fu.
2	piperine.
2	lung)
2	2-mercaptoethanol,
2	(ethanol,
2	acoet,
2	(r4)
2	insoluble,
2	metotrexate
2	mtx,
2	borders,
2	osteoid
2	neoformation
2	135.5
2	fitc-labeled
2	gal/galnac
2	cell-like
2	pisosterol-treated
2	15-deoxygoyazensolide
2	intercalation.
2	top1
2	alcl
2	(b-16)
2	extract).
2	separations.
2	healthcare.
2	51.8
2	66.2
2	5-14
2	jurkat,
2	safrole
2	'cell
2	fair
2	piplartine-treated
2	diels-alder
2	globe
2	unfortunately
2	chemists,
2	pharmacologists
2	antileukemic
2	hematoxylin/eosin
2	2,3,16,20(r),25-
2	28.7
2	martiusii
2	angulata
2	hydrogenation
2	b-16,
2	zago,
2	carneiro,
2	exp.
2	ther.
2	l.a.,
2	acacetin
2	lethedocin
2	corymbosin
2	21.5
2	blastulae,
2	pharmacophoric
2	17.2
2	hct-8.
2	marmelos
2	heartwood
2	(dl50
2	anacardium
2	b16,
2	autoxidation
2	quercetin-3-o-glucoside
2	goyazensolide
2	antiedematogenic
2	hae
2	nonpolar
2	18r
2	1.46
2	0.89
2	abietane
2	carnasol
2	kaempferol,
2	amburoside
2	isokaempferide
2	ligulum
2	polysyncraton
2	euherdmania
2	holozoidae
2	5:1
2	<2
2	sericeus
2	51.2
2	lonchocarpin
2	microculture
2	(ic50:
2	oncocalyxone
2	2.14
2	transmural
2	brum
2	double-gene
2	thyrotoxicosis-induced
2	site-dependent
2	fracture.
2	supraspinatus
2	humeral
2	paste
2	medicament
2	file.
2	calvaria-derived
2	harvesting.
2	autogenous
2	11.7%
2	defects;
2	dobutamine,
2	(ibat)
2	dobutamine
2	db
2	(trβ
2	mgi
2	database)-selective
2	gc-24-treated
2	trα1,
2	(ros17/2.8)
2	(mc3t3-e1)
2	ros17/2.8
2	(~20-90%)
2	(~90-98%)
2	(~2.8-
2	(~2-
2	4-fold),
2	co-transporting
2	lat1,
2	lat2
2	tibias
2	(trβ)-selective
2	(17-25
2	(50-70%).
2	(50-70%)
2	t3-
2	70-90
2	14-74%
2	15-23%
2	(trpv6
2	ephb6
2	ca2+)
2	1,25-dihydroxyvitamin
2	dermatitis.
2	tissues/organs.
2	deiodination
2	plating,
2	tgfβ,
2	(t4;
2	48/72
2	phospholipids)
2	disarray
2	endocardium
2	(trβ)
2	wt),
2	3-treated
2	vertebrae
2	(l2-l5),
2	10-15%.
2	(-52%
2	tr-selective
2	tsh-suppressive
2	(dd)
2	(ros
2	17/2.8).
2	atpase-6
2	amlc
2	density:
2	1,25d3
2	(roc)
2	(age
2	h(m)/h(p)
2	women).
2	bmd.
2	(0.5-1.0
2	subsegments
2	1xt
2	ovx+1xt
2	2xt
2	(fm)
2	(bw).
2	40-49
2	corrections
2	galuppo,
2	forti,
2	cortez,
2	giordano
2	stolf.
2	shed.
2	(scd100)
2	cd72
2	metacaspase
2	shock-induced
2	(hacat)
2	betulinic
2	(ba)
2	lysosome.
2	ba,
2	plexins
2	cd100,
2	trust
2	(dcl).
2	hyposensitive
2	leishmania´s
2	amastigotes’
2	opb
2	lc3-ii
2	quinonemethide
2	adventitia.
2	phagolysosome
2	pathogen-mediated
2	beatriz
2	bacteria/viruses,
2	thiol/pdi
2	dtnb,
2	phenylarsine
2	bref-a,
2	er-golgi-disrupting
2	pma-driven
2	thyroidectomy.
2	reproducibility.
2	non-malignant
2	machine,
2	ontogeny.
2	proteasome-mediated
2	synthesis)
2	agammaglobulinemia.
2	immunodeficiencies.
2	australia,
2	(hsct)
2	wiskott-aldrich
2	transplant,
2	barreiros,
2	segundo,
2	grumach,
2	torgerson,
2	ochs
2	jak3
2	circles)
2	t-b+nk-
2	banerjee,
2	castold,
2	ynoue,
2	arslanian,
2	barbosa-carvalho,
2	correia-deur,
2	weiler,
2	dias-da-silva,
2	lazaretti-castro,
2	pedroza,
2	mace,
2	autoimmune-polyendocrinopathy-candidiasis-ectodermal
2	(aire).
2	syk-dependent
2	fs,
2	aire-deficient
2	author’s
2	cd3+cd4+
2	2.5-year-old
2	docked
2	u3a
2	father's
2	il-12-dependent
2	resuspended
2	eotaxin-activated
2	mac-1,
2	(dko)
2	dampens
2	(net)
2	h2o2/o2-
2	immunological,
2	heterogeneity,
2	hla-matched
2	xhigm
2	well-being
2	hct.
2	consortium.
2	limits,
2	narrative
2	pharmacokinetics,
2	uso
2	disponíveis
2	nosso
2	meio.
2	imunoglobulina
2	primárias,
2	forma
2	(trecs)
2	spss
2	krecs/μl.
2	trecs/μl
2	scopus
2	prisma
2	95 %
2	2.12,
2	asians.
2	multicentric
2	(gme)
2	mendelian
2	apply,
2	324
2	0.43%
2	multiple,
2	microbiological,
2	mycobacteria,
2	(37%),
2	mandatory,
2	contraindicated
2	gwsa).
2	gene-encoding
2	23.9
2	lymphadenopathy
2	rag1
2	94.8%
2	selected:
2	4900
2	heterodimers.
2	distant,
2	(hc;
2	microbicide
2	il23
2	tnf-a,
2	macrophage-dependent
2	14-item
2	paediatricians
2	(35.7%),
2	paediatricians,
2	clinicians,
2	appropriately.
2	societies,
2	organizations
2	(sea
2	vcam-1-coated
2	adhesion)
2	(pidd)
2	specialists
2	pidd.
2	9.7
2	(35,
2	endosome
2	adapters
2	tirap
2	tlrs.
2	hoxa
2	tnf-related
2	atra
2	trail-mediated
2	eosinopoiesis
2	eotaxin,
2	charles
2	(lad)
2	lad
2	rac
2	hospitals.
2	ifn-γ/tnf-α.
2	ifn-γ/tnf-α
2	aeroallergens,
2	pediatr
2	(cgd),
2	sscp
2	dhplc
2	nm)-induced
2	(score
2	signiwcant
2	instances,
2	fellowship
2	albicans)
2	(pids)
2	polyendocrinopathy-candidiasis-ectodermal
2	(aire)
2	extrathymic
2	milk-mediated
2	(der
2	(n=29)
2	(n=48).
2	anti-der
2	methoxy-substituted
2	multienzymatic
2	chlorination
2	cybb,
2	(cgd).
2	k17.
2	description:
2	stay,
2	comments:
2	(lps)-activated
2	searched.
2	prednisone
2	fluticasone
2	21-hydroxylase
2	10.8
2	c4/cyp21
2	rccx
2	modules.
2	tracts,
2	(ebv)-transformed
2	absence,
2	adenosine-3′,5′-monophosphate
2	zaprinast,
2	(sq
2	shwachman
2	mg/day)
2	salbutamol
2	lagid
2	g>a
2	rheumatic
2	insertions,
2	novel.
2	otitis,
2	x-cgd
2	granulomas.
2	paraná.
2	(30.7%)
2	525
2	pteronyssinus,
2	crib
2	(gp
2	seven-fold
2	cgpx
2	(il-5)
2	one-hundred
2	skin-prick
2	gerd.
2	kindred.
2	flavocytochrome
2	chromosome)
2	60-65%
2	nonsense
2	a301
2	c8166
2	'classic'
2	run-on
2	properdin.
2	9).
2	no2-and
2	bizzarro,
2	ramírez-hernández,
2	peti,
2	cataneo,
2	wowk,
2	timóteo,
2	faccioli,
2	fogaça,
2	sorgi
2	sá-nunes.
2	saliva-host
2	rickettsii-dc
2	maruyama,
2	righi,
2	palmisano,
2	sá-nunes,
2	rickettsiosis
2	anticlotting,
2	vasodilatory,
2	9,560
2	96-120
2	antihemostatic,
2	(cds)
2	boxes,
2	lots.
2	revaccinated
2	fluorescent-labeled
2	plasmablast
2	revaccination.
2	microangiopathy
2	bacterially
2	drugs;
2	toxin-antibody
2	pre-incubation.
2	stx-intoxication
2	staging,
2	anti-tnfα
2	biosimilars
2	expiration
2	adalimumab.
2	adalimumab
2	bispecific
2	biomolecule
2	fl.
2	batches
2	30–35,
2	qp
2	high-producing
2	radiotracers
2	99m
2	successful,
2	anti-fgf2
2	3f12e7
2	rebmab200,
2	mx35.
2	<sup>99m</sup>tc-rebmab200
2	mx35
2	napi2b
2	ovcar-3
2	regulatory,
2	bioprocess,
2	hu3s193
2	(19.3%)
2	myotoxicity.
2	stings,
2	resonance,
2	construction.
2	pseudogene
2	gcr.
2	gcr
2	laborious,
2	pentapeptide
2	instant
2	3-peg
2	8-c(rgdyk)
2	streptavidin
2	7-h
2	dislodge
2	efficiently,
2	80-fold
2	chitin,
2	shells.
2	macromolecule
2	revs
2	(dtxd).
2	microencapsulation
2	s-s
2	tsa
2	(do)
2	puzzling
2	discourage
2	phosphoserine
2	post‐mortem
2	citation
2	plos
2	fibrinogenolytic,
2	(bm).
2	helminths,
2	anti-dc-sign
2	loxosceles,
2	pld,
2	sorter
2	scolopendra
2	viridicornis
2	centipede
2	(15 μg)
2	jararhagin-induced
2	2,4,6-
2	(tnbs).
2	(dai),
2	tnbs-mice
2	(ilc3)
2	cd4+tbet+
2	(lxa4
2	tnbs,
2	envenomings
2	(mabap1)
2	c43
2	13.6
2	scfvbap1,
2	th1/th2-related
2	(ova)-immunization
2	(tlr2
2	(tlr4-/-)
2	ova-primed
2	specific-immune
2	vanish
2	annexin-v
2	pro-allergic
2	anti-trail
2	interleukin-5-producing
2	ang-2
2	il-8.
2	immunoadjuvants
2	bf/ova
2	smval26
2	farias
2	eumenes
2	wasp.
2	peptides;
2	anti-hsa
2	mabap1
2	viperidae,
2	(18/14-tcra)
2	hsp-18
2	leprae.
2	protein-dodab
2	(80-100
2	dodab/protein
2	zeta-potentials
2	adjuvant/protein
2	silica-based
2	tris.hcl,
2	kda-hsp)
2	dodab-covered
2	bare
2	foot-pad
2	lincopan
2	deglycosylated
2	high-molecular-weight
2	understating
2	il-4-independent
2	indicate,
2	-7),
2	0),
2	hypersecretion,
2	igg1-reconstituted
2	il-12-/-
2	tlr4-
2	igg1-producing
2	β-hexosaminidase
2	aglycosylated
2	mg/animal)
2	(0.35
2	protein/animal)
2	(crotapotin),
2	mobilisation
2	metyrapone,
2	bsa-treated
2	ctx-injected
2	cdtv.
2	non-anaphylactic-type
2	il-4+/+
2	anaphylactic-type
2	il-4-dependent,
2	pca.
2	elicited,
2	ifn-γ;
2	deliberately
2	asc.
2	oa-stimulated
2	asc-immunized
2	substoichiometric
2	beer.
2	solved.
2	lysine,
2	zebrafish,
2	(cb1r),
2	nfkf
2	rpt2),
2	1-h),
2	neurolysin.
2	mixtures.
2	oligopeptidase)
2	ligand-induced
2	vgseliqky
2	(el28),
2	251–259
2	chymotrypsin,
2	el28/cell-penetrating
2	antibody-responder
2	(pvnfkflsh;
2	(epm),
2	(i.p.;
2	(p.o.;
2	(i.c.v.;
2	brain-peptide
2	6-iodonordihydrocapsaicin
2	sb366791
2	am251
2	fragment(s)
2	genuine
2	firmly
2	(hek293t)
2	bortezomib,
2	carfilzomib
2	proteosome
2	tripeptidyl
2	welvvlgkl
2	(pep5)
2	pep5-
2	pep5-cpp.
2	welvvl
2	leu-ala
2	death/signaling
2	im-54
2	necrostatin-1
2	q-vd-oph.
2	oligodendrocytes
2	demyelination.
2	stem/progenitor
2	heimann,
2	direct-acting
2	damped
2	enthusiasm
2	cci-rats
2	(egr-1ir)
2	(5ht1a
2	(α-2
2	ucl
2	1684
2	urb-584
2	(faah
2	jzl-184
2	(magl
2	anadamide
2	beta-5
2	hemoglobinderived
2	hemorphins
2	protein-derived
2	aghlddlpgalsal
2	(agh),
2	alpha-chain,
2	extralysosomal
2	ca2+-calmodulin
2	high-caloric
2	top)
2	gnrh.
2	beta-2
2	caution,
2	mcf7,
2	academia,
2	decisively
2	tap1/β2m-/-
2	antigen-processing
2	(schechter
2	112:3927-3938,
2	(liu
2	proc
2	natl
2	acad
2	96:6643-6647,
2	1999;
2	newton
2	wride
2	vis
2	9:360-396,
2	ohyagi
2	635:323-327,
2	1994;
2	schelshorn
2	cereb
2	metab
2	29:585-595,
2	2009;
2	richter
2	515:538-547,
2	2009)
2	(ivanov
2	biopoly
2	43:171-188,
2	1997;
2	karelin
2	neurochem
2	24:1117-1124,
2	1999).
2	(newton
2	faseb
2	23:3020-3029,
2	2009);
2	carboxypeptidase
2	ccp1/nna1,
2	proteasome-generated
2	glia.
2	h600a
2	ph-activity
2	ja-2.
2	kcat,
2	catalysis,
2	tyr612
2	sales
2	α-hemoglobin-derived
2	peptide-derived
2	forskolin.
2	calmidazolium.
2	pull
2	dynamin
2	<e
2	bpp
2	bpp-xie
2	fivefold
2	(nearly
2	s-glutathionylation,
2	conformation-state
2	(pvnfkflsh)
2	rimonabant.
2	intrathecal,
2	intraplantar,
2	hemopressin's
2	(thimet
2	transfer)
2	607
2	one-letter
2	used)
2	y605a
2	receptor),
2	receptor;
2	potentially,
2	discrete,
2	1000-fold
2	3.4.24.16),
2	neurotensin).
2	immuno-cytochemical
2	(d93
2	d159)
2	d93a
2	d93
2	afu/(min
2	cells)]
2	s644a
2	weight;
2	ate
2	vvypwtqry,
2	hemorphins,
2	phlogistic
2	multicatalytic
2	24.16
2	(ace).
2	24.11
2	apm
2	2×105
2	ep24.16,
2	xylem-dwelling,
2	insect-transmitted,
2	grapevine,
2	periwinkle,
2	oleander,
2	continent,
2	(temecula
2	pierce's
2	wine-grapegrowing
2	california.
2	95.7%.
2	phage-associated
2	n-(2,4-dinitrophenyl)
2	dendrites,
2	position,
2	1.11
2	k(cat)
2	96.7%
2	(top).
2	neuropeptide-
2	post-nuclear
2	non-reducing
2	coincidentally,
2	quenched-fluorescence
2	bradykinin-related
2	leu-arg
2	arg-arg
2	abz-rppgfspfrq-eddnp
2	abz-gfspfrq-eddnp
2	bfgf.
2	(opioid
2	[met5]
2	[leu5]
2	71kda
2	enkephalin-generating
2	h],
2	0.86,
2	0.34,
2	0.014,
2	0.88,
2	il-12p70/il-23
2	camp-responsive
2	a-independent
2	ifn-g
2	depleting
2	antihypernociceptive
2	b2ar-mediated
2	palatable
2	anecdote,
2	(foxp3
2	(ccr4(high)cd62l(low)
2	cd44(high)cd54(high)cd69
2	(ccr4(int)cd62l(high)cd44(int)cd54(int)cd69
2	faustino
2	ige-dependent
2	ondansetron,
2	rrms,
2	ppms
2	immunopathologic
2	ligand-activated
2	disability
2	abs-75-treated
2	cromolyn.
2	allergen-associated
2	ige-dependent,
2	suffices
2	mid-
2	late-pregnancy
2	reabsorptions
2	sativa
2	locas46
2	love30
2	moca45
2	(nhs).
2	tl-ibs
2	fromm
2	gelatin,
2	(mbl),
2	borrelia,
2	zoonosis.
2	(dgc)
2	cyclases,
2	(kd
2	(specific
2	amamura,
2	(mac).
2	c7,
2	c8,
2	(snpl)
2	c5-c9
2	-macroglobulin.
2	1,10-phenanthroline-
2	(lic13322)
2	sc5b-9
2	c6-c9
2	thermolysin,
2	mac-dependent
2	(ehec),
2	attack,
2	nile,
2	(ns1,
2	ns2a,
2	ns2b,
2	ns3,
2	ns4a,
2	ns4b,
2	ns5)
2	vitronectin,
2	plasmin(ogen)
2	c4bp.
2	(upa).
2	pathways),
2	(vn)
2	pathogenic,
2	(wnv),
2	breda
2	[fh]
2	(ccp)
2	heparin.
2	(big)
2	(liga7-8
2	ligb7-8)
2	ligb9-10.
2	protean
2	sahagún-ruiz
2	pasteurellosis
2	pneumotropica.
2	abscesses,
2	c3-convertases.
2	(ef-tu),
2	places,
2	(fh).
2	(fi).
2	wolff
2	related-1,
2	elastin,
2	tropoelastin,
2	ligs
2	2+.
2	d163-168a
2	fhtyr
2	(rlic11947)
2	rlic11947
2	sph2,
2	sphh
2	(1.3,
2	μg/ml-normal
2	45-190
2	gag4028
2	gaa4028
2	1289-1339.
2	cub
2	leptospires.
2	(gipr)
2	tumorswere
2	adenomaswhereas
2	rlic10365
2	45-kda
2	(leptospiral
2	protein-laminin
2	lic10365
2	microconversions
2	cyp21
2	-126c>t,
2	-113g>a,
2	promoter/regulatory
2	nc-21ohd
2	nci-h295a
2	non-classical
2	prop1.
2	(mri).
2	hypoplastic
2	gene's
2	cis-regulatory
2	imprh
2	gata
2	fate,
2	morphogenesis,
2	lh/hcg
2	gata-4,
2	lhr
2	59),
2	dysgenic
2	oviducts
2	wolffian
2	uts
2	dds
2	fs.
2	wt1
2	398.
2	dysgenesis
2	gonadoblastoma.
2	boar
2	intersexes
2	cyp19
2	regionally
2	zfy
2	impeding
2	grades,
2	oxamate,
2	p65-nfκb
2	oxamate
2	swainsonine
2	hpv-transformed
2	anti-cd40
2	relies,
2	peritonealmacrophages
2	residentmacrophages
2	frommice
2	withmacrophages
2	irf-1.
2	i.p
2	whilewt
2	well-established.
2	c33a.
2	(prpc),
2	(prnp+/+)
2	(prnp
2	0/0)
2	multipotentiality,
2	oligodendrocytes.
2	neurosphere-derived
2	prnp+/+
2	sti1-prp
2	neurosphere-forming
2	hpvs
2	tam,
2	f4/80,
2	c-ki-ras
2	destabilization,
2	steps:
2	controlled.
2	acth-receptor
2	cd34,
2	meca79
2	peaks,
2	execute
2	acth39,
2	untouched
2	resistant).
2	akt/pkb,
2	→g
2	→s
2	-arrested
2	kinases-mitogen-activated
2	(erk-mapk)
2	c-fox,
2	erk-mapk,
2	y-
2	transition:
2	(phorbol-12-miristate-13-acetate)
2	pka.
2	hemostasis,
2	interferon-γ(ifn-γ).
2	sge.
2	m2-associated
2	expression),
2	cytokine-binding
2	artifacts.
2	(amg9810
2	[2.85
2	inflammation-associated
2	pyrogens
2	µg·kg
2	·h
2	consumption)
2	shock-inducing
2	distress,
2	immune-to-brain
2	5-day-old
2	im)
2	(fever)
2	(modulating
2	consequential
2	22°c.
2	cl316,243
2	drops
2	ḋo2
2	ḋo2/v̇o2
2	hypometabolism
2	monoglycerides,
2	(lp-mc),
2	monomyristolein
2	(lp-mm)
2	(lp-mo).
2	lp-mc,
2	(56-64-fold)
2	permeability),
2	cutaneous/transdermal
2	coli-infected
2	(4.6
2	(had
2	temperature).
2	thermoneutral
2	age-associated
2	trpv1-mediated
2	2,500
2	higher-order
2	cold-defense
2	hyperthermia.
2	(1,000
2	(30°c),
2	(70-90
2	sc-560.
2	telemetry
2	thereafter;
2	nicotine,
2	(tc).
2	vagotomy
2	indwelling
2	hyperthermic
2	amg0347-induced
2	leptin-irresponsive
2	exaggerate
2	fever),
2	adaptive.
2	lesioning
2	spares
2	behavior;
2	receptor").
2	surged
2	post-lps)
2	brain).
2	si,
2	thermography
2	(2006).
2	pyrogen,
2	subthermoneutral
2	(latency,
2	mono-,
2	(response
2	catheter.
2	dlps)
2	ephrin-a1
2	epha2,
2	coordinated,
2	(avpo)
2	way-100635
2	sb-269970
2	o2).
2	24.6
2	se).
2	[such
2	nar
2	catheters,
2	agp-bound
2	nmol/kg
2	(recombinant
2	factor-alpha)
2	detailed,
2	-synthesizing
2	non-neural
2	speculated
2	intra-vsa
2	31°c,
2	sng
2	thermoneutrality,
2	fever;
2	po.
2	(v
2	(ho)-carbon
2	restraint-induced
2	rp-camps,
2	(5-ht1a)
2	serotonin-camp
2	avpo.
2	energetically
2	euthermic
2	(poa)
2	(zndpbg;
2	sc-560,
2	cox-2-selective
2	∼10
2	revolution
2	zndpbg.
2	(ho)
2	certainty.
2	pyretic
2	biliverdine
2	heme-induced
2	glycol),
2	anti-hyperalgesic
2	(7-ni;
2	abandoned
2	intracerebroventricularly.
2	0.5°c
2	ng/2
2	1.0°c
2	(basal
2	t(b),
2	t(b).
2	co-
2	17.4
2	1.49
2	blocker),
2	kawahara
2	(past
2	phosphoproteome
2	glycoproteome
2	2946
2	1733
2	glycosites
2	phosphosites
2	sequestering
2	id1-dbl2xb
2	notifications
2	index)
2	wealthy
2	life-even
2	(hbo)-protective
2	oxygen-sensitive
2	hif-1a
2	non-cm
2	8.9%
2	0.016),
2	mip
2	malaria;
2	monoxide,
2	rickettsemia
2	designs
2	a(-)
2	monomorphic
2	(5 mg/kg),
2	storm.
2	(ies)
2	(pm).
2	berghei-var-infected
2	dbl1-6
2	var2csa.
2	(il)-2,
2	(pfmnp)
2	dispersity
2	balbc
2	anti-msp119
2	103)
2	msp2.
2	pfmnp
2	tlr-induced
2	anchors.
2	ang-1
2	residence.
2	(pfemp1)
2	parameterized
2	(plns).
2	pc-gfp-irbcs
2	parasite/host
2	k173,
2	ankaδpm4
2	increasing,
2	(csa).
2	primiparous
2	entails
2	zoledronic
2	acc-t36
2	surprising,
2	bub1b
2	tcf21,
2	pink1,
2	nr5a1
2	tcf21/pod-1
2	intra-adrenal
2	pmah.
2	steroidogenesis.
2	zonation
2	hormones/cytokines
2	climbing,
2	(sf1
2	x-zone
2	rodents)
2	2-deoxy-d-glucose
2	adenoma-t7
2	(acth),
2	sf-1/nr5a1
2	fasciculata/reticularis
2	pcmvmycpod-1,
2	pod-1,
2	monica
2	hereafter,
2	p27kip1.
2	nek2
2	notch2
2	n-pomc,
2	w)
2	w/o),
2	fasciculata/
2	fgf2-treatment
2	w/o.
2	cysteines.
2	hyp
2	cycle-arrested
2	corticotropin
2	8-bromo
2	p42
2	p44
2	unmasked
2	moriscot,
2	koh,
2	electrotransferred
2	trophicity-related
2	emhc
2	hdac4.
2	atrogene
2	atrophy-related
2	2500
2	distributes
2	leucine;
2	(4e-bp1)
2	(eif4e)
2	post-injury
2	3-kinase/akt-protein
2	b/mammalian
2	(pi3k/akt/mtor)
2	time-to-peak
2	half-relaxation
2	(tβr-i)
2	(myhc-n)
2	tβr-i
2	(2-month-old)
2	postcryolesion
2	cryolesion-induced
2	3-kinase/akt/mechanistic
2	β-hydroxy-β-methyl
2	mafbx/atrogin.
2	hmb.
2	baptista
2	(surgery
2	transection),
2	(vastus
2	medialis)
2	(rectus
2	medialis
2	hydroperoxidation,
2	carbonylation
2	overactivation,
2	ncam
2	squats,
2	sfrp1:
2	d1:
2	post-venom.
2	post-venom,
2	(ring,
2	atrogin
2	murf2
2	calcipressin
2	ibm.
2	ibm
2	maximum;
2	mobility,
2	finger-1
2	subscales
2	hours).
2	(flst288
2	flst315),
2	follistatin-like
2	(flst-l3),
2	factor-associated
2	(gasp-1),
2	(actiib),
2	flst-l3,
2	actiib
2	(sets
2	ugrinowitsch,
2	bacurau,
2	aoki,
2	radicicol,
2	inductor,
2	(ncam)
2	(mhcn).
2	ncam-positive
2	post-ctx
2	mhcn-positive
2	(mafbx/atrogin-1,
2	murf-1)
2	(ubp45,
2	ubp69,
2	usp28)
2	mafbx/atrogin-1,
2	ubp45
2	ubp69
2	myo-d,
2	fk506,
2	anterior.
2	postlesioning
2	developmental/neonatal
2	stretching,
2	dorsiflex
2	plantar-flexor
2	ankle
2	nfatc1,
2	raptor,
2	s6k1,
2	4e-bp1,
2	(dry/wet)
2	(pl).
2	(immobilized
2	csa)
2	disuse.
2	rehabilitation.
2	96,
2	tre2
2	tre3,
2	tre1
2	tre3
2	tropism-related
2	weights,
2	transcription/
2	five-fold)
2	calcineurin-dependent
2	calcineurin.
2	nfatc1/gata2-dependent
2	(259.5
2	(15.5%;
2	cryoinjured
2	(ta:
2	2108
2	930
2	792
2	640
2	μm2;
2	soleus:
2	2209
2	764
2	439
2	m2;
2	w/v)
2	cafeteria-fed
2	myoprotective
2	myoprotection.
2	swallow-tailed
2	hummingbird,
2	eupetomena
2	macroura.
2	hummingbird
2	(hmucp)
2	(flight
2	915
2	ucp2,
2	12ca5-tagged
2	potential-sensitive
2	room's
2	torpor/rewarming,
2	hummingbirds.
2	torpor.
2	rewarming.
2	(serca2)
2	0.6-kb
2	water-
2	iopanoic
2	5'-dii.
2	(mef-2)
2	t3rα1
2	t3rβ1
2	t3r
2	isoform-specific
2	preexposed
2	alkanesulfonate-binding
2	phytopathological
2	biofuel
2	est8,
2	fosmid
2	6.0.
2	valerate.
2	detergents
2	alpha-beta
2	taurine
2	cysb
2	biofuels
2	h<inf>2</inf>
2	hyd-3
2	amblyomin-x.
2	amidolytic
2	exploited.
2	atp-driven
2	lobes,
2	(hvem)
2	attenuator
2	(btla).
2	adjuvant/antigen
2	hvem-expressing
2	(gde7),
2	plasmas,
2	mucosal,
2	parenteral,
2	hlt)
2	(lt4
2	plt).
2	(k4r,
2	n238d)
2	(s4t,
2	a46e,
2	e102k)
2	lt1.
2	(ltk4r),
2	cytotonic
2	k4r
2	crevice.
2	noticeably,
2	(d-domain)
2	(c-domain)
2	hvr,
2	(dc-domains).
2	(e467
2	d469),
2	(k568,
2	k569
2	k575)
2	d469a
2	dc-domains:
2	d-domain
2	(denv-2)
2	maltose/maltodextrins.
2	p6122,
2	304.20
2	asymetric
2	(xac
2	micronutrients.
2	oxyanion-binding
2	lies.
2	archaeglobus
2	fulgidus
2	moda.
2	ala38
2	ser151,
2	lt-encoding
2	(elta
2	eltb)
2	/st
2	(bsai,
2	ddei,
2	hhai,
2	hincii,
2	hphi,
2	mspi)
2	elta
2	eltb.
2	gm1-binding
2	lt4.
2	lt4,
2	(y-1
2	pathogeneses
2	c2221,
2	68.15,
2	172.14,
2	112.04
2	gmm
2	a1)
2	196,
2	atheroma
2	reactive-oxygen-species-(ros)-generating-enzyme
2	(trx-1)/p40phox
2	lipopolysaccharide-(lps)-cell
2	nuclear-factor-(nf)-κ
2	nf-κ
2	reductase-1
2	(trxr-1).
2	nox2/trx-1/nf-κ
2	hyperproduction
2	tumor-necrosis-factor-(tnf)-α
2	(lacl
2	auranofin
2	(aur),
2	cecal-ligation-and-puncture-(clp).
2	nox2-mediated
2	androwiki,
2	sartoretto,
2	couto,
2	veríssimo-filho,
2	(wb,
2	imunofluorescence),
2	(bacitracin,
2	tnfα-stimulated
2	pdi.
2	semirecombinant
2	incubated,
2	pdired
2	pulldown
2	(>80%
2	nox4,
2	nox2ds,
2	nox2-,
2	nox1-
2	nox4-oxidase.
2	scrambled
2	-γ
2	(α,
2	(γ,
2	ctα
2	ctγ:
2	kcl).
2	assistance
2	traffic,
2	platelet-derived
2	cd63,
2	exosomes.
2	aii-induced
2	pdiasodn.
2	p40phoxto
2	c-phosphorylated
2	nonphosphorylated
2	septa,
2	etn,
2	radiographed
2	etn
2	matrix;
2	sciarids
2	hydrolyses
2	npfb
2	deuterium
2	hydrophobicity.
2	chlorides,
2	individuals:
2	tlr3−/−
2	amarante-mendes,
2	adjemian,
2	zanetti,
2	weinlich
2	patterns-pamps),
2	patterns-damps).
2	unwanted,
2	damps.
2	hematologia,
2	hemoterapia
2	terapia
2	accumulate,
2	973,501
2	28.2%
2	(cdss),
2	annotated.
2	ureaplasmas,
2	urease,
2	(mib)-mycoplasma
2	(lipoproteins,
2	multiple-banded
2	lipoprotein).
2	(tlr2),
2	immunopathogenesis.
2	crosstalk,
2	86.9%
2	es-bax
2	9-fold
2	lncrna
2	inflammasome-activated
2	caspase-11
2	(caspase-4
2	humans),
2	provide.
2	(had5)
2	ctl-mediated
2	(target)
2	non-target)
2	18-24.
2	disadvantages
2	cancer-specific
2	prame,
2	ezh2,
2	cml.
2	ced-3
2	executioner
2	apoptosis)
2	objective-
2	nitro-fatty
2	(no2-fas)
2	nitrolinoleic
2	nitrooleic
2	chorioallantoic
2	sprouts
2	2-fas
2	transporter-1,
2	adrenomedullin.
2	spermine-nonoate
2	deta-nonoate,
2	no2-fas.
2	no2-fas,
2	hif-1α.
2	ficoll-hypaque
2	equipment.
2	inducers.
2	myelofibrosis
2	(pmf),
2	dr4
2	dr5
2	(nod-like
2	(caspase
2	4)/naip5
2	(fla-bsdot)
2	nlrc4-
2	naip5-deficient
2	fla-bsdot.
2	(fla-bs),
2	fla-bsdot-mediated
2	cdr
2	(chx)
2	anti-cd95
2	jararhagin.
2	pomolic
2	cross-talking
2	alomia
2	myriadenia
2	tunel-negative
2	philadelphia
2	death-inducing
2	butyrate-induced
2	2c4
2	fibrosarcoma.
2	(pha)-induced
2	myriadenolide.
2	tcr-mediated
2	thymocytes.
2	2bh4,
2	glucocorticoid-induced
2	noninflammatory
2	hydra
2	procaspase-3
2	proteinase.
2	calpain,
2	apoptosis-like
2	αψ(m)
2	bcl-x(l).
2	bcl-x(l),
2	perturbations,
2	cotransfected
2	p85.
2	zvad-fmk,
2	vp-16
2	act-d.
2	oligonucleosomal
2	(ice)/ced-3
2	gp23
2	e-5
2	16-kda
2	gp45
2	gp90.
2	necroptosis,
2	tumorigenicity
2	prebiotics,
2	procaspase-7
2	zymogen
2	(n),
2	trans-signaling
2	omics
2	pharmacogenomic
2	on-going
2	hypothesis-driven
2	(pdxs)
2	postthymic
2	(th2),
2	(th9),
2	(th17),
2	(tfh),
2	(itregs),
2	factor-β-
2	(tgf-β-)
2	(th3).
2	1-2%
2	immortomouse
2	tumorogenesis.
2	dcd-positive
2	crispr/cas
2	community)
2	(ph,
2	heat,
2	double-
2	molecular-pattern
2	nonprotein
2	catalogues
2	alignment,
2	dystrophin-associated
2	lessen
2	(omm)
2	(imm)
2	distends
2	ruptures.
2	widths
2	perforation
2	pushing
2	perforation.
2	imm,
2	contextually,
2	unimpeded
2	impermeable.
2	selectable
2	flp/frt
2	loss-of
2	nucleases
2	anti-mammalian
2	mycosis.
2	resumes
2	ins-rα,
2	proteasomes.
2	microarray-based
2	plko
2	208
2	dcd-rnai
2	(37%)
2	characterized;
2	alpha.
2	bsrm
2	balb/mk
2	cyclophilin
2	motivation:
2	scissile
2	pest-like
2	datasets.
2	(mpt),
2	ruptured.
2	herniating
2	wehi-164,
2	(cuns)
2	μm3
2	cuns
2	(47-89%)
2	mac16
2	loss),
2	loss).
2	s3.
2	(prb)
2	cdks,
2	tgf-/3
2	il-1/3,
2	en
2	pif
2	charcoal
2	α-alkynyl-β-substituted
2	chromanones
2	alkynylation
2	enolate
2	(dft)
2	miehei
2	chromanes
2	seven-
2	eight-membered
2	1-vinylcycloalkanols
2	ether)
2	htib
2	medium-ring
2	organisations
2	cis-
2	(+)-bakkenolide
2	(±)-
2	-cb[6]
2	cyclohexene
2	picture.
2	caramboxin,
2	4-methyl-1,2-dihydronaphthalene
2	alifáticas
2	67-77%
2	realizada
2	quatro
2	66-76%
2	37-66%
2	isopulegol
2	2-(3,4-dihydronaphthalen-1-yl)propan-1-ol
2	pyrans
2	(aliphatic
2	aromatic)
2	ch2cl2
2	(primary,
2	iodine.
2	aza-prins
2	trans-trikentrin
2	cycloalkenes
2	iodine(v)
2	iodine(i)
2	process)
2	functionalization.
2	high-yielding
2	chemoselective
2	summarized,
2	diaryl
2	reagent).
2	htibs,
2	assigned.
2	oxidations
2	miscellaneous
2	(r/s:
2	achiral
2	pseudomomas
2	(xyla)
2	ipt101.
2	dolosa.
2	pbbr1mcs-2,
2	dib
2	cis-hydrindanes
2	trimethylorthoformate
2	seven-membered
2	thallium(iii)-promoted
2	electron-withdrawing
2	electron-donating
2	iodosylbenzene,
2	2:1
2	acoh
2	equiv
2	phi(oac)2.
2	mutisianthol
2	diastereoselectivity
2	1-tetralones
2	3-alkenols
2	α-oxidation
2	exhaustively
2	short-bowel
2	satisfactory.
2	staging
2	(88%),
2	retropancreatic
2	intraoperatively.
2	mucopolysaccharide
2	chemoprevention,
2	isotropic,
2	me-60
2	association®
2	coencapsulating
2	(elacridar)
2	(45.2
2	(−4.2
2	verapamil-induced
2	p-gp;
2	ne-inhibited
2	elacridar-loaded
2	(1.4-fold,
2	monoolein-containing
2	monoolein-alginate
2	isotropic
2	mew
2	ishida.
2	non-toxicity,
2	mucoadhesive,
2	non-immunogenic
2	(mo),
2	(rhe)
2	(ptds)
2	(mes)
2	first-pass
2	nanodispersed
2	decylglucoside-based
2	(w/w/w)
2	me-o
2	w/o
2	me-43
2	me-50
2	(0.5%),
2	me-p
2	ternary
2	oil-in-water
2	([e
2	d])
2	(w/w,
2	brij-95
2	mono/diglycerides
2	(mcg)
2	lp-10
2	0.5%,
2	self-diffusion
2	(mk2i)
2	a7r5
2	arsenite
2	factor-induced
2	hyperplasia.
2	5%),
2	(52:48,
2	(indicative
2	spiked
2	172.6
2	safe)
2	mono
2	(regarded
2	(2-fold)
2	tgf-β1-induced
2	actin-depolymerizing
2	siberian
2	80:
2	cd-igs
2	surfactants,
2	surfactants.
2	ce.
2	p20.
2	wlr
2	lipid-based
2	vaseline
2	μg/cm2
2	∼2
2	monoolein.
2	yara,
2	tat,
2	ykac,
2	fmoc
2	penetrated
2	(nsaids).
2	scattering.
2	troubleshoot
2	specifics
2	[3h]ampa
2	aniracetam
2	gyki-52466
2	sd.
2	whey,
2	co-substrate
2	lfm
2	35 °c.
2	carbon.
2	whey.
2	crystallinity
2	thermomechanical
2	h16,
2	phac
2	p(3hb-co-3ha
2	antibiotic-free
2	84.2
2	3hb
2	plasmid-
2	bioprocess.
2	dsc,
2	high-value
2	engineer
2	xylose.
2	improvement),
2	available:
2	fulltext.]
2	petroleum-based
2	biopolymers.
2	pandoraea
2	[p(3hb-co-3hv)]
2	prp25
2	3hv.
2	biodiesel
2	orthopedics
2	intensified.
2	agglomerates,
2	mol%.
2	p(3hb-co-3hhx)
2	copolymer,
2	molding
2	flexural
2	scientia
2	agricola.
2	(μmax)
2	cardinali-rezende
2	kt2440
2	2/3.
2	logistical
2	complying
2	licensure
2	savings
2	drilling
2	thermoplastic
2	biorefinery
2	2g
2	hydrolysate,
2	f24
2	25.04
2	b. sacchari
2	4hb
2	supplied.
2	pha;
2	6.5,
2	polymers,
2	phas
2	isotopomer
2	-using
2	hydrolysates.
2	phosphotransferase
2	internalizes
2	ammonium,
2	lfm828
2	coir,
2	2-methylcitric
2	acnm,
2	2mcc
2	3-hydroxyvalerate
2	(3hv)
2	copolyester
2	supplied,
2	sustainability
2	048
2	h-1
2	phamcl
2	polyester
2	°c),
2	segmented
2	blending
2	2-methylcitrate
2	2-methylisocitrate
2	prpb
2	sugar-cane
2	nitrofurantoin
2	harmful.
2	balances
2	bottled
2	suppliers
2	3-hydroxy-4-pentenoic
2	sol-gel
2	gelation,
2	bleaching
2	pharmacology,
2	(βcd-carvacrol),
2	(mip-2),
2	vehicle-pretreated
2	(cus)
2	(7ni),
2	7ni
2	limitations.
2	contusion
2	1 h,
2	90 s)
2	(1 g).
2	9 j
2	(321.4 j/cm
2	henao
2	cavinato,
2	peixoto-santos,
2	muscará,
2	sinigaglia-coimbra,
2	pacheco-silva,
2	(mvs-mscs)
2	th17,
2	m1-m?s
2	thioglycollate-induced
2	(cd44,
2	cd105,
2	cd73)
2	microvesicle
2	(annexin
2	cd9).
2	m1-mφs,
2	arginase)
2	(mir-155
2	mir-21),
2	molecules).
2	m1-mφs
2	f4/80+/ly6c+/ccr2+
2	peppermint
2	epicatechin
2	6–8).
2	(37.5,
2	kg−1,
2	mda,
2	anti-histamines
2	anti-histamine-resistant
2	(8–80 nmol)
2	(30 mg/kg).
2	(40 nmol)
2	3 nmol)
2	0.3 nmol)
2	(200 nmol)
2	(10 nmol)
2	antipruritic
2	nahs;
2	(30 μg)
2	(20 μg)
2	sligrl-nh2-induced
2	pruritus;
2	aitc
2	(1000 nmol)
2	nahs.
2	(cgmp)-independent
2	par-2,
2	anti-histamines.
2	(nahs,
2	14 μmol/kg)
2	(1 mg/kg),
2	o2[formula
2	ova-challenge.
2	inos-inhibition
2	herrera
2	(h2s)-releasing
2	safeness.
2	subgingivally
2	donor)
2	radiographical
2	(mpo,
2	flatness
2	naproxen-treated
2	configuring
2	withstand
2	sideroxylon
2	cicatrization
2	anti-infammatory
2	polyvinyl
2	ic50value
2	(cgn)
2	kaolin-induced
2	μg/joint)
2	kaolin-injected
2	cgn
2	monoarthritis.
2	(released
2	c-fibres)
2	anti-inflammatory/analgesic
2	cxcl4.
2	histometric
2	staining;
2	factor-a
2	(20?mg/kg),
2	50?mg/kg),
2	10?mg/kg)
2	10?min
2	60?min
2	(300?μg/kg)
2	4?h
2	(3-nt)
2	3-nt
2	pancreatitis-related
2	efic®.
2	gw9962
2	pylorus
2	reestablishment
2	brenan,
2	"angico",
2	colubrina,
2	(p.o.),
2	(acetic
2	synovitis).
2	writhes
2	(100,
2	mieloperoxidase
2	anti-neoplastic
2	ut,
2	(nahs)
2	antigen-challenge,
2	(3-nt).
2	h2s-donor
2	deleterius
2	saos-2
2	prp,
2	600,000
2	(3-nt),
2	antidepressants
2	fibrogenesis,
2	2)-prone
2	myd88dependent
2	m1:m2
2	1:t
2	allodynia)
2	par-2-ap
2	identity),
2	pits
2	disks.
2	dish
2	2)-induced
2	grease-gap
2	post-injection
2	cdt-induced
2	20mg/kg/day
2	(no)-deficient
2	(l-name-treated)
2	radiographically.
2	(tbars;
2	index),
2	(nt;
2	nitration)
2	(mpo;
2	co-localizing
2	pgp9.5
2	substance-p-containing
2	par2-induced
2	endogenously,
2	(dl-propargylglycine)
2	[lawesson's
2	(lr)].
2	gait,
2	hindpaw,
2	propargylglycine
2	production),
2	therapies)
2	microg/kg,
2	(trap-5b),
2	trap-5b,
2	w256
2	(sp5c)
2	(24 h),
2	(15 days)
2	(14 days-24 h)
2	nnos-like
2	(nnos-li)
2	sp5c,
2	nnos-li
2	(108.3
2	49.2%;
2	chronic-phases
2	3rd,
2	(srs).
2	saline).
2	tmj-arthritis
2	provide,
2	chapters
2	a-associated
2	(ca2+),
2	ligature,
2	by sr140333.
2	(qpptppehrfpglm
2	aseptalglprifpglm)
2	histamine/7
2	pyrilamine,
2	venom-mediated
2	blt
2	diffusion.
2	a5330
2	neonatal,
2	production/release.
2	disfiguring
2	vasoconstrictors
2	(1.25,
2	unlesioned
2	calcium-independent
2	t50%
2	tnfα-dependent
2	nerves),
2	emigrate,
2	trans-endothelial
2	eta/etb
2	radiographs
2	mesial
2	2-/no
2	jia.
2	lymphomononuclear
2	nt-modified
2	(celecoxib,
2	dramatically,
2	(no)-releasing
2	defence,
2	naproxen,
2	il-10(-/-)/inos(-/-)
2	no(x)
2	(14.5
2	17%).
2	post-surgery
2	6-keto
2	gastrointestinal-sparing
2	antithrombotic
2	no-aspirin
2	parietaria
2	nonatopic
2	mg/d)
2	346
2	(6.3%)
2	constant)
2	equivalence
2	cilazapril,
2	sdbp
2	cilazapril
2	isothermal
2	invoked
2	ire1<alpha>
2	origene
2	protein-folding
2	upr-related
2	drugs'
2	stress-response
2	demodicosis
2	cd4+:cd8+
2	(human,
2	(eqpbmc)
2	(gapdh),
2	2216
2	endotoxin.
2	md-2
2	'relaxed'
2	athlete
2	poised
2	(edds)
2	(xbp-1)
2	bip/grp78
2	xbp-1.
2	xbp-1
2	mct
2	limb-girdle
2	dystrophies
2	sjl
2	engraft
2	human/mouse
2	gamma)
2	(interleukin-12)-induced
2	(eiu).
2	phosphate-buffer
2	pk136
2	r4-6a2
2	nk1.1-depleted
2	(kc)
2	(mip-2)
2	il-12-induced
2	cd70.
2	mucins
2	sn-2
2	(tgpi-mucins)
2	tgpi-mucins
2	activation/inhibition
2	ifn-γ-primed
2	costimulated
2	trypomastgotes
2	(tryp)(but
2	tryp.
2	monokine
2	glycosyl-phosphatidylinositol
2	anchor.
2	pharyngeal
2	limbs,
2	dengue-suspected
2	etiologies
2	2012-2013
2	(ip-10),
2	fda-approved
2	(chikv)
2	chikv,
2	description.
2	aracaju
2	capital
2	field-caught
2	(chikv),
2	east-central-south-african
2	(ecsa)
2	reemergence
2	guarujá,
2	science;
2	fetalmicrocephaly.
2	zikvchallenge
2	zikv-specific
2	rico.
2	dnavaccine
2	premembrane
2	zikvchallenge.
2	pre-membrane
2	(prm-env),
2	prm-env
2	viraemia
2	achievable.
2	(denv1
2	denv4)
2	denv1-,
2	denv2-,
2	denv3-,
2	denv4-infected
2	epitope-conformation-dependent
2	ns5-specific
2	alpha-producing
2	flaviviridae)
2	yap
2	caledonia
2	polynesia.
2	br)
2	organoids
2	betabaculovirus
2	administrations
2	georeferenced
2	bioinsecticide.
2	(velvetbean
2	caterpillar)
2	agmnpv;
2	pangenome
2	bro-a
2	rnf12-like
2	indels,
2	bunyaviridae
2	mid
2	1947.
2	velvet
2	caterpillar,
2	agmnpv-2d.
2	agmnpv-2d
2	149
2	(tbev)
2	eurasian
2	findings:we
2	1944
2	flavivirus.
2	crf28-bf
2	crf29-bf
2	crf28-bf,
2	macrophage-tropic
2	cities,
2	genomes),
2	editiora
2	interlaced
2	montpellier
2	x4
2	montpellier,
2	̃o
2	romano
2	interrupting
2	iap
2	baculovirus.
2	rampant
2	proximity,
2	urbanization,
2	encroachment
2	sprawling
2	urban,
2	cattle-raising
2	884
2	(case-fatality
2	39%).
2	2,500-km-wide
2	case-fatality
2	(lineage
2	r(0)
2	poxviruses
2	(agmnpv-2d).
2	<1
2	catt
2	-27.
2	10-2
2	(gbv-c)
2	gbv-a
2	host-virus
2	(pan
2	cerv-k
2	multilocularis
2	agb1,
2	agb4
2	post-infection),
2	non-overlapping
2	choristoneura
2	epiphyas
2	mori
2	nucleopolyhedrovirus.
2	sertifer
2	phyla.
2	baculovirus,
2	nucleopolyhedroviruses
2	log10
2	2.79
2	deforestation.
2	ecdysone
2	nucleocapsids
2	loobmnpv
2	(ufl-ag-286)
2	vaggala2
2	covary
2	retroelements
2	hearnpv
2	5'-noncoding
2	3.6%.
2	genealogy-based
2	outperform
2	hepatitis)
2	intrafamilial
2	passion
2	djjmnpv
2	(tbe)
2	louping
2	scotland
2	norwegian
2	because,
2	(clone
2	pandemics,
2	dollars
2	"exploring
2	mosquitoes"
2	affordable,
2	cheap,
2	cheaper
2	allocate
2	decoralin
2	anti-infective
2	polyandric
2	moments,
2	ethical,
2	containment,
2	biosafety
2	juazeiro
2	ovitrap
2	ovitraps
2	jacobina
2	(pedra
2	interruption,
2	juazeiro,
2	-terminus
2	sequence;
2	recapture
2	sporozoite,
2	phenylalanine,
2	brazil’s
2	cover,
2	standards.
2	(93.1%)
2	antiplasmodium
2	ox513a,
2	spanned
2	competitiveness
2	(dss)-induced
2	3-5)
2	5-8)
2	sge-treated
2	re-challenging,
2	vision,
2	repellency
2	unaffordable
2	desirable.principal
2	eb-injected
2	tulle
2	fabric
2	(eb-
2	host),
2	spectrometrically.
2	engorded
2	ingested,
2	repellent
2	attractant
2	sweat.significance:
2	(diet,
2	etc)
2	repellents
2	attractants,
2	ptps
2	try
2	battle
2	grand
2	(nyssorhynchus)
2	vtg
2	β-fold
2	sexing
2	aii.
2	(79%),
2	[ala5]-aii
2	8]-aii,
2	background:anopheles
2	transcriptome.methodology/principal
2	findings:a
2	7544
2	adult-specific
2	discussed.conclusions/significance:this
2	http://exon.niaid.nih.gov/transcriptome/an_aquasalis/anaquexcel.xlsx.
2	feeders
2	feeder,
2	tube,
2	device.
2	trait.
2	(dss).
2	viremia.
2	utilized,
2	jha1,
2	(i.c.)
2	pfu.
2	anti-envelope
2	(domain
2	gallinaceum,
2	anticoagulant,
2	achieve.
2	decs
2	(serotypes
2	insect-borne
2	76%,
2	afflict
2	(stegomyia)
2	589
2	blastx
2	ftp
2	(bateman
2	smart
2	(schultz
2	kbr
2	(haplotype
2	mdhexl1
2	darlingi
2	593
2	hemolymph,
2	(density
2	cdnas,
2	sex-,
2	antiparasite
2	apyrase
2	gland-specific
2	550
2	apyrase,
2	dissociates
2	9.0.
2	nitrosyl
2	(diptera)
2	∽
2	insect.
2	(cci).
2	thresholds
2	200 μg
2	lllt,
2	(fkn)
2	microglia,
2	incision.
2	(mor)
2	pod2,
2	mu-opioid
2	delta-opioid
2	rats.methods:
2	(sfi),
2	biopac
2	172%
2	pag.conclusion:
2	ox-42
2	l4
2	microglia.
2	aav2
2	meningeal
2	cx3cl1)
2	sin-induced
2	interleukin-1,
2	lancehead
2	vipers
2	bothrops)
2	painful,
2	intramuscularly,
2	facilitation,
2	neuritis
2	walls)
2	extra-territorial
2	frank
2	incisor,
2	il-1b,
2	ccl8
2	confused
2	(mhv3)
2	typhimurium.
2	ifn-γ-activated
2	il-6-,
2	tnf-α-
2	(tpa).
2	selections:
2	respects
2	habel
2	vna
2	(air):
2	tumorigenesis:
2	(qtl).
2	(dmba)-promotion
2	phenotypes/genotypes
2	genes/mechanisms
2	traits:
2	h(gp)
2	l(gp)
2	hybrids,
2	(apc)
2	tnp-specific
2	biozzi
2	cia.
2	interferon‐γ
2	(ifn‐γ)
2	anti‐cii
2	tcell
2	γa
2	(se).
2	breeding,
2	(air
2	(suspension
2	microbeads),
2	equipoised
2	inter‐line
2	log2
2	responder)
2	ends.
2	proteosomal
2	(cys76
2	cys221)
2	20spt
2	α5-subunit
2	trnas.
2	mta2
2	non-formylated
2	methionyl-trna.
2	mitoribosomes
2	mitoribosome
2	menadione.
2	aep3p,
2	[35s]
2	atp8p
2	allotopic
2	peroxiredoxins
2	qrs1/her2
2	cox2p
2	catalyzing
2	di-iron
2	r57,
2	s114e
2	non-structured
2	heptamers
2	gatcab
2	mischarged
2	gtf1p
2	(subunit
2	nde2p
2	nde1
2	encephalopathy,
2	fibroblasts;
2	gtpases,
2	mtg3p
2	mrpl4p
2	lifespan,
2	adt
2	bees
2	seal
2	propolis-mediated
2	correctable
2	relieves
2	coq10p.
2	(q
2	q-cycle
2	qh
2	-cytochrome
2	tunnel
2	tunnel.
2	sensing,
2	unearths
2	longevity.
2	atp9p
2	autosomal-recessive
2	childhood-onset
2	nad+.
2	+-dependent
2	oxidized,
2	α-ketoglutarate,
2	q2.
2	c92
2	xii.
2	cox23p,
2	cox23p
2	cox17p,
2	peroxidases
2	peroxide-removing
2	(cox),
2	ferredoxin,
2	tzagoloff,
2	lett.
2	temperature;
2	cox-specific
2	pregnenolone,
2	cardiomyoblasts
2	4-phenylbutyrate
2	(4pba)
2	bnip3,
2	foxo3a-dependent
2	4pba
2	loc-related
2	mct1
2	mg–1
2	min–1)
2	(nrcms)
2	hdac4,
2	mir-1,
2	nrcms
2	hadc4
2	nrcms.
2	hdac4
2	hadc4.
2	(ace2),
2	45kcal%
2	(hf45%)
2	60kcal%
2	(hf60%)
2	hf45%
2	mirna-29c.
2	gsk3β
2	mirna-21a-3p,
2	mirna-29c-3p,
2	mirna-144-3p,
2	mirna-195a-3p.
2	mirna-1
2	gd18.
2	(i/r),
2	-dp/dt
2	(at1r).
2	at1r.
2	serca2a
2	pdh,
2	coxiv
2	gd18
2	gd20.
2	β-mhc/mir-208b
2	α-mhc/mir-208a
2	event.the
2	β-mhc,
2	mir-208b
2	α-mhc,
2	mirna-208a/α-mhc
2	mirna-208b/β-mhc
2	echocardiography;
2	thioredoxin-1,
2	p-jnk/jnk,
2	p-gsk3β/gsk3β
2	(ros)/nitric
2	trolox,
2	hydrosoluble
2	analogue),
2	(at1/at2)
2	anion)
2	at1/at2,
2	nucleotidases
2	5'-nucleotidase
2	(at2r).
2	placońa
2	contraction-relaxation.
2	28-days
2	echocardiographic,
2	gsh/gssg)
2	p-gsk-3β/gsk-3β
2	immunocontent,
2	p-nph-5'tmp
2	(at1r),
2	(pd123319),
2	heart/body
2	th-related
2	(80%,
2	ths'
2	ths,
2	(sirna,
2	(90%,
2	(170%,
2	(85%,
2	(ly294002,
2	(120%,
2	(180%,
2	akt/gsk-3μ/
2	i/ii-at
2	r-akt/gsk-3μ/mtor
2	e-ntpdases
2	nucleosides.
2	hypoxanthine
2	sympathoadrenal
2	aga
2	ecto-nucleotide
2	angii,
2	27%)
2	adenosinergic
2	(rvw),
2	(lvw),
2	rvw
2	lvw
2	(anf)
2	hw/bw,
2	anf
2	rv.
2	(t4-10)
2	pd123319).
2	th-modulated
2	(e-ntpdase)
2	nucleotide-mediated
2	18 days
2	0.1 μm
2	t4-25
2	t4-100
2	ecto-ntpdases
2	ecto-5′-nt
2	signify
2	p-nph-5′-tmp
2	gadolinium
2	nervousness,
2	dcf
2	(cd/fd),
2	intercapillary
2	(icd)
2	(vw)
2	(vw/bw).
2	vw.
2	cd/fd
2	pcna-labeling
2	(vegf)-a
2	pronociceptive
2	420-day-old
2	0.45,
2	hyper-and
2	ntpdase1
2	glucocorticoid-mediated
2	ahpc
2	hfq
2	complementarity
2	srnas
2	medeiros,
2	(imuab
2	dnae2)
2	sos-mutagenesis
2	umudc.
2	umudc-dependent
2	rhlb.
2	epitope-tagged
2	rhle,
2	helicase,
2	na1000
2	hydroxamate
2	ferrichrome
2	aerobactin,
2	enterobactin,
2	59fe-citrate
2	na1000.
2	vmax,
2	pmol/109
2	(km,
2	fur-regulated
2	02277,
2	tbdt
2	02277
2	fepa
2	fur.
2	dps/bfr
2	comply
2	phase-induced
2	glyoxylate
2	znul
2	zinc.
2	lexa2
2	palindrome
2	motifs.
2	(fur)
2	iron-responsive
2	rpoh
2	hme-rnd
2	czrcba
2	nczcba
2	cadmium.
2	subfamily,
2	(csps)
2	enhancement.
2	atg
2	lttr
2	czta
2	(csd),
2	cspcd
2	fesod
2	fur-binding
2	-20
2	dead/deah
2	pila1
2	pili,
2	extracytoplasmic
2	anti-sigma
2	j1a12
2	σe-dependent
2	rsea
2	impossibility
2	chlorosis)
2	5,000
2	psp3,
2	xylella.
2	psp3
2	co-transcribed
2	chlorosis,
2	(orfs),
2	(trb)
2	stalked
2	camp‐dependent
2	emersonii.
2	introns,
2	ccaat
2	camp-binding
2	drastically.
2	pretranslational
2	43000
2	anoxia,
2	anxious-like
2	ca3-2
2	subfield.
2	geotaxis,
2	apprehension
2	ramón
2	hypertonia
2	non-hypertonic
2	james
2	fordisc
2	colipr
2	hispanic
2	misclassification
2	fleck
2	emerged:
2	cd13-ir
2	appearance,
2	(igl).
2	transcardially
2	plane.
2	(thionin)
2	demarcate
2	remainders
2	protocol).
2	monkey.
2	(vlgn)
2	(0.9%
2	ml/kg).
2	sufferers
2	fish-diet,
2	contradictory.
2	5-ht-immunoreactive
2	2001).
2	(mfc).
2	(bc)
2	(drn)
2	bibliographic
2	internet
2	experiential
2	gaba-
2	glycine-receptors.
2	gaba-receptor,
2	identified;
2	compositions,
2	glycine-,
2	brain-stem.
2	glycine-receptor,
2	γ2
2	ρ
2	double-immunolabeling,
2	glycine-receptors
2	brain-stem,
2	10%-15%
2	(hybrid)
2	orientalization
2	100635
2	100635,
2	jacchus,
2	wistar),
2	nucleus'
2	subjectivity
2	tailshocks
2	(fosir
2	5-ht)
2	psychopathology
2	(body
2	unfolding,
2	appraised.
2	(sf),
2	rmg
2	hexane-acetone
2	tamazato
2	longhi
2	(serpinb5)
2	non-inhibitory
2	suppressor,
2	post-lactational
2	(involution).
2	factor-starved
2	localizations.
2	reesei
2	conversely
2	225
2	detergent-insoluble
2	translocates
2	ebs,
2	mp+/+
2	ebs.
2	ectoderm.
2	tenascin,
2	(gr).
2	immunodepletion
2	dimerization,
2	heterodimers
2	homodimers.
2	homodimers
2	sfm
2	mcf10-a
2	prlr
2	dimerization.
2	lamp-2
2	β-casein.
2	competent.
2	igf-1,
2	ief
2	agglutinin)
2	lamininbinding
2	competency
2	(encoded
2	bhlha15
2	etiologically
2	esfs
2	(mnc)
2	scf-skp2/cks1
2	ghs-r
2	milk-born
2	tgfβ1.
2	suckling.
2	rs2066827
2	population-matched
2	acth-secreting
2	p27-v109g
2	cdkn1b
2	(p27)
2	men1-mutated
2	cdk2,
2	upsurge
2	he-stained
2	(tβri)
2	phosphorylation/activation
2	eecs
2	immunolabelled
2	(tgfβ).
2	3 h
2	strongyloides
2	stercoralis.
2	counting.
2	dissecting
2	submucous
2	1-,
2	kewense
2	(pe;
2	tβrii,
2	pe,
2	ltgf-β
2	(lhrh)
2	(controls:
2	1.52
2	non-labeled
2	22-d-old
2	neurons/mm2
2	tile
2	hyperproliferating
2	chow;
2	weaned,
2	0.09%
2	(0.20
2	th22
2	damps
2	tcd4,
2	anais
2	dermatologia.
2	skin’s
2	cd103
2	scd127
2	(esn)
2	cd56dim
2	cd38+
2	nkg2a,
2	tim-3,
2	(pam3csk4),
2	(pam3csk4)
2	7/8
2	"memory"
2	cd57+
2	up-regulated,
2	(ad),
2	(cytometric
2	timp
2	(v.o.)
2	v.o.
2	90 days
2	(cd19
2	(cd138
2	(il-4).
2	cysts;
2	ccl2,
2	cvid,
2	tnf-α+
2	il-22+
2	(pamps),
2	foxo3,
2	socs3,
2	ifn-i
2	cd38-t
2	apobec
2	3g
2	(apolipoprotein
2	(stimulator
2	hanifin
2	(58%),
2	23.3
2	dermatologists.
2	cxcl9
2	filaggrin,
2	claudins
2	(il-17)
2	lesional
2	(lamp-1)
2	endolysosomal/secretory
2	lamp-mediated
2	preconceptional
2	(transforming
2	(surgical
2	incisions,
2	procedure).
2	surgery).
2	mother-newborn
2	(tlr2,
2	cl097
2	factor-7
2	corticoid
2	cm2)
2	university,
2	(≤0.1
2	p=0·000),
2	beta-cell
2	(asst)
2	(ciu),
2	lovastatin
2	mitogens,
2	ifn-γ-
2	cpg.
2	natabs
2	macaques.
2	seb,
2	pokeweed
2	immunotherapies,
2	childhood,
2	fcεriα,
2	functionally,
2	nppc-klh
2	haptens,
2	nppc
2	nmbas.
2	haptens
2	antitransglutaminase
2	non-related
2	bt/ova
2	co-immunization
2	ova-sensitization
2	6th,
2	post-immunization
2	(dp),
2	immunoglobulins.
2	lupus-like
2	bwf1t
2	(0.25,
2	aaige
2	tolerization
2	heterosexual
2	iva
2	nzw)f1
2	(b/w)
2	pb(+)hc(-)
2	pb(-)hc(-)
2	infection-associated
2	anti‐dna
2	m̈g
2	p‐igg
2	p‐igm
2	postinfection.
2	ox8
2	precoated
2	equivalent)
2	rt1.b
2	t‐cell
2	1/20
2	ppd,
2	aa-like
2	conjugation,
2	pilsec404+
2	cunha,
2	sá,
2	piazza
2	(cc
2	epec/stec
2	nara,
2	martínez-laguna,
2	girón,
2	piazza.
2	non-fimbrial
2	(94-100%)
2	hcpa,
2	pilv,
2	sfpa,
2	daac,
2	sfa
2	(1-8%).
2	(ecp),
2	ecpa+
2	ecp.
2	62.5
2	point-of-care
2	(t3ss)
2	(y-p)
2	assembling,
2	t3ss
2	tir-cytoskeleton
2	(tccp/tccp2)
2	tccp/tccp2.
2	tiry-p,
2	autotransporters
2	(spate).
2	spate-encoding
2	47.1%
2	(24.3%),
2	espi
2	(21.2%),
2	(19.2%),
2	(13.5%),
2	eata
2	(1.0%),
2	espp
2	epea
2	espc
2	39.9%
2	23.3%
2	spate
2	phylogroup.
2	coli-secreted
2	citrobacter
2	ehxa,
2	paa,
2	o113
2	(o1:h8,
2	o11:h21
2	o125:h19)
2	eae-θ2/a,
2	eae-β1/b1,
2	eae-α2/b2
2	eae-γ1/d.
2	pulsetypes
2	lambs,
2	psittacidae
2	multiresistance
2	aflp.
2	infrastructural
2	ozaki
2	hybridoma-derived
2	cell-interacting
2	st-
2	lt/st-producing
2	ab5
2	n-glycosidase
2	o76:h19
2	(ehxa)
2	enterohemolytic
2	etxb
2	o111-etxb
2	(epec/ehec)
2	features;
2	laborious.
2	epec/ehec-secreted
2	espa/espb
2	production/secretion
2	dulbecco’s
2	eagle’s
2	cells-preconditioned
2	anti-espa/anti-espb
2	(ralt)
2	diagnosis;
2	high-impact
2	stx2-producing
2	anti-stx2
2	toxin-based
2	tryptone,
2	pet+
2	ruiz
2	anti-lt
2	espk
2	phenotypic,
2	attaching-and-effacing
2	non-locus
2	(localized-like,
2	diffuse)
2	intimin)
2	anti-bfpa
2	(stec),
2	enterotoxemia
2	citotoxic
2	66.6%
2	folded,
2	salmonella.
2	sarcosine
2	(1de
2	2de,
2	1de
2	patterns;
2	40-
2	41.5%
2	taddei
2	(int388-667).
2	338-667
2	(scfv).
2	pgem-t
2	bl21(de3)plys
2	(insoluble
2	denatured,
2	e2348/69.
2	(int
2	388-667)
2	menezes
2	facility
2	anti-bfp
2	bundlin,
2	iv-expressing
2	83%,
2	bfp-expressing
2	immunoserological
2	eaf-negative
2	stx-
2	peaf,
2	(eaf)
2	(ifl)
2	(ibl)
2	localized-adherence-like
2	shiga-toxin-producing
2	bfpa-positive
2	(β10;
2	fn391178)
2	o157:h45,
2	(β3.2-t;
2	391181)
2	35.0
2	stx-harboring
2	e-hly
2	(stx2v-ha
2	stx2vb-hb).
2	vca-negative
2	immunodot
2	wasvca-positive.
2	colony-immunoblot
2	vca-positive
2	immunodot,
2	proteus-like
2	(mr/p),
2	aaf/i,
2	adhesin-encoding
2	mrph
2	polymyxin-treated
2	lt-producing
2	egfp-er
2	paz
2	seriousness
2	anti-lt-i
2	intimins
2	neutralises
2	(fitc)
2	labelled-bav
2	neoglycoprotein
2	clumps,
2	clumping.
2	noninfected,
2	gal-
2	sc32
2	sc33
2	(ee),
2	ee-induced
2	cpp,
2	α4β2*,
2	(μ
2	nicotine-treated
2	conflicts,
2	(cpp).
2	ee,
2	(aldh)
2	(etoh)
2	faded
2	0%.
2	myelination,
2	underpinnings
2	addiction-related
2	stress-alcohol
2	g/kg),
2	homer2
2	oprm1,
2	54 h
2	(aeme).
2	cp-154,526
2	δ,
2	vo2,
2	37).
2	37),
2	(pcreb)/creb
2	soares-simi,
2	pastrello,
2	yonamine,
2	marcourakis,
2	opioid-mediated
2	retrieval,
2	grouping,
2	"loss
2	gabab1
2	gabab2
2	(h,
2	acid-b
2	(gaba
2	outbred,
2	phases),
2	"heavy"
2	"light"
2	phases).
2	(ethanol-naive
2	cocaine-aeme
2	(1.8.
2	sulpiride
2	=-0.31,
2	alcoholism,
2	acetaldehyde.
2	aud
2	deprivation)
2	aversion,
2	dba/2j
2	(10 mg/kg,
2	fyn-/-
2	mipscs
2	andrey
2	knockouts,
2	ethanol-like
2	ethanol-appropriate
2	handling-induced
2	control-fed
2	oblongata.
2	flower-pot
2	locomotor-activating
2	801
2	achase,
2	250-300
2	home-cage
2	obtention
2	(100,000
2	pellet)
2	(home-cage
2	5.7,
2	d-fenfluramine,
2	weight/day),
2	protein–protein
2	cache
2	xac2382
2	xac2383
2	phosphate-containing
2	architectures.
2	zimpel,
2	brandão,
2	ikuta,
2	heinemann
2	guimarães.
2	4,347,648
2	gc,
2	4,216
2	(2,805,
2	69.3%)
2	1,206
2	(30.07%)
2	hypothetical.
2	rds
2	(regions
2	animal-adapted
2	mtc
2	architectures
2	ohr/osmc
2	paleotropical
2	cpssr
2	adp-ribosyltransferase
2	arts
2	conflict-related
2	arts,
2	tet/
2	jbp
2	co-administration,
2	intra-genomic
2	toxin-coding
2	host-directed
2	phyletic
2	adp-ribose
2	apicomplexans
2	exapted
2	intra-cellular
2	rna-based
2	provenance
2	heteroloboseans
2	lses
2	class-i
2	methionyl-trna
2	peptide-
2	metal-binding
2	paralogs
2	aminoacylated
2	xacarray
2	ration.
2	2-oxoglutarate
2	wybutosine
2	fuscans
2	aurantifolii
2	repertoires.
2	chromatin.
2	chromatin-related
2	nucleocytoplasmic
2	modules,
2	motif,
2	anabaena
2	β-sandwich
2	divisome
2	paralog
2	diviva,
2	o-antigen
2	laser.
2	tendineae
2	valves
2	allocation
2	lequesne
2	dynamometer,
2	(t2)
2	intragroup
2	osteoarthritis.
2	asga
2	sealed
2	(tug),
2	p<0.02).
2	joules/cm2
2	(-42%)
2	(v̇o
2	ergospirometric
2	(3-5
2	(1-8
2	judo
2	dynamometer
2	(biodex
2	0.0044/p
2	fights.
2	fight.
2	extravasating
2	emits
2	(nir)
2	nir
2	tomography/computed
2	18f-fluoride
2	bunodosine
2	(bds
2	391),
2	ng/paw)
2	r118a
2	k115a
2	k116a
2	k122a
2	scenario.
2	subnanomolar
2	oncologic
2	arabian
2	“antinociceptive
2	region”,
2	incised
2	(s.c.),
2	15-epi-lxa4,
2	boc-2,
2	cζ.
2	zambelli
2	μg·kg-1)
2	crotalphine-induced
2	dehydrogenase-2
2	metabolizes
2	aldehydes,
2	(aldh2∗2),
2	aldh2∗1/∗2
2	analgesics.
2	llc-wrc
2	g/paw),
2	morphine,
2	n-2-polybia-mp-i
2	protonectarina-mp-nh2
2	n-2-polybia-mp-i,
2	β-neurotoxin
2	non-enzymatic,
2	(crotapotin).
2	anti-microbial,
2	(brp)
2	brps,
2	cyphokinin
2	thr6-bk,
2	1891
2	ctenidae)
2	co-occurs
2	microhabitats
2	misidentified
2	(ctenidae).
2	phoneutria,
2	hyaluronidasic
2	ctenidae
2	64 days.
2	α-adrenoceptors
2	κ-
2	(ctop)
2	n,n-diallyl-tyr-aib-aib-phe-leu
2	174,864),
2	nor-binaltorphimine,
2	(∼40%)
2	(p<0,001)
2	hour,
2	(cnqx),
2	l-n6-(1-iminoethyl)lysine
2	(l-nil),
2	hemorrhagic,
2	hgf/c-met
2	trnas,
2	timp-3,
2	carboplatin
2	(renca)
2	anti-angiogenic
2	vegfr1
2	(acc).
2	acc.
2	p21waf1
2	htz
2	self-grooming
2	single-locus
2	oxt
2	ty
2	l-dopa.
2	alcohol-heightened
2	ltd/international
2	variability;
2	rate);
2	hemody-namic
2	(mg/g),
2	(rfa,
2	(uf/min),
2	(ng/ml/h).
2	(au).
2	rfa.
2	pra.
2	interacting.
2	reached.
2	impulsiveness
2	aas-induced
2	emotion-related
2	5-ht-related
2	aas
2	disinhibition.
2	5-ht1b,
2	5-ht6
2	hsd.
2	emotion.
2	unspecified.
2	hypothalamic-pituitary
2	gd3,
2	hindpaw
2	reflexologic
2	(nacl
2	grosso).
2	(desi-msi)
2	er1/6
2	contention
2	widespread,
2	seminalis,
2	oomycete
2	moniliophthora
2	oomycetes
2	phytophthora
2	exchanging
2	romão-dumaresq
2	community's
2	cupana),
2	phyllosphere
2	(pcr-dgge)
2	haemophilus
2	colletotrichum.
2	bucephalogonia
2	planta
2	plant)
2	(figure
2	orchids
2	(keith
2	‘aloha
2	iwanaga’
2	‘sharry
2	2005).
2	ferment
2	maltose,
2	water-soaked
2	(ardra).
2	phalaenopsis
2	cattleya
2	miltonia
2	(ppfm)
2	borer,
2	saccharalis.
2	filiformis
2	filiformis.
2	(33.1),
2	c33.1,
2	cocoa,
2	perinwinkle
2	gfp-expressing
2	re-isolated
2	utmost
2	mycelia,
2	(hph)
2	cocultivation
2	plant-pathogen
2	(due
2	colonizer
2	noninoculated
2	n-acetyl-ß-d-glucosaminidase
2	ceratocystis
2	paradoxa,
2	pineapple
2	paradoxa
2	pinguicula
2	microorganism-plant
2	re-isolation,
2	fávaro
2	argfp
2	extorquens
2	racemosa,
2	atmt
2	grape
2	labrusca
2	gloeosporioides,
2	(syn.
2	reassessed.
2	cbs
2	citricarpa,
2	(healthy
2	anisopliae,
2	acetochlor.
2	k9
2	acetochlor,
2	ppaga
2	ege6gfp
2	(denaturing
2	clones),
2	bacteroidetes.
2	transect
2	alphaproteobacteria,
2	encompassed
2	10(7)
2	sprayed
2	endophytes,
2	sr1.6/6,
2	(dgge).
2	non-target
2	cladosporium,
2	xylaria.
2	fern
2	pinnae
2	rachis
2	(30.2%)
2	subtilis),
2	amphibacillus
2	gracilibacillus
2	larva's
2	seedlings,
2	(acyl-hsls)
2	acyl-hsls
2	(8%),
2	mucilaginosa,
2	cfu/g
2	pauca
2	endosphere
2	planted
2	avid
2	solubilizing
2	upcoming
2	(abs)
2	mango
2	(aflp)
2	tr-15
2	fujisawaense,
2	eucalyptus,
2	methylobacterium,
2	sinensis.
2	ppa3.0
2	definitively
2	xfp
2	mesophilicum.
2	[citrus
2	flaccumfaciens.
2	salmonicolor,
2	salmonicolor
2	nicotiana
2	sinensis,
2	nit1
2	nit
2	liberibacter
2	fe(iii)
2	bge
2	l.),
2	n-heptanoyl-homoserine
2	quorum-sensing
2	homogeneity,
2	pre-planting
2	glyphosate,
2	glyphosate.
2	singer
2	witches'
2	broom
2	cvc-symptomatic
2	endophytic,
2	pumilus,
2	conclusions,
2	dsza,
2	dszb,
2	petroleum-dbt
2	dbt-containing
2	erythropolis
2	µg/kg),
2	cardenolides
2	clp-wt
2	clp-
2	munhoz.
2	(nrf2)
2	energy-based
2	(der)
2	der,
2	fcx
2	nfᴋb
2	eaat4.
2	glycoside
2	nka,
2	(ipth)
2	ipth
2	anti-aging
2	approaches:
2	lentivirus-mediated
2	tryptase-like
2	erosion
2	trisodium
2	m-edta
2	patency
2	mg/kg, s.c.,
2	infarcted-induced
2	fictitious
2	(unt)
2	treadmill)
2	mi-t
2	sham-unt
2	chymotryp-sin-like
2	kinoshita,
2	orellana,
2	kawamoto
2	scavone.
2	atp1a2
2	atp1a3
2	α2/3
2	pkg,
2	rhm
2	23 %)
2	lewy
2	a30p)
2	mapk42/44
2	underpinning
2	autism,
2	orellana
2	agerelated
2	24-
2	axin2
2	oxide-na,k-atpase
2	30days.
2	kinoshita
2	ikb,
2	hyperactivated
2	dementia.
2	k{cyrillic}b
2	(nf-k{cyrillic}b)
2	renca-egfp
2	renca-egfp-sorted
2	nf-k{cyrillic}b1
2	c-rel
2	renca-egp
2	p50.
2	p50/bcl-3
2	low-flux
2	adenine,
2	uraemic
2	adenine-containing
2	dilatation,
2	12-,
2	2-/-)
2	2-/-.
2	stabilizers
2	(cort,
2	κb),
2	[erk
2	jnk/sapk
2	(c-jun
2	kinase/stress-activated
2	kinase)],
2	proinflammatory,
2	pro-oxidants
2	15d-pgj2
2	(nfκb).
2	saline;
2	i.p.);
2	after.
2	ω-
2	(cus),
2	ru-486,
2	[(+)-5-methyl-10,11-dihydro-5h-dibenzo
2	[a,d]
2	cyclohepten-5,10-imine
2	maleate],
2	agreeing
2	physalins,
2	glutamate-regulated
2	(snp
2	(snap
2	α2,3na+k+-atpase
2	[na+].
2	8-br-cgmp-induced
2	+k+-atpase
2	pkg),
2	pka).
2	nmda-nos
2	amp)
2	age-related.
2	(nos-2)
2	(s7,
2	s14).
2	(tace)
2	bb1101,
2	tace,
2	tace
2	nmda-no
2	dizolcipine
2	(mk-801)
2	7-nitroindazol
2	nmda/no
2	1,2,3
2	-na,k-atpase
2	[3h]-citrulline
2	(85,2%)
2	μci
2	3h-arginine.
2	dinucleotide),
2	mononucleotide)
2	(tetrahydrobiopterin)
2	cofactors.
2	(98.1%)
2	(98.8%).
2	trifluoperazine
2	(tfp)
2	73.2%
2	0.122
2	[3h]-arginine
2	[3h]citruline
2	(p<0.005)
2	receptor-binding
2	k-
2	v(max)
2	[na+]
2	k-atpase
2	(relevant
2	octopamine
2	pesticidal
2	rf.
2	(svf)
2	lipogenesis)
2	phosphorylation/activity
2	(nhp,
2	u/100
2	kisspeptin-1,
2	hydrocortisone,
2	mesenteric)
2	enzyme;
2	esterification.
2	amultifactorial
2	rats].
2	(cachexia
2	(tb4)
2	tb7
2	inos2+,
2	tnfα+,
2	hsl+
2	adl
2	responsiveness)
2	beluzi
2	asthenia;
2	(pgz)
2	loss;
2	anti-cachectic
2	pgz,
2	saline-control)
2	tp5
2	pgz/5
2	26.
2	-80o
2	day/group).
2	56.3%,
2	(53.4%,
2	pgz.
2	l-leucine-supplemented
2	emerged.
2	bolsoni-lopes
2	t3-l1
2	palmitoleic,
2	glycolysis),
2	(anaerobic
2	glycolysis)
2	glycerol-tag,
2	phospho(p)thr172ampkα,
2	pser473akt
2	pthr308akt.
2	pser660-hsl.
2	(v̇
2	(physical
2	detraining)
2	50-60%v̇o
2	(3,474
2	68.8;
2	1,945.7
2	45.6;
2	2,492.4
2	49.08,
2	insulin-stimulated)
2	pref-1
2	obesogenic.
2	leaner
2	(exercise
2	exhaustion),
2	periepididymal,
2	at)
2	clozapine
2	ziprasidone
2	(adscs)
2	reduced:oxidized
2	thr-phospholamban.
2	posttransplantation
2	ptld.
2	survivor
2	masses.
2	10-3m
2	ns),
2	nowadays.
2	0.06%
2	d-[u-14c]-glucose
2	polyphagia,
2	ally
2	lvm,
2	lvm
2	lhsd
2	hlsd.
2	16.8
2	cal/g)
2	2-fold,
2	3-,
2	2-,
2	opposite.
2	insulin-independent
2	salt-loaded
2	d-form
2	103%
2	c-glucose)
2	3-month
2	periods;
2	l-tranylcypromine
2	d,l-tc
2	ld<inf>50</inf>
2	d-or
2	dl-tranylcypromine
2	organ-transplanted
2	decorated
2	hadv-7
2	double-negative
2	cockroach,
2	15.5
2	4.2;
2	ad41
2	pentons
2	399
2	17-month-old
2	hal
2	genometyping.
2	conjunctivitis,
2	sero‐type
2	typed.
2	[1]
2	figs
2	fig
2	biosorbent
2	cereals
2	barley,
2	ecophysiological
2	(18,
2	mycoflora,
2	rice.
2	unprocessed
2	(aw)
2	sterilization
2	mucilaginosa.
2	(ftir).
2	dough
2	(s2),
2	(s4).
2	(p > 0.05).
2	fum1,
2	fum3,
2	fum6,
2	fum7,
2	fum8,
2	fum13,
2	fum14,
2	icb-161,
2	aflj
2	afls
2	afls/aflr
2	high-oleic
2	(hop)
2	icb-54)
2	ng/g
2	afld
2	(3%).
2	3-adon
2	(2%).
2	ni/nio
2	film-forming
2	©,
2	b<inf>1</inf>
2	study;
2	mycobiota,
2	87.5
2	innovation.
2	lfb-fiocruz
2	(ccgb)
2	257
2	826,
2	1ab
2	(nps)
2	mucilaginosa
2	(bertholletia
2	markets.
2	14.3%
2	commodity
2	itacoatiara,
2	shells
2	aspergillic
2	runner
2	11.4%
2	heterokaryon
2	hsi
2	replete
2	synergistic,
2	co-contaminants
2	almonds
2	phialemonium
2	phaeoacremonium
2	(11%),
2	(11%)
2	+weevil);
2	fumonisins.
2	sclerotia.
2	carry-over
2	frescal
2	starter
2	0.250
2	0.500
2	(52.1%)
2	kernels,
2	acclimated
2	10.0.
2	transference.
2	trans-resveratrol
2	verticillioides.
2	molds,
2	camellia
2	markets
2	(ame)
2	afg1
2	várzea
2	(mt),
2	odessa,
2	(dichloran
2	mycotoxicological
2	fb1;
2	junqueirópolis,
2	5.42
2	presence,
2	ears.
2	boron
2	(27%).
2	kg/ha)
2	fb1/(kg
2	diacetate-fda
2	coloration
2	γ-irradiation
2	(rh)
2	moulds,
2	ochratoxins
2	50μg
2	28-d
2	f)
2	references
2	(68%),
2	0.96,
2	cyanotoxins
2	microcystis,
2	radiocystis.
2	43.6%
2	radiocystis
2	fernandoi
2	20,000
2	(mean:
2	kg-1;
2	mean:
2	fb1,
2	fb1/kg,
2	(130)
2	(64.4%)
2	8-wk-old
2	(afb1),
2	(afm1),
2	(afb2a)
2	25°c.
2	hplc-dad.
2	bonito's
2	preto's
2	88.5%
2	93.5%
2	μg/g).
2	rations.
2	91.2
2	fb1/100
2	rainfall)
2	103,
2	(moisture
2	moniliforme,
2	moniliforme
2	putrescentiae
2	boxes
2	27.4
2	(tlc).
2	(11.7%),
2	isolate:
2	kaempheritrin
2	naringinin
2	ppm.
2	(hepatic
2	(2.30
2	(2.18
2	mycotoxin.
2	subglutinans
2	liquor,
2	fluorescence)
2	brevicaulus
2	mould
2	breda,
2	c1inh
2	nald
2	(ald).
2	special,
2	(hfde)
2	members'
2	macedo
2	steatohepatitis
2	igg4.
2	il-21,
2	cd59,
2	smcd59-like
2	tegument
2	smcd59
2	(cfh)
2	tyr402his
2	cfh,
2	(fb),
2	(amd)
2	fi,
2	y402h
2	1277ct
2	1277tt
2	ophthalmol.
2	c1r
2	glycohemoglobin
2	hba1c.
2	l314p
2	(fi),
2	1-year-old
2	sisters
2	probands
2	c3-deficient
2	opsonins
2	phagocytozed
2	probands.
2	bidimensional
2	e1012q
2	c1010a,
2	c3(nh3)*
2	c1010a
2	iga-depleted
2	opsonin
2	m1015
2	conformation-dependent
2	(salvia
2	hispanica
2	flour.
2	effects)
2	gcsf,
2	α-linolenic
2	il-10r
2	acsl1
2	ppara
2	rs1800206,
2	snps,
2	rs9997745
2	rs8192678
2	(mtp),
2	(l-fabp),
2	receptor-alpha
2	fabp
2	tcla,
2	lipolysis-related
2	(walker
2	kg/m2.
2	grs,
2	(wc),
2	ancestry,
2	wc.
2	(cc,
2	(wsc,
2	il8,
2	(ifngr1
2	ifngr2)
2	(7,
2	implantation).
2	heterogeneously
2	ifngr2
2	pao,
2	(n = 22)
2	non-supplemented,
2	hco3
2	chaos.
2	eight-weeks-old
2	1.0ml;
2	tumour-bearing,
2	epigallocatechin-3-gallate
2	diet+water
2	egcg-fed
2	ret,
2	cachexia-associated
2	afflicting
2	function-preserving,
2	metabolism-modulating
2	matos-neto,
2	figuerêdo,
2	riccardi,
2	radloff,
2	maximiano,
2	tokeshi,
2	otoch,
2	goldszmid,
2	trinchieri,
2	alcântara
2	seelaender.
2	magpix®
2	miyagi
2	abandon
2	cis-ex).
2	(cis).
2	prevention/
2	equipment,
2	low-intensity.
2	(ct,
2	n=7),
2	liver-derived
2	(vldl),
2	(n=18,
2	index>95th
2	(hi-it)
2	post2,
2	metabolism-related
2	post6
2	diseasome
2	threshold:
2	answering
2	treat/improve
2	nelo
2	eidy
2	zanchi
2	translocase
2	sinpe-gasape.
2	satiety-sensing
2	(trans).
2	control-control
2	trans-control
2	adipor1
2	satiety-sensing,
2	voax)
2	(nf-κbp50
2	nf-κbp65)
2	(tlr-2
2	tlr-4)
2	cascade;
2	il-6r,
2	traf6;
2	l-propionylcarnitine
2	cachexia-anorexia
2	sydrome
2	(60%vo
2	min/d,
2	wks.
2	(tnf-,
2	il1)
2	(rpat).
2	vo2maxfor
2	e0
2	edl;
2	(meat).
2	ended.
2	factor-κbp65
2	(nf-κbp65)
2	50min
2	1m/min,
2	ikbα
2	myd-88
2	traf6,
2	carciosarcoma.
2	(radioassay)
2	pge2was
2	octadecadienoic.currently,
2	archery
2	skill
2	archers
2	exertion
2	pioneer
2	tnf-)
2	overtraining-inducing
2	(r).
2	kbp65
2	(nf-kbp65),
2	recover,
2	comparisãon
2	overtraining
2	15weeks,
2	n=8);
2	energy-restriction
2	5days/week,
2	10weeks.
2	(r=0.464),
2	(r=0.508);
2	(r=0.342).
2	restriction)
2	(pai-1),
2	(mcp1),
2	icam/cd54,
2	endotoxinemia
2	0.85,
2	0.65;
2	0.55;
2	0.90;
2	icam/cd54
2	high-volume
2	high).
2	kj;
2	cho:
2	kj)
2	equalized.
2	damage/inflammation
2	stress).
2	inhibitor-1
2	(pai-1)
2	ldl-oxidized
2	ratio),
2	0.78;
2	0.0009),
2	0.69;
2	0.56;
2	38.2%
2	(36.5%,
2	(edl),
2	thoracotomy
2	trained)
2	(26%,
2	(58%,
2	(2.6-fold,
2	"anti-inflammatory
2	serum)
2	(il-6).
2	(34%,
2	vldl,
2	3.51
2	(edl,
2	(mesenteric-meat
2	retroperitoneal-rpat).
2	(55-65%
2	(44%;
2	(1.5-fold,
2	(30%;
2	(1.1-fold;
2	(mtp)
2	very-low-density
2	(thus
2	90%;
2	(-18%)
2	anorexia-cachexia
2	vldl-tag,
2	vldl-tag
2	10.1
2	(post-mi)
2	(ppars)
2	β-hydroxy
2	β-methylbutyrate
2	(ipc))
2	(scs)
2	(ips))
2	(47.8%)
2	(65.16%)
2	(38.4%)
2	(2.75
2	(44.53%)
2	(45.94%),
2	(61.7%
2	41.53%)
2	(40.8%)
2	(42.65%)
2	perivenous
2	l-fabp
2	(rpat),
2	enzymes)
2	[14c]-oleate
2	perimysial
2	gas.
2	reposition
2	(3.5-fold)
2	oa-fed
2	assembled,
2	pan-genome
2	intervention(s):
2	swabs,
2	(study
2	(brd)
2	non-fermentative
2	vaginosis
2	infertility,
2	fa4
2	pa3
2	hydrophobic,
2	fa4)
2	demographical
2	(62
2	(95%ci)
2	14.21,
2	3.67-55.018),
2	16.81,
2	4.19-67.42),
2	8.566,
2	2.04-35.94)
2	6.13,
2	1.53-24.61),
2	3.0%,
2	28).
2	=.062)
2	ovine/caprine
2	designation,
2	vulvo
2	orchitis,
2	ureaplasmas.
2	spa,
2	erythromycin,
2	etest
2	communityassociated
2	(ca-mrsa)
2	c80,
2	ca-mrsa
2	st398/cc398/sccmecv
2	camrsa
2	st5/cc5/sccmeciva
2	lc33,
2	st1/t127/sccmecv.
2	braga
2	percussion
2	dispar.
2	mucoid
2	single-enzyme
2	49782.
2	975,425
2	open.
2	(1.70
2	(3.40
2	flocculare
2	(94.90
2	hyorhinis.
2	16srns
2	mycoplasmas.
2	metagenomics
2	bacteroides,
2	turkeys.
2	hens
2	p97r1,
2	pct
2	synteny,
2	(pgf)
2	(hgt).
2	1,545
2	gain/loss
2	evolution.poorly
2	syntenies
2	shuffling
2	non-mycoplasma
2	mesoplasma
2	hospitals,
2	orale,
2	mycoplasma.
2	microbead
2	(mia).
2	suis-expression
2	inserts;
2	polyhistidine
2	mia.
2	(mfi)
2	pathogen).
2	mia,
2	(iha),
2	(grpe),
2	dinucleotide-dependent
2	(gapn),
2	(pgfs)
2	circovirus-2,
2	(78.43%)
2	preputial
2	oropharyngeal,
2	conjuctiva,
2	oropharynx,
2	(generic
2	class),
2	72.4%
2	(43.1%),
2	(41.4%),
2	(19.0%).
2	mycoplasmatales.
2	preputial/vaginal
2	27.58%
2	32.7%,
2	8.6%,
2	acholeplasmatales
2	cebus.
2	(nhps)
2	nhps
2	(serogroups
2	49783
2	(serogroup
2	probe-based,
2	assay's
2	nontarget
2	1·62×1011
2	2·75×108
2	copiesml-1
2	(7·5%)
2	(80·0%)
2	gs-flx
2	(454)
2	assembler
2	walking;
2	glimmer
2	manatee
2	(cds).
2	31.1%.
2	844
2	cds,
2	oric.
2	concise,
2	atp-synthase.
2	ribose,
2	rbcs,
2	uracil.
2	host'
2	life-span
2	wiedii.
2	panthera
2	onca
2	16s-23s
2	[origin
2	(wild-caught
2	zoo-born),
2	exposure]
2	(anemia,
2	polycythemia/hyperproteinemia,
2	leukopenia)
2	635.
2	(10/67.
2	=14.92%)
2	ci=0.00-0.451,
2	p=0.0028),
2	obstructed
2	area/intimal
2	26%,
2	haemominutum',
2	turicensis'
2	haematoparvum',
2	(refú
2	gio
2	vista,
2	yagouaroundi.
2	haemofelis-like
2	leo)
2	garden
2	haemominutum".
2	organism;
2	gardens.
2	69.6%
2	301
2	pg-21,
2	technicians
2	pi-plc
2	4°c.
2	1620,
2	2010b,
2	pi-1428
2	52,
2	0.078;
2	0.312;
2	(mbc
2	0.312
2	nctc
2	use-dilution
2	choleraesuis
2	cholerae
2	these.
2	stained,
2	meats,
2	0.116,
2	antimonials
2	63-fold
2	dendrocytes
2	fxiiia
2	fxiiia,
2	ddfxiiia
2	il18,
2	il13,
2	counseling,
2	travelers.
2	destination,
2	68.2%
2	coverage.
2	basaloid
2	cd10,
2	d2-40.
2	vegetables,
2	artesunate,
2	rpmi
2	36°c
2	paradisiaca
2	sm3
2	(83.3%)
2	[odds
2	(or=5.04,
2	1.07-23.7,
2	p=0.041).
2	acetogenins
2	25.9
2	me49
2	sativum
2	88.0%
2	co-localised
2	hiv-
2	psoriasis.
2	bore
2	microcopy
2	perihepatocytic
2	igm-
2	18%).
2	co-positivity
2	97.8%;
2	co-negativity
2	lana
2	haart.
2	bufadienolides
2	kato
2	katz
2	kinyoun
2	kkk
2	cd20,
2	cd45ro,
2	bronchus-associated
2	involvement,
2	hecht
2	dendritic,
2	disproportion
2	dlqi
2	sf-36
2	sf36
2	(tl)
2	266
2	home-grown
2	multicomponent
2	[stromal
2	(cxcl12)]
2	crassiflora
2	ovalifolia,
2	furfuracea,
2	lanceolata,
2	emarginata
2	quinoline
2	vegetables.
2	precluding
2	liposome-entrapped
2	tnfr-/-
2	(ml)
2	believe,
2	γ-irradiated
2	iron/kg
2	(87.5%)
2	abattoirs
2	unifocal
2	(ictx)
2	ictx.
2	125l
2	gy)
2	schwarz
2	postvaccination
2	mlu/ml
2	(17.0
2	gastrula
2	96.3%
2	90.9%
2	18-kda
2	(sephacryl
2	ift,
2	(vl).
2	chabaudi-infected
2	reticulin
2	mitsuda
2	cytoadherence,
2	oligo(dt)
2	trap,
2	di-p-tolyltellurium
2	dichloride.
2	indolamine
2	protease(s)
2	calmodulin.
2	acidocalcisomes.
2	tamil
2	>24
2	(>24
2	ip3-sensitive
2	2+-dependent
2	(serca)
2	thapsigargin-induced
2	pepstatin
2	e64
2	intra-erythrocyte
2	divergent,
2	kn62
2	time-increase
2	haemozoin
2	3r2
2	insp3r2-mediated
2	artemisia
2	plasmodium-infected
2	1,4,5-trisphosphate
2	triggers.
2	multistep
2	merozoite;
2	tryptophan-related
2	calcium;
2	technology;
2	pfsrs
2	pfsr10
2	(eefs).
2	dephosphorylate
2	tupinambis
2	ionomycin.
2	nat.
2	lizards,
2	utp,
2	udp,
2	(rbcs).
2	nigericin,
2	fluo-3
2	sarco-endoplasmic
2	ca2+-based
2	tyrphostins
2	b44
2	68%).
2	spectrin,
2	ß-mercaptoethanol
2	metal-dependent
2	spectrin
2	exposed,
2	ca2+/108
2	pmoles/107
2	ghosts.
2	air-dried
2	genistein,
2	nad-linked
2	(+
2	malate),
2	phosphorylating
2	megadalton
2	x-100
2	acrosomal
2	filament.
2	(bvocs)
2	slcfs
2	(sausage
2	salami)
2	(47.5%)
2	(asa),
2	22536
2	asa.
2	rizzo,
2	(n = 60),
2	esophagitis,
2	laryngitis
2	incorrect
2	meteorological
2	papotto
2	mpeg
2	pv1-fab'
2	podoplanin
2	cd31
2	frcs,
2	nts2
2	fire.
2	underestimates
2	finn1
2	reasonably
2	scaled
2	tc199
2	semi-volatile
2	low-volatility
2	nucleation
2	soa.
2	tall
2	observatory
2	micrometeorological
2	wind
2	atto
2	fog,
2	aqueous-phase
2	ooa-2
2	fires,
2	hourly
2	ppb
2	doubles
2	varies,
2	retinochoroiditis.
2	forty-three
2	retinochoroiditis,
2	activities)
2	campaign
2	plumes.
2	m-3
2	m-3,
2	0.6),
2	(pmf)
2	bboa,
2	plumes
2	(hmscs)
2	morbid
2	tgpi-mucins.
2	t1-type
2	(codon
2	phenotype)
2	retinitis.
2	sag1
2	aparecida
2	(n=139)
2	retrocervical
2	cx3cl1
2	ccl17
2	>30-year-old
2	long.
2	2.5)
2	vehicular
2	ninety-eight
2	cd4+cd25high
2	(covering
2	352371
2	hsp65,
2	161180
2	exacerbating,
2	perpetuating,
2	organ-restricted
2	irreversibility
2	commodaro
2	rejection/acceptance,
2	(c57bl/6xbalb/c)
2	(bio-plex)
2	(splenocytes)
2	indefinite
2	hypoferremic
2	eucaari
2	ended
2	(cuieiras
2	aethalometer
2	soot
2	contradicting
2	varicella
2	(vzv),
2	(cmv),
2	vitreous,
2	cmv,
2	co-transfer
2	dormant
2	cause.
2	35.3∈±∈4.5
2	[17.1∈±∈14.7%
2	8∈±∈11.3%
2	40:1
2	p∈<∈0.001].
2	post-surgical
2	(78.6%),
2	stemming
2	number-diameter
2	use;
2	clouds.
2	mice/group).
2	(proleukin,
2	chiron)
2	endostatin-producing
2	es).
2	mice/group
2	2.78-fold
2	cadets
2	ikb
2	(ntregs)
2	(vkh).
2	ntregs
2	(fingolimod)
2	sphingosine-1
2	(s1p1)
2	(7-21
2	postimmunization
2	[dpi])
2	fty
2	spirometry,
2	canopy.
2	voc
2	calculated,
2	60kda
2	[eau]
2	development/progression
2	hsp.
2	[irbp],
2	[rhsp65].
2	cd4+il-17+,
2	cd4+ifn-γc+
2	anti-hsp60/65
2	rhsp65
2	managers
2	commitment.
2	comprehensible
2	whistleblower
2	announcing
2	nts2,
2	galt
2	cd103+
2	cd4+lap+
2	alloantigen.
2	alloantigen
2	anti-cd3/anti-cd28
2	gina
2	sweden.
2	(57%
2	uppsala.
2	corticosteroids,
2	recurrences.
2	conjunctiva.
2	[hsp]
2	autoinflammatrory
2	[nzbxnzw]f1
2	span,
2	[mst]
2	teatment
2	abbreviates
2	mst
2	[p<0.001].
2	emigrated
2	self/non-self
2	birkhaueser.
2	c57bl/6)f1
2	infliximab.
2	β);
2	(prostaglandin
2	hcmv
2	cmv.
2	sag2.
2	(ebv),
2	aqueous,
2	vitreous.
2	prednisone,
2	(eau),
2	th1-mediated
2	protein-induced
2	biosphere-atmosphere
2	clouds,
2	troposphere
2	pm2.5,
2	σs,
2	interpretation:
2	keratinization,
2	eyelid
2	retinochoroidal
2	scars.
2	combustion
2	smoldering
2	trypanosma
2	encephalitogenic
2	phagocyte-derived
2	(swiss)
2	cds+
2	klh-specific
2	dba2
2	paracoccidioidomycoses
2	(asy)
2	ifn-γ-inducing
2	non-neovascular
2	angiography
2	indication.
2	tgf-β),
2	h-2(r)
2	t(h)2
2	th1-dominated
2	eau-susceptible
2	eau-resistant
2	(ifn-γ,
2	pollen
2	lid
2	mimicry
2	rpmi,
2	ab+
2	imune
2	mrna)
2	igc2a
2	(th1-like).
2	il-7,
2	s-antigen,
2	oophoritis
2	postthymectomy
2	interleukin-
2	neonatal-like
2	oophoritis.
2	f344
2	(klh)-specific
2	(th1
2	irbp-specific
2	restimulated
2	wished
2	crosslinking
2	(2x104/well)
2	default
2	pbl's
2	β2m(-/-)
2	autoantigens,
2	idiotypic
2	thymi
2	13-mer
2	cross-recognition
2	high‐ige
2	4‐producing
2	nitroarene-treated
2	myosin-
2	tilapias
2	rex
2	azevedo,
2	ponds
2	kyotorphin
2	(ktp)
2	vtn
2	vtn-immunized
2	il-1r1
2	il-17a-producing
2	batroxrhagin
2	(potamotrygon
2	permeate
2	toadfish
2	in vivo
2	subtraction
2	zymographic
2	natterins.
2	mcp-1).
2	porosissimus
2	il-21/il-23/il-33
2	derived-asc
2	innate-like
2	emigration
2	(myd88-independent).
2	cd49a
2	(il-12
2	il-13).
2	polarization:
2	f4/80lowmhciihi
2	stingrays,
2	central-west
2	esi-ms,
2	b1a
2	negcd43
2	(b220
2	il-23)
2	venom-mice
2	scorpaena
2	spv
2	f4/80r
2	envenoming,
2	glycan-binding
2	basic,
2	(bpps)
2	bj-pro-5a.
2	orpotrin,
2	(orp-desh1,
2	sting.
2	bothropasin
2	autolysis
2	bj-pi
2	piroxicam
2	mangiferin-treated
2	(leaves)
2	amenthoflavone
2	infiltrates,
2	inclusive
2	myonecrotic
2	fishermen,
2	wounds,
2	erythema,
2	(mucus
2	sting)
2	bjcul
2	arachnidic
2	(1.0%)
2	catalytic,
2	jararhagin-c,
2	immediate,
2	scobina
2	kininogen-derived
2	(lys-bradykinin).
2	57.5
2	subspecies.
2	(gfr),
2	preclude
2	m(w)
2	resatorvid
2	cyp-exposed
2	tir-domain-containing
2	adapter-inducing
2	ml204
2	peer-reviewed
2	cancer).
2	(vacht),
2	factorkappa
2	(p65-nf-kb)
2	vacht-deficient
2	janus-kinase
2	strengths
2	pyy(3-36)
2	2+/+
2	biie0246
2	fibres)
2	vgscs
2	cgrp8-37.
2	il-1β-induced
2	cholesterol-dependent
2	fluidity.
2	submembrane
2	1.5-fold,
2	sensing.
2	glucose;
2	n315
2	n315-infected
2	pg/μg
2	-generating
2	hexakisphosphate
2	casagrande
2	masson's
2	il-13)
2	25-hydroxyvitamin
2	two-puncture
2	zipper
2	tat-gilz
2	bmm
2	(7.5%
2	lr-treated
2	enterectomy
2	enterectomy.
2	ovalbumin/albumen
2	oa-challenged
2	immunized/challenged
2	il-10).
2	(hsptx)
2	hsptx.
2	creb-dna
2	ap/ptx
2	oxygenase-1,
2	capillary-like
2	(hgf)/c-met
2	vivo:
2	hgfa
2	prohgf,
2	prohgfa
2	balb-c
2	ro5-4864
2	pk11195
2	arp2/3
2	particles;
2	syk-gtpase
2	polarize
2	g0-g1
2	bmdmφ
2	cdtv,
2	(asta)
2	asta/kg
2	carbonyls
2	asta.
2	h92-e97
2	prolonged,
2	(51%)
2	b2n
2	(cats
2	(bovines,
2	rabbits),
2	(monkeys)
2	owners,
2	(dec).
2	phylogram
2	[enteroaggregative,
2	(ehec)];
2	h34
2	non-epec
2	(epec),
2	o111:h25
2	fepc,
2	o157/o154'
2	inv,
2	ial,
2	irp-2
2	septicemic
2	origin;
2	(fima,
2	crl,
2	pathogenicity-related
2	ehly,
2	ehly
2	o7:h10,
2	o111:h-,
2	o127:h40
2	extragenic
2	(rep)
2	crista
2	tufts
2	(calves,
2	ribotyping.
2	(typical
2	eaec)
2	aggr)
2	rhamnose
2	dulcitol
2	(24),
2	immunostimulation
2	selc
2	pheu
2	344
2	stx.
2	(rflp).
2	(a-f).
2	(mrp+,
2	suilysin+),
2	commensals
2	septicaemia
2	tarda
2	hemolysin.
2	exceptions,
2	(12.2%)
2	colicin,
2	bronchopneumonia,
2	septicaemia,
2	fas-negative
2	aerobactin
2	meia
2	catarrhal
2	piglets,
2	liable
2	anti-htlv-i
2	58.3%
2	97.7%
2	lt-ii,
2	stah,
2	verotoxins
2	vt2v
2	(58
2	h-
2	f41
2	oil-emulsified
2	hu,
2	b41
2	31a
2	vtec
2	diarrhoea,
2	bluetongue
2	(agid)
2	(rih)
2	gd1a
2	gt1
2	rih
2	(51.1%)
2	iim
2	immunoenzimatic
2	(rbc)
2	bisegmented
2	enteroxigenic
2	(pih),
2	anti-porcine
2	(anti-ltp),
2	(anti-lth),
2	anti-cholera
2	(anti-ct)
2	(anti-cg)
2	78.9
2	22.8)
2	pih
2	antigenicity,
2	enterocolitica,
2	lysing
2	pai-mors
2	yersinial
2	25°c,
2	antitoxin
2	k88
2	o6:h16
2	lt/st
2	ri/c
2	gut's
2	enterotoxinogenic
2	flavescens
2	terrae
2	fortuitum
2	thiosemicarbazone,
2	ypvcsp
2	(adc68)
2	gazzinelli,
2	anti-vla-4
2	gimenez,
2	françoso,
2	denapoli,
2	panatieri,
2	thiberge,
2	andolina,
2	nosten,
2	renia,
2	amino,
2	(pvcsp).
2	vivax-like),
2	pvcsp-all
2	pvcsp.
2	(pb/pvvk210).
2	multiallele
2	anti-dec205
2	(42-kda
2	19-kda)
2	∼200
2	(msp1),
2	anti-msp1
2	babesiosis,
2	isa
2	β1i,
2	β2i
2	vaccination-induced
2	pvama-1,
2	anti-ctla-4
2	rampazo
2	(i:c))
2	non-targeted
2	haplotype.we
2	prevent,
2	vaccinating
2	(radts)
2	prime/boost
2	(vlp)
2	anamnestic
2	fty720,
2	recirculation,
2	antigen-experienced
2	pvcsp-all-csp-epitopes.
2	tandem.
2	re-circulate
2	199-314)
2	arrhythmia
2	(csp)-based
2	cspof
2	behind.
2	typhimurium-derived
2	(tlr-3)
2	poly(i·c),
2	tlr-5/myd88
2	poly(i·c)
2	sufficed
2	(yf)
2	yf17d/ens1/tc
2	(msp)-3
2	(pvmsp-3)
2	(68.2%)
2	(79.1%).
2	pvmsp-3β,
2	pvmsp-3α,
2	tlr4-independent
2	(alum,
2	a,titermax®
2	freunds
2	adjuvant)
2	(alum
2	flagellin).
2	experimentally,
2	rodríguez
2	parvovirus-like
2	hla-drb1*
2	(76%).
2	c-28
2	ca3x
2	idr,
2	cd8-ifn-γ
2	sphingosine-1-phosphate
2	electrocardiogram
2	cd8-/-
2	ifnγ-/-pfn+/+
2	ifnγ+/+pfn-/-
2	cd8+ifnγ+
2	(interferon-gamma,
2	il-12),
2	mucin-like,
2	non-antibody
2	antigens/genes
2	ama-1-specific
2	(cd44hi
2	(56%
2	super-family.
2	adenovirus)
2	subdominant/cryptic
2	dominguez
2	multimer
2	(ifn-γ)-secreting
2	immunospot
2	(cd107a+
2	[tnf-α+])
2	(il-12)/il-23,
2	erode
2	15-week
2	safest
2	17dd
2	(pts)
2	post-vaccination
2	ifn-c/il-10
2	desialylated
2	resialylation
2	(dii)
2	dii.
2	(cfa/ifa),
2	saponin,
2	titermax.
2	dii-specific
2	leishmune®
2	(f1),
2	(p=0.000)
2	furthered
2	(cytotoxicity)
2	cd107a/ifn-γ
2	ifn-γ/tumor
2	alpha)
2	klrg-1.
2	h-2kk-restricted
2	tewetgqi.
2	colombia).
2	(asp-2
2	ts)
2	heart's
2	digenetic
2	alloantigens.
2	anti-cd25(pc61),
2	rat-igg,
2	24/72 h
2	qreal
2	30.3%(spleen)
2	67.8%(lymph
2	nodes).
2	43.1%(spleen)
2	90.22%(lymph
2	dta-1(anti-gitr)-treated
2	(igg:
2	150.10
2	50.04;
2	pc61:
2	187.23
2	31.38;
2	dta-1:
2	64.53
2	25.65,
2	dta-1
2	pc61(anti-cd25)
2	deleterious,
2	dta-1(anti-gitr)
2	vaccinologists
2	antibody-resistant
2	non-antibody-mediated
2	(cd4+th1
2	cd8+tc1
2	antigens/
2	domains:
2	di,
2	dii,
2	diii.
2	(di-ii
2	dii-iii),
2	di-ii
2	di-ii.
2	non-h-2kb-restricted
2	h-2kb-,
2	h-2kk-,
2	h-2kd-
2	h-2kk-
2	d-restricted
2	apcs.
2	rnai-treated
2	folded
2	α-helices
2	glycoprotein,
2	pcdna3
2	(gamma
2	gluthatione
2	261-500
2	cross-primed
2	lived.
2	immunity;
2	memory/protective
2	cl-brener,
2	tulahuen,
2	cross-protective
2	multiplication,
2	radiation-attenuated
2	immuno-epidemiological
2	(pvama-1),
2	pvdbp-rii
2	t-icell
2	clonotypical,
2	transcriptase-assisted
2	vα
2	costly.
2	hybridoma.
2	propionibacterium
2	(msp119).
2	(dydvvylkplagmyk).
2	his6msp119
2	dydvvylkplagmyk
2	jacchus)
2	mpl/tdm,
2	his6msp119-dydvvylkplagmyk-padre.
2	benznidazole,
2	(epimastigote
2	aminomethyl
2	cd19
2	gr-1
2	adjuvant-assisted
2	6msp119-padre
2	cfa/ifa
2	(gst-msp1
2	his6-msp119
2	93.5%,
2	anti-trans-sialidase
2	resins
2	nonreplicative
2	(asp-2),
2	82.3
2	a/sn,
2	prime-boost)
2	underway.
2	(pvmsp119)
2	(yf17d)
2	sialidase,
2	mucin,
2	(egf)-like
2	antigenic.
2	42.3
2	(pvmsp1)
2	13°c
2	20-
2	80-95%
2	malaria-specific
2	cs-specific
2	sporozoite-induced
2	(h-2b)
2	press.,
2	1988,
2	gp10/20
2	17-kilodalton
2	phe)
2	medication)
2	sets,
2	=.002),
2	medicated
2	non-exercising
2	70-80%
2	score)
2	(pd);
2	bestest
2	bestest,
2	0.003)
2	bfr-s
2	orthostatic
2	(pdt:
2	pdc:
2	(cv)
2	knee-extensor
2	#
2	0.028).
2	timed-up-and-go
2	subscale
2	extensors
2	plantarflexors
2	ballistic
2	ttv
2	optimizes
2	(psi)
2	disynaptic
2	(updrs-iii),
2	(one-repetition
2	maximum)
2	score),
2	jr,
2	(39.3%).
2	actiib,
2	(msa).
2	health-related
2	ipaq-sf
2	gwu
2	strength-trained
2	v̇o
2	1rm,
2	(adj
2	microlipid
2	nanosize
2	multilayer
2	(nmvs)
2	(dopc)
2	(dppg)
2	dopc,
2	nickel-containing
2	(dgs-nta
2	[ni]).
2	(rstx2b)
2	enterohemorragic
2	rstx2b-loaded
2	orchestrators
2	αdec205,
2	(scfv
2	iso),
2	(ediii)
2	sciso-ediii
2	anti-ediii
2	twins
2	609
2	excludes
2	medline,
2	potency,
2	(aka
2	agi/ii,
2	pac)
2	ltk4r
2	p1-based
2	antonialli,
2	sulczewski,
2	boscardin.
2	oligodeoxinucleotides
2	growth-associated
2	deformities
2	(bapcs)
2	bapcs-dna
2	bapcs
2	her2/neu.
2	e75-specific
2	anti-her2/neu
2	mdscs
2	adsorb
2	biolistic
2	o51:h40)
2	subunit;
2	(flid);
2	1711-4
2	flid.
2	flid,
2	immunolabeling,
2	enterohemorrhagic,
2	intracranially
2	co-immunisation
2	(hpvs)
2	ligac
2	self-assemble
2	nanometer-sized
2	h10407,
2	apobec2
2	(tlr)-5
2	flici)
2	(pulmonary)
2	flici+p10
2	tlr-5,
2	protected,
2	tlr-5
2	1,2.
2	bacteriophages,
2	933w
2	(ivis),
2	bacteriophages.
2	d-glucosamine
2	anti-bacteriophage
2	dimerize
2	reticulum;
2	neurofibrillary
2	bifidobacteria
2	heat-resistant
2	intranasal,
2	p1-specific
2	gut-colonizing
2	(185-kda)
2	(p139-512),
2	(flici).
2	(sag)-binding
2	p139-512-specific
2	sag,
2	sag-mediated
2	css
2	74.2
2	spores/ml
2	represents,
2	(ns1).
2	(αdec205
2	αdcir2)
2	dcir2
2	(i:c)),
2	irrespectively
2	targeted.
2	dec205(+)
2	ns1-specific
2	ccl17.
2	anti-self
2	lt-ii
2	up.
2	future,
2	(stx2)-producing
2	stec)
2	anti-hus
2	(stx2δab)
2	stx2δab,
2	nonflagellated
2	stx2δab
2	toxoids
2	oppa-knockout
2	rangpur
2	lime
2	limonia).
2	axonopodis.
2	pellicle
2	ua159.
2	heat-denatured
2	anti-p139-512
2	saliva-mediated
2	39-512
2	39-512,
2	lbg
2	sequelae.
2	t-cell-specific
2	high-specific-serum
2	cell-secreted
2	enterohaemorragic
2	(stx2b).
2	prime-boosted
2	sl3261
2	antigen-sorting
2	iptg-inducible
2	(pspac)
2	(plepa)
2	β-barrel
2	maleimide
2	(gsib)
2	segregationally
2	(fecal
2	iga)
2	transit.
2	orally-delivered
2	electrotransformation
2	r6k
2	(pwr-ss)
2	cole1
2	cell-bound
2	<5%
2	coli-b.
2	pmtlbs72
2	circles.
2	plepa,
2	controllable
2	promoters:
2	pxyla
2	pspac
2	htpg
2	precfa,
2	anti-cfab
2	indestructible
2	subtilis-based
2	factories
2	kanamycin-resistant
2	anti-type
2	cd4-cell-activation-dependent
2	probe-positive
2	o148:h28,
2	o159:h17
2	cs1
2	non-clonal
2	o78:h12
2	pblcfa
2	pblcfa-induced
2	cfa/i.
2	(fla
2	editions
2	medicales
2	enterotoxigenic,
2	enteroinvasive,
2	enteroaggregative,
2	[3h]benzylpenicillin.
2	coccoid
2	osmolarity-dependent
2	anti-lps
2	(lcr)
2	omps,
2	10-mer
2	types)
2	lucid
2	pestis,
2	h]-benzylpenicillin
2	43,000.
2	o6,
2	o78
2	o128
2	amdinocillin
2	furazlocillin,
2	97,000
2	pbps,
2	pbp2,
2	75-kb
2	penicillin-
2	temperature-inducible
2	plague-infected
2	(ppgpp).
2	nr,
2	reevaluate
2	nifurtimox.
2	ta100.
2	nitroreductases
2	daca
2	pbp5
2	ftsa,
2	ftsq,
2	ftsz,
2	filamentation
2	nitroimidazole-tiadiazole
2	(2-amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole,
2	98,
2	micrograms/plate.
2	64,855.
2	nitroimidazole-thiadiazole
2	(2-amino-5(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole),
2	ta102.
2	rat-liver
2	excision-repair-deficient
2	(hmspp).
2	(>1
2	wt%)
2	morganella
2	morganii
2	blages-5
2	blactx-m-59
2	nextera
2	xt
2	wgs
2	rna-encoding
2	pseudogenes.
2	transferable
2	xps
2	(1:2)
2	(hm)
2	irp2,
2	biofilm-producing
2	blactx-m-8,
2	phenicols,
2	sulphonamides,
2	tetracyclines,
2	gyra
2	sulfonamides,
2	(tga),
2	(gram-negative)
2	(gram-positive)
2	(pvp),
2	neomycin
2	hydrogel/neomycin
2	a5-miseq
2	st90
2	edta;
2	mpnp
2	96.7,
2	mcr-1-positive
2	carbapenemases
2	st11
2	tn4401b
2	polymyxins
2	rmtd
2	ctx-m-131
2	vre
2	faecium
2	meropenem
2	pyocin
2	s8
2	colonisation.
2	maleic
2	intercalation/exfoliation
2	pmrab
2	a009
2	a027.
2	blactx-m-2
2	inci1
2	carbapenem-resistant
2	metallo-β-lactamases
2	blaoxa-143
2	oxa-143-producing
2	oxa-23-producing
2	spm-1-producing
2	impermeability
2	(sds-page),
2	omp36-like
2	acra
2	travellers
2	410,
2	st224,
2	st1284
2	f-::a9::b1
2	c1::a9::b1
2	incf-type
2	is26
2	isecp1
2	blactx-m-15.
2	esbls
2	(mlst)
2	electrocompetent
2	ctx-m-8
2	ctx-m-encoding
2	eno,
2	fnba,
2	biofilm-associated
2	fib
2	medians
2	asp240gly
2	ctx-m-2
2	pyridinium
2	casting
2	vibrational
2	beta-lactamases
2	(esbls)
2	bla<inf>ctx-m-2</inf>
2	inc
2	mbl-producing
2	bla<inf>kpc-2</inf>-bearing
2	linezolid
2	oxford,
2	cc113,
2	cc109
2	cc92,
2	lactamica
2	omv
2	omv/dda-bf
2	omv/alum.
2	shv,
2	ctx-m-2,
2	consensus-pcr
2	ctx-m-15,
2	shv-12,
2	aada,
2	mbandaka
2	glans/foreskin
2	integron.
2	cpha
2	re-examined
2	blashv,
2	(6.2%)
2	(0.8%)
2	wards,
2	cholerae,
2	monodisperse
2	onychomycosis.
2	(18/14-tcra).
2	particles/ml
2	dda
2	18/14-tcra
2	(anacardiaceae),
2	1017,
2	(p).
2	dodab),
2	microbes.
2	physico-chemical
2	fungizone
2	nephrotoxicity,
2	g/l)
2	sizing.
2	water-insoluble
2	bilayer,
2	(doc/amb)
2	ζ-potentials
2	(ch
2	blimp-1–deficient
2	exacerbation,
2	(m2
2	st2.
2	cpg/culture
2	dna-hsp65,
2	cpg/cfp,
2	downmodulated
2	dna-hsp65-
2	mite-allergic
2	allergen-free
2	mite-induced
2	mycobacterial-specific
2	tt-induced
2	15n-labeled
2	c-stimulated
2	nkts
2	nut-allergic
2	mechanism;
2	allergen-
2	hsp65-specific
2	(cpg-odn),
2	(cfp),
2	(cpg/cfp).
2	cfp-specific
2	sympodialis,
2	(bte)-induced
2	baf.
2	(grrk
2	aad
2	node.
2	dna-targeting
2	sonicates
2	nest/antigen
2	lvs
2	mk886.
2	ovalbumin-restimulated
2	anti-eosinophilic
2	(10 mg/kg)
2	10 min
2	laminarin.
2	(tlr)-2
2	bdmp
2	trichophyton
2	rubrum,
2	bacteremia,
2	cd4+cd25
2	commentary
2	(mhc
2	microassay
2	(h2o2),
2	nki.1
2	anti-fas
2	bp2,
2	cba/ca
2	(il)-5
2	transgenic,
2	receptor-δ-deficient
2	γδ-deficient
2	(almost
2	absent)
2	2-type
2	tilorone,
2	ndv,
2	parvum,
2	osteoglycin
2	ets-binding
2	braf-induced
2	ecm-receptor
2	myh2
2	microprocessor
2	machineries
2	spliceosomes
2	pre-rnas
2	mir19a,
2	mir19a
2	cell-specific,
2	ptc,
2	(tcga)
2	mir-654-3p
2	mirna.
2	aided
2	semantic
2	discontinuity
2	cyp1a1,
2	product)
2	ahr,
2	0.044)
2	well-differentiated
2	(atc)
2	mirna-mrna
2	fuziwara
2	doxycycline
2	mir-17-92,
2	poorly-differentiated
2	under-expressed
2	(papillary
2	atc,
2	nf1
2	arise.
2	(utr)
2	autoregulation
2	modulated.
2	psmad2/3,
2	psmad2/3
2	thyroid-specific
2	dimensions,
2	ameloblasts,
2	papillomas
2	tetraploidy
2	nonnodular
2	p=0.04).
2	wro
2	cc=
2	(acta)
2	decapentaplegic
2	(smad)
2	smad2,
2	smad3,
2	canephora
2	single-pass
2	trimming
2	ftc.
2	≈23,500
2	≈1,250
2	one-pass
2	validation)
2	vindicating
2	follicular,
2	hürthle
2	isozyme-specific
2	plcγ,
2	ret/
2	effectors,
2	(ptcs)
2	tgfp
2	kurtis.
2	amifostine
2	marrows.
2	marrows,
2	marrows
2	(mng)
2	papillary,
2	kcn/kg
2	tgfb1
2	tgfbeta1
2	irradiation;
2	696,745
2	15,095
2	transcriptome.
2	130,000
2	transcription-pcr,
2	(orestes).
2	81,429
2	1,181
2	(1.45%)
2	(65.6%)
2	247
2	(44.6%)
2	(30.4%)
2	est-predicted
2	genscan.
2	(http://genes.mit.edu/genscan.html).
2	tgfβ2,
2	mng
2	(ish)
2	goiters.
2	dxs255
2	analyzed;
2	t3[t4]
2	t4and
2	t4/kg
2	practice;
2	pipeline.
2	coccidiosis.
2	sporoblastic
2	genseed
2	perl
2	classifier
2	html
2	anonymous
2	single-tube
2	spliceosome,
2	u2,
2	prp19
2	one-mode
2	system-dependent,
2	snrnas
2	coltri
2	pre-ribosomal
2	knockdown,
2	coimmunoprecipitation
2	34s
2	intron-lariat
2	lariat-intron
2	snrna.
2	pasbds
2	(panip7)
2	'ponkan'
2	htpx
2	chromatography/
2	hplc–ms/ms
2	metallodrug,
2	metal-metal
2	paddlewheel
2	tegu
2	autumn,
2	exponent
2	dormancy
2	vvep
2	cd133.
2	nestin-positive
2	(principally
2	dcx
2	co-labeling
2	g2-m
2	[ru2cl(ibp)4]
2	ruibp)
2	alzet
2	kga
2	gls-silenced
2	trioxide
2	gab
2	intractable
2	spongy
2	ibp
2	pge2).
2	ku80,
2	(p<0.001),
2	valent
2	μmat
2	e2f1
2	gla-treated
2	meglumine-eicosapentaenoic
2	mvd,
2	ru2(ii,
2	20:3
2	pelleted
2	percoll-purified
2	eicosatrienoic
2	2-deoxy
2	carbon-2
2	acivicin
2	supplement.
2	igf-i;
2	(smases
2	venom-loaded
2	chnp
2	vipers,
2	eveit
2	nigricollis)
2	rinsed
2	intra-species
2	mollissima
2	indistinctly
2	c4a,
2	c-regulator
2	loxoscelism,
2	bev-induced
2	mesoporous
2	hasarius
2	adansoni
2	fb-like
2	corallinus
2	frontalis
2	homogenate,
2	expression/secretion
2	phospholipases,
2	oxidases,
2	victim’s
2	legends
2	cartoon
2	semirufa's
2	c5a,
2	ps82,
2	c3a
2	bitis,
2	nasicornis
2	saharan
2	gabonica,
2	syntheses.
2	asarifolia
2	μλ
2	rutin,
2	nsp
2	nsps
2	nsp-mediated
2	f(ab')
2	institutes
2	anticomplementary
2	[ca,
2	na]
2	scorpions
2	recurring
2	serrulatus,
2	leu-enkephalin,
2	mimosa
2	villas-boas
2	abz-flrrv-eddnp
2	1,10-phenanthroline
2	anti-arachnidic
2	metalloproteinase(s)
2	sphingomyelin,
2	c-svmp
2	adamalysin
2	tanaka
2	1,10-phenanthroline.
2	daf,
2	cr1
2	taeniata
2	whooping
2	cross-reactivity.
2	"expressed
2	crotalidae
2	anti-loxoscelic
2	lipases,
2	fortunately,
2	tetracyclines.
2	intermedia)
2	(smased)
2	thrombomodulin
2	turístico
2	ribeira
2	corynebacteria
2	c-mediated
2	[tr
2	tr]f2
2	cumulated
2	(ige
2	tr)f2
2	mastocytes
2	tr-mice,
2	tr]f2-segregating
2	co-segregation
2	co-adaptative
2	preimmunized
2	1.85
2	his47
2	interfacial
2	lysophosphatidyl
2	(α/β)8
2	hemolysins.
2	caissarolysin
2	cross-reactivities
2	olfersii,
2	metalloproteinase-9
2	(mmp-9),
2	proteic
2	asp34,
2	hgp
2	nudel-oligopeptidase.
2	cys-273
2	disc1
2	p3.
2	co-ossified
2	6x
2	albumin-bound
2	non-susceptible
2	haemolysis.
2	venom/toxins
2	(daf)
2	(c)-dependent
2	bodoquena
2	98%,
2	hornet,
2	pro‐inflammatory
2	thrombin‐like
2	ml−1,
2	factor),
2	λgt11
2	mastocytoma
2	(oba-9)
2	tlr4)
2	(lagp)
2	nonsurgical
2	gagp,
2	[pd]
2	cal,
2	transmigration.
2	(g1)
2	(n = 32):
2	(hap-2).
2	cp-associated
2	th1/m1/th17
2	omp29
2	omp29,
2	fima.
2	g2:
2	g3:
2	kg/m
2	dmi.
2	intergroup
2	(ui:
2	ni:
2	[shallow
2	meshs
2	ando-suguimoto,
2	bueno-silva,
2	ds.
2	ncfm
2	(tukey,
2	bi-
2	wearers,
2	(il4-)
2	48 h.
2	wnt3a,
2	wnt5a,
2	sergio
2	romero,
2	(copd)
2	copd
2	nove
2	cti/ttd
2	s-haplotype
2	cti
2	invisus,
2	rhamnosus,
2	casei,
2	lactobacilli,
2	aae,
2	(sha)
2	dirienzo
2	dysbiotic
2	sputum
2	bueno-silva
2	chemotherapies
2	atopobium
2	(glycated
2	candidiasis-asymptomatic
2	bifidum
2	denture,
2	5-week
2	longo,
2	hazardous
2	scaling,
2	supra-
2	(n=5)
2	aa(r)cdt
2	bedran
2	cathelicidin
2	(p,
2	(bp).
2	(tf)
2	lap,
2	bop
2	capsule-producing
2	restorations.
2	composite.
2	uncultivated/unrecognized
2	mitsuokella
2	s. sputigena
2	(bm),
2	pr1.
2	nonadjacent
2	bop)
2	csf2,
2	root-filled
2	(kp=1)
2	(h&e)
2	(n=25),
2	serotype-specific
2	rankl-mediated
2	sealers
2	xylitol.
2	(nl-cfu).
2	elastolytic
2	μw
2	law.
2	control);
2	rm-gic
2	smoker-chronic
2	microaerobic
2	(fima
2	sub-gingival
2	plaque,
2	knoop
2	microhardness
2	non-lased
2	un-lased
2	(pmc)
2	mutacins
2	schoolchildren,
2	floss
2	twice/week
2	melaninogenica,
2	capnocytophaga
2	doxycycline.
2	39,
2	cdt-like
2	schoolchildren
2	child,
2	multi-level
2	(naf),
2	naf,
2	thepf
2	(cys
2	p-chloromercuribenzene
2	cytosol-accessible
2	extracellular-surface
2	(dphi/dt)m
2	ax,
2	refinements
2	reasoned
2	(dphi/dt)max
2	phs,
2	rhcg.
2	(vs.
2	2o-injected
2	decrease).
2	day-matched,
2	co2/nh3
2	)nh
2	(aqp1),
2	aqp4-m23,
2	pf&z.ast;
2	aqp6,
2	aqp9.
2	aqp4-m23
2	aqp0
2	(0).
2	aqp3
2	aqp7
2	(δphs&z.ast;)co2/(-δphs&z.ast;)nh3
2	aqp4,
2	electroneutral
2	aqp4
2	{nh}}-{
2	half.
2	decay,
2	pstc1,
2	pstb,
2	smu.1134
2	anti-psts
2	ta98dnp
2	nitroreductase
2	bromo-treated
2	(mea),
2	socio-sexual
2	undisclosed.
2	diestrus.
2	non-kisspeptin
2	body-mass
2	fat-mass
2	(stat5
2	(igf-1)
2	mhb-ip
2	(drc),
2	lhb,
2	mnr/drc,
2	outputs,
2	ip/mnr
2	prolactin's
2	stat5a/b
2	α1-adrenoreceptors
2	fos/orexin
2	(ox)
2	fos/melanin-concentrating
2	(lha).
2	intra-mnr
2	non-orexinergic
2	rp-hplc,
2	hgh
2	methionine.
2	(prolactin)
2	(pstat5).
2	dorsomedial,
2	that human
2	neurovegetative,
2	emotional/motivational
2	deepen
2	stat5-inducing
2	(pomc/lepr+
2	(pomc/lepr-
2	(α-msh
2	β-endorphin)
2	β-endorphin-positive
2	α-msh+
2	(tdtomato)
2	0.889
2	0.701.
2	fatness,
2	litters,
2	cyclicity.
2	fatness
2	lactogenesis.
2	(prlrs)
2	prlrs
2	prolactinoma
2	kisspeptins,
2	cytokinesignaling3
2	(socs3),
2	micelacking
2	(lepr)-expressing
2	(leprsocs3
2	socs3komiceexhibited
2	leprsocs3ko
2	fasting-orrefeeding-induced
2	expressioninthe
2	orexigenicneuropeptides
2	orexin,
2	hormone).
2	cish).
2	stat5-independent
2	(vacht
2	(erα).
2	gonad-intact
2	post-ovariectomy
2	(lhbm)
2	(lhbl).
2	(rmtg),
2	lhbl.
2	dr-projecting
2	gad67.
2	lhbm
2	serotonin-rich
2	focally
2	(vta)-nigra
2	g.kg-1)
2	[relative
2	gln+ala-lps
2	dip-lps
2	prolactin/placental
2	(lepr).
2	transcription-5
2	(pstat5-ir).
2	pstat5-ir
2	(mpa,
2	27-48%
2	(34-51%)
2	(nts,
2	16-24%)
2	(8-22%),
2	(11-15%)
2	(4-10%)
2	pstat5-ir.
2	excitatory/
2	(avpv/pen)
2	(rmp)
2	(irregular
2	(quiescent).
2	rmps
2	avpv/pen,
2	estradiol-induced
2	(leu)
2	(c;
2	v+i
2	[5%
2	lepr.
2	trpc
2	diet-low
2	ls+et
2	vmh-specific
2	cyclicity
2	(lepr,
2	db/db)
2	(gnrh)-secreting
2	determine.
2	(kiss1)
2	(kiss1r)
2	j2-4),
2	cre-dependent
2	leptin-responsivity
2	(mc4r).
2	18-28%
2	avpv,
2	lepr-null
2	leptin-signaling
2	transcription-3
2	(arc),
2	(pmv),
2	ob/ob),
2	firstorder
2	pkc-delta
2	-δ
2	nil
2	wc,
2	3.57%
2	0.08).
2	htb
2	fx,
2	papatasi
2	sge-induced
2	pathogenetic
2	toxocariasis.
2	pmol/μl)
2	bloodsucking
2	anst-d7l1,
2	aed7.
2	eosinophil-mediated
2	supplemental
2	post-infection).
2	μg.g-1
2	2h.
2	non-purified
2	megacephala
2	yil
2	blue-stained
2	capsulatum-infected
2	cells/ml).
2	p.o.).
2	(il)-5,
2	(siha
2	(c33a)
2	vulvar,
2	anal,
2	papillomavirus-transformed
2	hyperproliferative
2	e6wt
2	hpv16-positive
2	hpv-mediated
2	dismutase-2
2	0.4;
2	alpha-9
2	trachomatis.
2	caix
2	immortalization
2	asncmtrnas
2	asncmtrnas,
2	hfk
2	sncmtrna-2.
2	e7-induced
2	e7-expressing
2	fus
2	815
2	mtrrna).
2	stem-loop
2	mgh
2	(hcv),
2	matrigel™,
2	caski
2	phks
2	giemsa-light
2	giemsa-dark
2	endonucleases.
2	electroporated
2	cohorts,
2	designer
2	dvmn
2	dreadd-gs
2	pharmacogenetic
2	(0.154 m,
2	0.5 ml),
2	(3 m,
2	0.5 ml)
2	w/v,
2	0.5 ml).
2	(393 ± 29)-
2	(141 ± 11)-infused
2	saline-treated,
2	(47 ± 2
2	neurons/pvn
2	section).
2	(fos-positive)
2	(65 ± 7)
2	(37 ± 7)-treated
2	(16 ± 2).
2	ppads,
2	hyperosmotically
2	(hfhsu),
2	(hfd-h)
2	hypertension-resistant
2	(hfd-r)
2	(lf)/high-frequency
2	hfd-r.
2	cart-positive
2	hfhsu
2	induced-hypertension
2	(ppads)
2	nonanesthetized
2	hvgc
2	hvgc,
2	v1areceptors
2	nl,
2	-13
2	(change
2	real-time.
2	stimulus-locked
2	hydration,
2	hypothalamus)
2	tsna,
2	tsna.
2	eh
2	cnts.
2	dehydration-induced
2	vagally
2	lvdp/dt
2	pacing,
2	neurally
2	decorticate
2	2%;
2	comnts
2	antagonist);
2	b.p.m.).
2	methyl-atropine
2	orexins,
2	spns.
2	sfo
2	dup753
2	mnpo
2	μg/day
2	(h),
2	tac,
2	(g.20230g>a),
2	(c.3435c>t),
2	rs1128503
2	(c.1236c>t),
2	rs2032582
2	(c.2677g>t/a)
2	c0/d
2	27.7%
2	vla-4,
2	mg/day),
2	hypercholesterolemics.
2	simvastatin/ezetimibe
2	hypercholesterolemics
2	c.1236c>t,
2	c.3435c>t
2	r46l
2	e670g
2	i474v
2	mg/day/4.
2	normolipidemic
2	(agt
2	haplotype)
2	-.
2	ancestries
2	(aca)
2	self-described
2	aca
2	vinblastine,
2	bilobalide
2	be(2)-m17
2	mir-27a
2	mir-148a
2	c.388gg
2	54c>t
2	ciclosporin
2	pregnane
2	(*3c:
2	non-africans
2	*1d
2	pon2
2	55ll
2	quadrupedalism
2	goals:
2	pre-incubation),
2	regions;
2	207
2	polymorphism).
2	(tc:
2	ldl-c:
2	haematoxylin
2	autolysosomes
2	nlrp3-dependent
2	(tams)
2	es-treated.
2	es-transduced
2	ym-1,
2	cd209+
2	lpm.
2	spm,
2	nafld.
2	irs1/2
2	second-degree
2	(nondiabetic)
2	postburn,
2	g6pase,
2	(bcaa)
2	conditions?
2	ampk-α
2	fructose-
2	8 μg
2	5 weeks
2	serca-2
2	ouabain-hypertensive
2	lusitropic
2	irs-3
2	anaesthetics
2	however.
2	anti-obesity
2	isoprenaline-induced
2	2k.
2	p85/pi
2	captopril-treated
2	dimerized
2	g120k-peg,
2	g120k-peg
2	shc/grb2
2	anti-irs-1,
2	high-fructose,
2	-2.
2	3-kinase),
2	(irs-1/2)
2	receptor-associated
2	irs-1.
2	jak
2	2-stat
2	thal
2	spherocytosis.
2	β-thalassemic
2	phosphorylate
2	immunopurified
2	gh-treated
2	autophosphorylation,
2	305
2	(irs-1).
2	phosphonate
2	phne
2	pita
2	ugp
2	pppgpp
2	gppa
2	ruminants.
2	(ppgpp),
2	afflicts
2	high-rpos
2	amikacin
2	ciprofloxacin-mediated
2	surplus
2	(polyp).
2	ppx,
2	polyp.
2	hemb
2	ppx
2	spira
2	amber
2	stabs.
2	stabs
2	rpos.
2	gasp
2	archives
2	ecor
2	psta,
2	ppgpp,
2	phosphate-specific
2	pera
2	σd
2	eσs.
2	-13c
2	multiplicities
2	1-chloro-2,4-dinitrobenzene
2	σ
2	pst.
2	first-strand
2	nucleolus.
2	acrosin
2	5-phosphate,
2	s-nitrosylated
2	endocrine/metabolic
2	endotheliumderived
2	pba-infected
2	dihydrofolate
2	reductases,
2	tlr9.-1237.t/c
2	odds,
2	immunogenetics
2	dominantly
2	212,
2	ic95%
2	(ic95%
2	[plasmodium
2	recorded,
2	(z
2	fkbp
2	h3k4me2
2	h3k9
2	reinvasions.
2	24.0%
2	(12/50)
2	(02/50)
2	76.0%
2	brazilian/south
2	dblα
2	cube
2	panning
2	panned
2	rt-pcr/cloning/sequencing
2	multiadherent
2	hbs
2	th1-specific
2	interferon,
2	unglycosylated
2	presl
2	moderate-exercise
2	twelve-week
2	−/+
2	[wt])
2	toll-4
2	tissue-associated
2	(n-3)
2	(iwat
2	hfn3
2	ucp1-deficient
2	pdx
2	repositioning
2	agonism,
2	mtorc1-mediated
2	acclimation,
2	(mtsc1ko)
2	(mtsc1wt)
2	mtsc1ko,
2	displayed,
2	spasms
2	mtsc1wt
2	pro-resolution
2	dc.)
2	(pce
2	gae/kg
2	alex
2	yamashita
2	(t2d),
2	non-shivering
2	genetic-
2	(mtorc)
2	(bmdm).
2	me2so,
2	methylcellulose)
2	(2 mg/ kg/
2	il-4 + il-13,
2	(mtorc)1
2	density;
2	tnf-fl,
2	il-1fl
2	peroxidation;
2	anti-oxidant,
2	myriocin,
2	(nlrp3)-inflammasome
2	triglyceride-derived
2	ucp-1
2	uni-
2	(thr)
2	rosiglitazone-treated
2	fob3a
2	lpl-mediated
2	translates
2	pparγ-mediated
2	(ppar-γ)
2	hypertrophy),
2	mtorc1/s6k1
2	rosiglitazone-induced
2	β5
2	therein.
2	redistributes
2	glycerolphosphate
2	(gpat),
2	phosphatidate
2	lipin-1),
2	tag.
2	gpat
2	triglyceridemia,
2	glycerokinase.
2	binding/transport
2	(-20%)
2	triglyceridemia
2	(+35%)
2	intraabdominal
2	(g3p)
2	glyceroneogenesis.
2	glycerol-3-phosphate
2	esterify
2	rwat
2	(4°c)
2	(gyk)
2	gyk,
2	hemidenervation
2	response:
2	bat-denervated
2	mirabilis.
2	mmca
2	mmc-induced
2	maladapted
2	fitter
2	chelators,
2	uvra
2	(ind-)
2	2,2'-dipyridyl
2	transcranial
2	psi-dtms
2	-1.9
2	snakebite.
2	14-days
2	volume).
2	fibromyalgia
2	neurophysiological
2	1610
2	dmps
2	mitochondria-related
2	685
2	mjtx-ii
2	cm-2,
2	bjssuv
2	electrophysiology.
2	par4
2	subinflammatory
2	anti-mrp-14
2	(eaec).
2	aata
2	stones
2	(dec)
2	t84,
2	aata,
2	aap,
2	aggc,
2	aggr,
2	omicron
2	o125ac:h6
2	cystitis
2	espb,
2	sepl
2	espd
2	o127
2	o142
2	usher,
2	multifactorial.
2	aspu
2	41.4%
2	919
2	(pet),
2	ivoc
2	aafa
2	(cd4+,
2	foxp3+)
2	py
2	pyridostigmine-treated
2	salt-12
2	(cont:
2	salt-2:
2	(salt-2:
2	non-infarcted
2	cuff-induced
2	intima
2	(flow:
2	33258
2	bmcs
2	beat-to-beat
2	treadmill.
2	recapitulating
2	preconditioning,
2	artefacts
2	(aldh2)
2	background/objectives
2	ca2+-
2	governs
2	i/r-induced
2	βiiv5-3,
2	nitroglycerin-induced
2	47-57
2	(cr:
2	13;
2	pl:
2	phospholamban
2	phospho-ser
2	17-pln,
2	α2a/α2c
2	(dhpr)
2	plantaris.
2	α2a
2	α2c
2	nfatc3
2	(α2a/α2carko)
2	days/week.
2	constant-load
2	cd200,
2	(70-100
2	(e,
2	(el,
2	mg·l
2	(15-25
2	m·min
2	min.day
2	phosphorylated-nos
2	(p-nos)
2	h]l-arginine
2	h]l-citrulline.
2	(223%;
2	p-nos
2	(el
2	1019%,
2	548%
2	457%,
2	ser1177
2	200%)
2	p-nnos
2	ser852
2	(ñ50%)
2	mesopontine
2	medio-rostral
2	perineuronal
2	(p=0.041)
2	cd34-positive
2	idiopathic-dilated
2	0.012)
2	ki-67-positive
2	dorsocaudale.
2	ventrale,
2	dorsocaudale)
2	intermedium
2	5-hydroxytryptamine-immunoreactive
2	forty-five-days-old
2	nadph-diaphorase-containing
2	nadph-diaphorase-reactive
2	(ndc)
2	(ndc),
2	d1rp
2	protistologists
2	“alternative”
2	ent
2	tcrnb2,
2	tcrnt1
2	nucleobase
2	guanine,
2	localisation.
2	mpc2,
2	purified.
2	girard
2	arrhenius
2	(ln
2	amination
2	kj/mol
2	bcaas
2	crispim
2	nh4+in
2	carbon/nitrogen
2	synthetase;
2	gln1
2	cytosolic/mitochondrial
2	nh4+production
2	qua
2	co-solvent
2	thiophene
2	mb19,
2	transphosphorylation
2	phosphoarginine
2	meets
2	alternates
2	facts,
2	p5c
2	gapdh-telomere
2	homeostatically
2	cystathionine
2	peritrophic
2	perimicrovillar
2	peritrophin
2	e.c.
2	proline.
2	mankind,
2	trypanosomiasis,
2	filariasis
2	onchocerciasis,
2	impecunious
2	"general"
2	mnps.
2	signal-transduction
2	(aspat)
2	acid/purine/pyrimidine
2	dl-methionine
2	magdaleno
2	chagaś
2	drawbacks.
2	revisit
2	(vmax
2	ore1
2	(tborcl/cdc6)
2	gp82-mediated
2	k10
2	3.5.3.1)
2	l-ornithine
2	μmol/min
2	nonreactive
2	pmoles
2	calflagins
2	phosphoarginine,
2	epimastigote-like
2	tcp2β-mbp
2	ef-hand
2	unmyristoylated
2	67-kda
2	dependant
2	methyl-β-cyclodextrin
2	(sensitivity
2	multiplication.
2	lepr,
2	nonphagocytosable
2	(4°c
2	hs-c
2	(2.5 μg/ml)
2	culture-medium
2	ampk,
2	fgf-21
2	milk-clotting
2	subsite,
2	hla-g6
2	srhla-g6
2	svmpis
2	pre-hiie,
2	post-hiie,
2	crisp
2	immunometabolism,
2	resin)
2	chemoresistance.
2	accumulated,
2	(rhinocerophis
2	alternatus)
2	μg/μl,
2	(amp-activated
2	(vdac).
2	vdac1
2	´s
2	endoxylanase
2	apidermin
2	wake
2	µg/kg/d
2	ethg
2	s-1.
2	astrocytomas.
2	macrophages”
2	digestibility,
2	uninfested
2	flours.
2	beans
2	amelogenesis
2	fluorosis
2	(maldi-tof/tof)
2	mascot
2	aα
2	um)
2	canecpi-4
2	(hnrnp)
2	hnrnpa/b
2	42.
2	sds-stable
2	glioblastomas
2	oligodendroglioma
2	(npm1),
2	15months,
2	isobaric
2	triple-quadrupole
2	congeners
2	serum).
2	(p65)
2	subsites
2	radiolysis
2	electromagnetic
2	phe8
2	residue-
2	sequence-dependent
2	thermophilum
2	(chow
2	water);
2	interactome
2	(wild-type
2	p53)
2	artocarpus
2	integrifolia
2	(npm)
2	pb),
2	hj-biplot
2	pimentel
2	whole-crown
2	micro-etch
2	cross-linked
2	v1.6;
2	u5-15k
2	u5-200k
2	psd.
2	psd
2	aberrantly
2	conidia,
2	(hsp
2	tyr8-bk
2	loligo
2	grisea
2	qualify
2	smpi31
2	s-200
2	65°c
2	maltose.
2	aptia,
2	aptib,
2	aptic
2	plumosa
2	α-chymotrypsin,
2	hansenii
2	α-galactosidase
2	batroxlaao
2	jb-ig
2	glycomers
2	isobars
2	galβ(1-4)fuc
2	6-position
2	seventy-one
2	[na
2	(faa)
2	(fw)
2	macrobrachium
2	anisosmotic
2	l5f/v102a
2	v102a/l106f
2	speciosa
2	monoclinic
2	his48
2	18.5
2	w33
2	rot2
2	förster
2	κ2,
2	sub-nanosecond
2	sake
2	n-glycans
2	refolding,
2	rubino
2	coomassie
2	f107
2	u/mg
2	2134p,
2	coil
2	(es),
2	seg
2	shrimps;
2	[faa]/[cl−]
2	hsm-exposed
2	shrimps.
2	berenil
2	rf-induced
2	uhf
2	uncoupled.
2	upregulation.
2	enos-derived
2	aldosterone.
2	eugenol,
2	apamin,
2	icat
2	vasodilator-stimulated
2	(vasp)
2	17;
2	dimer/monomer
2	volume-dependent
2	re:
2	(∼8.0
2	μg/day,
2	20-week
2	+)-handling
2	sgk-1,
2	2.5-exposed
2	(endothelial
2	(wistar)
2	(wistar/e+:
2	shr/e+:
2	wss
2	(y-shr
2	idppiv)
2	idppiv
2	lv.
2	mi-g-csf
2	p-pkc-βii
2	trd:
2	1.24
2	tr:
2	(10%,
2	2002).
2	krebs-solution
2	(s;
2	lv-ang
2	(phe,
2	(kca)
2	kca
2	kca,
2	untreated:
2	ouabain-treated:
2	nmol/l-10
2	ln-induced
2	normotensive),
2	(10-6-10-2
2	(emax,
2	db4:
2	ct4:
2	p<.001).
2	k+-channel
2	ao,
2	(n=6,
2	hgcl2.
2	(pr-interval)
2	placodal
2	par3
2	residue.
2	neurites.
2	nephrin,
2	neph1
2	nephrin
2	neph
2	testicles,
2	hh29.
2	progenitors.
2	scrt2
2	neurom
2	embryo's
2	caudorostral
2	mesoderm.
2	(ice)
2	cpp32-like
2	acetylcysteine,
2	aurintricarboxylic
2	factor-deprived
2	ark.
2	pre-bӧtzinger
2	adult-onset
2	(pptg)
2	state-dependent
2	arrhythmogenesis
2	dβh-sap
2	(6-ohda)-model
2	-activated
2	dia
2	(rcpg)
2	late-expiratory
2	(late-e)
2	microcircuitry
2	rcpg
2	pfrg.
2	p-saporin
2	(abns)
2	abn
2	/ph.
2	disease?
2	(nk1r)
2	(rvrg).
2	(6-ohda,
2	24 μg μl
2	1 day
2	rvrg.
2	nk1r
2	60 days,
2	40–60
2	neuromodulator,
2	7–10%
2	(hypercapnia).
2	(8-pt)
2	a1-receptor
2	(dpcpx).
2	8pt,
2	(ggemg)
2	(abdemg)
2	(a5
2	sighs,
2	anti-dβh-sap-treated
2	rpa/ppy
2	kir4.1
2	fluorocitrate
2	purinergic-dependent
2	fct
2	(ve)
2	(40 days:
2	60 days:
2	a5-lesioned
2	(δtsn:
2	hawkins
2	co2/h+-induced
2	breathe,
2	co2/h+-reactivity.
2	p2y2/4
2	co2ventilatory
2	61 days,
2	(pe).
2	(th)-immunoreactive
2	a1/c1
2	(nts).
2	desaturation,
2	ictally
2	post-ictal
2	(phox2b+/th−)
2	(1 mm,
2	50 nl)
2	n2)
2	(68 ± 2
2	(35 ± 2
2	23 ± 4%
2	c1-pvh
2	increase/decrease
2	α1-/α2-adrenergic
2	inspiration,
2	backlabeled
2	urethaneanesthetized,
2	preapplication
2	(β-ar
2	rtn;
2	(coapplication
2	yohimbine)
2	α1-ar-dependent
2	α1-,
2	urethaneanesthetized
2	airflow
2	decarboxylase-67
2	(gad67).
2	cvrg
2	m1/m3
2	1,4,5-trisphosphate/ca+2
2	co2/h+-sensitivity
2	(i1)
2	artificially-ventilated
2	(250-350
2	sympathoinhibitory
2	371±8
2	161±11bpm
2	(mean±sem,
2	n=15,
2	115±2
2	131±4mmhg
2	methylatropine.
2	α<inf>1</inf>
2	prazosin.
2	(vlm),
2	apnea-induced
2	vlm.
2	chemoreceptors)
2	centres,
2	(kv7)
2	unexplained
2	(sudep),
2	sudep.
2	hyperpolarization-activated
2	cyclic-nucleotide-gated
2	(hcn)
2	hyperpolarizationactivated
2	(xe991)
2	(zd7288,
2	cs+)
2	sq22536
2	(adenylate
2	serotonin-mediated
2	(280-330
2	5-9/group)
2	pmol/100
2	(1,140
2	1,436
2	ml·kg-1·min-1),
2	(1,418
2	muscimol:
2	(1,827
2	3,179
2	(1,488
2	3,539
2	374
2	hypoxic,
2	h+-mediated
2	application;
2	p2-receptor-dependent
2	chemoreflexes
2	bötzinger
2	paired-like
2	(phox2b)-immunoreactive
2	chemically-coded
2	(ccrtn)
2	(phox2b+/th-)
2	(pef/lh),
2	(c-fos-ir)
2	c-fos-ir
2	7–8/group),
2	10 %)
2	sna,
2	2 mm–50 nl)
2	cap-induced
2	lpbn.
2	hypertension;
2	(mrs2365)
2	(≈55%),
2	(38±6%),
2	(23±1
2	chemoreceptor-mediated
2	mrs2365
2	c1-lesioned
2	mrs2365.
2	parapyramidal
2	(ppy)
2	thermoregulation.
2	urethane/α-chloralose-anesthetized,
2	paralyzed,
2	(n=14
2	30s)
2	(1.5±0.03
2	2.4±0.2hz)
2	(n=15
2	(1.7±0.1
2	2.2±0.2hz),
2	(n=3
2	(n=4
2	(n=2
2	5ht-ppy
2	(2.1±0.1
2	2.3±0.09hz).
2	biotinamide-labeled
2	serotonergic.
2	(aα-adrenoceptors/
2	nmol/2
2	transcriptor
2	(280-300
2	6-8)
2	21%),
2	68%),
2	(map,
2	/h+
2	nexus
2	(xe991,
2	(retigabine,
2	2-40
2	apamin-sensitive
2	(250-350g)
2	(c-fos
2	retrotrapezoid/parafacial
2	chemoreceptor.
2	2-evoked
2	contributes,
2	pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonate
2	loose-patch
2	slice,
2	(22-35°c)
2	responsivness
2	denervated,
2	(n=6-8/group),
2	(map;
2	δ=+33±4
2	(ssna;
2	δ=+97±13%,
2	(δ=+19±3
2	(δ=+63±5%,
2	(anti-dβh-sap)
2	(th
2	-phox2b
2	+).
2	(δ=+22±5
2	(δ=+68±9%,
2	commnts.
2	(280-300g)
2	(2mm)
2	(16±2mmhg,
2	36±3mmhg)
2	(250±17ml/min/kg,
2	641±28ml/min/kg)
2	(5±2mmhg,
2	26±5mmhg)
2	(20±6%,
2	149±15%)
2	(93±15%,
2	283±19%
2	baseline)
2	(0.04
2	urethane-anaesthetized,
2	d,l-2-amino-5-phosphonovalerate
2	7%).
2	(+/-)-α-methyl-4-carboxyphenylglycine
2	(pco
2	wakepromoting
2	behavior-specific
2	drive,
2	(nacn).
2	(250-280
2	n=5-8/group)
2	(66±11%)
2	(36±7%)
2	vglut2mrna).
2	gad-67mrna)
2	(9±4%)
2	(6±2%).
2	(snd)
2	glutamatergic.
2	bötzinger/c1
2	(bötz/c1)
2	sino-aortic-denervated,
2	10%).
2	7%.
2	(+/-)-alpha-methyl-4-
2	carboxyphenylglycine
2	bötz/c1
2	+43
2	+52
2	+41
2	bötz/c1,
2	bötz/c1.
2	(ssnd).in
2	baroreflex-response
2	pmol/50.
2	gaba-b
2	nl).
2	=-26
2	-41
2	(δ=-21
2	-78
2	0.4%,
2	cgp35348
2	gain.these
2	co2/ph-sensitive,
2	phox2b-egfp
2	isoflurane,
2	neurons:
2	protein-labeled
2	thik-1
2	(twik-related
2	halothane-inhibited
2	k2p13.1),
2	anesthetics,
2	rectification,
2	ph-insensitivity).
2	enhancedrtnneuronal
2	activitymaycontribute,
2	immobilizing
2	transitorily
2	(av3v
2	prelesion:
2	prelesion
2	(187
2	av3v+commnts-lesions,
2	(lh).
2	(α2-adrenoceptor
2	pilorcarpine
2	480
2	(357
2	446
2	automaticity.
2	(vglut2).
2	noncatecholaminergic
2	galanin-immunoreactive
2	galanin-expressing
2	pre-pro-galanin
2	(ppgal)
2	co-extensive
2	phox2b-ir
2	(phox2b+/th-
2	[sar9,
2	(o2)11]-substance
2	rtn/th-
2	(7/17,
2	ppgal-mrna.
2	chemo-receptors.
2	saporin-substance
2	(phox2b+th-).
2	2100
2	phox2b+
2	th-
2	ssp-sap,
2	pco2).
2	(8/12
2	anaesthesia.
2	co2is
2	p-expressing
2	ketanserin
2	ph-induced
2	mechanoreceptors.
2	urethan-anesthetized
2	phenylbiguanide
2	(pbg)
2	(73%),
2	(cyanide)
2	(rvrg)
2	(32%).
2	phox2b-immunoreactive
2	ambiguus,
2	(vrc)
2	(salivary,
2	vestibulocochlear)
2	(dorsomedial
2	(vestibulocochlear
2	efferents),
2	(vrc
2	pons)
2	oscillator.
2	(sars).
2	(pump
2	halothane-anesthetized
2	(12/36).
2	(gad67)
2	(ints).
2	toxin-b,
2	transporter2
2	(glyt2)
2	dextranamide
2	projection.
2	(α2-adrenoceptor/imidazoline
2	7-8)
2	(0.5 g/kg,
2	(60 mg/kg,
2	8 mmhg
2	4 mmhg),
2	5 bpm),
2	6 mmhg),
2	±6 bpm)
2	11%)
2	α1-adrenoceptors,
2	(sars)
2	halothane-anaesthetized
2	(peep;
2	2-6
2	cmh2o).
2	desynchronized
2	inflation-synchronous
2	inflation,
2	kynurenate
2	peep-sensitive
2	sars.
2	di-synaptic
2	(snd).
2	snd,
2	pnd,
2	(rvrg-pre-bötzinger
2	cvlm)
2	rvrg-pre-bötzinger/cvlm
2	(vesicular
2	mrna-containing
2	(cpg),
2	a6,
2	uninterrupted
2	(carotid
2	chemoresponsive
2	chemoreceptors).
2	waking.
2	(α2-adrenergic/imidazoline
2	(n=5
2	7/group)
2	(148±11
2	102±4
2	(417±11
2	379±6
2	bpm).
2	(68±9
2	359±7
2	(66±7
2	362±8
2	(104±6
2	(95±8
2	(cvlm)
2	urethane/chloralose,
2	bpm;
2	muscimol,
2	kyn,
2	(-48
2	-45
2	(-65
2	-113
2	29%).
2	(-46
2	6%),
2	2-adrenergic/imidazoline
2	(hindlimb)
2	(-50±13%
2	5±3%).
2	(15±5%
2	2±3%)
2	2±3
2	(88±12%
2	7±4%).
2	moxonidine,
2	(α2
2	(100mgkg-1)
2	(4μmolkg-1).
2	(10nmol)
2	(320nmol).
2	320nmol).
2	(320nmol)
2	(atropine-mb).
2	ketamine,
2	preweighed
2	μmol/1
2	icv.
2	α22-adrenergic
2	(α1-adrenergic
2	pre-weighed
2	(48±5,
2	17±2
2	15±2
2	73±7
2	(44±1,
2	14±2
2	20±3
2	51±2
2	(58±4
2	50±4
2	α2-adrenergic/imidazoline
2	thermal-dimorphic
2	mycoses.
2	concerns.
2	coville
2	scientifically
2	antiprotozoan,
2	antioxidant.
2	vaginitis
2	(f2
2	sub-fraction
2	fluconazole),
2	homogenates)
2	b-resistant
2	posadasii,
2	paracoccidioides.
2	radpbt
2	nosanchuk,
2	p10.
2	rossi,
2	melhem,
2	garcia,
2	caires,
2	taborda
2	azole
2	encourages
2	biphosphinic
2	cyclopalladate
2	hyphae/pseudohyphae
2	marginalization
2	(vaginal
2	canal)
2	(kidneys)
2	c7a.
2	(mlt),
2	alkylphospholipids,
2	1 µg/ml,
2	trimethoprim/sulfamethoxazole
2	≥1 µg/ml.
2	mlt,
2	melanosome-like
2	melanin.
2	tricyclazole,
2	dhn-melanin
2	melanogenesis.
2	pan-fungal
2	oligo
2	parente-rocha
2	posttreatment
2	c. albicans
2	m. alternifolia
2	sods
2	gsl
2	ccp
2	1,853
2	3,583
2	dermatophytes.
2	coccidioidomycosis
2	(lacaz
2	endometritis
2	aspergyllus
2	“reference”
2	blindly
2	titers)
2	oligomers.
2	wga
2	pp10
2	pil-12
2	cd44hi
2	visibly
2	tepitope
2	aafp.
2	pbls
2	melanin-like
2	rsafp2
2	acute/subacute
2	exocellular
2	relapses.
2	human-pathogenic
2	rigorously
2	3e5
2	complement-deficient
2	complement-independent
2	13f1
2	agglutination,
2	cryptococcosis;
2	(inno-lia
2	elisas
2	wb2.3
2	inno-lia
2	43-kda
2	antartida
2	immunoelectrophoresis.
2	protein/glycoprotein
2	<1/100.
2	slants
2	immunodiagnosis
2	200-300
2	counterimmunoelectrophoresis
2	immunoelectrophoresis
2	cfa.
2	10-110
2	myhc-i
2	foxo-3a
2	resistance-training
2	physically-active
2	n=11)
2	induction;
2	β<inf>2</inf>-adrenoceptor
2	(β<inf>2</inf>ko)
2	calibre
2	myofibres
2	β<inf>2</inf>-adrenoceptor.
2	play.
2	post-match
2	75%-1rm)
2	work-related
2	24-week
2	longissimus
2	dorsi
2	hyperoxic
2	(-10
2	(timps
2	bioengineering.
2	(emt)
2	keratocyst
2	biomaterials,
2	reconstructive
2	-7,
2	(p < 0.001),
2	(hoxa5,
2	hoxd11)
2	hoxa5
2	(wilcoxon,
2	wnt3
2	mmps-2,
2	odontogenesis,
2	maxillae
2	mineralization.
2	experimentation,
2	(gen-ox™
2	thickness)
2	avidin-biotin-
2	rankl+/total
2	opg+/total
2	anti-mmp-2
2	0.007)
2	(49.5
2	pyrrolidine
2	dithiocarbamate
2	f12
2	vascular-like
2	f12.
2	engineering.
2	endothelial-to-mesenchymal
2	(endmt)
2	apical-basal
2	macrovascular
2	(coronary
2	caecs;
2	paecs;
2	hpaecs)
2	tgf-β2.
2	il-9.
2	il9
2	il-13-expressing
2	lung-infiltrated
2	butyrate-treated
2	th9-mediated
2	climbing
2	(uuo).
2	kim-1
2	(post
2	ad-fish
2	(p=0.02),
2	<60
2	(aki),
2	nanoforskolin
2	(nff)
2	(ho-1),
2	stress/pkc-delta/p38
2	podocytes
2	pro-regenerative
2	allo,
2	fibrogenesis.
2	α-galactosylceramide
2	th17-related
2	+/rfp
2	dss-induced
2	gluta-mine
2	(placebo:
2	glutamine:
2	(mros)
2	netosis.
2	pf.
2	(0.92
2	immunopathology,
2	anti-metastatic
2	nod2,
2	msc-based
2	immune-associated
2	(shed)
2	(c57bl/6-foxp3gfp).
2	ifn-γ+cd8+,
2	il-4+cd8+,
2	il-4+cd4+
2	eae-affected
2	ilc
2	.01),
2	6.80
2	0.20,
2	network-based
2	ppargc1a,
2	(0.6%
2	menhaden
2	~60%
2	mate-1.
2	hiyane,
2	felizardo,
2	plns,
2	nlrp3-deficient
2	retusa
2	(timp-1)
2	po-msc
2	injury)
2	modulated,
2	metalloproteinase-1
2	pnu-282987,
2	hyperaldosteronism
2	rhabdomyolysis.
2	dyslipidemic
2	kdhom
2	apoptosis;
2	sakuranetin,
2	(collagen
2	dsa-positive
2	(aabmr
2	rt1
2	tens
2	ventral-dorsal
2	(ptd)
2	host-microbiota
2	moraes-vieira.
2	(white)
2	exposure).
2	(rcc),
2	dfa
2	dc5
2	cc5.
2	dfa5
2	(plns)
2	stz-injected
2	muramyl
2	hinnak
2	northoff.
2	exerciseinduced
2	(sleactive)
2	(sleinactive)
2	(∼70%
2	swim-trained
2	auto-reactive
2	clarified,
2	35–55
2	(5 mg/kg/day)
2	peron
2	immunoregulatory,
2	anti-fibrogenic,
2	pro-angiogenic.
2	(htmscs)
2	30mw/3j-660
2	(twice
2	76.
2	htmscs
2	cotherapy
2	kc),
2	nf-at
2	copd.
2	emphysema.
2	8-iso-pgf-2aα
2	p65-nf-κb
2	elastase-treated
2	iohexol
2	arf
2	pcreat
2	solution).
2	tgf-β3,
2	vinícius
2	andrade-oliveira
2	dynamically
2	"adipokines."
2	apelin,
2	hepcidin,
2	self-styled
2	"low-grade
2	state"
2	yrs;
2	bmi:
2	kg/m2),
2	vo2peak)
2	stnfr1,
2	programing
2	bligh-dyer
2	clp).
2	ldl,
2	hdl,
2	(tin)
2	tin
2	nephrotoxicity.
2	b2rbk
2	fsgs,
2	fsgs.
2	(2×105
2	cells/animal)
2	(adsc)
2	unnecessary.
2	larocca
2	stress-responsive
2	lumina
2	b2r)
2	nx+v,
2	ido,
2	galactose-deficient
2	igan.
2	long-term.
2	foscarnet
2	individualization
2	ido.
2	ontogeny,
2	pro-th1
2	glomerulosclerosis.
2	adipokine,
2	kidney-related
2	immune-
2	metabolic-related
2	su.
2	expanded,
2	mesodermal
2	cellular-based
2	gr1+low
2	gr1+high
2	castoldi
2	clp;
2	epor
2	adm-induced
2	gata-3/t-bet
2	ml/min;
2	2-mercaptoethanol.
2	cytochemistry.
2	xdh
2	(nlr),
2	cxcl10/ip-10
2	sflt-1
2	(arf)
2	antigen-independent
2	msc-secreted
2	cytoprotection.
2	if/ta
2	≥1.5
2	0.004).
2	(igf),
2	(sgf),
2	tissue-invasive
2	bmmc
2	(ctgf),
2	deceased-donor
2	igg-opsonized
2	(urbp)
2	≥1
2	(imt)
2	basel/switzerland.
2	sham-lipectomized
2	lipectomy
2	galectin-9,
2	(lnic;
2	lnic,
2	racnv
2	rav
2	can.
2	proteinuria/creatinine
2	ifn-γ/il-12
2	2 years
2	pedicles
2	(iri
2	gly-aki.
2	anti-hgf
2	untreated);
2	(five-sixth
2	nxlc3
2	nxlc
2	gb2
2	(acei)
2	acei-free
2	osteopontin
2	morphogenic
2	181),
2	(gag)
2	(ps
2	sulfated-gag
2	multi-functional
2	(banff
2	cadi
2	s-gag
2	50-59
2	antigenaemia
2	(gn)
2	thr399ile
2	asp299gly,
2	(2.05
2	(1.53
2	(67.0%
2	cd4-depleted
2	(84
2	(b1r
2	antigenemia
2	10 mg/kg
2	36.6
2	nonvascular
2	lnic
2	(atn)
2	urbp,
2	fas-l
2	hla-dr1
2	alloresponses
2	costimulating
2	cd80/cd86
2	oxalate
2	rejection-free
2	cadaver
2	ltrf
2	schema
2	cd45ro
2	renal-transplant
2	0.400
2	urbp.
2	medina,
2	cunha-neto,
2	(rhsp65)
2	rhsp65,
2	rhsp65.
2	ifn-gamma+
2	antigen-combined
2	rip2-/-
2	ltgf-β1
2	ot-ii
2	dta-1.
2	nod2-rip2
2	il17a
2	apa
2	65)
2	cd4+/cd4+
2	bcg/cfp-cpg
2	65-immunized
2	mk-886
2	mk-886-treated
2	bcg-cfp/cpg
2	cpg-odns
2	cfp/ifa-immunized
2	denv,
2	nitroxyl
2	cci)
2	mucosally
2	nih/3t3-lendires-il-2-sn
2	(rabv)
2	lyssavirus
2	v-3
2	anti-epec
2	ld50,
2	co-transfected
2	interstrain
2	sa;
2	lymph‐node
2	(hiv
2	liv)f2
2	anti-ehrlichia
2	16 s
2	(20.0%)
2	chitin
2	(hemoplasma)
2	genitalium,
2	gene-by-gene
2	turicensis’.
2	cats)
2	haemominutum’,
2	illinois,
2	ccz
2	leptospiruria.
2	wrong
2	wenyonii
2	ocelots
2	pardalis)
2	fawn,
2	edta-anticoagulated
2	ovis-like
2	ohio2
2	ovis,
2	blastocerus
2	primavera,
2	bezoarticus
2	emas
2	(59.7%)
2	c-rp
2	zoo-born
2	(p=
2	haemomuris
2	slaughterhouse,
2	lame
2	neighbourhood
2	buildings.
2	(~.
2	pomegranate
2	mini-osmotic
2	ltm
2	pmol,
2	kob2aβ
2	b2r,
2	dementia
2	ee-15
2	[125i]-α-bungarotoxin.
2	pa5
2	(kob1)
2	(kob2)
2	(car,
2	kob2
2	aβkob1
2	(1.30
2	m1-polarization
2	gpr40,
2	pahsa-treated
2	adipose-chrebp
2	ag4ox
2	fahfa
2	rbp4-overexpressing
2	(rbp4-ox)
2	rbp4-ox,
2	ttr-aso
2	ttr-asos,
2	"operational
2	il-4/stat6
2	endocytosis.
2	lit1
2	asm-depleted
2	canb,
2	canb
2	j18-treated
2	mucin.
2	c03
2	anti-j18
2	anti-c03
2	(eiec),
2	gp82-dependent
2	573,
2	cl-14,
2	cl-14.
2	588
2	actomyosin
2	multiepitope
2	αdechivbr8
2	apostólico
2	safer,
2	gp140
2	mdp
2	broad-based
2	eyfp
2	anti-cd11c
2	dc-targeted
2	ifn-ß
2	(q705k)
2	hd.
2	(ccr5)
2	european-derived
2	hivc
2	atp-treated
2	adj
2	rs12150220
2	siglec-1/cd169
2	sialoadhesin
2	rs3859664
2	non-carriers,
2	homology.;
2	differences.;
2	pathway.;
2	hypothesized.
2	phylogeny.
2	nlr-mediated
2	rs6509365
2	rs1143643
2	tnfaip3)
2	rs1143634
2	inflammasome'
2	il1b)
2	exome
2	ccr4-not
2	a/g
2	ttp-ccr4-not
2	il4-dc
2	immune-vaccines.
2	pontillo
2	trex-1
2	au-hiv
2	nlrps
2	pyd
2	mb;
2	pb)
2	crohn
2	hiv-1-positive
2	ctbs
2	dscs,
2	nlrp3/nalp3
2	hiv-dc
2	pfapa
2	(cinca)
2	retardation
2	(raw
2	264.7)
2	(mkd),
2	mkd.
2	ftis
2	goh
2	504
2	rs35829419
2	(ggpp),
2	pamidronate.
2	aminobisphosphonates.
2	3utr
2	geranylgeraniol
2	aminobisphosphonates,
2	his1
2	cercopithecidae.
2	delay.
2	new-world
2	-mutated
2	anakinra
2	-667
2	mdmm.
2	encephalopathies.
2	tg20
2	stem-like
2	-hop
2	hop-prp
2	(y705)
2	rnd1.
2	pias1,
2	(mglur1/5)
2	prpc-mediated
2	laminin-γ1
2	chain-derived
2	-null
2	prpc:hop/sti1
2	prp143-153
2	saxs
2	hop/sti1.
2	307-320
2	anti-ln
2	prpc-ln
2	rprp
2	mtle-hs.
2	mtle-hs
2	(asn171ser)
2	untreatable
2	losing
2	(systematic
2	enrichment)
2	pimecrolimus
2	fxr
2	pparδ.
2	hqsar
2	5-(hydroxyethyl)-4-methylthiazole
2	(thz)
2	90.0,
2	(pdxk)
2	95°.
2	©2014
2	oxythiamine,
2	oxythiamine
2	pyrophosphate-dependent
2	deamination
2	satena,
2	(selex)
2	antifolates
2	(thiamine)
2	(pyridoxal
2	imine
2	e4p
2	4pehz,
2	leiocarpus,
2	senegalensis
2	157,
2	å,α
2	å3
2	da-1.
2	harming
2	spermidine,
2	2.6.1.1)
2	pyrimidines.
2	pfsap
2	pfaspat,
2	salvaged
2	(thie).
2	salt-bridge
2	dodecamer,
2	5-phosphate
2	pyridoxyl-tryptophan
2	pt5
2	pt3
2	pdx1:pdx1
2	k151
2	emphasises
2	kadhs
2	tpk
2	tpks
2	kmapp
2	lipoyl-acp:protein
2	n-lipoyl
2	pfadometdc/odc
2	monofunctional,
2	homodimeric
2	nadp+
2	glutamicum.
2	(adometdc)
2	domain-domain
2	hebbian
2	mepsc
2	rate-dependent
2	corticocortical
2	reactivates
2	std,
2	amblyopic
2	cryptococcus,
2	(itc).
2	room-temperature
2	cryofixation
2	(tcan26,
2	alkylphosphocholine
2	rvvc
2	flz
2	duobushaemulonii
2	time-kill
2	sterols.
2	(atcc
2	anti-biofilm
2	blastoconidia
2	(itc),
2	itz
2	nystatin,
2	sub-inhibitory
2	(trb),
2	interdigital
2	scrapings
2	iturin
2	(sqs)
2	sqs
2	arylquinuclidine
2	ishida
2	coville,
2	barbatimão,
2	(mfc
2	(aza),
2	eil
2	azole-resistant
2	24-smti
2	budding,
2	gratissimum
2	isg
2	virus-containing
2	(vccs).
2	gaudin
2	pfdutpase
2	labmol-144
2	mtrap
2	pexel-bearing
2	ron
2	tj,
2	gametes.
2	npt1
2	frted
2	deleter
2	pip4k2a,
2	pip4k2
2	aml.
2	aml-bmmsc,
2	(mpn).
2	jak2v617f-positive
2	igf1
2	irs1/β-catenin
2	hck
2	ihck-37
2	neoplasms,
2	(aml),
2	aml,
2	il-32
2	aurka
2	aurkb
2	reversine
2	ten-eleven-translocation
2	5-methylcytosine
2	5-hydroxymethylcytosine
2	erythroid,
2	ruxolitinib,
2	jak2wt
2	ruxolitinib.
2	t-all
2	bl
2	raeb-1/raeb-2
2	thrombin-antithrombin
2	hematopoiesis,
2	hematopoietic-derived
2	globin
2	arg72pro
2	msi2
2	flt3
2	myelodysplasia
1	(nox
1	mg.kg-1.day-1
1	p22phox;
1	pro-inflamatory,
1	s473,
1	mtorc1/s6k
1	mtorc2/pkb/mtorc1/s6k
1	beltrán
1	cl-release
1	alkalization
1	exchangers.
1	bcecf-preloaded
1	minutes),
1	nhe2),
1	donor),
1	(db-cgmp),
1	(adenylyl
1	(βi)
1	(∼63%),
1	7.144-7.172).
1	βi
1	(∼94%
1	hoe-694.
1	db-cgmp
1	sta-decreased
1	h89.
1	(sta/increased
1	camp/increased
1	activity/reduced
1	(glp-1r)
1	μg•kg−1•min−1)
1	overnight-fasted
1	exendin-9-infused-rats
1	vehicle-infused
1	(nhe3ps552),
1	(sglt1)-mediated
1	na+-h
1	+exchanger
1	phlorizin-sensitive
1	barreled
1	ion.
1	6-mb-camp,
1	(y-shrs)
1	(a-shrs).
1	6-mb-camp
1	pp1α
1	pp1-mediated
1	bicarbonaturic
1	h<sup>+</sup>-atpase-mediated
1	(pkg
1	nh<inf>4</inf>cl.
1	bromoguanosine-cgmp
1	(8br-cgmp)inhibited
1	h<sup>+</sup>-atpase-dependent
1	(mdck)-c11
1	cyclase-c.
1	cgmp/pkg-dependent
1	(nhe)3-mediated
1	microelectrode.
1	h-89.
1	transcriptional,
1	translational,
1	glp-1.
1	μg·kg-1·min-1)
1	glp-1-infused
1	bsa/saline).
1	receptor-mrna
1	glomerulus
1	(nhe3)-mediated
1	glp-1-based
1	(nhe2),
1	v-type
1	cl/hco3-
1	cl/
1	ae1.
1	h+/k+-
1	nefrologia.
1	dissipate
1	atpase-mediated
1	irptc.
1	valinomycin,
1	chloride-proton
1	v-atpase
1	exendin-4.
1	(epac)
1	nhe3;
1	eels
1	1 μm,
1	1,76
1	0,11control
1	1,29
1	0,08ren
1	(jhco3-,
1	0.07control
1	0.06ren
1	1 μm;
1	(irptc).
1	0.066∈±∈0.014
1	(n∈=∈7)
1	0.14∈±∈0.021
1	(n∈=∈13;
1	(10-9∈m)-treated
1	v-atpase.
1	203580
1	fluorescein-derived
1	0.136
1	0.032
1	na+).
1	dphi/dt.
1	8-br-camp,
1	+pd
1	(potential
1	dphi/dt,
1	cl-ions
1	h+-adenosine
1	[ca+2]i
1	2′,7-bis
1	(2-carboxyethyl)-5(6)-carboxyfluorescein-
1	acetoxy-methyl
1	fluo-4-acetoxy-methyl
1	0.073±0.011
1	0.12±0.015
1	units/min,
1	n=10.
1	ca+2i,
1	99.72±1.704
1	(n=21)
1	401.23±33.91
1	(n=39).
1	ca+2i.
1	1,2-bis(2-aminophenoxy)ethane-n,n,n′,n′-tetraacetic
1	trimethoxy
1	ca+2i
1	mobilization).
1	pka-independent
1	salt-wasting
1	(kir1.1;
1	kcnj1),
1	(tal)
1	(cct).
1	hyperkalemic,
1	cct.
1	hypokalemia
1	romk-deficient,
1	henle
1	romk-deficient
1	(ibtx)-sensitive,
1	flow-stimulated
1	ibtx-sensitive
1	high-potassium-adapted
1	tal
1	max-k
1	(wp).
1	(12.66
1	4.24
1	25.30
1	(22.70
1	(16.41
1	2.09
1	24.06
1	w).
1	(1.520
1	0.214
1	weight-1;
1	(0.43
1	0.87%;
1	0.20%).
1	(substituted
1	gluconate)
1	(δph)
1	0.24±0.03
1	(n=28)
1	0.023±0.01
1	bumetanide
1	ba+,
1	2.5×10-4
1	na+-k+
1	sch28080
1	omeprazol
1	(-dv)
1	-10.24×1.96%
1	(dv=-2.12%
1	0.24±0.04
1	(260
1	mosmol/l),
1	(dv=+2.6%
1	0.52±0.07
1	[cl-]
1	(ca2+,
1	cgmp).
1	(jw
1	-0.16
1	μ1·min-1·cm-2)
1	(isc
1	1.55
1	μa/cm2).
1	a-23187
1	bumetanide,
1	na+-k+-2cl-
1	heatstable
1	isc.
1	water-solute
1	cotransporters.
1	h+-k+-atpase,
1	na+/hco3-
1	cotransport.
1	7.20±0.01
1	(n=136)
1	acid-releasing
1	0.167±0.006
1	units/per
1	(n=20).
1	4.6×10-8
1	h+-atpase).
1	5×10-5
1	h+-k+-atpase)
1	(0.065±0.01
1	(0.072±0.01
1	apically
1	(0.0304±0.005
1	basolaterally
1	(0.025±0.004
1	concanamycin-sensitive
1	membranes;
1	k+-dependent,
1	28080-sensitive
1	h+-k+-atpase
1	na+-
1	cl--free
1	0.0018
1	0.0021
1	0.42).
1	na+0
1	0.081
1	(hma)
1	co2/hco3/-
1	35).
1	-0.14
1	ph/min;
1	dids,
1	incubated-in
1	hco3/-
1	(j(k))
1	k+-sensitive
1	avp-containing
1	1.34
1	avp+10-6
1	mercapto-β-β-cyclopenta-methylenepropionyl1,
1	o-me-tyr2-arg8
1	(mcmv),
1	0.067
1	(control;
1	j(k).
1	nh4+,
1	absorbed.
1	ph;
1	nh4cl-containing
1	7.51
1	cotransport,
1	0.041,
1	8.10
1	0.117
1	(nh4)2so4
1	superfused,
1	alkalinization;
1	superfusing
1	7.78
1	reached),
1	ba2+-sensitive
1	constitutional
1	pioneered
1	richards,
1	1930s,
1	perfectioned
1	micromethods
1	/hco3/-
1	slips
1	nh4/+
1	(dphi/dt).
1	0.121
1	h+-atpase)
1	concanamycin,
1	h+-k+-atpase.
1	cl-/normal
1	atpase;
1	cl-free
1	8.14
1	m-2)
1	g·kg-1
1	unsalted
1	meat),
1	value)
1	coincident.
1	(nh4+)
1	gfr)
1	h+-ion-sensitive
1	(aldosterone
1	18-oh
1	(18-oh-b))
1	7.03
1	(6.78).
1	bicarbonate-loaded
1	11.9
1	3-μg
1	(220
1	investigations,
1	perfusates,
1	reabosorption
1	egta,
1	(ion-exchange
1	resin)/1
1	lumen)
1	hco3-or
1	hco3-exchange
1	(brb),
1	brb
1	0.14±0.033
1	0.95±0.10
1	5×10-4m
1	h(+)-atpase.
1	effected
1	h(+)-atpase
1	alpha-intercalated
1	h/k
1	h-ions
1	experiments).
1	tubule),
1	[hco
1	(j(hco
1	))].
1	hexamethylene-amiloride
1	(hma),
1	43.6
1	40.3%)
1	v(t).
1	benzamil,
1	-channel
1	75.9
1	74.9%
1	sch-28080,
1	ed,
1	nah2po4
1	h(+)‐hco3‐fluxes
1	gradients;
1	h(+)‐hco3‐backfluxes
1	h(+)‐hco3‐backflux.
1	h(+)‐hco3‐backflux
1	perfusions,
1	h(+)‐hco3‐flux
1	split‐drop
1	h(+)‐hco3‐backflux,
1	(h+
1	tonicity.
1	0.039
1	k(+)-supplemented
1	(-8.9
1	-32.7
1	(evidence
1	microcalorimetry
1	3h-inulin.
1	(32.9±4.57
1	(10.7±3.1
1	ethyl-isopropylamiloride
1	ethyl-
1	isopropylamiloride.
1	h-atpase,
1	h-k
1	amiloride-insensitive
1	(h-atpase)
1	chloride-dependent
1	válues.
1	co<inf>2</inf>-free
1	co2-free
1	urinary/plasma
1	double-barrelled
1	(8.38s
1	7.40s,
1	(5.44s).
1	3.97s
1	amiloride-dependent
1	urine-blood
1	amiloride-treated,
1	1.82
1	1.58
1	133.322
1	pa).
1	(18-oh-b),
1	(21.9
1	20.98
1	level).
1	(tptx)
1	thyroxin.
1	7.79
1	4.88
1	tptx,
1	5.65
1	tptx.
1	8.97
1	0.64
1	(7.40
1	s);
1	0.823
1	0.082
1	0.073
1	(rbf)
1	3.88
1	77.4
1	(p‐aminohippurate)
1	muequiv
1	min‐1
1	clamping,
1	severinghaus
1	6.77
1	6.65
1	5.07
1	4.39
1	1.63
1	s‐1,
1	rbf
1	ba2+.
1	4.25
1	1.71
1	12.53
1	k(+)-channel-dependent
1	[g.
1	malnic,
1	r.w.
1	berliner,
1	giebisch.
1	25):
1	f932-f1271,
1	1989]
1	[r.n.
1	khuri,
1	wiederholt,
1	strieder,
1	giebisch,
1	228:
1	1249-1261,
1	1975].
1	cation-selective
1	21-26
1	(2×10-5
1	antimony/reference
1	15-18
1	microcalorimetry.
1	chloride-free
1	nl/min.
1	2.32
1	volume-expanded
1	16-21%
1	0-35
1	nl/min),
1	k+-depleted,
1	k+-loaded,
1	resin-reference
1	nl/min
1	low-k+
1	k+-loaded
1	declines,
1	0.35-0.60
1	(11.9
1	133.3
1	pa)
1	(39.9
1	administration:
1	30.0
1	2.13
1	18-hydroxycorticosterone,
1	29.0
1	normal:
1	39.0
1	1.66
1	double-barrelled,
1	ph-sensitive,
1	sodium-dependent,
1	k-free
1	(481±40
1	444±50
1	(247±17
1	pmol/min)
1	(179±18
1	pmol/min).
1	severalfold
1	nonloaded
1	anhydrase.
1	(s3
1	segment),
1	henle,
1	hco3-/oh-
1	5×10-4
1	anhydrase,
1	voltage,
1	sits;
1	hco3-/cl-
1	non‐bicarbonate
1	stopped‐flow
1	micro‐electrode
1	6.69
1	6.37
1	1.57
1	7.2.
1	uncatalysed
1	h2co3
1	recirculation.
1	(t/2),
1	ion)
1	(phco-3)
1	10(-5)
1	min-1.
1	jhco-3,
1	pertibular
1	(j(v))
1	(j(hco3-))
1	(p(hco3-))
1	cm·s-1
1	j(hco3-),
1	necturus
1	7.44
1	7.56,
1	"active"
1	anion-conductive
1	6.88±0.5.
1	6.81±0.03
1	(n=80),
1	7.25±0.33
1	(80)
1	0.51±0.05
1	nmol·cm-2·s-1.
1	kidneys).
1	6.2,
1	±0.08
1	nmol·cm-2·s-1,
1	±0.34
1	(34)
1	pump-leak
1	kpa,
1	27-30
1	1.43±0.09
1	(11)
1	back-fluxes
1	10-46°
1	activtion
1	kcal·mol-1
1	9.30
1	alkalinization,
1	6.30
1	9.55
1	carrier-mediated,
1	dilatation.
1	bicarbonate/co2
1	10--40
1	tubules;
1	investigators.
1	(ph-equilibration
1	potassium-sensitive
1	attainment
1	(<1s),
1	intersected,
1	droplets,
1	p.d.s.
1	‐1
1	‐2
1	+0‐5
1	+1mv
1	charges.
1	interpolated.
1	7.51±0.01
1	7.39.
1	7.44±0.02
1	7.34.
1	acidbase
1	gravimetrically
1	sacs
1	hydrosmotic
1	(s.c.c.)
1	skins
1	(estradiol,
1	testosterone),
1	s.c.c.
1	mequiv/l
1	hormone-preincubated
1	mineralocorticoids;
1	tf/p's
1	furosemid.
1	tf/p=0.30)
1	tf/p=0.51)
1	1.27,
1	osmolar
1	(t/2=16.3
1	sec)
1	lissamine
1	act,
1	"single
1	countercurrent
1	intracrotidial
1	diuresis,
1	neurohypophysis.
1	1962
1	conifer
1	(araucaria
1	(bert.)
1	ktze)
1	(ses)
1	(abscisic
1	agents)
1	conjugate),
1	lines).
1	diamine
1	ses.
1	journals.
1	permissions@oup.com.
1	sisal-associated
1	growth.aims:
1	(agave
1	sisalana
1	perrine
1	engelm)
1	fertilizers.
1	(bnf)
1	promotion.methods:
1	burk’s
1	box-a1r
1	nifh-gene.
1	plants.results:
1	bnf
1	respects,
1	colonise
1	endophytic)
1	plantations,
1	(bacillaceae
1	paenibacillus,
1	(paenibacillaceae
1	family).
1	curvularia
1	polygalacturonase
1	pectate
1	solubilising
1	paenibacillaceae
1	b65
1	inoculant
1	'bacilli'
1	n-combined
1	beijerinckia,
1	diversities
1	177)
1	200).
1	177),
1	200),
1	183).
1	rod-shaped,
1	non-spore-forming
1	89t,
1	958t,
1	rhizophila
1	22075t,
1	nitritireducens
1	l2t,
1	geniculata
1	19374t,
1	hibiscicola
1	19867t
1	beteli
1	19861t.
1	pavanii
1	(=cbmai
1	564t
1	=lmg
1	25348t).
1	iums.
1	(mlsa),
1	(atpa),
1	(reca),
1	(rpoa)
1	(uvrb).
1	mlsa-based
1	mlsa,
1	(ddh)
1	cohesive
1	ddh
1	(www.steno.lncc.br/).
1	(cdeb)
1	organic,
1	(ara)
1	vials;
1	cropping
1	cassava,
1	nitrogen-deprived
1	brasilense.
1	rapd,
1	azospirillum,
1	herbaspirillum,
1	caroliniana,
1	crozalsiana,
1	texana,
1	sancti-angeli
1	tinctorum
1	nitrogen-free
1	stutzeri,
1	phytohormone
1	3-indoleacetic
1	phosphates
1	lichens;
1	(n)-fixing
1	[indoleacetic
1	polyamines]
1	(n-free
1	(combined-n
1	agitated,
1	plant-active
1	substances;
1	(pgr)
1	polyamines,
1	gained.
1	icb-10
1	2.8,
1	5.7);
1	sulphate;
1	thiosulphate.
1	condition),
1	(increasing
1	vi)
1	thiosulphate
1	sulphur-oxidizing
1	chemolitotroph,
1	acetivibrio
1	cellulolyticus
1	(cellobiose,
1	cellulose)
1	cellulose;
1	cellulose.
1	operators
1	slime
1	operators.
1	nh4+or
1	n2as
1	n2-grown
1	nh4+-grown
1	isoform)
1	(mek)
1	loading)
1	2-am,
1	(10−12
1	(10−6
1	nhe1.
1	bapta-am
1	plc,
1	[ca2+]i;
1	transports.
1	304:
1	f1258-f1265,
1	doi:10.1152/ajprenal.00401.2012.-the
1	0.078
1	nmol·cm_2·s_1
1	(10~12
1	10~9
1	(10~6
1	(nhe3).
1	([ca2+]i),
1	(10~12,
1	10~9,
1	10~6m)
1	151,
1	102,
1	dimethyl-bapta
1	(bapta)
1	isoform),
1	4cl,
1	0.195
1	tubules/number
1	16/96).
1	nhe1:
1	124%,
1	486,
1	phirr-regulating
1	aldo,
1	/cam
1	constructed:
1	ps120
1	(mm/min),
1	hnhe1
1	[49/19
1	measurements/no
1	tubules)]
1	4.20
1	(58/10).
1	transcription),
1	(hat1)
1	0.219
1	0.017
1	nontransfected
1	[0.211
1	12)].
1	(nhe-1)
1	0.21;
1	0.45;
1	3.86
1	(jhco3,
1	0.10;
1	3.28
1	1.87
1	s-1;
1	3.52
1	0.15;
1	8334.21
1	112.05;
1	10,217.55
1	100.66;
1	8478.21
1	119.81
1	4-am,
1	nh4c1
1	2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein-acetoxymethyl
1	2-am
1	4-am.
1	14);
1	dimethyl-1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic
1	(bapta)-am
1	10-9,
1	rusby
1	herb
1	fructans
1	freeze-thawing
1	precipitate.
1	inactin
1	dahlia
1	(sigma)
1	0.055
1	doubled.
1	inulins,
1	equal,
1	3.11
1	6.04
1	3.80
1	(blmpd)
1	-41.6
1	-29.7
1	mpt)
1	(5.09
1	3.92
1	blmpd
1	(-39.0
1	2.48
1	-52.0
1	2.72
1	l-glutamate)
1	perfusion.(abstract
1	mandin-darby
1	-sensitive
1	fura-2/am
1	perkin-elmer
1	ls-5
1	spectrofluorimeter
1	(excitation
1	340/380
1	](i),
1	li+;
1	licl
1	li+).
1	(11.3
1	(2.14
1	cm-2).
1	(-7.50
1	1.50
1	-20.5
1	4.47
1	(5.20
1	(3.11
1	(2.46
1	lumen-to-cell
1	alkalinization.
1	dtr/egfp
1	(dereg)
1	dereg
1	pcm;
1	(nlrp3),
1	(myd88),
1	vacca,
1	puccetti,
1	romani
1	paracoccidiodes
1	indoleamine-2,3
1	(pido)
1	pido,
1	(syk)
1	dectin-1.
1	clec7a-/-
1	dectin-1/syk/
1	ros/nlrp3
1	dioxygenase-1
1	(ido1)
1	kyn-mediated
1	ido1-deficient
1	(ido1-/-)
1	ilc1
1	il-27,
1	il-35
1	ido/ahr
1	th17/treg
1	zamboni
1	speck-like
1	(p2x7r).
1	scantily
1	(nlrp3-/-,
1	asc-/-)
1	(p2x7r-/-)
1	nlrp3-/-,
1	asc-/-,
1	caspase-1/11
1	14-year-old
1	boy,
1	loss-and
1	foxp3-expressing
1	(clrs)
1	dectin-1-/-,
1	dectin-1-/-
1	clrs
1	synergist
1	fornias
1	sperandio
1	follow.
1	subcutaneous)
1	air-pouches
1	air-pouch
1	pmn-rich
1	pmn;
1	bazan,
1	m2/m1
1	nrlp3
1	loures
1	hypersusceptible
1	aspergillosis.
1	hyphae.
1	dectin-2,
1	(pets)
1	citrullinated
1	interferon-induced
1	dectin-2;
1	β-glucan,
1	dectin-1-deficient
1	il-17<sup>+</sup>
1	<sup>+</sup>cd8<sup>+</sup>
1	inflammation.our
1	inflammation.in
1	1-methyl-dl-tryptophan
1	(1mt),
1	1mt
1	paracoccidoides
1	alpha1,3
1	glucan,
1	mannan-linked
1	mannosyl
1	(mr),
1	phagocytic,
1	(suppressor
1	signaling-3),
1	"m1-like"
1	arginase-1,
1	zone-1
1	(fizz1),
1	ym1
1	(chi313,
1	chitinase-like
1	lectin),
1	socs1,
1	"m2-like"
1	mannosyl-recognizing
1	feriotti
1	background:cellular
1	pcm.methodology/principal
1	findings:wild
1	pb-infected
1	background:nitric
1	infection.methodology/principal
1	findings:c57bl/6
1	circumscribed,
1	ctla4,
1	anti-cd25-mediated
1	felonato
1	f3b
1	toll-independent
1	toll-dependent
1	(tlr2)
1	lymphoproliferation,
1	nonorganized,
1	(cd28-/-)
1	cd28-sufficient
1	(mcp-1).
1	tlr4-competent
1	tlr4-normal
1	totally,
1	inefficiently
1	immobilized,
1	mannose-binding
1	mbl-sufficient,
1	mbl-deficient
1	pb265,
1	vitro-infected
1	lung-infiltrating
1	pcm:
1	anergic;
1	anergy,
1	1/type
1	type-1/type-2
1	neutrophil-depleted,
1	(th1)-
1	th2-regulated
1	[immunoglobulin
1	igg3].
1	th1-regulated
1	(igg2a,
1	(fasl)
1	prostaglandin-
1	factor-β-dependent
1	fasl-mediated
1	(mab)/week
1	mg/week
1	disease-promoting
1	propagules,
1	testicle
1	pb18-infected
1	laminin-treated
1	paracoccidiodomycosis,
1	th2-inducing
1	il-4-sufficient
1	nentrophils
1	similarity:
1	interferon-γ/(ifn-γ),
1	on),
1	twelfth
1	fungus-associated
1	immunoglobulin-positive
1	extrapulmonary
1	brasiliensis-specific
1	histopathologically,
1	disorganize
1	interfaces,
1	attractant,
1	'interlinking'
1	apoptotic.
1	host-cell.
1	receptor-containing
1	(th1)-mediated
1	cell-markers
1	proactive
1	(l-selectins)
1	host-inflammatory
1	host-response.
1	th2-associated
1	interleukin-10)
1	pancreas/peripancreatic
1	omentum
1	omentum;
1	nodule,
1	xantomatous-like
1	(igg1)-
1	igg2b-specific
1	immunity)
1	b10,
1	(preferential
1	antigen-elicited
1	monokines
1	tgf-ß)
1	(il-4,5,10)
1	il-2;
1	il-5)
1	washings
1	tgf-ß.
1	73,
1	pouches,
1	lucigen-enhanced
1	(pb).
1	pb-stimulated
1	lucigenin-
1	detects,
1	myeloperoxidase/hydrogen
1	pseudoxantomatous
1	(nu/nu)
1	hemopoiesis.
1	tumor-like
1	omental
1	milky
1	spleen),
1	cell-dependent,
1	41.5-
1	27.5-kd
1	cell-independent
1	(b10.d2/osn)
1	varied:
1	(a/snxb10.a)
1	granuiomatous
1	paracoccldloidomycosis.
1	brasiliensis;
1	1/21,000)
1	1/8000)
1	braslllensls;
1	braslllensls-reactive
1	vγ9vδ2
1	tcr;
1	brasilensis
1	(≪1
1	(pb265)paracoccidioides
1	(90th
1	dinitrofluorobenzene)
1	antigen-specific.
1	(candidin
1	histoplasmin)
1	c57bi/6,
1	involute
1	macrophage-pseudoxanthomatous
1	brasiliensis-ecm
1	encloses
1	"family"
1	involutive
1	(slightly
1	sustained-expansive
1	pb57
1	estimation,
1	paracoccidioidic
1	pb57.
1	infectant
1	analogous.
1	discernible
1	elisa),
1	(gf)
1	gf
1	(op).
1	10.a
1	(rr).
1	anatomopathology
1	subculturing;
1	64th
1	subcultivation.
1	fungus;
1	numer
1	pb267),
1	(b10.a-susceptible
1	a/sn-resistant)
1	estimations
1	24-week-period.
1	homogenous,
1	267),
1	sn),
1	tetani
1	antitoxins,
1	ultrastructure.
1	(fu)
1	10-30×
1	60-150×106
1	vitor
1	grande)
1	180-370×106
1	vitor,
1	267;
1	102.6
1	265).
1	yeast-phase
1	clump.
1	similar:
1	°;
1	morphology;
1	scanty,
1	cisternae;
1	electrondense
1	h-2,
1	determination)
1	(pathogenicity
1	avirulent.
1	prostaglandin,
1	complement-derived
1	(cof)
1	nature;
1	daltons,
1	antibody-dependent,
1	blood-stream
1	(nmsc),
1	(nmpc)
1	(ims).
1	effector-target
1	40:1,
1	nmsc
1	nmpc
1	(imsc)
1	imsc
1	macropahges.
1	diacetate-ethidium
1	(fda-eb)
1	fluorochromasia,
1	successfuly
1	simplicity.
1	"stimulated"
1	serum:
1	factor-b
1	β1c
1	β1a.
1	fungus-secreted
1	mancini
1	electro
1	comparatively.
1	(i.u.)
1	10.98,
1	60.34
1	117.40
1	i.u./mg
1	16.1,
1	151.5;
1	129.1
1	110.30
1	i.u./ml,
1	142.00
1	rational:
1	wet/dry
1	(cinc-1)
1	seven-days-ovariectomized
1	circulating,
1	leukocytosis.
1	postischemia.
1	bonemarrow,
1	highmortality.femaleshave
1	traumawhen
1	comparedwithmales,
1	indicatinga
1	process.here,we
1	i/rinmale
1	i/rwas
1	theclamping
1	thesuperiormesenteric
1	45min,
1	followedby
1	reperfusion.agroup
1	17b-estradiol
1	(280mg/kg,
1	minof
1	ischemia.morphometric
1	analysisof
1	showedi/rinduceda
1	thatwas
1	byestradiol.white
1	notablygranulocytes,weremobilized
1	wrapped
1	fluid,whereleukocytescount,tnf-a,andil-10levelswereincreasedby
1	i/r.serumchemokines
1	(cinc-1,mip-1a,mip-2),
1	mip-1a,
1	(6.13 mg/m3,
1	1 h/day,
1	5 days/week,
1	(1 %,
1	immune-mediating
1	inflating
1	bd,
1	mip-2)
1	therapeutically,
1	i/r)
1	noncardiogenic
1	(sma),
1	(unclamping
1	sma).
1	17β
1	(e2,
1	(ischemia
1	unclamping
1	(reperfusion
1	period).
1	(intercellular
1	[vcam])
1	(injected
1	cells-tae)
1	endocrinological
1	(ova)-induced
1	igg1-ova,
1	igg2a-ova
1	factor-α).
1	min/
1	inosine,
1	(zm241385),
1	(alloxazine),
1	(mrs3777)
1	zm241385
1	alloxazine
1	th2-cytokines,
1	interleukin-5,
1	evaluated.the
1	90min/day,
1	3days)
1	ova-sensitised
1	(ers)
1	rrs,
1	ac2-26,
1	guido
1	preestablished
1	euthanizing
1	postreperfusion
1	(amph).
1	gut-lung
1	(i/r);
1	biotransformation.
1	hq-exposure
1	aerosolised
1	ethanol/saline
1	(hq
1	0.04.
1	hq-exposed
1	chlorpromazine
1	(cpz)
1	hq-induced
1	cromoglicate-treated
1	hq-exposure-induced
1	cpz
1	parasympathetic-induced
1	3,4-methylenedioxymethamphetamine
1	(mdma),
1	ecstasy,
1	recreationally,
1	mdma,
1	marrow;
1	(l-selectin).
1	mdma-induced
1	50ppm
1	(1h/day
1	(0.1mg/ml/10min)
1	(fshs)
1	non-allergic
1	leukocyte.
1	vary.
1	ovx)
1	exacerbated.
1	75-day-old
1	blood;
1	mac-1.
1	tlr2/4-deficient
1	tlr2/4
1	traffic-related
1	(dep).
1	(n30);
1	dep:
1	30g
1	dep/10l
1	(n30).
1	instillations
1	[i.p.])
1	exsanguination.
1	mucus/gel-forming
1	(muc5ac)
1	bronchioles
1	muc5ac
1	detectable,
1	ltb4-receptor
1	normoreactive
1	i-i/r,
1	huvecs,
1	lymph-borne
1	egg-albumin
1	(21 days,
1	(1.0 mg/kg)
1	(1.0 mg/kg/day
1	(vmat2)
1	(ti),
1	ti/cell
1	titanium.
1	cellular-derived
1	attachment,
1	weibel-palade
1	breithaupt-faloppa
1	asthmatic.
1	rpmi-1640
1	dissodium
1	cromoglicate
1	blockade),
1	(neuropeptides
1	depletion)
1	(ciclooxigenase
1	hq,
1	oa-aerosolized
1	oa-challenge.
1	oa-specificity
1	cd6
1	cd45r
1	oa-activated
1	oa;
1	ici-182,780.
1	estradiol-to-progesterone
1	premenstrual
1	immunotoxicity.
1	(doses
1	lipopolyssacaride
1	compound)
1	(serotonin),
1	(intranasally,
1	benzoate.
1	(pc100)
1	[l-name])
1	(pentoxifylline
1	[ptx]).
1	reperfusion;
1	il-10;
1	tnf-α-related,
1	lymph,
1	values;
1	(yet
1	permeabilities.
1	intra-pulmonary
1	degranulation;
1	provocation,
1	menses.
1	lavages.
1	(ctmc)
1	(48/80)
1	30-90
1	dt.
1	mmc,
1	ctmc.
1	neuroimmunomodulatory
1	(smgx)
1	equal.
1	135%
1	berberine
1	leukotriene(s),
1	prostanoid(s),
1	activation/degranulation.
1	subcutaneously.
1	escapable
1	(s);
1	footshocks,
1	s;
1	ova-inhalation
1	shocked
1	(uvs)
1	anaphylaxis-induced
1	(scg)
1	aerosolization
1	segments;
1	oa-sensitized
1	(pmnls),
1	(paf)‐mediated
1	dose‐dependently
1	(aps;
1	16–18
1	55,
1	pmnl
1	(ans;
1	anti‐platelet
1	anti‐pmnl
1	61,
1	‐mimetic
1	(u‐44069;
1	paf‐induced
1	(14-16
1	(wnr)
1	wnr
1	wnr,
1	α1-adrenoceptors.
1	wnr.
1	(0.32).
1	genetically-induced
1	tci–tcvi
1	dtu,
1	(nfx)
1	n’-[(5-nitrofuran-2-yl)
1	bzd-
1	nfx-resistant
1	(hierarchical
1	two-to
1	25–30-fold
1	(bsf-38
1	bsf-40)
1	(si′)
1	si′
1	(nfx,
1	16.45;
1	bzd,
1	70-fold
1	(nfx).
1	nifuroxazide
1	lipinski's
1	drug-likeness
1	designing.
1	n′-[(5-nitrofuran-2-yl)
1	(tcii),
1	(tci),
1	(tcv).
1	nfx.
1	ng€2-((5-nitrofuran-2-yl)
1	methylene)biphenyl-4-carbohydrazide
1	(c20),
1	1.81
1	μ4m
1	cl1,
1	topological,
1	steric/geometric,
1	designing,
1	abcg-like
1	bz-resistance
1	reticulation
1	separated.
1	mosaics
1	"two
1	model"
1	blastp
1	abcg
1	bz.
1	40-47%
1	bz,
1	2-2.6-fold
1	(pdc)/indolepyruvate
1	(ipdc)
1	iaa-amide
1	iaa-ester
1	serpens-conditioned
1	bifunctionality
1	opinion
1	standardisation
1	strains/clones
1	drug-discovery
1	landscape.
1	(american
1	65 kda
1	(tsa-1).
1	hla-a
1	interlineage
1	tsa-1.
1	plentiful
1	pyruvate/indolepyruvate
1	(pdc/ipdc)
1	(548
1	indolepyruvate
1	decarboxylases
1	1.4.
1	reoxidise
1	t-dependent,
1	noncognate
1	marcia
1	duranti
1	1161
1	open-reading
1	~94%
1	~69%
1	vl10.
1	stage-regulated
1	re-named
1	i-vi.
1	genealogies.
1	reticulation,
1	species-wide
1	as-sociated
1	negativation
1	alter-native
1	7.6-32
1	3-51.4
1	if).
1	∼3%
1	(cchd)
1	make-up
1	(nd7)
1	(nd4/cr4,
1	coiii
1	coii)
1	clades/haplogroups.
1	(dtu)
1	iib)
1	(dtu
1	iid)
1	ancestrals
1	ef-1α,
1	dhfr-ts
1	hybrid-specif-ic
1	(networks)
1	(bayesian
1	phylogenies)
1	polyphyletic.
1	nd4,
1	nd5
1	nadh-linked
1	fadh2-generating
1	unify
1	i-vi).
1	justification
1	non-syntenic
1	rhs
1	retroelement
1	viper.
1	triatomid
1	glycoinositolphospholipids
1	(gipls)
1	bloodmeal
1	trifluoroacetic
1	β-galactofuranosyl
1	(0.6-3.3
1	mbp).
1	(acsdi).
1	acsdi
1	intra-group
1	form).
1	forms).
1	isolates:
1	tryparedoxin,
1	gp63,
1	cyclophilin,
1	(nd7).
1	222
1	677
1	catenated
1	maxicircle-encoded
1	maxicircles.
1	excepti,
1	intra-strain
1	approximates
1	non-edited
1	236-bp
1	5′-ends
1	nd5,
1	murf2,
1	murf2.
1	westenberger
1	bayboots.
1	misunderstanding
1	incompatible,
1	estimator
1	rubin
1	bootstrap.
1	bayes
1	marker's
1	credibility.
1	check.
1	consistent.
1	http://www.vision.ime.usp.br/~rvencio/bayboots.
1	2190
1	1893
1	(kog).
1	39.6%
1	introgression
1	3,400
1	2,084
1	(99.8%
1	agreement).
1	cardiopathies
1	weekends
1	5,998
1	710
1	(hybrid
1	(68/730)
1	harvests
1	730
1	(1.6-6.5-fold).
1	array-identified
1	(18/730)
1	(65/730)
1	(17-22)
1	mbp.
1	i-stained
1	b11/l1tc
1	(120,000
1	nine-fold
1	12-amino-acid
1	fgqaaagdk
1	immunodominance,
1	lamb.
1	gdkpspfgqaaa-lamb
1	aaagdk-containing
1	iupac-ifcc
1	practitioner,
1	designation
1	(hugo).
1	hugo
1	antonarakis
1	dunnen
1	communication,
1	(npu)
1	<http://www.iupac.org/publications/pac/2004/7609/7609x1799.html>.
1	(chagas
1	pak)
1	(94.8%
1	98.6%.
1	refrigeration
1	(acsdi),
1	acsdi-based
1	(3-18
1	corresponding,
1	(r=0.86062;
1	p<0.0001),
1	non-hybrid
1	195bp
1	cl1.
1	30±10kb.
1	field-gel
1	field-isolated
1	(dm28c
1	x10)
1	esmeraldo).
1	(non-coding)
1	i/t.
1	distinction.
1	pattern;
1	ix
1	iid/iie
1	kinetoplastida
1	diverging
1	serine,
1	heptapeptides
1	lsu)
1	1f8,
1	h49
1	(mix-elisa),
1	617
1	(goiás),
1	99.7
1	98.6
1	894
1	mix-elisa.
1	multiantigen
1	formerly-endemic
1	triatomids.
1	albiventris)
1	(12/21)
1	58.4
1	33.3%.
1	megistus)
1	palm
1	dwellings.
1	reinfestation
1	isoenzymic
1	(zymodeme
1	3-z3)
1	(itss)
1	brethesi
1	z3-a
1	z3-b.
1	clustering.
1	riboclade
1	2,150
1	constancy
1	(37-18
1	cretaceous
1	(144-65
1	mya)
1	cenozoic
1	(65-1.8
1	unrooted
1	wagner
1	complicates
1	rangeli-specific
1	542-bp
1	p542,
1	colombiensis
1	9/12
1	presumed.
1	fix.
1	heltc.
1	heltc
1	(h49,
1	jl7,
1	a13,
1	jl8,
1	1f8)
1	541
1	(argentina,
1	venezuela).
1	coating
1	125i-
1	96.2
1	99.6%.
1	trypanosamiasis
1	triatomines,
1	tamarins,
1	three-toed
1	sloth.
1	(44%
1	30/68)
1	(53%
1	36/68)
1	(2/68)
1	210-
1	originated:
1	265-bp
1	250-bp
1	mini-
1	well-characterised
1	(minas
1	parafba
1	piaui)
1	enzootic,
1	lineage-1
1	schizodeme
1	karyotyping,
1	nontranscribed
1	triatomines)
1	ketoconazole.
1	generations).
1	58±13
1	37°c;
1	zb;
1	(tdr)
1	filaria,
1	publicity,
1	steering
1	disease-endemic
1	efficiency;
1	low-resolution
1	dna-sequence
1	alberto
1	frasch
1	colleagues,
1	initiative.
1	capitalize
1	karyotypes
1	(yacs)
1	2,770
1	(bacs)
1	baci
1	bacii.
1	(bac
1	tandemly-repeated
1	mini-exon.
1	rdna/mini-exon
1	glycoinositolphospholipid
1	(gipl)
1	(phytomonas
1	serpens),
1	anti-tcr;cd3
1	gipls.
1	n-lignoceroyldihydrosphingosine
1	gipl.
1	n-palmitoylsphingosine,
1	n-palmitoyldihydrosphingosine,
1	n-lignoceroyldihydrosphingosine,
1	gipl-derived
1	alkylglycerol
1	8-methoxypsoralen-inactivated
1	trypomastigotes;
1	(galf)
1	micromethod
1	galf-containing
1	co-migrate
1	[3h]-palmitic
1	-galactose
1	-palmitic
1	unisil,
1	(igs)
1	anti-igs
1	30-kb
1	18s,
1	24sβ
1	pseudogene.
1	(c57
1	bl/10j)
1	(lytic
1	antibodies),
1	trypo
1	subjected.
1	80–90‐kda
1	50–60‐kda
1	tissue‐culture
1	cl‐14
1	class)
1	radioimmunoinhibition
1	β‐d‐galactofuranose
1	(1→3)‐α‐d‐mannopyranose
1	[3h]fetuin.
1	[3h]sialoglycolipids
1	[3h]palmitic
1	[3h]sialyl
1	[3h]sialic
1	(c7
1	derivative),
1	gangliosides,
1	(transglycosylase).
1	sonicated
1	(infective)
1	d-(3h)-galactose
1	glycolipids.
1	acid-labeled
1	sialoglycolipids.
1	(3h)-galactose,
1	glycosphingolipids.
1	sphingenine,
1	glycosphingolipid.
1	ganglioside-like
1	chloroform:methanol
1	(2:1)
1	radioactivity,
1	resorcinol-copper
1	1.22.
1	t.cruzi.
1	000,
1	anti-trypomastigote
1	anti-epimastigote
1	effecient
1	caffein
1	0.04-0.15
1	heat-stable,
1	non-dialysable
1	freeze-fracture
1	(atp
1	pyrophosphate-lyase
1	(cyclizing),
1	4.6.1.1)
1	-20°c
1	resisted
1	naf.
1	sigmoid
1	michaelian
1	km=
1	mm..
1	rifampicin.
1	[3h]uridine
1	trna.
1	5.4-6.0,
1	cotranscribed,
1	tunicate,
1	ascidia
1	acetylcholine-like
1	linearity.
1	same;
1	departing
1	mecholyl
1	benzoylcholine.
1	eserine.
1	atropine,
1	methantheline,
1	propantheline,
1	mytolon.
1	succinylcholine
1	preparation;
1	flaxedil
1	quiet
1	succinylcholine,
1	flaxedil,
1	d-tubocurarine,
1	mytolon,
1	acetylcholineceptive,
1	mg·kg−1,
1	iu·kg−1,
1	met,
1	(pgz),
1	sensitizer,
1	(5.0 mg·kg− 1,
1	1.0 ui·kg− 1,
1	12 days,
1	17 g)
1	30 g)
1	oxidase-2
1	(nox2)
1	(nox2-ko)
1	3 weeks at
1	30 mmol/l
1	(g10
1	g30),
1	(grx1-rogfp2),
1	(rogfp1)
1	(rogfp2-orp1),
1	∼1.7-fold
1	nox2-ko
1	20–30 mmol/l
1	grx1-rogfp2
1	nad(p)h,
1	g30,
1	detectably
1	glucotoxic
1	(gdp),
1	(1.5 g/kg,
1	hyperlactatemia
1	(gastrocnemius,
1	extensor)
1	(ins
1	ins+gdp),
1	(atgl
1	lhs)
1	munhoz
1	leucine-and/or
1	(vas2870-20
1	-dpi-5
1	mitosox
1	-0.93).
1	(sucrose
1	l-arginine)
1	(da),
1	p47phoxwith
1	gp91phoxsubunits
1	p47phoxwhile
1	unavailable
1	ubs)
1	(5 %
1	(10 %
1	(cecum
1	28 days
1	insulin/glucose
1	(υ-3),
1	(υ-3).
1	production.conclusions:
1	postweaning.
1	syntaxin-1a,
1	mir-29,
1	hallmarked
1	time-sustained
1	mir-29s
1	(gw9508)
1	(diphenyleneiodonium,
1	(calphostin
1	gw9508
1	gpr40-dependent
1	(5-20
1	hastens
1	glucolipotoxicity,
1	(rage)
1	glycoaldehyde.
1	(codes
1	rage),
1	nfkb1.
1	96h,
1	[hsd;
1	(hsd2)
1	(hsd1)],
1	normal-salt
1	(nsd;
1	1.3%),
1	(lsd;
1	euglycemic-hyperinsulinemic
1	uptake:
1	mg·kg-1·min
1	cholesterol:
1	triacylglycerols:
1	inside,
1	(pmca)
1	(ncx).
1	metabolizable
1	ca2+-channel
1	ca2+-extruding
1	pmca,
1	na/ca
1	inflow.
1	179±19
1	186±18
1	550±17
1	425±13
1	1.1±0.08
1	μu/islet/min.;
1	1.85±-0.2
1	μu/islet/min.).
1	tetradecanoyl
1	[3h][arg8]-vasopressin
1	(k(d))
1	(b(max))
1	[arg8]-vasopressin
1	25-fold.
1	rise.
1	sevenfold,
1	c-depleted
1	tpa.
1	13.3
1	km's
1	mg2+.
1	synarchistic
1	h‐fasted
1	2‐ketoisocaproate.
1	unimpaired
1	glucose‐induced
1	pre‐labelled
1	2‐ketoisocaproate
1	nutrient‐stimulated
1	determinant(s)
1	efflux).
1	polyphosphoinositides
1	(zero
1	[32p]phosphate.
1	inositol,
1	4,5-bisphosphate.
1	diacylglycerol.
1	1,3-bis(2-chloroethyl)-1-nitrosourea
1	(bcnu).
1	nutrient,
1	pancreases.
1	l-leucine.
1	(l-glutamate)
1	(l-leucine)
1	leucine-stimulated
1	pancreases
1	l-asparagine
1	l-glutamate,
1	l-norvaline
1	l-isoleucine,
1	l-lysine.
1	alpha‐ketoisocaproic
1	keto
1	d‐glucose.
1	mannoheptulose,
1	evoked,
1	non‐insulinotropic
1	(8.3‐10.0
1	ionic,
1	lactic,
1	32p,
1	86rb,
1	outflow),
1	phophorylation
1	(hexokinase-like)
1	(glucokinase-like)
1	phosphomannose
1	phosphoglucose
1	reduced86rb
1	affect45ca
1	rate,45ca
1	k+conductance.
1	0-aminoacridine,
1	(5μm),
1	ourflow
1	3.0-4.2
1	32p-orthophosphate.
1	flush.
1	(l-glutamine
1	l-lactate)
1	non-nutrient
1	(arginine,
1	theophylline).
1	bacl2
1	polarisation,
1	(tpa),
1	2.10-9to
1	2.10-7
1	non-tumor-promoting
1	4-methylphorbol-12,13-didecanoate
1	tpa-stimulated
1	d600
1	3’:5’-monophosphate
1	ionophores.
1	downloaded
1	cancerres.aacrjournals.org
1	dibutyryl-cyclic
1	decreased86rb
1	secretagogues.
1	echitrice
1	ponte.
1	extrusion,
1	quinine.
1	86rb.
1	(sie).
1	of86rb
1	acidification)
1	of86rb.
1	inhibited86rb
1	h+generation
1	on86rb
1	tea-sensitive
1	unmasks
1	(7.4)
1	gaz
1	14c-dmo,
1	45calcium
1	40ca45ca
1	na+ca2+
1	sugar-induced
1	nh4
1	summed
1	l-[1-14
1	l-[u-14
1	moles
1	2-ketoisovalerate,
1	mimicks
1	deamidation
1	γ-aminobutyrate
1	deamination,
1	2-keto
1	(pyruvate,
1	(alanine,
1	aspartate).
1	l-[u-14c]glutamine.
1	(drps)
1	pharmacy.
1	(adrs)
1	avoidable
1	harm.
1	prescribing,
1	(pcne)
1	methylphenidate
1	(mpd),
1	(pnd
1	39),
1	(adulthood).
1	sal-
1	neuroadaptation
1	psychostimulants
1	re-administration.
1	femproporex-induced
1	27)
1	60)
1	16))
1	compulsive
1	addiction,
1	pyritinol
1	(pyrithioxine,
1	encephabola,
1	prt)
1	nootropic
1	(vehicle-treated
1	(prt-treated
1	habituation.
1	(16.8
1	(1.75,
1	sch23390
1	pimozide
1	(15.0
1	cocaine-,
1	fencamfamine-,
1	amphetamine-treated
1	(nonsignificant
1	07:00
1	09:00,
1	09:00
1	[3h]-spiroperidol
1	(kd).
1	(amph),
1	(coc),
1	stereotypies
1	behavioral/da
1	psychosis
1	amphetamine-like
1	augmentation,
1	psychosis.
1	3-methoxy-4-hydroxyphenylethyleneglycol
1	(mhpg,
1	norepinephrine)
1	csf,
1	(hrp).
1	12.4
1	ng/hour
1	(ne)-containing
1	lc-neurons.
1	originates,
1	34%.
1	5‐hydroxyindoleacetic
1	(5‐hiaa)
1	(122ng/h)
1	(csf).
1	cerebrally
1	(265.0
1	ng/h)
1	ventricular‐cisternal
1	perfusates.
1	cisternal
1	probenecid.
1	csf.
1	(lumbar-cisternal
1	ventricular-cisternal)
1	μl/min.
1	semi-automated
1	hexachlorophene
1	(hcp).
1	hcp
1	pgk,
1	pk.
1	asp-t
1	ala-t
1	hcp.
1	medical-social
1	fdp.
1	gingipain,
1	par-2.
1	(mp).
1	(rt-qpcr).
1	(par1
1	treatment.material
1	fluid.results:
1	(p < 0.05),
1	(p < 0.05).conclusion:
1	pvat-derived
1	release/generation
1	norephinephrine
1	(o2[rad]−)
1	(metc)
1	o2[rad]−
1	dismutated
1	being.
1	androgen,
1	deleterious.
1	androgens/testosterone
1	(modulatory
1	prooxidative
1	(nadphox)-driven
1	(cox)-dependent
1	(ss,
1	1.25×10-3
1	(nadphox
1	3×10-4
1	n-[2-cyclohexyloxy-4-nitrophenyl]methanesulfonamide
1	(ns398,
1	vcam
1	(vascular
1	adventia,
1	ns398
1	nadphox-
1	cox2-dependent
1	-expressing
1	(sam)
1	(aorta)
1	(mesenteric;
1	ma)
1	seven-month-old
1	sam
1	(samp8)
1	(samr1)
1	western-type
1	(wd;
1	eosin-stained
1	red.
1	immunofluorescence;
1	samr1.
1	samp8
1	wd-induced
1	fat-enriched
1	non-senescent
1	vasculature,
1	periodontitis;
1	(p3).
1	reflective
1	(mmp-2),
1	dentilisin
1	(ozrs)
1	(lzrs)
1	myograph
1	lzrs,
1	ampk/enos
1	lobato
1	ovariectomyzed
1	hyperreactive
1	ne-hyperreactivity
1	peritendinous
1	j)
1	laser-treated
1	elasticity.
1	et-1/et-1
1	(pd98059)
1	pe-
1	mkp1
1	paula
1	(creb).
1	b1r-mediated
1	a2/cox-2-
1	caryocar
1	camb.
1	relaxed,
1	che.
1	guanylatecyclase
1	bf-induced
1	vasorelaxation.
1	tetraethylammonium.
1	denuded-endothelium
1	bf,
1	oxide/cyclic
1	lais
1	transgenerational
1	transgenerationally
1	inc.©
1	soce
1	(store-operated
1	entry)
1	(stromal
1	(stroke-prone
1	(wistar-kyoto)
1	(ovariectomized)
1	influx-induced
1	displayed:
1	stores;
1	orai1,
1	2+-loading
1	orai1.
1	fromovx-shrsp
1	reticulum)-buffering
1	stim1/orai1
1	stim/orai1
1	contender
1	lllt)
1	aimsglycosylation
1	udp-nac
1	(ogt)
1	o-glcnacase
1	(oga).
1	o-glcnacylated
1	resultsincubation
1	st045849
1	(ogt
1	atrasentan
1	(eta
1	(oga
1	y-27632.
1	(mypt-1),
1	inhibitor-17),
1	atrasentan.
1	pdz-rho
1	(guanine
1	p115-rho
1	st045849,
1	atrasentan.conclusionwe
1	cumulative-concentration
1	(ccrc)
1	ccrc
1	(erk)1/2
1	(doca)
1	telemetry,
1	(191±3
1	(172±7
1	(22±3
1	(13±2
1	10±2
1	(15±1
1	11±1
1	pd-98059
1	(14±2
1	(10±2
1	o-glcnac-proteins
1	β-n-acetylglucosaminidase,
1	19±5
1	11±2
1	anti-o-glcnac
1	(3-[2-adamantanylethyl]-
1	2-[{4-chlorophenyl}azamethylene]-4-oxo-1,3-thiazaperhyd
1	roine-6-carboxylic
1	deoxycorticosterone-acetate
1	prepro-et-1,
1	pmol/kg
1	18±2
1	10±3
1	o-(2-acetamido-2-deoxy-d-
1	glucopyranosylidene)
1	amino-n-phenylcarbamate,
1	β-n-acetylglucosaminidase.
1	millimeters
1	mercury)
1	et-1-infused
1	(117±3
1	123±4
1	libitum;
1	(selenium,
1	(o-glcnac)
1	[mn]
1	17.6±4
1	10.7±2
1	(47.6±6%
1	73.2±10%
1	units=3.8±0.3
1	2.3±0.3
1	μmol/l;
1	(18.2±2
1	10.7±3
1	(41.4±6
1	73.2±3
1	(phenylephrine,
1	16.5±3
1	18.6±3
1	n=6;
1	44.7±8
1	47.6±7
1	n=6).
1	ser-473(p<0.05)
1	o-glcnac-modified
1	glutamine:fructose-
1	amidotransferase,
1	o-glcnacase,
1	o-glcnacylation,
1	n-acetylglucosaminylation
1	o-glcnacylated,
1	(pyk2),
1	nonreceptor
1	pyk2.
1	(uni)
1	uni,
1	phospho-pyk2tyr402,
1	paxillin,
1	phospho-paxillintyr118
1	paxillin.
1	chlorpropamide-lowered
1	(200mg/kg,
1	15d,
1	homa-β),
1	normotension
1	14 mg/kg
1	rollers
1	l-selectin.
1	glicosuria,
1	n-szt
1	(endothelins)
1	21-amino-acid
1	(et-1,
1	et-3)
1	31-amino-acid
1	eces
1	(et-converting
1	enzymes).
1	sex-associated
1	hypotonic-
1	hyporesponsive
1	21,064
1	(20,925
1	solicited
1	hypotonic-hyporesponsive
1	episodeswas
1	1/1,744
1	1/1,495
1	1/5,231
1	precautions
1	contraindications.
1	(n-stz)-induced
1	(2-d-old)
1	microfluorography,
1	unanaesthetized
1	(unanaesthetized
1	animals),
1	na-mediated
1	potentiation.
1	(tetraethylammonium),
1	(indomethacin).
1	na+-,k+-atpase
1	ouabain)
1	cyclooxygenease
1	renin-dependent
1	(2k-1c),
1	cardiac-
1	aortic)
1	2k-1c,
1	angiotensins,
1	[ang-(1-7)],
1	je
1	049
1	(aprotinin,
1	sbti,
1	pksi
1	pmsf).
1	(adipokines)
1	adipocite
1	adyponectin,
1	adypokine
1	ii-contraction
1	(10.6
1	(5.8
1	(16.5
1	mol/l*)
1	mol/l*).
1	g*)
1	venoconstriction.
1	compromised,
1	(vwbc),
1	(vrbc).
1	cd11/18
1	molecule-1,
1	vwbc/vrbcratio
1	[ang-(1-7)]/bradykinin
1	ng)-induced
1	(2.2
1	[a-779
1	μg)]
1	krebs,
1	pgi
1	(non-related
1	overdistention
1	(5.45
1	μmol/day,
1	histomorphometry.
1	sacrifice.
1	2.44
1	23.1
1	neointima/media
1	(1.38
1	0.67,
1	0.07)
1	(ace1)
1	a-779.
1	intra-arterially.
1	ang-(1-7)-related
1	ace1
1	rollers,
1	rollers.
1	molecule-1.
1	post-leukotriene
1	cd11/cd18
1	leukoeytes.
1	microfluorography.
1	hydroethitine
1	(30.9±2.4%)
1	(12.3±2.5%;
1	(nad(p)h-oxidase
1	[angiotensin-ii
1	(at-1)
1	overexpression/activity
1	at-1-dependent
1	(oe).
1	e),
1	leuprolide
1	prostaglandin-h
1	(pghs)
1	oe,
1	pghs-derived
1	pghs-1
1	lh/
1	hypoestrogenism
1	emphasized,
1	physiopatologic
1	henseleit
1	5.5mm
1	(pgf2α)
1	txb2)
1	6-keto-pgf1α)
1	potentiation,
1	(tea))
1	n-ω-nitro-l-arginine-methyl-esther
1	(l-name))
1	adulthood)
1	(e/p).
1	nonfluorescent
1	(eb).
1	eb,
1	eb-positive
1	(28.4±4.3)
1	(14.2±3.9;
1	(15.7±2.2)
1	e/p
1	(14.8±0.8).
1	mannitol,
1	decomposes
1	xanthine-oxidase
1	l-[h3]arginine
1	l-[h3]citrulline.
1	0.38±0.14
1	1.06±0.11
1	0.54±0.08
1	0.80±0.10
1	(rod)
1	7.04±1.20
1	4.17±1.10
1	2.55±0.11
1	1.91±0.18
1	uninephrectomized,
1	mg/kg/week)
1	nacl/0.2%
1	irl-1620,
1	endothelin-b-
1	(et(b))
1	endothelium-denuded,
1	endothelium-intact,
1	ec20)
1	bosentan,
1	et(a)/et(b)-receptor
1	et(b)-receptors.
1	pmol)-induced
1	pmols.
1	l-nitroarginine
1	esther,
1	bk-
1	ang-(1-7)-induced
1	cyclooxygenase-related
1	(edrfs),
1	(edcfs)
1	(oe)
1	+progesterone.
1	(indo,
1	(dic,
1	(rid,
1	(daz,
1	oe-shr.
1	dic,
1	rid,
1	daz
1	reactivities.
1	pgf(2α),
1	6-keto-pgf(1α),
1	oe-shr
1	/pgf(2α)
1	(nr)
1	(2ml/min)
1	(table).
1	(cycloxygenase
1	(o-2scavenger),
1	(txa2/pgh2antagonist).
1	etya
1	aa861
1	superoxideanion
1	c4or
1	d4,
1	table:
1	(10x106cells)
1	79.3±4.8.
1	+l-name
1	45.4±4.3*
1	-28.1±6.2*
1	87.5±5.3
1	31.3±3.7*
1	-32.9±9.2*
1	•(
1	oxide;
1	overestimated.
1	3.8±0.7
1	(28.7
1	±12%.
1	infusions,
1	trapα-phenyl-n-tert-butylnitrone
1	(n=22).
1	n-methyl-d-arginine,
1	endo-thelial
1	(ec50s)
1	inhibitor/thromboxane
1	a2-prostaglandin
1	dazoxiben,
1	ridogrel.
1	α-phenyl-n-tert-butylnitrone
1	(pbn,
1	(epr).
1	pbn
1	3.2±0.9
1	4.1±0.7
1	7.0±1.5
1	(p<.005)
1	3.6±1.6
1	3.8±1.4
1	2.2±0.8
1	(p=ns).
1	endothelialized
1	flow-induced
1	(30.2±0.7
1	peak-induced
1	extracorporeal
1	114±8%
1	5.4±0.7
1	(n=31,
1	p<.001);
1	30-second
1	(p<.05,
1	n=4
1	(aascorbyl=0.02±1.6
1	p=ns);
1	60-second
1	tubing
1	sec;
1	3-[(3-cholamidopropyl)dimethylammonio]-1-propane
1	(chaps)
1	sex-linked
1	inhibitors;
1	m)-treated
1	noradrena-line,
1	rubbed
1	vasodilator).
1	agent),
1	(edrf).
1	ni-
1	troprusside,
1	nitroprus-
1	shr-precontracted
1	gower
1	vasolidation,
1	polyether
1	[3h]norepinephrine
1	([3h]ne)
1	strontium
1	barium
1	[3h]ne
1	reserpinized
1	multiphase
1	pla2-neurotoxins.
1	debris,
1	mitophagy-like
1	mlx-9,
1	(three-dimensional
1	(an,
1	bi-dimensional
1	splitting,
1	niche)
1	nestin,
1	sox1,
1	iii-tubulin,
1	tau,
1	splitting.
1	(ndel1),
1	an,
1	nonrosette
1	ndel1
1	fast-twitching
1	hypothetically,
1	(extensor
1	(edl))
1	(nav1.1-nav1.6
1	α-subunits)
1	muscle-selective
1	μ-cgtx-giiia,
1	sodium-acting
1	β-pompilidotoxins,
1	bciii,
1	tx2-6.
1	nav1.1
1	nav1.6
1	antigens),
1	vir-tags
1	first-infected
1	(aps)
1	repolarizing
1	'fast'
1	(2.2×0.3
1	v/s),
1	co2+,
1	omitting
1	myocytes:
1	a-type
1	rectifier
1	4-ap
1	repolarization.
1	conus
1	agelenopsis
1	aperta
1	osmoconforming
1	mollusc;
1	(rvd)
1	rvd
1	range)
1	rvd,
1	furosemide‐sensitive
1	na‐2cl‐k
1	cotransporter.
1	cytochalasins,
1	patches,
1	cytochalasins
1	chaetoglobosin
1	depolymerize
1	polymerizing
1	phalloidin,
1	bredemeyera
1	floribunda
1	willd.
1	diuretic,
1	nephrolithiasis
1	calculi).
1	diuretic.
1	110-220
1	(3-isobutyl-1-
1	methylxanthine),
1	3-isobutyl-1-methylxanthine.
1	n(g),2'-o-dibutyryladenosine
1	3',5'-cyclic
1	(dibutyryl-camp,
1	0.4-0.8
1	(p(o))
1	ccd
1	[sum
1	(np(o))
1	0.04].
1	cyclooxygenase),
1	lipoxygenase),
1	clotrimazole
1	epoxygenase)
1	(k(i))
1	seawater,
1	osphradial
1	r15
1	(95-80%)
1	r15;
1	r15,
1	so42-,
1	isethionate,
1	negligibly
1	insignificant,
1	insignificant.
1	(4-acetamido-4′-isothiocyano-2,2′
1	disulphonic
1	stilbene)
1	instantaneously.
1	single-barreled
1	corning
1	477913
1	kcl-filled
1	vm.
1	13.1
1	sd±4.5
1	(n=96).
1	90-103
1	-71.2
1	sd±4.9
1	mmol·l-1.
1	deduce
1	paracellular.
1	(n=53)
1	(n=118)
1	26±1
1	ctal
1	-2cl
1	-carrier
1	furosemide.
1	ieee.
1	collaboration.
1	(atr-ftir)
1	3,7,
1	nicolet
1	6700
1	atr.
1	discrimination,
1	among,
1	(1628
1	(1514
1	spectrum.
1	c=o
1	(70-80%)
1	n-h
1	(40-60%)
1	c-n
1	(18-40%).
1	cepid/fapesp
1	05/51689-2,
1	capes/procad
1	88881.
1	improved-insulin
1	(uoc)-treated
1	biochemical/metabolic
1	uoc
1	reduction;
1	(slc2a4);
1	(histomorphometrical
1	slc2a4/glut4;
1	micro-autoradiography
1	(rmar)
1	tritiated-
1	(3h-)
1	pulse)
1	dolichus
1	(dba)
1	(unk)
1	oscillated
1	pericytes
1	autonomously
1	modalities:
1	(oct),
1	(shg),
1	debridement,
1	burn.
1	concludes
1	ultra-short
1	skinburns,
1	operatory
1	embryo-implantation
1	fibril-forming
1	alloxaninduced
1	immunohistochemistry/immunofluorescence.
1	(eml)
1	(iml).
1	embryopathies.
1	90-110
1	50-70d
1	(progression
1	tro-phoblast
1	under-elucidated.
1	methacarn
1	(p-ser727)
1	mesome-trial
1	deciduas,
1	immunoreactiv-ity
1	p-ser727
1	trophoblasts,
1	spongiotro-phoblast
1	san
1	martin
1	scaffold.
1	scaffolds:
1	fibrin-agarose.
1	stromas
1	fibrin-agarose
1	scaffolds.
1	substitutes
1	biomaterial
1	h&e
1	spheroidal
1	retina).
1	postcoitum.
1	leucine-rich-proteoglycans
1	prepares
1	tissues.methods:
1	medroxiprogesterone
1	slrps,
1	tissues.results:
1	deposition.conclusions:
1	compartment-related.
1	(shg)
1	(tpefm).
1	turbid
1	modelocked
1	(spectra
1	physics)
1	fluoview
1	300),
1	ix81),
1	(40x,
1	1.30).
1	vapour
1	cryosectioned
1	?m
1	wavelength.
1	out-of-plane
1	photobleaching
1	phototoxicity.
1	(tpefm)
1	(shg).
1	osa/laop
1	alloxan);
1	alloxan).
1	contrarily,
1	myofilaments.
1	time-sensitive
1	(weakly
1	hypodermis
1	alexa488-labeled
1	jararhagin).
1	opposition,
1	collagens,
1	non-hemorrhagic
1	baldo
1	(dcn+/+)
1	decorin-deficient
1	(dcn-/-)
1	time-pregnant
1	contours
1	dcn+/+
1	hyaluronan-binding
1	17beta-estradiol
1	metaestrus,
1	e2+mpa
1	mpa-treated
1	v0,
1	cycle-stage
1	methodof
1	spongiotrophoblast,
1	chronology
1	reception
1	stage-dependent
1	diestrous,
1	fixation.
1	materno-fetal
1	anchorage.
1	(dprp)
1	decidualcells
1	(gdcs).
1	dprp.
1	gdcs
1	photobiological
1	8th,
1	22nd
1	irradiated-lesions
1	reepithelization
1	phagosomes.
1	irradiated-lesions,
1	irradiated-dermis
1	mammal's
1	crypt,
1	fibrilogenesis
1	morphodynamic
1	primordium
1	primordium;
1	nephric
1	fullthickness
1	l⊥
1	redifferentiates
1	baskets
1	(digoxin
1	digitoxin)
1	gynecomastia
1	trophism
1	users,
1	oophorectomized
1	extirpated.
1	(digoxin,
1	estradiol)
1	medication,
1	hysterectomized
1	wombs
1	laminae.
1	pre-implantation,
1	ridge,
1	displacement.
1	space-time
1	fifth,
1	methacarn,
1	paraplast
1	5-μm
1	3h-estradiol-17β
1	er-α.
1	1.5-7.5
1	er-α
1	3h-thymidine.
1	region-
1	time-specific
1	large-diameter
1	thin.
1	utilising
1	glycosaminoglycans.
1	homotrimeric
1	[α1(v)]3,
1	(rht)
1	hyaluronate
1	rht-positive
1	redifferentiate
1	30μl
1	pseudopregnancy,
1	endometrium;
1	(pas).
1	prolactin-stained
1	(granulated
1	(lilt)
1	n2on
1	0277-786x/01/$15.00.
1	abc,
1	f2-rods)
1	f2-rods.
1	f2-rods
1	f2-rods,
1	l-iduronic
1	d-glucuronic
1	multinucleation,
1	grow,
1	radiate
1	spatial-temporal
1	(rht).
1	rht.
1	(9-day-old
1	embryos)
1	pgcs,
1	797
1	aredifferentiation
1	(decidualization),
1	(nonpregnant
1	non-fibrillar
1	safranin
1	endometria,
1	endometria.
1	(pgcs),
1	salpingectomy
1	tubal
1	ultracytochemical
1	(gags)
1	processes;
1	hurdle
1	leistner
1	(1,2).
1	physico-chemical,
1	charquis.
1	he-
1	(λ=
1	i=
1	mw/cm2)
1	nitrogen:
1	s-polarized
1	twenty-
1	pseudo
1	0.70-0.75.
1	jerked
1	(jb)
1	shrinking
1	a-bands
1	m-line
1	fragmented.
1	salting
1	intermyofibrillar
1	3h-amino
1	radioautography
1	radioautograms
1	involuting
1	(predecidual)
1	desmosome-like.
1	desmoplakins
1	embryo‐implantation
1	lining,
1	detach
1	spindle‐shaped
1	breaching
1	macromolecules,
1	antimesometrially
1	mesometrially,
1	hormonally‐prepared
1	platelet‐activating
1	(tgf)
1	luteotropic
1	desmin,
1	radioautographic
1	disarranged
1	labeled,
1	39.18
1	20–80).
1	45.32
1	(30–170),
1	89.39
1	(30–270),
1	125.88
1	(20–370),
1	of<sup>3</sup>h-proline.
1	3h-proline.
1	lining-layer
1	10-,
1	30-,
1	[3h]-thymidine.
1	radioautographs
1	pulse-labelled
1	extraneous
1	corroboration
1	radioautography,
1	81'
1	81μ2of
1	was3h
1	uridine.
1	references.)
1	longer-term
1	4-weeks
1	(62,5
1	ml/day
1	o.)
1	cannulas)
1	artery/vein.
1	(nw-propyl-l-arginine,
1	perfusion/harvesting
1	supplemented)
1	cannulation,
1	blocked/attenuated
1	nitirite
1	(ascending
1	noradrenergic/descending
1	oxytocinergic;
1	otergic)
1	(dbh)+
1	(ot)+
1	(immunofluorescence + confocal
1	interval)
1	brainstem-pvn
1	buttler,
1	jordão,
1	fragas,
1	ruggeri,
1	ceroni
1	(fitc,
1	(t8).
1	cannula)
1	(iba1
1	early-activated
1	lucchetti,
1	ataides
1	lovo-martins,
1	tatakihara,
1	michelini,
1	pinge-filho
1	(tc,
1	(si,
1	(ti,
1	(699.73
1	42.37
1	742.11
1	25.35
1	(20.73
1	2.74
1	6.51
1	(il-12,
1	ifn-γ,)
1	cellular/molecular
1	pathways/mechanisms
1	etiologies,
1	morbimortality.
1	hf-related
1	(chat)-positive
1	avoided,
1	β-hydroxylase-positive
1	sympathoexcitation,
1	haemodynamic,
1	(choline
1	chatir;
1	β-hydroxylase,
1	dbhir)
1	(dmv),
1	hf-sed
1	sham-sed
1	(ihr),
1	dmv/na,
1	dbhir.
1	dmv
1	dmv.
1	neurone
1	saldanha,
1	lira,
1	santana-filho
1	outflows
1	masson,
1	barna,
1	pinge-filho,
1	arterial/venous
1	(loading/unloading
1	baroreceptors)
1	(immunohistochemistry)
1	(nitrite
1	9%),
1	-4.41
1	sed:
1	-2.42
1	b/min/mmhg),
1	carboxy-ptio
1	scavenger),
1	nw-propyl-l-arginine
1	inhibitors).
1	tr,
1	(-29
1	-9%,
1	(-63%
1	sed).
1	no-donor,
1	time-controls.
1	vs.wky-s
1	heart/vessels
1	(t4).
1	t12
1	nts)
1	wky-t,
1	(t2-t12)
1	t8
1	(hmgb1)
1	(arterial
1	freely-moving
1	hmgb1.
1	hmgb1,
1	p42/44
1	iκb-α.
1	hmgb1/cxcr4/microglia/proinflammatory
1	"wired"
1	"nonwired"
1	challenge/stress
1	(weeks
1	blotting).
1	angiotensins’
1	ii/ang
1	(~5-fold
1	aorta).
1	(1st–12th
1	week),
1	axis;
1	(36%,
1	t4-t8)
1	proportional,
1	vasoconstriction/vasodilatation
1	10mg/kg),
1	4-pba
1	(4-pba)
1	ib1a,
1	grp78in
1	witnessed
1	neuroregulatory
1	articulate
1	baroreflex,
1	metaboreflex,
1	(feedback
1	ergoreceptors
1	muscles).
1	metaboreflex-
1	pbs)
1	paraformaldehyde)
1	(wistar,
1	-8%;
1	-10%),
1	(-8%).
1	(twofold
1	shrs)
1	immunoractivity
1	(pvn-nts
1	afterpotentials.
1	(morphometric/stereological
1	evaluations)
1	(marked
1	elastin/collagen
1	collagen/connective
1	comparisons).
1	rupture/duplication
1	pulsatility,
1	traininginduced
1	(sad;
1	94:
1	630-640;
1	1103-1113,
1	2009).
1	anesthetized.
1	sliced
1	(2.6-fold
1	modifiable
1	cannulae).
1	vehicle)-1).
1	-11%)
1	(+31
1	+12
1	(-46%
1	(+2.5-fold
1	+15%
1	hypertension-
1	(peptide/receptor
1	(rest
1	during/after
1	(conveyed
1	co-ordinate
1	feedforward
1	nts-pvn
1	(wky).
1	[+3.4-fold
1	+70%,
1	wkys,
1	0.05].
1	(∼9%
1	(-8%
1	shr),
1	(-35%)
1	[aogen]
1	[at1a]
1	(177±2
1	357±12
1	121±1
1	320±9
1	wkys;
1	(-6.3%)
1	(versus
1	wkys)
1	+67%
1	+41%
1	aogen,
1	(y=5.95x
1	+41;
1	r=0.55;
1	(vpergic
1	otergic,
1	(dbs)
1	reflex-
1	dbs.
1	(nts/dorsal
1	vagus)
1	suprabulbar
1	(ot)ergic
1	(ext).
1	cardiovascular-related
1	(dvc)
1	(pvn-dvc)
1	[wistar-kyoto
1	(wky)]
1	[spontaneously
1	(shr)]
1	(dbhir)
1	(160%).
1	pvn-dvc
1	(130%),
1	wright
1	iowa.
1	community;
1	curriculum.
1	2-wk
1	topics,
1	aspirations.
1	appreciation
1	careers.
1	(nts)-projecting
1	(mncs),
1	(pvn-nts)
1	potentials,
1	frequency/current
1	frequency/time
1	relationships).
1	afterpotentials
1	(haps)
1	afterhyperpolarizing
1	(ahps),
1	spikes,
1	son/pvn
1	stem,
1	[dbs]).
1	normotensive,
1	(polyclonal
1	anti-ot)
1	probes).
1	(-10%,
1	(+3.5-fold),
1	(-39%
1	-56%,
1	(+78%
1	+45%,
1	cardiovascular-induced
1	at1a,
1	system-controlling
1	solitarii,
1	(142±4
1	146±2
1	autonomic/baroreflex
1	(otko
1	(102
1	(atenolol
1	atropine).
1	(+77
1	(-13.1
1	beats·min-1·mmhg-1,
1	maintenance;
1	reflex;
1	training-induced,
1	locomotor/nonlocomotor
1	nonmuscular
1	weeks);
1	(arterioles,
1	venules)
1	<30
1	(≈30%)
1	(soleus,
1	(≈2-fold)
1	growth/proliferation
1	(skeletal
1	(ventilatory
1	adjustments),
1	[nucleus
1	(nts)/dorsal
1	(dmv)]
1	(otant)
1	ot-immunoreactive
1	-56
1	-75
1	beats/min),
1	-5.68
1	-2.83
1	beats·min-1·mmhg-1).
1	atenolol-treated
1	atropine-treated
1	slowdown
1	d.wk-1for
1	(trained).
1	[3h]vasopressin
1	or3hp-aminoclonidine.
1	(ic50and
1	α2-adrenoceptors,
1	dorsal/ventral
1	nts/dmv)
1	nts/dmv,
1	autoregressive
1	baroreceptors.
1	(similar
1	(1.19+/-0.06
1	33+/-6%)
1	(0,42+/-0.03
1	54+/-6%),
1	low-frequency-to-high-frequency
1	at(1)
1	unloading.
1	(dufloth
1	273:
1	r1271-r1282,
1	(nts)-dorsal
1	(nts/dmv)
1	(0.4-1.4
1	km/h)
1	(saline),
1	(ot;
1	(ot(ant);
1	(4.5-
1	(2.7-fold)
1	(3.4-fold)
1	ot(ant)
1	26%)
1	(hypertension
1	1992;
1	19[suppl
1	ii]:ii-
1	198-ii-201
1	.)
1	1995;269:h812-h818).
1	(conscious
1	(3,30
1	0.37%/mm
1	losartan-
1	.33%/mm
1	sham-
1	baroceptor
1	±5
1	©1997
1	(avp(ant))
1	cannulas.
1	kin/h)
1	avp(ant)
1	35-46
1	v1antagonist
1	d(ch2)5tyr
1	meavp
1	23-34
1	13-19
1	beats/rain
1	10.43
1	2.78
1	weight-1).
1	(resting
1	2-mm
1	probe)
1	instantaneous
1	instantaneously
1	12.03
1	25.55
1	3.89
1	38.43
1	1.92
1	flowmetry
1	(ch),
1	coarctation.
1	nonsignificant
1	(-37
1	-29
1	captopril-
1	+79
1	pra
1	intracerebroventricularlly
1	neuroaxis
1	displacing
1	(bolus
1	0.2–25.6
1	(∼39%
1	112±3
1	(333±4
1	(264
1	±7
1	(418±14
1	−1.89±0.20
1	(−51%
1	−56%
1	(75%,
1	78%,
1	−3.92±0.42
1	developing.
1	cannulation
1	(0.2–25.6
1	(1–2
1	ng/kg/min).
1	intercept
1	δhr
1	δmap
1	−1.55±0.13
1	−14±5
1	intravenously,
1	(−2.29±0.91
1	(0.25-8
1	μ-g/kg)
1	(0.5-16
1	microinjected,
1	ng-0.2
1	d(ch<inf>2</inf>)<inf>5</inf>tyr(me)avp
1	μg-0.2
1	monitor,
1	(6.552
1	0.142
1	(7-fold
1	0.128
1	dyn/cm2,
1	(94.8%)
1	dilation.
1	[d(ch2)5
1	tyr(me)
1	morphine/chloralose-anesthetized
1	(va),
1	[d(ch2)5iyr(me)
1	ng/kg/mih)
1	magna;
1	(ncr)
1	one-kidney,
1	(rhr)
1	radius/thickness
1	rhr,
1	–40
1	+40
1	ncr
1	(142%)
1	caliber.
1	tgckbr57
1	cuts:
1	(longissimus),
1	coppa
1	(longissimus,
1	spinalis
1	dorsi,
1	rhomboideus),
1	tenderloin
1	(psoas
1	major),
1	(biceps
1	(semimembranosus),
1	(gluteus
1	medius).
1	coppa,
1	retina),
1	scholarship
1	funder
1	fapesp:
1	03193-8.
1	rioja-lang,
1	brown,
1	brockhoff
1	faucitano.
1	apicomplexa);
1	homeothermic
1	neural,
1	complicated.
1	researchers.
1	(farm
1	horses).
1	(947
1	horses),
1	1244
1	(10.3%)
1	seventy-three
1	(5.62%)
1	(farm,
1	carthorse)
1	(13.5%)
1	(5.0%)
1	chiebao,
1	pena,
1	passarelli,
1	santín,
1	pulz,
1	strefezzi,
1	sevá,
1	grisi
1	gennari
1	miscarriages
1	transmission-related
1	gondii-seronegative
1	tgcatbr71
1	withtgcatbr60
1	genotype).
1	chronification
1	impregnated.
1	theg1
1	withtgcatbr60briii
1	withtgcatbr71
1	occurred;
1	lamb
1	mummified
1	g2-briiixbri
1	31.6%
1	(6/19).
1	g2-briiixbri,
1	tracked
1	breeders.
1	contemplating
1	argentinian
1	patagonia,
1	born,
1	rescued.
1	2012–2015
1	(ipram)
1	cariacica,
1	espirito
1	sarcocystids-directed
1	stocked
1	sarcocystis-specific
1	falcatula/sarcocystis
1	neurona-
1	sag3
1	sag4).
1	(3.0%)
1	falcatula
1	falcatula-related
1	didephid
1	falcatula,
1	(npsc),
1	piauí
1	petrolina
1	pernambuco.
1	(4/75)
1	(2/60)
1	npsc
1	(0/17)
1	thrichomys
1	laurentius
1	npsc)
1	petrolina).
1	2012–2013,
1	domestica),
1	cricetidae
1	caviomorpha
1	(thrichomys
1	apereoides)
1	(euphractus
1	sexcinctus).
1	mimon
1	armadillos.
1	6/28
1	amblyommatis.
1	mimon)
1	amblyommatis
1	apereoides,
1	bradyzoites,
1	(13/40)
1	tghorsebrrs1,
1	#228
1	captive,
1	(tgbutstbrpe1)
1	(butorides
1	striata)
1	5’3’sag2,
1	otter
1	(lontra
1	longicaudis)
1	(ps-tglonlobrpe1)
1	heron,
1	otter.
1	(wlp)
1	wlps
1	(pecari
1	(ib)
1	conjugate,
1	83.3%,
1	0.904
1	0.717
1	1.0)
1	0.095.
1	pecari,
1	≥5)
1	(tgckbrsc1-4)
1	(toxodb-rflp
1	#26
1	#53
1	#278
1	new),
1	keys.
1	(taxonomic
1	habitat)
1	1256
1	(319
1	937
1	reptiles),
1	parasitized,
1	(6.6%
1	amphibians).
1	dissimile.
1	major:
1	(36.9%).
1	ensconced
1	510,000
1	buffaloes.
1	bubaline
1	ectoparasitic
1	infestation.
1	621
1	(115/621)
1	(49/621)
1	stricto),
1	(72/621)
1	haematopinus
1	tuberculatus
1	lice.
1	(31/60)
1	(11.5%
1	15.4%
1	lice)
1	lice,
1	floodplains
1	lice).
1	floodplain
1	serovars)
1	abortus.
1	(7.8%)
1	agoutis
1	aguti),
1	0.046).
1	(54.5%)
1	icterohaemorraghiae
1	paca.
1	muriqui
1	(brachyteles
1	arachnoides)
1	#21
1	5′3′
1	(tgovbrrs4),
1	(tgovbrrs2
1	tgovbrrs3)
1	toxodb-rflp#270
1	#271
1	(tgovbrrs1
1	tgovbrrs5,
1	(nc-sp1
1	bird)
1	weekly,
1	seroconvert,
1	1-week-old
1	ncwtdmn1
1	(52.2%)
1	(p =.023)
1	(p =.004).
1	habitats;
1	bushmeat);
1	illegal
1	trade.
1	blonde
1	flavius)
1	hemoparasites.
1	microfilariae
1	anaplasma,
1	ehrlichia,
1	wolbachia)
1	borrelia.
1	sloth
1	(bradypus
1	tridactylus),
1	metazoarians
1	filarids)
1	(tub2,
1	w35,
1	tgma,
1	b18,
1	b17,
1	m33,
1	iv.1,
1	x1.1,
1	m48,
1	m102,
1	n60,
1	n82,
1	n61,
1	n83).
1	tub2
1	diagnose,
1	(heart,
1	1:64.
1	(15/120)
1	2048.
1	non-mixed
1	cytauxzoon)
1	cervi
1	nine-banded-armadillos
1	pacas
1	marsupialis)
1	caimani)
1	spectacled
1	crocodilus),
1	mud
1	(kinosternon
1	scorpioides)
1	(n=1200)
1	titer.
1	farmers.
1	qui-square
1	(p≤0,05).
1	39.83%
1	(478/1200).
1	55.88%
1	(380/680)
1	88.24%
1	(30/34)
1	21.42%
1	(60/280)
1	(6/14)
1	15.83%
1	(38/240)
1	41.67%
1	(5/12)
1	backwoods
1	(n=459),
1	96.02%
1	(459/478)
1	(1/478).
1	or=4.64,
1	ci95%=3.36-6.41);
1	standing
1	(p=0.000
1	or=2.03,
1	ci95%=1.41-2.92),
1	or=2.71,
1	ci95%=2.08-3.53),
1	or=3.14,
1	ci95%=2.45-4.02),
1	or=2.74,
1	ci95%=1.73-433),
1	or=3.45,
1	ci95%=2.44-4.87)
1	or=4.99,
1	ci95%=3.15-7.92)
1	(p=0.002,
1	or=1.74,
1	ci95%=1.22-2.49)
1	sergipe.
1	(esperança,
1	olho
1	d’água,
1	malta,
1	patos)
1	(#273,
1	#274,
1	#277)
1	(14/29)
1	1990’s
1	storms
1	15.2%.
1	(tgcatbrfn1),
1	(tgratnobrfn1
1	tgratnobrfn2)
1	(tgratrabrfn1).
1	(nc-sp1),
1	genbank®.
1	vermicidal
1	prescriptions
1	coproparasitological
1	hazards.
1	panniculitis
1	deworming
1	endoparasites
1	hovet-usp.
1	paulicéia,
1	-sarcocystis
1	(23.8%).
1	(21.3%)
1	(6.4%).
1	paulicéia
1	(coragyps
1	atratus),
1	(mat;
1	(13.2%),
1	mummification,
1	(eastern,
1	semi-arid,
1	backlands)
1	mesoregions:
1	backlands,
1	(990
1	males).
1	(45.3%,
1	breeding/rebreeding/fattening
1	3.03;
1	1.97-4.68).
1	1.60;
1	1.26-2.03),
1	1.87;
1	1.45-2.41)
1	1.46;
1	1.13-1.88).
1	(resex)
1	phyllostomidae)
1	cryopreserve
1	success).
1	resex
1	northeastern,
1	central-western,
1	tocantins
1	urubu
1	(dpp®)
1	(8.6%)
1	(0.6%)
1	dpp®
1	(6.1%)
1	(1.2%)
1	mammal.
1	oocysts.in
1	paraguayan
1	(74.5%)
1	ininstitutions
1	(54.3%)
1	ofabortion
1	(felv).
1	silvestris
1	lymphadenomegaly
1	bronchopneumonia
1	anti-felv
1	rep-529.
1	toxodb-pcr-rflp
1	#10,
1	amazonia).
1	furipteridae,
1	mormoopidae,
1	natalidae,
1	phyllostomidae
1	vespertilionidae)
1	5,7%.
1	(tci
1	lineage),
1	parnellii.
1	​​
1	(uhe
1	monte)
1	amazon/brazil
1	businesses,
1	unclassified
1	(scnp),
1	(19/376)
1	(9/376);
1	(34/332)
1	(47/332);
1	(25/127)
1	(5/127)
1	(9/35)
1	(5/35),
1	(female)
1	year)
1	significative
1	abrolhos
1	nautical
1	kilometers
1	government.
1	seabird's
1	bárbara
1	redonda,
1	abrolhos's
1	point)
1	(34.8%)
1	34.8%
1	(8/23),
1	47.4%
1	(9/19),
1	(7/25)
1	suliformes
1	phaethontiformes.
1	clinicopathological,
1	apathy
1	dyspnea.
1	bronchointerstitial
1	reddened,
1	friable
1	whitish
1	subpleural
1	0.5–1.0 cm.
1	histiocytes
1	155-bp
1	them)
1	71·3%
1	4096.
1	pcr-rflp,
1	tgchbrud1and
1	tgchbrud2,
1	tgchbrud2
1	monospecific,
1	bioassaying
1	25.0%
1	(15/60).
1	tgckbrma1
1	manatus
1	manatus)
1	1:25,
1	1:500,
1	end-titrated
1	dilutions;
1	(10.9%)
1	1:51,200
1	manatee.
1	northward
1	(rcs)
1	(≤4
1	(≥4
1	sexed
1	identified),
1	penguins:
1	27.8%
1	magellanicus.
1	rhoptry-secreted
1	pseudokinases
1	(rop)
1	rop
1	rop18,
1	rop5,
1	rop16
1	rop17
1	american/european
1	south/central
1	clade-specific
1	haploblocks
1	haploblocks,
1	502
1	tests).
1	3,099
1	school.
1	dogs’
1	anthelmintics,
1	(102/635)
1	(7.1%)
1	(male)
1	canis;
1	coati
1	anthropized
1	70.70%
1	3200.
1	córrego
1	pastures.
1	1:50).
1	(47.05%)
1	(11.76%)
1	substantial.
1	opossums:
1	aurita
1	256)
1	87)
1	(mat-toto;
1	(ifat;
1	(mat-lepto;
1	22.7%,
1	serogroups-serovars
1	mat-lepto
1	autumnalis-butembo;
1	mini-mini;
1	ballum-castellonis;
1	icterohaemorrhagiae-icterohaemorrhagiae;
1	icterohaemorrhagiae-copenhageni
1	grippotyphosa-grippotyphosa
1	bananal.
1	conducted,
1	scrofa)
1	nhecolândia
1	10.8%,
1	four.
1	0.017).
1	1:40.
1	≥50)
1	≥50).
1	(value
1	kappa=0.051).
1	dryland
1	streets
1	x2
1	61.6%,
1	8.1%
1	0.041)
1	0.0006).
1	0.018)
1	32,768;
1	800;
1	geographic,
1	peculiarities.
1	felis-like
1	guttulus).
1	cats;
1	yagouaroundi,
1	guttulus,
1	colocolo.
1	identiy
1	(97-99%)
1	inhabitant
1	savanna,
1	near-threatened
1	(iunc).
1	-ehrlichia
1	88.2%
1	(15/17),
1	(3/17)
1	(9/17)
1	-leishmania
1	-e.
1	authorities.
1	maranhense,
1	mangue,
1	cocais,
1	restinga)
1	[elisa],
1	[ifat],
1	[dual
1	dpp®])
1	11.14%
1	(107)
1	cvl,
1	59.16%
1	(568),
1	(148),
1	(126)
1	dpp,
1	(0.73%)
1	biomes/ecosystems
1	favor,
1	furtado
1	1,245
1	familiaris)
1	(9.88%)
1	(45.5%)
1	(72.18%)
1	(13.1%)
1	(grippotyphosa)
1	(pomona)
1	(38.28%)
1	(82.76%)
1	ibiúna,
1	(55.1%;
1	50.9-59.2%)
1	(7.02%;
1	5.1-9.4%)
1	2.05),
1	(or=
1	2.47),
1	1.79)
1	3.29)
1	ibiúna.
1	1-85
1	freerange
1	5’
1	3’-sag2,
1	c22–8,
1	c29–2,
1	cs3).
1	56.7%
1	(131/231).
1	(89.3%)
1	(10.7%)
1	boca
1	ituxi
1	amphibians,
1	platypus,
1	rainforest).
1	frogs).
1	(2.7%)
1	cryopreserved.
1	an04,
1	an06
1	leptodactylus
1	latrans
1	(steffen)
1	pristimantis
1	chattoni
1	mathis
1	leger,
1	1911.
1	(an06)
1	population’s
1	responsibility
1	hurting
1	consumer
1	rights,
1	recommendations,
1	traceability.
1	biochip
1	rn,
1	brazil,was
1	werecollected
1	domiciled
1	forest(parque
1	cidade
1	dunas)
1	incenter
1	thegender
1	indirectfluorescence
1	13(12.7%,
1	7.0-20.8%)
1	(2.9%,
1	0.6-8.4%)
1	between:localities
1	(parks
1	ccz)
1	theparasites,
1	dogsliving
1	(hemoculture),
1	(6.77%)
1	didelphimorphia
1	parnellii,
1	neosporosis,
1	caninum-related
1	35 days
1	animal-level
1	mesoregion.
1	(44.44%)
1	(11.11%)
1	9.34;
1	mammalian,
1	reptilian
1	(28.6 %)
1	naponense,
1	humerale,
1	nodosum,
1	goeldii,
1	calcaratum,
1	coelebs,
1	pacae,
1	geayii,
1	rotundatum,
1	haemaphysalis
1	juxtakochi.
1	“candidatus
1	amblyommii”
1	naponense.rickettsia
1	juxtakochi,
1	close-related
1	canadensis
1	(13/151)
1	10.4%
1	(5/48)
1	3200,
1	norvegicus),
1	nigripes.
1	3466
1	14.7%,
1	87.4%,
1	hardjo,
1	wolfii,
1	grippotyphosa,
1	hebdomadis
1	shermani.
1	insemination,
1	hardjo;
1	hebdomadis.
1	abortions.
1	insemination.
1	service;
1	inter-mingled;
1	mules,
1	(67.11%),
1	(26.05%),
1	(6.84%)
1	(cutoff.
1	=.
1	(28.47%)
1	(82
1	mules).
1	donkey.
1	(pcr)-restriction
1	#163
1	(tgckbr220),
1	(114
1	seroreativity
1	(13.15%)
1	(14.37%)
1	seroprevalence.
1	amblyommii.
1	adults),
1	sanguineus).
1	sanguineus,
1	cantagalo
1	orthopoxvirus)
1	vesicopustular
1	milkers
1	orthopoxvirus
1	plaque-reduction
1	euphractus
1	sexcinctus),
1	tetradactyla),
1	whited-lipped
1	pecari),
1	(pseudalopex
1	vetulus),
1	lineated
1	woodpecker
1	(dryocopus
1	lineatus)
1	brachyurus).
1	"primary
1	samples",
1	(pcr/rflp),
1	l258,
1	piauí)
1	ompb.
1	63.5%
1	(40/63)
1	(2/3)
1	andeanae.
1	andeanae
1	felidae,
1	(36.1%)
1	(p<0.001;
1	u=.
1	1230.0),
1	(p=0.007;
1	u=3939.0).
1	enlarging
1	(15/18)
1	rufous-bellied
1	thrush
1	(turdus
1	rufiventris).
1	lábrea
1	(5/66)
1	anaplasmataceae.
1	anaplasmataceae,
1	39.4%
1	(26/66)
1	(6/33)
1	57.6%
1	(38/66)
1	filarial-
1	corrego
1	afects
1	defnitive
1	rodentia,
1	difcult
1	specifc
1	fuorescein
1	immunofuorescence
1	euryoryzomys
1	(wagner,
1	1848)
1	(rengger,
1	1830).
1	(linnaeus,
1	1758)
1	49)
1	modifed
1	confrm
1	russatus.
1	musculus)
1	(homologous)
1	free-living.
1	(crested
1	seriema,
1	cariama
1	cristata;
1	buff-necked
1	ibis,
1	theristicus
1	caudatus;
1	picazuro
1	patagioenas
1	picazuro;
1	owl,
1	athene
1	cunicularia)
1	(myrmecophaga
1	tridactyla)
1	nc-bahia,
1	coccidian,
1	nc-1.
1	fixed-time
1	(n=8;
1	buffaloes),
1	(n=5;
1	buffaloes).
1	5×108
1	70th
1	abortion=12.5
1	(frequency
1	abortion=100
1	states..
1	1457
1	stark
1	dominant.
1	clonal),
1	iii),
1	#9
1	#3,
1	#4
1	(#4
1	suidae
1	swine.
1	(wlp;
1	(cp;
1	pecari
1	wlp,
1	hunted
1	locals
1	bronchiseptica,
1	multocida,
1	circovirus
1	(pcv2),
1	suid
1	(suhv-1),
1	(ppv).
1	bronchiseptica
1	suhv-1.
1	suhv-1
1	peccaries.
1	616
1	anti-bat
1	2006-2011;
1	32.62%
1	(201/616)
1	2010-2011;
1	18.61%
1	(35/188)
1	2011)
1	0.144,
1	pvj.
1	gamma-glutamyl
1	cidade.
1	(53.7%)
1	(21.5%)
1	(52.8%)
1	(155bp),
1	lituratus,
1	carollia
1	perspicillata
1	glossophaga
1	soricina.
1	braziliancerrado.
1	alouatta
1	caraya
1	tapirs,
1	discontinuities,
1	tapirus
1	megatrypanum,
1	amazonia/cerrado
1	(19),
1	15.5%
1	(13),
1	confresa
1	(amazonia/cerrado
1	poconé
1	(pantanal
1	biome).
1	(2.4%)
1	co-evolutionary
1	223)
1	174)
1	long-furred
1	murina),
1	four-eyed
1	(metachirus
1	nudicaudatus),
1	short-tailed
1	(monodelphis
1	domestica).
1	34.4%
1	(n=31)
1	jaguarondi
1	(9/22),
1	(6/22),
1	(8/28),
1	(6/10),
1	(1/1)
1	colocolo
1	pampas
1	(1/7).
1	(63/433)
1	(16/56),
1	(8/43),
1	(15/83),
1	(7/63),
1	(3/56),
1	(2/44),
1	(6/44)
1	eyeball
1	(6/44).
1	5'3'sag2,
1	(lw#31tn
1	py#21sm
1	py#56br
1	10.0-24.6%),
1	(2.7%;
1	1.7-3.9%)
1	graze
1	10.34;
1	p=0.034),
1	3.78;
1	p=0.023)
1	6.51;
1	p=0.007)
1	babesiosis
1	anti-rickettsia
1	16.2%,
1	31.7%,
1	59.6%
1	29.1%
1	(15.7%)
1	(21.1%).
1	brachyurus)
1	free-living,
1	águas
1	emendadas
1	(esecae),
1	3/3
1	5/7
1	foxes.
1	esecae
1	station,
1	felines.
1	diversification.
1	(tgckbr234-281)
1	counties,
1	c22-8
1	sag3.
1	detections,
1	wild,
1	peri-urban
1	(cystoisospora
1	28.6
1	35-42
1	26-31
1	sporocysts,
1	(<1%)
1	caryospora-like
1	6-wk-old
1	sulfadimethoxine
1	cru
1	8-12
1	disases
1	euthanised,
1	bioassays).
1	(5'-3'sag2
1	sag2),
1	city:
1	velvety
1	free-tailed
1	tgbatbr1
1	tgbatbr2,
1	(tgbatbr1)
1	(tgbatbr2)
1	striking.
1	chiropterans.
1	(8·3%)
1	(10·1%)
1	(7·6%)
1	(5·1%)
1	rochalimae
1	vinsonii
1	berkhoffii,
1	lankan
1	greece.
1	inseminations
1	calving
1	arthritis-encephalitis
1	(caev),
1	(nat),
1	(agid),
1	(abortions,
1	kids)
1	zoosanitary
1	caev,
1	37.81%,
1	23.62%
1	17.23%
1	anti-caev
1	co-infection,
1	caev-induced
1	chlamydophila
1	farmer
1	s26/3
1	50.0%
1	(95%;
1	40.3%,
1	59.7%).
1	≥32,
1	9.3%.
1	2.35;
1	1.04-5.33)
1	3.06;
1	1.37-6.80)
1	immonufluorescent
1	60.5-78.4%).
1	(18.1%;
1	15.8-20.7%)
1	5.11;
1	0.045)
1	3.34;
1	510
1	(380
1	chickens)
1	(ihat,
1	imuno-hai
1	toxo®,
1	wama
1	diagnóstica,
1	40g)
1	minced,
1	40.4%
1	(206/510)
1	(titer≥1:16)
1	(198/510)
1	(titer≥1:25);
1	index=0.614).
1	tgckbr234-281)
1	(ihat
1	titers≥1:32)
1	(p.i).
1	english-speaking
1	veterinarians,
1	50-80%
1	child-bearing
1	5-23
1	10å
1	births,
1	2649
1	modifiied
1	nhecolândia,
1	67.5%
1	1:5.
1	1:5,
1	1:10,
1	1:20,
1	1:320,
1	1:640,
1	1:1280,
1	1:2560,
1	(14.8%)
1	1:10.240.
1	59.26%
1	(4.44%)
1	sacrifiiced
1	fiive
1	25.6%
1	(1:25).
1	infecton
1	3.32%
1	11.71%,
1	22.06%
1	22.06%.
1	daughters.
1	0.37%,
1	3.00%
1	6.94%
1	31.58%
1	11.11%
1	(nc-1
1	400).
1	(nested
1	(ihc).
1	(53.8%).
1	[mammalia:
1	sirenia])
1	(39.2%)
1	(titer,
1	microtechnique,
1	titrated.
1	(31.1%)
1	(patoc
1	21/23,
1	castellonis
1	2/23,
1	1/23,
1	1/23),
1	1,600.
1	(n=126)
1	(inia
1	geoffrensis)
1	mamirauá
1	(rdsm),
1	tefé,
1	(86.3%)
1	aguti)
1	cut-off)
1	(1:16
1	cut-off);
1	≤200
1	87.3%
1	(75.199.6%).
1	ppv.
1	(numida
1	meleagris)
1	(oryctologus
1	cuniculus)
1	higher).
1	tgnmbr1)
1	tgrabbitbr1,
1	tgrabbitbr2)
1	tgrabbitbr1
1	out-bred
1	tachyzoite-derived
1	tgnmbr1
1	atypical,
1	(tgrabbitbr1
1	tgcatbr5,
1	tgrabbitbr2
1	tgcatbr1,
1	fusca)
1	chinchillas
1	(chinchilla
1	lanigera)
1	(struthio
1	camelus)
1	jaguar.
1	chinchillas,
1	biv
1	duodenalis.
1	month-old)
1	≥400):
1	masseter;
1	caninum-specific
1	(n=60)
1	clinically.
1	(ifat≥50)
1	(32.7%)
1	(ifat≥16).
1	oligosymptomatic
1	(n=22),
1	(n=28).
1	(p=0.053)
1	eldorado,
1	verde
1	aquidauana
1	321
1	simpson's
1	0.90,
1	atypicality.
1	piauí,
1	teresina
1	18.0
1	78.1%,
1	piauí.
1	≥200).
1	1600
1	800,
1	(brain,
1	marrow)
1	belzebul),
1	aurita).
1	irmãos,
1	(titre
1	mat).
1	jaguarundi,
1	opossum.
1	(tgrhhmbr1)
1	(tgjagbr1)
1	(tgopbr1)
1	dipstick
1	(ict)
1	64)
1	states'
1	virginiana),
1	familiaris),
1	79;
1	hemaculture
1	negative)
1	brazil-strain
1	gerbils.
1	t61;
1	bubalis),
1	buffalos,
1	free-grazing
1	slaughtered,
1	nc5
1	(ifat<25).
1	buffalos.
1	economy.
1	manu
1	tambopata,
1	89.1%
1	101)
1	1100
1	13,200
1	87.7%
1	89.2%
1	positively,
1	125.
1	santarém.
1	k39.
1	(69.8%)
1	(5.4%),
1	(urban
1	rural)
1	(p<0.02)
1	caninum-negative
1	capybara,
1	hydrochoerus
1	hydrochaeris,
1	cuniculi,
1	neurona,
1	merozoites,
1	â‰¥
1	(16/26)
1	1:512.
1	(2/26)
1	(3/26)
1	15.4%.
1	apicomplexan.
1	(crassostrea
1	rhizophorae)
1	(mytella
1	guyanensis)
1	phenol-chloroform
1	guanidine-thiocyanate
1	molluscs.
1	sieved
1	155.
1	nested-pcr.
1	(3.3%).
1	rhizophorae,
1	helminth-free
1	tanniniferous
1	g/animal/day,
1	mearnsii
1	ct)
1	extract/kg
1	giv)
1	slaughtered.
1	hatchability
1	(there
1	data),
1	carcass-weight
1	(veg
1	1:512
1	1:4096
1	(41.7%)
1	ibiúna
1	sorocaba,
1	(39/260)
1	(97.4%)
1	(15.4%)
1	analisys.
1	norte)
1	goats)
1	(ne
1	(≥1:40)
1	(27.9%)
1	(crab-eating
1	chrysocyon
1	brachyurus
1	(maned
1	wolf),
1	lycalopex
1	vetulus
1	(hoary
1	cipó
1	(21/21),
1	(7/21),
1	(1/19)
1	(13/19)
1	(41/70),
1	(46/70),
1	(40/70)
1	platynossomun
1	trichuridae
1	pulex
1	rheas
1	semiárido
1	rheas)
1	ratites
1	toxoplasmoses
1	gardens
1	leisure,
1	recreation
1	sexes:
1	bearded
1	libidinosus),
1	goldenbellied
1	xanthosternus),
1	raccoons
1	(procyon
1	cancrivorus),
1	nasua),
1	tayra
1	(eira
1	barbara).
1	e"1:25),
1	seroaglutination
1	e"1:100)
1	leptospiras.
1	(53.1%)
1	(47.1%)
1	(26.7%)
1	(41.2%)
1	(11.8%)
1	(serovar
1	copenhageni)
1	golden-bellied
1	xanthosternus)
1	1036
1	932
1	retested
1	(53.5%),
1	(67.6%)
1	582
1	stud
1	(celisa)
1	equi.
1	(horses
1	equi)
1	farms).
1	(54.1%)
1	equi
1	(21.6%)
1	1787)
1	(canestrini,
1	1887)
1	(95%),
1	caballi-positive
1	equi-positive
1	periparturition
1	parturitions,
1	parturitions.
1	partum,
1	42.9,
1	68.0.
1	55.5
1	51.5
1	84.8
1	wellmanaged,
1	briii,
1	isolate);
1	isolate),
1	(non-infected
1	queens.
1	(74.3
1	cooperia
1	mbq
1	11,131
1	1500.
1	(tgi),
1	tgi
1	briii.
1	maternally-infected
1	1:10)
1	dag,
1	(18.5%)
1	(14.3%)
1	(35.3%)
1	apicomplexans,
1	hammondi
1	two-host
1	(vulpes
1	vulpes)
1	latrans)
1	carnivore
1	2-year-old
1	subspherical
1	pcrs,
1	(pcr-its1)
1	(pcr-hsp70).
1	(nc5-npcr).
1	nc5-npcr.
1	143
1	(32.2%)
1	goats;
1	tggtbr1-12.
1	(1.0×107),
1	(1.5×104),
1	nonreinfected
1	canines
1	gii)
1	miscarried
1	stillborn
1	lymphoadenopathy,
1	miscarriage,
1	1,024
1	4,096
1	256.
1	giii).
1	encephalon
1	stillborn,
1	miscarriages,
1	primoinfection.
1	(364
1	(17.1%)
1	1.8%.
1	agent's
1	(pernambuco,
1	cear,
1	alagoas)
1	(mat);
1	1:2,560
1	1:5,120
1	higher;
1	tgckbr165-187.
1	natimortality
1	bradyzoites
1	amplifcation
1	efciency
1	quantifcation.
1	non-signifcant
1	pratically
1	inaltered.
1	heartworms
1	1028
1	38.22%
1	(26.81%<ci
1	0.95<49.62%),
1	65536.
1	8.81%
1	(7.08%<ci
1	0.95<10.53%).
1	51200.
1	4.67%
1	(87.50%).
1	endothermic
1	381
1	(324
1	(92.8%),
1	(28.6%),
1	(65/381)
1	1.05%
1	(4/381).
1	495
1	(24.2%)
1	tgshbr
1	1-16.
1	anti-toxplasma
1	(rifie"16)
1	2.70%
1	81.25%.
1	commercialized.
1	(nate"25)
1	19.77%.
1	choroplethic
1	molissima
1	paddocks
1	(p=0.043),
1	(p=0.074),
1	(p=0.007)
1	(p=0.089).
1	drenching
1	fec
1	abomasum
1	(p<0.003),
1	endoparasite
1	retyped
1	(alagoas,
1	rondonia)
1	(pará)
1	(29/58)
1	≥1:25
1	dilution),
1	(76.6%)
1	tgcybr1-36.
1	25-90%
1	seridó
1	oriental
1	microregion,
1	25.9-35.6%]
1	1:16,384.
1	herd,
1	extensive/semi-intensive
1	(bsf;
1	rickettsii)
1	itabira
1	anti-r.
1	81.3%
1	356
1	htra
1	(sentinels
1	bsf)
1	appoint
1	sfg
1	(9.4%),
1	neospora,
1	hammondi.
1	locates
1	viia
1	overwhelmingly
1	virulent.
1	episcope
1	immunofluorescence-antibody
1	(81.25%)
1	confirm,
1	18-mixed
1	(uninfected
1	m-elisa
1	rhoptries
1	tox4
1	tox5
1	1024
1	ifa(s)
1	mat(s)
1	0.0001);
1	r-elisa(s)
1	0.7).
1	(3/10)
1	objetive
1	friesan
1	soronegative
1	pre-colostral
1	1:50;
1	dilution,
1	1:200,
1	first-stage
1	(l1)
1	teladorsagia
1	circumcincta.
1	l1.
1	(h.
1	circumcincta).
1	aqueouswater
1	0.043,
1	(se
1	0.0024),
1	circumcincta,
1	(beef
1	pelotas,
1	(53/339)
1	(6/109)
1	20.4%
1	(47/230)
1	3-years
1	4.1)
1	3-years.
1	2.8)
1	inquiries
1	adquiring
1	revision,
1	equidaes
1	equines)
1	eia),
1	ei-1
1	virusneutralizating
1	arteritis
1	ehv1,
1	wee
1	vee).
1	22.7%
1	hve1,
1	19.9%
1	ie-1,
1	ie-2,
1	21.0%
1	11.3%
1	vee,
1	91.4%
1	bratislava
1	(10.5%),
1	(8.7%),
1	(8.7%)
1	(26.6%)
1	wee.
1	non-zoonotic
1	19.8-29.7%]
1	4096,
1	1.6-5.9%)
1	400.
1	bogatá,
1	27),
1	giardias
1	heydorni,
1	hammondi,
1	(hammondia-like
1	organisms)
1	cyst-forming
1	toxoplasmatinae.
1	spacer-1
1	(its-1)
1	cyclospora.
1	(hydrochoerus
1	(5.52%)
1	cryptosporidium.
1	iiaa15g2r1.
1	semi-aquatic
1	(≥1:50)
1	302,
1	1:400-dog
1	342,
1	1:50-dog
1	27,600
1	oocysts).
1	(<1:50).
1	mongolian
1	ungulatus)
1	vesper
1	(calomys
1	callosus)
1	oocysts/animal).
1	thick-walled
1	callosus.
1	(35.8%)
1	apico)
1	thru
1	≥100
1	(90/329)
1	23.7%
1	(37/156)
1	(53/173)
1	(22.0%),
1	pyrogenes
1	(12.0%),
1	canicola
1	(7.5%).
1	3.3;
1	p=0.02)
1	2.3;
1	≥1:1280
1	six.
1	1755
1	(8.5%),
1	(2.4%).
1	ocurrence
1	(11.3%),
1	(6.1%),
1	(2.1%).
1	aplicomplexan
1	raisers
1	binucleated
1	nucleus-specific
1	cows'
1	cd-163,
1	mac-387
1	donatien
1	lestoquard
1	familiaris
1	(latreille)
1	amazon),
1	canis-reactive
1	≥40)
1	58/153
1	(37.9%)
1	40/161
1	(24.8%)
1	(162-165
1	household)
1	erlichial
1	2.3,6.2,
1	(monte
1	negro),
1	(jundiaí,
1	canis-infecting
1	ricketttsia
1	(11.6%)
1	(3.9%)
1	rhipicephali.
1	amblyommii
1	ro.,
1	anti-brucella
1	(32.4%).
1	(46.7%),
1	(10.0%).
1	(5.0%;
1	27;
1	(1.4%)
1	brucellosis.
1	(ham,
1	spareribs
1	picnic)
1	×104
1	59th
1	27/40
1	(67.5%)
1	9/40
1	(siamese,
1	persian,
1	breeds)
1	(25%,
1	≥64)
1	(24.5%,
1	≥16).
1	(χ2=
1	35.7;
1	1-year-old,
1	39.2%
1	(÷2=8.8;
1	(41/219)
1	31.5%
1	(57/181)
1	12-month,
1	(χ2=19.6;
1	mares.
1	483
1	(73/483)
1	reactant,
1	(19/325)
1	(10 nm)
1	blt-1
1	blt-2.
1	ovalbumin-loaded
1	do11.10
1	co-cultures.
1	(th2
1	treg,
1	(tbet)
1	(rorγt)
1	pedro
1	tôrres
1	muscle-associated
1	129/sve
1	(5lo
1	lt-sufficient
1	muscle-resident
1	(lgi).
1	lgi
1	toll-like/il1β
1	co-morbidity
1	129sve
1	leukotrienes-deficient
1	(5-lipoxygenase
1	knockout)
1	(cd11b+ly6chighly6g−)
1	arg1
1	chi3l3
1	phosphorylated-stat6.
1	(cd45+f4/80+cd206+)
1	(natural
1	products)
1	independently.
1	phomactins,
1	spurred
1	bioinspired,
1	congeners.
1	(sirs),
1	sirs,
1	mir125b
1	mir203b
1	gainof-
1	drosha-dgcr8,
1	mirna-processing
1	pten-deficient
1	drosha-dgcr8
1	sepsis-associated
1	silva-junior,
1	dalmaso,
1	herbster,
1	lepique
1	jancar.
1	(ptafr)
1	(rt),
1	ptafr
1	cancer-derived
1	(c33,
1	(scc90
1	scc78)
1	cv3938
1	(kbp)
1	(kbm).
1	cv3988.
1	radiotherapy,
1	acetylation/deacetylation
1	low-doses
1	marrow-differentiated
1	5 mm
1	25 mm
1	glucose).
1	6 days.
1	(hat)
1	conclusions/interpretation
1	(pam3cys),
1	(il-12p40,
1	pam3cys
1	lps-challenged
1	thieme.
1	andmicrobiocidal,
1	e2/interleukin-10
1	parfko
1	(pafr-knockout)
1	had:
1	ldlr
1	(t1dm)
1	(sepsis).
1	88)
1	alox5,
1	5-lo,
1	towild-type
1	t1dmmice
1	(eat).
1	2days,
1	facs,
1	(cox1),
1	(lag
1	progressed,
1	monocytes)
1	f4/80-gr1+cells
1	that.
1	phagocytes.we
1	signaling-1
1	(socs-1)
1	(blt1)
1	gai
1	mir-155,
1	mir-125b.
1	antagomirs
1	lt-deficient
1	regulatory/tolerogenic
1	(atl),
1	(ltb4).
1	(img3).
1	cd36).
1	raft-marker
1	gm1-ganglioside.
1	cd36;
1	m2-phenotype.
1	(web
1	cxcl2
1	(efferocytosis)
1	/il-
1	12p40
1	(70-80%).
1	coimmunoprecipitated
1	methyl-β-
1	cyclodextrin
1	/il-12p40
1	efferocytosis-induced
1	ferracini
1	inflammaging,
1	marcel
1	cesar
1	subtumorigenic
1	(tm1)
1	(5mg/kg
1	peritumoral
1	andré
1	lacerda
1	bachi
1	pafr-dependent
1	(web2086)
1	chemosensitisation
1	web2086.
1	claudia
1	onuchic
1	cv3988,
1	(p38
1	jnk).
1	synthesis/response
1	ofchallenge
1	2-selective
1	5-lipoxygenase-derived
1	(lts),
1	cofilin-1,
1	f-actin;
1	lim
1	(limks)
1	limk-2.
1	5-lipoxygenase-mediated
1	(5-lo-mediated)
1	il-18)
1	btl1,
1	socs1.
1	stat1-dependent
1	(pafr).
1	(web2170,
1	cv3988);
1	(pd98059),
1	(sb203580),
1	(sp600125)
1	diluents,
1	fitc-oxldl
1	oxldl,
1	(paf-r)-mediated
1	(dacarbazine,
1	dtic)
1	(web2170).
1	tumours:
1	melanoma.methods:
1	galectin-3,
1	cytometry.results:
1	paf-r.conclusions:
1	paf-r-dependent
1	ovalbumin/alum
1	140)
1	(r954)
1	(ltc4,
1	lte4)
1	(fcγr)-mediated
1	(pkc-α
1	-δ),
1	-α
1	engagement.
1	isoform-selective
1	pkc-α
1	-δ,
1	pkc-α,
1	(bq788)
1	antigen-challenged
1	788
1	mam-stimulated
1	of macrophages
1	(j774a.1
1	interferon-gamma,
1	immunopathologies.
1	5 ml/min,
1	(0.1-100 μg)
1	(emax
1	1 cmh2o,
1	sacrifice)
1	5 pg/g
1	tissue).
1	anaphylaxis),
1	b4/c4
1	bloody
1	15 min
1	factor-receptor
1	(web-2170)
1	stabilizers,
1	ketotifen
1	anti-pmn
1	fucoidan).
1	intima.
1	auto-regulate
1	oxldls
1	(hoxldl
1	loxldl)
1	(thp-1),
1	macrophage).
1	nimesulide,
1	cysteinyl-leukotrienes,
1	(tγδ,
1	strain-dependent.
1	cysteinyl-leukotriene
1	cysteinyl-leukotrienes
1	ets.
1	(ecv-304)
1	(bq-123,
1	air-conditioning
1	(iaq)
1	complaints.
1	14°c/57.2°f
1	(cold)
1	26°c/78.8°f
1	(rhinitis
1	stinging
1	breathlessness
1	air-conditioning-
1	oceanside
1	publications,
1	(43°c,
1	30min)
1	(no-synthesis
1	(pgs-synthesis
1	(kupffer
1	wassignificantly
1	epo-deficient
1	(nzw)
1	c57bl/c
1	ovalbumin/alum,
1	picrosirius,
1	hematoxylin-eosin;
1	osmium-stained
1	comparable;
1	conditioning-induced
1	was to
1	a control
1	12°c
1	a group
1	total cells
1	change-related
1	(ic)-induced
1	pre-formed
1	peroxyde
1	ic-stimulated
1	endothelins,
1	pufa-stimulated
1	lts.
1	phox-deficient
1	(pkc-δ)
1	pkc-δ-dependent
1	hemostasis:
1	bronchoconstrictor
1	h2.
1	bronchoconstriction,
1	(ovalbumin-sensitized
1	(intratracheal
1	r-594
1	intravascularly
1	perivascularly
1	mediator(s)
1	fcγr-dependent
1	ensue.
1	fibrinolysis,
1	leaks)
1	fitc-dextran
1	leaks.
1	-adrenoceptor
1	mg/ml-basis.
1	ldl-particle
1	(d-arg-[hyp3,thi5,dtic7-oic8]
1	(ac-orn[oic2,αmephe5,βd-nal7ile
1	8]des-arg9-bradykinin)
1	(182%),
1	(98%),
1	(192%),
1	(236%),
1	(840%),
1	(194%)
1	(246%).
1	catheter,
1	ml/h)
1	colitis)
1	colitis),
1	3/n
1	1:7.7
1	(lct,
1	1:7.0
1	lct,
1	1:4.5
1	1:3.0
1	ltc4),
1	(lw-3
1	mw-3)
1	lct-containing
1	manifestations;
1	intake-weight
1	mct/lct-containing
1	(ag;
1	1400w
1	(0.5-1
1	(intra
1	0.1-1
1	μmol;
1	(μmol)
1	inhibibitors
1	joint-1;
1	joint-1),
1	sin-1,
1	(tnfrbp)
1	197%,
1	172%,
1	173%,
1	tnfrbp
1	tnfrbp,
1	biliopancreatic
1	lexipafant
1	bacteriologic
1	(ewi).
1	(ova/al).
1	(4.85
1	(12.10
1	2.97
1	36.14
1	(4.83
1	11.95
1	(5.16
1	(2.89
1	(456.4
1	303.5
1	(205.7
1	two-fold),
1	((-)-2-[[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-
1	piperazinyl]methyl]-3,4-dihydro-2,5,7,8-tetramethyl-2h-1-benzopyran-6-ol,
1	dihydrochloride)
1	53,
1	216%,
1	hyperreactivity.
1	(leukotrienes,
1	broncholaveolar
1	(bq-123)
1	et(a)/et(b)-r
1	3.2-
1	63-fold,
1	209670
1	mid-dose
1	hb,
1	et(a)-r
1	et(b)-r
1	et(b)-mediated
1	77.86%
1	transfered
1	congestion.
1	pmn.
1	l-660,711,
1	peptido-leukotriene
1	edema:
1	(pancreatitis)
1	(pancreatitis
1	pancreatitis'
1	μ/rat,
1	pay
1	cerulein-induced
1	(60-70%
1	cerulein-pancreatitis,
1	(raw),
1	(edyn),
1	(rtis).
1	<.02).
1	quick-freezing
1	=.001)
1	airspaces.
1	laser-doppler
1	flowmeter
1	dazmegrel.
1	h1or
1	h2receptors,
1	acedemic
1	297,
1	328,
1	250,
1	192%
1	43-fold
1	82,
1	67,
1	econazol
1	arthritis-related
1	52021,
1	spasm
1	hydroperoxyeicosatetraenoic
1	(hpetes),
1	5-hydroxy
1	(hetes),
1	spasm.
1	15-hetes,
1	hetes,
1	15-hete
1	hetes
1	aa-861,
1	hpete
1	vasospasm.
1	(w3/25+
1	ox8+)
1	(holtzman)
1	(buffalo)
1	(aia).
1	suppressor)
1	cyclophosphamide,
1	aia.
1	peritone
1	alcavity.
1	(eia),
1	(cont)
1	326%
1	mediatory
1	slow-reacting
1	(srs-a)
1	srs-a
1	(ltd4),
1	f(2α).
1	nanogram
1	tachyphylaxis
1	sustained.
1	ng),
1	(ltb4;
1	(ltd4;
1	suspending
1	spasmogens
1	(ndga;
1	ml−l)
1	l‐655,240
1	(srs‐a)
1	fpl‐55712
1	bn‐52021
1	ml/g
1	speen
1	pancreas)
1	(paf)induced
1	(gplps)
1	(3.5,
1	(2.8,
1	(170
1	skf-88046
1	bw775c
1	gplps.
1	gplps,
1	margination,
1	evan's
1	paf-antagonist,
1	755c
1	fpl
1	55712
1	(ltd
1	(if
1	any)
1	substance(s)
1	(15s)‐15‐methyl
1	15‐methyl
1	bromothymol
1	(10−5
1	diphloretin
1	10−6
1	transpulmonary
1	16‐16‐dimethyl
1	seamount
1	south-western
1	interpolated
1	biogeography,
1	paraná-etendeka
1	igneous
1	cruises
1	bedrock,
1	low-productivity
1	open-database
1	large-scale,
1	rasters,
1	geomorphological
1	submarine
1	cruises,
1	seascapes
1	pavement
1	outcrops.
1	substrata
1	recolonisation
1	smothering
1	tailings
1	overburden
1	state-of-the-art
1	geological,
1	fine-resolution
1	ferromanganese
1	manned
1	submersible.
1	escarpment
1	submersible
1	biogeochemistry.
1	geothermometer,
1	fe-mn
1	oxyhydroxide-phase
1	firmicutes.
1	heterotrophs,
1	stratovolcano
1	100 °c
1	fumaroles,
1	glaciers.
1	extraterrestrial
1	psychrophilic
1	98 °c,
1	survivability
1	thermophiles
1	volcano,
1	spore-forming
1	saprolegnia
1	parasitica,
1	oomycetes,
1	trout,
1	aquacultures
1	broths
1	quellenin
1	violaceol-i
1	violaceol-ii
1	yk-76.
1	osedax
1	annelid,
1	bone-eating
1	parasitica
1	violaceol
1	bohannan
1	surroundings,
1	geothermal,
1	marine,
1	geochemistry
1	volcanoes.
1	deception,
1	98°c.
1	shallow-sea
1	deception.
1	"open-air"
1	adaptability,
1	backdrop
1	impacts.
1	(spring,
1	autumn)
1	gerlache
1	straits
1	elephant
1	sar11,
1	thaumarchaeota
1	(nitrosopumilus),
1	oceanospirillales,
1	sar324.
1	flavobacteria
1	(ns5
1	polaribacter),
1	(rhodobacterales
1	sar11
1	(oceanospirillales/balneatrix
1	cellvibrionales),
1	haptophyte
1	phaeocystis
1	corethron,
1	succession
1	interannual
1	bioenergy
1	microbiomes
1	700 ppm).
1	dna-sip
1	13co2
1	v6
1	gammaproteobacteria,
1	c-sources
1	350 ppm
1	pulse),
1	electing
1	sphingobacteriia,
1	cross-feeders
1	associated)
1	(113
1	(74.3%),
1	basidiomycota
1	(11.5%),
1	(7.1%),
1	(7.1%).
1	cadophora
1	malorum
1	diobovatum,
1	(41.6%)
1	>97%
1	metazoans
1	(4204
1	whale
1	hiseq.
1	mg-rast
1	seed,
1	represented.
1	(69%),
1	sulfurovum
1	nbc37-1
1	sox
1	(sulfur
1	epsilonproteobacteria,
1	incomplete,
1	pockmarks
1	iatá-piúna
1	human-occupied
1	shinkai
1	6500
1	margin.
1	2652–2752
1	angola.
1	photosynthesis-based
1	seep.
1	chemosynthesis-based
1	vesicomyid
1	bathymodiolus
1	siboglinid
1	mats,
1	seepage,
1	in/around
1	species),
1	hexactinellids
1	caulophacus
1	poliopogon
1	amadou,
1	saccocalyx
1	pedunculatus,
1	farrea
1	occa
1	chonelasma
1	choanoides;
1	isidid
1	octocorals,
1	brisingid
1	starfishes
1	galatheid
1	crabs.
1	poriferan
1	n-alkanes
1	pulschen,
1	fricker,
1	pellizari,
1	galante
1	planet.
1	recalcitrant,
1	stereo
1	slow-growing
1	lapillicoccus,
1	flavitalea,
1	quadrisphaera,
1	motilibacter,
1	polymorphobacter.
1	92.08
1	94.46%
1	thermoleophilia,
1	recalcitrant
1	nakayama,
1	peninsula)
1	hydro-oceanographic
1	(bathymetry,
1	glacier
1	turbidity,
1	fluxes)
1	(100-502
1	depth)
1	(693-1147
1	454-sequencing
1	(sediment
1	(92.4%
1	5.5%),
1	1.6%),
1	1.7%),
1	deltaproteobacteria
1	2.5%)
1	(0.7
1	1.3%).
1	biomineralizing
1	nano-sized,
1	membrane-bound,
1	iron-rich
1	chemically-stratified
1	salinities,
1	(62°23′s
1	58°27′w)
1	microanalysis
1	(fe3o4).
1	mtb-specific
1	mtb.
1	(always
1	1°c)
1	psychrophiles.
1	remediation
1	γ-proteobacteria,
1	zn-biomass
1	(kf
1	1.81)
1	carboxyl,
1	hydroxyl,
1	pearce,
1	alekhina,
1	terauds,
1	wilmotte,
1	quesada,
1	edwards,
1	dommergue,
1	sattler,
1	adams,
1	magalhães,
1	chu,
1	lau,
1	cary,
1	smith,
1	eguren,
1	matcher,
1	bradley,
1	vera,
1	elster,
1	hughes,
1	cuthbertson,
1	benning,
1	gunde-cimerman,
1	convey,
1	hong,
1	pointing,
1	pellizari
1	vincent.
1	south-polar
1	aerobiologists
1	antarctic,
1	arctic.
1	bight
1	hydrography
1	(tw),
1	(sacw)
1	(cw),
1	prochlorococcus,
1	transects,
1	23°s
1	31°s
1	39°w
1	49°w.
1	open-ocean
1	300×103
1	81×103
1	slope.
1	chlorophyll
1	mesotrophic
1	picoeukaryotes
1	sacw
1	gérikas
1	(eabgl1a)
1	(kcat)
1	6.92s-1
1	(cellobiose)
1	32.98s-1
1	(pnpg)
1	200mm
1	sairecabur
1	(5971 m),
1	desert,
1	high-altitude
1	(>98%)
1	friedmannii,
1	exophiala
1	holtermanniella
1	watticus,
1	toruloides.
1	desert.
1	uv-c,
1	uv-b
1	environmental-uv
1	(0.75-2.25 mol/l
1	friedmannii
1	watticus
1	-6.5°c.
1	pigments,
1	biosignatures
1	plankton-derived
1	sedimentary
1	algal
1	corers
1	phaeodactylum
1	tricornutun
1	phytoflagelate
1	tetraselmis
1	phytoflagellates
1	dall'agnol
1	al..
1	(2d-dige-ms/ms).
1	2,058
1	log2fc
1	≥1,
1	2d-dige,
1	denote
1	halophiles
1	atb1
1	cariri
1	1184
1	1185,
1	subclade.
1	cold-active
1	952)
1	moss
1	schistidium
1	antarctici
1	mortierella
1	(pufas),
1	y-(gamma)
1	48.3
1	48.7
1	26.9
1	(pyrrolo[1,2-a]pyrazine-1,4-dione,
1	hexahydro-3-(2-methylpropyl)
1	pyrrolo[1,2-a]pyrazine-1,4-dione,
1	hexahydro-3-(phenylmethyl))
1	edaphic
1	1,100
1	amylasic
1	esterasic
1	oceans.
1	pasture.
1	(endemics)
1	graças
1	mazei
1	methanogen
1	methanosarcinales
1	mats
1	fryxell
1	b7,
1	ginger
1	forth.
1	volcanoes,
1	deserts,
1	hypersaline
1	alkaline-saline
1	arid
1	shelf.
1	astrobiology,
1	microbiologists
1	non-brazilian
1	(proantar)
1	astrobiology.
1	researching
1	extremophiles,
1	astrobiology
1	(ade)
1	(a-arhd
1	caldeirão
1	(sf_bc
1	ag_bc,
1	libraries;
1	(opc)
1	sf_bc
1	biochar.
1	ruminally
1	avianderived
1	[dry-ground
1	silage
1	pulp].
1	square,
1	[control,
1	preparation].
1	(cipu)
1	isotricha
1	ciliate
1	carl
1	woese
1	domains):
1	eukarya,
1	kingdoms:
1	amazon;
1	1.1.band
1	thermoplasmata
1	mcg,
1	mbg-b
1	soil/sediment
1	(oxidoreductases)
1	ketones.
1	(rs)-1-(4-methyl-phenyl)ethanol
1	psychrotroph.
1	ferraz
1	(eacf)
1	117.9γmol
1	ch4m-2d-1,
1	51.3±8.5γmol
1	ch4m-2d-1
1	57.6γmol
1	ch4m-2d-1.
1	-11.3γmol
1	ch4
1	m-2d-1
1	mackellar
1	sink
1	granulometric
1	discarded,
1	methanogenesis.
1	methanogenesis
1	allochtonous
1	hydrogenotrophic
1	aceticlastic
1	methanosaeta.
1	botany
1	(mcg,
1	mg1,
1	mbg-b,
1	mbg-c
1	mhvg
1	euryarchaeota
1	rc-v
1	dhve-5
1	harsh
1	deschampsia
1	desv
1	(poaceae)
1	colobanthus
1	quitensis
1	(kunth)
1	barti
1	(caryophyllaceae),
1	representatives.
1	acidobacteria,
1	actinobacteria),
1	arcobacter
1	proteobacteria)
1	faecalibacterium
1	firmicutes).
1	sãouth
1	formate
1	biogas
1	0.138-mmol
1	ch4/g
1	matter/g
1	suspense
1	solids.
1	formate,
1	methanol.
1	methanobacteriaceae
1	permafrost
1	ice.
1	(q-pcr)
1	patchier
1	diversities,
1	zones;
1	rico,
1	toluene,
1	xylene,
1	nonane,
1	estuary.
1	(todc1,
1	ndob,
1	xyle
1	alkb1),
1	todc1
1	hydrocarbons;
1	ornithinolytica.
1	monooxygenases
1	(alk)
1	(alkb
1	53.10-69.60%
1	50.90-73.40%
1	silicibacter
1	pomeroyi,
1	gordonia
1	prauserella
1	nocardioides
1	farcinica,
1	acidisphaera
1	alcanivorax
1	borkumensis,
1	hydrocarbon-degrading
1	santista,
1	oxidoreduction
1	(>99%)
1	1a-6a
1	5.4t
1	biocatalysts
1	prochiral
1	3.5t
1	90-99%
1	excess,
1	mesophilic,
1	peninsula,
1	independent-culture
1	noncharacterized
1	cold-resistant
1	itanhaém
1	non-pneumophila
1	austrian
1	(pinus
1	polychlorinated-bp
1	(pcb)-contaminated
1	(sip)
1	13c-bp,
1	pseudonocardia,
1	kribella,
1	nocardiodes
1	sip,
1	utilizers
1	utilizer
1	metagenome
1	(13c-dna)
1	geochip,
1	6465
1	hydroxylating
1	dioygenase
1	β-ketoadipate
1	arhd
1	13c-dna,
1	arhds
1	arhds.
1	biotransformed
1	hydrochlorides
1	α,β-unsatured
1	terreus
1	niger.
1	phenylpropanol
1	para-methoxy-propiophenone
1	(novozym
1	435)
1	(s)-alcohols
1	(r)-acetates
1	1d,2d
1	excesses
1	(40-45%).
1	propiophenones
1	legionellosis
1	(dfa)
1	legionellae,
1	methods-when
1	protozoans.
1	ferraz,
1	amendment
1	hydrocarbon-degrader
1	moisture,
1	cryosols.
1	non-amended
1	treaty
1	prohibits
1	(coastal
1	acetophenone
1	bioreduction
1	(s)-chiral
1	≥99%
1	(s)-(-)-1-(2-bromo-phenyl)-ethanol
1	radioactive-compounds.
1	headspace-gas
1	chromatography/mass
1	(hs-gc/ms)
1	equilibration.
1	(toluene,
1	p-xylene,
1	nonane
1	naphthalene).
1	autoclaved
1	inoculates
1	81°c
1	noncontaminated
1	chloro-organics
1	29347
1	(pp
1	alkb),
1	q15
1	alkb2),
1	adp-1
1	(ac
1	alkm).
1	17484
1	(ndob),
1	(todcl),
1	33015
1	(xyle
1	cat23),
1	pseudoalcaligenes
1	kf707
1	(bpha).
1	alkm,
1	(todcl)
1	(bpha)
1	todcl
1	catechol-2,3-dioxygenase
1	(cat23)
1	biodegradative
1	gpo1,
1	alkb;
1	q15,
1	alkb2;
1	adp-1,
1	(pcr
1	rhodococcal
1	18/20
1	13/20)
1	9/10
1	7/10),
1	(15/20)
1	(5/10).
1	(1/30).
1	(0.55);
1	2.47%
1	(0.89)),
1	(1.13%
1	(0.50)),
1	(0.53%
1	(0.36)).
1	(1.9%
1	(0.55))
1	mesophiles
1	(0.41
1	(0.55)),
1	alkane-degradative
1	cryptosporidiosis
1	itaquaquecetuba
1	(pcb)
1	naphthalene,
1	cocontamination
1	cometabolism
1	pcbs.
1	bph,
1	nah,
1	tod
1	pcb-degrading
1	degrader,
1	nah
1	piezometers
1	geologically
1	coliformes,
1	proteolitic
1	mg/l).
1	sufite
1	coliforms
1	coliphages
1	none.
1	heterotrophs
1	hydrogeological
1	artificially-contaminated
1	macconkey
1	(macconkey-pa)
1	lactose-lauryl
1	tryptosetryptone
1	(stm-pa),
1	macconkey-pa
1	(artificially-contaminated
1	48%,
1	76%;
1	48%;
1	adequate.
1	simplicity,
1	coliphage
1	robustness,
1	immunoselection
1	“cancer
1	immunoediting”)
1	attractors
1	fixed-points,
1	chaotic
1	attractors,
1	period-doubling
1	feigenbaum's
1	universality.
1	doob-gillespie
1	algorithm.
1	unquestionably
1	assess,
1	cell-lysate
1	readout.
1	cell-reactive
1	misleading
1	patente,
1	evangelista,
1	(pea)
1	caspase-independent
1	c-raf.
1	c-raf
1	107,01
1	−29,62.
1	pea.
1	arylsulfonylhydrazone
1	co-workers.
1	sulfonylhydrazones
1	mda-mb-231,
1	annexin-v/pi
1	spartan’10
1	1.1.0.
1	mmff,
1	pm6
1	hartree-fock
1	3-31g*
1	computed.
1	142.4
1	pyknosis,
1	benzodioxol
1	sulfonylhydrazone
1	persuing
1	(vei)
1	microfluidization
1	(mfv).
1	(epc),
1	(dotap)
1	(dope)
1	vei
1	mfv,
1	0.18.
1	mfv
1	gene/immune
1	type-2-papillary
1	freed
1	mo-dcs-tumor
1	mo-dcs'
1	medrano
1	(ifns)
1	acknowledged,
1	jak-stat
1	ifn-αβ,
1	oxaliplatin,
1	labmol-12,
1	pyridinyl
1	nsclc.
1	(dc)-tumor
1	non-fused
1	electrofusion
1	cd11c+her2/neu+
1	dcs'
1	ctls
1	cmv-positive
1	(bfds)
1	bfds
1	b16f10.
1	ser338
1	accommodation/orientation
1	bay43-9006
1	(co-crystallized
1	sorafenib).
1	antimetastatic
1	taxol.
1	(cll)
1	cll.
1	abnormality,
1	il-4ra
1	il-4r
1	10-treatment
1	harness
1	differentiation/maturation,
1	(50/25/25%
1	molar)
1	0.13)
1	dehydration-rehydrationmethod
1	0.52).
1	dehydrated-rehydrated
1	(idcs)
1	bends
1	(mc-idc)
1	foxp3+,
1	indoleamine-2,3-deoxigenase
1	anti-pd-1
1	anti-pd-l1
1	anti-pd-l2,
1	idcs.
1	jsi-124,
1	nci-h292,
1	non-small-cell
1	(nsclc)
1	non-tumorigenic
1	ll24
1	g0/g1cell
1	chelerythrine,
1	chelerythrinoid
1	optimization.
1	tetradecapeptide
1	vespula
1	lewisii.
1	alkylsulfonamide
1	<sup>1</sup>h
1	lowest-energy
1	romagnoli,
1	zelante,
1	toniolo,
1	migliori
1	nanovesicles,
1	(exo),
1	(dc-exo),
1	(sk-br-3)
1	dcs-exo
1	sk-br-3-primed
1	dc-exo-treated
1	elispot),
1	non-dc-exo-treated
1	flourished
1	prospecting
1	(carcinoma,
1	non-cancerous).
1	beta-binomial,
1	shrunken
1	centroids
1	(nsc),
1	machine-recursive
1	(svm-rfe),
1	271
1	pre-qualify
1	benzo[d][1,3]dioxol-5-ylmethyl
1	alkyl/aryl
1	(b16f10,
1	sk-mel-28,
1	nci-h460,
1	sk-br-3,
1	(mrc-5).
1	(5f,
1	6c,
1	6e
1	lymphostimulatory
1	sirnacd83,
1	(29.0±10.0)
1	sirnascr-treated
1	(45.5±5.3).
1	confocal).
1	58.14%
1	34.29%.
1	dilution).
1	pd-l1,
1	cd205,
1	mo-dc’s
1	il-2rα
1	recurrence.purpose:
1	chromophobe
1	(chrcc),
1	34-year-old
1	chrcc,
1	removal.conclusion:
1	immunocompetence.
1	analysis—not
1	immunophenotype—may
1	“window”
1	furoxans
1	bfd-22,
1	revels
1	trail-r1/dr4-triggered
1	specially;
1	nanoliposomes
1	anti-inflammatory/suppressive
1	tgf-beta,
1	icos
1	nalio
1	ramos
1	pandr
1	(il-12p70)
1	p72syk
1	baleeiro
1	(m-mddcs)
1	(hp).
1	(gm-csf),
1	sanguinis,
1	phenotyped.
1	cd123,
1	5.8-fold
1	maintained/exacerbated
1	m-mddc.
1	needle-free
1	convenience,
1	microparticle-based
1	(scd40l,
1	cocktail,
1	cd3+cd25negfoxp3neg
1	cd25+,
1	polytetrafluoro-ethylene
1	(ptfe)
1	macroencapsulation
1	circumvents
1	neovascularization
1	later)
1	immunoisolation
1	es-expressing
1	anti-es
1	melanoma-bearer
1	(chp).
1	arms;
1	tumor-bearer
1	nondependent
1	gin-
1	gival
1	periodontitium
1	drug-
1	(dige).
1	dige
1	(idige)
1	idige
1	idige.
1	immunosuppressed.
1	pfaffia
1	multifarious
1	estrogen-positive
1	(s100+
1	cd1a+),
1	(cd68+),
1	tnf-α-positive
1	il-4-positive
1	cd14-cd80+
1	cd83+
1	happening
1	shows,
1	a459
1	a375
1	c81-61,
1	skbr-3
1	ar42-j),
1	(cd1a)
1	xiiia)
1	marl
1	sorbilis)
1	hepatocarcinogenesis
1	educed
1	diethylnitrosamine-induced
1	b16/f10
1	cells/
1	intothetail
1	cupanalg
1	antigen-positive
1	guaraná-treated
1	(gua)
1	68.6%
1	0.0043),
1	57.9%
1	23.75
1	20.54,
1	9.99
1	3.93,
1	0.026)lpnd
1	4.85-fold
1	66.95
1	22,95,
1	324.37
1	266.74
1	ab/mm
1	0.0152).
1	histogical
1	66-year-old
1	retroperioneal
1	medicina.
1	(13%
1	week;
1	bilirubinemia.
1	12/12
1	nsclc,
1	nmoles/2
1	7/12
1	(7/7)
1	(2/7).
1	dc-autologous
1	centrifugation,
1	(mlr),
1	mlr.
1	3/22
1	untoward
1	(caf1),
1	caf1
1	eat:
1	"unconscious"
1	perpetrate
1	pathogen)
1	population:
1	vanishes.
1	pathogen-independent
1	t-helper);
1	expansion/
1	evolutionarily,
1	51-year
1	applications).
1	cells-based
1	behavior-related
1	(submaxillary
1	ablation),
1	(til)
1	nerve-like
1	(ngf)/epidermal
1	(egf)-positive
1	sialectomized
1	ngf+
1	8-month-old
1	one's
1	machina
1	errors,
1	step-by-step
1	ca-15.3
1	vk
1	(gly4ser)3
1	pet21d
1	nonmelanoma
1	scfv.
1	tumor/host
1	mitomycin-c-treated
1	seerction
1	expansion).
1	(non-expanded
1	expanded-
1	nonexpanded
1	(pbbl)
1	25/36
1	10/13
1	4/10
1	(til).
1	mot,
1	mot-induced
1	(melanoma,
1	twentyfive
1	periopaper
1	crevice
1	pge2concentrations
1	(129.35
1	198.84
1	0.0169)
1	(198.84
1	0.0032).
1	pge2levels.
1	pge2from
1	0.0119
1	0.0076,
1	pge2initial
1	(baseline:
1	129.35
1	163.20
1	0.0379;
1	t3:
1	175.30
1	0.0005).
1	orthodontics
1	juveniles.
1	anti-e
1	opsonizing
1	particle.s
1	lysosyme
1	opsonize
1	adult)
1	co-dominant
1	"null"
1	"slow"
1	s-allotypes.
1	gruby,
1	1843
1	1906
1	(terrestrial
1	(african
1	(trypanosomes
1	(caimans);
1	cay03
1	(caimans
1	tabanids);
1	tab01
1	flies)
1	kaiowa.
1	multiplied
1	transcontinental
1	migrant
1	co-inhabiting
1	miocene.
1	(phyllostomidae)
1	trachops
1	cirrhosus
1	jamaicensis
1	(phyllostomids),
1	positioning,
1	pcr-surveys
1	blood/liver
1	pessoai,
1	self-sufficiency.
1	nech
1	(nsnp),
1	rifty
1	arba
1	minch
1	barcoding.
1	(47.8
1	flies/trap/day)
1	warthog
1	ungulate
1	(42%
1	guts),
1	22%,
1	19.9%,
1	(trypanozoon)
1	10.5%,
1	6.3%,
1	(61%).
1	“west
1	african-south
1	american”
1	(2.1%)
1	simiae.
1	valley.
1	(bc),
1	95/120
1	(79.2%)
1	(motus)
1	motus
1	bio-accumulators
1	non-culturable
1	bypassing
1	lainsoni.
1	hemocultures.
1	host-spectrum
1	brilhante
1	(ccl)
1	xapuri
1	domiciles
1	ccl.
1	ccl,
1	neal,
1	nicolle’s
1	(nnn)
1	its1,
1	andes,
1	(99–100%).
1	sp..
1	cis-andean.
1	tropicopolitan.
1	am80
1	025e,
1	tcvi.
1	low-virulent
1	am80,
1	025e
1	21-25
1	13,000
1	haplotyped
1	12,500
1	heterozygosity.
1	trans-sialidases,
1	dgf-1,
1	masp,
1	costa-martins
1	(shsps)
1	alpha-crystallin
1	(acd)
1	early-diverging
1	acd-like
1	(acdp)
1	frogs),
1	(mammals
1	lizards),
1	bodonids.
1	acdp
1	tryacd:
1	(hsp20,
1	tryp23a,
1	tryp23b
1	atom69),
1	(tryacdp,
1	trysgt1,
1	trydyx1c1
1	trynudc).
1	trynudc1/
1	trypnudc2
1	stage-regulated.
1	barcoding)
1	(3086)
1	(gnp)
1	(nnr)
1	(gnp/nnr
1	77.6%/90.5%)
1	(22.4%/9.5%).
1	guts.
1	(27%/63%),
1	(16.7%/29.7%)
1	(1.0%/0.3%)
1	(36.5%/6.1%);
1	(22.2%/17.7%);
1	(18.2%/7.0%);
1	(20.2%/25.7%);
1	(1.5%/5.2%);
1	suis/t.
1	suis-like
1	(9.4%/11.9%).
1	(21.9%/28%),
1	(19.2%/31.7%),
1	(19.2%/28.6%).
1	64%),
1	nnr.
1	mz;
1	species/genotypes
1	lewisi-like),
1	opportunistically
1	rat-borne
1	poverty.
1	(mozambique),
1	(thailand,
1	cambodia
1	lao
1	pdr).
1	(253
1	mastomys
1	natalensis
1	spillover
1	non-rodent
1	gerbil.
1	(amplified
1	pan-trypanosome
1	primers)
1	harboring,
1	hosts;
1	neotropics.
1	taxon-rich
1	tve
1	vespertilionis-like
1	hoch
1	tco
1	triatomine-transmitted
1	tropicopolitan
1	nandoum1
1	civet
1	(carnivore).
1	rooted
1	jumped
1	civets
1	life-cycles
1	rangeli)
1	urbanized
1	(tci-tcvi
1	tcbat),
1	disease)
1	identification-free,
1	sequence-independent
1	workflow.
1	tc-stams2.
1	spectrast.
1	confidence.
1	inter-laboratory
1	tci-tcvi
1	genomic-based
1	borghesan,
1	campaner,
1	matsumoto,
1	espinosa,
1	razafindranaivo,
1	paiva,
1	carranza,
1	añez,
1	camargo.
1	angomonas,
1	calliphoridae
1	(blowflies)
1	afrotropical
1	3,900
1	calliphoridae,
1	wallacemonas.
1	two-other
1	infraspecific
1	(dea1-dea4),
1	(kcr1-kcr4).
1	co-divergence,
1	angomonas/symbionts
1	blowflies,
1	lucilia,
1	cochliomyia.
1	desouzai,
1	cochliomyia
1	spillback
1	chrysomya,
1	neotropic.
1	afrotropic,
1	human-mediated
1	(lins),
1	2278,
1	3936
1	4062
1	liem-176
1	(venezuela),
1	il1392
1	lins
1	4684
1	(nigeria).
1	(dtus).
1	rrna)was
1	tciii.
1	tciii;
1	(bolivia,
1	lenti,
1	tm,
1	sc90);
1	(famema,
1	sc96,
1	si8,
1	y);
1	(qmm3,
1	qmm5,
1	si5)
1	(vector)
1	interlocked
1	(kaps),
1	(shts)
1	ß-proteobacterium
1	co-evolves
1	sht
1	aposymbiotic
1	symbiont-bearing
1	kap4
1	kap7
1	vivax-like)
1	tvva/b
1	ea)
1	tvvc/d
1	(exclusively
1	ea).
1	its-genotypes
1	tvv:
1	tvv1
1	(wa/ea
1	tvv2
1	tvv3-5
1	(ea).
1	wa/sa
1	ggapdh-groups
1	tvla
1	(tanzania/kenya)
1	tvlb-d
1	(mz).
1	its-genotypes,
1	tvl-gorongosa
1	subgenus,
1	wa.
1	wilderness
1	paratenic
1	inestimably
1	yacare),
1	(79.5%)
1	caimani.
1	19.6%
1	7.42%,
1	monozoic
1	dizoic
1	900 bp,
1	hepf300/hep900
1	hemo1/hemo2.
1	merogony
1	yacare.
1	(5·28%)
1	nuog
1	(13·97%)
1	(nuog)
1	ftsz
1	argonaute
1	(ago1),
1	(dcl1),
1	dicer2
1	(dcl2)
1	dcl2.
1	confidence,
1	ago1,
1	dcl1,
1	dcl2
1	progenitor,
1	kinetoplastea.
1	syntenic,
1	(exo)
1	llanos
1	23%)
1	examined).
1	trypanosomosis.
1	(mlg)
1	mlg.
1	(62.6%)
1	symptomatic/lethal
1	droughts,
1	babesiosis.
1	weaken
1	hemipterans.
1	a–f
1	infrageneric
1	(phy
1	clades).
1	phya,
1	hemipterans;
1	phyc
1	phye,
1	solanaceae.
1	phye
1	dolleti
1	solanum
1	arvelius
1	albopunctatus
1	(pentatomidae).
1	affiliation,
1	chaquensis
1	anura
1	trypanosoma,
1	multiplies
1	clumped
1	multiple-fission
1	flagella;
1	glove-like
1	cytostome
1	lamella,
1	pumpkin-like
1	catenation
1	spongiome
1	(tbds)
1	syncerus
1	caffer,
1	marromeu
1	groel,
1	msp2,
1	pcs20
1	vlpt
1	chaffeensis,
1	2.69
1	msp1β
1	copies/μl.
1	centrale.
1	centrale/a.
1	platys
1	hindgut
1	jabaquara
1	subway
1	trypanosomatidae,
1	ecotopes,
1	tree-reconstruction
1	america:
1	asp-box
1	vtvxnvxlynr
1	frip
1	(conserved
1	museum
1	liver/blood
1	guatemala
1	america)
1	(mormoopidae)
1	bat-seeding
1	spp-neobats
1	noctilionoidea
1	pteronotus.
1	wauwau/t.spp-neobats
1	crocodilus,
1	tsetse-transmitted
1	niloticus.
1	pcr-survey
1	nesting
1	yacare,
1	(haementeria
1	yacare)
1	terena,
1	hemoculturing,
1	lemos
1	hypostomus
1	affinis.
1	(brazilian)
1	(90-100
1	(0.9-1.0x102)
1	european,
1	sphaeromastigotes.
1	cytostome-cytopharynx
1	epi-
1	kinetoplast,
1	lysosome-related
1	(lros)
1	pleomorphic,
1	affinis
1	leeches.
1	tvicatl-pcr
1	pcr-amplifed
1	semiarid;
1	(16.6
1	(15.5
1	(pcv).
1	(tvibrrp)
1	subpatent.
1	tvibrrp
1	pallor,
1	farmers,
1	veterinaries
1	bats-trypanosoma
1	(cytb)
1	cavernicola
1	pilosa
1	ecuador.
1	rrna),
1	(retrieved
1	tcbat)
1	databanks
1	tcii;
1	tciv,
1	tci-tcbat.
1	tciv
1	assignment,
1	cytb,
1	stefański
1	parasitology,
1	pas.
1	peridomicile
1	jardim
1	mogi,
1	molecularly.
1	3014
1	multiloci
1	(mlgs)
1	(47isolates
1	guiana)
1	gambia,
1	faso,
1	benin
1	nigeria).
1	phylogenetic,
1	genotypes/47
1	genotypes/12
1	(mlg1-6),
1	(mlg7-10)
1	(mlg11)
1	mlg
1	(endemic
1	(outbreaks
1	mlgs1,
1	(canl),
1	luciliae,
1	(17/50)
1	dissimilarity
1	worthless
1	betaproteobacterium
1	co-evolution.
1	(shts
1	symbiont-haboring
1	endosymbiont),
1	(rts
1	trypanosomatids),
1	biotin,
1	riboflavin,
1	auxotrophic
1	ketopantoate
1	(ec:1.1.1.169)
1	bacteria;
1	gammaproteobacteria.
1	alligatorids
1	crocodilids.
1	haemoculturing.
1	crocodilian-restricted
1	niloticus
1	basins.
1	ralphi.
1	orinoco
1	osteolaemus
1	tetraspis.
1	paleontological
1	miocene/pliocene
1	(4-5
1	hydrographical
1	fermino
1	guessed
1	symbiont's
1	autotrophy,
1	cyclodeaminase,
1	ec:4.3.1.12)
1	enzymatic,
1	transfers,
1	endosymbionts,
1	2013alves
1	(rhinolophus
1	landeri
1	hipposideros
1	caffer)
1	hemoculture.
1	(fflb).
1	barcoding,
1	(large
1	(cytostome
1	reservosomes)
1	(candidatus
1	tpe
1	[trypanosomatid
1	endosymbiont])
1	hostmetabolism.
1	stereotypical
1	tpes,
1	ancestries.
1	informational
1	taylorella
1	g3
1	g4
1	tripomastigotes.
1	(albumin,
1	urea),
1	(ewe
1	34th
1	35th
1	ewes.
1	pallor
1	lutea,
1	barcoded
1	diptera,
1	(its1)
1	rhodesiense,
1	sub-species)
1	lewisi-like.
1	l-i,
1	truc
1	erneyi
1	america-restricted
1	suborders,
1	yinpterochiroptera,
1	yangochiroptera,
1	worlds
1	3.2-5.0.
1	(mya),
1	11.4.
1	taxon-specific
1	footprint.
1	super-continent
1	australia.
1	envisaged.
1	(municipality
1	lins).
1	jaundice,
1	hyperfibrinogenemia
1	1080
1	dysmetria,
1	ptyalism,
1	hemoparasites
1	diaminazene
1	599
1	(98.36%)
1	calcitrans.
1	biosolid
1	keds,
1	sheep-restricted
1	melophagus
1	ovinus
1	hippoboscidae).
1	croatia,
1	leader,
1	croatia
1	scotland,
1	host-restricted
1	re-emerge
1	(rainy
1	(dry
1	65.0%,
1	37.5%.
1	30.3
1	26.2×10
1	39.8
1	40.3°c),
1	15.7%
1	18.1%),
1	3.5)
1	dewlap,
1	coryza,
1	(12.73),
1	(15.55)
1	32×10
1	74×10
1	vivax-induced
1	pressing,
1	recumbence,
1	paddling
1	tremors.
1	coloring,
1	nonsuppurative
1	iatrogenically.
1	bubalis).
1	(itsrdna),
1	5srrna,
1	tthia,
1	tthia.
1	(megatrypanum).
1	incongruence
1	co-evolution,
1	(g):
1	necropsied,
1	batista
1	theileri,
1	centrifuge
1	(tthcatl-pcr)
1	tthii,
1	brener).
1	(tci,
1	tcvi)
1	tc1161
1	(josé-imt).
1	chromosome-sized
1	tb9
1	tb11
1	randomly,
1	flagellate's
1	synthesis-deficient
1	kinetoplastida.
1	co-divergent
1	prepuce,
1	vulva.
1	beta-2,
1	globulins.
1	aceturate,
1	relapsed
1	buffaloes,
1	human-infective
1	(fflb)
1	dionisii-like,
1	(ada)
1	n=13).
1	evansi-infected
1	proboscides
1	swynnertoni
1	(fflb),
1	(619%)
1	vivax;
1	midguts.
1	tanzanian
1	brucei-like
1	1043
1	trypanosome-infected
1	(25).
1	(32.4%)
1	(north
1	central).
1	(18.2%)
1	vespertilionid
1	pantanal/cerrado
1	southeast),
1	artiodactyls
1	tthii
1	iia,
1	west,
1	(tciic)
1	tciid/e,
1	tciia,
1	tciib
1	didelphids
1	tciic.
1	habitat,
1	cycles/ecological
1	paddock.
1	pseudoboa
1	clade).
1	v7-v8
1	serpentis
1	cascavelli.
1	evansi-specific
1	85.7%.
1	gamma-glutamyltransferase,
1	hemogram
1	248
1	herds)
1	(bct)
1	apathy,
1	cornea,
1	(pcv)
1	(tci).
1	(tc
1	sublineages,
1	(tciia)
1	tciia)
1	ssrdna,
1	tciib-e
1	confidently
1	cruzimarinkellei
1	platyrrhinus
1	planirostris
1	stali
1	(tvicatl1-9)
1	distances.
1	tvicatl1-4
1	(nigeria
1	faso)
1	tvicatl5-7
1	tvicatl8-9
1	kenya.
1	antigen)-blot
1	(tesa-elisa)
1	(epi-elisa)
1	49.4%,
1	(mato
1	tesa-blot,
1	tesa-elisa
1	epi-elisa.
1	(rondonia
1	amazonia)
1	4.5%
1	epi-elisa
1	tesa-elisa.
1	(alligatoridae)
1	(crocodilydae)
1	cay01
1	cay02.
1	(clade
1	grayi).
1	1ml
1	1.25×10
1	orquiectomized.
1	epididymides
1	anatomopathologically.
1	flabby
1	palid
1	triatominae
1	1.6%
1	quaraí,
1	biologically.
1	(tciic).
1	miotropism
1	african/south
1	(tragelaphus
1	angasi)
1	africa)
1	america),
1	africa),
1	africa).
1	tamarin,
1	saguinus
1	(callitrichidae),
1	(46.8%)
1	(7.3%)
1	(87.5%).
1	(85.7%)
1	(9.4%)
1	mixed.
1	genotyped:
1	(87.1%).
1	jararaca)
1	(pseudoboa
1	nigra).
1	behaviourally
1	indistinguishable.
1	viannamyia
1	cross-infection
1	squamate
1	flaws
1	nystagmus,
1	tetany
1	proeminence
1	hydropericardium
1	petechiae
1	ecchymoses
1	epicardium.
1	meningoencephalitis.
1	diminazena
1	anurans,
1	hylidae,
1	anuran.
1	morphotypes)
1	ecogeographical
1	died;
1	relapsed.
1	meninges,
1	proteinogram
1	normochromic-normocytic
1	neutrophenia
1	lymphocitosis;
1	trombocitopenia.
1	hyperproteinemia
1	interpretations
1	(triatomine
1	rhodnius)
1	(sl).
1	sympatry
1	ecotopes.
1	american,
1	venezuela)
1	west/east
1	(ssu,
1	(kenya)
1	species/subspecies
1	believed.
1	565
1	67.6%
1	(382/565):253
1	(61.7%)
1	(33.5%)
1	(bcp).
1	triatomine-bugs
1	91.5%
1	falcon
1	cojedes
1	artiodactyls.
1	'clade
1	theileri'
1	clade'
1	artiodactyls,
1	artiodactyl
1	buffalo;
1	cattle;
1	fallow
1	andamana
1	patoc,
1	(serovars
1	icterohaemorrhagiae,
1	autumnalis)
1	g1/g2-primed
1	(57.6%)
1	(33.3%),
1	p=0.04,
1	63.6%,
1	84.4%
1	(81.8%).
1	circulates,
1	barinas)
1	failure)
1	indistinguishable,
1	close-genetic
1	theileri-cluster
1	host-associated
1	(tth625),
1	theileri-specific
1	(tthc606
1	tthb606)
1	theileri-like
1	asiatic
1	akinetoplastic
1	(ethiopia,
1	philippines)
1	equiperdum,
1	rhodesiense.
1	te664)
1	te664
1	minichromosomes
1	field-epidemiological
1	squashes
1	(108/244)
1	coreidae
1	oligonucletide
1	(sl3′)
1	trypanosomatid-positive
1	close-relatedness
1	colombia)
1	microhematocrit
1	field-blood
1	(enzymes
1	ornithine-arginine
1	spliced-leader,
1	pyrrhocoridae,
1	coreidae,
1	lygaeidae,
1	choanomastigote
1	leptomonas;
1	cucurbita
1	moschata.
1	opisthomastigote
1	spined
1	(displaying
1	pocket)
1	isolate-specifc
1	camargoi
1	(giemsa
1	4′-6′-diamidino-2-phenylindole
1	sequence).
1	minicircles,
1	thwarts
1	epiphytotics
1	plantations.
1	myrna
1	serrano,
1	marta
1	erney
1	amebae
1	methanol-fixed
1	non-cultivable.
1	strains/species
1	palms
1	ssrrna.
1	(macropus
1	giganteus),
1	(vombatus
1	ursinus)
1	(ornithorhynchus
1	anatinus).
1	sp.;
1	binneyi.
1	hemidesmosomes
1	em.
1	cross-hybridization
1	vespertilionis]
1	leeuwenhoeki,
1	minasense,
1	conorhinil
1	kangaroo.
1	synonyms
1	discontinued,
1	100-bp
1	leader-
1	sl3'.
1	fruit,
1	slpcr
1	trypanosmatids,
1	endosymbiont-bearing
1	oncopelti)
1	acanthocephali
1	single-member
1	lucilae
1	592
1	opisthomastigotes,
1	hin
1	diii
1	1.500
1	(α-large
1	roitmani,
1	samueli
1	davidi
1	anglusteri,
1	dedonderi,
1	mcgheei
1	19-nucleotide
1	blastocrithidia,
1	leptomonas,
1	phytomonas‐specific
1	françai
1	localise
1	surface/internal
1	intra‐cellular
1	tomatoes
1	francai
1	phytomonads
1	372
1	(coreidae
1	pyrrhocoridae
1	lygaeidae
1	68.4%,
1	2.3%.
1	fifty‐one
1	ornithinc‐arginine
1	twenty‐one
1	5e7
1	cruzi:
1	tulahuen.
1	1g7,
1	5e7,
1	riteau,
1	moayeri,
1	maier,
1	mayer-barber,
1	kubler,
1	bishai,
1	d'império-lima,
1	sher
1	(ctsb)
1	(bmdms)
1	esat-6
1	ca074-me
1	ca07-me
1	ltak63.
1	(rbcg-ltak63
1	2.0-3.0
1	mucolytic
1	(ltbi)
1	acidity.
1	ltbi
1	tuberculosis-infected
1	(m2).
1	h37rv.
1	(arg-1).
1	arg-1.
1	arg-1
1	vitro-produced
1	ivp
1	culturing.
1	sof
1	ivc
1	ksr,
1	cm).
1	(tunel
1	oct3/4,
1	ssea1
1	fcs-supplemented
1	pluripotency.
1	cd5
1	th2-mode
1	disregulation
1	self-directed
1	deregulation,
1	immunopotentiation
1	argued,
1	ignorance
1	class-determination,
1	scientifically-based,
1	empirically-based
1	technologically
1	succeed,
1	(f3'ep-si),
1	b-cell-mitogenic
1	p90.
1	plaque-
1	hyper-gammaglobulinemia,
1	late,
1	(dna,
1	(klh,
1	levan
1	dextran),
1	elisaspot
1	clones;
1	klh
1	dextran)
1	181-188,
1	1990.-antigenic
1	transblotted
1	cross-reactive.
1	24,000
1	14-18,000
1	moojeni,
1	pradoi
1	enzyme-substrate
1	8:1,
1	3.1,
1	5.0).
1	uncleaved
1	fab′
1	f(ab′)2b.
1	anti-whole
1	12,800
1	[f(ab′)2b],
1	4800
1	[f(ab′)2m]
1	3200
1	(fab′b).
1	containing.
1	f(ab′)2b,
1	fab′b
1	13.8
1	virus-free
1	(asfv)
1	subfractionated
1	double-step
1	(f5'ep-asfv)
1	heat-unstable
1	3.88,
1	36,000
1	plaque-forming
1	23-fold.
1	f5'ep-asfv,
1	rbc,
1	f5'ep-asfv-treated
1	diastasis.
1	(ig)‐secreting
1	predominate.
1	reinoculation
1	unvariable
1	igg2b-secreting
1	imraperitonal
1	(cl.
1	lectin‐dependent
1	cr‐release
1	(ctl).
1	thy
1	onwards).
1	activity'
1	100‐fold
1	(c3h/hej).
1	cruzi‐infected
1	(ig
1	l3t4
1	dividing.
1	c57bl/(resistant)
1	(susceptible)
1	c3hihej
1	ig‐secreting
1	‐
1	iga‐secreting
1	helper‐dependent
1	palynological
1	bituminous
1	shale
1	missao
1	velha
1	araripe
1	stratigraphic
1	horizon
1	chronozone,
1	signifies,
1	aptian
1	stratigraphical
1	codo
1	(parnaiba
1	basin)
1	marizal
1	(reconcavo/tucano/jatoba
1	basin).
1	non-marine
1	dry.
1	-after
1	english
1	coordination.
1	ataxia-like
1	1534
1	p.asn64tyr
1	(gcps).
1	gcps
1	gli1–3
1	(cyclind1).
1	uva-light
1	reverted,
1	caffeine.
1	uva-ddr,
1	chk1
1	bate
1	palmas
1	(bapa)
1	claps
1	n-ethyl-n-nitrosourea
1	nucleotide,
1	1289
1	(k)-specific
1	(kmt2d)
1	kabuki
1	(ks).
1	fall,
1	presupposes
1	ι
1	ζ.
1	skipped,
1	hypermutation
1	retrace
1	(adaptive)
1	η.
1	photodamage
1	lamps,
1	dna repair
1	formamidopyrimidine-dna
1	(t4-endo
1	v),
1	(cpd),
1	break,
1	uva.
1	vistas
1	(hgt)
1	repair/translesion
1	h2o2-generating
1	(mcf12a)
1	inhalable
1	(pm10),
1	retene,
1	pm10-mediated
1	dysfunctional,
1	checkpoints,
1	(ber),
1	(mmr).
1	autophagy-dna
1	latitudes,
1	bryothamnion
1	triquetrum
1	halimeda
1	incrassata.
1	(eco
1	bam
1	reconnaissance
1	uvc-irradiated
1	enviromental
1	excelent
1	pinus
1	caribaea
1	(epc)
1	caribaea,
1	(0.1-2.0
1	enzymatically.
1	312
1	endo
1	mg/ml.
1	absorptives
1	excite
1	chromophores,
1	(cpds),
1	8-oxo-7,8-dihydro-2′-deoxyguanine
1	(8-oxodg)
1	cpds.
1	decoction
1	nice
1	hypotensor
1	radioprotector
1	antimutagenic
1	(essential
1	chromotest
1	photoaging
1	photons
1	chromophores
1	photoaging.
1	chaperone-mediated
1	(cma),
1	myc/c-myc-driven
1	tumorigenesis-related
1	myc-transformation.
1	c330027c09rik/kiaa1524/cip2a
1	cip2a),
1	ser62,
1	(ser62)
1	cma-mediated
1	(ser62
1	ala62)
1	cma-incompetent
1	nontumorigenic
1	goias
1	sunny
1	inhabitants).
1	polh.
1	(c.764
1	g>a),
1	(c.907
1	c>t,
1	p.arg303x).
1	(rnapii)
1	photolyase-mediated
1	sensor,
1	xpe,
1	hyperphosphorylation.
1	uv-pds-ner-atr-rnapii-as
1	p53-
1	h-silenced
1	(6-4pp)
1	(tls
1	pols)
1	gap-filling.
1	polη,
1	rev3l
1	(polζ
1	postreplication
1	rev3l,
1	postreplicative
1	gap-filling,
1	prr
1	polζ-dependent
1	stress-associated
1	subnuclear,
1	chromatin-associated,
1	nedd8.
1	oncosuppressor,
1	microenvironment/autophagy
1	tumourigenic
1	cross-complementation
1	ercc6
1	(csb).
1	hypomyelination,
1	(gh/igf-1)
1	csb-deficient
1	synchrony,
1	neuralspecific
1	cs.
1	3-hydroxypropionaldehyde
1	(3-hpa)
1	1,3-propanediol
1	(1,3-pd)
1	subproducts
1	polyurethanes.
1	catabolize
1	1,3-pd,
1	halalkalicoccusjeotgali.
1	(lgt).
1	1,3-pd.
1	xpc-complemented
1	dismal
1	(nrf2),
1	nfr2,
1	configures
1	adn.
1	pbluescript
1	0.01-4.0
1	vegetal
1	j/m2doses.
1	od.
1	(cq),
1	nac-containing
1	cq-induced
1	(lc3ii)
1	cq.
1	lc3ii,
1	mmp,
1	laminin-rich
1	lrecm)
1	atg5
1	doxo-induced
1	monolayer-cultured
1	p53-dram-autophagy
1	bru-seq
1	5'-3'
1	tc-ner
1	resumed
1	(tc-ner)
1	(gg-ner).
1	stall
1	η)
1	atr-depleted
1	atr-mediated
1	catastrophe,
1	spastic
1	paraplegia,
1	(spoan).
1	wheelchair
1	contractures
1	deformities.
1	non-progressive
1	genewas
1	herewe
1	spoan-derived
1	(chr11.hg19:g.66,024,557_66,024,773del)
1	reporter,
1	wild-type.
1	curly-tail
1	(uv)-induced
1	polη.
1	polη-deficient
1	stalling,
1	unmask
1	xp-c/polηkd
1	analogy,
1	ner-defective
1	(dna-spf),
1	(ld-spf),
1	radiation;
1	biodosimeter
1	sunscreens,
1	lysosome-dependent
1	dictating
1	sub-pathways,
1	(tcr),
1	proficient,
1	(tcr-deficient)
1	(ggr-deficient)
1	high),
1	transcribing
1	ortolan,
1	menck.
1	dosimeters
1	(320-400
1	(cyclobutane
1	6-4pps)
1	photoproducts.
1	adenovirus-mediated
1	skin-damaging
1	(prc2);
1	anrassf1,
1	5′-capped
1	polyadenylated;
1	rassf1a.
1	marks,
1	lncrna,
1	non-characterized
1	beckedorff
1	non-syndromic
1	(nscl/p)
1	malformation,
1	2.88×10
1	-5.02×10
1	brca1,
1	rad51,
1	msh2,
1	brca1
1	primordia,
1	nscl/p.
1	kobayashi
1	3′-endonuclease
1	(ercc5)
1	xp-g
1	photosensitized
1	xp-g/cs
1	c.83c>a
1	(p.ala28asp)
1	c.2904g>c
1	(p.trp968cys).
1	plasmids;
1	oxidative-stress-induced
1	repaired,
1	(ips)
1	ips
1	kunth
1	antigenotoxicity
1	(uvb)-irradiated
1	(mrc5-sv)
1	(xp4pa,
1	xpc)
1	cell-lines
1	(cpds).
1	slot-blot
1	36.03
1	3.59
1	4.42
1	53.14
1	14.52
1	1.97,
1	j/m
1	0.2%,
1	non-motile,
1	aerobic,
1	short-rod
1	coccobacillary
1	singly,
1	xylosoxidans.
1	m-cresol
1	o-cresol.
1	page).
1	phenol-cultures
1	c-1.
1	(phenol
1	meta-pathway
1	hydroxymuconic
1	4-hydroxy-2-oxovalerate
1	aldolase)
1	p-ketoadipate
1	dioxygenase,
1	biodegrading
1	wastewaters.
1	transcription-couple
1	(csb-ipsc).
1	nanoformulation
1	polyelectrolytes
1	(carboxymethylcellulose,
1	cmc;
1	ch;
1	polyethyleneimine,
1	pei)
1	([cis]
1	25-250
1	[cmc]
1	[ch
1	70-200
1	32-48
1	zeta-potentials.
1	nucleotide-excision
1	cmc/ch
1	dosimeter.
1	(dna-spf)
1	schuch
1	view-point
1	photometry
1	uvb/uva
1	onapplying
1	latitude,
1	lesion-pattern
1	additional,
1	cancerprone
1	(fa).
1	progeria
1	eta,
1	xpv)
1	dox-sensitive.
1	pikk
1	dox-treatment,
1	dose-limiting
1	sandwiching
1	polyelectrolytes:
1	(cmc),
1	cispt
1	biosphere
1	uv-wavelengths
1	justifying
1	soon,
1	duplexes
1	pseudomonas.
1	hydroquinone.
1	reactor
1	wastewaters
1	phenol-contaminated
1	39th
1	"south
1	border"
1	graciela
1	spivak
1	ofelia
1	olivero,
1	specialties
1	radiation-intensity
1	artificial-uv
1	pcmut
1	mbl50
1	contradict
1	(indels)
1	legionelalles,
1	chromatiales,
1	methylococcales,
1	thiotrichales
1	cardiobacteriales.
1	(dox),
1	ii-poisoning,
1	interstrand
1	cross-link
1	xpd-mutated
1	foci.
1	h2ax
1	knock-down
1	iiα
1	ner,
1	xp-deficient
1	xpd-function
1	1o2),
1	thermo-dissociated
1	dhfno2
1	photoactivated-methylene
1	t4-endov,
1	apurinic/apyrimidinic
1	relaxed-dna
1	dhpno2,
1	photoactivated-mb
1	ap-sites
1	1o,
1	hydroquinone)
1	(cvmp)
1	cell-growth
1	(catechol
1	hydroquinone).
1	orto
1	cathecol
1	hydroquinone,
1	meta-cleavage
1	lc/ms
1	ring-fission
1	phenol.
1	best-known
1	[(6-4)pps],
1	(6-4)pps
1	(dsbs)
1	8-oxo-7,8-dihydro-2′-deoxyguanosine
1	(8-oxog),
1	cross-talks
1	quinolinate,
1	(nad),
1	(aspartate-to-quinolinate)
1	(tryptophan-to-quinolinate).
1	quinolinate
1	viewpoint.
1	flavobacteriales,
1	(xylella
1	bacteroidales,
1	flavobacteriales
1	bcnu,
1	photoproduct
1	photolesions.
1	obliges
1	sunshine.
1	s.a.u.
1	licensors.
1	(xpd)
1	transcription/repair
1	6-4-photoproducts
1	(6-4pp).
1	photorepair;
1	6-4pps.
1	recruit,
1	tfiih-dependent
1	6-4pps,
1	tfiih.
1	trichostatin
1	transferred.
1	γ-proteobacteria
1	bordered
1	(flavobacteria
1	(eukarya
1	archaea),
1	nitrosoureas
1	[1-(2-chloroethyl)-1-nitrosourea;
1	cnu]
1	nimustine
1	[1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea;
1	acnu],
1	[1,3-bis(2-chloroethyl)-1-nitrosourea;
1	bcnu],
1	[1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea;
1	ccnu].
1	cnu
1	(p53wt)]
1	(p53mt)]
1	pifithrin-α
1	bcnu.
1	ddb2
1	acnu-induced
1	deciding
1	xpg)
1	xpv).
1	∼1376
1	∼4
1	∼2)
1	odorant
1	trematode
1	flatworm,
1	(serial
1	adult-worms,
1	68,238
1	tag-list
1	f10
1	pol-polyprotein,
1	hsp86,
1	46.9%
1	ditags
1	mapped,
1	rarest
1	alternative-polyadenylation
1	shorten
1	mansoni.
1	ojopi
1	gleam
1	qualifies
1	ubiquity
1	(xtha),
1	(nth),
1	o6-
1	methylguanine-dna
1	(ada
1	photolyase-like
1	uracil-dna-glycosylases.
1	alpha-proteobacteria,
1	configurations,
1	(malignant
1	gliomas).
1	n-methyl-n′-
1	nitro-n-nitrosoguanidine
1	(mnng)
1	o6-methylguanine-dna
1	(mgmt)
1	o6-benzylguanine
1	o6-methylguanine
1	(o6meg)
1	o6meg
1	fas/cd95/apo-1
1	(occurring
1	>120
1	o6meg-induced
1	(dsbs),
1	dna-pk(cs),
1	end-joining,
1	mgmt,
1	autosomal-transmitted
1	genodermatosis
1	(uvb
1	radiation)
1	victimized
1	viral-based
1	retroviruses)
1	adenoviruses).
1	third-generation
1	(xpa,
1	xpd).
1	repair-defective
1	detrimental,
1	dna-damage
1	fate:
1	2,787
1	camptothecin
1	(cpt).
1	1,512
1	strain:
1	fhda
1	forkhead-associated
1	tpra
1	tetratrico
1	repeat),
1	msha
1	muts
1	repair),
1	phba
1	homologue),
1	uvscrad51
1	csha
1	ercc-6
1	[cockayne's
1	protein]).
1	uvsbatr.
1	δuvsc
1	cpt;
1	uvsc,
1	δuvsb
1	(non-gamma-proteobacteria).
1	quarter
1	xanthomonad
1	(gus)
1	shoots
1	pthi322)
1	[2005].
1	[on
1	biology].
1	syndromes:
1	(ttd).
1	nine-protein
1	unwinding
1	5′→3′
1	ires
1	prone.
1	xpb-ttd
1	uvc-transcription
1	869
1	'uvc
1	signature'
1	portrait
1	(xpb)
1	(atxpb1
1	atxpb2),
1	thale
1	cress.
1	xp-mutant
1	they,
1	too,
1	mutagenic,
1	(adphr-egfp).
1	adphr-egfp-infected
1	photorepair,
1	uv-damaged
1	phr-egfp
1	dna-repair-deficient
1	adphr-egfp
1	japonicum
1	japonicum,
1	∼125
1	>14
1	now-sequenced
1	180,000
1	fluke
1	long-terminal-repeat
1	(ltr)-
1	non-ltr-expressed
1	retrotransposon,
1	saci-1,
1	perere,
1	uncorrupted
1	cercariae
1	miracidia,
1	balls.
1	tallying,
1	200-fold-higher
1	(saccharum
1	officinarum)
1	angiosperms,
1	sativa).
1	eudicots
1	angiosperm
1	novelties
1	eudicot
1	eudicots.
1	163,000
1	14,000
1	assignments,
1	metazoa-specific
1	eukarya-conserved
1	metazoa.
1	transcription/translation
1	aug,
1	aug.
1	stem-and-loop
1	rule,
1	kozak's
1	consensus.
1	reinitiation
1	import.
1	(ndpo2),
1	thermodissociation.
1	reactive,
1	mesorhizobium
1	loti,
1	sinorhizobium
1	meliloti,
1	solanacearum.
1	necrogenic
1	hemagglutinins,
1	offing.
1	g:cs
1	gc:ta
1	gc:cg
1	gc:at
1	(23%).
1	xpb/rad25
1	copy,
1	disrupted,
1	tie
1	synchrony.
1	recent,
1	atxpb
1	(tp).
1	presequences,
1	tandem,
1	tp
1	presequence)
1	(gusa)
1	immunogold-labeling
1	anti-thi1
1	thermodissociation
1	soxs'::lacz
1	inductions
1	soxr
1	e.coli
1	bh20
1	(fpg),
1	aym57
1	muty)
1	aym84
1	uvrc)
1	uvrc,
1	g→t
1	g→c
1	transversions,
1	violet-pigmented
1	nondiffusible
1	chromobacterium.
1	aerocyanidin
1	aerocavin,
1	3,6-dihydroxyindoxazene
1	y-to678h
1	arphamenine
1	fr901228,
1	immunoresponse,
1	potentiators
1	polyhydroxyesters
1	(ptk2)
1	post-replication
1	pyrimidine(6-4)pyrimidine
1	incisions
1	s-phase.
1	ribozymes
1	sequence-specific
1	(lycopersicon
1	esculentum
1	cerasiforme)
1	rhizogenes
1	8196.
1	triparental
1	subcultured
1	5-fluorocytosine
1	(5-fc),
1	deaminase.
1	cd-t-
1	transferred,
1	(1o2)-induced
1	apurinic/apyrimidinic-endonucleases
1	exonuclease-deficient
1	(xth).
1	transversions).
1	significatively
1	xpb,
1	drosophila.
1	2670
1	767
1	araxpb.
1	2800
1	araxpb
1	mtiia
1	ρ-
1	petite
1	3-aminobenzamide
1	(3ab
1	polymerase)
1	(hbsag)
1	(ebv).
1	hygromycin-b-resistant
1	xth,nfo,
1	formami-dopyrimidine-dna-n-glycosylase
1	bw535
1	(xth,
1	nfo,
1	nth),
1	bw535.
1	uv-sensitive
1	ab1886
1	(uvra)
1	1047
1	(predicting
1	(sti35)
1	th14,
1	nmt2
1	pombe.
1	motifs:
1	auxotrophy
1	thi4::ura3
1	(hbsag),
1	vesicule.
1	sv40-late
1	hbsag.
1	chapman
1	hall.
1	penaei
1	hepatopancreas
1	shrimp.
1	sv40-derived
1	3,3'1,4-naphthylidene)
1	oxygen-induced
1	deoxyguanosines,
1	deoxyguanosines
1	(πsvpc13)
1	3,3'-(1,4-naphthytidene)
1	(ndpoj-
1	plasmld
1	shuttled
1	e.coll
1	82.5%
1	(98.4%)
1	(50.8%),
1	(32.8%).
1	esidues.
1	thermus
1	aquaticus
1	deoxyguanosine,
1	myeloblast
1	(klenow
1	fragment)
1	positions,
1	ndpo2,
1	deoxyguanosines.
1	photoexcitation
1	chemiexcitation
1	(kq
1	kr
1	m-1s-1)
1	8-oxo-7-hydro-deoxyguanosine
1	(8-oxodg;
1	8-hydroxydeoxyguanosine)
1	2,6-diamino-4-hydroxy-5-formamidopyrimidine
1	(fapygua).
1	quenchers,
1	tocopherols.
1	ebv/sv40-based
1	t-antigen,
1	blue/white
1	genotoxic-induced
1	mutagen,
1	n-methyl-n′-nitro-n-nitrosoguanidine
1	(mnng).
1	230-fold)
1	single-base
1	mnng-induced
1	pcf3a,
1	pcf3a
1	(madzak
1	sarasin,
1	biol.,
1	(1991)
1	667-673)
1	polymerisation
1	(1o2),
1	(endoperoxide
1	3,3'‐(1,4‐naphthylidene)
1	dipropionate),
1	1o2‐damaged
1	pseudovirions.
1	encapsidation,
1	over-
1	undersized
1	capsids.
1	generated:
1	advantages,
1	co,),
1	3,3'‐(1,4‐naphthylidene)dipropionate
1	(ndpcx),
1	quencher
1	'ck
1	error‐prone
1	(πsvf1-a
1	πsvf1-b).
1	πsvf1-a
1	πsvf1-b
1	annealed
1	(single-stranded,
1	double-stranded),
1	πsvf1
1	lost.
1	pseudo-virions
1	40.
1	(ris)
1	interpyrimidine
1	dimer-specific
1	cairns-like
1	single-strand-specific
1	undamaged
1	strand;
1	okazaki
1	repair-linked
1	endonucleolytic
1	tailed
1	pseudovirions
1	hypersentive
1	acetone,
1	isobutanal
1	uv-endonuclease
1	leteus
1	nuclease.
1	strands,
1	caffeine;
1	equals
1	fluence.
1	(gaps)
1	2.0–2.5
1	j/m2
1	excise
1	unexcised
1	artifacts
1	short-wavelength
1	pre-replicative
1	dosolateral
1	maximise
1	explanations,
1	plausible,
1	choices.
1	rewarded
1	(discounting
1	experiences),
1	forgetting
1	hdi
1	[76,
1	94])
1	recency.
1	toj.method:
1	detectability,
1	"point
1	simultaneity",
1	0.04.conclusions:
1	“gold
1	standard”
1	integrate-and-fire
1	replicated:
1	neurophysiology.
1	noise.
1	discounted
1	(100 ms)
1	disjoint
1	200 ms,
1	inverts
1	brighter
1	inverted,
1	brightness.
1	hilbert
1	recast
1	discriminability.
1	(action
1	conditions),
1	(no-action
1	participants'
1	judgments.
1	calibration-type
1	football,
1	making.
1	(ars)
1	top-class
1	ars,
1	players,
1	response-level
1	compensation,
1	misses),
1	(cognitive)
1	novices
1	praised
1	rationality,
1	decisions,
1	probability.
1	perseverate
1	perseverate,
1	matching.
1	animat
1	(artificial
1	animats'
1	option:
1	perseverate.
1	non-periodical
1	strings,
1	animats.
1	settings:
1	pre-attentive
1	deriving
1	contiguity,
1	lift
1	synchronously
1	binding;
1	contiguity
1	effect.these
1	expectation.
1	(tle)
1	characterize,
1	electrophysiologically,
1	(swc)
1	swc
1	swc.
1	mislocalized
1	nijhawan,
1	rediscovered
1	implicitly
1	metaphor
1	postdiction.
1	engendering
1	grasping
1	pin
1	space–time
1	correctness
1	refining,
1	edifice
1	unique.
1	affect-laden
1	intuitions
1	decision-making,
1	reasoning.
1	inquiry,
1	latter)
1	impulsivity
1	(adhd)
1	executive
1	edition,
1	(dsm-iv)
1	intelligence
1	(iq)
1	≥89,
1	adhd.
1	ingredient.
1	michotte,
1	launch
1	estimation.
1	causality.
1	temporal-order
1	abrupt-onset,
1	task-dependent,
1	abrupt-onset
1	model's
1	indissoluble
1	pion
1	publication.
1	percept.
1	trajectory.
1	decide
1	act.
1	permeating
1	notions,
1	causality,
1	abridged,
1	thought-provoking
1	pioneering
1	wundt,
1	titchener,
1	libet
1	effect),
1	psychology.
1	ramp
1	mask.
1	(svi)
1	(73.72
1	7.37
1	109.02
1	27.87
1	svi,
1	luminance,
1	trajectory,
1	(fle),
1	(baldo
1	565-566),
1	judged)
1	alternating,
1	cueing
1	symbolic
1	fle,
1	engenders
1	embraced
1	accommodated
1	one-to-one
1	forged
1	constrains.
1	percept
1	ambiguous
1	originated,
1	ordinarily
1	accessing
1	execution.
1	esthetical
1	(position
1	priming).
1	2%,
1	speed-accuracy
1	trade-off.
1	pictorial
1	s1-s2
1	variation-type
1	(sps)
1	mris
1	architectonic
1	brodmann
1	generators,
1	way:
1	verbal
1	39;
1	diametrically
1	dots.
1	judgment.
1	findings;
1	dots;
1	dot;
1	suddenly
1	uncouple
1	eccentricity.
1	clockwise
1	judge,
1	imaginary
1	flashed.
1	observer,
1	(4.8°
1	9.6°).
1	eccentricities.
1	(2.5°,
1	7.3°
1	12.1°)
1	deployment,
1	whichever
1	unavoidably
1	entangled
1	coplanarity
1	orthogonality
1	circo-like
1	virus-brazil
1	(clv-br)
1	(rep),
1	clv-brs
1	circoviruses,
1	nanoviruses,
1	geminiviruses
1	cycloviruses.
1	finding.
1	2005-2006
1	p9.
1	hs1.
1	(cress-dna)
1	(bvdv)
1	bvdv-ib
1	ibsp11
1	porcellus).
1	(aluminum
1	hydroxide);
1	(montanide
1	isa50);
1	positive-control
1	bvdv-ia
1	singer;
1	taken,
1	(vn),
1	(ibsp11),
1	(bvdv-ia
1	nadl).
1	vn.
1	bvd
1	speeding
1	mm2).
1	h-intervals
1	(1.9
1	sec),
1	sec).
1	cytopatic
1	proportionally,
1	nm/
1	phototherapy.
1	powers
1	(fbs)
1	ingaalp
1	j/cm2.
1	irradiations;
1	(pit
1	latrine)
1	potability
1	(2004)
1	paying
1	microbiologic
1	(coliforms,
1	crytosporidium
1	adenovirus).
1	cryotosporidium
1	8-liter
1	60s),
1	eluates.
1	(20.6%)
1	(34.5%)
1	focus-forming
1	(ffu)/liter,
1	sewage,
1	tremembe,
1	rotaviral
1	(cbx)
1	(slc2a4)/glut4
1	(srebp1),
1	srebp1-binding
1	ubiquitin-modifier
1	(ubc9),
1	hypercorticosteronemia,
1	(t1d
1	t2d),
1	t1d-
1	t2d
1	tri-methylation
1	(h3k9me3)
1	(cebpa)enhances
1	(e2)facilitates
1	(esr1)-dependent
1	cebpa-mediated
1	nm)has
1	2–8),
1	cebp/slc2a4-binding
1	(∼50%)in
1	esr1/cebpa-mediated
1	expandability
1	(scl2a4
1	(nfkb1),
1	glucose-regulated
1	(grp78).
1	grp78/94,
1	phosphorylated-ikk-alpha/beta,
1	reticulum-
1	inflammatory-stress
1	hexokinase-2
1	(hk2)
1	glut4/hk2
1	651
1	(50-77%),
1	(50-100%),
1	mir-150-5p,
1	mir-199a-5p,
1	mir-345-3p,
1	mir-532-3p,
1	(p50)
1	mir-532-3p.
1	(codified
1	slc2a4),
1	esr1-mediated
1	(sp1)
1	esr-mediated
1	esr1/2-mediated
1	(ppt)
1	(dpn),
1	(immunoprecipitation)
1	(25-50%)
1	(20-45%)
1	slc2a4.
1	esr1/sp1
1	gomes-kjerulf,
1	machado-lima,
1	rocco,
1	nakandakare,
1	correa-giannella,
1	catanozi
1	(rct)
1	protein-transgenic
1	(cetp-tg)
1	min/day)
1	abca-1,
1	lox-1,
1	mediated-cholesterol
1	cetp,
1	perceptible
1	comprehended.
1	(18%,
1	(98%,
1	eif-2a
1	ire1a
1	(60%,
1	traf2
1	(23%,
1	(106%,
1	eif-2a,
1	xbp1
1	induced-repression
1	ire1a-traf2-ikk
1	converges
1	nfkb-induced
1	slc2a4/glut4.
1	17α-estradiol
1	pellets).
1	0.066).
1	tissues),
1	[rage
1	(ager)
1	ager1
1	(ddost)]
1	(24–39)
1	(interquartile
1	interval)]
1	117;
1	(30–42)
1	old];
1	stratifying
1	ddost.
1	≥12,872
1	end-products.
1	oxidative/endoplasmic
1	mg-132,
1	inhibit,
1	sirna-rage.
1	lc/ms.
1	pyr-albumin
1	(20–30%)
1	age-albumin.
1	abca1.
1	(vegfa)
1	17-beta
1	(esr1)
1	(mpp),
1	e2/esr1
1	(esr1/2),
1	esrs
1	tyrosine-protein
1	(src)
1	involvement;
1	serine/
1	threonine-protein
1	(pp2).
1	immunocytochemistry;
1	esr2,
1	pp2;
1	src-mediated
1	nucleus-plasma
1	translocation;
1	fabre,
1	thieme,
1	shimizu,
1	teodoro,
1	marie,
1	woods,
1	brimble,
1	pickford,
1	rye,
1	okamoto,
1	catanozi,
1	correa-giannela,
1	endproducts
1	lc/mass
1	age-treated
1	col12a1
1	c-albumin-treated
1	c-albumin.
1	itgam
1	ppara.
1	cd206,
1	adipoq,
1	retn,
1	(slc2a2
1	(sirtuin
1	codifier)
1	(rt-qpcr);
1	(pyruvate
1	(mirnas).
1	(0.5 hz),
1	(100 hz),
1	mir-133b-3p
1	(p < 0.01)
1	(2.5-fold).
1	mir-133a/b-3p,
1	mir-29a/b-3p,
1	mir-133a/b-3p.
1	insulinopenic
1	esteves
1	expression/translocation
1	mir-21a-5p,
1	mir-106b-5p,
1	mir-133b-3p,
1	mir-222-3p,
1	mir-223-3p
1	(albc)
1	(600mg/l;
1	albage+nac
1	albc+nac,
1	analyses;
1	carboxymethyl-lysine
1	age),
1	infiltration),
1	(4-hne,
1	immunostaining;
1	(ager,
1	nfkb1),
1	(agt,
1	ace),
1	(tgfb1,
1	col4a1),
1	(nox4,
1	txnip),
1	bcl2);
1	col4a1,
1	txnip,
1	isothiocyanate-phenol-chloroform
1	(trizol
1	isopropanol
1	42)
1	statistically.
1	homa-ir),
1	(ighd).
1	electromobility
1	(2m)
1	mri.
1	ghrhr
1	dual-luciferase
1	(av).
1	(c.-185t>c
1	c.-223c>t)
1	pou1f1/sp1
1	pou1f1
1	c.-185t>c
1	c.-185,
1	c.-223
1	stature
1	(t1d),
1	obligatory,
1	(nd);
1	(dp);
1	(di)
1	(dir).
1	(slc2a2),
1	(g6pc)
1	di);
1	di)
1	slc2a2/glut2,
1	dkd.
1	33.5
1	[27.0-39.7]
1	[15.0-28.0]
1	[7.3-8.9];
1	[interquartile
1	interval])
1	stages;
1	epithelium-like
1	(hek-293)
1	0.43;
1	β2m
1	b2m,
1	non-diabetic)
1	tubulopathy.
1	(gsm),
1	cn-o,
1	pd-o,
1	pd-o
1	(lbw),
1	lbw,
1	(asl)
1	activity);
1	(methicillin-resistant
1	sthaphylococcus
1	(bal);
1	0.9651
1	0.9613,
1	correlation).
1	chrysobalanus
1	coastline
1	hypoglicemic
1	(aeci)
1	sc;
1	aeci);
1	hfd;
1	aeci).
1	(13,682
1	1090
1	9828
1	485
1	(192.8
1	132.3
1	5.7%)
1	(72.60
1	3.83%,
1	.0001),
1	(txnip),
1	(trx),
1	(txn)
1	55)
1	161)
1	(dn),
1	neuropathy;
1	(focal
1	fsgs)
1	txn)
1	0.0023)
1	0.0027)
1	≥60
1	0.008).
1	-0.28)
1	-0.30)
1	≥5
1	dioestrus
1	involved;
1	(cocl
1	(akt).
1	(codifier
1	glut4)
1	30/40
1	cocl
1	hif1a/hif1a
1	hydroxyl-delta-5-steroid
1	(hsd3b)
1	akt/glut4-mediated
1	hif1a-modulating
1	luteum.
1	regresses
1	(rct),
1	twelve-week-old
1	m/min,
1	j774-macrophages
1	<sup>14</sup>c-cholesterol
1	hdl<inf>2</inf>
1	<sup>3</sup>h-cholesteryl
1	(<sup>3</sup>h-coe)-acetylated-ldl
1	(sr-bi)
1	(b-e)
1	cyp7a
1	<sup>14</sup>c-cholestrol
1	<sup>3</sup>h-coe-acetylated-ldl
1	230:
1	1250-1257,
1	(age)
1	maldi/ms.
1	agilent
1	(44000
1	c-hsa,
1	ai,
1	hdl3,
1	26%.
1	c-has-treated
1	stearoyl-coenzyme
1	dm2-hsa.
1	dm2.
1	xxxx:
1	xx-xx,
1	hyperglycaemic
1	glomerulopathy.
1	slc2a1)
1	complication.
1	(rs3820589,
1	rs1385129,
1	rs841847
1	rs841848)
1	18.0%.
1	0.36,
1	0.80,
1	(hr:
1	0.70;
1	aggt
1	established/advanced
1	dn.
1	(glut4
1	~50%,
1	oxysterols-receptor-lxr-alpha
1	peroxisome-proliferator-activated-receptor-gamma
1	sterol-regulatory-element-binding-protein-1
1	(srebp1)
1	(~30%,
1	slc2a4-nuclear-factor-nf-kappa-b-binding
1	(repressor),
1	nuclear-factor-kappa-b-kinase
1	(150-300%,
1	acid-related
1	poletto
1	(nfκb)-mediated
1	repression;
1	(ikk)/nfκb
1	(sat).
1	p∈<∈0.01)
1	p∈<∈0.05),
1	(44%,
1	p∈<∈0.05)
1	ikkα/β
1	shr.findings.
1	(northern-blotting)
1	(western-blotting)
1	longus)
1	hypoinsulinemic
1	expected;
1	alves-wagner
1	(nfkb)
1	(phosphatidylinositol-4,5-bisphosphate
1	(pi3k)-inhibitor),
1	ml9
1	(serine/threonine
1	repressor),
1	2a/d
1	(mef2a/d),
1	(hif1a),
1	(myod1)
1	(mrnas)
1	(pcr));
1	at-rich-
1	(myocyte-specific
1	(mef2)-binding
1	e-box-
1	(hif1a)-
1	(myod1)-binding
1	(140%)
1	ml9.
1	myod1
1	50%).
1	resistance-induced
1	optimal,
1	morbimortality
1	(charybdis).
1	sglt2-inhibitors
1	(scylla)
1	materials/methods
1	glucose/insulin/t3,
1	glucose/insulin/t3
1	post-fasting
1	fasting),
1	h-refed
1	(nhe-1).
1	co-transporters
1	pd-98059,
1	p-p38mapk
1	sb-203580,
1	mek/erk1/2/p90
1	(myocardial
1	infarction)
1	(iat).
1	0.036),
1	37%;
1	25%;
1	0.030).
1	17β-oestradiol
1	(slc2a1)
1	(fgf2);
1	(vegfa);
1	(flt1
1	kdr)
1	(0.84<r<0.98;
1	(r=0.61;
1	vascularisation.
1	overexpression;
1	4α
1	hnf-4α),
1	(foxa2),
1	protein-1c
1	(srebp-1c)
1	ccaat-enhancer-binding
1	(c/ebpβ)
1	cebpb
1	c/ebp-β
1	glucose/2
1	/264
1	(shr-d),
1	sabino-silva
1	hemodynamic,
1	n=15/group,
1	mg/g)
1	(sap),
1	(3-months
1	4.3±0.7,
1	3.9±0.9,
1	2.7±0.6;
1	4.2±0.6,
1	3.8±0.5,
1	2.4±0.6%·min
1	3-months
1	151±15,
1	190±11,
1	185±13
1	13×
1	3-months,
1	2×
1	coexist,
1	normoglycemia.
1	systemic/intra-glomerular
1	spontaneously-hypertensive
1	μg/kg/day
1	(r,
1	8,)
1	glycaemia,
1	0.77)
1	0.22)
1	(172.4
1	186.7
1	202.2
1	0.903
1	0.086;
1	0.654
1	0.025,
1	0.389
1	0.057
1	mu/mg),
1	264.8
1	15.4;
1	140.8
1	46.81
1	4.54;
1	40.30
1	5.39
1	26.89
1	ms-t
1	hour/day,
1	h-t
1	datawere
1	(ms-t
1	(h-t
1	0.5)
1	insulinsensitizer
1	rs5435
1	rs5418
1	smoker,
1	(il-6r),
1	130,
1	esr1/esr2.
1	esr1-
1	1,3,5-tris(4-hydroxyphenyl)-4-propyl-1h-pyrazole,
1	1,3-bis(4-
1	hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1h-pyrazole
1	dihydrochloride,
1	2,3-bis(4-hydroxyphenyl)-propionitrile,
1	(e2).
1	(2-deoxi-d-[3h]glucose
1	2-dg).
1	(~30%)
1	(~50%).
1	mpp,
1	(20-40%)
1	(~30%).
1	esr2-
1	(20-50%).
1	enhances,
1	represses,
1	ppt,
1	insulin+captopril
1	insulin/angiotensin
1	ischemia-reperfusion.
1	(langendorff
1	technique)
1	(kh)
1	25min.
1	(20min),
1	(30min)
1	kh),
1	kh+angiotensin-i
1	kh+angiotensin-i+captopril
1	ac),
1	kh+insulin
1	kh+insulin+angiotensin-i
1	ia),
1	kh+insulin+angiotensin-i+captopril
1	iac).
1	iac.
1	~31%
1	kh,
1	(tbooh)-induced
1	(~2.2
1	~35%
1	~28%
1	(monosodium
1	glutamate-treated
1	(-62.5%),
1	(>7
1	(>4
1	(~38%)
1	(~36%)
1	glut4-encoded
1	arachidonyl-2'-chloroethylamide)
1	antagonist/inverse
1	1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-
1	n-1-piperidinyl-1h-pyrazole-3-carboxamide).
1	(cb1
1	receptor-encoded
1	(srebp-1a
1	type-encoded
1	pcr);
1	(srebp)-1
1	(~2·5-fold)
1	cb1-induced
1	(18/group)
1	(3-mo),
1	(6-mo)
1	(9-mo)
1	ages)
1	(3-mo:
1	p<0.001,
1	6-mo:
1	9-mo:
1	0.015)
1	comparisons)
1	(mets:
1	9-mo,
1	57%;
1	gastrocnemius:
1	tissue:
1	69%).conclusions:
1	leguisamo
1	flavonoid,
1	(iκk)
1	palmitate-induced
1	placement.
1	(n=45;
1	angiotensin-i,
1	(+dp/dtmax)
1	(~73%)
1	(lvedp)
1	1.10
1	+dp/dtmax
1	(~85
1	94%)
1	lvedp
1	hyperinsulinization.
1	u/day)
1	insulinopenic-untreated
1	3u-treated
1	carboxykinase/glucose-6-phosphatase
1	hyperinsulinized
1	patients,we
1	goal:
1	exercised,
1	min/2x
1	day/60
1	60min/60
1	364.7
1	9.7,
1	372.4
1	368.9
1	6.7,
1	376.4
1	0,05g).
1	5.28
1	**;
1	*p
1	119.72±9.98;
1	143.09±9.09;
1	84.36±10.99*;
1	132.18±11.40#
1	au/
1	#p<0.01
1	uptaking
1	explored.methods:
1	glut2)
1	~250
1	not;
1	performed;
1	(spectral
1	blotting).results:
1	nondiabetics
1	(384.8
1	431.3
1	316.2
1	363.8
1	(55.75
1	25.21,
1	73.40
1	53.30,
1	148.4
1	stz-shr-
1	(1.62
1	7.38
1	squat.
1	(ce).
1	(n=8/group).
1	10-week
1	glut4-induced
1	(dph(i)/dt)
1	na(+)-glucose
1	na(+)/h(+)
1	0.169
1	(~40%,
1	(~50%,
1	(~100%,
1	(10(-6)
1	glucotoxicity
1	(glut2)
1	(wistar-epm)
1	(-33.0
1	(426.0
1	cm-1)
1	(349.1
1	842.6
1	(1.796
1	0.659
1	(1.901
1	0.766
1	1.262
1	0.450
1	1.244
1	0.407
1	au).
1	slgt1
1	(es).
1	infarction.methods:
1	(s+es),
1	(hf+es).
1	duty
1	50%-
1	contraction/15
1	rest).
1	hf+es
1	0.01).conclusion:
1	+-/
1	(glut).
1	slc5a2,
1	glucose-galactose
1	benefits,
1	unnoticed.
1	(wky).methods:
1	running/5
1	(kitt),
1	measured.results:
1	(+34%);
1	(+22%)
1	(+25%),
1	(+45%)
1	-28%;
1	-23%)
1	-19%;
1	-22%);
1	-35%;
1	-25%).
1	(gastrocnemius)
1	0.004).conclusions:
1	lehnen
1	β-adrenergic-dependent
1	β-blockade
1	β-stimulation
1	[extensor
1	(edl)]
1	β1-β2-,
1	β1-β2-β3-
1	(20-30%)
1	discrepant,
1	leii
1	(jnk1)
1	dosedependently,
1	c-peptideelicited
1	erk-
1	p38mapk-dependent
1	hnf-3β)
1	non-insulin-treated
1	low-potency
1	secretagogue,
1	sulphonylureas,
1	extra-pancreatic
1	phospho-glycogen
1	(p-gsk3)
1	(∼20%)
1	p-gsk3
1	(sglt)-2
1	(hnf)-1α
1	maturity-onset
1	regulation;
1	emsa)
1	sglt2).
1	(∼100%).
1	nondiabetic-rat
1	modulations.
1	insulinemia.
1	(∼260
1	gavage:
1	(d0.01,
1	(d1,
1	(d,
1	(24-h
1	urine),
1	d0.01,
1	d0.01
1	tubule-glomerular
1	diseases.here
1	4-12
1	phlorizin,
1	lowering.
1	role(s)
1	8-hour
1	fasting/refeeding
1	(∼25%,
1	(∼200%,
1	(∼60%,
1	overbalanced
1	metabolic/hormonal
1	tissue-specifically
1	understanding,
1	caveolin-1,
1	aromatase-knockout
1	mice].
1	2,3-bis(4-hydroxyphenyl)
1	propionitrile,
1	(homa-ir),
1	homa-ir
1	ivitt.
1	(pi3-kinase),
1	∼210
1	(diabetic,
1	shr-d).
1	results:the
1	1.8,
1	1.39
1	ng/24
1	12-year-old
1	parametrial
1	(369.9
1	89.9
1	∼45%
1	∼65%
1	light-to-moderate
1	ethanol-enhanced
1	ivitt
1	polysaccharides.
1	acarbose/100
1	acarbose,
1	acarbose-treatment
1	pair-weight
1	(msg-l).
1	(g/i)
1	insulinaemic
1	g/i
1	msg-l
1	(stz,
1	(codas,
1	khz).
1	(447
1	(296
1	355
1	(-1.68
1	-1.25
1	(-3.68
1	-1.75
1	-17
1	-86
1	-185
1	-208
1	-23
1	-95
1	-140
1	bpm),
1	(ffe)
1	5'nucleotidase,
1	47.4
1	cell-1
1	165.1
1	53.8
1	32.0
1	microns-2
1	10(-9)
1	respectively.(abstract
1	u/kg,
1	ev)
1	nonobese
1	(ffe),
1	20-24
1	glut-1,
1	nerve:
1	lihan
1	(phenuiviridae
1	wuhan
1	(chuviridae
1	jingmen
1	(flaviviridae
1	tymoviruses
1	(tymovirales
1	order),
1	guarapuava
1	tymovirus-like
1	tick-microbiota
1	rnai-mediated
1	ros-generating
1	oxidant-based
1	reeler
1	interference-mediated
1	molting,
1	(2×)
1	(8×)
1	galletti,
1	daffre
1	(rmsf).
1	sculptum.
1	sculptum,
1	sayegh
1	secondary/tertiary
1	opiliones
1	animal:
1	harvestman
1	acutisoma
1	longipes.
1	longipin.
1	(sgylpgkeyvykykgkvf)
1	heme-lipoproteins
1	3.8-7.5
1	(200-0.1
1	(popg:popc)
1	(popc),
1	carboxyfluoresceinloaded
1	popc
1	amyloid-like
1	thioflavin-t
1	(ivm)-resistant
1	bme26-ivm.
1	ivm-sensitive
1	step-wise
1	46-week
1	(lc50)
1	15.1.
1	1.6.
1	3.35.
1	0.09.
1	ivm-resistance.
1	{glutathione
1	(coxiii),
1	dynein
1	(dyn),
1	synaptobrevin
1	phosphatidylinositol-3,4,5-triphosphate
1	3-phosphatase
1	(phos)}
1	dscoxiii
1	[trp1]-gm,
1	[trp7]-gm,
1	[trp9]-gm,
1	absorbance)
1	(~8
1	(0-15
1	(0.3-6.0
1	detergent-peptide
1	motionally-restricted
1	(fva)
1	effort,
1	speculation,
1	(meizo)
1	clotting.
1	tix-5.
1	(esi),
1	(solvent
1	spray,
1	metalized.
1	film,
1	nanoinjector
1	ionization/spray
1	nanoinjectors
1	repeatability
1	(hemocidins)
1	sucking
1	vivo-generated
1	33-61).
1	98-114.
1	permeabilizing
1	(sds).
1	mygalomorph
1	anticancer,
1	anticryptococcal
1	backbone-cyclized
1	bonds),
1	[cys(acm)2,15]-gm
1	bonds)
1	dmso/nmp,
1	edc/hobt,
1	serum;
1	gm-derived
1	far;
1	(gm),
1	disulfide-stabilized
1	alpha2-macroglobulin
1	paulensis,
1	sub-cellular
1	389
1	sub-units,
1	shrimps,
1	crayfish
1	lobster
1	(70-90%
1	prawn
1	marsupenaeus
1	japonicus
1	mk571,
1	(lpt).
1	dfci
1	(http://compbio.dfci.harvard.edu/index.html).
1	melanization,
1	reveal,
1	copper-chelation
1	tick-immune
1	nymph-immune
1	p32,
1	rp8
1	anti-complement
1	rp23
1	anti-coagulant
1	rp8,
1	rp19
1	rp23,
1	hall
1	tickimmunity.
1	schuijt
1	complement-like
1	self/nonself
1	fibrinogen-related
1	thioester-containing
1	pro-phenoloxidase
1	proven.
1	lysozymes,
1	defensins
1	imminent
1	anaplasmataceae),
1	(boophilus)microplus
1	microplus-derived
1	bme26,
1	infection.results:
1	histamine-binding
1	(22hbp),
1	(94will),
1	(100silk),
1	kunitz-like
1	(108kunz)
1	bstni
1	(7bstni3)
1	interference.
1	(100silk)
1	subolesin
1	(4d8)
1	(93
1	meth),
1	subolesin,
1	zivkovic
1	anaplasmataceae)
1	fluo-4-am
1	nimodipine,
1	gomesin-induced
1	1794)
1	crambidae)
1	(hds1
1	hds2),
1	vfgtlgsddsglfgk
1	hds2.
1	lepidoptera
1	gloverins.
1	imagemaster
1	gloveri
1	gloverin
1	8.5).
1	14-kda
1	gloverins
1	gloveri.
1	hds2
1	saccharalis,
1	singlea-helical
1	α-helices:
1	gly-9
1	arg-21),
1	glu-27
1	asn-40),
1	arg-44
1	thr-54),
1	leu-57
1	tyr-64),
1	asn-67
1	cys-
1	disordered.
1	permeabilize
1	15n,
1	keratitis.
1	p6,
1	(gomesin),
1	p5,
1	(pkb).
1	insulin-triggered
1	(bme26).
1	ly294002)
1	pi3k's
1	(p85),
1	insulin-regulated
1	(gsk3β).
1	carbohydrate/glycogen
1	annulatus
1	(ufmg1)
1	marginale/tick
1	[logullo,
1	vaz,
1	m.h.,
1	paiva-silva,
1	g.o.,
1	faria,
1	f.s.,
1	zingali,
1	r.b.,
1	e.f.,
1	e.w.,
1	116,
1	525-532].
1	(byc)
1	[da
1	v.i.,
1	logullo,
1	velloso,
1	f.f.,
1	vet.
1	immunopathol.
1	331-341].
1	lc-ms,
1	p1'
1	dicroism,
1	vitellin,
1	kingdoms.
1	encrypted
1	(maldi)
1	single-cells.
1	linear,
1	open-ended
1	(α-helical
1	conformations,
1	β-hairpin-like
1	β-sheet,
1	α-helix/β-sheet
1	membrane-active
1	immune-stimulated
1	d-gomesin
1	membrane-permeabilizing
1	(immunoglobulins),
1	unsuccessfully
1	18-residue
1	cryptococci,
1	vertebrate/invertebrate
1	asexual,
1	pre-sporogonic
1	falciparum.when
1	exflagellation
1	ookinetes.
1	stephensi
1	cys2,15
1	cys6,11
1	l-proline.
1	d-pro9]-gm,
1	9]-d-gm
1	[(des-pglu1,
1	-thr2,
1	-arg
1	thr6,11,15,
1	d-pro9]-gm
1	32-fold
1	128-
1	512-fold
1	[d-thr
1	2,6,11,15,
1	pro8]-d-gm
1	d-arg4,16,
1	d-pro9]-gm.
1	β-conformation
1	cysteine-free
1	33-61
1	α-hemoglobin
1	(hb33-61a)
1	3.0%).
1	hb40-61a
1	hb33-52a
1	hb48-61a
1	(hb33-61a
1	hb40-61a)
1	(containing
1	element)
1	β-turn).
1	fluctuating
1	membrane/water
1	epr.
1	[toac1]-gm;
1	[toac1,
1	ser2,6,11,15]-gm;
1	[trp7]-gm;
1	trp7]-gm;
1	[trp9]-gm;
1	trp9]-gm
1	detergent's
1	(cmc).
1	[toac1]-gm
1	phyllomedusinae
1	polylysines,
1	ps-7
1	phylloseptin
1	dph-1,
1	(dph-1).
1	cys2-15/cys6-11
1	(sar)
1	disulfide-bridged
1	bounds
1	lactam-bridged
1	lactam/disulfide-bridged
1	gomesin;
1	events;
1	conformation;
1	bicyclo
1	(2-15,6-11)[glu
1	cys6,11,
1	lys15]-gm
1	hemocytes.
1	dansylcadaverine
1	(hemocyte
1	lysate),
1	341
1	penaeids
1	penaeus
1	monodon
1	decapods.
1	flsfpttktyfphfdlshgsaqvkghgak
1	hb33-61,
1	[fogaça
1	274,
1	25330-25334],
1	a270.
1	nonconventional
1	hinge,
1	side-chain-side-chain
1	h/d
1	micelle,
1	quest
1	genomics.
1	hematophagy,
1	ingurgitating
1	1,344
1	(neu5ac)
1	o-sialoglycoconjugates
1	mucin)
1	fetuin-agarose
1	(lectin),
1	82.5kda
1	hemocyanin.
1	34kda
1	multimeric.
1	153±10kda.
1	(2d-nmr)
1	well-resolved
1	two-stranded
1	turn.
1	protegrin-1
1	outlines
1	hemolymph:
1	darlingi,
1	abdomens
1	intruding
1	crosslinker,
1	hemolin,
1	ncam-related
1	concentration-dependant
1	kdo
1	calcium-regulated
1	calpa,
1	56c-d
1	mbn-2,
1	calpains,
1	carboxyterminal
1	haemolymph.
1	61f,
1	lysb,
1	adults;
1	caecae
1	lysx
1	metamorphosing
1	pupae.
1	lysd-like
1	malaise
1	haemolymph,
1	"typical"
1	lysozymes.
1	5000.
1	84,300
1	3000,
1	chicken-type
1	61f1-4
1	bacteria-induced
1	hemocoel.
1	foregut
1	fermenters,
1	lysozyme.
1	hydroxytyrosol
1	uridine,
1	alternanthera
1	littoralis
1	beauv.
1	bridged
1	benzoazepine
1	collisional
1	(cid).
1	alternamine
1	oracfl
1	extract;
1	encyst
1	acanthamoeba-conditioned
1	(acm),
1	elastin-congo
1	(ecr)
1	p-nitroanilide
1	ecr
1	metallopeptidases,
1	antipain,
1	elastatinal
1	1,7-phenanthroline
1	e-64.
1	suc-ala2-pro-leu-pna
1	suc-ala2-pro-phe-pna
1	(7.0-9.5)
1	suc-ala3-pna,
1	ecr-splitting
1	suc-ala2-pro-phe-pna-hydrolysing
1	0-0.6
1	70-130
1	elastases,
1	pinostrobin
1	pinocembrin
1	tectochrysin
1	galangin
1	3-methyl
1	markgravii
1	compounds;
1	naturforschung,
1	tübingen.
1	collections,
1	(vegetative,
1	multiplicative
1	nonnutrient
1	acanthamoeba-bacteria
1	yield;
1	scapigera
1	β-amyrin
1	11α,12α-oxidetaraxeryl
1	lupeol
1	crysoeriol
1	amastigotes-like
1	bloods
1	exsucca
1	hrgc
1	hplc-esi-ms,
1	agrestis.
1	(e)-3′-o-β-d-glucopyranosyl-4,5,6,
1	4′-tetrahydroxy-7,2′-dimethoxyaurone.
1	amaranthaceae
1	agrestis
1	(mpro/br/72/n41841)
1	4.8-5.0.
1	restarted
1	preadapted
1	log-
1	rod-specific
1	(∼65-70%
1	28-,
1	31-,
1	(aerial
1	dried),
1	methylenedioxyflavonol,
1	portulacoides,
1	trophozoites.
1	4.0-5.0
1	proteinases;
1	47,
1	>110
1	phenylmethylsulfonylfluoride
1	43-,
1	59-,
1	70-,
1	100-130-kda
1	(43,
1	supernatants'
1	1,10-
1	m2903
1	haemin
1	6.3.
1	(pfr),
1	pfr
1	1b10.
1	70/72
1	70/74
1	125i-labelling
1	promastigote-specific
1	(>100,
1	45/47
1	(lca)
1	agglutinins,
1	parasite-associated
1	tca-insoluble
1	radiolabel
1	cpm/μg
1	1.8-
1	2.9-times
1	z-tyr[125i]-alachn2,
1	restored,
1	5-h
1	(m379,
1	ioc-0561,
1	comigrating
1	(29-34
1	the125i-tagged
1	lysed,
1	mobility;
1	o-phenanthroline-sensitive
1	23-
1	z-tyr-alachn2
1	z-phe-alachn2;
1	z-phe-alachn2.
1	forms.©
1	n-benzyloxycarbonyl-l-tyrosyl-l-alanyl
1	(z-tyr-alachn2),
1	sulfate-acrylamide
1	faintly
1	trichloroacetic
1	z-tyr(125i)-alachn2.
1	megasomes,
1	tryptophanamide.
1	leu-ome,
1	n-benzyloxycarbonyl-phenylalanyl-alanyl
1	(z-phe-alachn
1	33-kda
1	leu-leu-ome)
1	ile-ome)
1	lysosomotropic
1	animo
1	15-60
1	z-val-phe-se
1	z-ile-phe-sc,
1	trp-nh2,
1	[3h]leu-ome.
1	unaffected,
1	leu-ome;
1	gly-obz
1	tyr-ome
1	ile-ome
1	met-ome
1	val-ome
1	ala-ome
1	gly-ome
1	d-leu-ome;
1	(leu-obz,
1	trp-ome
1	phe-ome).
1	gly-obz,
1	tyr-ome)
1	non-leishmanicidal
1	ile-ome,
1	val-ome)
1	(crithidia
1	acanthocephali,
1	seymouri,
1	collosoma,
1	samuelpessoai,
1	megaseliae,
1	muscarum
1	mariadeanei,
1	davidi,
1	schaudinni,
1	(l-threonine
1	hydro-lyase
1	(deaminating)
1	4.2.1.16)
1	symbionts:
1	symbiont-rich
1	deaminase,
1	(offset),
1	(overlap),
1	0-
1	of.89
1	and.94,
1	thompson
1	clap
1	music,
1	sing,
1	instrument,
1	dance,
1	entrainment.
1	non-musicians).
1	tasks:
1	self-paced
1	movements)
1	drawing
1	movements).
1	non-musicians
1	drawing.
1	thompson,
1	ammirante
1	cyclical
1	(clock
1	mechanism),
1	synchronization-continuation
1	feedback.
1	dive.
1	ball-contact.
1	high-pressure;
1	respond,
1	high-pressure,
1	(act).
1	keeper-independent
1	ignores
1	run-up,
1	preferable
1	kick.
1	in-field
1	intermediate-level
1	kicks
1	corners
1	goalkeeper,
1	(who
1	ball),
1	shot
1	shots
1	centralised,
1	goalkeeper.
1	knew
1	knowledgeable
1	non-targets.
1	practising
1	cabin
1	(temperature,
1	noise,
1	vibration)
1	(anxiety
1	ying,
1	personality)
1	airport
1	(smd),
1	modifi
1	fear)
1	(chronbach
1	0.974).
1	scales:
1	(stai),
1	cohen
1	acrophobia
1	situational
1	(sitq,
1	sitq
1	0.311),
1	0.375).
1	ight,
1	cabin.
1	ight
1	aerospace
1	alexandria,
1	va.
1	spinocerebellar
1	ataxias
1	(scas)
1	olfaction,
1	sca2,
1	friedreich's
1	β=0.55
1	1.90)
1	β=-4.58
1	-3.00)
1	(p=0.001,
1	β=-0.05
1	-0.01),
1	(p=0.19)
1	(p=0.41).
1	hyposmia
1	low-pressure
1	(acoustically
1	laboratory)
1	participative
1	audience).
1	lengthening
1	move.
1	goal-driven
1	stimulus-driven
1	color.
1	frst
1	half,
1	sober
1	endured
1	neurophysiology
1	"at
1	next"
1	as)
1	"the
1	next."
1	excerpt
1	textbook
1	openly
1	objection
1	transmission,"
1	(implicitly
1	unchanged).
1	misconception,
1	integration"
1	transmission"
1	rote
1	student.
1	olfaction.
1	(upsit)
1	(upsit-br2)
1	otorhinolaryngological
1	upsit-br2
1	culturally
1	translations
1	40-item
1	(upsit-40)
1	nondemented
1	0.76
1	0.70-0.81,
1	204,
1	covariate.
1	81.1%
1	individual's
1	fixate
1	screen.
1	0.08%
1	graphically
1	geostatistical
1	disengage
1	gaze.
1	reluctant
1	atomium
1	brussels
1	interaction:
1	.0026)
1	anova.
1	concluding
1	nonisoluminant
1	(law
1	violet-yellow
1	purple-turquoise
1	al.'s
1	fixating
1	magenta,
1	"neutral
1	attractor,"
1	tritan
1	turquoise,
1	deutan
1	trichromats
1	0.58);
1	disengagement
1	explanation:
1	(dis)advantage
1	opponent
1	cue-attractor-target
1	infrasound,
1	indispensable,
1	symmetrically
1	loft.
1	(experimentals)
1	anosmic
1	znso4
1	(34-44km)
1	(negative)
1	scatter
1	navigation.
1	chediak-higashi
1	(chs),
1	24-year-old
1	antiparkinsonian
1	kicks,
1	cup.
1	described:
1	(open
1	loop)
1	loop).
1	closed-loop
1	judgement
1	laterality.
1	groundwork
1	goalkeepers.
1	(doh,
1	re,
1	ti)
1	(valid
1	trials),
1	ignore
1	(invalid
1	trials).
1	dissonant
1	doh)
1	nondiatonic
1	two-octave
1	arpeggio,
1	arpeggio.
1	registral
1	pitch.
1	paranapanema
1	eared
1	(zenaida
1	auriculata)
1	colonially
1	sugar-cane,
1	weeds
1	(euphorbia
1	heterophylla,
1	plantaginea,
1	commelina
1	benghalensis)
1	estimators
1	asymptotically
1	(1950)
1	±3°
1	±5°.
1	c3°
1	-from
1	september,
1	hoffman
1	degrees(-)+/-
1	hoffmann
1	pigeons'
1	(ranvaud,
1	ganzhorn
1	bird's
1	compass,
1	(fortaleza,
1	nw
1	equator.
1	noon
1	vanished
1	north.
1	wiltschko
1	pick
1	wind.
1	contradicts
1	uniaxially
1	indium
1	5.6*108
1	insb,
1	semiconductors
1	high-precision
1	valence-band
1	fails,
1	zinc-blende
1	inversion-asymmetry-induced
1	hamiltonian;
1	couplings
1	difficulties.
1	hamiltonian,
1	eightfold
1	zinc-blende-type
1	invariants
1	momentum
1	calculus.
1	high-symmetry
1	[001],
1	[111],
1	[110]
1	group-theoretical
1	eigenstates
1	intraband
1	transitions.
1	far-infrared
1	(fir)
1	cyclotron-
1	combined-resonance
1	field)
1	[001]
1	[111]
1	fir
1	microwaves,
1	ge.
1	kane
1	k-linear
1	magnetoelectroreflectance
1	splittings
1	cdte-mnte
1	integrals
1	franz-keldysh
1	gasb
1	aspnes
1	low-field
1	σ+
1	σ-
1	nonparabolicity
1	(mer)
1	intermediate-field
1	fisica.
1	space-charge
1	(100),
1	(110),
1	(111)
1	nc*,
1	klitzing
1	shubnikov-de
1	haas
1	bangert
1	ohkawa
1	uemura,
1	lakhani
1	falicov
1	potassiumtetracyanoplatinate,
1	k2[pt(cn)4]
1	br0.3
1	3.2h2o,
1	potassiumdioxalatoplatinate,
1	k1.64
1	[pt(c2o4)2]
1	polysulfurnitride,
1	(sn)x,
1	(sn)x
1	platinates
1	10-1
1	1976.
1	(ns<1012
1	electrons/cm2).
1	sample-dependent
1	harmonic-oscillator
1	k2pt(cn)4br0.3
1	interband
1	147.
1	configuration.
1	e//0
1	//1
1	δ1,
1	heterojunction
1	deformed
1	one‐electron
1	kgaa
1	voigt
1	2·109
1	dyn/cm2.
1	(il)-1α
1	plasmodium-specific
1	(cd28ko)
1	succumb
1	gl7
1	leontopithecus
1	(golden-headed
1	tamarins)
1	chrysomelas,
1	(diseases
1	chrysomelas.
1	indometacin
1	posological
1	mianly
1	political
1	abetter
1	(hemocytes)
1	malaria-transmitting
1	(tcgf).
1	pbl.
1	crbc
1	(srbc).
1	(il‐2)
1	rosette‐forming
1	non‐t
1	il‐2
1	fey
1	il‐2,
1	antibody‐dependent
1	(adcc);
1	(licc)
1	adcc,
1	e-srbc
1	thymus;
1	eox-7s
1	(thymus
1	tonsils),
1	(tonsils),
1	fc(7s)
1	licc.
1	(tcgf)
1	human-stimulated
1	tcgf,
1	afterward,
1	cytotoxicity:
1	(licc),
1	(adcc).
1	attacker-target
1	(fcr)
1	51cr
1	immunoadsorbents
1	broadens
1	monolayers;
1	non-specific,
1	1-[butyl(dichloro)-λ
1	-tellanyl]-2-[1s-methoxyethyl]benzene
1	(organotelluranes
1	rf-13s)were
1	enantiodiscrimination.
1	enantiomers
1	rf-13s
1	stereodependent
1	history;
1	(hdfs)
1	(sun-protected)
1	(sun-exposed)
1	sun-protected
1	sun-exposed
1	sun-exposed-derived
1	hdfs,
1	ingredient
1	mesothelioma,
1	asbestosis.
1	cytokinetic
1	mislocalization
1	anillin,
1	septin
1	alix
1	tetraploidization
1	prenylated
1	benzophenone
1	(7-epiclusianone)
1	garcinia
1	(clusiaceae)
1	16.13
1	7-epiclusianone.
1	non-small
1	extracopies.
1	blocking,
1	non-synchronous
1	(fish).
1	mns,
1	erbb1could
1	heavy-metal
1	bioreactor,
1	450.0mg/g
1	(gac)
1	biofilm-gac
1	(bgac)
1	influent,
1	gac
1	bioreactors
1	(cscs)
1	appraise
1	scarring.methods:
1	(plastic
1	surgeon,
1	dermatologist,
1	physiotherapist,
1	biologist,
1	layman)
1	modulator.
1	stony
1	brook
1	scale.results:
1	good-quality
1	(80 %
1	75.2 %
1	scars),
1	51.2 %
1	satisfaction
1	verapamil.conclusions:
1	50 µm
1	modulator;
1	keloids
1	surgery.level
1	ratings,
1	www.springer.com/00266.
1	(ht-144)
1	melanocyte
1	(ngm).
1	ic§ssub§50§
1	esub§
1	activated-caspase
1	ngm.
1	milder.
1	micronucleation
1	lines.methods:
1	lapse.results:
1	erbb1,
1	transition.conclusion:
1	lauand
1	a+rna
1	diptera.
1	3?-untranslated
1	zinc-finger
1	mmp1.
1	50-μm
1	stellate.
1	(fitc)-phalloidin
1	verapamil-treated
1	tracks
1	fibrocontractive
1	isbi.
1	mesotheliomas.
1	metaphase,
1	telophase
1	centrosomes.
1	germarium
1	meroistic
1	polytrophic
1	oocyte.
1	scaptotrigona
1	postica,
1	eusocial
1	fitc-phalloidin,
1	postica
1	oogenetic
1	igm+
1	cd11b+.
1	(three-dimensional)
1	reductionist
1	(f-actin
1	microtubules)
1	(transmission
1	entosis.
1	(gjic)
1	malign
1	flattening.
1	ionta
1	shwachman-bodian-diamond
1	(sbds)
1	sbds,
1	sdo1p,
1	recycling.
1	ovarioles,
1	non-synchronic
1	germarium,
1	(23-28
1	fusomes
1	tubulin.
1	digestory
1	post-pharyngeal,
1	hypopharyngeal,
1	mandibular,
1	develop.
1	post-pharyngeal
1	queens,
1	castes.
1	hypopharyngeal
1	collector
1	arrangement.
1	request
1	scraping
1	(broken
1	(pyknosis,
1	karyolysis,
1	chromatin)
1	radiology.
1	nonribosomal
1	pre-40s
1	pre-60s,
1	nip7p,
1	co-transcriptionally
1	δnop53/gal::nop53.
1	rrp6p
1	polyadenylated
1	pre-rrnas.
1	(sl/dt)
1	scrape.
1	determinated
1	softwares,
1	sl/dt
1	amphibole
1	pieces.
1	interphasic
1	reconstructions.
1	fibers-containing
1	cytokinesis,
1	cellulite
1	plurality.
1	anticellulite
1	(sac)
1	silanol
1	silicon.
1	mannuronic
1	21.days
1	cellulite.
1	hirsutism.
1	(1-4)
1	variegatus).
1	(t47d
1	mcf7).
1	disorganizing
1	depsipeptides
1	jaspamide
1	dolastatins),
1	brl3a
1	shellfish
1	(oysters,
1	scallops,
1	crustaceans.
1	saxitoxins
1	ciguatoxins,
1	intoxicate
1	sebastião
1	(usp).
1	(pes)
1	(aqueous)
1	(aes)
1	(methylene
1	dinoflagellate
1	prorocentrum
1	78.75
1	32.56
1	190.50)
1	22.50
1	170.80)
1	65.07
1	27.40
1	154.60)
1	84.29
1	53.26
1	133.40
1	nop53p,
1	nip7p.
1	source-conditional
1	nop53
1	pre-rrnas
1	a-tagged
1	coprecipitated
1	his-nop53p
1	stains,
1	sytox
1	green®
1	advantages:
1	lasting;
1	rnaase
1	micronuclei.
1	amorphinopsis
1	arenosclera
1	brasilensis,
1	dellechiajei,
1	cliona
1	aff.
1	celata,
1	hadromerida
1	scopalina
1	ruetzleri
1	50≤30
1	dentist.
1	scrapping
1	brush,
1	microscopies.
1	(buds
1	(condensed
1	karyorrhexis)
1	pycnosis
1	0.90),
1	(dscr2)
1	©2004,
1	undifferentiated,
1	cone.
1	ceases,
1	368c
1	embryonic-maternal
1	nucleolus-organizing
1	polytenic
1	trisomy
1	(dscr),
1	dscr1-mutated
1	gfp's
1	dscr1.
1	pfister
1	a549.
1	cytokeratin-8,
1	αtubulin
1	phalloidin-tritc.
1	concentrically
1	radially,
1	cervix
1	(cervical
1	[cin]
1	116),
1	salvador-bahia;
1	57),
1	cytopathologic
1	1-3);
1	(n=27),
1	penal
1	institution,
1	colposcopic
1	nonsmokers.
1	(smokers
1	nonsmokers)
1	atypia
1	(ia)
1	ia.
1	hsil
1	coitus,
1	multiparity
1	contraceptives.
1	chromosomai
1	lines),
1	(fbs),
1	(10-9m
1	10-10m)
1	10-8m
1	phalloidin-fluorescein
1	(fitc).
1	153,
1	153.
1	boundary.
1	bimodal,
1	4c.
1	non-diploidy
1	0.875.
1	nurses
1	15.12,
1	freedom,
1	extensive,
1	d75
1	feulgen-dna
1	cytophotometry.
1	aneuploid.
1	extrareplication
1	hk-2
1	intermediary-sized
1	oncofetal
1	(alphafeto-protein,
1	gonatropin
1	lactogen)
1	(neurofilament
1	enolase)
1	sulphated
1	sulphate.
1	antiepileptic
1	diphenylhydantoin
1	hyperdiploidy
1	16.0.
1	mitotic-arresting
1	amnion
1	(pysc)
1	procollagen.
1	185,000
1	160,000,
1	pysc
1	ac**
1	renaturing
1	heterochromatic
1	euchromatin
1	repetitiveness
1	hydroxyurea
1	(h.u.)
1	angelae.
1	puff,
1	subcultures:
1	vero,
1	sirk,
1	mk-2,
1	bgm,
1	ib-rs-11
1	(s6)
1	3t6
1	3t6).
1	pre-4s
1	rnas.-autoradiographic
1	micronucleoli
1	(ribosomal
1	(mf),
1	mf,
1	phosphocholine,
1	(mt)-ros3.
1	unselected,
1	(ml).
1	68-year-old
1	(acl).
1	sequellae
1	/kg/day
1	epithelisation
1	36.4%
1	oil-free
1	cream)
1	luminescence,
1	time-consuming,
1	sb(v)-based
1	lipossomal
1	iminodibenzyl
1	(dado)
1	(ea),
1	(en)
1	(dien)
1	(dhr)
1	[cu(dado-ea)]2+
1	264,7
1	dado-en
1	aristolochia
1	cordigera
1	(semiarid)
1	(coastal).
1	palmitone
1	germacrene-d
1	hexanes
1	lignans,
1	neolignans,
1	aristolochic
1	indole-
1	-carboline,
1	3,4-dihydro-hyrtiosulawesine
1	-glucopyranosyl)hyrtiosulawesine,
1	neolignan,
1	-eupomatenoid-7,
1	eupomatenoid-7.
1	1d-
1	2d-nmr.
1	aristolochiaceae
1	eupomatenoid-7
1	neolignan
1	-glucopyranosyl)hyrtiosulawesine
1	144.2
1	miltefosine's
1	isobologram
1	fic
1	(fici)
1	fici.
1	vitrowere
1	muco-cutaneous
1	passaged
1	106wild
1	self-
1	luciferase-transgenic
1	regressed
1	late-healing
1	drug's
1	tamoxifen-resistant
1	multi-target
1	(lc-luc),
1	bioimaging
1	leishman
1	donovan
1	lc-luc-infected
1	alause
1	goiás
1	guyanensis-infected
1	g852e
1	schemes,
1	shortcomings
1	arsenal.
1	indifferent
1	drugs.©
1	amazonensis.methodology/principal
1	findings:raloxifene
1	30.2
1	38.0
1	raloxifene's
1	disbac2(3),
1	monodansylcadaverine.
1	burden.conclusions/significance:the
1	e/z
1	isomerization,
1	2-arylbenzothiophene
1	2-arylbenzothiophenes
1	benzothiophenes
1	culture-based,
1	(la-luc)
1	parasitizes
1	"stressful
1	conditions"
1	adenosine-receptor
1	nucleobases.
1	purines.
1	serafim
1	protuberance
1	notwithstanding
1	zauli
1	b-diketones
1	peroxide-assisted
1	trypanosomatid-specific
1	bis(trifluoroacetylacetonate)
1	redox-activemetals
1	antileishmanials.
1	sbic
1	48.0-kda
1	meta2-null
1	extra-chromosomal
1	rnai-induced
1	(hasp)
1	(metacyclic)
1	(amastigote)
1	sub-genus
1	hasp/sherp
1	leishmania-genus
1	hasps)
1	ohasps
1	haspb
1	depledge
1	cl14,
1	0.7-17.9
1	mtt-test.
1	ec50,
1	ec90
1	antimoniate,
1	r(+)-limonene
1	(v.)braziliensis
1	pentamidine.
1	metallodrugs.
1	cul2
1	trifluorolactate,
1	2-hydroxyisobutyrate,
1	trifluoro-2-hydroxyisobutyrate)
1	spectroscopies.
1	trifluorolactate
1	non-fluorinated
1	braziliensis-
1	leishman-donovan
1	antimonials,
1	compounded
1	antiestrogen
1	108.5±0.7
1	105.0±0.0
1	sustained:
1	1015.5±0.5
1	105.1±0.1
1	miguel
1	antioestrogen
1	snafl-calcein
1	4.5.
1	no-donors
1	s-nitroso-n-acetyl-l-cysteine
1	(snac)
1	68.8
1	22.86
1	68.9
1	181.6
1	gsno,
1	snac,
1	(dtt),
1	transnitrosation
1	meta2,
1	444
1	motility)
1	donovani.
1	2-kb
1	polypyrimidine
1	localises
1	1048
1	constructs,
1	schaudini.
1	dotted
1	non‐radioactive
1	20-mer
1	secret
1	(cspg)
1	collapse.
1	dcx+
1	cspg-rich
1	nogo
1	rhoa/rock
1	cs-impaired
1	pro-metastatic
1	anti-metastatic.
1	migration/invasion,
1	anoikis
1	fronts:
1	mir-200s,
1	mir-126,
1	mir-7,
1	mir-29a,
1	mir-30a,
1	mir-137,
1	mir-101,
1	mir-613,
1	mir-539,
1	mir-205,
1	mir-9,
1	mir-195),
1	mir-21,
1	mir-183,
1	mir-31,
1	mir-let7b,
1	mir-584,
1	mir-25,
1	mir-595).
1	(mir-151,
1	mir-145,
1	mir-31),
1	(streptozotocin
1	induced)
1	nonenzymatic
1	touted
1	elasticity
1	glycation-induced
1	desmoglein
1	anti-ages
1	placebo-controlled,
1	(nct
1	01295177)
1	normalized,
1	marrow),
1	cost-free
1	nct01295177.
1	neumayeri.
1	"comandante
1	ferraz"
1	analyses:
1	2°c
1	echinoid.
1	dichlorofluorescin
1	gsh,
1	sulfhydryl,
1	hyperprolinemic
1	methylcholanthrene-induced
1	sarcomas
1	carbohydrate-dependent
1	shp-2
1	phospho-paxillin
1	promigratory
1	pi-3
1	cho.k1
1	lg),
1	l-glucose
1	rac1.
1	lamers
1	reck+
1	(contractile
1	actin-myosin
1	bundles)
1	lamellipodia.
1	(p-fak)
1	p-fak
1	ruffles.
1	tumor-suppressing
1	background/objective:
1	ischemia-hypoxia
1	three-step
1	proliferation:
1	28-kda
1	es-related
1	hypermethioninemic
1	hypermethioninemia.
1	(pg).
1	(277
1	(650
1	(p∈<∈0.05).
1	homocystinuria,
1	homocysteine
1	radical-trapping
1	hcy
1	homocysteine.
1	hyperhomocysteinemia.
1	pedigraph,
1	(16-25
1	clubs
1	salamanca,
1	(n=37)
1	federated
1	sport.
1	footprint,
1	calcaneus-tibia
1	goniometer.
1	footprints
1	(chippaux
1	angle).
1	horawa
1	jawroski
1	classifications.
1	hindfoot
1	valgus
1	(180-200
1	submandibular.
1	zamora
1	league,
1	carter
1	(tetracompartmental
1	suprailiac
1	declined,
1	metalloproteinase-disintegrin
1	(jg)
1	(fak)
1	rhodamine-phalloidin
1	jg,
1	filopodia,
1	αv-containing
1	(swim
1	(nadph-diaphorase),
1	1.-
1	nadph-diaphorase-activity
1	2.-
1	synthesizing-neurons
1	3.-
1	excellence
1	tecniques
1	hypophysectomy
1	(gfap)-
1	post-hypophysectomy.
1	differentiated:
1	retrochiasmatic,
1	preinfundibular,
1	postinfundibular
1	ependymal,
1	external.
1	preinfundibular
1	modulation)
1	gfap-immunoreactive.
1	(ngf)-induced
1	steroid-regulated
1	neurites;
1	ngf-induced
1	aromatase,
1	hypophyses
1	34.40%
1	hypophyseal
1	0.84%
1	sex-dependent.
1	(dfmo),
1	dfmo,
1	m-rna
1	dfmo-treated
1	cross-linking,
1	α1-subunit.
1	α2β1,
1	ras-like
1	wound-induced
1	rho-guanine
1	(gdi),
1	rho-adp-ribosylating
1	exoenzyme,
1	rhot19n,
1	adp-ribosylated
1	rho-gdi
1	restitute
1	lh-immunoreactive
1	(cellular,
1	areas).
1	corticosterone-induced
1	lh-cells
1	(nd)-positive,
1	(vp)-immunoreactive
1	nd-parvicellular
1	(magno-
1	parvicellular)
1	adrenalectomy,
1	vp-parvicellular
1	subdivisions)
1	adenocorticotropin
1	pleckstrin
1	faciogenital
1	(fgd1),
1	cosegregates
1	aarskog-scott
1	gdp-gtp
1	microspikes,
1	dbl,
1	cdc42hs,
1	fgd1,
1	cdc42hs-specific
1	10-5m),
1	vip-
1	pcna-immunoreactive
1	mitoxantrone,
1	docetaxel,
1	cabazitaxel.
1	cabazitaxel,
1	sub-therapeutic
1	cabazitaxel
1	ad-pg,
1	ad-pgp53
1	adrgd-pgp53,
1	pc3.
1	h2ax,
1	p53-target
1	sestrin2
1	pig3,
1	adrgd-pgp53.
1	oxidant-induced
1	p53-expressing
1	oxidant-mediating
1	interferon-beta
1	(p53wt)
1	(adrgd-pg),
1	rgd-modified
1	ifnβ.
1	p53/p19arf
1	marketplace.
1	(adpgp53)
1	outperforms
1	du145.
1	adcmvp53.
1	adenovector
1	llc1
1	p19arf,
1	cxcl3,
1	cd274,
1	osm,
1	p19arf.
1	(cdkn2a,
1	(ifn-β,
1	cytokine)
1	succumbing
1	tumor-free
1	nod-scid
1	(nk
1	deficient).
1	ulbp1,
1	fas/apo1
1	killer/dr5
1	proepicardium,
1	(cosmcs).
1	(coes),
1	coes
1	coe/cosmc
1	ra-synthesizing
1	muscularization.
1	(proepicardial
1	[retinaldehyde
1	dehydrogenase-2]/vegf
1	overexpression)
1	hierarchical,
1	function.methods:
1	glioma)
1	p53wt,
1	western,
1	marking.
1	nutlin-3.conclusions:
1	p53-activating
1	sparked
1	oncoretrovirus
1	tragically,
1	reoccurrence.
1	typically,
1	suppressor.
1	element),
1	synergizing
1	3′-ltr,
1	region/enhancer
1	surpassed
1	parental,
1	nonmodified
1	cdna's.
1	obviates
1	retrovirus.
1	promising,
1	p16,
1	pcl-retrovirus.
1	retrovirus-
1	cdk
1	observance
1	undermine
1	(pq)
1	schizontocidal
1	cq-only
1	microscopy-detected
1	pcr-detected
1	92.1%
1	antirelapse
1	surveillance;
1	cq-mediated
1	identifier
1	nct02691910.).
1	(dbpii)
1	erythrocyte's
1	dbpii,
1	dbpii.
1	darc.
1	strain-transcending
1	mitogenomes
1	melanesia
1	americans.
1	simium
1	ecosystem,
1	human-to-monkey
1	transfers.
1	enslaved
1	conquest,
1	pre-columbian
1	(pvron2)
1	pvron21828-2080.
1	pvron2.
1	obaldia
1	malarious
1	transmissive
1	accumulation/sequestration
1	asexual-
1	gametocyte-stage
1	(gametocytes)
1	(schizonts)
1	revisiting
1	revisions
1	voice
1	miserably
1	nepal
1	bangladesh,
1	commendable,
1	south-asian
1	realistically
1	scalability
1	smallvolume
1	40-fold.
1	iscove's
1	[3h]hypoxanthine
1	ozzardi,
1	microfilaremic
1	(fil+)
1	(fil-)
1	ozzardi-endemic
1	co-endemic
1	cd39,
1	ectonucleosidase
1	microfilarial
1	cd4+cd39+t
1	reticulocytes.we
1	(tfr1)
1	reticulocyte-binding
1	(pvrbp2b).we
1	recognition.we
1	reticulocytes.these
1	tfr1-pvrbp2b
1	(rbps)
1	reticulocytes,
1	rbp1a.
1	rbp1a
1	rbp1
1	157–650
1	(rbp1:f8),
1	normocytes,
1	reticulocytes.
1	rrbp1:f8
1	anti-rbp1
1	vivax–exposed
1	1,180
1	juruávalley,
1	74.6%
1	0.14-0.57)
1	0.08-0.54),
1	amean
1	0.05-0.62
1	ml);
1	secondtrimester
1	andmaternal
1	(83.1%)
1	0.3%of
1	vivaxmalaria
1	2015–16
1	priorities.
1	(bra,
1	(per,
1	23),
1	(col,
1	(mex,
1	(nucleotide
1	π
1	10−4and
1	10−4)
1	undescribed)
1	dhfr,
1	dhps,
1	mdr1,
1	mrp1,
1	mrp-2,
1	(crt-o)
1	substructured
1	(pairwise
1	fstvalues
1	0.092).
1	fontoura
1	countrywide.
1	(rcd)
1	enrollment),
1	microscopy-
1	(qpcr)-based
1	163),
1	878),
1	841).
1	hh
1	confounders,
1	microscopy-based
1	49.5%
1	hhs.
1	27.6%
1	qpcr-positive
1	rcd.
1	(biabs)
1	anti-pvdbp
1	466
1	symptomatic,
1	>40%
1	terciles).
1	ctla-4,
1	ox40,
1	tnfrii,
1	19–23%
1	ox40.
1	ox40
1	(1.8:1)
1	(1.3:1)
1	cryopreservation.
1	locales.
1	unknown.methodology/principal
1	darc
1	india.conclusions/significance:
1	darc-negativity
1	asia-pacific
1	>300,000
1	inbreeding.
1	artesunate-mefloquine
1	(asmq)
1	4-73
1	42-day
1	46.3%
1	35.2%
1	enrollment,
1	gametocytemia
1	1-14
1	asmq.
1	37.6%
1	day-3
1	mq
1	(pfmdr1
1	amplification)
1	(mutations
1	kelch13
1	gametocytocidal
1	asmq-treated
1	(clinicaltrials.gov
1	nct01144702).
1	artemisinin-resistant
1	581
1	(420
1	(161
1	artemisinin-exposed
1	kreitman
1	(143,910
1	deaths)
1	focal,
1	shrunk.
1	99.5
1	submicroscopic
1	(nematoda:
1	onchocercidae)
1	nematode,
1	patrick
1	manson
1	midges
1	culicoides)
1	simulium).
1	bolivia
1	extremities,
1	itchy
1	rashes
1	keratitis)
1	mansonelliasis,
1	gaps,
1	word
1	uncontacted
1	koepfli
1	ofmicrosatellite
1	11microsatellitemarkers
1	841
1	1999–2008.
1	10.0–12.8),
1	(8.1–9.9)
1	(7.9–8.4),
1	(5.5–7.2).
1	se-asian
1	60–80%
1	2–6markers,
1	substructuring
1	se-asia
1	uzbekistan
1	exceptional,
1	near-clonal
1	(fst>0.2).
1	fst
1	(0.11–0.16)
1	(0.04–0.07)
1	persistencymust
1	kazuyuki
1	tanabe
1	coauthors
1	recombining/multimorphic
1	allele-rich
1	recombining
1	bottleneck,
1	25–40%
1	(snps).
1	barcode.
1	(hrm),
1	intergenic,
1	intronic,
1	guiana),
1	(ethiopia)
1	(sri
1	lanka).
1	ng/μl)
1	calls,
1	0.1).
1	informative,
1	community-level
1	moderate-to-high
1	0·699),
1	(78·5%)
1	(mci),
1	outbreak;
1	pre-outbreak
1	(mayv)
1	arthralgic
1	acrelândia
1	arthralgia.
1	acre/mayaro
1	questions:
1	imported?
1	from?
1	origins?
1	584
1	(march–april
1	(april–may
1	2013),
1	march–april
1	migrants
1	2–3%
1	remansinho:
1	43.8%
1	73.1%
1	declined;
1	32.8%
1	asymptomatic;
1	54.4%
1	pcr-detectable
1	gametocytemias;
1	(17.0%)
1	vitral
1	(hav)
1	(hev)
1	faecal-oral
1	397
1	anti-hav
1	79.2-86.6%).
1	(or),
1	1.097;
1	1.050-1.147;
1	1.603;
1	1.054-2.440;
1	50/388
1	(12.9%,
1	9.5-16.2%).
1	7/43
1	anti-igg
1	1.033;
1	1.016-1.050;
1	area.conclusions:
1	hev-
1	timor
1	guinea.
1	guyana,
1	standardising
1	(2003-2007).
1	(12-46
1	locus)
1	(expected
1	heterozygosity)
1	0·8744.
1	(mci).
1	0·04-0·25;
1	p≤0·0009)
1	2003-4
1	2006-7
1	(estimated
1	661
1	896
1	513
1	7057,
1	used).
1	mode-shift
1	0·15-0·33,
1	0·26)
1	bottleneck.
1	resurgence.
1	melanesia.
1	(n=87)
1	(n=164)
1	pursat
1	p=0.003),
1	(89.6%
1	47.6%)
1	11.1,
1	(fy)
1	duffy-positive
1	homozygotes.
1	fya
1	fyb,
1	customarily
1	pathways.in
1	duffy-dependent
1	gametocyte-specific
1	(95.4%)
1	bloodspots
1	pvmdr-1)
1	y976f,
1	(1.8%)
1	mirrors
1	pvmdr-1,
1	mefloquine
1	cq,
1	tak
1	drug-mediated
1	85),
1	paroxysms,
1	il-10/tnf-α,
1	il-10/interferon
1	il-10/il-6
1	stnfrii/tnf-α
1	stnfrii.
1	fast-multiplying
1	1000x
1	pre-cryopreservation
1	preparation.results:
1	in-solution
1	20%-80%).
1	iquitos,
1	).conclusion:
1	population-based,
1	1111
1	acrelândia,
1	deficiencies;
1	poisson
1	(apr)
1	iron-deficiency
1	45.4%,
1	quartile,
1	lowest,
1	(apr,
1	0.60;
1	0.37-0.98).
1	(<24
1	2.90;
1	2.01-4.20)
1	parity
1	(>2
1	2.01;
1	1.40-2.87)
1	(2.1;
1	1.4-3.0),
1	(1.4;
1	1.0-2.2),
1	(2.0;
1	1.3-3.1)
1	(>5
1	1.5;
1	1.1-2.2).
1	morbidities
1	561,000
1	structured.
1	field-oriented
1	gold-mining
1	enclaves
1	(sera5).
1	inter-species
1	(ks
1	0.076)
1	reichenowi,
1	oceania
1	(2562.
1	bp).
1	59-72)
1	continent-specific.
1	(fst)
1	"benign",
1	shadows
1	hypnozoite
1	vivax's
1	subsist
1	cumbersome,
1	guas
1	dihydropteroate
1	(dhps),
1	893
1	sulfadoxine
1	(fy).
1	41-50%
1	30-80%reduced
1	pvdbp-based
1	3α,
1	pfs230,
1	gametocyte/gamete
1	pfs230
1	(pvs230),
1	(pvs230:
1	pvx_003905).
1	pks230
1	pcys230,
1	8-kb
1	(θπ
1	0.00118)
1	replacements.
1	130-435
1	(pvdbp).
1	(pvdbpii),
1	neutrally
1	417,
1	419,
1	424,
1	458,041
1	countrywide
1	middle-income
1	(aggressive
1	insecticide-treated
1	insecticides)
1	silva-nunes.
1	phenotype-determining
1	characterized.results:
1	100-kb
1	(salvador-i,
1	resistance.conclusion:
1	levels.see
1	http://www.biomedcentral.com/1741-7007/8/90.
1	orjuela-sánchez
1	tropics
1	[1-3].
1	initiatives.
1	519
1	isolate).
1	oceania.
1	[4-7]
1	arrays.
1	csp-based
1	merozoite,
1	multi-gene
1	pfrh
1	senegal.
1	371
1	eba-175,
1	fst)
1	pfs45/48
1	eba-175
1	(dbp),
1	366
1	anti-dbp
1	reexamined
1	trinucleotide
1	3-44
1	0.7517
1	0.8450
1	0.8610
1	(asian
1	african)
1	78.2%
1	asian.
1	cati,
1	recognised:
1	organs)
1	nerves).
1	less-severe
1	(covert
1	toxocariasis)
1	toxocariasis).
1	531
1	(2281.53
1	follow-up)
1	20.6/100
1	6.8/100
1	(81.4
1	5.4-fold
1	population-wide
1	2.0%).
1	27.2%
1	slide-positive)
1	69.1%
1	house-protection
1	hypnozoites,
1	(26-40%
1	chloroquine-primaquine.
1	(consistent
1	hypnozoites)
1	(sharing
1	analyzed).
1	extraordinarily
1	recurrences
1	(msps)
1	(pvmsp4)
1	pvmsp4,
1	microgeographical
1	vaccine-candidate
1	(msp)-1,
1	inter-family
1	msp-1-associated
1	multi-allele
1	msp-7.
1	msp-7
1	pfmsp-6,
1	now-extinct
1	msp-6,
1	(nearly)
1	pfmsp-9
1	inter-unit
1	18-base
1	reichenowi.
1	(thick-smear
1	14.4%
1	[pcr])
1	covariates.
1	anti-disease
1	march-april
1	65.8%
1	60.8-70.8%)
1	(87.5%
1	eligible)
1	11.9%
1	(1,638)
1	(synonymous
1	noncoding)
1	neafsey
1	312m,
1	12-locus
1	alleles;
1	312m
1	312m-type
1	42m-type
1	1:0.5
1	1:0.25
1	312m:42m
1	509
1	489.7
1	30.0/100
1	16.3/100
1	forest-fringe
1	perpetuates
1	local-level
1	0.807)
1	global-level
1	asia)
1	relapses,
1	dwarfing
1	excretory-secretory
1	22.5-31.4%).
1	2.32;
1	1.11-4.86)
1	1.81;
1	1.3-2.52)
1	seropositivity;
1	0.46;
1	0.28-0.73)
1	0.32-1.02)
1	38.9%
1	denv-naive
1	seroprevalence,
1	18.3%)
1	3.67
1	episodes/100
1	poverty,
1	seropositivity,
1	seroconversion.
1	1gm
1	travel,
1	326
1	laboratory-confirmed,
1	(46.3%
1	35.3%
1	5-73
1	(fever,
1	myalgia,
1	(59.8%),
1	(48.4%)
1	ninety-six
1	(29.4%)
1	(96.9%
1	only),
1	symptom-less
1	"intense"
1	(fc27
1	3d7).
1	22-28%
1	(6-7%),
1	cross-reactive,
1	short-lived;
1	parasites),
1	inbreeding,
1	small-area
1	(recent
1	asthma)
1	interviewing
1	guardians.
1	19.8%
1	(prevalence,
1	8.5%);
1	21.5%
1	toxocara.
1	[adjusted
1	(aor)=2.21,
1	ci),
1	1.07-4.59,
1	p=0.033],
1	(aor=2.37,
1	1.17-4.77,
1	p=0.016),
1	448
1	replacements,
1	proliferations
1	type-
1	predating
1	7.8),
1	0.627
1	0.913
1	0.790).
1	398
1	causes;
1	geohelminth
1	(granada,
1	(53.4%)
1	(19.6%)
1	(12.7%);
1	(children
1	(5.3%),
1	690m,
1	48.1%
1	under-five
1	acrelandia
1	477).
1	nchs
1	weight-forheight,
1	weight-for-age,
1	height-forage
1	8.7%,
1	7.5%,
1	43.5%
1	reserves,
1	underestimate
1	towns,
1	stratum.
1	circa
1	multi-character
1	subfamilies,
1	pfmc-2tm
1	driven,
1	hypomesoendemic,
1	(1998
1	2003)
1	loc,
1	43),
1	34),
1	33),
1	70.003,
1	0.116).
1	loc
1	flores
1	thaton,
1	asia;
1	52.8%)
1	78.9%)
1	86.1%).
1	alphavirus,
1	orthobunyavirus,
1	42.6%
1	older,
1	(36.2%).
1	expansions.
1	(mrca)
1	200,000-300,000
1	mrca
1	homo
1	sapiens,
1	hominid
1	sapiens
1	immunity:
1	miners
1	msp-119,
1	chloroquine-resistance
1	72-76,
1	k76t
1	(s[tct]mnt,
1	s[agt]mnt,
1	cmnt,
1	cmet,
1	ciet)
1	15-loci
1	smnt
1	cmnt
1	1132
1	12.5%;
1	income,
1	attendance,
1	(wst-8)
1	quantitatively.
1	indonesia.
1	g6pd-normal
1	electricity,
1	(ssurrna)
1	genbank-available
1	(pov
1	(poc
1	1-2)
1	cameroon
1	mal/mai
1	(cameroon,
1	mal/mai,
1	isolates).
1	haplotyping
1	north-western
1	typed:
1	polyα,
1	ta42
1	ta81,
1	ta1,
1	ta87,
1	ta109
1	2490,
1	araii,
1	pfg377,
1	pfpk2,
1	ta60.
1	propagating
1	co-ancestry
1	e-tng-l,
1	non-telomeric
1	strand-slippage
1	mispairing
1	honduras1.
1	(n=60),
1	(n=14).
1	indonesian
1	fcr-3
1	(56/60),
1	fcr3-type
1	parasite-inhibitory
1	immune-evasion
1	interallele
1	(0.953
1	(0.813
1	0.047).
1	1044
1	(5.5%),
1	age-group,
1	(2.4%
1	wasting)
1	(p=0.05,
1	variables)
1	giardia)
1	height.
1	helminth-infected
1	height-for-age
1	-0.412
1	-0.637
1	-0.186],
1	-0.049-0.079)
1	semi-
1	full-nested
1	microtiterplate
1	1323
1	mph.
1	ovale-infected
1	coinfected
1	malariae.
1	quadruple
1	orange-stained
1	southern,
1	ratherthan
1	(aor)
1	confounders.
1	co-trimoxazole
1	[aor=0.30;
1	(ci)=0.15-0.60].
1	(aor=37.09;
1	ci=7.49-183.67)
1	(aor=10.20;
1	ci=2.00-51.90)
1	>400
1	cells/μl.
1	unadjusted
1	homosexual
1	bisexual
1	100/μl
1	recommended)
1	200/μl
1	anti-te
1	discrete-event
1	(initial
1	introduced)
1	average.
1	83%.
1	outcrossing
1	meiosis
1	quantitative,
1	thrombospondin-related
1	(pvtrap),
1	(pftrap)
1	a-domain
1	glycosaminoglycan-binding
1	acid-serine-proline
1	pvtrap.
1	amplicor
1	mpb64
1	(73%
1	ziehl-neelsen
1	antituberculosis
1	allelic-specific
1	hypo-endemic
1	113),
1	208)
1	ic1
1	between-family
1	10-13
1	homoplasy.
1	(representing
1	putative,
1	mid-80s
1	mid-90s
1	(1,016
1	1984-85
1	1,280
1	1995-96).
1	sun'eys
1	lugol-stained
1	fertiles
1	trends,
1	30.9%
1	10.7%),
1	helminthes
1	4.8%),
1	5.5%)
1	0.5%).
1	schooling)
1	intennediate
1	detenninants
1	(housing,
1	sanitation,
1	tlie
1	m'as
1	schooling,
1	sanitation.
1	40-residues
1	"snpvssep"
1	conjectured
1	or.
1	(29/33).
1	(msp1,
1	msp2)
1	ayala.
1	3'-regions
1	3'-regions,
1	msp-1,
1	msp-1:
1	5'-region
1	non-divergent
1	3'-region.
1	3'-region
1	compartmental
1	and-economic
1	(gts)
1	gts.
1	microscopists.
1	misidentification
1	blood-stages,
1	(k1,
1	mad20
1	ro33),
1	gene-types
1	gene-types.
1	statistic,
1	msp-1-based,
1	antigen-encoding
1	465
1	self-fertilization
1	(0.3-0.4)
1	(0.76-0.8),
1	asia/pacific
1	(0.51-0.65).
1	0.364)
1	outcrossing,
1	disentangle.
1	fumihiko
1	qing
1	indah
1	tantular
1	119)
1	anti-hbc
1	35.3%,
1	age-stratified
1	(average:
1	2.37
1	548
1	burmese
1	mph,
1	24.3%
1	(133/548).
1	malariae-specific
1	20-bp
1	115-bp.
1	mph-
1	thai-
1	54),
1	238)
1	79).
1	version)
1	vietnamese
1	17-24
1	cys-rich
1	(1989-1991)
1	sociodemographic
1	(july-october
1	1990)
1	jamary,
1	7,000
1	august.
1	(autochthonous
1	heterotochthonous
1	(imported)
1	town.
1	anti-spf66
1	sp66-induced
1	titre.
1	schedules.
1	centre-based
1	2411
1	0-1
1	andre,
1	consultations
1	public-domain
1	microcomputer
1	partial)
1	108.8
1	95.5-123.2
1	(28.9
1	17.9-38.3
1	nationwide
1	12.3-17
1	dwellers,
1	slum
1	45.7%
1	(17.2%);
1	entamoeba
1	histolytica.
1	(8.4%).
1	trichiura,
1	kato's
1	(e.p.g.).
1	e.p.g.)
1	lumbricoides-infected
1	trichiura-infected
1	overdispersed.
1	anaemia,
1	urupa,
1	mebendazole
1	(haemoglobin
1	[hb]
1	130)
1	9.2%
1	109)
1	29.7%
1	depleated
1	[serum
1	μg/l]
1	10.1%
1	g/dl
1	76.5%)
1	non-anaemic.
1	63)
1	2.85,
1	0.81-10.28).
1	urupa
1	forestry
1	1%.
1	163,
1	970
1	inhabitants.
1	16-40
1	thicksmear
1	(hemeron),
1	(32%
1	smears)
1	(candeias
1	velho).
1	villagers
1	rondonia.
1	icb2-5,
1	area--candeias
1	periurban
1	basin--a
1	1,068
1	(14.1%
1	population)
1	(measurement
1	(giemsa-stained
1	thick-smear
1	two-hundred
1	ninety-nine
1	(28.0%
1	anaemic,
1	(70.0%)
1	(41.2%,
1	7/17)
1	(44.4%,
1	8/18).
1	stoll
1	476
1	(44.6%
1	population);
1	(26.8%)
1	lumbricoides,
1	(14.1%);
1	non-parasited
1	lighter
1	(38.7%).
1	(18.9%).
1	overdispersed
1	age-distribution
1	unusual:
1	16-year-old
1	eluate
1	(alto
1	paraíso,
1	ariquemes
1	municipality)
1	ifat;
1	0.686)
1	0.818,
1	0.467)
1	numerically
1	(rs
1	microphotometer
1	readings
1	cardboard).
1	bio-remediation
1	scarcer
1	heavily-contaminated
1	hotspot.
1	(t-rflp)
1	t-rflp
1	48,553
1	seasons.
1	basidiomycota,
1	chytridiomycota,
1	zygomycota
1	neocallimastigomycota,
1	calcarisporiella,
1	didymosphaeria,
1	(ascomycota)
1	(basidiomycota)
1	aluminum,
1	dissimilarity,
1	anticancer,r
1	epicocconone
1	fluorophore,
1	d8646-2-6
1	taxol
1	taxus
1	brevifolia.
1	chemical-synthesis
1	e00552-17,
1	https://doi.org/10.1128/genomea.00552-17.
1	acknowledgments
1	pró-reitoria
1	pesquisa/university
1	(usp),
1	cnpq
1	02458/2013-3),
1	(institutional
1	grants),
1	2017/
1	12647-0).
1	venomous,
1	scyphozoan
1	chrysaora
1	lactea
1	cubozoans
1	tamoya
1	haplonema
1	chiropsalmus
1	quadrumanus.
1	medusozoa.
1	medusozoa
1	cnidaria
1	pontificia
1	javeriana.
1	fonte
1	importante
1	produzir
1	bioativos.
1	considerando
1	maioria
1	destes
1	pode
1	cultivar,
1	convertido
1	ferramenta
1	útil
1	este
1	potencial.
1	estudo
1	policetídeos
1	presentes
1	construída
1	partir
1	amostra
1	isolada
1	atlântica
1	brasileira.
1	compreende
1	insertos
1	caracterização
1	destas
1	moléculas
1	alternativa
1	promissora
1	elucidar
1	biotecnológico
1	bioativos
1	comunidades
1	microbianas.
1	avaliados
1	usando
1	degenerados.
1	sistemas
1	isolados
1	suas
1	nucleotídeos
1	analisadas
1	ferramentas
1	bioinformática.
1	avaliação
1	forneceu
1	disso,
1	variações
1	observadas
1	quando
1	comparadas
1	dados
1	cetosintases.
1	estas
1	descobertas
1	obtivemos
1	visão
1	relação
1	produção
1	metabólitos
1	secundários.
1	hydrozoan
1	tentacles
1	biopharmaceutical
1	1.5 l.
1	xylanase-rich
1	238 %
1	hemicellulose
1	xylanases
1	458.1
1	428.1
1	264.37
1	modes.
1	carbon-limited
1	liquor.
1	(gh10,
1	gh11,
1	gh62
1	cazy
1	cellobiohydrolase
1	(g6
1	gh7),
1	β-xylosidase
1	(gh3),
1	feruloyl
1	(ce1)
1	65.3%,
1	dr47.
1	6.26.
1	10.13.
1	5.0.
1	1.5l
1	gh54,
1	alexandrino
1	19450,
1	industrially
1	foremost
1	bagasse,
1	(2g).
1	hemicellulytic
1	2g.results:
1	deconstruction,
1	spoiled
1	books
1	29°c
1	steam-exploded
1	delignified
1	(deb)
1	(3:1),
1	xylanase,
1	cmcase,
1	fpase
1	pectin,
1	(bt2).
1	dr49.
1	media.conclusions:
1	dr49
1	robl
1	sambaquiensis.
1	cone-snails,
1	scorpions,
1	bee,
1	cytolysins,
1	neurotoxins,
1	prepro-haystatin
1	p-iiid
1	eumetazoan
1	technologists,
1	nutritionists
1	biotechnologists,
1	batrachochytrium
1	dendrobatidis
1	(bd),
1	reliably.
1	difficulties,
1	zoospores
1	tryptone-gelatin
1	hydrolysate-lactose
1	(tghl)
1	green-eyed
1	litoria
1	serrata.
1	bioaugmentation
1	chytridiomycosis
1	inter-research
1	midway
1	balimo,
1	province.
1	guinean
1	yersinia-like
1	balimo
1	pseudomallei,
1	palaeogeographical
1	australasia
1	kineosphaera
1	limosa
1	liu
1	streptoalloteichus,
1	streptacidiphilus,
1	poly(3-hydroxyvalerate)
1	d-producing
1	otindensis
1	collisionally-activated
1	llp
1	mer
1	cosd-dna
1	dn-
1	dx-dna
1	food-borne,
1	opportunistic,
1	gastroenteritis,
1	listeriosis
1	1/2a.
1	monocytogenes,
1	1/2b
1	multigenome
1	protein-,
1	acid-,
1	metabolism-,
1	linguistic
1	triplet-words,
1	triplet-words
1	(rnp)
1	ggy
1	ggr),
1	rpl18
1	rpl5
1	functioned
1	anthracyclinic
1	antitumoral.
1	qrtm
1	qrtm,
1	g/l,
1	c-10,
1	14-kb
1	cosg
1	cosk,
1	glycosyltransferases
1	deoxysugars
1	cosk
1	rimosus
1	avermitilis.
1	slp2.
1	seven)
1	instability),
1	avermitilis,
1	267/2h,
1	31267
1	267/2h.
1	ipt-85
1	mms
1	avermectin-aglycone-producing
1	85-62,
1	wl6
1	3088
1	α-amylases.
1	aureofaciens
1	prototrophic
1	(his+).
1	u.v.;
1	ntg
1	his+
1	4-nitroquinoline-1-oxide
1	(70),
1	(75)
1	(95)
1	57.8%
1	spray-dried
1	(ycw)
1	stool.
1	4.40 ± 1.05 kg
1	6.2 ± 0.54 years
1	ycw),
1	totalling
1	(p >.05).
1	quadratic
1	valerate,
1	cadaverine
1	microsurgery.
1	triturated,
1	(71.6%),
1	(48.3%)
1	extra-radicular
1	intra-radicular
1	32a
1	ap-pcr.
1	creviocaricanis,
1	cangingivalis
1	macacae;
1	circumdentaria.
1	(67.85%)
1	(63.63%)
1	circumdentaria
1	enteritic
1	non-outbreak
1	(38)
1	(opa-3)
1	(ntsys).
1	incriminated.
1	th17/il-17
1	(il-17ra)-knockout
1	il-17ra
1	acetic,
1	propionic,
1	mono,
1	a. actinomycetemcomitans,
1	a. actinomycetemcomitans.
1	bacteria-stimulated
1	free-fatty
1	(ffar2)
1	saha,
1	ms-275,
1	rgfp
1	966.
1	neutrophil's
1	[ne].
1	cc-1
1	[six
1	origin].
1	22.5%
1	host-microorganisms
1	culture-based
1	spp./parabacteroides
1	(35.5%),
1	(74.2%)
1	86.6%,
1	0.0092).
1	antibiotic-treated
1	0.0268),
1	0.0444),
1	0.0009).
1	iota-toxin
1	neurotoxigenic
1	bont
1	clostridial
1	c. perfringens.
1	(96.6%)
1	c. botulinum
1	bont/a
1	non-mineralized
1	(nod1)
1	host–microbe
1	microbe-induced
1	rip2
1	nod2.
1	rip2-ko
1	microbial-induced
1	μct
1	h/e-stained
1	qpcr-based
1	qpcr-focused
1	council
1	abutments,
1	zirconia
1	(zro2),
1	(be)
1	≤0.21
1	co-morbidities
1	sought.
1	vulgatus,
1	adolescentis
1	culture-method.
1	(0.015).
1	(0.022).
1	0.24;
1	0.026)
1	0.44;
1	(0.042).
1	-0.22;
1	0.039)
1	(bfpai).
1	(ntbf)
1	bfpai
1	bfpai-flanking
1	fragilis-positive
1	bft-negative,
1	fragilis,
1	fusobacterium.
1	furthers
1	umutina
1	dichotomous
1	interrelations
1	nigrescens.
1	statuses
1	lippia
1	(mill.)
1	n.e.br.
1	actinomycetemcomitans;
1	43717),
1	nucleatum;
1	25586)
1	gingivalis);
1	33277)
1	(mbc),
1	fragilis;
1	25285)
1	carvone,
1	ocs.
1	(cii)-reactive
1	nigrescens,
1	joint-protective
1	il-1.
1	192:
1	4103-4111.
1	86.4
1	%of
1	([96
1	(sialidase
1	nani
1	nanj
1	zootecnia,
1	showed.
1	dentition,
1	jaws,
1	assimilation.
1	(103)
1	(81.8%)
1	coccobacilli
1	(49%),
1	odontologia
1	bauru.
1	l:
1	ligature;
1	g-pg:
1	g-pgfn:
1	pg;
1	i-pg:
1	molars;
1	i-v:
1	phosphatebuffered
1	dunn
1	(interleukin-6
1	-1b)
1	factor-kb
1	osteoprotegerin)
1	2014;85:465-477.
1	32.1%
1	28.5%
1	canifelinum,
1	canifelinum.
1	clarithromycin,
1	procreation
1	paulostate
1	unesp)
1	fusobacteria,
1	rods,
1	chemoattractants,
1	met-rantes.
1	immune-targeted
1	repeke
1	cephalosporin
1	bacteriodales
1	(93%),
1	(47.3%),
1	(96.4%),
1	(34.2%)
1	(53.5%).
1	cfia,
1	ermf,
1	tetq
1	nim
1	62.3%,
1	76.3%,
1	periodontium,
1	chemokine/chemokine
1	actinomycetem
1	comitans
1	cytometry):
1	ccr5+f4/80+
1	ccr2,
1	ccr5+cd4+
1	pro-osteoclastic
1	loss)
1	tnf-α+,
1	ccr5.
1	rt.
1	citrobacter,
1	proteus,
1	46.8%
1	78.1%
1	roads
1	(110)
1	(150)
1	atheromas,
1	anti-glucocorticoid-inducible
1	(anti-gitr)
1	expression/production
1	(analysed
1	+cd25+
1	tregs-associated
1	lymphocyte-associated
1	expressed/produced
1	anti-gitr,
1	(gaalas)
1	neodymium-doped
1	yttrium
1	garnet
1	(nd:yag)
1	(3.75
1	machined
1	blasted
1	(tio2),
1	gingivalis-contaminated
1	implants.
1	tio2
1	(78.6%)
1	actinomycetemcomitans-infected
1	ccr5+,
1	ccl3ko-infected
1	(rankl
1	opg)
1	timp-3),
1	ccr1+,
1	metrantes
1	osteolysis-related
1	1/4
1	carbine
1	bur,
1	pulp;
1	htlv-1-seropositive
1	(cp/htlv-1
1	trended
1	(porphyromonas
1	(herpes
1	cp/htlv
1	thoroughly.
1	sequestra,
1	purulent
1	anaerobes;
1	aerobes.
1	aerobiosis,
1	actinomyces,
1	parvimonas,
1	asprogrammed
1	death-1(pd-1)playacriticalroleindownmod-ulating
1	inthe
1	lesionsite
1	andbloodwereevaluated
1	usingflowcytometry.
1	thepresence
1	pd-1+
1	actinomycetem-comitans
1	im-balanced
1	inaddition,
1	cd8+tcells
1	60-100
1	probe/primer
1	94.9
1	92.3
1	80.0
1	often.
1	between-subject
1	(tnfa)
1	-308g/a
1	177).
1	tnfa-308g/a
1	ga/aa
1	factor-alpha.
1	umutima
1	forty-
1	umutina,
1	paresi,
1	bororo,
1	bakairi,
1	kayabi,
1	irantxe,
1	nambikwara
1	ethnicities,
1	subgingival,
1	milli
1	tsbv
1	18.42%
1	26.32%
1	23.68%
1	28.95%
1	34.21%
1	mann-whitney,
1	inos-defieient
1	deyeloped
1	acid-phosphatase-positive
1	(trap+)
1	nf-kappab
1	stromal-cell-derived
1	factor-la
1	(sdf-lα/cxcl12),
1	(opg).
1	bone-resorption-modulattng
1	infection-stimulated
1	3954
1	[il-1β(3954)
1	snp]
1	117)
1	175)
1	additively,
1	hsv.
1	0.704).
1	10.3%
1	(24.1%);
1	plaque-associated
1	extra,
1	hygiene,
1	crevices
1	pockets,
1	emb
1	morphologies
1	200/mm3
1	0.0345).
1	sakazakii,
1	liquefaciens,
1	oxytoca
1	gr1+,
1	periodontium
1	ifn-ko
1	(ppe1,
1	ppe3,
1	ppf19).
1	irritative
1	ppe1
1	1:8,
1	pseudomones
1	1/32.
1	endodontics.
1	nonenterotoxigenic
1	fragilis-bile-esculin
1	co2/90%
1	n2),
1	moxifloxacin,
1	piperacillin/tazobactam,
1	tigecycline.
1	intermedia-p.
1	(75.8%),
1	(27.3%),
1	(9.1%)
1	(31.7%),
1	(23.3%).
1	forsythensis,
1	(25)
1	(36%),
1	forsythensis
1	(6.66%)
1	periodontitits,
1	periodontopahogens
1	p55-deficient
1	[p55tnf-knock-out
1	(ko)]
1	(cxcl1,
1	(cxcr2
1	ccr5)
1	p55tnf-ko
1	(mmp)-1,
1	tnf-ko
1	p55,
1	(29.2%)
1	vulgatus
1	bd26e
1	bc5j
1	(bft)
1	bft-1,
1	bft-2,
1	bft-3,
1	(bft-1
1	bft-2)
1	etbf.
1	ligand),
1	metalloproteinases)
1	(osteoprotegerin)
1	(realtime
1	interleukin-12,
1	(timp
1	mmps/timp
1	witen
1	27.5
1	ccr8
1	30:days
1	installation.
1	sulcus),
1	azithromycin
1	palladium,
1	lead,
1	implantology.
1	peri-implantitis,
1	agarbacitracin-vancomycin
1	(tsbv)
1	fu
1	5059s.
1	5059s
1	method's
1	limosum,
1	clostridioforme,
1	innocuum
1	innocuum,
1	sphenoides,
1	clostridioforme
1	paraputrificum.
1	paraputrificum
1	sphenoides.
1	limosum
1	antimicrobial.
1	capsulated,
1	β-hemolytic,
1	serum-resistant.
1	(18.75%)
1	100°c.
1	hemagglutinate
1	d-arabinose,
1	(p76a,
1	p76b).
1	uniformis
1	p3-2
1	ef-enterotoxigenic
1	fragilysin
1	4.4,
1	4.8,
1	wilkins-chalgren
1	90.6%
1	(1:10),
1	ht-29/c1cells
1	penicillin-resistance
1	digestions
1	dna-hybridization
1	nucleatum)
1	colonizers
1	periodontopathogen.
1	antiseptics
1	surgeries.
1	ultra-structure
1	metronidazole;
1	fimbries
1	fdc
1	y4
1	#38
1	y4,
1	subcultures,
1	strictu
1	(cx
1	βcd)
1	crystallography,
1	(mic50)
1	lentum,
1	actinomices
1	cfu/ml.
1	61.2%
1	10953
1	25586.
1	23745
1	coaggregation
1	host-bacteria
1	alpha-hemolytics.
1	[nine
1	(ljp)
1	(aids/nup)],
1	atcc43718,
1	43718.
1	(p24
1	p35)
1	leucotoxic
1	non-leukotoxic
1	pjl
1	leucotoxin
1	emptiness,
1	microecology
1	primed-polymerase
1	(primer
1	5059s)
1	(primers
1	m1211)
1	5059s,
1	m1211
1	subtyping,
1	examinated.
1	auto-antagonism
1	78.8%
1	iso-
1	hetero-antagonism.
1	auto-inhibition.
1	α-haemolytic
1	β-haemolytic.
1	d-lactose
1	d-raffinose
1	arbitrarily-primed
1	3.5-kb
1	aa16s
1	cell-directed
1	syringes.
1	spittoon
1	shut
1	omata
1	disraely
1	anaerobiosis,
1	biochemically.
1	67.6%,
1	(0.5%).
1	rh-
1	alpha-haemolysis.
1	(2.9%),
1	seventy‐seven
1	norfloxacin
1	0.125
1	micrograms/ml.
1	cefoxitin.
1	beta-lactam
1	caught,
1	penicillata.
1	‘global
1	distillation’
1	process),
1	(pops)
1	bioaccumulate
1	biomagnify
1	pops,
1	pops.
1	55),
1	mosses
1	austral
1	summers
1	2013–14
1	2014–15.
1	vegetation)
1	interference)
1	pesticides,
1	polybrominated
1	n).
1	hexachlorobenzene.
1	(a,b)
1	correct.
1	replaces
1	*+
1	+*;
1	+*
1	metallothionein-like
1	callinectes
1	exposures.
1	cananéia-iguape-peruíbe
1	(apa-cip),
1	µg/g)
1	values).
1	hepatopancreas,
1	lieberkühn
1	lieberkühn.
1	force-fed
1	pcna.
1	base-to-tip
1	lieberkühn,
1	keratinization
1	biomonitor
1	(contaminated
1	area),
1	br,
1	preta
1	biomonitoring
1	semimetal
1	scribing
1	paper-based
1	pyrolyze
1	paperboard,
1	non-graphitizing
1	graphene
1	composites
1	aluminosilicate
1	active/geometric
1	fabrication
1	portable
1	nanotubes,
1	pb,
1	lamella.
1	multi-walled
1	pollutants.
1	nematicide
1	europe;
1	carbofuran,
1	multiwalled
1	(hno
1	-mwcnts)
1	8.0 mg/l),
1	mwcnts
1	2.0 mg/l)
1	8.0 mg/l)
1	1.0 mg/l
1	mwcnts.
1	aquarium,
1	transversely
1	aneurism,
1	toxicants,
1	ecotoxic
1	nanotechnologies.
1	proximally
1	crocodilians.
1	exportation
1	jejunum.
1	inclusions.
1	<200 nm
1	lacteals.
1	lacteals
1	halogen-light-irradiated
1	(pahs1),
1	(pahs2).
1	benzocaine
1	peripheric
1	mcdowell's
1	thin-sectioned,
1	(h&e).
1	(gc-ms)
1	pahs2
1	(nma).
1	benzanthracene,
1	nma
1	metynnis
1	(0.275,
1	27.5 μg
1	l<sup>−1</sup>)
1	2,4-dichlorophenoxyacetic
1	(2,4-d)
1	4-chloro-2-methylphenoxyacetic
1	(mcpa).
1	polarography
1	2,4-d
1	mcpa
1	rica.
1	alginolitycus.
1	cannibalism
1	ectothermic.
1	individuals'
1	photographed
1	macroscopically,
1	(heterophilic
1	granuloma)
1	noticeably
1	comparatively,
1	(vwf)
1	33°c,
1	leather.
1	wagler,
1	1824
1	(wagler,
1	1824),
1	ramify,
1	sac-like
1	unicameral,
1	faveolar
1	ina.
1	vestige
1	holes.
1	fused,
1	air-to-blood
1	microcephala.
1	amphisbaenia
1	galleries
1	lives,
1	renewal,
1	urchin's
1	chordate
1	endosulfan
1	carpio).for
1	pure)
1	(lsi)
1	cytocrome
1	(cyp),
1	cyp1a
1	ethoxyresorufin-o-deethylase
1	(erod)
1	(g6pdh).
1	carpio).
1	(sn-aif-1)
1	17.430
1	4.92,
1	handlike
1	aif-1.
1	aif-1
1	aif-1,
1	sponge.
1	469:
1	co-authors
1	alicia
1	kowaltowski.
1	euryhaline
1	(bloch;
1	sneider,
1	1801),
1	guppy,
1	adaptability
1	interlamellar,
1	dusky
1	(epinephelus
1	marginatus)
1	serranida
1	(wsf).
1	wsf
1	(0.4,
1	cerevisiae;
1	wsf.
1	snook
1	centropomus
1	parallelus
1	aquaculture.
1	ceca
1	ferritin.
1	snook.
1	(wakefulness).
1	(sleep
1	(sleep)
1	(wakefulness)
1	dimethylnitrosamine
1	(12.2%).
1	hepatic-lesion
1	(ast,
1	(31.6%)
1	perisinusoidal
1	(42.3%),
1	(57.7%).
1	(rhinella)
1	inflate
1	macroglands.
1	the macroglands
1	emptied.
1	slit.
1	bufonids
1	scale-less
1	adiposum
1	post-procedure
1	(hpp)
1	fronts
1	edge.
1	re-epithelization
1	sooner
1	lucunter,
1	(pindá)
1	tides.
1	lucunter.
1	tgr(asraogen)-680.
1	counts/min
1	counts/min,
1	(slope
1	(0.79
1	(pmev)
1	papayas.
1	fluidic
1	stems.
1	oxidises
1	"sticky"
1	texture.
1	pmev
1	rt-rapd
1	(c05-3′)
1	669-nucleotide
1	c05-3′
1	rt-pcr-based
1	fields,
1	silk,
1	silks
1	(spidroins).
1	tags,
1	nephilengys
1	nephilidae).
1	(polyala,
1	(ga)n,
1	(ggx)n,
1	(gpggx)n).
1	spidroin,
1	glycine.
1	0°c,
1	liver/carcass
1	subantarctic
1	60-300
1	gariepinus,
1	scaleless
1	62.3%
1	(vv),
1	25.7%),
1	1.4%).
1	adiposum,
1	oblong
1	compactum,
1	7-14
1	møs
1	oyster-derived
1	20:206-212],
1	22:417-424]
1	(2002)
1	60:466-478].
1	2°c.
1	anaesthesia,
1	abundant;
1	exudes.
1	oedematous.
1	23-30
1	sphincter
1	33.3-43.4
1	μm/day.
1	bivalves.
1	subanarctic
1	charcoti,
1	(nototheniidae:
1	pisces).
1	snug-fitting
1	withstanding
1	recolonize
1	shallow-water
1	scours.
1	bi-nuclear
1	guerin
1	(bcg)-suspension
1	fertilizers,
1	(bnf).
1	diazotrophs
1	gluconacetobacter
1	diazotrophs,
1	rubrisubalbicans
1	(http://sucest.lad.ic.unicamp.br/en/).
1	rubrisubalbicans.
1	variegatus.
1	amebocytes,
1	amebocytes'
1	variegatus,
1	constrictor.
1	coverslips.
1	(0°c),
1	echinoderms.
1	microinjecting
1	blastocoele.
1	rose.
1	blastocoele
1	late-gastrula
1	nonself.
1	'identity'
1	(self)
1	42.29
1	10.50%
1	52.57
1	13.96%
1	amoebocyte,
1	starfish,
1	amphisbaenians
1	plugged
1	holocrine
1	semiochemical
1	demarcation
1	(zoomorphology
1	113:199-203,
1	1993;
1	morphol.
1	221:101-109,
1	1994).
1	tunnels,
1	abraded
1	plug
1	plug.
1	ground,
1	gland's
1	volatilization
1	semiochemicals,
1	tunnels.
1	pseudoterranova
1	catgut
1	thread,
1	macerate
1	decipiens.
1	pinocytosis
1	preanal
1	valve,
1	rectum
1	pinocytosis.
1	perimysium
1	lysosomes)
1	(cytoplasm
1	interdigitations);
1	amphioxus,
1	(end
1	observation),
1	disorderly
1	vessel-like
1	endothelial-like
1	endotelial-like
1	unusual,
1	chordates
1	neo-vascularization
1	71.55%
1	121.05%.
1	picrossirius
1	2.07%
1	44.57%;
1	hepatectomy
1	1.98%
1	1.24%
1	37.46%;
1	metchnikoff,
1	reinvestigate
1	allograph
1	afflux
1	(parra
1	114.16
1	7.90%
1	irrigated
1	(27.14%)
1	(19.22%).
1	18.68%
1	24.28%,
1	importance;
1	details.
1	a. altiparanae,
1	fixative,
1	anti-pcna.
1	oogonium
1	astyanax,
1	annulate
1	oogonia,
1	pellucida
1	one-nucleolus
1	micropylar
1	spawning,
1	lentic
1	label-retaining
1	testis:
1	aund.
1	decondensed
1	nuages
1	cooperatively
1	post-ovulatory
1	follicle-stimulating
1	(fshb),
1	(lhb),
1	(gpha).
1	siluriformes
1	cypriniformes.
1	real-time,
1	gpha,
1	specific-developed
1	mrnas/proteins
1	distalis.
1	17α,20β-dihydroxy-4-pregnen-3-one
1	fixed.
1	∼0.6%
1	lineatus.
1	300:589–599,
1	(gth)
1	serrasalmus
1	spermatogenesis)
1	pimelodus
1	spermatogenesis).
1	adenohypophysis,
1	β-follicle-stimulating
1	β-luteinizing
1	gth-producing
1	gths
1	spermiogenesis.
1	continuous)
1	(environmental
1	adolfi
1	lambari
1	(astyanax
1	altiparanae)
1	ostariophysi
1	male-specific
1	sox9.
1	spermiation,
1	ictiologia.
1	companhia
1	energética
1	12h;
1	20h,
1	regressing
1	8h;
1	12h,
1	drawdown
1	satisfactory,
1	ostheogenesis
1	fecundation
1	juvenile,
1	blastopores
1	metamorphosis,
1	organs'
1	fry
1	elongatus,
1	instances.
1	mn-based
1	mn(iii)-salen
1	euk108
1	characiform
1	aquaculture,
1	(characiformes,
1	characidae),
1	dah),
1	anlage
1	β-fsh
1	β-lh
1	andirá,
1	mallory's
1	anti-cytokeratin.
1	melanomacrophage
1	characids
1	(lambari)
1	characidae.
1	spermatozoa,
1	upriver
1	"almost
1	threatened"
1	riparian
1	broodstocks
1	adenohypophysial
1	(somatolactin)
1	nucleus/cell
1	environments).
1	honji
1	decapeptide
1	(lh
1	steroidogenesis
1	gametogenesis.
1	("lambari").
1	gnrh3
1	gnrhs
1	tegmentum,
1	torus
1	longitudinalis,
1	ecology,
1	characiformes.
1	(k),
1	post-spawning
1	polymodal
1	pirarucu
1	(arapaima
1	gigas),
1	osteoglossomorpha
1	(bonytongue
1	teleosts),
1	(rpd)
1	penetrates
1	prolactin-producing
1	growth-hormone-producing
1	melanotropic,
1	adrenocorticotropic,
1	somatolactin-producing
1	neurohypophyseal
1	gigas
1	actinopterygii
1	brood
1	(natural)
1	gonadossomatic
1	(oogonium,
1	vitellogenic,
1	ripe)
1	(postovulatory
1	spawn
1	fecundity)
1	hatcheries.
1	(early,
1	late),
1	recrudescence.
1	cachara,
1	(oocytes
1	41st
1	80th
1	81st
1	(summer
1	(autumn
1	a0
1	437.5
1	1,187.5μm,
1	radiata,
1	(gsi),
1	photophase
1	(fertilization,
1	spermatogenesis,
1	cachara
1	(82.5%
1	(cpe),
1	(hcg),
1	iu/g;
1	iu/g
1	(cpe+hcg);
1	(saline).
1	53.44±18.3
1	54.81±11.8%;
1	165,330±94.1
1	158,570±20.6,
1	cpe+hcg
1	ovulate.
1	stripping,
1	1062.5
1	1125.0
1	56.08±30.9
1	81.90±17.3%;
1	364,547±244
1	633,129±190,
1	hcg.
1	brycon
1	cephalus,
1	chromatin-nucleolus;
1	perinucleolar;
1	alveoli;
1	vitellogenesis;
1	growth),
1	(chromatin-nucleolus
1	(perinucleolar
1	balbiani
1	oocytes),
1	(cortical
1	hydration.
1	(stage
1	maturation),
1	cubical
1	helicoidal
1	matrinxa
1	(brycon
1	cephalus)
1	'matrinxa'
1	ribeira-cepar,
1	fishery
1	pariquera-acu
1	secondary);
1	pacu,
1	mesopotamicus,
1	bream
1	(pglu-his-trp-ser-tyr-gly-leu-ser-pro-gly-nh2,
1	1113.4
1	gnrh-ii
1	(pglu-his-trp-ser-his-gly-trp-tyr-pro-gly-nh2
1	1236.6
1	(pglu-his-trp-ser-tyr-gly-trp-leu-pro-gly-nh2,
1	1212.3
1	da).
1	frsh
1	11-ketotestosterone
1	(11-kt)
1	11-kt
1	-kt
1	17α-20β-dihydroxy-4-pregnen-3-one
1	(17-20p),
1	(lhrha;
1	(e2=2172
1	lhrha
1	lhrha.
1	(2917
1	3498
1	387
1	17-20p
1	(2163
1	alpha-galactosidase
1	nonclassic.
1	fabry’s
1	morningness–eveningness
1	horne
1	ostberg;
1	actigraphy
1	7 p.m.)
1	7 p.m.
1	= 7.8),
1	= 3.8)
1	= 2.0).
1	(insulin-regulated
1	aminopeptidase)
1	leu-4me-β-naphthylamide
1	ne-stimulated
1	(pinx),
1	(pinx/mel)
1	3 hours
1	pinx/mel
1	lhs
1	adrβ3,
1	lhs,
1	sub-thermoneutral
1	worker's
1	(cesarean
1	forceps)
1	apgar
1	womb
1	newborn.
1	(radiotherapy
1	gland)
1	tomography-mri.
1	hypomelatoninemia
1	light-at-night
1	b-blocker
1	regularity,
1	episode,
1	daytime,
1	nervous/endocrine
1	come.
1	fetuses'
1	time-domain-acting
1	considerations,
1	endocrinologia
1	metabologia.
1	synchronizer
1	organism’s
1	amphiphilic,
1	time-giving
1	disruptions.
1	(ilae)
1	brain."
1	excitotoxicity,
1	anti-epileptic
1	(aeds)
1	aeds
1	anticonvulsant,
1	occurring.
1	epilepsy;
1	edizioni
1	minerva
1	medica.
1	(peh)
1	evening.
1	(randomized
1	am)
1	(6:30
1	pm).
1	(e:
1	ergometer
1	2peak
1	paired/-test
1	(116±
1	120±10
1	nnnhg,
1	p=0.04)
1	(7981±1294
1	8583±1523
1	mmhg.bpm,
1	(128±11
1	130±10
1	p=0.03)
1	smith-magenis
1	(sms)
1	(iprgc)/melanopsin
1	light-inhibitory
1	(plr)
1	1-second
1	(640
1	activation),
1	(iprgc
1	driven)
1	return,
1	640-nm
1	flash,
1	plr
1	photoinhibition
1	melanopsin.
1	melanopsin-based
1	photoreception,
1	tunning
1	epilepsy-related
1	aeds.
1	melatoninergic
1	(aeme),
1	methylecgonidine,
1	(1.12
1	randomised,
1	18-65
1	aura,
1	(p=0.009),
1	(p=0.19).
1	brito
1	(peh),
1	morning.
1	(7:30am)
1	(5pm).
1	(cycling,
1	50%vo<inf>2</inf>peak)
1	(sitting
1	rest)
1	post-interventions
1	[(post-pre
1	exercise)-(post-pre
1	control)]
1	systolic,
1	(-7±3
1	-3±4
1	(-460±771
1	(+7±5
1	+10±5
1	(+1.5±1.6,
1	(+120±179
1	-70±188
1	u,
1	dantas-ferreira
1	food-anticipatory
1	(faa).
1	hamster,
1	faa.
1	wheel-running
1	dusk).
1	daylength,
1	wheel.
1	ovaries)
1	melatonin-forming
1	(aanat
1	asmt),
1	(clock,
1	cry2)
1	(coc)
1	coc.
1	melatonin-related
1	cumulus/oocyte
1	"marker
1	rhythm".
1	(6u/day)
1	(daily
1	(mesor,
1	acrophase),
1	mean∈±∈sem.
1	posttest.
1	p∈<∈0.05.
1	melatonin)
1	efficient;
1	corrective
1	diabetes-associated
1	(aogen)
1	[0.8-1.5]
1	[2.2-6.1]
1	[iqr]
1	(8.1
1	0.64,
1	0.36-0.81,
1	pra,
1	peres
1	transcription-translation
1	cnidarian-bilaterian
1	clock.results:
1	anemones
1	(tryptophan
1	hydroxyindol-o-methyltransferase),
1	midday.
1	'clock'
1	supplementation.conclusions:
1	light-dependent
1	vectensis.
1	darkness.
1	h:12
1	(ld12/12),
1	mem
1	branes.
1	(peaks
1	per1
1	ne-stimulation),
1	ne-synchronized.
1	cry2,
1	clockwork
1	deuterostome
1	echinaster
1	chronobiotic,
1	anti-obesogen
1	weight-reducing
1	mobilizing
1	chronobiotic
1	activity/feeding
1	rest/fasting
1	shift-work
1	synchronised
1	transcription-based
1	light-sensitive
1	synchronisation
1	regulating/timing
1	steroid-mimetic
1	disorganisation
1	neuroendocrinology.
1	p-ampk.
1	p-akt,
1	pgc-1
1	creb-pgc-1
1	control-trained
1	(tm).
1	(mapk),
1	(pinx).
1	(gtt),
1	(ptt)
1	(itt).
1	beginning.
1	(ccs)
1	(cocs)
1	cocs
1	0.5μg/ml
1	5.0μg/ml
1	(fsh-lh);
1	-9m
1	fsh-lh+mel
1	(fsh-lh-mel).
1	(cleavage)
1	(blastocyst).
1	(37.6±2.4)
1	fsh-lh-mel
1	(28.0±2.4)
1	fsh-lh
1	(17.8±2.41)
1	sleep-wakefulness
1	phenomenology
1	noradrenergic-stimulated
1	alcohol-treated
1	hour-12
1	off.
1	bmal1-flattened
1	synthesizer,
1	gluconeogenesis)
1	rac-α
1	prompts
1	chain-binding
1	protein-homologous
1	tribble
1	rapamycin;
1	fibromyalgia,
1	depression)
1	questionnaires:
1	chalder
1	somnolence
1	inventory,
1	beck
1	inventory.
1	objectively
1	(tnc)
1	trigeminovascular
1	(saline-ethanol-tween
1	8:1:1,
1	(vei,
1	(cap,
1	(px,
1	(sh,
1	(px
1	cap,
1	(cap
1	magna,
1	tnc
1	(layer
1	headaches.
1	(amt6s)
1	(12-h
1	[14.0
1	49.4
1	19.0;
1	(143)
1	-15.1;
1	-40.0
1	-30.8;
1	[49.4
1	42.5
1	27.9;
1	(140)
1	1.7;
1	-1.2
1	14.8;
1	0.094].
1	pathway:
1	hydroxyindole-o-methyltransferase.
1	ip3-and
1	blockaded
1	undergoes,
1	(gcs).
1	(p19).
1	prl-induced
1	(dex).
1	peripartum
1	[santa
1	(si)]
1	[romney
1	suffolk
1	(su)]
1	21°59's,
1	(four/breed)
1	(17:00,
1	(04:00,
1	06:00
1	08:00
1	(17:00
1	night-day
1	(6:00
1	21°59's
1	[tgr(asraogen)].
1	telemetry.
1	(bld),
1	dark-light
1	(dl)
1	(free-running
1	bld
1	fitting)
1	reentrainment
1	(12h:12h
1	inoculation).
1	310.9
1	918.1
1	indolamine.
1	cavity-isolated
1	melatonin/serotonin
1	transpineal
1	2%-3%
1	overuse,
1	338
1	(13/patient)
1	insomnia.
1	chronobiologic
1	hyperdopaminergic
1	insomnia
1	chronodrugs,
1	opinions
1	and86rb
1	(00.00,
1	04.00,
1	08.00,
1	12.00,
1	16.00
1	substimulatory
1	(5.6-8.3
1	the86rb-permeability
1	ewes,
1	preterm.
1	autocorrelation
1	preterm,
1	ganglionectomized
1	conarii
1	5-hydroxytryptophan.
1	dp,
1	(nas)
1	phase-shifting
1	igl-lesioned
1	dark-killed
1	photostimulation,
1	geniculo-pineal
1	decomposed
1	monosynaptic
1	ganglion-vas
1	adenylyl‐imidodiphosphate
1	(amp‐pnp),
1	p2‐purinoceptor
1	nm)‐stimulated
1	(0.03
1	amp‐pnp
1	concentration‐dependent
1	nm)‐induced
1	p2‐purinoceptors
1	(12:00
1	h/12:00
1	6:00).
1	21:00,
1	12:00
1	24:00
1	15:00
1	100.34±1.6
1	(nitrite).
1	(e.c.1.15.1.1)
1	(e.c.1.11.1.9)
1	(suprachiasmatic
1	(103.13
1	(132.83
1	4.73
1	(253.91
1	n.u.)
1	(0.027
1	(0.103
1	hr/12
1	(24:00
1	(12:20
1	6:30
1	vasa
1	deferentia
1	(circadian)
1	(ultradian)
1	truck
1	"well-"
1	days-on
1	day-off,
1	autorhythmometric
1	psychophysiological
1	self-ratings
1	(calmness,
1	alertness),
1	(detection
1	,na
1	17-oh
1	waking
1	midday
1	(11:00
1	19:00h),
1	early-morning
1	(03:00
1	11:00
1	(18:00
1	02:00
1	days-off.
1	"well-adapted"
1	feels
1	"adapted"
1	electrocorticographic
1	(alert
1	wakefulness),
1	(somnolence),
1	(superficial
1	(maxima
1	curve)
1	23:39,
1	07:59,
1	08:37
1	13:25
1	atonia
1	14:18
1	somnolence,
1	(spvh)
1	spvh
1	item
1	didactic
1	"intrauterine"-deprivation
1	(prenatal)
1	"postnatal"-deprivation
1	(lactation)
1	"perinatal"-deprivation
1	"preperinatal"
1	variables--activity,
1	exploring,
1	grooming,
1	curling
1	down--were
1	near-12-min
1	zero-amplitude
1	0.034),
1	0.059),
1	preperinatal
1	0.055),
1	transposition.
1	object.
1	≃12
1	posthatch.
1	(n=12
1	chicks),
1	(n=12),
1	score;
1	imprinting:
1	tubercle.
1	thrusting
1	dark-reared
1	post-hatch
1	(imhv
1	ha)
1	imhv.
1	retention:
1	lesioned.
1	training:
1	chicks)
1	imprinted.
1	commencing
1	hatch.
1	(lca;
1	rocking
1	bead,
1	millet
1	p-protein
1	anti-gfp
1	p-proteins
1	rnp.
1	l-protein
1	p-protein.
1	(ib),
1	(cta).
1	hhp.
1	kbar
1	16.
1	213.
1	ctb/liter
1	(hrsv)-specific
1	(structural
1	syfpeithi
1	pred/
1	(h-2kd,
1	dd)
1	vivo-stimulated
1	h-2d-restricted
1	nucleoprotein,
1	hek-293t
1	immunoprecipitated,
1	methyl-transferase,
1	methylosome
1	tropomysin,
1	tropomysin
1	nucleophosmin.
1	caboxi
1	oligomerize,
1	constraints,
1	non-optimized
1	ribonucleocapsid
1	proteins),
1	anti-n
1	anti-p
1	pmal-c2e
1	lysate.
1	amylose
1	enterokinase
1	(raec),
1	nitric-oxide-generating
1	s-nitroso-n-acetylpenicillamine,
1	8brcgmp
1	no/cgmp-stimulated
1	phosphorylation-
1	ras-binding
1	fpt
1	kt5823,
1	phosphorylation-signaling
1	n17ras.
1	cgmp-stimulated
1	8brcgmp.
1	mek.
1	p21ras-raf-1
1	kinase-mek-erk1/2.
1	redirecting
1	retargeting.
1	gp120.
1	ablate
1	trimerization
1	anti-c4
1	trustworthy
1	(xp).
1	sun-sensitive
1	(gre),
1	(ltr).
1	promonocyte
1	(u937)
1	(cem-t4)
1	ltr.
1	granulocyte/macrophage-colony
1	(gm-csf).
1	cem-t4
1	dex.
1	oncogene,
1	cell-laminin
1	oncogene-induced
1	α6β1,
1	β1-integrins;
1	leukoagglutinin
1	pre-β1-integrins
1	pre-β1-
1	α6-chain.
1	n-acetylglucosaminyltransferase
1	[j.
1	dennis
1	(washington
1	dc),
1	236:
1	582-585,
1	1987].
1	spontaneously.
1	c-jun-transfected
1	self-aggregate.
1	foreskin
1	(ltr)
1	e1a.
1	trans-dominant
1	trans-activation
1	gene-mediated
1	trans-activation.
1	hr5.
1	cotransfection
1	(v79
1	pulse-labeled
1	nionsubstituted
1	density-distribution
1	pausing
1	665–678.e1–e23;
1	2018)
1	(depicting
1	cgrp-positive
1	rabies-infected
1	pbndl
1	pbnel
1	dat-ires-cre
1	vgat-ires-cre
1	representation,
1	re-colored,
1	resubmission.
1	files,
1	gut-brain
1	gut-innervating
1	self-stimulation
1	preferences,
1	parabrachio-nigral
1	excitation.
1	post-ingestive
1	sugar's
1	energy-seeking
1	cytoarchitectonically
1	(meav),
1	meav.
1	modest.
1	parts),
1	intraamygdaloid
1	predators.
1	macronutrients,
1	uncertain,
1	trpm5
1	sweetness.
1	taste-independent
1	nutrient-specific
1	anti-metabolic
1	carbohydrate-specific
1	nodal
1	[ikemoto
1	(2007)
1	circuitry:
1	accumbens-olfactory
1	56:27-78].
1	tier
1	interfascicular,
1	tiers.
1	double-immunostained
1	pha-l-labeled
1	spiralated
1	striato-nigro-striatal
1	reward-association
1	(tfc),
1	(cfc)
1	[ferreira
1	tl,
1	ikeda
1	bueno
1	ofa,
1	mgm
1	987:17-24].
1	(postraining)
1	pre-test
1	acquisition/consolidation
1	intra-vta
1	(rli),
1	polymorph
1	layer)
1	rli,
1	non-dopaminergic,
1	(directly
1	(apir)
1	(entl).
1	entl,
1	(eac)
1	fluorogold)
1	entities.
1	subicular
1	operations,
1	(lot)
1	outputs.
1	ipsilaterally
1	contralaterally
1	organized,
1	divisions).
1	lot,
1	lot.
1	homonymous
1	nonpheromonal
1	(eac;
1	[bstl]-central
1	[ce]
1	continuum)
1	(acsh)
1	a8-a14
1	districts.
1	area-a10,
1	compacta-a9,
1	nucleus-a8
1	a10
1	(a10dc).
1	dr/pag
1	dopaminergic.
1	acsh.
1	acsh,
1	gray-a11
1	(ipac)
1	terminalis-central
1	eac).
1	(fluoro-gold
1	reciprocate
1	(shammah-lagnado
1	[1999]
1	94:1097-1123)
1	ipacm
1	supraspinal
1	(prv),
1	transynaptic
1	dopamine-β-hydroxylase
1	prv.
1	t3-t12
1	(t1-t13).
1	subcoeruleus
1	multisynaptic
1	lopps
1	(bsts).
1	merges
1	districts).
1	ring-
1	macrostructure
1	acetylcholinesterase,
1	(alheid,
1	olmos
1	beltramino,
1	ammon
1	basomedial,
1	overlying
1	commissure.our
1	circuits;
1	dopamine-rich
1	district.
1	terminalis)
1	terminalis).
1	mnemonic,
1	lenticularis,
1	extent),
1	peduncle.
1	entopeduncular
1	peduncle
1	suprageniculate
1	nucleus/peripeduncular
1	brachium
1	sagulum,
1	gp,
1	probst's
1	paragigantocellular
1	gigantocellular
1	supratrigeminal
1	tract),
1	reticulata,
1	oralis;
1	basalis,
1	cuneiform,
1	trigeminal,
1	dorsalis
1	microelectrophoretic
1	horse-radish
1	forel's
1	caudalis,
1	gigantocellularis,
1	exceptions:
1	"ascending
1	systems",
1	fink‐heimer
1	ob,
1	(sublamina
1	structures:
1	tenia
1	tecta,
1	scanty),
1	sulcal,
1	peculiarities;
1	sulcal
1	gnathic
1	(hif-1α),
1	(n = 20),
1	(n = 18),
1	dentigerous
1	(n = 11),
1	(n = 8),
1	(df)
1	rc,
1	cystogenesis,
1	tks5,
1	(om)
1	om.
1	(adam-12),
1	(hb-egf)
1	ame,
1	ccots
1	anti-notch1,
1	anti-adam-12,
1	anti-hif-1α,
1	anti-hb-egf.
1	axioscope
1	axiocamhrc
1	camera
1	(kots).
1	timp-1.
1	erk-1/2
1	ameloblastomas.
1	metallothionein.
1	immunohistochem-istry
1	ag73-treated
1	ag73-dependent
1	(isobm)
1	maghemite
1	broncho-alveolar
1	antigen-1.
1	malignancy-related
1	non-integrin
1	67lr,
1	yigsr-enriched
1	fibroblast-like,
1	epithelioid.
1	ionomer.
1	(baseline-0
1	spp)
1	trends.
1	leiomyosarcoma
1	40-year-old
1	stomatology
1	intraoral
1	colored
1	60-mm
1	ill-demarcated
1	radiolucent
1	interlacing
1	fascicles
1	blut-ended
1	hyperchromatic,
1	vacuoled
1	cigar-shape.
1	hhf-35
1	desmin.
1	leiomyosarcoma.
1	(ccl102)
1	1/f
1	self-affine
1	gravitational
1	roughness)
1	down.
1	brefeldin-a
1	(bfa),
1	±30%
1	plasmacytoid-like,
1	morphoregulates
1	sialoprotein
1	(bsp)
1	(fp1
1	predentine
1	weaker,
1	osteonectin.
1	pulps.
1	odontoblastic
1	dentine.
1	low-grade,
1	cobblestone
1	ae1/ae3
1	s-100.
1	2051,
1	noncontact,
1	spray-cooled,
1	2055
1	quartz
1	fiberoptic
1	50/10,
1	cooled,
1	mj
1	mj/2
1	dried,
1	sputtering
1	etching-like
1	edges,
1	lava-like
1	bubble-like
1	voids.
1	(contact
1	cooled)
1	repairs
1	self-cure
1	sandpaper,
1	microetch.
1	acid+pb,
1	(applied
1	+pb,
1	silane+pb.
1	(charisma,
1	shade
1	a3)
1	built.
1	stereomicroscope.
1	microetching
1	microetching,
1	(matrigel)
1	(haematoxylin
1	eosin)
1	(nomarski).
1	type-iv
1	duct-like
1	verruciform
1	xanthoma
1	(vx)
1	(55.5%)
1	(44.5%).
1	44.9
1	(69.7%).
1	verrucous
1	hyperparakeratosis
1	inflammatory.
1	laminin-coated
1	myxoma
1	remedy
1	alloplastic
1	(fmm1
1	biocompatibility.
1	hydroxyapatite,
1	hydroxyapatite.
1	104cells
1	dishes.
1	triplicate,
1	biocompatible.
1	myofibroma
1	myofibroblastic
1	maxillofacial
1	myofibroma,
1	imunohistochemical,
1	polymorphous
1	7,8,10,13,14,18,19,
1	sub-types.
1	sub-types,
1	delineated.
1	plga.
1	acinar-intercalated
1	hypercondensation
1	adjoined
1	wehi-3
1	teneposide)
1	thapsigargin.
1	affixed
1	golgi-associated
1	semi
1	serially.
1	conglomerates
1	pinching
1	(ap2
1	(matrigel).
1	intercommunicating
1	multi-layered
1	double-layered
1	cuboidal,
1	organiser
1	(nors)
1	(bcc)
1	(1.652
1	(2.354
1	0.054).
1	myoepithelioma,
1	questioned.
1	pan-keratin
1	(ae-3)
1	ae-3
1	cytokeratin.
1	myogenous
1	dispersed.
1	microtubules;
1	microtubule‐free
1	nocodazole
1	reassemble
1	reassembly.
1	microanatomic
1	(uch)
1	uch,
1	stereocilia
1	framework.
1	300-500
1	fuzzy
1	enmeshes
1	map-1a
1	map-ib
1	65.0
1	(at+)
1	signs:
1	at+,
1	at-.
1	25.0
1	percent);
1	at-).
1	balloon-induced
1	fibrin-poor
1	thrombi.
1	elec
1	tron
1	disaggregable
1	let
1	acti
1	vation
1	beta-
1	thromboglobulin
1	(33.8
1	erupt
1	erupts,
1	monolayer.
1	microcolonies
1	haphazardly
1	matures
1	angle-glenoid
1	fossa
1	fractures
1	hemarthrosis
1	fracture,
1	50±6%
1	epicardial
1	n=10);
1	1,3-dimethyl-2-thiourea
1	(n=9).
1	angioplasty-induced
1	(28.9±6.3%
1	baseline).
1	24-69%
1	zymosan-stimulated
1	(7±3
1	30±6
1	nmol/min/106
1	p=0.003);
1	(>15%
1	(p=0.028);
1	trichosporosis
1	trichosporon
1	beigelii;
1	hairs
1	(hyphae
1	arthrospores)
1	cementant
1	underwear,
1	clothes.
1	leukoplakia
1	tonque.
1	acanthosis
1	parakeratosis,
1	corrugations.
1	swollen,
1	prickle
1	herpes-type
1	botryoid
1	histogenetic
1	ameloblastic
1	odontologenic
1	someone
1	phenylpyrazole
1	fipronil)
1	cyclodiene
1	(resistance
1	phenylpyrazoles.
1	(tm2)
1	dieldrin.
1	fipronil-susceptible
1	166).
1	australia;
1	fipronil-
1	(a286s
1	a286
1	(s281
1	v317i,
1	t328
1	a329s)
1	a286s.
1	documentation
1	traveler
1	(aits),
1	(lits)
1	(lpts)
1	interpretable
1	1.49,
1	1.01.
1	1.83
1	4.62.
1	lpt.
1	impregnated
1	piperonyl
1	butoxide
1	(pbo)
1	triphenyl
1	89.4
1	1,020.6.
1	(<20%),
1	pbo
1	lc50s
1	mono-oxygenases
1	organophosphates,
1	macrocyclic
1	(mls)
1	amitraz
1	documented;
1	(lit).
1	dose-mortality
1	regressions,
1	lc90
1	estimates.
1	defined:
1	differences),
1	rr50<2)
1	rr50≥2).
1	lc50/90,
1	(incipient
1	rr90
1	emergent.
1	ivm.
1	uruguay.
1	phenylpyrazolic
1	acaricide-resistant
1	(dilave,
1	uruguay),
1	(95.3%)
1	(lpt),
1	lit,
1	2.6,
1	rr50s
1	6.9.
1	rr50,
1	(2007-2008)
1	3635
1	(8.
1	fipronil-resistant.
1	uruguay's
1	(infestations
1	host;
1	highly-resistant
1	8.06.
1	ivermectin-resistance
1	(knockdown
1	pyrethroid-resistant
1	(haematobia
1	irritans)
1	1,804
1	(north,
1	central-west,
1	southeast,
1	south)
1	87.08%
1	12.92%
1	11.70%
1	1.22%
1	homozygous.
1	(hwe)
1	ranch
1	metapopulations
1	hwe
1	(central-west
1	ranch.
1	(ait,
1	26),
1	(lit,
1	71)
1	(lpt,
1	(mozo).
1	fecundity.
1	lc99.9
1	estimated:
1	7.64
1	2365.8
1	6.96
1	343.26
1	202.4,
1	1.52.
1	956
1	66.9%.
1	28.8%.
1	amblyomma-specific
1	(adoratopsylla
1	antiquorum
1	antiquorum,
1	atopus,
1	rimatus,
1	roberti
1	roberti,
1	tripus,
1	lugubris,
1	lutzi
1	lutzi),
1	dubitatum,
1	sanguineus)
1	bellii),
1	horse,
1	resistant-suspected
1	(barra
1	(ci95%)
1	3.78
1	(3.47-4.12),
1	francisco,
1	resistance-suspected
1	(f1
1	f2)
1	aurita),
1	(349/350)
1	ixodes.
1	loricatus.
1	amplifier
1	needed),
1	colleted
1	lago
1	café,
1	examinaded
1	glt
1	(pcr)/sequencing
1	(bsf).
1	ompa,
1	sequencer
1	bioedit®
1	(19.1%)
1	indentical
1	31.0%
1	(49/161).
1	(ompa)
1	rickettsiae.
1	(bsf)-endemic
1	-nonendemic
1	bsf-endemic
1	serologie
1	bsf-nonendemic
1	(77.3%)
1	4,048),
1	akari,
1	cross-absorption.
1	africae.
1	visited.
1	unconfined
1	pig)
1	(packard)
1	male).
1	tortoises,
1	yellow-footed
1	red-footed
1	(spix).
1	2-44)
1	tortoise.
1	tortoises
1	carapace
1	plastron.
1	neck,
1	shoulders
1	legs.
1	seven-colored
1	climber,
1	wide-foraging
1	kentropyx
1	calcarata
1	spix,
1	aragao
1	1952
1	(bmg
1	colony)
1	(csp,
1	psp,
1	invalidate
1	bmg,
1	conspecificity
1	colia
1	bsk
1	(ixodes)
1	berkenhout
1	rengger,
1	lund
1	(i.)
1	≈7
1	(alectorobius)
1	amblus
1	chamberlin
1	seagull
1	(larus
1	chile.
1	27°c,
1	75-80%
1	rh,
1	domesticus;
1	preoviposition,
1	molts.
1	molt,
1	nymphs.
1	n2-n6
1	coxal
1	articular,
1	envolvement;
1	burgdorferi;
1	sorologycal
1	form;
1	geographycal
1	ixodid
1	micro-organism
1	borrelias
1	microscope;
1	sorology
1	oxes,
1	dissimile
1	blooded
1	amapá
1	marinus
1	gerais.
1	(asd)
1	speech
1	asd.
1	valproic
1	(vpa),
1	endophenotypes.
1	(p29-35)
1	immunoassays,
1	full-field
1	electroretinograms
1	(ergs).
1	gad,
1	synapsin-1,
1	fmrp
1	a-wave
1	amplitudes
1	vpa-exposed
1	b-wave
1	vpa-induced
1	excitatory/inhibitory
1	(drn),
1	(nrm),
1	(dhsc)
1	(5ht)
1	5ht-ir
1	enk-ir.
1	synaptophysin).
1	(te,
1	(sn),
1	(6-ohda).
1	sub-groups:
1	(sed
1	6-ohda),
1	6-ohda).
1	astrocyte,
1	microglial,
1	apormorphine
1	carvacrol.
1	forelimbs
1	6-hydroxy-dopamine.
1	6-hydroxy-dopamine,
1	whole-brain
1	(akt),
1	hypoxia-ischemia.
1	spiny
1	(ampars),
1	activity-regulated
1	ampars
1	4 months.
1	3×/week.
1	1 month
1	arc.
1	glua2/3.
1	(iba-1)
1	cognizant,
1	atp-activating
1	hemiparkinsonism
1	stereotactic
1	(bbg)
1	fenofibrate.
1	bbg,
1	hemiparkinsonian
1	(egr-1)
1	(ae1,
1	(ae2,
1	(ae4,
1	(ae1
1	ae2)
1	sys,
1	(ae4)
1	striatum;
1	mechanistics
1	(<30
1	electrocorticogram
1	fast-beta
1	(21-30
1	xrn2-positive
1	papd4-positive
1	calretinin-and
1	camkii-positive
1	unbalances
1	(eg).
1	children’s
1	waterloo’s
1	2-alternative
1	forced-choice
1	binocularly,
1	cd/m
1	4,145
1	11.25,
1	of.25,
1	(cpd;
1	53%,
1	the.25,
1	inferotemporal
1	(types,
1	(glua1
1	glua2/3)
1	(synapsin
1	synaptophysin)
1	(ite)
1	(every
1	chen
1	mcao
1	hypoxia-ischemia
1	trpm7-like
1	(>200
1	ogd-induced
1	bcl-2/bax
1	p-akt/t-akt
1	stroke.
1	kinjo
1	synchronizing
1	(cx)-mediated
1	frequencies.cx36
1	anti-epileptogenic
1	6-hydroxydopamine-
1	(6-ohda-)
1	six-ohda
1	6-ohda-injected
1	sn.
1	6-ohda-induced
1	marina
1	exoribonuclease,
1	hippocampi.
1	uncorrelated
1	biology:
1	antagonistically
1	"make
1	sense"
1	stability-related
1	age-specific
1	adulthood;
1	anhedonia
1	novelty-suppressed
1	(adolescents
1	(males
1	neurotoxicant,
1	descendants.
1	(dentate
1	gyrus)
1	synthase-dependent
1	trpv1-induced
1	colocalize.
1	ap-5,
1	cnqx,
1	c-.
1	(200.
1	(15.
1	multi-protein,
1	(nox)-dependent
1	redoxsensitive
1	(ieg)
1	(mpfc),
1	(ca1),
1	(exp).
1	(nov)
1	nonshock
1	(nsh)
1	nsh
1	nov,
1	nsh.
1	accruing
1	penumbra
1	openers
1	death/viability.
1	(cbx),
1	cx36-channel
1	paschon
1	km/h,
1	(te),
1	times/day
1	nf68,
1	jacchus),
1	subsectors
1	y-,
1	gad-,
1	serotonin-,
1	enkephalin-
1	p-labeled
1	(trp
1	thermosensation,
1	trps.
1	taeniae
1	pigeon's
1	(tna)
1	livia),
1	eg);
1	shock-alone
1	(shock
1	sg);
1	tone-alone
1	(tone
1	tg);
1	(context
1	cg),
1	(naive
1	retina,increased
1	capsase-3
1	capsazepine.
1	amacrine-like,
1	pkc-alpha
1	values.our
1	(cpu)
1	(glur1
1	glur2/3).
1	(ex7),
1	(ex15),
1	(ex30),
1	meters/min
1	ex30),
1	(ex3).
1	exercise-dependent,
1	full-blown
1	(encapsulation
1	recollection).
1	lamme's
1	'level
1	consciousness,
1	wakefulness.
1	psychology
1	(apocynin)
1	61%).
1	(rgc)
1	unilateral,
1	intraorbital
1	63%).
1	acutely-lesioned
1	gfap-expressing
1	(72.5%
1	(75.7%
1	(7-ni
1	pre-labeled
1	rgcs
1	trpv1-containing
1	neuroblastic
1	punctate,
1	(p15).
1	receptor-induced
1	p2y1,
1	p2x-heteromultimers
1	analogue-induced
1	transients.
1	p2y6,
1	p2x2/p2x6
1	brdu-incorporation
1	atp-,
1	utp-,
1	2-mes-atp-
1	adp-βs-induced
1	atp-provoked
1	proliferation-
1	differentiation-induction
1	inositol-trisphosphate
1	typology
1	(dnd)
1	(vnd)
1	deiter's
1	(lvn)
1	vnd,
1	glur4+
1	giant),
1	glurs.
1	lvn
1	correspondence,
1	vnd
1	dlvn
1	vlvn.
1	mediodorsally
1	pv-immunoreaction
1	seeming
1	delimit
1	cb-,
1	pv-,
1	cavy
1	neuropil,
1	(machr)
1	[resende
1	(2008)
1	107-121].
1	muscarine
1	gαq/11-coupled
1	m5
1	gαi/o-protein
1	(pde6brd1).
1	cx57
1	regulates,
1	(machrs)
1	α2-α7,
1	m1-m5
1	α4-α7,
1	agonist-evoked
1	ryanodine,
1	machr-induced
1	ryanodine-sensitive
1	neuron-glia
1	(ssea-1)
1	nestin.
1	(p2x)
1	(p2y)
1	p2x2,
1	p2x6,
1	p2y6
1	p2x3,
1	p2x4,
1	p2x5
1	ca2+-response.
1	ca2+-response
1	glutamate-n-methyl-d-aspartate
1	pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic
1	(ppads),
1	blue-2.
1	neurites,
1	flip/flop
1	isoforms;
1	(pv).
1	e12-e14.
1	porphyrias
1	heme-associated
1	(iap)
1	5-aminolevulinate
1	5-dioxovalerate
1	(dova)
1	(same),
1	parabigeminal
1	dova-promoted
1	plumbism.
1	plasticity-associated
1	ctb-immunoreactive
1	interanteromedial,
1	parafascicular.
1	universality
1	midline/intralaminar
1	pretectalis
1	ovoid-shaped
1	10-20-fold
1	parvalbuminergic
1	calretinergic
1	d28k
1	amino-cupric
1	30-45%
1	(nanomolar
1	range),
1	subcommissural
1	calcium-permeable
1	permeable.
1	(teo).
1	(e5-e20)
1	(glur1,
1	glur4)
1	e5,
1	e9
1	e20.
1	teo,
1	α-amino-3-hydroxy-5-methyl-4-isoxazole
1	(ampa)-type
1	pretectum.
1	ampa-positive
1	glur1-
1	glur2/3.
1	glur1-positive
1	ampa-triggered
1	y-containing
1	pacemaker,
1	noncircadian
1	bromo-deoxy-uridine
1	(brdu,
1	anisomycin
1	(1.0-3.2
1	brdu,
1	brdu-
1	pcna-labelled
1	muller
1	subunits;
1	little,
1	(igl),
1	cytoarchitecture
1	marmoset.
1	triangularly
1	chiasm
1	npy-ergic
1	sp-staining
1	throughout.
1	vip-neurons
1	cb-immunoreactive
1	wedge-shaped
1	dorsomedially
1	npy-neurons,
1	cb-neurons,
1	pv-neurons
1	sp-
1	5-ht-fibers.
1	milking.
1	(viperidae)
1	unmilked
1	tyrosine-hydroxylase-like
1	milking,
1	widening
1	(cabps)
1	snakes:
1	(bothrops
1	terrificus);
1	(micrurus
1	corallinus),
1	(phylodrias
1	oxyrhopus
1	trigeminus).
1	trigeminus
1	leaflet)
1	leaflet.
1	2,3,
1	glurl
1	kainate
1	differed.
1	(e14)
1	ka-2;
1	e16.
1	small-to-medium
1	calretinin-containing
1	tropic
1	capricorn
1	solstice,
1	overhead,
1	geomagnetic
1	-25○
1	-29○
1	30',
1	10○
1	30○
1	oriented,
1	bearings)
1	5○
1	paraformaldehyde.
1	(chemicon).
1	avidinbiotin-peroxidase
1	giur
1	chemicon)
1	sigma)
1	ctb-directed
1	parvalbumin-containing
1	paramedian
1	(pmr)
1	pmr.
1	calbindin-d28k
1	calbindin-like
1	reappeared
1	parvalbumin-like
1	arborize.
1	medium-to
1	axon-like
1	medium-to-large
1	nachr-containing
1	(αbgtachrs)
1	(αbgt)
1	125i-αbgt
1	hatchling
1	α7α8
1	17%.
1	sub-
1	α-bgt-insensitive
1	completed,
1	(glv).
1	retrained
1	leaflet,
1	thalami,
1	ovoidalis,
1	paraventricularis,
1	trochlearis,
1	semilunaris.
1	α7‐li
1	hypothalami,
1	suprachiasmaticus,
1	habenularis
1	lentiformis‐mesencephali,
1	externus,
1	superficiale,
1	opticum
1	appear,
1	(detelencephalated
1	pigeon).
1	detelencephalation
1	subtelencephalic
1	7–10
1	arborized
1	(marc,
1	12–20
1	(britto
1	8–15
1	8–20
1	(ehrlich,
1	1981;
1	hayes,
1	rhodamine-iabeled
1	(glv),
1	decorticated
1	preferring
1	singel
1	ipsilaterally,
1	thnce
1	optomotor
1	dogiel.
1	relays,
1	68)
1	non-organized.
1	weak,
1	anatomical,
1	vestibulo-cerebellum
1	(foles)
1	(n=63)
1	(0.2g
1	fat/kg
1	weight/d)
1	(omegaven®)
1	(mct/lct;
1	lipovenos
1	mct®)
1	cd32,
1	id:nct01218841.
1	lipid-soluble
1	(23.4
1	174.4
1	78.3
1	bodipy
1	(here,
1	-fold
1	(auto-induced)
1	glycogen-accumulating
1	5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside
1	(aicar).
1	(fao)
1	glucagonemia,
1	hyperglycemic.
1	akt/protein
1	dephosphorylation/activation
1	7.4-fold
1	hyperglucagonemia
1	aicar-induced
1	glucose-lowering
1	aicar,
1	insulin-deficient
1	vitzel
1	(crp);
1	capacity;
1	il1-ra,
1	50%-80%,
1	fourfold,
1	ribbon.
1	bandage
1	failure;
1	scf,
1	srebp
1	cytokine-inducing
1	inhibitor-1,
1	kinase-β
1	inhibitor-α
1	inos-null
1	s-nitrosation-induced
1	(pcp)
1	(t2dp)
1	>140mg/dl
1	>7%.
1	dader's
1	pwdt
1	(pharmacist's
1	soap
1	(subjective
1	pharmacotherapy
1	anthropometry.
1	lifestyles
1	medications.
1	pcp.
1	(p=0.0022),
1	(p=0.0072),
1	triacylglycerolemia
1	(p=0.0204)
1	malewistar
1	6mbcamp
1	glycogenolytic
1	docosahexaenoic-(dha)-rich
1	(fo
1	marathon:
1	polarization;
1	2.5-fold),
1	rich-fo
1	(les)
1	les
1	(id:
1	nct01218841)
1	fat/kg/d)
1	medium/long-chain
1	(mcts/lcts)
1	(t0)
1	(t1
1	death;
1	tripled
1	74%.
1	mct/lcts
1	nutrient-
1	pathogen-sensing
1	(pkr)
1	betweeninflammatoryandmetabolic
1	studywasperformed
1	pkr+/+
1	isanimprovement
1	sensitivity,andin
1	tolerance,anda
1	oncogene-1
1	serine307
1	certainly,
1	cinc-
1	mip-3
1	il-6),
1	(iga
1	igm),
1	(crp
1	c3),
1	(2.0-fold)
1	(4.5-fold)
1	inflammations
1	bortolon
1	[il]-8,
1	il-1ra)
1	(26.4
1	70.2
1	ml·kg
1	-1·min-1,
1	(1.3-fold).
1	(1.6-fold)
1	(6.0-fold).
1	(5.8-fold),
1	(4.8-fold)
1	15(s)-hete.
1	mp-1,
1	porelike
1	(70:30).
1	stern-volmer
1	prefers
1	cholesterol-containing
1	(graph
1	wingate
1	test.results:
1	(10.5
1	iron-driven
1	ferric-reducing
1	(frap),
1	creatine-fed
1	subjects.conclusions:
1	insults,
1	creatine-induced
1	energy-depleted
1	creatine.
1	56days.
1	'all-or-nothing
1	process'
1	(xanthine-xanthine
1	140-180
1	80-110
1	sepsis.©
1	esicm
1	(gprs).
1	84,
1	(incretin,
1	glucagon),
1	gpr
1	insulin-resistance,
1	(nac;
1	(500mg/kg,
1	(ebd),
1	nac-treated
1	muscle-derived
1	ebd
1	ahsg
1	kcnj11
1	210-240
1	(17.09
1	(2-fold
1	(50-150μm)
1	3/9,
1	(10mu/ml/30min)
1	glut-4.
1	insulin),
1	(triglyceride),
1	(phospholipids
1	prevails.
1	4,5-diaminofuorescein
1	(x-xo),
1	sod-peg
1	glycol).
1	x-xo
1	(saturated)
1	(monounsaturated)
1	(epa),
1	(γa)
1	sa-induced
1	(2d-dige)
1	(fbp-1)
1	fibroblast-associated
1	fbp-1
1	magdalon
1	100μm
1	(pmecs)
1	2μg/ml)
1	(intercellular),
1	vcam-1(vascular)
1	endothelial)
1	2e1
1	(cyp2e1)
1	(10μm,
1	translocation-dependent
1	nordic
1	(prd)
1	prostaglandin-e2,
1	macrosteatosis
1	microsteatosis
1	prd-fed
1	mammaplasty
1	(18-30
1	18.5-30
1	kg/m2,
1	ii/controls).
1	prosthesis
1	220-280)
1	1200-3000).
1	preoperative,
1	2-month,
1	1.2,
1	3.0,
1	2.7,
1	procoagulatory
1	medium/ω-6
1	triglyceride-based
1	(mct/ω-6
1	le)
1	lct-based
1	plasma-free
1	le-dependent
1	2-deoxy-d-[2,6-3h]
1	deoxy-d-[2,6-3h]
1	polyphenols
1	antidiabetogenic
1	(bmns)
1	chemotax
1	bmns
1	directionality
1	ez-taxiscan
1	gpr43-/-
1	bmns.
1	pkb,
1	rac1/2
1	s6.
1	pi3kγ,
1	vinolo
1	lipids/carbohydrate
1	activity?
1	exercise?
1	contraction-relaxation
1	cycle?.
1	pparγ/gapdh
1	2.21
1	thp1
1	(pparγ/gapdh
1	cd40l-stimulated
1	pparγ-specific
1	sirna)
1	(cd80/gapdh
1	cd40/cd40l
1	saa.
1	(r=0·99
1	p≤0·001).
1	diphenyliodonium
1	(lg)
1	hypoglycaemia.
1	(sih)
1	sih.
1	(10mgkg
1	(sih
1	150min
1	120min
1	(5mm),
1	sih
1	(arachidonic
1	[e.g.
1	angptl
1	(angiopoietin-like
1	ech1
1	(peroxisomal
1	δ3,5,
1	δ2,4-dienoyl-coa
1	isomerase),
1	(cyclo-oxygenase-1)
1	p<0.05].
1	(lipoxygenase)
1	[ros
1	levels]
1	(inducible
1	κb)
1	'lipotoxic'
1	(c2),
1	(c4)
1	(gpr41
1	gpr43)
1	inhibiton
1	(hdac).
1	cinc-2).
1	scfas.
1	(leukocytes,
1	(lgp)
1	detemir
1	(st-iih),
1	77.8
1	14.5
1	6.0).
1	(cog).
1	(st-iih
1	lt-iih)
1	cog).
1	"all
1	nothing"
1	std)
1	(rm).
1	std-dag
1	rmdag).
1	rm-dag
1	akt1
1	muscle's
1	instauration
1	(ffa),
1	(6%),
1	cytokineinduced
1	(cinc-2α/β)
1	(34%),
1	(41%)
1	cells.we
1	endotoxemia,
1	parp-1,
1	unesterified
1	(0.11,
1	cinc-2αβ.
1	cinc-2αβ)
1	(upr)-mediated
1	il6-induced
1	rac-alpha
1	aktin
1	pacorrelatedwith
1	pa-stimulated
1	(atf4)
1	(chop)
1	factor-2α
1	tribble3
1	(trib3)
1	trib3
1	μmtestosterone
1	10μmtestosterone.
1	0.1μm
1	&sons,
1	wks,
1	α-chloralose,
1	tracheostomized,
1	(-25
1	(-20
1	immuno-sorbent
1	(aa).
1	fawere
1	(pa=66.75%;
1	63.09%;
1	la=43.86%;
1	47.40%)
1	(pa
1	63.99%
1	52.72%;
1	55.99%;
1	63.40%)
1	invivo
1	(ecomotion
1	pró),
1	16.4%.
1	ecomotion
1	pró
1	race-induced
1	(1.0mg/kg/subcutaneously)
1	t-(cd4)
1	bmp9,
1	akt2,
1	smad1/8,
1	ship2.
1	myoblasts.
1	pyruvate-dependent
1	shuttles
1	(taci)
1	anaplerosis,
1	cataplerotic
1	anaplerosis.
1	ββ-cells,
1	(npl)
1	(6%)-protein
1	(lpl).
1	npl,
1	np;
1	1-associated
1	pi3k/mammalian
1	(slo)
1	(sedslo,
1	(ex,
1	(exslo,
1	1°c,
1	sedslo,
1	ex,
1	exslo
1	contraction-stimulated
1	2-[3h]deoxyglucose
1	(g6pdh);
1	(hkii),
1	contraction-mediated
1	(500 nm)
1	(pem)
1	iκbα,
1	traf-6,
1	ikk,
1	(pl;
1	creatine-supplemented
1	(crs;
1	-1/kg
1	aldolase
1	oxaloacetic
1	(got),
1	(gpt),
1	(mvp)
1	got,
1	mvp
1	rossii,
1	3/n-
1	rossii
1	stearic)
1	eicosapentaenoic,
1	docosahexaenoic)
1	surface-functionalized
1	(mnps-dmsa)
1	cell-targeted
1	mnps-dmsa.
1	1015
1	nanoparticles/ml
1	3-(4,
1	5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium
1	macrophage-1
1	integrin-targeted
1	character:
1	hypusine,
1	e10.5
1	e13.5.
1	e13.5
1	e12.5
1	eif5a.
1	adipostatic
1	(r1);
1	(tnfr1
1	respirometry
1	100-hz
1	(voltage
1	(atlas
1	array;
1	clontech
1	laboratories).
1	transducers/effectors/modulators.
1	cross-education
1	aim/hypothesis:
1	(inos)-mediated
1	nos2)-/-
1	(l-nil;
1	(short-chain
1	(l-selectin
1	integrin),
1	transmigration,
1	[cinc-2αβ
1	chemoattractant-2αβ),
1	(interleukin-1
1	β),
1	protein-1α)
1	(tumour
1	factor-α)].
1	kinase-3
1	(gsk-3)
1	(akt
1	(glycogen
1	short-duration
1	(sdt)
1	(ldt-half
1	ironman)
1	sdt.
1	(tnf-),
1	(ifn-),
1	il-10].
1	(capn1)
1	calpastatin
1	(cast)
1	indicus)
1	×bos
1	taurus
1	angus
1	rubia
1	gallega
1	canchim,
1	brangus
1	braunvieh
1	crosses,
1	[af-248054.2:g.6545c>t
1	[af-159246.1:g.2959a>g
1	ribeye
1	backfat
1	(mfi).
1	10.5%
1	tenderness,
1	0.008),
1	tt.
1	taurus,
1	(nt+lp,
1	(t+lp,
1	of).
1	peers
1	(rer)
1	(45.6
1	low-protein-fed
1	onwards.
1	trans-mufa,
1	(ea;
1	18:1-9t)
1	vaccenic
1	(va;
1	18:1-11t)
1	cis-monounsaturated
1	(18:1-9c)
1	18:0)
1	(10-150μm).
1	trans-fatty
1	(o2̇-)
1	trans-mufa
1	nȯ,
1	3-[1-[3-(dimethylamino)propyl]-1h-indol-3-yl]-4-(1h-indol-3-yl)-1h-
1	pyrrole-2,5-dione,
1	phosphatidylinositol-3
1	mufa.
1	(mc-la,
1	mc-lr,
1	mc-yr)
1	fmlp,
1	chemotaxic
1	hyperinsulinemia/hypoglycaemia
1	hypoglyceaemic
1	anerobic
1	importat
1	colonocytes,
1	(o2•-,
1	hocl)
1	(p47phox)
1	o2•-,
1	hocl
1	neutrophil-associated
1	umbellata,
1	(4-nc),
1	umbellata.
1	investigating.
1	20-40
1	2/4
1	immunopharmacological
1	fetoplacental
1	medline
1	lilacs
1	bireme
1	(148.3
1	1.8%,
1	(67.5
1	5.5%,
1	lipopolysaccharide-elicited
1	46.4%
1	(10.4
1	unopsonized
1	13-acetate-elicited
1	(2-km
1	80-km
1	20-km
1	running).
1	(antiapoptotic)
1	(proapoptotic)
1	triathlon.
1	0.688,
1	(nontoxic)
1	μmol-l-1
1	μmol-l
1	(additional
1	ampk/acc
1	phosphorylation/activation,
1	∼26.5%,
1	∼43.5%,
1	∼50%,
1	∼47%,
1	(∼2.5-fold)
1	(∼3-fold)
1	malonyl-coa
1	(∼38-60%).
1	∼32%
1	(∼35%)
1	ncreased
1	∼2.3-,
1	∼3-,
1	time-dependent:
1	(∼65%)
1	chemoattractant-
1	2α/β,
1	production/liberation
1	etomoxir
1	bromopalmitate
1	(infα)
1	half-ironman
1	triathletes,
1	g·d-1)
1	g·d
1	(pg·ml-1,
1	(7.08
1	0.63),
1	(76.50
1	5.60),
1	infα
1	(18.32
1	1.20),
1	(23.42
1	5.52),
1	(39.71
1	3.8).
1	infα,
1	atherogenesis.
1	atherosclerosis-associated
1	cysteine-reactant
1	(lipocardium
1	symbolizes
1	facet
1	acat
1	hydrolases)
1	keap1)
1	a-series)
1	termination.
1	(sse)
1	gs),
1	lauric,
1	(gs+sse)
1	(mc),
1	cyanobacteria,
1	mc-la,
1	mc-yr
1	(cinc-2αβ)
1	neutrophil-derived
1	(placebo)
1	(mgln)
1	glutamine:fructose
1	(gfat)
1	gfat
1	(lac)
1	(pyr).
1	pyr.
1	lac,
1	(glycerol)
1	(lac
1	pyr)
1	ketogenesis,
1	octanoate
1	(vegf-α)
1	(cinc-2α/β).
1	(ffas)
1	survivors(n
1	nonsurvivors
1	19).the
1	troponin,
1	(5.11
1	(6.88
1	3.85
1	lfnu
1	(palmitic,
1	(epas))
1	(sod).
1	hyperinsulinemia/hypoglycemia
1	kg(-1)).
1	microm),
1	glucagons,
1	phosphorylase.
1	(mufa)
1	(ooe)
1	6-hour
1	ooe,
1	postinfusion.
1	(viability,
1	extemalization,
1	accumulation).
1	lecithin,
1	kg(-1)
1	(tag),
1	cona.
1	(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
1	(+29%)
1	(+92%).
1	a-ketoglutarate
1	76%.
1	h(-1)
1	mg(-1)
1	381.8
1	14.9.
1	(wco)
1	1.6-fold
1	(wfo)
1	3.8-fold.
1	(553
1	150)
1	(297
1	50).
1	(168
1	(mn-sod),
1	cu,zn-superoxide
1	(cu,zn-sod),
1	(gpx).
1	cu,zn-sod,
1	(p≤0.05)
1	(54×106±3.5).
1	neutrocytosis
1	(178.8×106±11.4
1	173.2×106±3.1,
1	(78%±1.3
1	74.8%±3,
1	(96.4%±0.6
1	94.2%±1,
1	(dha;
1	(epa;
1	(pa;
1	c18:0)
1	>50
1	c18:1
1	n-9)
1	(la;
1	c18:2
1	density-gradient
1	jak1),
1	(erks)
1	(pkc)-ζ
1	fas.
1	leandro,
1	c.g.,
1	a.c.
1	levada,
1	s.m.
1	hirabara,
1	manhães-de-castro,
1	c.b.
1	de-castro,
1	t.c.
1	pithon-curi.
1	cond.
1	21(3):
1	751-756.
1	2007.-moderate
1	10-stage
1	(210-226
1	decimates
1	newest
1	surgical)
1	(lipocardium)
1	lipocardium-treated
1	(still
1	antilipogenic
1	cytoprotector
1	induction).
1	lipid-raft-associated
1	explained.
1	(survival,
1	(pa,
1	(sa,
1	c18:1,
1	n-9),
1	(la,
1	c18:2n-6),
1	(dha,
1	(6.6-fold)
1	(p22phox,
1	126%),
1	22%)
1	2.8-fold)
1	(l-ala)
1	(l-gln)
1	(l-g
1	l-a).
1	l-a.
1	ureagenic
1	l-ala.
1	peroxides,
1	bolus.
1	(59%),
1	(non-esterified
1	(acetoacetate
1	β-hydroxybutyrate)
1	starvation)
1	(il)-8,
1	electrolyte-specific
1	hyperosmolarity.
1	post-traumatic
1	nervous,
1	aggressive/stressful
1	orzymosan
1	miristate
1	(pma)-induced
1	(nos-1,
1	nos-3).
1	0.0041),
1	9.6-fold
1	(1-h,
1	0.0022)
1	95.5%-augmentation
1	incubation;
1	0.0220),
1	isoform;
1	0.0319),
1	(nf-κb)-dependent,
1	nf-κb-dependent
1	hypusination.
1	(gc7)
1	deoxyhypusine
1	describes,
1	gc7,
1	(hfgln)
1	hyperinsulinaemic-euglycaemic
1	immunoprecipitation/immunoblotting
1	irs-phosphatidylinositol
1	(pi3-k)-protein
1	b-forkhead
1	01
1	irs-pi3-k-akt
1	(jnk),
1	(ikkβ)
1	ikkβ,
1	(tlr)4
1	(oxstress):
1	attained.
1	oxstress-induced
1	oxstress,
1	'physiological'
1	oxstress
1	(gastrocnemius),
1	oxs.
1	training-dependent
1	(hsp70),
1	80%-fall)
1	([gssg]/[gsh]
1	38-fold).
1	[gssg]/[gsh]
1	(lcfa)
1	(lipovenus
1	emulsion)
1	(g-6p)
1	(rg)
1	(wg)
1	wg
1	not-stimulated
1	ffa-uncoupling
1	backgorund/aims:
1	(nt
1	concanavalin-a-induced
1	luminol-
1	unsaturation.
1	nla,
1	electrostimulation
1	h2hff.
1	oxidase/xanthine
1	115%,
1	10-day
1	α1-type
1	(19.0-,
1	16.7-,
1	4.3-fold,
1	(helper
1	cytotoxic),
1	/kg)
1	ω-6:ω-3
1	ω;-6
1	emulsion,
1	made:
1	cytometry-cell
1	species-and
1	microscopy-chromatin
1	emulsions.
1	[u-14c],
1	[6-14c]glucose;
1	(2-4iu/day)
1	(1-14c]glucose
1	[u-14c]glutamine;
1	[6-14c]glucose
1	(cp-pgs),
1	cp-pg-induced
1	(mrp1/gs-x
1	s-conjugates
1	pmol/min/mg
1	(0-40
1	digitorium
1	caprylic,
1	bearing,
1	high-fo
1	(14.6
1	tumor-bearing,
1	bearing.
1	lawrence
1	erlbaum
1	associates,
1	thioglycolate-injected
1	(thio-treated)
1	proportions:
1	thioglycolate-treated
1	180μm
1	25%),
1	three-fold,
1	aa-pre-loaded
1	lines-jurkat
1	cells-were
1	(apoptosis),
1	(necrosis)
1	death)
1	(apoptosis,
1	donated
1	(irβ)
1	b/akt
1	s-nitrosated,
1	expression-diet-induced
1	mice-we
1	(stearic
1	c18:1),
1	c18:2)
1	(γ-linolenic
1	c18:3),
1	t-lymphocyte-derived
1	b-lymphocyte-derived
1	(nitro
1	tetrazolium)
1	fibronectin)
1	ask1,
1	p70s6k).
1	publication,
1	2máx..
1	2max.
1	non-tumor-infiltrating
1	(bcl-xs,
1	caspase-3)
1	(bcl-2
1	bcl-xl)
1	cysticercus
1	metacestode;
1	190%
1	extract),
1	(scolex)
1	(membrane).
1	self-protection.
1	granulating
1	especial
1	b-lymphocytes.
1	bcl-xs,
1	b-lymphocyte-mediated
1	s91
1	ductile
1	center>periphery>mammary
1	(61.3%
1	(7.0%),
1	(19.0%),
1	(11.0%),
1	(16.0%).
1	diagnostic.
1	(inf-γ),
1	over-simplification
1	ureogenic
1	lct.
1	(15d
1	ciglitizone)
1	(raji)
1	(inf)-γ;
1	1.5-fold).
1	(25.9%
1	investigated)
1	(8.4%
1	(hrp)
1	prodrug/enzyme
1	thioglycollate-
1	cytometry:
1	(pd3b),
1	n6-monobutyryl-camp
1	(n6-mb-camp),
1	pd3b.
1	n6-mb-camp
1	(lde),
1	pronouncedly
1	non-associated
1	ld90
1	lde-carmustine-
1	carmustine-treated
1	fiagmentation
1	blood-circulating
1	palpable,
1	weignt).
1	(cf,
1	(f1).
1	dam's
1	acid/epa
1	(necrosis),
1	(apoptosis).
1	peroxidase;
1	cat)
1	(pbs),
1	thioglycollate-injected
1	(thio)
1	phorbol-myristate
1	intestine)
1	53.5%
1	84.3%
1	7-
1	40-fold,
1	(alp),
1	18:2n-6,
1	20:4n-6,
1	20:5n-3,
1	22:6n-3
1	(polyunsaturated
1	14:0,
1	18:0
1	(saturated
1	tba-mda/mg
1	ftom
1	840
1	1110
1	234.10
1	342.84
1	9.38
1	20.06
1	u/g,
1	95.41
1	120.32
1	234.75
1	254.41
1	2.73
1	u/l,
1	287.28
1	315.98
1	[14c]-labelled
1	(chol)
1	(thio-elicited
1	thio-elicited
1	labelled-mø
1	thio-stimulated.
1	(51%
1	(naproxen)
1	(wk).
1	ncbi).
1	lacticidemia,
1	lacticidemia
1	(carcass-initial
1	-2%.
1	ncbi)
1	ncb
1	fuel.
1	incorporation;
1	(tnf)-α;
1	anti-apoptosis
1	carnitine,
1	choline-like
1	(d-carnitine
1	19.7
1	2.1%,
1	paralyzed
1	isomer-induced
1	fade.
1	d-carnitine,
1	dl-carnitine-induced
1	enemas
1	exagerated
1	pro-inf
1	lammatory
1	stress-inducing
1	contemplate
1	(123.9%)
1	(78.3%)
1	34%)
1	externalized
1	fluorochrome
1	123,
1	precoating
1	polyalcohol
1	(mfde).
1	mfde-dose
1	interrelated
1	(undifferentiated
1	polymorphonuclear-like
1	raji,
1	16-fold),
1	ceasing
1	n-ethylmaleimide,
1	diphenyleneiodonium.
1	xanthine-xanthine
1	(200-220
1	8br-camp
1	6mb-camp,
1	(325
1	emission).
1	34%),
1	12%),
1	21%)
1	67.12
1	75.30.
1	desaturation.
1	[il-1β],
1	[ifn-γ])
1	(cu/znsod).
1	sense)
1	antisense).
1	mnsod.
1	8-h
1	cu/znsod
1	mnsod,
1	13.5%
1	hypertriacylgylcerolemia,
1	leptin-incubated
1	123%
1	release).
1	acid-tg
1	14c,
1	(incorporation
1	tg)
1	energy-dissipating
1	[14c]-linoleic
1	up:
1	(con),
1	(3.3
1	(crex).
1	-20°c,
1	cr),
1	©journal
1	(2002).
1	greater,
1	(t-lymphocyte)
1	(b-lymphocyte).
1	bonds:
1	vacenic
1	caproic
1	nanomagnetic-based
1	time-decay
1	(bmf)
1	(de-mf)
1	1-21
1	(5×1015
1	particles/kg),
1	(aa)-induced
1	leukocytes:
1	toxic;
1	10-400
1	6-24
1	oxidative-reductive
1	(tbars),
1	disulfide/reduced
1	ascorbate,
1	[u-14c]-,
1	[1-14c]-and
1	[2-14c]-pyruvic
1	u/rat
1	[u-14c]-
1	(pdg)
1	(bas)
1	(lps
1	μl)-1).
1	bas
1	30.5
1	42.7
1	protein);
1	52.0
1	36.5
1	76.6
1	mmol·kg-1·d-1)
1	(glycerol
1	l-glutamine)
1	(iih),
1	u/kg).
1	(each
1	(glycerol,
1	l-alanine)
1	(l-glutamine)
1	iih,
1	(mf
1	(125%)
1	(mf1st
1	(5g)
1	(12g)
1	day-12g)
1	(8:00
1	(metamizol)
1	(37.5-300
1	cytoprotective,
1	(100-200
1	(25-50
1	poly(adp)-ribose
1	cp-pgs,
1	(mg2+-dependent
1	gs-conjugate
1	pump),
1	adenovirus-retrovirus
1	partially.
1	mrp-transfected
1	(mtl)
1	(mln)
1	(16.7-fold)
1	particular:
1	peri-parturition
1	period:
1	pgfm
1	metabolite),
1	dismutase-sod,
1	catalase-cat
1	peroxidase-gsh-px),
1	(tbar)
1	tbar
1	l-camitine
1	ammonia.
1	ammonia;
1	oxi-reduction
1	(ht),
1	pyruvate-dehydrogenase
1	(pdh)
1	pdh
1	skeletal.
1	lipopenic
1	don't.
1	(mufa)-rich
1	(11.47%),
1	(18.27%)
1	(9.34%).
1	mufas.
1	97.79
1	86.83
1	77.51
1	69.64,
1	oxidation/peroxidation
1	0.428
1	0.505)
1	9.425
1	127.792)
1	180%).
1	(comparison
1	86%.
1	peffused
1	(cn
1	question:
1	fermentable
1	nonfermentable
1	metabolism?
1	fiber-enriched
1	(0.3)
1	(0.14).
1	low-fiber
1	(potential,
1	pk)
1	uncharged,
1	8-24
1	12-19
1	1200-7000
1	3.335
1	δpk
1	one-tenth
1	(dmpc)
1	0.6;
1	lecithin),
1	(pc(a-s)),
1	pc(a-
1	(ifn)-γ;
1	reversal.
1	pc(a-s))
1	cocultured,
1	washed,
1	shinomiya
1	hell
1	naomi's
1	answered:
1	mfs?
1	burns,
1	infeccious
1	benefical
1	chemoterapic
1	(ohcs)
1	"motor"
1	glut-5,
1	"prestin,"
1	impart
1	ohcs.
1	corti.
1	electromotility.
1	(5u/kg
1	hanvood
1	468
1	sterol,
1	hove
1	omegas
1	involving:
1	chylomicron
1	non-cachetic
1	[3h]-triacylglycerol
1	[14c]-cholestery]
1	hypoinsulemia
1	instaled.
1	[3h]-tg
1	[14c]-ce
1	h]-tg
1	moitiés
1	na2+and
1	rat:5:
1	food-restricted,
1	pk(a),
1	(procopio
1	fornes,
1	phys.
1	829)
1	fluctuation,
1	fluctuation-dissipation
1	theorem
1	kirkwood
1	shumaker
1	(proc.
1	sci.,
1	863)
1	fluctuational
1	minimized.
1	protonic
1	underinvestigated
1	topic.
1	13-acetate-induced
1	extensively.
1	glucocorticoid)
1	(50-70
1	5.88
1	(10,000
1	246%
1	304%
1	(397%)
1	(527%)
1	(tg-elicited)
1	(mφ).
1	c]-labeled
1	inoleic
1	c]-fa
1	(280%).
1	(24.2
1	(32.0
1	(23.8
1	mmol/g)
1	(15.2
1	mmol/g,
1	108.6
1	(glycogenolysis)
1	(445.0
1	91.0
1	428.0
1	72.0
1	nmol/106
1	cells/h,
1	eric
1	newsholme's
1	intracetlular
1	gained,
1	(opx)
1	neutrophii
1	(pdg),
1	(am.
1	physiol.273:
1	1124,
1	ceils
1	(10?
1	gtycogen
1	pdg,
1	(21h),
1	dehydrogenise
1	pentosephosphate
1	fapesp,
1	cnpq,
1	pronex.
1	24°c
1	0.25mm.
1	(mu)
1	9);
1	(pu)
1	cent)-
1	(53
1	lu
1	'mad
1	hatter',
1	carroll,
1	'alice
1	wonderland',
1	intoxication,
1	mistaken
1	macrophages/foam
1	autacoids
1	(unstimulated)
1	carbaprostacyclin
1	(cpgi2,
1	μm))
1	(thioglycollate-elicited)
1	cpgi2
1	pge2-derivative
1	pga2
1	129%
1	(snap,
1	improve,
1	mating,
1	(nb)
1	weights.
1	(25.3%)
1	fetal.
1	1.1.1.49)
1	(ms)-
1	cocconut
1	fat-oil;
1	(ls)-
1	(mu)-
1	(n-9);
1	(pu)-
1	(n-6).
1	mu.
1	86%,
1	pu.
1	131%,
1	[u-14c]d-glucose.
1	sixfold.
1	eightfold,
1	investigated.the
1	(gsh-px);
1	peroxyl
1	chemicals)
1	chemotherapeutics.
1	s-(2,4-dinitrophenyl)-glutathione
1	(dnp-sg)
1	electrophilic/oxidant
1	cyclopentane
1	cytotoxic/cytostatic
1	γ-glutamylcysteine
1	(γ-gcs,
1	biosynthesis)
1	inducibly
1	electrophiles,
1	cp-pgs.
1	(larynx
1	γ-gcs,
1	(gsrd)
1	(gspx)
1	17.0-,
1	28.5-
1	12.3-fold).
1	pga1,
1	gsrd
1	gspx
1	(pga1
1	93.4%-inhibition
1	addition).
1	leukemias.
1	mitogen-stimulated.
1	(quiescent)
1	(bcg)-activated
1	self-defense
1	gs-conjugates
1	promyoblasts
1	v-h-ras
1	intracerebroventricularly,
1	(l-nna)
1	(catalase
1	glutathione-dependent
1	gsh-px)
1	cent.
1	173.9
1	pmol/107
1	lipoprotein-dependent
1	nmoles
1	pre-labelling
1	111%-increase
1	nmol/107
1	91%,
1	macrophages).
1	single-well
1	contact),
1	two-compartment
1	contact).
1	[2-14c]thymidine
1	blood),
1	atherosclerosis)
1	combined:
1	saponification
1	underivatized
1	chromatography).
1	saponified
1	hexane.
1	(c8-shimadzu)
1	refractive
1	(rid-6a-shimadzu).
1	(soybean
1	butter)
1	(spleen
1	racemization.
1	(cs),
1	(mln))
1	(gastrocnemius
1	adrenodemedullated
1	shamoperated
1	(42%))
1	(67%).
1	(71%),
1	(43%)),
1	56%.
1	(126%),
1	(223%),
1	(360%)
1	(31%).
1	(142%),
1	(47%).
1	(cb).
1	c]-labelled
1	follow:
1	(368.57
1	21.62)
1	(274.52
1	15.41)
1	(42.11
1	8.31)
1	(36.53
1	nmol/10
1	mφ/10
1	(85%
1	(71%).
1	c]-isotope
1	bubalis.
1	phosphoglycerate
1	equilibrium,
1	rnncosa
1	présents
1	relis
1	interat
1	cjiiterocvtes
1	u)
1	couid
1	enteru
1	cvtes
1	letal
1	ham-f12
1	2-1-well
1	3h-
1	μci/ml)
1	fill.
1	preg
1	nant
1	pro-labeled
1	12h.
1	h-cholesterol
1	scintillating
1	'h-cholesterol
1	wa.s
1	;i
1	3h-cholesterol
1	fapesp.
1	gonadectomy
1	whale,
1	type)
1	tumor)
1	(86%
1	(87%
1	hr),
1	(76%
1	rbl-2h3,
1	mcf-7.
1	[thymus,
1	(mln)]
1	changes:
1	bran-(obd)
1	bran-enriched
1	(wbd)
1	(15%).
1	wbd,
1	pronounced:
1	cases:
1	aldolase,
1	phosphohexoseisomerase,
1	(phosphate-dependent
1	glutaminase)
1	(6%
1	(0.40
1	102.3
1	72.6
1	(malnourished
1	protein-malnourished
1	(prepared
1	169.1
1	202.9
1	(218.8
1	264.5
1	193.2
1	223.7
1	(300.4
1	352.2
1	15.9
1	emission,
1	(mmi)
1	physiological.
1	c]-glucose
1	c]-glutamine
1	maintained,
1	just-weaned,
1	glycocorticoids,
1	dysfunctions:
1	demedullation,
1	thyroidectomy,
1	l-tri-iodothyronine
1	cuzn-sod,
1	mn-sod.
1	gpx.
1	thioglycollate‐
1	bcg‐stimulated
1	hypothyuroidism
1	rasied
1	[u‐14c]‐glutamine
1	[u‐14c]‐glucose
1	(malate)
1	asparagine)
1	propionyl-coa
1	transfering
1	[l-14c]-palmitate
1	fibre-rich
1	butter,
1	(cashew
1	(soya
1	cashew,
1	[u-14c]-glutamine,
1	[3-14c]-pyruvate.
1	(2.7-fold
1	pyruvate),
1	(4.4-fold)
1	(6.3-fold)
1	(4.6-fold)
1	carboxylation
1	oxaloacetate.
1	(activated).
1	pronounce
1	onco-bcg
1	(mature)
1	(aged).
1	peroxides.
1	hyper-
1	gastrocnemius-white
1	(ldlox)
1	(hmdm)
1	autoxidized
1	ldlox.
1	foam-cell
1	[2-14c]
1	cell-stimulating
1	cytosol)
1	mitochondria).
1	peroxidase),
1	mn-sod),
1	inversely:
1	45-50
1	wk:
1	(polyunsaturated/saturated
1	[p/s]
1	2.9/1)
1	diets:
1	(ud)-p/s
1	7.6/1
1	p/s
1	0.3/1.
1	d/wk
1	(lo-thymus,
1	gastrocnemius)
1	substances)
1	dismutase.-sod-,
1	peroxidase).
1	summatory
1	exercise-training,
1	swimming-training
1	reducing-equivalents
1	(citrate
1	synthase-mitochondria
1	dehydrogenase-cytosol)
1	(soleus-red
1	gastrocnemius-white)
1	cirtrate
1	tbars-monitored
1	fourthly,
1	dehydrogenase/glutathione
1	[1-14c]-propionate
1	[1-14c]-palmitate
1	(133%)
1	(pufa),
1	(48%;
1	274.23
1	(70%;
1	9.18
1	96.25
1	89.43
1	23.13
1	(274.23
1	342.48
1	15.39,
1	189.67
1	9.57
1	(30.31
1	17.42
1	29.34
1	16.73
1	59.67
1	3.45
1	48.87
1	161.66
1	9.97
1	diets)
1	lymphocytes.(abstract
1	pentose‐phosphate
1	2·4‐fold)
1	6‐phosphate
1	tumour‐implantation
1	reticular-like
1	(eightfold)
1	amounts;
1	mmol/1.
1	15-month-old
1	thioglycollate-injected,
1	tumor-implanted
1	spleen).
1	fat),
1	78%.
1	41%)
1	reported;
1	3-14c]
1	exporting
1	(uc),
1	(10).
1	lead-exposed
1	autoxidize
1	red)
1	white)
1	(cytosolic)
1	(mitochondrial)
1	iia)
1	(35%).
1	(n-6)-rich
1	3h2o,
1	cachectic,
1	(ca++,
1	mg++,
1	zn++,
1	k+)
1	zn++
1	(pu-fa
1	(pufa
1	chows.
1	(futile)
1	(tg-fa
1	tritium
1	3h-h2o
1	triglyceride.
1	(cond)
1	(nonfood-restricted)
1	controls);
1	insulinemia;
1	emptying;
1	on;
1	metabolized.
1	hydrolase,
1	acetylcarnitine
1	nad+-
1	dehydrogenases,
1	thiolase,
1	respiratoryr
1	acetyl-
1	palmitoyl-carnitine
1	[1-14c]pyruvate.
1	t.g.,
1	alia
1	(newly
1	weaned),
1	(15-month
1	34.2%
1	65.6%
1	37.1%
1	adp:
1	(mf)
1	(ff)
1	discipline
1	β-hydroxy-β-methyiglutaryl-coenzyme
1	substrate;
1	acids:
1	acetoacetate,
1	citrate:
1	butyrate;
1	proprionate,
1	trichloro-methoxyphenylhydrazone;
1	"buffer"
1	(coa)
1	cholesterologenesis,
1	demanded
1	branch-point
1	meal-feeding,
1	free-eating
1	pyruvate)
1	libitum-fed)
1	(pepck)
1	fat-pad
1	mm-glutamine
1	mumol/h
1	wt.,
1	mm-glucose.
1	dehydrogenase;
1	double-reciprocal
1	linear.
1	α-cyano-4-hydroxycinnamate,
1	brain-chain
1	transamination.
1	ketoacid
1	oxidized:
1	liver).
1	muscle?
1	ultilized
1	pyrimidines,
1	'essential'
1	burns:
1	messengers.
1	6-phosphofructokinase
1	6-phosphatase
1	bisphosphatase
1	'metabolically'
1	(decarboxylating)
1	malate,
1	7:30
1	9:30
1	intermedal
1	6-phosphofructokinase,
1	'resting'
1	6-phosphofructokinase:
1	coa-transferase
1	nmol/h
1	palmitoyltransferase.
1	arabinose
1	coroa
1	avião
1	(rtastv)
1	(rtcv),
1	rtastv
1	rtcv
1	goose,
1	turkey),
1	birds’
1	calicivirus.
1	746
1	vtm
1	pancoronavirus
1	(rdrp)
1	gammacoronaviruses
1	deltacoronavirus
1	gamma-
1	deltacoronaviruses
1	urban-
1	poultry-farm
1	rhinovirus,
1	bronchiolitis,
1	(hrsv
1	(hrv
1	(wgcna)
1	infection—comparatively
1	infection—was
1	host-response
1	paving
1	533
1	hl18nl11
1	fruit-eating
1	(artibeus
1	lituratus).
1	aspirates.
1	(10.4%)
1	(57.7%)
1	virus-3,
1	(28.8%)
1	virus-4,
1	(1.9%)
1	virus-2.
1	(6.7%)
1	virus-3
1	virus-4.
1	min/day;
1	0.01]
1	[bal]),
1	beas-2b
1	dichlorodihydrofluorescein
1	il-10/nf-κb,
1	virus–associated
1	nile.
1	gnatcatcher
1	(polioptila
1	plumbea)
1	parvoviral
1	genomes)
1	distance-based
1	previously),
1	parvovirinae.
1	(dependovirus,
1	aveparvovirus
1	tetraparvovirus).
1	4-year
1	(2009-2012)
1	oropharyngeal/cloacal
1	(3.96%)
1	h2n2
1	h6nx
1	h9n2
1	h12n5
1	ferrets
1	paraguay
1	“desmodus
1	rotundus”.
1	“zorro”
1	asuncion
1	agv2,
1	(domestic
1	species)-related
1	(cricetidae),
1	(molossidae
1	phyllostomidae),
1	(didelphidae).
1	omegatorquevirus
1	sigmatorquevirus,
1	anelloviruses,
1	anelloviruses.
1	virus-a
1	(ten
1	1961
1	prematurity)
1	85.7%
1	red-tailed
1	parrot
1	(amazona
1	rasa
1	nest.
1	nests,
1	parrots
1	viruses’
1	oxytoca.
1	nestlings’
1	cacipacore
1	(cpcv),
1	bird-associated
1	3,253
1	culicidae
1	(grouped
1	pools)
1	2002-2006
1	cpcv-infected
1	thomazelli
1	paramyxovirus
1	(apmv)
1	14,952
1	(3'-np-p-m-f-hnl-5')
1	apmv.
1	rs-1177
1	1,707
1	(vpker↓l),
1	apmv-10,-2
1	and-8,
1	60.1%
1	apmv-10
1	58.7%
1	58.5%
1	apmv-8
1	apmv-2
1	unclassified/calidris-fuscicollis/brazil/rs-1177/2012
1	apmv
1	apmv-15.
1	(quidel
1	corp,
1	usa)
1	influenza.
1	313
1	negativity
1	98.8%,
1	94.6%,
1	e96/h4n7
1	anseriformes
1	geolocator
1	summer/spring
1	falkland
1	petrels.
1	frequented
1	petrel.
1	paramyxoviruses,
1	nipah
1	henipa-like
1	faeces.
1	sandra
1	goals.
1	(2013-2015)
1	(0-6
1	(pcr-real-time
1	conventional,
1	(14%
1	unit).
1	98.9%;
1	(77.6%)
1	(76,7%
1	hrsva).
1	on1
1	(n=34),
1	na1
1	(n=1),
1	na2
1	(n=4).
1	(ba9-n=10;
1	ba10-n=3).
1	bronchiolitis.
1	on1,
1	2009–2010,
1	1006
1	charadriiformes,
1	anseriformes,
1	stop-over
1	flyway.
1	positive;
1	illnesses.
1	nsp1
1	alphaviruses.
1	83.05 °c
1	85.28 °c.
1	84.83
1	85.28 °c
1	83.34 °c
1	84.68 °c
1	genetically-diverse
1	high-profile
1	re-emergence
1	c-like
1	indurative
1	c-like.
1	vesiculoviruses
1	(vsv)
1	vsv.
1	piry,
1	vesiculovirus
1	81.02
1	0.8°c,
1	piry
1	vesiculovirus.
1	apinco
1	ciencia
1	avicolas.
1	wetland
1	flood
1	migratory.
1	wn
1	poconé,
1	mist
1	nets.
1	passeriformes,
1	orders,
1	columbiformes,
1	psittaciformes,
1	anseriformes.
1	thamnophilidae,
1	(21.0%),
1	tyrannidae
1	(7.6%)
1	furnariidae,
1	(qrt-pcr).
1	birdlife
1	nearctic
1	moulting
1	feathers
1	plumage,
1	grounds.
1	plover
1	(charadrius
1	semipalmatus),
1	(actitis
1	macularius),
1	sanderling
1	pusilla)
1	january,
1	plumage.
1	moulting,
1	morais
1	1,600
1	(amazon
1	rondoˆnia
1	forest)
1	1,310
1	igg-elisa,
1	(6.2%),
1	(5.8%)
1	populous
1	hurtado
1	flyways,
1	aiv.
1	delaware
1	ducks
1	teals
1	hantaviruses.
1	green-based
1	rt-pcr-positive
1	sequencing;
1	87:725-732,
1	715
1	zerofive
1	(ile5asn)
1	(ser291pro)
1	child’s
1	br-85
1	palivizumab
1	(pz)
1	≤24
1	october-may
1	2001-2008
1	nasal/throat
1	8762
1	(4.3%)
1	receipt,
1	(14.9%)
1	12/42
1	(28.6%)
1	receipt.
1	infrequent,
1	rsv-associated
1	stopover
1	orotracheal/cloacal
1	(rrt-pcr).
1	virus-positive
1	rrt-pcr.
1	interpres),
1	caeté
1	canelas.
1	igg-positive,
1	miscarriage
1	ultrasound.
1	bellwether
1	papua)
1	adeliae)
1	demographics
1	histories.
1	d-loop
1	29)
1	300,000
1	400,000
1	centuries
1	(alri)
1	(adv)
1	(rsv).
1	alri,
1	metapneumovirus,
1	(gadv
1	(grsv
1	1,121
1	npa,
1	813
1	50.3%
1	virus;
1	surveyed,
1	15.8%.
1	gadv
1	grsv
1	134)
1	noteworthy:
1	gadv.
1	persistent/latent
1	(rffit)
1	virus-neutralizing
1	(fat),
1	(rt)-
1	dead.
1	rffit
1	10.8%.
1	mit,
1	rtpcr
1	virology
1	hku1,
1	oc43,
1	229e
1	nl63
1	year-to-year
1	cumulatively
1	7.4-15.6%
1	prevalence)
1	betacoronavirus
1	tracheal-bronchial
1	air-liquid
1	hku1.
1	hong
1	kong
1	france.
1	(w197f,
1	f613y
1	s752f)
1	nsp3
1	subdomain.
1	pandemic,
1	standard-dose
1	(cri)
1	crs.
1	(nine
1	amminiotic
1	placenta)
1	(1a,
1	cri.
1	argasid
1	carios
1	fonsecai
1	(fat)
1	intra-coelomic
1	mit.
1	mit
1	unviable
1	patients/methods:
1	2885
1	15·8%
1	(february
1	may),
1	cocirculated
1	ga5.
1	fortaleza
1	wnvacross
1	678
1	478
1	wnv-specific
1	(prnts).
1	from992
1	macerates
1	928
1	results:we
1	wnvantibodies
1	prnt90
1	confirmedwnvpositivity
1	prnt90,
1	ai-subtype
1	hemagglutination-inhibition
1	(22.58%),
1	h5
1	(41.94%),
1	(9.7%),
1	anti-nucleoprotein
1	dog-related
1	dog-endemic
1	bat-and
1	marmoset-related
1	marmosets,
1	(cdv)
1	bats)
1	biritiba
1	mirin
1	paraguayanus,
1	ihering,
1	(diphylla
1	ecaudata
1	anoura
1	caudifer)
1	(paho)
1	calling
1	paho
1	importations.
1	swabs)
1	1997-2004
1	1g.
1	rv-infected
1	lasota-ls-(vaccine
1	joao
1	meriti-sjm-strain
1	vaccinated/infected
1	(sjm
1	influenzavirus
1	(flua
1	flub),
1	(hrv).
1	may/2004
1	september/2005.
1	(148/272)
1	(79/272)
1	23.1%
1	(63/272);
1	(14/272);
1	(9/272);
1	2.9%
1	(8/272);
1	flub
1	(4/272),
1	flua
1	(3/272),
1	(1/272).
1	incidences
1	coldest
1	driest
1	(ndv).
1	exporter
1	embargoes,
1	1,022
1	tracheal/cloacal
1	(0.7%)
1	low-pathogenicity
1	velogenic-ndv
1	(agv-2),
1	(agv-3),
1	965
1	samples.we
1	ba-like
1	rarely,
1	infrequently.
1	koehlerae
1	henselae;
1	cytauxzoon,
1	phagocytophilum
1	fcov
1	relocation
1	diagnosticians.
1	reversetranscriptase
1	bats'
1	agv-3,
1	agv-4,
1	agv-6;
1	picornavirus
1	runny
1	montensis,
1	cursor,
1	juliomys
1	thaptomys
1	nigrita,
1	nigripes,
1	molossops
1	1157
1	1445nt.
1	buildings,
1	yard
1	jundiaí
1	house's
1	attic,
1	captured,
1	genetically,
1	colony.
1	bocavirus
1	(hbov)
1	511
1	hospital-acquired.
1	scenery
1	hyper-endemic
1	dhf/dss
1	rt-hemi-nested-pcr
1	(culicidae,
1	1700)
1	denv-1,
1	(3.8%).
1	haemagogus
1	leucocelaenus
1	albopictus.
1	figueiredo
1	serologic,
1	histopathologic,
1	(b19),
1	(a-6
1	lali)
1	(v9).
1	∼10%.
1	genotype-3-related
1	gh2768,
1	ghana
1	kelp
1	gull,
1	larus
1	(lichtenstein,
1	1823),
1	(since
1	1978-1979).
1	dominicanus,
1	abandonment
1	zoologia.
1	(genescan
1	1,670
1	702
1	2003-2004.
1	(56/545
1	a3.
1	(59%).
1	(afm)
1	pygoscelid
1	afm
1	july,
1	(parvovirus
1	enterovirus),
1	borreliosis
1	western-blotting.
1	6.2%(12/193).
1	(83.2%);
1	(66.7%);
1	(58.3%);
1	summer/fall
1	itching;
1	(338°)
1	maculo-papular
1	urticaria-like
1	scarlatiniform
1	cardiologic
1	remembered
1	(cpv-2).
1	(cpv-2a),
1	(cpv-2b),
1	bl21a
1	(gbs),
1	18-year-old
1	gbs
1	use-simplicity
1	cross-contamination
1	(hu-usp),
1	(45.1%)
1	(33.2%)
1	(42.5%)
1	(n=435)
1	parvovirus-was
1	plunged
1	refrigerated
1	adolfo
1	(73.03%),
1	(8.42%),
1	(8.42%)
1	(3.37%).
1	rsv-positive,
1	(months)
1	uai
1	2.41%.
1	(ari),
1	(molossus
1	molossus)
1	"rondônia",
1	24):
1	pachydermatis,
1	(20.8%)
1	furfur,
1	globosa
1	sympodialis.
1	immunochromatography
1	(ica-bd)
1	91.2%
1	(npv)
1	91.2%,
1	98.0%,
1	89.0%,
1	84.0%
1	99.0%,
1	ifa.
1	79.5%
1	95.4%
1	86.0%,
1	ica-bd,
1	(hep-2,
1	hela-i)
1	hu-usp
1	hela-i,
1	nci-h292.
1	(43).
1	(73.2%)
1	benchmark,
1	hela-i.
1	(ia
1	ib),
1	(aris)
1	universitário,
1	(lrti)
1	24.1%,
1	17.8%,
1	8.3%,
1	44.1%.
1	(12.8%
1	hmpv,
1	hpiv,
1	aris
1	cpv,
1	cocirculating
1	1990s
1	(ω
1	4.9).
1	acquire,
1	vp1/vp
1	donations,
1	vertical,
1	dismembering.
1	139,678
1	(0.23%)
1	hcv-rna.
1	false-positives,
1	99.83%.
1	1:200,000
1	1:500,000
1	hcv-rna
1	cia-1
1	[renshaw
1	rw,
1	soiné
1	weinkle
1	o'connell
1	ohashi
1	watson
1	virol
1	1996;70(12):8872-8].
1	878
1	cav,
1	mdcc-msb1
1	singled
1	mdcc-msb-1
1	childrens'
1	60.9%
1	(73.5%-
1	b3,
1	b5,
1	infants'.
1	type/genotype.
1	passage.
1	iu/ml.
1	102,469
1	(0.04%)
1	non-reactive)
1	1:102,469.
1	1:600,000
1	1:3,100,000
1	papular-purpuric
1	"gloves
1	socks"
1	(ppgss)
1	dermatosis
1	pruritic
1	hands
1	gloves-and-socks
1	ppgss
1	22-year-old
1	woman.
1	(fhv
1	(fcv),
1	(fpv),
1	(fiv),
1	(plv).
1	fhv
1	fcv,
1	fcov,
1	fpv,
1	fiv,
1	plv
1	high-titered
1	infant,
1	consuming,
1	hopefully
1	1000,
1	micld50
1	route)
1	reassorts
1	(h5n1)
1	[juruviara(br)
1	red-eyed
1	vireo(usa)]
1	[tuque(br)
1	(usa)]
1	duplex/pcr
1	gloria
1	symptoms:
1	coryza.
1	b95a
1	(felv),
1	gammaretrovirus,
1	catus).
1	cytoproliferative
1	cytosuppressive
1	devastating.
1	herpailurus
1	yaguarondi,
1	oncifelis
1	zoologic
1	esophageal-pharyngeal
1	dichotomus)
1	microti,
1	africanum),
1	(urti)
1	14-49%
1	parainfluenza,
1	attacks.
1	(2-14
1	i:
1	later);
1	iii:
1	non-asthmatic,
1	(cough
1	sneeze,
1	turbinates,
1	retropharynx
1	fever)
1	rhinovirus.
1	11.1%
1	2/36,
1	1/36,
1	parainfluenzae
1	≤12
1	anti-rsv
1	eia.
1	rsv-infected
1	(63.0
1	9.0%).
1	(71.0
1	17.7%).
1	tcid50)
1	misdiagnosis
1	b19)
1	(hhv
1	diagnosis:
1	5.9%
1	attributing
1	>40,000
1	246/
1	measles-related
1	(genotypes
1	d6)
1	resurgence,
1	56-year-old
1	antimitochondrial
1	proven,
1	ward.
1	non-respiratory
1	414
1	included-239
1	(2.9%)
1	(41.8%),
1	(4.6%),
1	(5.8%).
1	june.
1	pneumonias.
1	(vp7)
1	(vp4)
1	g5
1	[7].
1	nonporcine
1	g-p
1	rotaviruses.
1	cpv2b
1	measleslike
1	igm-capture
1	pairs,
1	classic;
1	measles.
1	subitum
1	kawasaki
1	post-vaccine
1	igm-negative
1	(turkey
1	rhinotracheitis)
1	(swollen
1	(shs))
1	(npcr).
1	npcr,
1	ppv,
1	ns-1.
1	puc18
1	(come)
1	continned
1	tympanometry.
1	33.6%,
1	16.5%.
1	66.4%
1	isolatedin
1	16.6%.
1	staphilococci,
1	adenoviruses,
1	syncitial
1	b19-specific
1	xi'an,
1	japan,
1	convalescent-phase
1	(hhv-6)
1	(hhv-7).
1	exanthem,
1	hhv-7.
1	≤5
1	hhv-
1	(coara).
1	anti-rotavirus
1	genus-specific,
1	(5')
1	(3')
1	species-specific,
1	oligo/dna
1	streptavidin-coated
1	peroxidase-streptavidin
1	colorimetric-peroxidase
1	0.0001%
1	laboratory-induced
1	hoped,
1	polyarteritis
1	nodosa
1	wegener's
1	granulomatosis.
1	vascultis
1	necrotisingvasculitis
1	anti-digoxigenin-alkaline
1	format,
1	infectiosum,
1	crisis,
1	hydrops
1	digoxigenin-
1	gctaaaagtgttccagtatatggca
1	infectiosum
1	anemias
1	100-fold.
1	virologist
1	13-month
1	(university
1	hospital).
1	(intervals
1	biotin-avidin
1	(mab
1	se7).
1	astroviruses
1	cowan
1	agglutination.
1	87.2
1	94.2%.
1	(bcg),
1	technic
1	(autoclave
1	120°c
1	water-bath
1	min.,
1	cooling)
1	(formaldehyde
1	hcl-1
1	min.)
1	greenish
1	pink.
1	oscillates
1	clock-mediated
1	clocks,
1	hyperthyroid.
1	(tef),
1	arnt-like
1	(bmal1)
1	(nr1d1)
1	nr1d1
1	tef.
1	acrophase.
1	(tgfa)
1	(10-9m)
1	(mapk/erk
1	tgfa.
1	aace.
1	(lats)
1	mets/t2dm
1	terms:
1	“hypothyroidism”
1	“diabetes”
1	“metabolic
1	syndrome.”
1	3.45;
1	4.7)
1	(sch).
1	1.09-fold
1	miu/l
1	1.12),
1	1.15;
1	1.26)
1	miu/l.
1	1.31;
1	1.60).
1	(hmb),
1	(320 mg/kg
1	nacl-0.9%)
1	(akt/4e-bp1/s6)
1	(fbxo32
1	trim63).
1	sub-set
1	(three-fold).
1	(one-fold)
1	fluctuate
1	t3-mediated
1	(bmal1,
1	nr1d1,
1	rora)
1	(pdk4,
1	acot1,
1	cd36)
1	cafeteria-diet-induced
1	(1.5 μg
1	100 g
1	(tshr)
1	(tpo)
1	non-athletes
1	(treadmill).
1	morpho-physiological
1	arginine-treated
1	(ie;
1	nai/l)
1	follicles,
1	(tshr,
1	tpo,
1	mct8)
1	(nkx2.1,
1	pax8).
1	hypermethylation
1	hypoaceylation
1	h4,
1	(ie)
1	hypothalamus–pituitary–thyroid
1	trhr,
1	tsha
1	slc5a5
1	diiodothyronine
1	(3,5-t2)
1	t3-like
1	(3,3-t2)
1	diiodothyronines
1	(ucps)
1	extra-cardiac
1	stimuli/stresses
1	time-of-day
1	(tod)-dependent
1	intermediates)
1	(4-h
1	(ccm)
1	dio1,
1	thra1
1	thra2
1	bmal1)
1	interrogated
1	thyroiditis.
1	0.005%)
1	nai+naclo4
1	nai-treated
1	thyroxine/triiodothyronine
1	iodine-exposed
1	nondiabetic,
1	(1.5 μg/100 g
1	4 weeks).
1	(150 mg/kg,
1	250 mg/dl
1	cis-acting
1	p65-pax8
1	symporter-mediated
1	cytochromes,
1	heme-protein,
1	calcium-signaling
1	(trh),
1	non-receptor-mediated
1	voltage-independent
1	pacemaking
1	natively
1	(cga),
1	thyroidstimulating
1	ß-chain
1	(tshb),
1	(trhr).
1	cga,
1	tshb,
1	trhr.
1	oftrh
1	functionaltrhreceptors.
1	therewasalso
1	folliculostellate
1	lactotroph
1	network;
1	trh-stimulated
1	(left
1	ventricles)
1	(i-)
1	expression/activity.
1	tsh/insulin-starving
1	2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one)
1	(akt1/2
1	(mitosoxred),
1	2-phenyl-1,2-benzisoselenazol-3-(2h)-one
1	asanovel
1	i--induced
1	autoregulation,
1	7-42
1	(0.5-50
1	7-28,
1	(12-fold).
1	p0-p5,
1	4.5-fold;
1	p15.
1	(5%),
1	conditions.male
1	[15
1	150.
1	μmols,
1	i.p.]
1	13-14),
1	qpcr.serum
1	peak.the
1	d-mannitol
1	arg-treatment
1	oxidation;
1	473),
1	p-acc
1	(ser79),
1	p-gsk-3α/β
1	21/9)
1	ampk-α.
1	aromatase.
1	noael
1	toxicity)
1	sixty-dayold
1	preference;
1	fsh;
1	testes,
1	epididymis
1	mount;
1	masculinization
1	hypersecretion
1	perchlorate.
1	(mfr)
1	(ucps).
1	con.
1	2+-atpase
1	(serca1).
1	surface/volume
1	problembased
1	(pbl),
1	hypo-/hyperthyroidism
1	hands-on
1	criminal
1	story
1	clues,
1	vascularization,
1	lesson.
1	pictures,
1	stuffed
1	toy
1	illustrations
1	inviting
1	stimulating.
1	lesson
1	teach
1	euthanization.
1	(320.
1	(mrna
1	blotting/real
1	hmβ-treated
1	hmβ-treatment
1	iodolipids
1	hours/days
1	promptness
1	adenylation,
1	methylmercaptoimidazole
1	(0.03%)
1	μg/0.5
1	saline)
1	pr,
1	group's
1	weaning;
1	(-29%
1	-18%,
1	ninety-day-old
1	(-5%),
1	(+5%);
1	180-day-old
1	(+12%)
1	(+19%
1	+22%,
1	respectively);
1	-17%,
1	3,5,3′-triiodo-l-thyronine
1	(t3)/100
1	diffusion,
1	scavenges
1	(0.3-100
1	provided:
1	libitum)
1	rt3
1	senescence-related
1	ornitargin®
1	citrulline
1	(cit)
1	(orn)]
1	(hemipituitaries
1	μl/min,
1	(1%)/formaldehyde
1	32p-cdna,
1	32p-18s
1	arg-mediated
1	ot,
1	somatotrope
1	5′-deiodinase
1	thyrotropes,
1	somato-tropes
1	lactotropes.
1	tetraiodothyronine
1	propylthiouracil-insensitive,
1	t3-suppressible
1	t3levels
1	hypothyroxinemia
1	(25ug/100g,
1	(fast)
1	(slow)-fibers
1	(ptu)-treated
1	(met,
1	(94.12
1	18.55
1	199.30
1	31.47
1	μg/mg,
1	(1.95
1	4.26
1	(347
1	trh/tsh
1	production/secretion,
1	(gh)gene
1	thyoidectomized
1	methimazole-treated
1	rapidity
1	thyrotropin)
1	(cim
1	100mg/kg
1	h2-ha
1	cim-treated,
1	cim-treated
1	cim
1	(thyrotropin
1	anti-histamine
1	hypersecretion.
1	5'-deiodination
1	(5'-d)
1	micrograms)
1	microgram/100
1	isoleus
1	phosphoproteinformation
1	3—10
1	calciumdependent
1	14—21
1	thyroxine.
1	engendered
1	30—50%
1	parametersofthe
1	stabilizer)
1	disrupter
1	bw48-80.
1	t4-primed
1	(raiu)
1	raiu
1	pb131i,
1	enriched-cholesterol
1	(chd)
1	hypothalamus-pituitary
1	nutitional
1	g%),
1	g%.
1	(0.19%
1	0.26%);
1	(4.92,
1	57.66);
1	(328.22
1	(6.97
1	μu/ml,
1	(1g%)
1	μg%)
1	(0.40%)
1	(0.26%),
1	0.28),
1	(0.25%
1	0.15%)
1	(98.13
1	(8.32
1	tendon-healing
1	advancement.
1	(ppnl)
1	u-suture,
1	kessler-tajima,
1	strangulation
1	6.8-times
1	5.2-times
1	ppnl,
1	80-nm
1	27.79%
1	kessler-tajima
1	ppnl.
1	conclusion/clinical
1	(f1,
1	crush-type
1	(15kg)
1	6):
1	1-control;
1	2-exposed
1	3-injured
1	4-lllt
1	(15j/cm
1	780nm,
1	30mw,
1	5-f1
1	(0,1mg)
1	6-lllt&f1
1	(med:0.8;
1	q1:0;
1	q3:55.5%area).
1	(med:70.7;
1	q1:64.4;
1	q3:77.5%area)
1	(med:17.3;
1	q1:14.1;
1	q3:21.7%
1	(injured.
1	med:29.5;
1	med:17.7
1	lllt&f1.
1	med:19.4%area).
1	(med:35.1;
1	q1.30.6;
1	q3.39.6%area)
1	(med:18.5;
1	q1:16;
1	q3:25%area).
1	distributed.
1	acceleration;
1	dome-shaped,
1	heterogenic
1	seams
1	projection,
1	descriptions,
1	trained/ovariectomized
1	(ot).
1	extremity,
1	misalignment
1	species);
1	salmonid
1	cortland®
1	sperm.
1	straws
1	°c/min
1	(freeze
1	control®).
1	post-thawing
1	(gsh/gssg)
1	mm/10
1	ratios)
1	o2−i
1	lipoperoxides
1	fractionated,
1	scramblase
1	drp1-mediated
1	redistributing
1	tmj;
1	mercox
1	lateral-lateral
1	convex
1	anterior-posterior
1	meatus.
1	(85-15
1	meandering
1	retrodiscal
1	macroscopic,
1	79:806-813,
1	cury
1	bones,
1	enthesis
1	fibrocartilaginous.
1	months-old
1	months-old.
1	fibrocartilage
1	non-growing,
1	rostro-ventral
1	sharpnose
1	rhizoprionodon
1	denticles,
1	leaf-like
1	interlocking,
1	hexagonal,
1	magnification.
1	denticle
1	drag,
1	ram
1	abrasion
1	(cg);
1	(eg);
1	(ig);
1	(lg);
1	(lpg).
1	(lllt;
1	(ischiadicus)
1	ig,
1	f1;
1	lhg,
1	cg;
1	ig;
1	lhg
1	anatomy.
1	proprierties.
1	sunmushroom.
1	remedies
1	reporters
1	(epicardium,
1	endocardium)
1	picro-sirius:
1	trachinotus
1	carolinus,
1	cytogenotoxic
1	1.5μg
1	3.0μg-tio
1	-npg
1	(ph>13),
1	(ena)
1	ena,
1	overexposed
1	masseteric
1	hrs/j.
1	j/cm2),
1	photobiomodulatory
1	mamie
1	mizusaki
1	iyomasa
1	twisting
1	stretching)
1	proteomics.
1	carotid,
1	mammary,
1	(g,
1	rigidity.
1	expression/organization
1	reginato
1	conic
1	multifilamentary
1	orifice
1	lateral-caudal
1	dowley
1	cores.
1	carnivora,
1	pinnipedia,
1	otariidae
1	morphophysiological
1	(arctocephalus
1	flat;
1	pericardium
1	mammals;
1	(hahs)
1	(hevea
1	f1)
1	(axonotmesis)
1	photomicrographed
1	imagej
1	1.47k
1	(nih,
1	bethesda,
1	md).
1	(myelin
1	area/nerve
1	(minimum
1	g-ratio)
1	hah,
1	biomaterial,
1	point-dried,
1	gold-palladium.
1	(length,
1	length/width
1	bacilli).
1	(2.5%
1	glycocalyx
1	(p1,
1	kgf,
1	axonotmesis)
1	exposed;
1	p1;
1	lpg.
1	cryofracturing
1	casts/angioarchitecture.
1	plane;
1	stratigraphy
1	cryofracture
1	dysfunction;
1	(gaalas,
1	j/cm2;,
1	hrs/j
1	ten)
1	cistern,
1	pinocytosed
1	ten,
1	cost-benefit.
1	(ketamine
1	150/10
1	transcardially,
1	a-,
1	i-,
1	h-bands
1	m-
1	sarcomere.
1	disks,
1	2.071
1	0.3383,
1	0.537
1	0.278
1	1.024
1	0.352
1	length/lesser
1	1.929
1	0.965.
1	23.4%
1	45.3%
1	herbivore
1	pyriform
1	intracorpuscular
1	diameters.
1	bundle-surrounded
1	condyle,
1	biomechanics
1	(delivered
1	endothelialization.
1	(mm2)
1	struts,
1	sirulimus-eluting
1	0.08,
1	0.120).
1	sirolimuseluting
1	01,
1	03
1	0.133).
1	conclusion:after
1	non-drug
1	invaginations.
1	processes,"
1	hypoactivity,
1	dolphin
1	(pontoporia
1	blainvillei)
1	i-0;
1	ii-0.5;
1	iii-1.0;
1	iv-2.5;
1	v-5.0;
1	vi-20j/cm
1	vegfr-2)
1	photomicrographs
1	immunostainings
1	vegfr-2),
1	biomodulation.
1	digastrics
1	intermyofibrillary
1	periphericals
1	fiber's
1	microtendons
1	tenocytes.
1	subspecialization
1	(hrsem),
1	toluidin
1	tetroxide.
1	1/15m
1	7.4).
1	dymethylsulphoxide
1	cracked.
1	mitochondriales
1	cistern
1	20-25
1	canaliculus.
1	histochemically
1	histochemic
1	(nadh-tr
1	(nadh-tr).
1	fiber,
1	ultrastructuraly,
1	guianensis.
1	photo-documented
1	(s.e.m.).
1	anterolateral
1	s.e.m.
1	americana).
1	papilla-like
1	rudimentary
1	rhea,
1	humidification
1	swallowing
1	impulses
1	myotendon
1	sacrified
1	(tmds),
1	malocclusion,
1	(hrs/j
1	(experimental,
1	n=5),
1	halothane
1	(2-bromo-2-chloro-1,
1	1-trifluoroethane,
1	aldrich,
1	india)
1	20j/cm2,
1	40mw,
1	20sec.
1	(35.91%±6.9%;
1	32.08%±6.3%,
1	27.88%±6.3%),
1	(11.08%±3.9%;
1	16.52%±5.7%,
1	15.96%±3.9%),although
1	small;
1	(0.16%±0.3%)
1	(9.68%±6.0%
1	9.60%±4.0%).
1	300mg
1	drinker,
1	overdose.
1	"alfac",
1	karyometric
1	biggest,
1	d/d
1	stereologic
1	cytoplasm/nucleus
1	surface/basal
1	wilcoxon-mann-whitney
1	karyometry
1	diameters;
1	stereologically,
1	mm3
1	drinkable
1	300mg/l
1	lactant
1	sectioned.
1	6μm
1	(submandibular,
1	sublingual)
1	aging).
1	keratinous
1	duly
1	delimited,
1	cracks.
1	molten
1	look.
1	holes,
1	dentinary
1	resolidified
1	evidently
1	biomodulator
1	dosages,
1	(jeol
1	1010)
1	contoured
1	crests.
1	effectivity
1	winkelman
1	schmit,
1	1957.
1	1/15
1	tanaka,
1	intrafusal
1	golgi's
1	sarcoplasm.
1	myofilaments
1	perineurium.
1	buttons
1	evaginations
1	button,
1	fills
1	beak-like
1	sagittally
1	longitudinally,
1	immersion-fixed
1	capsules,
1	connective-
1	naoh,
1	posteriorly.
1	cornified
1	(atpase),
1	(nadh-tr)
1	(sdh))
1	weibel
1	(point-counting
1	test-system.
1	myosinic
1	fatigable
1	exodontia.
1	meriones
1	unguiculatus
1	intracardially
1	neurohistologic
1	winkelmann
1	schmitt
1	40μm
1	leica
1	-30°c.
1	bony
1	completed.
1	uplifted
1	scherle
1	880
1	magnifications
1	3000×,
1	6000×,
1	30,000×
1	ultrastructures.
1	ramifications
1	intermyofibrilar
1	electronlucid
1	myofibrils.
1	adhesive/composite
1	mj/pulse,
1	2hz,
1	width),
1	etching.
1	(11.7
1	(6.1
1	mpa),
1	laser+acid
1	(p=0.0006
1	p=
1	0.00019,
1	(p=0.0003).
1	laser-prepared
1	studies:
1	aponeurosis.
1	aponeurosis
1	periodontium's
1	cavia
1	porcellus.
1	experimental-animals
1	capillary,
1	solsution
1	ctc,
1	peptide/
1	enhancer-skin
1	comeosomes.
1	togue
1	platinum-palladium.
1	hematoxilin-eosin
1	azo-carmin.
1	o-d-o
1	dryer,
1	gold-palladium
1	s-900.
1	lobules
1	microprojections.
1	excretor
1	microplicae.
1	ultrastructurally.
1	methodologies:
1	hematoxylineosin
1	ci-2b
1	812
1	contour.
1	'hair-pin'
1	rarefying
1	micropinocytic
1	caveolas.
1	microangioarchitecture,
1	palladium.
1	s-900,
1	cl-2b
1	smoother/flatter
1	hair-pins
1	karnovksy
1	um.
1	μm.then
1	nadh-positive
1	som-positive
1	(ian),
1	transganglionic
1	perikaryon,
1	pulpectomised
1	corpuscles,
1	cell-neurite
1	gingiva,
1	cheek,
1	0.2-0.4
1	(20-50
1	multilayered.
1	pursues
1	(floor
1	mouth)
1	day-old)
1	retrieved,
1	(alcohol,
1	formaldehyde)
1	plane,
1	drill.
1	durations.
1	oso4
1	jsm-6100.
1	(filiform,
1	conically
1	shaped;
1	projections;
1	vallate.
1	jsm-6100
1	1.94
1	micrometers
1	thirds,
1	millimeter
1	3,281
1	32,313
1	nitric-acid-demineralized
1	hematoxylin-eosin,
1	azo-carmine
1	carborundum
1	handpiece.
1	transversal
1	curvatures,
1	interglobular
1	predentin,
1	predentin.
1	mastication
1	researchers;
1	inhomogeneous
1	1,5
1	scheme:
1	mj;
1	mj.
1	300ms,
1	μs
1	0,005
1	mm2.
1	laser-oral
1	wether
1	mucous,
1	seromucous
1	(serous)
1	(mucous)
1	supranuclear
1	myofilaments,
1	desmosomal
1	lucent
1	endpieces.
1	analyze,
1	900mj
1	900,
1	450,
1	90ms,
1	005
1	1605-7422/02/$15.00.
1	picro-sirius.
1	endomysium,
1	rabbits'
1	(mercox
1	cl-2b)
1	arrangements.
1	interdental
1	rugae,
1	inter-rugal
1	rugal
1	rabbit's
1	8-month
1	(mr).
1	(future
1	fossae)
1	circularly
1	(br)
1	symphysis.
1	laminar,
1	trabeculae.
1	precedent
1	(sharplan
1	40c,
1	tel
1	aviv,
1	israel)
1	superpulsed.
1	moistened
1	erect
1	midcolon,
1	coloring
1	ferrocyanide
1	beams
1	(incisors
1	canines),
1	treatament
1	paiva
1	crowns
1	cicunscribed
1	cracks
1	watts.
1	conclued
1	nd:
1	yag
1	124.3
1	complete.
1	appr.
1	smooth.
1	albinus)
1	(purina
1	brandy
1	gay
1	lussac
1	(v/v).
1	estro
1	(90,
1	autolysis.
1	prismless
1	silverstone
1	(caries
1	1975;
1	9:373-387),
1	(buccal
1	thirds).
1	twisted
1	cylindrical
1	hole,
1	oval-shaped
1	hairpin-like
1	(connective
1	hvtem
1	7.3).
1	apparatuses
1	histo-differentiation
1	ribossomes
1	digitations
1	mitochondriales.
1	shape;
1	rod-shaped
1	freeze-fractured
1	hcl-treated
1	acinus.
1	coarser
1	naoh-extracted
1	dense-collagenous
1	evacuated
1	smoothened
1	apically-located
1	fiber-diameter
1	medium-diameter
1	(0.28
1	micron).
1	(0.22-3.2
1	microns)
1	portion;
1	seen:
1	ramus:
1	portions:
1	cracks,
1	descamative
1	watts)
1	lobuli
1	channel-like
1	odo
1	microtopographical
1	callosus'
1	oso4,
1	drying.
1	surfaces;
1	bifurcated
1	pores.
1	vallum.
1	freeze-cracking
1	aldehyde-osmium-dmso-osmium
1	cisterns,
1	micron
1	vlp-immunoreac-tive
1	desorganized
1	lymphoplasmocytic
1	serous.
1	esophagogastric
1	extension;
1	dome-shaped
1	cobblestone-like
1	topography.
1	albinus
1	lester
1	alii
1	jsm-p15.
1	(winkelmann
1	schimitt).
1	subepithelia
1	invests
1	orientatons
1	oxytalan,
1	deformation
1	sphenoid.
1	concluded:
1	(6.27%),
1	(4.05%)
1	(3.04%).
1	roots'
1	peri-axonal
1	lip,
1	mechanoreceptors,
1	corpuscles.
1	scab
1	neoformed
1	imature
1	descamation
1	carbon-gold
1	coating.
1	cilia,
1	supraependymal
1	sprague-dawly
1	glycogen-like
1	microfilaments.
1	beak
1	faces.
1	attachments
1	interdigitated
1	protrusions,
1	ending.
1	outher
1	neurotubules,
1	bulbous
1	envelops
1	ensheathing
1	approximatelly
1	enveloping
1	(sprague
1	dowly)
1	desmosomes,
1	(ph=7.4).
1	812.
1	40-80
1	knives
1	lkb
1	ultramicrotome.
1	philips
1	em-301
1	mucosae,
1	endings;
1	subdivides
1	discoidal
1	expansions;
1	corpuscle;
1	mylin
1	bodies;
1	macerated,
1	radiopacity
1	lateral-inferior
1	orbit,
1	zygomaticoalveolar
1	zygomaticotemporal
1	sutures,
1	split-lines
1	non-decalcified
1	micro-elevations
1	foramina,
1	landzert
1	127.58°,
1	113.95°.
1	skulls.
1	upright
1	base;
1	ramus
1	monkeyscebus
1	splits.
1	gallus).
1	logarithmic
1	sphenoparietal
1	emissary
1	occipital
1	sphenopetrosal
1	sinus;
1	tributaries
1	basicranial
1	base,
1	mth
1	transparent
1	hemi
1	protractor.
1	roentgenographs.
1	angles.
1	mth.
1	noted:
1	hyoid
1	arch,
1	subclavian
1	petrosal
1	drains
1	foramen;
1	facial,
1	primal
1	circa-strike
1	panicolytics.
1	(>60 µg)
1	kcn-responsive
1	(air/saline)
1	40-µg
1	(air/kcn),
1	/saline),
1	/kcn).
1	/saline
1	/kcn
1	caudoventrolateral
1	air/kcn
1	suffocation
1	bob
1	inspiration
1	socially
1	conspecific-responsive
1	juxtaparaventricular
1	regions)
1	suggesting,
1	septo-hippocampal-hypothalamic
1	confrontation.
1	canteras,
1	pavesi
1	carobrez.
1	predator3
1	(pagdl),
1	pagdl
1	paradigm;
1	subsistence.
1	rostro
1	1-3.
1	transmission),
1	antipanic
1	interoceptive
1	anticipatory
1	septo-hippocampus
1	anxiogenesis.
1	(pilo)
1	non-convulsive
1	methyl-scopolamine
1	(1mg/kg)
1	(350mg/kg)
1	(100pmol)
1	epm.
1	risk-assessment
1	head-dipping,
1	stretch-attend
1	open-arms
1	naturalistic
1	"behavior
1	column"
1	reproductive.
1	undisturbed,
1	aphagic
1	adipsic,
1	swallow
1	reject
1	(dlpag)
1	learning;
1	(ofc)
1	thalamo-cortical
1	dlpag.
1	kincheski
1	conspecifics,
1	told
1	(vlcp)
1	fibers-of-passage,
1	caudoputamen;
1	lidocaine-induced
1	cue-based
1	motivation.
1	3.5mg/kg
1	18-20
1	threat;
1	fluoro
1	adrenoceptor,
1	(ofc).
1	intra-pmd
1	(iso;
1	odorthe
1	(β-1
1	(dpag),
1	(ap5,
1	threat-induced
1	neuropsychopharmacology.
1	35.47
1	3.23;
1	2.6;
1	9.3
1	4.9).temporary
1	anxietyrelated
1	54.4
1	4.7;
1	4.1;
1	9.1).
1	post-commissural
1	inhibition-intended
1	rlpag,
1	opioid-induced
1	0.023).
1	fear-provoking
1	hipoccampal
1	flight,
1	neuroimaging
1	puerperal
1	(3.5.
1	[s.c.])
1	s.c.;
1	mm0.5,
1	mm1.0,
1	(ms
1	(sm0.5,
1	sm1.0,
1	sm1.5
1	(ss
1	(mm1.0
1	(sm1.5
1	foraging,
1	(rlpag),
1	attention-related
1	amygdalar,
1	β-blocker
1	(propranolol)
1	(nadolol)
1	pmd-fos
1	portray
1	(mhz)
1	plenty
1	food-lacking
1	involve,
1	(anti-predator
1	epitomize
1	asserting
1	interdependence
1	mouse),
1	concealed
1	predator-exposed
1	nmda-receptor
1	2-amino-5-phosphonopentanoic
1	(ap5),
1	(mptp).
1	apomorphine.
1	tyrosine-hydroxylase
1	hplc-ed
1	ipsiversive
1	contraversive
1	large-size
1	[3h]raclopride
1	[3h]sch-23390
1	snpc-lesioned
1	supersensitivity.
1	marsupial,
1	aurita,
1	(gallyas)
1	nadph-diaphorase.
1	eutherian
1	cyto-
1	3.0 mg/kg
1	curtain
1	curtain.
1	pre-training,
1	task:
1	platform;
1	pool;
1	(irrespective
1	configuration)
1	psychostimulant-induced
1	(lrs)
1	novelty.
1	discontinuation,
1	sr48692.
1	(cck)
1	neuroprotectant
1	neuroprotectants.
1	(85
1	(k/x)
1	(∼67%)
1	(∼91
1	k/x,
1	neurotoxins.
1	mpit-
1	(declarative)
1	(variable
1	start)
1	start),
1	snc,
1	1-methyl-4-phenyl-
1	1,2,3,6-tetrahydropyridine.
1	variable-start
1	constant-start
1	(psycinfo
1	apa,
1	reserved).
1	postsubiculum,
1	retrosplenial
1	momentary
1	heading.
1	supragenual
1	l-shaped
1	area's
1	(lhasfa)
1	interbrain
1	(defensive
1	(foraging
1	(septo-hippocampal
1	(projecting
1	(nociceptive
1	information),
1	foraging)
1	canteras
1	allomonal
1	nondefensive
1	footshock,
1	antipredator
1	cm-the
1	compartment)
1	hallway
1	25-cm
1	walls).
1	low-defense
1	baseline;
1	exposure;
1	incertus)
1	coeruleus).
1	incertus;
1	mptp.
1	6-ohda-
1	exploratory/motor
1	catalepsy
1	hypolocomotor
1	postpiriform-transition
1	rhomboid
1	prey's
1	taste,
1	eating.
1	predation.
1	criterion,
1	odorant.
1	1-methyl-4-phenyl-1,2,3,6-
1	tetrahydropyridine
1	(da).
1	(submersed)
1	online-maintained
1	exemplar
1	emotionality
1	(typically
1	freezing),
1	unconditioned,
1	painless
1	sequellae.
1	predator-induced
1	defense-related
1	psychopathologies
1	describe,
1	non-dopaminergic
1	collicular
1	tectonigral
1	dopamine-containing
1	discriminations
1	opiate's
1	electroacupuncture's
1	(36s)
1	(tail-flick
1	(immo)
1	(eanp)
1	immobilisation,
1	non-acupuncture
1	(vlpag),
1	non-point.
1	endorse
1	gray's
1	underlain
1	drivers,
1	confrontation
1	cat).
1	fos-labeled
1	reflect,
1	electroacupuncture.
1	180-230
1	animals/subgroup).
1	c-fos-immunoreactive
1	cells/10,000
1	μm2.
1	immobilization-induced
1	(mptp),
1	0.4μl
1	striatal-dependent
1	(sp),
1	pro-aversive
1	fk888,
1	'per
1	se'
1	ls.
1	task)
1	maze),
1	maze).
1	levodopa
1	a(2a)
1	(pmd).
1	subserving
1	mptp-induced
1	(crh)
1	crh,
1	extrapituitary
1	cortex),
1	raphé)
1	phase-contrast
1	origination
1	(outer
1	apical)
1	(onl/opl);
1	traverses
1	onl,
1	onl/opl
1	cones.
1	1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine
1	(unconditioned
1	ucs)
1	(conditioned
1	cs)
1	ucs
1	amnesia
1	retinoceptive
1	precomissural
1	tegemental
1	rostrodorsomedial
1	subcuneiform
1	fos-labelled
1	(darting
1	darting
1	phaseolous
1	vulgaris-leucoagglutinin.
1	intrahypothalamic,
1	intermix
1	parastrial
1	perisuprachiasmatic)
1	through,
1	innervates,
1	sparse,
1	parastrial)
1	mammillary).
1	phaesolus
1	(ventrally);
1	(bst)
1	telencephaon;
1	thalamus;
1	raphé.
1	autonomic‐related
1	anteroventral,
1	parts)
1	hypotha
1	lamic,
1	dorsomeclial,
1	ventrolaterally
1	(tu)
1	(pha‐l).
1	premamillary
1	accurmbens
1	piriform‐amygdaloid,
1	entorhinal,
1	postpiriform
1	massive,
1	peripeduncular
1	pontine,
1	gigantocellular,
1	paragigantocellular,
1	(ahn)
1	(pha‐l)
1	septofimbrial
1	fimbria;
1	peduncularis.
1	ahn,
1	interanterodorsal,
1	medullaris
1	descends
1	caudalmost
1	bilateral,
1	considerably.
1	fornix;
1	hunger,
1	thirst,
1	septotemporal)
1	(bst),
1	re‐examined
1	alveus
1	piriformamygdaloid
1	bst
1	fornix,
1	“shell”
1	cell‐poor
1	generator.
1	ascends
1	inputs‐one
1	hormones‐and
1	feed‐forward)
1	(periventricular)
1	feed‐back)
1	circuit.©
1	cortico‐amygdaloid
1	amygdalo‐hippocampal
1	olfactory‐related
1	endopiriform
1	medially
1	ca.;
1	peduncularis;
1	mineralocorticoid)
1	obvious.
1	vb
1	conclusive.
1	kinase/signal
1	(jak/stat)
1	egr1,
1	-42-bp
1	anti-egr1
1	promoters;
1	incubator
1	7.21±0.02)
1	(6.95±0.07)
1	(7.11±0.03)
1	(6.86±0.01)
1	-466
1	-153
1	localised.
1	alike,
1	nhe3:
1	okp,
1	10-11m
1	cis-elements
1	(5'fs),
1	-85
1	-33,
1	consensual
1	-1196
1	-467
1	-152,
1	-479
1	-152
1	5720.
1	atll
1	(htlv-i)
1	challenger.
1	(tcr-β)
1	htlv-i-negative
1	post-thymic/mature
1	tcr-β
1	beta-chain
1	(tcr-beta)
1	(htlv-i)-positive
1	unconfirmed
1	bank,
1	vbeta-5
1	vbeta-8
1	glucocorticoid-receptor
1	(grα)
1	standard-curve
1	precision.
1	(coefficient
1	variation)
1	0,990
1	acyclovir
1	(acy)
1	phosphaturia
1	pediatric)
1	non-aids
1	bw/d
1	sodium/potassium/phosphate
1	na-pi
1	(na-pi-iia)
1	(nkcc2).
1	(aqp2)
1	hyperphosphaturia
1	hypophosphatemia
1	hyperphosphaturia.
1	10-6m
1	blockers:
1	u-73122
1	ro-31-8220
1	kn-93
1	(ca2+/calmodulin-dependent
1	go-6983,
1	α/γ
1	go-6983
1	u-73122.
1	erythrophoroma
1	phosholipase
1	melanogenesis
1	neopterigian
1	(holostei
1	teleostei),
1	lightening),
1	tetrapods,
1	darkening).
1	isoforms:
1	iota
1	(carassius
1	auratus
1	erythrophoroma),
1	(amphibian)
1	melanophores;
1	tetrapod
1	adrenalectomized,
1	adrenalectomized-aldosterone
1	(adx
1	h+transport
1	adrenalectomized-corticosterone
1	22,162±1828
1	units/min;
1	37,020±2722;
1	42,344±3044
1	(p<0.01
1	others).
1	corticosterone-replacement
1	abundance;
1	swell
1	hyposmotic
1	5-hydroxydecanoate,
1	diazoxide.
1	∼140
1	nmol·min
1	-mg
1	atp-inhibited
1	hybridization;
1	chaperones/chaperonins
1	ischemia;
1	preconditioned
1	symbol
1	slc9a1)
1	exon,
1	798
1	tata-box,
1	c)-boxes,
1	homopyrimidine
1	(llc-pk1),
1	708
1	orientation-dependent
1	growth-factor-activatable
1	(2448
1	(726
1	(128
1	highes
1	(ar)-expressing
1	intromissions,
1	intromission
1	ejaculations,
1	ill-developed
1	female-type
1	regions/tracts.
1	(nei,
1	amide)
1	somas,
1	(ihy,
1	incerta)
1	(dl-plh)
1	nei/th
1	(trh-r1)
1	(plh)
1	(hpt).
1	plh
1	dysthyroidism
1	neuromodulation,
1	parkinson’s,
1	huntington’s,
1	ailments
1	arousal-promoting
1	dam’s
1	orexin–fos
1	corticotrophin
1	ucms,
1	stress/anxiety:
1	amygdalas
1	ddr.
1	bnst
1	grey.
1	wings
1	panicogenic-like
1	(wpns)
1	sleep-promoting
1	dominance,
1	“switch”
1	<1%
1	co-release
1	[mpoa],
1	pmch
1	mpoa.
1	intra-dmh
1	crfr2-modulating
1	antisauvagine-30
1	panicolytic-like
1	urocortin-2
1	2-b.
1	turbecle,
1	paramediam
1	wake–sleep
1	derives.
1	hypothalamic-mediated
1	sexual,
1	coordinator
1	hypothalamic-dependent
1	(crfr2)
1	sub-effective
1	2-b,
1	crfr1,
1	(mpoa),
1	56)
1	(ws
1	(lha
1	ihy).
1	suckling-induced
1	reward.
1	[acb]
1	acb;
1	inputs?
1	[mch-ir]
1	[fluoro-gold®
1	fg®]
1	[shell
1	core],
1	[gaba]-ir
1	[chat]-ir
1	[acbsh].
1	acbsh,
1	[ihy],
1	double/single
1	[.
1	5.33
1	0.66/16
1	0.93,
1	33.33%]
1	(aa-nat).
1	(he)
1	duct-ligated
1	(bdl),
1	anxiety-mediating
1	(ucn1)
1	(ucs)
1	fos-ir)
1	crf-containing
1	ucn1-containing
1	ucs.
1	fos-ir,
1	crf/ucn1
1	(ikkε)
1	cayman10576
1	tbk1,
1	irs-1ser307phosphorylation
1	ir/irs-1/akt
1	action/signaling
1	glutamic-acid-isoleucine-amide
1	(hypot,
1	(hypert,
1	l-t4
1	surge.
1	(p-pm),
1	(p-am).
1	hypert
1	(peflh)
1	p-pm.
1	(ovlt
1	avpv).
1	energy-homeostatic
1	(lateral
1	thwarting
1	'lean'phenotype
1	vale's
1	2012),
1	tirelessly
1	falter.
1	ganglion;
1	peptide-producing
1	interpositus
1	bda
1	1-immunoreactive
1	eponymous
1	accommodation.
1	consumptive,
1	(iii),
1	confusing.
1	connectivity.
1	(ewpg)
1	projecting,
1	(ewcp)
1	6-hydroxytrypargine
1	(6-ht)
1	alkaloidal
1	tetrahydro-β-carbolines
1	(thβc)
1	bistriata.
1	monoamine-oxidase
1	(mao),
1	hallucinogenic,
1	tremorigenic
1	spiders;
1	fos-protein,
1	immunehistochemistry
1	free-magnesium
1	cerebro-spinal
1	(acsf).
1	trypargine,
1	sub-types
1	rglu2/3
1	nmr1,
1	"brain
1	slices"
1	epileptogenic
1	epilepsy-prone
1	wistars.
1	gd-hilus
1	radiatum
1	pyramidale
1	bc1-/-
1	bc1,
1	(nge)
1	(rodents,
1	primates).
1	prosencephalon,
1	mch/nei,
1	(mch-ir
1	nei-ir)
1	overarching
1	lha.
1	(anatomical,
1	hodological,
1	data)
1	hypothalamic-pituitary-thyroid
1	(hpt)
1	6-propyl-1-thiouracil
1	postinduction
1	eminence-arcuate
1	(pituitary-adrenal)
1	stresslike
1	neurobiology.
1	universe
1	urocortins),
1	(crfrs),
1	ligand-containing
1	crfrs,
1	clarifying
1	gamut
1	(war)
1	epileptic-prone
1	epileptogenesis,
1	semiology,
1	amygdale,
1	eeg,
1	(dg).
1	(glur2),
1	α-amino-3-hydroxy-
1	5-methyl-4-isoxazoleopropionic
1	splice-variant
1	subfields
1	p77pmc
1	surface-expressed
1	striatopallidum,
1	thalamic,
1	circuits/regions.
1	(clenching
1	grinding
1	sleep).
1	(regio
1	myoclonic
1	(jme)
1	efhc1.
1	1-dayold
1	jme.
1	neuropeptide-glutamic
1	neuropeptide.
1	lys129-arg130
1	arg145-arg146
1	amidated).
1	nge,
1	gonadotropes.
1	(crns)
1	loud
1	(mot7).
1	conjunction:
1	fluoro-gold,
1	levator
1	auris
1	connection,
1	auditory-responsive
1	crns.
1	mot7
1	subnucleus.
1	hypophagia.
1	(100 μg/kg)
1	6 days
1	prepro-mch.
1	sparsely,
1	ovariectomized;
1	brainstems
1	riboprobe.
1	(ldt)
1	(acetylcholine
1	enzyme).
1	14-amino
1	prepro-melanin-concentrating
1	(ppmch).
1	forebrains
1	benzoate,
1	sesame
1	terminal-like
1	ways:
1	neurohormones.
1	soiled
1	bedding.
1	(olfactory)
1	apt
1	(nadph-d)
1	dysgranular
1	oap.
1	non-pyramidal.
1	(17.24 ± 1.73 μm)
1	infragranular
1	(9.83 ± 1.03 μm),
1	markedly.
1	araneidae
1	β-carboline
1	bistriata,
1	'cerrado'.
1	1-4-guanidinobutoxy-6-hydroxy-1,2,3,4-tetrahydro-β-carboline,
1	pwtx-ii.
1	(ld50=
1	12±3
1	ηg/mg
1	honeybee),
1	(ld50=9.75
1	enacted
1	(mo5).
1	encircled
1	corticofugal-mo5
1	dyskinesia
1	mo5,
1	catecholamine-processing
1	oralfacial
1	chromatography-
1	(lc/esi-ms).
1	proceeded
1	leptin-related
1	neuropeptide-like
1	carboxy-terminus
1	'teneurin
1	peptide'
1	(tcap).
1	carboxy
1	tcap-like
1	teneurin-1
1	mouse/rat
1	low-anxiety
1	high-anxiety
1	tcap
1	tcap,
1	emotionality.
1	cart-derived
1	long-form
1	splice-variant.
1	cart.
1	dual-
1	proestrous
1	premammillary.
1	immunohistochemistry/in
1	intermingle
1	(ewn)
1	wing
1	mesodiencephalic
1	distributionof
1	chat+
1	ucn+
1	transcondylar
1	magnum.
1	(evandro
1	hung
1	wen
1	helder
1	tedeschi)
1	cadaveric
1	cholecystokinin.
1	comments
1	matured.
1	mother-infant
1	dopamine-mediated
1	thresholds.
1	mentioned.
1	normative
1	crf-r1.
1	lobe.
1	'mismatches'
1	reconciled.
1	(lha),
1	mch-gene-overprinted-polypeptide
1	(mgop).
1	mgop-processed
1	mgop.
1	mgop-immunoreactivity
1	mgop-expressing
1	zi/lha
1	numerous,
1	putamen,
1	lha/zi
1	nursing,
1	corticotropin-
1	(crf-rs),
1	crf-rs)
1	crf-stimulated
1	activational
1	crf-r,
1	(crf)-related
1	(crf-r2).
1	(lso),
1	colchicine-treated
1	lso,
1	precerebellar,
1	lso
1	crf-r2,
1	seats
1	piscine
1	integration;
1	crf-r2-expressing
1	diamidino
1	(dy).
1	dy
1	septum/diagonal
1	(ms/dbc)
1	(spcd),
1	ms/dbc,
1	dbc.
1	spcd,
1	37.15%
1	(zim),
1	lha(p),
1	20.2%
1	nei-
1	spcd.
1	pallidus.
1	rostrocaudally
1	diamino
1	benzidine
1	origin(s)
1	tb-filled
1	(zim)
1	(lhat).
1	lhat
1	tracer-filled
1	nei-ir.
1	primary,
1	mch(m)-gene(g)-
1	overprinted(o)-polypeptidc(p).
1	mgop-
1	mch-specific
1	peptide(s)
1	pro-mch
1	(crf),
1	brain1,
1	responses2.
1	sauvagine
1	homologues3
1	4,5.
1	urocortin,
1	(63%
1	adrenocortico-tropic
1	receptors6-9,
1	corticotropes.
1	receptors10-13
1	nonadecapeptide
1	melanin‐concentrating
1	prepro‐mch
1	(ppmch)
1	nei),
1	(nge),
1	cross‐reactivity
1	α‐msh,
1	grf
1	tegmentum
1	conformed
1	interanterodorsal
1	mch‐stained
1	apparatus;
1	nei‐stained
1	dense‐cored
1	ppmch‐derived
1	incerto‐hypothalamic
1	sp-immunoreactive
1	transport-immunohistochemical
1	peduculopontine
1	catecholamine-synthesizing
1	knife
1	so;
1	inhibin
1	(iβ),
1	somatostatin‐28
1	(ss‐28),
1	)nts(
1	(pvh).
1	iβ‐stained
1	enk‐positive.
1	enk
1	minimum:
1	maximum:
1	1127)
1	(rmch)
1	165
1	peptide-a
1	rmch,
1	nei,
1	amsh
1	hgrf-(1−37)
1	dorso-lateral
1	maternity
1	study),
1	4697
1	study).
1	3650
1	exposure:
1	4291
1	3882
1	[30.7%]
1	[36.6%]
1	[8.1%]
1	[7.3%]
1	3.15;
1	1.52-6.53;
1	p = .002;
1	1.91;
1	1.21-3.04;
1	p = .006).
1	(sdf2)
1	labor,
1	hofbauer
1	histiocyte-like
1	envelop
1	deciduitis
1	uncommitted
1	syncytiotrophoblasts.
1	cd74.
1	hypoxia/re-oxygenation
1	(rmif)
1	apoptosis-inducer
1	4-(trifluoromethoxy)phenylhydrazone
1	h/r-exposed
1	anti-cd74
1	mif/cd74
1	offsprings.
1	mismatched
1	losses;
1	tobacco-associated
1	mainstream
1	congestion,
1	hyalinization
1	walls,
1	hemosiderin.
1	vitality
1	intercurrences
1	prematurity
1	gestations.
1	gestations
1	(37-39
1	(csa,
1	62.5,
1	125,
1	1250
1	(aza,
1	aza-treated
1	aza/125
1	<.05),
1	knots
1	(24-48
1	sflt1
1	csa-treatments
1	ops,
1	chlorpyrifos
1	(cpf),
1	insecticides,
1	syncytiotrophoblast-like
1	β-hcg,
1	abcg2,
1	100 μm.
1	maternal-placenta
1	porphyrias,
1	(same).
1	coproporphyrin
1	carbonyls,
1	therapeutic-driven
1	xavier-neto
1	hematogenic
1	fvb/nj
1	immunodeficient,
1	gastrulation
1	embryos/fetuses.
1	(second
1	humans)
1	post-coitum
1	(dpc)
1	7.5–9.5
1	intra-amniotic
1	embryos/fetuses
1	(iugr),
1	harbinger
1	arthrogryposis,
1	zikv-induced
1	teratogenesis
1	gastrulation,
1	neurulation
1	krüppel-like
1	(klf6)
1	endovascular
1	klf6.
1	sublocalized
1	(sdf)
1	2l1
1	arabidopsis,
1	second-trimester
1	(ctbs)
1	cells-ctb
1	bewo-also
1	(bip)
1	protein-associated
1	placental-related
1	(pi3k)/akt
1	(mdm2)
1	normoglycemia
1	(nd;
1	(mgh;
1	(gdm;
1	(dm2;
1	ape1)
1	ber.
1	ape1,
1	fen1).
1	hyperglycemia-associated
1	participated,
1	(mgh),
1	(gdm)
1	(dm2).
1	immunolocalized.
1	0.0190),
1	0.0228).
1	0.0150).
1	preimplantation
1	preimplantational
1	(treated
1	[tf]:
1	tf-d4
1	(tf-d5)
1	[cf]
1	tf-d4,
1	number/embryo)
1	cf-d5
1	developed)
1	cf-d5.
1	trophoblast-like
1	saa-induced
1	syncytialization
1	βhcg
1	syncytialization.
1	placentae,
1	evt.
1	sandri
1	anchorage,
1	spiral
1	talks
1	placenta.methods:
1	amniochorion
1	ascertained.results:
1	cytokeratin-7
1	(ck-7),
1	(hla-g1),
1	ck-7
1	hla-g1.
1	invasiveness)
1	culturing,
1	(tgf)-beta,
1	modulator.conclusions:
1	explant-derived
1	gestations,
1	borbely
1	carla
1	letícia
1	bandeira
1	cripto-(cr)1
1	placentas:
1	densely-compacted
1	accreta
1	increta
1	0.000
1	percreta
1	(accreta,
1	0.0001,
1	cr-1-producing
1	(sdfs)
1	sdf1
1	sdf4
1	chemokines;
1	sdf5
1	sdf2l1,
1	reticulum-stress
1	inducible-gene.
1	sdf2l1)
1	er-stress.
1	anti-sdf2
1	sdf2,
1	er-resident
1	sdf2-like.
1	motifs;
1	er-stress,
1	jusciele
1	brogin
1	moreli
1	hyperglycemia.when
1	overwhelm
1	generations.these
1	reviewaims
1	ofdnadamage
1	integrity.while
1	adulthood.hence,
1	practice,maternal
1	controlmay
1	mole,
1	choriocarcinoma.
1	mif's
1	dialog.
1	porcine,
1	ovine,
1	spatially-dependent
1	dialog
1	ifpa
1	intraperitoneally),
1	socialization
1	autistic
1	xenarthra
1	eutheria,
1	perceptions
1	anteaters,
1	context.methods:
1	intermingled.
1	mess
1	pgf,
1	flt1/kdr
1	decidual,
1	microbiocidal
1	exclusively,
1	48hr
1	cytokine-enriched
1	lysosome-endosome-like
1	partake
1	analised
1	(flt-1)
1	vegf-receptor
1	vegf/vegfr
1	hypercapillarization
1	disturbance.
1	counter-regulating
1	pregnancy.methods:
1	17.5.
1	days.results:
1	(gd7.5),
1	(gds
1	10.5-17.5),
1	proceeded.
1	gd13.5
1	0.048)
1	0.009).conclusions:
1	three-layered
1	(giant
1	zones),
1	faria
1	hubrecht
1	(1889)
1	nutritive
1	histotrophic
1	ubc
1	deliveries.
1	apoptotic-associated
1	constitutive.
1	predominate,
1	histochemistry/immunohistochemistry
1	(nadph)-oxidase,
1	endotheliochorial
1	hematoma
1	hematoma,
1	territorially
1	q6/sulfhydryl
1	(qsox)
1	e13.5,
1	e16.5
1	mesoderm-
1	ectoderm-derived
1	endoderm-derived
1	developmentally-regulated,
1	metastasize
1	arrived
1	inoculation:
1	resorptions.
1	pro-gestational
1	(stag).
1	stag,
1	(spn),
1	mif.
1	autocrine/paracrine
1	homeostasis;
1	disabilities,
1	term-placentas
1	babies,
1	tunel/bcl-2
1	(tgc)
1	(endoreduplication)
1	mitoses.
1	347
1	term)
1	tgcs
1	lobulated
1	feulgen
1	argyrophilic
1	(agnors)
1	agnors.
1	347.
1	acytokinetic
1	centrioles
1	polyploidizing
1	irregular.
1	restitution
1	bubalis,
1	bnc-specific
1	placentomal
1	(2-10
1	2-3-month
1	ultrastructurally,
1	exportation.
1	lactogen,
1	protein-i,
1	dolichos
1	vicia
1	villosa
1	bncs.
1	trinucleate
1	(ifats)
1	conjugates:
1	(guinea
1	anti-maned
1	-fluorescein
1	[fitc]),
1	(rabbit
1	anti-dog
1	-fitc),
1	-fitc).
1	(69.5%),
1	(74.6%),
1	(71.2%)
1	a-fitc
1	outermost
1	mouse-trophoblast
1	cone-derived
1	anti-ifn-gamma
1	(mrifn-gamma)
1	mrifn-gamma
1	ifn-gamma-induced
1	receptor-mediated.
1	beta-chains
1	beta-chain,
1	inflammatory/immune
1	albieri
1	midwestern
1	(ei).
1	zoos.
1	(91.7%)
1	toxics
1	parathion
1	direct,
1	maternal-placental
1	pacos.
1	op,
1	interdigitation.
1	apposition.
1	continues,
1	extensive.
1	vascularized,
1	indent
1	camelids
1	pacos,
1	(acp)
1	larger.
1	(akp)
1	-page
1	plh-like
1	areolae,
1	iron-storage
1	trophoblast-epithelial
1	interdigitation,
1	akp
1	indented
1	micro-regional
1	histiotrophic
1	perorally
1	me49.
1	abortifacient,
1	(dop),
1	ninth
1	organogenesis.
1	uterotrophic
1	receptivity
1	camel-llama
1	apposing
1	camels
1	camel
1	avidin-peroxidase
1	n-glycan,
1	n-glycan
1	glycan-glycan
1	cooled
1	falls.
1	warming.
1	(eg)
1	nonfrozen
1	embryos;
1	cryoprotectant,
1	(nitrogen
1	vapor),
1	cytochemically
1	pre-implanting
1	vascularity.
1	cmrl
1	1066
1	chemotactic-like
1	p30)
1	p30-
1	trails
1	blastocyst-endometrial
1	outgrowths
1	b/matrix
1	(mmp-9).
1	nothern
1	promoter/luciferase
1	alloplasma
1	fresh,
1	(c3)-depleted
1	tcs,
1	phagosomes/tcs.
1	c3-complement
1	c3b-bound
1	c3b-receptors
1	thermosensitive
1	c3-c3b
1	pmn-depleted
1	all-trans-retinal
1	phagosomic
1	erythrophagosomes
1	(tgc).
1	tgc,
1	macrophaes,
1	wer
1	recipeint
1	collosus,
1	trespass
1	embryomaternal
1	trophblast
1	luminol-sensitized
1	all-rra/w-retinal
1	dihydronicotinamide
1	dinucieotide
1	(nadh)-dependent
1	means,
1	blastocyst‐endometrial
1	embryo‐maternal
1	identifiable.
1	insinuating
1	mesometrially
1	antimesometrially,
1	habitually
1	fibrilar
1	microfibrils
1	eight‐days‐old
1	(hn)
1	(nhn).
1	nhn:
1	nonphagocytic
1	well‐developed
1	above‐mentioned
1	sulphosialomucin.
1	1978,
1	[1-(n)-3h]-phytol.
1	chromatography–mass
1	nitisinone,
1	database:
1	[leishmania
1	mhom/gt/2001/u1103]
1	(cbz28005.1).
1	cytotoxicity;
1	hydroxy-naphthoquinones.
1	hydroxy-naphthoquinones
1	chloroquine-resistant
1	(dd2),
1	483.5
1	714.9
1	315.8
1	532.6
1	nbd-phosphatidyl
1	nbd-glccer
1	nbd-acylated
1	glcdhcer
1	nbd-glcdhcer
1	nbd-pc
1	glucosylceramidesynthase
1	biosynthesize
1	inositolphosphoceramides,
1	glycosylinositol
1	perillyl
1	(poh)
1	anka-induced
1	20–37
1	(3d7),
1	microhaemorrhage.
1	inflammation/damage
1	synthase/geranylgeranyl
1	(n-bp),
1	α-tocopherolquinone
1	438,000
1	scented
1	food-flavouring
1	1000 mg/kg/dose
1	>99%
1	(oral)
1	(inhalation)
1	inhalation-treated
1	(p > 0.05).
1	di-o-methylation
1	squalestatin,
1	uredovora,
1	supra-additivity
1	cosmetics,
1	flavoring
1	0.010-5.
1	0.0017
1	0.0035.
1	peltatum
1	o-acylation
1	o-alkylation
1	1,2-o,o-diacetyl-4-nerolidylcatechol
1	[1-(n)-<sup>3</sup>h]geranylgeranyl
1	diester
1	2-o-benzyl-4-nerolidylcatechol
1	blood/blood
1	glycome
1	n-azidoglucosamine
1	glycolipidic
1	2-c-methyl-d-erythritol-4-phosphate
1	carotenoids,
1	biosynthesised
1	50]
1	prenylation
1	[m+li](+)
1	pm),
1	esi(li(+))-ms
1	esi(li(+))-ms/ms
1	na235so4
1	sulfoglycosphingolipids
1	saponification,
1	spf1
1	degradations
1	sulfolipidic
1	nor-harmane
1	disulfated
1	20:1
1	c18:0
1	(ppmp)
1	sulfoglycolipid
1	sulfoglycolipidic
1	sulfoglycolipids
1	solanesyl-diphosphate
1	polyprenyl-diphosphate
1	ubiquinone-9
1	(uq-9),
1	ispb
1	punctuated
1	dikinase,
1	glycosomes.
1	glycosomes
1	uq
1	reoxidation
1	(rp-hplc)
1	sulfonium-salt
1	[3h]ggpp
1	21-28-kda
1	electrospray-ionization
1	[35s]cysteine
1	[m
1	li]+
1	[lod]
1	ρm),
1	esi(li+)-ms
1	esi(li+)-ms/ms
1	polyprenol
1	plasmodiumfalciparum
1	linalool,
1	[1-(n)-
1	triammonium
1	([3h]fpp)
1	linalool
1	udp-[14c]glucose
1	glycosylate
1	dihydroceramide.
1	(ppmp).
1	monohexosylceramide,
1	trihexosylceramide
1	tetrahexosylceramide
1	ppmp
1	amazing
1	metabolism;
1	q8
1	q9),
1	waiapi
1	amapa
1	viola
1	surinamensis.
1	phenylpropanoids
1	obtained).
1	[u14c]-glucose
1	[14c]acetate
1	mevastatin,
1	3-hydroxy-3-methylglutaryl-coa
1	mevastatin
1	(uag)
1	50-55
1	50-55-kda
1	α/β-tubulin.
1	argentinean
1	nne
1	6.0;
1	4.5;
1	5.1;
1	trypomastigote-shed
1	skepticism.
1	a-sepharose
1	n-glycanase®,
1	200-30
1	(ribonucleoproteins
1	[rnps])
1	(immunoblot)
1	(cardiomyopathy
1	megaviscera).
1	doubtful
1	vivax:
1	cruzi-derived
1	antigen-capture,
1	(m(r))
1	(pi):
1	6.4-6.27;
1	5.2-4.8;
1	5.1-4.8.
1	100°c
1	(b2/5)
1	urines
1	(iso-
1	(150—
1	(nitrocell-mr,
1	polychaco
1	argentina)
1	"latex"
1	esferocell
1	(esferocell-mr,
1	polychaco).
1	pis)
1	5.5),
1	6.0),
1	7.0).
1	fulfills
1	conflictive
1	d-[14c]mannose
1	d-[14c]glucose.
1	tc-85.
1	mannobiose
1	β-elimination
1	n-asparaginyl
1	linkages,
1	oligosaccharide.
1	asialooligosaccharide
1	sialooligosaccharide.
1	(sag)
1	(cag)
1	parasiticidal
1	demonstration.
1	cag,
1	iodination,
1	85-kda
1	(p2-wga),
1	72-kda,
1	68-kda
1	46-kda
1	anti-p2-wga
1	immunoprecipitates
1	48-kda
1	cell‐surface
1	lectin‐affinity
1	(trypomastigote)
1	non‐infective
1	(90kda,
1	pi5.5–6.5)
1	(80kda,
1	pi5.3‐6.3).
1	concanavalin‐a‐binding
1	(70kda,
1	pi5.5)
1	components:
1	pi5.5),
1	pi5.0),
1	6(100kda,
1	pi6.5),
1	(12kda,
1	pi6.3),
1	(68kda,
1	pi6.7)
1	high‐molecular‐mass
1	pi6.3–7.5),
1	n‐acetyl‐d‐glucosamine
1	(tc‐85).
1	vertebrate‐cell‐invasion
1	4h,
1	trysin‐removed
1	cell‐penetration
1	obsereved
1	saccharides.
1	131i-labeled
1	agglutinin-sepharose
1	unnafected
1	n-acetyl-d-glucosamine
1	n-acetyl-d-glucosamine-specific
1	gm-tiih
1	precipitogen,
1	precipitogen
1	mentioned,
1	ieph
1	nussenzweig
1	goble
1	precipitogens
1	saccharides,
1	produced:
1	5,7-diene
1	ergosterol);
1	wheat-germ-
1	phytohemagglutinin.
1	nollin
1	(1977)
1	antimicrobiol.
1	chemother.
1	500-513),
1	origin)
1	isothiocyanate-labelled
1	azide.
1	ligand;
1	proved.
1	serum‐neutralizing
1	effectively.
1	106trypomastigotes
1	(nrs).
1	105trypomastigotes
1	104trypomastigotes
1	nrs,
1	106,
1	105or
1	104parasites
1	nrs.
1	ats,
1	filariasis,
1	oviparous
1	self-proteolysis
1	engorgement.
1	vectorbase
1	(vectorbase.org)
1	extra-ovarian
1	post-blood
1	ready
1	egg-laying
1	vitellogenins,
1	vt3),
1	(oti-vit-1)
1	oti-vit-1.
1	(p40),
1	100-kda
1	uniprotkb
1	almenara
1	carnivorous.
1	carnivory
1	plantaginaceae,
1	digests
1	angiosperms
1	nutrient-acquisition
1	nutrient-impoverished
1	hotspots.
1	α-proteobacteria
1	welcomed
1	understanding.
1	quinquefasciatus,
1	complex.samples
1	pipientis
1	wolbachia-free
1	wsp
1	gene.total
1	fertility:
1	rafts/fed
1	fecundity:
1	eggs/raft,
1	viability:
1	larvae/eggs.
1	lower.summarising,
1	vitellins.
1	chromatographically
1	anti-fluorescein
1	100 kda,
1	p100.
1	worm's
1	vitellin-binding
1	100 kda
1	self-assembling
1	α-methyl
1	mannoside
1	briggsae,
1	(inserted
1	codons),
1	protosplice
1	(introns
1	a/cag
1	g/a).
1	nematoda.
1	topologies,
1	hirsch-index,
1	moh-index
1	("model
1	h-index"),
1	moh-indexes,
1	formats.
1	asis&t.
1	(epns)
1	epns
1	lpp2
1	lpp4
1	lpp7
1	baujardi
1	tth
1	lpp2,
1	lpp3,
1	lpp4,
1	lpp9
1	lpp5,
1	lpp7,
1	lpp8
1	lpp10
1	cew1.
1	rhabditidae
1	dna/haploid
1	83.4%
1	7.2%
1	caenorhabditis.
1	cassette-ligation-mediated
1	rhabditids,
1	acrylamide.
1	graphs.
1	1.3%.
1	pre-mrnas
1	monocistronic
1	(sl),
1	cew1).
1	sl1
1	sl2
1	trans-spliced
1	pre-dates
1	rhabditidae,
1	regressed,
1	32.4-kda,
1	pupate.
1	a-rich
1	acs
1	replication/amplification.
1	taxon,
1	vilellogenin
1	cew1-vit-6,
1	poly(a+)
1	vit-6.
1	ce-vit-6,
1	(38-41
1	nt),
1	(vpe1)
1	vpe2,
1	ce-vit
1	ce-vit-
1	vitellogenins.
1	bothropsjararaca
1	hens.
1	190,
1	polypepüdes.
1	vitellogenin(s)
1	bothropsjararaca.
1	polypepüdes
1	anüserum,
1	(nematode,
1	rhabditida)
1	polypeptides:
1	vt1,
1	175.2,
1	a-sepharose.
1	yp115.
1	odontophrynus
1	americanus
1	(426.5
1	phosphoglycopeptides:
1	vtg1
1	207.5
1	vtg2
1	202.4
1	lipovitellins
1	glycopeptides
1	(lv1α,
1	lv1β,
1	(lv2α,
1	lv2β,
1	lv2γ,
1	phosphopeptides
1	yolk:
1	(pv,
1	phosvettes
1	(pvt1,
1	(pvt2,
1	26.1
1	220,000
1	67,000
1	55,000
1	phosphoglycopeptides.
1	silk-like
1	20,300
1	152,000.
1	contribution.
1	histones,
1	histone,
1	urea/polyacrylamide
1	labelling,
1	puffing
1	meanings
1	manners
1	(hsp70-variant)
1	acl.
1	non-variant
1	english-language
1	chapters,
1	thomaz-soccol
1	paraguay´s
1	(phlebotominae).
1	(cdc-light
1	trap)
1	terezinha
1	(sti)
1	townships
1	transects
1	stockholm
1	organization´s
1	laudable.
1	worse.
1	articulated
1	north–south
1	boundaries.
1	peru)
1	climate-related
1	continuity
1	forecasts
1	broader-scale
1	heath
1	multi-trapping
1	(center
1	cdc)
1	light-baited
1	bases)
1	"serra
1	navio"
1	shield.
1	8,685
1	captured:
1	(3,388),
1	maripaensis
1	(995),
1	anduzei
1	(550),
1	trichophoromyia
1	ubiquitalis
1	(400),
1	(291),
1	(116),
1	bichromomyia
1	anduzei)
1	maripaensis,
1	anduzei).
1	guianan/amazon
1	eurasia
1	hrm
1	eurasia/africa
1	2002-2003
1	''floresta
1	tapajós'',
1	belterra
1	difco
1	b45
1	9,704
1	flies:
1	gomezi
1	nectomys
1	(5.5×106/ml)
1	(2.8×105/ml)
1	(mbol/br/2000/cpqam95)
1	xenodiagnoses
1	passira,
1	heterogeneities
1	inoculation),
1	8.1×103(skin),
1	2.8×103(spleen),
1	8.9×102(liver).
1	18/18
1	6/18
1	squamipes,
1	rattus.
1	peri-domestic
1	species.leishmania
1	casanova
1	(avl)
1	vector.a
1	compiled.
1	chemotypes
1	2,204
1	south-easterly
1	there,
1	south.
1	(s)-9-methylgermacrene-b
1	cembrene-1
1	region.the
1	(s)-9-methylgermacrene-b.
1	at-risk
1	priorities
1	bates
1	(isops)
1	phylogenetics,
1	mcabs).
1	identifications
1	(25.6%)
1	santarensis,
1	(13.9%)
1	mcabs
1	braziliensis:
1	i-7,
1	ii-1,
1	iii-3
1	sub-specific
1	rank,
1	santarensis.
1	6pgdh
1	three-band
1	region-western
1	y.l.
1	jennings
1	evandromyia
1	evandroi,
1	gonostyle.
1	specimen,
1	gonostyle,
1	anomalies,
1	identifications.
1	phenology,
1	landsat
1	suites
1	sordelli,
1	tupynambai
1	donalisio
1	382
1	st1
1	(32%),
1	(11%).
1	st4
1	6q27.
1	fam120b,
1	sudan,
1	10-7)
1	[sem,
1	0.7])
1	dll1.
1	delta-like
1	notch3,
1	spatiotemporally.
1	april.
1	diverse:
1	l.whitmani
1	forecasting
1	occurence.
1	pecies
1	named.
1	juruti,
1	g6pd):
1	(9/12;
1	75%)
1	(3/12;
1	25%).
1	105).
1	(psychodopygus)
1	juruti.
1	recidiva,
1	scars;
1	rodents;
1	(mlee)
1	sybr-green
1	peruviania
1	quantifies
1	6-year
1	(1997-2002),
1	outpatients'
1	paulo's
1	(58.8%)
1	(seven),
1	lainsoni-like
1	(two),
1	guyanensis-like
1	(one).
1	phenomana
1	war,
1	civilian
1	immuno-suppression
1	globalization
1	0.95-1.66;
1	0.003<p<0.018)
1	(6q27,
1	7q11.22
1	17q11.2-q21.3)
1	1.08,
1	1.34,
1	1.14;
1	p=0.013,
1	0.007,
1	17q11.2-q21.3,
1	ccl16,
1	1.6mb
1	17q12.
1	83,499
1	claustrei,
1	recife.
1	paudalho.
1	complexa.
1	magnolia
1	cat's
1	nose.
1	520bp
1	map)
1	(173
1	(176
1	(192
1	(10q26.13,
1	11q12.3,
1	20p12.1)
1	1.31,
1	1.85,
1	1.78;
1	p=0.007,
1	0.0018,
1	0.0021)
1	(6p21.32,
1	17q22,
1	20p13)
1	(hla-dqa,
1	3.23,
1	p=5.8
1	10-5;
1	d17s1868,
1	2.38,
1	p=0.0005;
1	d20s889,
1	1.51,
1	p=0.004).
1	d20s889
1	d20s115
1	(151
1	words).
1	(viannia),
1	43/153
1	(nectomys
1	squamipes),
1	13/81
1	15/103
1	(bolomys
1	lasiurus),1/14
1	(holochilus
1	scieurus),
1	2/50
1	arviculoides),
1	5/37
1	albiventris).
1	12/61
1	8/58
1	2/460
1	ground-loving
1	tegumentar
1	modelling.
1	subsampling
1	random-selection
1	quadrant-based
1	unsampled
1	predictivity
1	re-emerging;
1	straightforward.
1	utingensis
1	(w
1	64°30′
1	63°00′
1	10°00′
1	11°00′)
1	85,850
1	males/
1	1/1.131.
1	hirsutus.
1	(13.1%),
1	(11.6%),
1	(10.2%).
1	2×106
1	19-29
1	inoculum;
1	post-primary
1	post-challenge,
1	post-challenge.
1	amazonensis-infection
1	seroconversion).
1	(logistic
1	0.08-0.18).
1	(<63%),
1	(24%).
1	infectiousness,
1	culling.
1	hla.
1	(dqb1
1	tnfa)
1	(87
1	638
1	individuals).
1	multi-point
1	allegro,
1	(splink)
1	(allegro)
1	(>lod4;
1	0.00001)
1	61%)
1	penetrances
1	(hladq/dr;
1	82-1/82-3/-238bptnfa;
1	lta/62/tnfa)
1	monoclonals
1	b12.
1	guyana
1	random-amplified
1	deoxyribonucleic
1	(m13-40,
1	qg1,
1	l15996
1	λgt11r)
1	(nj)
1	unweighted
1	pair-group
1	(upgma)
1	mega
1	nj
1	m13-40
1	(nyssomyia)
1	strains'
1	curtailed
1	numerous.
1	reaction-based
1	unmeasurable
1	(1166
1	fit:
1	(hla-dqb1
1	hla-drb1
1	0.0000003)
1	0.00002,
1	lta
1	tnf*1
1	(tnf*1/lta*2)
1	(tnf*2/lta*2)
1	mhc.
1	98%.
1	(78-88%)
1	0-135
1	(84%),
1	(93-100%)
1	racial
1	asymptomatic:disease
1	(824
1	(λ2s
1	signficantly
1	∼0.002.
1	pointer,
1	additive,
1	0.0017,
1	0.0002.
1	(mhom/br/89/jsc89-h1
1	mhom/br/89/jsc89-h2)
1	(mhom/br/96/lsc96-h3
1	mhom/br/97/lsc97-h4)
1	laboratory-reared
1	cured,
1	3747
1	(0.092/year),
1	lutsomyia
1	(0.81-0.87)
1	(0.0042)
1	ilhéus,
1	bahia).
1	past)
1	inter-breeding
1	demes
1	hardy-
1	weinberg
1	(n(e)m)
1	2.73,
1	1418
1	(lepac/uem)
1	(67.3%)
1	804
1	(84.2%)
1	(69.6%)
1	658
1	(68.9%)
1	males;
1	523
1	(54.8%)
1	advice
1	(7.7%)
1	ivaí
1	(10.2%),
1	doutor
1	(9.8%),
1	terra
1	(6.0%)
1	cianorte
1	serodema
1	(dcl)
1	(mcl).
1	(proliferative
1	interferon-γ)
1	pifanoi
1	p8.
1	dcl
1	gp46
1	p8
1	captive-bred
1	standardise
1	trypsinization.
1	pedigrees,
1	704
1	beta.
1	rejected,
1	pointer.
1	two-gene
1	(il8rb,
1	d2s1471,
1	nramp1,
1	excluded,
1	inbred,
1	'scan'
1	genes/candidate
1	(nramp1)
1	genes/regions
1	sib-pair
1	centimorgans,
1	centimorgan
1	megabase),
1	demonstrate:
1	(mhc:
1	man:
1	17/human
1	6p;
1	induding
1	tnfα/β
1	tuberculosis;
1	jvramp1,
1	positionally
1	ity/lsh/bcg
1	1/human
1	2q35),
1	17q
1	(candidates
1	nos2a,
1	scυra2-5)
1	scl1gene
1	't
1	(proximal
1	11/human
1	5q;
1	il9,
1	irf1,
1	cd14)
1	'mouse-to-man'
1	(dogs
1	(303):
1	(16),
1	(65),
1	(102),
1	(105);
1	(82):
1	(68),
1	salvaterra/marajó/pará
1	positive),
1	(14),
1	belém;
1	(9):
1	promastigots
1	(98.4%
1	(97.5%
1	(84.8%)
1	71.4%)
1	vl;
1	marajo.
1	(cladistic,
1	taxonomy)
1	(evolutionary
1	taxonomy).
1	cladograms
1	subgeneric
1	eco-epidemiology
1	zoonoses,
1	man's
1	lsh/ity/bcg
1	2q33‐q37
1	lsh/ity/bcg‐containing
1	markers/linkage
1	2q33‐q37,
1	(310
1	(2q33‐q35)
1	crygp1,
1	fn1,
1	tnp1,
1	vil1
1	(2q35‐q37)
1	col6a3,
1	d2s55
1	d2s3.
1	map92
1	two‐point
1	order/map
1	crygp1‐4.65‐map2‐3.45‐fn1‐5.95‐tnp1‐3.41‐vil1‐3.01‐des‐20.14‐col6a‐10.91‐d2s55‐3.67‐d2s3.
1	des‐col6a3
1	6.02),
1	(cryg,
1	fn‐1,
1	tp‐1,
1	vil,
1	col6a3)
1	(149
1	(dsl)
1	laboratory‐bred
1	man‐biting
1	willingness
1	catholic
1	membrane-enriched
1	ns-1
1	(n1-n5).
1	cross-panel
1	naiffi.
1	n5
1	n4
1	glycophospholipids
1	ponta
1	pedras,
1	oocysts:
1	1968;
1	1990;
1	unrecorded
1	13.9
1	(11.1‐16.5
1	11.1‐16.5)
1	(1.0‐1.2).
1	0.6‐1.0
1	0.75‐2.5
1	(6.0‐8.8
1	4.0‐5.7)
1	(1.2‐1.5),
1	sub‐stieda
1	10‐20
1	discernablc.
1	sympatrically
1	sau
1	3a-restricted,
1	puc
1	1316.library
1	cross-hybridizing
1	wellcomei.
1	nanograms)
1	s.s.,
1	póvoa,
1	ishikawa
1	chiropotes
1	satanas),
1	(choloepus
1	sandfly,
1	30.5%
1	(rodentia:
1	dasyproctidae),
1	tucuruí,
1	"paca",
1	paca,
1	(74·2%)
1	occasion
1	(glucantime®)
1	(51·6%)
1	immuno-inhibition.
1	pustular
1	dermis;
1	pap
1	(linn.)
1	portel,
1	1968,
1	(31.2–43.7
1	23.7–35.0)
1	(1.0–1.5).
1	2.5–3.7
1	layers;
1	brown‐yellow
1	striations,
1	one:
1	globule
1	globules.
1	(20.0–22.5
1	10.0–12.5)
1	(1.6–2.2).
1	granules:
1	zygodontomyis
1	zygodontomys
1	(lund)
1	para.
1	cylindrical,
1	(13.7–18.7
1	11.2–12.3)
1	(1.2–1.5).
1	colorless,
1	single‐layered
1	thick:
1	5.5(7.5–8.7
1	5.0–6.2)
1	(1.4–1.7),
1	enclose
1	(primates:
1	cebidae)
1	infiltrate;
1	nodules;
1	epitheliode
1	granuloma;
1	(sometimes
1	"foreign-body
1	granuloma");
1	cicatrization.
1	leishmaniotic
1	venezuelensis.
1	dies
1	subculture.
1	novemcinctus
1	(edentata:
1	dasypodidae),
1	diffco
1	(b47),
1	acon.
1	49,
1	blood-meal.
1	63,
1	110,
1	135,
1	blood-meal,
1	"metacyclic"
1	1084
1	parasite/vector
1	amazonensis/lutzomyia
1	braziliensis/psychodopygus
1	"wellcomei"*
1	*
1	lutzomyia..
1	ubiquitalis,
1	hirsutus,
1	paraensis,
1	ps."wellcomei",
1	nordestina
1	trinidadensis.
1	wild-caught,
1	"wellcomei".
1	oviposit
1	rôle
1	furcata
1	fly's
1	foregut,
1	(costa
1	lima),
1	(ready
1	al.),
1	p.s.squamiventris
1	p.ayrozai
1	(barreto
1	coutinho)
1	fraiha.
1	le.b.guyanensis
1	floch
1	lu.anduzei
1	rozeboom,
1	lu.umbratilis
1	lu.whitmani
1	coutinho,
1	p.daustrei
1	abonnenc
1	lu.pinottii
1	arouck
1	lutzomyia.
1	bite,
1	identifiable,
1	monoxenous
1	sobral,
1	populations),
1	spot)
1	spot).
1	chromatograph/mass
1	psychodidae),
1	”pian
1	bois—-type
1	mammal-baited
1	fraiha
1	terrestrial)
1	(periodic,
1	spatial)
1	trees)
1	(1700–0700
1	chagas,
1	1937
1	mpi.
1	principal,
1	oup
1	765
1	braziliensis)
1	hirsuta
1	hirsuta,
1	homes,
1	491
1	(7.14%)
1	ofl.
1	promastigptes
1	(bahia
1	states).
1	trichechi
1	figured
1	manatee,
1	trichechus
1	inunguis,
1	∼36h
1	26°c.
1	13.40
1	13.30
1	uni-layered,
1	thick;
1	8.65
1	4.62
1	recurved
1	ends:
1	ac]19821113
1	s.l.
1	climax
1	enzootics
1	light-trap
1	phletobomine
1	man)
1	native-forest
1	(drawing
1	observations)
1	rodent-baited
1	(disney)
1	non-climax
1	man-made;
1	given).
1	amazônia.
1	worrying
1	highly-disfiguring,
1	"diffuse
1	leishmaniasis".
1	(lutzomyia)
1	neiva,
1	1912).
1	cachoeira
1	arari
1	undoubted
1	chicken-houses.
1	cyclopei
1	sub-spherical,
1	23.6
1	asymmetrical,
1	pear-shape,
1	plug-shaped
1	sporocyst.
1	sporocysts:
1	uninucleate
1	meront,
1	microgamont
1	macrogamont
1	morphologically.
1	∼27.5
1	24.1
1	∼7.1
1	unequal
1	28.4
1	choloepi
1	two-toed
1	23.0
1	∼2.0
1	granule.
1	egg-shaped
1	globules:
1	recurved.
1	∼8.0
1	∼18.3
1	ac]19820212
1	gd),
1	s.l.,
1	drier,
1	sporadic,
1	thous,
1	locality.
1	wooded
1	endemics
1	enzootic.
1	unsatisfactory.
1	cure,
1	antituberculous
1	intercurrent
1	para-aminosalicylic
1	antimycobacterial
1	amazonensis;
1	saline-glucose
1	sig
1	lificantly
1	chaga’s
1	oup.
1	“pian-bois”,
1	tetradactyla)
1	marsupialis),
1	guyannensis).
1	(five)
1	whitmani*
1	(five),
1	field-workers
1	marsupialis,
1	philander
1	metachirus
1	nudicaudatus)
1	dasyprocta
1	peripylarian
1	cinctus)
1	rhipidomys
1	leucodactylus
1	(one)
1	(three)
1	culture:
1	closest,
1	edentates
1	acon,
1	acp)
1	guyanensis'.
1	mpi)
1	acp),
1	buoyancies
1	6pgdh.
1	pard
1	(z)
1	z2.
1	didelpkis
1	mar-
1	supialis;
1	cinctus
1	brevicaudata.
1	“distance”
1	zl,
1	z2
1	(zl)
1	(cyclopes
1	didactylus).
1	occasions:
1	26-28°c,
1	foodstuffs
1	beef.
1	dwelling-places.
1	enzymically
1	leishmaniae.
1	1,197
1	haematozoa.
1	varietv
1	marsuoials
1	(dideluhidae).
1	porcunines
1	(coendou
1	nobemciktus)
1	coatimundis
1	nasua).
1	1969.
1	5,319
1	suburbs
1	1:64,
1	equivocal
1	1:16.
1	(hemiptera:
1	pictipes
1	habitat:
1	danger,
1	importation
1	vector-species
1	highways,
1	haemogregarines
1	piro-plasms
1	armadillo.
1	continent;
1	infected1.
1	chemotherapy2,
1	(hemiptera,
1	problematical.
1	cardiomegaly,
1	megaoesophagus.
1	indistinguishable3,
1	prudently
1	suspected4
1	enigmatic,
1	disease6,7.
1	cross-immunity
1	panamensis.
1	complex;
1	mid-1971.
1	altamira,
1	itaituba,
1	28,000
1	logical
1	leishmanias,
1	commenced
1	1972,
1	altamira.
1	colonists.
1	2.6%
1	posts,
1	mayaro,
1	guaroa,
1	itaporanga
1	oropouche
1	cluded
1	purpura,
1	drome
1	(hsa),
1	black-fly,
1	fections
1	didelphys.
1	succeeding,
1	generation:
1	roads.
1	etrenol.
1	planorbid
1	blastomycose
1	altamira;
1	mexicoma
1	(cricetidae).
1	"coatimundis",
1	narica
1	(carnivora:
1	procyonidae)
1	tridactylus
1	(edentata).
1	didactylus.
1	fulminating
1	pneumocystosis
1	pre-existant
1	plasma-cell
1	weakened
1	adult:
1	coatimundi
1	respect.
1	(echimyidae),
1	highway,
1	standardization,
1	exo-antigen.
1	trypamosomin
1	anergid
1	arthus-type
1	uncommon;
1	uranoscodon
1	superciliosa
1	(sauria:
1	iguanidae)
1	audaciosa,
1	garnia
1	multiformis,
1	vacuolatum
1	spp.nov.,
1	uranoscodoni
1	super-ciliosain
1	eperythrozoon
1	microfilaria
1	haemosporines,
1	audaciosa
1	multiformis
1	erythroblasts
1	bone-marrow,
1	haemosporines
1	57.0
1	16.0
1	medium:
1	occult
1	229
1	blood-films,
1	10.0%.
1	1975,
1	(haemosporidiidea:
1	garniidae)
1	neusticurus
1	bicarinatus,
1	gametogony
1	thrombocytes
1	modesta
1	sp.nov.,
1	iguanid
1	hispidus,
1	thrombocytes.
1	‘exo-erythrocytic
1	stages’
1	saurian
1	toed
1	edentate,
1	sloths.
1	caryospora
1	1932
1	olfersi,
1	barcarena,
1	snake:
1	∼18
1	10.03
1	8.25
1	micruri
1	egg‐shape,
1	20.20
1	14.90
1	12.80
1	6.60
1	μn;
1	liophi
1	colubrid
1	liophis
1	cobella,
1	belém.
1	14.53
1	13.83
1	10.20
1	5.50
1	redescription
1	poecilogyri
1	1933
1	leimadophis
1	poecilogyrus
1	leimadophi,
1	snake.
1	17.09
1	16.64
1	thick.
1	pear‐shaped,
1	12.10
1	5.20
1	1973,
1	anthropophilic.
1	tribe
1	(xikrín)
1	skin-tests
1	83·9%
1	38·8%
1	14·3%
1	4·8%
1	2,701
1	rodent-biting
1	1,656
1	stressed:
1	man-biters
1	reservoir-hosts
1	bait.
1	catch
1	psychodopygus.
1	24·5%
1	daylight
1	predominent
1	ground-level;
1	topsoil
1	january.
1	"igapo"
1	"terra
1	firme"
1	loving
1	reluctance
1	fly/man
1	kinosternon
1	scorpioides
1	(reptilia,
1	chelonia)
1	sarcosporidian
1	reptiles.
1	spines:
1	poles.
1	1971,
1	erected
1	haemosporidiidea
1	(protozoa:
1	sporozoa),
1	blood-parasites
1	lizards.
1	plasmodiidae
1	haemoproteidae
1	leucocytozoidae
1	1971.
1	roncador,
1	gallery
1	forest-the
1	streams
1	rivers.
1	{a
1	presented}.
1	(nectomys)
1	histiocytomata
1	latin-american
1	brazileinsis
1	races
1	1970.
1	marmosa
1	murina,
1	outskirts
1	microdistribution
1	1,523
1	utinga,
1	(17·98%)
1	baited
1	oryzomys,
1	mangabeira.
1	(0·69%)
1	leptomonads
1	2,706
1	(0·29%).
1	ascertained.
1	1966
1	(noss),
1	(nnos).
1	dark-adaptation,
1	subtle,
1	(epr),
1	polyphenols,
1	(-)-epigallocatechin
1	(egcg).
1	blood-retinal
1	electroretinography
1	claudin-1
1	retinopathy.
1	(pkcα),
1	bipolars
1	sections;
1	nasal,
1	2900
1	10,000-12,000
1	deg
1	6,360,000
1	387,433
1	s.d.,
1	anti-pkcα
1	convergence.
1	trahiras
1	(hoplias
1	malabaricus)
1	μg/g,
1	anti-parvalbumin
1	anti-αprotein
1	(αpkc)
1	(pv-ir)
1	αpkc
1	(αpkc-ir)
1	isodensity
1	1306
1	cells/mm2)
1	(1886
1	892
1	1040
1	845
1	μg/g),
1	(1312
1	microphysiometry.
1	(div4,
1	div5),
1	α8-like
1	div4
1	div5,
1	dihydro-β-erythroidine
1	nm-2.0
1	imputed
1	white-noise
1	aural.
1	landmark.
1	hemifield.
1	deactivation,
1	deactivations
1	choline-acetiltransferase
1	calretinin/nr1-positive
1	theme:
1	topic:
1	deg/sec
1	1-1.5
1	kindly
1	bravo
1	(bristol-myers-squibb).
1	worn
1	diffusers
1	then.
1	self-motion,
1	curare,
1	saw
1	fos-labeling
1	motion-sensitive
1	a-bungarotoxin
1	(a-bgt)
1	(/32
1	a3),
1	(pkc).
1	a8-
1	pkc-like
1	(a8-li
1	pkc-li)
1	sending
1	40-53#x0025;
1	6-8#x0025;
1	s.d.;
1	#x00b1;0.8
1	#x03bc;im)
1	#x03bc;m).
1	a8-li.
1	pkc-li,
1	ampa/kainate-
1	35s-utp-labeled
1	(glur1-glur7)
1	glur3-glur7
1	inl,
1	horizontal,
1	glur1-glur3
1	semithin
1	glur1-glur3,
1	29–36%
1	5–12
1	7–21
1	9–37%
1	gaba‐containing
1	(ens),
1	s100b/rage/nfκb
1	villi,
1	nls
1	nitrite/nitrate,
1	s100b/rage/nfκb-dependent
1	3-dimensional
1	ecms
1	overlooked,
1	lagomorphs
1	decellularized
1	calcification,
1	sodium-phosphate
1	cotransporters,
1	phosphoglycoprotein
1	(mepe)
1	phosphate:
1	(nx/lp
1	(nx/np
1	(nx/hp
1	(fgf-23),
1	napi-iib
1	pit-1/2
1	mepe
1	nx/np
1	fgf-23.
1	(like
1	humans);
1	mono-layered
1	nanog
1	(th+)
1	postconception
1	unevenly
1	(tnbs;
1	ipans,
1	(neurons
1	irinotecan
1	(cpt-11)
1	(ens).
1	ens
1	mucositis.
1	(60mg/kg,
1	0.6mg/kg;
1	1.0mg/kg;
1	1.2mg/kg;
1	2.4mg/kg)
1	iba-1)
1	mucositis,
1	gliosis,
1	androgen/estrogen
1	hystricomorph
1	(p450arom),
1	17α-hydroxylase/17,20-lyase
1	(p450c17)
1	oxido-reductase
1	(cpr)
1	p450s,
1	(immature,
1	pre-pubertal,
1	post-pubertal)
1	(cyp19,
1	cyp17
1	cpr)
1	(cyp19a1
1	cyp17a1).
1	ihc,
1	p450arom
1	(leydig
1	cells/sertoli
1	s100β-positive
1	35 min
1	72 h,
1	24.1 %
1	24.5 ± 2.3 %
1	17.2 ± 2.0 %
1	post-ischemia.
1	(oversized)
1	(colitis
1	anti-huc/d
1	(pan-neuronal)
1	(pan-glial).
1	(nos)-,
1	chat-,calbindin-,
1	60 %
1	29 %,
1	21 %
1	nos-
1	20 %
1	disintegration
1	goblet
1	baishideng
1	(c57bl/6j
1	(+/+)
1	(calr).
1	calrir
1	(neuron/cm<sup>2</sup>)
1	6579
1	837;
1	4556
1	407)
1	16.5%
1	7796
1	528;
1	6513
1	610)
1	calretininir
1	og,
1	6200
1	310;
1	8125
1	749)
1	nadh-diaphorase-positive
1	(p2x2r)
1	(calr)
1	(cm2)
1	p2x2r-positive
1	(naddh)
1	p2x2r,
1	(neuron/cm2)
1	57%,
1	nnos-ir,
1	naddh
1	naddh-diaphorase
1	ileus
1	nnos.
1	outweigh
1	(bfgf,
1	fgf-2)
1	autocrine,
1	intracrine
1	fashions
1	(xii)
1	ca+2-binding
1	stumps)
1	counterstaining
1	(gfap,
1	astrocytes),
1	fgf-2.
1	nissl-positive
1	microdensitometric
1	11-day-transected
1	two-color
1	gfap/fgf-2
1	co-localization,
1	chat-ir,
1	(n);
1	(d);
1	inhibitory,
1	afferent,
1	normal-fed
1	(n42),
1	(d42),
1	protein-recovered
1	(r42).
1	esophagi
1	(nadh),
1	(nadph)-diaphorase
1	(vip),
1	n42
1	(undernourished
1	hypoproteinic
1	(normoproteinic
1	casein)
1	(63%).
1	protocols)
1	(tnbs)-induced
1	tnbs.
1	tnbs-treated
1	ablated,
1	re-epithelialisation.
1	tnbs-induced
1	ileitis
1	briefer
1	anesthetised
1	dendrites)
1	(intrinsic
1	blebbing.
1	anti-hu
1	anti-neurofilament
1	anti-calcitonin
1	(vacht).
1	(tk)-immunoreactive,
1	chat-immunoreactive.
1	chat/calretinin/±
1	coding.
1	hystochemical
1	(ache).
1	ganglionar
1	1433
1	187.71
1	120.67
1	perikaryon
1	reactives
1	216.40
1	1809.30
1	198.20
1	2096.25
1	3294.67
1	1960.33
1	526
1	elderly.
1	postnatally,
1	42 days,
1	nourishment.
1	42 days
1	maifrino
1	microm2
1	microm2.
1	(igles)
1	esophagus,
1	caecum
1	varicosities.
1	igles.
1	(pchat)
1	co-localisation
1	cchat-ir.
1	(ipans),
1	pchat.
1	interneurons)
1	pchat-immunoreactive,
1	cchat.
1	neun)
1	vasoactive-intestinal-peptide-immunoreactive
1	(non-cholinergic
1	excites
1	70-90%
1	neurotransmitter.
1	subunit-expressing
1	(nos)-immunoreactive
1	13±3%
1	npy-expressing
1	unweaned
1	(refed
1	peptide-immunoreactive
1	(no)-soluble
1	(ccr)
1	ccr
1	(pde-5
1	0.1),
1	0.12)
1	102.2
1	2.5%),
1	0.2;
1	10.2%),
1	0.1;
1	6.5%)
1	121.3
1	15.3%)
1	no-sgc-pde-5
1	injectable
1	contraceptive.
1	derivatized
1	dansyl
1	0.005−0.15
1	1008
1	16.83
1	21.07
1	0-last
1	14.07
1	6.32
1	ng.h/ml.
1	½
1	(vd/f),
1	(cl/f)
1	(mrt)
1	89.65
1	76.04
1	28038
1	9636
1	49.02
1	10.62
1	l/h
1	576.05
1	238.32
1	50 - 75%
1	0.02 mg
1	0.10 mg
1	42.7 ± 22.2 ng/ml,
1	47.6 ± 20.1 ng/ml,
1	11.32%.
1	contraceptives
1	(luts)
1	(bph).
1	tadalafil.
1	(cgmp)–pde5
1	lut
1	(bladder
1	prostate)
1	hypercontractility.
1	add-on
1	luts-bph
1	α1-adrenoceptors
1	option.
1	(gmp).
1	abf
1	(adaptive
1	biasing
1	gln817
1	(q817g).
1	gln817.
1	thiazide
1	hydrochlorothiazide/amiloride
1	counterbalances
1	hydrochlorothiazide-induced
1	disruptive
1	hexamethylamiloride
1	hexamethylamiloride,
1	(efs).
1	nerve-evoked
1	(enac)
1	(α-,
1	phenylephrine-,
1	chloride–
1	enac,
1	implication:
1	limitations:
1	enac.
1	2019;16:500–511.
1	(cgmp
1	camp)
1	pyridopyrimidines
1	5-(3,5-bistrifluoromethylphenyl)-1,3-dimethyl-5,11-dihydro-1h-indeno[2,1
1	5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione
1	(fpipp)
1	(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
1	(lactate
1	t834
1	fpipp.
1	anatomo-physiological
1	amoxicillin.
1	500 mg
1	17.03
1	5.51 kg,
1	46.21
1	38.82
1	3.32 kg/m
1	0–tlast
1	(3.5-fold);
1	percentage.
1	identifiers:
1	nct03588273
1	nanocapsule
1	(nanorap—test
1	i–iii
1	prilocaine)
1	sensation
1	quadrants
1	(57.2%,
1	41.6%,
1	38.6%,
1	37.3%
1	14.20
1	tolerability.
1	benzothiazole
1	amyotrophic
1	precise,
1	2.16,
1	riluzole.
1	significantlyshorter
1	sta.
1	(gcc),
1	uroguanylin,
1	viewpoint,
1	coli-
1	gcc-mediated
1	phenylpyrimidinone
1	sta-induced
1	mg/animal).
1	area-under-the-curves
1	280.3
1	86.1
1	805.7
1	252.4
1	12.73%
1	0.14%.
1	(efs)–induced
1	panterophis
1	guttatus.
1	frequency-induced
1	(paraganglioma
1	tumour)
1	sg1002
1	promise.
1	zofenopril,
1	atb-346.
1	chemoprevention.
1	1533-1540.
1	(ttx)-resistant
1	efs.
1	inflow;
1	penis.
1	(endothelin-1,
1	vasorelaxing
1	vasoconstricting
1	vascular-related
1	(cgmp).
1	imidazolic
1	97.3%.
1	(t½)
1	2.1-2.5
1	2.5-4.2
1	l/h/kg
1	9.0-14.4
1	l/kg.
1	(cyp51)
1	n=3),
1	n=3).
1	karl
1	5-fluorouracil,
1	thymi-dine
1	phosphorylase,
1	(150-mg
1	three-period,
1	semi-replicated
1	(rrt,
1	rtr,
1	trr)
1	capecitabine/xeloda®
1	104.34%
1	(98.74
1	110.25%)
1	103.06%
1	(97.48
1	108.96%)
1	104.07%
1	(88.13
1	122.90%)
1	xeloda®
1	2-sequence
1	tr)
1	4-hydroxydebrisoquine.
1	propafenone/ritmonorm®
1	100.44%
1	(88.39
1	114.13%)
1	99.84%
1	(90.31
1	110.36%)
1	99.30%
1	(90.08
1	109.47%)
1	ritmonorm®
1	intermediate/extensive
1	intromitent
1	penis,
1	1mm),
1	n-methyl–d-glucamine).
1	immuno-histochemistry
1	guanethidine.
1	methyl-d-glucamine
1	(nmdg)
1	ttx,
1	a803467
1	cathecolamine
1	clorana™
1	(hydrochlorothiazide
1	sanofi).
1	analytes,
1	liquid–liquid
1	auc(0–last)
1	auc(0–inf)
1	80–125%
1	clorana™.
1	(5-cyclopropyl-2-[1-(2-fluorobenzyl)-
1	1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine)
1	(4-({(4-
1	carboxybutyl)
1	(5-fluoro-2-{[40-(trifluoromethyl)
1	biphenyl-
1	4-yl]methoxy}phenyl)ethyl]
1	300 nm)
1	(70-
1	5.7-fold,
1	prostate.
1	(cyp)
1	(20–25
1	gavage),
1	spots.
1	cyp-injected
1	(nvcs),
1	7days,
1	lanza
1	endoscopies
1	outcomes).
1	endoscopists
1	0.728).
1	1005
1	129pg/ml
1	41pg/ml
1	999
1	109pg/ml
1	13pg/ml
1	-334.870
1	345.650;
1	0.975).
1	clinicaltrials.gov,
1	nct02632812.
1	(d5)
1	(50/50,
1	derivatization.
1	gemini-nx™
1	d.)
1	tibolone
1	(0-last)
1	(0-inf)
1	97.48-111.51,
1	95.35-103.20
1	96.42-103.86,
1	tablet),
1	(12-16
1	stimulation-response
1	nmol/l-100
1	n(
1	)-nitro-l-arginine
1	(100μmol/l)
1	(+13%).
1	rock1
1	lidocaine/prilocaine
1	(nanorap,
1	molluscum
1	contagiosum
1	(mc).
1	mc.
1	d-8
1	88.49%
1	81.19
1	96.46)
1	concentration/dose
1	102.55%
1	100.62
1	104.51)
1	/dose.
1	(p =.215).
1	(p =.0016),
1	(p =.4193).
1	metal-based
1	cis-[ru(bpy)
1	imn(no)]
1	(for0811).
1	(pe)-precontracted
1	112.9±10.6%.
1	(106.8±7.3%),
1	(107.6±4.1%)
1	(103.4±3.8%),
1	l-n
1	-nitroarginine
1	heme-site
1	sgc-cgmp-dependent
1	imidazole,
1	pityriasis
1	(pv).design
1	cream.
1	dermatologist
1	testing.results:
1	(22/26)
1	(25/27)
1	[effect
1	size]
1	8.0%,
1	difference:
1	8.69%,
1	-6.3
1	22.3%).
1	0.126).
1	ketoconazole-treated
1	(13%;
1	4/30).conclusion:
1	non-inferior
1	(4-({(4-carboxybutyl)
1	(5-fluoro-2-{[4′-(trifluoromethyl)
1	biphenyl-4-yl]methoxy}phenyl)ethyl]
1	(cc).
1	fours
1	(pde-5),
1	(odq
1	60-2770);
1	odq).
1	7.58
1	(0.19)
1	(4)%,
1	4.2-
1	6.3-leftward
1	(scd),
1	nocturia,
1	enuresis,
1	incontinence.
1	berkeley
1	(ss).
1	(25-30
1	(1nm-10ìm)
1	(carbachol
1	(cch;
1	nm-100ìm),
1	mm-300mm),
1	cacl<inf>2</inf>
1	(1ìm-100mm),
1	á,â-methylene
1	1-32
1	10nm-100ìm)
1	vivo),
1	dsm,
1	â3-adrenergic
1	(mirabegron)
1	â-adrenergic
1	(isoproterenol)
1	á,
1	â-methylene
1	continence,
1	enuresis
1	(2.5%)
1	(2.5%).
1	nanorap.
1	vol/vol).
1	(40/30/30,
1	50/30/20,
1	vol/vol/vol)
1	ropivacaine
1	cryofracture.
1	1.72
1	nanocapsules
1	(>30%
1	pain)
1	(α1)-blockers,
1	(bph)
1	(β3-ar)
1	(pec<inf>50</inf>)
1	(e<inf>max</inf>)
1	mirabegron.
1	(pec<inf>50</inf>:
1	6.01
1	0.12;
1	e<inf>max</inf>:
1	3%),
1	β1-ar
1	β2-ar.
1	l748,337
1	six-fold
1	(apamin,
1	charybdotoxin,
1	tetraethylammonium)
1	α1-blockers
1	heme-oxidized
1	(1mg/kg/day,
1	intracavernosal
1	(icp),
1	10-5m)
1	4-10hz)-induced
1	methylthiouracil
1	acetate).
1	(es-).
1	(4.6mm×150mm
1	methanol/water/acetonitrile
1	(40/40/20,
1	v/v/v)+0.1%
1	-60
1	(ev)
1	2.5min
1	20-5000ng/ml.
1	20ng/ml.
1	109.28%
1	(103.63-115.25%)
1	115.60%
1	(109.03-122.58%)
1	103.31%
1	(100.74-105.96%)
1	103.40%
1	(101.03-105.84)
1	(2.5min).
1	20ng/ml
1	auc).
1	tioconazole
1	(100×2.1mm
1	(80/10/10,
1	v/v/v)+ammonium
1	(0.5mm).
1	(es+)
1	415.1>159.2
1	387.0>131.0
1	tioconazole,
1	3.8min
1	0.2-100ng/ml
1	(r=0.9998).
1	0.2ng/ml.
1	±10%.
1	multiple-dose
1	antiftmgal
1	vohmteers.
1	fitzpatrick
1	emolled
1	two-treatment
1	occwred
1	(oab),
1	(usm)
1	oab.
1	[acid
1	4-({(4-carboxybutyl)
1	[2-(5-fluoro-2-{[4-
1	(trifluoromethyl)
1	biphenyl-4-yl]
1	methoxy}
1	phenyl)
1	ethyl]
1	amino}
1	methyl)
1	benzoic]
1	monophosphate)
1	(acidified
1	nitrite),
1	(s-nitrosoglutathione
1	trinitrate),
1	[5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-pyrazolo[3,4-b]
1	pyridin-3-yl]-
1	pyrimidin-4-ylamine]
1	stimulator)
1	[1h-[1,2,4]oxadiazolo[4,
1	3-a]quinoxalin-1-one]
1	usmfrom
1	obesemice,
1	male/female
1	2:1)
1	chloride-precontracted
1	(6.47
1	monophosphate-independent
1	(ecp).
1	(wp)
1	l-nitro-arginine-methyl-ester
1	wp.
1	wp,
1	semen.
1	reptile
1	sphenodon
1	cloaca-cloaca
1	mating.
1	crocodilians,
1	testudinata,
1	propulsor.the
1	(oab)
1	mucosa-intact
1	mucosa-denuded
1	(ser1177)
1	atf4.
1	3.0-fold
1	non-voiding
1	stress-dependent
1	oab
1	paracetamol
1	100%;
1	-20°c).
1	(2.1×100
1	5-400
1	(r>0.9983).
1	ng.ml-1.
1	9.6%,
1	8.9%,
1	9.2%,
1	108.9%,
1	99.9%,
1	101.1%,
1	6.9%,
1	101.9%,
1	104.1%,
1	103.2%
1	94.4%,
1	101.2%,
1	(according
1	[range]):
1	males:
1	32.40
1	[23.00-46.00],
1	[1.62-1.85],
1	72.48
1	10.22
1	[60.20-88.00];
1	females:
1	28.60
1	9.54
1	[18.00-44.00],
1	[1.54-1.70],
1	58.64
1	6.09
1	[51.70-66.70].
1	t1/2,
1	vd,
1	clast.
1	2044
1	641)
1	3.2)
1	clast,
1	15.8)
1	1-6)
1	(p=0.0136)
1	(1706
1	704)
1	ng.hr.ml-1)
1	(p=0.0205)
1	(2.91
1	1.41
1	l/hr),
1	2383
1	1.76
1	l/hr,
1	mendes
1	(qsars)
1	sta-stimulated
1	r2=0.7208,
1	q2=0.6583,
1	s=16.9,
1	f=46
1	r2=0.8986,
1	s=14.6
1	n=19,
1	r2=0.6689,
1	q2=0.5683,
1	s=17.6,
1	f=34
1	r2=0.8998,
1	s=12.1
1	r2=0.7141,
1	q2=0.6525,
1	s=14.7,
1	f=45
1	r2=0.8858,
1	s=19.5
1	set).
1	phosphodiesterase-9
1	(pde9)
1	dimethylsulfoxide)
1	nitrite;
1	pde9a
1	73-6691,
1	(8-32
1	no-cgmp-mediated
1	tolerability,
1	openlabel,
1	dose-escalation,
1	sequentially,
1	escalating
1	(amap)
1	relevancy.
1	pre-dose,
1	1.75,
1	post-dosing.
1	amap
1	prodrug.
1	0.4)
1	1.1)
1	haem-oxidized
1	haem-independent
1	(fluoforte).
1	μg/ml)-
1	u/ml)-induced
1	haem-oxidizing
1	odq-induced
1	mendes-silverio
1	obesity/metabolic
1	cystometry,
1	(pdbu;
1	0.001-3
1	gf109203x
1	detrusor.
1	leiria
1	oxide-cgmp
1	ejaculatory
1	haem-dependent
1	odq-sensitive
1	ejaculation.
1	diethyl-ether/hexane
1	(hplc-esi-ms/ms).
1	(acetonitrile/water/formic
1	(90/9/1,
1	4.0min
1	flow-rate
1	1.5mlmin
1	c18,
1	(150×4.6mm
1	200ngml
1	10ngml
1	dextrorphan.
1	9.5%,
1	88.9
1	105.1%,
1	92.2
1	107.1%,
1	4min.
1	30mg
1	hydrobromide
1	12.5mg
1	gmp-phosphodiesterase-5
1	[sgc]
1	(pde5
1	μm)-precontracted
1	(l-name,100
1	7.34
1	(66
1	(0.0001-300
1	(16.0-
1	5.2-fold
1	(41.0-
1	9.7-fold
1	right.
1	no-sgc-pde5
1	(emp)
1	(pmp)
1	emp,
1	pmp,
1	(epc).
1	(n=26).
1	(atorvastatin
1	1-3;
1	2-4).
1	(cd34+/cd133+/kdr+),
1	(cd51+)
1	(cd42+/cd31+),
1	visit.
1	[c
1	max],
1	p=0.002;
1	[auc
1	last],
1	p=0.03).
1	p=0.009;
1	p=0.039).
1	p=0.006)
1	(rho=-0.54,
1	p=0.01),
1	(rho=-0.44,
1	(cd133+/kdr+)
1	(rho=0.48,
1	p=0.025).
1	(70/30;
1	(50/50
1	v/v)+0.1%
1	(150mmx4.6mm
1	4min
1	10ng/ml
1	(r2>0.99).
1	0.05ng/ml.
1	cyproheptadine+cobamamide
1	(4mg+1mg)
1	(cobactin®
1	zambon
1	solvay
1	farma
1	formulation)).
1	mg+1mg
1	(cobactin®)
1	cyproheptadine.
1	inter-contraction
1	y27632.
1	metaproterenol
1	(non-selective,
1	3-selective
1	3-mediated
1	β-adrenoceptor-
1	(88%).
1	(diethyl
1	70/30
1	(v/v)).
1	(4.6×150mm
1	(70/30,
1	3.4min
1	0.1-60μg/ml
1	(r>0.99).
1	0.1μg/ml.
1	13.5%.
1	81.2%,
1	48.0ng/ml
1	ciprofibrate,
1	-51v,
1	-16ev
1	-5v,
1	auc0-168h,
1	93.80%
1	ci=88.16-99.79%)
1	98.31%
1	ci=94.91-101.83%)
1	97.67%
1	ci=94.45-101.01%)
1	auc0-168h.
1	auc0-168h
1	(lipless®
1	oroxadin®
1	(100mg
1	(viagra
1	tm),
1	(levitra
1	(cialis
1	5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1hpyrazolo[3,4-b]pyridin-3-yl]-
1	pyrimidin-4-ylamine
1	mg/rat/day),
1	(racc).
1	1-adrenoceptor
1	(0.01-1000
1	four-week
1	cystopathy
1	incapacitating
1	(l-vocc).
1	l-vocc.
1	formalin-fixation
1	paraffin-embedding,
1	lability
1	microwave-retrieved
1	tris-hcl
1	stellate,
1	basket,
1	tuberculoma
1	anti-inducible
1	anti-endothelial
1	anti-neuronal
1	retrieving.
1	timeless,
1	overactivity.
1	guanlylate
1	hydrochrolide
1	number/min)
1	(0.49
1	number/min),
1	025
1	number/min;
1	(27%
1	y-27632,
1	412272
1	(d-sd)
1	y-27632
1	bronchodilation.
1	5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine
1	carbachol-precontracted
1	(pec50=6.68±0.14).
1	(100μm)
1	(10μm)
1	(0.01-1μm)
1	1-32hz).
1	1μm)
1	412282
1	(0.001-100μm)
1	61.3±6.6%,
1	95.1±9.9%
1	91.7±5.9%,
1	100μm,
1	wells.
1	fura2-am-loaded
1	spectrofluorimeter.
1	(pac-1).
1	(0.01-300μg/ml)
1	cyclohexamide,
1	(peg-sod)
1	(300μg/ml)
1	7.5-fold
1	v4)
1	day-clinic.
1	d22)
1	(d8
1	d29).
1	(cone
1	technique),
1	spectrometry).
1	baseline),
1	0.005;
1	v4).
1	v3),
1	v2).
1	64544-07-6),
1	106.1
1	(100.8%-111.8
1	109.4
1	(104.8%-114.2%)
1	90%ci
1	co-generates
1	-(-)epigallocatechin
1	sin-1-treated
1	kda-nitrated
1	α-actinin-1-cytoskeletal
1	nitration.
1	betahistine
1	5579-84-0)
1	(lc-msms)
1	98.94%
1	(92.21%
1	106.16%)
1	95.42%
1	(91.74%
1	99.25%)
1	s.a.)
1	(lexapro®;
1	lundbeck
1	ltda)
1	97.35%
1	90.28
1	104.96%)
1	99.60%
1	92.93
1	106.74%)
1	99.92%
1	93.34
1	106.97%)
1	lexapro®
1	lipopolyssacharide
1	ova-challenged,
1	ng/g.
1	(pde)-5
1	transducers.
1	(107%
1	(111%
1	(4.0-fold),
1	(4.6-fold),
1	(3.2-fold)
1	chlordesmethyl-diazepam
1	(cddz
1	delorazepam),
1	cloxazolam,
1	(internal
1	standard)
1	cddz
1	(diethyl-ether/hexane,
1	80/20,
1	rp-c18
1	(1/x
1	weighted)
1	lloq
1	(0.500
1	-1.5,
1	-2.7
1	bioanalytical
1	(fda
1	anvisa)
1	(cloxazolam
1	lab.
1	olcadil®
1	s/a).
1	anvisa.
1	histamine/5-hydroxytriptamine
1	cyproheptadine,
1	pca4248,
1	intra-nasally
1	liability
1	single-blind
1	inhaled-cocaine
1	1 mg
1	liking
1	(el)
1	3.311,
1	3.947,
1	(cocaine
1	5.229,
1	0.026;
1	4.946,
1	0.030),
1	path.
1	ecnp.
1	(bis-(2-{4-[4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-benzenesulfonyl]piperazin-1-yl}-ethyl)carbonate)
1	lodenafil.
1	(0.001-100 μm)
1	(0.01-100 μm)
1	1-20 hz)
1	norlodenafil
1	prodrug,
1	5-cyclopropyl-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine
1	(u+)
1	(u-)
1	7.77
1	0.09)
1	6.84
1	0.19)
1	[4,3,-a]quinoxalin-1-one
1	(sevenfold)
1	hz),
1	odq-resistant
1	bacteraemia,
1	ninety-six-well
1	platelets)
1	glycol-sod
1	(nk-1)
1	at300
1	α.
1	(9-,
1	123-fold,
1	(1h-[1,2,4]
1	[4,3,-a]quinoxalin-1-one)
1	pde5-induced
1	vasorelaxations
1	tadalafil)
1	cacl
1	5-[2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1-methyl-3-
1	propyl-1,6-dihydro-7h-pyrazolo[4,3-d]pyrimidin-7-one,
1	(6a-v),
1	sulfonyl
1	n-4-substituted
1	piperazines
1	oxide-dependent
1	6f
1	6r
1	6u
1	pde5.
1	delayed-released
1	[dr]
1	tablet;
1	104.6540%
1	(90.8616%-120.5401%)
1	99.9708%
1	(90.9987
1	%-109.8275%)
1	95.6634%
1	(85.2675%-107.3267%)
1	89.3500%
1	(83.6630%-95.4237%)
1	80-125
1	(il-4)-type
1	dysplasia.
1	enzyme-linked-immuno-spot
1	.0001)
1	2/23
1	(il-13
1	5/23
1	metaplasia.
1	metaplasia,
1	immunopattern
1	metaplasia
1	gastroenterologica
1	s.r.l.
1	(5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]-py
1	rim
1	idin-4-ylamine)
1	non-embolized
1	embolized
1	(intravenous
1	microspheres)
1	1 mg/kg/h
1	(1 ml/kg/h
1	1.13%
1	volume/volume).
1	embolization
1	ergot
1	microsomes,
1	lc-ms/
1	1.93
1	dihydroergocornine,
1	dihydroergocryptine
1	0.98,
1	calcium-channel
1	photonization
1	(appi).
1	[m+h]+
1	appi,
1	[m-h]-
1	2-hydride
1	[m-h]-.
1	1,2-hydride
1	nitro-phenyl
1	m/z122.
1	appi
1	dihydropyridines
1	modified-release
1	electrocardiography,
1	21-42
1	years];
1	kg/m2
1	19.3-27.0
1	kg/m2]).
1	tablets,
1	auc0-last(test,
1	504.21
1	361.28
1	140%
1	121%
1	161%.
1	76.46
1	19.20
1	398%
1	316%
1	503%.
1	excerpta
1	medica
1	resered.
1	bio-equivalence
1	capsule)
1	(1):
1	(advil2
1	wyeth-whitehall
1	(itapevi,
1	(2):
1	(alivium®;
1	brazil))
1	auci
1	truntmax
1	114.24%
1	105.67,
1	123.50%)
1	,,
1	98.97%
1	94.69,
1	103.44%)
1	99.40%
1	95.21,
1	103.78%)
1	108.38%
1	100.19,
1	117.25%)
1	100.79%
1	96.39,
1	105.40%)
1	101.26%
1	96.94,
1	105.77%)
1	advil®
1	alivium®
1	phosphodiesterases
1	positive-ion
1	19774-82-4)
1	food:
1	auc0-240h,
1	auc0-72hand
1	107.61
1	(92.73-124.89)
1	100.6
1	(94.1-107.5)
1	107.05
1	(95.88-119.51)
1	107.27
1	(95.78-120.15)
1	(97.0-104.8)
1	auc0-72h,
1	106.76
1	(95.84-118.94)
1	auc0-240hand
1	105.15
1	(94.18-117.41)
1	100.7
1	(96.6-105.0).
1	auc0-72,
1	cmaxratios
1	94-20-2)
1	93.99%
1	(87.11%-101.41%)
1	92.45%
1	(85.96%-99.44%)
1	90.30%
1	(83.35%-97.82%)
1	20 mg/rat/day)
1	(30 mg/rat/day)
1	(0.001-10 μm)
1	dl-propranolol,
1	(80 mm),
1	(1-10 mm)
1	ulcerogenicity
1	aspirinate,
1	(aspirin®)
1	aspirinate
1	h-bonds,
1	(1.2 km/h,
1	5 days/week).
1	(10 nm-100 μm),
1	(100 pm-100 nm)
1	(1 nm-3 μm)
1	54%),
1	(sd/sham);
1	(sd/ir)
1	(tr/ir)
1	60 min/day
1	5 days/week
1	90 min
1	reperfusing
1	120 min.
1	(hist),
1	hist
1	tr/ir
1	(8.23
1	sd/ir
1	(7.85
1	a-adrenergic
1	(sd/ir:
1	6.75
1	tr/ir:
1	sd/sham
1	(7.33
1	(anastrozole)
1	dexchlorpheniramine
1	(i.s.)
1	i.s.
1	ether:dichloromethane
1	acetonitrile:water
1	(50:50;
1	0.05-10
1	(ncx899)
1	(auc0-24h)
1	29.18
1	4.72,
1	229.37
1	51.32
1	5159.23
1	514.88
1	nitro-enalapril,
1	auc0-24h
1	704.53
1	158.86
1	4149.27
1	847.30
1	0.1-10
1	pharmacokinetic/
1	enalapril)
1	treated;
1	metastasized.
1	hodgkin's
1	leave-one-out.
1	svm
1	(c-tr),
1	(ln-sd)
1	(ln-tr)
1	(ln-sd:
1	135±2
1	141±2
1	l-name)
1	ln-sd
1	(154±1
1	175±2
1	47±3;
1	52±1;
1	53±3%)
1	89±1;
1	98±1;
1	95±1%).
1	beagles)
1	wedge
1	(pcwp),
1	(isvr
1	mpap,
1	ipvr.
1	citrated
1	heparin-protamine.
1	(gliclazide
1	ltda.)
1	(diamicron
1	limited).
1	gliclazide.
1	diethylether
1	(80:
1	120a
1	4u.
1	0.9993).
1	gliclazide/diamicron
1	588.68%
1	491.16,
1	705.58%)
1	423.50%
1	338.25,
1	530.23%)
1	1395.77%
1	1116.62,
1	1744.72%)
1	gliclazide/
1	207.96,
1	207.96
1	188.04%
1	151.72,
1	233.05%)
1	hexane/diethylether
1	(20:80,
1	>0.9965).
1	(clonazepam
1	ranbaxy
1	rivotril
1	laboratóries
1	myotoxic.
1	insularis.
1	bintx-ii,
1	4.49)
1	13,975
1	13,788,
1	(pa2_botin,
1	swissprot
1	q8qg87)
1	his48,
1	asp49,
1	tyr52
1	asp99,
1	α-helices,
1	β-wing,
1	μg/paw);
1	bintx-1
1	biventer
1	cervicis
1	bombesin/gastrin-releasing
1	(bn/grp)
1	rc-3095,
1	twice-daily
1	ug/kg.
1	(96
1	ug/kg)
1	hypergastrinemic
1	zollingen-ellison
1	gastrin
1	grp-expressing
1	8.6-10.9
1	554-13-2)
1	genders
1	li+concentrations
1	aucinfand
1	cmaxwere
1	96.81-107.44%,
1	98.44-109.54%
1	98.60-111.33%,
1	(80%-125%)
1	bioequivalent,
1	(no)-cgmp
1	l-propranolol
1	1h-[1,2,4]oxadiazolo[4,3-
1	a]quinoxalin-1-one
1	cacl2-induced
1	(5-ismn)
1	5-mononitrate,
1	ionization.
1	(lle).
1	0.995).
1	7.0%
1	(1800
1	94.9%,
1	(bay),
1	(173±11.1
1	109±5.0
1	(112±5.1
1	vv
1	cotreatment.
1	[5-amino-n-butyl-2-(2-propynyloxy)-benzamide]
1	[5-amino-n-butyl-2-cyclohexyloxy-benzamide],
1	[5-amino-n-butyl-2-phenoxy-benzamide]
1	[5-amino-n-butyl-2-(p-tolyloxy)-benzamide]
1	post-mitochondrial
1	(s9)
1	phenobarbital/β-naphtoflavone
1	added)
1	ta1535
1	ta1537.
1	s9,
1	ta98.
1	2-19
1	pa7,
1	2-14-fold
1	(%),
1	regioselectively,
1	hydroxy-derivatives.
1	oxide-mediated
1	no-induced
1	snp-mediated
1	min)-treated
1	tyrosine-nitrated
1	(p12814)
1	nitrated
1	α-actinin,
1	(ramipril
1	aventis
1	pharma
1	(sueano,
1	36-hour
1	ramiprilat,
1	ramipril/triatec®
1	ramiprilat/triatec®
1	104.69%
1	93.21
1	117.59%)
1	102.49%
1	92.76
1	113.24%)
1	103.60%
1	93.56
1	114.73%)
1	108.48%
1	98.86
1	119.03%)
1	105.88%
1	101.55
1	110.39%)
1	97.30%
1	90.17
1	104.99%)
1	6.44
1	nω-nitro-
1	55%.
1	cristália
1	dohme
1	(82.2-105.0%)
1	(92.5-105.9%)
1	(92.7-105.8%)
1	(91.5-106.0%)
1	97.9%
1	(93.3-102.7%)
1	(93.6-102.9%)
1	discriminative.
1	0.993).
1	90.7%
1	11.9,
1	9.8%,
1	dexchlorpheniramine/betamethasone
1	mg/0.25
1	tablets.
1	1.00-500
1	quattro
1	ultima
1	intra-run
1	16.3%
1	(loq).
1	92.9
1	95.2
1	115.3%
1	loq,
1	98.2
1	100.8%
1	103.1%
1	(dhec)
1	8′-hydroxy-dihydroergocristine
1	(8′-oh-dhec)
1	(dhecm)
1	shifts.
1	(iskevert®).
1	3.50
1	5.63
1	3.34
1	13.36
1	lcms
1	inclusion.
1	μ-bondapack
1	ionization/mass
1	14,245.4
1	14,186.2
1	lmtx-ii,
1	pro65
1	(lmtx-ii).
1	behaviour;
1	35-45°c.
1	cu2+
1	zn2+
1	lmtx-i,
1	eu.
1	protein-bound
1	furaltadone,
1	nitrofurantoin.
1	derivatisation
1	(propranolol),
1	(atenolol,
1	betaxolol)
1	(aconitine
1	veratridine),
1	site-3
1	(ts3
1	toxin),
1	(ts1
1	(brevetoxin-3).
1	aconitine
1	veratridine.
1	brevetoxin-3,
1	betaxolol
1	118,551.
1	site-3,
1	(5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-
1	pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine)
1	(no)-independent,
1	6.59
1	6.19
1	4.9-
1	41-2272-elicited
1	diethyl-ether
1	(50/50;
1	0.1-200
1	0.997992).
1	(carvedilol
1	coreg®
1	químicos
1	s.a
1	coreg
1	(citalopram
1	schering-plough,
1	168-hour
1	diethylether:
1	high-perfomance
1	μn,
1	0.999887).
1	citalopram/cipramil
1	98.28%
1	(94.24
1	102.49%)
1	96.44%
1	(90.20
1	103.11%)
1	98.54%
1	(94.70
1	102.54%)
1	25812-30-0)
1	max.
1	90.29
1	(81.39-100.17)
1	96.26
1	(90.33-102.59)
1	96.04
1	(90.21-102.23)
1	auc0-24h,
1	96.62
1	(90.82-102.78)
1	0-∞.
1	adenosine-3′,
1	5′-monophosphate
1	(0.1-10.0
1	ibmx
1	ibmx)
1	ibmx-pretreated
1	ibmx-treated
1	2.0-2.5
1	(odq).
1	3-(4,5-dimethylthiazol-2-
1	yl)-2,5
1	xa-like
1	20745.7
1	bombycoidea.
1	(bn)
1	(grp),
1	small-cell
1	(d-tpi-gln-trp-ala-val-gly-his-leuψ(ch2nh)leu-nh2),
1	10000
1	(8000
1	±0.0,
1	felodipine,
1	felodipine
1	eluent.
1	(0.06
1	[6-chloro-1β,
1	2β-dihydro-17α-hydroxy-
1	3′h-cyclopropa(1,2)-pregna-1,4,6-triene-3,20-dione
1	acetate]
1	antiandrogen
1	androgenization
1	hirsutism
1	acne.
1	(100-
1	2.1-mm
1	i.d.),
1	96.2%
1	2.7%,
1	paullinia
1	(guarana;
1	sapiedaceae),
1	(catuaba;
1	meliaceae),
1	(muirapuama;
1	olacaceae)
1	officinale
1	(ginger;
1	zingiberaceae)
1	aphrodisiac.
1	nonadrenergic
1	indomethacine
1	48.9
1	6.4%)
1	(52.7
1	58.6
1	5.6%).
1	7.1%;
1	(62.7
1	26.8
1	3.9%;
1	ca-channel
1	blockers)
1	59.3
1	5.2%).
1	katp-channel,
1	phentolamine-mediated
1	1.4%;
1	nonadrenergic-noncholinergic
1	katp-channel.
1	(hplc/ms/ms).
1	1.0-1000
1	0.999427).
1	(ticlopidine
1	brasil,
1	sanofi-synthelabo,
1	(benzocaine),
1	(lidocaine)
1	(bupivacaine)
1	phosphatidylcholine:cholesterol
1	bupivacaine
1	benzocaine.
1	oasis®
1	spe
1	(60:40,
1	triethylamine.
1	2.00-200
1	(cv%)
1	6-cyclopentyladenosine
1	n-ethylcarboxamido-adenosine
1	(neca)
1	n6-(3-iodobenzyl)-5′-n-methylcarbax-amidoadenosine
1	(ib-meca)
1	(6.10
1	5.66
1	1-(5-isoquinolinesulfonyl)-2-
1	methylpyperazine
1	(h7;
1	50-200
1	inactivator
1	significantly)
1	(ipla2),
1	arachidonil-trifluoromethyl-ketone
1	(atk;
1	0.2-20
1	neutrophil-stimulated
1	2-am.
1	atk
1	(atp)-dependent
1	transducer.
1	1-minute
1	intervals)
1	opener
1	cromakalim
1	post-ova-challenge.
1	fibronectin-covered
1	103577-45-3)
1	acetonitrile/
1	water/methanol
1	(57:25:18;
1	5.0-5,000
1	quadrapole
1	-5.0
1	(ultra-run)
1	(inter-run).
1	pantoprazole.
1	{2-[(5-nitro-2-furanyl)methylene]-
1	hydrazinecarboxamide},
1	salted
1	2-nitrobenzaldehyde.
1	nitrophenyl
1	chromatography-tandem
1	sub-plantar
1	adrenallectomized
1	45.4%
1	cyclooxigenase
1	ritoddne,
1	8-hydroxy-5-[(1r)-1-hydroxy-2-[n-[(1r)-2-(p-methoxyphenyl)-1-methylethyl]amino]
1	ethyl]carbostyril
1	(ta
1	2005)
1	1h-[1,2,4]-oxadiazolo-[4,3,-a]quinoxalin-1-one
1	[9-(2-tetrahydrofuryl)
1	adenine]
1	β2-agonists
1	isoproterenol-evoked
1	)-1-[2,3-(dihydro-7-methyl-1h-inden-4-yl)oxy]-3-[(1-methylethyl)amino]
1	-2-butanol
1	unity.
1	118,
1	551
1	ritodrine.
1	1-[2-((3-carbamoyl-4-hydroxy)phenoxy)
1	ethylamino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl)-phenoxy]-2-propanol
1	(cgp
1	20712a)
1	3%,
1	0.5%)
1	1.2%,
1	1.7%).
1	(at1r);
1	(nof).
1	(nxpre).
1	nxv
1	nxlos
1	nxnof
1	(los/nof).
1	nxpre
1	glomerular,
1	vascular,
1	nxpre.
1	monotherapies.
1	(snap)
1	n-formyl-l-methionyl-l-leucyl-
1	-7m)-induced
1	(ms/ms).
1	5.0-150
1	0.9952).
1	(bromazepam
1	químico
1	farmacêutico
1	auc0-240
1	(linear)
1	streptokinase,
1	β-hemolytic
1	euglobulin,
1	fibrinolytic
1	weakest,
1	streptokinases
1	s-2251™
1	vial,
1	streptonase™
1	(94.7
1	strek™
1	(32.9
1	weakest
1	densitometric
1	furaltadone.
1	nitrofurazone.
1	spices.
1	initialized
1	(results
1	azodicarbonamide
1	chromatographic/atmospheric
1	(lc-apci-ms-ms)
1	glypizide,
1	(70:30
1	acid/acetonitrile
1	(20:80
1	494.2→368.8)
1	446.0→347.3)
1	400-μl
1	(within-run
1	(between-run
1	30-300pmol),
1	k-8644
1	(0.3-3nmol)
1	k-8644-evoked
1	inhibition),
1	mg;
1	novaquímica
1	divisão
1	nature's
1	crossover,
1	(fpia)
1	axsym
1	cyclo-trac
1	diasorin.
1	microoral/neoral
1	94.5%
1	(90.8-98.4%)
1	(89.7-98.1%)
1	(94.5-101.8%)
1	fpia
1	96.1%
1	(91.9
1	100.6%)
1	95.2%
1	(90.2-100.5%)
1	99.4%
1	(96.4-102.4%)
1	us-fda,
1	(regitine
1	novartis,
1	vasomax,
1	postdose.
1	auc(0-720min),
1	cmax/auc(0-720min),
1	108.29%
1	98.58
1	118.96)
1	(auc(0-720min))
1	(auc(0-720min)
1	102.33%
1	97.21
1	107.72)
1	(ppg).
1	ppg.
1	tezosentan
1	(10-mg/kg
1	10-mg/kg/h
1	ppg,
1	txa2-
1	(ts3)
1	ts3-induced
1	relaxations;
1	[4,3,-alquinoxalin-1-
1	one]
1	ts3-evoked
1	adrenergic,
1	tyramine
1	phentolamine,
1	(cch,
1	neostigmine
1	tsv-and
1	ach-evoked
1	(renitec,
1	(narapril,
1	(enalaprilat)
1	narapril
1	(pec50=6.82±0.
1	06)
1	(pec50=6.12±0.10)
1	batrachotoxin,
1	veratridine,
1	γ-toxin),
1	brevetoxin-3
1	(batrachotoxin,
1	veratridine)
1	(brevetoxin-3)
1	slow-onset
1	na+channel
1	antigen-4
1	(fn)
1	0.1mm
1	65.5
1	44.6%,
1	hp2/1,
1	icrf
1	microfilament-
1	microtubule-depolymerizing
1	dihydrochalasin
1	(vla-4,
1	25.3±4.8%),
1	(zocor,
1	(simvast,
1	(β-hydoxy
1	simvast
1	zocor
1	(pla2s)
1	cascavella,
1	(1nmol/site)
1	w/v
1	(60-70
1	bronchiolar
1	(full
1	(partial
1	diethyl-ether-dichloromethane
1	(90:10;
1	v/v)+10
1	2.5-2000
1	3.4%.
1	lansoprazole.
1	alpha-toxin
1	(tsv).
1	7427.66+/-0.15
1	rbcc;
1	microm)
1	(p1-16,
1	p17-32,
1	p33-48,
1	p49-64,
1	p9-24,
1	p25-40,
1	p41-56,
1	yglpdkvptkt)
1	bukatoxin
1	(isolated
1	buthus
1	martensi
1	karsch
1	(buka11,
1	buka11-b,
1	pdkvp,
1	pdsep)
1	(crtp)
1	passiflorae,
1	claribacteri
1	ssp,
1	crtps
1	(%tna+).
1	%tna+
1	phenomenom.
1	(ag),
1	anti-inos
1	"tubular"
1	"interstitial"
1	glycation.
1	fractions;
1	nephropathies,
1	receptor-linked
1	excitotoxicity.
1	neuroimaging,
1	neocortical
1	(nonhs;
1	autopsy
1	(aut;
1	aut,
1	dentata
1	(fd);
1	ca4,
1	ca3,
1	aut
1	nonhs.
1	deafferentation.
1	6hr,
1	24hr
1	(12.8-fold
1	increase),
1	(2.5mg/kg
1	(1μg/site)
1	6hr
1	methotrexate-treated
1	co-stored
1	histamine/serotonin
1	oedema),
1	inducible.
1	5×10-7
1	1h(1,2,4)-oxadiazolo(4,3,-a)quinoxalin-1-one
1	n-(3-(aminomethyl)benzyl)acetamidine
1	(1400
1	0.1-1.0
1	s-nitroso-n-acetyl-penicillamine,
1	inhuman
1	dibenzepine
1	10-5000
1	0.9970).
1	(3000
1	(nevirapina
1	far-manguinhos,
1	química
1	nevirapina/viramune
1	96.4-104.5%
1	auc(0-last),
1	91.4-105.1%
1	95.3-111.6%
1	curve;
1	concentration).
1	auc(0-last)
1	nevirapina
1	serendipity
1	6-month,
1	yrs.)
1	dmards
1	2.6)
1	4/18
1	20;
1	50;
1	tender
1	dmards.
1	β-blockers.
1	thrive,
1	(porcine
1	ii-
1	(bothropstoxin-i,
1	piratoxin-i),
1	iii-
1	bothropstoxin-i,
1	heparinase
1	41.5
1	(3-[4-(2-chlorophenyl)-9-methyl-6h-thienol-[3,2-f]
1	[1,2,4]-triazolo-[4,3-a]
1	[1,4]-diazepine-2-yl]-1-(4-morpholynil)-1-propionate)
1	[2-(12-hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone]
1	heparin/heparan
1	(hk1),
1	phenylacetyl-phe-ser-arg-eddnp,
1	[emim
1	(2000),
1	1099-1107].
1	positively-charged
1	selective.
1	(trim;
1	i/type
1	2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine
1	(amt;
1	(fmlp).
1	immunomagnetic
1	naftifine
1	3.6%,
1	3.8%,
1	4.1%:
1	-2.7%,
1	7.7%,
1	4.8%,
1	-2.7%
1	80.0,
1	250.0,
1	1500.0
1	5.8%,
1	-1.4%
1	(terbinafina®:
1	farmacêutica.
1	lamisil®
1	(novartis
1	s/a,
1	90.5%
1	110.0%
1	108.1%
1	91.3%
1	107.5%
1	endothelial.
1	lymphomas,
1	tumours,
1	(ny),
1	(nhl)
1	lymphocytic/cll,
1	lymphoma),
1	5/10
1	15/16
1	14/16
1	3/10
1	dot-like
1	nitrotyrosine.
1	tri-deuterated
1	(3d-rsd921)
1	≤7.27%
1	≤7.39%
1	≤5.06%
1	accuracies,
1	±2.59%,
1	±1.23%
1	±1.64%
1	stepwise-ascending
1	3d-rsd921
1	in-source
1	proton-pump
1	pylori-infected
1	(auc0-2h)
1	auc0-2h
1	omeprazole.
1	1.14.99.1)
1	[br.
1	1824.].
1	etodolac
1	q.d.),
1	nabumetone
1	b.i.d.).
1	interleukin-1β-treated
1	(cyclooxygenase-2
1	(cyclooxygenase-1
1	etodolac-treated
1	nimesulide.
1	nabumetone-treated
1	hoped
1	(gastrointestinal)
1	toxicities.
1	methyl-n-vanillyl-6-nonenamide)
1	intrapleurally)
1	(ig)e,
1	positive)
1	endoscopy.
1	(rapid
1	antral
1	oesophagitis,
1	erosions
1	gastroduodenal
1	(12/30
1	3/23).
1	oesophagitis
1	-negative
1	(nadph).
1	(5-amino-n-butyl-2-(2-propynyloxy)
1	benzamide)
1	(5a),
1	commercialised
1	brand
1	synovial®,
1	benzamides,
1	parsalmide,
1	5b,
1	11b,
1	indomethacin-induced
1	(seb;
1	[but
1	(d-name)],
1	(0.25-1.0
1	μmol/paw),
1	μmol/paw).
1	nmol/paw).
1	(0.125-0.5
1	enantiomer,
1	auc(0-96
1	99.2-111.1%
1	95.6-117.5%,
1	minoderm
1	minomax
1	(etm).
1	(d-name,
1	kg-1)-induced
1	anxiolysis.
1	learned,
1	etm.
1	precipitation.
1	50-10
1	≤4.8%
1	4.4%
1	±2.6,
1	gabentin
1	(progresse
1	biosintética,
1	parke-davis,
1	progresse/neurotin
1	87.9-115.6%
1	88.6-111.7%
1	progresse
1	98319-26-7)
1	bioavailabillty
1	(flaxin®
1	liequid
1	2.05
1	2.55%
1	3.81%
1	0.09%.
1	auc0-48,
1	auc0-x,,
1	cmax/auc0-48,
1	95.71
1	88.70%
1	95.70-120.20%
1	94.60-121.30
1	auc0-∞
1	88.70-108%
1	androctonus
1	(aav)
1	buthotus
1	judaicus
1	(10μm),
1	(ach,
1	0.6nmol),
1	(30μg)
1	(30μg).
1	(mb,
1	30μm)
1	[4,3,-alquinoxalin-1-one]
1	scopolamine
1	(1μm,
1	münich-wistar
1	(3.2%
1	na);
1	hs+n,
1	d-1;
1	hs+n+mmf,
1	mmf,
1	d-1.
1	(amlodipine®
1	indústrias
1	químicas,
1	144h
1	101.2
1	(92.9-110.2%)
1	(91.5-108.4%)
1	(89.0-109.1%)
1	amlodipine®
1	(amoxicilina
1	farmaceûtica,
1	smithkline
1	beecham
1	103.70%
1	103.15%
1	106.79%
1	97.82
1	109.94%,
1	97.40
1	109.24%,
1	96.38
1	118.33%,
1	93.26%
1	93.27%
1	90.74%
1	85.0
1	102.33%,
1	85.12
1	102.31%,
1	80.14
1	102.73%,
1	auclastand
1	auco-∞were
1	catigua,
1	olacoides)
1	cupana-
1	officinalis-induced
1	>50%
1	catigua.
1	(143%
1	200%
1	(150%
1	89%,
1	43.8
1	vla-4-
1	(mabs).
1	34.3
1	45.24
1	5.6%,
1	cytometrical
1	(mac-1)
1	36.3
1	7.4%.
1	h-[1,2,4]
1	73.5
1	91.7
1	eosinophil's
1	‘
1	micromol/l).
1	phenobarbital.
1	mg/day).
1	γ-glutamyl
1	transpeptidase
1	iu/l
1	(icg)
1	ccl4.
1	icg
1	γ-ggt
1	86386-73-4)
1	(auc)(0-168h),
1	(c(max)),
1	(t(max)),
1	(t1(/)2).
1	formulation/reference
1	97.18-108.60%
1	0-168h),
1	90.87-111.11%
1	104.88-114.88
1	90.38-136.79
1	k(e),
1	91.87-108.93
1	(-)1.5-(-)0.10
1	(fda),
1	(zoltrix(tm))
1	permselectivity.
1	standard-salt
1	(ss;
1	(φ)
1	tripled.
1	(bthtx-ii)
1	(pla2s),
1	(14.9±15.5
1	17.6±1.6x106
1	(57.3±3.4x106
1	(p-bpb)
1	([14c]5-ht).
1	p-bpb
1	n(ω)nitro-l-arginine-methyl
1	(1-64
1	(135
1	37%)
1	fasciculation
1	preteating
1	acethylcoline
1	muscarinic,
1	prtx-i-mediated
1	([14c]5-ht;
1	μg/site),
1	platelet-free
1	preactivated
1	unactivated
1	preactivation
1	mobile,
1	ketanserine
1	21-hydroxydeflazacort
1	21-acetate
1	nebulizer
1	1-400
1	7.1,
1	dfz
1	(denacen
1	marjan
1	comercio,
1	merrell
1	lepetit,
1	denacen/calcort
1	89.8-109.5%
1	80.7-98.5%
1	denacen
1	moderate)
1	(13-20%
1	(20-34%
1	subendocardial,
1	subepicardial,
1	midmyocardial
1	decrease),
1	(7.1±0.2
1	(5.9±0.2%).
1	a2)
1	spla2(s)
1	(5-30
1	u/paw).
1	u/paw)
1	adamanteus,
1	heparin-sensitive
1	(cefadroxila
1	cefamo®
1	bristol-myers
1	squibb,
1	cefadroxila/cefamox®
1	103.97%
1	104.08%
1	95.23%
1	98.14-
1	110.16%,
1	98.37-110.12%,
1	85.59-105.96%,
1	cefadroxila
1	cefamox®
1	14-hydroxyclarithromycin
1	semiquantitatively
1	clarithromycin/ml.
1	48h)),
1	c(max)/auc((0-48h));
1	15.7%,
1	between-runs
1	auc((0-48h)),
1	∞))
1	(test/reference)
1	88.7%
1	103.7%
1	99.6%,
1	hydroxyclarithomycin
1	80.3%-
1	108.6%,
1	110.1%
1	112.6%,
1	charithomycin
1	clamicin
1	hydroxyclarithromycin,
1	salivary,
1	chromatography/liquid
1	auc(0-2h).
1	pylori-
1	1530786-5)
1	(diclofenac
1	cataflam®,
1	post-dosing,
1	hplc-uv.
1	92.8%
1	h)),
1	117.2%
1	131.0%
1	70-143%,
1	(svri),
1	(svi),
1	svri,
1	svi.
1	was-maintained
1	svri
1	l-name-mediated
1	(vai)
1	vai,
1	time-dependent,
1	(27±2.3%
1	28±1.3%
1	(22±1.1%).
1	β-adrenoceptor-mediated
1	diltiazem,
1	(208
1	0.1%,
1	(14.9
1	1.2%)
1	1.5%)
1	(morning
1	afternoon).
1	(3003
1	578
1	(77
1	evening).
1	fluoconazole
1	(auc)((0-168h)),
1	auc(-∞),
1	cmax/auc((0-168h)),
1	(ke),
1	half-
1	(t(1/2)).
1	-1.5%
1	-9.7%,
1	auc((0-168h)),
1	fluconal/zoltec
1	(fluconal;
1	ltda,
1	zoltec;
1	168h)),
1	94.7%
1	(arithmetic
1	27.5%
1	fluconazole's
1	70-143
1	nitroarginine
1	(name),
1	(anp).
1	gtp.
1	excretion;
1	10-fold,
1	macula
1	densa
1	anp-
1	microembolism.
1	(pae).
1	ml/kg.
1	5-60
1	>15
1	135%,
1	(196%
1	282%,
1	tensions
1	saturations
1	small-dose
1	672-hour
1	(sir).
1	kolmogorov-smirnov's
1	histograms,
1	plots,
1	o.15
1	o.50
1	norfluoxetine,
1	nor-fluoxetine
1	auc((0·672h)),
1	c(max)/auc((0·672h)),
1	metabolizers).
1	27.0
1	2064.0
1	85.4
1	2532.0
1	psiquial√rprozac®
1	121.1%
1	auc((0·672h))
1	fornorfluoxetine,
1	psiquial®/prozac®
1	90.3%
1	108.3%
1	auc((0.672h)
1	84.5%
1	106.3%
1	psiquial®
1	prozac®
1	(spe-712-1).
1	mg/15
1	rotram,
1	female).
1	auc(0-infinity),
1	spe-712-l/rotram
1	105.0-128.3%
1	78.4-96.9
1	two-one
1	sided
1	0.8-1.25
1	spe-712-l
1	rotram
1	profitable
1	atria.
1	(ott)
1	(du)
1	142)
1	dinner)
1	ott,
1	subcitrate,
1	meals),
1	bedtime),
1	dinner).
1	clinicas
1	69)
1	ranitidine.
1	(128/142)
1	(58/69)
1	0.2).
1	(96%,
1	137/142,
1	48/69;
1	(tolrest
1	zoloft
1	pfizer,
1	96-hour
1	c(max)/auc((0-96)
1	t(1/2).
1	probit's
1	kolmogorov
1	smirnov's
1	tolrest/zoloft
1	95.22%
1	99.87%
1	100.4%
1	103.6%
1	93.7%
1	t(max).
1	(h))
1	tolrest
1	zolof
1	(clamicin(r)
1	(biaxin(tm)
1	500mg
1	(biaxin
1	post-dose.
1	clarithromyicin
1	hydroxiclarithromycin
1	(lcmsms).
1	(vol.
1	xviii)
1	rinithis
1	(auc(0-48h)
1	92.4%
1	cl=85.8-99.6)
1	95.6%
1	(90%cl=88.7-103.1)
1	(auc(0-48h))
1	cl=85.4-112.6)
1	hydroxy-clarithromycin
1	93.4%
1	cl=80.3-108.6)
1	80%-
1	biaxin(tm)
1	lys-bradykinin
1	(lys-bk),
1	met-lys-bradykinin
1	(met-lys-bk)
1	des-arg9-bradykinin,
1	(never
1	removal).
1	≃2
1	≃90
1	nitrovasodilator
1	(gtn)
1	(kinins,
1	acetylcholine)
1	(74%),
1	met-lys-bk.
1	1h[1,2,4]
1	oxadiazolo[4,3,-alquinoxalin-1-one]
1	lys-bk,
1	met-lys-bk,
1	sodium-channel
1	tetrodetoxin
1	gtn-
1	iiirely
1	q.d.s.).
1	(18/25)
1	(13/25)
1	8/8
1	4/7;
1	nof.
1	flurbiprofen.
1	(p(gc))
1	p(gc)
1	nx).
1	22.1
1	0.8%,
1	(walker)
1	prothrombin.
1	diisopropylfluorophosphate
1	caterpillars.
1	bothropstoxin-ii.
1	histamine/5-hydroxytryptamine
1	(et-1)-mediated
1	(selective
1	agonists/antagonists)
1	(37°c),
1	(sapp).
1	(eta/etbagonist)
1	etaantagonist
1	fr-139317,
1	etbagonist)
1	[indo;
1	irl-1620)
1	etaand
1	etbreceptors
1	concomi-tant
1	(ets).
1	(used
1	vasoconstrictor)
1	1620-induced
1	ethanol-perfused
1	(30.2
1	(54%
1	2-amino-5,6-dihydro-6-methyl-
1	4h-1,3-thiazine
1	fmlp-
1	[4,3,-a]
1	synthase(s)
1	(svr).
1	(mabp)
1	thermodilution
1	svr,
1	(isvr),
1	isvr.
1	μg/kg/min;
1	isvr
1	(<3.0
1	ng/kg/min;
1	svr.
1	vasodilator.
1	svr
1	(fio2
1	125.1
1	139.0
1	po2
1	oxygen).
1	hyperoxemia.
1	(microchemotaxis
1	chamber)
1	(fmlp),
1	metrizamide
1	(163
1	subendocardium.
1	(0.01-0.1
1	sapp.
1	strep-tozocin-diabetic
1	hyperfiltration.
1	angioten-sin
1	μg/kg/min,
1	hyperperfusion
1	munich-
1	pressure-natriuresis
1	collapse,
1	(ppk)
1	kallikrein.
1	3-200
1	nmol/site,
1	bz-f-f-s-r-eddnp
1	p(ac)-f-s-r-eddnp
1	esp6),
1	bz-f-f-a-p-r-nh2,
1	esp8),
1	p(ac)-f-f-r-p-r-nh2
1	esp9)
1	bz-f-f-s-r-nh2
1	esp11)
1	ppk.
1	esp5
1	esp8
1	esp9
1	esp11
1	bz-f-f-r-p-r-nh2
1	esp1),
1	bz-f-f-pna
1	bz-f(nh2)-f-r-p-r-nh2
1	esp7)
1	bz-f-f-s-p-r-nh2
1	esp10)
1	nmol/site.
1	kallikreins.
1	platelet-rich
1	(prp).
1	fura2-am
1	[32p]-phosphate
1	[14c]-s-hydroxytryptamine
1	chrondroitin
1	(0.96
1	(wp;
1	platelets).
1	rgds.
1	plekstrin
1	μbondapack
1	repurification
1	pnv4)
1	migrates
1	16,600.
1	17,213
1	trp.
1	aeltscfpvghecdgdasncnccgddvycgcgwgrwnckckvadqsya.
1	pleurisy.
1	d-name.
1	2k-1c)
1	(4-200
1	irl/endothelin-1
1	inibitor
1	(20-200
1	(breakdown
1	(prostacyclin
1	e2)
1	nephrectomy),
1	nonpeptide
1	salt-restricted
1	sodium-depleted
1	et<inf>a</inf>receptors,
1	renin/angiotensin
1	promitogen,
1	et<inf>a</inf>inhibitor
1	n<sup>w</sup>-nitro-l-arginine
1	fr139317.
1	et<inf>a</inf>receptor,
1	(pge1)
1	(gtn),
1	3-morpholino-sydnonimine
1	(4-400
1	d-arginine).
1	nitrovasodilators,
1	(30–60
1	intra‐cavernously
1	balamo‐preputial
1	sulcus.
1	grades:
1	tumescence,
1	(3–100
1	dose‐dependent
1	(5–10
1	co‐infusion
1	intracavernously
1	(66%).
1	erections
1	haematoma
1	priapism.
1	impotence
1	astemizol
1	erection‐promoting
1	(>50
1	et<inf>a</inf>/et<inf>b</inf>agonist),
1	sarafotoxin
1	6b
1	(s6b;
1	et<inf>a</inf>agonist),
1	(et<inf>b</inf>agonist)
1	(cyclo-oxygenase
1	n<sup>om</sup>l-nitro
1	o<inf>2</inf>/5%
1	fr-139317
1	et-1)
1	effluent,
1	g-10
1	xiii)
1	(pnv3)
1	14,475.
1	avfaiqdqpc.
1	glx
1	(tx2.1,
1	tx2.5
1	tx2.6)
1	hyporeninemia,
1	hyporeninemia.
1	hyperreninemia,
1	0.4–200
1	(txb2).
1	800%
1	233%
1	205%
1	scbedule
1	heticobacter
1	“triple
1	therapy,”
1	pytori.
1	tinidazol,
1	ranitidine,
1	bealing
1	follow‐up.
1	forty‐three
1	endos‐copy
1	tinidazol
1	age‐
1	sex‐matched
1	post‐treatment
1	drugs).
1	resutts:
1	95%;
1	77%;
1	89%),
1	signiflcant
1	(prp),
1	(0.7-2.0
1	faster.
1	(34.6
1	(74.4
1	8.7%)
1	α-granules.
1	(4-40
1	migration)
1	cl28a,
1	cyclo-oxygenase,
1	(6-oxo-pgf1α)
1	6-oxo-pgf1α.
1	polylysine.
1	(i-xvi)
1	histamine)
1	d-arg,[hyp3,thi5,8,d-phe7]-bk,
1	sephadex,
1	(pnv1)
1	13,899.
1	asx
1	glx.
1	calcitonin-gene-related
1	dialysed,
1	lightly-anesthetized
1	(iotalamato
1	iohexol,
1	(i.e.),
1	vocalization,
1	hyperpnea,
1	rcm.
1	cap-
1	l-arginine-derived
1	s-nitrosocysteine,
1	bk-like
1	rr-analogues
1	(adp),
1	free‐bases
1	(fb)
1	d‐arginine.
1	arachdonic
1	(0.25–1
1	(4–16
1	luminally‐perfused
1	(3.3–10
1	ec,
1	l‐arginine,
1	5-aminosalicylic
1	unsuitable
1	misoprostol,
1	intramucosal
1	potassium.
1	164±6
1	108±3
1	125±6
1	(98±3
1	hypoperfusion,
1	narrowing,
1	obliteration,
1	l-glycine,
1	(et‐1),
1	endothelin‐3
1	(et‐3)
1	blood‐perfused
1	(1.0–10
1	et‐3;
1	et‐3.
1	et‐3)
1	equiefficacious
1	haemodynamics.
1	(edrf),
1	re-cently
1	mg/min).
1	hypoperfusion.
1	single-nephron
1	(sod;
1	(fcc;
1	aggregatory
1	co-operate
1	3–30
1	(adp,
1	2–6
1	(fb;
1	10–20
1	7.5–8.0
1	8.6–9.5.
1	(na2co3)
1	l‐
1	(rhc
1	80267)
1	(r59022)
1	(na2co3).
1	rhc
1	80267
1	omitted
1	(na2co3;
1	(3–30
1	(2–6
1	ng‐monomethyl‐l‐arginine
1	(nmma;
1	(10–30
1	(na2co3
1	fb;
1	8.6–9.5).
1	l‐but
1	(30–100
1	6‐oxo‐prostaglandin
1	f1α.
1	alkalinisation
1	weight-dependent
1	poly-l-arginine.
1	exuberant
1	5-hydroxytryptamine.
1	polyanion,
1	iloprost.
1	polycations
1	lnmma
1	spirally
1	0.5-2.5
1	8644.
1	nethylene
1	dihydropyrinide-sensitive
1	pmol-1
1	(vasodilatation)
1	(vasoconstriction).
1	intraportally
1	catecholamine.
1	nonrelaxant
1	wheal
1	flare
1	[d-arg0,hyp3,thi5,8,d-phe7]-bk,
1	[leu8],des-arg9-bk,
1	(rbas).
1	rbas.
1	pmol-300
1	bioassayable
1	abluminally
1	luminally.
1	transmission)
1	pyrogallol
1	generator)
1	thrombin;
1	occuring
1	(iloprost)
1	nitroprusside)
1	(0.03-30
1	summation,
1	(2.5-50
1	gossypol
1	(et-3,
1	µm),
1	µm).
1	vasoconstrictions.
1	(acetylcholine,
1	diphosphate)
1	constrict
1	nondepolarized
1	(aa,
1	oxyhaemoglobin
1	blood)
1	oxyhemoglobin.
1	oxide-like
1	'challenged'
1	hydrochloric
1	vascularly
1	[125i]-labeled
1	et)
1	et).
1	µci
1	pig,
1	retained.
1	f(1α).
1	(phosphatidylcholine
1	cholinephosphohydrolase,
1	3.1.4.3).
1	gentamycin.
1	bk‐stimulated
1	prostacyclin.
1	releasers
1	pithed
1	6-oxo-pgf1α
1	paf-acether
1	(b.a.)
1	neutrophils),
1	(∼300-fold),
1	(∼200-fold),
1	(∼80-fold)
1	cpla2α
1	(∼10
1	nmol/mg.
1	(16:0
1	n-9c).
1	lipidomics
1	(lds)
1	(15-deoxy-delta-12,14-prostaglandin
1	j2)
1	15-d-pgj2.
1	pld.
1	15-d-pgj2,
1	casais-e-silva,
1	teixeira.
1	micrurine
1	micrurus.
1	(1–10μg/paw)
1	(mcs).
1	prometazine,
1	h3/h4receptor
1	bk2receptor
1	nk1-
1	nk2-receptor
1	(sr
1	48968,
1	p-releasing
1	c-fibers.
1	nkb,
1	c-fiber-derived
1	'lemnitoxin',
1	toxicologically.
1	arg15,
1	ala100,
1	asn108,
1	109,
1	lemnitoxin.
1	nigrocinctus
1	nigroxin,
1	notechis
1	scutatus
1	notexin,
1	pseudechis
1	mulgotoxin,
1	pseudonaja
1	textilis
1	textilotoxin,
1	inoculation;
1	(tend)
1	660-
1	780-nm
1	5 j/cm
1	10 s.
1	viability/mitochondrial
1	780 nm
1	(lds).
1	pgj2,
1	abrogated.
1	abrogated,
1	leiguez
1	h-7-dihydro
1	h-7-dihydro,
1	spla2-mt-iii
1	vanessa
1	echinometrin.
1	echinometrin
1	cryptide
1	adjuvanticity
1	salts;
1	co-precipitation
1	increasing:
1	recruitment;
1	anthocyanins
1	anthocyanin-enriched
1	mulberry
1	cyanidin-3-glucoside
1	(c3g),
1	anthocyanin
1	g/animal)
1	pge<sub>2</sub>
1	neuza
1	mariko
1	aymoto
1	hassimotto
1	lys49plahomologue
1	cpla
1	splahomologue
1	pgethat
1	pgeformation
1	karina
1	giannotti
1	lys49pla2
1	ipla2,
1	p38(mapk)
1	ipla2.
1	1-(2,6-dichlorophenyl)indolin-2-one
1	gastro
1	nonulcerogenic
1	mtiii,
1	osmiophilic
1	spla2-stimulated
1	sb202190
1	(p38mapk
1	pyr-2
1	bel
1	(cpla2
1	ptk
1	pla2-
1	ptk,
1	myotoxin-iii
1	(cytosolic
1	arachidonyl
1	trifluoromethyl
1	(aacocf3),
1	(bel),
1	(0.3-6
1	(0.3-1
1	disappearing
1	c48/80,
1	(2.5-10
1	pgd2.
1	promethazine,
1	eterocoxib
1	(cyclooxygenase
1	dexamethazone
1	h2,
1	sub-cytotoxic
1	time-course.
1	aacocf3,
1	pacocf3
1	bel,
1	pgs'
1	(25-28
1	(pop)
1	(99-110%)
1	(21%).
1	(51-84%)
1	pop.
1	mφs.
1	algesia
1	cyclosporine-treated
1	olivo
1	rat-knee
1	joint)
1	mg.kg
1	cyclooxygenases,
1	(cdtv),
1	cyclooxygenases-1
1	(cox-1)
1	rofecoxib,
1	bav-
1	cox-1-derived
1	protoplasts
1	40kda.
1	prostaglandin-dependent
1	asper.
1	(hemorrhage
1	myonecrosis)
1	paralles
1	bav-induced
1	naphthylamide
1	aminopeptidase,
1	cystyl
1	puromycin,
1	bestatin,
1	amastatin
1	diprotin
1	6-17-fold)
1	debris;
1	revascularization
1	acceptors.
1	(ptx),
1	abrogating
1	anti-cytokine
1	cysteine-rich,
1	metalloproteinase)
1	pro-domain,
1	(dc-hf3)
1	2-mediated
1	opsonized-zymosan
1	dc-hf3
1	anti-α
1	anti-β
1	(0.01-2.5
1	(≥0.5
1	cyclooxygenases),
1	5-ht1/5-ht2
1	aspervenom
1	(lfa-1)
1	myonecrosis),
1	(myotoxin
1	(mt-iii))
1	(bap1)
1	6-day-old
1	1,10-phenantroline
1	pouches;
1	(rpa),
1	albumin-treated
1	(rpa
1	[leu
1	]desarg
1	[sar
1	,met
1	]-sp
1	rpa-induced
1	indomethacin-sensitive
1	intruded
1	greenstone
1	2760
1	(rb-sr
1	dating;
1	suita
1	nilson,
1	proterozoic
1	(salobo
1	fresco
1	lithostratigraphic
1	outcrops
1	drill-holes
1	intrusion
1	dunite,
1	peridotite,
1	pyroxenite,
1	norite
1	gabbro
1	seams,
1	plagioclase
1	pyroxenites
1	dunite
1	peridotite.
1	thicknesses
1	centimetres.
1	equigranular
1	texture,
1	show:
1	atoll-like
1	olivine
1	orthopyroxene
1	pseudomyrmekitic
1	intergrowth
1	pgms
1	(braggite
1	sperrylite)
1	predates
1	contemporaneous
1	weathering
1	mineralogy
1	chromitite,
1	minerals
1	microprobe,
1	chromites
1	ranging,
1	chondritic
1	ppge
1	(diella
1	re-os
1	richer
1	(lu3)
1	(lu
1	horizons.
1	stillwater
1	marcantonio
1	(ug1,
1	ug2
1	hulbert
1	gregoire,
1	pge-rich
1	(fig.
1	reef,
1	chur
1	mantle-melt
1	mantle.
1	os)(i)
1	envisaged:
1	metasomatized
1	haemoconcentration.
1	vasopermeability
1	shock-like
1	2170.
1	l663,536,
1	(ltc4/d4)
1	c3h/hepas.
1	ltb4)
1	stir
1	hanks'
1	(hbss)
1	hbss
1	(56°c)
1	sudo.
1	1425-1431,
1	1994.-the
1	amethopterin.
1	lymphocytopenia,
1	be2+/kg)
1	zoxazolamine-induced
1	n-demethylation
1	meperidine
1	amino-pyrine
1	o-demethylation
1	quinidine
1	beryllum
1	p-450,
1	phenylbutazone.
1	regio
1	c–h
1	chemocatalytic
1	oxy-functionalization
1	oxysporum,
1	myrothecium
1	verrucaria,
1	rhinocladiella
1	2-oxo-functionalization
1	13,14-(c–c)double
1	(8).
1	1–7
1	atcc35984
1	halimane-diterpenoid
1	(moa),
1	(sars),
1	gram-scale,
1	antiproliferation
1	install
1	macrolides
1	amphidinium.
1	macrolide
1	px1-px3
1	(1–4),
1	stereochemistry
1	a2058.
1	(vocs)
1	microextraction
1	(hs-spme)
1	(fid)
1	vocs
1	hs-spme,
1	spme
1	(hca)
1	(hct−116),
1	(ovcar−8)
1	(sf−295)
1	bauermeister,
1	velasco-alzate,
1	jimenez,
1	lotufo,
1	gaudêncio
1	costa-lotufo.
1	(micromonosporaceae)
1	mass-spectrometry-based
1	(portugal,
1	macaronesia)
1	arenicola,
1	rifamycins,
1	(mpas)
1	particularly:
1	protected;
1	permission
1	no-take
1	shortfalls
1	ban
1	mpas.
1	reconciling
1	(−)-trachelogenin,
1	dibenzylbutyrolactone
1	lignan
1	combretum
1	fruticosum,
1	0.8–32.4
1	beclin-1.
1	pradimicin-ird,
1	amycolatopsis
1	ird-009
1	spectrometer)
1	aminoglycosyl
1	the compound
1	pradimicin-ird
1	(mic 3.1 μg/ml)
1	0.8 μm
1	2.7 μm
1	prospects,
1	endeavor,
1	illustrate,
1	cytarabine,
1	trabectedin,
1	eribulin
1	brentuximab
1	vedotin,
1	glycosidase
1	1,2,3-1h
1	triazoles
1	1,2,3-1h-triazoles
1	9a-k
1	epithelium).
1	allylation
1	iodocyclization
1	1,3-dipolar
1	cu(i)
1	alkynes
1	1h-1,2,3-triazol-1-ylmethyl-2,3-dihydronaphtho[1,2-b]
1	furan-4,5-diones
1	1,2,3-triazole
1	(9c,
1	9d,
1	9e,
1	9i)
1	1,2,3-1h-triazole
1	serinicoccus.
1	(esi-ms/ms),
1	congeneric
1	zoanthids,
1	variabilis,
1	ophionereis
1	chamigrene
1	sesquiterpenes,
1	(+)-elatol
1	6s,9r,10s
1	mosher's
1	chamigrenes
1	laurencia
1	fast-flow
1	(lpp1)
1	mono-q
1	(lpp1-p1
1	p6)
1	125 μg/ml
1	2.9 μg/ml.
1	bloodstreams,
1	salinities
1	psu.
1	(tus)
1	(blm)
1	synergistic/antagonistic
1	dose-level
1	dose-ratio
1	dependencies.
1	deviations;
1	psu),
1	speciations
1	2-hydroxy-3-arylnaphthalene-1,4-diones
1	(3-aryllawsones)
1	suzuki-miyaura
1	3-iodolawsone
1	arylboronic
1	acids/esters.
1	n,n-diethyl
1	carbamates.
1	carbamate,
1	ornatus.
1	1d/2d
1	agnostic
1	ritterostatin
1	gn1n,
1	cephalostatin–ritterazine
1	hsp70s,
1	(er)-based
1	ergostane-type
1	24(r)-7α-hydroperoxy-ergost-5-en-3β-ol
1	6β-carboxyl-24(r)-(8→6)-abeo-ergostan-3β,5β-diol,
1	(hresims),
1	6β-carboxyl-24(r)-(8→6)-abeo-ergostan-3β,5β-diol
1	(hct-116)
1	abeo-sterol
1	archipelago,
1	nonylprodigiosin,
1	cyclononylprodigiosin
1	methylcyclooctilprodigiosin
1	(bgc)
1	actinomycetes.
1	bgc
1	putatives
1	redj
1	redl-like
1	pks,
1	redg-like
1	rieske
1	oxygenase,
1	prodiginines,
1	cyclononilprodigiosin
1	methylcyclooctylprodigiosin
1	alkylbenzenes,
1	tributyltin;
1	chromium,
1	tributyltin.
1	mucuripe.
1	(eif4f)
1	m7gpppn
1	cap-dependent
1	eif4g
1	eif4a.
1	eif4f
1	elisabatin
1	allolaurinterol
1	enzymological
1	atp-competitive,
1	mda-ma-468
1	phycological
1	(fucales,
1	phaeophyceae)
1	natans
1	fluitans
1	characteristics;
1	(0%-3%)
1	macroalgae,
1	sargassum.
1	slicks
1	sargasso
1	m-2
1	allelopathic
1	macroecology
1	south/north
1	east/west
1	arborescens.
1	rel-(18r,22r)-5β,6β:18β,20-diepoxy-3β,18α-dimethoxy-4β-hydroxy-1-oxowith-24-enolide,
1	rel-(20r,22r)-5β,6β-epoxy-4β,16α,20-trihydroxy-1-oxowitha-2,24dienolide,
1	rel-(20r,22r)-16α-acetoxy-6α-chloro-4β,5β,20-trihydroxy-1-oxowitha-2,24-dienolide
1	rel-(20r,22r)-16α-acetoxy-20-hydroxy-1-oxowitha-2,5,24-trienolide.
1	sf-268
1	panc-1).
1	0.3–1.7
1	rel-(18r,22r)-5β,6β:18β,20-diepoxy-3β,18α-dimethoxy-4β-hydroxy-1-oxowith-24-enolide
1	rel-(20r,22r)-5β,6β-epoxy-4β,16α,20-trihydroxy-1-oxowitha-2,24dienolide
1	non-cytotoxic.
1	wiley-vhca
1	paul's
1	(m).
1	31.55
1	hr-lc/ms
1	dereplication
1	hr-ms
1	antimarin
1	glucopiericidin
1	n-methylstaurosporine,
1	hydroxydimethyl-staurosporine
1	n-carbamoylstaurosporine,
1	salinisporamycin
1	rifamycins
1	bra-199,
1	glucopiericidin,
1	diketopiperazines,
1	cyclo(l-phe-trans-4-oh-l-pro),
1	cyclo(l-phe-l-pro),
1	cyclo(l-trp-l-pro).
1	streamlined
1	octocoral
1	amphidinium;
1	coral,
1	b8
1	hct-116.
1	phylogenic
1	3-hydroxy-4-methoxybenzamide
1	2,3-dihydro-2,2-dimethyl-4(1h)-quinazolinone
1	nocardamine
1	l. ericoides
1	(edc)
1	feminization
1	growths
1	unplanned
1	urbanization.
1	sphoeroides
1	testudineus
1	disruptors
1	measure/weighted
1	desiccated
1	(males,
1	undifferentiated),
1	undifferentiated).
1	edcs
1	(estrone,
1	17α-estradiol,
1	17β-estradiol,
1	17α-ethinylestradiol,
1	diethylstilbestrol,
1	estriol)
1	alkylbenzenes (labs),
1	(ahs)
1	(pahs).
1	ahs
1	pharmacoelectrochemistry
1	biflora.
1	spectrophotometry
1	(uv-vis
1	fluorimetry).
1	dna-biflorin
1	fluorimetry.
1	biflorin-dsdna
1	aneuploidogenic
1	(25r)-spirost-5-ene-3β,26β-diol
1	(25r)-spirost-6-ene-3β,5β-diol
1	diosgenin
1	4)-β-d-glucopyranoside
1	chonglouoside
1	sl-5
1	paris
1	hresi-ms,
1	(6)δ-spirostanol
1	c-26
1	(5)δ-spirostanol
1	formosanin
1	spirostanol
1	furostanol-type
1	3-o-β-d-glucopyranosyl-(1→4)-β-d-galactopyranosyl-(1→4)-β-d-galactopyranoside,
1	3-o-β-d-glucopyranosyl-(1→2)-α-l-rhamnopyranosyl-(1→4)-β-d-galactopyranoside,
1	3-o-β-d-galactopyranoside
1	3-o-β-dgalactopyranosyl-(1→4)-β-d-galactopyranoside,
1	3-o-β-d-galactopyranoside,
1	(hl-60),
1	(ovcar-8),
1	(mbs)
1	2-hydroxy-1,4-naphthoquinone.
1	leukaemia)
1	ic50=
1	1.1–19.2
1	salicylaldehydes
1	2-pyridinecarboxaldehyde
1	epiicversus
1	ic50(μm)
1	a–c,
1	salicylaldehydes)
1	epiicvalues.
1	2-pyridinecarboxaldehyde)
1	ic50and
1	epiicvalues,
1	mbs,
1	bonding.
1	mysidopsis
1	(length
1	l-1),
1	(lc20
1	toxicity;
1	photoprotection.
1	polyenes
1	(carotenes
1	xanthophylls)
1	(esicid-
1	ms/ms)
1	(nanoesi-cid-ms/ms).
1	(qtof)
1	nanoesi
1	(fticr)
1	formulae
1	accurate-mass
1	charge-remote
1	pericyclic
1	electrocyclic
1	retro-ene
1	eliminations
1	(assisted
1	sigmatropic
1	shift).
1	isomerization
1	carbocation
1	epoxides
1	oxonium
1	esi-
1	nanoesi-cid-ms/ms
1	vellozia
1	kolbekii
1	(velloziaceae)
1	(5r,8r,9s,13r)-halim-1,10-ene-15,16-diol
1	studiedfor
1	occurrenceof
1	nitrogen-containing
1	thisstudy,
1	andstigmasterol.
1	tfour
1	bisabolanes
1	1–4,
1	triacetyl
1	gorgonian
1	pseudopterogorgia
1	rigidacollected
1	bahamas.
1	cytotoxictoward
1	pere-zone
1	12-cellline
1	wasassayed
1	scavenger(l-nac)
1	andlessened
1	l-nac
1	mechanismof
1	perezone-induced
1	inductionof
1	species,commonly
1	zooxanthellae,
1	photosynthetically
1	host.the
1	arevery
1	thesymbiotic
1	corals
1	containingsymbiotic
1	theoctocoral
1	nudibranch
1	marionia
1	limceana,
1	offortaleza
1	3-o-methyl
1	amphidinolidep,
1	reportedonly
1	amphidinium
1	identificationof
1	polyketides
1	anatural
1	symbiosis,
1	besides,marine
1	talented
1	leads.although
1	macroalgae
1	thereis
1	wasto
1	brazil-ian
1	bostrychia
1	(j.v.
1	lamouroux)
1	(ceramiales,
1	rhodophyta).
1	forty-fiveendophytic
1	cytotoxicity,antifungal
1	andother
1	xylariasp.
1	remark-able
1	marineendophytic
1	macroalgab.
1	bea
1	acremonium
1	implicatum
1	firstlydescribed
1	marineseaweed
1	andbiological
1	(cytotoxic,
1	antibacterial)
1	decaturense
1	andp.
1	waksmanii
1	widespreadprevalence
1	2α-10bα-dihydroxy-9-o-demethylhomolycorine,
1	5-(hydroxymethyl)furfural,
1	piscidic
1	eucomic
1	hippeastrum
1	solandriflorum.
1	techniques:<sup>1</sup>
1	(hsqc),
1	(hmbc),
1	overhauser
1	(noesy),
1	(ei-hrms).
1	(hct-116,
1	ovcar8
1	sf-295)
1	35.7
1	pyrroloisoindolone
1	dehydropyrrolizine,
1	semisynthetic
1	(iaf)
1	heno1,
1	eno1,
1	(brf
1	030)
1	cytotoxicity-guided
1	potato-dextrose-sea
1	hetero-spirocyclic
1	γ-lactams
1	fd-838
1	methylsulochrin
1	bis(dethio)bis(methylthio)gliotoxin
1	specifically-target
1	kapakahines,
1	c(3)-n(1′)
1	fluorescently-labeled
1	reliant
1	limae,
1	kaempferol-3-o-glucoside,
1	ombuin-3-o-rutinoside
1	aleuritolic
1	(ovcar-8)
1	ic<inf>50</inf>values
1	7.14,
1	8.19
1	ml<sup>-1</sup>,
1	n<inf>b</inf>-methyl-triptamine
1	bis-quinoline
1	n-8″-formyl-calycosidine
1	n-8″-methyl-n-1′-demethyl-iso-calycosidine,
1	margaritopsis
1	carrascoana,
1	calycosidine
1	hodgkinsine.
1	hodgkinsine
1	ovcar-8,
1	plakortides,
1	7,8-dihydroplakortide
1	spongosoritin
1	6-8,
1	plakortide
1	plakortis
1	angulospiculatus.
1	dihydrofuran
1	7-9,
1	plakortides
1	dihydrofurans
1	g<inf>0</inf>/g<inf>1</inf>
1	g<inf>2</inf>/m
1	pecém's
1	(northeast
1	brf082,
1	dichotomomyces
1	cejpii
1	rpb2
1	brf082
1	gliotoxin
1	bis(dethio)bis(methylsulfanyl)gliotoxin
1	6-acetylbis(dethio)bis(methylsulfanyl)gliotoxin
1	quinazolinone
1	fiscalin
1	demethylchromomycin
1	paracuru
1	beach,
1	nm-range
1	malme-3m,
1	0/g1
1	lc3-a
1	lc3-b.
1	chromomycins.
1	2-ferrocenyl-1,1-diphenylbut-1-ene
1	noncancerous
1	hyperchromicity
1	uv/vis
1	dsdna,
1	1,1,2-triphenylbut-1-ene
1	noncancer
1	serinicoccus,
1	autophagocytosis
1	dermcidin.
1	preselection
1	bioactivities
1	withaferin
1	(wa;
1	(2-37)
1	heat-shock-inducing
1	enone
1	bioactivities.
1	27-oh
1	4-epi-wa
1	(28)
1	β-oh
1	(30)
1	β-oac
1	4,27-diacetyl-wa
1	(16)
1	(36),
1	27-oh,
1	selectively,
1	product-inspired
1	aggregation-associated
1	disulfide-containing
1	acting,
1	regulation:
1	1940s
1	matayba
1	aublet
1	(sapindaceae)
1	diglycosides:
1	matayoside
1	cupanioside
1	mulungu"
1	erythrina,
1	effects.methods:
1	spirocyclic
1	catalyst
1	carcinoma).results:
1	catalyst.
1	8-oxo-erythraline
1	phytomedicine
1	guaratini
1	communciations
1	9-[n-(leucyl)-isoleucyl]-
1	8-hydroxy-8-isopentyl-7,8-dihydroadenine
1	n-[n-(leucyl)-isoleucyl]phenethylamine
1	thymidine,
1	2'-deoxyuridine
1	chrysogenum,
1	11-bromo-17-hydroxybromoroquefortine
1	lc/hr-ms.
1	bromoroquefortine
1	brominated
1	11-br
1	alkaloid.
1	trachylobane
1	floribundus,
1	ent-trachyloban-19-oic
1	15β-hydroxy-ent-trachyloban-19-oic
1	ent-trachyloban-19-ol
1	ent-kaur-16-en-
1	19-oic
1	ent-kaur-16-ene-6α,19-diol
1	ent-16α-hydroxykaur-11-en-19-oic
1	(8-11).
1	14.32,
1	13.47
1	goniopsis
1	estuaries.
1	estuary,
1	cu.
1	geoaccumulation
1	zn.
1	copepods
1	(reproduction)
1	amphipods
1	(survival),
1	elutriate
1	sediment-water
1	(development).
1	othercontaminants
1	mid-estuary.
1	biflorin.
1	(p<.
1	alkylbenzenes
1	butyltins;
1	impoverishment
1	governmental
1	non-substituted
1	nitrate.
1	α-isomers
1	voltammetry.
1	release;
1	ltd.all
1	northeasttern
1	0101
1	0120,
1	0102,
1	0103,
1	0106,
1	0113
1	ic50determination
1	by1h
1	3.62
1	ml-1(for
1	84.65
1	0106
1	cis,cis,trans-[pt(hl1-3)cl
1	2(oh)2]
1	(hl
1	2-hydroxy-3-[(r1-amino)
1	(pyridin-2-yl)methyl]-1,4-naphthoquinone,
1	n-butyl,
1	hl2
1	hl3)
1	cis-[pt(hl1-3)cl2]
1	mecn
1	quasi-reversible
1	naphthoquinonate
1	(nqo
1	l-)
1	cis,cis,trans-[pt(nh3)2cl2(oh)2].
1	2-hydroxyl
1	axially
1	2b-3b,
1	(hl2-hl3)
1	thiazacridine
1	(atzd)
1	(5z)-5-acridin-9-ylmethylene-3-(4-methylbenzyl)-thiazolidine-2,4-dione
1	ac-4;
1	ze)-5-acridin-9-ylmethylene-3-(4-bromo-benzyl)-thiazolidine-2,4-dione
1	ac-7;
1	(5z)-5-(acridin-9-ylmethylene)-3-(4-chloro-benzyl)-1,3-thiazolidine-2,4-dione
1	ac-10;
1	ze)-5-(acridin-9-ylmethylene)-3-(4-fluoro-benzyl)-1,3-thiazolidine-2,4-dione
1	ac-23.
1	atzd,
1	depolarisation
1	caspase-dependent.
1	topoisomerases
1	3-substituted
1	nor-β-lapachones
1	nucleophiles
1	2h-pyrazole
1	(piperlongumine,
1	5,6-dihydro-1-[(2e)-1-oxo-3-(3,4,5-
1	trimethoxyphenyl)-2-propenyl]-2(1h)-
1	pyridinone)
1	(piper
1	piperaceae).
1	ayurvedic
1	antiangiogenic,
1	antimetastatic,
1	antidepressant,
1	anti-atherosclerotic,
1	antidiabetic,
1	schistosomicidal
1	patent.
1	termite
1	representative.
1	termite,
1	nasutitermes
1	macrocephalus
1	(silvestri,
1	1903)
1	(isoptera,
1	nasutitermitinae),
1	monoterpenes
1	(α-pinene
1	limonene)
1	(β-transcaryophyllene
1	α-selinene)
1	gc-eims,
1	trinervitane
1	eims,
1	hresims,
1	rotation)
1	3α-hydroxy-
1	trinervita-1(15),8(19)-dien-2-one
1	2α,3β-dihydroxytrinervita-1(15),8(19)-diene
1	3α-hydroxy-15-rippertene
1	bmb
1	9393,
1	31.2
1	unbranched
1	svhv,
1	czapek
1	ss46
1	(poepp.)
1	rob.,
1	asteraceae,
1	anhydrofusarubin
1	beauvericin
1	ss50
1	(gc-ms),
1	alkanes.
1	sulfonylated
1	1h-1h
1	cosy,
1	1h-15n
1	hmbc
1	spectra,
1	n-((2s,3r,4e,8e)-1,
1	3-dihydroxyoctadeca-4,8-dien-2-yl)-
1	n-((2s,3r,4e
1	)-1,3-dihydroxy
1	octadeca-4-en-2-yl)-
1	cucurbitacins
1	cucurbitane
1	cong.
1	(cucurbitaceae),
1	2β,3β,16α,20(r),25-pentahydroxy-
1	22-oxocucurbita-5-en
1	(hl60)
1	-g/ml.
1	-g/ml).
1	1-treated
1	(eosinophilia),
1	5-fu,
1	carbohydrate-based
1	13a-c
1	phenylhydrazono
1	14a-l
1	mda-mb435,
1	9a-c
1	mda-mb
1	14i
1	c-apt,
1	cosy-
1	hetcor
1	heteroaromatic
1	(3a-f)
1	1-(7-chloroquinolin-4-yl)-2-[(1h-pyrrol-2-yl)methylene]hydrazine
1	(mdamb-435).
1	aveiro,
1	pca-factor
1	86.8%
1	(62.7%)
1	(positive)
1	(negative).
1	(24.1%)
1	(ev10)
1	principals.
1	ev10
1	isocoumarins
1	cis-4-hydroxymellein,
1	trans-4-hydroxymellein,
1	pisonis
1	cambess.,
1	lecythidaceae,
1	triterpenes:
1	β-amyrin,
1	uvaol
1	erythrodiol,
1	3β-friedelinol
1	(friedelan-3β-ol),
1	(e)-phytol.
1	ethereal
1	pisonis'
1	polycephala
1	terpenoid
1	naphtoquinones,
1	6-[10-(12,12-dimethyl-13α-
1	(22-methyl-21-butenoyloxy)-16-
1	methenylcyclohexyl)ethyl]-naphtalene-1,4-dione
1	(6-[10-(12,12-dimethyl-13α-(tigloyloxy)-
1	16-methenylcyclohexyl)ethyl]-
1	naphtalene-1,4-dione,
1	cordiaquinone
1	(1-5)
1	neosergeolide,
1	quassinoid
1	picrolemma
1	sprucei
1	hook.
1	may-grünwald-giemsa's
1	neosergeolide.
1	submicromolar
1	(0.05,
1	quassinoid.
1	cytokinesis-block
1	neosergeolide-mediated
1	comprehensive,
1	biodiversity,
1	assert
1	tubulin-interacting
1	arborescens;
1	whitaphysalins
1	undefined,
1	5-acridin-9-ylmethylene-3-benzyl-thiazolidine-2,4-diones
1	n-alkylation
1	2,2-dimethyl-(3h)-3-(n-3'-nitrophenylamino)naphtho[1,2-b]furan-4,5-dione
1	(qphno
1	nor-beta-lapachone
1	(nor-beta),
1	protic
1	aprotic
1	(dmf/tbabf
1	apoptosis/necrosis
1	linearity,
1	cerastoderma
1	thiocholines
1	(eserine,
1	bw284c51
1	iso-ompa)
1	cholines
1	propionyl
1	(prsch)-cleaving
1	carboxylesterases
1	(cae).
1	adductor
1	prsch
1	che,
1	(psa,
1	2-hydroxy-7-oxostaurosporine
1	3-hydroxy-7-oxostaurosporine
1	mid-polar
1	anthracyclinones,
1	4,6,11-trihydroxy-9-propyltetracene-5,12-dione
1	7,8,9,10-tetrahydro-9-hydroxy-
1	10β-carbomethoxy-7,8,9,10-
1	tetrahydro-4,6,7α,9α,11-pentahydroxy-9-propyltetracene-5,12-dione
1	noesy)
1	sedimentology
1	(mucuripe
1	pecém)
1	(santos)
1	ratings.
1	shelf
1	mud.
1	sediments.
1	n-acyl-hydrazones
1	(nervous
1	(3g,
1	3k
1	3n)
1	ic50of
1	2.04μg/ml,
1	biota,
1	mrm
1	hydroxy-7-oxo
1	polysubstituted
1	7-chloro-4-quinolinylhydrazone
1	(3a-n)
1	3c,
1	3j
1	3n
1	0.7483
1	5.572
1	methoxy
1	3,4,5
1	(3j)
1	(hl60
1	(mda
1	mb-435
1	pseudoalteromonas
1	prodigiosin,
1	tripyrrole
1	erbb-2
1	erbb-2,
1	water-extracted
1	(pfcm)
1	passiflora
1	microanalysis,
1	galacturonic
1	(esterified
1	unesterified).
1	rhamnose,
1	40.59%
1	48.73%
1	5-fluorouracil.
1	5.68μm,
1	4.0μm
1	1/s,
1	pht,
1	antitubulin
1	(1a-e)
1	aza-pterocarpanquinone
1	oxyarylation
1	azaarylation
1	(k562
1	hl-60)
1	(mda-mb435)
1	(3-8)
1	bioselective
1	1c-e,
1	1c
1	(3a-u)
1	3j,
1	(0.7967-
1	4.200
1	electronwithdrawing
1	(3h),
1	(3b)
1	(3r)
1	ferrocenyl
1	never-reported
1	glioblastoma),
1	cancer),
1	(eemus),
1	(9.5-16.7)
1	25.1
1	(17.3-36.3)
1	38.1
1	(33.5-43.4)
1	μg/ml].
1	hl-60-treated
1	plumel
1	apocynaceae
1	janaguba.
1	uses.
1	(hdlp)
1	megakaryocyte
1	8β-
1	8α-epimers,
1	8-hydroxymirabilin
1	(1,8a;8b,3a-didehydro-8-hydroxyptilocaulin),
1	monanchora
1	arbuscula
1	1h-,
1	13c-
1	(bb),
1	13c-dept)
1	hmbc)
1	epimers
1	inactive,
1	61.5
1	40.0
1	ptilocaulin,
1	(u343
1	ahol1),
1	1.8μg
1	1.0μg
1	1.8μgml-1
1	30.9
1	48.2%
1	33.3
1	55.7%.
1	pht.
1	8-hydroxy-lawsone,
1	9-hydroxy-α-lapachone
1	7-hydroxy-β-lapachone
1	α-lapachone
1	cheap
1	furano
1	hydroxyiso-β-lapachone
1	na2hpo4
1	koh/dmso
1	furnished
1	stenocarpoquinone-a
1	avicequinone-c
1	oxone/acetone
1	stenocarpoquinone-b
1	antitumoural
1	mid-west
1	semideciduous
1	polarities
1	tabebuia
1	heptaphylla
1	bignoniaceae,
1	tapirira
1	aubl.,
1	allemão,
1	schinus
1	terebinthifolius
1	raddi,
1	mart.,
1	amaranthaceae,
1	attalea
1	phalerata
1	spreng.,
1	arecaceae,
1	eugenia
1	uniflora
1	myrtaceae,
1	dioica
1	st.-hil.,
1	annonaceae.
1	casearupestrins
1	a-d
1	(1-4),
1	rupestris.
1	2,7-di-o-acetylcasearupestrin
1	2,6-di-o-acetylcasearupestrin
1	casearupestrin
1	ortho-naphthoquinone,
1	h23
1	14.61
1	melanoma-bearing
1	(25mg/day)
1	33.3±0.9
1	44.5±3.4
1	(treated).
1	2-(benzo[d]thiazol-2-yl)-8-substituted-2h-pyrazolo[4,3-c]
1	quinolin-3(5h)-ones
1	(3a-g)
1	methyl-2h-pyrazolo[4,3-c]quinolin-3(5h)-one)
1	bromo-2h-pyrazolo[4,3-c]quinolin-3(5h)-one)
1	anhydrides.
1	hct-8)
1	3-o-carboxymaleinate
1	(3a/3b)
1	3a/3b,
1	perturbation,
1	3/7,
1	sylvestris,
1	anti-ulcer,
1	anti-ophidian
1	potentialities.
1	antiulcerogenic
1	antiphospholipasic
1	bioguided-assay
1	(a-x)
1	casearvestrins
1	(a-c),
1	δ-tocotrienol
1	ei-ms
1	23.58
1	(comet
1	color)
1	acerola.
1	malpighia
1	glabra
1	fruit),
1	(unripe)
1	β-lapachone-based
1	prototypes.
1	1-bromoheptane
1	dna-glycosylase
1	(endoiii).
1	anti-ulcer
1	l),
1	(-)-hardwickiic
1	(0.7,
1	3.0μm).
1	0.4μm)
1	(pbmc,
1	1.2μm).
1	5-bromo-20-deoxyuridine
1	(36.6
1	1.5μm,
1	x-treated
1	antitumor-related
1	papulaspora
1	immersa
1	hotson
1	(poepp.
1	endl.)
1	rob.
1	yacon.
1	(22e,24r)-8,14-epoxyergosta-4,22-diene-
1	3,6-dione
1	2,3-epoxy-1,2,3,4-tetrahydronaphthalene-c-1,c-4,8-triol
1	chromone
1	papulasporin
1	(24r)-stigmast-4-en-3-one
1	24-methylenecycloartan-3β-ol
1	(22e,24r)-ergosta-4,6,8(14),22-tetraen-3-
1	(-)-(3r,4r)-4-hydroxymellein
1	(-)-(3r)-5-hydroxymellein
1	6,8-dihydroxy-3-methylisocoumarin
1	(-)-(4s)-4,8-dihydroxy-α-tetralone
1	naphthalene-1,8-diol
1	6,7,8-trihydroxy-3-methylisocoumarin
1	7-hydroxy-2,5-dimethylchromone
1	(12),
1	tyrosol
1	(14).
1	iμm,
1	2-4,
1	5.70
1	16.40
1	α-methylene-
1	γ-lactone
1	functionalities,
1	4.35
1	(laas)
1	hl-60).
1	1a/1b-treated
1	3-(aminomethyl)
1	3-[(r1-amino)(pyridin-2-yl)methyl]-2-hydroxy-1,4-naphthoquinones
1	n-bu,
1	bn,
1	hl2;
1	furfuryl,
1	hl3;
1	hl5)
1	atoms.
1	cis-[pt(hl)cl2]
1	bidentate
1	cis-[pt(l-)(nh3)2]no
1	31b-5b
1	atoms,
1	leukaemia),
1	(brain),
1	(ovary)
1	proligands
1	chlorido
1	n-heptyl)
1	proligand
1	29.9
1	n-heptyl
1	n-decyl)
1	(e)-2-benzothiazole
1	hydrazones
1	(breast)
1	(colon).
1	antimutagenic,
1	tiphymurium,
1	ta97a
1	glycosylases.
1	mutagenicity,
1	radical-scavenging
1	genotoxic.
1	9-58%
1	p-benzoquinone
1	1h-
1	13c-nmr
1	phytotoxicity
1	cucumis
1	sorgum
1	bicolor,
1	mol/l.
1	dicotyledonous
1	(7-74%).
1	grandifolia
1	(dicotyledonous)
1	decumbens
1	2,5-bis(alkylamino)-1,4-
1	benzoquinones
1	sf-
1	alamar
1	(51.83%)
1	iodoacetamide.
1	(-)-kaur-16-en-19-oic
1	xylopia
1	sericeae
1	hill,
1	(comet,
1	assays).
1	14-hydroxy-kaurane
1	sericeae,
1	(3-5).
1	(-)-kauran-19-oic
1	(kah),
1	(pbls),
1	cerevisiae)
1	kah
1	metalloporphyrins,
1	monooxygen
1	mimetize
1	iodosylbenzene
1	iron(iii)
1	manganese(iii)
1	porphyrins
1	di-hydroxylated
1	phthalimides
1	2b,
1	gmbhand
1	skin),
1	breast),
1	colon).
1	lantana
1	langsdorffii,
1	momordica
1	charantia.
1	charantia
1	fucata
1	charantia,
1	(nq)
1	(1.7μm)
1	0.88μg/ml
1	(4.7μm)
1	0.69μg/ml
1	(3.7μm)
1	bromo-substituent
1	juglone,
1	nq
1	juglone
1	halogen
1	5-methoxy-1,4-naphthoquinone,
1	(hsrs)
1	8p24.
1	hsrs.
1	hsrs,
1	alleles),
1	1,4-naphthoquinone
1	leucocephala
1	2.7-6.6
1	3-arylamino
1	3-alkoxy-nor-β-lapachone
1	system),hct8
1	para-nitro
1	orthonitro
1	lapachones,
1	blainvillea
1	rhomboidea
1	-tigloyloxy-grazielia
1	derrone,
1	acacetin,
1	7-methyl
1	p-(1-methyl-ethan-1-ol)-phenol.
1	(1h
1	hreims)
1	7-o-metyl-luteolin,
1	hplc-dad-ms/ms
1	provenances
1	electrochemically
1	hplc-dad-ms
1	hplc-dad-ms/ms.
1	(asclepiadaceae)
1	assessments,
1	acetate-
1	acetone-treated
1	53.1%,
1	compound(s)
1	tumor-decreasing
1	program,which
1	(2),the
1	occi-dentale)
1	lipid,and
1	fused-ring
1	g-lactones,phthalides.
1	(hl-60
1	leukemia,sf295
1	(6),and
1	interestingly,1a
1	damage,triggering
1	diterpene,
1	cdcl3
1	clerodane,
1	c(18)
1	c(19)
1	2-(r-phenyl)amino-3-(2-methyl-propenyl)-[1,4]-naphthoquinones
1	4-ferrocenyl,
1	4-me,
1	3-me,
1	4-no2
1	nor-lapachol
1	[2-hydroxy-3-(2-methylpropenyl)-1,4-
1	naphthoquinone]
1	ome,
1	2b),
1	half-wave
1	aminonaphthoquinones
1	3-propenyl
1	2a-k
1	hammett
1	phenylamino
1	methoxy-nor-lapachol
1	4-ferrocenyl
1	2c.
1	pbe1pbe
1	functionals
1	6-31g(d)
1	3-(2-phenylhydrazone)-naphthalene-1,2,4-trione
1	keto-hydrazone
1	ib)
1	enol-azo
1	mol-1)
1	mol-1),
1	phenylene
1	hl1-hl13,
1	2-hydroxy-1,4-naphthoquinone
1	arylamines
1	4-n
1	2-c6h5,
1	4-cl,
1	2-i,
1	4-cooh,
1	3-cooh,
1	4-no2,
1	3-no2,
1	2-no2).
1	(against
1	lines)
1	hl1-hl13
1	[cu(l1-13)2],
1	3-i),
1	complexation.
1	[cu(l13)
1	2]
1	duguetia
1	furfuracea
1	(annonaceae)
1	leishmanicidal.
1	dicentrinone
1	β-n-oxide
1	9.32
1	caseobliquins
1	bioactivity-directed
1	rel-6β-hydroxyzuelanin-2β-benzoate
1	rel-2α-hydroxyzuelanin-
1	6β-benzoate
1	2β-hydroxyzuelanin-6β-
1	cinnamate
1	clerodanes
1	diterpenoids
1	kauren-19-oic
1	14-hydroxykaurane
1	(k562,
1	sf295)
1	9.1-14.3
1	ka-treated
1	(5-bromo-2′-deoxyuridine
1	intercalates
1	10α-acetoxy-3-oxo-1,7αh,6,11βh-guai-4-en-6,12-olide
1	isofotosantonic
1	10α-hydroxy-3-oxo-1,7αh,6,11βh-guai-4-en-6,12-olide
1	lumisantonin
1	acid/water
1	reactors
1	diisopropyl
1	organolithium
1	3-oxo-7αh,6βh,11-(phenylselenyl)-eudesma-1,4-dien-6,12-olide
1	3-oxo-7αh,6βh-eudesma-1,4,11-trien-6,12-olide
1	11,13-dehydrolumisantonin
1	10α-acetoxy-3-oxo-1,7αh,6βh-guai-4,11-dien-6,12-olide
1	(9).
1	10α-acetoxy-3β-hydroxy-1,7αh,6,11βh-guai-4-en-6,12-olide
1	3β,10α-hydroxy-1,7αh,6,11βh-guai-4-en-6,12-olide
1	(11).
1	uacc-257
1	(lung),
1	ovacar-8
1	(ovarian),
1	a704
1	(renal),
1	0.36-14.5
1	α-methylidene-γ-butyrolactone
1	timeline,
1	reality.
1	muell.
1	arg.,
1	'velame-de-cheiro',
1	kinds,
1	constituents,
1	48.0
1	20-mg/kg
1	2-azetidinones
1	2h-azirine
1	2-azetidinone
1	2-formyl-3-phenyl-2h-azirine-n-arylimines
1	diphenylketene.
1	cns).
1	hydroalcohol
1	(mda-mb-435),
1	thiazolyl
1	annonaceae,
1	apocynaceae,
1	clusiaceae,
1	flacourtiaceae,
1	sapindaceae,
1	sapotaceae,
1	zingiberaceae.
1	19.1
1	lingua
1	simarouba
1	glaucarubinone,
1	gtg-banded
1	(hsr)
1	re-incubated
1	hsr
1	(hsrs
1	chromosomes)
1	peltata
1	multigram
1	straight-forward
1	extraction-column
1	mono-o-methyl,
1	mono-o-benzyl,
1	o,o-dibenzyl
1	o,o-dibenzoyl
1	0.67-22.52
1	mono-o-methyl
1	lh-60
1	(melanoma).
1	labile,
1	{5,6-dihydro-1-[(2e)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1
1	h)-pyridinone}
1	alkamide
1	tuberculatum.
1	(mnpces).
1	andean
1	sphaerica
1	betae
1	8-hydroxy-6-methoxy-3-methylisocoumarin
1	(22e,24r)-ergosta-4,6,8(14),22-tetraen-3-one
1	pimara-7,15-dien-3-β-ol
1	gc/ms,
1	homo-
1	hetero-nuclear
1	(hmqc,
1	cosy
1	noediff)
1	rotation.
1	bioprospecting
1	guanidine-type
1	nitensidines
1	pterogynine
1	pterogynidine
1	galegine
1	pterogyne
1	nitens.
1	sf-245
1	lichexantonicum
1	depsidone
1	xanthone
1	depside
1	atranorin.
1	o-alkyl
1	mda/
1	435).
1	lichexanthone
1	norlichexanthone,
1	3-o-
1	methylnorlichexanthone,
1	3-o-methyl-6-o-prenylnorlichexanthone,
1	3,6-di-o-prenyl-norlichexanthone,
1	3,6-bis[(3,3-dimethyloxyran-2-il)methoxy]-1-
1	hydroxy-8-methyl-9h-xanten-9-one
1	3,6-bis[3-(dimethylamine)propoxy]-1-
1	hydroxy-8-methyl-9h-xanten-9-one.
1	stilbene-based
1	perkin
1	(41.7
1	isobrucein
1	1,12-diacetylisobrucein
1	12-acetylneosergeolide
1	franciscana,
1	5-27
1	1.0-4.0
1	3.2-4.4
1	75.0
1	larvicides.
1	feldmannii
1	(cf-pls).
1	48.62
1	48.16%
1	48.66
1	68.32%.
1	cf-pls-treatment.
1	cf-pls.
1	folicules
1	murrill,
1	polysaccharides;
1	α-(1
1	4)-glucan-β-(1
1	6)-glucan-protein
1	host-mediated
1	polysaccharide.
1	resonance)
1	1he
1	(infrared)
1	mode).
1	cinco
1	derivados
1	1,2,3-triazólicos
1	nor-β-lapachona
1	azidonaftoquinona,
1	avaliada
1	linhagens
1	células
1	neoplásicas:
1	(sistema
1	nervoso
1	central),
1	(cólon),
1	(leucemia),
1	(próstata)
1	(melanoma
1	murino).
1	0,43
1	9,48
1	obtidos.
1	3-(4-(1-hidróxicicloexil)-1h-1,2,3-triazol-1-il)-2,2-dimetilnafto
1	l[1,2-b]furan-4,5-dione
1	apresentou-se
1	altamente
1	encontrado
1	doxorubicina
1	(controle
1	positivo).
1	tentativa
1	obter
1	físico-químicos
1	(potencial
1	redução
1	citotóxica,
1	estudos
1	realizados
1	tampão
1	acetato,
1	4,5,
1	eletrodo
1	carbono
1	vítreo,
1	calculados
1	(clog
1	interação
1	estrutural
1	conjugativa
1	sistema
1	quinônico
1	triazólico,
1	observou-se
1	influência
1	heterocíclico
1	comportamento
1	voltamétrico,
1	deslocamento
1	anódico
1	potenciais
1	redução.
1	verificou
1	citotóxica.
1	outro
1	lado,
1	comparação
1	atividades
1	tripanocidas,
1	já
1	descritas,
1	reafirmou
1	tendência
1	maior
1	biológica
1	quinonas
1	eletrofílicas
1	direta,
1	verificar
1	influencia
1	citotóxica:
1	quanto
1	lipofilia
1	p),
1	citotoxicidade
1	nor-β-lapachone-based
1	azidonaphthoquinone
1	(prostate)
1	melanoma).
1	9.48
1	3-(4-(1-hydroxycyclohexyl)-1h-1,2,3-triazol-1-yl)-2,2-dimethylnaphtho[1,
1	2-b]furan-4,5-dione
1	triazole),
1	voltammetric
1	reconfirmed
1	electrophilicity
1	cytoxicity,
1	©2009
1	qu
1	imica.
1	triperpenoids
1	(3-7)
1	furanosesquiterpene
1	ximenia
1	olacaceae.
1	htc-8
1	gc-fid.
1	monoterpenoids,
1	constituent.
1	(33.9-17.0%),
1	p-cymene
1	(22.3-21.6%),
1	camphor
1	(13.0-3.1%)
1	knot
1	meloidogyne
1	incognita.
1	incognita,
1	hydromethanolic
1	numbered
1	promyeloblastic
1	stearate),
1	(cholesterol,
1	campesterol,
1	β-sitosterol),
1	{(1,2-propanediol,
1	3-(heptadecyloxy),
1	1,2-propanediol,
1	3-[(methyloctadecyl)oxy]}
1	(thymidine
1	2′-deoxyguanosine).
1	anthracyclines,
1	mitoxantrones
1	lapachol,
1	2-butanoylamine-1,4-naphthoquinone
1	2-propanoylamine-1,4-naphthoquinone
1	2-amine-1,4-naphthoquinone
1	potente
1	33.48
1	42.35%
1	37.65
1	55.24%
1	enzimatic
1	aminotransferase-ast
1	aminotransferase-alt),
1	paramenter
1	tubes;
1	ec50values
1	3.35
1	2.89
1	l-1for
1	ec50was
1	l-1regardless
1	acceptable,
1	minimization
1	glassware.
1	phytochemicals
1	spices
1	divaricatum.
1	38.71%
1	40.68%
1	spice
1	(mncl2
1	4h2o).
1	mncl2
1	4h2o.
1	clastogenicity
1	piperaceae
1	amides,
1	piplartine.
1	tuberculatum,
1	stationary-or
1	exponential-growth
1	piplartine-induced
1	7h2o.
1	(svlv)
1	(svhv)
1	svlv.
1	alginate.
1	cross-links,
1	micronucleus.
1	mg/m2)
1	38.7%
1	mg/m2,
1	piplartine-
1	5-fu-treated
1	28.67%
1	47.71%,
1	68.04%.
1	(0.4;
1	tripan
1	martiussi
1	benth
1	(labiatae)
1	procera.
1	fractionating
1	pronase,
1	(dtt)
1	peperomia
1	elongata
1	(piperaceae)
1	(hexane),
1	hexane:acoet,
1	insoluble),
1	11.6
1	hexane:
1	leaves)
1	(prostate),
1	nor-β-lapachone.
1	nor-α-lapachone
1	ortho-derivative.
1	bisphosphosnate
1	(mtx)
1	(0,1
1	cell/ml
1	mtx
1	radioluscency
1	radiotransparence;
1	exherted
1	osteoprotective
1	mandibles.
1	maxillaries
1	benzofuran
1	benzopyran
1	harpalyce
1	derivatives:
1	a-i,
1	leiocarpin,
1	medicarpin,
1	cabenegrins
1	a-ii,
1	maackiain
1	leiocarpin
1	a-i.
1	leiocarpin.
1	lectin-binding
1	sperms
1	33.4
1	inactivated.
1	lactotransferrin.
1	competencies
1	α-naphthyl
1	treated-animals
1	(sls)
1	(rad3),
1	(rad6),
1	(rad52),
1	15-deoxygoyasenzolide
1	15-deoxygoyazensolide-induced
1	15-deoxygoyazensolide,
1	sl,
1	(al
1	3+
1	neurodegeneratives
1	(alcl
1	prescreen
1	tachia
1	grandiflora
1	maguire
1	weaver
1	(gentianaceae)
1	srb
1	(mcf-7)
1	(hct-8)
1	butanol,
1	water-methanol
1	eluent
1	(leukemia
1	previously)
1	ic50.
1	(phaeophyta)
1	(svhv
1	svlv)
1	alginates,
1	74.8%
1	mg/m2/day,
1	1.89,
1	mg/m2/day.
1	alginates-antitumor
1	treated-animals.
1	3-benzyl-furan-2(5h)-one
1	(2a)
1	3-(4-bromobenzyl)-furan-2(5h)-one
1	(2b)
1	tbdmsotf
1	tert-butyldimethylsilylfuran
1	ethers.
1	furans
1	3-benzyl-5-arylidene-furan-2(5h)-one
1	nostoclide
1	lactones,
1	2,3,9-trimethoxypterocarpan,
1	molt-4,
1	k562)
1	peptidyl-like
1	1,3-benzodioxole
1	(4f)
1	(4g)
1	safrole.
1	cycle-nonspecific'
1	(38%
1	cycle-specific'
1	{5,6-dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1h)pyridinone}
1	jukart,
1	molt-4
1	5-bromo-2'-deoxyuridine
1	piplartine-mediated
1	tricyclo[6.2.1.0
1	2,7]undeca-4,9-dien-3,6-dione
1	cage-like
1	ascidians.
1	2′-deoxyuridine
1	2′-deoxyinosine
1	2′-deoxyguanosine
1	cholestanol,
1	cholestanone
1	1-heptadecyloxy-2,3-
1	propanediol
1	1-nonadecyloxy-2,3-propanediol
1	phytomedicines
1	etc.,
1	growing.
1	8500
1	shoreline
1	"phytochemistry"
1	c28-steroidal
1	ergostane
1	actvity
1	arborescens,
1	concentration-dependent,
1	3.5 μm
1	5-bromo-2
1	́-deoxyuridine
1	20 μm)
1	cucurbitacins,
1	pentahydroxy-11,22-dioxocucurbita-5-en
1	(cucurbitacin
1	pentahydroxy-22-oxocucurbita-5-en
1	2,3,16,20(r),25-pentahydroxy-22-
1	oxocucurbita-5,23(e)-diene
1	(deacetylpicracin,
1	(29.6
1	9.1)
1	(56.8)
1	(38.8
1	3.0)
1	(76.6)
1	(μm),
1	{5,6-dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-
1	2-propenyl]-2(1h)pyridinone}
1	{1-5-(1,3)-
1	benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine}
1	piper.
1	amides.
1	52.3%
1	55.1
1	56.8%
1	microvesicular
1	benth.
1	tanshinone
1	7β-hydroxy-11,14-dioxoabieta-8,12-diene
1	7α-acetoxy-12-hydroxy-11,14-dioxoabieta-8,12-diene
1	(7α-acetoxyroyleanone)
1	means.
1	(ent-kaur-16-en-19-oic
1	hypotensive,
1	(v79)
1	5,10,
1	methylmethanesulfonate
1	5α-ethoxy-6bβ-hydroxy-5,6-dihydrophysalin
1	blastulae.
1	cyclohexanone
1	c-5
1	c-6.
1	angulata.
1	in-vitro,
1	15.18
1	2.43
1	angulata,
1	n-hexane,
1	wood
1	esenbeckia
1	almawillia
1	(rutaceae)
1	mcf-7).
1	3,3-diisopentenyl-n-methyl-2,
1	4-quinoldione
1	2-12,
1	[markus,
1	w.m.,
1	r.c.,
1	18-22;
1	j.m.,
1	w.,
1	reno,
1	nicotine-induced
1	hi]
1	305,
1	525-530;
1	sampaio,
1	l.f.s.,
1	hamassaki-britto,
1	d.e.,
1	braz.
1	603-613].
1	-protein.
1	-protein
1	calmidazolium,
1	/calmodulin,
1	carbohydrate-recognizing
1	96.3
1	glycoconjungate
1	binding-proteins
1	n-acetylglucosamine/n-acetylneuraminic
1	binding-protein
1	fitc-conjugates
1	fitc-conjugates.
1	embryotoxicity
1	alibertia
1	myrciifolia
1	spruce
1	schum.
1	apometzgerin,
1	apometzgerin
1	pterocarpans:
1	(+)-3,10-dihydroxy-9-methoxypterocarpan,
1	(+)-3,9-
1	dimethoxypterocarpan
1	[(+)-homopterocarpin],
1	(+)-2,3,9-trimethoxypterocarpan,
1	(+)-3,4-dihydroxy-9-methoxypterocarpan
1	(+)-3-hydroxy-9-methoxypterocarpan
1	[(+)-medicarpin],
1	flonbundum,
1	-8.10
1	-7.91
1	-7.97
1	cleavages,
1	2-methoxy
1	bangladeshi
1	indicum
1	19.6
1	frist
1	aegle
1	indicum.
1	indicum,
1	moringa
1	oleifera
1	aegles
1	isoflavonoids,
1	7-hydroxy-6,4′-dimethoxy-isoflavonequinone
1	2′-hydroxy-6,4′,6″,4‴-tetramethoxy-[7-o-7″]-
1	bisisoflavone
1	3-hydroxy-9-
1	methoxypterocarpan
1	(medicarpin),
1	3,10-dihydroxy-9-methoxypterocarpan,
1	3,9-dimethoxypterocarpan
1	(homopterocarpin)
1	3,4-dihydroxy-9-methoxypterocarpan
1	(vesticarpan)
1	2′,4,4′-
1	trihydroxychalcone
1	(isoliquiritigenin),
1	7,4′-dihydroxyflavanone
1	(liquiritigenin)
1	3-6
1	{5,6-dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-trans-2-propenyl]-2(1h)
1	pyridinone}
1	{1-[5-(1,3)-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]
1	piperidine},
1	32.3
1	non-isoprenoid
1	macrolactones
1	constitutents
1	(cnsl).
1	(scrophulariaceae)
1	o-naphthoquinone
1	water/alcohol
1	(1as*,1bs*,7as*,8as*)-4,5-dimethoxy-1a,
1	7a-dimethyl-1,1a,1b,2,7,
1	7a,8,8a-octahydrocyclopropa[3,4]cyclopenta[1,2-b]
1	naphthalene-3,6-dione
1	meroterpenoid
1	benzoquinone,
1	microphyllaquinone
1	naphthoquinone,
1	globosa.
1	quercetin-3-o-glucoside,
1	eupatorium
1	ballotaefolium.
1	furanoheliangolide
1	(goyazensolide)
1	furaheliangolide
1	melanome
1	(hae)
1	aeolanthus
1	suaveolens
1	(ashae-h),
1	(ashae-a),
1	(ashae-e)
1	(ashae-ppt)
1	ashae-a
1	ashae-e
1	ashae-h.
1	myorelaxant
1	rota
1	arborescens
1	(solanaceae)
1	(17s,20r,22r)-5β,6β:18,20-diepoxy-4β,18-dihydroxy-1-oxowitha-24-
1	enolide
1	18s),
1	18s).
1	2,3-unsaturated
1	aegiphila
1	ihotzkyana
1	uncinatone,
1	cyrtophyllone
1	teunvicenone
1	sugiol
1	12,16-epoxy-11,14-dihydroxy-6-methoxy-17(15-16)-
1	abeo-abieta-5,8,
1	11,13,15-pentaene-3,7-dione.
1	3-(4,5-dimethyl-2-
1	thiazolyl)-2,5-diphenyl-2h-tetrazolium
1	11,14-dihidroxy-8,11,13-abietatrien-7-one.
1	cleavages.
1	amburana
1	cearensis
1	isokaempferide,
1	cearensis.
1	kaempferol.
1	isokaempeferide
1	millar,
1	1977,
1	monniot
1	(sluiter,
1	1895),
1	trididemnum
1	dellechiajei
1	(della
1	valle,
1	1877),
1	(v/w).
1	(ld50=34.7
1	(ic50=74.8
1	(ic50=35.3
1	175.2
1	lonchocarpus
1	derricin,
1	lonchocarpin,
1	fertilized
1	(26.2-35.3)
1	(42.1-62.3)
1	sericeus,
1	(13.7-22.6),
1	13.0
1	(12.0-14.0)
1	(5.6-19.1)
1	μg/25
1	oleo-resin
1	84.2μm)
1	44.7μm
1	<10μm
1	78μm
1	74.0
1	56.4μm,
1	auxemma
1	taub.
1	boraginaceae
1	"pau-branco".
1	(12.4-27.2)
1	6],
1	(13.7-19.2)
1	6].
1	08.30
1	17.00
1	(2-months-old)
1	age-related,
1	21-day-old
1	[3h]n-methylscopolamine
1	pilocarpine,
1	[3h]gaba
1	trimethylsulfonium,
1	hare
1	brasiliana,
1	trimethylsulfonium-induced
1	2.70
1	4.16
1	pa2
1	5.79,
1	[3h]-nicotine
1	27.1
1	cholinoreceptors,
1	purine,
1	1,3-dimethylisoguanine
1	muscle/myenteric
1	(mol.
1	squirt
1	10.09
1	1.12,
1	viridis,
1	sebastiao
1	(southeastern
1	coast),
1	lh-20.
1	(1h,
1	2d-nmr)
1	alkylpyridine
1	compressa
1	haliclona
1	rubens).
1	(500,
1	da;
1	compressa.
1	antimitosis,
1	petiveria
1	alliacea
1	(phytolaccaceae)
1	ascites.
1	45.02
1	12.40
1	22.40,
1	44.80
1	54.10
1	neofiti-papi,
1	miranda-rodrigues,
1	gouveia.
1	-adrenoceptors
1	(α2a/2c-ar-/-)
1	(hbm)
1	α2a-ar,
1	α2b-ar
1	(α2c-ar-/-)
1	hbm
1	th-induce
1	(α2a-ar-/-),
1	elbow
1	trustees
1	tear,
1	advised
1	recommendation.
1	infraspinatus
1	shoulder,
1	repaired.
1	repairs.
1	biomechanically
1	tear
1	humerus
1	ossifications
1	grecco
1	emonstrated
1	(α2a/2c-ar-/-).
1	α2a/2c-ar-/-
1	(t3).
1	α2car-/-
1	thyrotoxic
1	(bv/tv)
1	(tb.n),
1	(tb.sp)
1	three-point
1	tibia.
1	bv/tv,
1	tb.n
1	(tb.th),
1	tb.sp,
1	l5,
1	osteogenesis,
1	denitrosylase
1	osteoblastogenesis
1	(fabp4).
1	s-nitrosylation.
1	reductase-dependent
1	osteogenesis.
1	microtomography
1	(micro-ct)
1	(pui),
1	(f5),
1	single-rooted
1	protaper<sup>®</sup>
1	f4
1	(dentsply
1	maillefer)
1	hydroxide/propylene
1	paste.
1	(pui)
1	(file
1	f5),
1	(f4,
1	(skyscan
1	1174,
1	resolution:
1	14.36
1	microtomographic
1	anova/tukey's
1	kruskal-wallis/student-newman-keuls
1	(alpha:
1	(6.4%;
1	ca(oh)<inf>2</inf>.
1	(6.4%)
1	(3.8%;
1	α<inf>2a</inf>-ar,
1	α<inf>2c</inf>-ar
1	(α<inf>2a/2c</inf>-ar<sup>-/-</sup>
1	(abmd)
1	dexa),
1	microstructural
1	μct)
1	stiffness)
1	osteoprotegerin,
1	β<inf>1</inf>-ar
1	α<inf>2</inf>-ar
1	phosphate),
1	non-immunosuppressed
1	critical-sized
1	grafts;
1	2–5
1	histomorphometrically,
1	60.27%
1	16.13%
1	23.02%
1	38.35%
1	19.59%
1	51.48%
1	0.30)
1	61.80%
1	2.14%
1	0.88)
1	(arβ1-3)
1	arβ2
1	(arβ2ko).
1	arβ1,
1	arβ3
1	cold-and
1	β-receptor
1	(db)
1	(ko
1	(β1ko))
1	(hfd;
1	steatohepatitis.
1	iodothyronines,
1	sodium-independent
1	(oatp1),
1	(ntcp),
1	(lat1)
1	(lat2),
1	(mct8).
1	1-9
1	mct8,
1	oatp1
1	ntcp
1	lat1
1	(analyzed
1	differentiation).
1	lat2,
1	yoghurt),
1	sham-ovariectomized
1	(sham-ovx)
1	(c-ovx)
1	(c-sovx),
1	sham-ovx,
1	ml/(kg
1	day))
1	right-side
1	(bmd).
1	2+-permeable
1	d-dependent
1	exocrine
1	trpv6,
1	(3.8-fold)
1	(2.4-fold).
1	(0.25%)
1	hypocalcemia.
1	deoxypyridinoline
1	"rescue"
1	corneum,
1	alopecia
1	(ord)
1	125i-rt3
1	125i-t4
1	6-n-propylthiouracil
1	insensitive,
1	thyrotoxicosis.
1	calvaria
1	much.
1	confluence.
1	mg132.
1	[1,25(oh)2vb]-induced
1	confluence,
1	dysgenesis,
1	factor-1;
1	(trs)
1	hormone-responsive
1	10−8
1	reverse-transcribed,
1	true-positive
1	(atpase-6).
1	true-positives
1	including;
1	nonmuscle
1	alkali
1	(nm
1	amlc),
1	atpase-6,
1	t3-induction
1	(2.1-fold).
1	1.4-fold,
1	1.7-fold.
1	osteoblast-derived
1	∼3-fold
1	∼5.4-fold,
1	osteopontin,
1	∼4-fold
1	∼1
1	cells/dish
1	cells/dish.
1	dihydroxyvitamin
1	(1,25d3)
1	(means
1	s.e.m.)
1	0.2-fold)
1	run-off
1	5′-flanking
1	-1750
1	dose-,
1	confluence-dependent
1	605).
1	22-97
1	densitometer.
1	53.7
1	9.5)
1	-2.5
1	osteoporosis
1	h(a);
1	h(m);
1	(h(a)/h(p)
1	h(m)/h(p))
1	(20-49
1	(50+
1	l2-l4
1	heights;
1	+0.1.
1	h(a)/h(p)
1	+0.01,
1	-0.72,
1	bmd;
1	8-15%
1	bono
1	81-day-old
1	[bw]/day),
1	(dxa)
1	(l2-l5)
1	sem)-day-old
1	(ovx);
1	(~1.0
1	bw/day;
1	dose);
1	(~2.0
1	bw/day);
1	ovx+2xt
1	dxa
1	85.
1	l2-l5,
1	2xt4
1	substantially,
1	(trabecular
1	cortical),
1	(bw),
1	(lm)
1	(50.1
1	menopause
1	(l2-l4)
1	(neck)
1	(40-79
1	20-69
1	years-age)
1	(40-49
1	(mbmd)
1	30-39
1	(60-79
1	mbmd-bw
1	0.97;
1	0.72%/kg).
1	spine,
1	(-8.3
1	-5.7%/decade)
1	(fourth
1	decade)
1	40-59
1	60-79
1	69,
1	north-american
1	populations;
1	north-americans;
1	bmd-age.
1	rezende
1	antropozoonosis
1	gp63
1	(mca),
1	ecotin-like
1	isp3
1	triterpenoid
1	destabilizing
1	misbalance
1	mitochondrial-lysosomal
1	lipofuscinogenesis,
1	lipofuscin,
1	imperfect
1	senescence-inductors.
1	(ecs).
1	monocyte-ec
1	binding.cd100
1	monocyte-endothelial
1	pro-death
1	mimics,
1	in-silico.
1	essentially,
1	bafilomycin-a1.
1	lysosome,
1	mimics.
1	laden
1	semaphorin
1	cd100/sema4d.
1	atheroprotective
1	engulfment
1	luque
1	forward.
1	dye-staining
1	immunoassaying
1	(cvs),
1	3-[4,
1	5-dimethylthiaolyl]-2,
1	5-diphenyl-tetrazolium
1	(nru)
1	nru
1	(aau),
1	b16-f10,
1	hacat,
1	mes-sa,
1	mes-sa/dx5
1	microplate.
1	triterpenes,
1	maytenin
1	barks
1	(celastraceae).
1	243.65
1	46.61
1	193.63
1	23.85
1	(qsoxs)
1	qsox2.
1	qsox1,
1	secretion/maturation
1	subendothelium,
1	emulating
1	qsox1.
1	data-oriented
1	ontologically-linked
1	(krt4,
1	vwf
1	comp);
1	(klk7,
1	lama3
1	evpl);
1	(evpl,
1	klk6,
1	klk7,
1	klk8,
1	serpinb13,
1	serping1
1	slpi).
1	hklk7
1	unanswered.
1	display.
1	(vdr).
1	signals)
1	interdisulfide
1	thiol-based
1	pdis
1	insightful
1	coevolutional
1	stolf
1	nonmalignant
1	leave-1-out
1	cross-validation
1	trios,
1	>92%
1	3800
1	class).
1	notice,
1	1300×.
1	glass-array
1	368
1	(arna)
1	(dye-swap
1	measurements).
1	(1.45-fold
1	2.02-fold
1	(r2=0.962)
1	(r2=0.975),
1	i.e,
1	(igfbp5),
1	199,
1	fapesp/licr
1	4512
1	t-statistics,
1	deviations.
1	self-organizing
1	supervised
1	single-array
1	stem-cell
1	cd40l–cd40
1	ifn-γ/interleukin
1	(rna-seq),
1	virus–transformed
1	(b-ebv)
1	chemoattraction,
1	tryptophanyl-transfer
1	ifnrd
1	1952.
1	needs,
1	semi-structured
1	responded,
1	783
1	diagnosis>24
1	poliomyelitis
1	polio
1	enumerated,
1	20.3%
1	116)
1	xla
1	successes
1	alike.
1	123).
1	22 months,
1	67)
1	(was)
1	71.6%.
1	(13%).
1	referral,
1	hasten
1	kindreds.
1	(t-cell
1	(kappa-deleting
1	krecs.
1	scid.
1	bcgosis,
1	moniliasis;
1	(c.2350g
1	nonfunctional.
1	po-162
1	“chronic
1	mimetizing
1	sarcoidosis”
1	micheli
1	barsioti.
1	michele
1	baziotti
1	roxo-júnior,
1	pérsio
1	roxo-júnior
1	updated.
1	frança,
1	maximo,
1	lambert,
1	forte
1	(cd40lg)
1	(x-higm),
1	28-year-old
1	(cvid).
1	pharyngotonsillitis,
1	rhinosinusitis,
1	dermatosis,
1	helminthiasis.
1	6-nucleotide
1	cd40lg,
1	complexities
1	vendramini,
1	ishizuka,
1	borgli,
1	(bcgitis).
1	manifestation,
1	bullous
1	bcgitis.
1	c.376t
1	c126r
1	il-12r1
1	il-12–
1	il-23–dependent
1	1/600,000
1	1/600
1	1/1000
1	1/10,000
1	ethnicity-adjusted
1	−8
1	89.31;
1	1725).
1	4.2%,
1	ifn-,
1	jak,
1	p1057a
1	tyk2.
1	interferon-?
1	stat4,
1	(pstat4)
1	(b-lcl)
1	c.1952
1	a>t
1	(p.e651v)
1	father.
1	pstat4,
1	b-lcl
1	pstat4.
1	rhil-12.
1	ferreira-duarte,
1	pinheiro-torres,
1	anhê,
1	desouza.
1	(apc).
1	il-8-
1	vla4,
1	lfa-1a
1	3.5-fold
1	1:3500-5000
1	(abd)
1	created.
1	(rhcd40-muig)
1	13-acetate,
1	scd40l,
1	17,234,
1	2346-19,279
1	18,289,
1	413-19,883
1	hcs
1	47.5,
1	33.7-26.7
1	(88.7
1	(89.2
1	20.1%
1	(27.1
1	18.8%
1	allelic,
1	life-saving,
1	hsct,
1	hla-identical
1	hla-mismatched
1	hla-haploidentical
1	4-108
1	(xhigm)
1	jeffrey
1	modell
1	1964
1	8.5 ± 7.2 years
1	0.1-36.2 years).
1	(p = .671).
1	1987-1995;
1	1995-1999.
1	4.9;
1	2.2-10.8;
1	p < .001).
1	survivors,
1	karnofsky/lansky
1	(p < .001).
1	1 year
1	(1964-2013).
1	well-being,
1	optimism
1	guarded
1	consensus,
1	production-related
1	(routes
1	intervals),
1	(major,
1	reporting),
1	resumo
1	últimos
1	anos,
1	novas
1	primárias
1	defeitos
1	genéticos
1	têm
1	sido
1	descritos.
1	recentemente,
1	imunoglobulina,
1	aprimoramento
1	composição
1	subcutânea,
1	tornaram-se
1	orientar
1	médico
1	membros
1	grupo
1	assessoria
1	alergia
1	imunologia
1	produziram
1	um
1	documento
1	teve
1	revisão
1	narrativa
1	literatura
1	experiência
1	profissional,
1	atualizando
1	consenso
1	publicado
1	apresentam-se
1	conhecimentos
1	indicações
1	eficácia
1	aspectos
1	relevantes
1	produção,
1	utilização
1	(vias
1	administração,
1	farmacocinética,
1	intervalos),
1	efeitos
1	adversos
1	(principais
1	efeitos,
1	prevenção,
1	notificação),
1	monitorização
1	paciente,
1	apresentações
1	obtenção
1	recurso
1	terapêutico
1	kappa-deleting
1	(krecs)
1	trecs,
1	(ibm®,
1	armonk,
1	ny,
1	6,881
1	1,006
1	4/μl
1	trecs.
1	1,097
1	krecs/μl,
1	krecs/μl
1	meta-analysis
1	hla-drb1,
1	hla-dqb1
1	statement.
1	fifty-six
1	meta-analysis.
1	hla-drb1*08:03
1	1.95,
1	1.29–2.96),
1	hla-dqb1*06:01
1	1.78,
1	1.39–2.28),
1	hla-dqb1*06:09
1	2.27,
1	1.04–4.96)
1	hla-dqa1*01:01
1	1.11–4.03)
1	hla-drb1*07:01
1	0.74,
1	0.56–0.97),
1	hla-dqb1*03:01
1	0.77,
1	0.61–0.97),
1	hla-dqb1*04:02
1	0.57,
1	0.39–0.83),
1	hla-dqa1*04:01
1	0.50,
1	0.26–0.95)
1	hla-dqa1*05:01
1	0.48–0.92)
1	caucasians
1	hlas
1	susceptibility/resistance,
1	controls’
1	ptb,
1	admixture.
1	tradition
1	persian
1	asia1-3,
1	disease4.
1	variome
1	1,111
1	subregional
1	bottlenecks.
1	(rohs)
1	theorized
1	‘genetic
1	purging’.
1	sevenfold.
1	8715
1	elution,
1	ssps.
1	8,682
1	2,181
1	(0.56%)
1	trecs/μl)
1	reanalyzed.
1	trecs/μl).
1	full-term
1	retest
1	teams
1	vaccination;
1	ulcerans.
1	(76%)
1	(27%),
1	(pca),
1	estimations,
1	studiess
1	(gwsa).
1	(wes)
1	filters.
1	gwsa,
1	1,000-kb
1	0.94
1	genome-
1	76.3%
1	wes,
1	17.7%
1	83.5%,
1	7.4%,
1	9.1%,
1	substructure,
1	proand
1	(atm)
1	atm,
1	damageresponse.
1	neurodegenerationand
1	overproduce
1	ros-deficient
1	52.7
1	(76.8%),
1	(59.4%),
1	(49.3%),
1	(42%),
1	(41.9%),
1	(29%),
1	(23.2%),
1	(21.7%),
1	(20.3%),
1	(15.9%).
1	p.w361g,
1	p.c282x,
1	p.w483r,
1	p.r226x,
1	p.q93x),
1	c.75_76
1	del.gt
1	hemizygous
1	(rag)
1	(scid),
1	rag-dependent
1	delayed-onset
1	granulomatous/autoimmune
1	(cid-g/ai),
1	anti-ifn-α
1	anti-ifn-ω
1	cid-g/ai
1	rag-deficient
1	s723c/s723c
1	scid,
1	virus-recognizing
1	tlr3/mda5,
1	tlr7/-8,
1	rag-associated
1	macchiaverni
1	blo
1	58.6%of
1	93.5%and
1	unconvincing
1	(th2).
1	2014),
1	fellowships
1	schools,
1	biannual
1	meetings,
1	envision
1	tackle
1	summarises
1	hs-ii,
1	(3c)
1	"super-repressor"
1	upstream,
1	phagocyte-mediated
1	116:
1	2008-2017,
1	rheumatology
1	(bd).
1	(abd;
1	n=30),
1	(ibd;
1	n=31);
1	(sp;
1	n=25);
1	n=30).
1	3-(4,5-dimethylthiazol-
1	2-yl)-2,5-diphenyltetrazolium
1	(zymosan
1	microrganisms)
1	dihidrorhodamine
1	manifestation)
1	(br-bdcafs)
1	sanguinis-
1	br-bdcafs
1	ifnκ,
1	5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-pyrazolo[3,4-b]pyridine-3
1	-yl]-pyrimidin-4-ylamine
1	41-
1	2272
1	answers.
1	4026
1	1628
1	(40.4%),
1	1436
1	962
1	(23.9%).
1	40.3%
1	48.08%
1	(±16.06).
1	18.3%
1	pids,
1	neverending
1	tenacity,
1	abroad,
1	paved
1	pid-centered
1	(lasid
1	asid).
1	registries,
1	pid-related
1	meetings)
1	"expert
1	committee"
1	(iuis).
1	mite,
1	up-to-now
1	aureus-derived
1	icam-1-coated
1	eotaxin-,
1	rantes-induced
1	icam-1-
1	alongwith
1	inflammation/autoimmunity,
1	educative
1	specialties.
1	pulmonologists,
1	gastroenterologists,
1	dermatologists,
1	hematologists,
1	specialists.
1	specialty.
1	immunedysregulation.
1	immunodeficiencies),
1	(icon)
1	document,
1	map3k14
1	(nf-
1	b-inducing
1	nik,
1	nf-
1	lymphopenia,
1	class-switched
1	icosl
1	perturbed.
1	(p=.058)
1	(p=.009).
1	(60/70)
1	(74.3%).
1	42.9%)
1	(hsct).
1	(29%,
1	esmon
1	publicidad.
1	(higm)
1	(lasid).
1	(aid)
1	(cd40lg).
1	microsporidium
1	belli.
1	(tlr1,
1	tlr6)
1	(tlr3,
1	tlr8,
1	tlr9)
1	toll-il-1r
1	(tir)
1	tir-containing
1	tram.
1	irak
1	(irak-1
1	irak-4)
1	(irak-2
1	irak-3/m).
1	hirszfeld
1	wroclaw,
1	poland.
1	(hoxa-as2)
1	hoxa3
1	hoxa4
1	(atra).
1	caspases-3,
1	hoxa-as2-mediated
1	114:
1	2375-2383,
1	ccr3+,
1	vla4+,
1	ccr3+vla4+,
1	gm-csf)
1	ccr3+
1	ccr3+vla4+
1	ccr3-dependent
1	ccr3/vl4
1	vcam-1.
1	subspecialty
1	steadily.
1	aeroallergen
1	excessively
1	internists
1	tribute
1	prof.
1	naspitz,
1	pioneers
1	specialty
1	(pids),
1	killer.
1	kostmann
1	shwachman-diamond
1	insufficiency),
1	stature),
1	proteinosis
1	proteinosis),
1	p14
1	failiure).
1	lad-1(deficiency
1	subunit),
1	lad-ii
1	slex,
1	rolling)
1	lad-iii
1	(caused
1	papillon-lefrève
1	il-23/ifn-γ
1	staphylococcus.
1	prophylaxis,
1	granulocyte-colony-stimulating
1	(g-csf),
1	tolerable,
1	indicator.
1	(28.8%),
1	(32.7%),
1	(38.5%).
1	34.1%
1	45.72%
1	(±17.87).
1	26.6%
1	pediatricians,
1	protein-α),
1	eighty-four
1	(rw)
1	eu/mg)
1	(il)-12p70
1	pulmonol.
1	47:1054-1060.
1	(dhplc)
1	gdna,
1	dhplc.
1	(c.904
1	insc,
1	c.141+5
1	g>t,
1	c.553
1	t>c,
1	c.665
1	a>t).
1	dhplc,
1	counselling
1	(jsle).
1	o2-by
1	diverent
1	classiwed
1	sledai
1	<3)
1	≥3)
1	(56.52%)
1	(43.47%)
1	jsle.
1	inxammatory
1	methylthiazoletetrazolium
1	chemiluminescence;
1	napdh
1	co-incubation,
1	goals,
1	registry,
1	person
1	acinetobacter,
1	condyloma
1	(c.433
1	t>g
1	c.476
1	g>c)
1	(c.484-485insaa)
1	tnfh
1	freeze-drying
1	(efd)
1	raf-1-mediated
1	(4-hydroxy-3-methoxyacetophenone),
1	picrorhiza
1	kurroa,
1	4-fluoro-2-
1	methoxyphenol
1	(f-apocynin),
1	atom,
1	chlorinating
1	(pidds).
1	outreach
1	l-project);
1	programme;
1	(msmd)
1	macrophage-specific
1	'experiment
1	nature'
1	msmd
1	microbicidal,
1	oxygen-dependent
1	co-immunoprecipitating
1	aire,
1	(k17)
1	scalp
1	(pidd).
1	reimbursed.
1	reimbursement
1	pidd,
1	awareness.
1	collaborations
1	gp91-phox,
1	nox2.
1	lists
1	collaborate
1	pediatrician
1	irritability.
1	nitrobluetetrazolium
1	indecating
1	chemoprophylaxis,
1	hla-compatible
1	diapocynin,
1	sirpα,
1	aiha
1	basal;
1	erythrophagocytic
1	aiha.
1	12.04),
1	second.
1	beclomethasone,
1	budesonide
1	salt-wasting;
1	simple-virilizing)
1	(ch50)
1	allotype
1	monomodular
1	well-protected
1	factor-κ-b
1	cyba,
1	ncf1,
1	ncf2.
1	(iκbα-s32a/
1	s36a)
1	epsteinbarr
1	anhidrotic
1	(eda-id),
1	(x91°
1	cgd).
1	s32i
1	(a47°)
1	repressor-transfected
1	patients'cells.
1	repressor.
1	(phagocyte
1	p22-phox,
1	p67-phox.
1	gp91-
1	p22-phox
1	p47-
1	p67-phox
1	gp91-phox)
1	(scd)
1	scd.
1	5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-pyrazolo[3,4-b]
1	pyridin-3-yl]-pyrimidin-4-ylamine
1	(0.3-10 μm)
1	(o2•-)
1	9-(tetrahydro-2-furanyl)
1	22,536)
1	48 h)
1	0.5 mm),
1	endoscopy,
1	scan,
1	bacterioscopy
1	δf
1	508.
1	(cf).
1	affections.
1	genotype-dependent.
1	clinic,
1	pulmonology,
1	dropouts.
1	intervention:
1	7-19
1	(pc20).
1	pc20
1	magnesium.
1	(fvc),
1	(fev1),
1	25-75
1	fev1/fvc
1	fluticasone.
1	countries:
1	mexico,
1	paraguay,
1	3321
1	registered,
1	(53.2%)
1	22.6%
1	inmunodeficiency,
1	agammaglobulinemia,
1	0.72
1	3.79
1	underreported
1	91-kd
1	c.1267_1268insa
1	c.1326
1	médica
1	santiago.
1	members)
1	meningitis;
1	(ch50),
1	c3dg/c3d.
1	(x-cgd).
1	(a47-cgd);
1	δgt
1	feature,
1	pyoderma,
1	sinusitis,
1	abscess.
1	a47-cgd
1	(pbm),
1	mattresses
1	londrina,
1	aspirated
1	beds),
1	cribs).
1	758
1	slides:
1	(69.3%)
1	289.9
1	136.7
1	875.0
1	183.6
1	mites/g.
1	(ncf-1)
1	ncf-1
1	91phox)
1	(saa)-stimulated
1	(normal:
1	hb).
1	phagocytes'
1	(cgpx)
1	(mild,
1	severe).
1	auto-oxidation,
1	(rt)-pcr
1	epstein
1	hexamers.
1	1-5,
1	3-9,
1	7-13.
1	(nitroblue
1	eosoniphilic
1	(ig)e
1	nonwheezing
1	babies.
1	technetium
1	(99tc)
1	upper,
1	gerd)
1	(wbs)
1	(efa)
1	cisapride.
1	ger
1	esophagus;
1	(p<o.05)
1	ger,
1	kindred
1	(ebv)-
1	normal)
1	(1.4%
1	normal),
1	preponderance
1	kindred,
1	(localized
1	(gp91-phox),
1	(ivs12-2a→g).
1	r91x,
1	w106x,
1	r157x,
1	r290x
1	substitutions:
1	e225v
1	c244y.
1	kindreds,
1	epstein-barr-virus
1	x910)
1	'variant'
1	(x91-).
1	x91-
1	x910
1	cytokine-differentiated
1	pmastimulated
1	propositus
1	intron:
1	att/gtaagt
1	att/gtaagc.
1	permanent,
1	septicemia.
1	c3-derived
1	(c3dg/c3d)
1	c3c
1	c3dg.
1	reconstitution,
1	regaining
1	(cousins,
1	degree)
1	3/4
1	obviously
1	heterozygously
1	60.8%
1	101);
1	4.9%
1	id,
1	16);
1	31);
1	60),
1	(national)
1	12.7%.
1	iga-deficient,
1	hypogammaglobulinemic,
1	dissemination;
1	(rhuifn-γ)
1	(neu)
1	(mon)
1	μg/m2of
1	(no2-)
1	(no3-)
1	mon,
1	diuresis),
1	no3-were
1	no3-in
1	lsp1.8.
1	2,608
1	(91.6%)
1	availabilities.
1	2,2′-dipyridyl,
1	down-regulated.
1	v-like
1	pili/fimbriae.
1	(cgnsnpksc)
1	99mtc-hynic-peg4-c
1	(gx1)
1	skmel28
1	mda-mb231
1	mkn45
1	uptakes
1	semisolid
1	“non-inferiority,”
1	biosimilar,
1	biobetters,
1	welfare.
1	ciencias
1	farmaceuticas
1	(biblioteca).
1	nineteenth
1	approved,
1	fc-fusion
1	antibody-drug
1	(adc)
1	glycoengineered
1	immunomodulators,
1	car-t
1	monoclonal-oligoclonal
1	insulinoma,
1	(glp-1).
1	exendin
1	(9-39),
1	technetium-
1	99m.
1	hynic-βala
1	(c-
1	terminus)
1	exendin,
1	(n-
1	terminus).
1	protein-producing
1	per.c6
1	rebmab100
1	picker
1	timeframe
1	(qp)
1	fl)
1	50–55
1	50–55,
1	r6
1	qp,
1	per.c6(®).
1	technetium-99m,
1	radioconjugates.
1	radiocomplexes.
1	microspect/ct
1	profi
1	blocking.
1	tc-hynic-e-[c(rgdfk)-c(gx1)]
1	tc-hynic-peg
1	-c(gx1).
1	nonglioma
1	melanomas,
1	3f12e7,
1	low-ph
1	early-adopted
1	lindegren
1	ovarian-specific
1	α-radioimmunotherapy
1	<sup>211</sup>at-rebmab200.
1	<sup>211</sup>at-rebmab200
1	bioimaging.
1	mx35,
1	biodistribution,
1	single-photon
1	radioimmunotherapy
1	biologicals
1	expiring.
1	comparability,
1	marketing.
1	biosimilarity
1	(qbd),
1	specifications
1	actually,
1	comparability
1	production-process
1	hu3s193,
1	lewis-y
1	resistant/refractory
1	fallopian
1	two-stage,
1	multicenter,
1	mg/m<sup>2</sup>
1	(objective
1	complete/partial
1	[clinical
1	9.77%-46.71%)].
1	16.1).
1	[16.1
1	0.0058)].
1	treatment-related
1	(16.2%).
1	1/2;
1	asparagine-glycine-arginine
1	(ngr)
1	technetium-99.
1	ill,
1	dizziness
1	f(ab)′2-based
1	stings.
1	napi2b,
1	antibody's
1	per.c6®
1	complement-dependent-cytotoxicity
1	rebmab200.
1	dosage.
1	hybridoma,
1	amplifications,
1	phagemid
1	(pcomb3x)
1	digoxin-bsa.
1	checked,
1	fabs,
1	chosen,
1	framework1
1	digoxin-bsa
1	biacore
1	®,
1	glucocerebrosidase
1	(gcr)
1	gaucher
1	gaucher's
1	$
1	cho-dxb11
1	(dhfr-)
1	methotrexate.
1	cell-associated
1	(63-69
1	subclones
1	5.14
1	pg/cell/day
1	producer.
1	biopharmaceuticals
1	radiopeptides
1	(dup-1)
1	s-acetyl-mag3
1	6-carbon
1	aminohexanoic
1	itlc
1	-2.41)
1	-0.39).
1	dup-1.
1	78.32%
1	dup-
1	diagnosis.©
1	pegylated
1	mercaptoacetyltriglycine
1	(mag
1	skmel28).
1	(>97%)
1	99mtc]-mag
1	(7.85±2.34%injected
1	dose/g
1	injection).
1	99ntc]-mag
1	radiobombesin
1	analogues;
1	nano-bombesin
1	(b-morf),
1	bbn
1	(b-bbn)
1	peg),
1	cmorf
1	1:1:2
1	sa:b-morf:b-bbn,
1	99mtc-cmorf
1	morf.
1	(pc-3)
1	(5.06±1.98
1	progressed.
1	1.05±0.35
1	incubations.
1	99mtc-mag3-cmorf,
1	2.58±0.59
1	%id/g
1	b-bala-bbn,
1	(roi)
1	tumor/blood
1	clearance;
1	tumor/muscle
1	5.95.
1	concept.
1	morf,
1	cytosine,
1	worthwhile.
1	fvfc,
1	fitc-conjugated
1	western-blot,
1	sec-hplc,
1	assessedby
1	antibody.the
1	fvfc
1	versions.
1	okt3)
1	(pbmcs),
1	il-10/ifn-γ
1	foxp3.
1	α-(1-4)-amino-2-deoxy-β-d-glucan,
1	deacetylated
1	crustacean
1	nontoxicity,
1	(reverse
1	vesicles)
1	chitosan-revs
1	polyvinilic
1	chitosan-sandwiched
1	(revs-chi)
1	revs.
1	revs/dtxd
1	[aif
1	al(oh)3].
1	titrations.
1	vehiculated
1	revs-aif
1	revs-al(oh)3,
1	poly(lactic-co-glycolic
1	microsphere
1	thimerosal®(tm)
1	thiosalycilic
1	(tsa),
1	diphtheric
1	-sh
1	reinterpret
1	degradation-stabilization
1	microspheres,
1	s-s.
1	preservative.
1	(cdr)-grafting
1	germline-based
1	vh.
1	sub-populations,
1	mouse-human
1	(l37)
1	paratope
1	humanize
1	(vh)
1	(cdrs).
1	(scfvs),
1	capability.
1	straightforward,
1	bubble-column
1	hollow
1	cylinders.
1	do,
1	503
1	productivity,
1	0.019
1	immuno‐therapy,
1	radioimmunotherapy,
1	chemoimmunoconjugates
1	(bimabs).
1	anti‐tenascin
1	(tn)
1	bimabs
1	retrovirus‐mediated
1	geneticin
1	tn,
1	high‐pressure
1	hydroxylapatite
1	mito‐genic
1	tnf‐α
1	tn†
1	pursuing
1	reported:
1	conventionally
1	(x2/3
1	38.00)
1	causation
1	parasite‐infected
1	sex-phenotype
1	(χ<sup>2</sup>
1	0.35).
1	generalization
1	(psp),
1	d‐and
1	l‐phosphoserine,
1	isozyme,
1	post‐translational
1	(psp
1	2‐1
1	3‐1
1	three‐banded
1	isozyme
1	hycanthone
1	methanosulfonate.
1	spelled
1	eliana
1	faquim-mauro.
1	é,
1	faquim-mauro
1	el,
1	lr,
1	d’império
1	13(8):
1	e0202522.
1	https://doi.org/10.1371/journal.pone.0202522
1	(plds),
1	astacin-like
1	(almps)
1	antigen’s
1	lgrec1alp1,
1	almp
1	gaucho.
1	lgrec1alp1
1	(fprs)
1	(lxa4)
1	ctx's
1	cb-but
1	ca-induced
1	p38/erk1/2-mapk
1	fprs
1	dcs;
1	fpr
1	secretory/excretory
1	(clrs),
1	mannose-
1	complex-type
1	pi-alexa
1	clrs,
1	(plds)
1	lgrec1,
1	(egfp)
1	(facs)
1	platelets’
1	paresthesia
1	(sv)
1	(h1r),
1	(h2r)
1	(h3/h4r).
1	(38–91%),
1	(50–59%)
1	pt-18
1	7.5 μg)
1	two-dimension
1	three-dimension
1	α2β1
1	penguins,
1	birds:
1	(iga),
1	(igy).
1	magellanicus).
1	delipidation,
1	one-dimensional
1	batch-to-batch
1	antivenons,
1	pmst3
1	(g4s)3
1	(scfvbap1).
1	scfvbap1
1	scfvbap1-sumo
1	anti-ldl
1	fibrinolysis
1	sumo,
1	mabap1,
1	studies).
1	sub-apoptotic
1	mmp-10.
1	(5-ttgacgttcg-3)
1	[dodab]
1	[cpg]
1	overcompensation.
1	bf/ova/cpg
1	bf/ova.
1	bf/ova/cpg-immunized
1	venom-allergen-like
1	(smvals)
1	scp/taps
1	(sperm-coating
1	protein/tpx-1/ag5/pr-1/sc7)
1	cercarial
1	0-6
1	schistosomulum.
1	eggs'
1	rsmval4
1	smval
1	rubrofemoratus
1	fraterculus.
1	spectrometry)
1	eumenitin-r
1	(lnlkglikkvaslln)
1	eumenitin-f
1	(lnlkglfkkvasllt),
1	eumenitin,
1	emp-er
1	(fdimglikkvagal-nh2)
1	emp-ef
1	(fdvmgiikkiagal-nh2),
1	mastoparan-af
1	(emp-af),
1	dichroism)
1	tfe
1	(trifluoroethanol),
1	dodecylsulfate)
1	hsa/cfa
1	hsa/alum
1	immunised.
1	humoural
1	medically-important
1	(kd),
1	kds
1	(moojeni
1	insularinase
1	neuwiedase).
1	fcγriii
1	ab.
1	il-4/
1	tcr-tg
1	ova+pi-immunized
1	ova+pi,
1	ag-presenting
1	cytokine-deficient
1	il-4-dependent.
1	dinitrophenyl-conjugated,
1	dinitrophenyl-ovalbumin
1	(anti-dnp),
1	(e-asc)
1	protein/
1	(60-85%),
1	(50-70%),
1	(below
1	(70-90%)
1	e-asc/animal
1	anaphylactic-
1	al(oh)3
1	(cfa),
1	alum-injected
1	lgg1.
1	lgg2a
1	il-4-deprived
1	lge
1	suum)
1	il-4-independent,
1	il-4(+/+)
1	il-12(-/-)
1	ab-treated
1	(mhv)
1	specific-pathogen-free
1	mhv-contaminated
1	(mhv+)
1	mhv-negative
1	(mhv-)
1	mhv-infected
1	parasite-antigen
1	anti-cd3-stimulated
1	(piii),
1	(igg1,
1	ige)
1	different:
1	anti-asc
1	piii.
1	th2-dependent
1	cytokine-specific
1	neutralized.
1	asc-induced
1	pansuppression.
1	a)-induced
1	freund’s
1	oa-immunized
1	tetrachloride.
1	2–7.
1	extractable
1	interfere.
1	wine,
1	2019.
1	(zebrafish)
1	consolidated
1	triplex
1	411
1	isoleucine.
1	nt-degrading
1	original.
1	iubmb
1	tells
1	run.
1	heimann
1	pep5-induced
1	clic1
1	plectin
1	fibers'
1	ubiquitin–proteasome
1	ï¿½
1	spectrometry-based
1	peptidomes.
1	certain.
1	(sthdhq7/q7)
1	(sthdhq7/q111)
1	(sthdhq111/q111).
1	glutamines.
1	sthdhq7/q7
1	(nln)
1	endooligopeptidase,
1	nln-knockout
1	nln.
1	proenkephalin,
1	met-enkephalin
1	octapeptide.
1	80's
1	frederic
1	checler
1	colleagues.
1	neurotensin-mediated
1	inhibitor-based
1	neurolysin-knockout
1	mouse.this
1	entitled:
1	peptidomics,
1	cancun
1	guest
1	editors:
1	césar
1	lópez-camarillo,
1	victoria
1	pando-robles
1	bronwyn
1	jane
1	barkla.
1	paradox,
1	carfilzomib,
1	mg132,
1	mg262,
1	mln2238,
1	am114,
1	clasto-lactacystin
1	β-lactone.
1	mg262
1	mln2238
1	(butabindide)
1	(bestatin)
1	peptidome,
1	presume
1	(nscs)
1	nscs
1	oligodendrogenic,
1	oligodendrogenic
1	oligodendrogenesis
1	foreseen,
1	cannabinoids
1	oligodendroglial
1	demyelinating
1	xapelli,
1	agasse,
1	bernardino,
1	schitine,
1	ferro,
1	sebastião,
1	reis
1	malva.
1	5-500
1	hours),
1	50-500
1	bortezomib-mediated
1	gelman
1	(hek)
1	sirna-transfected
1	14-3-3ε,
1	14-3-3ε
1	(vfdvell;
1	vfd-7)
1	(wd)
1	intra-protein
1	disulfides
1	inter-protein
1	anti-glutathione
1	thiolate
1	s-thiolation.
1	s-glutathiolated
1	posing.
1	s-glutathionylated
1	malvezzi
1	persented:
1	peptidomimetics
1	sh3
1	retro-inverso
1	separation-free
1	(ec3.4.24.15;
1	α-neoendorphin,
1	β-neoendorphin
1	circuitry;
1	treated-rats.
1	proenkephalin
1	prodynorphin
1	peptide-generating
1	sh-sy5y,
1	degradome
1	egypt
1	bread
1	biopharmaceuticals.
1	(transporter
1	microglobulin)
1	double-knockout
1	(~2-fold),
1	(kgpgpggpggaggarggagggpsgd)
1	(6-fold)
1	tap1
1	β2microglobulin
1	(ccp1/nna1),
1	metallocarboxypeptidases.
1	nondegenerating
1	ccp1/nna1
1	mouse;
1	3.4.24.15,
1	metallo-oligopeptidase
1	(dcp
1	ace-2)
1	hinge-bend
1	his600.
1	s1′
1	dcp
1	ace-2.
1	ph-profile
1	nh2-terminus
1	tyr605
1	oxyanion
1	(gpcrs)
1	dollars.
1	neurodegenerative,
1	psychiatric,
1	gpcrs.
1	9-residue
1	(rvd-hpα)
1	(vd-hpα)
1	β-hemoglobin-derived
1	(vd-hpβ).
1	rvd-hpα
1	vd-hpα
1	endocannabinoid,
1	2-arachidonoylglycerol,
1	hu-210.
1	lipid-
1	(hek293)
1	9-11
1	(at1r-cho-s).
1	baits
1	α-adaptin
1	substrate-capture
1	(bpp),
1	<enwphpqipp
1	(xc),
1	<eggwprpgpeipp
1	(xiiia)
1	<earpphppipp
1	(xie)
1	residue).
1	(<earpphppippap);
1	bpp-ap.
1	microcirculations
1	μg·μl-1),
1	μg·μl-1)
1	bpp-xie.
1	thiol-rich
1	cleft;
1	intraprotein
1	s-glutathionylated.
1	10 μm.
1	oligomerization.
1	interprotein
1	(neurolysin)
1	abz-gfsxfrq-eddnp
1	[where
1	o-aminobenzoyl;
1	ile,
1	tyr,
1	trp,
1	gln,
1	his,
1	pro;
1	n-(2,4-dinitrophenyl)-ethylenediamine]
1	site-mutated
1	ph-dependence
1	600-612
1	(ghlaggydgqyyg;
1	599-611
1	(ghlaggydaqyyg;
1	ja-2
1	{n-[1-(r,s)-carboxy-3-phenylpropyl]ala-aib-tyr-p-aminobenzoate},
1	y605f
1	y606f
1	ph-k
1	/k
1	y606f.
1	activation-dependent
1	midportion
1	deglycosylate
1	efficacies.
1	conformation-specific
1	gαi-
1	(δ-opioid,
1	cannabinoid,
1	α2a-adrenergic)
1	gαs-
1	(β2-adrenergic)
1	gαq-
1	angiotensin)
1	allow,
1	seven-transmembrane-helix
1	(ec-2),
1	(ec-3)
1	r2).
1	ec-3
1	pain-sensing
1	n-[1(r,s)-carboxy-3-phenylpropyl]-ala-alaltyr-p-aminobenzoate
1	intracellular,
1	docked,
1	helices,
1	3.4.24.15),
1	3.4.15.1).
1	's.
1	(ep24.15:
1	ec3.4.24.15),
1	epsilon,
1	phosphoserine/threonine-
1	organizes
1	ser644
1	[1.4
1	[2.54
1	kt5720.
1	ansiotensin-converting
1	three-copy
1	(lc-esi-ms/ms)
1	peaks;
1	(1-and
1	lvvypwtqry
1	oligopeptidase;
1	(apm),
1	(dpp
1	(mep
1	24.15)
1	(nep
1	24.11)
1	enhanced;
1	(sin-1;
1	pentobartibal-anesthetized
1	n-[1-(r,s)-carboxy-3-phenylpropyl]-ala-aib-tyr-p-aminobenzoate
1	(ja2),
1	metalloendopeptidases.
1	tyr613
1	a607g
1	abz-gfsifrq-eddnp
1	(kcat/km=3×105
1	position;
1	2.5×104
1	ep24.15),
1	ep24.16),
1	3.4.15.1;
1	hexxh
1	(pvnfkflsh,
1	lvvypwtqry)
1	1.86
1	27.76
1	pvnfkflsh,
1	(top)
1	abz-ggflrrxq-eddnp
1	(abz,
1	ortho-aminobenzoicacid;
1	eddnp,
1	ethylenediamine),
1	r-x
1	l-r
1	0.05-0.2
1	0.025-0.1
1	na2so4.
1	na2so4
1	na2so4,
1	enthalpy
1	(δh*)
1	(δs*)
1	cytoplasmic.
1	tubulovesicular
1	endosomes.
1	(pelyenkprrpyil)
1	top),
1	neprilysin
1	3.4.24.11
1	nep).
1	abz-lyenkprrpyilq-eddnp
1	n-(2,4-dinitrophenyl)ethylenediamine
1	ortho-aminobenzoic
1	q-eddnp
1	p-y
1	y-i
1	s′1
1	abz-nkprrpq-eddnp
1	5882
1	s-1),
1	3.4.21.26).
1	abz-nkprapq-eddnp
1	14.03
1	17,110
1	3.4.24.16)
1	(top,
1	p4
1	p3′
1	abz-gfspfrqeddnp
1	p4-f5
1	f2-s3
1	p1′
1	sub-sites
1	p-f
1	f-s
1	neuropeptide-metabolizlng
1	resuited
1	phosphate/mol
1	644
1	(gnrh,
1	gnrh1-9,
1	neurotensin)
1	(mca-plgpdl-dnp
1	orthoaminobenzoyl-ggflrrv-dnp-edn)
1	substrate-specific,
1	serine-phosphorylated,
1	pka-mediated
1	644,
1	serine-proteinase
1	detected;
1	thiol-metallo-endo-oligopeptidase,
1	thimet-
1	mercaptoethanol
1	3.4.24.15).
1	homogenate.
1	neurolysin,
1	(ec3.4.24.15)
1	metalloenzyme,
1	gonads.
1	centrifugation.
1	membrane-impermeable,
1	thiol-cleavable
1	cross-linker,
1	3,3'-dithio-
1	bis(sulpho-succinimidyl-propionate)
1	(dtssp),
1	thiol-reduction,
1	non-fixed
1	internalization),
1	discernable
1	att20.
1	trans-golgi
1	syntaxin-6,
1	juxtanuclear
1	cfp-ala-ala-tyr-pab
1	(ep24.16c,
1	neurolysin)
1	(ep24.16m).
1	ep24.16c.
1	(ep24.15,
1	oligopeptidase),
1	zinc-containing
1	ep24.16.
1	pro-ile
1	carboalkyl
1	(cfp-aay-pab)
1	establish,
1	(qf)
1	opioid-
1	3.3.24.15).
1	hydrolyse,
1	qf
1	dynorphin(2-8)
1	[qf-dyn2-8;
1	abz-ggflrrv-eddnp,
1	o-aminobenzoyl
1	ethylenediamine],
1	qf-dyn2-8q,
1	abz-rppgfspfr-eddnp
1	abz-gfspfr-eddnp
1	phe-ser
1	pro-phe
1	neuropeptide‐metabolizing
1	biopeptides
1	neuron‐like
1	qf‐erp7.
1	dtt,
1	dtnb
1	cfp‐aaf‐pab,
1	pmsf.
1	anion‐exchange
1	cross‐reacted
1	(bfgf),
1	endopeptidase,
1	cysteine-endopeptidase
1	p-hydroxymercuribenzoate
1	5,5'-dithiobis-(2-
1	nitrobenzoic
1	cys-(3-nitro-2-pyridinesulfenyl)
1	dynorphin-derived
1	p'1
1	p'3
1	[nomenclature
1	schechter
1	berger]
1	3.4.22.19)
1	arg8-arg9
1	phe5-ser6
1	rhythmometric
1	(mil
1	enzyme/mg
1	7.62,
1	2.89,
1	(φ
1	23:08
1	23:03
1	3.15,.
1	01:12
1	0.005,
1	2.62,
1	22:35
1	4.27,
1	17:12
1	rhythmi-city
1	dc-driven
1	(β2ar)
1	lpsstimulated
1	engagement,
1	(hif1-α)
1	reprograming
1	(eatp)
1	eatp.
1	nonrepressible
1	(gcn2),
1	(gcn2
1	(mog35-55),
1	(th1/th17).
1	kinase-dependent
1	differentiation/expansion
1	phyllanthin,
1	niranthin,
1	5-demethoxyniranthin.
1	beta2-adrenergic
1	(b2ar)
1	self-tolerance.
1	b2ar.
1	treg-cell-induced
1	foxp3-
1	ch-4009
1	(switzerland).
1	subsets:
1	il-17f
1	ibcb,
1	sibs,
1	(5-ht)2
1	ondansetron
1	mast-cell-degranulation-induced
1	informatic
1	relapsing-remitting
1	(rrms)
1	(spms),
1	(ppms)
1	adrenoleukodystropy,
1	rrms
1	spms.
1	cns-derived
1	immunopathogenic
1	(th17).
1	2,3,7,8-
1	tetrachlorodibenzo-p-dioxin
1	6-formylindolo[3,2-b]carbazole
1	ligand-specific
1	(abs-75)
1	anti-excitotoxic
1	myelin-oligodendrocyte
1	(mog).
1	halted
1	tgf-β-dependent
1	neuroinflammation,
1	(er).
1	neurodegeneration-related
1	arachidonyl-2′-chloroethylamide
1	(acea)
1	(lipopolysaccharide,
1	(tunicamycin)
1	(neuro-2a
1	(eif2α),
1	(chop),
1	survival/death
1	erk1/2-related
1	er-related
1	cannabis
1	spasticity
1	(opcs)
1	lps/ifnγ
1	cb2,
1	pparc
1	tunicamycin-induced
1	opc
1	cbd,
1	cbd.
1	eif2α,
1	eif2α
1	lps/ifnγ.
1	(chop,
1	'oligoprotective'
1	morris'
1	hyperphosphorylated
1	disease-like
1	hijack
1	(leptospira
1	canicola),
1	icterohaemorrhagiae)
1	santarosai
1	tarassovi),
1	[used
1	(mat)].
1	evading
1	attenuation.
1	liga,
1	lsa23
1	mat-reference
1	nhs.
1	lic13322
1	(tl-ibs)
1	reaggregate
1	thermolysin/l
1	sec-purified
1	autoproteolysis
1	α-chain,
1	hhp-based
1	ibs.
1	menezes,
1	kitano,
1	heinemann,
1	isaac,
1	serrano
1	(lpf)
1	exoproteomic
1	conjunctive
1	c-di-gmp,
1	lic13137
1	(lcd1),
1	fhla
1	(gaf)
1	separately,
1	gaf-ggdef
1	lcd1.
1	0.24 μm)
1	0.13 s− 1).
1	abreu
1	c3/c3b,
1	c4/c4b
1	stce,
1	ehec,
1	conde,
1	mohana-borges.
1	sub-tropical
1	zika,
1	polyprotein.
1	prm/m,
1	mini-review,
1	reassociates
1	surface-anchored
1	enolase-bound
1	enolase,
1	spirochaetes
1	serovars.
1	(ef-tu)
1	upa
1	panoply
1	"classical"
1	enolases
1	proteolytically
1	plasminogen,
1	urokinase-type
1	lig-bound
1	(fhl-1),
1	related-1
1	(fhr-1)
1	lig-transformed
1	wildtype.
1	isaac
1	regulators;
1	surroundings.
1	fh-like-1
1	pathway).
1	(plg)
1	plg
1	molecule),
1	(spr)
1	ns1-vn
1	vn,
1	denv2,
1	salazar
1	aureus-particularly
1	infections-represent
1	(mntc),
1	manganese-binding
1	ion-scavenging
1	surfaceexposed
1	lysines,
1	ε-aminocaproic
1	mntc-bound
1	urokinase
1	anti-staphylococcal
1	apo-
1	2+-bound
1	(d163-168a,
1	q67a,
1	s247a)
1	d163-d168a
1	q67a
1	s247a
1	adhesins'
1	anti-adhesin
1	biopharmaceuticals,
1	abrasions
1	degeneration-associated
1	fh-leptospira
1	sub-saturating
1	disappear.
1	immunophatology.
1	sphingomyelinases,
1	sph1,
1	sph4,
1	sph2
1	tlya,
1	spirochetal
1	warm-climate
1	serum-resistant
1	serum-intermediate
1	cell-extracellular
1	spirochaetes,
1	lic10507,
1	lic10508,
1	lic10509
1	(huvecs).
1	detergent-phase
1	lipl32.
1	domains(s)
1	subfragments
1	dose-dependent,
1	30-kda
1	gelatin-binding
1	matrix-binding
1	anti-lsa21
1	atzingen
1	duf1565.
1	hexahistidine
1	metal-charged
1	lic10365-encoded
1	lic10365-coding
1	e-selectin.
1	pseudogenes
1	(nc-21ohd)
1	-110t>c,
1	-103a>g
1	4676
1	leukocytes'
1	-132/-97
1	-110t>c
1	v281l
1	-126c>t
1	-126t
1	-132/-121
1	cyp21a1p
1	21ohd.
1	adhesin-mediated
1	lic12906,
1	adhesin;
1	saturable.
1	x-114-solubilized
1	(cphd).
1	cphd.
1	(tsh,
1	gonadotrophins).
1	q8n6h0
1	siblings.
1	alu
1	stem-loop-mediated
1	cphd
1	treacher
1	collins
1	malar
1	delimitated
1	346c
1	38%.
1	346t
1	descendents.
1	700g
1	factors'
1	ssc7q
1	sw1409
1	s0102.
1	contig,
1	ssc7q,
1	lengthened.
1	walking,
1	panels,
1	7000rad
1	imnprh
1	12000rad
1	(bes)
1	hsa6p21
1	ssc7p11
1	q11-q14
1	hsa6p12
1	shuffled
1	punctual
1	insertion/deletion)
1	ssc7p11-q14
1	accomplish,
1	gata-4.
1	(lh/hcg)
1	non-metastasizing
1	metastasizing/recurrent
1	gata-6,
1	(lhr)
1	totality
1	lhr.
1	predictors.
1	cdkn2a,
1	mc1r.
1	founders
1	duroc
1	melim,
1	cdkn2a
1	mc1r,
1	scan.
1	penetrance,
1	(ssc)
1	44-103,
1	1.9-18,
1	59-73
1	47-62
1	mc1r
1	9p,
1	16q
1	6p,
1	(dsrna)
1	(rnai).
1	ullrich-turner
1	(uts)
1	(sex-determining
1	sequence-tagged
1	sy57,
1	sy59,
1	sy85,
1	sy94,
1	sy124
1	sy157
1	(sy57
1	5c,
1	5g,
1	5p,
1	6f,
1	(loci)
1	(gby).
1	gby
1	y-derived
1	sy57
1	sy94
1	(45,x/46,x
1	mar).
1	streaks.
1	(amidst
1	stroma),
1	remnants.
1	gonad-derived
1	remnants,
1	denys-drash
1	frasier
1	(wt1),
1	(zf)
1	dds,
1	wilm's
1	intersex
1	genitalia,
1	(zf2),
1	cga-arg
1	tga-stop
1	(zf3)
1	c→t
1	+4
1	gonadoblastoma,
1	13q14,
1	mapped.
1	0.6%.
1	sterility,
1	downgrading
1	taint.
1	reversion,
1	38,xx
1	phenotypically,
1	hermaphrodites
1	ambiguities.
1	sex-reversal.
1	hybridization:
1	amh
1	(anti-müllerian
1	(wilms’
1	(ssc2)
1	q14->q21
1	p14->q11
1	xix)
1	ftzf1
1	(fushi
1	tarazu
1	[drosophila]
1	alias
1	[steroidogenic
1	1])
1	(ssc1)
1	q14->q17
1	q210->q211
1	cytogenetically
1	panel:
1	embryo)
1	1q12->q17,
1	ahc
1	(alias
1	dax1
1	congenital)
1	xp24,
1	(sry
1	y-box
1	13q23->q41
1	12p13->p11
1	informations
1	masculine
1	constitution.
1	eunochoid
1	genitalia.
1	46,
1	karyotype.
1	(hmg
1	box)
1	pseudoautosomal
1	(46,
1	xy,
1	agonadic
1	sisters,
1	46,xx
1	karyotype,
1	genitalia
1	mullerian
1	marriage,
1	endocrinological,
1	testis-determining
1	sry-negative.
1	sibs
1	silveira
1	α-mannosidase,
1	(sw)
1	biopanning
1	α-mannosidase.
1	(hr-hpv)
1	initiation/progression,
1	immune-response
1	regulation/execution,
1	(tnfr1)
1	(ros/rns)
1	hpv-infected
1	rossetti
1	pro-tumoral
1	tolerogenic,
1	hurdles.
1	opportunities;
1	partnerships
1	funding,
1	excisional,
1	iatrogenic
1	hpv18,
1	il-16
1	cervix,
1	papillomavirus,
1	tc-1,
1	m2-like,
1	growth.results:
1	nodes.conclusions:
1	bolpetti
1	(tam)
1	e6-
1	e7-expressingtc-1mouse
1	oftamont-cell
1	depletedtam,
1	clodronate-containing
1	(il-10);
1	inosii
1	m1phenotype,
1	lipopolysaccharide/ifng,
1	phentoype.
1	e749-57-specific
1	hpv16-associated
1	c-ki-ras-gtp,
1	kinase/protein
1	harasn17
1	c-ki-ras-gtp
1	serum-starved,
1	mek/erk
1	camp/protein
1	thr58
1	fgf2-induced
1	cxcl12/cxcr4
1	(cxcl12)
1	thymus-specific
1	deconstruct
1	proto-oncogene.
1	typified
1	minutes;
1	(acth-r)
1	acth-r
1	camp/pka-mediated
1	dephosphorylation/deactivation,
1	differentiate.
1	fluctuations.
1	meca79,
1	madcam
1	camp/pka:
1	mad/max/myc
1	(pd98059
1	sensitive),
1	pka-deficient
1	(fusion
1	estrogen-receptor),
1	ras•gtp.
1	ras•gtp,
1	˙v
1	ml/kg])
1	intracebroventricular
1	µl]
1	amg7905
1	[28.5
1	µl])
1	amg9810.
1	shock)
1	temperature:
1	cryogens;
1	synthase-1.
1	(0–20
1	(0–1
1	post-lps
1	unrecognized,
1	(rer;
1	[lps]
1	o55:b5
1	o127:b8)
1	(0.5–2 mg/kg).
1	ceiling
1	nonmetabolic
1	aid,
1	rewarming,
1	surprising.
1	2005-2012
1	36.0°c
1	35.5°c
1	succumbed.
1	(97.1%)
1	self-limited;
1	34.0°c.
1	sedatives,
1	neuroleptics,
1	self-limiting,
1	nonterminal
1	sig-naling
1	compelling.
1	3–5
1	postinjection,
1	(ng-nitro-l-arginine
1	31–32°c.
1	35–36°c,
1	huddling,
1	immuneto-brain
1	endotherms.
1	(anapyrexia)
1	instance)
1	instance).
1	thermoregulation,
1	cl316,243,
1	(ḋo2)
1	(v̇o2)
1	hetastarch
1	(30°c)
1	pre-emptive
1	fever-hypothermia
1	(sc-236,
1	25-μg
1	(intra-arterially).
1	malady
1	cfu/kg),
1	exaggeration,
1	lessened
1	(lps-induced)
1	coli-induced)
1	(aea)
1	cannabinoid-1
1	(cb1),
1	cannabinoid-2
1	(cb2)
1	(trpv1).
1	22°c,
1	nadir
1	postinjection.
1	sr144528
1	slv319
1	rimonabant,
1	hypometabolic
1	hypervasoconstricted
1	(resiniferatoxin
1	anandamide)
1	(amg0347)
1	(observed
1	hypometabolism,
1	thermopreferendum,
1	hyperkinesis.
1	copyright©2011
1	(cryogenic
1	(febrigenic
1	signaling).
1	incapacity,
1	(corticosterone).
1	icv)
1	icv).
1	on-target
1	thermosensors.
1	(polymodal),
1	dorsal-root
1	nodose)
1	thermosensor,
1	disinhibits
1	hyperthermia-free
1	neither,
1	mediate(s)
1	(tas).
1	(22°c),
1	nadir)
1	(cox-1-mediated
1	(tb),
1	leptin).
1	(22 °c),
1	0.5 °c)
1	(250 μg/kg
1	normothermic
1	(120 min
1	post-infusion)
1	8 ng/ml)
1	leptin-responsive
1	1000 μg/kg
1	(febrile)
1	anti-hypothermic
1	(il)-6.
1	cooler
1	(22 °c)
1	(28 °c)
1	(3500 μg/kg
1	excessive,
1	non-physiological
1	542 ng/ml
1	30 min;
1	75 ng/ml
1	120 min
1	post-infusion).
1	set-up
1	(2 μg/kg
1	surges
1	nicotine)
1	intrabrain
1	ip);
1	no-nicotine
1	proliferation).
1	septic.
1	thermoeffectors.
1	end-expired
1	intra-raphe
1	brain-mediated
1	tc;
1	truncal
1	(trpv)
1	decisively.
1	[(e)-n-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-
1	yl)-3-(2-(piperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)acrylamide],
1	(tail-skin
1	thermogenesis),
1	tail-skin
1	(intracerebroventricularly)
1	(intrathecally)
1	(intravenously),
1	amg0347;
1	exaggerated,
1	hypothalamo-pituitary-adrenal
1	exaggeration
1	hypothermia).
1	(pvh),
1	[lps])-induced
1	(5,000
1	electrocoagulation
1	excitotoxin
1	destroys
1	passage,
1	ibotenate
1	("warmth
1	melastatin-8
1	("cold
1	(first)
1	pge2-
1	brain),
1	tlr4-dependent,
1	tlr4-bearing,
1	cox-2-positive
1	endotheliocytes
1	(cpla2)
1	(cox)-2.
1	anti-pge2
1	steiner
1	behaviorally,
1	apparatus),
1	multichannel
1	implantable
1	loggers
1	conducted;
1	heating)
1	(trpv1
1	trpm8
1	si-associated
1	si.
1	tas
1	thermocouple
1	thermometry.
1	(100-104
1	(just
1	suprathreshold)
1	(100-101
1	(101.5
1	(101.75-104
1	∼3
1	bi-,
1	near-threshold
1	doses).
1	(-/-)
1	(+/+).
1	(31°c).
1	masks
1	lps:
1	cox-1b
1	(cox-3),
1	(endotoxin
1	tlr2.
1	tlr2-dependent
1	immunocytes
1	055:b5
1	decontaminated
1	subjecting
1	phenol-water
1	reextraction.
1	c3h/heouj
1	(20°c),
1	clps.
1	erythropoietin-producing
1	(eph)
1	ephrins,
1	16-fold)
1	21-fold)
1	counter-directed
1	ephb3,
1	ephrin-b2
1	epha1
1	epha3,
1	ephrins-a1
1	-a3
1	epha2
1	ephb3
1	phase-specific
1	transmigration)
1	(5-ht1,
1	5-ht2,
1	5-ht7)
1	5-ht1
1	μ/100
1	0.7°c
1	0.8°c
1	microinjection,
1	μg/0.1μl)
1	e2]
1	lipopolysaccha-ride
1	amphipaths
1	nagase
1	analbuminemic
1	(nar).
1	normalbuminemic
1	α1-acid
1	(agp)]
1	nar,
1	[paf-agp]
1	(aggregated)
1	(∼1.5°c)
1	(<10
1	latency.
1	polyphasic,
1	interleukins-1beta
1	fallen.
1	divider
1	bbb,
1	(pges).
1	"physiological,"
1	low-scale
1	pges
1	multiple;
1	ep3
1	"fever
1	receptor."
1	ep3-bearing
1	point-based
1	(offered
1	new"
1	orexins)
1	"old"
1	cholecystokinin)
1	magic
1	bullets
1	mpges-1,
1	(8-methyl-n-vanillyl-6-
1	nonenamide,
1	cap),
1	vr1
1	channel-vanilloid
1	(trpv-1),
1	trpv-1-bearing
1	trpv-1.
1	long-evans
1	mgk
1	ultrapotent
1	(rtx;
1	hyperpyretic
1	(n-[2-(4-chlorophenyl)
1	ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2h-2-
1	benzazepine-2-carbothioamidem,
1	cpz;
1	cap.
1	cap-sensitive
1	rtx-
1	cpz-insensitive.
1	trpv-1-independent.
1	ng/kg)
1	μg);
1	fever-enhancing
1	(2.5-100
1	re-examined.
1	electrolytically
1	6-hydroxydopamine;
1	(23°c)
1	i.c.v.)
1	sub-neutral
1	(23°c,
1	(28°c,
1	vasoconstriction)
1	catheters;
1	sk)
1	s-nitrosoalbumin
1	(sng),
1	afebrile
1	i.v.)-treated
1	glutathione).
1	sna-
1	sng-treated
1	fever-attenuating
1	à
1	vasoconstriction).
1	24°c,
1	fall).
1	uninvolved
1	(anapyrexia).
1	(po),
1	thermointegrative
1	likeness
1	plethysmograph,
1	(dca,
1	(paco2),
1	(pao2),
1	ve,
1	paco2,
1	pao2
1	(vt).
1	vo2.
1	(zndpbg),
1	(po).
1	230-260
1	biotelemetry,
1	cgmp-containing
1	av3v.
1	β-adrenoceptor/serotonin
1	micro-injection
1	ng-monomethyl-l-arginine,
1	rp-cgmps,
1	hypoxia-associated
1	(dca).
1	24-26°c.
1	flushed
1	correspondingly,
1	(l-nmma,
1	(8-brcgmp)
1	8-brcgmp
1	antipyretic.
1	animais
1	physiologists.
1	(db-camp,
1	22.7±1.8
1	17.0±1.0
1	fmol/μg
1	aminophylline.
1	db-camp
1	db-camp.
1	co-microinjection
1	(rp-camps,
1	(rp-cgmps,
1	fever-like
1	(ho).
1	(v̇e)
1	plethysmograph
1	oxygen)
1	vt.
1	conformably,
1	(tris)
1	(10th
1	(until
1	tris
1	cox-2-deficient
1	improbable
1	categorically
1	out;
1	cox-1-selective
1	routes;
1	second;
1	(∼30
1	min);
1	(ho),
1	biliverdine,
1	pyresis.
1	pyresis
1	1h-[1,2,4]oxadiazolo
1	[4,3,-a]quinoxaline-1-one.
1	(sgc).
1	intra-plantar
1	(zinc
1	(ho
1	substrate)
1	(1h-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one),
1	(ng-monomethyl
1	l-arginine),
1	neurone.
1	(neuronal,
1	inducible)
1	∼2.8°c
1	(t(b)),
1	n(g)-nitro-d-arginine
1	μg/μl)
1	thermo-regulatory
1	l-name).
1	toads.
1	intracerebroventricularly)
1	11-h
1	24.8
1	vasotocin
1	(avt)
1	nonmammalian
1	(avp).
1	ectotherms.
1	pmol/kg)
1	pmol/kg),
1	peripherally,
1	ectotherm,
1	avt/avp
1	antipyresis
1	(co)-heme
1	prostagandins
1	[thermal
1	μl;
1	1.7°c
1	(vehicle/lps:
1	indomethacin/lps:
1	(vehicle/heme:
1	1.4°c
1	indomethacin/heme:
1	terrestrially
1	frogs,
1	anti-freeze
1	cryoresistance
1	amphibians:
1	rana
1	catesbeiana
1	40.35
1	131.87
1	20.72
1	3.94
1	toads,
1	27.25
1	73.72
1	13.50
1	1532
1	728
1	mm3).
1	cryoresistent.
1	paracnemis,
1	freeze-intolerant
1	36.8
1	0.2°c).
1	(thermal
1	0.2°c,
1	0.4°c),
1	anapyrexia)
1	bujo
1	(10-40
1	avp-blocker
1	36.52
1	0.29°c.
1	0.33°c
1	0.41°c
1	(v1-receptor
1	0.13°c
1	(v2-receptor
1	36.53
1	0.08°c.
1	35.44
1	0.19°c
1	35.74
1	0.10°c
1	[β-mercapto-
1	β,β-cyclopentamethylenepropionyl
1	,o-et-tyr
1	,val
1	,arg
1	]vasopressin
1	37.33
1	0.23°c,
1	cross-breeding
1	parasite-placenta
1	>2,000
1	(>25%),
1	oceanian
1	insertions/deletions
1	african-specific
1	(2014-2016)
1	co-distribution,
1	"ecological"
1	west-
1	(water
1	supply/storage
1	management)
1	co-viral
1	dombrowski
1	(lbw).
1	(1283
1	infected),
1	63.9%
1	(p.)
1	(sga)
1	lbw)
1	(sga—or
1	1.24,
1	1.02–1.52,
1	0.035;
1	lbw—or
1	1.39,
1	1.03–1.88,
1	1.54,
1	1.09–2.18,
1	1.59,
1	1.11–2.27,
1	0.011).
1	epiphanio.
1	429,000
1	(ma-ali/ards),
1	monoxide-
1	ali/ards,
1	marginale)
1	inexistence
1	(msp1a)
1	omp7,
1	omp8
1	omp9
1	msp1a/omp7/8/9
1	atrophies
1	(g6pd)-deficient
1	(g6pdd)
1	juruá,
1	five-hundred
1	(beutler
1	carestart™
1	clinical-epidemiological
1	interview.
1	g6pdd,
1	kompetitive
1	g6pdd.
1	a(+)
1	(0-0.04%).
1	∼1/23
1	personalize
1	(hce)
1	chenopodium
1	ambrosioides
1	(spr).
1	plasmodicidal
1	(ip.),
1	(45 mg/kg)
1	(ic50=
1	25.4 g/ml).
1	(amazonas,
1	wbc
1	"recurrent
1	malaria".
1	(domains
1	dbl1x
1	dbl6ε)
1	(emap1)
1	var2csa-based
1	midgestation
1	berghei-var2csa
1	berghei-var)
1	ies.
1	ies,
1	dbl1-6-emap1
1	(recdbl1-6).
1	cities:
1	luís,
1	cedral
1	buriticupu,
1	(tgf-β
1	vk210,
1	comparisons,
1	non-regulated
1	440,000
1	(ma-ali/ards).
1	ataíde
1	foetus.
1	circulate.
1	primigravid
1	angiopoietin
1	(ang)-1,
1	ang-2,
1	tie-2,
1	knots,
1	tie-2:ang-1
1	mip.
1	pos
1	graduacao
1	saude
1	coletiva.
1	(sinasc)
1	live-birth
1	indicators.
1	completeness
1	“unknown”)
1	civil
1	mother’s
1	incompleteness
1	tally
1	incentive
1	inclusion,
1	príncipe
1	scenarios:
1	elimination;
1	pre-control
1	re-acquisition
1	bandeiras
1	(1.0.
1	chabaudi-gfp-infected-red
1	(pc-gfp-irbcs)
1	infected-red
1	woman,
1	foetus
1	(2003-2012)
1	interrogate
1	mid-term
1	k173
1	rodrigues-duarte
1	baby.
1	(vsas)
1	vsapm
1	pfemp1.
1	vsa-dependent
1	(ali),
1	(ards),
1	effusion,
1	splenectomization
1	epiphanio
1	re-visit
1	primigravida
1	non-recrudescent
1	multigravida.
1	pregancy
1	anka-gfp
1	mip-1
1	oppurtunity
1	neres
1	mitotane.
1	mitotane,
1	sunitinib,
1	mts
1	dense,
1	homogenously
1	sized,
1	nilotinib,
1	passaia,
1	kremer,
1	antonini,
1	fragoso
1	lotfi.
1	(tcf21)/podocyte-expressed
1	(pod1)
1	pten-induced
1	(pink1)
1	tcf21-nr5a1
1	steroidogenesis-related
1	ccne1
1	pmah-related
1	zonation.
1	adrenocorticotropin
1	proopiomelanocortin.
1	hypoplasia,
1	adrenogonadal
1	5.97-fold
1	0.41-fold
1	0.64-fold
1	t36,
1	lotfi
1	mendonca.
1	alpha-melanocyte
1	pod-1/capsulin/tcf21
1	cyp11b2,
1	malheiros
1	frança
1	sf-1/sf-1
1	fzt-f1
1	sf-1,
1	shp,
1	shp/shp
1	mendonca
1	(n-pomc).
1	(zf-fraction
1	zg-fraction)
1	ccnb2,
1	camk2a,
1	nek2,
1	zg
1	zf
1	notch.
1	pro-opimelanocortin
1	1-28n-terminal
1	(n-pomc1-28)
1	(zg)
1	zg.
1	pomc-derivate
1	pod-1/.
1	pod-1.
1	sf1/luc
1	pod-1-transfected
1	(steroidogenic
1	h295r/pod-1
1	acc-t36/pod-1
1	accs
1	n-pomc-
1	acth-stimulated
1	(hyp)
1	(dex)-treated
1	1-28)
1	(acth).
1	methionines
1	dex-treated
1	dex-pomc
1	7-38,
1	1-39
1	(igf-ir)
1	(nvp-aew541)
1	carcinomas)
1	h295
1	(270.5
1	130.2
1	13.3;
1	1.84;
1	1.28-2.66;
1	nvp-aew541
1	hypophysectomy-induced
1	junb
1	c-jun/jund
1	c-fos/fosb,
1	junb,
1	proliferation-related.
1	jun-/fos-positive
1	reticularis,
1	jun-positive
1	reticularis.
1	adrenocortical,
1	nonmitogenic
1	factor-2
1	(percent
1	anti-cfos
1	(bromodeoxyuridine
1	0·969.
1	erk1/2-map
1	immunocitochemistry
1	(50μm),
1	acth39.
1	(phorbol
1	12-myristate-13-acetate)
1	n-butanol,
1	([3h]-thymidine
1	br-du
1	incorporation),
1	bromodeoxyuridine.
1	kin-8,
1	midpoint
1	mid-g1.
1	mid-g1
1	acth-regulated
1	(ta97,
1	ta104)
1	gasoline,
1	direct-action
1	mutagens.
1	tribbles
1	(trb3)
1	pseudokinase
1	∼15%
1	e3-ubiquitin
1	ligases.
1	atrophy.-choi,
1	mcconahay,
1	silvestre,
1	s.,
1	carson,
1	h.-j.
1	(rt–bfr)
1	(hrt)
1	hrt,
1	rt–bfr,
1	hiseq
1	hrt
1	rt–bfr
1	femoris
1	ligase,
1	punctiformily
1	pax7
1	(~35%,
1	<.001
1	~12%
1	atrogenes.
1	foxo3
1	(mdm2
1	pro-trophic
1	1–3
1	immobilized.
1	(foxo3a)
1	(vps34;
1	pi3k)
1	cruciate
1	femoris,
1	femoris).
1	protein.©
1	fromwild-type
1	recovery;
1	positive-satellite
1	fromwild-typemice,
1	themuscles
1	amount.
1	(27.4
1	(squat
1	1rm/body
1	thrice
1	6.4-fold,
1	3.3-fold,
1	7.3-fold,
1	24.9-fold,
1	2.7-fold,
1	34.1-fold,
1	7.7-fold,
1	atp;
1	lobulation
1	tufts,
1	b-box,
1	coiled-coil)
1	murf1-ko
1	fiber-types.
1	double-deficient
1	murf1.
1	myozenin-1,
1	myozenin-1
1	myozenin-1.
1	shift,
1	(raptor),
1	rapamycin-insensitive
1	m-tor
1	(rictor),
1	expression].
1	4ebp-1
1	improvements;
1	hypertrophy-related
1	(ibm)
1	weakness.
1	65-yr-old
1	15.9%,
1	form-36
1	600%.
1	3.97-fold,
1	0.62-fold.
1	1.18-and
1	1.28-fold,
1	flare.
1	army
1	(1-rm),
1	1-rm
1	uchida,
1	crewther,
1	rfp,
1	23(7):
1	2003-2008,
1	2009-this
1	(ck).
1	workouts
1	load:
1	50%-1rm
1	(75%-1rm
1	90%-1rm
1	(90%-1rm
1	110%-1rm
1	(110%-1rm
1	res).
1	equated
1	(repetitions
1	(post)
1	ck.
1	range-of-motion
1	manually)
1	myo-d
1	later),
1	sessions)
1	sessions).
1	(myo-d),
1	(myostatin),
1	(atrogin-1),
1	stretch,
1	(myod),
1	case-controlled
1	35°c.
1	chain-β
1	∼60-kda
1	mmp-1
1	mmp-3.
1	(tres).
1	tre1,
1	palindromes.
1	(tre2)
1	(tre3),
1	coactivator-1-containing
1	coactivator-1
1	tres,
1	superimposable,
1	(0.05%;
1	trizol™
1	student-newman-keuls
1	post-test.
1	∼72,
1	3′,3-dihexyloxacarbocyanine
1	12-14°c
1	3',3-dihexyloxacarbocyanine
1	(lif)
1	3,3',
1	5-triiodo-l-thyronine,
1	(t3)-
1	lif
1	3.2-kb
1	twofold,
1	t3-unresponsive
1	5'-deiodinase
1	(5'-dii)
1	co2-95%
1	carhoxylase
1	receptor-saturating
1	(~50%
1	11-10-5
1	ne-generated
1	ne-
1	(serca
1	(t3rs)
1	t3rα1-
1	t3rβ1-specific
1	enhancer-specific
1	transaction
1	heart-derived
1	cotransfected.
1	mef-2,
1	chlorampenicol
1	mef-2
1	t3r.
1	(camp
1	egr-1)
1	t3rs
1	β-adrenoceptors,
1	(g(q))
1	t3-stimulated
1	(tre)
1	wt-1
1	28°c,
1	(ne).
1	nrtt,
1	nrtcb,
1	nrtt
1	xantham
1	nrta
1	complementary.
1	organic-sulfur
1	enco-ded
1	sulfate-binding
1	°a
1	struc-tural
1	in-creasing
1	α/β
1	sectors,
1	esterase/lipase,
1	recombinantly,
1	structurally.
1	1.85-ǻ
1	rationalize
1	(met213
1	phe217)
1	valerate
1	pegos
1	pstscab
1	permeases.
1	esterases;
1	uncharacterized.
1	pl14.h10
1	74 %
1	parvibaculum
1	lavamentivorans
1	[genbank:
1	wp012110575.1]
1	45 °c.
1	caprylate.
1	0.5 mm
1	mn+2,
1	li+,
1	1 %
1	ctab
1	10 %
1	esterases,
1	leather
1	perfumes
1	biodiesel.
1	biocatalysts,
1	4224
1	esterase/lipase
1	(accession
1	adm63076.1)
1	aryl-esterase
1	fluorescens
1	anti-kazlauskas
1	(patent
1	us20050153404).
1	solvents,
1	sulfur,
1	alkanesulfonate/sulfonate
1	xam1,
1	lb.
1	sulfonates
1	alkanesulfonate/sulfur
1	xam1
1	bacterioplankton
1	non-chlorophyll-based
1	biohydrogen
1	hydrogenases,
1	hyd-4,
1	hyfr,
1	hyf
1	hyd-3.
1	proton-translocating
1	nadh-ubiquinone
1	δμ<inf>h</inf><sup>+</sup><inf>.</inf>
1	hydrogenases
1	phor/phob,
1	pstsbac
1	phor/phob
1	unoin
1	containment.
1	microrganisms
1	characterized:
1	3.0å
1	male),
1	(malf
1	malg)
1	(malk).
1	maltose/trehalose-
1	(xac-male)
1	p6522
1	2.8å
1	xac-male
1	orthologues,
1	lab,
1	(est).
1	(tfpi)-like
1	tenase
1	(fviia/tf).
1	tfpi-1
1	tfpi-2,
1	transporters)
1	molybdate,
1	interdomain
1	k127
1	d59,
1	closed.
1	k127s
1	d59a,
1	crystallisation
1	simulations,
1	state.©
1	consumptive
1	coagulopathy.
1	(lonomia
1	stuart
1	antilonomic
1	(rlosac)
1	x-deficient
1	γ-carboxyglutamic
1	domainless
1	rvv-x
1	nuclease,
1	glucose-repressed
1	(adh2)
1	microcosm
1	whenever
1	escapes
1	disfavours
1	16sv6-v8
1	(tgge)
1	16sv6
1	tgge
1	α-diversity,
1	firmicutes/bacteroidetes
1	dysbiosis.
1	x-100-soluble
1	challenge-infected
1	4th.
1	arthrobotrys
1	(panagrellus
1	panagrellus
1	preyed
1	upon,
1	transactivate
1	restenosis
1	nox1.
1	restenosis.
1	disrupture
1	transnitrosation,
1	diabetes).
1	learnt
1	nox(es)
1	121-134.
1	erp46)
1	tnfα-
1	icam
1	nonpermeative
1	pdi-neutralizing
1	ras/raf/mek/erk
1	g-lisa
1	endo-pdi.
1	ap-1-driven
1	pdi-mediated
1	cellfree
1	scrrnase
1	bacitracin
1	∼40%),
1	∼60%)
1	serine-mutated
1	cxxc
1	∼70%.
1	supports,
1	down-regulates,
1	thiol-mediated
1	phox.
1	pdi-p47
1	reduced)
1	arachidonate-dependent
1	(re)cycling.
1	b-loop
1	nox4-oxidase
1	nox1-,
1	nox2-oxidase
1	(pdi),
1	dithiol
1	pdi's
1	oxidaseisomerase.
1	obscure,
1	microparticle-dependent
1	diethylamine-nonoate
1	coelenterazine
1	2′,7′-dichlorofluorescein
1	tetraspanins
1	cd9,
1	cd81,
1	nox.
1	urate
1	gambim
1	thiols.
1	thiol-dependent
1	dithiol/disulfide
1	(aii,
1	rnase,
1	26-83%
1	57-71%
1	(pdiasodn).
1	nox4.
1	vsmcs.
1	aii-driven
1	traffic/assembling.
1	o2-from
1	p67phox,
1	rac2
1	b558.
1	p47phoxby
1	p40phox,
1	unphosphorylated
1	p40phox.
1	p40phoxinhibits
1	p47phoxand
1	p67phoxin
1	p40phoxon
1	p67(phox),
1	cytosol-containing
1	sds-activated
1	chondroclasts
1	(aln)
1	etidronate
1	(etn)
1	aln,
1	tibiae
1	epiphyses
1	osteogenesis
1	trap-positive
1	nfκb1
1	spp1
1	runx2
1	bisphosphonates.
1	rank.
1	anti-resorptive
1	osteogenesis-related
1	instar,
1	(nor)
1	sciarids.
1	consolidate
1	54:361–378,
1	chloroformate,
1	heptafluorobutyrate,
1	2.349
1	53.207
1	2.745
1	53.333
1	(kobs),
1	sigmoidal.
1	δg≠
1	[water],
1	quasi-mirror
1	δh≠
1	δs≠;
1	l2o
1	0.190,
1	0.890
1	0.180,
1	0.529,
1	0.890,
1	downward.
1	(npcf)
1	(npfb).
1	(kobs)
1	[water].
1	micro-heterogeneous;
1	"micro-domains,"
1	hydrogen-bonded
1	npfb.
1	outer,
1	micro-domains
1	interiors.
1	[kobs],
1	solvatochromic
1	benton
1	davis
1	tedious
1	spots/phages
1	filter,
1	photo-sensory
1	(blast).
1	(phytochromes,
1	cryptochromes
1	phototoprin)
1	e-values.
1	phytochrome
1	chloroformate
1	aqueos
1	dodecylbenzene
1	sulfonate,
1	alkyltrimethylammonium
1	alkyldimethylbenzylammonium
1	chlorides
1	(alkyl
1	cetyl
1	dodecyl)
1	polyoxyethylene
1	nonylphenyl
1	kobs,
1	surfactant-substrate
1	ks,
1	kobs
1	solubilzation
1	chloroacetate,
1	solubilizate
1	'medium'
1	'electrostatic'
1	midpalatal
1	foetuses,
1	receptor/adaptor
1	paracoccidioidomycosys
1	ifn+cd8+t,
1	il-17+cd8+t
1	celular
1	zap-70,
1	zap-70-positive
1	(tk).
1	(tkis)
1	tkis
1	(wasp)
1	c-abl
1	tk.
1	cml,
1	tki
1	bcr-abl1-positive
1	bcr-abl1-induced
1	bcr-abl1-
1	tki-resistant,
1	trail/apo-2l
1	trimerization.
1	cells/tissues
1	receptor-specific
1	mab)
1	trail-related
1	anomalies.
1	trail/trail
1	clone(s)
1	t-and
1	celular.
1	(bh3)
1	bh3
1	es-bax.
1	6.5-fold.
1	es-bax/g
1	inxs,
1	bcl-x,
1	non-tumors.
1	1903
1	nt-long
1	5′-capped,
1	sam68
1	splicing-modulator.
1	786-o
1	bcl-xs/bcl-xl
1	inxs-expressing
1	activity.this
1	tumor-selective
1	death.in
1	trail.however,
1	use.our
1	prame/ezh2
1	therapy.a
1	approaches.©
1	ligandtnfsf10
1	(trail),
1	(ra);
1	(prame)
1	zeste
1	(ezh2);
1	sensibility.
1	accidental,
1	unravelled
1	destined
1	ced-3,
1	already-committed,
1	(mpds)
1	miltenyi
1	kit,
1	haes-steril
1	sybrgreen
1	abiprism
1	7500
1	-δδct.
1	faim
1	polycythaemia
1	thrombocythaemia
1	pmf,
1	pmf
1	mpds.
1	self-reactive
1	calmodulin/calcineurin
1	transactivating
1	ineffectiveness
1	antimelanoma
1	(subclone
1	nex4,
1	serum),
1	(igg2ak)
1	protocadherin
1	β13.
1	cdr3
1	cdr1
1	cdr2
1	cdrs
1	(atcc19274)
1	moreau)
1	(fas/apo-1)-mediated
1	c/apaf-1/caspase-9
1	apoptosome
1	bcl-2-positive
1	chx-treated
1	granting
1	hl-60/neo.
1	anti-mdr
1	envenomings.
1	(tend).
1	40μg/ml)
1	pro-caspase-3
1	bax/bcl-x
1	catalysis.
1	lucena
1	(δψm).
1	zvad-fmk
1	ara-c,
1	etoposide
1	thp-1.
1	1-acetyl-n
1	2-formyl-5-methoxykynuramine
1	(afmk)
1	(lps)-mediated
1	(asteraceae).
1	(thp-1)
1	myriadenolide,
1	caspase-8/bid
1	devd-fmk
1	caspase-8/
1	nick-end
1	(tunel)-positive
1	bongkrekic
1	autophagy/
1	-6.
1	post-translational,
1	mitochondria-dependent
1	sti571.
1	sti571
1	phosphotyrosine-containing
1	hl-60.bcl-2
1	hl-60.bcl-xl
1	mcl-1,
1	c-iap-1,
1	c-iap-2,
1	xiap
1	pro-caspases-2
1	schultz-bip.
1	ex.
1	labdane-type
1	cd3+cd4-cd8+
1	cd3+cd4+cd8-
1	(cd14+
1	hypodiploid
1	mhc/peptide
1	nonselected
1	bcl-2-mediated
1	cd4+cd8-
1	cd4-cd8+
1	[3].
1	[4].
1	vulgaris,
1	[5].
1	altruistic
1	[7-9].
1	apaf-1
1	datp,
1	procaspase-9
1	ionophore-stimulated
1	microvesiculation,
1	procaspase-9,
1	procaspase-3,
1	gelsolin,
1	c-δ.
1	noncaspase
1	'apoptotic'
1	microvesiculation.
1	procaspase-
1	caspase,
1	(αψ(m)),
1	pore.
1	actinomycin-d,
1	αψ(m).
1	cccp
1	hl-60s
1	indictment).
1	judgement).
1	"eat-me"
1	execution).
1	burial).
1	pro-myelocytic
1	phosphotyrosine-binding
1	(flvres)
1	(hl-60/bcr-abl)
1	p185
1	bcr-abl;
1	(cml)-blast
1	p210
1	ara-c
1	(hidac),
1	sphingoid
1	sphingosine,
1	sphinganine)
1	[adp]-ribose)
1	(dff),
1	lck
1	ber-abl
1	lck-y505f
1	tyr-688
1	tyro
1	heterodimer,
1	phosphoproteins
1	anticipated.
1	dismissal
1	outcast
1	serenely,
1	resign
1	point-of-no-return
1	"initiator"
1	"executioner"
1	starts.
1	broadspectrum
1	anti-cd95-triggered
1	insulted
1	donogenic
1	zvad-fmk.
1	p185bcr-abl
1	hl-60.p185bcr-abl
1	baf3.p185
1	wnile
1	blebbing
1	tdt-mediated
1	10-50
1	typify
1	(fas/apo-
1	fodrin,
1	celts.
1	fodrin
1	interleukin-1β-converting
1	ice,
1	proenzyme,
1	autocatalytic
1	cowpox
1	crma,
1	b-mediated
1	multilayers,
1	hemidesmosomes.
1	adjoining
1	anti-cytokeratin
1	thy-1.1,
1	pma-
1	signal(s).
1	lymphoepithelial
1	(e-5).
1	(ti-6),
1	necessitate
1	non‐covalently
1	(gp23,
1	gp90).
1	gp23/45‐mediated
1	neophosphorylation
1	pb-infection.
1	(cy)
1	(indo),
1	cyclophosphamide-sensitive
1	pathogen-infected
1	cell-induced
1	co-stimulatory,
1	tnf-α/β,
1	cd95/fasl,
1	granulysin,
1	granzymes
1	hyper-activated
1	self-immune
1	life-death
1	non-caspase-mediated
1	inflammasome-
1	fam3b/pander
1	cytokine-like
1	beta-cells.
1	lentiviral-mediated
1	du145/fam3b
1	inducers,
1	tnf-alpha,
1	camptothecin,
1	anchorage-independent
1	tumorigenicity.
1	fam3b-secreted
1	tnf-alpha.
1	anchorage-
1	xenografted
1	fam3b-overexpressing
1	acid/krebs
1	(oxphos),
1	interleukin-13
1	symbiotics,
1	prodomain,
1	(p20),
1	and-9,
1	autocatalysis
1	iqad198↓s
1	self-activation
1	(n18a/p26a)
1	(s199a/p201a),
1	caspase-7.
1	s199a/p201a
1	(kcat/km)
1	(devd)
1	pest-amino
1	self-activation.
1	myokines
1	il-6/il-6
1	gp130
1	il-6r
1	il-6/jak/stat
1	fgf/p38αβ
1	tailoring
1	renewal.
1	belizário,
1	sangiuliano,
1	perez-sosa,
1	neyra
1	moreira.
1	pharmacogenomics.
1	submit
1	cbioportal.
1	cellminer.
1	oncogenomics
1	patient-targeted
1	bancovik
1	dermicidin
1	(dcd),
1	metacore
1	(dcd-sv)
1	her2+
1	highjack
1	dcd's
1	napolitano.
1	(non-pathogenic)
1	co-evolved
1	gene-products
1	nutraceutics
1	(prebiotics
1	probiotics)
1	(alterations
1	obesity).
1	outlook
1	microbiomes,
1	sentenced
1	detergents)
1	overload)
1	cytoplasmatic,
1	mitochondrion-centered
1	triple-
1	flip,
1	fadd
1	antinecrotic
1	(ripk1),
1	ripk3,
1	(mlkl)
1	necroptosis
1	sangiuliano
1	self-proteins
1	death-associated
1	(cdamp),
1	(damp)
1	thiol-regulating
1	cdamp/damp
1	exomes,
1	(epigenome)
1	(transcriptome)
1	datasets,
1	unparalleled
1	ontological
1	disease's
1	comprehensively
1	websites
1	retriever
1	(grmd)
1	dystrophin-glycoprotein
1	examined;
1	(td-
1	phospho-nfκb
1	bortezomib-td
1	β-dystroglycan,
1	(gmo).
1	practicable,
1	drug-inducible
1	homologous-directed
1	gain-
1	(zfns)
1	rna-expressing
1	disadvantages.
1	vise-versa.
1	poznan.
1	databank
1	o-phenanthrolin
1	top,
1	top-like
1	(il-1α),
1	(damps),
1	receptors/il-1
1	(tnfrs)
1	(nf-kappab)
1	(irf)
1	anti-cell
1	subclone
1	socs-1,
1	phosphorylated-r),
1	-7.
1	106dqpd/y110
1	staurosporine-treated
1	taf15-ciz/nmp4-fused
1	caspase-interacting
1	multicomplex
1	particle,
1	26s/20s
1	n-and
1	(dcd)
1	12q13
1	co-amplified
1	mda-361
1	egfr/erbb-1
1	betacellulin
1	amphiregulin,
1	egfr/erbb
1	calcium-calmodulin-dependent
1	kinase-ii
1	sirolimus,
1	ly-294002
1	wortmannin.
1	lbmsn,
1	blasticidin
1	balb/mk,
1	(death
1	bsrm),
1	dokeb.
1	lbmsn
1	chromatography:
1	dichlorofluorescein
1	solutes,
1	intraorganelle
1	smac/diablo,
1	htra2/omi,
1	translocase,
1	apoptosis-induced
1	inner/outer
1	cysteineproteases,
1	bound.
1	(e/d),
1	structural/sequential
1	caspredictor,
1	(111/137)
1	peptidecutter
1	peps
1	1644
1	9986
1	entries.
1	(mac16),
1	(mac13),
1	151%
1	177%
1	mac13
1	(1-5%
1	campaign.
1	(cdk)
1	cdk-1
1	cdk-2,
1	wehi,
1	butyrolactone.
1	(wehi,
1	(wehi)
1	butyrolactone-induced
1	40-200
1	110-90-
1	50-kda
1	(cytokines),
1	(ifn-α),
1	prominence.
1	(4-32
1	(424±57
1	(bolus)
1	neoplastia
1	(ii-
1	1/3),
1	(tgf-/9)
1	tnf/actinomycin
1	a-23187.
1	tgf-/3-
1	longed
1	13-acetate.
1	tgf-/3-mediated
1	hanced
1	tgf-/3.
1	tgf-0
1	gã—phase
1	k;
1	(pif)
1	diagphragm
1	ultrafiltered
1	quin-2
1	dextran-coated
1	(11/22)
1	200.75
1	pr;
1	20/22
1	362.5
1	addition/hypervalent
1	iodine-based
1	α-alkynylation.
1	cu(i)-catalyzed
1	alkyl-aluminum
1	grignard
1	1-ethynyl-1
1	,2-benziodoxol-3(1h)-one
1	(ebx)
1	34-89%
1	examples).
1	upscaled
1	functionalization
1	alkynylated
1	homopropargylic
1	scalability,
1	gram-scale
1	oxygen-and
1	nitrogen-substituted
1	1,2-dihydronaphthalenes.
1	acetoxy
1	benzoyloxy
1	60-71%
1	9-fluorenylmethyloxycarbonyl
1	(fmoc)
1	smoothly
1	64-77%
1	tosyl-protected
1	1-substituted
1	indanes.
1	alkenes,
1	methyl.
1	acetal
1	1,2-dihydronaphtalenes,
1	phi(oh)ts
1	reagent),
1	computationally
1	stereoselectivity
1	torsional
1	1,2-dihydronaphthalene.
1	(meoh)
1	continuum-microsolvation
1	benzofused
1	cycloalkane-containing
1	enantiopure
1	fluorescens,
1	cylindracea
1	acetates
1	enantioselectivity
1	enantiocomplementary
1	tetralins.
1	mdpi
1	carbocycles
1	heterocycles
1	(phi(oh)ots).
1	α-acetylene
1	1-[(trimethylsilyl)ethynyl]-1,2-
1	benziodoxol-3(1h)-one
1	(tms-ebx)
1	t-buok
1	tbaf
1	alkynylated.
1	cyclopentanes,
1	trans-hydrindanes,
1	(±)-,
1	(-)-
1	(+)-trans-trikentrin
1	(±)-indatraline
1	halogens
1	cb[6].
1	-cb[6]·4h
1	(br
1	-cb[6]·10h
1	bromination
1	bromohydrin.
1	envisioned
1	caramboxin:
1	phenylalanine-like
1	convulsant
1	(phi,
1	tsoh)
1	[htib
1	reagent].
1	1-methyl-2-tetralone
1	epoxidation/rearrangement
1	tsoh
1	catalisada
1	iodo
1	álcoois
1	homoalílicos
1	investigada.
1	condições
1	anidras
1	atmosfera
1	inerte
1	necessárias
1	neste
1	protocolo
1	ausente
1	metais.
1	reação
1	2-(3,4-di-hidronaftalen-1-il)propan-1-ol
1	simétricas
1	levou
1	produto
1	desejado
1	assimétricas,
1	levando
1	correspondentes
1	piranos
1	também
1	alcançada
1	aromáticas
1	finalmente,
1	monoterpeno
1	acetona
1	sucesso.
1	unsymmetric
1	ketones,
1	additives.
1	1,4,5,6-tetrahydro-2h-benzo[f]isochromenes
1	54%-86%
1	tertiary)
1	dihydropyrans
1	52%-91%
1	4-iodo-tetrahydropyran
1	29%-41%
1	hexahydrobenzo[f]isoquinolines
1	solvent-free
1	cis-trikentrins
1	herbindoles,
1	unsubstituted
1	trans-1,3-dimethylcyclopentyl
1	isomer.
1	target?
1	again!
1	(see
1	scheme).
1	cis-related
1	oxygen-containing
1	benzo-fused
1	hydroxy(tosyloxy)iodo]benzene
1	[phi(oh)ots,
1	htib].
1	2h-chromene
1	4-methyl-2h-chromene
1	4h-chromene
1	cis-3,4-dialkoxy-4-methyl-3,4-dihydro-2h-chromenes,
1	benzofurans
1	dihydrobenzoxepines
1	2,2-dimethyl-2h-chromenes,
1	populene
1	isochromene
1	loggi
1	0.91)
1	nci-adr/res,
1	ovcar-3,
1	1-oxo-1,2,3,4-tetrahydroisoquinoline-3-
1	dimedone.
1	purifications
1	dimedone
1	chlorotetrolic
1	diels-alder/retro-
1	indanamide
1	ambulation,
1	indanamide.
1	ortho-substituted
1	ethers,
1	halo-substituents,
1	racemization-prone
1	heteroaromatics
1	tetrahydrofuran
1	cyclofunctionalization
1	(htib,
1	kosers
1	5-endo-trig
1	cyclization,
1	4-exo-trig
1	5-endo-tet
1	cyclization.(figure
1	phi(oh)ots
1	(meoh,
1	2,2,2-trifluoroethanol
1	(tfe),
1	1,1,1,3,3,3-hexafluoroisopropanol
1	(hfip),
1	1:4
1	tfe:ch2cl2)
1	diastereoselectively
1	electron-rich
1	[hydroxy(tosyloxy)iodo]arenes
1	(htibs)
1	arenes
1	polyfluorinated
1	high-yielding.
1	transformations.
1	wieland-miescher
1	ketone.
1	transformations:
1	octalone
1	(ttn);
1	cis-fused
1	junction;
1	trinorsesquiterpene
1	senecio
1	humillimus
1	chalcones;
1	alkenes;
1	alcohols;
1	thallations;
1	couplings,
1	phenols.
1	3.1.1
1	3.1.1.1
1	3.1.1.2
1	3.1.1.3
1	flavanones
1	3.1.1.4
1	chalcones
1	3.1.2
1	3.1.3
1	cyclopropanes
1	3.2.1
1	3.2.1.1
1	alkenols
1	3.2.1.2
1	3.2.2
1	-oxidation
1	3.2.3
1	thallation
1	3.2.4
1	3.2.4.1
1	3.2.4.2
1	non-phenolic
1	3.2.5
1	phenols
1	3.2.6
1	3.2.7
1	3.2.8
1	deprotection
1	thioketals
1	(±)-1-trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1h-indene-1-carboxamide,
1	racemate
1	50/50)
1	crystallizing
1	(p21/c,
1	a=9.3180(1)å,
1	b=7.9070(2)å,
1	c=19.7550(4)å,
1	β=103.250(1)°,
1	v=1416.75(5)å3
1	z=4).
1	diastereomers
1	dimer.
1	centrosymmetric
1	c-h...o
1	c-h...π-aryl
1	(±)-1-trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1h-indene-1-carboxylic
1	racemates
1	50/50).
1	crystallize
1	(aliphatic)
1	hexahydrobenzo[f]isochromenes
1	4-hydroxy-tetrahydropyran,
1	54-81%
1	benzaldehyde,
1	hexahydrobenzo[f]isoquinoline.
1	conveniently
1	acetonitrile.
1	trisubstituted
1	(chemical
1	polyalkylated
1	(±)-trans-trikentrin
1	five-membered
1	bartoli's
1	heck
1	nonaromatic
1	(diacetoxyiodo)benzene
1	(dib)
1	esi-ms/ms,
1	[phi(oh)oiph]+
1	440.8864,
1	[phi(oac)oiph]+
1	482.8947,
1	[phi(o)(oac)oiph]+
1	498.8887.
1	cis-octalins
1	cis-octalones
1	1,2,3,4,4a,5,8,8a-octahydro-4a-methylnaphthalene
1	1,2,3,4,4a,5,8,8a-octahydro-4a,7-dimethylnaphthalene
1	1,2,3,4,4a,5,8,8a-octahydro-6,8a-
1	dimethylnaphthalen-1-ol
1	(tmof).
1	(phl(oh)ots).
1	chemica!
1	cyclopenta[g]indole
1	trikentrins
1	herbindols,
1	thallium(iii)-
1	cyclopentyl
1	indatraline,
1	3-phenyl-1-indanamine
1	phl(ots)oh,
1	generalizing
1	indans.
1	suitably
1	3-(2,3-dihydro-1h-inden-3-yl)-2-methyl-3-oxopropyl
1	4-bromobenzoate
1	52-55%
1	(ttn).
1	gave,
1	stereocenters.
1	α,α-dichloro-cyclic
1	bleach
1	-withdrawing
1	five-,
1	six-,
1	aryl-cycloalkanones
1	indans,
1	bakkane
1	cis-octalins.
1	hydrindanes
1	cycloalkanones
1	iodotoluene
1	difluoride,
1	(koser's
1	β,γ-unsaturated
1	2-(3,4-dihydronaphthalen-1-yl)-propionic
1	3-indan-1-yl-2-methyl-3-oxo-propionic
1	β-keto
1	2-(3,4-dihydronaphthalen-1-yl)-ethanol
1	indan,
1	triacetate
1	(tta)
1	acoh;
1	tris-trifluoroacetate
1	(ttfa)
1	tfa;
1	ttfa
1	ch2cl
1	tripropionate
1	(ttp)
1	tris-[(s)-(-)-triacetoxypropionate]
1	(s)-(-)-2-
1	acetoxypropionic
1	tta
1	trans-dimethoxylated
1	thallium-promoted
1	(tmof)
1	glycolic
1	naphthalenes,
1	1,2-
1	dihydronaphthalenes
1	no2.
1	acoh,
1	meoh/h
1	base)
1	(esi-ms/ms).
1	meoh/h2o
1	[phi(oac)2na]+,
1	[phi(oac)2k]+,
1	[phi]+,
1	[phioac]+,
1	[phioh]+,
1	[phio
1	2ac]+,
1	[phio2h]+
1	[ph2i2o2ac]+.
1	[phiome]+
1	koh
1	bis(trifluoroacetate)
1	phi(o2ccf3)2
1	3cn
1	(friedel-crafts
1	resolution)
1	1-methyl-1,2-dihydronaphthalene
1	6-methoxy-1-tetralone
1	jungianol.
1	unit)
1	wittig
1	olefination
1	chain).
1	2-(3,4-dihydro-1-naphthalen-1-yl)propan-1-ol
1	alkenol
1	methyl,
1	benzyl
1	4-phenylbenzyl
1	diastereomer,
1	(63-71%).
1	oxidant,
1	diastereomers,
1	12-24%
1	9-24%
1	alkenol,
1	furnishing
1	37-57%.
1	reformatsky
1	bromo-esters
1	2-bromopropionate,
1	bromoacetate
1	2-bromobutyrate),
1	β-hydroxy-ester
1	acoh/h2o,
1	2-tetralones
1	annulative
1	sesterterpenoid
1	variecolin
1	hemiketal,
1	expeditious
1	samarium(ii)
1	bakkanes
1	β-methylene-γ-butyrolactones
1	1,2-dihydronaphthalene,
1	1-methyl-1,2-dihydronaphthalene,
1	8-methoxy-1,2-dihydronaphthalenes
1	1-n-butyl-4-methyl-1,2-dihydronaphthalene
1	cis-2-decalones
1	regio-
1	regiochemistry
1	decalone
1	k-10
1	indan-1-carboxylates)
1	(2-methoxy-1-tetralones),
1	pentane
1	α-spirocyclopentyl-γ-butirolactones
1	(1989-1998)
1	(sbs)
1	malabsorption,
1	sbs
1	megaileum
1	r).
1	0.3%.
1	resections
1	patents).
1	preoperatively,
1	resectability
1	nonresectional
1	preoperatively;
1	possible:
1	4-alkylcyclohexanones
1	alkylcyclopentanecarboxylic
1	stereoselectivity.
1	2-methylcyclohexanone
1	2,6-dimethylcyclohexanone
1	diastereoselectivities
1	mckillop
1	22-month-old
1	methylmalonic
1	aciduria
1	homocystinuria
1	macula,
1	sclera
1	mucopolysaccharide.
1	fibrocytes;
1	keratocytes,
1	scleral
1	fibrocytes.
1	microneedles
1	(me-15),
1	(me-29)
1	(me-60)
1	newtonian
1	me-15
1	me-29
1	(tewl)
1	me-60,
1	(1.3–4-fold).
1	microneedle
1	roller
1	punctures
1	tewl;
1	tewl,
1	(1.6–4-fold)
1	(3.3-fold),
1	(2:1 w/w),
1	cacl2solution.
1	alginate-only,
1	1.44-fold
1	larger,
1	1.40-fold
1	1.30-fold
1	24 h).
1	(created
1	wound)
1	favored.
1	layer/receptor
1	non-aqueous
1	pharmaceutically
1	sparingly
1	(progesterone,
1	lycopene)
1	treatment/prevention
1	brij,
1	e-tpgs,
1	surfactant-co-surfactant
1	tributyrin,
1	(mepg)
1	(mew)
1	bicontinuous.
1	2.5–38-fold;
1	compound),
1	mew,
1	(2–2.5-fold).
1	mepg-mediated
1	lipophilicity.
1	polyethylenimine
1	(pei)
1	carrier/sirna
1	complexing
1	(∼90%),
1	triton-x
1	15.6-fold
1	3.3-fold
1	disease-specific
1	pepe
1	(polyoxyethylene
1	monocaprylin,
1	transportan
1	(me-t),
1	(me-p),
1	(me-tat)
1	(32.3–40.7
1	(+4.1
1	+6.8
1	1–12
1	ptd-containing
1	dermis)
1	me-t,
1	me-tat
1	(1.6-fold
1	less).
1	triton.
1	triton,
1	paclitaxel-containing
1	enhancers,
1	into/across
1	exclusively)
1	iontophoresis
1	dmso.
1	protein-transduction
1	phagedisplayed
1	suggests,
1	nanocarriers,
1	α-tocopherol-lipoic
1	codrug.
1	(isopropyl
1	(10%-30%,
1	2.9-7.8-fold
1	myristate)
1	bioequivalents
1	codrug-containing
1	codrug,
1	μg/cm2)
1	tocopherol-lipoic
1	pharm
1	103:2530-2538,
1	mono-dicaprylin.
1	surfactant:
1	oil:
1	60:
1	30:
1	(me-o)
1	46:
1	23:
1	(me-w),
1	(me-wphy)
1	me-wphy-treated
1	-4.3
1	+29.1
1	mv.
1	o/w.
1	me-wphy.
1	(penetratin)
1	(brij:ethanol:propylene
1	2:1:1,
1	(oil
1	1.3:1
1	(me-30),
1	(me-43),
1	(me-50).
1	me-30
1	bicontinuous
1	(me-p)
1	+5.2
1	transdermal)
1	me-43,
1	1.3-fold.
1	(twofold)
1	phytosphingosine-containing
1	barrier-disrupting
1	microemulsions.
1	δcutaneous/δtransdermal
1	uv-radiation.
1	sugar-based
1	monoglycerides
1	(0.04%
1	(me-mc),
1	monolaurin
1	(me-ml)
1	(me-mo)
1	3.3-
1	(1.5-3-fold),
1	me-mo
1	me-ml.
1	2.2-times
1	10.2-fold,
1	phthalocyanine
1	tetrasulfonate
1	(znpcso
1	compound's
1	(span®
1	80/tween®
1	80),
1	(pg)/water
1	(3:1)
1	rheological,
1	monomerization
1	photometrically
1	oil:surfactant:pg-water
1	38:47:15
1	corneum)
1	33.0-
1	28.0-fold
1	1.6-
1	5.6-fold
1	naltrexone,
1	brij
1	(pg,
1	5-70%,
1	10-90%
1	brij:pg
1	95:5
1	brij-95)
1	80:20
1	brij-80)
1	pbs),
1	pseudo-first
1	brij-80
1	brij-80,
1	brij-97,
1	(lp-10)
1	(lp-20),
1	selected;
1	(threefold),
1	(fourfold).
1	[at
1	(w/w)],
1	lp-20,
1	paclitaxel-loaded
1	1.3-2
1	(hsp)27
1	(mapkap
1	thickening.
1	pretreated)
1	17%),
1	(17%
1	(48.2%
1	acetonitrile:methanol
1	accuracy)
1	quantification).
1	88.3
1	90.5%;
1	100-1000
1	68.6-74.9%.
1	hspb6,
1	mid-1990s
1	hspb1
1	hspb5.
1	action;
1	implications.©
1	(0.05%,
1	brij-propylene
1	(2:1,
1	blend)
1	mgor
1	tg-containing
1	(6-
1	3.6-fold,
1	41.1
1	103.1
1	ng/cm2,
1	cuprac
1	moderate-tosevere
1	μmg/ml.
1	diglycerides
1	(pgt).
1	1070%
1	solvent)
1	(nonpolar
1	solvent);
1	glycol,
1	2.5-
1	7-fold,
1	2050%,
1	pgt.
1	smaller.
1	(moderate-to-severe
1	irritant).
1	glycerides
1	(progesterone)
1	(adenosine)
1	glycerides,
1	(1:1:1,
1	blend,
1	water/oil
1	chosen;
1	(47:20:33
1	63:14:23
1	surfactant/oil/water,
1	w/w/w).
1	(4-fold
1	μg/cm2/h)
1	me-hi,
1	lipophilic,
1	safe),
1	(hsp27)
1	mapkap
1	(mk2),
1	hsp27,
1	(ctgf)
1	heat-shock-related
1	(hsp20),
1	displaces
1	phospho-cofilin
1	azx100,
1	hsp20,
1	factor-β-1
1	(tgf-β1)-induced
1	cremophor-free
1	(pac)
1	solubility,
1	surfactant-oil
1	surfactant-myvacet
1	lecithin:
1	butanol:
1	(lbm,
1	48.5%)
1	centromix
1	cps:
1	1-butanol:
1	(cps,
1	45.15%)
1	capmul
1	mcm:
1	(cpm,
1	27.6%)
1	capryol
1	90:
1	(cp-p80,
1	23.9%)
1	capmul:
1	(cm,
1	20%).
1	(o/w)
1	(687-1010
1	water-in-oil
1	(w/o)
1	(272-363
1	zetasizer
1	(d2o)
1	10-11,
1	1.97
1	m2/s,
1	(cm
1	lbm)
1	o/w
1	cpm.
1	11-fold
1	taxol®
1	(ce,
1	cremophor:
1	pgp/cyp3a4
1	area-under-the-curve
1	lbm,
1	wlr.
1	(vs);
1	2.33-fold
1	(2.88-fold)
1	non-attached
1	camp/camp-dependent
1	(asm).
1	shock-related
1	protein-pka
1	(pki-gfp)
1	pka-induced
1	cofilin.
1	iso-induced
1	(vitk)
1	bruising.
1	vitk,
1	(2.5%,
1	vaseline,
1	(mo-vitk-water
1	77.5/2.5/20,
1	(mo-vitk-poloxamer-water
1	15/2.5/0.9/81.6,
1	w/w/w/w).
1	(sc):
1	9.50
1	post-application,
1	4.90
1	2.0-3.7
1	gel)
1	(∼3-fold
1	nanodispersions
1	(cyclosporin
1	cysa)
1	monoolein,
1	poloxamer,
1	obtainment
1	cryo-tem
1	diffraction.
1	181.77
1	2.8-times
1	[e+d],
1	nanodispersion.
1	mesophases
1	25-40
1	phosphaditylcholine
1	(suv).
1	co-lyophilized
1	drug/pc
1	non-lipossomal
1	120-140°c
1	240-260°c.
1	(ptd),
1	nontransducing
1	(ykac).
1	yara-p20,
1	tat-p20
1	(monoolein
1	(topical
1	(transdermal
1	spectrofluorimetry.
1	ykac.
1	recoveredfrom
1	([e+d]),
1	(methanol).
1	rp-18
1	acetonitrile:
1	(67:33
1	150ng/ml.
1	0.15-500
1	between-day
1	enhancer)
1	5-70%
1	uv-hplc.
1	cysa.
1	(20-70%
1	w/w),
1	cysa,
1	multilamellar
1	micelar
1	31p
1	dichlorophenyl
1	(40:10:0.04
1	sonicaion.
1	chromatoraphy
1	liposoes.
1	mg/mg
1	(ampar)
1	potentiator,
1	100mg/kg,
1	10mg/kg,
1	(100mg/kg)
1	sd-induced
1	b.v.,
1	polyhydroxyalkanotes
1	35 °c,
1	co-substrate,
1	(3-hb)
1	considerably,
1	3-hb
1	(ralstonia
1	tsm81
1	atcc7966
1	phac)
1	3-polyhydroxyalkanoate
1	(pha
1	lfm046)
1	lfm461).
1	mini-tn7.
1	marker-free
1	plasmid-free
1	co-substrates
1	terpolyester
1	3-hydroxybutyrate,
1	3-hydroxyhexanoate,
1	3-hydroxydecanoate
1	lfm461
1	3ha
1	3hb-co-3ha
1	co-substrates.
1	non-naturally-occurring
1	3hb,
1	3hd
1	(3ho,
1	3hddδ
1	3hdd
1	amounts)
1	(acetone
1	chloroform)
1	ftir,
1	tga
1	gpc.
1	blocks:
1	chassis
1	bioproduction
1	scale:
1	inherently
1	[p(3hb)]
1	bglbrick
1	tunable
1	xylr
1	(55.5%
1	(77.27%
1	p(3hb).
1	sacchari.[figure
1	substitutes,
1	feedstocks.
1	(sugarcane
1	hydrolysates).
1	non-model
1	xylulokinase
1	(harboring
1	pbbr1mcs-2),
1	p3hb/xil
1	 = 0.35 g/g).
1	xylb
1	ma03
1	g−1.
1	valeric
1	21.9
1	mol%,
1	g−1,
1	63.7%
1	henceforth,
1	p(3hb-co-3hv)
1	by-products.
1	biotechnol.
1	prog.,
1	33:1077–1084,
1	(p(3hb))
1	biodegradability.
1	ratios:
1	p(3hb):nd(16:1),
1	(12:1)
1	(8:1).
1	nds
1	tga,
1	p(3hb):nd(8:1),
1	aggregates;
1	12:1
1	modulus
1	biopolymers
1	co-monomers
1	3-hydroxyhexanoate
1	[p(3hb-co-3hhx)]
1	polyethylene.
1	(unable
1	(phapcj)
1	biopolymer
1	productivities
1	0.45
1	945%,
1	ma03.
1	10–50 g l−1
1	cultivations
1	49.0%
1	(cdw).
1	30 g l−1
1	25.9 mol%
1	added-value
1	biodiesel,
1	pha-producing
1	carlos.
1	p(hb-hv),
1	94%hb
1	6%hv,
1	4-6nm,
1	nanoidentation,
1	dma,
1	xrd,
1	tga.
1	crystallinity,
1	crystallite
1	nanoidentation
1	injection-molded
1	compression-molded,
1	cytoxicity.
1	alterna­tives
1	plastics.
1	halomonas
1	hg01,
1	mine
1	3,665,487
1	nadp
1	dehydrogenases.
1	entner-doudoroff
1	zwf-1
1	(pputg6pdh-1),
1	principles,
1	(g6p).
1	pputg6pdh-1
1	1/3.
1	g6p.
1	stoichiometric
1	lfm046
1	(phamcl)
1	(carbohydrates,
1	5.97
1	66%.
1	job
1	waiting
1	job,
1	nonproductive
1	(npt).
1	2,800
1	successfully,
1	allowable
1	npt
1	(hse)
1	penalties
1	breaches
1	committed.
1	felt
1	usd
1	drilled
1	(use
1	mindful
1	bioprocesses,
1	1g
1	mill
1	f24,
1	(p3hb).
1	non-detoxified
1	(cdw)
1	poly-3-
1	hydroxybutyrate-co-3-hydroxyvalerate
1	(p3hb-co-3hv)
1	levulinic
1	cdw
1	bioplastics
1	cosubstrates
1	odd-numbered
1	65 mol%
1	4-hydroxybutyrate,
1	9·1 mol%.
1	1·6 mol%
1	p3hb-co-3hhx.
1	3hv,
1	3hb.
1	ultrahigh
1	poly-3-hydroxybutyric
1	shaken-flask
1	xl1
1	psk::phacab
1	(6.0,
1	mda.
1	mda).
1	phas,
1	costs;
1	lmf046
1	gc-ms.
1	[1-13c]glucose-allow
1	[u-13c]glucose
1	glucose-
1	balances,
1	i5
1	prediction.
1	1.35:0.55,
1	satisfactorily,
1	bioprocesses
1	(pts),
1	non-pts
1	pentoses.
1	lfm828.
1	parental.
1	automotive
1	sisal.
1	(ibama-e.
1	1988)
1	(din
1	53739,
1	1984).
1	extractives,
1	lignin,
1	holocellulose,
1	ashes,
1	biodegradation,
1	testing;
1	latex.
1	(phb)-producing
1	ma3.3
1	msl7
1	δccpa
1	(gltab),responsible
1	ma3.3.
1	gltab
1	ccpa.
1	msl7.
1	3-hydroxydodecanoate
1	3-hydroxy-6-dodecenoate
1	(3hddδ6)
1	3hddδ6
1	tailor-made
1	(2mcc)
1	0.81-0.96
1	g·l
1	2mcc.
1	feedstock
1	3,152
1	684,
1	ma3.
1	06
1	(3hb)
1	atp/3hb
1	thermoplastic,
1	biodegradable,
1	petrochemical
1	plastics
1	characterisation,
1	blends.
1	assimilate.
1	048.
1	101.
1	growth-limiting
1	high-cell-density
1	p3hb.
1	ipt046
1	elastomeric
1	hydroxydecanoate
1	hydroxyoctanoate
1	(20-25%)
1	non-terminal
1	kdalton
1	diffractogram
1	crystalline.
1	(-39.7
1	thermically
1	film.
1	polyurethanes
1	polycaprolactone
1	(pcl)
1	polyurethane.
1	(mn=2000)
1	semicrystalline,
1	(mn=530)
1	crystallize.
1	sturm
1	polyurethane
1	copolyesters,
1	(prpr,
1	prpb,
1	orf5)
1	42,691
1	propionate-negative
1	ipt189
1	(orf4)
1	orf5,
1	2-methylisocitric
1	hf39,
1	orf1
1	(prpr)
1	70,598
1	(orf6,
1	opf7,
1	orf8)
1	orf5
1	copolyesters
1	ipt101t,
1	burkholderia.
1	19450t
1	cct
1	6771t)
1	p3hb-co-3hv
1	(y(3hv/prop))
1	c.a.
1	y(3hv/prop)=1.20
1	nitrofurantoin,
1	12,5%
1	(μphb)
1	eutrophus,
1	μmaxeven
1	mic.
1	μmaxonly
1	50%mic.
1	μphbwhen
1	considered)
1	emitters
1	springs
1	0.185
1	msv
1	year-1.
1	polyhydroxyalkanoic
1	poly-(3-hydroxybutyric
1	phb.
1	3-hydroxyvaleric
1	eutrophus.
1	3-hydroxybutyric
1	surcose
1	ipt77b,
1	poly(3-hydroxybutyric
1	co-3-hydroxy-4-pentenoic
1	100/mol
1	occurence
1	pendant
1	gaschromatographic
1	tetraethyl
1	orthosilicate,
1	ethanol;
1	regime,
1	)-based
1	whitening;
1	tissues/cells.
1	concentration-dependent;
1	split-mouth
1	bleaching.
1	sham+cmc
1	ligature+cmc
1	ligature+diclofenac
1	ligature+etoricoxib
1	euthanized.
1	prostacyclin),
1	selectins,
1	immunoglobulins)
1	hypertension),
1	(830 nm;
1	100 mw;
1	3.57 w/cm
1	1 j–35.7 j/cm
1	3 j–107.1 j/cm
1	9 j–321.4 j/cm
1	(histology)
1	trauma;
1	contusion.
1	contusion-induced
1	(830 nm,
1	100 mw
1	35.71 w/cm
1	9 j;
1	1 j
1	(35.7 j/cm
1	(p < 0.05
1	9 j)
1	arruda
1	mentha
1	piperita
1	(peppermint)
1	(lhae)
1	lhae.
1	(49-57%)
1	(34.6-53.4%)
1	(15.3-63.5-fold)
1	(34.4-73.6-fold)
1	lps-unstimulated
1	(3.6-6.6-fold
1	cardiac)
1	(parotid
1	submandibular)
1	tbars)
1	gpx).
1	pilocarpine-stimulated
1	immunosuppressants,
1	ca<sup>2
1	+</sup>
1	expre
1	ssion
1	biociencias.
1	“quixabeira”
1	infammatory
1	2,2-diphenyl-1-picrylhydrazyl
1	(dpph)
1	ml-1of
1	lanette®cream)
1	(1.04
1	1.15
1	ml-1dpph,
1	(30 mg/kg)
1	(75 mg/kg)
1	3 d.
1	hemi-mandibles
1	cxcl4
1	(p < 0.001)
1	bone-resorbing
1	(ocs),
1	(pbmps)
1	ocs,
1	cd14+pbmcs
1	(rankl),
1	(m-csf).
1	resorbing
1	osteologic
1	formation).
1	interferon-g,
1	(il)-1α,
1	il-1rγ,
1	(mip)-1α,
1	m-csf.
1	pbmc-derived
1	2014;85:e72-e81.
1	estrogen-deficient
1	weekly)
1	times-of-day
1	machado-nils
1	indole-thiazolidine
1	pan-agonist
1	(ppar
1	pan)
1	lyso-7,
1	ethanol/hcl-induced
1	(et/hcl)
1	(60%/0.03m).
1	l-ng-nitroarginine
1	lyso-7-mediated
1	santin
1	brute
1	hydroethanolic
1	(bhe)
1	choroformic
1	(chcl3)
1	n-butanolic
1	(buoh),
1	oxindole
1	mg.kg-1)
1	inversely,
1	chcl3
1	poas
1	dreifuss
1	lm;
1	lg/ml;
1	(il)-1b
1	b2integrin
1	(nf-jb)
1	α-mem
1	g/ml)
1	no2-,
1	sicam-1
1	(il-1ra)
1	cannot)
1	il-1β/tnf-α
1	colonocytes
1	"metabolic
1	barrier"
1	bacteria-derived
1	(trpv-4)
1	tmjs
1	par-2-activating
1	(par-2-ap)
1	(index
1	par-2-ap.
1	tmjs,
1	trpv-4.
1	n-(g)-nitro-l-arginine
1	(5mg/kg,
1	intraperitoneally).
1	(1μg/ml)
1	(asp,
1	(clo,
1	ligatures,
1	ubiquitin,
1	3-nitrotyrosine,
1	als.
1	endostatin,
1	antiplatet
1	s.c.);
1	p.o.;
1	i.p.;
1	(vehicle).
1	(tnf-alpha)
1	calcitriol
1	trap-5b
1	calcitriol/calcitonin
1	(cox-2)-selective
1	(w256)
1	7th,
1	(prs),
1	epilepticus,
1	epilepticus.
1	subjected,
1	(cyclosporine
1	a/simvastatin)
1	a/simvastatin
1	gingivomucosal
1	liftings.
1	thermal,
1	knockouts.
1	inflammation-resolving
1	resolvin
1	(rve1)
1	multinuclear
1	oc,
1	rve1,
1	chemr23
1	3h]rve1
1	u75302
1	18r-hydroxy-eicosapentaenoic
1	hyperdynamic
1	acid-back
1	grow.
1	cox/nos
1	capsaicin-
1	a5330-treated
1	enos/inos/cox-2
1	csa-associated
1	(balp),
1	tartrate-resistent
1	osteblasts,
1	osteoclasts;
1	balp,
1	tacrolimus,
1	(patho)biology,
1	atrial,
1	(patho)physiology
1	(nees)
1	castiglioni
1	(paw
1	edema).
1	(180-220
1	(250,
1	mg·kg-1).
1	ear,
1	ethyl-acetate
1	hydromethanol
1	topically,
1	mg·kg-1)
1	mg·kg-1
1	hydromethanol)
1	2-day-old
1	(nos):
1	(sc;
1	(nnos,
1	[3h]l-arginine
1	[3h]l-citrulline.
1	p7
1	have.
1	no-treatment
1	(t50%).
1	12.6)
1	83.2%
1	20.5)
1	18.3)
1	[50%
1	15)].
1	cox-inhibiting
1	(cinods)
1	multi-pathway
1	donation.
1	multiorgan
1	renal-sparing
1	ischemia/reperfusion,
1	analgesia,
1	(•no)
1	second-messenger
1	disfunctions
1	•no,
1	(fk-506)
1	overgrowth.
1	hystometry
1	fk-506.
1	fk-506,
1	nonpeptidic
1	glomerulosclerosis;
1	damage;
1	allergic)
1	recuperation
1	eto1
1	etoricoxib;
1	eto2
1	etoricoxib.
1	2-),
1	nt-containing
1	(jia).
1	(fmlp)
1	[erythrocyte
1	score]
1	no2-/no3-
1	jia
1	(13.9
1	2-/no3-
1	dup-697
1	aspirin)
1	ischaemia-reperfusion-induced
1	damage)
1	dup-697),
1	cyclo-oxygenase-1
1	ncx-4016,
1	derived,
1	cyclo-oxygenase-2.
1	(apap)
1	overdosing.
1	hepatotoxic,
1	100-500
1	compounds).
1	≈40
1	centrilobular
1	apap-glucuronide
1	hbv-transgenic
1	apap.
1	fas-agonistic
1	checkpoints
1	marketplace
1	inflamed.
1	gastric-sparing,
1	(ncx-4016)
1	aspirin-treated
1	phenylephrine-pre-contracted
1	'2k,
1	1c'
1	hct-3012,
1	naproxen-
1	hct-3102
1	releases,
1	(inos(-/-)/il-10(-/-)
1	(inos(+/+))
1	(no(x))
1	(macroscopic
1	microscopic)
1	fivefold.
1	no(x),
1	inos(-/-)/il-10(-/-)
1	(celecoxib),
1	(hct-3012)
1	e2levels
1	pge2levels,
1	methylester
1	(pg)f(1α)
1	pgf(1α)
1	arginine-vasopressin
1	(148%)
1	ulcération.
1	(ncx-4215
1	ncx-4016;
1	nicox
1	sa)
1	injurious
1	oxide-associated
1	(5-aminosalicylic
1	(ncx-456;
1	no-mesalamine)
1	(il)-1̄
1	(splenocytes
1	(damage
1	mesalamine,
1	splenocytes;
1	(no-naproxen)
1	scoring.
1	>90%.
1	no-naproxen-treated
1	no-naproxen.
1	(il-1)
1	(mbsa).
1	mbsa
1	(2mg/ml)
1	n-omega-nitro-l-arginine
1	(lname)
1	n-omega-nitro-d-arginine
1	(dname)
1	count),
1	(evans's
1	method),
1	(no2.)/nitrate
1	(no3.)
1	(radioimmunoassay),
1	dname
1	n02./no3.,
1	il-1-induced
1	intragastral
1	(ipec)
1	ipec,
1	(135.4
1	102.6/mm
1	(59.8
1	25.4/mm
1	6/12
1	atopics
1	arthrosis.
1	3-week,
1	multicenter
1	20.9%
1	best-tolerated
1	cataflam,
1	ciba-geigy)
1	inter-subject
1	nonsulfhydryl
1	enzyne
1	men;
1	dose-finding
1	weeks'
1	mg/day,
1	sitting
1	(sdbp)
1	(≤90
1	postdose
1	(pra),
1	107.6
1	97.2
1	antibody-antigen
1	(42°c).
1	productively
1	conformer,
1	(eg.
1	conformers.
1	(i.
1	affinity).
1	sensors.
1	equations,
1	space:
1	limit-cycle
1	fixed-point
1	double-attractor
1	mistake
1	“purified
1	(usa)”
1	“full-length
1	(usa)”.
1	proteostatic
1	adapts
1	ire1α),
1	client.
1	predilection
1	grp78-upr
1	tunes
1	borsa
1	sensors:
1	pkr-like
1	(perk),
1	(atf6),
1	inositol-requiring
1	(ire1).
1	proteins'
1	curtail
1	customize
1	benefit.
1	infection's
1	(arv)
1	upr's
1	simultaneously:
1	esvd
1	acvd.
1	hypothesis/objectives:
1	demodicosis,
1	age/breedmatched
1	equalled
1	lps-sensitive
1	chimpanzee,
1	horse)
1	lps-resistant
1	md2.
1	glyceraldehyde-3p-dehydrogenase
1	hypoxantine
1	ribosyltransferase
1	(hprt)
1	(sdha),
1	qbaseplus.
1	oligodeoxynuclotide
1	(cpg-odn
1	2216)
1	hprt/sdha
1	eqpbmc
1	hprt/gapdh
1	pma/ionomycin.
1	endotoxaemia.
1	misfolded/unfolded
1	(upr).
1	fail.
1	lineage-independent.
1	cord-blood
1	nonpolarizing
1	activation-associated
1	nonpolarized
1	rested;
1	+ccr4
1	-ccr4
1	lineage-independent
1	accessibility-associated
1	persistent.
1	'relaxed',
1	0.0064)
1	horse.
1	mare
1	foal.
1	2704
1	1424
1	kolmogorov-smirnov
1	ethylenediaminedisuccinic
1	[cd(edds)],
1	cd2+
1	'trojan
1	horse:
1	s,s-ethylenediaminedisuccinic
1	quenching
1	(metal
1	zn)
1	1,2,3-dihydrorhodamine
1	dihydrochloride.
1	fe-edds
1	trolox
1	α-cyano-4-hydroxycinnamic
1	metal-edds
1	(k562)
1	(lgmds)
1	(lgmd2b),
1	dysferlin
1	lgmds
1	(hascs)
1	delivery;
1	hascs
1	©alphamed
1	(rags)
1	v(d)j
1	rag-1
1	rag-2
1	jawless
1	discuses
1	phylogenetics
1	omenn
1	(os),
1	immunomics
1	henry
1	stewart
1	factor-α-,
1	interleukin-12-
1	oxide-inducing
1	mucins.
1	unsaturated,
1	alkyl-acylglycerolipid
1	lipopeptide
1	glycosylphosphatidylinositol-mucins
1	(chtx)
1	mimetics,
1	chtx
1	il-12(p40),
1	(cmi)
1	host).
1	inducing/modulating
1	glycosylphosphatidylinositol-anchored
1	glycoprotiens
1	(gpi-mucins)
1	gpi-mucins.
1	lipophosphoglycans
1	glycoinositolphospholipids)
1	epimastigotes),
1	epimastigotes)
1	monokine-inducing
1	nonsaturated
1	synovium,
1	embryology
1	grossly,
1	c-shaped
1	arches
1	ridge.
1	eyelids,
1	nose,
1	vibrissae,
1	forelimb,
1	bowel,
1	spine.
1	>43%
1	1/vp2
1	arborviruses.
1	sight.
1	reintroduced.
1	1,400,000
1	macro-region.
1	contextualise
1	genbank,
1	macro-regions
1	guillain-barre
1	(zbr)
1	mr766
1	(zaf)
1	cells-derived
1	zbr
1	(hbca).
1	hbcas
1	cxcl-10
1	(rantes).
1	hbca
1	virus-induced
1	cisternae.
1	(cai)
1	drift,
1	showcase
1	emergences,
1	phylodynamics,
1	(npcs)-microglia
1	sofosbuvir,
1	npcs.
1	75.35%
1	(107/142)
1	asthenia
1	chikv-negative
1	1937,
1	(arthropod-borne
1	virus’
1	(ap61)
1	(vero)
1	viral-host
1	ortiz-baez
1	ardisson-araújo
1	(disagv)
1	crambidae),
1	monocot
1	454-pyrosequencing
1	98,392
1	lepidopteran-infecting
1	(orf).
1	betabaculovirus-specific
1	chocgv,
1	erelgv,
1	piragv
1	clangv,
1	calgv,
1	cpgv,
1	crlegv,
1	adorgv,
1	phopgv
1	epapgv.
1	gp64
1	alphabaculoviruses.
1	betabaculovirus.
1	cpgv-related
1	gp64,
1	villabona-arenas
1	brazil.we
1	354
1	cladogenesis
1	notifications.
1	unapparent
1	(rvfv)
1	tri-segmented
1	ssrna
1	phylodynamics.
1	dynamics;
1	dating.
1	camels,
1	antennatus
1	dakar
1	(<ext-link
1	ext-link-type="uri"
1	xlink:href="http://www.pasteur.fr/recherche/banques/crora/"
1	xlink:type="simple"
1	xmlns:xlink="http://www.w3.org/1999/xlink">http://www.pasteur.fr/recherche/banques/crora/</ext-link>)
1	1968.
1	côte
1	d'ivoire.
1	n154
1	dalzieli
1	faye
1	budded
1	(bv)
1	occlusion-derived
1	(odv)
1	intra-and
1	inter-host
1	gemmatalis.
1	(agmnpv-2d)
1	maldi-
1	quadrupole-tof
1	bv.
1	biopesticide
1	behave.
1	functionalities.
1	(grn)
1	synchronicity,
1	grn,
1	(149),
1	modularity
1	1953
1	slovakia,
1	austria
1	350-year
1	ingressions
1	slovakia
1	(danube
1	(birds,
1	deer)
1	indepth
1	long-distance
1	(denv-3)
1	background:denv-1
1	health.methodology/principal
1	6.56×10-4
1	substitutions/site/year.
1	oscillations.
1	broadcast
1	indochina
1	americas.conclusions/significance:the
1	villabona-arenas,
1	zanotto.
1	introduction:culex
1	(cxfv)
1	bg-sentinel
1	aspirators.
1	cxfv,
1	louis
1	(slev)
1	cxfv.
1	slev
1	(urfs)
1	cocultivation.
1	(crfs)
1	(crf28-bf,
1	crf31-bc,
1	crf39-bf,
1	crf40-bf,
1	crf46-bf).
1	(urfs),
1	jphmm
1	dual-tropic
1	(x4/r5)
1	(x4)
1	(r5)
1	v3-loop
1	gwgr-carrying
1	much-anticipated
1	urfs
1	bunyaviridae)
1	epizootics
1	mauritania.
1	barkedji
1	soumaré
1	paraná).
1	1960
1	capitals
1	curitiba)
1	(paraná
1	(santa
1	0.64)
1	intermixing
1	sub-cluster.
1	bello
1	inhibitor-naïve
1	tallying
1	non-b
1	integrases
1	4924
1	hxb2)
1	grna
1	stutter.
1	drug-naïve
1	raltegravir
1	(ral)
1	elvitegravir
1	(evg)
1	v151i
1	mosaics,
1	iamarino
1	jundiaí,
1	(68:876)
1	1954
1	phylodynamic
1	east-to-west
1	8×10
1	ž
1	d'á
1	kaplice
1	1956-2008
1	(tropical
1	malaysia-thailand
1	cross-correlation
1	(france).
1	gpgr
1	(53.5%
1	31.0%),
1	gwgr
1	(23.0%)
1	considered:
1	cxcr4-using
1	(x4
1	variants)
1	(37.5%
1	19.1%),
1	botucatu.
1	cells/μl;
1	co-circulate.
1	hcv-related
1	banks,
1	non-risk
1	ns5b
1	591
1	piggybac-related
1	idt
1	transposon)
1	2531
1	(tpase)
1	1719
1	572
1	piggybac
1	tpase
1	country-specific
1	circumspect
1	southeast-asia
1	transmissions
1	thailand)
1	1890,
1	1970s,
1	10.700
1	prm,
1	(denv
1	1-4).
1	conducive
1	dengue-like
1	m-n-pcr
1	geo-coded.
1	aligned.
1	criterion.
1	(tmrca)
1	geo-code
1	399-nucleotide-long
1	isle
1	martinique
1	2000-2001.
1	occasions.
1	1.13.
1	tmrca
1	dna-dependent
1	polymerase-based
1	(dddp)
1	inter-genome
1	co-divergence
1	dddp
1	satellite,
1	significantlymore
1	co-infecting
1	symbionts.
1	departure
1	zanotto
1	rodent-borne
1	bunyaviruses
1	arvicolinae,
1	murinae,
1	muridae.
1	(substitutions/site/
1	substantiated,
1	anomalous.
1	subfamilies:
1	(sigmodontinae),
1	dobrava
1	(murinae),
1	puumala
1	(arvicolinae),
1	tula
1	(arvicolinae).
1	substitutions/site/year
1	disparity
1	rodent-hantavirus
1	reevaluated.
1	most-virulent
1	nucleopolyhedrovirus,
1	(sfmnpv-19),
1	132565
1	computer-simulated
1	3ap2
1	1427
1	(semnpv)
1	agrotis
1	segetum
1	(agsemnpv-a),
1	synthenic
1	collinearity
1	power-law
1	c/hepatitis
1	fixes
1	∼10-7
1	(new
1	viruses)
1	codiverged
1	codivergence.
1	sub/site/year,
1	reconciliation
1	gbv-a,
1	(macaca
1	mulatta;
1	rherv-k)
1	troglodytes;
1	cerv-k).
1	(mybp),
1	mybp,
1	herv-k,
1	rherv-k,
1	rherv-k
1	cerv-k.
1	demography
1	(agb),
1	metacestode,
1	(devoid
1	emagb1-emagb4
1	emagb2
1	(erv)
1	copious
1	(homo
1	sapiens)
1	troglodytes)
1	(herv-k),
1	(cerv-k).
1	ltrs
1	18.3
1	(million
1	present),
1	s/s/y
1	(substitution
1	year).
1	o/n
1	mybp.
1	a/t
1	hypermutation.
1	(agmnpv-2d),
1	mol%)
1	agmnpv-2d,
1	(ag31)
1	v-cath
1	(cfdefnpv).
1	bro-coding
1	heliothis
1	parsimonious
1	phenograms
1	(agmnpv,
1	cfdefnpv,
1	postvittana
1	npv,
1	orgyia
1	pseudotsugata
1	mnpv),
1	(acmnpv,
1	rachiplusia
1	ou
1	bombyx
1	pv),
1	pcr-derived
1	(agb)
1	(echinococcus
1	granulosus,
1	multilocularis,
1	oligarthrus
1	vogeli)
1	(agb1,
1	agb2,
1	agb4),
1	agb5
1	agb3.
1	agb2.
1	58.85-65.90m.u.
1	1221
1	10h
1	postvitanna
1	preexistence
1	low-frequency-resistant
1	unsuppressed
1	(dn/ds)
1	(117
1	(270
1	sequences).
1	n/ds
1	counter-acting
1	neodiprion
1	(nesenpv),
1	sawfly,
1	(hymenoptera:
1	diprionidae),
1	86,462
1	c+g
1	methionine-initiated
1	ld130
1	non-baculovirus-related
1	bir
1	finger,
1	nesenpv.
1	(nese18
1	nese19)
1	duplicates
1	(bro).
1	nesenpv,
1	nigripalpus
1	(cuninpv)
1	hymenopteran
1	granuloviruses.
1	(sars-cov)
1	sars-cov
1	frankfurt
1	interrelationships,
1	phylogenetic{plus
1	rule}ecological
1	nonvectored
1	ecologies.
1	recreation,
1	reclamation,
1	transportation,
1	persistent{plus
1	rule}chronic
1	udp-glucosyltransferase
1	(sfmnpv)
1	gp37
1	(fusolin),
1	ptp2
1	flanks
1	mamestra
1	configurata.
1	obliqua,
1	saturniidae
1	(loobmnpv).
1	95.52
1	kbp.
1	amsacta
1	albistriga.
1	(paggal)
1	(polh)
1	(vaggala2)
1	pulse-chase.
1	non-vector-borne
1	slight,
1	civilization
1	outset.
1	pre-historical
1	technologically,
1	overpopulation,
1	inbalance
1	effets
1	pandemics
1	(eg.,
1	(agmnpv),
1	hindiii
1	psti
1	(agmnpv-'79)
1	(agmnpv-'85),
1	eleven.
1	agmnpv-'79
1	(iplb-sf-21ae)
1	(ufl-ag-286).
1	agmnpv-'85
1	velvetbean
1	defoliation.
1	(lef-2)
1	primase
1	processivity
1	multinucleocapsid
1	(mnpvs)
1	granuloviruses
1	(gvs),
1	single-nucleocapsid
1	(snpv).
1	snpv
1	(hearnpv).
1	696
1	(cagt)
1	boxes.
1	polya
1	aataaa,
1	(ii
1	udp-glucosyl
1	transferases
1	(chen
1	1997a).
1	polyhedrin/granulin
1	(rvfv),
1	phlebovirus
1	rvfv,
1	(m),
1	egypt,
1	central-east
1	incongruences
1	phylogenies,
1	95)
1	76),
1	137)
1	(hav),
1	hbv,
1	hdv,
1	(non-a-e
1	hcv.
1	ns3
1	contagion
1	kuru,
1	scrapie,
1	(bse),
1	creutzfeldt-jakob
1	(cjd).
1	undiscovered
1	transmissable
1	propagation.
1	emergence.
1	highlithted
1	juno,
1	passion-fruit
1	(passiflora
1	flavicarpa)
1	araguarí,
1	djjmnpv.
1	agraulis
1	vanillae,
1	tracheoblast
1	nucleoplasm.
1	embeded
1	polyhedra,
1	polyhedra.
1	dine
1	(zanotto
1	1995),
1	westerly
1	dine.
1	li-related
1	isles
1	(genotypes)
1	england,
1	wales
1	systematics
1	substitutional
1	clinal
1	negishi
1	(neg)
1	li-like
1	vasilchenko
1	siberia
1	10928
1	10871
1	likelihood,
1	polyproteins,
1	serocomplex,
1	(67-94%
1	3'-non-
1	arthropod)
1	phleboviruses
1	egyptian
1	sub-saharan.
1	resampling,
1	transcriptases
1	appendiculatus
1	helicase.
1	fruitfly,
1	dispersal,
1	tempo
1	cline
1	tyuleniy
1	(tyu)
1	saumarez
1	(sre)
1	tyu
1	sre
1	aedes-borne
1	aedes,
1	chikungunya.
1	weapon
1	mass-rearing
1	male-only
1	opens-up
1	(gcss)
1	species-specificity,
1	pests,
1	non-polluting
1	programs,
1	fit-for-purpose.
1	subprogramme
1	fao/iaea
1	systems:
1	scalable,
1	section:
1	(fapesp;
1	2013/19921-9).
1	coordenação
1	aperfeiçoamento
1	pessoal
1	nível
1	(capes).
1	gravid
1	space-consuming,
1	space-saving
1	“oviplate”.
1	oviplates
1	12-or
1	insectary
1	12-and
1	oviplates,
1	oviplate
1	space-efficient
1	wasp-derived
1	ades
1	5–7
1	start;
1	interrupted;
1	confirmation.
1	committees
1	insectaries
1	promise,
1	(disulfide-crosslinked)
1	(>40%)
1	(98%
1	gallinaceum),
1	reemerging
1	culicidae),
1	(ceased).
1	pre-release
1	(mandacaru),
1	14.41
1	(mean ± se = 4.44 ± 0.44),
1	(oi = number
1	eggs/total
1	recovered)
1	(0.13 ± 0.01).
1	branca),
1	(1.72 ± 0.72),
1	oi
1	0.83
1	(0.095 ± 0.032).
1	(mandacaru)
1	17 weeks
1	branca)
1	32 weeks.
1	5 months
1	over-flooding
1	jacobina,
1	4–5 months
1	that the
1	kojin
1	receptor/ligand-like
1	)-terminal
1	(c)-terminus.
1	(sindbis
1	virus-mediated)
1	(piggybac-mediated
1	transgenesis)
1	gallinaceum-infected
1	diastereomer
1	d-amino
1	all-d-aii
1	all-d-vc5
1	vc5,
1	random.
1	bent
1	interior,
1	rigid.
1	conformations.
1	headgroups
1	winskill
1	parameterised
1	travelled
1	52.8m
1	49.9m,
1	56.8m)
1	malaysia:
1	58.0m
1	51.1m,
1	71.0m).
1	insects’
1	haemolytical
1	short-peptides
1	forefront
1	2010-2011,
1	census
1	7415
1	>28.
1	(3.2
1	(72.3
1	>32
1	slum-like
1	28-32.
1	gardens,
1	streets.
1	contrasted
1	transparency
1	(cysteine)
1	suburb
1	92.2%-97.5%)
1	74.9-85.2%)
1	no-release
1	(0.031;
1	0.025-0.036)
1	(0.059;
1	0.210),
1	target-strain
1	(ptps)
1	anautogenous
1	ptps.
1	ptps,
1	ptp1b.
1	orthovanadate
1	difmup
1	implicate,
1	moretti
1	(sit)1-3.
1	(release
1	lethal)4,
1	sit,
1	radiation-sterilization5-8.
1	cayman9,10;
1	80s.
1	released:
1	adults11,12.
1	reared13,14.
1	jove
1	2006-2014.
1	rises.
1	(ivm),
1	ineffective;
1	threatening,
1	curry,
1	1932,
1	culicidae.
1	(aspartic
1	ornithine),
1	(>70
1	bridgehead
1	n-terminus),
1	chirality.
1	eliminate/separate
1	interim
1	sexing.
1	sex-linkage
1	stop-gap
1	investment.
1	(2013-2018)
1	radiation-sterilised
1	mosquitoes)
1	disease-transmitting
1	di-,
1	tetra-deletions)
1	conformations;
1	synthesize.
1	amide-capped
1	ile5
1	his6
1	6]-aii
1	3]-aii,
1	[ala1]-aii,
1	aii-nh2
1	[ala7]-aii,
1	[ala4]-aii,
1	2]-aii
1	45%.
1	[ala4]-aii
1	[ala6]-aii.
1	sporozoiticidal
1	foundations
1	aael010714,
1	odorant-binding
1	aaegobp45.
1	aael010714
1	obp
1	aaegobp45
1	merrifield's
1	chromatography/esi
1	(lc-esi(+)/ms),
1	overtime
1	least-square
1	position-wise
1	rutledge-type
1	parafilm-m
1	0.1189)
1	artificial-fed
1	(51.3%
1	engorgement)
1	mice-fed
1	(40.6%).
1	"glytube"
1	frameworks
1	(ofe),
1	escorts
1	ofe
1	prolixus,
1	follicle,
1	rp45,
1	chitin-associated
1	unfolded-protein
1	(rs)
1	stephensi.
1	vitellogenesis,
1	hirudo
1	medicinalis
1	(ldti).
1	(raati).
1	(sit)
1	area-wide,
1	1950's.
1	sterility.
1	rear
1	sort
1	sterilize,
1	distribute,
1	looks
1	(who/tdr)
1	funded
1	mosqguide,
1	legal/regulatory
1	deployment.
1	commissioned
1	project's
1	risk/benefit
1	researchers,
1	officials,
1	audiences,
1	decs,
1	initiatives,
1	issues/response
1	deploy
1	(viz.
1	ridl®
1	[release
1	lethal],
1	1-4),
1	biosafety,
1	ethical-social-cultural
1	(esc)
1	timelines
1	championed
1	institutions,
1	nations
1	(undp),
1	(who)
1	(gcgh)
1	co-sponsored
1	melinda
1	gates
1	angiotensins
1	vaniceres
1	(vc1-vc6)
1	thoraces
1	p.gallinaceum
1	us),
1	(guinea,
1	uganda),
1	(singapore,
1	tahiti).
1	african/asian
1	(nca),
1	nca
1	insecticide-resistant
1	post-genomics
1	1.111
1	1.143
1	10,516
1	preproapoliphorin
1	3332
1	apolipophorins:
1	apolipophorin-i
1	280,000)
1	apolipophorin-ii
1	81,000).
1	elements)
1	3′-end
1	1852
1	1958.
1	departments.
1	genealogical
1	andes),
1	andes)
1	interpopulational
1	φst
1	iquitos.
1	hexamerins,
1	metamorphosis.
1	mdhexf1,
1	5′-end
1	untranscribed
1	mdhexf1
1	(lsp)
1	calliphora
1	vicina
1	gland-derived
1	categories:
1	ninety-three
1	anophelin,
1	apyrases
1	haematophagy.
1	sugar-feeding
1	(α-glucosidases
1	α-amylase)
1	ninety-
1	ninety-seven
1	tabular
1	annotations
1	http://www.ncbi.
1	nlm.nih.gov/projects/mosquito/a_darlingi_sialome/.
1	epicuticular
1	(z)-9-tricosene,
1	(z)-9-tricosene
1	provisioned
1	excluded.
1	(∼240
1	(∼85
1	(chino,
1	1985)
1	domestica.
1	pupation.
1	larval-specific
1	hex-l,
1	hex-l.
1	female-enriched
1	hex-f,
1	protein-fed
1	hex-f.
1	phase-dependent
1	(lsp1)-type
1	lsp2-type
1	hexamerins.
1	multigenic
1	anti-circumsporozoite
1	n2h6d5,
1	heavy-
1	light-chain
1	sindbis
1	n2scfv
1	genetically-engineered
1	sex-
1	sugar-feeding.
1	d7,
1	immunoscreening
1	d7-related
1	gland-
1	culicine
1	nonvitellogenic
1	(nvfp),
1	430
1	f0
1	lsp-2
1	hexamerin.
1	f2-cdna
1	anti-nvfp
1	nvfp.
1	nvfp
1	domestics.
1	83,000.
1	arylphorin
1	550,000
1	26,000.
1	heterogeneous;
1	apoferritin
1	anti-ferritin
1	stadium.
1	peroxynitrite,
1	visceralization
1	anti-nitrotyrosine
1	nitrating
1	apolipoproteins:
1	224,000)
1	73,000).
1	lipophorins
1	lepidoptera.
1	(lepidoptera)
1	apolipoproteins,
1	209,000)
1	85,000)
1	1.124
1	lipophorin.
1	manduca
1	sexta
1	lipophorin,
1	apoproteins,
1	253,000)
1	85,000).
1	1.152
1	1.106
1	pharate
1	housefly.
1	insufficiently
1	(anti-ngf)
1	latency,
1	anti-ngf,
1	drg,
1	(drg).
1	(l4-l6)
1	(µ-opioid
1	receptor).
1	µ-opioid
1	(200%)
1	drg;
1	compression,
1	(drg),
1	randall-selitto,
1	frey,
1	hargreaves
1	post-surgery.
1	relief.male
1	(85 mg/kg)
1	(allodynia).
1	56 days
1	mwpk,
1	0.13 cm2,
1	6,23 j/cm2.the
1	rats.the
1	100 μg
1	cfa-induced
1	session;
1	(50%;
1	aline
1	carolina
1	giardini
1	(pod)
1	sf_sf,
1	sf_trai,
1	sf_trac,
1	nal_tra,
1	incision,
1	(l3–l6)
1	pod3,
1	pod7,
1	(injection
1	freund́s
1	gastrocnemius-soleus
1	l5
1	(tnf-α;
1	immunhistochemical
1	shorter.
1	mini-pump
1	normalised
1	(cx3cl1)
1	(cx3cr1)
1	(minocycline)
1	antagonists/inhibitors
1	enhancement:
1	(il1),
1	cx3cr1.
1	anti-cx3cr1
1	(hargreaves
1	il1,
1	implicated,
1	neuron-to-glia
1	strategy;
1	glial-selective
1	adeno-associated
1	aav2)
1	aav2-il-10
1	beta-galactosidase
1	milligan
1	(cx3c
1	ligand-1;
1	neuron-to-glial
1	fractalkine.
1	(neutralizing
1	cx3c
1	receptor-1;
1	cx3cr1)
1	anti-gx3cr1
1	releasel
1	product(s)
1	(zymosan)
1	allodynias.
1	inhibitors/antagonists
1	allodynias,
1	interleukin-6),
1	immune-derived
1	mid-axon.
1	mysterious
1	touch/pressure
1	innocuous.
1	trauma/inflammation.
1	(mechanical
1	mid-thigh
1	(ipsilateral
1	image)
1	(peri-spinal)
1	cni-1493,
1	signaling;
1	(40-400
1	hindpaws.
1	('mirror')
1	inflammation/infection
1	hindleg.
1	hindlegs,
1	perisciatic
1	cytokine;
1	endoneurial
1	vessels;
1	sciatic,
1	("mirror")
1	(μct),
1	(pcrarray)
1	histormophometric
1	bmp2,
1	bmp4,
1	bmp7,
1	runx2,
1	alp.
1	3d,
1	cxcl2,
1	cxcr1,
1	7d.
1	tgfb,
1	‘sterile’
1	chemokines’
1	cxcl16,
1	∼24,000
1	migration"
1	adhesion"
1	junctions"
1	ccl2/je
1	ccl3/mip-1α
1	(mip-1α)
1	cxcl1/kc
1	un-infected
1	(airmin).
1	(dnav)
1	7.3%
1	dnav
1	dnav,
1	resistance/susceptibility.
1	assay-like
1	virus-binding
1	salmonellae
1	nramp1r
1	microsatellites.
1	antibody-controlling
1	coincident,
1	activation/infection.
1	(bgp1a,
1	bgp2
1	bgp1a
1	smb
1	(cvs
1	potency-rp)
1	neutralising
1	(vna)
1	vaccine).
1	293.3
1	5.8).
1	proliferate.
1	"resistant"
1	"susceptible"
1	(250-fold
1	800-fold
1	l).
1	antirabies
1	'high'
1	host-infection
1	(h(gp))
1	(l(gp))
1	backcrosses
1	104.5-
1	cvs.
1	erythrocytes)
1	co-isogenic
1	h-2(s)
1	hybridomas.
1	apc.
1	ovaxab
1	pulsing
1	tnp-ova,
1	handling/processing
1	collagen‐induced
1	(cia)
1	hii
1	h‐2q,
1	v‐β
1	cii.
1	anti‐bovine
1	cii
1	interleukin‐5
1	(il‐5)
1	igg1‐ige,
1	il‐5
1	elispots
1	ifn‐γ
1	hii,
1	th2‐dependent
1	igg1‐ige
1	isotype‐producing
1	switch‐over
1	hii.
1	preeminence
1	(tcr)‐γ
1	(ag).
1	high‐responder
1	iow‐responder
1	tcr‐γb
1	penetrance
1	liva
1	low‐responder
1	co‐selected
1	γδ5
1	compensating
1	(h-l)
1	isotype-restricted
1	(selections
1	[10,19,22].
1	(20spt),
1	(open/closed)
1	nonviable,
1	(α5-c76s
1	α5-c221s)
1	α5-c76s
1	α5-c221s
1	(s35p/c221s)
1	α-synuclein)
1	c76s,
1	c221s,
1	s35p/c221s,
1	s35p
1	s35p/c76s
1	cys76
1	α5-subunit,
1	5’ends
1	rpm2p
1	saccharomycetaceae
1	trnas;
1	mta1
1	rpm2.
1	mta1p,
1	mta2p,
1	pet130p,
1	gep5p
1	rpm2p.
1	co-immunopurification
1	mta1p.
1	formylation
1	trna-met,
1	formyltransferase,
1	fmt1p
1	mtfmt
1	fmt1p,
1	msc6p,
1	(ppr)
1	ppr
1	fmt1msc6
1	mif-2,
1	ifm1.
1	mif-2.
1	mif-2-dependent
1	mitochondrial-specific
1	54s
1	cox3,
1	milestones
1	p.s487l
1	α-synuclein.
1	α-synuclein-expressing
1	α-synuclein/menadione-challenged
1	mitophagy,
1	shimamoto
1	mrna-specifc
1	fnd
1	atp8-atp6
1	unformylated
1	specifcally
1	atp8.
1	pre-mrna.
1	arg8m
1	(natp8)
1	high-expression
1	cen
1	1-cys
1	preprotein
1	presequence
1	subcompartments
1	prx1:
1	octapeptidyl
1	(oct1).
1	(prx)
1	prx3
1	imp2
1	prxs
1	msc6,
1	glutamyl-trnaq
1	glutaminyl-trnaq.
1	aminoacyl
1	synthetase.
1	qrs1p
1	biochimie
1	biologie
1	moléculaire
1	(sfbbm).
1	(coq1-coq11).
1	demethoxy-q
1	(dmq
1	carboxylate-bridged
1	d53,
1	s114.
1	residues;
1	coq7
1	v111g/s114a
1	dmq
1	phosphomimetic
1	poly-ubiquitinylated
1	deubiquitinylated,
1	unfolded,
1	poly-ubiquitinylation
1	(β-rings)
1	(α-rings)
1	gating.
1	α-rings
1	α-rings,
1	amidotransferases
1	gtf1p,
1	connector
1	her2p.
1	pet112.
1	her2/ts11
1	fermentative
1	q):
1	nde1p,
1	ndi1p.
1	ndi1p
1	predominantnadhdehydrogenase
1	coq4
1	loss:
1	(c.504+1g>a)
1	(required
1	division-1)
1	pathomechanism
1	sif2
1	duf155
1	mtg1
1	mtg2
1	yqeh
1	convention.
1	80-nucleotide
1	temperature-
1	immunobloting
1	lifespans
1	nucleoid).
1	nucleoid
1	glucose-sensitive
1	trna-dependent
1	(adt)
1	gtf1,
1	1-f
1	sector.
1	gft1
1	pet112
1	adt.
1	b66,
1	essentiality,
1	gatf
1	propolis,
1	resins,
1	honeycombs
1	hive
1	entrance.
1	(nuc1p)
1	yca1
1	4,800
1	high-copy
1	over-produced
1	coq3p
1	coq4p
1	q-biosynthetic
1	over-producing
1	myxothiazol.
1	semiquinone,
1	antimycin-dependent
1	(coq10-k50e,
1	coq10-l96s,
1	coq10-e105k
1	coq10-k162d)
1	mitochondria-nuclear
1	(ndna).
1	143b206
1	ρ0
1	ndna
1	crabtree-positive
1	kluyveromyces
1	lactis,
1	crabtree-negative
1	(reading
1	ymr098c
1	xiii),
1	f0.
1	atp9p,
1	atp6p
1	atp8p,
1	atp9p.
1	halves
1	atp25p,
1	q10
1	(coq10
1	ubiquinone)
1	ataxia.
1	infantile-onset
1	multisystemic
1	snp-based
1	revealed a
1	1q41.
1	splice-site
1	aarf-domain-containing
1	(adck3).
1	ubib
1	lymphoblasts,
1	(glc)
1	[calorie
1	(cr)]
1	sir2p
1	(pnc1δ,
1	npt1δ,
1	bna6δ)
1	matrix-soluble
1	dihydrolipoyl-dehydrogenases
1	cr-preventable
1	lpd1
1	npt1δ
1	bna6δ
1	dehydrogenase-containing
1	cox1,
1	cob
1	ylr204w,
1	cox24,
1	ai2
1	ai3.
1	ai3
1	intronless
1	pre-mrna,
1	cox14-cox24
1	yol008w,
1	coq10,
1	coq2,
1	coq7,
1	coq8/abc1,
1	q6,
1	"aromatic-rich
1	family"
1	pfam03654
1	polyhistidine-tagged
1	0.032-0.034
1	q6/mol
1	q6-binding
1	cqq9
1	lipoid
1	quinone.
1	nadh-cytochrome
1	coq9,
1	ylr201c
1	coq9
1	coq8/
1	abc1.
1	coq8/abc1
1	c92,
1	cog9
1	coq9p
1	coq8p.
1	dinitrophenol.
1	generation)
1	rtg2
1	yhr116w
1	cua
1	cox23
1	cox17
1	postmitochondrial
1	cox23p.
1	2+-induced
1	δctpxi
1	disrupted)
1	(cyc3
1	mutants)
1	mitoplasts
1	hemes
1	oxidases.
1	(protoheme)
1	c-8.
1	(barros,
1	carlson,
1	glerum,
1	(2001)
1	492,
1	133-138)
1	three-component
1	temperature-conditional
1	δ-aminolevulinic
1	ferredoxin.
1	impinge
1	[glerum
1	272
1	(1997)
1	19088-19094].
1	pombe
1	yah1,
1	(adrenodoxin).
1	cox15p.
1	(arh1p)
1	(yah1)
1	adrenodoxin,
1	ypl252c.
1	(fdx1)
1	chimerical
1	arh1,
1	(nobrega,
1	nobrega,
1	m.p.
1	(1992).
1	embo
1	3821-3829;
1	lacour,
1	dumas,
1	(1996).
1	174,
1	289-292),
1	arh1
1	(adrenodoxin
1	sterols,
1	arh1p
1	mirna-29b.
1	mirna-29b,
1	col1,
1	col1
1	hypoxia–reoxygenation
1	h/r
1	deteriorated
1	kk,
1	precondition
1	(7 μg/100 g
1	krebs–henseleit
1	set-up.
1	45 min.
1	lvdp
1	(mmhg),
1	+ dp/dt
1	− dp/dt
1	(mmhg/s).
1	cardioprotector
1	(loc)-related
1	na+-lactate
1	19.3±0.5
1	23.8±0.3
1	42.2±1.3
1	60.5±1.5
1	h–1
1	mg–1)
1	(mct1)
1	1.0±0.06
1	1.7±0.2
1	a.u.),
1	(nadox),
1	nadox,
1	(mi-lactate
1	1.3±0.08
1	a.u.).
1	(mi-lactate:
1	54.5±4.2
1	(mi:
1	1.1±0.1
1	(hyper)
1	(gd9)
1	(pnd90)
1	lvdp,
1	gabriel-costa
1	lactate-sensitive
1	(o2.-/h2o2)
1	pgc1αand
1	(o2.-/h2o2
1	nrf-2
1	o2.-/h2o2.
1	lactate-induced
1	o2.-2/h2o2
1	(gd9),
1	gd20,
1	i/ang
1	gd20
1	reprints
1	permissions:
1	sagepub.co.uk/journalspermissions.nav.
1	preconditions
1	(pd123,319;
1	mode;
1	zero-flow
1	contracture
1	(lvdp,
1	máx
1	-dp/dtmin)
1	hormones)
1	(sf).
1	t4/100
1	(t4-25,
1	t4-50,
1	privation.
1	elements-mediated
1	at2)
1	venae
1	cavae
1	123319
1	venoconstriction,
1	thyroidectomy)
1	freezing/thawing
1	mek-1,
1	erk1/2-promoted
1	nω-nitro-.
1	(30.
1	(l-name-treated
1	ntpdase2,
1	ntpdase3
1	npp3
1	phospho-pkc
1	9.5.
1	(michaelis
1	eadie-hofstee
1	59.7±
1	134.8±
1	6.7±
1	143.8±
1	pi/min/mg
1	(means±s.d.,
1	n=4)
1	excitation-contraction-coupling
1	(ecto-nucleoside
1	diphosphohydrolase),
1	(ecto-nucleotide
1	pyrophosphatase/phosphodiesterase)
1	(30 mg/kg/day
1	30 mg/kg/day
1	washout,
1	23 mmhg.
1	(lvwi)
1	washout.
1	87%,
1	(angiotensin-
1	13-year-old
1	girls)
1	[aga
1	(appropriate-for-gestational
1	31]
1	[sga
1	(small-for-gestational
1	35].
1	angiotensin,
1	diphosphohydrolases
1	(e-ntpdases)
1	pyrophosphatase/phosphodiesterases
1	(e-npps)
1	ecto-5'-nucleotidase,
1	induces,
1	ectoenzymes.
1	5000 pmol),
1	(21,
1	(22,
1	angiotensin-receptor,
1	arteriosclerosis.
1	0.100
1	ecto-5′-nucleotidase/cd73
1	(ecto-5′-nt/cd73)
1	(vsmc).
1	50nm
1	dose-independent.
1	ecto-5′-nt/cd73
1	ecto-5′-nt/cd73.
1	vasodilatator
1	surface-located
1	nucleotide/nucleoside
1	tri-iodothyronine
1	ntpdase,
1	hippocampal,
1	210%,
1	pyrophosphatase/
1	(e-npp)
1	5′-thymidine
1	(p-nph-5′-tmp)
1	e-npp,
1	e-npps:
1	chelator.
1	p-nitrophenol/min/mg
1	p-nph-5′-tmp,
1	6-cyclopentyladenosine;
1	cpa)
1	(tar),
1	[t4-25
1	t4-100;
1	(bw)•per
1	respectively)].
1	election
1	(hw/bw)
1	hyperthyroid,
1	(acting
1	neurotransmitter)
1	(ntpdase3,
1	3.6.1.5)
1	3.1.3.5).
1	(cyclodextrin-encapsulated
1	17β-estradiol),
1	dheas,
1	pregnenolone
1	(1.0,
1	2-mo-old
1	(od,
1	(oc,
1	(138
1	(342
1	364
1	(-2.2
1	-3.6
1	3.04
1	40.8
1	his-leu·min-1
1	hypothyroid.
1	ecto-5′-nucleotidase,
1	(tfl).
1	ecto-nucleotidases
1	high-energy
1	ecto-enzyme
1	5′-nucleotidase.
1	(cd73)
1	cd73.
1	supply-to-demand
1	)-induced
1	(hw/bw),
1	(hypothyroidism)
1	thyroidectomies,
1	μg·100
1	(ena),
1	(los)
1	propanolol
1	(prop).
1	ena.
1	hw/
1	ena
1	prop
1	actinomycin.
1	(5-,
1	60-,
1	150-
1	330-day
1	14-52%
1	11-month-old
1	8:1
1	dipyridamol
1	(triiodo-1-thyronine)
1	(thyroxine)
1	(100-500
1	ecto-atp
1	ecto-atpase,
1	rnase-protection
1	dexamethasone's
1	(actinomycin
1	(cycloheximide,
1	steady-
1	50-fold.
1	δoxyr
1	assimilative
1	histidine.
1	rpoh-dependent
1	(katg,
1	ahpcf).
1	oxyr.
1	osra
1	oxyr,
1	sm-like
1	α-proteobacterium
1	hfq-binding
1	(hits-clip).
1	leaden,
1	lorenzetti,
1	alegria,
1	schulz,
1	koide
1	(ferric
1	regulator).
1	iron-bound
1	iron-containing
1	(rna-seq)
1	iron-regulated
1	2-2-dypiridyl
1	oxidation-sensitive
1	iron-limited
1	multienzyme
1	endoribonuclease
1	rhlb,
1	rhlb
1	rho,
1	s1,
1	asperchromes,
1	ferrichromes,
1	malonichrome,
1	catecholates.
1	catecholate
1	aposiderophore
1	thermodynamics
1	[59fe]apoferrichrome
1	(equilibrium
1	[kd],
1	[km],
1	cells/min)
1	fhua.
1	feca
1	cells/min).
1	00028,
1	00138,
1	03023
1	tonbdependent
1	(tbdt)
1	sarcosinate
1	tbdt:
1	(00028,
1	03023),
1	(00210
1	01196).
1	clustalw
1	δ02277
1	huta
1	heme/hemoglobin
1	utilization).
1	ferritins
1	ferritins,
1	dps,
1	cc_0557.
1	lacz-transcriptional
1	(2.5-fold
1	induction)
1	fe-responsive
1	sufficiency,
1	fur-independent
1	(1.4-fold)
1	2′,2-dipyridyl
1	h2o2resistance,
1	spdr/spds
1	spds
1	auto-regulated.
1	microarray.
1	hfq.
1	nuse
1	nusg,
1	pare1
1	cc0517
1	spdr-regulated
1	cc0731
1	antiterminators.
1	assimilatory
1	acea,
1	mazzon
1	membrane.results:
1	(znughi),
1	(znuk,
1	znum)
1	(zrpw).
1	znuk
1	systems.conclusions:
1	lexa.
1	(lexa1
1	lexa2)
1	auto-proteolytic
1	recn,
1	dinp,
1	lexa1,
1	tttgn
1	caaa.
1	ttgtan
1	tacaa,
1	lexa1
1	α-proteobacterium,
1	unknown.results:
1	feoab),
1	riboflavin
1	fur-mediated
1	fixk,
1	fixt
1	ftrb
1	modulon,
1	fe-s
1	motility.conclusions:
1	stimulon.
1	fixk
1	regulons.
1	iron-acquisition
1	resistance-nodulation-division
1	(hme-rnd)
1	δczra
1	δncza
1	czra-like
1	ncza,
1	cobalt.
1	czra
1	hme2
1	ncza
1	hme1
1	valencia
1	downshift.
1	csps:
1	andcspc
1	cspaand
1	lowtemperature,
1	cold-related
1	cspacspb
1	maybemore
1	carriedout
1	5=-untranslated
1	(5=-utr)
1	acommon
1	otherbacteria,
1	thiswork
1	ofexpression
1	catalases
1	peroxidases,
1	constructed;
1	-42
1	-91
1	h2o2-dependent
1	katg,
1	downshift
1	csps,
1	signalization
1	cspd.
1	(spdr)
1	aspartyl
1	lysr-type
1	(lttrs).
1	mini-tn5lacz
1	isolated;
1	here)
1	autoregulated.
1	(generated
1	paraquat)
1	hydroperoxide.
1	ahpc,
1	chlorosis.
1	habitat.
1	54-predicted
1	glna
1	synthetase),
1	cspab
1	cspabd
1	characteristic.
1	tune
1	rhotn5
1	fluorophore
1	cuznsod
1	alkylhydroperoxide
1	iron-fur
1	sufficiency.
1	repressor,
1	-80°c,
1	cryotolerance
1	20°c
1	-20°c.
1	<10%
1	adda
1	(resistance,
1	nodulation,
1	division)
1	15°c,
1	supercoiling
1	(rpon)
1	j1a12,
1	(xf2542),
1	σ54-
1	pila
1	paralogues,
1	pila1,
1	rsea,
1	(ecf)
1	σe-
1	(xf2241).
1	xf2241
1	5700
1	kinase/response
1	2fe-2s
1	bicyclomycin
1	(5′-utr)
1	5′-utr.
1	(cspa,
1	cspc)
1	(cspd),
1	7-kda
1	21-kda
1	α-proteobacteria.
1	cspa,
1	(km)-resistant
1	inserted,
1	j15)
1	spirochete.
1	three-member
1	methyl-accepting
1	peptidyl-prolyl
1	isomerase.
1	determined;
1	σ32
1	(glutamate
1	l-aspartate
1	(exonuclease
1	recj).
1	na1000,
1	37g10,
1	rho.
1	therho
1	caulobacter.
1	pbluescript,
1	pxf1.3.
1	xpsd
1	transformants,
1	(orf1)
1	streptomyces.
1	(orf3),
1	abc1
1	hexgh
1	ctra.
1	conjugation-related
1	pxf51,
1	(tra)
1	orit
1	incp
1	germination.
1	(sporulating
1	(vegetative
1	e-boxes,
1	sporulating
1	e-boxes
1	sporulation.
1	σ54-dependent
1	flbd
1	flif
1	taca.
1	ntrc
1	sp2016),
1	stalk,
1	clear-plaque
1	φcb5.
1	division:
1	reinitiate
1	pole-specific
1	best-understood
1	flagellum.
1	c‐subunit
1	amino‐terminal
1	70‐amino‐acid
1	cα
1	c‐gene‐coding
1	57–69
1	5′‐flanking
1	44,263
1	rii
1	translatable
1	(marques
1	eur.
1	178,
1	803,
1	1989).
1	purified;
1	fungus'
1	zoospore
1	blastocladiella.
1	emerosonii
1	58000,
1	36000,
1	camp‐binding
1	sporulation,
1	gremination,
1	sporualtion.
1	sporualtion
1	immumoprecipitation
1	isdn
1	30-hour
1	anoxia-induced
1	subfields,
1	disruptions,
1	new-borns
1	perinatology
1	anoxia.
1	lenght,
1	medio-lateral
1	startle,
1	(cc-by)
1	music.
1	(musical
1	notes)
1	enabling,
1	listening,
1	dissociable
1	hedonia.
1	marck
1	athias,
1	iberian
1	pillars
1	mindset
1	vicissitudes
1	“periphery”
1	historiographical
1	center-periphery
1	(science
1	periphery),
1	iberia
1	german
1	unlocked
1	(exe
1	(no-exe
1	wheels
1	(mwm)
1	(mwm-hd)
1	(mwm-nh).
1	mwm.
1	mwm
1	survival;
1	mwm-hd
1	mwm-nh
1	double-labelled
1	subdivision.
1	day/night
1	parvalbumin-,
1	calbindin-containing
1	pv-ir,
1	geniculate.
1	darkness,
1	palsy.
1	kits'
1	horns.
1	5-htr2
1	corticospinal
1	william
1	darwin
1	thoughts
1	"plasticity"
1	popularization
1	notions
1	century;
1	"mental"
1	james;
1	"structural"
1	plasticity:
1	considerations;
1	work;
1	defelipe.
1	anthropology
1	repeatability;
1	legal
1	statistically-based
1	confounds
1	intra-population
1	3.1.293,
1	1.5.2
1	3d-id
1	afro-brazilians,
1	ancestry).
1	afro-brazilians
1	misclassification.
1	crania,
1	fdb
1	fordisc.
1	inconsistency
1	(60-71%
1	specimens)
1	atypically
1	software,
1	crania.
1	socio-philosophical
1	kuhn,
1	wittgenstein.
1	discourse,
1	inadequation
1	reorientation
1	"sick
1	subject"
1	subjectivities
1	"person's
1	doctor".
1	dante
1	pazzanese
1	cardiology
1	(idpc),
1	(δct),
1	gene.©
1	puromycin-insensitive
1	(apm/cd13)
1	msg-fd
1	17-fold).
1	fd.
1	msg-fd,
1	(7-fold)
1	(5.6-fold)
1	apm.
1	semi-hermetic
1	oximetry,
1	gasometry,
1	l/min
1	101.7.
1	kpa
1	indentifying
1	serotonin-specific
1	neurons/terminals
1	promoted:
1	pre-weaning
1	dr;
1	(area,
1	dg.
1	"anomaly"
1	neglects
1	qualified
1	specialties,
1	doctors,
1	doctor-patient
1	suffering,
1	valued
1	feeding-regulatory
1	control-diet
1	(pvh,
1	142%).
1	(dmh,
1	271%)
1	(lh,
1	303%).
1	fish-diet
1	(161%),
1	(177%),
1	(81%),
1	(127%).
1	vmh/pvh
1	(rht),
1	(ght).
1	(npy),
1	scn.
1	rht,
1	regionalization
1	(diurnal
1	neuro-trophic
1	-tropic
1	cd-21
1	(5:00
1	(gazzolo
1	49:967-970,
1	chim
1	330:131-133,
1	58:1170-1174,
1	2005),
1	(fukuyama
1	46:35-38,
1	2 h/day,
1	15 days).
1	(mfs),
1	(mfi),
1	satiety
1	(mfsa)
1	(lrn)
1	(mrn),
1	(prn),
1	(nrm)
1	(nro)
1	mfsa
1	(nrp).
1	prn
1	(fos-ir
1	5-ht-ir)
1	food-induced
1	setter
1	chart
1	biomedicine.
1	survey:
1	nomenclatures
1	definitions;
1	addressed;
1	complaints,
1	nomenclature;
1	psychic
1	disorder;
1	singularities
1	michel
1	foucault,
1	colin
1	campbell.
1	blossoming
1	midst
1	alternation
1	theodicy
1	oriental.
1	5-ht1a-receptor
1	n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)
1	ethyl)-n-(2-pyridinyl)
1	cyclohexane
1	(way
1	100635).
1	100635.
1	receptor-ir.
1	"inverse
1	agonist"
1	biomedicine
1	epistemology
1	analytic
1	thomas
1	kuhn
1	ludwik
1	styles.
1	reflections
1	improving/transforming
1	paradigm,
1	shuttlebox
1	helplessness
1	th)
1	unhandled
1	antidepressive
1	bioamines
1	lengths)
1	(ear
1	opening)
1	(righting,
1	acceleration,
1	cliff
1	vibrissa
1	placing)
1	clearcut
1	monoamine,
1	5:00
1	17:00
1	13:00
1	weigh
1	(fst).
1	fst:
1	(lae)
1	(bi)
1	lae
1	bi.
1	neuroadaptation.
1	(raphe
1	rpa;
1	obscurus,
1	rob)
1	"meal-feeding"
1	'search
1	'ingestion
1	'satiety
1	(saf)
1	continuous,
1	rmg.
1	rob
1	saf
1	af.
1	autonomie
1	supra-ocular
1	obex
1	sub-nucleus
1	handled.
1	bureaus.
1	formaldehyde.
1	hood.
1	accessories
1	disassembled
1	hood
1	(42.
1	peroxidovanadate
1	phosphoforms.
1	trhxt1,
1	δtrhxt1
1	trxht1
1	trhxt1
1	antimaspin
1	supramolecular
1	p53-targeted
1	maspin-expressing
1	tm40d-mp
1	maspinδn
1	transiocation
1	maspinδrsl.
1	maspin.
1	desensitizes
1	maspin-based
1	epiblast.
1	disorganized,
1	mp-/-ebs,
1	mp+/-
1	cell-substrate
1	(c/ebp)
1	c/ebpβlip.
1	stat5a,
1	stat5a-stat5b
1	stat5-dna
1	stat5.
1	stat-dependent
1	(mec)
1	(sfm)
1	prevented,
1	accelerated.
1	iv-coated
1	dishes,
1	mecs
1	pcd,
1	mec
1	(prlr)4
1	(stat).
1	phosphoamino
1	phosphate-labeled
1	lactogen-induced
1	tetra-antennary
1	isolectin
1	lysosomal-associated
1	cosylation
1	mammary-specific
1	(dip)
1	(rtk)
1	dip,
1	confluency
1	tire
1	(fgf)-2,
1	(pdgf)
1	(scf),
1	(erk2)
1	competency.
1	scf.
1	laminin‐binding
1	collagen‐binding
1	(elution
1	sds‐page
1	wga‐sepharose
1	maa
1	(maackia
1	ammurensis
1	gna
1	(galanthus
1	nivalis
1	agglutinin),
1	dsa
1	(datura
1	stramonium
1	maa;
1	glycosylation.
1	2‐dimensional
1	tenascin.
1	e8
1	egf-
1	bfgf-grown
1	ins-
1	pdgf-grown,
1	non-competent
1	neonatal-maternal
1	(nms)
1	deprives
1	moesin
1	(gre)
1	moesin.
1	gre
1	gr-gre
1	c-pepsin
1	parenting
1	epithelium-derived
1	(pedf)-null
1	(eca),
1	unopposed
1	converse
1	(esfs)
1	(cafs),
1	(eecs).
1	eecs,
1	pg-induced
1	esfs,
1	cafs.
1	cafs
1	hormone-regulated
1	pedf,
1	cafs,
1	exemplifies
1	(glucocorticoid
1	(zc)
1	zc,
1	mist1,
1	zc.
1	zc
1	early-adult
1	tgf-β/smad2/3
1	ubiquitylation
1	p27kip1(p27)
1	cdk2
1	apc/c
1	ubiquitylates
1	prompting
1	knocking-down
1	skp2/cks1
1	obviated
1	skp2.
1	cdh1-depleted
1	ecas
1	reverse.
1	cks1/skp2
1	ontogenesis
1	(ghs-r)
1	([.
1	d-lys-3]-ghrp-6)
1	early-weaned
1	beta1
1	(tgfβ1),
1	hyperproliferation
1	(phospho-p27thr187)
1	phospho-p27thr187/p27
1	fiore
1	corticosteroid-binding
1	(cbg),
1	15-d-old
1	kip1
1	neoplasias
1	(men)
1	unrecognized.
1	(p27-v109g),
1	(pituitary
1	nz252;
1	pheochromocytomas,
1	nz125;
1	nz51;
1	nz19)
1	885
1	(p=0.01),
1	(p=0.005).
1	gh-secreting
1	men2-component
1	somatotropin
1	menx
1	men4.
1	corticotropinoma
1	(men1)
1	unaccounted
1	for.design:
1	men4
1	(menin),
1	individuals.methods:
1	c.326t>g
1	(v109g)
1	(ors)
1	regression.results:
1	v109g
1	(or=2.55,
1	p=0.019,
1	ci=1.013-5.76).
1	≥30
1	truncating
1	or=18.33;
1	p=0.002,
1	ci=2.88-16.41).
1	bonferroni's
1	correction,
1	men1-related
1	hyperparathyroidism,
1	enteropancreatic
1	(mek
1	cdk4,
1	p27)
1	(threonin
1	187),
1	osaki,
1	gama.
1	erk5,
1	mapks,
1	pi3k-akt,
1	tgfβ/smad
1	renewing
1	cascades.
1	tgfα,
1	sialoadenectomy
1	(sialo)
1	proportionately
1	ghrelin-immunolabeled
1	3days
1	ag1478,
1	p-src
1	brdu-labelled
1	(suckling
1	weaning)
1	(fed
1	fasted)
1	factor-β3
1	(tgf-β3)
1	receptor-i
1	powered
1	fasted.
1	(tgfα)
1	dam,
1	reagent+alcian
1	bandeiraea
1	simplicifolia
1	16th
1	post-weaning)
1	tgfα/egfr
1	corticosterone-binding
1	(cbg)
1	wanes
1	(1 ng/g
1	wt.)
1	tβrii-receptor
1	pulse-labeling
1	180 min
1	(17 kda)
1	tissue-expressed
1	(eecs),
1	pmol/l
1	ubiquitin-mediated
1	secretory-phase
1	kinase-driven
1	eecs.
1	eca,
1	17β-estradiol-driven
1	(14-day-old
1	pups)
1	hypoproliferation
1	(60-day-old
1	14-d-old
1	60-d-old
1	bac.
1	smad2/3.
1	b.wt.)
1	tgfβ3,
1	parasitosis
1	nontropical
1	jejunum,
1	immunolabelling,
1	ammoniacal
1	dopa
1	stainings
1	cosmetics.
1	function-1
1	(af-1)
1	(hute),
1	(muts),
1	trs.
1	micro-environmental
1	af-1
1	estrogen-induced
1	pr.
1	ontogenesis.
1	(bac).
1	benzalconium
1	immunolabeling.
1	263.7
1	control-saline
1	468.9
1	denarvated
1	denervated-saline
1	sp-treated
1	14-,
1	last.
1	β3,
1	(5-hydroxytryptamine,
1	planarian
1	bipalium
1	(cslm),
1	net.
1	brain;
1	unipolar,
1	(50-120
1	5-ht-ir
1	planarians.
1	(ltgf-β)
1	(tβrii)
1	phosphorylate/activate
1	smad2/3,
1	(ecas;
1	0.0066).
1	ecas,
1	(smad2p),
1	22;
1	11;
1	polyadenine
1	tβr-ii
1	(23.5%
1	7.4%).
1	ltgf-β.
1	luteinizing-hormone
1	milk-
1	(3-d)
1	dmem/f12
1	0.53;
1	0.21)
1	sacrifice
1	brdu-labeled
1	11.7
1	1.1),
1	quadruplicated
1	methapasic
1	10-15%
1	early.
1	nursing;
1	nonresponsive
1	(6n,
1	6d)
1	(19n,
1	19d)
1	giemsa's
1	6n=593.1
1	95.75,
1	6d=639.1
1	130.8,
1	19n=580.1
1	175.6
1	19d=402.0
1	144.8.
1	weak/
1	6d
1	(55.3%),
1	6n,
1	19n
1	19d
1	seventeen-day-old
1	lhrh,
1	(li).
1	trointestinal
1	(18-day-old)
1	(22-day-old)
1	corticosterone-treated
1	hormone-releasing
1	22-day-old
1	vincristine.
1	(10:00
1	milk;
1	18-day
1	(2.25
1	0.22%
1	2.49
1	0.28%,
1	(1.67
1	1.84
1	0.05%,
1	22-day
1	(fasted
1	0.28%).
1	(1.02
1	0.16%)
1	0.03%).
1	(il)-22,
1	(cd4+il-22+il-17a-ifn-γ-)
1	(cd8+il-22+il-17a-ifn-γ-)
1	il-22.
1	ad:
1	(damage-associated
1	(pathogen-associated
1	αβt
1	(tdp−cd4+cd8+),
1	(cd4+cd8−),
1	(cd4−cd8+),
1	tdp,
1	tdp
1	nlr3.
1	migration/maturation
1	(th1/tc1,
1	th2/tc2,
1	th17/tc17)
1	hapten-specific
1	mendonça
1	gut-homing
1	equilibrating
1	dysbiosis,
1	retinoids
1	anna
1	cláudia
1	calvielli
1	castelo
1	dualistic
1	histamine:
1	(hcs)
1	(atp).
1	torrealba
1	(ctcl),
1	il-7/il7rα
1	cd8+cd38+
1	cd127/il-7r
1	cd26
1	scd38
1	tlr3-induced
1	nkg2a
1	inhibitory/exhaustion
1	brüggemann,
1	fernandes,
1	sato,
1	arantes-costa.
1	smoke.
1	pdl2,
1	icosl,
1	regs
1	mischaracterization
1	cd8α
1	backgroud:
1	xerosis.
1	(idec),
1	(mdc).
1	non-ad
1	matched.
1	fcεri,
1	(seb),
1	mdc;
1	idec-like,
1	(b10)
1	manfrere
1	profiled
1	nkg2c+
1	(degs)
1	nfκb/jnk
1	(ifn-α/β)
1	il-12a.
1	ifn,
1	venereology
1	multifunctional,
1	(timps).
1	(tlr)-2/6
1	(fsl-1)
1	array),
1	tlr2/6
1	(fsl-1).
1	lin1−ccr3+
1	cd23
1	cd62l
1	dermatitis,
1	(tlr2/6
1	mmp/timps
1	ifn-α+
1	(pdcs);
1	(mdcs);
1	(tregs);
1	il-17-,
1	il-10-,
1	il-22-,
1	cd8+cd25+foxp3+cd127low/-
1	cd4+il-10+
1	cd8+il-22+
1	ifn-γ+t
1	tlr7/8/9
1	tlr-mediated
1	(cd45ra-ccr7-)
1	(cd45ra+ccr7-).
1	(cd45ra+foxp3low),
1	(cd45ra-foxp3high)
1	splenomegaly,
1	(43.7
1	(cd3+cd4+cxcr5+pd-1+icos+)
1	th22/tc22
1	(il-22+,
1	ifn-γ-,
1	il-17a-)
1	tlr7/8/cl097
1	(il-17a,
1	tnf)in
1	responsive,
1	hiv-seronegative
1	esns.
1	(ifn)-related
1	(apobec-3g,
1	trim5-α,
1	samdh1,
1	sting,
1	tbk1)
1	(trex,
1	apobec-3g
1	(ifns-α,-β/-?)
1	ifn-induced
1	trex
1	esns,
1	(ifn-i)
1	cl097.
1	tlr7-8
1	cell-secreting
1	hiv-1-exposed
1	(eus),
1	p15
1	il-17+
1	p24.
1	(hervs)
1	hervs
1	(hc) donors.
1	herv-k18
1	herv-w
1	mrna-editing),
1	mxa
1	(myxovirus
1	interferon-dependent
1	irf-7
1	hervs.
1	inflammatory/malignant
1	1-3%
1	80-100%
1	anti-staphylococcus
1	rajka's
1	65,
1	anti-seb
1	(2.63%),
1	(34.6%),
1	38.5
1	19.2%).
1	superantigens.
1	autoreactivity
1	tlr2/tlr1
1	[poly(i:c)-rig],
1	(lipopolysaccharide),
1	(flagellin),
1	(imiquimod),
1	(cpg).
1	10-12)
1	22-24)
1	agonists;
1	venereology.
1	(th1/th2/th17)
1	rajkacriteria,
1	(easi).
1	17a,
1	array).
1	dermatosis.
1	(hesn)
1	activating/
1	activating/memory
1	(ifn-g)
1	cd94,
1	nkg2c,
1	nkg2d,
1	cd107a,
1	hiv-p55gag
1	gag.
1	741
1	secreted,
1	exosome-like
1	vaccinology
1	godinho
1	do.
1	ova-
1	(matabs)
1	matab
1	matabs,
1	(heu)
1	(art)
1	(n=16),
1	(n=10-13)
1	(n=5-6)
1	(n=21).
1	(mncs)
1	(decidua)
1	(chorionic
1	villus)
1	mrna-editing
1	(a3g),
1	a3f,
1	family-5α
1	(trim-5α),
1	trim-22,
1	myxovirus
1	(mxa),
1	(sting)
1	mother-cb
1	a3g
1	α-defensin
1	trim-5α
1	tetherin
1	(interleukin-6,
1	il-6;
1	factor-β1,
1	tgf-β1)
1	(wavelength
1	fluency
1	j).
1	60-and
1	84-h
1	60-h
1	(mtct)
1	tlr5)
1	(tlr7,
1	tlr9).
1	tlr7.
1	cl097-treated
1	(irf-7),
1	maternal-neonatal
1	prognostic.
1	hospitalization,
1	atopy.
1	(scorad)
1	conditions);
1	denied
1	(asgaal,
1	0,04
1	0.3).
1	therapeutically)
1	18-month
1	(march
1	placebocontrolled
1	new-onsett1dm
1	cholecalciferol,
1	1c,
1	c-peptide;
1	(184.6
1	[101.1]
1	121.4
1	[55.8]
1	(4.55%[1.5%]
1	3.34%[1.8%])
1	islet-cell
1	number)
1	(t1ad),
1	[interleukin
1	(il)-12,
1	ii-1β,
1	il-10]
1	(cxcl10,
1	ccl2)
1	t1ad,
1	(r=0·80;
1	(r=0·60;
1	p=0·000);
1	(r=0·57;
1	p=0·001)
1	(r=0·93;
1	p=0·000).
1	decarboxylase-65
1	(gad-65)
1	(gada)
1	(r=-0·45;
1	p=0·011)
1	(r=-0·65;
1	(r=-0·38;
1	p=0·027).
1	dr3,
1	dr3/dr4
1	ptpn22
1	gada.
1	pre-t1ad
1	gada
1	t1ad.
1	th1-polarizing
1	neonatal-specific
1	cd4+cd25+foxp3+t
1	enconding
1	rigato
1	cytokine-chemokine
1	(bhr).
1	c-c
1	2/c-x-c
1	(ccl2/cxcl8)
1	ccl2/cxcl8
1	hypercholesterolaemia
1	phytohaemaglutinin
1	[il-6
1	(mip)-1α]
1	(tlr)-4,
1	down-regulatory
1	(pdc)
1	(tlr)9-sensing,
1	36)
1	inhibitory-oligodeoxynucleotide
1	tlr9-activation
1	inhibitory-odn
1	tlr9-induced
1	bjd
1	(lamp/gag),
1	immaturity
1	biomodulation
1	asgaal
1	procedure;
1	(p<0.07).
1	(p>0.07).
1	cells/factors
1	period.results:
1	antigen-specifc
1	th2/th1
1	stage;
1	mothers.conclusion:
1	cpg-containing
1	(igad)
1	(natabs)
1	igad,
1	(lamp-1;
1	miic
1	compartment),
1	lamp-1/gag
1	aureus);
1	exotoxins
1	interleukin-18
1	(il-18),
1	phytohemaglutinin
1	(pwm),
1	(cma).
1	(tt,
1	cma,
1	pha)
1	neonate,
1	(do11.10)
1	immunization;
1	post-birth.
1	(asst).
1	asst-positive
1	asst-negative,
1	il-10 mrna
1	basopenia,
1	(il)-3
1	releasability.
1	cd63
1	asst+
1	recoverable
1	urticaria.
1	curare-like
1	(nmba)
1	anesthesiology
1	nmba
1	nitrophenylphosphorylcholine
1	(nppc)
1	(klh).
1	hapten.
1	nmbas
1	16 mm
1	suxamethonium,
1	choline-derived
1	mother/neonatal
1	downmodulatory
1	(anesthesia,
1	laparotomy)
1	8x105
1	1st(pod1)
1	8th(pod8)
1	pod8
1	pneumoperitoneum.
1	parana
1	hemotherapy
1	antiendomysium
1	(distal
1	duodenum)
1	(gastrointestinal
1	complaints).
1	niece).
1	biopsy-confirmed
1	1:417,
1	wjg
1	(ag)-specific
1	primed-fed
1	double-treated
1	naïve-fed
1	anti-cd28
1	ova-fed
1	b7.2
1	righs
1	epicutaneous
1	(2×10
1	cells/well)
1	(156.25;
1	78.13;
1	19.53;
1	9.77
1	2.44μm)
1	pokeweed,
1	(okt3)
1	(si).
1	(84.21%)
1	allergens;
1	contrariwise,
1	bt-sensitization.
1	240-fold
1	co-immunization,
1	control-immunized
1	alloantigens
1	0.0018).
1	mucosal-exposed
1	1.0-mg
1	(13,340
1	3,519
1	29,280
1	2,971
1	iga-secreting
1	re-immunization
1	cell-culture
1	pteronysshtus
1	fed-mice
1	dp-immunization
1	murine-type
1	bt-immunization,
1	newborn's
1	diaplacental
1	(pbs)-fed
1	pbs-fed
1	(rtgf-β)
1	anti-tgf-β,
1	ige-secreting
1	(il-5),
1	(nzb/nzw)f1(bwf1)
1	lupus-
1	bwf1mice,
1	correspondingly
1	(tgf-β).
1	(dermatophagoides
1	dp)
1	tolerized
1	mg),
1	dp-specific
1	ige-
1	igg1-positive
1	dp-sensitized
1	(ige).
1	anti-f(ab')2γ
1	anti-fcγ
1	autoantibodies,
1	igg-ige
1	ige-tnp
1	ige-dansyl
1	(hdm)
1	50.0
1	ug
1	(aaige)
1	aaigg
1	aaige-ige
1	(il-2).
1	ctll-2
1	hsa,
1	f(ab′)2,
1	hsa.
1	anticytokine
1	hemophiliacs
1	numbers;
1	percent)
1	women's
1	iii-cdc,
1	consistantly
1	(il)-10;
1	(pbag)
1	brasiliensix
1	[pb(+)hc(-)]
1	[hc(+)pb(-)],
1	nonsensitized
1	6-9
1	hc(+)pb(-)
1	donors'
1	pbag.
1	12-day
1	pbag-activated
1	lupus‐prone
1	(high‐grade
1	(p‐igg)
1	(p‐igm)
1	cryoglobulin
1	chabaudi‐infected
1	d23
1	idiotype
1	vβ8.1,2,
1	vβ10
1	vβ14
1	attempt,
1	transitorily,
1	furth
1	(cytotoxic/suppressor
1	(pwm).
1	pwm
1	leptospiral-derived
1	pwm.
1	irreversibly
1	(2d7
1	1e2)
1	imported.
1	(rt1
1	(rtl
1	degalan‐v26
1	w3/25
1	(anti‐cd4
1	w3/25‐/0x8
1	(cd8
1	ox4
1	(anti‐rt1.b)
1	a.th
1	anti‐a.tl
1	alloantiserum
1	(anti
1	i‐e,
1	cross‐reacts
1	rtl.d)
1	rtl.
1	+,.
1	‐,.
1	‐.
1	a‐stimulated
1	lyhc
1	7″
1	rti.b+
1	+/rt1.b
1	graft,
1	polyadenomegaly
1	isohaemagglutinin
1	cd-4/cd-8
1	sk-sd
1	(varidase),
1	trichophytin
1	levedurin
1	(candidin).
1	(pha,
1	con-a,
1	pwm)
1	reevaluation
1	denomination,
1	"late-onset
1	immunodeficiency".
1	attaching/effacing
1	interweaves
1	o119:h6)
1	(aa)-like
1	(la/aa-like+).
1	pathovar.
1	la/aa-like
1	(ec404/03),
1	c1096
1	(pilsec404
1	pilsc1096)
1	pathovars.
1	(55.2%)
1	pilsec404
1	pilsc1096
1	(25.1%).
1	pils.
1	26.2%
1	65.1%
1	pilsc1096+
1	transconjugants
1	aa-like+,
1	pathovars,
1	gioia-di
1	chiacchio,
1	davies,
1	franzolin,
1	guth,
1	elias,
1	knöbl.
1	by).
1	coli),
1	shiga-toxin
1	stx2f
1	o137:h6
1	st2678.
1	(o137:h6/st2678)
1	(lt-i)
1	cutting.
1	99.5%
1	caetano,
1	carvalho,
1	luz.
1	(espb),
1	injected,this
1	espb-bearing
1	anti-espb
1	z2335,
1	(uspf).
1	uspf
1	α/β,
1	sonnei
1	freundii.
1	usp
1	frequentely
1	cockatiels,
1	budgerigars,
1	agapornis)
1	clermont
1	phylotyping
1	19.4%
1	(8/42)
1	(8/171),
1	8.47%
1	budgerigars
1	(5/59),
1	4.47%
1	cockatiels
1	(3/67),
1	agapornis
1	(0/45).
1	serogroup.
1	non-typeable,
1	stx2+
1	stec-positive
1	mention
1	toxins:
1	(stxb)
1	globotria(tetra)osylceramide
1	(gb3/gb4)
1	high-affinity,
1	gkiefskyneddtf
1	(hus).
1	o65:h-
1	o75:h14
1	o169:h7
1	(87.1%)
1	(saa,
1	lpf<inf>o113</inf>)
1	(subab
1	cdtv)
1	o65:h-.
1	forbidden
1	lt)
1	o111-cytochrome
1	vaxcine™,
1	post-vaccination,
1	vaxcine™
1	(stx)-producing
1	hus,
1	igg-antibody
1	years.results:
1	46.1%
1	wb.
1	62.9%
1	child's
1	age.conclusions:
1	seroepidemiolgy
1	guirro
1	94-kda
1	(scfv-intimin)
1	eae-
1	scfv-intimin,
1	(st).
1	st-,
1	st/lt-producing
1	anti-st
1	system-secreted
1	h11
1	h32.
1	flich11,
1	flich8
1	o26:h8
1	h8
1	o26:h32
1	nonvirulent.
1	(espa)
1	(espb)
1	serodiagnostic
1	ehec-infected
1	smegmatis
1	(smeg)
1	pmip12
1	bamhi/kpni
1	pmip_bfpa
1	pmip_intimin
1	smeg
1	rsmeg_pmip_(bfpa
1	rbcg_pmip_(bfpa
1	intimin).
1	tnf-γ
1	(e2348/69)
1	approved.
1	(anti-stx1)
1	(anti-stx2)
1	fatalities
1	lecitinase,
1	(cp-plc)
1	exotoxin.
1	emulsifications,
1	hemolityc
1	perfringolisine
1	eritrocytes
1	sporulated)
1	cpb2
1	cp-plc
1	sprorulated
1	(24.0
1	u.a.h).
1	(n=16)
1	(0.12-0.47
1	ml/cm)
1	enterotoxemia.
1	supernantants
1	cp-plc,
1	â2
1	etiopathogenecity
1	β-intimin
1	rodentium.
1	casei-intcv
1	cviga
1	int
1	immunohistological
1	sada,
1	purported
1	full-length,
1	anti-sada
1	alum-precipitated
1	afforded.
1	culture-
1	luria-bertani
1	penassay
1	buffered-peptone
1	syncase
1	stec-expressing
1	108-kda
1	polyvinylidene
1	difluoride
1	shigella,
1	campylobacter,
1	toxin-i
1	eristostatin
1	detectors.
1	6xhis
1	tag-coding
1	paz,
1	vector)
1	(imac)
1	egfp-er,
1	egfp-labeled
1	egfp-fused
1	non-producing
1	attachment-and-effacement
1	(a/e).
1	citometry
1	immuno-dot
1	(gal)
1	n-acetylgalactosamine
1	(galnac)
1	gal-negative,
1	(galα(1-3)galβ(1-4)glcnac-r)
1	melibiose
1	(galα(1-6)glc)
1	3-o-α-d-galactopyranosyl
1	α-d-galactopyranoside).
1	gal-negative
1	infestans
1	sordida
1	megistus.
1	sete
1	barras,
1	solium
1	(tso)
1	anti-bodies
1	neurocysticercosis.
1	neurocysticercosis,
1	(95.6%)
1	m-tso
1	(91.3%)
1	(vf-tso,
1	m-tc,
1	vf-tc).
1	98-92
1	56-52
1	m-tso;
1	98-94
1	115-108
1	vf-
1	tso:
1	m-to;
1	95-92
1	vf-tc.
1	neurocysticercosis
1	(ella:
1	reader.
1	sc4,
1	sc24,
1	sc25,
1	sc28,
1	(cona),
1	(pna),
1	(sba)
1	sc28
1	sc25
1	sc24
1	sc4.
1	0.986,
1	10-4)
1	n-acetyl-d-galactosamine
1	(mog35-55)-induced
1	(8-day
1	post-immunization),
1	dngr
1	psychostimulants,
1	(cpp),
1	“binge”
1	cocaine-related
1	problems)
1	use/abuse;
1	place-preference
1	alcohol-drinking,
1	“social
1	neuropeptide”
1	otr.
1	sociability
1	∼3.5-fold
1	carbetocin
1	(6.4
1	l,369–899
1	oxytocinergic-dependent
1	use/misuse
1	environmental-social
1	(nachr),
1	(minipump,
1	24 mg·kg
1	regimes:
1	0 h·day
1	running.
1	mecamylamine-precipitated
1	24 h·day
1	ca2/3
1	α4β2*
1	nicotine-dependent
1	articles:
1	themed
1	http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc.
1	preweaning,
1	drug-taking
1	(mice)
1	adolescents,
1	adolescent-specific
1	carrara-nascimento,
1	hoffmann,
1	contó,
1	marcourakis
1	drinking-inthe-dark
1	escalation.
1	adolescent-sal,
1	adolescent-etoh,
1	adult-sal
1	adult-etoh).
1	threebottle
1	8%–15%
1	sucrose)
1	reexposures.
1	adolescent-etoh
1	adult-etoh.
1	adult-etoh
1	adolescent-etoh.
1	licit
1	illicit
1	neurogenesis,
1	vascularization.
1	deficit/hyperactivity
1	disorder)
1	lifespan.
1	marianno
1	drinking-in-the-dark
1	(ee24h).
1	(ee3h).
1	(ebs)
1	psychostimulants.
1	labs,
1	11-day
1	unpredictable,
1	consumption/preference
1	percent),
1	intoxicating
1	mglu1α,
1	homer2,
1	cβ
1	subregion.
1	mglu1α
1	subregions.
1	oprk1,
1	(50 µg/kg,
1	testing)
1	(em
1	euthanasia.
1	undisturbed.
1	-nontreated
1	(machrs).
1	machrs
1	[3h]inositol
1	l-[n-methyl-3h]scopolamine
1	subtype;
1	machrs,
1	hyperresponsive
1	three-bottle,
1	[v/v]
1	(ac;
1	(w;
1	(re;
1	(ad;
1	system-mediated
1	β-endorphin,
1	enkephalin,
1	dynorphin,
1	oprd1,
1	(dor),
1	quotient.
1	ethanol-pretreated
1	(76.3
1	(74.6
1	lactate)
1	(baecke
1	elderly).
1	4.53;
1	13.63;
1	0.33)
1	risk-taking
1	novelty-seeking
1	(pcreb)
1	saline/cocaine
1	cocaine-pretreated
1	withdrawal-induced
1	cocaine-abstinent
1	still-developing
1	valzachi
1	(becs)
1	(pnd = 28
1	(pnd = 70)
1	2-bottle
1	3 weeks
1	(cycles
1	(16 hours)
1	(8 hours).
1	air-exposed
1	becs.
1	200-250
1	crouching,
1	pup,
1	crouching
1	baclofen,
1	intake"
1	housed,
1	bottles:
1	(ac,
1	(w,
1	day-free-choice
1	day-only-water),
1	(re,
1	control"
1	phases)
1	drinkers
1	free-choice.
1	baclofen.
1	aeme,
1	1.0mm
1	aeme's
1	196.1
1	40.0%
1	52.2
1	craving
1	mesoaccumbens
1	phenomenon;
1	(0-0.03
1	(0-30
1	ethanols
1	tests)
1	(mci)
1	(mmse).
1	mmse
1	0.68,
1	0.029)
1	2011-ios
1	(abuse
1	aud)
1	aud.
1	(adh)
1	presteady
1	(anti-anxiety)
1	intersection
1	alcoholism
1	self-administer
1	binge
1	casual
1	sensitization)
1	experimenter.
1	(i.e,
1	appetitive,
1	reinforcing)
1	(dopaminergic,
1	cannabinoid)
1	inter-relationship
1	i.p)
1	cocaine-treated
1	glu.
1	ethanol-avoiding
1	ethanol-preferring
1	preexposure,
1	ethanol/sucrose
1	strain-dependent
1	preexposure.
1	(nmdar)
1	nmdars
1	acute/sedative
1	ifenprodil,
1	129s
1	prohormone.
1	unlimited-access
1	(saccharin
1	continuous-access
1	4-g/kg
1	continuous-
1	limited-access
1	(ppf).
1	(mipscs)
1	(3-aminopropyl)
1	(diethoxymethyl)
1	phosphinic
1	ppf,
1	spillover,
1	n-[z-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide
1	proceedings
1	montreal,
1	ryabinin,
1	chair
1	koob.
1	introduction,
1	heinrichs;
1	catherine
1	rivier;
1	allostasis
1	koob
1	amanda
1	roberts,
1	alcohol:
1	microinjections,
1	olive,
1	kristin
1	mehmert,
1	camarini,
1	joseph
1	kim,
1	heather
1	koenig,
1	michelle
1	nannini,
1	clyde
1	hodge;
1	urocortin-containing
1	ryabinin
1	ryan
1	bachtell.
1	two-lever
1	gabaa-positive
1	non-competitive
1	mk-801.
1	saline-appropriate
1	1.2±0.14
1	(0.68±0.13
1	self-administered.
1	(0.3-10.0
1	reinforcer,
1	pentobarbital,
1	supersensitive
1	ethanol-containing
1	withdrawal-associated
1	(pedunculopontine
1	(achase),
1	cerebrum.
1	achase)
1	(medulla
1	-1mg
1	photometrically.
1	(student
1	t-test)
1	147.8
1	12.8,
1	169.3
1	17.4,
1	p<0.025)
1	167.4
1	29.0,
1	191.9
1	15.4,
1	171.0
1	189.5
1	19.5,
1	147.6
1	16.3,
1	163.8
1	oblongata).
1	(nlx),
1	nlx's
1	methyl-d-aspartate
1	mk-
1	21'
1	ethanol-
1	locomotor-stimulating
1	electroconvulsive
1	depression;
1	(down-regulation
1	handled
1	182.6
1	14.8,
1	162.2
1	14.2,
1	133.6
1	145.8
1	12.3,
1	231.0
1	34.5,
1	298.9
1	18.5,
1	203.9
1	30.9),
1	yawning
1	supernatant),
1	supernatant)
1	(40,000
1	152.1
1	152.7
1	24.9
1	127.9
1	13.8).
1	126.4
1	21.5,
1	127.8
1	20.4,
1	14.2).
1	188.8
1	19.4,
1	154.4
1	±7.5,
1	p<0.005)
1	850.9
1	59.6,
1	742.5
1	34.7,
1	p<0.005).
1	monosialoganglioside
1	injections).
1	dl-fenfluramine,
1	dl-f
1	enfluramine,
1	dl-fenfluramine
1	(5-hydroxy-5-p-chlorophenyl-2,3-dihydro-5h-imidazo-2,1-a-isoindole)
1	phenylethylamine
1	amphetamines.
1	23-month
1	carbamazepine
1	(cbz)
1	(aw).
1	euphoric
1	feelings
1	alcohol-dependent
1	(c-di-gmp)
1	c-di-gmp
1	cyclases
1	(xac2382
1	xac2383)
1	xac2382,
1	dgc,
1	xac2383,
1	xac2382.
1	xac2382–xac2383
1	"weaponry"
1	polypeptide;
1	signaling/metabolism,
1	(pro)phages.
1	zincin-like
1	jump-start
1	dnabinding
1	reused
1	xpc/rad4-dependent
1	rnases
1	osmc
1	cys-based,
1	iterated
1	searches,
1	species).
1	lipoyl
1	fijiensis
1	mf_1
1	(mfohr),
1	sigatoka
1	dihydrolipoamide
1	(dithiols),
1	β-mercaptoethanol
1	(monothiols),
1	excess;
1	(cuooh
1	tbooh)
1	peroxide;
1	(k=3.18
1	(±2.13)×108 m−1 s−1).
1	cys87
1	cys154
1	hydroperoxides.
1	cysp
1	5.7±0.1
1	monobromobimane
1	guadua
1	guaduachacoensis
1	srrs
1	chacoensis
1	136,334
1	135,403 bp
1	quadripartite
1	lsc
1	chusqueinae,
1	guaduinae,
1	arthrostylidiinae,
1	hickeliinae
1	bambusinae + melocanninae.
1	141.8
1	plastomes
1	(38.15)
1	ssr
1	tribe.
1	©springer
1	nad+-dependent
1	(art),
1	sirtuins,
1	tm1506.
1	modify.
1	offensive
1	toxin–antitoxin
1	virus-host
1	(polymorphic
1	toxins),
1	symbiont/parasite
1	effectors/toxins,
1	regulatory/epigenetic
1	neurl4),
1	pierisin
1	carp-1
1	gig2-like
1	arts).
1	macro,
1	glycohydrolase,
1	nadar,
1	sirtuins
1	anjana
1	rao,
1	(sent
1	2013)
1	methylpyrimidines
1	demethylation.
1	lineage-specifically
1	starkly
1	basidiomycetes,
1	transposons,
1	kdz
1	(kyakuja,
1	dileera,
1	zisupton)
1	hmg
1	transposases
1	zn-chelating
1	insert,
1	tet/jbps
1	occasions,
1	viridiplantae,
1	amoebozoa.
1	calnexin-independence
1	(cif1),
1	pombe,
1	transposon-tet/jbp
1	inter-organismal
1	cassettes.
1	type-ii,
1	type-v,
1	(esx),
1	photorhabdus
1	(pvc)"
1	prsw-dependent
1	muf
1	phage-capsid-like
1	autoproteolytic
1	hint,
1	zu5,
1	prsw,
1	caspase-like,
1	papain-like,
1	deaminases,
1	adp-ribosyltransferases,
1	ribosyl
1	rela/spot-like
1	nucleotidyltransferases,
1	glycosyltranferases
1	anywhere
1	gene-neighborhood-analysis
1	trafficking-related
1	logic
1	protein-length
1	inter-cellular
1	rhs/yd,
1	life-style
1	'cheating'
1	nucleo-cytoplasmic
1	viruses.conclusions:
1	ribosylation,
1	heteroincompatibility,
1	messengers.reviewers:
1	iz.
1	zhang
1	(nad)
1	adp-ribose.
1	ybia
1	2′-3′
1	ybia-related
1	nad-dependent
1	adp-ribosyltransferase.
1	adp-ribosylglycohydrolase
1	ribosylglycohydrolase
1	drag-drat
1	adp-ribosyltransferases/ribosylglycohydrolases
1	adp-
1	ribosyltransferases
1	waddlia
1	throw
1	polyadp-ribosyltransferases
1	neurl4-like
1	centrosomal
1	nicotinate-derived
1	ampylating
1	ligase.
1	trajectories
1	endoparasites.
1	adhesion-
1	glycosylation-related
1	eukaryote-specific
1	rna-processing
1	rna-processing.
1	antibiotic/siderophore
1	restriction-modification,
1	phages)
1	remodeling/modifying
1	"nurseries"
1	spur
1	nucleogenesis
1	g-proteins
1	parabasalids,
1	stramenopiles.
1	arf-like
1	neomorphic
1	trichomonas,
1	gβγ
1	naegleria,
1	(lses).
1	concomitant,
1	naegleria
1	eukaryote,
1	membrane-linked,
1	redox-associated,
1	adhesion-dependent
1	molecule-induced
1	early-branching
1	gα-rgs
1	mushrooms
1	mating-type
1	(gpcrs),
1	gefs
1	domains)
1	gαs.
1	stramenopiles
1	rate-constants
1	alveolate
1	g-proteins,
1	g-protein-independent
1	aminoacyl-trna
1	(aatrs)
1	ligation.results:
1	cyclodipeptide
1	(cdpss)
1	hup
1	rossmannoid
1	cdpss
1	cupin
1	n6
1	(mtrs).
1	mtrs
1	atp-grasp
1	condensation-domains.conclusions:
1	aatrs,
1	cdpss.
1	ligations
1	mprf/fem/murm-type
1	peptidoglycan,
1	n-end
1	aminoacylation
1	valinamycin.
1	tetrapyrrole
1	mycothiol
1	here.reviewers:
1	andrei
1	osterman
1	igor
1	zhulin.
1	aravind
1	(xacarray).
1	m13r
1	m13f.
1	totaled
1	6,144
1	768
1	624
1	slide.
1	fluorophores,
1	cy3
1	cy5.
1	2,365
1	escrt
1	escrt-i/mvb12
1	crag,
1	ubap1-mvb12-associated
1	mvb12
1	ubap1
1	escrt-i.
1	contact:
1	aravind@ncbi.nlm.nih.gov.
1	information:
1	ftp://ftp.ncbi.nih.gov/pub/aravind/uma/mvb12.html.
1	modifiers,
1	hydroxylation/peroxidation
1	trnaphe.
1	protein-and
1	acid-modifying
1	dsbh
1	epimerases
1	isomerases.
1	2-oxoglutarate-dependent
1	under-appreciated
1	2-oxoacid-binding
1	superfamilies.
1	β-helix
1	collagen-like
1	hydroxylase/peroxidase
1	c.results:
1	ptha,
1	xope3
1	xopai,
1	effector-like
1	cankers
1	lipopolysacharide
1	xacpnp,
1	protein.conclusion:
1	plant-microbe
1	superkingdom
1	dna-packaging
1	ihf/hu
1	zn-finger
1	papillomaviruses,
1	demethylases
1	ben
1	polydnaviruses.
1	chromatin-interacting
1	lxcxe
1	replication-associated
1	topoisomerases,
1	rad50/sbcc-like
1	swi2/snf2
1	a18-like
1	heh
1	tethering
1	tet/jbp-like
1	thymine
1	hydroxylases.
1	3,702
1	surfaceome).
1	(asrt)
1	rhodopsin,
1	generality
1	tropheryma,
1	thermobifida.
1	topologies.
1	elaborate
1	ypsb.
1	phylogentic
1	diviva-like
1	bacillales
1	lactobacillales.
1	z-ring
1	septation.
1	diviva
1	positioning.
1	ftsa.
1	(amidase
1	domain),
1	xanthomonadaceae
1	3636
1	1470
1	1026
1	xanthomonas-specific
1	xanthomonadin
1	intersections
1	salmonella's
1	spi-7
1	hms
1	kdgt
1	citri;
1	avrbs
1	restriction-
1	nickase
1	restriction-modification
1	(xf-9a5c)
1	xf-9a5a
1	xac.
1	wall-degrading
1	avirulence
1	chemotatic
1	xf-9a5c
1	xac,
1	colicins,
1	restriction/modification
1	90 %
1	valvular
1	flail
1	chordae,
1	laser)
1	(subjected
1	photonic
1	irradiation).
1	3 w,
1	60 j.
1	(48),
1	knee.design:
1	groups.setting:
1	services.subjects:
1	osteoarthritis,
1	genders.intervention:
1	exercises)
1	exercises).main
1	(vas),
1	goniometer,
1	ontario
1	mcmaster
1	universities
1	(womac)
1	weeks).results:
1	relief,
1	knees.
1	knees),
1	knees)
1	knees).
1	knee,
1	j/point.
1	lequesne,
1	(vns),
1	goniometry
1	dynamometry
1	vns-resting
1	0.5g/kg/day.
1	(39.5
1	44.4
1	(18.6
1	30.8
1	(38.5
1	31.4
1	(134.8
1	143.8
1	g/dl),
1	(141.0
1	141.0
1	(130.1
1	126.2
1	(36.1
1	36.1
1	(65.6
1	(25.0
1	650-nm
1	myeloperoxide
1	3.7-4.3).
1	1.9-3.1),
1	1.2-2.4),
1	0.9-2.1),
1	slightly,
1	0.63-1.11),
1	0.24-0.76),
1	0.44-0.96)
1	1.34-1.96;
1	dexamehasone
1	(gaas
1	(-70%).
1	(-38%;
1	3-j/cm(2)
1	(904
1	ergospirometry
1	sports,
1	aptitude,
1	voluntarily
1	being:
1	t-student
1	v<o
1	0,05);
1	practicing
1	18):
1	cre-nat
1	(1-4
1	sportive
1	competitions,
1	fights
1	endurances,
1	90s,
1	180s,
1	300s
1	fighting,
1	athlete.
1	fight,
1	(90°/s)
1	torque.
1	0.0033/p
1	0.00059),
1	0.0033),
1	0.0033)
1	0.0180)
1	0.0392).
1	intermuscular
1	0.0129),
1	0.0137)
1	dynamometry.
1	non-toxicity
1	γ-counter.
1	(458
1	emission.
1	settling
1	γ-counter
1	incapacity.
1	orally,
1	multi-joint
1	dynamometer).
1	concentric,
1	180°/s.
1	volunteer,
1	intra-class
1	(icc)
1	(sem
1	(icc
1	0.80).
1	8.5%)
1	purpose--to
1	methods--fifty
1	beverage
1	results--there
1	conclusion--in
1	capsicum
1	peppers
1	raf/mek/erk
1	trpv1/6
1	6g,
1	6g.
1	(pet/ct)
1	photon
1	(spect/ct)
1	miniaturization,
1	(dpi).
1	dpi),
1	progression)
1	99mtc-methyl
1	diphosphonate
1	(99mtc-mdp),
1	99mtc-mdp
1	advocates
1	pet/spect/ct
1	cangicum,
1	(1.2-12
1	(0.6-6.0
1	391,
1	ketanserin,
1	antinociception;
1	displace
1	biguanide,
1	formalin’s
1	non-peptidic
1	belong,
1	iia/iib
1	painful)
1	lys49-phospholipase
1	(lys49-pla2)
1	lys49-pla2s
1	lys49-pla2-induced
1	h48q
1	plethysmometer.
1	bthtx-i.
1	non-dependent
1	(toxins)
1	crotalphine's
1	longlasting
1	trpa1-expressing
1	crotalphine-mediated
1	desensitizing
1	hc030031
1	trpa1-deficient
1	“clinical
1	effects”,
1	urinate
1	defecate;
1	ptosis.
1	(3.8ngkg-1)
1	patrícia
1	brigatte
1	(hyperalgesia
1	allodynia),
1	a4.
1	(fprs).
1	fprs,
1	fprs.
1	(0.008-1.0
1	(0.0006
1	paw)
1	am630
1	paw),
1	anti-dynorphin
1	paw).
1	(51.7%)
1	(28.5%)
1	vitroa-eia
1	am630.
1	∼540
1	heterozygotic
1	aldh2-selective
1	(alda-1).
1	(r2=
1	0.90)
1	(egr1)
1	4-hydroxynonenal).
1	acetaldehyde-
1	formalin-induced
1	non-narcotic,
1	cardiac-safe
1	asians'
1	monocultured
1	256cells.
1	(0.3μg/ml)
1	3.7-
1	3.2-fold
1	lxa
1	2.3-
1	15-epi-lxa
1	nor-binaltorphimine
1	n,n-diallyl-tyr-aib-phe-leu
1	174,864,
1	(ctop,
1	ammatory,
1	(5ml
1	gcro
1	(3.8ng.kg-1
1	crotalphine),
1	u50-488h),
1	(0.1mg.kg-1
1	morphine)
1	(4.4mg.kg-1
1	phenylbutazone).
1	ammatory
1	(140°c)
1	lrfcesc
1	lrfcisq
1	acylamino
1	cangicum.
1	esims/ms)
1	wasps,
1	(hyperalgesic)
1	protonectarina
1	sylveirae,
1	mellitin
1	mellifera),
1	(polybia
1	paulista),
1	(protonectarina
1	sylveirae)
1	paquimeter.
1	protonectarina-mp-nh2,
1	wasps.
1	bk-related
1	threonine6-bradykinin
1	(thr6-bk)
1	cyphononyx
1	fulvognathus.
1	cyphokinin.
1	cyphokinin,
1	thr6-bk
1	kinin-related
1	stumps
1	(0.01 mm
1	10 s),
1	long-lasting,
1	neurectomy-induced
1	neuroma
1	(100 mg/kg,
1	(2 mg/kg,
1	(4 mg/kg,
1	(1 mg/kg,
1	n-methyl
1	(30 mg/kg,
1	<efspencqgesqpc,
1	14-amino-acid
1	γ-chain
1	(0.008-25
1	e2-
1	(0.0032-0.04
1	(s.c.,
1	0.00006-0.3
1	(liv)
1	(0.1-5
1	phenylephrine-contracted
1	liv-induced
1	serotonine.
1	plethysmography,
1	(632.8
1	nociceptors
1	2,5
1	randall
1	selito,
1	(1957).
1	hyperalgesia)
1	(p<0,001),
1	(p<0,01),
1	leakage)
1	(p<0,01)
1	(p<0,05)
1	(i.pl)
1	82334)
1	94800)
1	(cgrp8-37)
1	(nmda;
1	ap-5),
1	(aida
1	mpep)
1	neurokinins
1	cyclooxigenases
1	(pge2)-induced
1	oz
1	1h-(1,2,4)oxadiazolo[4,3-a]quinoxaline-1-one
1	seletive
1	rp-cgmp
1	triethylamine,
1	e2-induced
1	cgmp/pkc
1	(capsazepine),
1	pglu-ala-asp-pro-asn-lys-phe-tyr-pro
1	(spiro-γ-lactam)
1	leu-trp-nh2
1	(gr82334)
1	phenyl-co-ala-ala-d-trp-phe-d-pro-pro-nle-nh2
1	(gr94800),
1	dizocilpine
1	(mk
1	801),
1	(±)-2-amino-5-phosphonopentanoic
1	((±)-ap-5),
1	6-cyano-7-nitroquinoxaline-2,3-dione
1	long-term-treated
1	cross-tolerance
1	u-trans,
1	damgo,
1	(bb-94)
1	batimastat,
1	cana2edta,
1	naloxone.
1	n(g)-methyl-l-arginine
1	i.pl.,
1	intraperitoneal,
1	supraspinally
1	giorgi,
1	bernardi
1	cury.
1	1257-1265,
1	1993.-crude
1	antivenin.
1	endorphin-like
1	thyroparathyroidectomy,
1	intracutaneously
1	(heat-killed
1	tuberculosis),
1	amino-glutethimide,
1	thyroxin,
1	tumor–stromal
1	co-receptors.
1	matricellular
1	c-met.
1	nanosized
1	cargos
1	biofluids
1	(ngs)
1	small-
1	long-rnas,
1	enables,
1	brevican.
1	metastases,
1	-5,
1	borderline,
1	malignant.
1	brevican,
1	adamts-5,
1	motifs"
1	(adamts)
1	nih-ovcar-3
1	es-2,
1	es-2
1	nih-ovcar-3.
1	chemogenomic
1	carboplatin,
1	(hur)
1	hur
1	sensitise
1	mln4924,
1	resensitise
1	italia.
1	32.14 %
1	50 %
1	nery
1	non-fibrillary
1	aβ1-42
1	5dpf
1	screenings.
1	translocations,
1	p53-controlled
1	reentry
1	degradation.methods:
1	fbxw7,
1	lines.results:
1	51.5%
1	45.5%
1	21.2%
1	iii-iv.
1	intestinal-type
1	diffuse-type
1	cells.conclusion:
1	calcagno
1	cost-effectiveness
1	(pho-s)
1	(huvec).
1	sunitinib.
1	(er)α,
1	line;
1	e2-targeted
1	anti-oestrogens
1	pakt,
1	rehydration
1	(wd-pr).
1	(htz).
1	wd-pr,
1	159%,
1	need-induced
1	htz.
1	obsessive-compulsive
1	open-field,
1	fear-potentiated
1	marble
1	prepulse
1	neurochemicals
1	loci).
1	intervals;
1	ejection,
1	t11062g,
1	g13744a,
1	a13808g,
1	g13813a,
1	aa)
1	lg/j.
1	repeat-variant
1	imprinted
1	(sy),
1	(ty),
1	times/wk/8wks.
1	(lvh)
1	(agt)
1	sy.
1	lvh
1	l-3,4-dihidroxifenilalanine
1	(l-dopa)-induced
1	dyskinesias
1	(aims)
1	(6-ohda)-lesioned
1	ng-nitro-l-arginine,
1	fosb/δfosb,
1	anti-dyskinetic
1	dyskinesia.
1	padovan-neto,
1	echeverry,
1	chiavegatto
1	del-bel.
1	pi3kγ/akt
1	increasedactivation
1	nonadaptive
1	(aha)
1	non-heightened
1	(ana)
1	[5-hydroxytryptamine
1	(5-ht)]
1	androgenic
1	steroid.
1	anabolic-androgenic
1	(aas)
1	decanoate
1	motor-related
1	aas-injected
1	opponents.
1	abusers.
1	psychopathologies.
1	(5-ht)-related
1	5-ht1a,
1	5-ht2a,
1	2c,
1	5-ht3a,
1	hydroxylase-2
1	single-housed
1	(nos-1-/-
1	nnos-/-)
1	'down-stream'
1	'anxiety-like',
1	'depressive-like'
1	'anxious'
1	'despair'
1	porsolt
1	motivational,
1	unanticipated,
1	lsd,
1	hypothalamicpituitary-adrenal
1	ts65dn
1	(ds).
1	isolation-induced
1	diagonal
1	ds,
1	delayed-type-hypersensitivity
1	inter-male
1	interacting,
1	impulsivity.
1	κ1.5%
1	(gm2/gd2
1	gm3
1	neuropathies,
1	abilities,
1	walk
1	labored
1	twelve-month-old
1	tremor
1	catalepsy.
1	(sheikh,
1	sun,
1	kawal,
1	crawford,
1	proia,
1	griffin,
1	schnaar.
1	wallerian
1	proc.
1	96:
1	7532-7537),
1	54.3
1	open-field.
1	h3-antagonist
1	h3-agonist
1	n-α-methylhistamine.
1	h1-antagonist
1	mepyramine.
1	h2-
1	hypokinetic
1	135.8
1	counter-proof.
1	dopac/da
1	5ht
1	h3-receptors
1	heteroreceptors
1	h1-receptor
1	h2-receptors
1	(dph),
1	vomiting.
1	antihistamine-containing
1	dams;
1	geotaxis
1	accelerated,
1	fostering
1	2-21
1	cross-fostered
1	mother-offspring
1	dph-exposed
1	dph,
1	(h1)
1	(stolons
1	utricles)
1	grosso)
1	(utricle
1	stolon).
1	breviscapa.
1	colony-associated
1	glycerophosphocholine,
1	glycerophosphoglycerol,
1	glycerophosphoinositol
1	wilt
1	(pw)
1	per-
1	(gmos)
1	(glyphosate)
1	(bt
1	plants)
1	gmo,
1	(gmms)
1	bioreac-
1	tors)
1	biofuels,
1	(maldi-msi)
1	tc3.4.2r3
1	monoculture
1	pyochelin
1	rhamnolipid
1	rha-rha-c15-c14
1	maldi-msi
1	perniciosa,
1	citrophtora,
1	capsici,
1	palmivora.
1	monocultures,
1	interkingdom
1	oomycetes.
1	desi-msi
1	rhamnolipid,
1	microorganism–microorganism
1	microorganism–host
1	physiochemical
1	specialization,
1	niches,
1	(biotic
1	abiotic)
1	microbial–host
1	reviews,
1	structuration
1	a23,
1	desferoxamines,
1	antimycins
1	candicidin,
1	predicted.
1	(root
1	rhizosphere)
1	non-genetically
1	(sp80-1842)
1	(imi-1,
1	planting)
1	(weeding
1	treatments).
1	virens,
1	fungal-plant
1	ascomycota.
1	rhizosphere).
1	(gfp)-expressing
1	v.223
1	bogas
1	pcr-denaturation
1	(2.40e<sup>−4</sup>).
1	(1.4e<sup>−4</sup>),
1	(2.1e<sup>−3</sup>)
1	arsenophonus
1	(3.6e<sup>−5</sup>)
1	aquicella
1	(3.5e<sup>−3</sup>)
1	(1.1e<sup>−3</sup>),
1	cross-comparisons
1	shannon–weaver
1	simpson
1	libshuff
1	heatmap
1	nmsd
1	anosim
1	restructure
1	cupana.
1	xylem,
1	internerval
1	sharpshooter
1	xanthopis.
1	xanthopis
1	(insecta),
1	epiphytically
1	endophytically.
1	seedling-roots
1	96 h
1	methylotrophic-related
1	methylobacterium-soybean
1	glutathione-related
1	(ims)
1	spray-based
1	wadayamensis,
1	(desi)
1	sonic-spray
1	(easi)
1	metal-bound
1	(january
1	march)
1	pseudobulbs
1	2005;
1	malavolta
1	1998).
1	27°c
1	water-soaked,
1	benomyl
1	µg/ml)
1	baby’
1	oxidase-and
1	urease-positive,
1	anaerobically,
1	uv-fluorescent
1	king’s
1	2-nitrophenyl-ß-d-galactopyranose,
1	d-melibiose,
1	l-arabinose,
1	malonate,
1	citrate.
1	p027f
1	1378r
1	(andreote
1	776-bp
1	kp735965).
1	koch’s
1	baby’.
1	pseudobulb
1	dark-brown
1	gummy
1	$2.7
1	2014;
1	sales,
1	distribution;
1	nurseries.
1	manuella
1	nóbrega
1	dourado
1	(c1),
1	methylamine.
1	epiphytes.
1	cytokinins,
1	fabricius.
1	acridum.
1	vahl
1	genlisea
1	st.-hil.
1	(firmicutes)
1	(γ-proteobacteria)
1	acidobacterium
1	(acidobacteria)
1	hydrocarpa.
1	(46.8%),
1	(33.9%),
1	(9.3%),
1	chloroflexi
1	gemmatimonadetes
1	chlamydiae
1	tenericutes
1	(otu0.03)
1	utilisation.
1	actinobacterium
1	mannopeptimycin
1	~7.0
1	6,006
1	73.5%
1	pjtt
1	cry1ac7)
1	33.1:pjtt.
1	stalks
1	stalks,
1	33.1:pjtt,
1	re-isolation
1	borer.
1	(pantoea
1	pr2/7,
1	citrus)
1	(catharanthus
1	roseus).
1	c33:1gfp
1	colonizer.
1	(cbs),
1	citriculture.
1	cbs.
1	protein)and
1	pfat-gfp,
1	gfp.
1	agrotransformation
1	[acetosyringone
1	as]
1	time).
1	cellulose's
1	200μm
1	96has
1	hph
1	symbiotically
1	(endophytically
1	epiphytically)
1	bacteria-bacteria
1	bacteria-plants,
1	exuded
1	homoserine
1	molecules)
1	(n-acyl-homoserine
1	lactones)
1	methylobacterium-plant
1	(mxaf),
1	(crti,
1	sss),
1	(acds)
1	(patatin
1	ahl
1	colonization),
1	ahl,
1	(gfp)-tagged
1	reisolation,
1	33.1-inoculated
1	cross-colonization
1	cross-colonization,
1	n-acetyl-ß-d-glucosaminidases,
1	chitobiosidases
1	endochitinases.
1	soil-borne
1	plurivorous
1	damping-off
1	rhizoctonia
1	sclerotinia
1	sclerotiorum,
1	sclerotiorum
1	bladderwort
1	reniformis,
1	gibba,
1	neottioides,
1	subulata,
1	benedicta.
1	reniformis
1	sequencer,
1	population-level
1	interpopulation
1	pinguicula.
1	botanical
1	4,5-dimethylresorcinol.
1	epicolactone
1	tumefaciens.
1	4-hydroxymellein.
1	plummet
1	(next-generation
1	sequencing)
1	unequally
1	pan-genomes
1	(meta)genome
1	annotation.
1	falcatum,
1	xanthomomas
1	albilineans.
1	endophytism
1	phylloplane
1	ar1.6/2,
1	(egla),
1	aregla,
1	co-inhabit
1	extorquens-x.
1	plant-nodulating,
1	cytokinin
1	generalists
1	plant-species.
1	congruency
1	inhabitance
1	function-based
1	impelled
1	laguncularia
1	tumefaciens-mediated
1	(atmt).
1	mitotically
1	(tail-pcr)
1	agrobacterium-mediated
1	phaseolorum
1	(vitis
1	niagara
1	rosada)
1	salesópolis,
1	herbemontis
1	aporospora
1	terricola,
1	aureobasidium
1	pullulans,
1	bjerkandera
1	adusta,
1	boninense,
1	helianthi,
1	nigrum,
1	flavodon
1	subglutinans,
1	lenzites
1	paraphaeosphaeria
1	pilleata,
1	sordida,
1	phyllosticta
1	pleurotus
1	nebrodensis,
1	preussia
1	africana,
1	tinctoporellus
1	epiniltinus,
1	berteri.
1	gloeosporioides
1	herbemontis.
1	background:epicoccum
1	purpurascens
1	ehrenb.
1	schlecht)
1	darkly
1	muriform
1	conidiophores
1	sporodochia
1	biocompound
1	species.methodology/principal
1	techniques),
1	nigrum.
1	sp.conclusions/significance:this
1	asserts
1	reclassified,
1	161.73
1	spot;
1	amylases,
1	endoglucanases
1	pectinases,
1	methylesterase
1	endopolygalacturonase;
1	endopolygalacturonase
1	(theobroma
1	cacao)
1	branches).
1	parenchymatic
1	conidiogenisis
1	(nrr1)
1	(cag8),
1	cag8
1	nrr1
1	funpec-rp
1	www.funpecrp.com.br.
1	(sd1,
1	k9)
1	asburiae,
1	amnigenus.
1	(81%
1	sd1,
1	k9),
1	bands)
1	(340
1	620
1	acetochlor).
1	(k9
1	(sd1
1	acetochlor
1	herbicide-contaminated
1	scavenging.
1	(2,734
1	ege6
1	eucalyptus).
1	238(a),
1	250(b),
1	131(c),
1	129(d)
1	plgm1
1	pgfpmut3.0
1	gfp),
1	sticks.
1	well-preserved
1	cardoso,
1	coastline,
1	library).
1	(40.36%
1	(19.28%
1	clones)
1	(27.71%
1	deltaproteobacteria,
1	(rda)
1	mangroves,
1	land.
1	('universal'
1	alphaproteobacteria)
1	(betaproteobacteria
1	actinobacteria)
1	actinobacteria.
1	(variety
1	sp80-1842)
1	(imi-1
1	(rrna)-based
1	tm7
1	op10.
1	verrucomicrobia,
1	bassiana
1	10(5),
1	10(9)
1	tick-infested
1	conidia/ml.
1	18-32%
1	tick;
1	conidia.
1	b95
1	b157,
1	amorpha.
1	(cultivar)
1	root-associated
1	e119
1	(eersteling,
1	robijn
1	karnico).
1	gel-electrophoresis
1	imidazolinone-tolerant
1	isoline
1	(herbicide
1	climates,
1	epicoccum,
1	guignardia,
1	pestalotiopsis
1	microbial-plant
1	solubilise
1	phosphates,
1	indole-acetic
1	gyrb
1	dicksonia
1	sellowiana
1	(64.2%)
1	nitroreducens).
1	sellowiana,
1	fern.
1	j.e.
1	smith
1	acyl-hsls,
1	(s)-n-dodecanoyl
1	(s)-n-tetradecanoyl-hsl
1	odd-chain
1	n-tridecanoyl-hsl
1	(s)-n-(2e)-dodecenoyl-hsl
1	(s)-n-(7z)-tetradecenoyl
1	(s)-n-(2e,7z)-tetradecadienyl-hsl
1	hsls
1	3s.
1	co-isolated
1	cvc-infected
1	(eucalyptus
1	citriodora,
1	grandis,
1	urophylla,
1	camaldulensis,
1	torelliana,
1	pellita,
1	urophylla)
1	pellita.
1	lactococcus
1	bacterial-fungal
1	(ceys),
1	flavescens.
1	stomata
1	cvc,
1	gfp-labeled
1	xanthophis,
1	nonpathogenic,
1	xylem-associated
1	xanthophis.
1	interfacing
1	(fame-midi),
1	vibrionales,
1	actinomycetales
1	bacillales.
1	(amylases,
1	lipases)
1	vibrionales
1	potato.
1	cultivar-dependent
1	rifampin-resistant
1	dipped
1	(pcr-dgge).
1	p9r,
1	p9r-specific
1	unweighted-pair
1	azotoformans,
1	veronii,
1	syringae.
1	phytosphere.
1	bacterization
1	meristematic
1	strawberry
1	fame
1	sphingopyxis.
1	petiole
1	sphingopyxis
1	shoots.
1	harnessed
1	seedling
1	strawberry.
1	(dgge),
1	orchards,
1	tenuissima
1	arborescens).
1	fingerprintings
1	39/3
1	25m
1	plots.
1	lemon
1	sustainability.
1	rhizobiales
1	(rhizobiales-like
1	eucalyptus.
1	(wt17
1	wt18)
1	(tr-9,
1	tr-15,
1	tr-22,
1	tr-23)
1	tr-9
1	pcr-dgge,
1	nontransgenic
1	wt17
1	nodulans,
1	isbiliense,
1	radiotolerans.
1	(tr-15).
1	lhcb1-2
1	(responsible
1	burkholderiales,
1	rhizobiales,
1	actinomycetales,
1	xanthomonadaceae,
1	bacillaceae,
1	mycobacterium.
1	genotype-distinct
1	dual-culture
1	seed-associated
1	life-history
1	bacillus,
1	ppagfp
1	ninety-percent
1	endophyte,
1	arb18)
1	kanamycin,
1	kanamycin.
1	otu.
1	paraphyletic
1	ananatis,
1	stewartii,
1	homaechei.
1	pantoea/enterobacter
1	heidelber
1	(xfp)
1	chromeazurol
1	csáky
1	(hydroxamate-type)
1	arnow
1	(catechol-type).
1	cas-positive
1	hydroxamate-type,
1	catechol-type
1	siderophores.
1	pantoea,
1	microbacterium.
1	pyrrolnitrin,
1	cenocepacia
1	(gv.
1	(l.)],
1	grove
1	(l.)]
1	pcr-primers
1	periwinkle.
1	doubly-
1	roseus,
1	erythricium
1	coffee,
1	rubber,
1	(sexual
1	parasexual
1	reproduction)
1	carbendazim
1	fungicides,
1	fungicides;
1	decomposition;
1	a.i.,
1	agrochemical
1	clevelandii.
1	(kp342),
1	roseus.
1	sublineolum,
1	anthracnose,
1	specialization.
1	chlorate
1	(nit
1	mutants),
1	chlorate-resistant
1	(nit1),
1	(nit6
1	niia
1	(nit3),
1	(nit2),
1	molybdenum
1	(nitm),
1	(crn).
1	10-5)
1	sublineolum.
1	worldwide-spread
1	ananatis
1	(serrano
1	1928)
1	chromatography-electron
1	(s)-(-)-n-hexanoyl-hsl,
1	chromatography-flame
1	tumefaciensntl4(pzlr4)
1	assintomatic
1	(escape)
1	(cvc)-affected
1	lightcycler®
1	[li,
1	w.b.,
1	pria
1	l.p.m.w.d.,
1	qin,
1	j.s.
1	hartung,
1	2003.presence
1	phytopathology
1	93:953-958.],
1	asiaticus.
1	(madagaskar
1	periwinkle)
1	(clevelands
1	tobacco).
1	β-proteobacteria.
1	ce-esi-ms
1	(siderophore
1	resins.
1	sheath-liquid
1	optimized,
1	100mmol/l
1	methanol:h2o
1	25:75
1	0.05%
1	liquid.
1	cze-esi-ms
1	mrof
1	1004.3
1	798.3
1	(retrotransposons)
1	transposons)
1	(transposition
1	recombination)
1	psidii
1	ibsbf
1	435t
1	rot
1	flowers,
1	guava
1	(psidium
1	guajava
1	losses,
1	[s-(-)-n-hexanoyl
1	lactone],
1	lactone.
1	antibiosis
1	β-1,4-endoglucanase
1	egla,
1	glycosyl
1	(gh9)
1	cellulose-binding
1	(cbm3).
1	5-8,
1	6-8.6.
1	50-60°c
1	glyphosate-resistant
1	plant-endophyte
1	noncultivable
1	(glycine
1	(pre-planting).
1	calcoaceticus,
1	junii,
1	burkholderiasp.,
1	gladioli,
1	sakazaki,
1	oryzihabitans,
1	straminea,
1	pickettii,and
1	sphingomonassp.
1	maltophilia.
1	oryzihabitans
1	gladioliwhich
1	crinipellis
1	(stahel)
1	(theobromacacao
1	cultivation.
1	phytopathogen,
1	acremonium,
1	blastomyces,
1	botryosphaeria,
1	colletotrichum,
1	cordyceps,
1	diaporthe,
1	geotrichum,
1	gibberella,
1	gliocladium,
1	lasiodiplodia,
1	monilochoetes,
1	nectria,
1	pestalotiopsis,
1	phomopsis,
1	pleurotus,
1	pseudofusarium,
1	rhizopycnis,
1	syncephalastrum,
1	trichoderma,
1	verticillium
1	perniciosa.
1	(gliocladium
1	catenulatum)
1	(foscarin
1	cristalina).
1	pseudomonaceae,
1	burkholderiacea
1	solubilization;
1	ripening
1	foscarin
1	(v6).
1	soybean-associated
1	ralstonia,
1	acinetobacter.
1	pr2/7),
1	(pec3.0/18,
1	pceie,
1	pgfp),
1	greenhouse,
1	pec3.0/18
1	bacteria-seed
1	gmes
1	citrus-variegated
1	[l.]
1	osbeck
1	pera).
1	blanco)
1	plate-clearing
1	pi-repressible
1	pacc
1	ph-regulated
1	μl.
1	sub-categories
1	automata
1	modeling.
1	bassiana,
1	double-auxotrophic
1	diploid)
1	non-parental
1	bassiana.
1	domesticate
1	fundaments
1	races,
1	kingdoms
1	debates
1	mycorrhizal
1	microbiota)
1	haploidization,
1	crossing-over,
1	leaf,
1	midrib
1	'pera'
1	'murcott'
1	tangor
1	cvc-causing
1	xylella-citrus
1	cvc-resistant
1	quickly.
1	cvc-affected
1	cultivation-independent
1	radiotolerans,
1	zatmanii),
1	campestris.
1	reticulata)
1	sweet-orange
1	nonculturable
1	penicillin-g.
1	(citrus,
1	grapevine),
1	penicillin-g
1	sulfur-containing
1	desulfurizing
1	sulfurous
1	dibenzothiophene
1	(dbt)-containing
1	(fsl
1	soil)
1	utilizers,
1	(pcr-dgge),
1	desulfurization
1	dszc.data
1	degraders
1	affiliation.
1	unpolluted
1	dbt-utilizing
1	petroleum.
1	dszb-related
1	dsza-
1	dszc-related
1	sulfur-free
1	erythropolis.
1	dszb
1	desulfurize
1	dbt.
1	igts8)
1	igts8
1	disinfected
1	rootstocks.
1	lentus,
1	agglomerans.
1	insects-pests
1	grasses
1	(gsh),
1	(pco)
1	twice),
1	(85%),
1	(70%).
1	unacceptably
1	anti-senescence
1	klotho-haploinsufficient
1	(clp-
1	levels),
1	heart-rate
1	haploinsufficient
1	exploratory,
1	if.
1	malfunction
1	(fcx),
1	(s14
1	1d),
1	(s14),
1	fcx,
1	wnt-β-catenin
1	creb/bdnf
1	eaat4
1	ouabain-mediated
1	fgfr1,
1	monocarboxylic
1	klotho-induced
1	(nka),
1	5d)
1	challenge.objectives:
1	hyperphosphatemia,
1	transtheoretical
1	(tmbc).subjects
1	hypophosphatemia.
1	tmbc
1	post-intervention.results:
1	literacy.
1	117/179
1	300pg/ml
1	reductions,
1	literacy
1	co-receptor
1	fgf23,
1	α-klotho.
1	kl-vs
1	consider.
1	tryptases
1	mbsa/il-1β.
1	sperm-associated
1	(hspag11b/c),
1	apc366.
1	-6,
1	-17a
1	cxcl1/kc,
1	spag11c
1	phspag11b/c
1	apc366
1	cxcl1/kc.
1	hyaline
1	subchondral
1	mbsa/il-1β-induced
1	lentivirus-based
1	patency,
1	high-efficiency
1	(guarulhos,
1	1:1:1
1	anticoagulant/chelation
1	(m-edta)
1	(tsc)
1	hfor
1	allocation.
1	(18/23)
1	(4/22)
1	(2/23)
1	methyllycaconitine
1	(mla;
1	(meca;
1	α7-
1	αxβy-containing
1	quintas,
1	(a1-4).
1	neuron-specific.
1	hemiplegic
1	(fhm2),
1	rapid-onset
1	dystonia-parkinsonism
1	(rdp)
1	hemiplegia
1	(ahc),
1	areflexia,
1	pescavus,
1	sensorineural
1	(capos)
1	amyloid-β.
1	nka-associated
1	cabral-costa,
1	mazucanti,
1	kawamoto.
1	hormones/glucocorticoids
1	cardiotonic
1	k+-
1	(nka).
1	cts.
1	cts
1	(rhm)
1	(roughly
1	40 %).
1	34 %).
1	yshii
1	aα-synuclein
1	(aα-syn)
1	pre-synaptic
1	(nf-κb
1	prospero:
1	crd42015020829
1	low-calorie
1	aging-associated
1	mechanistic)
1	(sirt)
1	insulin/insulin
1	(iis)
1	sirt
1	iis
1	inflexibility.
1	gramnegative
1	infection/inflammation.
1	hypozincemia,
1	alternations,
1	hypozincemia
1	lepsch
1	jacqueline
1	leite
1	nfb
1	glutamate-nitric
1	α1,α2,3
1	3-nitrotyrosine-containing
1	α2,3-na,k-atpase
1	(ups),
1	mi-induced
1	hyperactivation,
1	branded
1	(genzyme
1	manufacturer)
1	(ems
1	manufacturer).
1	(cdk
1	5d),
1	4-hour
1	mid-week.
1	phosphate-binder
1	obstipation
1	gbr
1	12909
1	reuptake),
1	anesthetic),
1	(brain-derived
1	(ckd),
1	c57/bl-6
1	(animals
1	(mice
1	tld
1	examined.resultsadenine-fed
1	foreign-body
1	mac-2-
1	infiammatory
1	era-edta.
1	acid-reactant
1	alzheimer's,
1	disappointing,
1	(tnfr2)
1	tnfrs.
1	(pc12
1	3-nitropropionic
1	(aβ25-35;
1	6-15%
1	1-/-)
1	endothelial-dependent
1	endothelial-independent
1	relaxating
1	endothelial-mediated
1	patterning,
1	surviving.
1	valproate
1	intensify
1	parthenolide,
1	parthenolide);
1	ed1
1	(macrophages/monocytes)
1	medullae.
1	emsa.
1	cisplatin-injected
1	parthenolide.
1	secosteroidal
1	(intestine
1	lungs)
1	reperfusion-associated
1	il-10-enhancing
1	ru486.
1	secosteroids
1	(i.p.)]
1	novelty-induced
1	factor-κbα
1	co-factor.
1	anti-il-10,
1	parasite-induced
1	l.(l.)
1	overriding
1	enzymeimmunoassay,
1	3h-arginine
1	3h-citruline
1	clomipramine,
1	(p<0.005).
1	clomipramine.
1	[3h]l-citrulline
1	iu/day,
1	psychopharmacology
1	40's,
1	neuroimage
1	psychotropics,
1	potassium-activated
1	atpase).
1	(camp).
1	(pkg),
1	cgmp-
1	oxide-generating
1	n(ω)-
1	nitro-l-arginine,
1	k-atpase.
1	α3-na,k-atpase
1	neuron-deficient
1	8-br-cgmp,
1	mgiurs.
1	excitability),
1	excitotoxicity).
1	excitability,
1	no-containing
1	atriopeptin,
1	nonrenal
1	monoamines.
1	glial)
1	reuptake.
1	improvements,
1	cocaine-inhibitable
1	synaptosomal-containing
1	insecticidal
1	coca
1	octopaminergic
1	amine-reuptake
1	(lf),
1	(lsb)
1	lsb.
1	lsb
1	lf.
1	subsensitivity
1	(rsb).
1	rsb
1	homovanilic
1	α-methyl-p-tyrosine
1	(α-mpt)
1	stereotypy,
1	α-mpt
1	[3h]haloperidol
1	[3h]dihydroergocriptine.
1	non-amphetamine
1	lipogenesis/lipolysis
1	(apoptosis/adipogenesis)
1	(inguinal;
1	(retroperitoneal;
1	rp)
1	(6-wk
1	50–60%
1	capacity).
1	9.48%
1	(srebp)-1c,
1	(pparγ),
1	receptor/insulin-like
1	(ir/igf1r)
1	ir/igf1r
1	(intraperitoneally
1	[intraperitoneally
1	solution]
1	territories.
1	tissue-renin-angiotensin
1	(3ace)
1	carcasses,
1	(v˙
1	(1ace)
1	(retroperitoneal
1	11-hydroxysteroid
1	(11βhsd1)
1	26,8%
1	hypercortisolism.
1	ketosis
1	β-hydroxybutyrate
1	(βhb)
1	ketonemia.
1	ketonemia,
1	adiponectinemia.
1	administrations,
1	ldl/hdl
1	hdlc
1	ketosis.
1	(aliskiren,
1	b-adrenergic
1	-60%
1	responsiveness),
1	aliskiren
1	(+49%
1	and+292%
1	young—14 weeks
1	old—and
1	middle-aged—16 months
1	d-[u-<sup>14</sup>c]-glucose,
1	d-[u-<sup>14</sup>c]-lactate,
1	[9,10(n)-<sup>3</sup>h]-oleic
1	(fasting
1	(pe
1	(+50 %)
1	beta-adrenergic-stimulation.
1	(+62 %)
1	34 %
1	(+90
1	82 %,
1	(+100
1	11 %,
1	streptozotocininduced
1	puppies
1	weighted.
1	co<inf>2</inf>,
1	fromoffspring
1	vitrowas
1	(detrained),
1	(34.55%)
1	dyslipidaemia
1	outburst
1	prolific
1	(lipolysis,
1	(ap2-b1/b1-/-).
1	(sga).
1	propensities
1	olanzapine,
1	antipsychotic
1	haloperidol,
1	clozapine,
1	adscs
1	adscs.
1	haloperidol-mediated
1	(ptld)
1	(ebv)
1	single-center
1	transplantations
1	(13/242
1	survivors;
1	5.4%).
1	47),
1	ebv-naïve
1	(92.3%),
1	(69.2%),
1	waldeyer
1	(23.0%),
1	(30.7%),
1	adenopathy
1	(15.3%),
1	(30.7%).
1	gancyclovir
1	anti-cd20
1	53.8%.
1	pancytopenia,
1	(10-3m).
1	swiss-3t3
1	(tet-off
1	(swiss-lap
1	preadipocytes,
1	promoter/reporter
1	c/ebpβ.
1	normal-
1	(3.12%
1	na+;
1	hs),or
1	(2dgu)
1	-[u-14c]-glucose
1	14co2.
1	2dgu
1	metabolization,
1	marketing
1	surgeons,
1	easiest
1	high-yield
1	(cfus)
1	92+/-
1	exclusion,
1	eagle
1	7,2
1	1,3
1	milliliter
1	liposuctioned
1	confronted
1	(ns;
1	na+),
1	3.12%
1	+),
1	(ls;
1	na+)
1	bp;
1	masses;
1	size;
1	naaso.
1	(hyperglycemia,
1	tolerance)
1	prediabetic
1	(5-day
1	2-deoxy-d-[3h]glucose
1	14co2;
1	endocrinal
1	atherogenetic
1	explanatory
1	lypolisis,
1	(leptin)
1	(tnf-alpha,
1	adiponectin).
1	(adipogenesis),
1	(myoblasts,
1	chondroblasts,
1	osteoblasts),
1	not-too-distant
1	widened.
1	(obesity,
1	arteriosclerosis)
1	enemy.
1	(lvm),
1	(km),
1	(lsd)
1	(lhsd)
1	(hlsd).
1	pathophysiologic
1	rebuilding
1	arteriosclerosis,
1	dislipidemias
1	preoccupying
1	adipogenesis,
1	(205
1	26.4
1	pl;
1	(0.24
1	0.049
1	pmol/cm2;
1	(1.57-
1	2.38-fold;
1	irs-1/phosphatidylinositol
1	(pi3)-kinase
1	irs-2/pi3-kinase)
1	(2.06-
1	3.15-fold,
1	irs/pi3-kinase/akt
1	150-200
1	(~1.8
1	(~3.8
1	(cafeteria
1	5-fold,
1	overfeeding.
1	overfeeding
1	(0.15%
1	(7.94%)
1	(146
1	0.23)
1	ec50from
1	0-15
1	deoxy-d-glucose
1	~70%
1	udp-glucose,
1	glucose-6-phosphate)
1	(i-plus
1	d-form)
1	niddm,
1	msg-obese
1	(pmol
1	fmol
1	(31.2
1	(72.6
1	101.0
1	250%
1	hyperinsulinemic.
1	synthetize
1	sub-sequent
1	restimulate
1	ligand-
1	concentrations),
1	ed50for
1	116%
1	ed50value
1	ed50by
1	183%.
1	coregulation
1	(confirming
1	observation).
1	postbinding
1	desensitization,
1	glu4-tyr1by
1	acti-vated
1	histone-2b
1	cellulo
1	ppl80
1	coupling),
1	ligand-bound
1	glucose/insulin-induced
1	noninsulin-dependent
1	kinase-independent
1	(<50%)
1	cho-b
1	(~75%),
1	57-59%
1	dexamethasone’s
1	dexamethasome
1	cyclo-heximide-treated
1	4-fold.
1	adipocytes:
1	dexamethasone-mediated
1	hypercortisol-ism.
1	feeding/22
1	(n=38)
1	(n=34)
1	6.3±0.4
1	4.8±0.3
1	(0.14±0.02
1	(0.44±0.10
1	steeply
1	invarient
1	went
1	unlocks
1	replenishment
1	single-meal
1	inter-meal
1	ingested.
1	nocturnal)
1	hours);
1	long;
1	d,l-,
1	d-tc
1	emptyinh
1	l-tc
1	d,l-tc.
1	effectice
1	d-isomer.
1	dl-,
1	l-isomer.
1	gastroenteric,
1	hexons
1	anti-hexon
1	41.
1	(41)
1	(hadvs)
1	2-27%
1	fortaleza,
1	(hvr1-hvr6).
1	hadv-b,
1	-c
1	dodecahedron
1	five™
1	'site-specific'
1	(hadv-7)
1	(ard).
1	7a-7l.
1	ard
1	wheezing,
1	hadv-7,
1	7p
1	(gomen).
1	7m.
1	7m
1	7p.
1	1743
1	16.1k,
1	19k,
1	20.1k
1	20.5k
1	orfs.
1	hadv-positive,
1	hrsv-positive
1	single-target
1	washes.
1	.0001
1	.008,
1	2.7;
1	.03).
1	(em),
1	p/.
1	(sa-11)
1	(belisa)
1	(hia)
1	anti-vp2,
1	anti-vp4,
1	anti-vp6,
1	anti-vp7
1	(iba).
1	6-to
1	(iba),
1	vp7.
1	'immune,'
1	ant-vp6
1	'partially
1	immune.'
1	'nonimmune.'
1	identificate
1	identificated
1	ad3,
1	ad3
1	one‐year
1	(el‐ara)
1	(ad40/41)
1	(3/7)
1	(5/9),
1	hek‐293
1	seroneutralization
1	av‐7‐d5
1	diarrhea),
1	av‐1‐d10
1	case),
1	av‐31‐d2
1	av‐12‐d7,
1	untyped.
1	av‐41‐d1.
1	(barley
1	beer).
1	steeping,
1	(62%,
1	51.5%,
1	zen,
1	rootlets
1	consumers.
1	posting
1	[2,
1	3],
1	[1,2].
1	b.1.“btk
1	b.2.
1	“fv
1	b.1.
1	“btk
1	experiment.(graph
1	presented).flow
1	.fcs
1	[3]
1	apply.
1	ochrochloron,
1	sossego
1	mine,
1	copper-contaminated
1	canaã
1	20 min.
1	200 mg/l.
1	0.2 g
1	0.5 g
1	50 ml
1	7.53 mg/g
1	75.0%.
1	freundlich
1	ochrochloron
1	trichothecenes
1	(ef-1α
1	rpb2).
1	lc-ms.
1	sambucinum
1	tricinctum
1	(zea)
1	(90.6%
1	87.5%,
1	ecophysiology
1	(0.90,
1	0.99)
1	tas1,
1	(587.8
1	(440.5
1	tas1
1	grain-mold
1	sorghina.
1	beverages.
1	(hordeum
1	ingredients
1	(zen)
1	76)
1	73.6%,
1	1700
1	7500 μg/kg
1	630 μg/kg,
1	don,
1	nanoparticle
1	sustainable,
1	cost-effective.
1	photoelectric
1	electronics,
1	versatility,
1	oxides
1	metal/oxide
1	(core-shell)
1	post-harvest,
1	parboiled
1	pre-harvest
1	post-harvest
1	90.56
1	126.31
1	stipulated
1	commission.
1	biodeterioration
1	librarians
1	supercritical
1	(scco2)
1	scco2
1	pieces:
1	processing)
1	294
1	eurotium
1	amstelodami
1	derivated
1	cobalt-60,
1	(49.0 mg g−1).
1	11.0 nm,
1	capped
1	nanobiosorbent.
1	(s3),
1	87.4%
1	(s4),
1	sorghina
1	s2,
1	1234
1	µg/kg.
1	rots.
1	(2b710hx,
1	30f35yg,
1	2b710,
1	30f35,
1	2b710hx
1	30f35yg
1	field;
1	fumonisin-producing
1	(ffsc),
1	fum15
1	silking
1	/fb
1	beers.
1	89.6%
1	93.3%
1	beer,
1	adjuncts.
1	bertholletia
1	excelsa
1	0.273
1	0.994.
1	1052
1	(20.5%)
1	37.25 mg/kg;
1	(0.08 mg/kg);
1	(78.5%)
1	nigri,
1	(uspmtox48).
1	(icb-01,
1	icb-151,
1	icb-165)
1	25 °c
1	(aflr
1	afls),
1	(aflh,
1	aflp),
1	(maoa,
1	pks-nrps).
1	icb-151
1	(77.11%)
1	aflh
1	(32.75%),
1	cpa-producing
1	icb-161
1	maoa
1	(63.72%),
1	(43.52%),
1	(42.63%).
1	icb-01
1	(47.79%),
1	(42.77%),
1	(39.5%),
1	(38.02%).
1	icb-198
1	(hops).
1	productive,
1	durability
1	hops.
1	api-zym
1	speed.
1	aplications:
1	kernels.
1	(γ-oryzanol,
1	neem
1	bran)
1	barley.
1	fungicides.
1	γ-oryzanol,
1	graminearum.
1	tri5
1	diametric
1	(aflr,
1	afld,
1	laea).
1	(icb-1,
1	icb-12,
1	(icb-141,
1	icb-198).
1	(15,803.6
1	icb-54).
1	0.10).
1	laea
1	(icb-54).
1	parana,
1	microdochium
1	nivale
1	isolated:
1	meridionale
1	cortaderiae
1	austroamericanum
1	706
1	70.9
1	57.9
1	parana.
1	tralamazza,
1	braghini
1	corrêa.
1	(fgsc)
1	fgsc
1	3-adon.
1	nanobiotechnology
1	(hrtem),
1	(afm),
1	superconducting
1	(squid).
1	nanobioremediation
1	barroso,
1	ferreira-castro,
1	michelotto
1	correa.
1	thuringiensis)
1	yg,
1	(30f35
1	2b710)
1	(fb1
1	fb2)
1	fum15,
1	hybrids;
1	(nps),
1	nanobiotechnology.
1	biosorption.
1	nanomaterials,
1	93%.
1	0.80.
1	53.32
1	65.66%,
1	70.61
1	84.15%
1	10-kgy
1	5-kgy
1	(fb<inf>1</inf>)
1	cereal,
1	(hplc-fl).
1	10<sup>3</sup>cfu
1	phoma,
1	958
1	4,906μg
1	kg<sup>-1</sup>.
1	koningiopsis.
1	koningiopsis
1	(xps).
1	21.1
1	local.
1	aculeatus
1	(afm).
1	5.89
1	rochaet
1	rpm.
1	(xps)
1	nano-adsorbent
1	feedstuffs,
1	mycotoxicoses,
1	mycotoxicosis.
1	excelsa),
1	non-timber
1	importers
1	(74.4%),
1	(12.7%).
1	a.flavus
1	(afb),
1	22.85%
1	a.nomius
1	afg
1	supermarkets
1	package
1	eighty-eight
1	(83.8%)
1	(634,
1	703,
1	1269
1	1876
1	legislative
1	constantly.
1	wastewater,
1	dead,
1	rpm
1	accountable
1	forest:
1	extrolites,
1	heat-resistance
1	(75.5%),
1	(22.3%),
1	(2.2%).
1	(cpa).
1	(92.7%)
1	excelsa)
1	37,000
1	tons
1	(3.36
1	107kg)
1	shells)
1	[aflatoxins
1	(afs),
1	acid]
1	60.0%
1	74.3%
1	peanuts.
1	cottonseed,
1	pistachio,
1	peanut,
1	liabilities.
1	(afls)
1	immunosuppressive.
1	self-incompatible
1	(hsi)
1	nonutilizing
1	(nit)
1	hsi.
1	nuts,
1	amds
1	omta
1	d-glucosamine,
1	region:
1	flavus-parasiticus
1	(16%),
1	8μg/kg,
1	(9.5%)
1	almonds.
1	98.65
1	161.2μg/kg.
1	hose
1	(flasks
1	flavus);
1	verticillioides);
1	+weevil),
1	+weevil).
1	posteriorly,
1	carcinogenic.
1	polymorphic.
1	91.7%
1	83.9%
1	wageningen
1	(afm1)
1	hepatocarcinogen
1	manufacture:
1	starter,
1	starter.
1	30.64%
1	42.26%.
1	afm1.
1	cheese,
1	commodities.
1	aflatoxin-producers,
1	52.8%
1	aflatoxigenicty,
1	7282
1	knpv.
1	(husks
1	(13.4%).
1	12.7μg/kg,
1	117.8μg/kg.
1	tupã
1	uprooting
1	rhamdia
1	quelen
1	4.2±0.1,
1	5.2±0.1,
1	6.3±0.1,
1	7.2±0.1,
1	8.0±0.1,
1	9.0±0.1
1	7.0-7.6),
1	phytoalexin
1	(trans-resveratrol)
1	(runner
1	caiapó)
1	(rainfall,
1	pods,
1	varieties,
1	variety.
1	(61.8%)
1	helminthosporium
1	(33.4%).
1	368.78
1	0.58.
1	"life
1	cycle"
1	non-autonomous,
1	copies)
1	euchromatic
1	toxicokinetics
1	5mgfb1/kg
1	96h.
1	post-intoxication.
1	bilirubin,
1	36h
1	2h,
1	282μg/ml.
1	0.93%
1	75min
1	41h
1	(561μg/ml)
1	84h
1	(peumus
1	boldus,
1	ilicifolia,
1	cassia
1	angustifolia)
1	drugstores,
1	wholesale,
1	open-air
1	(gammacell)
1	(aoh),
1	7 kgy,
1	(98.5%)
1	(99.9%)
1	5 kgy,
1	(fb1,
1	(afb1,
1	afb2,
1	afg2)
1	74.5%
1	fb2,
1	9.67
1	3.16
1	fb2.
1	(10.5%)
1	afg2.
1	co-contamination
1	odessa
1	irradiated),
1	(1×106
1	spores/ml)
1	drbc
1	dcma
1	alternata.
1	630
1	dosing,
1	enterohepatic
1	(sphingosine-so
1	sphinganine-sa)
1	(fb1).
1	(arachis
1	hypogaea
1	vital,
1	maturity.
1	hull
1	218.52
1	g/kg.
1	4.20 μg/kg
1	198.84 μg/kg
1	260 μg/kg
1	600 μg/kg.
1	preharvest
1	(hulls
1	tupã,
1	(67.7%
1	(10.3%
1	21.8%
1	kernels),
1	15-23.9
1	3.3-5.6
1	μg/kg);
1	7.0-116
1	28.3%
1	3.3-45.5
1	afb2.
1	silks.
1	t1,
1	t2,
1	t5,
1	non-sprayed
1	silks,
1	t2.
1	(nitrogen,
1	boron)
1	sowing.
1	rose-bengal
1	24.3
1	marked.
1	fluorecein
1	bromide-eb.
1	(97.5%)
1	cupana)
1	pharmacies
1	street
1	brewery
1	by-product,
1	transportation.
1	"reconcavo
1	baiano".
1	(72.5%)
1	226.5
1	50.30
1	908.47
1	trimester,
1	"recôncavo
1	baiano"
1	(bahia,
1	(42.5%),
1	mucor,
1	ochratoxins,
1	33.75%
1	(27/80)
1	-day
1	periods)
1	shell.
1	200,μg
1	1/kg+
1	aflatoxin,
1	consumers'
1	thermoresistant
1	inoculate
1	autoclave
1	(gibberella
1	(spar-pcr).
1	mat-2
1	(g.
1	spar
1	mat-1:mat-2
1	5:17
1	14:7
1	(aoh)
1	(49.9%),
1	(47.7%)
1	(10.9%).
1	(24.9-170.9
1	(14.1-108.6
1	ng/g).
1	belém-pa,
1	reservoir's
1	aphanizomenon,
1	nostoc,
1	oscillatoria,
1	planktothrix
1	30.8%
1	microcystis
1	aphanizomenon
1	gracile
1	coelomoron
1	pusillum
1	4.22
1	fernandoi.
1	traded
1	(fb2).
1	(0.5-7.2
1	(0.1-1.8
1	μgkg
1	weight-1
1	manufacturers
1	batteries
1	cages,
1	applied:
1	necropsied.
1	2450
1	fb1/kg.
1	afb1-treated
1	infiltrates.
1	agglomeration,
1	excreta
1	fb1-treated
1	97-99%
1	0.88-0.94.
1	gram,
1	(rice
1	culture),
1	12.00
1	3282.50
1	5.38
1	(91.5%)
1	(fb1);
1	(afb1);
1	afb1;
1	b2a
1	aflatoxicol
1	(afl)
1	afb1kg-1
1	afb1kg-1.
1	0.03-0.37
1	0.01-1.03
1	0.01-0.03
1	(afl).
1	cellophane
1	wrapping
1	esterilized
1	petri
1	slide,
1	fleshly
1	germination;
1	hyphae;
1	arthroconidiae.
1	(spc714)
1	non-axenic
1	microcystin
1	asm-1
1	25±1°c,
1	irradiance
1	20μmolphotonm
1	-2s-1
1	aeration.
1	ld100
1	hepatotoxicity.
1	hplc-dad
1	microcystins,
1	3.83
1	neutered
1	f:
1	number;
1	hematocrit;
1	bilirubin;
1	aminotransferase.
1	aumented
1	organ/body
1	(hearth,
1	bimonthly
1	(zea
1	mays
1	(1008
1	(moulds
1	yeasts)
1	g-1)
1	(freshly
1	harvested)
1	0.74-22.6
1	0.81-23.7,
1	postharvest
1	harvesting/predrying
1	preto.
1	55.5%
1	0.70-0.80.
1	(0.09-10.87
1	(fb2)
1	(0.05-0.52
1	μg/g);
1	(0.11-17.69
1	61.3%
1	(0.05-5.24
1	7-wk-old
1	(afb1)/kg
1	afb1/kg.
1	vacuolation
1	afb1-contaminated
1	(ynb)
1	triplicate.
1	anion-exchange,
1	end-capped
1	(c18
1	ec)
1	silicas
1	clean-up.
1	cartridges.
1	unattended
1	refuel,
1	clean-up,
1	o-phthaldialdehyde
1	derivatization,
1	integrator
1	(n=3)
1	88.3%
1	(rsds)
1	5.04
1	6.22%,
1	rsds
1	5.84
1	7.88%
1	(s/n=3)
1	1-0
1	bw.;
1	2-72
1	3-0
1	4-0
1	5-72
1	6-72
1	bw.
1	absolute/relative
1	(2.79
1	(130.35
1	μ/l
1	471.00
1	μ/l,
1	singly.
1	(grain
1	(42.7%),
1	(25.0%),
1	(21.4%)
1	cfu/g,
1	moniliforme.
1	7-33
1	74.2%
1	0.11-0.15
1	(assis,
1	preto)
1	20.2%.
1	(40)
1	2168
1	615
1	30.750
1	tyrophagus
1	grain.
1	30°c)
1	15.4
1	16.9%,
1	0.89.
1	cfu/g),
1	23.7
1	moist
1	manufactory
1	mycoflora.
1	(71.7%),
1	(28.3%),
1	absidia
1	(26.7%),
1	mucor
1	(1.7%),
1	crysosporium
1	11.0%
1	24.6%
1	0.61,
1	pergram
1	memoriam
1	cotia,
1	itupeva)
1	(june
1	(67.7%;
1	moniliforme),
1	(58.3%;
1	flavus)
1	(52.0%),
1	(fusarium
1	(aspergillus
1	3.1x
1	(penicillium
1	(46.1%)
1	(14.6%)
1	287μg/kg
1	carryover
1	kaempherol,
1	quercitin,
1	(nrrl6513)
1	erlenmeyer
1	yes
1	photodensitometry.
1	(60.5%),
1	kaenepheritrin
1	kaempherol
1	(40.0%).
1	quercitin
1	(36.0%
1	(99.0%)
1	b1(afb1)
1	each:
1	intraperitonealy
1	ml/g)
1	(6.20
1	strains's
1	biotransform
1	c57/b1/6
1	ml/g),
1	ng/g),
1	leukoencephalomalacia
1	(elem)
1	97.4%
1	35.9%.
1	82.0%.
1	toxicosis,
1	be),
1	neurocryptococcosis.
1	df-be
1	scopulariopsis
1	(oxoid),
1	intercalar
1	chlamydoconidia-like
1	standing,
1	peptone,
1	e.d.t.a.,
1	aerobiosis
1	bromide-eb-solution)
1	(miles
1	misra
1	(student's
1	non-dimorphic
1	castro,
1	bavia,
1	granados-martinez,
1	vasconcellos
1	(lpf).
1	(c1inh)
1	masps
1	(nald)
1	nald.
1	ten-week
1	(hfdg)
1	hepatomegaly,
1	centro-lobular
1	tfg-β
1	eight-
1	ten-week-old
1	b6c5+
1	equicaloric
1	(hfdm)
1	(tg
1	cholesterol),
1	tgf-β)
1	9-year
1	brother.
1	(3450-3549)
1	ted
1	(nucleotides
1	6690313-6690961)
1	6690626
1	classical,
1	(93%)
1	(c1q,
1	c1r,
1	c1s,
1	c2)
1	lorena
1	bavia
1	hfdm-fed
1	hfde-induced
1	toxoids,
1	abnormal,
1	nuanced
1	c5-normal
1	backcrossing,
1	preferred.
1	c5-,
1	c5-
1	a/j).
1	c5-dependent
1	background:it
1	cd59-like
1	strategy.methodology/principal
1	findings:herein,
1	hcd59
1	three-fingered
1	(tfpd).
1	cercaria
1	surface-localized;
1	complement-resistance
1	rnai.
1	activation.conclusions:our
1	tfpd
1	intra-parasite
1	(fd),
1	creactive
1	nephelometry.
1	amd.
1	(y402h)
1	56.30%
1	36.51%
1	(1277cc
1	36.98%,
1	38.65%
1	24.37%
1	1277cc
1	13.16%,
1	46.71%
1	40.13%
1	4.63,
1	american.
1	(dbss)
1	269
1	janzi
1	4-year-old
1	fh.
1	fhl-1
1	g453a
1	mother,
1	arg127
1	(sle).
1	undetectable,
1	parents'
1	(c3,
1	masp-2)
1	938
1	males:27
1	5-17
1	9%):
1	(ig),
1	(turbidimetry);
1	(cph
1	(10/33)
1	(23/33)
1	cph,
1	aph,
1	9/33
1	8/20
1	anaphylotoxin
1	rnrna
1	substitution;
1	p577,
1	s798
1	a1437;
1	r848ster
1	nonsense-codon-mediated
1	(neonates:
1	month-1
1	adults:
1	(c4
1	bp),
1	(<50
1	199-532
1	1204
1	1205
1	nonsense-mediated
1	welcome,
1	cross-react
1	(5067
1	972;
1	t→c
1	1001
1	transition;
1	1716.
1	paternal
1	dnas.
1	∼20-fold
1	eldest
1	(20-year-old)
1	auto-immune
1	micro-organisms,
1	8-year-old
1	(l.a.s.)
1	autoradiographs
1	35s-labelled
1	c3b),
1	proband.
1	(alpha2m)
1	lipopolysacharide,
1	thioglycollate,
1	guerin,
1	electroimmunoassay.
1	(18.60%)
1	(27.90%).
1	ppd.
1	fulfilling
1	thioester-region
1	precluded,
1	convertase,
1	c4b2a,
1	c3(h2o)
1	aminolysis
1	re-form
1	c3(h2o),
1	alternative-pathway
1	convertase.
1	c3(nh3)*.
1	e1012q.
1	cleavability
1	permissible
1	opsonins.
1	defatted
1	anton
1	(my43)
1	fcα
1	fcαr.
1	opsonins,
1	α2-macroglobulin.
1	thioester-forming
1	italics:
1	1005v-t-p-s-g-c-g-e-q-n-m-i-g-m-t-p-
1	t1021.
1	g1009
1	category,
1	p1007g,
1	p1020g,
1	e1012q,
1	q1013n,
1	autolytic
1	thioester-intact
1	(c4b2a),
1	thioester-
1	c3(h2o).
1	subagglutinanting
1	α2m,
1	(a2m),
1	immunomodulator,
1	125%,
1	300%,
1	galactosylated
1	asialoerythrocytes.
1	parasite-cell
1	epi-and
1	ruffling,
1	oxygen-independent
1	10-11%
1	clarifies
1	sedentarism,
1	lipopolysaccharides,
1	hand),
1	caffeic
1	literature;
1	effects).
1	(vdr),
1	contexts,
1	contributions,
1	circulation;
1	atrophy;
1	irreversible,
1	influenced,
1	(wsc;
1	n = 7)
1	(n = 9).
1	(972.914).
1	stat-3,
1	ifn-α,
1	multiplex.
1	ifn-α;
1	gcsf
1	il6r
1	(pre-dm)
1	early-reversible
1	mexican
1	565)
1	(adipoq
1	rs2241766,
1	rs9997745,
1	rs1800588,
1	pparg
1	rs1801282
1	rs8192678)
1	ascl1
1	3.39,
1	snp*bmi
1	1.10,
1	pre-dm,
1	biondo,
1	batatinha,
1	alonso-vale,
1	oyama,
1	seelaender
1	neto.
1	5'-adenosine
1	monophosphate-activated
1	chemotherapy-induced
1	c57/bl6
1	(dx),
1	(dx
1	met).
1	–cp);
1	(csf),
1	(ccla),
1	(tp),
1	(tsf),
1	(tcla).
1	(ppar-alpha),
1	(apob),
1	tcla
1	umbrella
1	anorexia-related
1	address.
1	(wsc).
1	carcinosarcoma).
1	epidydimal
1	(atgl),
1	identification-58
1	(cgi-58),
1	(tnf-alpha).
1	ic,
1	profound,
1	ltd/university
1	(grs)
1	608)
1	(fmp),
1	(me).
1	grs*physical
1	(adrb2
1	rs1042713,
1	rs512535,
1	rs361525,
1	rs7832552
1	rs16892496)
1	rs512535
1	rs361525
1	fmp.
1	grs.
1	grs
1	highlighted,
1	microarchitectural
1	re-arrangement,
1	weight-losing
1	signing
1	consent
1	21).
1	alpha-smooth
1	(αsma),
1	fibroblast-specific
1	(fsp1),
1	αsma
1	fsp1
1	(20-fold)
1	myofibroblasts;
1	tetrachloride
1	(ccl
1	hepatotoxin,
1	(pao)
1	hepatoprotective
1	handmade
1	coldpressed
1	cold-pressed
1	4 × 107
1	(300 mg/kg
1	weight/day;
1	(water;
1	pl)
1	(n = 6),
1	40 days,
1	(ct;
1	n = 6).
1	30 %
1	(p = 0.03),
1	(p = 0.65).
1	(p = 0.096).
1	(p < 0.0001).
1	(p = 0.0007
1	p = 0.004,
1	(p = 0.03)
1	(p = 0.001).
1	(p = 0.03
1	p = 0.0007,
1	(p = 0.08).
1	(p = 0.07).
1	ck-creatine
1	(scat)
1	n=11),
1	n=9)
1	(non-cancer)
1	<25kg/m2.
1	wsc.
1	scat.
1	(cd)68
1	(egcg)
1	(cw)
1	(hfw)
1	(hfe).
1	ml/day)
1	hfw
1	(homa-ir);
1	(ogtt)
1	hfe
1	ogtt
1	irα
1	(egcg),
1	egcg,
1	(ret)
1	placebo-fed
1	normolipidic
1	nf-κbp50,
1	nf-κbp50
1	mcp-1),
1	(iκb-α).
1	non-cachectic).
1	iκb-α)
1	rodolfo
1	gonzalez
1	discuss,
1	curated,
1	s˜ao
1	privacy,
1	security.we
1	illustrative
1	endeavor.
1	catalogue
1	xmdd
1	philosophy,
1	sketch
1	dywa
1	jabc
1	(concurrent
1	(tv)
1	tv
1	hypothalamic-
1	pituitary-adrenocortical
1	circumstance.
1	throught
1	nonpharmacologic
1	(tb,
1	(rttb,
1	climbed
1	8weeks.
1	6thweek
1	(3×107
1	310.8±9.8g),
1	288.3±4.9g).
1	(0.28±0.9mmol/l)
1	(0.57±0.1mmol/l).
1	(1.31±0.12mmol/l)
1	(1.13±0.7mmol/l)
1	(1.07±0.07mmol/l).
1	(577±131ng/ml)
1	(254±41.3ng/ml)
1	(221±23.1ng/ml).
1	(23μg/ml)
1	(11μg/ml).
1	(5.95pg/μg),
1	(3.64pg/μg)
1	(2.91pg/μg).
1	(7.18pg/μg)
1	(4.63pg/μg)
1	(3.8pg/μg),
1	(4.4pg/μg)
1	(3.2pg/μg)
1	(1.2pu/μg).
1	"chaos"
1	(11.4-fold)
1	(5-fold)
1	fábio
1	models;
1	symptom.
1	256).
1	animals/each
1	(pparg)
1	(cebpa)
1	(srebf1)
1	perilipin.
1	(f4/80,
1	mif-1α)
1	cachexia)
1	lipid-storing
1	'fat-reducing
1	effect'
1	debate,
1	resolution-related
1	venue
1	(160-250
1	(mi-ct,
1	(mi-ct)
1	11.8%
1	cpt-i,
1	cpt-ii,
1	(fabp;
1	(lpl;
1	(nmol·min-1·mg
1	83%).
1	hi-it,
1	"time-efficient"
1	impinged
1	small-volume
1	(tr,
1	program)
1	tomography)
1	(post2),
1	(post6)
1	pre,
1	post6,
1	post6.
1	(pre
1	-0.72)
1	tr.
1	(cn),
1	(fat/cd36),
1	(ppar-alpha)
1	(octn2)
1	(150%)
1	l-carnitine,
1	hyperlipidaemia,
1	hypertriglyceridaemia,
1	hypercholesterolaemia.
1	factors.attention
1	ikk/nf-κb
1	cachexia.in
1	therapeutically.
1	anorexiacachexia
1	(pc
1	mca-sarcoma-bearing
1	mg/kgbw/d;
1	(equal
1	volume;
1	.01
1	cytokines'
1	.02).
1	anorexiacachexia,
1	ml/100cm2
1	respecting
1	2cm
1	80ml/min.
1	observation)
1	(kic),
1	kic
1	strength),
1	sports.
1	conditions)
1	contributory
1	archer
1	shoot
1	arrow
1	gesture
1	(indoor
1	outdoor).
1	handgrip
1	events(34°c
1	60%).
1	(∼115%
1	cho.
1	[triglycerides
1	(hdl)-cholesterol,
1	(ldl)-cholesterol,
1	tg/hdl-c
1	(3·59
1	0·72;
1	2·91
1	0·56;
1	4·26
1	0·69
1	251·1
1	56·0
1	215·2
1	28·6
1	310·4
1	64·9
1	high;
1	rm);
1	90%-1
1	rm.
1	reps
1	(triglycerides
1	[tg],
1	[hdl-c],
1	specific-intensity
1	volitional
1	(12%,
1	(tnf-a)
1	deteriorative
1	cardiotropin-1,
1	"antiinflammatory
1	dyslipidaemia,
1	(∼90%
1	(8.00
1	1.83;
1	7.82
1	2.66;
1	9.09
1	(496.0
1	224.8;
1	411.5
1	223.1;
1	592.1
1	369.9
1	(vldl)
1	vldl-triglyceride
1	(vldl-tg)
1	(hf;
1	energy)
1	motor-driven
1	times/week
1	intralipid
1	nacl).
1	(-23%)
1	diverted
1	mediates,
1	neurochemical/metabolic
1	(vldl).
1	(followed
1	vldl-cholesterol,
1	(hdl-cholesterol)
1	affirm,
1	mtp.
1	tyloxapol
1	(125.3
1	67.1
1	dl-1)
1	(61.6
1	29.4
1	dl-1),
1	(45.5
1	36.9
1	dl-1).
1	(47.5
1	148.5
1	(mi-s,
1	(mi-t,
1	m·m)
1	min·d,
1	d·wk,
1	wk);
1	(sham-s,
1	(sham-t,
1	[2-c]-thymidine
1	con-a
1	mi-s
1	sham-s
1	mi-s.
1	palmytoiltransferase
1	(cact)
1	(il)-1,
1	(25%),
1	2.7-,
1	8.1-,
1	1.7-
1	3.7-fold
1	interferon-α,
1	operated)
1	(ligation
1	(ml·kg-1·min-1),
1	(mφ{symbol}s),
1	(lps)-stimulation,
1	athletes,
1	drinks,
1	"fat
1	burning"
1	guarana,
1	(g1-0.130
1	g/kg;
1	g2-0.325
1	(dg1,
1	dg2).
1	g2;
1	decaffeination.
1	guarana.
1	liver-acinus
1	lipid-metabolism
1	radioassay)
1	cachexia:
1	zonation,
1	(species
1	radioimmunoassay)
1	depots:
1	rt1b
1	(indicating
1	mhcii)
1	(commercial
1	kits).
1	(sf,
1	(ser,
1	sf);
1	(tf,
1	(ter,
1	v̇o2max)
1	d·wk-1
1	1-type
1	phenol-denervated
1	87%.
1	radioassay
1	0.68
1	adrenodemedullation,
1	(imtag)
1	histological-morphometrical
1	intramyocellular,
1	endurance-trained
1	(gas)
1	gas,
1	extramyocellular
1	sedentary),
1	sol.
1	gas),
1	multi-analytical
1	discernment
1	intramyocellular
1	carcinosarcoma,
1	eat,
1	projections)
1	bodies).
1	(47.1
1	(68.8
1	(10.1
1	cona
1	(38.2
1	metabolic/functional
1	interconversion,
1	acids/triacyglycerol
1	orotic
1	(fo;
1	(vldl)-associated
1	fo-
1	reesterification.
1	oleate.
1	virulome
1	conquista
1	resistomes
1	virulomes
1	identified.results/key
1	4484
1	multiresistance,
1	beta-lactams,
1	fluoroquinolones,
1	macrolides.
1	(s):
1	73)
1	31).
1	endocervical
1	luminex.
1	dyspareunia.
1	interleukin-1β.
1	genitalium.
1	colegio
1	(n=41).
1	dispar,
1	(crackle/snoring/whistle),
1	mucopurulent/purulent
1	39.5°c
1	breaths/min
1	non-identified
1	purulent/mucopurulent
1	(p=0.017).
1	(p=0.020),
1	(p=0.066),
1	(p=0.066).
1	clara
1	correia
1	melgaço
1	(lamp).
1	(bv),
1	lactobacillus,
1	(hmvii)
1	autoaggregation
1	28.55%
1	31.82%
1	31.66
1	41.65%,
1	65.33%
1	71.12%
1	toluene.
1	ph=4.32
1	ph=4.33,
1	lactobacilli.
1	41.03%
1	2.43%
1	pa3)
1	34.29%
1	14.06%
1	14.61%
1	pa3),
1	conquista.
1	60.6%
1	gonorrhoeae,
1	42.4%
1	hayflick
1	“fried
1	egg”
1	=.035)
1	=.036)
1	=.057)
1	=.045)
1	=.003).
1	sccmec,
1	(47.3%)
1	sccmec
1	(iv
1	(cc):
1	ampicillin,
1	32.8%,
1	7.1%,
1	4.3%,
1	vancomycin
1	sec,
1	attendees
1	multi-professional
1	sheltering
1	refusal
1	hellen
1	eoc
1	citral
1	aureus.thus,
1	mannheimia
1	haemolytica,pasteurella
1	spp.,in
1	unhealthy)
1	paulo,brazil.
1	(15.50
1	sp.,staphylococcus
1	sp.,escherichia
1	coli,klebsiella
1	oxytoca,pseudomonas
1	(70.83
1	%),mycoplasma
1	(2.94
1	(38.23
1	(p=0.025).
1	whistling
1	(p=0.076)
1	(p=0.046)
1	coughing
1	pasteurellamultocida[p=0.035;
1	(ci),1.12-26.89],but
1	mucopurulent
1	(p=0.0215;
1	ci,1.55-34.5)
1	(p=0.068;
1	ci,19-28.5),submassive
1	(p=0.031;
1	ci,1.23-75.5),fine
1	(p=0.058;
1	ci,1.23-20.1)
1	(p=0.046;
1	ci,2.38-70.8).
1	unhealthy
1	(pfge),
1	(se-aflp),
1	62.7%
1	mrp+/epf+/sly+
1	mrp-/epf-/sly-
1	epf
1	mrp/epf/sly
1	28.1%
1	gonorrhoeae
1	42.4%,
1	mothur
1	low-quality
1	chimeras,
1	(otus).
1	blastn
1	megan
1	victivallis
1	otus;
1	disorder-positive
1	histophilus,
1	victivallis,
1	alistipes,
1	coriobacteriaceae
1	otu
1	representation.
1	(crd)
1	sinusitis
1	tenosynovitis
1	bursitis
1	f-vaccine
1	broiler-breeders,
1	(multiplex
1	(27.9%),
1	gpo-3
1	(sense)
1	mgso
1	(antisense).
1	micoplasma
1	albicans;
1	56.5
1	15.2%,
1	contaminated.
1	confident
1	(yamaguti,
1	(strait
1	2008)
1	(vranckx
1	2011).
1	p146r3,
1	h2r1
1	h4.
1	4.9*104
1	3.9*106
1	p146r3
1	monit.
1	aureus.material/methods:
1	144,
1	procalcitonin
1	(pct)
1	transcriptase),
1	pcr).results:
1	septa.
1	kidneys.conclusions:
1	pathophysiology,
1	vitoria
1	premises.
1	antibiogram
1	oxacillin.
1	oxacillin/methicillin
1	(27.58%)
1	(72.4%)
1	(enterotoxin
1	(panton-valentine
1	leukocidin),
1	clfa
1	(clumping
1	(21.8%),
1	lysoform®,
1	digluconate,
1	peracetic
1	vinegar.
1	disinfectants:
1	(96.8%)
1	vinegar
1	(93.8%)
1	salivarium,
1	microbe,
1	balanopostitis,
1	spermatozoids,
1	semen,
1	eubacteria
1	(46.42%)
1	laidlawiii
1	vulvovaginitis
1	(gpo
1	mgso),
1	(ugpf
1	ugps)
1	(uni
1	ach3).
1	chamydophila
1	re-inoculated
1	semiquantified
1	mild,
1	diffuse).
1	0.67),
1	0.53),
1	4.0%,
1	0.82)
1	(0.08
1	0.76).
1	plaque/intimal
1	0.047)
1	co-inoculation
1	(1,046)
1	piped
1	breeders,
1	hatchery,
1	72.7%.
1	(60.6%),
1	poultry.
1	(g37
1	1019v).
1	g37
1	high-passage
1	1019v
1	low-passage
1	diverge
1	adherence-related
1	undermining
1	144/240
1	155/240.
1	(technicians
1	hold)
1	specific;
1	animal-holding
1	(sp-4)
1	25.0%,
1	63.4%
1	sp-4
1	9.8%
1	35.0%
1	ureasplasma
1	premises
1	se-aflp.
1	a1a
1	a1b.
1	52.05%
1	90.96%
1	6.16%
1	34.84%
1	vaccinal,
1	(mg)f
1	typeability
1	(mollicutes)
1	(30.9%)
1	(22.9%)
1	(5.4%).
1	(32.6%)
1	59.2%,
1	laidlawi
1	20.4%,
1	14.3%,
1	11.2%,
1	8.2%.
1	(61.2%)
1	(30.6%)
1	non-certified
1	colony;
1	listed.
1	pathogen-free
1	meniscus
1	(fibrochondrocytes-fcrc)
1	units-cfu)
1	1428
1	pg-6.
1	effects-cpe
1	dependant.
1	fcrc
1	fcrc.
1	fibrochondrocytes
1	(caseinase
1	hightest
1	β-hemolysis
1	trimethoprim-sulfametoxazole
1	β-lactams
1	ticarcillin-clavulanate
1	inanimate
1	cfu/ml
1	technicians.
1	(kilodaltons)
1	pulmonis.
1	vulvitis,
1	endometritis,
1	salpingitis,
1	168)
1	pcr-
1	(30.77%)
1	ufc/ml.
1	xylosoxidans,
1	2.48,
1	marcescens,
1	xylosoxidans
1	(qacs)
1	qacs
1	biocide.
1	sausage,
1	cheese,)
1	groceries
1	phosphatidylinositol-specific
1	phosphalipase
1	(ribotype
1	(atcc-15313).
1	(96.7%)
1	(hemolysin
1	pi-plc)
1	intra-articularly
1	pg-21
1	hominis.
1	urealyticum.
1	223,
1	168,
1	165,
1	142,
1	134,
1	115,
1	277,
1	237,
1	penetrans
1	mbcs
1	(micrograms
1	milliliter)
1	azithromycin,
1	0,625;
1	0.156;
1	doxycycline,
1	gentamicin,
1	levofloxacin,
1	0.625;
1	1.25.
1	levofloxacin
1	(cowan
1	fourty
1	m.pulmonis,
1	arthritidis,
1	m.arginini,
1	m.orale,
1	a.laidlawii,
1	m.hominis
1	m.pneumoniae
1	aoac
1	qualification
1	disinfectant's
1	formaldehyde,
1	cresols,
1	undiluted.
1	vibriocides
1	vibriocide
1	1:2.
1	microbiologically,
1	(95.5
1	gl)
1	1:3,
1	agua
1	sanitária
1	lysoform
1	unnoticed,
1	chromosomic
1	mycoplasmology
1	(iom)
1	pippeting,
1	(48.65%)
1	(40.55%),
1	(5.40%).
1	(antisera
1	arginini,
1	laidlawii)
1	"fried
1	egg"
1	digitonine
1	dienes
1	culture.(abstract
1	advertised
1	(use-dilution
1	simplified,
1	1--parachlorophenol
1	(0-benzil)
1	2--eter
1	2.4.4'
1	chloro
1	hydroxiphenylic
1	3--n-alkyl
1	dimethylbenzyl
1	n-alkyl
1	dimethylethybenzyl
1	50%-1.6%;
1	4--formaldehyde
1	(0.3%
1	solution);
1	5--no
1	6538,
1	15442
1	10708.
1	(99.999%)
1	cells/ml.
1	gondii),
1	cystogenic
1	y-maze
1	anti-toxoplasma,
1	(mobility)
1	l-felinine
1	(stag)
1	(1500
1	gy),
1	cd19+,
1	cd3+cd8+
1	stag.
1	alimentos
1	ital.
1	zoonosis,
1	artisanal
1	handcrafted
1	undercooked.
1	defrosting
1	shops
1	(14.28%)
1	option,
1	(fel)
1	162nm.
1	infantumamastigotes,
1	0.9μg/ml,
1	60μg/ml.
1	0.2μg/ml,
1	9μg/ml.
1	vitroactivity
1	39-fold
1	ten-times
1	drug-containing
1	437
1	(11.4
1	sharpened
1	hansen
1	reword
1	(apcs).
1	(ddfxiiia)
1	anti-cd123
1	suspected)
1	cd123.
1	fxiiia-positive
1	amastigote.
1	benzoyl-thymol
1	(8.67
1	acetyl-thymol
1	acetyl-thymol.
1	tgf-beta.
1	"up"
1	dhf.
1	diagnostic,
1	specific-igg
1	anecdotal
1	(delisa).
1	(7/70)
1	(3/88),
1	traveler's
1	phone-interviewed
1	humanities,
1	schools.
1	(37/44,
1	84.1%),
1	forties
1	fifties
1	(32/44,
1	72.7%),
1	15.9%
1	(7/44)
1	(12h)
1	(30/44)
1	travelers,
1	trips.
1	(41/44)
1	(14/44)
1	leisure.
1	(61.4%)
1	11/30
1	(9/30)
1	insurance
1	(13.6%)
1	trip.
1	abroad.
1	orthopedic,
1	educated
1	risks,
1	insurance.
1	planning.
1	328
1	guideline
1	restaurants.
1	employees.
1	toxoplasmosis:
1	restaurants
1	immunocompromised.
1	bottles,
1	cotrimoxazole,
1	pyrimethamine,
1	trimethoprim.
1	prism
1	0.075μm
1	2.003μm.
1	0.482μm
1	11.178μm.
1	cotrimoxazole
1	pyrimethamine.
1	musa
1	(banana
1	tree)
1	spondias
1	(cajazeira)
1	sm1
1	sm2
1	mp1
1	mp4
1	11.26μg/ml
1	0.27μg/ml.
1	tannic
1	complementing-group
1	(ercc1)
1	(g19007a)
1	(hnscc)
1	hnscc
1	bivariate
1	20.2%,
1	28.6%
1	51.2%.
1	45years
1	ercc1
1	(or)=4.86,
1	1.2-19.7,
1	p=0.027],
1	51.2%
1	(or=6.67,
1	1.40-33.33,
1	5years,
1	36%,
1	(median=30months).
1	agent-containing
1	(ma)-containing
1	ma-containing
1	≥10-fold
1	≥40-fold
1	(80:20)
1	acetogenin-rich
1	o-methylarmepavine,
1	benzylisoquinolinic
1	trihydroxy
1	bistetrahydrofuran
1	acetogenin
1	squamosa,
1	acetogenins,
1	annonacinone
1	corossolone,
1	muricata.
1	43.5
1	79.9
1	annonaceae
1	toxoplasmosis;
1	disabled
1	tachyzoites,
1	255.
1	me49,
1	slaughtering
1	packages
1	cyanhemoglobin
1	freeze-thaw
1	1.35%
1	(1/74)
1	chagasi)
1	prohibition
1	aloe
1	(aloe),
1	coriandrum
1	(coriander),
1	ricinus
1	(castor)
1	264.7.
1	(ic50),
1	(bromide
1	3-4.5-dimethylthiazol-2-yl-2,5-dephenyltetrazolium),
1	undertake
1	dose-rate
1	brachytherapy
1	(hdrb)
1	3d-conformal
1	(ebi).
1	four-hundred
1	hdrb
1	5.5-7
1	implant,
1	conformal
1	ebi.
1	48.4
1	94.3%,
1	86.6%
1	92.4%,
1	85.3%,
1	palpation,
1	pro-apoptosis
1	(bthx-1),
1	bthx-i.
1	(native)
1	bthx-i
1	(50.
1	(82.5%)
1	liposome-loaded
1	anecdotal.
1	encephalitis.
1	(28/150),
1	hiv-negative
1	(31.3%,
1	[18/58]
1	[10/92])
1	corrected,
1	gondii-associated
1	cyst-containing
1	blamed
1	epidemics.
1	sternum.
1	59-700
1	log),
1	144/mm3,
1	ryan-holm
1	step-down
1	fissured
1	(ft,
1	or=2.7;
1	1.3-5.6),
1	(gt,
1	or=5.0;
1	-16.8).
1	psoriasis,
1	hepatomegaly.
1	(residual)
1	lobule.
1	pit,
1	disse
1	ito
1	nonfibrous
1	(prbc).
1	self-resolving,
1	subsided
1	bthx-1,
1	t-butanol,
1	kiadó.
1	risky,
1	rrop2,
1	rrop2.
1	chaotrope
1	igg-positive
1	amniocentesis
1	(gestational
1	nested-b1-pcr
1	(40.47%)
1	amplifications:
1	(63.49%)
1	(12.69%)
1	af146527,
1	(23.80%)
1	re-tested
1	(nested-b1-pcr),
1	(9/50
1	b22/b23.
1	practical.
1	(ihc).methods:
1	(90.9%
1	68.8%
1	ihc),
1	cascavel,
1	cascavel
1	54.2%,
1	53.9%,
1	0.963781;
1	98,7%)
1	0.975857;
1	(2.4%/year)
1	(χ
1	(2%/year).
1	kaposi
1	(ks)
1	(hhv-8).
1	(aids-ks).
1	(lana),
1	haart).
1	aids-ks,
1	patch/plaque
1	cks.
1	ifn-γ-expressing
1	ks.
1	response-modified
1	herpesvirus,
1	colonoscopy
1	(cch).
1	<200
1	cell/mm3)
1	cch
1	cardioactive
1	neglected,
1	macrogland
1	telocinobufagin
1	hellebrigenin.
1	hellebrigenin
1	telocinobufagin,
1	(kkk).
1	(cd4,
1	cd68,
1	[nk],
1	[s100])
1	(interferon,
1	[il]-1,
1	il-12).
1	age-paired
1	cd20+,
1	nk+,
1	alveolus-
1	il-10-
1	il-1-,
1	nk+
1	viscerotomy
1	jungle
1	s100,
1	(cd57),
1	(s100).
1	hepatocytic
1	granzymes/perforins.
1	(qol),
1	self-answered
1	instruments:
1	(sf-36)
1	10-item
1	(dlqi)
1	(r2=0.26)
1	(r2=0.20),
1	(14/
1	75),
1	(19/75),
1	(5/75)
1	(37/75);
1	41-year-old
1	image-based
1	pneumonias,
1	diagnosis--especially
1	m-specific
1	non-contagious
1	flaviviridae,
1	terrible
1	menace
1	nkt+
1	th3
1	(73.3%),
1	1:1,600
1	(well
1	river)
1	0.002
1	(76.1%)
1	(75.4%)
1	(55.2%).
1	(≥1:16),
1	(73%)
1	poorest
1	isoquinoline
1	value=24.89
1	value=41.60
1	ovalifolia
1	value=63.88
1	value=37.88
1	89.8%,
1	crassiflora,
1	coriacea,
1	guianensis,
1	australis,
1	emarginata.
1	arsenals
1	antimony.
1	4b.
1	antilesihmanial
1	200,000
1	contaminate
1	unfeasible
1	sentinels,
1	infection-like
1	(iha)
1	50.5%
1	(101
1	concordance,
1	viannia
1	mini-exons
1	177bp
1	posome-entrapped
1	(sb-lp)
1	srs.
1	14.11
1	225.9
1	energy-dependent
1	flurescent
1	2004;
1	spleen-dependent
1	tnfr
1	inos-blocked,
1	aminoguanidine-treated
1	no-inhibited
1	anatomopathological
1	reactivation,
1	(balt),
1	death:
1	criteria:
1	heath-edwards'
1	quantities.
1	arsenicals
1	choice,
1	stibogluconate,
1	anka)
1	peaks.
1	t-140,
1	200gy
1	formaldehyde-killed
1	(il-10,
1	(olp)
1	lesions;
1	school,
1	(focaccia
1	infec
1	dis
1	269),
1	8.8%,
1	(p=0.002),
1	(p=0.0003)
1	(0.6%).
1	pasteurized
1	cysts/ml
1	refrigerator
1	pasteurization
1	15mg
1	n=12).
1	g/100ml;
1	(13.7
1	1.2)
1	2.0),
1	iron/kg,
1	(hb:
1	1.0),
1	1.8).
1	(37.5%;
1	0.0104).
1	predictor.
1	396
1	5-month
1	(300)
1	(96).
1	(32.3%)
1	(9.6%),
1	counter-immuno-electrophoresis
1	(cie),
1	cie,
1	cf,
1	accurately.
1	emílio
1	ribas,
1	8/38
1	10/33
1	(18/71),
1	10,000/mm3
1	350/mm3.
1	antivenins
1	125l-labeled
1	(iha).
1	(nctx),
1	inn
1	(liver
1	(scvr)
1	(dose-rate
1	gy/h)
1	(probucol
1	sulphate)
1	intracytoplasmic
1	probucol
1	sulphate,
1	measles-specific
1	(elisa)-igg
1	mlu/ml.
1	biken-cam70
1	(lai,
1	≤29%)
1	avidity.
1	6-10
1	edmonston-zagreb,
1	233/242
1	(96.3%)
1	14%).
1	vaccinees,
1	56%),
1	(2-5
1	vaccination).
1	lai.
1	nonresponders
1	mlu/ml),
1	lai),
1	indices).
1	radiosensitivity
1	biomphalaria
1	gastrula,
1	(4.3
1	radiosensitive
1	gy).
1	exogastrulas,
1	everted
1	radiation-specific
1	realized,
1	immunofluorecence
1	anti-cryptosporidium
1	immunoflorescence
1	ifi
1	77.8%(igg
1	igm).
1	excreters.
1	dot-elisa,
1	0.552
1	0.0127).
1	[biotech.
1	(1994)
1	1241-1246].
1	(monoq)
1	s-100).
1	rays,
1	gamma-irradiation
1	measles-vaccinated
1	(ift)
1	(1.00).
1	(0.85)
1	(0.63)
1	(1.00)
1	ift
1	(41.1%),
1	(29.9%)
1	infants/year
1	llc-mk2-infected
1	indeterminate,
1	clear-cut
1	positives.
1	class-specific
1	ld50),
1	terminations,
1	(mesocricetus
1	auratus)
1	pyroninophilic
1	periodical
1	recrudescences.
1	bacteriological,
1	paucibacillary
1	multibacillary
1	fite-faraco
1	stains;
1	bacillary
1	(anti-bcg
1	(anti-s-100
1	anti-serum).
1	(++)
1	(+++)
1	structures;
1	anti-bcg
1	anti-serum;
1	knobs,
1	knobs
1	rat-serum
1	oxtrated
1	determines,
1	17s
1	di-p-tolyltelluride
1	ferric,
1	cupric
1	glacial
1	hydroxychloride
1	telluride
1	dichloride
1	dibenzoate.
1	1964.
1	dada
1	ubiquitin/proteasome
1	pfpk7,
1	(pfpk7-
1	parasites)
1	re-introduction
1	pfpk7-
1	cell-signalling
1	abz-aikffarq-eddnp
1	fluo4/am,
1	bapta/am
1	(50,
1	fluo4/am
1	2+-containing
1	tnp-atp
1	"sleeping
1	sickness"
1	acidocalcisomes,
1	polyphosphates
1	antiarrhytmic,
1	amiodarone,
1	oxidosqualene
1	posaconazole,
1	seemingly,
1	posaconazole.
1	alkyl-lysophospholipid
1	repurposed
1	old-known
1	schizont-stage
1	ring-trophozoite
1	tryptamine
1	community-based,
1	nadu,
1	(<12
1	464
1	4.1%
1	covariates,
1	∼78%
1	risk=1.78
1	(ci)=1.03
1	3.10)).
1	nadu.
1	low-resource
1	ip3-dependent
1	ip3.
1	fluo-4/am
1	caged-ip3.
1	photolytic
1	discharged,
1	store.
1	inositol-polyphosphate
1	uncaging
1	er-localized
1	endoplasmatic
1	sarco/endoplasmatic
1	exchanger)
1	exchanger).
1	(bapta/am)
1	(egta)
1	phenylmethylsulphonyl
1	(pmsf)
1	throphozoite
1	membrane-permeant
1	mysterious.
1	[ca2+]c.
1	(ring),
1	(trophozoite)
1	(schizonts),
1	(zn
1	ix)
1	vesicle-like
1	pfho
1	oxygenase)
1	(biliverdin)
1	(mrp2)
1	bile.
1	(insp3r2)
1	sandwich
1	(gfp)-mrp2
1	insp3r1
1	insp3r3
1	vaso-pressin
1	insp3r2.
1	5-chloromethylfluorescein
1	(cmfda)
1	1,2-bis(o-aminophenoxy)ethane-n,n,n′,n′-tetra-acetic
1	choleretic
1	tauroursodeoxycholic
1	(tudca)
1	gfp-mrp2
1	"fevers,"
1	annua,
1	opiacea,
1	lancea)
1	artemisin,
1	seventeenth
1	chinchona
1	"jesuits'
1	powder."
1	1820
1	madeira-mamoré
1	railroad
1	resistence
1	carmargo
1	melatonin-receptor
1	asynchrononous
1	host-derived
1	asynchronous,
1	bagnaresi
1	rack1.
1	(insp3r).
1	insp3r-mediated
1	insp3r,
1	photorelease
1	insp3.
1	insp3-mediated
1	indole-related
1	supentine
1	(7-tm)
1	receptor-like-proteins..
1	pfsr1,
1	pfsr10,
1	pfsr12
1	pfsr25,
1	pfsr1
1	mr12
1	exo-erythorcytic
1	traversal
1	yoelli
1	potassium-treated
1	eefs
1	non-permissive
1	pp2c,
1	merianae
1	p2y-type
1	tropidurid
1	teiidae,
1	monensin-nigericin
1	calcium-free
1	2+]clevels,
1	p2x-like.
1	(rbcs),
1	extracelullar
1	beraldo
1	garcia;
1	decodification
1	enforces
1	2-aminoethyl
1	diphenylborinate
1	(2-apb)
1	2-apb
1	8brcamp,
1	'capacitative
1	entry'
1	(ao)
1	collapsing
1	h+-pump
1	3-am,
1	nigericin.
1	tryptamine).
1	-acetyl-n
1	-formyl-5-methoxykynuramine
1	(afmk),
1	schizont),
1	spectrofluorophotometer
1	infected-rbc,
1	fluo-4
1	(trophozoite
1	schizont).
1	(hotta,
1	c.t.,
1	m.l.
1	gazarini,
1	f.h.
1	beraldo,
1	f.p.
1	varotti,
1	r.p.
1	pozzan,
1	c.r.
1	2:466-468).
1	n6-benzoyl/pka
1	(6-bz-camp)
1	(abolished
1	monophosphorothioate/8
1	isomer,
1	pki
1	[cell
1	peptide],
1	h89).
1	6-bz-camp
1	tryptophan,
1	n-acetylserotonin,
1	tryptamine,
1	trophozoite.
1	indolamines
1	u73122.
1	emerging,
1	atpγs
1	2mesatp,
1	2clatp,
1	α,β-atp,
1	200-μm
1	41.77
1	48.11
1	53.11
1	30.78
1	atpγs.
1	p2y4-like
1	(653-3146
1	ionomicin
1	ethyl-eps-leu-tyr-cap-lys(abz)-
1	nh2,
1	ethyl-eps
1	ethyl-(2s,3s)-oxirane-2,3-dicarboxylate.
1	rhod-2,
1	rhod-2
1	uncoupler,
1	fccp,
1	plasmodia.
1	n′-acetylserotonin
1	(ecar),
1	0.12)-induced
1	ecar
1	(3.64
1	0.18),
1	2mesatp
1	(3.56
1	2mesadp
1	(3.65
1	0.13).
1	receptorantagonists
1	a3′p-5′p
1	a3′p-5′ps
1	ecar-induced
1	ecar.
1	[ca2+]i-dependent
1	(racks)
1	rack
1	(pfrack)
1	1.4kbp
1	972bp,
1	323
1	35.8kda
1	6.38.
1	chlamydomonas
1	reinhardtii
1	racks,
1	wd40
1	(dvfsvsf)
1	(stinslcf)
1	schizont.
1	mature.
1	(<100
1	divide.
1	∼40
1	re-invades
1	-75%),
1	58%),
1	r03
1	75%),
1	b46
1	n-acetyl-serotonin,
1	monensin;
1	ip3,
1	synchronicity?
1	cycle?
1	merianae.
1	20nm
1	serca,
1	nbd-ci
1	(0-600
1	onoo-)
1	onoo-).
1	diethylenetriaminepentaacetic
1	onoo--induced
1	desferrioxamine,
1	desferrioxamine
1	trolox®
1	(0-1
1	melatonin).
1	puzzled
1	millimolar
1	arise:
1	protozoa;
1	pathways?
1	celia
1	distonin
1	arsenate
1	3-acid
1	tbhq
1	(2,5-di(ter-butyl)-1,4
1	benzohydroquinone).
1	thapsigargin-
1	tbhq-sensitive
1	chloroquine,
1	insp3-induced
1	insp3-sensitive
1	insp3-dependent
1	45ca2+,
1	free-medium
1	7-chloro-4-nitrobenz-2-oxa-1,3-diazole
1	(nbd-cl)
1	am-labeled
1	non-mitochondrial
1	arsenazo
1	poisons,
1	oligomycin.
1	2,5-di-(t-butyl)-1,4-hydroquinone
1	(bhq),
1	sequesters
1	exchangeable
1	15.05
1	22.97
1	3.84
1	particle-like
1	(staurosporine,
1	2,5-dihydroxycinnamate,
1	b46,
1	lavendustin
1	r03)
1	(staurosporine)
1	impeded
1	sub-micromolar
1	millimolar.
1	implied.
1	427
1	gradient-consuming
1	stunning
1	reflow.
1	others;
1	indicator,
1	fura-2,
1	evaluated,with
1	predetermined
1	atpases.
1	signific
1	pc2500,
1	[32p]
1	orthophosphate.
1	unphosphorylated.
1	cavitation.
1	80-μm
1	102-kd
1	13-å
1	scruin:
1	5-kd
1	protease-sensitive
1	47-kd
1	56-kd
1	protease-resistant
1	actin-binding
1	poxviruses,
1	kelch,
1	~50-amino
1	β-stranded
1	'superbarrel'
1	superbarrel
1	folds,
1	biogeophysical
1	albedo,
1	forcers
1	(slcfs),
1	(rf;
1	slcfs,
1	offsetting
1	rcp8.5
1	slcf,
1	nonlinearities
1	extracted.
1	(46/118).
1	(adenylate-cyclase
1	lonien,
1	malvezi,
1	suzukawa,
1	yamauchi,
1	yamada-ogatta,
1	bordignon
1	pinge-filho.
1	dc-enriched
1	(dc-pbmc)
1	(cel),
1	22,536,
1	adenilate
1	(asa,
1	cox-inhibitors.
1	cel
1	(n = 26),
1	(n = 16).
1	frequencies:
1	(62.5%),
1	(6.7%),
1	(15.4%).
1	(lpr).
1	(gerd)
1	esophagogastroduodenoscopy
1	ph-metry.
1	1,751.37
1	544.76
1	2,534.65
1	920.69
1	gerd,
1	publish
1	weather,
1	“regulatory
1	cells”
1	“endometriosis”
1	databases:
1	cochrane,
1	embase
1	lilacs.
1	endometriotic
1	instructive
1	up-to-date
1	poising
1	(pv1),
1	(eau).
1	ifn-ã+
1	restimulation,
1	ifn-ã
1	ifn-ã-producing
1	severino,
1	palomino,
1	alvarenga,
1	pasqualim,
1	salvalaggio,
1	aloia,
1	bromberg,
1	marti.
1	(frcs).
1	(pdpn/gp38)
1	(dncs),
1	lns,
1	pdpn
1	cd31,
1	ln-derived
1	chemokine-induced
1	ccl20.
1	(13/15,
1	87%)
1	(3/42,
1	10e–8).
1	b1;
1	glomap
1	(pm2.5)
1	(aod)
1	satellite-derived
1	(gfed3,
1	finn1)
1	66&ndash;84
1	overestimation
1	3.4.
1	dominate,
1	omits
1	aod.
1	(-80
1	0°c),
1	(dimethyl
1	tc199;
1	ophthalmos),
1	nonpreserved
1	factor-beta,
1	microphysics
1	(assuming
1	(accounting
1	condensation).
1	(aie)
1	(soa).
1	sink,
1	organically
1	mass-based
1	aie
1	climatic,
1	biogeochemical,
1	<br><br>
1	(atto)
1	manaus.
1	towers
1	mid-2015.
1	turbulence
1	visibility.
1	cryptogamic
1	covers.
1	dioxide,
1	methane,
1	voc,
1	no<inf>2</inf>,
1	oh
1	reactivity).
1	microphysical,
1	(ccn)
1	hygroscopicity.
1	ecological,
1	meteorological,
1	hiv/m.
1	(amaze-08).
1	isoprene-rich,
1	ho<inf>2</inf>-dominant
1	positive-matrix
1	"hoa"
1	hydrocarbon-like
1	"ooa-1"
1	"ooa-2,"
1	epoxydiols
1	haze,
1	"ooa-3,"
1	gas-to-particle
1	suffixes
1	ooa
1	ordinal
1	campaign-average
1	loadings
1	1.4:1
1	ooa-3,
1	particle-phase
1	hadgem2
1	wildfires,
1	burning,
1	residential
1	combustion.
1	overestimates
1	5-15
1	±20,
1	"high"
1	zero)
1	season)
1	yr-1.
1	substantial,
1	oxide-donating
1	(no-nsaids)
1	no-indomethacin-treatment
1	no-nsaids
1	no-nsaid-based
1	caution.
1	fail,
1	ophthalmology
1	non-toxoplasmic
1	37.21%
1	(16/43)
1	2.33%
1	(1/43)
1	16.27%
1	(7/43)
1	credits
1	cycle.methods:
1	non-mandatory
1	graduation,
1	gender.results:
1	3,809
1	credentialed,
1	free-standing,
1	1.251;
1	p=0.009)
1	1.022;
1	0.4%.
1	1.4%.conclusion:
1	instruments,
1	monitor.
1	(sambba)
1	september/october
1	ppm),
1	co),
1	(bb)
1	13.7
1	nh4,
1	so4,
1	no3,
1	0.44,
1	(bce)
1	organics
1	(submicron
1	bce),
1	(bboa)
1	1.35).
1	-0.5,
1	δoa
1	δco
1	volatilization.
1	(lv-ooa).
1	near-surface
1	soas
1	aloft,
1	dominates
1	normanton
1	hmscs,
1	contact-independent
1	prostaglandin-independent
1	(cd127)
1	hmscs-lymphocytes
1	interleukin.
1	inf-y
1	inf-y/il-17
1	(cd3),
1	(cd28,
1	ctla-4)
1	(b7-1
1	b7-2,
1	cd86),
1	fr104,
1	(gvhd)
1	robotics
1	(lsg)
1	robotic-assisted
1	sleeve
1	gastrectomy
1	(rsg)
1	incurred
1	rsg.
1	cd40-cd40l
1	lúcia
1	jamli
1	abel
1	caren
1	grabulosa
1	rs1800470
1	t/c),
1	rs1800471
1	c/g)
1	rs2430561
1	(+874
1	t/a)
1	t/a
1	producer)
1	chorioretinitis
1	anti-toxoplasmic
1	vitritis.
1	plana
1	vitrectomy.
1	humours
1	hyperpigmented
1	pcr-dna
1	vitritis
1	alx-receptor
1	donizette
1	malvezi
1	g<a
1	-174
1	g>c
1	-1082
1	p=0·01).
1	(or)=2·37,
1	1·16-4·84;
1	p=0·02]
1	(rrt)
1	(or=3·82,
1	1·19-12·23;
1	p=0·02).
1	rrt
1	(ts),
1	phytoflagellate
1	leukopenia.
1	(t-reg)
1	(canadian
1	ii-2).
1	patient(s):
1	videolaparoscopy,
1	22),
1	endometriosis-free
1	(cxcl9,
1	cxcl11,
1	xcl1,
1	(ccl17
1	ccl21)
1	rectosigmoid
1	ccl17,
1	1,008
1	<2-year-old
1	<2-years-old
1	-years
1	apeced.
1	<10-years
1	three-quarters
1	-years-old
1	2-5-years
1	-old
1	eof
1	kilometers.
1	(light
1	absorption)
1	aerosol;
1	component;
1	sahara
1	dust.
1	comprising,
1	(january-june),
1	(july-december),
1	(pm2)
1	(40-80%
1	mass),
1	(ssa)
1	below-3.5
1	out-of-basin
1	occasionally.
1	advected
1	(al,
1	fe)
1	ssa
1	full-dose
1	(25,083
1	19,359
1	0.065).
1	(54,509
1	annals
1	company.
1	conurbations
1	(masp,
1	million)
1	fleet.
1	masp
1	fleet,
1	rush-hour,
1	stagnant
1	clear-sky
1	104-3.2
1	weekdays,
1	nucleation-mode
1	fridays.
1	12-33
1	21-64
1	mm-1,
1	1.8-5.0
1	bc.
1	pbl,
1	rush-hour
1	weekday
1	single-scattering
1	(ω0)
1	0.59-0.76.
1	(toa)
1	ω0,
1	toa
1	masp.
1	weekend
1	&omega;0
1	0.074
1	weekdays.
1	(npf)
1	h-1.
1	sulphuric
1	proxy
1	36.5%
1	1.15%
1	(il-6:
1	327.5
1	195.5
1	tgf-β:
1	171.5
1	recipient.
1	synge-neic
1	recipient,
1	availabilities
1	(dmaic)
1	beneficente
1	israelita
1	albert
1	einstein.
1	headings:
1	compliant
1	guide.
1	facto
1	(eucaari).
1	legacy
1	clouds
1	fron
1	pan-european
1	parameterizations
1	computations
1	uncertainties
1	quality-climate
1	abatement
1	(fazenda
1	nossa
1	senhora,
1	rondônia)
1	amazonas),
1	aethalometers:
1	7-wavelength
1	(ae30)
1	(vis)
1	2-wavelength
1	(ae20)
1	nir.
1	exponent,
1	log-log
1	plot.
1	1.5)
1	exponents.
1	forcings,
1	450-880
1	misjudgment
1	non-soot
1	uveal
1	sclera,
1	cornea
1	male)
1	(hsv-1),
1	(hsv-2),
1	(toxo)
1	toxo,
1	vzv
1	(11.1%
1	recur
1	erechim,
1	idiopathic,
1	(5-lo)-derived
1	5-lo-derived
1	ozone,
1	tropospheric
1	canopies
1	canopy,
1	ozone.
1	mesocosm,
1	-0.6
1	-1.5
1	<sup>-2</sup>
1	s<sup>-1</sup>
1	in-canopy
1	7%-28%
1	(46%-61%
1	within-canopy
1	ozonolysis,
1	union.
1	(amaze-08),
1	fine-
1	coarse-mode
1	î1/4m
1	characterization;
1	material;
1	thermodenuder-induced
1	spectra;
1	satellite-based
1	hydrometeor
1	amaze-08
1	(63%),
1	spirometry
1	(29.0%)
1	(9.7%).
1	(6.5%
1	whole;
1	diagnosis).
1	2.61s;
1	60.21w)
1	(aug-oct).
1	(ground:
1	2 m;
1	canopy:
1	28 m,
1	top:
1	40 m).
1	(voc)
1	(cpc)
1	anemometer.
1	(ptr-ms).
1	nighttime,
1	light-absorbing
1	(76 nm)
1	(144 nm),
1	0.82 mg m-2 s-1
1	noon.
1	fine particle
1	0.05 ± 0.10
1	106 m-2 s-1
1	and deposition
1	daytime.
1	53-year-old
1	chorioretinal
1	herpetic
1	instituted,
1	round-to-elliptical
1	loci:
1	sag4,
1	gra6
1	gra7.
1	gra7
1	(tgf)-β.
1	(ndga,
1	(5-lo-/-)
1	(inos-/-)
1	(tbh).
1	il-17-secreting
1	thrombospondin-1
1	(tsp-1)
1	(mog
1	(tsp-1
1	(2d2·tsp-1
1	vitro-activated
1	2d2·tsp-1
1	pre-activated
1	infertility).
1	intevention(s):
1	videolaparoscopy.
1	(gina)
1	guideline.
1	uppsala,
1	uppsala
1	self-management,
1	visits,
1	school/work
1	(46%
1	long-acting
1	gina.
1	health-economic
1	majority,
1	parameters.these
1	24-month
1	postnatally
1	misconceptions
1	physiopathogenesis
1	pteronyssinus.
1	derp-specific
1	d.pteronyssinus.
1	cd8+cd45rblow
1	cd8+cd44high
1	time-point.
1	seven days
1	semi-allogeneic
1	(cvid),
1	paradox.
1	predisposition,
1	persistent/recurrent
1	clinical/immunological
1	cytopenias,
1	rituximab
1	substitutive
1	cyclooxygenase-mediated
1	scaning
1	activ
1	(activated
1	(epidermal
1	fgf4
1	(fibroblast
1	bfgf
1	(basic
1	kgf
1	(keratinocyte
1	(hepatocyte
1	factor).
1	fgf4,
1	kgf.
1	(hcmv)
1	cmv;
1	readly
1	gra6.
1	(8t)
1	restraint,
1	deviation.
1	mucosas.
1	(quantikine
1	®).
1	2,867.6
1	1,588.5
1	(p=0.015).
1	lpr,
1	revista
1	otorrinolaringologia.
1	specificity)
1	vitrectomy
1	clinicians.
1	staff.
1	aqueous.
1	(arn).
1	three(60%)
1	ophthalmological
1	il-4/ifn-gamma
1	il-4/il-2
1	il-10/
1	il-10/il-2
1	anti-inter-photoreceptor
1	(anti-irbp)
1	non-isogenic
1	igg1-
1	26-year-old
1	obliterans,
1	γ-globulin
1	constipation
1	days'
1	guarding,
1	edematous.
1	shock;
1	thiabendazole
1	(gal-1),
1	privilege,
1	regulatory-mediated
1	rgal-1-treated
1	gal-1
1	(lba-smocc)
1	(σs
1	haze
1	(225
1	μgm-3),
1	(1435
1	mm-1),
1	(3.0),
1	(3000ppb).
1	1617m
1	(545
1	(diameter
1	(ω>0
1	0.92±0.02.
1	(δσs/δcn)
1	2-10
1	endothelia.
1	α4-integrin
1	(irbp)-specific
1	(α4-api)
1	anti-irbp-specific
1	α4-api
1	α4-integrins
1	cvid;
1	therapy).
1	haart,
1	cataract,
1	vitreitis,
1	cystoid
1	epiretinal
1	(irs).
1	vitreitis
1	(amt)
1	(lscd)
1	lscd,
1	keratoplasty
1	(pkp)
1	noncomparative,
1	lscd
1	autograft
1	(60.6%)
1	stevens-johnson
1	compatibility)
1	lscd.
1	declines
1	lba-smocc
1	(large-scale
1	climate)
1	(co2),
1	aircraft.
1	(ercn/co)
1	14-32cm-3
1	ppb-1
1	savanna
1	(combustion
1	efficiency).
1	ercn/cobetween
1	co-to-co2
1	(erco/co2),
1	stretched
1	flaming
1	(rsc)
1	aircraft,
1	1.5-2.1.
1	detrainment
1	(cdl)
1	in-cloud
1	non-precipitating
1	cdl
1	nucleating
1	laryngoscopic
1	annexin-positive
1	cd95,
1	immunized/infected
1	lastingly
1	semihistocompatible
1	inos-/-).
1	reticulocytosis
1	t-butyl
1	(t-bht)
1	anti-ctla-4-treated
1	(hml-1).
1	hml-1.
1	hml-1
1	(ocular
1	mucosa)
1	cd8/hml-1,
1	cd4/hml-1,
1	cd3/
1	cd3/cd4,
1	cd3/cd25,
1	cd8/cd25,
1	cd4/cd25
1	flowcytometry.
1	cd8/hml-1
1	cd4/hml-1
1	cd4+)
1	regulatory/supressor
1	il-5.
1	(cby.d2)
1	50-100%
1	klh.
1	intra-uterus,
1	(acquired)
1	(aids).
1	25-year-old
1	choroid,
1	neovascularization,
1	neovascular
1	glaucoma.
1	hypodense
1	contrast-enhanced
1	enucleated.
1	oropharynx.
1	paracoccidioidomycoses,
1	trimethoprim-sulfamethoxazole
1	(≥1
1	γ-producing
1	vα)
1	(ihr)
1	ragweed-sensitized
1	il-4ko,
1	il-12ko,
1	ko,
1	mab-treated,
1	il-12-treated,
1	il-12ko
1	ihr
1	th1-inducing
1	(rpe)
1	choriocapillaries
1	(armd)
1	(geographic
1	[ga]).
1	65-year-old
1	armd
1	best-corrected
1	photography,
1	angiography,
1	ophthalmoscope
1	perimetry,
1	retinotomy
1	superotemporal
1	ga.
1	immunosuppressants.
1	phosducin
1	ga,
1	(daclizumab)
1	sight-threatening,
1	nonrandomized,
1	antimetabolites,
1	daclizumab
1	lieu
1	sight-threatening
1	acuity.
1	letters
1	implication,
1	(il)-10.
1	rolipram,
1	monocyte/macrophages.
1	rolipram.
1	(afferent
1	(efferent
1	irbp-driven
1	(il-
1	cytokine-independent
1	1-like,
1	ng/d
1	(ifn-
1	antigen-
1	ifn-γ-deficient,
1	(inos)-deficient,
1	bcl-2(lck)
1	protected.
1	aborts
1	curtailing
1	hyperinduction
1	primed.
1	hierarchy:
1	crossreacted
1	peptide-fed
1	peptide-reactive
1	crossreactive,
1	multi-
1	il-12)
1	igg1-dominated
1	th0/th2-like
1	uveitogen.
1	ragweed-induced
1	swr/j
1	chemosis,
1	redness
1	ragweed-specific
1	ragweed-activated
1	doubt
1	(cunha-neto
1	(1996)
1	98:
1	1709-1712).
1	6/1000
1	u.s,
1	transmiting
1	3hthymidine
1	ifn-yand
1	similiar
1	gondü
1	(b10.a,
1	c57bl/10,
1	balb/k)
1	(akr)
1	th2-dominated
1	undiminished
1	lymphotoxin
1	il-6-producing
1	gkos
1	allergic-like
1	gene-dose
1	deviant
1	uniqe
1	'feeding'
1	oophoritis,
1	gamma).
1	interferon-gamma).
1	thymus-dependent
1	polyglandular
1	(interferon-gamma
1	'null',
1	f344-like
1	(th1-low/th2-low)
1	hapten-klh
1	ige).
1	(il-4(-/-
1	))
1	retrovirus-reduced
1	maids.
1	(gε)
1	(pε)
1	nippostrongylus
1	transcripts;
1	pε
1	pε.
1	preimmune
1	(dth),
1	irbp-primed
1	dth,
1	antigen-reactive
1	irbp-responsive
1	afferent-acting
1	(eiu)
1	irbp-immunized
1	106cells/mouse.
1	injected;
1	105cells/mouse.
1	vβ8.2-
1	vβ6-positive
1	vβ8.2.
1	h-2rhaplotype.
1	cycles).
1	"suppressive"
1	cytokine-based
1	sp35,
1	s-antigen.
1	methods;
1	(apc),
1	flat-bottom
1	peptide/apc-driven
1	(2μg/ml)
1	(5x105/well).
1	anti-cd3,
1	anti-cd28.
1	antigen/apc-driven
1	1x105
1	5x105
1	-cd3/anti-cd28,
1	10ng
1	apc's,
1	plateaued
1	30-50%,
1	noncritical
1	function(s).
1	low)
1	(3h-thymidine
1	18-21
1	eau;
1	unexposed)
1	'low-dose'
1	uveoretinitis.
1	cds-depleted
1	il-12-treated
1	(il-4)-dependent
1	it)
1	tolerance-inducing
1	antigen-specific,
1	clonotypic
1	(klh)‐specific
1	lymphokines.
1	co‐transfer
1	trinitrophenol
1	(tnp)‐klh/mouse)
1	tnp‐klh/mouse)
1	interleukin‐4
1	(il‐4)
1	cell(s)
1	il‐4
1	ifn‐γ.
1	3-day-old
1	multi-organ-
1	organ(s)
1	(mel-
1	14(low))
1	il-2r
1	mlr
1	mlr-reactive
1	3dtx
1	aduh
1	apc-containing
1	anti-parietal
1	self-peptides
1	h-2b,
1	h-2(k),
1	epitope(s)
1	20-amino
1	c57bl/10
1	(h-2b),
1	b10.br
1	(h-2(k)),
1	(h-2(r))
1	161-180,
1	sgipyiisylhpgntilhvd,
1	165-177
1	(proliferation)
1	immunomanipulation,
1	supplementing
1	3x-fed
1	il-2-treated
1	payer's
1	redundant,
1	'neutralize'
1	tnp-klh.
1	anti-tnp-specific
1	antiil-4
1	ccells.
1	tritiated-uridine
1	(mϕ)
1	(high‐ige
1	h‐2‐identical
1	(low‐ige
1	high‐
1	low‐ige
1	down‐regulation
1	low‐
1	2-nitroimidazole,
1	5-nitrofuran
1	5-nitroimidazole
1	rabbits;
1	nitroarene
1	nitroarenes
1	37·8
1	malignant,
1	mixed-cell
1	32·4
1	41·6
1	growths,
1	mk-436
1	indiscriminate
1	sa-activated
1	cruzi-reactive
1	nonoverlapping,
1	self-tolerance
1	unopposed,
1	tissue-damaging,
1	(apps)
1	ceruloplasmin,
1	transferrin.
1	fluvial
1	stingray,
1	leukocytes-endothelial
1	symptomatology
1	misdiagnosed.
1	(hbp)
1	leakage.
1	walter,
1	lopes-ferreira,
1	vidal,
1	leomil,
1	tanuri
1	thompson.
1	blooms
1	eutrophication
1	campina
1	metagenomics,
1	(microcystin,
1	nodularins,
1	cylindrospermopsin),
1	10.6%
1	cylindrospermopsis,
1	ponds.
1	pond
1	araçagi
1	62.9
1	0.8%),
1	boqueirão
1	(lethality
1	0.8%).
1	ktp-amide
1	(ktp-nh2)
1	enkephalinases
1	angiotensin-converting-enzyme
1	dipeptidyl-peptidase
1	ktp-nh2.
1	cxcl-1
1	ktp-nh2,
1	metyrapone.
1	full-fledged
1	glucocorticoid-independent
1	(vtn)
1	il17a-producing
1	raf-mek-erk
1	il-1/il-1r-dependent
1	tnp,
1	cuprizone
1	piii-class
1	atroxlysin-ia,
1	pi-class
1	(piii-class),
1	batroxrhagin,
1	atroxlysin-ia.
1	nidogen.
1	pii-
1	henlei)
1	st2−/
1	trif−/−
1	il-17a−/
1	il-18r−/−
1	w(sh)/w(sh)-,
1	ahr-,
1	nlrp3-,
1	ice-,
1	il-1β-,
1	p2rx7-,
1	cd39-,
1	il-17ra-,
1	tbx21
1	refine
1	il-33/st2
1	il-33-producing
1	(l-tyr-l-arg-nh2;
1	ktp-nh2)
1	crossing.
1	d-tyr
1	ktp-nh2-dl,
1	(lps):
1	ktp-nh2-dl.
1	0.38)
1	(hot-plate
1	0.8)
1	maculosa,
1	restinga
1	(venezuela)
1	frets
1	(present
1	peaks)
1	vaz
1	tgf-β1-mediated
1	tgf-β-targeted
1	(itreg)
1	(phd)
1	phd
1	competitor
1	pm26tgf-β1
1	neutrophils'
1	chemoattraction.
1	botropic
1	intravital.
1	(mmp-2
1	mmp-9)
1	natterins-treated
1	tlr4-myd88-mediated
1	asking
1	finalization
1	tlr2-tlr4/myd88
1	lopes-ferreira
1	nattereri(niquim)
1	topics.
1	toxinology,
1	interconnection
1	pseudoplatystomafasciatum
1	choreographed
1	pge2),
1	(kc
1	leukotrine
1	batrachoididae
1	toadfish,
1	porosissimus,
1	midshipman
1	pporosissimus
1	dismiss
1	cd19-positive
1	hierarchic
1	cd45r/b220
1	igg1-secreting
1	derived-asc.
1	cd45r/b220.
1	baff-r
1	il17-a
1	grund
1	affinity-ige.
1	(b1a
1	b1b
1	b220pos.
1	egress,
1	b220neg.
1	(swiss;
1	muscle.the
1	antithrombin.
1	seasons.in
1	henlei,
1	16072.8
1	(micrococcus
1	escherichiacoli)
1	(candida
1	tropicalis)
1	stingray.
1	(peritoneum,
1	bone-marrow).
1	(120d)
1	venom-response
1	highcd43
1	120d
1	(eosinophils,
1	cd44+
1	cd40l+
1	ly6c+
1	anti-il-5-
1	anti-il17a-neutralizing
1	neg
1	pos,
1	il-17a.
1	(spv)
1	spv-induced
1	(hoe-140).
1	s-2302
1	(pro-phe-arg-pna),
1	integrin-mediated
1	rgd-dependent
1	geitlerinema
1	amphibium,
1	city's
1	cyanotoxins.
1	quantitation,
1	essays.
1	[125
1	(b.w.)]
1	washings.
1	day-nattectin
1	ly6
1	nattectin-mice
1	bmdcs
1	nattectin-treated
1	bmdc
1	posing
1	bathers,
1	galactose-specific
1	non-glycosilated,
1	(pros)
1	(bj)
1	(<ekwap),
1	bj-pros
1	(machr-m1)
1	transillumination
1	machr-m1
1	bj-pro-5a-mediated
1	orbignyi,
1	nle
1	orp-nle
1	orp-pro/ala,
1	orp-desh1
1	orp-nle,
1	orp-pro/ala)
1	orp-desh1,
1	orbigyni,
1	middle-western
1	porflan
1	esivrpppveakveetpe
1	(mw
1	2006.09
1	bothropasin,
1	bj-pi,
1	caseinolytic
1	(uf)
1	induced-alterations
1	(%tna+control
1	81.1
1	±0.86;
1	%tna+60
1	78.04
1	±1.18;
1	%tna+90
1	76.16
1	±3.34;
1	%tna+120
1	79.49
1	±0.87)
1	(%tk+control
1	72.29
1	±1.12;
1	%tk+60
1	75.41
1	±0.65;
1	%tk
1	+90
1	71.23
1	±2.55;
1	%tk+120
1	76.62
1	±1.04)
1	pp,
1	molar.
1	(abl)
1	(alveolar
1	cellularity),
1	(lipoxin
1	a4),
1	(rolling
1	endothelial-leukocyte
1	adhesion),
1	(metalloproteinases,
1	(pcna,
1	cxcr4)
1	abl.
1	antiophidian
1	mouriri
1	gardn.
1	(melastomataceae),
1	byrsonima
1	niedenzu
1	(malpighiaceae),
1	davilla
1	hill.
1	(dilleniaceae)
1	strychnos
1	pseudoquina
1	hil.
1	(loganiaceae)
1	(leaves),
1	hemorrhages.
1	(quercetin
1	myricetin)
1	myricetin,
1	holocrine-type
1	integument,
1	bradykinin-like
1	nordestina.
1	pre-fractionated
1	low-molecular-mass
1	kplwrl-nh2
1	rplswlpk
1	vppkgvsm
1	vasoconstrictor.
1	vwa-containing
1	svmp,
1	anti-alpham/beta2
1	footpads.
1	footpad:
1	t. maculosa
1	post-venom
1	fitc-dextran.
1	justifiable
1	stomachache
1	hcl/60%
1	etoh,
1	ligature)
1	sulfhydryls
1	antisecretory
1	metaloproteinases,
1	(pba).
1	gelatinolytic,
1	caseinolytic,
1	healths,
1	tourism.
1	rapidally
1	12-fold
1	edematous
1	there.
1	swimmers
1	sudoresis,
1	indisposition,
1	venom-elicited
1	(edematic
1	myotoxic)
1	μg/30
1	intraplantar),
1	(bjcul)
1	agarose-d-galactose
1	32028,
1	dimmer
1	hemagglutination.
1	60min,
1	15min.
1	(0.039-5.0μg/100μl)
1	(1.25-10μg/30μl)
1	bjcul,
1	orbignyi.
1	hggykptdk,
1	aligns
1	97-105,
1	subclasses-isolated
1	(aav)-to
1	igg(t).
1	demostrate
1	efficacies,
1	depurate
1	poison,
1	excruciating
1	myotoxicity;
1	775
1	clusterin
1	(1.5%),
1	retrotransposon-like
1	(18.8%)
1	(0.8%).
1	multi-domain
1	conserving
1	platelet-aggregation.
1	trans-illuminated
1	250%)
1	haemodinamic,
1	o-phenanthrolin-treated
1	jararhagin-c.
1	potamotrygonidae
1	orbignyi).
1	vigorous.
1	orbignyi
1	effects:
1	(ms3),
1	fractionated.
1	natterin,
1	trasylol
1	tki.
1	databanks.
1	natterin.
1	spectrometry/2dge.
1	kallikreins,
1	new.
1	tourists.
1	eletrophoretical
1	bands:
1	(0.1-6
1	(209.5
1	135.0
1	syntase,
1	fentanyl
1	(tki,
1	(pksi
1	two-fold.
1	serino-,
1	aspartyl-
1	cysteino-proteinase
1	tissue-kallikrein-like
1	subspecie
1	dl50
1	crotoxins
1	con-a.
1	(j774a1)
1	(intraplantar)
1	niquim,
1	240-280
1	6g%
1	(%tna+),
1	(%tk+)
1	(%tcl-).
1	(n=6).
1	rvr.
1	uf.
1	uf,
1	%tna+,
1	%tk+,
1	%tcl-.
1	hyalin
1	fibrin.
1	thrombi,
1	hypercontracted
1	hypercontracted,
1	perimysium.
1	1:8,192,000
1	(ed50=141.5
1	μl/mg)
1	stung
1	'ictismo'
1	fisiopathologic
1	jobs
1	sequels.
1	(pain,
1	natteriri
1	jerking
1	motions,
1	hair,
1	violent
1	edematous,
1	19,000.
1	amido
1	whcih
1	cystitis/bladder
1	(ic/bps)
1	(cyp)-induced
1	[wild-type,
1	(wt)]
1	(tlr4−/−)
1	cyp-injection
1	urodynamic
1	cystometry.
1	88,
1	free-moving
1	volumes.
1	tlr4−/−
1	resatorvid-treated
1	cyp-induced
1	ic/bps
1	virulence;
1	(trpc5)
1	trpc4.
1	coli-derived
1	(lps-)
1	trpc4/trpc5
1	thioredoxin-treated
1	macrophage's
1	phagocytose.
1	thioredoxin-administered
1	trpc4
1	trpc5,
1	anti-bacterial
1	non-neuronal
1	cinnamaldehyde-treated
1	trpa1-dependent
1	non-communicable
1	via,
1	sadly,
1	itch
1	sensations
1	c-fibre
1	(nk1+/+)
1	(nk1-/-)
1	nk1-/-,
1	(0.05 ml)
1	intercostal
1	100 nmol/site),
1	(0.3-10 μg/site)
1	scratching,
1	100 nmol
1	(1 nmol)
1	(3 μg/site)-induced
1	(18.5
1	s.e.m.,
1	5-7),
1	(120 nmol/kg,
1	4-6;
1	nk1-dependent
1	dissect,
1	'grease
1	gap'
1	neuropharmacological
1	conducts
1	easily.
1	prostanoids.
1	99mtc
1	picomole
1	npy,
1	1-preferred
1	34npy
1	2-preferred
1	2+/+.
1	pmol).
1	pyy(3-36)-induced
1	(cgrp),
1	ngf-mediated
1	negated
1	endothelial-derived
1	ngf-dependent
1	ngf.
1	desheathed
1	grease
1	(cap)
1	sub-type
1	ttx-sensitive
1	(vgsc)
1	ttx-insensitive
1	cgrp8-37
1	cgrp1
1	cgrp-related
1	adrenomedullin
1	μg/paw)-induced
1	(s)-1-[2-[3-(3,4-dichlorophenyl)-1
1	(3-isopropoxyphenylacetyl)piperidin-3-yl]
1	azoniabicyclo
1	cloride
1	s.c.+120
1	(s)-n-methyl-n[4-(4-acetylamino-4-phenyl
1	piperidino)-2-(3,4-dichlorophenyl)butyl]-benzamide
1	(sr48968)
1	d-arg-[hyp3,thi5,d-tic7,oic8]bradykinin
1	140;
1	nmol/paw)-induced
1	andmouse
1	hydroxyl-methylglutaryl-coa
1	(sim)
1	isoprenyl
1	sim-induced
1	gsis,
1	<0.2%
1	somatostatin.
1	epac2-deficient
1	([camp]
1	epac2
1	[camp]i.
1	currents,
1	microfluorimetry.
1	(tirfm)
1	depolarization-evoked
1	hypoinsulinemia.
1	20-50%
1	(normalized
1	tirfm
1	(>70%)
1	sur1
1	(v59m)
1	cre-lox
1	sulfonylurea
1	v59m
1	kir6.2,
1	sur1,
1	perforated
1	current-
1	1.22ns.
1	waveforms
1	0.17ns.
1	subthreshold
1	-55mv)
1	capacitive
1	non-β-cells,
1	13.5ms
1	0.2pc.
1	dialysed
1	k,atp
1	2.5ns
1	0.1ns
1	15mm
1	4mm.
1	i</sub>
1	80μms
1	α-cells
1	glucose-increasing
1	(paracrine
1	(exerted
1	itself)
1	atp-regulated
1	-channels
1	snare
1	nsf-attachment
1	∼15
1	single-vesicle
1	exterior
1	∼1.4
1	obligatorily
1	sieve.
1	didactically
1	divided.
1	demanding,
1	expenses.
1	undergraduate
1	discussions.
1	casagrande,
1	tessaro,
1	mamizuka
1	immunocompromized
1	aureus-induced
1	materials/methods:
1	(pelf),
1	pelf;
1	25923
1	αhl
1	atcc-infected
1	fig.
1	(0–25
1	(0–45
1	diphosphoinositol
1	pentakisphosphate
1	(ip
1	β-cell,
1	instigator
1	(ip6k1
1	translators
1	mendes-braz
1	joilson
1	(hyperglycaemia)
1	beccaria
1	service,
1	c57bl-6
1	(pelf)
1	(il-)
1	pyrophosphates
1	5-di-phosphoinositol
1	pentakisphosphate,
1	ip7,
1	hit-t15,
1	inositide
1	ip7.
1	suspicious
1	poisons.
1	(ip6ks)
1	(wortmannin,
1	ly294002),
1	pi4k
1	(phenylarsine
1	pao),
1	(u73122)
1	(hnmpa).
1	ip6k.
1	erroneously
1	ip7's
1	(bmdm)
1	(alloxan
1	(308-thr
1	473-ser)
1	pkcα/β
1	delta.
1	p-p38,
1	p-sapk/jnk,
1	p-pi3k
1	(p55)
1	(473-ser)
1	lps-insulin
1	(mkk)
1	mkk2,
1	intravenous)
1	(al(oh)3,
1	(balf),
1	(pas),
1	leonardo
1	bella
1	background/aims.
1	(wbc),
1	(pel),
1	wbc,
1	tessaro
1	dm-related
1	eicosanoid-related
1	(pel)
1	fluids;
1	(elisa);
1	slides;
1	(urea,
1	(alp)
1	analyses);
1	(hematoxylin
1	staining).
1	1iu
1	4iu,
1	alp,
1	clp-induced
1	(gc)-induced
1	(gilz)
1	gc.
1	gc-induced
1	trans-activator
1	(tat)-gilz,
1	survival-controlling
1	mcl-1.
1	gilz<sup>-/-</sup>
1	(bmm),
1	(physiological
1	(mhcii,
1	pan-macrophage
1	kim2r,
1	cd11b)
1	(lc)3,
1	(atg)12
1	(bmm).
1	from.
1	vesicle-bound
1	(io).
1	(lr)
1	io,
1	enterectomy/enteroanastomosis
1	necrotized
1	(9.0-fold)
1	salineytreated
1	50%in
1	(14%),
1	(57%).
1	strangulated
1	taurocholate-induced
1	patrol
1	driven.
1	descriptors:
1	explainable.
1	surgeries,
1	regrettably
1	commands
1	introduced,
1	demystify
1	command.
1	pancreatitis-associated
1	(ap).
1	bbci,
1	sti,
1	160.0
1	leucocyte-endothelial
1	scrotal
1	scrotum
1	chemo-attractant-1
1	bbci.
1	factor-,
1	elastase,
1	(o3)
1	laparotomy;
1	procedures;
1	clp+
1	p<0.05
1	(clp
1	clp+o2).
1	(rl).
1	b/camp
1	(nf-κb-creb)
1	creb-binding
1	(cbp)
1	ptx).
1	(i-κb)
1	(emsa).
1	cbp
1	immunoprecipitation.
1	nf-kb-cbp-binding
1	creb-cbp-binding
1	binding-activity
1	prbc-induced
1	mapk-associated
1	ap-induced
1	(ptx;
1	i-κbα,
1	camp-response
1	a-independent.
1	ptx-mediated
1	(rl)
1	postresuscitative
1	(rl),
1	resuscitated
1	(cinc)
1	hemeoxygenase-1
1	andimmunohistochemistry.
1	cinc
1	0.09).
1	matrigel-3d
1	(mmp-2,
1	(hgfa)
1	(vicc),
1	vicc
1	(prohgfa
1	thromboelastometry
1	(colorimetric
1	thromboelastometric
1	bjv-injected
1	(410.0
1	4-(2-aminoethyl)benzenesulfonyl
1	(aebsf),
1	-edta)
1	kupa,
1	drewes,
1	barioni,
1	sampaio
1	farsky.
1	(translocator
1	tryptophan-rich
1	sensor)
1	(1,100
1	ltb4's
1	ltb4-induced
1	tlr4-elicited
1	vav1,
1	arp2/3.
1	philip
1	newsholme
1	triacylglycerols,
1	cytokines).
1	inmacrophage
1	meditator
1	succinate)
1	reprogramme
1	function/phenotype
1	macrophagemetabolism
1	p-ampk,
1	p-p38
1	queiroz
1	rosana
1	pagano
1	interleukin-(il-)
1	(bmdmφ).
1	cocultivated
1	(fungicidal
1	presentation)
1	(peritoneal
1	cavity).
1	scruff
1	fc,
1	reprogramming,
1	bcg-induced
1	durissusterrificus
1	inh
1	ibited
1	anti-tumor,
1	anti-diabetic,
1	asta-fed
1	(i.p.
1	mg/bw)
1	(tbars
1	pma-stimulation.
1	secretion/sensitivity
1	'glucolipotoxicity'
1	pinkish-orange
1	crabs,
1	salmon),
1	photoprotective,
1	immunodepression,
1	(o2•-),
1	(no•),
1	(h2o2);
1	ca2+;
1	asta-fed/diabetic
1	(precursors
1	peroxynitrite),
1	no•/h2o2-mediated
1	(cdtv).
1	scrotum.
1	(a selective
1	c. durissus
1	(par)
1	s100a9,
1	deactivates
1	paw;
1	potentialize
1	(h92-g102)
1	mannose-receptor
1	ex-vivo,
1	zinc-binding
1	extra-intestinal
1	(expec)
1	o4
1	iucd
1	fyua
1	trat
1	cvac
1	papc/.
1	papef
1	malx
1	(mdr),
1	pathotypic
1	reaction-
1	(h-)
1	faster,
1	non-reactive
1	circumstantially.
1	carry,
1	ehxa
1	(rflp)-pcr
1	stx-,
1	o128:h2/β-intimin
1	o145:h2/γ,
1	o153:h7/β
1	o178:h7/η.
1	stx1cstx2d-o118
1	(46·9%),
1	stx1c
1	(27·2%),
1	stx2d-o118
1	(23·4%),
1	stx1cstx2dox3a
1	(2·5%).
1	disregarded.
1	non-diarrhoeic
1	non-diarrhoeic,
1	diarrhoeic.
1	eae-θ
1	eae-κ
1	eae-α1
1	eae-α
1	eae-α2,
1	eae-β1
1	eae-ε
1	typeable.
1	o125:h6,
1	o125:h6
1	clearly.
1	157-kb
1	α-haemolysin
1	ehec-haemolysin-encoding
1	ehec-virulence
1	po157
1	edl933,
1	unrelated.
1	9227-bp
1	(7252
1	phly152,
1	(99.2%
1	hlyr
1	(98.8%
1	hly
1	phly152
1	is2
1	hlyc
1	phly152.
1	(irp-2,
1	fyua,
1	iuca),
1	(iha,
1	o157/o141'
1	toxb)
1	(inv,
1	ial-related
1	(n=24)
1	toxb
1	iuca,
1	iuca
1	fepc
1	(apec),
1	sep17,
1	septicaemia.
1	afa,
1	o157/oi-141,
1	lpfao157/oi-154,
1	toxb,
1	inva/inve
1	ibea)
1	(lac+,
1	lpfao157/oi-154)
1	hb101
1	(lac-,
1	smr,
1	csga)
1	sep17
1	c3888
1	26:
1	h-)
1	ht-29-human
1	shrank,
1	compact.
1	(enteropathogenic
1	eae-harboring
1	o22:h16,
1	o119:h-
1	o174:h21,
1	o26:h11,
1	o123:h11
1	o177:h11
1	o7:h7,
1	o111:h19,
1	o123:h2,
1	o132:h51,
1	o173:h-,
1	o175:h49.
1	θ/γ2
1	μb
1	o123:h?
1	autoagglutinating
1	o113:h21,
1	o118:h16,
1	o174:h21
1	serogroup/serotype
1	o128:h2
1	palindromic
1	(n=24),
1	(n=11).
1	rep-types.
1	stx1c.
1	stx2c,
1	stx1+2+2c
1	(16.5%
1	stx2d
1	(0.9%),
1	stx2+2c(2vha)
1	stx2c(2vhb)
1	4.8%).
1	sulphazotrin
1	flowthrough
1	more-diffuse
1	(qs)
1	qsea
1	qs
1	ssp
1	rr2,
1	434,
1	opr2,
1	opr8,
1	opr13
1	dendrogram.
1	co-aggregate
1	enterohemolysin.
1	α-hemolysin.
1	fimbriae-related
1	agglutinins
1	(msa),
1	(cba
1	b1/10)
1	dose-time
1	26)
1	(8.3%)
1	ε,
1	(locus
1	effacement)
1	o111:h25,
1	o119:h2
1	o142:h6,
1	(depec)
1	(n=205)
1	(12.7%)
1	(28/139,
1	(16/205,
1	7.8%)
1	enterohaemolysin
1	(41.6
1	50.0%,
1	o111:nm
1	o111:h8
1	(two)
1	o118:h16
1	stec-related
1	(50.0%)
1	(38.1%)
1	ont:h8,
1	o5:h-,
1	o16:h-,
1	o75:h-,
1	o75:h8,
1	o87:h16,
1	o91:h-,
1	o146:h21,
1	o172:h-,
1	or:h-,
1	ont:h-
1	ont:h16.
1	non-o157
1	(se-aflp)
1	(0-0.07
1	dissimilarity)
1	(0-
1	dissimilarity).
1	b-f.
1	(58.8%),
1	(21.5%),
1	(13.7%),
1	(3.9%),
1	muramidase-released
1	(mrp),
1	(ef),
1	suilysin.
1	ef*,
1	ef+,
1	(mrpv,
1	ef-,
1	suilysin-),
1	(eric)-pcr
1	eric-types
1	(a-d),
1	(rapd)-pcr
1	(rflp),
1	nontypable
1	rough,
1	edwardsiella
1	east-1),
1	(stx-1,
1	stx-2),
1	(cnf-1,
1	cnf-2),
1	(eaf),
1	(enthly)
1	(hly)
1	serobiotyped
1	(50.6%)
1	(15.6%)
1	cnf1,
1	cnf2
1	o132:h2
1	af/r2
1	(epec).
1	af/r2+
1	o132:h2:b30
1	serobiotype
1	omphalitis,
1	serogroups,
1	haemolysin,
1	cytotoxin,
1	untypable,
1	untypable
1	rough.
1	(hela,
1	kpcc),
1	hog
1	endocarditis,
1	fibrinous
1	polyserositis,
1	piggeries
1	a-hemolytic
1	voges-proskauer
1	(inulin,
1	salicin,
1	trehalose,
1	glycerol).
1	6,5%
1	strep
1	serotyping:
1	(58,8%)
1	(21,6%)
1	(13,72%)
1	(3,92%)
1	(1,96%).
1	concerned,
1	cytotoxins
1	serogrouping
1	atypical.
1	fas-positive
1	(0-11
1	987p
1	f41.
1	sta,
1	slt-i,
1	slt-ii,
1	slt-iiv)
1	42.8%
1	eaea
1	(o?:h11,
1	o26:h-,
1	0123:h1)
1	(o103:h2)
1	typable.
1	o103:h2
1	o26:h-isolates
1	localized-like
1	diarrheogenic
1	penitentiaries,
1	minimum-security
1	immunoassay-hiv-1
1	hiv-2
1	(meia)
1	(abbott
1	laboratories)
1	blot-hiv-1
1	(cambridge
1	biotech
1	corporation)
1	meia.
1	14.4%.
1	prisons:
1	prison
1	10.9%.
1	inmates,
1	wb,
1	imprisonment.
1	(s32)
1	25.15
1	mean).
1	(0.25mg/ml)
1	70%-80%
1	(10mg/ml)
1	(100°c/5
1	640,
1	least.
1	jab-1
1	jab-1.
1	s32,
1	rhuteniun
1	perfringes
1	(htlv);
1	herpesviridae
1	hepadnaviridae
1	co-transmitted
1	prisoners
1	penitentiary
1	(meia-abbott
1	lab).with
1	(14/24-number
1	reactions/number
1	examined)
1	(3/24)
1	(43/44)
1	(38/40)
1	11.36%
1	(5/44)
1	(1/40)
1	(5/39)
1	stap,
1	stb)
1	vt2,
1	vte)
1	false-
1	stb
1	seropathotypes
1	predominant:
1	o149:k91:h10
1	k88+
1	lt-i+
1	stb+,
1	o141:k85ab:h-
1	p987+
1	stap+,
1	o138:k81:h14
1	stap+
1	vt2v+.
1	n-acetylgalactosamine.
1	colibacillosis.
1	(1,500
1	(0101,
1	sta+,
1	k99+,
1	f41+).
1	stools.
1	k99-f41-harboring
1	tnphoa,
1	bz2468)
1	bz43).
1	bz43
1	colisepticaemia,
1	invasiness
1	colisepticaemic
1	(362)
1	88.0
1	43.0
1	ampicilin.
1	(tnpho
1	362
1	enterochelin
1	verotoxin-producing
1	(vtec)
1	(vt1
1	vt2)
1	stap
1	stb).
1	o26:k-:h11
1	o103:k-:h2
1	o128:k?:h-
1	o4:k-:h4
1	o113:k-:h21
1	o81:k?:h28
1	o157:k-:h-
1	o157:k-:h7
1	(25.94%)
1	(15.05%)
1	(btv-s4)
1	nmwp,
1	(iif)
1	(50.5%)
1	(52.7%)
1	(51.6%)
1	(54.2%)
1	(52.3%)
1	(93.8%
1	92.1%),
1	(91.4%
1	88.2%)
1	(91.8%
1	89.7%)
1	(93.48%
1	90.9%)
1	bt-infected
1	(iim
1	(20.45%)
1	(15.84%)
1	polyacrilamide
1	(51.7%),
1	electrophoretype,
1	ib,
1	iic,
1	iiib,
1	iva.
1	(10.61%)
1	coprocultures
1	easier,
1	(84,6%)
1	piggery
1	(iea-a)
1	(iea-b)
1	scrological
1	delipidized
1	gangliosides:
1	picobirnaviruses
1	912
1	sa11
1	glucose-dependent.
1	7.4.
1	f42-positive
1	deoxycholate-soluble
1	sepharose-4b.
1	focusing,
1	verocytotoxigenic
1	diarrhoca
1	(pih).
1	(petec)
1	0149
1	(pih)
1	-70°c.
1	lt+)
1	(-xhb),
1	lt-.
1	(coded
1	567/7)
1	rnicrohemaggluti-
1	(mrmh),
1	(k88,
1	f41).
1	firnbrial
1	(provisionally
1	f42)
1	567/7
1	discs.
1	(srih)
1	extracellular.
1	enterotoxigenicity
1	interrelated,
1	enteritidis.
1	g-100.
1	anti-f1
1	antitoxin.
1	tl-like
1	sanarelli-shwartzman
1	staples
1	(sag
1	(caye)
1	(lt+,
1	st+)e.
1	plotted,
1	caye
1	lincomycin
1	ug/ml)
1	concomitantly.
1	stationarily
1	37‡c
1	enterotoxin-producing
1	(non-etec)
1	microhaemagglutination
1	(mrmh)
1	haemagglutinating
1	-stable
1	(lt/st)-producing
1	o63:h-
1	0139:h28
1	o128ac,
1	mices
1	intubation.
1	intestines/carcass
1	(ri/c)
1	0.085.
1	artifactual
1	lt-e.
1	lamna
1	epithelial's
1	vacuolizations.
1	veronal-buffered
1	diluent,
1	antitoxin,
1	lt-positive
1	bacteriologically
1	gordonae
1	nitid
1	48,46%.
1	tuberculostatic
1	isoniazid.
1	ethionamide,
1	ethambutol,
1	rifampicin,
1	capreomycin,
1	viomycin
1	intracellulare),
1	dean's
1	st-producing
1	0.122.
1	st-negative
1	0.059
1	0.069.
1	0.070
1	0.075.
1	lags
1	merging
1	vivax-like).
1	(ypvcsp-allfl)
1	(ypvcsp-allct)
1	isa720.
1	(adhu5)
1	pb/pvvk210
1	pb/pvvk247
1	cariste,
1	virgílio,
1	moraschi,
1	bruna-romero,
1	menin
1	ruiz,
1	lannes-vieira,
1	vasconcelos.
1	anti-lfa-1
1	anti-lfa-1,
1	fas/cd95
1	(19 kda)
1	(pvama166-msp119).
1	pvama166-msp119
1	c57bl/6)
1	ifn-gamma-secreting
1	pvama166
1	advantageous,
1	hemoparasite
1	multi-subunit
1	msa-2a1,
1	msa-2b
1	msa-2c
1	emulsifying
1	720,
1	msa-antigen
1	msa-2a1
1	msa-2c.
1	immunoproteasomes
1	inducer).
1	(tko)
1	cd8+effector
1	(cd8+cd44highcd62llow)
1	(vnhrftlv)
1	(ifn-γ+/tnf+)
1	(ifn-γ+)
1	sánchez-arcila
1	polyparasitism
1	malaria-intestinal
1	(m);
1	(ci);
1	sub-classes
1	ny-eso-1
1	(cl-14-ny-eso-1)
1	ny-eso-1-specific
1	cl-14-ny-eso-1
1	unbalance.
1	(rad)
1	(radasp2)
1	radasp2+radts
1	(radvax)
1	(ifn)γ-producing
1	dpi).
1	post-therapy
1	pre-therapy
1	ifnγ-mediated
1	(anti-cd3
1	anti-cd28),
1	reshaped
1	vaccine-based
1	rad
1	re-programming
1	previously-described
1	(pvcsp)
1	epitopes)
1	(hbcagpvcsp).
1	rpvcsp-me,
1	areas.mice
1	66%,
1	il-2-secreting
1	generate,
1	klrg1
1	cd27low
1	cd43low
1	cd183lowt-
1	bethigh
1	eomeslow
1	gzmbcreert2/rosa26eyfp
1	indelibly
1	primeboost
1	(mpla),
1	(ifa).
1	mpla
1	mpla.
1	"conditions
1	practice"
1	invasioninhibitory
1	vaccine.in
1	rts,s
1	recombinantproteins
1	poly(i.c)
1	(protein-protein)
1	(adenovirus-protein)
1	nonrepeated
1	vk247.
1	morrot
1	mhc-class
1	skin-draining
1	helpers.
1	-independent.
1	foreseeable
1	mhc-restricted
1	virgilio
1	(f3).
1	1-103)
1	anti-nh36
1	nh36-specific
1	cross-protection
1	cross-immunity.
1	a34480
1	nico,
1	alves-silva,
1	morrot,
1	palatnik,
1	palatnik-de-sousa.
1	(asp)
1	(cb10xbalb/c)
1	colombian).
1	adriano
1	(pvmsp-119)
1	cd4§ssup§+§esup§
1	evidenced,
1	subclass.pvmsp-119-induced
1	riccio
1	carboxi-terminal
1	cruzís
1	(asp2).
1	protocol)
1	asp2
1	(ad-asp2)
1	c3h/he).
1	ad-asp2.
1	cd107a.
1	cassette.
1	(yf17d/ens1/tc)
1	producing-cells
1	(tewetgqi)
1	ns2b-3
1	cd95.
1	erosion.
1	dominguez,
1	ersching,
1	tararam,
1	bruna-romero
1	gonzález-aseguinolaza
1	jr
1	7(4),
1	e34445
1	(2012).
1	cd8+cytotoxic
1	ankara
1	meaningful.
1	cd8+multifunctional
1	cd8+t-cell-mediated
1	ethnically
1	-dqb1*
1	276)
1	(msp-1),
1	dqb1*
1	hla-dqb1*03.
1	pvmsp1-19
1	(86.7%),
1	pvmsp-3
1	pvmsp-9
1	hla-dqb1*03
1	hla-drb1*01
1	non-responders
1	pvmsp-9,
1	drb1*16
1	pvmsp3
1	lima-junior
1	chiococca
1	bidesmosides
1	glycidic
1	aglycone.
1	contains:
1	arabinose-rhamnose
1	arabinose-rhamnose-xylose
1	ca3x;
1	arabinose-rhamnose-apiose
1	arabinose-rhamnose-apiose-apiose
1	saponin.
1	hydrophile/lipophile
1	12.7,
1	19.9.
1	elisa-antibody
1	(idr)
1	(78%).
1	cd4-tnf-α,
1	cd8-tnf-α
1	(p=-0.007).
1	tnf-α-receptor
1	xylose-containing
1	(hd
1	50=87μg/ml).
1	idr
1	+pdca1
1	re-circulated
1	receptor-1.
1	re-circulation
1	(ccc).
1	kinase-mb
1	(ifnγ)
1	(pfn)neg
1	ifnγnegpfn+
1	pfn+
1	silverio
1	cruzi-associated
1	tlr-activated
1	trypanosomiasis).
1	mauricio
1	invasion-related
1	isa720
1	igg2a),
1	cd62lhi)
1	cd62llo)
1	ama-1,
1	(ad/ad,
1	ad/p,
1	p/p),
1	sites:
1	ns2b
1	ns3.
1	(protozoan)
1	t-cd8+
1	cpg-adjuvanted
1	il-15
1	(pil-15)
1	[with
1	elisas,
1	il-2),
1	assays]
1	detected>6
1	re-stimulation.
1	eickhoff
1	therefore,are
1	(amino-acids
1	36.73612.33%
1	ifn-c
1	percents
1	tnfa/il-10
1	(90.5-88.23%;
1	long-lasting.
1	nh36,
1	nhs-dependent
1	nico
1	β-galactose
1	agglutinin.
1	resialylate
1	acid-containing
1	115-kda
1	cd43,
1	st3gal-i-deficient
1	cd43
1	iynvgqvsi
1	trans-sialidase-mediated
1	peptide-major
1	1-103
1	104-198
1	199-314
1	pet28b
1	bl21de3
1	riedel
1	haen
1	67.8%
1	splçeen
1	gamma/il-10
1	repectively,
1	(138.57/20.57
1	(181.42/64.71
1	saponin-nh36
1	amastigote-expressed
1	plasmid-injected
1	claser
1	(ck18)
1	cruzi-host
1	(rnai)-mediated
1	ck18-rnai
1	escaped
1	co-localize.
1	vtvxnvflynr
1	ck18,
1	ck-18.
1	rnai,
1	protein-3α
1	alanine-rich
1	heptad
1	coil.
1	msp-3α,
1	cc4
1	cc5,
1	cc5
1	fml,
1	(92-95%
1	76-80%
1	efficacy)
1	saponin-containing
1	36-kda
1	fml-saponin-leishmune
1	tolerization;
1	unmethylated
1	odn,
1	cross-priming.
1	mechanistically
1	28,712
1	hastened
1	tzelepis
1	icr
1	ts,
1	asp-2-like,
1	tc24.
1	asp-2-like
1	tc24
1	tc24,
1	msp-1(pvmsp
1	n-1
1	(pvdbp-rii)
1	95,
1	72.7,
1	re-infection
1	unsurpassed
1	(radasp2).
1	p154/13,
1	humoral,
1	p154/13.
1	crust-infected
1	intraventricular
1	extrasystoles.
1	p2β,
1	trans-sialidase)
1	styrene-1%
1	divinylbenzene
1	(amr),
1	swelled
1	amr
1	5.5.
1	acetyl-(nanp)3-amr
1	dodecapeptide
1	43-487)
1	(97.3%)
1	refolded.
1	48.5%
1	(pv66/ama-1).
1	cruzipain-derived
1	dr-binding
1	19kda
1	padre.
1	(cfa/ifa)
1	mpl/tdm.
1	cfa/ifa.
1	semi-purified
1	his6-msp1
1	19-padre)
1	(pichia
1	(ymsp119-padre)
1	gst-msp119,
1	6-msp119,
1	his6-msp119-padre
1	ymsp119-padre
1	98.3%
1	(his6-msp119
1	6-msp119-padre)
1	(ymsp119-padre).
1	patients),
1	diethylaminoethyl-attaching
1	anion-exchanger
1	deae-macroprep
1	a50
1	peptide-resin
1	peptidyl-resins
1	side-chain
1	potentiality,
1	peptidyl
1	supports.
1	capacities,
1	applying,
1	igg1/igg2a,
1	non-glycosylated
1	(85.6
1	dicorynomycolate
1	β-strands
1	tick-born
1	hindrance.
1	nanp
1	(17d/8)
1	17d/8
1	(his6-msp119)
1	pgex
1	pmal
1	titermax,
1	mpl/tdm/cws
1	dna-induced
1	ts-inhibitory
1	(ifn-γ)-producing
1	glycoinositol
1	red-stained
1	α-galactosyl
1	blebs,
1	sialylated.
1	mgcl2
1	charges
1	anti-α-galactosyl
1	(ts).
1	whole-parasite
1	78.6%
1	71.4%
1	(a/sn).
1	vr1012,
1	cotijuba,
1	pvmsp119,
1	76.6,
1	29.8%,
1	(77.4%)
1	(<6
1	(43.9%),
1	(6.25%).
1	(tc1)
1	dna-vaccinated
1	iynvgqvsi.
1	19-kd
1	belem
1	13-
1	11.2%
1	dramatic.
1	(b:4:p1.15),
1	(n44/89).
1	b:4
1	serosobtypes:
1	p1.15,
1	p1.7,1,
1	p1.3,
1	p1.9,
1	plnt,
1	b:8,19,23:
1	p1.16
1	(cu385/83)
1	(pora
1	vaccinees.
1	vaccinees
1	serosubtype
1	p1.15.
1	p1.15
1	meningococci.
1	roadblocks
1	α-2,3-
1	sialidases.
1	transsialidase
1	sequential-type
1	(hydrolysis),
1	sialyllactose
1	35°c,
1	trans-glycosylation
1	methyl-umbelliferyl-n-acetyl-neuraminic
1	long-
1	enzyme-sialosyl
1	methyl-umbelliferone
1	aglycon
1	transglycosylation
1	glycosidic
1	immunoglobulin,
1	dues
1	(83.8
1	51.4
1	54.5%
1	h-2k(k)-
1	h-2k(d)-restricted
1	syvpsaeqi
1	chromium-51
1	36-48
1	intrasplenic
1	complex-restricted
1	sporozoite-challenged
1	make-up.
1	non-responsiveness
1	dones
1	(ya23
1	ya26)
1	(yb8
1	ya15)
1	activityon
1	“protective”
1	“nonprotective”
1	lymphocyte(ctl)
1	granuleassociated
1	of“associating”
1	yb8
1	cd44.
1	wereprotective
1	lfa-l-mediated
1	homotypic
1	aggregate.
1	ofmediating
1	ofan
1	h-2d-restricted,
1	cba
1	bystander,
1	cba,
1	ofneutralizing,
1	anti-ifn-g
1	(rpvcs-2)
1	pvcs-2
1	308-320.
1	d/a
1	p308-320,
1	p344-355
1	p353-364
1	p308-320
1	h-2a
1	p353-364,
1	277-288
1	sporozoite-immunized
1	cytolysls
1	mhc-compatlble
1	rlbosomal
1	intrahepatocytlc
1	yoelll.
1	mechanlsm(s)
1	stage‐specific
1	metacydics
1	pre‐incubated
1	(0‐5
1	mg/mouse)
1	the‘in‐vitro’
1	kd‐primed
1	metacyclics,
1	non‐immunized
1	gp10/20,
1	l3t4+
1	tropica.
1	(gp-10/20
1	anti-gp-10/20
1	(g25)
1	96.5%
1	specises
1	repeated-measures.
1	62.7
1	scale;
1	“on”
1	repetition,
1	2-minute
1	intervals).
1	+45
1	+73
1	+18
1	+31
1	=.003
1	and.007,
1	+63
1	+54
1	+61
1	=.04),
1	evidence:
1	ideation
1	(aemc)
1	methods/design:
1	blinded,
1	superiority,
1	dsm-v
1	episodes)
1	cae,
1	raters
1	montgomery-asberg
1	"ppsus
1	2015".
1	pragmatic
1	(rebec)
1	rbr-9zgxzd
1	jan.
1	(balance
1	[bestest]
1	[biodex
1	])
1	(falls
1	scale-international
1	[fes-i]
1	(montreal
1	[moca]
1	published)
1	(bestest
1	sections)
1	−0.75,
1	rti,
1	falling,
1	(lactate)
1	(electromyography;
1	emg)
1	high-load
1	(bfr)
1	(bfr-i),
1	(bfr-s),
1	bfr.
1	1-repetition
1	maximum.
1	hl.
1	(1.47)
1	(0.66)
1	(0.59).
1	57:
1	107–111,
1	(modified
1	2–3)
1	[pdt]
1	[pdc]
1	exercises,
1	(deep
1	valsalva
1	maneuver,
1	61±17
1	[nu]
1	47±20nu;
1	60±14nu
1	63±10nu;
1	−14±11mmhg
1	−6±10mmhg;
1	−12±10mmhg
1	−11±10mmhg;
1	(abpv)
1	(sddn)
1	(arv),
1	abpv.
1	66 ± 2 years,
1	2–3
1	yahr)
1	64 ± 1 years
1	cv,
1	arv.
1	(10·4 ± 0·9/12·3 ± 0·8
1	7·0 ± 0·3/9·9 ± 0·5%,
1	p<0·05;
1	12·6 ± 1·0/9·1 ± 0·5
1	8·6 ± 0·4/7·5 ± 0·3 mmhg,
1	(10·9 ± 0·8/8·2 ± 0·5
1	8·2 ± 0·3/7·1 ± 0·2 mmhg,
1	(8·8 ± 0·6/6·9 ± 0·3
1	7·2 ± 0·2/6·0 ± 0·2 mmhg,
1	sdd,
1	cvd,
1	avr.
1	posttraining.
1	pittsburgh
1	[psqi])
1	intervention;
1	subscores(i.e.,
1	dysfunction),
1	improved)
1	kneeextensor
1	20.58,
1	(ttv)
1	(forward
1	torque,
1	posttraining,
1	0.068),
1	0.58,
1	0.020).
1	(dri)
1	analysis);
1	0.0154)
1	[confidence
1	0.1-
1	0.5]
1	-1.1)
1	(r=-0.69,
1	0.051)
1	infscale
1	montreal
1	(moca)
1	(pdq-39)
1	devices),
1	bosu®
1	(tug).
1	(moca),
1	(pdq-39),
1	maximum).
1	tug,
1	moca,
1	tug
1	(-1.9
1	updrs-iii
1	(-4.5
1	pdq-39
1	(-5.2
1	cross-sectional.
1	(n=68)
1	(n=48;
1	66±8y;
1	"on"
1	(n=20;
1	64±9y).
1	ergometer.
1	(vo2),
1	[at]
1	exercise).
1	(vo2:
1	14.6±3.6ml·kg·min
1	17.9±5.5ml·kg·min
1	17.7±4.8ml·kg·min
1	21.5±6.6ml·kg·min;
1	rate:
1	119±17beats/min
1	139±12beats/min
1	132±20beats/min
1	158±13beats/min;
1	sbp:
1	151±17mmhg
1	172±20mmhg
1	166±21mmhg
1	187±24mmhg;
1	p≤.05).
1	(102±14beats/min
1	110±13beats/min;
1	p≤.05),
1	unauthorized
1	prohibited.
1	eo,
1	tricoli,
1	roschel,
1	avn,
1	silva-batista,
1	wilson,
1	28(11):
1	3215-3223,
1	2014-concurrent
1	(17.08
1	17.9%,
1	(53.9%)
1	flst-3,
1	foxo-3a,
1	18.5%;
1	17.6%).
1	living,
1	bosu,
1	dyna
1	ball)
1	go,
1	stand,
1	33.3%,
1	28.6%,
1	42.3%,
1	40.1%,
1	128.1%,
1	100.0%.
1	12.7-fold
1	falls,
1	(flexibility,
1	cardiorespiratory)
1	(ipaq-sf).
1	21-43
1	sit-and-reach,
1	sit-ups
1	push-ups,
1	20-m
1	(mets
1	min·wk-1)
1	min·wk-1
1	vigorous-intensity
1	176)
1	flexibility,
1	ipaq-sf's
1	1rm)
1	(gwu)
1	warmup:
1	(sdli;
1	(ldli;
1	(sdmi;
1	(ldmi;
1	2max),
1	no-gwu
1	ldli
1	(367.8
1	70.1
1	ldmi
1	(345.6
1	70.5
1	sdmi,
1	sdli,
1	(359.4
1	69.2
1	359.1
1	69.3
1	359.4
1	70.4
1	anthropometrical
1	leg-press
1	(hsp1rm)
1	(lsp1rm)
1	mean±sd
1	292.8±52.1kg,
1	84.7±17.9kg,
1	19249.7±1645.5mm2and
1	50.8±7.2%
1	hsp1rmand
1	254.0±51.1kg,
1	69.2±8.1kg,
1	15483.1±1104.8mm2and
1	51.7±6.2%,
1	lsp1rmin
1	r2=0.35,
1	p=0.0001)
1	lsp1rm(adj
1	r2=0.25,
1	p=0.002).
1	hsp1rm,
1	r2=0.38,
1	familiarization
1	bland-altman
1	(17kg
1	19%)
1	(9kg
1	14%)
1	familiarizations
1	(pil-10r).
1	(pgde7h).
1	treatable
1	(czs)
1	(npcs).
1	dizygotic
1	czs.
1	czs-affected
1	czs-unaffected
1	twins.
1	non-vaccination
1	ncbi-pubmed,
1	lilacs,
1	(scielo),
1	non-vaccination,
1	narcolepsy.
1	non-scientific
1	disseminating
1	truthful
1	reignited
1	papillomavirus-induced
1	co-delivery.
1	hospitalization.
1	microbead-based
1	88.4%
1	gamma-induced
1	(trm)
1	recirculate.
1	recirculate,
1	parabiosis
1	tfgβ
1	extrapolate
1	20–30 nm
1	peptide-dna
1	250 nm.
1	(hpv-16).
1	oligo-peptides
1	nonviral
1	dna/gene
1	endowing
1	e75,
1	b-subunit
1	(stxb),
1	(her2/neu
1	trastuzumab)
1	hla-class
1	her2/neu-expressing
1	cells-a
1	tumorspecific
1	(mdsc),
1	(hpv-16)-associated
1	mdsc
1	dna-coated
1	gun)
1	(dioctadecyldimethylammonium
1	microparticles.
1	(acs46)
1	envelope-specific
1	acs46-primed
1	polyfunctional,
1	virus/hiv-1
1	(pgm-csf)
1	(hla)-dr
1	interleukin-2.
1	e6/e7-specific
1	therapeutic-approach,
1	immunoglobulinlike
1	(ligac)
1	ligac,
1	antileptospirosis
1	nanospheres.
1	alpha-emitting
1	radionuclides
1	peptide/dna
1	nanofibers
1	condense
1	ratios).
1	travelers'
1	strand-complemented
1	cfae
1	(dsccfae),
1	cfa/i-etec
1	2*107
1	dsccfae,
1	orogastric
1	suckled
1	antenatally
1	20*ld50
1	ltk63
1	birthing
1	vaccine-specific
1	corroboration,
1	antiadhesin
1	antifimbrial
1	dsccfae
1	faithfully
1	neurovirulence.
1	cd8<sup>+</sup>
1	induce.
1	(dsdna)
1	mrna-editing,
1	polypeptide)-mediated
1	tbk-1
1	(tank-binding
1	apobec3a
1	apobec2-specific
1	(hlt)
1	hlt,
1	hlts,
1	hlt.
1	hltadjuvants
1	proffered
1	ltiic
1	(dln)
1	experimental,
1	bamyloid
1	tangles
1	b-amyloid
1	bifido
1	unfermented
1	animalis
1	hn019
1	hpv-specific
1	hpv-expressing
1	nonclinical
1	(css)
1	cs21,
1	self-aggregation,
1	cs21-mutant
1	pig-derived
1	cs21-
1	cs21-mediated
1	lnga
1	anti-lnga
1	intra-stomach
1	(denv2)
1	(lt
1	anti-virus
1	fa-adjuvanted
1	g33d.
1	anti-dengue
1	ccl22
1	silico)
1	(her2/neu,
1	gp100)
1	(cd44high)
1	(icos+)
1	(lt-i
1	lt-ii)
1	holotoxins
1	(lt-iiab
1	lt-i.
1	papillomaviruses.
1	(pgd-e7e6e5)
1	(e7,
1	e5)
1	gun.
1	μg/dose)
1	e7-
1	(inf-γ)-producing
1	20,000-100,000
1	shakers
1	bioreactors,
1	(tuf).
1	tuf
1	52.2%
1	think
1	non-preventable
1	getting
1	(e5,
1	e7)
1	transplantable
1	pgd-e7e6e5,
1	requirement,
1	priming/boosting
1	succinimidyl
1	(cfse)-labeled
1	h-2db-restricted
1	e5
1	hpv-16-associated
1	lb,
1	25-2
1	factorial
1	(1.06
1	170rpm,
1	μgml-1
1	od600=0.6,
1	(5.60
1	od600=0.5.
1	verocytotoxin
1	(stx),
1	globotriaosylceramide
1	pentamer.
1	(pstx2δab)
1	nonfused
1	stx-specific
1	pstx2aab
1	mucosal/transcutaneous
1	biological/immunological
1	(lt2)
1	(s190l,
1	g196d,
1	s224t)
1	(t75a).
1	accumulation)
1	lt2.
1	typhimurium)
1	(flici),
1	(fljb),
1	flici,
1	fljb
1	flici.
1	fepa,
1	terminus.
1	fepa.
1	energy-
1	periplasm,
1	expulsion
1	β-barrel.
1	fluoresceination
1	ball-and-chain
1	ganglyoside
1	(gm1
1	lt-quantification
1	antibody-capture
1	(celisa).
1	lt-specific
1	49.8
1	2415
1	anti-etec
1	hg3,
1	salmonella-boosting
1	(ltr192g)
1	cfab-specific
1	etec-associated
1	(putrescine
1	spermidine)
1	j53
1	type-16
1	e7-encoding
1	gd-encoding
1	vitro-transfected
1	dna/dose)
1	pwecfa,
1	(hg3)
1	propose,
1	primer-salmonella
1	immunogenicities
1	(rapd-pcr),
1	(mlee).
1	ont:hnt,
1	o7:h24,
1	o48:h21,
1	o88:h25,
1	o159:h21.
1	st-h
1	o159:h17,
1	o148:h28
1	o6:h-.
1	o6:h-
1	cs6,
1	rapd-pcr,
1	intra-serotype
1	overlooked
1	frustrating
1	factory
1	(cfs).
1	middle-eastern
1	biology-based
1	(nasal/oral)
1	(i.p.))
1	sl1438
1	inoculations.
1	cfa/i-mediated
1	pblcfa,
1	pblcfa-tranfected
1	cross-reacting
1	fimbra
1	lt((r192g)).
1	lt((r192g))
1	15-amino-acid-long
1	vdpvidllqadgnal
1	(cs1)
1	cfa/i,
1	cs1,
1	cs2,
1	pcfo166
1	cs4.
1	cfs
1	parenterally/orally-administered,
1	flagellated,
1	sl5929
1	ctp3
1	50-64)
1	b-subunit.
1	ctp3-
1	sl5930,
1	nonhybrid
1	peyer
1	(etec).
1	compartments:
1	(ppolycfa)
1	(pblcfa).
1	cfa/i-encoding
1	dna-primed/salmonella-boosted
1	(bhk-21)
1	th-1-type
1	igg).
1	and-or
1	cs1-cs3
1	cs2-cs3
1	coccoid-to-ovoid
1	magnetically
1	α-subclass
1	polynucleotide
1	post-embedding
1	mabrj12,
1	mabrj58
1	morphotype
1	pre4
1	precfa.
1	immunizated
1	(pcfa-1)
1	f'laci(q).
1	isopropyl-β-d-
1	thiogalactopyranoside
1	(iptg)
1	4/5
1	o6:h16,
1	o27:h7,
1	o29:h21,
1	o128ac:h12,
1	o153:h45,
1	(colonization
1	intraserotype-
1	h31,
1	non-motile
1	h31
1	1-15),
1	11-25),
1	32-45)
1	88-102),
1	enterocyte-like
1	(s-cfa/i
1	17:8)
1	idllq
1	pepscan
1	vidll
1	feaaal
1	anti-fla
1	s-cfa/i
1	17:8
1	endosymbiont.
1	sarkosyl-soluble
1	[3h]-benzylpenicillin.
1	(pbp1)
1	(pbp2).
1	[3h]-benzylpenicillin
1	[3h]-benzyl-penicillin
1	pbp1
1	muenchen
1	(h1-d)
1	flagellin-coding
1	motile.
1	(flaii)
1	(flaiv)
1	solid-phase-bound
1	(flal)
1	(flaiii)
1	(elsa)
1	cfa/i-positive
1	(pbp3),
1	pbp3-overproducing
1	42°c,
1	σs)
1	σ32)
1	σ32.
1	(h10407
1	4011-1)
1	annealing
1	(omp)
1	(flagellar
1	(toxins
1	enzyme-immunosorbent
1	(dot-elisa)
1	pha-positive
1	pha-negative,
1	useful,
1	(stationary
1	iodogen
1	131i,
1	n-hydroxysuccinimidyl
1	6-biotinylaminohexanoate
1	(biotin
1	x-nhs)
1	avidin.
1	x-nhs
1	radiolabelling
1	pestis.
1	(slt)
1	murein
1	autolysin
1	slt
1	overproducing
1	bio-synthesis
1	fomration
1	guanosine-5′-diphosphate-3′-diphosphate
1	sarkosyl
1	dodecyl-sulfate
1	nadh-dehydrogenase
1	fraction-1
1	17,000
1	gold-conjugated
1	(ev76)
1	temperature-dependent
1	full-pathogenic
1	vw
1	pesticin-fibrinolysin-coagulase
1	14.9,
1	megadaltons
1	fingerprint.
1	penicillin‐binding
1	carboxyl‐coding
1	runaway‐replication‐control
1	pbp5s).
1	carboxyl‐terminal
1	21‐amino‐acid
1	wild‐type
1	9‐amino‐acid
1	dd‐carboxypeptidase
1	x‐100.
1	[14c]benzylpenicillin
1	short‐lived
1	acyl‐enzyme
1	pbps.
1	pbp5,
1	well‐formed
1	x‐ray
1	plasmid-coded
1	ftsh,
1	(ftsi),
1	reca441
1	ftsh
1	y16
1	(ftsh)
1	3-overproducing
1	fts
1	/ag,
1	elastomer,
1	styrene–ethylene/butadiene–styrene
1	(sebs),
1	polyolefin,
1	high-melt-strength
1	(dls)
1	dls
1	auerus.
1	dumbbell
1	thermogravimetry
1	diffraction,
1	founded.
1	diplococcus
1	meningococcal
1	(imd).
1	(omvs).
1	alum.
1	in1390.
1	vim-2
1	owner,
1	human–animal–environment
1	zooanthroponotic
1	vim-2–producing
1	(kp10)
1	5915
1	255
1	kp10
1	(st340)
1	(cc258)
1	blakpc-2,
1	kp10.
1	(alg)
1	carbodiimide
1	alg:
1	(1:0.5),
1	(1:2).
1	(ftir-atr),
1	(tga)
1	ftir-atr
1	alg
1	(43.5
1	(4962
1	661%)
1	pao1/leca:lux
1	carbapenemase-2-producing
1	(kpc-kp),
1	(hv)
1	hypermucoviscous
1	(fimabcdefghik,
1	mrkabcdfhj,
1	wabg,
1	entb,
1	uge,
1	irp1,
1	trat,
1	iuta
1	ureade)
1	hvhmkpc-kp
1	(cg258).
1	st437
1	cg258
1	hv
1	workbench
1	5442
1	5492
1	blactx-m-55
1	fosa3
1	o8:h4-fimh97
1	(xdr)
1	st644
1	(bumblefoot)
1	nextseq®
1	150-bp
1	v.1.2.10,
1	(mapping
1	reads)
1	6357
1	fosfomycin;
1	(thr83ile),
1	parc
1	(ser87leu),
1	phoq
1	(arg61his)
1	(tyr345his),
1	polymyxins,
1	xdr
1	human–animal
1	tamariz
1	delhi
1	(ndm-1)-producing
1	(st155),
1	5,061,184
1	trimethoprim,
1	fluoroquinolones.
1	high-melt-strength-polypropylene
1	hms-polypropylene-clay
1	-silver
1	extruders.
1	(ppnc)
1	gamma-radiation
1	(60co)
1	(edx)
1	hmspp
1	nanocomposite.
1	biocompatibility
1	dressing
1	(n-vinyl-2-pyrrolidone)
1	(ethylene
1	glycol)
1	(peg),
1	sterilization.
1	1100%
1	immersion.
1	dressing.
1	(47vl
1	13b)
1	cow),
1	300-bp
1	geneious
1	v.r9.
1	v.3.2
1	enterobase.
1	47vl
1	770
1	13b
1	190×
1	80×
1	macrolides,
1	relatedness.
1	(clonal
1	cc23)
1	axb1.
1	edta:
1	combined-disk
1	(cmr)
1	μg/ml);
1	nordmann/poirel
1	(mpnp);
1	(rzp
1	zp≥edta/zp-edta).
1	≥4-fold
1	rzp
1	≥2.5;
1	colistin-edta,
1	cmr,
1	rzp,
1	95.1,
1	89.6,
1	83.3,
1	mcr-1-producing
1	(kpc-2),
1	(ctx-m)
1	(pmqr)
1	cc258
1	(st11)
1	cc10
1	(st617),
1	extra-hospital
1	incx-type
1	confering
1	blakpc-
1	blandm-type
1	(mcr-type
1	incx3
1	pkp1194a)
1	non-tn4401
1	(ntekpc)
1	tnpr-tnpa
1	(partial)-blakpc-2-δiskpn6/tran,
1	st340/cg258,
1	spades
1	3.10.1
1	857
1	5331
1	oxa-17
1	(st520).
1	(st198)
1	lettuce,
1	perineal
1	sulphonamides
1	(st508)
1	028
1	498
1	cephalosporins,
1	noticed,
1	(ec2)
1	5527
1	ec2
1	(st395)
1	rmtd2
1	vana-containing
1	interhospital
1	st114,
1	st203,
1	st412,
1	st478
1	st858
1	sort,
1	incx4-plasmid-mediated
1	recreational
1	beaches
1	tourist
1	blakpc-2
1	worrisome,
1	biocidal
1	isotactic
1	acetylene.
1	rheology
1	50/50 wt%
1	0.25%;
1	1.0%;
1	2.0%
1	wt%.
1	kirby-bauer
1	shv-
1	tem-type
1	esbl-producers,
1	ctx-m-type,
1	pandemic.
1	st345
1	ctx-m-15-producers.
1	tn3-like
1	2343
1	(et02).
1	tn6350
1	7,367
1	(is481
1	(dde
1	type),
1	tn3
1	resolvase,
1	imp-1,
1	spm-1,
1	vim-1,
1	ges-5,
1	mcr-1-harboring
1	(kp171,
1	tiet-4200)
1	st340/cc258,
1	non-fermenting
1	st235,
1	6.7 mb
1	polyethylene,
1	lldpe
1	ldpe
1	(non-polar)
1	(pe-g-ma),
1	nanoclay-matrix-interaction.
1	lldpe,
1	ldpe,
1	pes
1	1wt%
1	0.5–1.0wt%
1	blow
1	(penc),
1	(a027)
1	(a009)
1	(a027ind
1	a009ind).
1	lpxacd
1	vancomycin,
1	teicoplanin,
1	oxacillin
1	erythromycin.
1	isaba125
1	lpxa.
1	a009ind
1	a009ind.
1	mcr-1-carrying
1	(st74)
1	st1850,
1	5,022,083
1	4,950,681
1	colistin.
1	cmy-2-
1	ctx-m-2-producing
1	condemned
1	airsacculitis
1	cmy-2-type
1	ampc,
1	pjb10
1	tnpa-blacmy-2-blc-suge
1	94-kb
1	cmy-2-encoding
1	(cc258),
1	(st340).
1	st340
1	(crab)
1	crab,
1	mic ≥ 4 μg/ml,
1	blaoxa-type
1	isaba-1
1	-3.
1	blaoxa-positive
1	(±sd)
1	(±15.1),
1	58.9%
1	eighty-percent
1	(77.6%).
1	(59.0%).
1	(51.2%)
1	crab.
1	(mic ≥ 4 μg/ml),
1	tigecycline
1	mics > 2 μg/ml.
1	oxa-123-
1	(agnps),
1	extruder,
1	nanosilver
1	requires,
1	matrices)
1	nanoclay-nanosilver-matrix
1	(pp-g-ma).
1	microstructures
1	exfoliated.
1	lescano
1	campomanesia
1	(myrtaceae)
1	rheumatism.
1	simulations.
1	cyquant
1	255.70
1	569.50
1	mcr-1-bearing
1	self-transmissible
1	incx4-type
1	intercontinental
1	st79
1	st277
1	carbapenem-induced
1	(n = 22)
1	(esbl)-
1	ampc-producers
1	mueller–hinton
1	[0.5 × the
1	(mic)].
1	mics,
1	omp35-like,
1	acra)
1	ompr)
1	porins
1	ompr
1	4-fold,
1	porins,
1	(ecdc).
1	4,620
1	mcr-1-harbouring
1	(wwtps)
1	blaesbl-containing
1	blactx-m-15,
1	blashv-28.
1	blactx-m-8
1	is26.
1	(st4401,
1	st4402,
1	st4403,
1	st4445)
1	(st1574),
1	st307
1	st131.
1	ctx-m-producing
1	48.5–209 kb,
1	inci1,
1	incf,
1	incm1
1	shv-28
1	golden-handed
1	tamarin
1	(saguinus
1	midas
1	midas).
1	st60
1	st1263.
1	cerdeira
1	1194/11,
1	(st340;
1	cc258),
1	multidrugresistant
1	coproduced
1	ctx-m-15.
1	(silver
1	nanoparticles)
1	sonochemical
1	bacteria-staphylococcus
1	aureus;
1	bacteria).
1	(microbial
1	adhesins)
1	(implicated
1	coagulase-positive
1	coagulase-negative
1	ebps,
1	fnbb
1	fib)
1	(bap)
1	eno
1	(82.1%),
1	fnba
1	(72.6%),
1	(71.7%)
1	ebps
1	fnbb).
1	sccs
1	ctx-m-type
1	blactxm-2
1	blactxm-8
1	sold
1	iscr1-associated
1	dfr
1	aada
1	blactx-m-type
1	rettgeri
1	blactx-m-131
1	112-kb
1	cefotaximase
1	ceftazidime.
1	bme-pt.
1	carboxymethyl
1	(cmcab),
1	poly(4-vinyl-n-pentyl
1	(qpvp-c5),
1	polymer,
1	(ftir),
1	(dsc)
1	miscibility
1	cmcab
1	blends,
1	t<inf>g</inf>,
1	cmcab.
1	wettability
1	wt%
1	dropa
1	strains.methodology:
1	(intl),
1	pbrt.
1	bla<inf>ctx-m-59</inf>
1	bla<inf>tem</inf>
1	bla<inf>shv</inf>
1	ctx-m-2/59-containing
1	inca/c
1	incf
1	bla<inf>ctx-m-2-group</inf>-containing
1	tem-15,
1	shv-45,
1	shv-55
1	50/50
1	poly(n-vinyl-2-pyrrolidone)
1	(pvp)
1	ultraviolet-visible
1	pp-pvp1%
1	agnp
1	nanoscale,
1	revertant
1	thewgscomprises
1	2.5mbwith
1	16rrna
1	1882,
1	spoilers,
1	metallo-beta-lactamase-producing
1	ndm-1
1	neves
1	carbapenemases,
1	(mbls),
1	(65.7
1	f8-related
1	myovirus
1	(pbunalikevirus
1	(st442),
1	pfcf1305
1	pfcf3sp
1	2005.©
1	vancomycin-resistant
1	(vre)
1	linezolid-
1	vancomycin-
1	(lrvre)
1	tertiary-care
1	lrvre
1	brazil.©
1	carbapenemase
1	carbapenem-hydrolyzing
1	(chdl)-encoding
1	oxa-carbapenemase-producing
1	brazil.a
1	pulsotypes.
1	mlst-uo
1	(multilocus
1	http://pubmlst.org/abaumannii/),
1	402-407).
1	cc104,cc109
1	(st339,
1	407).in
1	blaoxa-23-
1	blaoxa-143-like
1	st/cc,
1	oxa-carbapenemase-encoding
1	sts,
1	oxa-23-like
1	plasmids).
1	cc104,
1	cc113
1	cdhl-carrying
1	trend,
1	(ambler
1	alagoas,
1	distrito
1	federal,
1	oxa-23-and/or
1	(so
1	effluents,
1	(mlst-bartual
1	http://pubmlst.org/abaumannii/)
1	cc104
1	ampicillin/sulbactam,
1	(polymyxin
1	e).
1	lactamica,
1	(omv)
1	(dda-bf)
1	dda-bf
1	colloidally
1	omv/dda-bf,
1	omv/alum
1	ctx-m,
1	veb,
1	bes
1	ges
1	ctx-m-9
1	identifed.
1	identifed
1	dire
1	agribusiness,
1	morbidity/mortality.
1	carbapenemic
1	[ipm]).
1	metallo-betalactamase
1	(spm-1
1	rmtd,
1	oprd
1	porin,
1	worrisome.
1	treat;
1	methicillin
1	ready-to-eat
1	ges-like
1	dice
1	coefficient.
1	59/65
1	(90.8%)
1	ctx-m-59,
1	shv-2,
1	shv-2a,
1	shv-5,
1	shv-31
1	shv-31,
1	chromosome-encoded
1	shv-type
1	(70.8%),
1	worrisome
1	foodstuff
1	sulfamethoxazole-trimethoprim
1	nalidixic
1	teta,
1	sul1/sul2,
1	blatem-1
1	blatem-1,
1	sul1
1	dhfr1
1	brandenburg,
1	agona,
1	alachua.
1	derby
1	integron-borne
1	ship
1	glans
1	foreskin.
1	co-producing
1	spm-1
1	uncircumcised
1	burkitt's
1	clinically,
1	aztreonam
1	(systemic)
1	(topical)
1	balanoposthitis,
1	co-production
1	blatem,
1	esbl-encoding
1	jandaei.
1	blatem-116.
1	blashv-40,
1	blatem-116
1	ceftazidime
1	trimethoprim-sulphamethoxazole
1	blages
1	greece
1	metallo-β-
1	lactamases
1	(mbl)-encoding
1	eighty-seven
1	46)
1	thioglycolic
1	97·6%
1	blaimp,
1	blaspm-1
1	87·8%
1	10·9%
1	cpha-positive
1	inpatients
1	(75.6%)
1	morganii,
1	mirabilis,
1	oxytoca,
1	rettgeri,
1	stuartti,
1	63%,
1	immobilize
1	self-assembled
1	particles/ml,
1	(0-0.025
1	ct).
1	isotherms,
1	monomolecular,
1	biospecific
1	antigen-antibody,
1	receptor-ligand,
1	immunodiagnosis,
1	separations,
1	desian
1	intermediate-risk
1	three-month
1	swabbing
1	colonised.
1	3.66-41.2,
1	amikacin.
1	0.05-0.99;
1	imipenem-resistant
1	blaoxa-51-like
1	(301
1	(dda)
1	18/14
1	dda/pss
1	(al(oh)3)
1	protein/mg
1	antigen/biomimetic
1	al(oh)3.
1	cajueiro
1	hepato-biliary
1	exams.
1	ta97,
1	ciclophosphamide.
1	dodab/pss
1	bsa,
1	langmuirian
1	1017
1	3.39
1	m-1,
1	micrograms/ml
1	pss/dodab/biomolecule
1	dodab/amb)
1	hepatotoxicity,
1	desoxycholate/amphotericin
1	fungizone)
1	intraperitonially
1	amb;
1	dodab)
1	dose-toxicity
1	(miconazole
1	1:20).
1	dispersion.
1	k2hpo4
1	(0.2-2
1	surrounds
1	lipid-covered
1	>250
1	cfu/ml,
1	(mg/l)
1	dodab).
1	(dod/amb).
1	0.4mg/kg/day
1	desoxycholate
1	(doc)/amb
1	dod/amb.
1	(doc/amb),
1	doc.
1	doc/amb.
1	doc/amb,
1	leucocytic
1	full-scale
1	multiresistant
1	75-year-old
1	(imp-1)-producing
1	imp-1
1	solvents.
1	dodab/amb,
1	deoxycholate/amb
1	biocides,
1	(chitosan,
1	ch)
1	poly(methyl
1	methacrylate)
1	(pmma)
1	stabilization/flocculation
1	dispersions
1	ch,
1	(overcompensation)
1	(stabilization).
1	(high)
1	(dodab).
1	entropic
1	overcompensation
1	(dodab
1	65-75
1	(dodab),
1	bilayer-forming
1	(dod/amb)
1	≤0.1
1	dod/amb,
1	lymphocyte–induced
1	(blimp-1)
1	(rag-1)
1	deleting
1	zakeri
1	immune-modulatory
1	f4/80+/cd80low
1	bortolatto
1	tlr-independent
1	diphtheria,
1	pertussis,
1	(dpt)
1	(mpla)
1	minnesota,
1	interferon-β-(trif-)
1	tt),
1	th2-cellular
1	alum/tlr-based
1	ber-specific
1	cd1d+c1r
1	inkt-deficient
1	cd1d-
1	(hocl),
1	b1-a.
1	"jarrinha"or
1	"milona",
1	sympodialis
1	eichl.
1	(cse)
1	warifteine
1	cse
1	(taf)
1	(baf);
1	anaphylaxis;
1	cse,
1	taf
1	baf
1	cse-treated
1	(rbcg)
1	(rbcg-s1pt)
1	rbcg-s1pt.
1	multipurpose
1	aeroallergens
1	protocol.objectives:
1	doses.methods:
1	intranasally,
1	tropicalis-specific
1	(ova)-specific
1	bte.results:
1	inflammatory-cell
1	anti-bte
1	mouse)
1	allergy-associated
1	responses.conclusions:
1	bte-induced
1	baqueiro
1	taste.
1	flavors
1	antiallergic,
1	3-o-[β-d-glycopiranosil-(1
1	6)-α-l-ramnopiranosil]-7-o-α-l-ramnopiranosil-kaempferol
1	(grrk)
1	(aad)
1	(ova)/alum
1	(hour)
1	mechanic
1	(il-5
1	syzygium
1	dc.(myrtaceae),
1	'jambolão',
1	stomachache.
1	(hce).
1	mediators'
1	nitrite.
1	cfu.
1	anti-septic
1	wetested
1	(lvs)
1	2-dimensional
1	(hereafter
1	"acute-phase
1	signs"
1	[aps])
1	diarrhea).
1	contractile,
1	structural/contractile
1	105.696,
1	bwa4c
1	cd4-)
1	(ccl)5
1	ccl11
1	ccl11,
1	ccl5.
1	chemokine-producing,
1	(saa),
1	mapks.
1	c57bl/10sccr
1	(22-day)
1	57%)
1	73%),
1	85%).
1	10 mg/kg),
1	82%),
1	62%,
1	61%,
1	49%).
1	suppressors,
1	allergies.
1	subendocardic
1	a20
1	tnf-α/lt-α
1	lymphocyte-deficient
1	b-1a,
1	b-1b,
1	b-2,
1	nonspecific,
1	b-1-derived
1	(bdmp)
1	aminoguanidine-treated,
1	th1-skewed
1	dppc
1	iposomes
1	siboney,
1	allergenicity.
1	ncapsulated
1	(pbsa)
1	(al).
1	pbsa
1	dermatophytosis,
1	dermatophytosis.
1	rubrum.
1	cd54).
1	(tlr4-deficient)
1	(tlr4-normal)
1	(gni).
1	sequestration,
1	(c3h/hej)
1	gni,
1	focus.
1	+foxp3+cd45rbiow
1	exhaled
1	copper-oxidized
1	normo-and
1	crosswise
1	modified,
1	(airway
1	casein-fed
1	aa-fed
1	microassays
1	2-5
1	circumvented.
1	≤2
1	(iak)
1	iak
1	economical.
1	jα18
1	vα14+
1	(ivα14),
1	litter-mates,
1	reconstitutes
1	jα18-/-
1	(cd69+)
1	anti-cd1d
1	cd1d-dependent
1	(aa-mice)
1	tcrαβ
1	aa-mice,
1	pre-weaned
1	cd4(+)cd25(+)
1	kynurenine-like
1	(ifn)-γ-inducible
1	(ido).
1	n1-acetyl-n2-formyl-5-methoxykynuramine
1	(afmk).
1	ifn-γ-sufficient
1	(1-methyltryptophan)
1	thymectomy.
1	(pk-136)
1	activation/memory
1	(cd45rb)
1	cd45rb-.
1	(ig)m
1	euthymic,
1	(gld)
1	gld
1	hypoplasia.
1	trypanocydal
1	nifurtimox-treated
1	megakaryoblasts
1	erythroblasts.
1	repopulating
1	units-spleen
1	granulocyte/macrophage,
1	megacariocyte
1	(actd)
1	actd-untreated
1	(512
1	(71.5
1	(256
1	(78.9
1	orally-induced
1	anti-γδ
1	ovalbumin-immunized
1	oral-tolerance.
1	cd3+αβ-γδ+
1	mhv3-infected
1	gradually,
1	peritoneum.
1	anti-mhv3
1	serum-containing
1	ribopolynucleotide
1	ri:poly
1	rc),1
1	(ndv),
1	pyran
1	copolymer.
1	tilorone
1	preirradiation
1	extraperitoneal
1	splenectomy.
1	splenectomy,
1	lymphocyte-mediated
1	mouse-strain
1	lps‐induced
1	akr
1	8‐fold
1	csa‐induced
1	i:poly
1	0.1–10.0
1	6‐fold
1	cardiomyopathies
1	coração-hcfmusp.
1	17.8
1	years),
1	rejections
1	cardiomyopathies,
1	mirna-155
1	appreciate
1	whether,
1	(ogn),
1	rounded.
1	tlr4-agonist
1	mapk/erk–sensitive
1	ets1
1	signaling-dependent
1	tumor-oncogenic
1	driver
1	mapk/erk/ets1
1	prooncogenic
1	(pre-mir-886),
1	vault
1	(vtrna
1	2-1)
1	(nc886).
1	nc886/vtrna2-1/pre-mir-886
1	dnmts
1	tcga
1	geo
1	normal/neoplastic
1	prostatectomies
1	tcga-prad
1	t-value
1	gleason
1	-in
1	status-
1	nude-mice
1	tcga-prad.
1	oncogenesis,
1	-associated
1	-correlated
1	diagnosis/prognosis
1	“tumor-suppressor”
1	differentiation/function,
1	radioiodine-refractory
1	freire
1	myoblasts,
1	align
1	(ogn)
1	secretome,
1	3´-untranslated
1	(3´
1	utr).
1	myogenesis.
1	sirna-ogn,
1	lipofectamine
1	(80–90%),
1	3’utr.
1	(myh2,
1	myog)
1	3’utr
1	myog
1	myog,
1	braft1799a-transgenic
1	(tg-braf)
1	14q32.
1	14q32
1	tg-braf
1	metastasis-related
1	14q32-encoded
1	medical-imaging
1	mappings
1	theoretical-practical
1	algorithms.
1	segmentation,
1	image-exams
1	non-cancer.
1	computer-aided
1	extractors
1	signalized
1	releasers.
1	(erβ),
1	1a2,
1	1b1,
1	82)
1	air;
1	(caps)
1	μg/m
1	40-51
1	(erβ-1,
1	erβ-2,
1	cyp1a2,
1	cyp1b1),
1	(erβ,
1	ahr)
1	(alcian
1	blue)
1	(periodic
1	schiff's)
1	stains.
1	erβ-2
1	cyp1b1
1	cap-exposed
1	caps,
1	0.048),
1	(dio3,
1	metast
1	atic
1	objectiveofthis
1	studyistoinvestigate
1	celllines
1	(k1
1	tpc-1cells)or
1	usedtodetermine
1	(brafv600e)
1	(ret/ptc1)
1	(p<0.007
1	p=0.02
1	(p!0.001).
1	oncogene(plx4032,3
1	(u0126,10-20
1	μm)orp38(sb203580,10-20
1	mm)signalingwasassociatedwithdecreasesin
1	(shh)
1	cyclopamine
1	geraldo,
1	de-regulation
1	mirna:mrna
1	(thrs);
1	thrα1
1	thrβ1.
1	hypo-or
1	inductions.
1	adrb2,
1	myh7
1	hcn2
1	adrb1,
1	myh6
1	atp2a2
1	thrβ.
1	mir-199a
1	thrβ-mediated
1	t3-regulated
1	tumor-suppressive
1	mir-19a
1	mir-19b,
1	cluster's
1	oncogenicity.
1	mir-17-92.
1	hedgehog,
1	braf-mediated
1	braf.
1	(pc-brafv600e-6)
1	ktc2
1	anti-mir
1	anti-notch1
1	sirnas
1	3′-utr/mir-19
1	tgfβ-treated
1	brafv600e-
1	mir-19a/b.
1	mir-19.
1	3′-utr.
1	braf-activated
1	g1-cell
1	tgfβ.
1	anti-mir-19.
1	v600e-induced
1	mir-19,
1	oncogene-mediated
1	deregulation.
1	curable,
1	histotype,
1	histotype.
1	histotypes,
1	(~22
1	nt)
1	histotypes
1	mir-222
1	radioiodine,
1	classically,
1	follicular),
1	mirnas'
1	inmaintaining
1	mir-200
1	mir-30
1	(emt),
1	overactivated
1	(mpnst)
1	neurofibromin
1	(nf1)
1	542
1	(everolimus)
1	suppressors.
1	lin28,
1	cyclins,
1	e2f2
1	cycle;
1	igf2bp1
1	casp3
1	improves,
1	scicence
1	mitogenactivated
1	70%of
1	(ptcs).
1	notch,
1	γ-secretase
1	(5%)
1	irresponsive
1	mir146b-5p
1	aggressive,
1	braft1799a-positive
1	short-time
1	abem
1	(mirna)
1	(ptc).
1	acid-modified
1	anti-mir-146b
1	bcpap.
1	ptcs.
1	selenoproteins
1	thyroids
1	0-72
1	administration),
1	selenoproteins.
1	selenoprotein
1	tgf-b/activin
1	(psmad2/3)
1	activin,
1	tgf-β/activin
1	radiation-related
1	radiation-exposed
1	iodine-rich
1	ret/ptc3-activated
1	ptc3-5
1	doxycycline-inducible
1	ret/ptc3,
1	pathway-related
1	(braf,
1	perk,
1	pret)
1	(natrium-iodide
1	[nis]
1	[tshr])
1	(rt)-polymerase
1	tshr
1	antioncogenic
1	deviation,
1	costello
1	angiosarcomas,
1	angiosarcomas
1	hras-gene
1	ret/ptc-ras-braf-mitogen-activated
1	d1)
1	ofmolecular
1	titf1
1	(wolff-chaikoff
1	thyrocyte
1	3 m
1	(nai).
1	(sage)
1	tpo.
1	organification
1	uncharacteristic
1	skull-base
1	iomm-lee
1	compressing
1	pleomorphism,
1	meningiomas,
1	dura
1	bioluminescent
1	hes1
1	facs-sorted
1	karyotyping
1	r-smads
1	2/3)
1	co-smads
1	tgfβ/activin
1	(smad7)
1	(smurfs).
1	protooncogene
1	(1.49±1.21
1	0.94±0.81
1	p=0.016).
1	inracreased
1	(0.58±0.27
1	0.58±0.20
1	p=0.88).
1	h-ras.
1	(r2=0.51;
1	∼22-nucleotide
1	1000.
1	(lgals3)
1	(npa,
1	wro,
1	aro),
1	peripherical
1	sscp.
1	cc)
1	67%;
1	23%;
1	68%;
1	20%;
1	12%)
1	cc=16%).
1	hormonogenesis
1	autoantigens.
1	tsh-induced
1	transfecting
1	(pax8)
1	(ttf)-1
1	pax8,
1	endotoxin-treated
1	implication.
1	rubiaceae
1	arabica
1	market,
1	214,964
1	130,792,
1	12,381
1	10,566
1	17,982
1	32,155
1	function).
1	33,000
1	unigenes.
1	http://www.lge.ibi.unicamp.br/cafe.
1	sustainability,
1	(papillary--ptc
1	follicular--ftc)
1	b-type
1	(v600e)
1	implemented.
1	(ret/ptc),
1	20-30%
1	receptorgamma
1	(ppargamma)
1	30-50%
1	trgamma,
1	pten,
1	pkar1a,
1	ddit3,
1	arg2,
1	itm1
1	c1orf24--some
1	expression--,
1	"low
1	t(3)
1	syndrome"
1	131i-thyroid
1	(down
1	rtg.
1	microg/kg).
1	neuromediators
1	physostigmine
1	microg/kg),
1	trh,
1	physostigmine,
1	normalized.
1	3,3′,5-triiodothyronine
1	(dio2
1	(bat)-specific
1	∼4-fold);
1	hyperresponse
1	ββ′
1	-methyl-substituted
1	α-ω-dicarboxylic
1	c14-c18
1	hyperadrenergic
1	exhausting
1	parafolicullar
1	(anaplastic
1	carcinoma).
1	t→a
1	1796.
1	braf-positive
1	dedifferentiated
1	(pkc)ε,
1	pkcs.
1	pkcε,
1	(2-6
1	ret/ptc3y541f,
1	ret/ptcy541f.
1	trk
1	v599e,
1	78;
1	35.8%).
1	brafv599e
1	ptcs,
1	46).
1	ret/ptc,
1	activins
1	(βb,
1	βb)
1	activinβa
1	methimazole-induced
1	βa,
1	transcription;
1	smad6
1	smads2/3.
1	tgfβ-sensitivity,
1	(npa
1	©2003,
1	2/3,
1	smad7),
1	megakaryocytes,
1	immunopositivity
1	amifostine-
1	hypocellular
1	non-irradiated,
1	amifostine.
1	conduct.
1	(follicular,
1	(adenoma,
1	45%;
1	mng,
1	mng-expressed
1	77.0%.
1	thiocyanate,
1	(9.0
1	3.0-9.0
1	colloid,
1	(non
1	(irradiated
1	7gy,
1	gy/min.
1	tgfbeta.
1	cyanogenic
1	goitre
1	(kcn).
1	carcase
1	normocytic
1	normochromic
1	tgfβ-immunostaining
1	tgfβ-positivity
1	(pcna),
1	interfollicular
1	intrafollicular
1	paradox
1	goitres
1	mng.
1	n=19).
1	subclones,
1	three-dimensionally
1	collagen-embedded
1	passages.
1	acquired.
1	anti-igf-i
1	goiter;
1	(fa);
1	x-chromosomal
1	m27β,
1	multiallelic
1	polyclonal,
1	monoclonal.
1	ras-gene
1	m27
1	x-chromosome.
1	poly-clonal
1	histomorphologically
1	growth-marker
1	nodule.
1	t45’-deiodinase
1	(5’d-ii).
1	t3or
1	t3receptors
1	hypothyroxinemia.
1	hypothyroxinemia,
1	bat-facultative
1	methimazole-blocked
1	(undetectable
1	t3)
1	subreplacement
1	µg/kg
1	µg/kg-day,
1	plasmaborne
1	(t3[t3])
1	[131i]t3
1	t3(t3[t4])
1	[125i]t4.
1	nuclear-plasma
1	t3[t3],
1	(0.71
1	t3/mg
1	t3concentrations
1	t4normalized
1	predictably
1	t3normalized
1	(qo2),
1	t4-replaced
1	t3-re-placed
1	t4/kg/day
1	qo2to
1	adrener-gic-induced
1	5’d-ii,
1	t4-dependent
1	qo2.
1	(evbc),
1	utrecht,
1	netherlands,
1	virology,
1	to)
1	(meta-)genomics,
1	threefold:
1	virologists
1	bioinformaticians
1	industrial,
1	professional,
1	postdoctoral
1	fellows,
1	investigators;
1	evbc
1	renowned
1	speakers.
1	ivanauskiene
1	underpins
1	security.
1	repeat-poor
1	chromoviruses.
1	(eimeriatdb),
1	eimeriatdb
1	systematics,
1	immunobiology,
1	55-60.
1	45,000
1	merozoites.
1	orestes/est
1	countings,
1	(http://www.coccidia.icb.usp.br/eimeriatdb),
1	website
1	cross-specific
1	500.
1	0.8-1.7
1	all-against-all
1	overlaps,
1	target-specific
1	sensible
1	curvature
1	symmetry,
1	gaussian
1	3891
1	85.75%.
1	front-end.
1	gene-dense
1	simple-sequence
1	segmentation
1	peppered
1	telomere-like
1	repeat-free
1	finder
1	comma-separated
1	gff
1	files.
1	repetitive,
1	hla-dqa1*0501(dq7),
1	-dr1,
1	-dr2;
1	hla-dq7-restricted
1	[fgqaaag(d/e)kp]
1	gqa
1	(tcr)-exposed,
1	s15.9
1	s15.4
1	pathogenically
1	generic,
1	job.
1	third-party
1	coed,
1	(scar)
1	scardb)
1	internet,
1	epizootiological,
1	genome-related
1	happy
1	(sequence-characterised
1	811
1	homogeneously,
1	cross-interference.
1	thermocycler
1	consumables
1	labour
1	epizootiological
1	1,184
1	automatedly
1	666
1	singlets
1	knowlesi,
1	e-value
1	<10-30
1	manually
1	(go)
1	769
1	gc-content
1	maxima.
1	acervulina
1	stringency
1	under:
1	regulation/alternative
1	pre-messenger
1	(snrnas)
1	u4,
1	u6
1	snrnas,
1	tri-snrnp,
1	brr2.
1	crispr-edited
1	gst-rnf113a.
1	prp19,
1	dynamical
1	fragile
1	pervade
1	thinking
1	semi-independent
1	(modularity)
1	nestedness,
1	elements;
1	interact)
1	networked
1	metapopulations,
1	webs
1	metacommunities.
1	connectedness.
1	theorize
1	webs.
1	food-web
1	ensembles
1	intracelullar
1	(u1,
1	u4/u6
1	u5).
1	ntc
1	co-migrates
1	spliceosomes,
1	brr2p.
1	prp19p
1	non-consensus
1	branchpoint
1	oliveira.
1	ftsj3,
1	spb1p,
1	nip7-interacting
1	a0,
1	nip7.
1	morello
1	strengthening
1	weakening
1	rna:rna
1	rna:proteins
1	3m
1	sub-complexes.
1	5′exon,
1	u2/u5/u6
1	sub-complex.
1	(ntc)
1	(shwachman-bodian-diamond
1	syndrome)
1	40s/60s
1	21s
1	nip7-depleted
1	co-sediments
1	40s-80s,
1	panip7,
1	au-rich
1	poly-ra
1	poly-au
1	exosome.
1	strongly.
1	rrp43p,
1	monomelic
1	five-stranded
1	β8
1	β12,
1	helix,
1	pseudo-uridine
1	archaeosine-specific
1	transglycosylases).
1	rna-interacting
1	arctgt
1	(archaeosine
1	trna-guanine
1	transglycosylase)
1	(r151,
1	r152,
1	k155,
1	k158)
1	(a/g160,
1	i161,
1	f164,
1	a167)
1	polyuridine,
1	polyuridine
1	(sweet
1	coffee)
1	pw
1	(xpsl
1	xpse
1	xpsel
1	crystallization.
1	diffract
1	88.49,
1	90.28,
1	63.35
1	134.29̊.
1	siras
1	xdm,
1	xdm
1	45°c
1	pet32xa/lic,
1	(mpges1)
1	(ptgr1).
1	15-hydroxyprostaglandin
1	(15-hpgd)
1	(pgems)
1	15-hpgd
1	ptgr1
1	20-carbon
1	2-series
1	occidental
1	epoxygenase
1	classifies
1	astrocytoma.
1	anti-tumorigenic
1	cell;
1	pgd2's
1	apoptosis/mitosis
1	(hoechst
1	stain),
1	u251mg,
1	fuelled
1	tumour-promoting
1	chloridotetrakis(ibuprofenato)diruthenium(ii,iii)
1	([ru2(ibp)4cl]
1	ibp = carboxylate
1	ibuprofen)
1	[ru2(ibp)4]
1	bonded
1	[ru2(ibp)4(cf3so3)]
1	[ru2(ibp)4(etoh)2]pf6
1	(ftir,
1	raman)
1	(uv/vis/nir)
1	re-prepared
1	axially-modified
1	metallodrugs,
1	proliferation/mitosis
1	smaller;
1	tegus.
1	elongated;
1	midwinter,
1	hv,
1	svep,
1	(59%,
1	29%)
1	spring.
1	tegus,
1	(vmax)
1	hoad,
1	atrophy/ischemia
1	(50%);
1	vvlp
1	prevailingly,
1	(sgz)
1	(svz).
1	controversial.methods:
1	autopsies.
1	examined.results:
1	septo-hypothalamic
1	continuum.
1	nestin-expressing
1	plexus;
1	sgz
1	newborn)
1	adults).
1	chiasm.
1	fimbria-fornix,
1	coincide
1	stream.
1	βiii-tubulin
1	observed.conclusions:
1	minimum,
1	ruthenium-containing
1	cisplatin-resistant
1	diruthenium-gla
1	(ru2gla)
1	ru2gla-treated
1	2.18-times
1	fibre-binding
1	diruthenium-ibuprofen
1	μl/h
1	sbic.
1	(ga)
1	sfxl
1	ln229
1	gls)
1	gsh-dependent
1	(jc-1
1	t98
1	gab,
1	gls2,
1	(gsh/gssg
1	synergizes
1	multi-angle
1	anti-glioma
1	(ato)
1	glutatione
1	overexpressed.
1	morpho-functional
1	(tupinambis
1	merianae)
1	reconciled
1	autumn.
1	arousal.
1	lacunary
1	unity
1	hypometabolism.
1	~.
1	migratory,
1	(ibp)
1	ibp,
1	(fitc-lehd-fmk
1	fitc-devd-fmk
1	(167%)
1	(36%).in
1	colquhoun;
1	hibp.
1	(cox1
1	cox2).
1	ruthenium-ibuprofen
1	enriching
1	[ru2(agla)4cl]
1	ru2gla.
1	diruthenium(ii,iii)
1	carboxylate.
1	ru2glawas
1	(gla).
1	ru2glawere
1	icp-aes
1	<0.02
1	(22±5.2%)
1	(44±2.3%).
1	(18±1.5%)
1	285
1	roscovitine
1	flavopiridol.
1	ku80.
1	(44%).
1	gla's
1	iubmb.
1	acid-drug
1	acid/epirubicin/mitomycin
1	intravesical
1	arachnoidal
1	flk1,
1	(mmp2,
1	mmp9),
1	acid-mediated
1	(rhamm),
1	(ha),
1	(cox2),
1	(bfabp),
1	(pcna).
1	(ki67,
1	mi)
1	(mvd).
1	bfabp.
1	bfabp
1	(vegf,
1	flt1,
1	flk1)
1	bfabp,
1	[ru2(dnsaid)4cl]
1	[ru2(dnsaid)4(h2o)2]pf6
1	dnsaid
1	hibp
1	hnpx
1	drug-carboxylate
1	diruthenium
1	ibuprofen.
1	ru2-ibp
1	ru2-npx
1	(anti-angiogenic
1	anti-matrix
1	metalloprotease)
1	nami-a
1	unproven
1	nadp+-malate
1	compliment
1	gla,
1	20:4
1	22:4
1	22:5
1	(gcms)
1	(66.5%)
1	subfractions,
1	(om),
1	gcms.
1	n-9,
1	18:2
1	22:6
1	om,
1	21.299
1	6.747,
1	61.6%
1	malonyl
1	interlinked
1	i+iii
1	caspase-3-like
1	dha/epa.
1	coas
1	epa-exposed
1	dha-exposed
1	low-gamma-linolenic
1	(2.98%)
1	(5.55%)
1	twelve-day
1	gla-rich
1	metabolised
1	peroxisomes
1	pufa-treated
1	sparsity
1	thioesterase,
1	mte-i,
1	α-linolenic,
1	0.89,
1	0.98
1	0.842
1	0.798
1	2-deoxy-3-[1-(r)-(ethoxycarbonyl)ethyl]-α-d-allo-pyranose
1	2-deoxy-3-[methoxycarbonyl
1	methyl]-α-d-allo-pyranose
1	3-[1-(s)-(ethoxycarbonyl)ethyl]-α-d-allo
1	a1-specific
1	s-enba
1	r-pia
1	s-pia
1	[6-3h]-thymidine
1	0.02-0.24
1	[l-(αs,5s)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic
1	acid],
1	sulphoximine,
1	glutamine-deficient
1	rate-controlling
1	al.y
1	265:
1	503–509,1990).
1	glucose-phos-phorylation
1	cell-lines,
1	glucose-phosphorylating
1	1.1–20
1	nmol/min/mg
1	untransformed
1	nmol/
1	min/mg
1	(8–11.8
1	dim);
1	(i50
1	glucose-6-phosphate.
1	(25–75%
1	mannoheptulose)
1	(i5o,
1	65–79%)
1	mg/g
1	avocados
1	toxicity),
1	factor-i
1	(190-200
1	(prolonged
1	administration).
1	igf-i.
1	lost:
1	mu/l)
1	mu/l).
1	spiders’
1	docking-based
1	0.59
1	µm.
1	silva-de-frança
1	annulifera,
1	l-amino-acid
1	morocco
1	saudi
1	arabia.
1	(svsp).
1	immunochemically.
1	fibrinogen-degrading
1	kinin-releasing
1	kn-ba.
1	who's
1	narrow-sized
1	(chnp)
1	(<160
1	immunoadjuvant.
1	chnps
1	moths
1	victim
1	presses
1	hairs.
1	bullae,
1	erosions,
1	petechiae,
1	ulcerations.
1	osteochondritis,
1	deformity
1	predators;
1	moths,
1	caterpillars’
1	antitoxins
1	france
1	fascinating!
1	lives:
1	(elapid
1	“spitting
1	cobras”,
1	spit
1	blinding
1	blepharitis,
1	blepharospasm
1	erosions.
1	(eveit)
1	spitting
1	mossambica,
1	lanceolatus)
1	(hr-oct)
1	mossambica
1	opaque.
1	opacification
1	cobra,
1	lanceolatus.
1	disorganization,
1	rinsing
1	ophthalmia,
1	ophthalmia.
1	nigricollis,
1	1350
1	angola,
1	cuanza
1	benguela,
1	huíla
1	malanje.
1	erythromelas.
1	(cnps)
1	(ah).
1	ah,
1	peptide/protein
1	(pohl)
1	baill.,
1	(j.
1	mollissima),
1	(aejg)
1	(aejm)
1	decoction.
1	chemically,
1	(tlc)
1	(hplc-dad)
1	(bev),
1	aejm,
1	aejg,
1	anti-edematogenic
1	aejm.
1	epidermidis,
1	cereus.
1	c-glycosylated
1	endotoxic-like
1	peroxynitrite)
1	compstatin
1	c-pathways.
1	(c1-inh),
1	c-regulators,
1	c1-inh,
1	lipl21
1	lipl45
1	lipl21,
1	(mmp).
1	lanceolatus,
1	‘fer-de-lance’,
1	martinique.
1	(hacat),
1	(eahy926).
1	pro-inflammatory.
1	snakebites,
1	b. erythromelas
1	(bev).
1	post-envenomation)
1	in vitro.
1	ouchterlony
1	activities).
1	post-envenomation
1	whilst,
1	in vivo.
1	ouchterlony's
1	antiophidic
1	j. gossypiifolia,
1	encapsulate/adsorb
1	immunoresponsiveness
1	sba-15.
1	hbsag:sba-15,
1	macroporosity.
1	bicinchoninic
1	non-influence
1	(fernandes-pedrosa
1	(lox-c3)
1	race-pcr.
1	5178
1	bps
1	c3-like
1	salcitidae),
1	altirostris
1	surinamensis
1	paralyzes
1	preys,
1	mammalians
1	(nep)-like
1	nep-inhibiting
1	ylpt,
1	proctolin
1	(rylpt).
1	[des-arg1]-proctolin
1	proctolin.
1	cockroaches,
1	proctolin-like
1	[des-arg1]-proctolin,
1	preys.
1	corrêa
1	(matrilysin-1),
1	atractaspididae,
1	colubridae.
1	undeniable
1	need,
1	mistake.
1	figs.
1	interchanged.
1	below:
1	ellipses
1	histidines
1	(h12
1	h47)
1	(e32,
1	d34
1	d91)
1	sticks,
1	green.
1	balls,
1	numbering
1	pdb
1	1xx1
1	(murakami
1	cyan
1	colour
1	myamoto
1	protostomes
1	cnidarians,
1	ancient.
1	lox-fb,
1	race-pcr
1	fb/c2
1	lox-fb
1	(ccp),
1	(vwfa),
1	(midas)
1	vwfa
1	c2/fb
1	conserved;
1	lox-fb.
1	lox-
1	(fb-3)
1	jumping
1	salcitidae.
1	intrachain
1	noxiousness,
1	villas
1	boas
1	semirufa,
1	sensation,
1	incident.
1	"pararamose
1	",
1	synovitis,
1	ps82
1	paixão-cavalcante
1	arietans,
1	1–7.
1	nasicornis.
1	serinoproteases
1	13,038
1	(buthidae)
1	n-butanol
1	etoac,
1	n-buoh,
1	asarifolia,
1	endorsed
1	(nsp)
1	neutrophil-activating
1	26-
1	27-kda
1	c5a-induced
1	myeolomonocytic
1	c5ar,
1	nsps.
1	c5a-
1	nsps,
1	kingdom
1	(who).
1	list.
1	(ears).
1	butantan,
1	c3a;
1	aggregates)
1	aggregates,
1	scorpion,
1	ethylenediaminetetracetic
1	phenylmethanesulfonylfluoride,
1	(sav)
1	(aav).
1	sav
1	characterizations,
1	serrulatus.
1	angélica
1	(walker,
1	1856),
1	rubber
1	deformities,
1	synovitis.
1	pararama.
1	extract-treated
1	bristles,
1	characterises
1	bahiensis
1	stigmurus.
1	anti-scorpion
1	(yggflrrirpklk)
1	metallopeptidase(s).
1	leu-enkephalin
1	hyaluronidases
1	preparation.copy;
1	anti-crotalus
1	marajoensis.
1	ion-channels;
1	kexxg
1	ile
1	β-ktx
1	propeptide
1	keilg
1	kellg
1	sicariidae
1	17-year
1	brazil.methodology/principal
1	findings:sds-page
1	32-35
1	spiders'
1	viability;
1	male.conclusion:we
1	background:snake
1	c-components
1	c-activating
1	venom.results:using
1	c-svmp,
1	c-pathways
1	activity.conclusion:we
1	c-components,
1	c1-inhibitor,
1	pidde-queiroz
1	c5a:
1	c5ar/cd88,
1	(adam)
1	arctiidae),
1	multiples
1	joint-space
1	caterpillar's
1	anti-collagen
1	pararama
1	micrurus,
1	(serpentes,
1	elapidae),
1	cardiotoxicity,
1	myotoxicity.results:
1	c3α
1	control.conclusion:
1	latu)
1	(butantan
1	institute)
1	97.5%.
1	metallo-and
1	ressonance
1	abz-fassaq-eddnp,
1	abz-rppgfspfrq-eddnp.
1	disagreement
1	tyrosine-specific
1	angiotensin-degrading
1	venom-neutralizing
1	anti-snake
1	non-relevant
1	humanizing
1	spadafora-ferreira
1	encapsulated/adsorbed
1	c-activation,
1	metallo-
1	serine-protease
1	envenomations,
1	assist,
1	domesticus).
1	v-c
1	accumulated.
1	igy,
1	immunodiagnostics
1	services,
1	brazili,
1	bothriopsis
1	pertactin,
1	hemagglutinin.
1	non-vaccinal
1	inefficient,
1	micrurus:
1	frontalis,
1	corallinus,
1	hemprichii,
1	altirostris,
1	surinamensis,
1	ibiboboca,
1	lemniscatus)
1	fulvius)
1	mexico.
1	tag",
1	lb3,
1	boneti,
1	hyperimmunization
1	alternatus,
1	neuwiedi.
1	anti-smase
1	lagochilascaris
1	lagochilascariosis,
1	minor,
1	encysted
1	ifnγ.
1	3,008
1	1,357
1	transcript;
1	"possible
1	toxins",
1	serinoproteinases,
1	hyaluronidases,
1	c-lectins,
1	cystein
1	fernandes-pedrosa
1	leading,
1	haemorrhage).
1	anti-lonomic
1	obliqua's
1	haemostasis,
1	(bidimensional
1	immunoblotting).
1	serpins.
1	lipocalin
1	lopap
1	bristles'
1	keratinocytic
1	haemostasis.
1	karstic
1	karstics
1	(iporanga,
1	touristic
1	caves.
1	ceramide-1-phosphate.
1	c8-depleted
1	(sap)
1	pentraxins
1	c-activation.
1	antipeptides,
1	bpps
1	bpps,
1	hapten-carrier
1	ion-dependent
1	histidines.
1	tetrahedrally
1	trigonal-bipyramidal
1	intra-chain
1	(cys53-cys201).
1	bonetti
1	95gly
1	134pro
1	face.
1	glicerophosphodiester
1	phosphoesterases
1	ceramide-phosphate
1	barrel.
1	intermedia.
1	(pro-leu)
1	caissarum
1	anemone.
1	15495
1	hemolysins
1	(19757
1	da),
1	eqt
1	0.270
1	(bcs
1	bcs
1	actinoporin
1	mesostructure
1	mesopore
1	mesostructures
1	nanosystems
1	colubrids
1	helicops,
1	oxyrhopus,
1	thamnodynastes
1	philodryas.
1	xenodontinae
1	patagoniensis,
1	ecchymosis
1	anti-bothrops
1	(smased),
1	-9,
1	leptodactylid
1	physalaemus
1	proteinic
1	attacking,
1	macroglands,
1	softer
1	21a1,
1	pertussis.
1	21a1
1	1-phosphate
1	choline,
1	1.75-å
1	"quick
1	cryo-soaking"
1	anode
1	barrel,
1	glu32,
1	asp91,
1	his12
1	asp52,
1	trp230,
1	233,
1	asn252.
1	(lmv)
1	venom;
1	(se),
1	i-vi
1	superdex®75.
1	72-48
1	superose®12
1	exempt
1	anti-lachesis
1	providing,
1	(araneae,
1	sicariidae)
1	(petar),
1	non-synanthropic
1	troglophile
1	adelaida,
1	petar,
1	(nudel)
1	disrupted-inschizophrenia
1	(disc1)
1	nudel
1	(eopa),
1	nudel,
1	disc1-binding
1	scottish
1	cohort,
1	nudel-oligopeptidase,
1	decomplementation,
1	c6-deficient
1	c-depletion
1	dermatology,
1	casqued
1	phragmosis,
1	lissamphibians
1	corythomantis
1	greeningi,
1	casque-headed
1	frog.
1	phragmotic
1	greeningi
1	skull.
1	variants:
1	viscerocutaneous
1	(sphingomyelinases)
1	(dermonecrosis)
1	(complement
1	haemolysis)
1	(p1
1	laeta).
1	loxoscelic
1	[fernandes-pedrosa
1	(2002),
1	biophys.
1	commun.
1	298,
1	638-645].
1	light-scattering
1	monomodal
1	3.57
1	sparse-matrix
1	laboratório
1	síncrotron
1	(lnls,
1	(space
1	p61
1	p65),
1	140.6,
1	113.6
1	heavy-atom
1	denmark
1	1-phosphate.
1	hampers
1	lysophosphatidylcholine
1	(lpc),
1	sphingosylphosphorylcholine,
1	(∼20-40
1	lysophospholipase
1	lpc.
1	(lpa),
1	hyperpermeability,
1	lpa1
1	receptor-negative
1	smased,
1	lpc-containing
1	unappreciated
1	tag"
1	aleatory
1	h17
1	32-kda
1	c-resistance
1	(mcp)
1	(mhci).
1	mcp.
1	mcp,
1	c-susceptibility
1	toxin/venom
1	pld-induced
1	pld-
1	p1-treated
1	pld-mediated
1	similis.
1	"pitangueiras"
1	cave
1	"lago
1	azul"
1	cave,
1	bonito,
1	boyden's
1	bap-1
1	agent(s)
1	venom-activated
1	(scr
1	metalloproteinase-activated
1	e-bound
1	cr1,
1	cd59.
1	gpb,
1	gpc
1	gpa
1	(f35)
1	spiderlings;
1	spiderlings
1	instars.
1	homology,
1	p2.
1	trypanosoma-decay
1	(t-daf),
1	87-93-kd
1	chromic
1	hemagglutination).
1	96%,
1	convertases
1	inactivators.
1	c5b
1	cytolytical
1	arthropoda
1	(loxosceles)
1	honeybee,
1	jacket,
1	white-facet
1	mellitin,
1	c9.
1	elapidae,
1	amplificator,
1	multimolecular
1	(e(h))
1	(cs-nhs)
1	c9-depleted
1	(c9d-nhs)
1	cs-nhs,
1	c9d-nhs.
1	50°c
1	ca2+/mg2+
1	egta.
1	c1,
1	venom-treated
1	c-resistant
1	c-susceptible
1	thirty-five-kilodalton-related
1	ibiboboca
1	spixii)
1	(cof),
1	oedema‐producing
1	ml−1
1	chelated
1	mg2+‐egta.
1	ibiboboca.
1	(haemorrhagins).
1	victim.
1	sulfo-n-hydroxy-succinimidobiotin
1	(sulfo-nhs-biotin)
1	sulfo-nhs-biotin
1	t-daf,
1	developer.
1	complement-regulatory
1	87-
1	93-kda
1	decay-
1	chromatography-purified
1	t-daf.
1	daf
1	nicholson-weller,
1	burge,
1	fearon,
1	weller,
1	austen,
1	129:184-189,
1	igg2a)
1	fabμ
1	(p815)
1	dependent;
1	(mastocytoma
1	bt;
1	adcc;
1	present;
1	eac1,4,2,3
1	c14b2a
1	(gecs).
1	w83
1	atcc33277)
1	(moi)
1	1:1000
1	2 hours.
1	cxcl8)
1	gecs.
1	gecs,
1	p. gingivalis.
1	pathogen's
1	(gagp)
1	(amoxicillin
1	metronidazole).
1	[cal],
1	(gm-csf,
1	[agp
1	deepest,
1	(bop)
1	radiography;
1	bop,
1	loss]
1	agp.
1	debilitating,
1	cleanliness
1	(ohrqol)
1	0.005%
1	λ = 660 nm,
1	9j
1	radiant
1	318 j/cm),
1	(g2)
1	(luminex
1	corporation,
1	austin,
1	tx).
1	scale),
1	(digital
1	caliper),
1	ohrqol
1	ohip-14
1	(baseline),
1	(immediately
1	pdt),
1	pdt).
1	nct03576105.
1	att/ttc
1	(periodontopathogens).
1	(lymphocytes
1	(omp29)
1	(agp).
1	(gagp),
1	(lagp),
1	treatment—scaling
1	(srp+a).
1	1-year.
1	omp29.
1	(ns)
1	(sm).
1	recession
1	expired
1	(apdt)
1	(fs),
1	g1:
1	apdt;
1	scraper,
1	scraper.
1	chromatm
1	categorical
1	(p < .05)
1	halitosis.
1	non-smoking
1	≤40
1	(dmi-hba1c
1	(dma-hba1c
1	<7.8%).
1	4–6
1	v5–v6
1	16srrna
1	gs-flx-
1	homd
1	qiime
1	phylotoast
1	pipelines.
1	two-sample
1	t-tests.
1	propionate/succinate
1	butyrate/pyruvate
1	anginosus
1	preparation:
1	(n = 25)
1	(n = 25).
1	(s3)
1	intracanal
1	amebocyte
1	mann–whitney
1	u-test
1	1.49 × 106
1	8.55 × 105
1	1.41 × 104;
1	3.53 × 104;
1	p < 0.001).
1	4.29 × 103;
1	1.08 × 104;
1	p < 0.01).
1	(ighd)
1	(ghrhr)
1	(prob-ing
1	[al])
1	(c-reactive
1	[mmp]-8,
1	[il]-1α,
1	[tnf]-α,
1	lep-tin)
1	≤3
1	sites]
1	≥7
1	[deep
1	sites]).
1	(aggregatibacter
1	forsythia)
1	poly-l-lactide
1	(plla)
1	antimicrobials,
1	amoxicillin,
1	azithromicyn
1	electrospinning
1	pyogenes.
1	pyogenes
1	amoxicillin-film
1	azithromycin-meshes
1	42-year-old
1	matsubara,
1	ishikawa,
1	nakamae
1	probiotics.
1	(lactobacillus
1	lr32,
1	l324m,
1	ncfm)
1	(cle7a,
1	clec7a
1	il-1ß,
1	pro/anti-inflammatory
1	development. high
1	probiotic-containing
1	cheeses
1	lr-32
1	8 weeks,
1	mouthwash,
1	(cfu/ml)
1	unimaxillary
1	dentures.
1	lr-32,
1	(a.a.)
1	clinical/immunological/microbiological
1	596)
1	(il8+);
1	(il8-);
1	(il4+);
1	ttd/cti
1	(il4-).
1	periods).
1	haplotypes),
1	interrelationship
1	neovestitol's
1	raw264.7
1	0.22 µm
1	neovestitol,
1	nutraceutical,
1	50–80 µg/ml
1	60 µg/ml
1	il12p40,
1	il12p70,
1	mcp1
1	brp-effects
1	adm,
1	wnt2b,
1	txn1,
1	herpud1,
1	axin2,
1	car9,
1	id1,
1	hes5,
1	icam1,
1	tnfsf10,
1	mapk1,
1	noxa1
1	cav1,
1	wnt6,
1	calm1,
1	rb1,
1	dab2.
1	romero
1	santos.
1	"romero
1	ss"
1	"santos
1	rs".
1	exacerbations,
1	oho
1	orientation)
1	(pdt);
1	oho.
1	instruments
1	george's
1	(ohip-14).
1	nct02514226.
1	#1.
1	foundation)
1	#2015/20535-1.
1	received:
1	julho
1	university.
1	tooth-supporting
1	(s-haplotype)
1	(p-haplotype)
1	shaplotype,
1	p-haplotype
1	p-haplotype,
1	phaplotype
1	th2/m2
1	(hap-2)
1	-590,
1	+33
1	cytometry)
1	jm
1	il4;
1	689
1	(61.84%)
1	(38.15%)
1	yet-uncultivable
1	yet-uncharacterized
1	filifactor
1	alocis,
1	peptostreptococcus
1	stomatis
1	phocaeicola
1	abscessus,
1	lachnospiraceae
1	micra.
1	(43.5%),
1	(13.2%).
1	recolonization
1	cochrane
1	‘periodontitis’,
1	‘chronic
1	periodontitis’,
1	‘probiotic(s)’,
1	‘prebiotic(s)’,
1	‘symbiotic(s)’,
1	‘bifidobacterium
1	‘lactobacillus’.
1	(rcts)
1	rcts
1	laced
1	(scaling)
1	entity.
1	monoazide
1	<.0001),
1	live/dead
1	(25.5–61.8 %)
1	(p > 0.05),
1	yeast-to-hyphae
1	entailed
1	exometabolites
1	filamentation.
1	clarifies,
1	candicidal
1	vt1169.
1	candida;
1	alleviation
1	(aacdt).
1	(bmmc)
1	≥3nuclei,
1	aacdt,
1	rank),
1	(transcription
1	ctpk
1	pre-osteoclastic
1	osteoclastogenesis.
1	exacerbation.
1	copd;
1	(srp)+oral
1	(oh))
1	(experimental;
1	srp+photodynamic
1	therapy+oh).
1	dissemination:
1	julho.
1	(brp),
1	îg/ml
1	mrc1
1	m1.
1	ifn-î,
1	il-1î
1	î±
1	tgf-î
1	brp.
1	(pdk1,
1	mtcp1,
1	gsk3b,
1	elk1)
1	il1î
1	il1f9
1	(fold-change
1	nf-î°b
1	adaptor-like
1	(mal),
1	tirap,
1	food-source
1	exhacerbated
1	(spie).
1	[chlorhexidine
1	(rmgic)],
1	ledtb
1	[photodynamic
1	(pact)
1	rmgic],
1	lmb
1	[pact
1	rmgic].
1	gingival,
1	dmft/dmfs
1	followups
1	sobrinus,
1	rimae,
1	sobrinus.
1	medknow.
1	[hba1c]
1	<8.0%)
1	(dma
1	(hba1c
1	≥8.0%)
1	(dmi
1	>6
1	hemiarch,
1	dunn's
1	prosthodontists.
1	poured
1	hs111,
1	acidophillus
1	hs101,
1	capsules.
1	92.0%
1	16.7%
1	acidophilus,
1	(together
1	(euploids).
1	euploids
1	45 days.
1	zi,
1	studies.we
1	fetus-placenta
1	placenta-fetal
1	(st,
1	(it,
1	planing.
1	(vpi),
1	(gbi),
1	(bop),
1	(mcp)-1
1	(hba1c)
1	post-therapy.
1	0.034)
1	(rdna)
1	(rrna
1	persistent/secondary
1	intraradicular
1	72.2%
1	rrna-
1	rdna-based
1	canals,
1	noti
1	house-keeping
1	f+k+
1	(n=4),
1	f-k+
1	f+k-
1	f-k-
1	(n=2).
1	diversity;
1	fimbriated
1	p.gingivalis.
1	mucosa-associated
1	perpetuating
1	(aacdt)
1	bioparticles.
1	aa(r)cdt.
1	pro-inflammatory/anti-inflammatory
1	beta-defensin-3
1	(hbd-3)
1	(ll-37)
1	synergy.
1	overlaid
1	gro-alpha,
1	g-csf,
1	35)
1	(34.3%).
1	species/phylotypes
1	78.3%
1	21.7%
1	(60.9%)
1	uncultivable
1	(dmi+p,
1	(dma+p,
1	(dm,
1	(pl),
1	(gb),
1	(hbalc).
1	dmi+p
1	dma+p
1	(p=0.025)
1	(pg),
1	(gap)
1	load),
1	tf.
1	tf,
1	atmospheres
1	n-hexadecane;
1	invade,
1	transcritption
1	omp100
1	pga
1	(related
1	cdtb)
1	(emaa).
1	makeup,
1	(cp).
1	(tci/cci
1	ttd/cti)
1	(il4+)
1	il4-)
1	il4-).
1	il4-
1	(q-pcr).
1	enterococcal
1	virulence/antibiotic
1	erbium,
1	chromium:yttrium-scandium-gal-
1	lium-garnet
1	(er,cr:ysgg)
1	mutanst
1	<g1=control)
1	er,-
1	cr:ysgg
1	=2.78
1	fim,
1	du
1	ration≅140
1	600-jim
1	tip)
1	g4:
1	g5:
1	g6:
1	g7:
1	2.25
1	g8:
1	g9:
1	g10:3.0
1	g11:
1	g12:
1	g13:
1	g14:
1	clearfil
1	flowable
1	thermo-
1	tests;
1	microleakage.
1	er,cr:ysgg
1	custom-designed
1	pan-genomic
1	jp2-specific
1	non-jp2-specific
1	(nap
1	operon)
1	tol-pal
1	rna-oligonucleotide
1	u-test.
1	cs002),
1	gerencseriae
1	depth≥5mm)
1	depth≤3mm)
1	depthof
1	≤3mm
1	(r=0.77;
1	(r=0.60;
1	dianae
1	ew076)
1	(r=0.42,
1	deregulating
1	w83,
1	(pr1)
1	(pr11),
1	pr11
1	fetal-placental
1	placenta/fetus
1	pr11,
1	mid-gestation
1	(bop).
1	(cal≥5
1	(p≤53
1	(grappad
1	prism5®).
1	(d'agostino-pearson
1	telma
1	blanca
1	lombardo
1	factor-κb-dependent
1	factor/colony-stimulating
1	osteoclastogenesis,
1	cpsa
1	cpsb
1	(14/22),
1	phylotypes,
1	methane-producing
1	(lb)
1	17-35
1	dentacult
1	kits,
1	(laborclin™)
1	(kp)
1	minitab
1	(version
1	15.1.0.0).
1	s=0.53,
1	p>0.05).
1	s=0.77,
1	examiner.
1	inter-examiner
1	(kp=0.94).
1	maxillas
1	(λ=660
1	mw.
1	ribosomal-rna
1	sample).
1	ruminococcaceae.
1	10.0,
1	sample;
1	rimae
1	(50.0%),
1	oris,
1	pseudoramibacter
1	alactolyticus,
1	(33.3%).
1	(gagp;
1	(ph;
1	(10/group).
1	samples/subject
1	27/28
1	26/30
1	curvum/congolense
1	mazeii
1	oralis.
1	(archaea/total
1	prokaryotes)
1	gagp.
1	implants;
1	tooth,
1	implants,
1	oralis,
1	congelense/curvum
1	a/s..
1	pulse-field
1	leukotoxin,
1	a-f,
1	(7.7%),
1	genotype;
1	serotypes/apah
1	non-jp2-like
1	aae/apah
1	xhoi
1	intervention,
1	bacteria-reactive
1	osteoclast-induction
1	(now
1	rankl)
1	(upregulation
1	downregulation)
1	osteoclast-signal
1	down-modulating
1	mikihito
1	kajiya
1	ando
1	de-gennaro
1	faveri
1	feres
1	mayer
1	mpa.
1	periodont
1	2010;
1	45:
1	471-480.
1	genotoxin
1	80)
1	a/b/c
1	(cdta,
1	cdtc)
1	75.0%
1	81.8%
1	(66.7%)
1	(54.5%).
1	cdtc.
1	nm-diode
1	k-files.
1	naocl
1	edta-t
1	nm/p
1	2.5w/i
1	w/cm2)
1	(n-rickert/ahplustm/apexit®).
1	methylene-blue
1	fusioned
1	n-rickert
1	ahplustm
1	sealers.
1	apexit®
1	apexit®,
1	hydroxide-based
1	sealer,
1	pleiades
1	105cfu
1	ms/ml
1	happydent-xylit®for
1	x/day,
1	began,
1	13.17
1	(nl-cfu)
1	9.45
1	10.31
1	c2;
1	(hg1259-like,
1	hg1467-like
1	icbmo583-like)
1	(atcc33270-like
1	icbmo36).
1	collagenolytic
1	(oct)
1	thedemineralization
1	theses
1	(correctedby
1	refraction
1	1.62@856
1	cdtb.
1	92.7%
1	(68.0%).
1	serotype;
1	281
1	12-methacryloyloxydodecylpyridinium
1	(mdpb)
1	(rm-gic;
1	(2.83%
1	mdpb);
1	composite;
1	(gii;
1	85.17
1	15.2%)
1	shallower
1	(gi;
1	100.00
1	10.04%),
1	mdpb
1	(giv;
1	101.95
1	21.32%).
1	(giii;
1	82.68
1	12.81%
1	gv;
1	85.65
1	15.42%),
1	(gv)
1	(gi).
1	(n=15),
1	(gagp,
1	n=25),
1	(chp,
1	n=50)
1	checkerboard
1	host-compatible
1	lagp,
1	gracilis,
1	nodatum
1	(≤3
1	(≥7
1	mm)]
1	(90%).
1	(90.5%)
1	shallow,
1	(2.4%,
1	4.6%,
1	15.5%,
1	17.7%,
1	non-tested
1	arcab
1	accordingly.
1	anaerobiosis.
1	arcb,
1	9f
1	1525r.
1	1007
1	taxa)
1	sputigena,
1	noxia,
1	ew084,
1	ew076,
1	ft050,
1	p2pa_80,
1	gaa14.
1	selenomonas,
1	5-8
1	opa2
1	biofilm-forming
1	non-typeable
1	kdii
1	865
1	33277
1	cements.
1	(streptococcus
1	mutans).
1	(controls;
1	80.6
1	(g1,
1	g5)
1	(g2,
1	g6).
1	restoration,
1	thermocycled
1	cement,
1	mesio-distal
1	direction;
1	nail
1	varnish
1	squared
1	(2×4
1	cement-enamel
1	double-deionized
1	23μm
1	detector,
1	demodulator
1	urn,
1	depicts
1	contactless
1	jw22/23.
1	mouths.
1	(6.6%)
1	supra-gingival
1	(46.6%)
1	stomachs,
1	sequences-polymerase
1	(4.1%)
1	(3.2%)
1	(2.5%),
1	extraoral.
1	(khn)
1	oral-oral
1	fecal-oral
1	pylori.
1	(89.4%)
1	(8.0%)
1	(37.3%)
1	(19.6%).
1	(6.1%).
1	(17.8%)
1	multiracial
1	full-mouth
1	22/23
1	43629
1	(26.6%).
1	urease-positive
1	digluconate
1	paramonochlorophenol
1	melaninogenica.
1	2.67
1	80.00
1	microg/ml,
1	46.67
1	213.33
1	microg/ml.
1	isolate;
1	13-16-year-old
1	programs;
1	telephone
1	in-between-meal
1	teenagers.
1	planing,
1	hydro
1	a);
1	b);
1	(baseline).
1	(p=0.007),
1	(p=0.005),
1	coagulase
1	kenya,
1	vitro".
1	gingivalis;
1	superinfectant
1	superinfectants
1	bbl
1	enteric/nonfermenter
1	(31.2%)
1	25-30
1	cfu)
1	increment,
1	cariogenicity.
1	ms-infecting
1	tongue-blade
1	incisors,
1	30-month-old
1	(wig)
1	sucrose-dependent
1	protein-stained
1	gtf
1	cpu)
1	3-5-year-old
1	indices:
1	i/ii,
1	adults'
1	immaturity.
1	ducreyi,
1	cdta,
1	cdtb,
1	ducreyi
1	ωkan-2
1	interposon
1	expression-negative
1	(virulence
1	(integrase),
1	(bacteriophage
1	(ljp).
1	leukotoxin.
1	ljp-susceptible
1	non-ljp
1	22.50,
1	c.i.).
1	incisors),
1	(salivary
1	streptococci)
1	1.0-
1	piracicaba
1	=12.08,
1	(decayed
1	surfaces)
1	(80.3%)
1	=28.67,
1	=4.11,
1	=6.24,
1	salty
1	=10.30,
1	variables:
1	anti-streptococcus
1	pertaining
1	self-diagnosis
1	ensued
1	visits.
1	perpetual
1	improvement;
1	results;
1	boys.(abstract
1	hexetidine
1	(hx),
1	cetylpyridinium
1	sanguinarine
1	(sg),
1	(nh4f)
1	(s-ha).
1	cx,
1	nh4f
1	hexadecane
1	s-ha.
1	nh4f,
1	s-ha
1	3‐yr
1	dmfs
1	1-20,
1	21-40
1	impractical,
1	impossible.
1	catesebeianus,
1	(aqp)
1	defolliculation
1	biotinylation,
1	andmeasurements
1	osmoticwater
1	haqp1flag
1	[flag,
1	(dykddddk)
1	aqp1],
1	haqp8,
1	(pcmbs),
1	whereasaqps
1	haqp1c189s
1	[residuecys
1	s)]
1	haqp7
1	insensitive.
1	raqp3
1	tomercury,
1	mercury-sensitive
1	hydration-dehydration.
1	intracellular-ph
1	surface-ph
1	/ph
1	7.50.
1	rise;
1	(dphi/dt)max,
1	(ph).
1	augments,
1	non-co2/hco3
1	hepes),
1	[co2],
1	meridian
1	extracellular-solution
1	slower)
1	[co2]
1	reaction-diffusion
1	series)
1	replenishes
1	exiting
1	(phs),
1	from)
1	gpi-linked
1	“cis”
1	neverthe
1	less,
1	co2/10
1	(pho
1	7.5)
1	supra-additive.
1	nonerythroid
1	co2/33
1	nh3/nh4+
1	biotinylation
1	rhbgd178n
1	rhcgd177n
1	aqua-porins
1	(ut-b)
1	(slc14a1),
1	c]urea
1	(aphs)
1	/33
1	nh3/nh^
1	20-fold,
1	o-injected
1	phloretin
1	ut-b-dependent
1	(aph
1	membrane-embedded
1	energetics
1	mutating
1	threonines
1	ut-b.
1	co2/h2o
1	0-9,
1	h2o-injected
1	δphs&z.ast;.
1	aqp6.
1	(δphs&z.ast;)co2
1	aqp0,
1	(δphs&z.ast;)nh3
1	aqp3,
1	aqp7,
1	aqp8,
1	(δphs&z.ast;)co2/pf&z.ast;
1	;gt;
1	(δphs&z.ast;)nh3/pf&z.ast;
1	aqp8
1	aqp8.
1	aqp4-m1.
1	selectivities
1	h2o.
1	aqps,
1	proteins?
1	aqp1b.
1	postfertilization
1	(hpf)
1	rerio,
1	hpf,
1	ionocytes
1	(*)
1	f*)
1	(δphs*)
1	co2/pf*
1	(δphs*)nh3/pf*
1	(∼1
1	produce-from
1	crnas-exogenous
1	ion-transport
1	exogenously-expressed
1	transporter-mediated
1	hco3-),
1	ion-movements
1	expedites
1	(aqp1)
1	rh-family
1	aqp
1	(δph
1	day-matched
1	nkcc2,
1	pept1.
1	phs).
1	τ
1	δphs(nh
1	f).
1	δphs
1	channelexpressing
1	*/p
1	f*,
1	aqp4.
1	*/δphş(nh
1	*,
1	rhag.
1	nh3/nh
1	4+.
1	(-δphi
1	(-δphs
1	0.2)-indicative
1	influx-followed
1	[nh3/nh4+]
1	(bacterial
1	homologue)
1	exaggerates
1	-δphs
1	nh3/nh4+,
1	overshoot
1	nh3/nh4+.
1	dispose
1	membrane-amtb-enhances
1	slc4a10
1	ncbe,
1	4,4′-diisothiocyanato-stilbene-2,2′-disulfonic
1	acid-sensitive,
1	electroneutral.
1	cl--sensitive
1	exchangers,
1	cl-.
1	36cl
1	ncbe-expressing
1	co2/hco3--stimulated
1	self-exchange
1	rename
1	na/hco3
1	nbcn2.
1	(pco2)
1	aqp1-expressing
1	18o
1	suspensions.
1	[co2].
1	rbcs;
1	(sd;
1	n=85)
1	pcmbs,
1	aqp1-deficient
1	dids-sensitive
1	gum.
1	nitroimidazole-thiodiazole
1	derivate
1	cl64,855-induced
1	i-proficient
1	nitroreductase-proficient
1	ta98nr.
1	jr.
1	pdf
1	dieters.
1	(agrp)
1	agrp-specific
1	(pegvisomant)
1	alerts
1	(agrp).
1	α-melanocyte-stimulating
1	(α-msh).
1	melanocortin-4
1	(mc4r)
1	mc4r-reporter
1	mc4r,
1	(pa).
1	mc4r
1	appositions.
1	pomc,
1	cartpt
1	prlh
1	iroquois
1	(irx3)
1	(fto)
1	droplet-sequencing
1	>20,000
1	irx3.
1	irx3,
1	hormetic
1	energy-handling
1	fund:
1	2013/07607-8
1	(lav)
1	2017/02983-2
1	(jdj);
1	r01dk083567
1	(ybk).
1	(bromo)
1	mellitus;
1	hyperprolactinemia.
1	arc-attenuated
1	lipohypertrophy
1	cross-fostering
1	(mrn)
1	serotonin-producing
1	non-serotonergic
1	satiety.
1	adaptions.
1	(−3%;
1	rhythms;
1	(aβos),
1	sub-toxic
1	(1 pmol)
1	aβos.
1	aβo-infused
1	aβos,
1	pegvisomant
1	(somavert®).
1	lambda-pl
1	g120r-hgh,
1	e. coli
1	1.34 ± 0.24 μg/ml/a600
1	(∼0.79 mg
1	g120r-hgh/g
1	30 °c
1	a600
1	37 °c,
1	6 h,
1	4.3 ± 0.3
1	a600.
1	hpsec
1	ba/f3-llp
1	(100 ng/ml)
1	(1 ng/ml).
1	hprl
1	(mtor).
1	already-obese
1	non-t<inf>h</inf>2
1	(icv)-injected
1	kd<sup>hom-/-</sup>),
1	(na),
1	pre-ganglionic
1	drug-treatable
1	(hsps).
1	(gln+ala),
1	l-alanyl-l-glutamine
1	(dip),
1	glutamine-glutathione
1	b6.129f2/j
1	(lipopolysaccharides
1	mg.kg-1,
1	(0.61
1	(gln+ala-lps
1	(dip-lps
1	group]
1	(gssg/gsh
1	gln+ala
1	glutamine-gsh
1	endotoxemia.
1	6weeks
1	anabolism
1	(igf-1),
1	glucose-6-phosphatase,
1	3-hydroxy-3-methyl-glutaryl-coa
1	(hmg-coa)
1	anabolism.
1	dio.
1	katpchannel
1	(bcat1,
1	bcat2
1	bckdk)
1	suppressant
1	protein/rna
1	rthat
1	balance),
1	(cnr1
1	sr141716
1	[n-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole
1	carboxamide]
1	casein);
1	l-valine
1	(val)
1	l-isoleucine
1	(ile)];
1	l-lysine
1	(lys)
1	l-tyrosine
1	(tyr)
1	l-threonine
1	(thr)];
1	l-leu
1	l-val
1	l-ile).
1	v+i,
1	leptin-sensitive
1	loxp-flanked
1	(loxtb),
1	recombinase.
1	loxtb
1	hyperglucagonemia,
1	(sarcopenia)
1	(osteopenia).
1	six-month-old
1	con-veys
1	con-ditions
1	elias.
1	playedby
1	physiologyis
1	channel(s)
1	brains-tem
1	(pi3k).
1	(lepr
1	leptinon
1	inhibitionof
1	leptin-induced-hyper
1	signalingin
1	(ref),
1	(tnf-)
1	ref,
1	0.019).
1	0.019),
1	0.022)
1	0.042).
1	torres-leal
1	vmhspecific
1	appetite.
1	(leprb)
1	leprb.
1	hyperpolarizes
1	non-5-ht
1	transporter-cre
1	(sertcre)
1	non-5-ht)
1	sertcre
1	sertcre-mediated
1	meaningfully
1	appetite-related
1	pkc-theta
1	(pkc-θ),
1	(npkc),
1	npkc
1	(pkc-δ),
1	non-hypothalamic
1	immunohistochemisty
1	(lepr-b)
1	(orx)
1	orx
1	lepr-b
1	oxytocin-enhanced
1	vasopressin-enhanced
1	(avp-egfp)
1	(diet
1	0.59%
1	l-leucine),
1	(igf).
1	(c20:5
1	epa)
1	(c22:6
1	dha)
1	rats/group):
1	ain93m
1	omega-l0.5
1	omega-l50
1	21.4%.
1	anabolism,
1	l-phenylalanine
1	(weight
1	wc).
1	2 weeks
1	(wc-con)
1	(wc-aa).
1	(pf-con)
1	36.1%
1	18.9%
1	detailing
1	(gonadotropin-release
1	hormone),
1	(luteinizing
1	(follicle-stimulating
1	amenorrhea,
1	woman's
1	(bcaa;
1	4.76%)
1	(ain-93m)
1	(s1:
1	s2:
1	4.76%
1	(60 min
1	(1h)
1	44%,
1	(262%
1	222%,
1	l-leucine/kg
1	obese.
1	"leptin
1	thesis".
1	"prevents"
1	hematobin
1	(htb),
1	htb.
1	(il-12p40)
1	htb;
1	pemphigus
1	foliaceus
1	(pf);
1	georeference
1	simuliidae
1	simuliidae)
1	(sges)
1	relatives,
1	1965
1	plotted.
1	nigrimanum,
1	neivai,
1	eighty-five
1	(13.3%)
1	(p<0.001
1	both),
1	(p=0.115
1	p=0.552,
1	anti-desmoglein
1	(r=0.3848,
1	p=0.039;
1	r=0.416,
1	p=0.022,
1	etiopathogenesis.
1	cd3<sup>+</sup>
1	infer,
1	antigen-dependent
1	downmodulates
1	a-phenyl
1	n-tertiary-butyl
1	nitrone
1	(pbn;
1	trap),
1	mnte-2-pyp
1	mntbap
1	(mn-phorphyrin),
1	mitoquinone
1	(mitoq)
1	mitotempo
1	antioxidants),
1	(egcg;
1	tea)
1	pbn)
1	ic50s.
1	(diethyldithiocarbamate)
1	(diphenyleneiodonium)
1	separations
1	pilocarpine-derived
1	transferring,
1	serpin.
1	glycine-rich,
1	cement-like
1	thyropin
1	sparc
1	mined
1	hazard,
1	under-recognized.
1	eat-induced
1	transfusion-related
1	(trali)
1	alloantibodies
1	(brms)
1	hemocomponent
1	(non-immune
1	brms
1	hna-2+
1	(anti-cd177,
1	7d8)
1	hna-2
1	nod/scid
1	mip-2,
1	administrated.
1	event(s),
1	vox
1	objective-blood-sucking
1	arthropods'
1	antihemostatics.
1	results-several
1	32.4-kda
1	lufaxin,
1	tight,
1	noncompetitive,
1	(fxa).
1	lufaxin's
1	dansyl-glu-gly-arg-fxa,
1	â‰̂3
1	1:1.
1	fecl3-induced
1	conclusion-lufaxin
1	slow-tight
1	prohemostatic
1	objective-the
1	coagulation-inflammation
1	defibrotide
1	(ec)-protective
1	comatose
1	veno-occlusive
1	results-df
1	(pf-gpi)
1	(8-p-sulfophenyltheophylline)
1	poly-a,-c,-t,
1	and-g.
1	aptameric
1	amurine
1	ifn-γlevels,
1	phlebotomus
1	(collagen-induced
1	[cia])
1	cia,
1	(ado)
1	a2areceptor
1	(ecto-5′-nucleotidase
1	cia
1	alboserpin,
1	albopictus,
1	stoichiometric,
1	competitive,
1	(picomolar
1	site-blocked
1	fxa,
1	outcompetes
1	phosphatidylcholine/phosphatidylethanolamine
1	56-day-old
1	third-stage
1	4-dependent
1	microcon
1	micro-hplc
1	∼110
1	(pge2
1	camp-pka
1	ado,
1	sialome
1	catalogs
1	immunoparasitologists
1	immunome
1	sialogenins
1	greek
1	sialo:
1	saliva;
1	gen:
1	immunoglobulin-binding
1	(cyslts).
1	stephensi,
1	aed7
1	(ltc4)-induced
1	obp-like
1	aed7,
1	bonding
1	v-5
1	52.
1	lte4
1	what,
1	presents,
1	lagged
1	own,
1	ginkgo
1	biloba,
1	allium
1	pacari,
1	(compounds
1	extracts),
1	(sialol)
1	scapularis.
1	sialol.
1	10-kda
1	sialol,
1	illuminate
1	hosts)
1	barriers,
1	armamentarium,
1	ticks).
1	3,500
1	accessble
1	http://exon.niaid.nih.gov/transcriptome/tick-review/sup-table-1.xls.gz.
1	ag-immunized
1	5-lipoxygenase-/-,
1	5-lipoxygenase-/--infected
1	18th;
1	total-reflection
1	(srtxrf),
1	(ni-liver)
1	5091
1	(p-thymus)
1	μg.g-1.
1	25.88
1	(noss)
1	no-producing
1	(uil),
1	yeast-injected
1	(yil),
1	blowfly
1	megacephala,
1	malpighian
1	(mk886)
1	in-vitro.
1	tlr-9
1	(<1/2000)
1	(microcon
1	filtration,
1	sieving,
1	chromatography),
1	(dilution
1	1/200;
1	immunologically.
1	vimang®,
1	mangifera
1	50 mg/kg
1	vimang®.
1	immunomagnetically
1	aa4
1	(nil),
1	(yil).
1	post-injection,
1	inhaled.
1	(cfags)
1	histoplasmin
1	886,
1	alkali-insoluble
1	anti-il-5
1	(trfk-5,
1	diluting
1	rosenfeld-stained
1	cytospin
1	(8.4
1	(0.07
1	trfk-5
1	1mgml-1
1	(dscg)
1	dscg
1	proposed:
1	bark.
1	pacari.
1	il-5-mediated
1	(phk),
1	(trex1)
1	phk
1	anchorage
1	subg1
1	precancerous
1	hmgb1-tlr4
1	rabelo-santos
1	(hr-hpv),
1	sod2)
1	(cin3),
1	(adc).
1	(64%).
1	logist
1	27.50,
1	6.16-122.81)
1	12.67,
1	4.04-39.74)
1	3.30,
1	1.23-8.86)
1	3.51,
1	1.03-11.87)
1	endless
1	experimentation.
1	originated.
1	deregulate
1	faithful
1	papillomavirus-related
1	stretches,
1	carcinogens,
1	papillomaviruses-associated
1	polyomaviridae,
1	(poly)
1	(omas)
1	(tumor)
1	(mcpyv),
1	trichodysplasia
1	spinulosa
1	(tspyv),
1	cunningham
1	(jcpyv)
1	(bkpyv)
1	mcpyv
1	carcinogen
1	mcpyv,
1	tspyv,
1	jcpyv
1	bkpyv
1	(hr-hpv)-related
1	e6/e7-dependent
1	ski
1	e6/e7,
1	slug,
1	zeb
1	hr-hpv-induced
1	pir-silenced
1	egfr/erk
1	pi3
1	k/akt
1	e7-mediated
1	redirects
1	anxa1,
1	carcinoma-derived
1	e6ap.
1	hpv-16-positive
1	e6wt.
1	dicer-substrate
1	(dsirna)
1	cotransduced
1	hpv16,
1	(dlg1),
1	misdistribution
1	hpv-11
1	hpvs,
1	(sod2)
1	gastric,
1	colorectal,
1	casuistic
1	44.8%
1	(cin)
1	mmp-9-reck
1	liquid-based
1	(cin2/
1	cin3)
1	lletz,
1	cin1.
1	hpv-dna
1	[or,
1	2.2-7.8]
1	0.2-0.7)
1	cin2/cin3/scc
1	neoplasia/cin1).
1	1.3-11.3).
1	impact:
1	metastisation.
1	cd147,
1	cervicitis,
1	lsil,
1	hsil,
1	parameters.results:
1	caix,
1	transfection.conclusions:
1	(ncrnas)
1	ncrna
1	(sncmtrna)
1	(asncmtrnas).
1	(hfk)
1	asncmtrnas.
1	factors(s)
1	non-hpv-induced
1	pro-mmp-9
1	precancer
1	mmps/reck-timp-2
1	cardeal
1	oncoproteins,
1	hpv18
1	override
1	tcn1
1	(transcobalamin
1	ifi44
1	(interferon-induced
1	44),
1	hmgb2
1	(high-mobility
1	[fusion
1	t(12;16)
1	liposarcoma)]
1	hp-vassociated
1	journals.permissions@oxfordjournals.org.
1	(lxsn)
1	(mgh)
1	(lit/
1	scid).
1	mgh/106
1	cells/day.
1	lit/scid
1	mgh-secreting
1	2374
1	mtrrna
1	(ncrna)
1	re-assume
1	ncmtrna.
1	ncmtrna
1	(hbv),
1	(htlv-i),
1	(hiv-i)
1	58,
1	(iarc).
1	virus-induced/associated
1	caski)
1	recreate
1	papillomavirus)-positive
1	matrigel™
1	self-assembles
1	(vlps).
1	lactose-inducible
1	(plac)
1	casei.
1	casei-produced
1	anti-hpv-16
1	vlp
1	h16.v5.
1	frugiperda-produced
1	(hpv)-immortalized
1	(phks)
1	basal/parabasal
1	strata.
1	ink4a,
1	cip1,
1	kip1,
1	nonrandomly
1	rays.
1	subgenomes
1	i-induced
1	bamhi.
1	g-banding
1	breakage-prone
1	γ-rays.
1	(c)1998
1	metaphases.
1	g1-
1	s-phases
1	g-bands,
1	nuclease-sensitive
1	(obese),
1	(lean).
1	400μm,
1	brain-organ
1	brain-liver
1	(dvmn)
1	g(s)
1	(dreadd-gs).
1	clozapine-n-oxide.
1	dvmn,
1	dvmn.
1	dreadd-gs-expressing
1	cardio-vagal
1	(0.90%
1	hs)
1	(0.27%
1	cont)
1	corpuscle
1	human'
1	sodium-driven
1	non-anesthetized
1	atp-glutamate
1	pvn-rostral
1	applied)
1	(89%),
1	4-[[4-formyl-5-hydroxy-6-methyl-3-
1	[(phosphonooxy)methyl]-2-pyridinyl]azo]-1,3-benzenedisulfonic
1	+-amino-3-hydroxy-5-methylisoxazole
1	=13)
1	(ampa
1	amplitude:
1	area:
1	52%).
1	=12)
1	(bapta,
1	=10).
1	(mannitol
1	mosm,
1	=8)
1	=6).
1	extrasynaptic
1	location)
1	synthesize,
1	(hgp),
1	nu/µl)
1	(hvgc)
1	hgp.
1	(svn)
1	2%),
1	(lssn)
1	(–6
1	svn
1	(–2
1	lssn
1	ica
1	hydromineral
1	osmolality.
1	wanted
1	salt-
1	mosmol/kgh2o),
1	v1areceptor
1	(−14
1	(−19
1	salt-induced
1	v1areceptors,
1	-22
1	-32
1	microinjections.
1	chf,
1	(lsna).
1	(pyridoxalphosphate-6-azophenyl-20,40-disulphonic
1	ppads)
1	(kynurenic
1	kyn)
1	ppads.
1	non-n-methyl-d-aspartate
1	(6-cyano-7-nitroquinoxaline-2,3-dione
1	cnqx),
1	(dl-2-amino-5-phosphonopentanoic
1	ap5),
1	avp-egfp
1	fibre-optic
1	'optrodes')
1	(latency
1	pre-stimulus
1	haemorrhage)
1	neurohormones/chemicals
1	non-technical
1	urination,
1	sweating
1	(eh)
1	(t)sna.
1	transections,
1	medulla-spinal
1	(cnts)
1	(anaesthetized/conscious)
1	supra-brainstem
1	jund
1	cnts,
1	fosb,
1	reciprocating
1	structure-switching
1	inotropy
1	rat;
1	(lvdp/dt).
1	zatebradine
1	lvdp/dt;
1	force-frequency
1	(dependence
1	unpaced
1	lvdp/dt.
1	(microtip
1	millar
1	catheter),
1	kcn.
1	(-108
1	b.p.m.)
1	paced,
1	(+16
1	dp/dt
1	(+778
1	mmhg/s).
1	tachypnoeic
1	non-anaesthetized
1	hypothalamo-neurohypophyseal
1	(hns)
1	function-related
1	(giot1),
1	giot2,
1	3-like
1	(mcns)
1	giot1
1	mcns
1	hns
1	water-deprivation-induced
1	(118
1	anteriodorsal
1	posterioventral
1	(175
1	dea-nonoate,
1	up-reguation
1	(hs,
1	bolus),
1	(kg
1	water)-1,
1	hs-induced
1	non-nacl
1	osmolyte,
1	(0.5%);
1	(mannitol),
1	precollicular
1	hyperosmotic-induced
1	isoguvacine
1	isoguvacine:
1	kynurenic:
1	blocker:
1	(tsna)
1	(comnts)
1	(whbp),
1	500 mm)
1	250 mm,
1	(100 mm,
1	10 mm,
1	mcpg.
1	sympathoexcitatory,
1	whereas/although
1	whbp.
1	(pna;
1	+105
1	18%)
1	(tsna;
1	+44
1	(hr;
1	377
1	25,100
1	mmol/l;
1	-82
1	1%)
1	-179
1	demedullation
1	outpointing
1	(kcn,
1	tachypnoea.
1	tachypnoea
1	sub-regions
1	(0.31,
1	phosphate-6-azophenyl-2′,4′-disulfonic
1	(eaa)
1	(trans-acpd;
1	(-64
1	(-206
1	2-amino-5-phosphonovaleric
1	-methyl-4-carboxyphenylglycine
1	baroreflex-like
1	(hypotension
1	bradycardia).
1	(α-methyl-4-carboxyphenylglycine,
1	mcpg,
1	baroreflex.
1	hypocretin
1	sleep/wakefulness.
1	orexin-containing
1	(iml)
1	thoracolumbar
1	intrathecal.
1	(1:500
1	16-day-old
1	spns,
1	discharges.
1	μm)-containing
1	a-immunoreactive
1	iml,
1	(sfo)
1	dipsogenic
1	at1-
1	at2-angiotensin
1	pd123319,
1	arginine-
1	d(ch2)5-tyr(me)-avp,
1	30-h
1	20-h
1	water-deprived
1	furosemide-treated
1	(65%,
1	at2-receptor
1	(45%,
1	v1-type
1	d(ch2)5-tyr(me)-avp
1	(mnpo).
1	ovariectomized,
1	0.4,
1	18,82
1	ovariectomzed
1	9,58
1	(slc)
1	(pk)
1	(ddi),
1	pharmacodynamics.
1	intervariability
1	(fo),
1	c+fo
1	(cfo)
1	h+fo
1	(hfo).
1	(tcai)
1	(citrate,
1	pgc1-a
1	tcai
1	gpat1,
1	(pgc1α
1	cpt1
1	ucp3).
1	(obesity
1	calorimetry,
1	mir-1a,
1	mir-133a/b,
1	let7b-5p,
1	mir-23b-3p,
1	mir-29-3p,
1	mir-143-3p
1	(phospho-ampkα2,
1	cpt1b),
1	expenditure;
1	mir-1a
1	phospho-ampkα2
1	cav-1
1	mir-1a-3p
1	(srl).
1	dose-adjusted
1	(c0/d)
1	(pred),
1	(mps),
1	pred,
1	mps.
1	(g.31611c>t),
1	cyp2c8
1	rs10509681
1	(c.1196a>g)
1	c0/d.
1	c0/d,
1	non-vesicular
1	958–966,
1	(n=151),
1	(g.31611c>t)
1	rs776746
1	(g.6986a>g),
1	g.20230a,
1	g.31611c,
1	g.6986a
1	0.37,
1	0.28,
1	(co/d,
1	c.1236t,
1	c.3435t,
1	c.2677t/a
1	0.33/0.04.
1	c.1236tt+c.3435tt+(c.2677tt+ta)
1	each/day)
1	monotherapies,
1	psgl-1
1	hscrp
1	(abcb1)with
1	c.2677g>t/a
1	c.2677g>t
1	region-abelson
1	(bcr-abl1),
1	(slc22a1)
1	(59.1
1	38.3%;
1	(mmr)
1	(64.7
1	45.7%;
1	effluxes
1	>60%.
1	(0.51
1	1.42
1	slc22a1
1	1236ct/3435ct/2677gt
1	1236tt/3435tt/2677tt
1	subtilisin/kexin
1	(pcsk9)
1	e670g,
1	i474v,
1	normolipidemics
1	(nl).
1	128)
1	mg/d/4
1	wk).
1	=.059).
1	670g
1	=.03)
1	>.05).
1	cyp3a5.
1	121)
1	cyp3a4*1b
1	(rs2740574),
1	cyp3a4*22
1	(rs35599367),
1	(rs776746),
1	(rs15524)
1	6-beta-hydroxy-cortisol
1	(r2=0.039,
1	p=0.037)
1	(r2=0.047,
1	(r2=0.071,
1	p=0.022).
1	(p<0.045),
1	snplex
1	[1.5-3.2],
1	=0.0001)
1	rs1984112
1	[1.9-7.0],
1	=0.0002)
1	(>.
1	160.
1	514t
1	(rs1984112)
1	514c.
1	>.
1	34-plex
1	(aim)
1	white,
1	brown-intermediate
1	<0.25
1	>0.50
1	outlier
1	<0.25.
1	components;
1	multiplexed
1	aim-snps
1	(mir
1	mirna)
1	cocaine)
1	(mir-18a,
1	-27a,
1	-27b,
1	-124a,
1	-148a,
1	-324-3p,
1	-328,
1	-451,
1	-519c
1	-1291)
1	mir-124a
1	methadone
1	fluoxetine)
1	mir-27b,
1	-148a
1	-451
1	drug-drug
1	one-hundred-thirty-six
1	andtreated
1	snapshot
1	(c.388a>g,
1	c.463c>a
1	c.521t>c)
1	(-71t>c)
1	c.388aa+c.388ag
1	0.034).
1	slco1b1*15
1	(c.521c
1	c.388g)
1	ci95%:1.3-8.0,
1	c.388a>g
1	(nl,
1	166)
1	c.4g>a,
1	c.1080ot
1	540t
1	field:
1	(pks)/pharmacodynamics
1	reader
1	gain:
1	pks/pds
1	(oatp)1b1
1	(mrp)1,
1	mrp2,
1	oatp2b1,
1	oat1b3
1	oatp1a2,
1	solute-linked
1	(slco1b1
1	slco2b1)
1	speculative,
1	hyper-cholesterolemic
1	atorvastatin's
1	undear.
1	androstane
1	apolipoproteins
1	(c3435t
1	g2677t/a)
1	(g2012t)
1	(pcr)-rflp
1	singleplex
1	0.039).
1	(<0.024)
1	(33.4
1	31.3%)
1	(>0.085:
1	40.3
1	14.3%;
1	10.7%;
1	3a5
1	(cyp3a5)
1	xenobiotics.
1	(10 mg/day/4 weeks).
1	salting-out
1	cyp3a5*3c,
1	cyp3a5*6
1	>frequencies
1	47.8%
1	*1d:
1	55.2%)
1	84.9%
1	84.8%,
1	*3a
1	(*3c
1	non-*3a
1	cyp3a5*3a
1	(ami).
1	(<40
1	(n=113)
1	n=99)
1	flow-mediated
1	(fmv)
1	(fmn)
1	(l55m,
1	q192r)
1	(s311c)
1	l55m
1	1.589;
1	1.077-2.343).
1	fmv
1	55ll/192qq
1	(or:5.25,
1	1.28-21.58,
1	p=0.022)
1	(or:5.71,
1	1.22-26.88,
1	p=0.027).
1	ldl-c,
1	vldl-c,
1	55m
1	(lm+mm
1	genotypes)
1	55ll/192qr+rr
1	3.05,
1	1.01-9.20,
1	p=0.048)
1	3.91,
1	1.25-12.18,
1	inter-variability
1	statins,drug-interactions
1	havebeen
1	thomson
1	researches,
1	compartmentalization;
1	m-atpase,
1	h.e..
1	(fg,
1	so)
1	compartmentalization,
1	(fg
1	fog)
1	anatom.
1	waist,
1	hip,
1	waist-to-hip
1	hdl-
1	(0.10)
1	(0.07,
1	p=0.210).
1	(p=0.040),
1	(p=0.040)
1	(aip;
1	p=0.003)
1	non-carriers
1	©2005,
1	peroxisome-proliferator-activated
1	receptor-γ2
1	(ppar-γ2)
1	hip
1	fragment-length
1	(0.09)
1	(0.06,
1	0.185).
1	0.036)
1	pro12
1	caucasians.
1	p-glycoprotein,
1	g2677t
1	0.536
1	0.464
1	3435c
1	3435t
1	0.580
1	2677g
1	0.384
1	2677t
1	0.036
1	2677a
1	anova;
1	t/t
1	non-t/t
1	278
1	anova/tukey
1	m-atpase
1	(fg),
1	(fog)
1	histoenzymologically
1	57.5%,
1	dislocation.
1	fore
1	cross-regulated
1	autolysosome
1	(pms)
1	pms
1	trypanossoma
1	nlrp3-mediated
1	deadliest
1	(oip5)
1	oip5-negative
1	lomustine,
1	death-induced
1	lomustine.
1	(naip)/nod-like
1	(nlr)
1	(card)
1	(nlrc4)
1	naip
1	pro-caspase-1.
1	naip6
1	naip1
1	naip2
1	phagosomal
1	buzzo
1	inflammasome-deficient
1	inflammasome-driven
1	(il-1r)
1	(nos2)-mediated
1	leishmania-induced
1	tlr-initiated
1	brucella.
1	asc-dependent
1	virb
1	heatkilled,
1	accelerate,
1	expanding.
1	autolysosomes)
1	process);
1	dictyostelium)
1	fungi).
1	equate
1	reviewers
1	critiques
1	formulaic
1	rules,
1	m∅
1	f4/80.
1	(spm),
1	differences:
1	lpm,
1	no;
1	reinterpreting)
1	mø.
1	nlr,
1	naip5,
1	il-33.
1	639
1	(7.51%)
1	synthesis/remodeling
1	wall/membrane.
1	wall/membrane
1	dimorphism.
1	bastos
1	(nafld).
1	repurposing
1	weight-relevant
1	akkermansia
1	muciniphila
1	modulations,
1	steroid,
1	perimenopause.
1	postmenopause
1	vldl-c
1	dhea)
1	prague,
1	republic.
1	igf1-receptor
1	(igf1-r)
1	(sed+los),
1	(ex+los).
1	1rm).
1	igf1-r
1	(at1r
1	β-arrestin-2
1	igf1-r,
1	re-induced.
1	β-arrestin-dependent
1	excisional
1	hematoxylin/eosin,
1	contraction;
1	dehydroespiandrosterone
1	consequence.
1	kg-1);
1	chrebp,
1	lxr,
1	g6pase
1	postmenopausalwomen;however,
1	operated,
1	(ovx+e2).
1	cσactivation
1	cθactivation
1	ofovxmicecomparedwithshamandovx+e2.
1	increasingo2
1	(dag)
1	leucine)
1	macronutrients
1	resistance?
1	skeletal-muscle
1	atendency
1	g/d
1	12w).
1	0.78)
1	hb1ac
1	-0.68),
1	mechano
1	(mgf)
1	high-speed
1	ee-velocity
1	akt/mtorci/p70s6khypertrophy
1	(20°·s-1;
1	es)
1	(210°·s-1;
1	ef)
1	(t1),
1	p70s6ktotal
1	postintervention.
1	p70s6kprotein
1	ef.
1	mgf
1	velocitydoes
1	akt/mtorci/p70s6k
1	glucose-free
1	non-hexose-treated
1	haptoglobin
1	mmol,
1	glucose-rich
1	fructose-rich
1	irs-3)
1	irs-2/
1	whatsoever
1	anaesthetize
1	thiopental,
1	ether.
1	shp2,
1	dhea.
1	pi3-kinase/akt
1	pi3k/atypical
1	(β-ar)-mediated
1	two-kidney,
1	isoprenaline,
1	(2k).
1	reloading
1	2+-reloading
1	atp)
1	phosphoserine-containing
1	(lg
1	sg)
1	8/group).
1	homogenized,
1	immunoblotted
1	28-week-old
1	msg-insulin
1	10-week-old
1	28-week-old-msg
1	(ir;
1	(irs1;
1	irs1/irs2
1	irslars2
1	p85/phosphatidylinositol
1	(275%,
1	(i80%(180%,
1	discrepancy,
1	5-inositol,
1	(ship2),
1	phosphoinositide-3
1	(pi-3
1	bc3h-1
1	lh/human
1	transcription-1
1	(stat-1),
1	stat-5b,
1	(shc)
1	irs-1/phosphoinositol
1	/growth
1	(grb2)
1	v-akt)
1	theca.
1	ghr,
1	substrate-1,
1	shp2.
1	serine-kinase
1	epinephrine-treated
1	postreceptor
1	erks,
1	irs-1/
1	irs-1/growth
1	(grb2),
1	irs-1/irs-2-associated
1	akt-1/pkb
1	transporter-4.
1	40±3%
1	38±5%
1	44±7%
1	(janus
1	transcription).
1	(itt,
1	itt
1	wistar-hannover
1	(110-130
1	(cna
1	(fna
1	itt.
1	fna
1	antiinsulin
1	anti-igf-1
1	jak-2
1	stat-1.
1	(shp2)
1	tyrosine-phosphorylation
1	irs2/pi
1	insulinsensitive
1	160%,
1	170%,
1	pp185,
1	irs-1/2
1	grb2,
1	(jak)
1	metabolising
1	phosphorylation-activation
1	pathway-jak
1	tyrosine-
1	ss,
1	sβ,
1	thalassemias
1	5β
1	thal),
1	anti-band
1	sd;
1	7.8-
1	2.7-fold;
1	3.8-
1	1.3-fold;
1	sβ
1	5.2-
1	2.0-fold).
1	4.3-
1	3.7-fold).
1	hemoglobinopathy
1	hemoglobinopathies
1	erythrocyte:
1	p72syk.
1	irs-1/shptp2
1	anti-shptp2
1	1(irs-1),
1	gestation)
1	antipeptide
1	253%
1	inhibitor-treated
1	"knockout"
1	6-week-old
1	(paracrine)
1	parallel.
1	±24%,
1	p±0.05)
1	cooh-terminus
1	phosphotyrosine-associated
1	glucagon-treated
1	anti-peptide
1	1.3-fold
1	ocurred
1	1.2-fold
1	irs-1-associated
1	dup
1	753,
1	aii-receptor
1	creatures.
1	pi-uptake
1	ugp,
1	phosphate-uptake
1	epsp
1	glyphosate-induced
1	(p)ppgpp
1	rela.
1	discerned.
1	pppgpp.
1	corrigendum
1	[1],
1	doi
1	gama
1	pertained
1	low-rpos
1	adhe-sins
1	outcompeted
1	trade-off
1	pstscab-phou
1	pi-transport
1	exopolyphosphatase,
1	phob,
1	(polyp)
1	(p<inf>i</inf>)
1	energyrich
1	phosphoanhydride
1	pst,
1	buildup
1	encode,
1	glycerol-2-phosphate
1	(g2p)
1	glycerophosphodiester
1	pita,
1	thr<sup>217</sup>
1	eaf,
1	lee,
1	eaf.
1	penta
1	orf,
1	supressor
1	non-suppressor
1	sigma70-dependent
1	σs-dependent
1	rpos+
1	σ70-dependent
1	rposam.
1	shipping
1	instabilities
1	accumulate.
1	mailing
1	mail
1	lb-stabs
1	mailed
1	is1
1	rssb.
1	mc4100tf,
1	storage-transfer
1	(rpos)
1	ecors
1	low-ppgpp
1	high-ppgpp
1	microevolution.
1	proportionality
1	ferenci
1	phou.
1	pi-limitation
1	phosphate-limited
1	(hfq,
1	rpos).
1	hfq,
1	benefit,
1	redirect
1	degeneracy
1	pharmacopoeia
1	(leukemia)
1	forficata
1	link.
1	(leguminosae)
1	pachystachya
1	trc.
1	(urticaceae)
1	forficata,
1	genes'
1	ribonuclease
1	e-dependent
1	ribonucleases,
1	mazf,
1	phosphate-replete
1	stabilisation
1	rpos),
1	(mc4100)
1	mg1655.
1	mg1655,
1	mc4100.
1	microevolution
1	esicherichia
1	constitutivity,
1	δpst
1	ler
1	σ70.
1	pi-limited
1	chemostat,
1	low-σs
1	osmolarity,
1	counterselection
1	tradeoff
1	self-preservation
1	environment-dependent.
1	spancare
1	rpos/ppgpp
1	(ihf).
1	(eσd).
1	σs-
1	ihf,
1	eσd.
1	0.1.
1	arnold
1	σd-associated
1	it:
1	phoe
1	ugpb
1	pho,
1	position-13
1	hybrid-primer
1	ultrafiltration.
1	thioacetamide.
1	genes-tap
1	ankyrin-binding
1	glycoprotein-1,
1	thioacetamide-induced
1	phosphate-regulated
1	(psts)
1	pst-specific
1	primer-extension
1	post-transcriptionally.
1	14c-labeled
1	(phoa)
1	c,a,b,u)
1	(ihf)
1	spot-dependent
1	δrela
1	δspot
1	(phoa
1	psts)
1	ppgpp0
1	p(i)
1	3',5'-bispyrophosphate
1	acrosome
1	anion-channel
1	(4,4′-diisothiocyanostilbene-2,2′-disulfonic
1	(4-acetamido-4′-isothicyanostilbene-2,2′-disulfonic
1	probeneid
1	tributylin
1	(tbtc),
1	cl-/oh-
1	ca2+-uptake,
1	(dibutyryl
1	(dbcamp)
1	ca2+-uptake
1	keywords:
1	factor-a,
1	0.461;
1	=.001),
1	0.512;
1	<.001),
1	0.407;
1	0.547;
1	prematurity,
1	circulating/functional
1	esr2/erβ
1	(l-nil).
1	(asmcs)
1	asmcs,
1	inos-no
1	esr2/erβ.
1	(ctr)
1	artemisinin-based
1	stromaticum
1	(ext-ts)
1	nf54
1	(ihrbcs)
1	ihrbcs
1	parasitaemia;
1	(pba),
1	ext-ts,
1	ihrbcs.
1	enoyl
1	pyrimethamine-resistant
1	low-endemic
1	ninety-five
1	rflp,
1	tlr9.-1486.t/c
1	tlr6.p249s
1	odds.
1	(22%).
1	(i602s)
1	(p249s)
1	602s
1	‘‘hypo-responsiveness’’
1	(frα)
1	(tf).
1	rtffrα
1	contruct
1	mimesis
1	exosome,
1	nanotherapeutic
1	103–104,
1	103–104).
1	growth-inhibition
1	reinvasion-blocking
1	liposome-formulated
1	mandatory.
1	2d-electrophoresis,
1	highresolution
1	gel-based
1	immunoproteome
1	hsp70-1
1	hsp70-x,
1	machinery/ptex
1	translocon.
1	macedo-silva
1	invasions
1	surf4.1,
1	destabilized
1	surf4.1
1	surf4.1.
1	inedited
1	xl
1	msp119)
1	(11%-20%
1	balb/c).
1	proteoliposomes
1	parasites:
1	ovale.
1	uneven
1	regions),
1	inst.
1	trop.
1	(kerteszia)
1	addressed,
1	palestina,
1	juquitiba,
1	residences
1	blood-meal
1	13,441
1	(ker.)
1	0.01%,
1	happen.
1	underexplored
1	(irbc)
1	icam1
1	irbc-exposed
1	staying
1	antigens.methods:
1	msp
1	ebl
1	gst-fusion
1	plasmas.results:
1	9.26/p
1	0.0047)
1	8.29/p
1	0.0069)
1	2-mad20
1	6.41/p
1	0.0206,
1	210.5,
1	189.5,
1	197,
1	mann-whitney's
1	0.112,
1	0.021-0.585)
1	0.125,
1	0.030-0.529,
1	tab
1	chances,
1	1.29-69.25)
1	1.12-29.62,
1	regression),
1	status.conclusions:
1	(calcium-dependent
1	1)]
1	auto-inhibitory
1	(junction)
1	j-gfp
1	(destabilization
1	(j-gfp-dd).
1	j-gfp-dd
1	autoinhibitory
1	12-months
1	(differing
1	locus).
1	pm09-299
1	(apcs),
1	-2.39,
1	0.017)
1	716
1	villages.
1	-0.09,
1	0.933).
1	fkbp12
1	shld-1,
1	shld-1
1	dd29,
1	stabilised
1	dd29.
1	(resa)
1	on/off
1	reinvasions
1	"poised"
1	trimethylated
1	transcription-associated
1	swiftly
1	cabral
1	guariba
1	clamitans)
1	saõ
1	(thin
1	smears),
1	(pvc),
1	(pvk
1	pvl),
1	malariae/p.
1	pvc,
1	(04/50)
1	pvk,
1	(03/50)
1	pvl,
1	28.0%
1	(14/50)
1	pf,
1	(21/50).
1	pfmsp1-19.
1	ifa,the
1	31.3%
1	(15/48).
1	protocols).
1	(09/50)
1	(38/50)
1	simians
1	(var)
1	350-430
1	microregion
1	identifiers
1	(dsids)
1	dsid
1	subcontinent.
1	diversify
1	erythrocyte-surface
1	cytoadhesive
1	reinvasions,
1	documents,
1	excel
1	single-table
1	microsoft
1	fulfilled,
1	(http://clinmaldb.usp.br)
1	field-research
1	modularization
1	storage;
1	views;
1	visualization,
1	pre-annotation
1	vir,
1	clinmaldb's
1	sql
1	downloadable
1	http://clinmaldb.usp.br.
1	iadis.
1	bactericidal,
1	tumoricidal,
1	-resistant
1	establishment;
1	coma.
1	(hbo)
1	ata,
1	cm-specific
1	pressurized
1	blanco
1	50-60
1	cho-cell
1	transcription/pcr/cloning/sequencing
1	untransfected
1	cho-745
1	pfd995/pfd1000c
1	rt-quantitative
1	monophenotypic
1	gölnitz
1	non-symptomatically
1	recombinatorial
1	(pfemp1),
1	ongoing,
1	var-transcribing
1	pcr-typing
1	unlikely.
1	matured
1	msp2
1	(prbcs)
1	(sequestration)
1	unparasitized
1	prbcs
1	(rosetting)
1	(hbs)
1	hbs.
1	(pvmsp1(19)-hbs).
1	pvmsp1(19)-hbs.
1	pvmsp1(19)-hbs
1	20-45
1	immunoprecipitable
1	vivax-positive
1	pvmsp1(19)
1	terminus)-hepatitis
1	(ppcmsp119-hbs)
1	pc1-infected
1	rpcmsp119-glutathione
1	ppc-msp119-hbs,
1	anti-msp119-specific
1	elicited.
1	cytokine-expressing
1	interleukin-2,
1	node-targeting
1	msp119-hbs
1	gp27.
1	labelings.
1	unreduced-reduced
1	pairing.
1	gp27,
1	subviral
1	dissipates
1	ucp1-dependent
1	(epa)-enriched
1	hf-fed
1	22 °c
1	ucp1),
1	thermoneutrality.
1	(pgc1α)
1	(mtdna)/nuclear
1	(nucdna)
1	ucp1;
1	pgc1α.
1	lard
1	(hfn3)
1	lipidome,
1	bioenergetics.
1	serca-mediated
1	creatine-driven
1	cyclings.
1	deyhydrogenase
1	(idh)
1	glioblastomas.
1	idh2
1	pathologically
1	d-2-hydroxyglutarate
1	(2hg),
1	ketoglutarate,
1	hypermethylated
1	5-azacytidine
1	(5-aza).
1	(hf/bcaa)
1	(iwat)
1	(bcat)2
1	α-ketoacid
1	(bckdh)
1	lipodystrophy,
1	bcaa.
1	bcat
1	bckdh
1	lipoeutrophic
1	lipodystrophic
1	(ibat).
1	(iwat),
1	improvements.
1	iwat.
1	316,243).
1	using11c-acetate,
1	2-deoxy-2-[18f]-fluoro-d-glucose.
1	portraying
1	ibat.
1	recruitable
1	polyphenol-rich
1	cagaita
1	(eugenia
1	dysenterica
1	(pce)
1	high-fat/high-sucrose
1	(hfs)
1	hfs
1	(gae)/kg
1	(hfs
1	(mtorc1),
1	brite,
1	"brown
1	white")
1	(ucp1)-positive
1	heatthrough
1	weightand
1	homoeothermy
1	1(ucp-1),
1	generation.energetically,
1	bat-elevated
1	oxidizefatty
1	lipidand
1	homoeostases.
1	poekes
1	supportingevidence
1	factordriving
1	foz/foz,
1	amouse
1	alström
1	(alms1)
1	alströmsyndrome.
1	exposureattenuated
1	foz/foz
1	theimportant
1	glucosehomoeostases
1	mtorc1.
1	(lpl)-mediated
1	23 days)
1	10-h
1	17-h
1	ad libitum
1	~twofold
1	lmf1
1	gpihbp1.
1	(fat/cd36,
1	fatp1
1	fabp4)
1	(gpat,
1	agpat
1	dgat)
1	(tsc)1
1	visceral,
1	(browning)
1	pro-browning
1	errα.
1	background/objectives:stearoyl-coa
1	desaturase-2
1	(scd2)
1	δ9
1	mice.subjects/methods:male
1	hypothalamus.results:the
1	neuropeptide-y
1	short-hairpin
1	intake.conclusions:thus,
1	(adicerko)
1	branchedchain
1	adicerko.
1	dr-induced
1	hyperactivation.
1	dr-modulated
1	(campomanesia
1	phaea
1	berg)
1	ellagitannins
1	phenolic-rich
1	high-fat,
1	(hfhs)
1	disarrangements
1	(fat-1)
1	(lyzm-pparγ<sup>ko</sup>)
1	nondeletion
1	(lyzm-pparγ<sup>wt</sup>)
1	(lard)
1	(fish
1	n-3.
1	non-myeloid
1	phosphoinositide-3-kinase
1	(mtorc2)
1	rictor,
1	sceptic
1	festuccia
1	tractable
1	multi-cellular
1	interrelationships
1	coactivators,
1	mtor-interacting
1	(deptor)
1	obesity/leanness
1	highest-priority
1	promotes,
1	proadipogenic
1	akt/pkb-ppar-γ
1	(ppar)γ
1	lipemia,
1	accretion,
1	lpl-dependent
1	tag-derived
1	(136%),
1	mrna/activity
1	(2-
1	6-fold),
1	visceral)
1	(wat;
1	(bat;
1	266%).
1	triacylglycerol-clearing
1	dyslipidemias,
1	hypertriglyceridemic
1	festuccia,
1	deshaies.
1	mg·kg-1·day-1,
1	cgi58)
1	(lipoprotein
1	coactivator-α
1	protein-β
1	(thermogenesis),
1	factor-45-like
1	monoacylglycerol
1	(lipolysis),
1	(transcription),
1	(tag
1	(5°c,
1	(hyperplasia
1	ppar-γ-mediated
1	(mtor)/p70
1	(s6k1)
1	obesity-linked
1	nutrient-sensing
1	3-kinase)/akt
1	phenotyping.
1	coactivator-1α
1	foxo1,
1	crtc2,
1	substrate/pi
1	mtorc1/
1	mg/[kg
1	d];
1	rahway,
1	nj),
1	(-28%),
1	β-oxidation,
1	(+38%).
1	higher-dose
1	thiazolidinediones,
1	thiazolidinediones
1	synthesis/degradation,
1	carbohydrate/lipid
1	(15 mg/kg
1	bnp,
1	400%),
1	glycogenin
1	udpg-ppl
1	calpain-mediated
1	degradation).
1	rpn
1	(retroperitoneal)
1	(inguinal)
1	acyltransferase.
1	(1.5-
1	vf.
1	(2.8-
1	1.9-fold)
1	lipin
1	(4.6-
1	1.5-fold)
1	sf,
1	additivity
1	3mg
1	(rsg,
1	5mg
1	(adipo-r2)
1	antisteatotic
1	adipo-r2
1	(pap
1	(dgat).
1	(-80%),
1	(-50%),
1	pyrophosphorylase
1	(-40%),
1	udp-linked
1	3-phosphate-generating
1	dgat
1	lipin-1-mediated
1	pap-1,
1	(fat-free)
1	(-30%)
1	cooh,
1	(epididymal,
1	cooh.
1	0.9)
1	post-lpl
1	(ap2,
1	fat/cd36,
1	fatp-1).
1	hypotriglyceridemic
1	(wat
1	bat)
1	mg/kġd)
1	wat(>50%)
1	(-40%)
1	deiodinases,
1	(-34%)
1	(-66%)
1	(-47%)
1	pro-energy
1	pparγ-induced
1	wholebody
1	(-41%)
1	(+47%),
1	(+39%),
1	(bat,
1	+46%)
1	(+33%),
1	(+48%),
1	lipoprotein-tg
1	high-sucrose,
1	mg/kg·d)
1	25-50%
1	(fas,
1	scd1,
1	dgat1)
1	(lipolysis/reesterification,
1	pepck)
1	oxidation-promoting
1	(1.5-5-fold)
1	synthesis/cycling
1	11β-hsd1,
1	mesenterical
1	lipemia.
1	sensitizers
1	lipemia
1	agonism.
1	(rsg;
1	postprandially.
1	(-54%)
1	60-90%
1	rsg,
1	(fatty
1	protein-4),
1	(diacylglycerol
1	acyltransferase-1),
1	trapping.
1	(40%).
1	(norepinephrine)-stimulated
1	agonist-treated
1	(mgl)
1	recycling,
1	nefa-lowering
1	lipid-retaining
1	(14-fold)
1	(4-fold),
1	uptake-,
1	retention-,
1	esterification-promoting
1	ap2,
1	compensates
1	glycerol-3-p
1	(retro)
1	(tag).
1	98%),
1	71%,
1	p-enolpyruvate
1	(pepck-c)
1	pepck-c
1	glyceroneogenesis,
1	(tag)-glycerol.
1	wr
1	1339,
1	14c-pyruvate
1	3h2o.
1	lpl,
1	diet-derived
1	45%-55%
1	carboxylase,
1	75%-86%
1	high-protein-diet-fed
1	4°c),
1	sources)
1	glyceride-fa
1	-glycerol
1	non-glucose
1	c]-pyruvate
1	phospho
1	eno/pyruvate
1	g3p,
1	high-protein
1	20-25%
1	(norepinephrine,
1	isoproterenol)
1	(cl316,243,
1	brl37,344,
1	clenbuterol)
1	isobutyl-methylxanthine
1	(29%).
1	droplet.
1	(sns),
1	(prv).
1	(fcn);
1	fcn.
1	(rwat)
1	rwat,
1	rwat.
1	(tag)-glycerol
1	(pepck).
1	nonglucose
1	incorporations)
1	(bat).
1	phenoxybenzamine,
1	μg/h),
1	cl316243
1	(β3)
1	(non-selective)
1	(β1).
1	β-adrenoreceptors,
1	β3.
1	mutators,
1	mutators
1	(rif
1	(fos
1	(mics
1	8–64
1	mmcb,
1	(mmc),
1	glyoxalases/dioxygenases
1	epistasis
1	(dnae2),
1	synthesis-dependent
1	imuabc-mediated
1	'point'
1	double-strand-break
1	dna-damage-
1	general-stress
1	envelope-protein-stress
1	mutagenesis-defective
1	implicated:
1	sos/dinb
1	σ32,
1	i-scei-induced
1	dsb-repair-associated
1	σe,
1	evolve.
1	amprc
1	enterobacteria,
1	lac-
1	(dsbr)
1	dinb.
1	forward-mutation
1	dsbr-associated
1	reversions
1	outnumber
1	change-of-function
1	rpos-controlled
1	general/starvation
1	dnadamage
1	(operator-constitutive)
1	constitutively.
1	sos-"off"
1	lexa(ind-)
1	hypermutable
1	slade
1	(2009)
1	deinococcus
1	radiodurans
1	gets
1	reassembled
1	shattered
1	ordinary.
1	can't
1	repair?
1	telling
1	themes.
1	mutation-generating
1	dna-break
1	antibiotic-resistance,
1	stress-induced-mutation
1	breakage
1	chelators.
1	glycosylase,
1	endonuclease-null
1	2,9-dimethyl
1	(nc)
1	fenton
1	(dnasb)
1	neurology.
1	insula
1	(tms)
1	(cnp)
1	double-blinded,
1	sham-controlled,
1	3-arm
1	psi-rtms,
1	acc-rtms,
1	sham-psi-rtms,
1	sham-acc-rtms
1	stimulations
1	psychophysics,
1	(numeric
1	[nrs])
1	55.02
1	rtms
1	mood,
1	(1.58,
1	0.09-3.06])
1	(-1.02,
1	-2.10
1	0.014),
1	acc-dtms
1	(-2.96,
1	-1.7])
1	(-0.78,
1	0.018).
1	acc-
1	cnp
1	acc-dtms.
1	clinicaltrialsgov
1	identifier:
1	nct01932905.
1	(635
1	immediately,
1	(ces)
1	cortex(m1)
1	m1-based
1	advocated
1	dysranular
1	μs,
1	v).
1	1-cannabinoid
1	(cb1r)
1	esi-induced
1	esi-treated
1	sub-areas
1	processing/modulation.
1	(68±3.3
1	non-filtered
1	hypovolemia,
1	infused.
1	0.5-fold
1	transfused
1	hypovolemia
1	illumina-humanmethylation450
1	beadchips.
1	(dmps)
1	dmp
1	hypomethylated
1	(1p34;
1	6p21;
1	10q26;
1	17q25;
1	19q13).
1	gene-gene
1	bulimia,
1	clusterization
1	hypomethylation
1	repair/free
1	nadur-andrade
1	(bmv),
1	time-pcr
1	due,inpart,
1	edema-inducing.
1	mjtx-ii.
1	proeminent
1	(optc)
1	(optb)
1	(α2-adrenergic
1	oligopeptidases.
1	first-aid
1	(bjssuv).
1	venom-injected
1	(685
1	beam)
1	transcutaneously
1	lett,
1	antiproteases
1	elafin,
1	(pr-3)
1	pr-3,
1	pr-3),
1	nave
1	intracolonic
1	elafin.
1	(tnbs)
1	(dss)
1	re-equilibrated
1	dss,
1	pr-3
1	neocortex
1	benefiting
1	formalin,
1	n-type,
1	cathepsins,
1	tryptase,
1	(pars).
1	par1,
1	par2,
1	inflammation:
1	redness,
1	dual.
1	(e37a-
1	e37b-containing)
1	tailors
1	(pvnfkflsh),
1	α1-chain
1	(ep24.15),
1	(ep24.16),
1	(h92-g110)
1	papain-induced
1	irritants,
1	atinociception
1	anti-mrp-14.
1	irritant.
1	anti-neutrophil
1	fems.
1	(uti).
1	uti.
1	(expec).
1	uti-causing
1	o78:h10
1	abilities.
1	utis.
1	enteropathogen,
1	enterotoxins/cytotoxins,
1	toxin-expressing
1	(peaf),
1	(lee)-encoded
1	espd).
1	perabc,
1	lee-encoded
1	(intimin)
1	(espd),
1	(perabc)
1	aaia,
1	aaig,
1	94.3%
1	cfu/cm2
1	(60.4%)
1	prefixed
1	clsm
1	(undetermined
1	adherence).
1	hebert
1	culler
1	catheterism
1	hpma,
1	(97.15
1	hi4320
1	protein-encoding
1	(cah,
1	eata,
1	ehaabcdj,
1	espc,
1	espi,
1	espp,
1	sat,
1	tiba)
1	39.3%.
1	notbe
1	worldwide;
1	elfa,
1	hcpa)
1	hcpa
1	(98.6%),
1	ecpa
1	elfa
1	csga
1	(19.7%).
1	(hcp)
1	(elf)
1	curli
1	agglutination)
1	immunofluorescence)
1	(ecp)
1	36.6%
1	ecp)
1	nonfimbrial
1	(lee).
1	(aepec),
1	(lal),
1	espfu-expressing
1	(pkc471)
1	pkc471
1	espfu
1	pathogenesis:
1	colonization);
1	bacterium-mucus
1	(aggr).
1	"stacked
1	brick"
1	pathogenicity;
1	defined;
1	dispersin-encoding
1	(aap)
1	e. coli,
1	aap
1	non-eaec
1	(nonclassical
1	serogroups).
1	pathogenic.
1	(upec)
1	(o1,
1	o4,
1	o7,
1	o14,
1	o15,
1	o18,
1	o21,
1	o25,
1	o75,
1	o175)
1	(pap,
1	hly,
1	aer,
1	cnf).
1	agg3c,
1	asta,
1	o113,
1	pathotype.
1	uropathogens.
1	eae).
1	subgrouped
1	(aepec);
1	(epec
1	(bfp).
1	characteristically,
1	microcolonies)
1	hela/hep-2
1	bfp,
1	looser
1	microcolonies.
1	(6h)
1	(la6).
1	la6
1	eae-defective
1	o125
1	tir,
1	espabd,
1	attaching-effacing
1	uroepithelium,
1	mirabilis:
1	mannose-resistant/proteus-like
1	(mr/p)
1	uroepithelial
1	(uca),
1	renamed
1	nonagglutinating
1	ambient-temperature
1	(atf).
1	uropathogenesis,
1	enterotoxic
1	mucinolytic
1	anti-pic
1	sepl,
1	94%,
1	epec-based
1	o26:h--based
1	o157:h7-specific
1	diverse.
1	conservation/diversity
1	o127:h21,
1	o142:h34.
1	diarrhoeagenic
1	serogroups.
1	selc.
1	o142.
1	accentuation
1	mannose.
1	(o44:h18),
1	o128:h35
1	(o128:h35
1	fimd,
1	042::fimd
1	18::fimd.
1	marker;
1	(94.3%),
1	(91.4%),
1	(74.3%)
1	(44.8%).
1	(cases)
1	chain-like
1	7.9%,
1	aggc.
1	66.7%,
1	11.1%,
1	shf
1	(ivoc)
1	ussing
1	042-infected
1	rounding,
1	intercrypt
1	crevices,
1	subjectively
1	aperture
1	042,
1	(aaf/ii),
1	65-mda
1	paa2.
1	paa2
1	aaf/ii
1	fimbria.
1	invasin
1	plasmid-borne
1	(aaf/i
1	aaf/ii)
1	agga,
1	(cvd432),
1	o26,
1	o111,
1	toxin-
1	stx-producing
1	o111ac
1	rariane
1	(0.9%,
1	(30ng/kg,
1	(py),
1	(m1/m2)
1	mg·kg−1·day−1)
1	groups—denominated
1	groups—were
1	noninfarcted
1	peri-infarcted
1	(cd4+cd25+foxp3+),
1	(cd25+foxp3−)
1	(cont),
1	(salt-2)
1	(salt-12).
1	two-weeks
1	2mm
1	intima/media
1	salt-2
1	(31.1±6%).
1	0.6%)
1	7.4%;
1	6.8%)
1	+72%;
1	+45%)
1	-54%;
1	-60%).
1	(+80%),
1	non-hemodynamic
1	(n=5):
1	(sco),
1	(tco),
1	(ks),
1	(kos)
1	(kot).
1	vv[lam];
1	vv[col]
1	cwt,
1	rigidity
1	compliance,
1	estrogen-deprived
1	ace.
1	stiffening
1	andre
1	bento
1	(0.14
1	pyridostigmine,
1	finalized
1	b.p.m./mmhg,
1	(-0.42
1	b.p.m./mmhg)
1	frequency/high
1	(0.81
1	ngnitro-
1	phosphodiesterase-3
1	(dp/dt)
1	lname.
1	sildenafil-induced
1	phosphodiesterase-5.
1	impairmant
1	(brs)
1	∼42%)
1	bpv.
1	abolishment
1	hrv,
1	4-copy
1	(42.4
1	45.7
1	(2.4-fold,
1	[2.41-fold
1	2.14-fold
1	respectively]
1	counterproof
1	(enalapril)
1	revascularize
1	stain,
1	arterial-vein
1	morphology/function
1	(nm),
1	(not-atrophied)
1	council.
1	msc)
1	bm)
1	bmc,
1	msc,
1	44.4%,
1	[1%]
1	110±5
1	162±1.5
1	109±6.7
1	144±10
1	354±28
1	303±25
1	380±34
1	298±30
1	maps),
1	162±26
1	34.8±8.6
1	variability)
1	58±9.6
1	36±4.7
1	variability).
1	9.5±0.2
1	21.9±1.7
1	milliseconds).
1	(streptozotocin,
1	(td:
1	(284
1	mitochondria-targeted
1	disposing
1	re-establishes
1	chloroquine.
1	mg.kg−1.day−1)
1	atg7
1	5x/week,
1	proteostasis.
1	(aldh2).
1	acetaldehyde,
1	(e487k),
1	macroautophagy/autophagy
1	12 wk
1	8 wk
1	4 wk
1	number:size
1	reprogrammed
1	embryonic-like
1	revolutionize
1	self-renew,
1	"new
1	signature"
1	complies
1	epigenetics
1	ipsc,
1	(pad)
1	obstructions.
1	cessation,
1	limb,
1	fusion-fission
1	bozi,
1	bechara,
1	proteostasis,
1	noncanonical)
1	(δpkc)
1	gapdh-dependent
1	pseudo-gapdh
1	(ψgapdh)
1	δpkc-mediated
1	tetramerization,
1	gapdh-mediated
1	δpkc.
1	dynamics)
1	(mitophagy)
1	speckle
1	(sbf)
1	overestimated
1	rejecting
1	sliding-windows.
1	hindlimbs
1	(fi
1	hindlimbs)
1	registers
1	(fib
1	fcb
1	hindlimbs).
1	ischemia)
1	(fi/fc).100
1	mib
1	(fib/fcb).100
1	30±4%
1	23±3%
1	hindlimbs,
1	(p<0.05,
1	student-t).
1	[(mi-mib)/mib].100
1	45±14%
1	(mean±se).
1	corrupted
1	reviews.
1	americans
1	fastest-growing
1	aldh2∗2.
1	560
1	descent,
1	juliane
1	peroxidation-generated
1	(4-hne)
1	surgery)
1	aldh2-mediated
1	(aldhs)
1	aldh,
1	aldh2*2)
1	health-promoting
1	selectivealdh2activator
1	(alda-1),
1	(4-hne)-protein
1	alda-1-treated
1	cytochromec
1	tackling
1	multiorganellar
1	lysosomal-like
1	(ll)
1	gapdh-driven
1	246
1	phosphorylatedgapdhpromotes
1	phosphorylation-defective
1	gapdh/pkcδ
1	switch,
1	imagein
1	000-fold
1	mrsi
1	[1-13c]pyruvate
1	[1-13c]lactate
1	dinucleotide,
1	form),
1	(n=9)
1	13c-lactate
1	(r2=0.76).
1	background--ischemia
1	postmyocardial
1	results--we
1	p110,
1	fis1/drp1,
1	fission,
1	lmol/l)
1	28±2%
1	70+1%
1	conclusions--together,
1	cause,
1	phenomena:
1	(mi-hf)
1	re-establishing
1	dahl
1	six-week
1	βiipkc-specific
1	6weeks,
1	2+-handling
1	+/ca
1	control-treated
1	βiipkc-treated
1	βipkc,
1	βiipkc,
1	βiv5-3,
1	(late-phase
1	nitroglycerin,
1	prior,
1	infarcts
1	aldh2.
1	nitroglycerin.
1	stressor,
1	entitled
1	"key
1	failure".
1	hyperactivity)
1	βii
1	(pkcβii)
1	(βiiv5-3
1	35%)
1	(tat
1	alone).
1	mid-ventricle
1	150%
1	tgf-smad
1	purposes:
1	g•d-1)
1	(hba1c).
1	0.004;
1	-1.1%,
1	-1.9%
1	-0.4%).
1	-7790
1	4600,
1	7614;
1	surrogates
1	(arb)
1	anti-remodeling
1	2carko),
1	induced-hf.
1	(5-7
1	8wks).
1	(pln),
1	16-pln,
1	(pp1),
1	+-ca
1	2+/calmodulin-dependent
1	(camkii)
1	camkii,
1	16-pln
1	serca2:ncx
1	17-pln
1	ncx,
1	hyperactivityinduced
1	5-mo-old
1	rotarod,
1	ambulation
1	α2a/α
1	release-related
1	[α1-,
1	β1-subunits
1	(ryr)]
1	reuptake-related
1	[sarco(endo)plasmic
1	(serca)1/2
1	(ncx)]
1	(mlssw).
1	mlssw,
1	fiber-typing
1	(gsh:gssg)
1	fast-to-slow
1	dhpr
1	gsh:gssg
1	resultsusing
1	3.8-fold
1	ipc,
1	32;
1	ipc.
1	ipc-induced
1	pkc-mediated
1	(calcineurin/nfat,
1	camkii/hdac)
1	(akt-mtor)
1	(α2a/α2carko
1	(calcineurin/
1	nfat)
1	(camkii/hdac)
1	camkii/hdac
1	calcineurin/
1	pathway-induced
1	α2c-adrenoceptors
1	(ace
1	pringer-verlag
1	supplement,
1	(crossover
1	series),
1	extents,
1	rest-recovery
1	futures
1	prescribing
1	pn,
1	(twofold).
1	sh-induced
1	β-blockers,
1	/α
1	-arko
1	(mlss)
1	(mlssc)
1	(mlssw)
1	mlssw.
1	interobserver
1	(19.0
1	mlss
1	(emerging
1	post-stress)
1	bodily
1	adversity,
1	toward)
1	injuries,
1	endangerment
1	kainic
1	(ccl2
1	cinc-1),
1	(cx3cl1,
1	cd22,
1	endangerment.
1	cx3cl1,
1	cd22
1	hippocampus;
1	"proinflammatory"
1	occludin,
1	blood-
1	brain-barrier
1	neurosurgery,
1	ex-vivo-engineered
1	injury-responsive
1	manley
1	cortisol.
1	(mdas),
1	socio-demographic
1	(vas).
1	dentally
1	anxious
1	complained
1	income;
1	dentist
1	(gcs),
1	("er/gr")
1	hormone-binding
1	transduces
1	transgene.
1	retrieval.
1	estrogen-like
1	er/gr-treated
1	ln(reo4)3.8(vl)
1	(ln=pr,
1	eu;
1	vl=δ-valerolactam)
1	ln(reo4)3.7(vl)
1	(ln=tb)
1	compounds)
1	single-crystal
1	compound).
1	valerolactams
1	oxygens.
1	metal-ligand
1	electrostatic.
1	polyhedron
1	d4d
1	(square
1	antiprism).
1	isomorphous
1	octa-coordinated
1	resurged
1	punishments.
1	mnr,
1	5-ht-dependent
1	lhb-raphe
1	(rmtg)
1	(gaba)ergic
1	(vta).
1	specify
1	subnuclear
1	(lhbl),
1	(lhbm).
1	lhbl
1	stromal-derived
1	(sdf-1α)
1	38).
1	8226
1	thalidomide.
1	brain's
1	pre-programmed
1	tenascin-c,
1	nidopallium/mesopallium
1	ventrale),
1	578,
1	putting
1	pictures:
1	recurrent,
1	deformations
1	odns,
1	(p=0.012)
1	micro-environment
1	odn-treated
1	vegf188
1	vegf164
1	decoy-treated
1	ventriculectomy
1	18);
1	13);
1	12);
1	-0.383;
1	ventriculectomy.
1	ventrale.
1	(64%
1	neostriatum,
1	uniform,
1	(5-ht+)
1	ectostriatum,
1	intermedium,
1	taeniae,
1	fine,
1	beaded
1	axons,
1	non-varicose
1	swellings,
1	sparser.
1	site-specific,
1	precocial
1	5-hydroxytryptamine-positive
1	(129.2%)
1	(82.2%),
1	(86.9%)
1	(depending
1	241.8%
1	398.7%)
1	counter-regulative
1	(nadph)-diaphorase-reactive
1	socially-deprived
1	(85.5%),
1	nadph-diaphorase-positive
1	disinhibited
1	accumbens.our
1	nadph-reactive
1	experience-induced
1	(dnc)
1	'imprinting'
1	interconnects
1	polysensory
1	stimulus-evoked
1	ndc.
1	(dnc
1	subareas,
1	retro-
1	tracing.
1	(imhv).
1	dorsale
1	(nd),
1	ovoidalis.
1	ectostriatal
1	(dlp),
1	ndl,
1	frontale,
1	trigeminalis
1	(nft),
1	subregions,
1	parasensory
1	(po
1	p14)
1	(p90).
1	diaphorase-positive
1	ii-vi
1	spineless
1	v-vi
1	serotonin-
1	(v-vi)
1	calbindin-d
1	nitridergic
1	dopaminoceptive
1	(d1rp),
1	darpp-32,
1	good,
1	paleostriatum
1	augmentatum.
1	rind
1	pallium.
1	hyperstriatal
1	darpp-32.
1	restful
1	pallium,
1	mnh,
1	vicinity,
1	imprinting,
1	caudate/putamen
1	lpo,
1	subrotundus.
1	intratelencephalic
1	caudale
1	neostriatum.
1	da-immunoreactive
1	lpo.
1	da-
1	shafts,
1	telecephalon
1	subsystems
1	mesolimbocortical
1	(welvvlgkl)
1	infective,
1	llc-mk
1	pep5-binding
1	calmodulin-ubiquitin-associated
1	ex vivo
1	divides
1	kinetoplast)
1	abeli,
1	equilibrative
1	(ents).
1	cruzi-encoded
1	(tcrnb1,
1	tcrnt2)
1	tcrnb1
1	93.8
1	for)
1	adenine.
1	guanosine/inosine
1	(inosine
1	tcrnt2
1	223.5
1	2’-deoxypyrimidines.
1	nt4.
1	non-dividing
1	oxopurines
1	aminopurines
1	2′-deoxypyrimidines.
1	ents
1	pyrimidine-selective
1	mpc1
1	oligomer.
1	mpc1,
1	co-purifies
1	homo-oligomers
1	proteoliposomes.
1	distinctly,
1	thiazolidinedione
1	high-order
1	acid:
1	(metacyclogenesis).
1	e00338-18,
1	https://doi.org/10.1128/mspheredirect.00338-18.
1	/rt).
1	/rt,
1	/n
1	transporters).
1	want
1	denaturation,
1	1/t
1	remark
1	graphs
1	triplicates
1	replicas.
1	osmoregulation,
1	low-specificity
1	nonstereoselective
1	66.4
1	~436,000.
1	chemical,
1	metabolized,
1	toolbox
1	aminotransferases.
1	14c1-dl-leucine,
1	(bcaas)
1	aminotransferases,
1	(asat),
1	transaminate
1	substrates;
1	transaminates
1	tat.
1	t. cruzi.
1	alcohol-free
1	quality-by-design
1	optimisation
1	18.38
1	masking
1	bzl.
1	mg/kg/day.
1	growth-arrested
1	transitioning
1	semicarbazone,
1	calculations)
1	(100 μm),
1	140 μm.
1	250 μm
1	(b3lyp
1	6-311g(d,p))
1	cys25.
1	mantilla
1	sub-species.
1	(insect)
1	succinate,
1	essentiality
1	undisrupted
1	-pyrroline-5-carboxylate
1	(tbp5cdh),
1	gamma-glutamate
1	(γgs)
1	(δψ
1	proline-glutamate
1	ep-procyclin.
1	tsetse,
1	fly’s
1	bloodmeals.
1	3,4-ethylenedioxy
1	mb17,
1	mb38.
1	mb38
1	annexin-propidium
1	cho-k1
1	(cc50)
1	13.47±0.37
1	0.14±0.12
1	(<90).
1	annotated,
1	oxidisable
1	(<-6.96
1	kcal/mol),
1	nontoxic;
1	price;
1	(bcaa),
1	kinetically
1	51.30
1	merli
1	heme-proteins
1	heme-protein
1	parasite’s
1	imports
1	(tchte)
1	lhr1
1	transport),
1	tchte
1	differed,
1	8.5.
1	na+/gaba
1	energized
1	na+-exporting
1	energizing
1	(p5c),
1	(tcp5cdh)
1	protomers.
1	put2
1	role;
1	kcat/km)
1	lysates.
1	addition,tcp5cdh
1	(6-fold
1	change)
1	pariona-llanos
1	misincorporated
1	(rtcgapdh)
1	dinucleotides
1	(nad+/nadh).
1	non-proliferative
1	telomeres.
1	vivo.we
1	protists,
1	β-synthase
1	(cbs)
1	transsulfuration
1	(rtp)
1	γ-lyase
1	(cgl)
1	cgl-null
1	dl-propargylglycine
1	rtp
1	organisms;
1	diagnosed)
1	memantine,
1	amastigote)
1	prolixus
1	(am),
1	pro-enzymes,
1	chitinous
1	gut-specific
1	wax
1	hindgut.
1	lkbp1/amp
1	blood-based
1	osmoregulation.
1	(p5c)
1	(tcprodh,
1	1.5.99.8)
1	16.58±1.69
1	66±2
1	fad-dependent
1	(put1)
1	proline-dependant
1	paes
1	(mnps)
1	time-varying
1	(tvmfs).
1	sickness,
1	protozoan-induced
1	fe3o4
1	tvmfs.
1	choanomastigotes
1	overnight,
1	uploaded
1	tvmfs
1	applicator
1	249
1	ka/m),
1	mnps,
1	cárdenas
1	termini,
1	silber.
1	"hypothetical
1	proteins."
1	l-methionine
1	sulfone
1	(mso),
1	(mse),
1	-ketoglutaric
1	nadp+levels,
1	mse,
1	mso
1	remarks
1	anahí
1	complexes),
1	cco
1	lmjf32.2640
1	desulfhydrase,
1	h2s.
1	(sat),
1	carboxy-terminal-c10
1	bi-enzyme
1	5.34
1	anti-glucose
1	glycosome
1	reservosome
1	heterohexamer
1	(orc)
1	orc6,
1	orc1/cdc6;
1	cdc6.
1	orel.
1	cdc6,
1	orc1/cdc6.
1	tcorc1/cdc6
1	tborc1/cdc6
1	cdc6
1	orcl/cdc6
1	rotenone
1	nonstarved
1	fashions.
1	y-strain
1	dm28
1	dm30
1	(acetylation,
1	adp-ribosylation)
1	histones.
1	bromodomains,
1	chromodomains
1	histone-binding
1	sant
1	"histone
1	code"
1	reading.
1	bromodomain,
1	tcbdf1-4.
1	tcbdf2,
1	h2a
1	anti-histone
1	anti-tcbdf2
1	lysines
1	k14.
1	tcdbf2
1	co-immunoprecipitation.
1	bisbenzimidazoles
1	(4-6),
1	3,4-ethylenedioxy-extension
1	ds-dna.
1	ds-dna
1	dimmers
1	agglomerate
1	ds-rna.
1	thiazolidine-4-carboxylic
1	(t4c).
1	0.89±0.02
1	28°c),
1	(0.54±0.01
1	affect,
1	sphingolipids,
1	0.253
1	0.246
1	7.09
1	threonine,
1	ten-fold
1	monoxenic
1	trypanosomatid,
1	coevolution
1	metabolisms.
1	endosymbiont-containing
1	(wild)
1	endosymbiont-free
1	(aposymbiont
1	cured)
1	l-proline,
1	unsupplemented
1	(km=0.
1	153±0.022
1	vmax=0.239±0.011
1	aposymbiont
1	m=0.177±0.049
1	vmax=0.132±0.012
1	(l-arginine
1	amidinohydrolase,
1	23.9(±0.96)
1	192.3
1	(±14.3),
1	21.5(±0.90)
1	144.9(±8.9)
1	324.
1	exceptions.
1	=0.59±0.04
1	=0.123±0.003
1	52.38±4.7
1	oxaloacetate,
1	alanine.
1	cross-reactions
1	(aid).
1	c29
1	236-serum
1	chimera.
1	(systemic
1	arthritis)
1	pyogenes,
1	(tcp2βfl)
1	(tcp2βn)
1	tcp2βfl
1	tcp2βn
1	tcp2βn.
1	(0.874
1	0.564
1	0.0017).
1	osmoregulation
1	things,
1	98.34
1	asparagine,
1	trifluoromethoxyphenylhydrazone,
1	52.38
1	spp.-infected
1	calflagin.
1	detected)
1	(94%
1	braziliensis).
1	coendemic.
1	haematic
1	reduviidae
1	nifurtimox®
1	benznidazole®,
1	(trypomastigote).
1	phosphagen
1	"amino
1	permeases"
1	iteratively
1	proline-requiring
1	(cho-k1),
1	(permissive
1	(restrictive
1	temperature),
1	(8.09
1	(3.81
1	1.55)
1	(0.45
1	pmolmin-1
1	h+-mediated,
1	p2β
1	(tcp2β)
1	(tcp2β-mbp)
1	(tcp2β-trx)
1	di(+)
1	(93.7
1	tcp2β-trx),
1	di(-)
1	(90.5
1	tcp2β-trx)
1	cross-reaction
1	super
1	calcium-modulated
1	29-kda
1	(rc29)
1	calcium-acyl
1	intein
1	rc29,
1	3.3±0.5
1	1.9±0.2
1	m-1.
1	8-anilinonaphthalene-1-sulfonic
1	(ans)
1	ca2+-loaded
1	sensor.
1	(adp)
1	buffering.
1	transfectant
1	(llgp-67)
1	llgp-67,
1	non-derivatized
1	llgp-67
1	98.11%
1	l-tryptophan,
1	d-proline
1	stereospecific.
1	independant
1	p-trifluoromethoxyphenyl
1	oligomycin,
1	gradient-dependant
1	ordering
1	(mβcd).
1	phospholipids/cholesterol,
1	mβcd/cholesterol.
1	(epr)
1	stiffens
1	headgroups,
1	(rafts),
1	prerequisite.
1	galactose-dependent
1	lectin-immuno-histochemistry
1	63%.
1	33-,
1	41-,
1	42-,
1	56-,
1	58-,
1	66-,
1	97-kda
1	f29.
1	692
1	genome).
1	obtaining,
1	615-bp-long
1	692-bp
1	junin
1	bromoconduritol,
1	glucosidase
1	(de50:
1	1-deoxynojirimycin,
1	glucosidases
1	1-deoxymannojirimycin
1	swainsonine,
1	mannosidase
1	bromoconduritol
1	ad-associated
1	(aβos)
1	(eif2α-p).
1	eif2α-p
1	ikkβ/nf-κb
1	ghrelin's
1	(ghsr)
1	co-xpression
1	ghsr.
1	(ovx;
1	estradiol;
1	redundancies
1	obscured
1	re-expressed
1	renilla
1	(hrgfp)
1	r26-tdtomato
1	cravo
1	high-calorie
1	millions.
1	orexin-a
1	13-acetate-stimulated
1	cd64
1	u/ml;
1	ifn-γ-pretreated
1	sustained,
1	allostatic
1	°c/4.
1	neuro-immune-endocrine
1	phosphate-oxidase.
1	experiment):
1	done:
1	(nonactivated)
1	(excluding
1	non-phlogistic
1	lipopolysaccharide-activated
1	6-fold,
1	(icigg)
1	(fcrii
1	fcriii).
1	(ca2+
1	icigg
1	complement)
1	ic3b
1	pmn,
1	rp-fplc,
1	carboxypeptidase,
1	phosphodiesterase,
1	glutaminyl
1	quali
1	(10 days)
1	(2.5 µg/ml)
1	(1 µm)
1	met.
1	(c-sle)
1	recalls,
1	sledai-2
1	slicc/acr-di,
1	ancova.
1	k-cluster
1	(lcbmp)
1	(lcwmp).
1	(cvd)
1	c-sle.
1	cvd
1	lcwmp.
1	(16:1n-7)
1	stearoyl-coa
1	desaturase-1,
1	immune–metabolic
1	human-based
1	exercise-mediated
1	(n = 4)
1	(n = 8).
1	[tc],
1	[tg])
1	(1 μm).
1	2d-electrophoresis
1	neutral,
1	neutral–alkaline
1	(ampk),
1	(pparα),
1	irs).
1	srebp-1.
1	fgf-21,
1	2168–2177,
1	chrysosporium
1	∼38 kda,
1	50 °c,
1	3–8
1	55 °c
1	1 h.
1	60–65 °c
1	20 mm
1	cacl2.
1	antigen-g
1	(hla-g)
1	(-g1,
1	-g2,
1	-g3
1	–g4)
1	(–g5,
1	-g6
1	–g7).
1	scape.
1	(srhla-g6)
1	23,603.76
1	mald-tof/tof.
1	(pm,
1	16:1n-7)
1	nfκb.
1	underexplored.
1	600 μmol/l
1	24 hours.
1	il1β
1	pparβ
1	acox-1
1	pparϒ
1	baltmpi)
1	four-step
1	60.5
1	42.4 kda,
1	pi = 5.27.
1	baltmpi,
1	edman's
1	(svmpi)
1	bj46a
1	(78–82%).
1	batroxase
1	bjussump-i.
1	(−80,
1	−20,
1	100 °c),
1	fibrinolytic,
1	batroxase.
1	steatohepatitis,
1	tolerances,
1	nafld,
1	1008–1019,
1	(iugr)-induced
1	1356
1	determine:
1	(hiie)
1	(conc)
1	recreationally
1	26.9 ± 4.3 years)
1	hiit
1	5-km
1	(mas)),
1	(80%
1	pre-conc,
1	post-conc,
1	post-hoc
1	(f = 6.72;
1	p < 0.05),
1	pre-hiie
1	post-hiie
1	(difference = −5.99;
1	p = 0.09).
1	(f = 5.31
1	2.50;
1	p = 0.005
1	pre-conc
1	pre-hiie.
1	(11.42 ± 3.09 pg ml−1
1	8.88 ± 1.29 pg ml−1).
1	hiie
1	(crisps)
1	bj-crp,
1	s-200,
1	15q
1	c18)
1	24.6 kda
1	crisps.
1	(c3
1	c4),
1	(c3a,
1	c5a).
1	edições
1	desafio
1	singular.
1	constantly,
1	"crosstalk"
1	immunometabolism.
1	co-morbidities.
1	anti-atherogenic
1	myokine
1	ppar,
1	lysine-dependent
1	chrysosporium.
1	5.7-fold
1	∼23-kda
1	(sephadex
1	g-50
1	(source
1	abz-klrsskq-eddnp,
1	45–55 °c.
1	∼80%
1	4–9;
1	50 °c
1	1 h).
1	cetyltrimethylammonium
1	bromide;
1	dithiothreitol;
1	chaotrope,
1	guanidine;
1	ion;
1	peptidase-specific
1	iodoacetic
1	n-ethylmaleimide.
1	s’1
1	lysine-dependence
1	subsite.
1	dacarbazine
1	(dtic)
1	cisplatin;
1	deprivation;
1	tunicamycin,
1	(plis)
1	alpha-type
1	(rbaltmip)
1	∼21
1	19.57
1	maldi/tof
1	plis
1	baltmip
1	0.1256
1	0.6183
1	pli
1	freud's
1	0.02581
1	0.02810
1	rbaltmip,
1	myotoxicity)
1	asthenia,
1	(dox
1	(ct
1	[5-aminoimidazole-4-carboxamide
1	(aicar)]
1	hyperglycaemia,
1	amkp
1	aicar.
1	dox,
1	(aicar)
1	intramitochondrial
1	bax-induced
1	vdac2
1	graminicola
1	(excg1)
1	(17.3
1	monomeric.
1	halotolerance,
1	3.0–10.0
1	4.0–10.0
1	481.3
1	34.0
1	mg−1
1	(w/v)
1	l−1.
1	xylobiose
1	xylotriose
1	4-o-methylglucuronic
1	halotolerant
1	lignocellulose
1	byproducts
1	integumentary
1	(amelcpr
1	endocuticle
1	sgabd-8-like,
1	loc100577363,
1	loc408365,
1	loc413679,
1	loc725454,
1	loc100576916,
1	loc725838,
1	3-c
1	analogous).
1	hydrolases.
1	larval,
1	pupal,
1	integument.
1	rhizomucor
1	k-casein
1	(abz-lsfmaiq-eddnp)
1	powder.
1	37 kda,
1	55 °c.
1	45 °c
1	(twsisygdgssasgilak,
1	asnggggeyifggydstk,
1	gslttvpidnsr,
1	gwwgitvdra),
1	rhizopuspepsin.
1	aromatic,
1	formed:
1	polysomnographic
1	organomercurials
1	organomercurial-mediated
1	“proteomic
1	profile”
1	ethylmercury
1	(ethg).
1	mehg)
1	ethg)
1	(2-de),
1	ionization–time
1	(maldi-tof/tof).
1	mehg-
1	ethg-mediated
1	organomercurial
1	pycnoporus
1	rp15
1	corncob
1	(lacps1)
1	milled
1	corncob,
1	mmoŀ
1	cuso4,
1	mŀ
1	g-1),
1	138.6
1	u·
1	carbohydrate).
1	2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonate)
1	(abts)
1	74.4
1	3.0–8.0,
1	55–60
1	(0.747
1	nhe).
1	abts
1	ĉmoŀ
1	413.4
1	u·mg-1
1	3140.1
1	149.6
1	ŀ
1	mmol-1·
1	bromophenol
1	(bpb),
1	remazol
1	(rb4),
1	bpb
1	rb4
1	dye-containing
1	envenomation-induced
1	moojenactivase
1	(mooa),
1	85,746.22 da,
1	piiid
1	disulfide-bonded
1	chains:
1	(prothrombin)
1	α-thrombin
1	xa,
1	mooa;
1	hemostatically
1	marie
1	(melk)
1	stathmin/oncoprotein
1	(stmn1),
1	infiltrative
1	pilocytic
1	0.741,
1	(breslow
1	0.092,
1	stmn1,
1	silenced.
1	stahtmin
1	biondo
1	thr172
1	acc)
1	(pparg,
1	c/ebpa,
1	srebp1c)
1	chrysalis
1	76 %
1	(hydrolases,
1	isomerases,
1	mannosidases.
1	endo-n-acetyl-β-d-glucosaminidase
1	10.14-fold
1	167,
1	ssaccharalis.
1	“classically
1	anti-tumoricidal
1	anti-bactericidal
1	“alternatively
1	(m2)
1	interferon-regulatory
1	(ppars),
1	(hifs),
1	(stats).
1	υ.
1	centro
1	pesquisa
1	processamento
1	alimentos.
1	(pdcaas),
1	(per),
1	(npr)
1	flours
1	fluorosis.
1	etched
1	desorption/ionization-time-of-flight/time-of-flight
1	wyqsirppyp
1	x-encoded
1	amelogenin)
1	mplpphpghpgyinf
1	dimorphism)
1	fluence-dependent
1	pdt,
1	shift.
1	photooxidizable
1	lipokines
1	inflammation-lipolysis
1	branched-chain-amino-acid
1	perilipin-1,
1	alpha-keto
1	e1,
1	transketolase.
1	ferrara
1	huanglonbing
1	(hlb)
1	phloem-limited
1	asiaticus
1	(clas)
1	psyllid
1	hlb.
1	hemiptera,
1	(dccathb).
1	pichiapastoris,
1	z-f-r-amc
1	z-r-r-amc
1	(km=
1	um).
1	ca-074
1	0.095
1	egg.
1	175-fold
1	3333-fold
1	leather,
1	detergents,
1	myceliophthora
1	185-fold
1	36.2
1	sequences:
1	gvvanmslggsysasinnaaaalvr
1	stgnaaitgvpsgttnr.
1	p′2.
1	alves-ferreira
1	(mcl),
1	~10%
1	(lbrm)
1	(lbrc)
1	divergences
1	(lrv).
1	f2-alpha
1	24–48
1	~37-kda
1	elav
1	gimenez
1	2-5%
1	itraq-based
1	oligodendrogliomas.
1	78kda
1	(grp78),
1	nucleolin
1	(ncl)
1	90kda
1	(hsp90b1)
1	(rkip/pebp1)
1	(hspb1/hsp27)
1	4months,
1	0.00045).
1	(nova1)
1	0.0082).
1	casuistry.
1	triad,
1	npm1,
1	ncl
1	hsp27/hspb1
1	uncovered:
1	nova1
1	oligodendroglioma,
1	hspb1/hsp27,
1	(cpt1),
1	(pparα)
1	(pparα
1	cpt1)
1	(malate
1	\hypothalamic
1	1β.
1	trainings
1	prevention/treatment
1	tissue.to
1	unripe,
1	(malpighia
1	materials/methods.
1	caf-fed
1	caf
1	obese)
1	hsl§ssup§ser660§esup§
1	ionization-mass
1	lc-esi-ms/ms)
1	subcells,
1	(itraq),
1	isotopecoded
1	(icat),
1	(silac)
1	nonlabeling
1	(label
1	free)
1	(srm),
1	(mrm),
1	spectrometer;
1	collisioninduced
1	lc-srm-ms
1	(labeled
1	free).
1	pp'-dichlorodiphenyldichloroethylene
1	(pp'dde)
1	ubiquitous,
1	women/newborns
1	algarve,
1	1.62±0.39ngml-1and
1	1.11±0.69ngml-1-for
1	1.45±0.25ngml-1
1	0.85±0.50ngml-1for
1	153>180>130,
1	cord/maternal
1	0.76,
1	σpcb
1	pcb.
1	provides,
1	human-biomonitoring
1	algarve
1	non-industrialized
1	non-intensive
1	camila
1	ppar-α-knockout
1	(ola,
1	il1-beta,
1	il1-ra
1	il1-beta
1	ppar-α.
1	al+3+3
1	intramolecularly
1	(60,000
1	mm-1s-1)
1	gapwglgsishk
1	edson
1	mo),
1	mo).
1	(cid-ms/ms)
1	(drvyihpf,
1	aii)
1	(rppgfspfr,
1	bk),
1	(drvyihpfhl,
1	ai),
1	melanocyte-stimulating
1	(ac-sysmehfrwgkpv-nh2,
1	α-msh)
1	(rpkpqqffglm-nh2,
1	m-tyr
1	phe5
1	a-msh
1	analogue.
1	backbones.
1	(crotoxin
1	cb)
1	atoxic
1	(crotapotin,
1	ca).
1	intercro
1	(ca/cb)
1	neurotoxin.
1	species.hk1
1	interactomes.
1	bn/sds-page
1	spectrometry.our
1	a/type
1	cellobiose.
1	exoglucanase
1	endoglucanase,
1	45.6
1	cmcase
1	dithiotreitol
1	ß-mercaptoethanol-stimulated
1	stabilities
1	ilex
1	paraguariensis
1	(ctl+e),
1	(hfd+e).
1	(kcal),
1	ctl+e.
1	iκb.
1	kgy)
1	(2,2,6,6-tetramethypiperidine-1-oxyl-4-
1	amino-4-carboxylic
1	(angii)'s
1	-bk,
1	0.5-1.0
1	acetyl-α-melanocyte-
1	(ac-α-msh)
1	ortho
1	isomers)
1	bpirmp,
1	23.1kda,
1	mhd
1	50μg,
1	bβ
1	cvm
1	met-turn
1	fibrin(ogen)olytic
1	thrombolytic
1	bothops
1	pirajai,
1	pi-svmp.
1	cw
1	extract);
1	(cg
1	uplc
1	epigallocatechin,
1	20.8
1	gallocatechin
1	gallate.
1	hsl,
1	abhd5,
1	cláudio
1	(vdac
1	100-200μm
1	poly-d-lysine,
1	smokers,
1	breads,
1	(mutant
1	tumorigenesis.results:
1	over-representation
1	tpis
1	ldhb
1	respectively.conclusions:
1	ramão
1	d-mannose-specific
1	(rartinm)
1	pet29a(+)
1	bl21(de3)-codon
1	plus-rp.
1	37°c)
1	(130,
1	rpm)
1	(0.01-4
1	(1-19
1	bl21-codonplus(de3)-rp
1	(incubation
1	20°c,
1	rartinm.
1	rartinm,
1	glycoarray
1	monomeric,
1	(jartinm).
1	16,099.5
1	esi-cid-ms/ms
1	structure.conclusions:
1	pranchevicius
1	npm1-sirna
1	hypoexpressed
1	tmz-treated
1	(cu),
1	(ni),
1	chromium
1	(algarve).
1	metallothioneins
1	delta-aminolevulinic
1	categorize
1	alad
1	obesogenic,
1	20-mu
1	(94%).
1	obesity/dm-associated
1	cholecystokinin,
1	like-peptide
1	(glp-1);
1	proteins.results:
1	separation.
1	chloroform/methanol.
1	(2-d)
1	four-month-old
1	mascot.
1	eighty-six
1	development.conclusion:
1	proteome.
1	1950s,
1	chemist
1	linus
1	pauling
1	"appetite
1	centre"
1	anorexia-associated
1	nutritionists.
1	gut-central
1	sl-cathl,
1	sphenophorus
1	levis
1	(10.49%)
1	972bp
1	preproenzyme
1	coleopterans.
1	pastoris,
1	42kda.
1	39kda
1	1250-fold
1	fase,
1	(z-leu-arg-amc,
1	z-arg-arg-amc
1	z-phe-arg-amc)
1	z-leu-arg-amc
1	cat/k
1	m=37.53mms
1	cystatins.
1	i=0.196nm),
1	diagenesis
1	(n=2)
1	(n=2;
1	1100)
1	time-of-flight/time-of-flight
1	swiss-prot
1	hcl.
1	mummy
1	x-isoform
1	archeological
1	immunosuppressor
1	(urti),
1	(ktxs)
1	23-43
1	ktxs
1	families:
1	α-,
1	β-,
1	γ-
1	κ-ktx.
1	v1.4;
1	v1.5;
1	v1.8
1	dmna
1	v1)
1	v1.1
1	v2.1;
1	v3.1;
1	v4.2;
1	v4.3;
1	shaker
1	erg).
1	ts15,
1	3956
1	two-electrode
1	v1.2
1	v1.3
1	ktxs,
1	α-ktx21
1	α-ktx21.1.
1	blue-sepharose
1	50.0%.
1	hemopexin-null
1	cxcr2
1	(hfds)
1	d3.
1	maintained)
1	il-6/il-10
1	(trans
1	splicing)
1	snrnps),
1	snrnps
1	u5-102k
1	u4/u6-u5
1	tri-snrnps.
1	trypanonosomatid
1	u5-cwc21
1	u5-cwc-21
1	35s
1	sec63
1	lactosyl-sepharose
1	desorption/ionization-time-of-flight
1	5.2)
1	heating,
1	galatrox's
1	abbs
1	shanghai
1	95th
1	ultrasonography.
1	-0.46,
1	-0.43,
1	.03)
1	-0.69,
1	ß-hydroxy-ß-
1	diagenesis,
1	micro-etching
1	enamel),
1	conservative,
1	easier.
1	y-isoforms
1	amelogenin,
1	ameloblastin,
1	enamelin
1	fossil/archeological
1	(experimental).
1	accustomed
1	grade).
1	grade)
1	(psd)
1	(tnf)-
1	psd;
1	(rkip)
1	ras/raf/mapk
1	desorption/ionization-time
1	flight-mass
1	(maldi-tof
1	1130
1	ungerminated
1	protein-expression
1	reveled
1	35.
1	both)
1	stress-protector
1	cobalamin-independent
1	rppgfspfr)
1	co60
1	m-tyr8-bk
1	m-tyr8-bk.
1	position-structural
1	(c4),
1	va,
1	plei
1	pealei
1	synaptotagmin
1	synaptosomes.
1	insolens
1	homodimer.
1	thermoidea,
1	6.0-6.5,
1	cellobiose,
1	p-nitrophenyl-β-d-glucopyranoside,
1	p-nitrophenyl-β-d-fucopyranoside,
1	p-nitrophenyl-β-d-xylopyranoside,
1	p-nitrophenyl-β-d-galactopyranoside,
1	o-nitrophenyl-β-d-galactopyranoside,
1	salicin.
1	p-nitrophenyl-β-d-fucopyranoside
1	2-fold)
1	cellulosic
1	(pi31)
1	(smpi31)
1	suc-leu-leu-val-tyr-4-mca
1	smpi31.
1	niveus
1	deae-fractogel
1	sephacryl
1	glycosylation,
1	bio-sil-sec-400
1	α-d-
1	glucopyranoside
1	65°c.
1	amylopectin.
1	malto-
1	malto-oligosaccharide
1	(g10),
1	maltopentaose,
1	maltotetraose,
1	maltotriose
1	isomaltose,
1	β-ciclodextrin
1	α-ciclodextrin
1	hydrolyzed.
1	1,4-alpha-glucosidases
1	jecorina.
1	jecorina
1	gel-lc-ms/ms,
1	neutrophil-secreted
1	centaurin
1	first-time.
1	tomazella
1	lowe
1	superdex-75
1	mono-s
1	beta-strands
1	apti
1	β-ii
1	midpoints
1	isoinhibitors
1	α-chymotrypsin
1	(spr),
1	0.39,
1	thielaviopsis
1	debaryomyces
1	α-galactosidases,
1	54.5
1	54.8
1	(maldi-tof),
1	5.15
1	4.15
1	p/values,
1	α-galactosidases
1	thermostability
1	ufv-1
1	(7.16
1	3.29
1	p-nitrophenyl-
1	α-d-galactopyranoside
1	pnpαgal,
1	melibiose,
1	stachyose,
1	0.32,
1	10.8,
1	32.8
1	acompetitively
1	cu(11)
1	ag(1).
1	stachyose
1	laao
1	column;
1	lentil
1	batroxlaao.
1	"asp
1	glu"
1	laaos.
1	laaos,
1	pc12.
1	α-1-acid
1	(agp)
1	inos/no/cyclic
1	3,5-monophosphate-dependent
1	≈80%
1	embody
1	multidomains
1	bjussump-i,
1	1641bp
1	metalloproteases:
1	pre-pro-peptide,
1	lyses
1	reporting,
1	rgd-p-iii
1	metalloprotease/catalytic
1	(threading)
1	reprolysin
1	charge-positive
1	substitute,
1	(jb-ig).
1	o-glycans.
1	associatioin,
1	(ndk)
1	ndk
1	coding-sequence
1	his6-tag
1	chitobiose
1	(ccms)
1	hydrazine
1	3,6-positions
1	6-positions
1	protein-linked
1	glcnac.
1	(pngase
1	f/a)
1	alkylated
1	glycome.
1	3-linked
1	galactosidases.
1	spectrum-matched
1	(msn).
1	3-position
1	hex-fuc
1	msn.
1	hex-hex-fuc
1	glcnac
1	glycomers.
1	6-linked
1	fucosyl
1	glycome,
1	totals
1	glucosaminyltransferase-i
1	(gnt-i)
1	gnt-ii
1	(pc)-substituted
1	msn
1	unobserved
1	hydrazine-release
1	ccm
1	isomers,
1	(msn)
1	instruments.
1	12 million
1	(ndkb),
1	(txnpx)
1	rab1-protein,
1	host/parasite
1	glycoconjugate,
1	(jbe,
1	exoantigen)
1	paracoccin,
1	purification.
1	anti-paracoccin
1	n-acetyl-galactosamine
1	l-fucose.
1	nontumoral
1	(average)
1	cbb
1	twofold.
1	pmf/maldi-tof,
1	17/34
1	4-7,
1	glutathionylation
1	melan-a.
1	oncogene/tumor
1	antinutritional
1	(eq),
1	(pdcaas)
1	resources:
1	(cms),
1	powder,
1	(kti-lox-
1	soybean),
1	textured
1	beans.
1	cms,
1	digestibility.
1	fao/who.
1	kti-lox-soybean
1	sulfurized
1	(methione+cysteine)
1	kti-lox-
1	pdcaas
1	sbcta.
1	(xyna)
1	g/11
1	bsxa
1	pt7t3
1	pt7bsxa.
1	pt7bsxa,
1	post-translation
1	ph-
1	temperature-dependences
1	pt7bsxa
1	diadromous
1	21‰s
1	hydrate;
1	(+5%)
1	gills.
1	(+64%),
1	187%
1	(-75%)
1	(+247%),
1	(+253%)
1	(+150%),
1	(+426%),
1	(+415%)
1	(+139%)
1	(-70%)
1	(22-70
1	mmol/kg)
1	0.5-2.4%
1	(3-7
1	mosm/kg)
1	osmolalities
1	fw.
1	accentuating
1	crustacea,
1	(bothropstoxin-i)
1	lys49-pla2
1	lys49)
1	phe5/ala
1	102/phe106
1	asp49-pla2s
1	5/val102/leu106
1	lys49-
1	leu5/val102/
1	leu106
1	single-and
1	double-mutant
1	phe5/ala102/phe106
1	(tm),
1	2+-independent
1	native,
1	l106f
1	(leu106
1	l5f/f102a/l106f
1	l5f,
1	v102a,
1	l5f
1	tm.
1	l5f/v102a/l106f
1	carbohydrate-protein
1	cratylia
1	mollis
1	cramoll,
1	meαman,
1	groove
1	lactose-sepharose.
1	265mg/100g
1	(especl)
1	specificity;
1	(mic)=0.25
1	n-acetyllactosamine,
1	mic=0.5mm,
1	α-galactopyranoside,
1	mic=2mm.
1	e1%1cm
1	14.5.
1	58kda
1	27.6kda.
1	metaloprotein
1	70°c
1	10min
1	10min.
1	λmax
1	affinity-modifying
1	haptenic
1	n-acetylimidazole
1	β-pleated-sheet
1	corallodendron
1	(pi∼4.5)
1	(btha-i-pla2)
1	∼13.7kda
1	1slwqfgkminyvm-gesgvlqylsygcycglggqgqptdatdrccfvhdcc51.
1	2.0å
1	a=33.9,
1	b=63.8,
1	c=49.1å,
1	β=104.0°.
1	myotoxic,
1	bthtx-ii,
1	d49
1	time-independent
1	btha-i-pla2
1	4-bromophenacyl
1	anti-asp49-bthtx-ii
1	anti-lys49-bthtx-i
1	cross-reaction.
1	btha-i-pla2,
1	glossoscolex
1	paulistus
1	d-chain
1	endo-glu-c
1	endo-lys-c
1	globin.
1	129.
1	cε2
1	cδ2
1	atoms)
1	w129.
1	rotamers
1	rot1,
1	rot3,
1	radiationless
1	w33,
1	(κ2=0.945)
1	rot1
1	(κ2=0.433)
1	rot3
1	(κ2=0.125).
1	κ2
1	(2.903)
1	(κ2=0.191).
1	quenching,
1	lifetimes.
1	lifetime,
1	〈τ〉=3
1	apomonomer
1	emitter
1	w33-1
1	w33-2
1	w33-3
1	ps).
1	oxymonomers
1	7:
1	(7.4%).
1	lifetimes,
1	nanosecond
1	sausage.
1	72,000
1	dissipated
1	motive
1	carbohydrate-mediated
1	multi-systemic
1	'functional
1	proteomics'
1	jararacussussu
1	noncatalytic
1	dna-coding
1	pet11-d,
1	bl21(de3).
1	refold
1	red-blood
1	leprae-specific
1	(rrf)
1	srbc.
1	(nhs),
1	sedimented.
1	(mw),
1	β2-glycoprotein
1	(β2-gp1),
1	phospholipid-binding
1	methanol-treated
1	trimolecular
1	β2-gp1
1	antiphospholipid
1	(anti-pl)
1	β2-gp1-dependent
1	anti-pl.
1	anti-f18ac
1	~17kda.
1	f18ac,
1	6.8-fold
1	sds-page),
1	68.5
1	(bio
1	sec-400
1	fplc).
1	8.4.
1	6.5/60
1	5.0/55
1	maltase
1	ba++
1	(7.8%);
1	mn++
1	25.5%
1	carbohydrate.
1	67.2
1	5.61
1	starch,
1	thermoidea.
1	deae-sephadex,
1	superose
1	trypsin-sepharose.
1	bbti-i
1	bbti-ii,
1	bbti-ii
1	h-pro-phe-arg-amc
1	nm);
1	bradykinin-containing
1	lgmislmkrppgfspfrssri-nh2
1	abz-mislmkrp-eddnp
1	abz-frssrq-eddnp
1	(jackfruit),
1	residues/mol,
1	moraceae
1	jackfruit,
1	acetyl-blocked
1	posttranslationally
1	unites
1	β-chains
1	sterically
1	asp141
1	(α-d-mannose,
1	α-d-glucose,
1	derivatives).
1	accepting
1	hydroxyls
1	disfavored
1	β-bulges.
1	colibacillosis
1	coil:
1	rains
1	(30.0)
1	987p,
1	f42.
1	enteropathogenesis.
1	cohlmn
1	s1)s-page
1	anti-2134p
1	(;old
1	ilnmunolabeling
1	2134
1	paltern
1	tll';p-2
1	n-termini
1	(92.5)
1	i107
1	olfersii.
1	eyestalks
1	(vnc),
1	supraesophageal
1	(seg),
1	high-salinity
1	(hsm,
1	salinity).
1	hsm.
1	derivatizing
1	phenylisothiocyanate.
1	[faa]:[cl−]
1	(gly,
1	vnc
1	experiments;
1	experiments)
1	[pro]/[cl−]
1	fw-exposed
1	[glu]/[cl−]
1	[val]/[cl−]
1	[cl−]
1	seg,
1	β-trypsin
1	reacton
1	p-diazoniumbenzamidine
1	cm-p-benzamidino-azo-β-trypsin
1	ser-146
1	lys-
1	156,
1	tyr-39,
1	tyr-172,
1	100:7:3.
1	tyr-151-
1	(p-benzamidino)-azo-β-trypsin
1	k(cat),
1	ks',
1	(4,4'-diazoamino-bis-
1	benzamidine),
1	β-trypsin,
1	azo-β-trypsin.
1	s'2,
1	covalently,
1	s1-s3
1	s'2
1	azo-β-trypsin,
1	tyr-151.
1	(ab,
1	36),
1	(abspi,
1	(sham,
1	29).
1	(atrial
1	fibrosis)
1	(tgf-β1,
1	i/iii,
1	cav1.2)
1	inducibility
1	(episodes
1	(31/36,
1	86%;
1	15/29,
1	52%;
1	abspi
1	(16/20,
1	80%;
1	ns).
1	(>30
1	shams
1	28%;
1	vulnerability.
1	(hf)-related
1	(uhf)
1	(thf).
1	(ach)-
1	uhf,
1	achinduced
1	dimer-to-monomer
1	no/soluble
1	tetrahydrobiopterin,
1	(β-ars)
1	overstimulation.
1	synthase-derived
1	anticontractile
1	victorio,
1	fontes,
1	davel.
1	endothelial-denuded
1	(rvr)
1	minipump
1	ng·kg−1·min−1,
1	cotreated
1	mg·kg−1·day−1),
1	(rpf),
1	rvr
1	effacement,
1	(gal-3),
1	β-galactoside-binding
1	aldosterone-salt-treated
1	pectin.
1	gal-3-silenced
1	hyperaldosteronism,
1	high-aldosterone
1	(size
1	200-300-μm)
1	(icat)
1	denudation.
1	tram-34
1	hc-067047,
1	hc-067047-sensitive
1	(sirna)-mediated
1	hc-067047.
1	vasorelaxation,
1	postmenopause,
1	sham)
1	(ovx-tra
1	sham-tra).
1	±3.3
1	ovx:
1	57±3.0%,
1	ovx-tra
1	ovx-tra:
1	88±2.0%,
1	sham-tra
1	sham-tra:
1	80±2.2%,
1	(β-ar)
1	kg-
1	(edp).
1	extralobar
1	blot),
1	(diaminofluorescein-2
1	3′,5′-monophosphate
1	kit).
1	rv-sp
1	(l-name);
1	cgmp/vasp
1	hypotheses:
1	(msna)
1	<40%
1	microneurography.
1	metaboreceptors
1	(peca).
1	peca
1	(metaboreflex),
1	(mechanoreflex),
1	receptor-4,
1	thromboxane-a2
1	mirna-146
1	nf-κb/
1	(ang)-(1-7),
1	angii.
1	methods/main
1	(sham-s),
1	(sham-ex),
1	(chf-s),
1	(chf-ex).
1	plantaris)
1	at2,
1	ang-(1-7)/angii
1	ang-(1-7)-mas
1	gomes-santos
1	(β1ko,
1	β2ko)
1	μg.g-1.day-1,
1	+34%)
1	98,059
1	giα-3
1	(+50%)
1	(+90%)
1	(+100%)
1	β2-adrenoceptor/giα
1	uncoupling-mediated
1	davel
1	rostafuroxin
1	(rosta),
1	(1mg/kg
1	mesenteric-resistance
1	(mras)
1	na+k
1	(re).
1	intensity),
1	(et-a
1	+/k+
1	0.8%;
1	=-1.2
1	0.1%),
1	=-0.1
1	=-6.5
1	0.6%).
1	et-a
1	0.4%).
1	0.4%)
1	=-6.1
1	tuning
1	α2c-adrenergic
1	(α2a/α2c-arko)
1	(msas)
1	(wild-type,
1	noradrenaline-
1	serotonin-induced
1	subcutaneously)
1	(10-10
1	cox-derived
1	phosphorylated-phospholamban
1	na(+)/ca(2
1	bm-mnc,
1	de-endothelized
1	(efs),
1	dea-no
1	(o2),
1	efs;
1	dea-no.
1	dea-no-induced
1	(8-37).
1	vasoconstrictive
1	&wilkins.
1	(db),
1	(c/sd),
1	(sd/db),
1	(tr/db).
1	(i.p.:
1	tromboxane
1	(u46619)
1	(rage),
1	(nox-),
1	nε-(carboxymethyl)
1	biomarker).
1	sd/db
1	tr/db,
1	enos/no
1	delbin
1	irritability,
1	tremors,
1	headaches,
1	dysarthria,
1	incoordination,
1	hallucinations,
1	bruna
1	(sgk-1)
1	day-1).
1	sgk-1
1	(aerodynamic
1	≤2.5μm,
1	600μg/m
1	prc,
1	n=17),
1	(mmi,
1	n=10)
1	(lmi,
1	n=14)
1	(li+)
1	(ry).
1	ca(2+)-atpase
1	(plb)
1	phospho-ser(16)-plb
1	decays
1	ry
1	lmi.
1	(72±7%
1	47±9%
1	phospho-ser16-plb
1	(75±5%
1	46±11%,
1	(175±20%)
1	ca(2+)
1	cholesterol-independent
1	synthase).
1	kinase);
1	ampk.
1	(nnitro-l-arginine;
1	phospho-enos
1	(ser1177),
1	phospho-akt
1	-ampk
1	dilations
1	(acetylcholine)
1	depolarized,
1	u46619-pre-constricted
1	lnna
1	ampkα
1	simvastain
1	ampk/phospho-enos
1	(ser1177)/no-dependent
1	mechanismafter
1	ir.malewistar
1	nitritre/nitrate
1	x-)
1	(drp)
1	(peg
1	(wss)
1	2.8;
1	2.7%),
1	36;
1	drp.
1	pressure-flow
1	(approx.
1	μg·day-1)
1	(5-week-old)
1	(shrs;
1	14-week-old).
1	(a-shr
1	a-shr)
1	(y-wky
1	a-wky).
1	y-wky
1	y-shr,
1	a-shr,
1	background/aim.
1	(200-250g)
1	(mi-gcsf)
1	pressure-volume
1	(36±2.8
1	44±2.1%
1	(28±2.2
1	36±1.4%
1	0.46±0.42,
1	15.5±2.43,
1	mi-gcsf:
1	5.34±3.34%;
1	diabetes;
1	streptozotocin-pretreated
1	(50mgkg-1,
1	(1-10mm)
1	(0.1mmol/l)
1	gö-6976
1	(59%)
1	(bk;
1	arg-pro-pro-gly-phe-ser-pro-phe-arg)
1	(lys-bk)
1	prekallikrein
1	xii,
1	[thr
1	6,leu8]-bk.
1	open-chest
1	(infarct
1	risk)
1	335
1	(c0x-2)
1	g-nitro-l-arginine
1	tetraetylamonium
1	2/thromboxane
1	c0x-2
1	c0x-2.
1	function.©
1	(mi-gcsf
1	mi-gcsf
1	(74%
1	untreated-mi
1	679
1	117,
1	0.11;
1	(sd);
1	(tr);
1	(sdd)
1	(trd)
1	(70-80%
1	(nox-)
1	(sod-1)
1	(sdd:
1	(trd:
1	2.57
1	8;
1	13%),
1	fed-rats
1	(pg)f
1	cox-1/2
1	(indomethacin
1	(furegrelate),
1	(tranylcypromine)
1	2/
1	548),
1	548.
1	acetylcholine-stimulated
1	6-oxo-pgf
1	n-omeganitro-l-arginine
1	vessels)
1	(mulvany,
1	(amodeo
1	2003).
1	flow)
1	decanoate;
1	2x/wk),
1	(sl;
1	(t+s),
1	(t+sl;
1	14/group)
1	weight-to-body
1	(cvf)
1	hydroxyproline
1	cvf
1	0.88;
1	exercising.
1	sc).
1	third-order
1	myography
1	myography.
1	stiffer.
1	adventitia
1	hypotrophic
1	(salt
1	(phe
1	bms182874,
1	0.001-100
1	isolated-perfused
1	(ped
1	0.07;
1	shr/e+,
1	oua.
1	shr/e+
1	shr/e+.
1	(2k)
1	large-conductance
1	(bkca)
1	ns1619
1	[1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)
1	-2h-benzimidazol-2-one],
1	bkca
1	(≃8.0
1	3h]noradrenaline.
1	(dbp)
1	dbp,
1	[3h]noradrenaline
1	unmodified.
1	hypertensive),
1	(indo-4
1	hypertension).
1	beds;
1	(k+-induced
1	relaxation)
1	indo.
1	+,k+-atpase
1	clove
1	vasorelaxant
1	(5-125
1	downwards.
1	(0.25-3
1	precontraction
1	(rubbing),
1	receptor-operated
1	endothelial-generated
1	(db1)
1	(ct1),
1	(db4)
1	125±8.4%
1	89.8±4.5%,
1	156±4.2%
1	125±3.8%,
1	29548
1	free-ca2+
1	ct1
1	db1
1	(pgh2)/thromboxane
1	(l-name)induced
1	l-nametreated
1	tetraethylammonium,
1	k+atpase
1	opener.
1	(cau)
1	cau
1	tetraethyl-ammonium,
1	cau.
1	cau,
1	(ao),
1	ouabain-
1	(127±1
1	160±2
1	n=24,
1	(102.8±3.9
1	67.1±10.1%
1	(82.5±7.5
1	52.2±5.8%,
1	(dauc)
1	56.6±9.6
1	198.3±18.3
1	(n=9,
1	85.5±15.4
1	165.4±24.8
1	13.0±6.1
1	39.5±10.4%
1	p<0.05.
1	64.8±4.6
1	84.0±5.1%,
1	14;
1	39.1±3.9
1	43.3±7.8%,
1	n=6,
1	p>0.05)
1	62.1±5.5
1	41.4±8.2%,
1	reflex-blocked
1	l-omega-n-nitro
1	bolus)-evoked
1	uninephrectomized)
1	(1k1c
1	na+,k+-atpase.
1	471
1	streptozotocin-treated
1	(cox)-
1	(250-270g)
1	phenylephrine-
1	acetylcholine-evoked
1	(10-4m)
1	(10-5m).
1	cannulated,
1	36°c.
1	(prazosin
1	acetylcholine-vasodilated
1	hgcl2-induced
1	hgcl2's
1	(tetraethylammonium;
1	tea).
1	deendothelialization
1	na+,k+-adenosine
1	na+,k+-
1	l-h
1	opener,
1	(lv
1	rv)
1	(abp)
1	(0.035
1	(μm
1	abp
1	isometrically
1	pressures.
1	α1adrenergic
1	ventricular-developed
1	flow-perfused
1	(np).
1	α1adrenoceptors
1	synergistically.
1	(pe)-evoked
1	severed
1	u).
1	ml/
1	(0.62,
1	chaps,
1	(isp),
1	pr-interval.
1	extrasystoles,
1	a-v
1	brady-
1	tachyarrhythmias
1	(mbp),
1	pr-interval,
1	conduction,
1	arrhythmogenic
1	cuboidal
1	placode,
1	833
1	(t833)
1	apkc-binding
1	placode.
1	t833
1	(hnrnps)
1	40love,
1	pseudoallele
1	(grd)
1	nuclear-restricted
1	andreou
1	myosin-va,
1	(gtd)
1	recognition/interaction.
1	filopodial
1	myo5a
1	gtd
1	length)
1	trka-positive
1	hh25.
1	(hh34).
1	neph1-3,
1	podocytes,
1	homodimers,
1	nephrotic
1	finnish
1	neph3
1	mammalian-like
1	diaphragms.
1	make,
1	post-embryonic
1	paralogues
1	neph2
1	hh14,
1	hh28.
1	ggneph2
1	hh20-28,
1	mesonephros,
1	dermomyotomes,
1	postgenomic
1	electroporation,
1	insurmountable
1	unfamiliar
1	scratch2
1	(cscrt2)
1	hh15
1	hh22-23
1	onwards
1	phospho-histone
1	brdu-labeling
1	neurom/ath3/neurod4.
1	cscrt2-positive
1	e-box-driven
1	e-box-transactivator.
1	fascinated
1	spemman
1	mangold
1	blastopore
1	multi-step
1	laevis.
1	samba,
1	wnt-1,
1	wnt-3a,
1	wnt-4,
1	wnt-5a,
1	hamburger
1	hamilton
1	(hh14).
1	hh14
1	hh19.
1	ciona
1	intestinalis
1	fundamental,
1	zoology,
1	chordates,
1	picturing
1	chambered
1	peristaltic
1	chordates.
1	secondary/anterior
1	inflow/outflow
1	anteroposterior
1	cardiogenesis
1	pan-antagonist
1	(hh4-7)
1	sino-atrial
1	raldh2.
1	morphogen
1	(hh7-8)
1	encircling
1	evolutionary-conserved
1	(kt7515),
1	indolocarbazole
1	subjection
1	cep-1347.
1	threefold,
1	cep1347.
1	aspartases
1	member(s)
1	ice-like
1	(nerve
1	cpp32-like,
1	ice-
1	like,
1	pseudosubstrate
1	activity/activation
1	interleukin-1-converting
1	8-bromo-cgmp,
1	8-(4-chlorophenylthio)-camp
1	zvad-fluoromethylketone
1	deferoxamine,
1	(lnac)
1	lnac,
1	ngf-deprived
1	n-acetyl-d-cysteine
1	(dnac).
1	antioxidants)
1	acetylcysteine
1	nac's
1	anti-oxidant/radical
1	reductant.
1	2,3-dimercaptopropanol,
1	survival-
1	cereus
1	electroencephalographic
1	epilepsies,
1	(ark)
1	stimuli/day).
1	ark,
1	ark
1	shortness
1	breath,
1	dyspnoea,
1	(10 μg μl
1	0.5 μl)
1	thorax)
1	compacta,
1	viscance,
1	stiffened
1	mechanics,
1	pd-related
1	phox2b-progenitor
1	ablating
1	∼800
1	phox2b-positive,
1	olig3-negative
1	behaviours.
1	neuro-axonal
1	dystrophy,
1	vacuoles/phagosomes.
1	arousal-dependent
1	co2/h+,
1	(10 mm/100
1	(ve).
1	(5 mm/50–75 nl)
1	pfrg,
1	(c1)
1	arteriovenous
1	(dopamine-β
1	[dβh-sap])
1	overload-induced
1	hypothalamus/perifornical
1	(lh/pef)
1	anti-orexin-b
1	lh/pef
1	prebötzinger
1	rhythmogenesis,
1	prebötc)
1	(lvv-prsx8-chr2-eyfp;
1	lvv-prsx8-chr2-eyfp
1	(viral
1	channelrhodopsin-2
1	(chr2)
1	neuron-preferring
1	(prsx8)
1	chr2-transduced
1	(kyn),
1	prebötc.
1	(8-cyclopentyl-1,3-dipropylxanthine,
1	dpcpx;
1	rectifying
1	epscs
1	ipscs.
1	g-protein-regulated
1	inward-rectifier
1	(girk)-like
1	presynaptically,
1	snpc,
1	diaemg,
1	amplitudes.
1	(t4-t8)
1	(anti-dβh-sap—2.4 ng/100 nl)
1	fluor-gold
1	(250–280 g,
1	n = 7–9/group).
1	spared.
1	c1)
1	serotonine-expressing
1	pallidus/parapyramidal
1	(rpa/ppy)
1	(6-hydroxydopamine;
1	µg/µl)
1	89%.
1	hypercapnia-activated
1	anti-sert
1	co2/h+-evoked
1	channels;
1	phsensitive
1	co2-dependent
1	(nbc)
1	(fct)
1	p2-recepetor
1	pyridoxalphosphate-
1	6-azophenyl-2′,4′-disulfonate
1	fct.
1	mrs2179
1	(p2y1-receptor
1	fct-induced
1	pd-induction.
1	(24 μg/μl)
1	pd-induced
1	(n = 6/group),
1	(1257 ± 81
1	1185 ± 49 ml/kg/min).
1	(674 ± 39 ml/kg/min).
1	hypercapnia-induced-fos+
1	38 ± 3
1	8.5 ± 0.9
1	78 ± 3
1	46 ± 4
1	94 ± 22
1	1 ± 1
1	(anti-dβh-sap).
1	7–8 days,
1	(280–350 g)
1	(tsn)
1	(80–90 g).
1	(n = 7–8)
1	(n = 5–6)
1	sympatho-excitation,
1	110 ± 12%
1	58 ± 8%,
1	p < 0.01)
1	9.5 ± 1.4%
1	3.9 ± 1.7%,
1	p < 0.05)
1	(nociception,
1	(anti-dβh-sap;
1	2.4 ng/100 nl)
1	(270–300 g,
1	n = 5–8/group).
1	60–75%
1	co2),
1	(task-2,
1	gpr4)
1	kf,
1	(bda)-labeled
1	(vglut2),
1	fluorgold
1	(fg)-immunoreactive
1	kf)
1	hydroxylase.
1	co2-induced
1	(bda)
1	(cvrg),
1	transporter-2.
1	emanated
1	ae-induced
1	generation/modulation
1	triphosfate
1	(atp)-mediated
1	(ppads
1	mrs2179).
1	p2-recepor-dependent
1	(pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonate
1	epoch
1	(ans).
1	0-7
1	7-20
1	comp.
1	neurol.
1	524:1259-1269,
1	dispel
1	wake-on
1	slice-patch
1	(oxotremorine;
1	m1-
1	(pirezenpine;
1	m3-
1	(diphenyl-acetoxy-n-methyl-piperidine;
1	nicotinic-receptor
1	(mecamylamine;
1	pirenzepine,
1	diphenyl-acetoxy-n-methyl-piperidine
1	2-aminoethoxydiphenyl
1	borate
1	(4,5,6,7-tetrabromobenzotriazole;
1	(xe991;
1	nucleus/parafacial
1	(rtn/pfrg)
1	(40-45
1	rtn/pfrg.
1	1447
1	2405
1	±174
1	2172
1	1255
1	(furo)
1	nmol/0.2
1	(12.2
1	vs.,
1	ml/180
1	baro
1	ph-responsive
1	(crc).
1	propriobulbar
1	intrinsic.
1	phox2b,
1	apnea.
1	syndrome).
1	buddhist
1	compassion
1	chi
1	paracoccidioides,
1	coccidioides,
1	pathogen-host
1	turkevich
1	cytoviva®
1	dark-field
1	micrographys
1	(hrtem)
1	strange
1	cellulose,
1	cell-walls
1	gold-citrate
1	anaerobical
1	asociación
1	española
1	micología
1	cohabit
1	indoors.
1	indoors,
1	droppings
1	inspected,
1	places.
1	thermally-dimorphic
1	pathogens:
1	dermatitides,
1	(penicillium)
1	marneffei.
1	self-resolution
1	mycoses:
1	[wb])
1	(symptomatic,
1	(asymptomatic,
1	(negative,
1	igg-specific
1	0.925).
1	holanda
1	cd4+t-cell
1	virus-derived
1	(his)6-purified
1	(rpbt)
1	(radpbt)
1	p10-specific
1	vlp/p10
1	rittner,
1	trimethoprim-sulfamethoxazole.
1	primed-dcs
1	β-(1,3)-glucan
1	polysaccharides,
1	proposition.
1	dermatozoonosis
1	anthropozoonotic
1	saprozoonotic
1	felines,
1	fmvz/usp,
1	epm/unifesp,
1	investigated;
1	antifungals,
1	peptidorhamnomannan
1	(prm)
1	scedosporium
1	(lomentospora)
1	scedosporiosis.
1	prolificans.
1	cd4+cd62llow
1	prm-immunized
1	gerodontology
1	alternifolia
1	biofilm.background:
1	stomatitis,
1	denture.
1	polymethylmethacrylate
1	stomatitis.materials
1	co. officinalis
1	thermopolymerised
1	0.75%,
1	0.375%,
1	0.188%
1	six-well
1	1 × 10(7)
1	 cells/ml
1	atcc1023
1	sc5314
1	roswell
1	memorial
1	(rpmi)
1	12 h,
1	counted.results:
1	0.375%
1	(3.4 mg/ml)
1	atcc10231
1	0.093%
1	(0.84 mg/ml)
1	sc5314.conclusions:
1	c. albicans.
1	prophylaxes
1	tamayo
1	defend
1	expresses,
1	(sods).
1	(s1,
1	ps2,
1	ps3
1	pb01-like)
1	mycelia-to-yeast
1	yeast-to-mycelia
1	bueno,
1	thomaz,
1	(gsls)
1	gsls
1	discloses
1	well-studied
1	308
1	beta-oxidation
1	thioredoxins
1	(thx)
1	(ccp).
1	(~51,2%)
1	sulfa
1	screen,
1	2-(2-oxo-morpholin-3-yl)-acetamide
1	gem-dimethyl
1	morpholin-2-one
1	n-(biphenyl-3-ylmethyl)-2-(4-ethyl-6,6-dimethyl-2-oxomorpholin-3-yl)acetamide
1	(87),
1	molds
1	adolpho
1	1908,
1	four-year
1	emaciated,
1	hoarseness
1	(reviewed
1	“pseudococcidial
1	hyphoblastomycosis”
1	(pseudococcidial
1	hifoblastomycosis),
1	blastomycosis
1	splendore-almeida
1	medellín,
1	mycologists
1	adaptiv.immune
1	mare's
1	dermatobac®,
1	dermatobac®.
1	(14.71%),
1	sowing
1	sensitivity).
1	cytology,
1	endometritis.
1	vidal
1	inconsistencies
1	pcm.background:
1	succeeded.methodology/principal
1	immunodifusion
1	counterimmmunoelectrophoresis,
1	scores:
1	(negative),
1	(healing
1	titers),
1	center's
1	titers;
1	“major”
1	better.
1	(hsp60)
1	hsp60-binding
1	7b6
1	high-burden
1	radioisotope
1	scintigraphic
1	renal;
1	hepatobiliar
1	t-cd4<sup>+</sup> helper-1
1	p10-stimulated
1	100 %
1	200 days
1	80 days.
1	(gxm),
1	glycans,
1	chitin-like
1	lectin-treated
1	cryptococci.
1	wga-treated
1	chitin-derived
1	generation/expansion
1	(pcdna3-p10)
1	pcdna3-p10
1	unimmunized
1	granuloma-like
1	wien
1	ifn-?-dependent
1	hyperinfl
1	ammation
1	brosis.
1	azoles,
1	plasmid-vaccination
1	rittner
1	published,
1	country.the
1	qtliaihtlairyan,
1	thet-cd4+
1	co-adjuvant
1	travassosand
1	(p10),
1	1,000-fold
1	vaccination)
1	vaccines;
1	(carrying
1	epitope),
1	interferon-γ-mediated
1	nanotechnology,
1	adjuvancy,
1	immune-stimulating
1	caves,
1	attics,
1	ceilings,
1	roofs
1	shelter.
1	2427
1	(3·6%).
1	(74),
1	nyctinomops
1	macrotis
1	tadarida
1	rufus
1	eumops
1	glaucinus
1	0.5-64.0
1	<0.015-0.25
1	0.015-0.5
1	0.062-2.0
1	12.98
1	44.60
1	gattii.
1	(fiv)-infected
1	felv-negative.
1	speciated
1	22/25
1	13/35
1	dermatophytes
1	2/25
1	gypseum,
1	canis)
1	3/35
1	(m
1	gypseum).
1	(51.6%).
1	28.6%).
1	cd4:cd8
1	isfm
1	poly(lactic
1	acid-glycolic
1	nanotherapy
1	'free'
1	vitro-grown
1	aromatic-l-amino-acid
1	(pbddc),
1	lumazine
1	(pbls)
1	(pbctr3)
1	pbddc
1	pbctr3.
1	vivo-induced
1	(iviat),
1	pbddc,
1	pbctr3
1	anti-cd18
1	antiidiotypic
1	ig-derived
1	unifesp.
1	zygomycosis
1	(̃
1	51.2%).
1	(50.9%)
1	list,
1	(30.2%),
1	(10.1%)
1	rsafp2,
1	glucosylceramides,
1	prophylactically
1	poor.
1	drug/peptide
1	cfus
1	p10-based
1	j774.16,
1	mh-s,
1	gp43-derived
1	nhvripigwav
1	sequels
1	(sulfamethoxazole/trimethoprim,
1	tyrosinases,
1	laccases,
1	catecholases,
1	("ghosts")
1	schenckii,
1	dermatitidis,
1	posadasii.
1	multiple-antigen-peptide
1	preimmunization
1	anergic,
1	minigene
1	antithrombotic,
1	anti-tumour,
1	(sulfametoxazol/
1	trimethoprim),
1	ajoene-treated
1	dwellers
1	(restrepo,
1	1985;
1	mcewen
1	1995;
1	chronic/recurrent
1	(coutinho
1	(sano
1	j774.16
1	mh-s
1	ketoconazole,
1	sulfamethoxazole.
1	antigen-dr
1	plo
1	(m10).
1	describe:
1	m10;
1	m10-elicited
1	igg1-opsonized
1	well-phagocytozed
1	(cr3),
1	glucuronoxylomannan-cr3
1	inocula,
1	sod-encoding
1	(sod1)
1	neoformans;
1	anti-capsular
1	c3-/-
1	(gxm)
1	iga-mediated
1	(cd11b/cd18)
1	(cd11c/cd18),
1	cd18-deficient
1	igg1-mediated
1	gxm,
1	cd18.
1	peritoneal,
1	tilers
1	43,000-da
1	sputa.
1	sputum,
1	[inno-lia])
1	(htlv)
1	(wb2.3
1	wb2.4).
1	wb2.3.
1	elisas),
1	new-generation
1	(wb2.4),
1	inno-lia.
1	18,169
1	(1.61%)
1	(vital
1	based)
1	wb2.3;
1	[htlv-i],
1	[htlv-ii],
1	nontypeable),
1	inno-lia,
1	nontypeable
1	inno-lia;
1	ab)
1	positive-untypeable
1	15-amino-acid
1	lymphoproliferations
1	12-mer
1	htlair
1	>200-fold
1	halting
1	well-demarcated
1	dalton
1	43)
1	deglycosylation.
1	immunocomplexes
1	t-cd4-dependent
1	β-1,3-glucanases
1	42,227.
1	α-d-mannopyranosyl,
1	β-d-galactofuranosyl
1	n-acetylglucosaminyl
1	10:2:2,
1	(31.3%).
1	periodate-
1	economical,
1	(mabs
1	17c,
1	21a,
1	21f,
1	32b)
1	1:819,200,
1	1/800,
1	i/200,
1	pengu
1	>1/800,
1	1/200,
1	o-[3-piperidino-2-hydroxy-1-propyl]-nicotinic
1	amidoxime
1	(bgp-15)
1	(15 mg/kg)
1	(e-myhc),
1	anion-selective
1	(vdac2)
1	70-kda heat
1	protein (hsp70)
1	termedia
1	o.o.
1	(210°.s-1)
1	(20°.s-1),
1	actriib,
1	(fst),
1	fst-like-3
1	(fstl3)
1	velocities,
1	inhibitors'
1	stuttgart-new
1	strength-training
1	power-training
1	(p;
1	n=11).
1	fl-3
1	factor-β2
1	(tgfβ2)
1	dystrophicmuscles
1	newlight
1	nationally
1	(17.6
1	3-hour
1	courts
1	(sj)
1	(cmj)
1	mb)
1	(1rm
1	strength:
1	-35.2
1	10.4%,
1	sj:
1	-7.0
1	6.0%,
1	cmj:
1	-10.0
1	6.3%)
1	post-match,
1	coaches
1	doms.
1	doms,
1	(n=20)).
1	lama2dy/2j
1	(gaas)
1	(power:5
1	mw;
1	intensity:
1	77.14
1	mw/cm2,
1	spot:0.07
1	(ctx).
1	(n05
1	each):
1	(pima)
1	pima
1	ctx-injured,
1	lasertreated,
1	copy;
1	workplace-based
1	health-,
1	fitness-,
1	(bus
1	drivers).
1	bus
1	prescreening.
1	periodized
1	workplace
1	employers
1	setup,
1	work-based
1	tas,
1	gastrocnemius;
1	ne;
1	(7%),
1	(ars).
1	ne-activation
1	(kcnq
1	α1-ars
1	α2-ars.
1	(bda).
1	bda-labelled
1	toxinb(ctb)
1	intortn.hypoxia-activated
1	ia-treated
1	92±13%
1	12±9%
1	urethane-chloralose-anaesthetized
1	(10%co2),
1	nacn).
1	rtnco2
1	(10-15%
1	o2;
1	ofmuscimol
1	chemosensitivity
1	comm
1	(i.v.),
1	(-42
1	(-22
1	(-62
1	15%),
1	(-50
1	(lonmol
1	moxonidine-induced
1	(-11
1	(-13
1	(-18
1	8bpm).
1	matrisome
1	(global
1	proteome)
1	cell-anchored
1	mechanotransduction,
1	osteoblast/osteocyte
1	(osteoporosis
1	metastasis),
1	repair/regeneration,
1	snail,
1	kots,
1	immunoexpression.
1	'cadherin
1	switching'.
1	cyst.
1	(goc)
1	adenomatoid
1	(aot),
1	goc.
1	aot,
1	ceot
1	mmp7.
1	bone-forming
1	(axial
1	appendicular
1	bones)
1	(precursor
1	bones).
1	cartilage-forming
1	cartilaginous
1	non-ecm
1	remodeling),
1	(biomechanical
1	properties);
1	reck),
1	up-date
1	endure
1	orthopedy.
1	biomaterials
1	new-guided
1	possibilities.
1	physicists,
1	engineers,
1	biotechnologist,
1	well-oriented
1	write
1	bioengineering,
1	cell/material
1	(ccot)
1	auspicious
1	(mmps-2,
1	-14),
1	(timps-2,
1	reck)
1	(emmprin)
1	mmp-14
1	(p = 0.004)
1	(r = 0.661,
1	p = 0.003).
1	proteins/enzymes
1	ccot,
1	inducer/inhibitors
1	prospero
1	(prox1)
1	(oscc).
1	scc9
1	scc9-prox1-overexpressing
1	prox1-overexpressing
1	ck19
1	wisp3,
1	individualize
1	non-cancerous
1	(margin),
1	(p=0.03).
1	hoxa5,
1	hoxd11
1	(>4-fold)
1	(oraov1)
1	40years
1	(one-way
1	(spearman,
1	p=0.85).
1	ossc
1	mmp1,
1	mmp3,
1	turkey.
1	(cleft
1	lip/palate)
1	wnt9b,
1	clf1
1	wnt8a,
1	wnt11,
1	wnt3,
1	wnt9b
1	subphenotypes
1	plink
1	0.0003;
1	1.61;
1	1.29-2.02)
1	lip/palate.
1	clefting.
1	(reversion-inducing-cysteine-rich
1	motifs),
1	metalloproteinase-2),
1	seam
1	(e13),
1	e14.5.
1	(zymograms).
1	shelves
1	ish
1	non-isotopic
1	8.5-
1	13.5-day-old
1	e8.5-13.5).
1	e8.5,
1	endoderm.
1	bmp-4
1	meckel's
1	palatogenesis,
1	shelves.
1	mesenchyme,
1	miogenesis,
1	palatogenesis
1	reversion-inducing-cysteine-rich
1	(reck)
1	mmp-regulator
1	post-secretory
1	ameloblasts.
1	infra-nuclear
1	ameloblast,
1	immuno-competent
1	(macrophages
1	dendritic-like
1	amelogenesis.
1	amelogenesis,
1	group-i
1	micro-granules)
1	group-ii
1	macro-granules).
1	low-renewal
1	macrophage-
1	pan-cd68
1	xenogenic
1	(mmp-9)
1	hypercementosis
1	(suggestive
1	lymphocytes).
1	granulocyte-like
1	e17
1	e21)
1	time-line
1	mmp-regulator.
1	post-operatively
1	3/period).
1	hemimaxillae
1	osteogenic
1	cd68+.
1	(0.553
1	0.153
1	0.483
1	0.189,
1	.0012;
1	(0.519
1	0.339
1	0.117,
1	.0322;
1	rankl+/opg+
1	(1.336
1	0.723)
1	(1.404
1	0.385)
1	cd68+/total
1	(0.381
1	0.040)
1	(0.307
1	0.068)
1	welch
1	correction).
1	cancellous
1	fasciae
1	6/period).
1	anti-cd68
1	(103.2
1	39.1),
1	3.67;
1	(45.9
1	13.1).
1	6.75;
1	10.4)
1	(19.5
1	8.9).
1	resorbed
1	granuloma,
1	lightly
1	(pdtc),
1	(pdtc
1	(2%
1	drink),
1	+hs.
1	“onion-skin”
1	ii-positive
1	renin.
1	+hs
1	nephrogenesis
1	fachi
1	hif-1
1	[m199,
1	sheds]
1	rt-qpcr;
1	ortotopic
1	7aad
1	m199,
1	signal–regulated
1	signal⁻regulated
1	basso,
1	sales-campos.
1	infirmities
1	entities:
1	refractoriness.
1	(fmt)
1	microbial-based
1	remission,
1	uc.
1	fmt
1	(5/6nx)
1	eight-week-old
1	sd);
1	re);
1	phosphatidylinositol‑3
1	(cd86,
1	(cd206,
1	fizz1
1	ym1)
1	pi3kγ.
1	inflammatory-prone
1	(ctl,
1	ad-ctl,
1	(cxcl10),
1	(cxcl9),
1	ad-ctl
1	speculative.
1	(urbp),
1	(mdrd)
1	79.9%
1	40.7%
1	cmv-,
1	(p=0.02)
1	(50.3
1	25.8
1	59.8±
1	26.4ml/min,
1	(p=0.04),
1	(p=0.005
1	1-month
1	(p=0.03),
1	(p=0.01).
1	high:
1	61.0±
1	p<0.001.
1	testicular,
1	neck.
1	(ct).
1	(cd69+
1	cd25+)
1	trained).
1	(free-form/ff).
1	forskolin’s
1	neuron-like
1	nanostructured-forskolin
1	photobiostimulatory
1	incell
1	(inf)
1	(nffc).
1	nanocontrol
1	(inc)
1	(nnfc).
1	neural-protein
1	complementarily,
1	promisor
1	autophagy-associated
1	recover.
1	ng·kg
1	·min
1	grp
1	78/bip
1	0.01);
1	eif2-α
1	mapk-mediated
1	mapk-nhe1-mediated
1	at1r/er
1	nhe1-mediated
1	(adr).
1	munich–wistar
1	(mmf),
1	nrk52-e
1	collagen-1.
1	proinflammatory/profibrotic
1	(namely,
1	fibro–adipogenic
1	(fap)
1	faps
1	replenished
1	(allo)
1	(xod)
1	(ua)
1	expansion/inflammation/fibrosis.
1	ua
1	oxigenase-1
1	ngal
1	injury/inflammation.
1	antifibrotic
1	elasticity,
1	debit
1	(jα18−/−)
1	sulfatide.
1	jα18−/−
1	α-galactosylceramide–sulfatide-treated
1	th2-driven
1	nkt-activated
1	ccr2.
1	liposome-encapsulated
1	clodronate,
1	rfp/rfp
1	adora1,
1	adora2a/2b.
1	>20-fold
1	(epo),
1	cd39−/−
1	per2−/−
1	epo.
1	cd39-
1	adenosinergic-dependent
1	per2.
1	(ibds) affect
1	ibds.
1	shortening.
1	(f4/80
1	(cd11c
1	immunoregulatory-associated
1	recruitment)
1	supplemen-tation
1	g/day,
1	(ovalbumin,
1	as-sessed
1	(-21d),
1	(-1d)
1	(+5d)
1	(-8.2%±
1	4.1%)
1	(-8.5%±2.4%)
1	(-0.6%±1.4%).
1	wisconsin
1	un-changed
1	-21d=5,251±2,986;
1	-1d=17,428±22,374;
1	+5d=21,125±21,934;
1	-21d=6,096±3,549;
1	-1d=11,029±17,113;
1	+5d=28,186±21,032
1	fi)
1	-21d=4,421±3,634;
1	-1d=3,329±6,283;
1	+5d=3,243±
1	2,553;
1	-21d=4,051±3,186;
1	-1d=3,106±2,625;
1	+5d=4,981±
1	4,598)
1	ki-nase
1	(-21d=125.2±54.1;
1	-1d=187.2±
1	73.5;
1	+5d=111.3±59.1
1	u/l)
1	(-21d=136.2±58.2;
1	-1d=
1	168.8±65.0;
1	+5d=129.7±64.0
1	u/l).
1	fre-quency
1	associ-ated
1	khan,
1	sweezey
1	palaniyar.
1	(nox)-independent
1	(netosis).
1	citrullination,
1	(6.6,
1	6.8,
1	mitotempo,
1	ionophore-mediated
1	pad4
1	citrullination
1	(cith3)
1	ionomycin-induced
1	netosis
1	a23187-induced
1	decondensation.
1	pad4-mediated
1	calcium-mediated
1	streptomyces,
1	dioxide.
1	(1,5
1	mg/m
1	(cxcl1)
1	tickening.
1	re-emergent
1	(arbovirus)
1	polyarthralgia.
1	metformin's
1	(nsg)
1	cd8-effector-memory
1	b16f10-transplanted
1	gr-1+cd11b+
1	rorγ+
1	il17+cd4+
1	b16f10-injected
1	rag-1-/-
1	metformin/sitagliptin
1	brafv600e/pten
1	tamoxifeninducible
1	for-cause
1	post-transplant).
1	(ptc
1	0.56cells/mm2
1	glomerulitis,
1	factor-α;
1	rnam
1	κb,
1	pcr-array
1	lbp,
1	irf7
1	post-ablation.
1	antecedes
1	detaining
1	amedical
1	(n=169),
1	allografts,
1	injury-associated
1	inmice
1	high-iron
1	thenrf2
1	nrf2-related
1	highiron
1	reconstitute
1	ischemia-reperfusion,
1	belief,
1	trophic/growth
1	aryl-hydrocarbon
1	msc-associated
1	msc-mediated
1	immunoregulation,
1	ahr-mediated
1	(hfsc)
1	(dwat)
1	dermal/vennule
1	annulus
1	(ilcs)
1	(ilc1,
1	ilc2
1	ilc3).
1	coelho-júnior
1	67.1±4.6
1	index:
1	28.03±4.9
1	135.1±21.1
1	equalized
1	8–10
1	(difficult)
1	(moderate)
1	quantification)
1	completion.
1	marrow–mesenchymal
1	(bm-mscs)
1	(islet +
1	(islet
1	islet +
1	factor–
1	(13.40
1	9.90
1	(51.30
1	9.00
1	1.80,
1	1.00,
1	.04).
1	(25.60
1	1.96
1	2.80
1	(188.40
1	4.60
1	4.55
1	p = .0001),
1	(34.20
1	bm-msc
1	xenotransplantation
1	grafts,
1	(bmi)-matched
1	40-min
1	nfkbia,
1	mapk3,
1	actb
1	ppara).
1	il-18r1,
1	crlf2,
1	acaca,
1	cebpa,
1	tnfrsf1b,
1	ikbkb).
1	nampt
1	il-8),
1	transporters;
1	mate-1,
1	estrela,
1	wasinski,
1	malheiros,
1	barros,
1	bader
1	araujo.
1	tnfr2.
1	'kidney
1	kidneys'.
1	yaochite,
1	tostes,
1	ramos,
1	zamboni,
1	camara,
1	ryffel
1	family-pyrin
1	asc-/-
1	nlrp3-and
1	il-1r-deficient
1	asc-deficient
1	insulitis,
1	(th17
1	tc17)
1	(nadh).
1	(mdna)
1	mdna
1	th17/tc17/th1/tc1
1	mdna-mediated
1	metalloprotease-9
1	sakurnaetin
1	(il-8
1	homolog)
1	mmm-9
1	timp-1-positive
1	pezato,
1	perez-novo,
1	berghe,
1	gregorio.
1	polyps
1	polyp-mscs
1	(po-mscs)
1	(bm-mscs).
1	morphologic,
1	immunosuppressive,
1	osteogenic/adipogenic
1	cd117,
1	pdl-1,
1	pdl-2),
1	bm-mscs.
1	cd133
1	abcb1),
1	fgf10,
1	kdr,
1	gdf6).
1	po-mscs,
1	shrnai
1	(shr-socs1)
1	shrnai-socs1
1	c-kit,
1	epha3
1	cytokine/tyrosine-kinase
1	shr-socs1-transduced
1	metallo-proteinases
1	cd-10
1	socs1-silenced
1	anti-melanoma
1	bassi,
1	anderson,
1	origassa,
1	andrade-oliveira,
1	semedo,
1	reis,
1	moreira-filho,
1	verjovski-almeida,
1	pacheco-silva
1	câmara.
1	(mvs),
1	mirna/mrna
1	mir-880,
1	mir-141,
1	mir-377,
1	mir-21)
1	wnt/tgf-β,
1	α-7
1	(nachrα7)
1	inseveraldiseases,
1	respiratorydistress
1	syndrome(ards).giventhepotentialimportanceof
1	a7nachras
1	target,we
1	whetherpnu-282987,
1	ana7nachragonist,
1	inflammation.we
1	c57bl/6mice.
1	nf-kbphosphorylation
1	alongwithcollagen
1	lungmrnalevels
1	ofm1macrophages,
1	them2-relatedmarkerscd206
1	themacrophage
1	anagonist
1	ofa7nachr,
1	reduceslps-induced
1	experimentalali,
1	notionthatdrugs
1	a7nachrs
1	humans.-pinheiro,
1	santana,
1	r.,
1	almeida,r.r.,guerreiro,
1	m.,martins,m.a.,caperuto,
1	l.c.,ĉamara,n.o.
1	s.,wensing,
1	prado,v.
1	f.,tiberio,
1	prado,m.a.m.,
1	prado,
1	a7nachr
1	(nlrp3
1	(casp-1
1	(il-1r
1	μg·kg
1	·d
1	mini-pump)
1	il-1r,
1	(allo),
1	im);
1	glycerol;
1	glycerol-injected
1	8-isoprostane-pgf2a
1	(f2-isop)
1	f2-isop
1	lesion/inflammation
1	(systemic,
1	muscular),
1	(atn),
1	hyalinosis
1	(ah),
1	(it),
1	outcomes:
1	(ecd),
1	(cva)
1	32%.
1	53%.
1	(49.8
1	64.5
1	[or]
1	3.159
1	1.22–8.16];
1	0.018),
1	8.91
1	2.21–35.92];
1	1.10–7.84];
1	3.96
1	1.46–10.70];
1	0.96
1	0.93–0.98];
1	1.10–5.44];
1	cva
1	1.05–5.15];
1	(dm-pc/d),
1	(dm-wc/d),
1	(ng/d),
1	(ng/nd).
1	(mda),
1	dm-pc/d
1	normoglycemics
1	dm-wc/d
1	dm-pc/d.
1	normoglycemics.
1	nachr)
1	(uuo)-induced
1	damages.
1	nachr,
1	wharton’s
1	jelly-derived
1	(wj-mscs)
1	hepatic,
1	untreated;
1	injected,
1	wj-mscs.
1	gfr;
1	klotho;
1	attenuate.
1	2016;5:1048–1057.
1	approval
1	arazyme,
1	ifnγ-dependent,
1	tlr4-myd88-trif-dependent,
1	mapk-dependent
1	4t1
1	flavone
1	(20 mg/kg/mice)
1	(5 mg/kg/mice);
1	fibers),
1	(eosinophils
1	nf-kb)
1	(8-isoprostane)
1	(distilled
1	mg/m3,
1	days/week),
1	tlr4-nf-kb
1	broadened
1	(tfh).
1	(il23r),
1	icos,
1	c-maf,
1	cxcr5
1	cxcl13.
1	cxcr5+
1	help,
1	deregulated,
1	steunstichting
1	esot.
1	cd56,
1	cd57,
1	donor-specific
1	(dsa).
1	dsa-negative
1	biopsies-from
1	(atcmr)
1	(aabmr)
1	c4d+)
1	c4d
1	c4d-).
1	aabmr.
1	atcmr.
1	arquivos
1	cardiologia.
1	prescription,
1	(sh).
1	(vertical
1	climbing),
1	overloads
1	(mwc),
1	[206
1	(sbp)]
1	(wky;
1	sbp)
1	(sed-wky)
1	(sed-shr);
1	rt1-shr
1	(~40%
1	mwc);
1	rt2-shr
1	mwc
1	(~70%
1	mwc).
1	12-weeks.
1	(delta
1	sed-shr
1	(140%;
1	(11%;
1	(tens)
1	insufficiency.methods:
1	(ls);
1	(ln),
1	(cs);
1	crown-rump
1	(crl),
1	fronto-occipital
1	(fod),
1	(tvdd)
1	(avdd)
1	(glut-1)
1	junctional,
1	slides,
1	reaction.results:
1	crl
1	(27.51/28.95
1	30.16
1	fod
1	(6.63/6.63
1	7.36
1	avdd
1	(7.38/8.00
1	8.61
1	tvdd
1	(6.46/6.87
1	7.23
1	glut-1
1	(1.8%).
1	(29.67
1	20.83
1	7.63)
1	(26.46
1	10.21
1	10.86
1	8.94)
1	group.conclusions:
1	ptd,
1	azathioprine,
1	randomization,
1	mofetil,
1	ubiquitination,
1	ignacio,
1	morales,
1	almeida.
1	millennia
1	ankylosing
1	spondyli-
1	tis
1	b27
1	fre-
1	quency
1	(asp299gly
1	399ile)
1	hla-b27
1	p-values
1	43.1
1	(71%)
1	non-caucasian
1	hla-b27.
1	tatiana
1	venancio
1	(cetp),
1	(clp),
1	acyloxyacyl
1	(aoah)
1	promissory
1	oxygenase-1.
1	adenocarcinoma,
1	kunitztype
1	pgp)
1	(nih3t3),
1	fluorescence-labelled
1	excreted.
1	anti-rcc
1	donizete
1	júnior
1	offspring).
1	nos3,
1	cfa2,
1	dfa2,
1	dc2
1	cfa5.
1	cfa5
1	(nod2),
1	nod1,
1	vehicle-injected
1	(abx)
1	abx-treated
1	dipeptide,
1	peak)
1	stat4)
1	nodes:
1	58;
1	edges:
1	195;
1	sleactive,
1	pyy
1	succeeding
1	burgos-silva
1	(aki
1	cki)
1	fvb
1	adsc-treated
1	miranda
1	(fa),
1	degranulated,
1	pollutant.
1	(mld-stz)
1	(w/wv
1	wsh/wsh)
1	insulitis
1	il-6-deficient
1	mld-stz
1	taguchi
1	retusa,
1	mmp-12,
1	mmp-9-
1	mmp-12-positive
1	tnf-aα,
1	uninversity
1	michigan.
1	cd1d.
1	(αgalcer).
1	(il)-4.
1	c57bl/6j,
1	γko
1	(kim-1),
1	ifn-γko
1	passos
1	(incl)
1	disadvantages;
1	iohexol.
1	(iocl)
1	(arf),
1	(200-300
1	(n=19).
1	(pcreat)
1	colorimetrically.
1	pcreat,
1	(r=0.792).
1	(r=-0.587)
1	(r=-0.722)
1	background:diseases
1	programming.methods:diabetic
1	(diabetics,
1	respectively.results:creatinine,
1	dams.conclusion:fetal
1	agudelo
1	subdivide
1	(stnfr1
1	stnfr2)
1	25.6±3.4
1	26.1±4.8
1	bmi-matched
1	(∼50%
1	(p>0.05),
1	90th,
1	120th,
1	150th,
1	(p=0.034)
1	(p=0.05)
1	(p=0.028),
1	recovery)
1	(fa)-induced
1	250mg/kg)
1	250mg/kg).
1	korkes
1	tof-tof
1	glycerophosphoserines-gp03
1	52.30%
1	glycerophosphoethanolamines-gp02
1	glycerophosphocholines-gp01
1	flavanoids-pk12
1	(flv),
1	24.03%,
1	9.47%
1	8.39%
1	flv
1	preeclampsia,
1	56.28%,
1	macrolides/polyketides-pk04
1	32.77%,
1	pk04
1	hyperpermeability
1	(apoa-i)
1	post-clp,
1	(slit2
1	robo4)
1	filtration;
1	improved;
1	apoa-i
1	common;
1	slit2,
1	robo4,
1	hdl-dependent
1	4f,
1	chemotherapies;
1	tnf-α).
1	function-dependent
1	exercise/physical
1	insult,
1	perception,
1	depleted.
1	polyposis,
1	rogério
1	pezato
1	(stnfrs)
1	age-,
1	index-comparable
1	stnfrs
1	moderate/intense
1	0.093)
1	0.084),
1	(b2rbk;
1	bdkrb2)
1	(adm).
1	dalbk.
1	slit-diaphragm-related
1	less-inflammatory
1	renin-angiotensin-system
1	(ras)-dependent
1	msc.
1	oliveira-sales
1	catabolizes
1	biliverdin
1	ho-catalyzed
1	biliverdin/bilirubin,
1	ho-1-mediated
1	ferritin).
1	receptors-2,
1	(pdtc;
1	ikk-α,
1	fibrosis/inflammation.
1	ochratoxin
1	(ota)
1	asper-gillus
1	70%-90%
1	ibrahim
1	ota.
1	(5-fold
1	ota-containing
1	aerolized
1	(saline
1	sulfoxide,
1	dmso),
1	gmc-sf
1	bioplex
1	8-isoprostane
1	remodelling;
1	insertion/deletion
1	+9/-9
1	kidney-transplanted
1	(n=215
1	n=203
1	443
1	+9
1	creatinine.
1	post-transplantation,
1	boston
1	disappointing
1	nx+l,
1	monotherapy;
1	nx+lh,
1	l+h
1	nx+ahhz,
1	relaxant,
1	hydralazine,
1	advanced.
1	renoprotection,
1	detained
1	ahhz
1	thiazides
1	normalization.
1	arias
1	amano
1	camara;
1	(ho)-1
1	immediate.
1	co/ho-1
1	periglomerular
1	tubulointerstitium
1	vasoactive,
1	nephrons,
1	i-iv)
1	multipotentiality
1	(hgf,
1	ho-1)
1	(pge-2,
1	hla-g5)
1	fibrosis;
1	(420%)
1	10x
1	il-10(450%),
1	(259%),
1	(460%)
1	(370%)
1	(igan),
1	20-40%
1	igan,
1	mesangium
1	igan
1	(cd71)
1	large-molecular-mass
1	iga1-containing
1	iga1-dependent
1	cell-podocyte
1	ciclosporin,
1	80's,
1	survivals.
1	allograft.
1	alloreactivity,
1	20-60%
1	viruria
1	biopsies.to
1	(gcv),
1	cidofovir
1	valaciclovir
1	recipients.these
1	gcv,
1	granulocytopenia
1	(neutropenia)
1	unbalance,
1	hypocalcemia
1	required.severely
1	(ul54)
1	(ul97).
1	gene.the
1	pre-conditioning
1	milestone
1	erbb,
1	diagram
1	maneuvers,
1	hmox1
1	hemin.
1	maneuvers.
1	(ascs)
1	immediately.
1	asctreated
1	shrank
1	fsp-1,
1	hypoxyprobe.
1	podocin
1	fibrogenic-related
1	(mmp9).
1	peri-glomerular
1	(α-sma),
1	α-sma
1	glycosiltransferase
1	cd8pos
1	cd11bpos
1	post-adm,
1	(controls);
1	(do
1	maldi-ms.
1	(pls-da)
1	1290
1	m/.
1	glycerophosphocholines
1	[gp01],
1	glycerophosphoserines
1	[gp03],
1	glycerophosphoglycerols
1	[gp04],
1	glycosyldiradylglycerols
1	[gl05]
1	glycerophosphates
1	[gp10].
1	microangiopathy.
1	(su),
1	s+v,
1	s+su,
1	su,
1	v;
1	nx+su,
1	interstitium
1	(gs),
1	microthrombi,
1	nx+su.
1	tissue-protective
1	(sham-operated);
1	clp+epo.
1	(4,000
1	n-nitro-
1	(clp+epo+l-name).
1	(clp+epotreat)
1	postprocedure,
1	clp+epo+l-name
1	clp+epotreat
1	pre-clp
1	(epor)
1	downregulation.
1	(fsgs).
1	gsl-1,
1	monoglycosylceramide
1	adriamycin(adm)-based
1	pro-fibrogenic
1	eotaxin.
1	adm-
1	gsl-1-treated
1	inkt-mediated
1	phosphosmad2/3
1	(cera)
1	immunoblotting-to
1	(nkcc2),
1	(aqp2),
1	(epor),
1	(nf-κb)-and
1	(p&0.05
1	p&0.01,
1	(p&0.01),
1	(p&0.05).
1	counterregulate
1	challenged.
1	well-nourished
1	il-4/ifn-γ
1	dgf.
1	(59.3%),
1	(63.9%
1	55.3%;
1	.36).
1	(8.2%
1	28.5%;
1	(58.3%
1	17.1%;
1	(59.2
1	53.3
1	14.4;
1	.023).
1	.024),
1	.045).
1	.039).
1	dgf,
1	are.
1	dermolipectomy
1	(xdh)
1	precipitates
1	tubuli.
1	allopurinol,
1	cockcroft-gault
1	567
1	foundation/kidney
1	(crcl)
1	57.8
1	61.9%
1	1-year-crcl
1	0.58;
1	-2.38
1	(-11.9
1	-3.92
1	-2.03
1	=.046).
1	-1.49
1	ml/min/y,
1	posttransplantation.
1	2.38
1	ml/min/y.
1	crcl.
1	germline-encoded
1	dangers-associated
1	well-studied,
1	cxcl10/ip-10,
1	sflt-1,
1	electrochemiluminescence
1	109.5
1	52.28
1	13,636
1	2020
1	(tbi)
1	(nscs).
1	tbi
1	layla
1	galindo
1	(dgf),
1	(are),
1	628
1	(cit;
1	.008).
1	.047).
1	>45
1	59.6
1	(55.5
1	19.3
1	60.7
1	20.4;
1	.009).
1	94.0%
1	non-dgf
1	cit.
1	podocytopathy.
1	podocin,
1	α-actinin-4
1	podocyte-related
1	alarmins,
1	(a299g/t399i)
1	8.5%
1	heme-oxygenase-1
1	hemin-treated.
1	proteinuria/creatininuria
1	hemin-treated
1	scar.
1	(cr).
1	cytokeratin,
1	markers).
1	epitheliomesenchymal
1	1.44
1	.033)
1	.015),
1	deterioration.
1	(if/ta)
1	glomerulopathy
1	(ctg)
1	1.5-3.0%
1	glomerulopathies
1	(rgn)
1	rgn
1	65).
1	if/ta.
1	(acei;
1	(mmf;
1	0.17,
1	0.026),
1	7.29,
1	0.003),
1	5.32,
1	0.011),
1	≥0.5
1	g/24
1	4.55,
1	.005).
1	.013)
1	.012)
1	.002),
1	.003),
1	.044)
1	(bmmcs)
1	enact
1	profiling.
1	non-amelioration
1	bmmc-treated
1	(bmp-7),
1	(sgf)
1	133,
1	297.
1	.028).
1	gfrs,
1	.004).
1	igf.
1	gfr.
1	sorting.
1	pax6,
1	ngn-3,
1	isl1,
1	neurod1,
1	nkx2.2,
1	nkx6.1
1	.05),
1	endocrine-specific
1	cys-lts
1	(montelukast)
1	ova/alumen
1	(50:1)
1	(30:1),
1	(10x
1	(4x
1	15x
1	montelukast,
1	montelukast
1	ltc
1	(73%).
1	banff's
1	(36.7%)
1	(if/ta),
1	5.290
1	(ho)-1,
1	(pges)
1	imt-treated
1	pges,
1	wistar-epm
1	cd73+cd90+
1	(fsp-1),
1	fsp-1
1	(is),
1	re-growth
1	non-excised
1	is.
1	(el),
1	lipectomy,
1	7-consecutive-day
1	lipectomy.
1	(anvr),
1	(avr),
1	perforin.
1	13.99
1	6.99
1	48.13
1	54.47
1	238.63
1	333.14
1	0.526,
1	0.016).
1	(gearray
1	ohs-018.2
1	series-superarray)
1	(ar,
1	vascular).
1	gearray
1	ar:
1	pellino
1	ube2v1.
1	irak-3.
1	(b1r).
1	unveiled.
1	(b1b2wt)
1	(b1b2wt:
1	12.16
1	1.53%
1	b1ko:
1	1.07%,
1	ho-1.
1	harvested.
1	q-pcr.
1	cd20.
1	nephropathy).
1	cells/hpf)
1	51.6%.
1	6 months,
1	50/hpf
1	cd73,
1	cd29
1	31.
1	osteocyte.
1	105 cells)
1	(24 h:
1	3.23
1	0.89 mg/dl,
1	bcl-2/bad
1	(kt/v
1	(kt/v)
1	0.51).
1	0.38).
1	0.99,
1	(neural
1	npcs)
1	1-hour
1	succinimydylester
1	(cfse).
1	3.33
1	2.95
1	0.78mg/dl,
1	79.7
1	14.2%,
1	npc-cfse
1	(gfap)-positive
1	(astrocyte
1	sox-2
1	npc-treated
1	inf-γ).
1	glycerol-induced
1	(gly-aki)
1	cd43+,
1	(t-bet,
1	il-1β)
1	(gata-3,
1	th1-polarized
1	gly-aki
1	lineage-negative
1	lin
1	(laparotomy
1	(five-
1	nxlcl
1	15);
1	45).
1	nxlc1
1	(inulin
1	cell-treated
1	calcineurin-inhibitors
1	(ta/if)
1	tubular-interstitial
1	ta/if
1	α-1-microglobulin,
1	nacetyl-
1	beta-d-glucosaminidase,
1	alpha/pi
1	s-glutathione
1	transferases,
1	β-2
1	microglobulin,
1	(antigenemia),
1	gb1v
1	(46.4%),
1	(35.2%),
1	gb2v
1	(2.8%),
1	gb4v
1	(4.9%).
1	75.1
1	(1-1000).
1	0.010),
1	49.5
1	120.7
1	0.048).
1	non-randomized
1	biopsy-proven
1	(g2).
1	mmf.
1	(86.9
1	67.7%;
1	0.079,
1	0.015-0.426;
1	fibrosis/tubular
1	iri.we
1	wks
1	(opn),
1	(bmp-7).
1	anti-actin
1	il-1-β,
1	ctgf,
1	guanosine-thymidine
1	(gt)
1	subclasses:
1	(<27
1	repeats)
1	(≥27
1	repeats).
1	47.5%
1	(50.3%),
1	(can;
1	nonmanipulated
1	[35s]-inorganic
1	syndecan-4.
1	[35s]-labeled
1	regenerated.
1	desquamation
1	ischemic-reperfusion
1	neutrophils/macrophages,
1	mastocyte
1	enzymatically,
1	264.4
1	85.21
1	123.74
1	29.64
1	macrophage-related
1	cadi)
1	(acei),
1	cadi,
1	acei,
1	glomerulopathy,
1	non-bacterial
1	(dmso).
1	(s-gag)
1	durin
1	healty
1	s-gag/cr
1	treatrnent
1	60-yr-old
1	(50-59
1	transplantation:
1	(elderly
1	(younger
1	(37.6%)
1	86.7%
1	0.49).
1	0.33).
1	contraindication
1	anti-lymphocyte/thymocyte
1	(88.9%)
1	(ar
1	=30),
1	(559.19
1	644.41)
1	(3.78
1	7.20),
1	(0.54
1	0.76),
1	(50.40
1	38.71),
1	(4.69
1	12.62),
1	(0.38
1	0.44)
1	(ptx-gn)
1	13.7-yr-old
1	(0-204)
1	hematuria
1	(10-2160)
1	(4-1170),
1	0.24).
1	=0.24,
1	0.017],
1	0.06,
1	fas-ligand
1	taqman.
1	97)
1	(5672.51
1	9002.16
1	1866.59
1	2426.38,
1	(166.62
1	174.94).
1	anti-rejection
1	0.73;
1	asp299gly
1	201
1	thr399ile,
1	asp299gly/thr399ile
1	.400).
1	follow-up;
1	(72.3%,
1	methylprednisolone;
1	corticosteroid),
1	(raasb)
1	153.4)
1	12.5)
1	24.2).
1	52.9%,
1	(27.2%
1	48.1%,
1	.40)
1	(73.2%
1	60.4%)
1	(62.5%
1	38.0%,
1	.26),
1	raasb,
1	raasb;
1	14.8%
1	pattern-associated
1	endogen
1	clamped
1	(msc),
1	flasks,
1	.05,
1	ischemically
1	cyclosporine-related
1	tacrolimus.
1	antiproliferative,
1	advocated.
1	day-1.
1	(bmp)-7
1	(0.57
1	.002)
1	.040).
1	(3.05
1	0.41,
1	.006)
1	(6.33
1	4.97
1	0.38,
1	.024)
1	(4.03
1	0.83,
1	(c57bl/6,
1	(gk1.5,
1	ii-major
1	gk1.5
1	39%;
1	non-depleted
1	cd4-positive
1	βc
1	granzyme-b
1	(b1-/-),
1	(b2-/-)
1	b1b2+/+)
1	(ul54),
1	kidney-pancreas
1	oscillating
1	(m460v),
1	594
1	(a594v)
1	595(l595s/f).
1	(47.4%)
1	l595s
1	a594v
1	(11.1%),
1	a595f/a594v
1	l595s/a594v
1	(22.2%).
1	m460v
1	anti-drug
1	tapering
1	1 ml/kg/day),
1	(10 mg/kg/day)
1	10 mg/kg/day).
1	28 days,
1	(arteriolopathy
1	arteriolopathy
1	2.86%)
1	(37.0
1	3.59%
1	1.72%,
1	pioglitazone),
1	(3.96
1	7.53
1	1.38,
1	(1.79
1	smad7.
1	(anvr;
1	(avr;
1	host-driven
1	rejection:
1	1.000,
1	anvr
1	1.429,
1	3.904
1	.022
1	0.733
1	.04;
1	0.528-0.939).
1	vasculopathy
1	(2.05±0.23
1	(2.30±0.33
1	(1.54±0.4
1	(0.63±0.09
1	(68.53±2.30
1	43.63±3.11%,
1	(1.32-fold).
1	ischemic-injured
1	(1.85
1	md/dl,
1	.367)
1	atn:
1	2.51
1	.852)
1	(1.87
1	3.12
1	hours:
1	.009)
1	cyclosporine-induced
1	(100 mg/kg)
1	0.23 mg/dl),
1	±0.6 mg/dl),
1	(0.63
1	0.09 mg/dl,
1	(2.06
1	folds).
1	cyclosporine.
1	calculated)
1	(urinary
1	urbp)
1	37.7
1	1.61
1	1.31
1	67.7
1	61.18
1	(1.73
1	m2)-1,
1	1.06,
1	0.412-6.396
1	(29.6%)
1	3.47,
1	semi-quantified
1	(regulated
1	secreted)
1	(pao2)
1	45.12
1	5.85%
1	(73.1
1	35.96
1	11.64
1	9.65%,
1	0.002,
1	recipient's
1	alloreactivity
1	overimmunosuppression
1	13),
1	fas-l,
1	cd3+,
1	hla-dr+,
1	fas-l+,
1	icam-1+
1	fas-l+
1	(ho-1).
1	24,48
1	results/conclusions:
1	il-12-deficient
1	(tcr)-mediated
1	cd4+d25-
1	cd4+d25+regulatory
1	cd3ζ
1	ζ-associated
1	immunoreceptor
1	vav
1	appreciated,
1	tcells,
1	incompetent
1	anti-cd86
1	cd86-mediated
1	(fe),
1	(caox)
1	post-transplant,
1	(82.4
1	63.0%,
1	(creatinine
1	(47%
1	twelve-year
1	(49.7
1	74.1%,
1	0.013).
1	24/28
1	32.43±13.67
1	sirolimus-free
1	46.5±18.5
1	reperfuse
1	urea)
1	(219±54.5
1	338±51
1	106±51
1	326±86
1	94±14
1	138±38
1	(128±33
1	219±54.5
1	cox-1/-2
1	(nc),
1	(long-term
1	[ltrf]),
1	(atn).
1	+cd8
1	-cd8
1	(double
1	negative-dn
1	0.09%,
1	0.14%,
1	atn,
1	(p=0.263).
1	(52.11%)
1	(11.04%).
1	(il-4-producing
1	subset)
1	(42.86%),
1	+vβ
1	specific-subsets
1	(csa;
1	neoral®)
1	haplo-identical
1	haploidentical
1	(299.70
1	154.03
1	1.00).
1	56.3%).
1	0.430).
1	pre-transplant
1	(cd152),
1	relocate
1	ligated,
1	cd45ra
1	(naïve),
1	(memory),
1	39±10
1	re-transplants.
1	banff-graded
1	rejections.
1	okt3,
1	(urbp).
1	(82.6%)
1	nephropathy-free
1	(57.5%
1	p=0.0004;
1	70.7%
1	p=0.0002).
1	(rr=5.3,
1	1.45-19.58,
1	p=0.012).
1	[hla-a2]
1	138-170)
1	alloresponse
1	semiallogeneic
1	("linked
1	suppression").
1	precommitted
1	non-self-peptides
1	3.87,
1	han
1	david,
1	sesti-costa,
1	frade,
1	baron,
1	ianni,
1	chevillard,
1	marin-neto
1	targetable
1	counterbalancing
1	myocarditis.
1	ebi3-deficient
1	ebi3.
1	bloodstream.
1	il-27p28,
1	kanashiro,
1	benevides,
1	bonfá,
1	gozzi,
1	borges,
1	alves-filho,
1	exacerbated,
1	gata3-repressive
1	intensifies
1	nod2-deficient
1	nod2-knockout
1	nod2-dependent
1	(ltgf-β1),
1	(garp)/lrrc32.
1	garp
1	αvβ8
1	(gitr),
1	tnfrs18
1	phenotype/function
1	(il-17a)-producing
1	profiling,
1	mapk.
1	nod2-/-
1	disorders;
1	pseudotuberculosis,
1	post-resolution
1	inflection
1	(idc)
1	il17,
1	ccl20
1	th17.
1	gene-expression
1	nonmetastatic
1	protumor
1	il17.
1	idc
1	vacuolization,
1	transaminases.
1	multi-deregulated
1	bonfá
1	genes)-booster
1	(apa)
1	6,6=-trehalose
1	dimycolate
1	(tdm)
1	coencapsulated
1	(bcg-apa),
1	(bcg-apa)
1	(bcg/dna-hsp
1	(cfp)-cpg
1	(bcg/cfp-cpg)
1	bcg/cfp-cpg-immunized
1	cd4+:cd4+
1	pvaxhsp65;
1	calmette-guérin.
1	(4-11/group)
1	bcg)
1	(prime)
1	(boost).
1	prime-boost-immunized
1	mk-886-treated,
1	th1-driven
1	(pvaxhsp65).
1	pvaxhsp65.
1	dnahsp65
1	(cfp/cpg),
1	single-dose,
1	(entr-hsp65)
1	(comp-hsp65),
1	comp-hsp65,
1	comp-hsp65
1	naked-dna.
1	rosada
1	hsp60/65
1	dna-hsp65.
1	immunization),
1	efn-γ
1	(th1/th2)
1	el-5,
1	easiness
1	priming/dna-hsp65
1	(bcgin/dna)
1	bcgin/dna
1	th1-induced
1	prime/dna-hsp65
1	(cfps),
1	(cpg-odns)
1	(cfp/cpg)
1	(cfp/ifa).
1	(th1)-biased
1	antibody/igg1
1	cfp/ifa
1	cfp/cpg-immunized
1	1901.
1	flavivirideae
1	sleepiness,
1	dopamine-related
1	d1r
1	narcolepsy,
1	modafinil,
1	ifn-mediated
1	h1n1
1	(zikv),
1	declare
1	(pheic).
1	ziika
1	uganda,
1	lately,
1	yfv
1	everything
1	skyrocketing
1	(czs),
1	arthrogryposis
1	czs,
1	angeli's
1	(cci)-induced
1	(7th
1	1h-[1,2,
1	4]oxadiazolo[4,3,-a]quinoxalin-1-one
1	[pkg])
1	(glb,
1	(7-14
1	iba-1),
1	iba-1,
1	interleukin-33
1	(il-33)
1	cgmp/pkg/atp-sensitive
1	(eae,
1	0127:b8,
1	120μg/kg)
1	(7days
1	[p.i.]),
1	(20days
1	p.i.),
1	protein/mrna-expression
1	cns-infiltrating
1	severity;
1	(gfap
1	immunoreactivity).
1	lps-exposed
1	il-10-secreting
1	(nod)
1	25μg
1	white-matter
1	luxol
1	callosum,
1	t1-gadolinum
1	(t1-gd)
1	relapsing-progressive
1	genitourinary
1	rccs
1	es-based
1	(mrcc).
1	(vcam-1)
1	cd4-interferon
1	cd49b-tumor
1	(1.4-fold;
1	cd34/icam-1
1	(8.1-fold;
1	cd34/vcam-1
1	(1.6-fold;
1	mrcc
1	(mrcc)
1	treatment-resistant
1	bicistronic-treated
1	0.0016).
1	(ifn)γ-producing,
1	ifnγ-producing
1	(cd49b)
1	cell-modified
1	il-10+
1	il-27.
1	factor-beta;
1	nigricans.
1	nigricans,
1	nigricans
1	meningitis.
1	lyssavirus,
1	well-conserved
1	(v-3),
1	(v-2)
1	(v-m)
1	v-2
1	v-m.
1	proportional.
1	5hr
1	(rvgp)
1	(πrvgp)
1	(airmax,
1	(car-s,
1	car-r)
1	drifts,
1	(agv3)
1	(pv1
1	43/3).
1	43/4
1	agv3.
1	negri
1	(rrvgp)
1	schneider
1	(s2acrvgp)
1	(s2).
1	rrvgp.
1	(h-iva)
1	(l-iva)
1	anti-ova,
1	h-iva
1	l-iva,
1	glomerulonephritis.
1	(airmin
1	immunofluoriscence
1	macrophages/field,
1	potentialities
1	[l
1	iii×hiii]
1	overdominance
1	anti-lonomia
1	hiii,
1	variances
1	intraline
1	unselected
1	acrylamide-induced
1	cd131,
1	(il)-3,
1	all-trans
1	founding
1	schenckii.
1	cfu,
1	precociously
1	non-clearance
1	cachexy
1	(rsa).
1	labor;
1	trimester;
1	cd4‐specific
1	anti‐sheep
1	erythrocyle
1	co‐injection
1	non‐specific
1	cd3‐specific
1	moab.
1	antigen‐specific
1	protein‐primed
1	mab:
1	hiii.
1	salmonella-induced
1	liii,
1	microbeads
1	breedings,
1	"multispecific
1	effect,"
1	(iv-a)
1	(hiv-a
1	liv-a)f2
1	iv-a,
1	hév
1	lév
1	(ags)
1	immunogens.
1	"quantitative
1	responsiveness"
1	(polygenic
1	regulation).
1	catabolized
1	(salmonellae,
1	yersinia,
1	brucellae,
1	leishmania)
1	(pneumococcus,
1	trypanosoma).
1	potentialities,
1	selections.
1	elsevier.
1	pig's
1	(tlr8,
1	gamma-activated
1	(gbp1,
1	gbp2,
1	il15,
1	cd274)
1	(29.09%)
1	networks:
1	interleukin-15
1	compiles
1	presentation:
1	year-old
1	captive-born
1	(bison
1	bonasus)
1	inevitably
1	caseous
1	acid-alcohol
1	petragnani
1	stonebrink
1	wildlife-related
1	(27.4%),
1	(2.1%),
1	(19.5%)
1	of >98.0%
1	onca).
1	cardozo
1	caviae
1	chz306,
1	marine-derived
1	chitinases.
1	4.78
1	chitin-degrading
1	cervids.
1	dichotomus,
1	(foz
1	iguaçu,
1	serovars),
1	rhinotracheitis
1	foot-and-mouth
1	(15.6%),
1	serjoe
1	zoo.
1	settlement’s
1	bites;
1	59/132
1	haematoparvum’
1	both).
1	1/100
1	attempts.
1	>1
1	0.0014).
1	overexposure
1	4.37
1	hemoplasmosis.
1	[eperythrozoon
1	parvum]
1	domestic,
1	illinois.
1	rod-
1	bacteremia.
1	tiniest
1	cats:
1	shelter
1	(21.40%)
1	50/369
1	(13.55%)
1	turicensis’,
1	10/369
1	(2.71%),
1	8/369
1	(2.16%).
1	4/369
1	(1.08%),
1	turicensis’
1	5/369
1	(1.35%).
1	(0.81%)
1	income/social
1	marital
1	rural/urban
1	pinhais,
1	door-to-door
1	zero-inflated
1	(zinb)
1	13,555
1	30,380
1	(44.62%)
1	interviewed.
1	(62.43%)
1	(29.97%
1	19.71%,
1	ownership
1	(p=0.001)
1	ownership,
1	zinb
1	pets;
1	households.
1	indiana.
1	564,395
1	(hemoplasma),
1	haemocanis.
1	(63.7%)
1	(ani)
1	(vth),
1	neighborhood
1	case-by-case
1	253
1	vth.
1	dogs'
1	dog's
1	(leptospiremia)
1	(leptospiruria).
1	canicola,
1	20.0%,
1	8.4%
1	ccz,
1	(cbc),
1	(alanine
1	aminotrasferase
1	creatinine)
1	urinalysis
1	0.009),
1	glucosuria
1	(serology,
1	leptospiremia),
1	ccz.
1	leptospiruria,
1	inefficacy
1	haemolamae,"
1	red-cell
1	camelids.
1	756,845
1	39.3%
1	925
1	(cdss).
1	announce
1	650,228
1	g+c%
1	33.9.
1	geoffroyi),
1	jaguarundis
1	margays
1	wiedii),
1	(bela
1	sanctuary),
1	parań
1	(3.5)
1	seropositive:
1	cynopteri
1	(200).
1	captive-born,
1	5-yr-old
1	21-yr-old
1	illinois
1	919,992
1	reindeer;
1	coccoid,
1	bacillary,
1	ring-shaped
1	72-day-old
1	hemoplasma-infected
1	cbcs
1	nonclotted
1	does.
1	hemoplasma-specific
1	ovis-specific
1	fj824847)
1	(af338268),
1	nonregenerative
1	left-shift
1	unremarkable.
1	fawn.
1	uracil
1	cmp
1	70.6%
1	cdss.
1	"paralog
1	pool"
1	haemofelis.
1	27/31
1	21/22
1	nana;
1	4/6
1	dichotomus.
1	26/27
1	98.2-98.8%
1	(genbank,
1	af338268)
1	98.6-99.4%
1	(fj824847);
1	97.6%
1	uncultivatable
1	1,152,484
1	(38.8%
1	suis).
1	adaption
1	dichotomus
1	ozotocerus
1	46/64
1	4/
1	erythrocervae',
1	ehrlichia.
1	ewingii
1	mash
1	muris
1	eperythrozoonosis.
1	negatives
1	b64i/b64ii,
1	latex-agglutination
1	49/62
1	(34.7%)
1	(87.7%)
1	urine)
1	(38.8%)
1	azotemia,
1	(37.1%)
1	leukocytosis,
1	curve=
1	0.68).
1	hypoalbuminemia
1	leptospiremia,
1	considared
1	felidae
1	geoffroyi;
1	wiedii;
1	tigrinus;
1	sanctuary,
1	binacional,
1	38/57
1	(66.67%;
1	53.66-77.51%)
1	(71.43%).
1	(p≤
1	0.6892;
1	0.7528-1.66)
1	0.6267-24.052).
1	pre-frozen
1	non-domestic
1	haemomuris,
1	hydrochaeris).
1	coccoides-pcr
1	haemomuris.
1	farrow-to-finish
1	laminitis.
1	radiographed,
1	digit.
1	lateromedial
1	digit,
1	digits.
1	periosteal
1	buildings
1	doormen
1	residents.
1	apartments,
1	7429
1	surveyed.
1	13.05
1	86.38
1	neighbourhoods
1	curitiba.
1	haemotropic
1	haemoplasma
1	smear.
1	amplicon,
1	haemominutum'.
1	uneventfully.
1	esfm
1	(eperythrozoon
1	suis)
1	sows,
1	boars)
1	(18-2
1	(33-1
1	(p<0-05).
1	posttranscriptionally
1	sad)
1	8/group)
1	(lvw)
1	(rvw)
1	(anp),
1	alpha-skeletal
1	(α-skelectal),
1	(11.
1	0.3.
1	(6.8.
1	5.02.
1	0.21.
1	(5.1.
1	4.2.
1	0.12.
1	(3.8-fold
1	2.7-fold
1	rv,
1	3.35-fold
1	artery).
1	6-fold)
1	5-fold)
1	α-skelectal
1	(300%)
1	(546%).
1	balthazar,
1	schöwe,
1	cipolli,
1	viel.
1	dementia,
1	pdgfb-appswind
1	(tg-ee)
1	(wt-ee).
1	(tg-ctrl)
1	(wt-ctrl).
1	85.1%.
1	(sr-b1)
1	morzelle
1	(punica
1	granatum)
1	(ppe)
1	1-42
1	pumps.
1	(p.o.-
1	βa+ppe,
1	neurotrophin
1	ppe.
1	(tbi).
1	(stm
1	ltm).
1	ltm,
1	-hoe140
1	hoe140.
1	desarg
1	(2.3
1	37.5
1	tbi,
1	neurostimulation
1	(tg-pdgfb-appsw,ind).
1	(cg-tg(pdgfb-appswind)20lms/2j)
1	neurohistopathological
1	tangles.
1	b2r).
1	(wtaβ)
1	(kob2aβ)
1	(kob1aβ).
1	ofwtaβ,
1	wtaβ
1	kob1aβ,
1	kob2aβ.
1	glycogen-synthase-kinase
1	3-α
1	rationale,
1	300μg,
1	mini-mental
1	lifetime.
1	(2months
1	15months
1	(ee-15).
1	(sc-15).
1	17months
1	(ee-2).
1	(c-2).
1	ee-2
1	-80°c.
1	(20μm,
1	-18°c)
1	thaw-mounted
1	α4β2
1	ee-2,
1	α4β2,
1	rehearsal
1	(stimulated
1	s-aβ
1	(non-stimulated
1	n-saβ
1	n-sc),
1	(car)
1	n-saβ.
1	s-aβ,
1	saβ
1	methyllycaconitine,
1	kinins.
1	(i.c.v).
1	duality
1	kalikrein-kinin
1	(fmol/mg
1	laminas
1	(sp5)
1	(pa5).
1	(28.2%).
1	(21.9%)
1	(36.1%).
1	khz.
1	vocalization
1	tenor
1	speech-language
1	singers
1	notes,
1	"breakage"
1	singing
1	mo;
1	(3mo:
1	6mo:
1	0.6%;
1	12mo:
1	18mo:
1	12-month-old-wt
1	12-month-old-kob1
1	12-month-old-kob2
1	kob1
1	1-40
1	shuttle-box
1	(550
1	μl/h,
1	(t0),
1	(t7;
1	t35).
1	t0,
1	(cwt
1	6.7%;
1	ckob1
1	46.7
1	4.0%;
1	ckob2
1	64.4
1	5.8%)
1	(aβwt
1	3.0%;
1	66.8
1	8.2%;
1	58.7
1	5.9%)
1	t7,
1	(41.0
1	control-kob2
1	(72.8
1	2.2%,
1	t35,
1	aβwt
1	3.3%)
1	(41.2
1	10.7%)
1	14.0%)
1	t35.
1	(68.6
1	20.9%,
1	(90.8
1	4.1%;
1	[125i]hpp-[des-arg10]-hoe-140
1	(1.23
1	(1.31
1	(1.05
1	fmol/mg,
1	(1.26
1	([125i]hpp-hoe-140,
1	(2.04
1	meynert
1	(1.84
1	(1.66
1	(1.68
1	fmol/mg).
1	[125i]hpp-hoe-140
1	denervation-like
1	(4-month-old)
1	(20-month-old)
1	ε
1	extrajunctional
1	nondepolarizing
1	relaxants
1	cerebroventricular
1	arg-pro-pro,
1	kinin-processing
1	diathesis
1	selenium,
1	z-vad-fmk.
1	oxidants.
1	mechanisms;
1	secretor
1	(atms)
1	the jak2-stat3 and
1	the pi3k-akt-mtor pathways.
1	the low-grade systemic
1	caspase-9-dependent
1	znf142
1	on-off
1	on-phase
1	(dsb),
1	8-oxoguanine,
1	tyrosine-nitrosylation,
1	peroxinitrite.
1	-macrophage
1	znf142)
1	syed
1	pflimlin
1	hfds
1	minimal/no
1	supplier
1	immunorregulation.
1	anti-microbicidal
1	hydroxystearic
1	∼1.4-
1	3-fold.
1	chow-fed,
1	hfd-fed,
1	syed,
1	(dnl)
1	adipose-specific
1	(adchrebp
1	sucrose-induced
1	dnl
1	vijayakumar
1	jéssica
1	x/a-like
1	(ghs-r).
1	ghrelin,
1	(t2d).
1	(pahsas),
1	unmet
1	5-pahsa
1	(stool
1	hematochezia,
1	appearance),
1	paneth
1	gpr120.
1	gpr120-dependent.
1	inflammation-driven
1	contribute.
1	(ag4ox)
1	hydroxy-fatty
1	(fahfas),
1	hydroxy-stearic
1	isomer-specific
1	adipocyte-
1	rbp4-ox
1	ctla4-ig,
1	ctla4-ig
1	macrophage-induced
1	transthyretin
1	(ttr)
1	(rbp4)
1	(asos)
1	rbp4.
1	asos,
1	30-60%
1	hyperinsulinemiceuglycemic
1	45-60%
1	ttr-rbp4
1	lepr-deficient
1	(fahfas)
1	16-
1	palmitic-acid-9-hydroxy-stearic-acid,
1	9-pahsa).
1	gpr120
1	fahfas
1	cd206+
1	rbp4-activated
1	pre-b-cell
1	viewpoints
1	vdj
1	anti-nucleic
1	deoxythymidine.
1	v[formula:
1	text]
1	naive,
1	(bregs)
1	(cd40)/signal
1	bregs,
1	tolerance"
1	regulatory/inflammatory
1	(foxp3,
1	tgfbr1/
1	tbx21,
1	ifng)
1	renal-transplanted
1	(hi).
1	(reg)
1	tgfb
1	reg
1	reg/inflamma
1	repercussions.
1	leads,
1	tolerance."
1	transcription)
1	(ot),
1	(sta),
1	stat6,
1	nisin
1	bicelles
1	nisin/dioctadecyldimethylammonium
1	cana
1	(tccana2)
1	functionally.
1	canb.
1	mn2+/ni2+.
1	tccana2/canb
1	tccana/canb,
1	orrego
1	resealing
1	cavin
1	ca2+-triggered
1	sphingomyelinase,
1	resealing.
1	corrotte
1	(leishmania
1	iron-poor
1	(fesod)
1	mittra
1	cd200-fc.
1	cd200
1	self-healing
1	cd200-fc
1	cd200-dependent
1	(asm)
1	wounded,
1	parasite-containing
1	asm-dependent
1	ceramide-enriched
1	lysosomal-enriched
1	cell-invasion
1	requisite
1	(can),
1	tissue-culture
1	(tct)
1	(62-64%)
1	anti-phospho-serine/threonine
1	phosphorothioate
1	tccanb-cl,
1	tccanb
1	tccan
1	tccanb-cl
1	begun.
1	tm5,
1	melan-a,
1	(gst).
1	flipping
1	longer.
1	interact,
1	(tct),
1	1,4,5-triphosphate,
1	acidocalcisomes
1	prelude
1	glycoprteins
1	gp85
1	down-modulator
1	sterol-
1	sphingolipid-enriched
1	infectivities.
1	(mβcd)
1	mβcd
1	filipin
1	(ctx-b)
1	ctx-b
1	hematoxilin-eosin.
1	longer,
1	egima
1	59.1%
1	c03,
1	3f6.
1	5.4,
1	3f6-reactive
1	discrepancy.
1	f-actin-disrupting
1	latrunculin
1	f-actin.
1	disassembly,
1	ca2+-signaling
1	ca2+-signal-inducing
1	(j18)
1	gst-treated
1	∼6-fold
1	invasion-promoting
1	~threefold
1	peak),
1	587.
1	g82
1	587,
1	∼70:kda
1	pepsin.
1	2:h
1	shorter,
1	nh4cl,
1	internalisation
1	gp35/50.
1	non-virulence
1	gp82-expressing
1	gp30,
1	thapsigargin-sensitive
1	∼90
1	∼70%,
1	gp30.
1	metacyclic-stage-specific
1	gp35/50,
1	(spzs),
1	infectivity1–5,
1	‘dotty
1	death’
1	anti-repeat
1	inoculation-dependent
1	complement-
1	γ-independent
1	dotty
1	species-transcendent
1	spzs.
1	motor-dependent
1	stripping
1	pore-forming-like
1	membrane6.
1	moving7,
1	tissues7–9
1	apostólico,
1	lunardelli,
1	boscardin
1	rosa.
1	(hivbr8)
1	(αdechivbr8),
1	(pvaxhivbr8).
1	pvaxhivbr8
1	αdec
1	prime/dna
1	boost.
1	denv.
1	endocytose
1	naïve-t
1	neutralizing,
1	non-neutralizing
1	(cmi).
1	(gp140).
1	immunogenic/effective
1	utterly
1	trimer.
1	ifn-production
1	r848
1	prime-protein
1	adjuvant-antigen
1	kelly
1	licensing
1	threatening.
1	goal.
1	(rts,s/as01).
1	rts,s/as01,
1	formulated.
1	mg38,
1	dec-205
1	(αdec-csp),
1	(hc04)
1	150,000
1	(pfspz)
1	poly-iclc
1	live-attenuated
1	today.
1	promoter-enhanced
1	(eyfp)
1	histo-compatability
1	sinus.
1	subintimal
1	cd1d,
1	valves.
1	exo-erythrocytic
1	(irsp)
1	eefs.
1	non-cs
1	irsp
1	eefs,
1	transgenics
1	irsp.
1	hapten,
1	(4-hydroxy-3-nitrophenyl)
1	(np),
1	ova-np.
1	antihapten
1	anti-np
1	jem
1	(gp82)
1	glycosylated.
1	letting
1	(recurrent
1	remittent/rr,
1	progressive/pp
1	progressive/sp),
1	(edss)
1	il-18-mediate
1	hands,
1	(-511
1	>t)
1	-511c
1	>t
1	rs479333
1	>c
1	pre-eclampsia
1	pe.
1	c–c
1	leucocytes)
1	nkgc2
1	central-southeast
1	(156
1	genetic/ethnic
1	(rs333)
1	ccr5δ32.
1	(case/control
1	(relapsing
1	remitting
1	progressive)
1	(edss,
1	msss
1	index).
1	rr-ms
1	(hivc)
1	vaccinations,
1	polymorphisms’
1	pard3b,
1	ccl5)
1	activation/exhaustion
1	pd1,
1	il7ra,
1	eomes),
1	anti-viral
1	apobec3g,
1	ppia),
1	trials;
1	(ra)’s
1	casp1)
1	0.044,
1	1.77,
1	0.999)
1	(haq)
1	il1r
1	ra.
1	(dkd)
1	(t1d).
1	dkd,
1	rs11651270,
1	asthma-related
1	ros),
1	il1a
1	rs17561
1	bronchodilators.
1	nlrp1)
1	il1a,
1	il18).
1	entitled,
1	(w.c.
1	t.m.
1	oshiro,
1	d.c.
1	d.d.g.s.
1	festa
1	2016)
1	(rs6509365);
1	(rs1143643)
1	(rs5744256
1	rs1834481)
1	susceptibility/protection.
1	dc-it.
1	tsg101
1	(smm)
1	smm
1	stratification,
1	breslow
1	nevus.
1	smm.
1	inflammasome-related
1	nlrp6,
1	246/310).
1	rs1834481
1	hpv/host
1	virus/persistence
1	88:1646–1651,
1	(latent
1	tb)
1	hla,
1	nrpam1,
1	il10)
1	tb.recently,
1	tb.for
1	amazon.our
1	populations.these
1	nlrp3/nlrp12-dependent
1	malaria.157
1	mefv.
1	analysis.our
1	anaemia.polymorphisms
1	vivax/host
1	nlrp1-inflammasome.
1	pro-il1
1	"di
1	se"
1	sle-associated
1	nlrp1-inflammasome
1	juvenile-onset
1	(jsle)
1	90)
1	144).
1	jsle,
1	adult-
1	pro-il1ß
1	309
1	conlclusions:
1	(l155h)
1	1.58),
1	recognises
1	(il-1,
1	il-33)
1	g/g
1	0.012;
1	0.37).
1	stability;
1	exonic
1	infinium
1	humanexome
1	beadchip.
1	zcall
1	snp-centred
1	genabel
1	gene-centred
1	(cnot1)
1	(16q21),
1	0.00075).
1	rs7188697
1	0.0031;
1	33.00;
1	1.74-624.66),
1	(a/a
1	a/g+g/g
1	0.0009;
1	107.66;
1	3.85-3013.31),
1	weak/transient
1	responders,
1	tristetraprolin
1	(ttp).
1	(cnot1
1	ttp)
1	rs11884476
1	pard3b
1	over-dominant
1	(il4-dc)
1	(ifn-dc)
1	(hiv+).findings:
1	il4-dc.
1	unresponsive"
1	individuals.conclusions:
1	monocytes-dc
1	rs3135945
1	(al-hiv)
1	(au-hiv)
1	(nacht,
1	lrr
1	domains-containing
1	nlrp
1	patients.disease-associated
1	nlrp3),
1	(327
1	multibacillary,
1	paucibacillary,
1	(147.
1	64.
1	(leprosy
1	hc)
1	(mb
1	ethnicity.whereas
1	rs2137722/g-rs12150220/t-rs2670660/g
1	rs2137722/g-rs12150220/a-rs2670660/g
1	pb.nlrp1
1	leprosy:
1	(hiv+tb+)
1	polymoprhims
1	il1r,
1	hsp90)
1	recife,
1	pernambuco).
1	10-5),
1	polymoprhim.
1	coinfection,
1	(nlr
1	1/nlrp1,
1	3/nlrp3,
1	4/nlrc4)
1	protein/pycard
1	[lps]).
1	pycard,
1	(ctbs),
1	(dscs),
1	casp1
1	dscs.
1	decs.
1	induce,
1	inflammosome,
1	devolvement
1	n=276)
1	n=266).
1	(rs2137722,
1	rs34733791,
1	rs11657747,
1	rs11651595)
1	paulo)
1	rs12150220-rs2670660
1	a-g
1	nephritis,
1	vitiligo
1	(hc-dc)
1	(hiv-dc)
1	alditrithiol-2-inactivated
1	hc-dc,
1	ipaf/nlrc4
1	casp1-increased
1	il1b-increased
1	hiv-dc.
1	(jia),
1	(crd),
1	(hpf),
1	crd
1	neurologic,
1	neonatal-onset
1	(nomid),
1	subcloning
1	(69.2%).
1	35.8%
1	7.9%).
1	relatives;
1	nondescript
1	mosaicism.
1	genotype-matched
1	(mkd).
1	caspase-3-related
1	caspase-1-associated
1	(ftis)
1	ftis,
1	tipifarnib
1	(tip)
1	lonafarnib
1	(lon),
1	(lova)
1	(goh)
1	icl
1	ald-lova-raw
1	ftis.
1	objectives:celiac
1	nalp3/nlrp3
1	cd.methods:two
1	(rs12150220,
1	rs2670660)
1	(rs10754558,
1	rs35829419)
1	controls.results:the
1	(p=0.029;
1	(or)0.56).
1	(p=0.003;
1	or1.38),
1	(p=0.002;
1	or1.42).conclusions:we
1	cias1/nalp3/nlrp3
1	gastroenterology.
1	aminobisphosphonates
1	induced-inflammation
1	pamidronate
1	unpredictable.
1	[nuclear
1	(nr3c1)],
1	nacht
1	leucine-rich-repeat
1	(nalp1)
1	nalp3/nlrp3/cias1
1	disorders.we
1	(t1d,
1	=196),
1	(cd,
1	=165),
1	=192).our
1	=4exp-3)
1	rs358294199
1	=5exp-4)
1	caucasoid
1	ad.since
1	nonsterol-isoprenoids
1	mevalonate-derived
1	concatenation
1	ggpp.
1	(nalp1,
1	ipaf)
1	hyper-expression
1	decrement.
1	nalps-innate
1	response-could
1	135),
1	hiv+.
1	nalps
1	(mevalonate
1	mkd)
1	(aminobisphosphonates)
1	(goh),
1	farnesol
1	(foh),
1	(ggoh)
1	menthol
1	(moh),
1	by-pass
1	reconstituting
1	alendronate,
1	goh,
1	foh,
1	moh
1	non-sterol
1	geranylgeranylpyrophosphate
1	attacks.the
1	ggpp,
1	farnesyl-transferase
1	patients.the
1	(neis).manumycin
1	ald-treated
1	ald-monocytes
1	neis
1	pathway.in
1	neis,
1	mkd-monocytes,
1	dipeptide.
1	(dcs)-based
1	immuno-treatment
1	vaccine:
1	mbl2
1	rs10824792
1	rs693534.
1	(brazilians,
1	caucasian)
1	hiv-infected,
1	progressions.
1	histidine-rich,
1	ape,
1	hylobatidae
1	his1,
1	cercopithecus,
1	24-residue
1	antimicrobially
1	histatins,
1	nomascus
1	amphipathic,
1	criptococcus
1	hst5
1	mycoses,
1	asserted
1	muramyldipeptide.
1	isoprenoids-geraniol,
1	geranylgeraniol-was
1	alendronate-muramyldipeptide,
1	hepcidin/leap-1
1	gibbons,
1	old-world
1	hepcidin's
1	(ferroportin),
1	segat
1	/cryopyrin
1	sometimes,
1	cryopyrin.
1	interactor
1	cryopyrin,
1	anti-il1
1	(anakinra)
1	immunologic,
1	-842c
1	3.044,
1	1.42-6.52).
1	2.95,
1	1.31-6.82).
1	-52(g/a)
1	-44(c/g)
1	-20(g/a),
1	ll-37,
1	hylobatidae,
1	cercopithecidae,
1	callithricidae,
1	cebidae.
1	amphipathicity.
1	leaf-eating
1	rl-37
1	frog,
1	orangutan,
1	hylobates,
1	salt-dependent
1	andmayalso
1	(tnf)-induced
1	(traps)
1	tnf-mediated
1	traps.
1	single-nucieotide
1	(hbd-1)
1	perinatally
1	children),
1	(mdmm).
1	mdmm
1	lps-activation
1	neutrophil-mdmm
1	iglesia
1	(escs),
1	receive,
1	finely-tuned
1	trophectoderm
1	(pre).
1	(evs),
1	renewal
1	fate.
1	morphogens,
1	evs.
1	escs
1	spongiforsm
1	(tg20)
1	(gscs)
1	partner,
1	hsp70/90
1	(hop),
1	cd133,
1	cd15,
1	oct4,
1	sox2;
1	gscs.
1	stemness.
1	gbm,
1	gliomagenesis.
1	(y705),
1	(nn,
1	n = 12),
1	(n = 33),
1	(n = 12),
1	(n = 85)
1	nn.
1	nns.
1	(s727),
1	recurrence-free
1	phosphorylation-independent
1	(gbms)
1	crucial.
1	(hsp70)-hsp90-organizing
1	i-iii.
1	hop-prpc
1	phosphatidylinositide
1	extracellular-signal-regulated
1	(hop
1	230-245)
1	intratumor
1	embryonic,
1	hsp-90/70
1	(hop,
1	sti1)
1	prpc-organized
1	multicomplexes
1	warranting
1	dendrite
1	outgrowth,
1	rnd1
1	rnd1-plexin-a1-mediated
1	retraction.
1	rnd1-induced
1	18days
1	(d9,
1	d14,
1	d18,
1	d9,
1	d14
1	objects,
1	d9.
1	d18.
1	22-24days
1	hsp90,
1	irradiation-mediated
1	interactors.
1	interactors,
1	sub-nuclear
1	co-immunoprecipitate
1	sti.
1	sumoylation
1	sumoylated,
1	yeast-two
1	450-480
1	pias1.
1	co-opts
1	1/alpha7
1	(sti1/α7nachr)
1	laminin/type
1	(ln-γ1).
1	mglur1/5
1	ln-γ1,
1	(trpc)
1	α7nachr
1	axonogenesis.
1	prpcmultiprotein
1	fromlamininγ1
1	mglur1,
1	(prpc).
1	labeling,
1	20-50,
1	100-200,
1	300-400
1	rab5
1	rab7
1	(vps4a),
1	(mvbs),
1	evs,
1	mvbs
1	self-perpetuation
1	glycosylphosphatidylinositol,
1	γ1-chain
1	signalregulated
1	coimmunoprecipitation,
1	mglur1
1	-ln,
1	prions,
1	encephalopathies
1	(tses).
1	tses.
1	encephalophaties,
1	ancillary
1	approached.
1	process-bearing
1	adam23,
1	(gpi)-anchored
1	secretable
1	(saxs).
1	compaction
1	hop/sti1,
1	sti1-induced
1	prpc;
1	dynamin-dependent
1	sti1-dependent
1	prpc-vitronectin
1	105-119
1	307-320,
1	arg-gly-asp
1	prpc-knockout
1	(neural-cell
1	aversively
1	(stm)
1	(ltm)
1	intra-hippocampal
1	ltm.
1	106-126,
1	230-245,
1	106-126.
1	prpc-derived
1	(and)
1	amnesic
1	prpc-binding
1	ln,
1	ctsp-1,
1	ny-br-1.
1	169)
1	(59.0%)
1	(58.0%)
1	(57.0%)
1	141)
1	(20.8%),
1	(20.0%),
1	-interacting
1	(his
1	-sti1)
1	sti1-promoted
1	-sti1,
1	-sti1
1	misfolded,
1	β-sheet-rich
1	(prpsc),
1	δ32-121,
1	121).
1	rprpδ32-121,
1	fourier-transform
1	temperature-induced
1	rprps,
1	misfolding
1	(mtle-hs)
1	remediable
1	(prnp)
1	180).
1	(asn→ser),
1	heterozygosis
1	lobectomy
1	17.33,
1	91.8%
1	free,
1	sialoglycoprotein
1	-binding
1	hydropathy.
1	−7
1	inter-action
1	113-128
1	pharmaceutics.
1	endoplasmaic
1	ligand-based
1	membrane-anchored,
1	44.2
1	19.1 μm,
1	300 μm.
1	newlands
1	tyrosines.
1	necessity.
1	fis1
1	(dynamin
1	fission.
1	fis1,
1	dyn1,
1	dyn2.
1	p. falciparum,
1	mitotracker
1	cmx
1	ros)
1	(na)-based
1	acid-based
1	md,
1	(pxr)
1	hereby,
1	minimise
1	efficiencies;
1	pazopanib,
1	4.1 µm,
1	(lbd)
1	co-factors.
1	lbd.
1	pazopanib
1	co-repressor
1	co-activator.
1	docking,
1	pxr-regulated
1	lunev
1	(pf
1	mdh)
1	inter-oligomeric
1	substrate/cofactor
1	sub-millimolar
1	self-incorporate
1	deactivated
1	mutant:wild-type
1	recourse
1	effect—particularly
1	(pfatc)
1	t-state
1	liganded
1	r-state
1	2,3-napthalenediol,
1	2,3-napthalediol
1	2,3-napthalenediol.
1	farnesoid
1	(fxr)
1	anthranilic
1	(aads).
1	(q2loo,
1	q2(f2),
1	q2(f3)),
1	sd-based
1	residuals
1	aads.
1	copyright©
1	publishers;
1	queries,
1	email
1	epub@benthamscience.org.
1	currently.
1	pan-agonists.
1	(fibrates)
1	(glitazones),
1	agencies,
1	anymore
1	microbiologyopen
1	challenging—particularly
1	leverages
1	hindrance
1	(e-ntpdase),
1	di-phosphate
1	lifecycle
1	500 bp
1	e-ntpdase-gfp
1	dxs,
1	4-phosphate
1	anti-infectives
1	1-deoxy-xylulose-5-phosphate
1	druggable
1	triclosan.
1	aminopyridine
1	fabi.
1	holographic
1	(hqsar)
1	2pred
1	0.696
1	0.854,
1	maps.
1	untapped
1	(thiamin).
1	pro-drugs
1	(sathim;
1	2.7.1.50),
1	sathim
1	pyrimidine-biosynthesis
1	indirect)
1	dihydroorotate
1	(pfdhodh),
1	pyrimidine-synthesis
1	carbamoyl
1	n-carbamoyl-l-aspartate
1	(pfatc).
1	87.0,
1	103.8,
1	87.1
1	117.7,
1	90.0°.
1	pfatc.
1	evolutional
1	target’s
1	protein’s
1	soraya
1	bosch
1	diseases:
1	indispensable.
1	b6,
1	(odc,
1	polyamines),
1	(aspat,
1	biosynthesis),
1	hydroxymethyltransferase
1	(shmt,
1	thales
1	kronenberger
1	tropica)
1	b6-biosynthesis
1	(pfpdxk).
1	52.7,
1	62.0,
1	93.7å,
1	2å
1	permeases
1	produces,
1	eflornithine,
1	(mdr).
1	community-associated
1	mrsa.
1	expenses
1	co-factor,
1	dana
1	ditgen
1	outpace
1	retreat
1	helminth-associated
1	secretome-derived
1	helminth-derived
1	thiamine-related
1	pyrophosphate)
1	hypersensitizes
1	1,700-fold,
1	antimetabolite.
1	dehy-drogenase
1	antimetabolite
1	tena
1	(satena)
1	aminopyrimidine,
1	4-amino-5-hydroxy-methyl-2-methylpyrimidine
1	(hmp)
1	(thz),
1	tena,
1	multi-resistant
1	21.6%
1	homotetramer
1	p212121,
1	small-angle
1	(saxs)
1	oligonucleic
1	high-flux
1	flávia
1	zimbres
1	deaths;
1	destinations,
1	jasmin
1	lindner
1	prioritizes
1	chemotherapeutics,
1	biosyntheses,
1	drug-target
1	(folate)
1	(pyridoxine)
1	high-affinities
1	reiterative
1	5′-phosphate)
1	pfpdx1,
1	(d-ribose
1	5-phosphate)
1	(dl-glyceraldehyde
1	3-phosphate).
1	accommodates
1	formations,
1	plp.
1	(d-erythrose
1	4-phosphate)
1	phospho-sugar
1	e4p,
1	r5p,
1	hydrazide
1	(4-phospho-d-erythronhydrazide),
1	(1o2).
1	3-(p-aminophenyl)
1	restrictively
1	pixel-area
1	200-600
1	700-1,200
1	1,400-2,500
1	(ring
1	(schizont
1	anogeissus
1	muellerianus,
1	ellagic,
1	gentisic,
1	potently.
1	(ic50=10.8
1	khaya
1	(ic50=12.5
1	(ic50=2.88
1	(ic50=11.74
1	-40.1
1	2.88
1	11.74
1	muellerianus;
1	gentisic
1	leiocarpus;
1	(mdh)
1	(pfmdh)
1	pfmdh,
1	101,
1	tetramers,
1	pfmdh.
1	5′-phosphate),
1	2(singlet
1	live-cell
1	6-biosynthetic
1	pdx1/pf
1	pdx2-overexpressing
1	thim
1	[5-(hydroxyethyl)-4-methylthiazole
1	kinase;
1	2.7.1.50]
1	62.06,
1	62.40,
1	107.82
1	92.25,
1	91.37,
1	101.48°
1	protomers
1	b9.
1	simple-structured
1	supply,
1	between,
1	(tena)
1	aminopyrimidines,
1	4-amino-5-hydroxymethyl-2-methyl-
1	b1),
1	usng
1	orthorhombic,
1	p212121
1	103.5,
1	104.1,
1	109.6
1	matthews
1	(aspats;
1	(pfaspat)]
1	aspats,
1	exploits
1	glideosome-associated
1	(gap50),
1	diand
1	triphosphates
1	5-7.
1	gfp-fusions
1	(pfsap),
1	-ketoglutarate
1	(pfaspat)
1	(tena),
1	4-amino-5-hydroxymethyl-2-methylpyrimidine
1	(thid),
1	(thim)
1	epimerase
1	(tpk).
1	(selex),
1	highaffinity
1	selex)
1	aptamer
1	ligand-mediated
1	parasitederived
1	reporters,
1	rival
1	metallo-protein
1	binuclear
1	spin-coupled
1	co-ordination.
1	trimer;
1	host)
1	rmsd
1	inter-monomer
1	glu295
1	arg404,
1	independence
1	dodecameric
1	scattering,
1	ramachandran
1	stereo-chemical
1	dodecamer.
1	(plp),
1	pyridoxine/pyridoxal
1	pyridoxyl-amino
1	channelled
1	pdxk,
1	plp-dependent
1	pt3,
1	(ic50-value
1	non-cyclic
1	pyridoxyl-histidine
1	phme
1	plp-binding
1	(pfodc)
1	pyridoxyl
1	difluoromethylornithine
1	(dfmo)
1	convincing.
1	thenceforward
1	(adometdc/odc),
1	apicomplexen
1	(plp).
1	r85,
1	h88
1	e91
1	d26,
1	k83
1	(dkk),
1	rhe
1	nutant,
1	dkk
1	pdx1:pdx2
1	holoenzyme.
1	(tmp)
1	tmp
1	pyrophosphorylation
1	tpp.
1	vitamer
1	5′-phosphate.
1	antimalarials,
1	α-keto
1	(kadhs)
1	organelle-specific
1	octanoyl-[acyl
1	protein]:
1	n-octanoyltransferase
1	(lipb)
1	(lpla1).
1	lipb
1	(>90%).
1	sole,
1	apicoplast-located
1	lipoylation,
1	organelle.
1	targeted,
1	lipoate
1	(lpla2).
1	lpla2
1	günther
1	vitamer,
1	pyrophosphorylated
1	(tpk)
1	accepted.
1	tpks.
1	co-staining
1	pftpk
1	5-(2-hydroxy-ethyl)-4-methylthiazole
1	(thim),
1	4-amino-5-
1	hydroxymethyl-2-methylpyrimidine
1	(hmp)/
1	hmp-p
1	(thid)
1	pfthim
1	pfthid
1	thz
1	hmp.
1	pfthie
1	thie-negative
1	hmp
1	thiamine.
1	nova,
1	snz1-p
1	sno1-p,
1	auxotroph
1	(pdxk).
1	metalloproteins
1	agmatinase.
1	dissociation,
1	his-193-ala
1	his-233,
1	pfarginase.
1	ring/young
1	pfsod1,
1	(pfsod2)
1	35-fold
1	pfsod2.
1	α-kefo
1	(kadhcs).
1	lipa
1	lipb.
1	kadhcs.
1	kadhcs
1	hinge-linked
1	[p.
1	(s-adenosylmethionine
1	decarboxylase)/odc
1	decarboxylase)]
1	adometdc/odc
1	274
1	multiple-deletion
1	neighbouring,
1	reductase-thymidylate
1	[yuvaniyama,
1	chitnumsub,
1	kamchonwongpaisan,
1	vanichtanankul,
1	sirawaraporn,
1	taylor,
1	walkinshaw
1	yuthavong
1	struct.
1	357-365].
1	smallest,
1	non-globular
1	(icdh)
1	detectable;
1	d-isocitrate
1	cosmids
1	(86.6%)
1	pbelobac11
1	3168
1	(3.28
1	mb).
1	2304
1	(pf),
1	s-adenosyl-l-methionine
1	odc,
1	diamine.
1	polymerization,
1	pfodc/adometdc
1	(adometdc),
1	adometdc,
1	odc/adometdc.
1	(rpfodc).
1	(rpfhinge-odc).
1	161.5
1	rpfodc.
1	rpfodc
1	87.6
1	cgp52622a
1	cgp54619a,
1	frame,
1	pask
1	iba3
1	adometdc-
1	odc-
1	ewh331.
1	superdex
1	~333
1	~326
1	exploitable
1	metaplastic
1	supergranular
1	(mepsc)
1	de,
1	mepscs
1	scaling.
1	nmda-receptor-independent
1	agedependent
1	transductional
1	age-dependent,
1	v2),
1	(v1).
1	unspecified
1	(mglurs)
1	input-specific
1	involved),
1	mglurs.
1	metaplasticity,
1	(ltd)
1	spike-timing-dependent
1	butbythe
1	near-coincidental
1	postsynapticfiring.wefound
1	timing-dependent
1	firing.
1	synapse.
1	plasticity-induction
1	modulatory.
1	(prhc)
1	familiarity-based
1	bidirectionally
1	(ort).
1	ort
1	erk2
1	deficit;
1	reconsolidation
1	silingardi,
1	angelucci,
1	pasquale,
1	borsotti,
1	squitieri,
1	brambilla,
1	putignano,
1	pizzorusso
1	berardi.
1	v2).wefound
1	similar;
1	"driver")
1	"modulator").
1	(v1)
1	(gratings)
1	v1.
1	gratings
1	input/output
1	(mimicry).
1	ltp-like
1	occludes
1	(occlusion).
1	paradigmatic
1	(monocular
1	md)
1	sensory-motor
1	single-unit
1	md.
1	pcpa.
1	rejuvenates
1	reinstatement
1	reinstate
1	juvenile-like
1	(dlgn)
1	(vglut-2)
1	theta-burst
1	dlgn.
1	(veps)
1	vglut-1
1	(vgat),
1	excitation/inhibition
1	(std),
1	(iltd)
1	std
1	endocannabinoid-dependent
1	iltd
1	cortex.wefind
1	(md).
1	reinstates
1	electrophysiologically
1	behaviorally.
1	amblyopia
1	(amblyopia)
1	dominance.
1	extracellular-matrix
1	(planktonic
1	lifestyles)
1	mfs.
1	postantifungal
1	8.15
1	mfs-treated
1	irregularities,
1	anima
1	(d-amb)
1	poly-aggregated
1	(p-amb),
1	nonlipid
1	pamb
1	d-amb.
1	pulsed-therapy
1	p-amb,
1	pulsed-therapies
1	glutaraldehyde-based
1	cryofixation/freeze
1	freeze-substitution
1	emc
1	fullest,
1	structural/functional
1	10231
1	parapsilosis
1	22019.
1	spectrophotometry,
1	(dls).
1	(mfc)
1	agnps.
1	candidaemia,
1	echinocandins
1	glabrata.
1	caspofungin.
1	biofilm-derived
1	biofilm-related
1	tc70)
1	(disruption
1	thickness).
1	adamantylidene-substituted
1	(rvvc)
1	partners;
1	(flz)
1	chromagar
1	e-test.
1	duobushaemulonii,
1	glabrata,
1	8->
1	flz-resistant
1	flz-susceptible.
1	flz.
1	borba-santos,
1	visbal,
1	gagini,
1	lopes-bezerra,
1	rozental.
1	δ24-sterol
1	(24-smt)
1	22-hydrazone-imidazolin-2-yl-chol-5-ene-3β-ol
1	(h3)
1	(ergosterol
1	precursors)
1	14α-methylated
1	14a-methyl
1	electron-density,
1	microfibrillar
1	mitotracker®
1	cmxros
1	more)
1	luiz
1	10231)
1	violet-based
1	(amphotericin
1	fluconazole).
1	dumbbell-shaped
1	(psc),
1	voriconazole
1	(2011-2012)
1	earlier)
1	m38-a2
1	m27-a3
1	(recommended
1	institute).
1	(mfcs),
1	psc.
1	vrc
1	lymphocutaneous
1	cutaneous/lymphocutaneous
1	antimelanin
1	b-deoxycholate
1	(amb-d)
1	(itz),
1	(p.i.),
1	(amb-d/itz).
1	45-day
1	monodispersed
1	1.68
1	cryptococcus.
1	nonhospitalized
1	maringá,
1	93.1%
1	99.0,
1	67.0%
1	literature's
1	datas
1	tc106
1	tc117)
1	alkylphospholipid
1	(mfc),
1	alkylphospholipids
1	(38%-71%)
1	(32%-44%),
1	(24%-30%)
1	(15%-20%),
1	(51%-74%),
1	(24%-30%).
1	p<0.0001,
1	candidaemia
1	pulmonary,
1	(flc)
1	trb,
1	calcofluor
1	esterase,
1	(fssc)
1	(fosc).
1	multicelled
1	macroconidia
1	microconidia,
1	phialides,
1	chlamydospores.
1	kribbensis.
1	pronase
1	uplc/mass
1	1,014
1	chromatogram.
1	withdraw
1	kribbensis,
1	p450-dependent
1	c14α-demethylase
1	(cyp51),
1	parapsilopsis
1	strains.methods:
1	arylquinuclidines
1	parapsilopsis.
1	(3-[1'-{4'-(benzyloxy)-phenyl}]-quinuclidine-2-ene)
1	(wsp1267)
1	wsp1267
1	nuclei.conclusion:
1	quinuclidine-based
1	(bpq-oh,
1	e5700,
1	er-119884)
1	(flc),
1	(amb).
1	quinuclidine
1	28707,
1	flc,
1	ic90
1	incubation)
1	14-methylated
1	(c18:3),
1	(c18:2)
1	(c18:1)
1	prolife
1	(barbatimão)
1	adstringens.
1	750,
1	1500,
1	2250mgkg-1
1	5.0±0.8
1	(mean±s.d.),
1	9.1±1.7,
1	10.6±1.9
1	(mnpce).
1	21.0±3.8
1	mnpce.
1	antimutagenicity
1	750mgkg-1
1	cyclophosphamide;
1	8.7±1.4
1	1000mgl-1
1	8.7±0.6,
1	7.7±0.6,
1	5.7±1.2
1	(9.7±0.6).
1	leguminosae,
1	flavan-3-ols
1	prodelphinidins
1	prorobinetinidins.
1	anti-candidal
1	(subfraction
1	acapsular
1	(t1-444
1	28957)
1	f2.4.
1	b16f10mammalian
1	δ24(25)-sterol
1	(24-smti),
1	20-piperidin-2-yl-5α-pregnan-3β-20(r)-
1	diol
1	24(r,s),25-epiminolanosterol
1	(eil),
1	mic50
1	eil,
1	mic90
1	itraconazole-resistant.
1	(cna)
1	guilliermondii,
1	zeylanoides,
1	lipolytica,
1	24-smti,
1	cross-resistance.
1	krusei
1	6258,
1	flc-resistant)
1	aza,
1	eil.
1	cell-wall
1	disconnection
1	sulforhodamine
1	(clusiaceae),
1	"pau
1	santo"
1	"saco
1	boi"
1	1503.0
1	538.8
1	repeated-dose
1	correlations.
1	examinations,
1	'barbatimão'.
1	(csh),
1	germ-tube
1	nystatin
1	7.80
1	csh
1	prodelphinidin
1	prorobinetinidin
1	2114
1	tannins.
1	ocimum
1	phytotherapeutic
1	cloaking
1	(ifn)-
1	(isg)
1	tbk1
1	motors.
1	trafficked
1	berre
1	"viral
1	reservoirs"
1	replication-competent
1	immobile.
1	vccs,
1	virions,
1	overtime,
1	pack
1	overtime.
1	correlative
1	viruscontaining
1	(vccs)
1	stored.
1	vcc-limiting
1	kif3a+
1	vcc
1	kif3
1	paton
1	(2019)
1	atovaquone,
1	gametes,
1	labor-intensive
1	ookluc,
1	hts.
1	venture
1	ookluc
1	melo-filho,
1	cassiano,
1	cravo,
1	muratov,
1	calit,
1	urging
1	deoxyuridine
1	(pfdutpase)
1	combi-qsar
1	relationship)
1	2d-
1	3d-qsar
1	chembridge
1	(w2)
1	labmol-146
1	ookinete
1	hit-to-lead
1	surface-associated
1	(thrombospondin-related
1	in parasite
1	the malaria
1	merozoite-trap
1	(mtrap)
1	has been
1	mtrap-deficient
1	rodent-infecting
1	p. berghei
1	human-infecting
1	gamete-containing
1	motor-binding
1	egress.
1	expropriation
1	heretofore,
1	(trnas)
1	membrane-docking
1	structurespecific
1	protein-designated
1	trip
1	(trna
1	protein)-is
1	trip,
1	thatmultiplies
1	importing
1	translocon
1	(ptex)
1	(pexel).
1	mutatagenesis
1	exp2,
1	ptex.
1	exp2
1	hsp101,
1	ptex,
1	ama1.
1	rh-ama1
1	(rh-ama1<sup>ko</sup>)
1	amnis
1	ama1<sup>ko</sup>
1	mesothelial
1	rh-ama1<sup>ko</sup>
1	integrin-like
1	(pi-plc),
1	(ip3)
1	gliding,
1	pi-plc/ip3
1	invasin,
1	zoites.
1	1-rhoptry
1	apicomplexans.
1	vivo.©
1	(tj)
1	seconds.
1	ama1-ron
1	tj.
1	(tj),
1	glide.
1	(ron)
1	sporozoite.
1	tachyzoite,
1	zoite
1	zoite-cell
1	npt1,
1	gametocytogenesis
1	flp-frt
1	frt
1	sites)
1	(flp)
1	stage-specifically-called
1	'deleter'
1	flp
1	sporozoite-specific
1	igf1r/irs1
1	(all)and
1	(igf1r-irs1/2
1	inhibitor)and
1	(igf1r/ir
1	4-ebp1
1	cytostatic.
1	phosphatidylinositol-5-phosphate
1	4-kinase
1	(pip4k2)
1	(2013)
1	pip4k2b,
1	related-gene
1	(bmmsc)
1	kunitz-type2
1	(spint2/hai-2),
1	(hd).
1	aml)
1	5-azacitidine
1	mds-
1	hd-bmmsc
1	lentivirus.
1	hs-5
1	cd49b,
1	cd49d,
1	cd49e.
1	mds-bmmsc
1	(spint2)
1	(hgfa),
1	(hai)
1	pro-hgf
1	methylated,
1	silence
1	(kis)
1	u2af
1	sf3b155.
1	cd19+)
1	(cd34+)
1	megakaryocytic-,
1	monocytic-
1	granulocytic-induced
1	erythrocytic-induced
1	(mds),
1	factor-independent
1	jak2v617f-expressing
1	ba/f3
1	knock-in-induced
1	polycythemia
1	multitarget
1	mpn:
1	jak2/stat
1	haematology.
1	improperly
1	kinetochrore,
1	mad2l1,
1	anaphase-promoting
1	complex/cyclosome
1	(mad2l1-dependent
1	mechanism)
1	apparatus-related
1	(mad2l1-independent
1	mechanism).
1	rhoan19
1	rhocn19
1	(irs)
1	(canonical
1	(noncanonical
1	(irs1)
1	substrate-2
1	hematologic-related
1	(epor,
1	igf1r).
1	irs1/abl1
1	irs2/jak2
1	substrate-4
1	(irs4)
1	substrate-5
1	(dok4)
1	substrate-6
1	(dok5)
1	hematopoiesis-related
1	lymphoblasts
1	(igf1)
1	(irs1),
1	(osi-906).
1	phospho-igf1r
1	118:
1	1774–1781,
1	haematopoiesis
1	leukaemia.
1	(snp-a)
1	uniparental
1	disomy
1	(upd).
1	cytoscan
1	cytogenetics.
1	cytogenetics,
1	upds
1	(hck)
1	(ihck-37)
1	hck,
1	(sfk)
1	member,
1	early-stage
1	mapk/erk.
1	erythropoiesis
1	myelodysplasia-related
1	(mrc),
1	well-recognized
1	mds-msc
1	aml-msc
1	msc/t
1	aml-mrcderived
1	rpge2,
1	il32,
1	aml-mrc
1	bcr-abl1,
1	(aurka)
1	(aurkb)
1	reversine,
1	bcr-abl1+
1	catastrophe
1	scopim-ribeiro
1	(tet2),
1	(5-hmc)
1	mds/aml
1	oncotarget.
1	(fam64a)
1	calm
1	(picalm)
1	calm/af10.
1	xenotransplant
1	cats-silenced
1	gli-1.
1	(jak2v617f)
1	non-hematological
1	jak2/irs2
1	thrombocythemia
1	jak2wt.
1	jak2-mutated
1	(t-all)
1	nvp-bkm120,
1	pan-class
1	molt-4)
1	(daudi
1	namalwa)
1	4ebp1,
1	bax:bcl2
1	ankyrin-repeat
1	siva,
1	co-imunoprecipitation
1	siva/stathmin
1	vasp.
1	(ankyrin
1	tumourigenicity,
1	ankhd1.
1	u266
1	leptomycin
1	(lmb)
1	ptdins5p,
1	ptdins4,5p<inf>2</inf>.
1	≥5%
1	blasts.
1	(lowest
1	tertile
1	tertiles)
1	ferrata
1	storti
1	hemoglobinopathy;
1	specifically.
1	thromboembolic
1	d-dimer,
1	d-dimer
1	molecule-1)
1	osteonecrosis.
1	hypercoagulable
1	ruxolitinib-induced
1	phenocopy
1	microtubule-stabilizing
1	ruxolitinib;
1	tet2,
1	(tet)
1	(5-mc)
1	(5-hmc),
1	4q24
1	controversial;
1	64),
1	22).
1	classifications,
1	hippo
1	ccna2,
1	(hsc)
1	self-renewal.
1	(spint2),
1	(sdf-1)
1	spint2-knockdown
1	cd49e
1	microtubule-destabilizing
1	clonogenicity.
1	destabilizer
1	kinases)
1	globins.
1	members:
1	daughter.
1	imatinib,
1	dasatinib
1	pkc412
1	domaincontaining
1	α2γ2)
1	anemias,
1	β-thalassemia
1	(β-thal).
1	(hpfh)
1	hpfh
1	klf1,
1	switching,
1	mier1,
1	hook3.
1	newly-defined
1	ctla4.
1	gtpase-activating
1	(rhogaps)
1	rhogap
1	pc3,
1	arhgap21,
1	rho-gtpases.
1	rho-gtpases,
1	cdc42.
1	ofarhgap21in
1	redistributed
1	epithelialmesenchymal
1	α-tubulin,
1	rho-gap
1	acetylation.
1	ankhd1-shrna
1	(u266)
1	(mm1s)
1	mdm2/p53
1	(mds).
1	snp309,
1	snp309
1	musashi2/numb
1	erythropoiesis;
1	erythropoietin,
1	thrombopoietin;
1	myelodysplasia.
1	high-risk,
1	cytopenia
1	(hotspot
1	mutations)
1	(jak2),
1	fms-like
1	(flt3)
1	french-american-
1	ringed
1	sideroblasts,
1	blasts,
1	blasts
1	pi3k-akt/mtor
1	shrna-lentiviral
1	bax.
1	crkl
